1,Erythrocyte Mean Corpuscular Hemoglobin Test,5.703086693043039e-75,26.80658814869341,4582.66329744413,1.2581009244852944e-71,"HBS1L,DHRS13,THRB,TFRC,HFE,ZAN,ITSN1,UBE2L3,HK1,SCGN,DSTYK,AKAP10,CCND3,HMGN4,ACOXL,ALDH2,CDH1,MYB,LEPR,FBXO7,EPHB4,ZNF322,RAB8A,UBXN6,PLS1,MEF2C,USP49,ZBTB38,TFEB,WIPI2,BTN3A2,CPT1B,FRS3,GIGYF1,XRN1,TST,DNASE2,MAPT,KCTD17,HIST1H2BD,GCDH,UNC119B,NUP205,GYPA,TMPRSS6,MAX,NPRL3,TMEM72,SEZ6,GMPR,WDR61,LMF2,AK9,TYMP,GK5,SPTA1,PSMB5,TERT,ERI1,SERTAD2,EXOSC9,PRDM16,NPHP3,MLEC,SLC17A1,SH2B3,SLC17A3,MPST,DENND4A,BCL11A,TEX33,ARHGAP27,BYSL,RCL1,FIG4,SLC25A37,TF,KANSL1,TAF8,ZNF217,TMCC2,TRIM38,ANP32B,ALDH8A1,HIST1H4C,CPEB4,ATR",DisGeNET
2,Finding of Mean Corpuscular Hemoglobin,5.703086693043039e-75,26.80658814869341,4582.66329744413,1.2581009244852944e-71,"HBS1L,DHRS13,THRB,TFRC,HFE,ZAN,ITSN1,UBE2L3,HK1,SCGN,DSTYK,AKAP10,CCND3,HMGN4,ACOXL,ALDH2,CDH1,MYB,LEPR,FBXO7,EPHB4,ZNF322,RAB8A,UBXN6,PLS1,MEF2C,USP49,ZBTB38,TFEB,WIPI2,BTN3A2,CPT1B,FRS3,GIGYF1,XRN1,TST,DNASE2,MAPT,KCTD17,HIST1H2BD,GCDH,UNC119B,NUP205,GYPA,TMPRSS6,MAX,NPRL3,TMEM72,SEZ6,GMPR,WDR61,LMF2,AK9,TYMP,GK5,SPTA1,PSMB5,TERT,ERI1,SERTAD2,EXOSC9,PRDM16,NPHP3,MLEC,SLC17A1,SH2B3,SLC17A3,MPST,DENND4A,BCL11A,TEX33,ARHGAP27,BYSL,RCL1,FIG4,SLC25A37,TF,KANSL1,TAF8,ZNF217,TMCC2,TRIM38,ANP32B,ALDH8A1,HIST1H4C,CPEB4,ATR",DisGeNET
3,Mean corpuscular hemoglobin concentration determination,4.735421888351847e-46,54.07686453576864,5643.669424952986,6.964227123802783e-43,"GCDH,MACF1,HBS1L,THRB,TFRC,MAX,TMPRSS6,HFE,ZAN,NPRL3,GMPR,LMF2,UBE2L3,HK1,TYMP,SPTA1,SCGN,CCND3,ALDH2,MYB,SLC17A1,SLC12A7,SH2B3,ZNF322,SLC17A3,MPST,USP49,DENND4A,BCL11A,TEX33,TFEB,MYO9B,FRS3,BYSL,RCL1,SLC25A37,TF,TST,RSRP1,TMCC2,DNASE2,TRIM38",DisGeNET
4,Mean Corpuscular Volume (result),4.0390090902492994e-42,22.797038642109065,2172.8444443783383,4.4550270265449776e-39,"THRB,TFRC,TRRAP,HFE,ITSN1,UBE2L3,HK1,CCND3,ACOXL,ALDH2,CDH1,LEPR,SLC12A7,FBXO7,EPHB4,RAB8A,PLS1,MEF2C,USP49,NCOA4,H2AFV,ATP11A,WIPI2,KCTD17,GCDH,UNC119B,GYPA,TMPRSS6,MAX,NPRL3,GMPR,SPTA1,PSMB5,TERT,SERTAD2,EXOSC9,PRDM16,NPHP3,SLC17A1,MPST,BCL11A,DENND4A,MYO9B,RCL1,SLC25A37,TF,KANSL1,ZNF217,TMCC2,CPEB4",DisGeNET
5,Red cell distribution width determination,1.7004895238899248e-28,22.663028001898432,1449.1072443893447,1.2504266299003914e-25,"KANK2,HBS1L,THRB,CD82,TMPRSS6,ITSN1,PLD1,UBE2L3,HK1,TYMP,SPTA1,CCND3,PSMB5,SEC14L4,APOE,SLC12A7,AP1M2,GCKR,RRM1,BCL11A,GALNT2,PABPC4,MYO9B,ATP11A,TMC6,RCL1,MYO1D,SLC25A37,TF,DNAJA4,TMBIM1,RSRP1,CPEB4",DisGeNET
6,RDW - Red blood cell distribution width result,1.7004895238899248e-28,22.663028001898432,1449.1072443893447,1.2504266299003914e-25,"KANK2,HBS1L,THRB,CD82,TMPRSS6,ITSN1,PLD1,UBE2L3,HK1,TYMP,SPTA1,CCND3,PSMB5,SEC14L4,APOE,SLC12A7,AP1M2,GCKR,RRM1,BCL11A,GALNT2,PABPC4,MYO9B,ATP11A,TMC6,RCL1,MYO1D,SLC25A37,TF,DNAJA4,TMBIM1,RSRP1,CPEB4",DisGeNET
7,Reticulocyte count (procedure),4.05851902528871e-26,12.80593220338983,748.7166813631361,2.5580265627962556e-23,"KANK2,HBS1L,THRB,TFRC,TMPRSS6,UBXN2A,HFE,MAST2,NPRL3,GMPR,SPPL3,UBE2L3,HK1,SPTA1,HMGCL,CCND3,PSMB5,SLC22A16,CDH1,APOE,SH2B3,RBM38,GCKR,BCL11A,SMOX,TMC8,MYO9B,TMC6,ATP11A,WIPI2,RCL1,MYO1D,SLC25A37,KANSL1,DNAJA4,TMCC2,DNASE2,ANP32B,ATR",DisGeNET
8,Red Blood Cell Count measurement,6.867088519678828e-21,15.176042001500054,704.5863992425154,3.7871993186028735e-18,"HBS1L,THRB,MAX,HFE,ZAN,MAST2,NPRL3,HK1,CCND3,ACOXL,TERT,PSD4,MYB,PRDM16,SLC12A7,SH2B3,MEF2C,GCKR,USP49,DENND4A,BCL11A,ZBTB38,TMC6,RCL1,SLC25A37,TOX2,ZNF217,ANP32B",DisGeNET
9,Hemoglobin measurement,1.947776877156353e-10,9.990874337156246,223.3875805309257,9.548435091126477e-08,"MPST,THRB,DENND4A,BCL11A,TMPRSS6,HFE,NPRL3,GMPR,HK1,TYMP,SPTA1,RCL1,CCND3,ALDH2,PPARG,SH2B3",DisGeNET
10,Blood basophil count (lab test),6.1549854475409706e-09,5.395859424920128,102.01413685816753,2.615345956220205e-06,"BRD3,GCKR,NDFIP1,MAST2,KLF3,FADS2,AHI1,SPRED2,DSTYK,ACOXL,RAD50,BCL2L11,PTPRC,TERT,ARIH2,LEPR,NLRP3,BUD13,JAK2,SLC12A7,SH2B3",DisGeNET
11,Platelet Count measurement,6.520581486496431e-09,5.673299137590891,106.9320570698311,2.615345956220205e-06,"BRD3,TRABD,MEF2C,GYPA,GCKR,NDFIP1,GALNT2,HFE,MYO9B,HDAC7,RCL1,AKAP10,TERT,NLRP3,TMCC2,BUD13,APOE,JAK2,SH2B3,AP1M2",DisGeNET
12,Platelet hematocrit measurement,1.495553118074005e-08,6.045769487008661,108.93379082854081,5.498650297452092e-06,"TRABD,RTEL1-TNFRSF6B,HBS1L,MEF2C,GYPA,RTEL1,GCKR,NDFIP1,H2AFV,MYO9B,HDAC7,RCL1,FADS2,TERT,PRDM16,JAK2,SH2B3,AP1M2",DisGeNET
13,Ferritin measurement,1.8090767579590286e-08,27.72733469665985,494.3191550292487,6.139728197011718e-06,"TAGLN,TF,TMPRSS6,HFE,BUD13,PCSK7,SLC17A1,SIDT2",DisGeNET
14,High density lipoprotein measurement,2.05866917677575e-08,4.2304173232348905,74.8725528783494,6.487748862810436e-06,"FTO,MACF1,IL1RN,TOMM40,SNX13,LPL,UBE2L3,FADS2,CCND3,APOE,APOB,IL6R,PLTP,GCKR,ABCC2,GALNT2,PABPC4,DDB2,TLR1,MSRA,PIK3CA,IL2RB,PPARG,BUD13,SIDT2",DisGeNET
15,Uric acid measurement (procedure),5.399860274955747e-07,7.400073072707344,106.7958016032498,0.00015882789022069835,"SCGN,GCKR,SLC4A1AP,FNDC4,ALDH2,HFE,TRIM38,HIST1H4C,SLC17A1,GPN1,SH2B3,SLC17A3",DisGeNET
16,C-reactive protein measurement,5.825557162716291e-07,11.716153846153846,168.19524181521683,0.00016063973876190171,"FTO,FADS2,GCKR,TOMM40,PABPC4,LEPR,NLRP3,APOE,IL6R",DisGeNET
17,Eosinophil count procedure,6.609903445534785e-07,4.544303797468355,64.66329178515865,0.00016201607778721928,"BRD3,GCKR,NDFIP1,KLF3,RCL1,SPRED2,RAD50,BCL2L11,PTPRC,TERT,ARIH2,LEPR,NLRP3,PPARG,BUD13,JAK2,SLC12A7,SH2B3",DisGeNET
18,Eosinophil count result,6.609903445534785e-07,4.544303797468355,64.66329178515865,0.00016201607778721928,"BRD3,GCKR,NDFIP1,KLF3,RCL1,SPRED2,RAD50,BCL2L11,PTPRC,TERT,ARIH2,LEPR,NLRP3,PPARG,BUD13,JAK2,SLC12A7,SH2B3",DisGeNET
19,"Myeloid Leukemia, Chronic",9.952311681956189e-07,2.61089863448354,36.08337836986312,0.00023110315337258267,"BLK,CEBPA,RTEL1,GYPA,IL1RN,TFRC,MPG,CITED2,EPAS1,PDCD5,ADAR,ETS2,SPRED2,CCND3,BCL2L11,CCND2,TERT,CDH1,PRDM16,MYB,LEPR,JAK2,SH2B3,CTSB,HSPA8,PTPN1,PDGFRA,ASXL1,AHI1,KITLG,DOK2,PIK3CA,AXL,KIT,HIST1H4H,PPARG,HIST1H4J,HIST1H4C",DisGeNET
20,Lipids measurement,1.665818663935761e-06,16.73841449070807,222.70784979695748,0.00036747959726422883,"GCKR,TOMM40,DOCK7,LPL,APOE,APOB,PLTP",DisGeNET
21,Leukemogenesis,1.8680176833988803e-06,2.686440129449838,35.435845157042,0.0003924616199598029,"CEBPA,RTEL1,IL1RN,TFRC,EPAS1,PCSK7,ETS2,BCL2L11,TERT,CDH1,PRDM16,MYB,LEPR,LONP1,JAK2,SH2B3,FBXO7,HBZ,PTPN1,PDGFRA,MAP3K1,GADD45A,BCL11A,RHOA,ASXL1,AHI1,PTPRC,PIK3CA,AXL,PRC1,KIT,ANP32B,TRIB1,ATR",DisGeNET
22,Neutrophil count (procedure),3.2441186589620013e-06,6.080544980965739,76.84998224682451,0.000650593251060925,"BRD3,FADS2,AHI1,IL1RN,GCKR,NDFIP1,TERT,MAST2,LEPR,NLRP3,SLC12A7,SH2B3",DisGeNET
23,Dyslipoproteinemias,3.863115329804982e-06,20.66869918699187,257.61542354908426,0.0007410462971782427,"LEPR,LPL,PPARG,APOE,APOB,PLTP",DisGeNET
24,Metabolic Syndrome X,4.8699107035247955e-06,2.846415537823962,34.81859292722434,0.0008614837315083528,"FTO,CEBPA,IL1RN,TOMM40,MAX,HFE,LPL,FADS2,ALDH2,LEPR,NLRP3,APOE,APOB,IL6R,PTPN1,GCKR,GALNT2,BTN2A1,TFEB,GPN1,CPT1B,SIRT3,SLC25A37,AHI1,PIK3CA,PPARG,BUD13,ZNF410",DisGeNET
25,Transferrin measurement,4.881480799571356e-06,123.35757575757576,1508.6707924799618,0.0008614837315083528,"FADS2,TF,TMPRSS6,HFE",DisGeNET
26,Triglycerides measurement,5.537159505223484e-06,3.2988744432406403,39.92967164260243,0.0009396133745017696,"FTO,TAGLN,MEF2C,GCKR,TOMM40,GALNT2,DOCK7,LPL,PCSK7,GPN1,MRPL33,FADS2,MSRA,PIK3CA,IL2RB,LEPR,BUD13,APOE,APOB,TRIB1,PLTP,SIDT2",DisGeNET
27,Fatty Liver,6.745404876751055e-06,3.156576459710473,37.58424808601307,0.0011022491228231724,"CEBPA,GCKR,ABCC2,TFRC,EPAS1,HFE,LPL,CPT1B,SIRT3,HADHA,FADS2,MSRA,TF,ALDH2,PIK3CA,LEPR,NLRP3,DNASE2,PPARG,APOE,APOB,PLTP,CTSB",DisGeNET
28,Thalassemia,5.238721661165353e-05,7.111656441717791,70.09851624846729,0.007796223849724224,"HBZ,TFRC,TMPRSS6,BCL11A,HFE,NPRL3,APOE,JAK2",DisGeNET
29,alpha^+^ Thalassemia,5.238721661165353e-05,7.111656441717791,70.09851624846729,0.007796223849724224,"HBS1L,HBZ,TFRC,BCL11A,MYB,NPRL3,ZNF410,ATR",DisGeNET
30,Systemic arterial pressure,6.0081740418478864e-05,5.969165302782324,58.019120264147965,0.007796223849724224,"MSRA,GCKR,KLF13,PRC1,HFE,DLG5,MYO9B,BUD13,SH2B3",DisGeNET
31,Blood Pressure,6.0081740418478864e-05,5.969165302782324,58.019120264147965,0.007796223849724224,"MSRA,GCKR,KLF13,PRC1,HFE,DLG5,MYO9B,BUD13,SH2B3",DisGeNET
32,Blood pressure finding,6.0081740418478864e-05,5.969165302782324,58.019120264147965,0.007796223849724224,"MSRA,GCKR,KLF13,PRC1,HFE,DLG5,MYO9B,BUD13,SH2B3",DisGeNET
33,Serum iron measurement,6.332956811216239e-05,30.830303030303032,298.0414175833727,0.007796223849724224,"SCGN,TF,TMPRSS6,HFE",DisGeNET
34,Transferrin saturation measurement,6.332956811216239e-05,30.830303030303032,298.0414175833727,0.007796223849724224,"FIG4,TF,TMPRSS6,HFE",DisGeNET
35,Unsaturated iron binding capacity measurement,6.332956811216239e-05,30.830303030303032,298.0414175833727,0.007796223849724224,"FIG4,TF,TMPRSS6,HFE",DisGeNET
36,Acute Erythroblastic Leukemia,6.361379387807617e-05,3.794935344827586,36.66924671639656,0.007796223849724224,"NFE2,HBZ,GYPA,KLF13,TFRC,ETS2,TF,PIK3CA,MYB,KIT,PPARG,JAK2,RAB8A,ZNF410",DisGeNET
37,Cholesteryl Ester Transfer Protein Deficiency,7.256528337475818e-05,15.45288753799392,147.28184108117077,0.008652919736471166,"GALNT2,LPL,APOE,APOB,PLTP",DisGeNET
38,Chronic myeloproliferative disorder,7.66638973585995e-05,3.5245403078650632,33.398824721403685,0.008901081977530027,"NFE2,PDGFRA,CEBPA,TFRC,HFE,ASXL1,KITLG,PTPRC,TERT,PIK3CA,BLOC1S2,MYB,KIT,JAK2,SH2B3",DisGeNET
39,Non-alcoholic Fatty Liver Disease,9.203270013317015e-05,3.043356122656197,28.28302416605126,0.010411494179167863,"CEBPA,PTPN1,GCKR,ABCC2,TMPRSS6,HFE,LPL,TLR1,SAMM50,TERT,ALDH2,LEPR,NLRP3,PPARG,APOE,TRIB1,APOB,JAK2",DisGeNET
40,Thalassemia Intermedia,0.00010281503471334591,14.046697982868196,128.98491340498938,0.011014586077705427,"NFE2,TFRC,BCL11A,HFE,MYB",DisGeNET
41,Aspartate aminotransferase measurement,0.00010281503471334591,14.046697982868196,128.98491340498938,0.011014586077705427,"GCKR,TOMM40,HFE,LPL,APOB",DisGeNET
42,Granulocyte count,0.00010485326728550043,5.498823529411765,50.38543757811749,0.011014586077705427,"AHI1,GCKR,NDFIP1,TERT,MAST2,LEPR,NLRP3,SLC12A7,SH2B3",DisGeNET
43,Myocardial Ischemia,0.00011382799172821687,2.585811186983741,23.481291356410548,0.011679281383834717,"IL1RN,GCKR,TFRC,DUSP1,HFE,LPL,PLD1,CPT1B,TYMP,HK1,HADHA,KITLG,PSMB5,CCND2,ALDH2,PIK3CA,KIT,LONP1,PPARG,APOE,APOB,JAK2,TRIB1",DisGeNET
44,Acral Lentiginous Malignant Melanoma,0.00012418164855074857,92.23867069486406,829.5729425886379,0.011910639856650059,"TERT,SNIP1,PLD1",DisGeNET
45,Hematocrit increased,0.00012418164855074857,92.23867069486406,829.5729425886379,0.011910639856650059,"EPAS1,JAK2,SH2B3",DisGeNET
46,Hemoglobin increased,0.00012418164855074857,92.23867069486406,829.5729425886379,0.011910639856650059,"EPAS1,JAK2,SH2B3",DisGeNET
47,response to statin,0.00014188388628955093,12.874873353596758,114.07783513886903,0.013318972474670185,"GCKR,LPL,BUD13,APOE,GPN1",DisGeNET
48,Carcinoma of lung,0.00014619660667802628,1.7125112326959608,15.122430144531618,0.013437904763821916,"IL1RN,TFRC,CD82,MPG,HFE,PDCD5,ADAR,ETS2,HK1,SCGN,LAPTM4B,FADS2,CCND3,CCND2,SLC22A16,ALDH2,CDH1,PSD4,LEPR,LONP1,SNIP1,JAK2,IL6R,EPHB4,ZNF322,CTSB,MAP2K2,ABCC2,BTN3A1,DUSP1,TRPC1,TFEB,ATP11A,RHOA,DDB2,TLR1,HADHA,TOX2,DOK2,PIK3CA,KIT,PPARG,FTO,CEBPA,NUP205,TAGLN,GYPA,TOMM40,EPAS1,TYMP,BCL2L11,TERT,APOE,APOB,SH2B3,HSPA8,RRM1,MAP3K1,GADD45A,IL37,BTN2A1,MYO9B,QKI,ASXL1,KITLG,AXL,TDP2,ATR",DisGeNET
49,beta Thalassemia,0.0001543975830742845,5.191794871794872,45.56308574810084,0.013902084418851905,"SPTA1,HBS1L,TFRC,TERT,BCL11A,TMPRSS6,HFE,MYB,APOE",DisGeNET
50,Hematopoietic Neoplasms,0.00016523160759246235,3.639797507788162,31.695947749709195,0.014580037053958876,"PDGFRA,ABCC2,TFRC,BCL11A,CCND2,TERT,PIK3CA,MYB,KIT,LEPR,LONP1,PPARG,JAK2",DisGeNET
51,Blast Phase,0.00017833839668404333,3.4080910852713178,29.418055059592223,0.015428019728823515,"CEBPA,PTPN1,GYPA,ADAR,RHOA,ETS2,ASXL1,CCND2,CDH1,MYB,KIT,LEPR,JAK2,SH2B3",DisGeNET
52,Steatohepatitis,0.00020264032254591315,2.4240860215053766,20.61461650996907,0.017193251982164783,"CEBPA,GCKR,THRB,TFRC,EPAS1,HFE,NSMCE2,LPL,CPT1B,SIRT3,TYMP,HADHA,FADS2,MSRA,TF,SAMM50,ALDH2,PIK3CA,LEPR,NLRP3,DNASE2,PPARG,APOE,APOB",DisGeNET
53,Aortic Valve Stenosis,0.00020919735459318443,4.45679012345679,37.75896200128088,0.017414692989908106,"FTO,SNIP1,NPHP3,PPARG,APOE,APOB,JARID2,IL6R,PLTP,KLF3",DisGeNET
54,Acute pancreatitis,0.00022210247878014184,4.917085020242915,41.36434670595085,0.017662440181580075,"IL1RN,PTPRC,ALDH2,NSMCE2,KIT,MYO9B,APOE,JAK2,CTSB",DisGeNET
55,"Leukemia, Myelocytic, Acute",0.0002270335349593632,1.7995291859715412,15.09879275247158,0.017662440181580075,"IL1RN,TFRC,CD82,MPG,CITED2,SPO11,HFE,PPP2R2A,PCSK7,ETS2,CCND3,CCND2,SLC22A16,CDH1,MYB,LEPR,LONP1,JARID2,JAK2,IL6R,CTSB,PDGFRA,MEF2C,ABCC2,DUSP1,NSMCE2,ZFP91,WIPI2,ELF1,PIK3CA,KIT,PPARG,TRIB1,CEBPA,RTEL1,GYPA,EPAS1,CEBPG,BCL2L11,TERT,PRDM16,SH2B3,PTPN1,RRM1,BCL11A,ASXL1,KITLG,PTPRC,AXL,PRC1,IL2RB,ATR",DisGeNET
56,Hodgkin Disease,0.00022922781172326579,2.355374274717068,19.73990714961834,0.017662440181580075,"HBS1L,RTEL1,TFRC,HFE,LPL,ACOXL,BCL2L11,CCND2,MYB,LONP1,APOE,JAK2,IL6R,PTPN1,PDGFRA,DUSP1,BCL11A,ASXL1,TLR1,AHI1,PTPRC,PIK3CA,KIT,IL2RB,ANP32B",DisGeNET
57,hypopigmented skin patch,0.00023175408643573702,6.580947085534241,55.08143283081537,0.017662440181580075,"RTEL1,KITLG,TERT,KIT,TMC8,TMC6,DDB2",DisGeNET
58,Lung Neoplasms,0.00023700228745376234,1.9462943071965628,16.246576440914943,0.017662440181580075,"CEBPA,RTEL1,IL1RN,THRB,TFRC,MAX,CEBPG,LPL,TYMP,HK1,BCL2L11,CCND2,ALDH2,TERT,CDH1,APOE,JAK2,EPHB4,CTSB,HSPA8,PDGFRA,RRM1,MAP3K1,MAP2K2,ABCC2,GADD45A,IL37,DUSP1,MYO9B,RHOA,HADHA,TOX2,TF,KITLG,DOK2,PIK3CA,KIT,SERPING1,PPARG,SIDT2",DisGeNET
59,leukemia,0.00023881138412495294,1.7515975572725127,14.60803725085308,0.017662440181580075,"IL1RN,THRB,TFRC,CD82,MPG,HFE,PDCD5,ADAR,ETS2,SMPD2,CCND3,CCND2,SLC22A16,CDH1,MYB,LEPR,LONP1,JAK2,IL6R,EPHB4,RAB8A,PDGFRA,MEF2C,ABCC2,DUSP1,DOK2,PIK3CA,KIT,PPARG,TRIB1,TRABD,CEBPA,RTEL1,GYPA,EPAS1,HSD17B13,HDAC7,PSMB5,BCL2L11,TERT,PRDM16,APOE,SH2B3,GADD45A,BCL11A,ASXL1,AHI1,RAD50,TF,KITLG,PTPRC,AXL,PRC1,IL2RB,ZNF217,ANP32B,ATR",DisGeNET
60,Nasopharyngeal Neoplasms,0.00024289672439518534,5.525835037491479,45.99082990817145,0.017662440181580075,"RTEL1-TNFRSF6B,ACOXL,RTEL1,KITLG,ALDH2,PIK3CA,TERT,CDH1",DisGeNET
61,Ovarian Carcinoma,0.0002441996489293709,1.71346911149397,14.251821201625772,0.017662440181580075,"IL1RN,TFRC,CD82,MPG,CITED2,SPPL3,ETS2,LAPTM4B,ACOXL,CCND2,ALDH2,CDH1,PSD4,LEPR,JARID2,JAK2,IL6R,EPHB4,CTSB,PDGFRA,MAP2K2,ABCC2,BTN3A1,DUSP1,TRPC1,NCOA4,ATP11B,BTN3A2,RHOA,DDB2,TLR1,DOK2,ALDH5A1,PIK3CA,KIT,PPARG,MAPT,EPAS1,HSD17B13,TYMP,HDAC7,BCL2L11,TERT,APOE,SH2B3,RBM38,CD164,PTPN1,MAP3K1,GADD45A,SLC25A37,RAD50,KITLG,PTPRC,AXL,ZNF217,HIST1H4H,RPL22L1,HIST1H4J,HIST1H4C,MUC20,ATR",DisGeNET
62,Vitiligo,0.00028481762457537377,3.423309510720176,27.94674004257858,0.020267989671395953,"NFE2,PDGFRA,TRPC1,MSRA,FADS2,DSTYK,KITLG,PTPRC,CDH1,KIT,APOE,SH2B3,ZNF410",DisGeNET
63,Anemia,0.0002954579425035625,2.519532384548359,20.47619952233683,0.020575788186751917,"NFE2,RTEL1,IL1RN,TFRC,TMPRSS6,EPAS1,BCL11A,HFE,AK3,HK1,TLR1,SPTA1,SLC25A37,AHI1,TF,TERT,KIT,NLRP3,FLOT2,DNASE2,JAK2",DisGeNET
64,Soluble Transferrin Receptor Measurement,0.000303133778816608,46.11480362537765,373.59153422151684,0.020575788186751917,"TMPRSS6,PCSK7,SIDT2",DisGeNET
65,Iron Metabolism Disorders,0.000303133778816608,46.11480362537765,373.59153422151684,0.020575788186751917,"TFRC,TMPRSS6,HFE",DisGeNET
66,alpha-Thalassemia,0.0003175809956479513,6.203669724770642,49.96918035725459,0.021229808375738804,"HBS1L,HBZ,TFRC,BCL11A,MYB,NPRL3,ATR",DisGeNET
67,Congenital anemia,0.00038064066467419287,3.774946415813289,29.72262483527886,0.02506547182899312,"SPTA1,ASXL1,HBZ,PDGFRA,CEBPA,RTEL1,RPS28,TMPRSS6,KIT,JAK2,HK1",DisGeNET
68,Crohn Disease,0.0003890405351102803,2.046661643600217,16.070033186662688,0.02524186530744936,"IL1RN,MPG,DOCK7,LPL,UBE2L3,HDAC7,FADS2,CCND3,CDH1,NLRP3,APOE,JAK2,SH2B3,IL6R,EPHB4,NKX2-3,RTEL1-TNFRSF6B,GCKR,NDFIP1,MAP3K1,IL37,GALNT2,ZBTB38,MYO9B,RHOA,TLR1,ELF1,PTPRC,DLG5,TMBIM1,PPARG,CPEB4",DisGeNET
69,Beta thalassemia intermedia,0.0004047313640015722,15.409090909090908,120.38024074036545,0.025748314508420085,"HBS1L,TFRC,TMPRSS6,MYB",DisGeNET
70,Carcinogenesis,0.0004088691331019303,1.53601890542592,11.98419678910641,0.025748314508420085,"IL1RN,TFRC,CD82,MPG,TRRAP,HFE,ITSN1,PPP2R2A,ICAM5,ETS2,LAPTM4B,CCND3,HMGN4,CCND2,CDH1,MYB,LEPR,LONP1,SNIP1,IL6R,EPHB4,ZNF322,PDGFRA,MAP2K2,DOK2,TRIB1,FTO,RTEL1,GYPA,MAX,EPAS1,PLD1,SPTA1,ARHGAP21,BCL2L11,LARP1,TERT,ZKSCAN3,NLRP3,APOE,NKX2-3,CD164,GADD45A,TNK2,QKI,MFHAS1,AHI1,PTPRC,TDP2,DLG5,TRIP6,HIST1H4H,HIST1H4J,ANP32B,HIST1H4C,CNOT8,MUC20,ATR,THRB,CITED2,ADAR,HK1,ALDH2,PSD4,FLOT2,JAK2,CTSB,BRD3,ABCC2,DUSP1,NCOA4,TFEB,WIPI2,RHOA,DDB2,SIRT3,TLR1,TOX2,PIK3CA,KIT,PPARG,KANK2,CEBPA,TAGLN,SERTAD2,P4HTM,RBM38,PTPN1,RRM1,SMOX,BYSL,RAD50,KITLG,AXL,DNAJA4,PRC1,TAF8,ZNF217",DisGeNET
71,Lymphocyte Count measurement,0.0004177516354092056,4.048821548821548,31.502355991651942,0.025748314508420085,"SPTA1,GCKR,ACOXL,ELF1,PTPRC,ZBTB38,SH2B3,KLF3,UBE2L3,HDAC7",DisGeNET
72,Lipoidosis,0.000420190082639675,9.652355623100304,75.04516704000488,0.025748314508420085,"FADS2,TAGLN,FNDC4,LPL,PPARG",DisGeNET
73,"HEMOCHROMATOSIS, TYPE 1",0.0004428927778560465,7.142589118198874,55.156379219272544,0.026767711450696948,"TF,TFRC,ALDH2,TMPRSS6,HFE,APOE",DisGeNET
74,Hematocrit procedure,0.00047946241194676527,4.37625,33.447000679882436,0.028586326506880113,"FTO,GCKR,TMPRSS6,HFE,NPRL3,PRDM16,PPARG,SH2B3,HK1",DisGeNET
75,Inflammatory Bowel Diseases,0.0005371045602900121,2.004535970244035,15.09278830238461,0.031318498344354025,"FTO,IL1RN,MAST3,LPL,TM9SF4,UBE2L3,HDAC7,FADS2,CCND3,TERT,NLRP3,APOE,JAK2,SH2B3,IL6R,EPHB4,NKX2-3,RTEL1-TNFRSF6B,GCKR,NDFIP1,IL37,MYO9B,ZFP90,TLR1,PTPRC,FNDC4,DLG5,IL2RB,TMBIM1,PPARG,ZNF410,CPEB4",DisGeNET
76,T-Cell Lymphoma,0.0005394845589689269,2.7789707773028947,20.911467183043708,0.031318498344354025,"PDGFRA,RTEL1,GADD45A,RHOA,TF,CCND3,CCND2,BCL2L11,TERT,KIT,IL2RB,LONP1,PPARG,JAK2,FBXO7,ATR",DisGeNET
77,Mastocytosis,0.0005651197113406113,5.565200345016859,41.619200357194956,0.0314683462691378,"ASXL1,PDGFRA,KITLG,MPG,KIT,JAK2,IL6R",DisGeNET
78,Malignant Neoplasms,0.0005691909930087212,1.8130754445624269,13.546020625730636,0.0314683462691378,"FTO,MACF1,CD82,CITED2,MAX,EPAS1,HFE,ADAR,HSD17B13,ETS2,LAPTM4B,CCND3,CCND2,ALDH2,TERT,CDH1,MYB,LONP1,FLOT2,APOB,JARID2,JAK2,RAB8A,RBM38,CD164,GCKR,TNK2,GPN1,RHOA,SIRT3,ASXL1,TLR1,RAD50,TF,PIK3CA,AXL,PRC1,KIT,TAF8,PPARG,TRIB1,CPEB4,ATR",DisGeNET
79,Ethylmalonic encephalopathy,0.0005700452404067419,13.695622895622895,102.3034931151118,0.0314683462691378,"HBS1L,BCL11A,MYB,TYMP",DisGeNET
80,Carney Triad,0.0005919929148545868,30.740181268882175,228.46151569186478,0.0314683462691378,"PDGFRA,EPAS1,KIT",DisGeNET
81,HYPERALPHALIPOPROTEINEMIA 1,0.0005919929148545868,30.740181268882175,228.46151569186478,0.0314683462691378,"APOE,APOB,PLTP",DisGeNET
82,NADH cytochrome B5 reductase deficiency,0.0005919929148545868,30.740181268882175,228.46151569186478,0.0314683462691378,"LPL,PPARG,APOE",DisGeNET
83,Primary acquired melanosis,0.0005919929148545868,30.740181268882175,228.46151569186478,0.0314683462691378,"PIK3CA,TERT,KIT",DisGeNET
84,ovarian neoplasm,0.0006003097342315558,1.9683178975110898,14.60110973480265,0.03153055413606696,"IL1RN,THRB,CD82,ETS2,TYMP,CCND2,TERT,CDH1,PSD4,APOE,IL6R,EPHB4,CTSB,CD164,PDGFRA,RRM1,MAP3K1,MAP2K2,GADD45A,DUSP1,ATP11B,RHOA,QKI,DDB2,TLR1,RAD50,KITLG,PIK3CA,AXL,KIT,ZNF217,PPARG,ATR",DisGeNET
85,Oxyphilic Adenoma,0.0006230844235638044,6.6310975609756095,48.94299410980775,0.032341746785453,"KITLG,CD82,CDH1,KIT,TFEB,AP1M2",DisGeNET
86,Solid Neoplasm,0.0006390562336959075,2.029298617305977,14.926542719649346,0.03278507096588772,"GYPA,IL1RN,TFRC,CD82,MPG,EPAS1,LPL,TYMP,HK1,LAPTM4B,BCL2L11,TERT,CDH1,MYB,LONP1,FLOT2,JAK2,SH2B3,CTSB,PDGFRA,DUSP1,WIPI2,MFHAS1,DOK2,PTPRC,PIK3CA,AXL,KIT,PPARG,ANP32B",DisGeNET
87,"Carcinoma, Small Cell",0.0006473522993753672,4.179058553386912,30.685238495208417,0.03282894649246115,"PDGFRA,RAD50,THRB,TERT,PIK3CA,AXL,MYB,KIT,PPARG",DisGeNET
88,Malignant neoplasm of lung,0.0006561073710708794,1.6229344637003926,11.894788723925416,0.03289483774050818,"IL1RN,TFRC,CD82,MPG,HFE,PDCD5,ETS2,HK1,LAPTM4B,CCND3,CCND2,SLC22A16,ALDH2,CDH1,PSD4,LEPR,LONP1,SNIP1,JAK2,IL6R,EPHB4,ZNF322,CTSB,MAP2K2,ABCC2,DUSP1,TRPC1,TFEB,RHOA,DDB2,TLR1,HADHA,TOX2,DOK2,PIK3CA,KIT,SERPING1,PPARG,SIDT2,FTO,CEBPA,NUP205,RTEL1,TAGLN,GYPA,EPAS1,TYMP,BCL2L11,LARP1,TERT,APOE,APOB,SH2B3,HSPA8,RRM1,MAP3K1,GADD45A,IL37,MYO9B,QKI,ASXL1,KITLG,AXL,TDP2,ATR",DisGeNET
89,Cooley's anemia,0.0007321766752130323,6.401808242220353,46.217782350988266,0.0362962190004483,"TFRC,TERT,BCL11A,HFE,APOE,IL6R",DisGeNET
90,Hypertriglyceridemia,0.0007761392170380262,3.7088477366255144,26.559721229375526,0.03691841979873129,"GCKR,GALNT2,DOCK7,LPL,NLRP3,PPARG,BUD13,APOE,APOB,PLTP",DisGeNET
91,Beta thalassemia trait,0.0007781987854220331,12.324848484848484,88.22777985388169,0.03691841979873129,"TMPRSS6,BCL11A,HFE,LPL",DisGeNET
92,Hypoplastic myelodysplasia,0.0007781987854220331,12.324848484848484,88.22777985388169,0.03691841979873129,"ASXL1,TERT,KIT,JAK2",DisGeNET
93,Lipidemias,0.0007781987854220331,12.324848484848484,88.22777985388169,0.03691841979873129,"LEPR,LPL,APOE,APOB",DisGeNET
94,Primary malignant neoplasm of lung,0.0007868926397705694,1.6315364896115303,11.661274474181058,0.03693372687944417,"IL1RN,TFRC,CD82,MPG,HFE,PDCD5,ETS2,HK1,LAPTM4B,CCND3,SLC22A16,ALDH2,CDH1,PSD4,LEPR,LONP1,SNIP1,JAK2,IL6R,EPHB4,ZNF322,CTSB,MAP2K2,ABCC2,DUSP1,TRPC1,TFEB,ATP11A,RHOA,DDB2,TLR1,HADHA,TOX2,DOK2,PIK3CA,KIT,PPARG,FTO,CEBPA,NUP205,TAGLN,GYPA,EPAS1,TYMP,BCL2L11,TERT,APOE,APOB,SH2B3,HSPA8,RRM1,MAP3K1,GADD45A,IL37,MYO9B,QKI,ASXL1,KITLG,AXL,TDP2,ATR",DisGeNET
95,Hemoglobinopathies,0.0008115465901635193,8.125899856023036,57.82852506434653,0.03768993216633102,"HBS1L,GYPA,BCL11A,GYPE,MYB",DisGeNET
96,"Chromosome 8, trisomy",0.0008359892732765019,5.166156982670744,36.61201093233468,0.038420673684332565,"ASXL1,PDGFRA,GYPA,PTPRC,TERT,KIT,JAK2",DisGeNET
97,Platelet mean volume determination (procedure),0.0009940669661860036,3.1236024844720496,21.595669185934494,0.04521467479188297,"BRD3,NFE2,MEF2C,AKAP10,MAX,PRC1,PDCD5,PRDM16,H2AFV,TMCC2,MYO9B,SLC12A7",DisGeNET
98,HFE-Associated Hereditary Hemochromatosis,0.0010116319550177567,23.052870090634443,158.97698268116935,0.04554408352590146,"TF,TMPRSS6,HFE",DisGeNET
99,Malignant lymphoma - lymphoplasmacytic,0.001034794181323344,11.203305785123966,77.00651307180925,0.04565511927998594,"CCND3,CCND2,BCL11A,LPL",DisGeNET
100,Piebaldism,0.001034794181323344,11.203305785123966,77.00651307180925,0.04565511927998594,"RTEL1,KITLG,TERT,KIT",DisGeNET
101,"Lupus Erythematosus, Systemic",0.0010520241856513282,1.8789061600460564,12.883733145148776,0.04595574957518475,"BLK,IL1RN,ADAR,ICAM5,SPPL3,ETS2,UBE2L3,SPRED2,BCL2L11,TERT,LEPR,NLRP3,APOE,SH2B3,IL6R,KLF13,ABCC2,GADD45A,IL37,BTN2A1,MYO9B,ZFP90,AHI1,FAM167A,ELF1,PTPRC,PIK3CA,SERPING1,ZSCAN26,PPARG,TRIM38,ANP32B,PDE7A,RBM23",DisGeNET
102,Hepatitis C,0.0011182745759186648,2.058182465913139,13.987342873755265,0.04837085714659951,"RTEL1,IL1RN,TOMM40,TFRC,CD82,HFE,LPL,ADAR,BCL2L11,LEPR,NLRP3,STX4,APOE,APOB,HIST1H1B,HSPA8,ABCC2,IL37,DUSP1,PTPRC,XRN1,PIK3CA,AXL,KIT,SERPING1,PPARG",DisGeNET
103,Iron deficiency,0.0011495013777876424,5.799923780487805,39.25636080174819,0.0492388357164959,"TFRC,EPAS1,TMPRSS6,HFE,PPARG,PDE7A",DisGeNET
104,Iron Overload,0.001200271799561106,4.820319401970778,32.41764698077825,0.05091922288138077,"SLC25A37,TF,TFRC,EPAS1,TMPRSS6,HFE,APOE",DisGeNET
105,Calcification of coronary artery,0.001283247141213293,2.461687188358604,16.390803407523045,0.05392082273364808,"GCKR,TOMM40,THRB,GALNT2,ZBTB38,DOCK7,LPL,PLD1,GPN1,SPPL3,MRPL33,FADS2,MLEC,BUD13,APOE,APOB,PLTP",DisGeNET
106,Endometrial Neoplasms,0.0013129015696539687,2.8622701943749727,18.992638676351877,0.05440434810846339,"FTO,IL1RN,CD82,TYMP,CCND3,TERT,SLC22A16,PIK3CA,TDP2,CDH1,LEPR,PPARG,SH2B3",DisGeNET
107,Cognition,0.0013227786389526186,5.623614190687362,37.273431407217736,0.05440434810846339,"CEP57,MEF2C,DENND4A,BCL11A,MAPT,RBM23",DisGeNET
108,Dysgerminoma,0.0013454554683839503,10.268686868686869,67.88652183456014,0.05440434810846339,"MAP3K1,PIK3CA,CDH1,KIT",DisGeNET
109,Hereditary spherocytosis,0.0013454554683839503,10.268686868686869,67.88652183456014,0.05440434810846339,"SPTA1,GYPA,HFE,HK1",DisGeNET
110,Cytopenia,0.0013564094043361226,3.4211775878442543,22.589742124869332,0.05440434810846339,"SPTA1,ASXL1,PDGFRA,CEBPA,RTEL1,RPS28,TMPRSS6,KIT,JAK2,HK1",DisGeNET
111,Sickle Cell Trait,0.0014255398662648474,7.015750207239569,45.97564711627271,0.05666199900865321,"HBS1L,HBZ,TERT,MYB,APOE",DisGeNET
112,Reticular pattern on pulmonary HRCT,0.0015806168266557857,18.4404833836858,118.94001345207991,0.06064070816700284,"RTEL1,TERT,ATP11A",DisGeNET
113,Ground-glass opacification on pulmonary HRCT,0.0015806168266557857,18.4404833836858,118.94001345207991,0.06064070816700284,"RTEL1,TERT,ATP11A",DisGeNET
114,Honeycomb lung,0.0015806168266557857,18.4404833836858,118.94001345207991,0.06064070816700284,"RTEL1,TERT,ATP11A",DisGeNET
115,Low density lipoprotein increased,0.0015806168266557857,18.4404833836858,118.94001345207991,0.06064070816700284,"LPL,APOE,APOB",DisGeNET
116,Childhood Acute Lymphoblastic Leukemia,0.0016102346994782686,2.3387383617533213,15.04130421371486,0.06124444391463898,"BLK,CEBPA,ABCC2,THRB,TFRC,TMPRSS6,MPG,HFE,HIST1H2BK,PPP2R2A,HDAC7,RAD50,BCL2L11,PTPRC,CCND2,TERT,LEPR,JAK2",DisGeNET
117,Non-Small Cell Lung Carcinoma,0.0016785619093643656,1.59507498036635,10.192238595160076,0.06329756533432121,"IL1RN,CD82,MPG,PPP2R2A,ETS2,HK1,LAPTM4B,CCND3,CCND2,TRIM4,CDH1,MYB,LEPR,LONP1,SNIP1,FLOT2,JAK2,IL6R,CTSB,PDGFRA,MAP2K2,ABCC2,DUSP1,TRPC1,NCOA4,TFEB,FRS3,DDB2,SIRT3,TLR1,PIK3CA,KIT,PPARG,RBM23,CEBPA,TAGLN,EPAS1,LPL,TYMP,BCL2L11,TERT,NLRP3,MPST,NFE2,RRM1,GADD45A,IL37,BCL11A,TNK2,KITLG,TP53I3,AXL,TDP2,HIST1H4H,HIST1H4J,HIST1H4C,ATR",DisGeNET
118,Senile lentigo,0.0017157869344260725,9.477855477855478,60.353879036205086,0.06354973825825472,"KITLG,MAP2K2,PIK3CA,TRPC1",DisGeNET
119,Cerebral Hemorrhage,0.001728460696054072,5.3012195121951216,33.718534136020956,0.06354973825825472,"IL1RN,MAX,APOE,JAK2,APOB,SH2B3",DisGeNET
120,Hyperuricemia,0.001728460696054072,5.3012195121951216,33.718534136020956,0.06354973825825472,"GCKR,ALDH2,HFE,PPARG,APOE,JAK2",DisGeNET
121,Idiopathic Pulmonary Fibrosis,0.0017640152119694126,2.383083596214511,15.109137722623453,0.06432095136536403,"RTEL1-TNFRSF6B,RTEL1,TAGLN,IL1RN,HFE,ATP11A,RHOA,ETS2,HDAC7,PTPRC,PIK3CA,TERT,PRC1,NLRP3,HIST1H4H,HIST1H4J,HIST1H4C",DisGeNET
122,Splenomegaly,0.0019565130302500863,2.7258985134541804,17.00031537990291,0.06971083781287354,"PDGFRA,IL1RN,HFE,LPL,HK1,PTPRC,PIK3CA,NLRP3,DNASE2,APOE,MAPT,JAK2,SH2B3",DisGeNET
123,Pancreatic Neoplasm,0.0019582086547593885,1.9985453237880422,12.462379389526278,0.06971083781287354,"CEBPA,TAGLN,ARPC1A,TYMP,HDAC7,ALDH2,TERT,CDH1,PSD4,APOE,JAK2,IL6R,CTSB,RRM1,MAP3K1,ABCC2,GADD45A,DUSP1,SIRT3,PIK3CA,AXL,DLG5,KIT,PPARG,ATR",DisGeNET
124,"Diabetes Mellitus, Non-Insulin-Dependent",0.0019592347889384226,1.6358199217050893,10.199666495474958,0.06971083781287354,"IL1RN,TFRC,PGAP3,HFE,SPPL3,HK1,SCGN,FADS2,CCND2,ALDH2,LEPR,JAK2,IL6R,ABCC2,TRPC1,PABPC4,CPT1B,SIRT3,PIK3CA,SERPING1,PPARG,FTO,BLK,CEBPA,MACF1,TOMM40,TMPRSS6,EPAS1,NPRL3,LPL,PLD1,TYMP,BCL2L11,PRDM16,NLRP3,STX4,APOE,APOB,PLTP,MPST,PTPN1,GCKR,IL37,GALNT2,BTN2A1,BCL11A,AHI1,TF,PRC1",DisGeNET
125,Gingival Diseases,0.0021263295137672177,3.8180273714016044,23.49368934146,0.07452275826598623,"IL1RN,RTEL1,TERT,ALDH2,NLRP3,PPARG,APOE,CTSB",DisGeNET
126,Lymphoma,0.002128256469064883,1.723749853886616,10.605288569741232,0.07452275826598623,"CEBPA,RTEL1,IL1RN,MPG,EPAS1,TRRAP,HFE,HDAC7,SPTA1,CCND3,BCL2L11,CCND2,TERT,CDH1,MYB,LONP1,NLRP3,APOE,JAK2,FBXO7,EPHB4,RBM38,PTPN1,PDGFRA,ABCC2,GADD45A,DUSP1,BCL11A,ZFP91,RHOA,TLR1,AHI1,SLC7A6,PTPRC,PIK3CA,AXL,KIT,PPARG,ATR",DisGeNET
127,Stomach Carcinoma,0.002193130655979139,1.5622190990457874,9.564569630958898,0.07618970436362174,"IL1RN,THRB,CD82,CITED2,HFE,PDCD5,ETS2,HK1,LAPTM4B,CCND2,ALDH2,CDH1,CLDN23,LEPR,FLOT2,JAK2,EPHB4,CTSB,PDGFRA,ABCC2,BTN3A2,RHOA,DDB2,SIRT3,TLR1,DOK2,PIK3CA,KIT,PPARG,MAPT,TRABD,KANK2,FTO,GTF2A1,TAGLN,EPAS1,PLD1,TYMP,HDAC7,TERT,APOE,PTPN1,RRM1,MAP3K1,GADD45A,SMOX,TNK2,SLC25A37,KITLG,PTPRC,PRC1,IL2RB,ZNF217,HIST1H4H,HIST1H4J,ANP32B,FBXL5,HIST1H4C,ATR",DisGeNET
128,Siderosis,0.002315358484185784,15.365558912386707,93.24114247074891,0.07663911441236955,"TFRC,HFE,APOE",DisGeNET
129,Warts,0.002315358484185784,15.365558912386707,93.24114247074891,0.07663911441236955,"PIK3CA,TMC8,TMC6",DisGeNET
130,Amelanotic Skin Melanoma,0.002315358484185784,15.365558912386707,93.24114247074891,0.07663911441236955,"KIT,RAB8A,CTSB",DisGeNET
131,Apraxia of Phonation,0.002315358484185784,15.365558912386707,93.24114247074891,0.07663911441236955,"BCL11A,APOE,MAPT",DisGeNET
132,Rales,0.002315358484185784,15.365558912386707,93.24114247074891,0.07663911441236955,"RTEL1,TERT,ATP11A",DisGeNET
133,Dyspnea on exertion,0.0023276612264862915,6.172036474164134,37.42038612504452,0.07663911441236955,"RTEL1,TERT,ATP11A,JAK2,SH2B3",DisGeNET
134,Hypermelanotic macule,0.0023276612264862915,6.172036474164134,37.42038612504452,0.07663911441236955,"RTEL1,PIK3CA,TERT,KIT,DDB2",DisGeNET
135,Rheumatoid Arthritis,0.002395810061146414,1.617335772970258,9.759058841646862,0.07829862214650354,"IL1RN,CD82,MPG,HFE,PDCD5,ETS2,UBE2L3,FADS2,SPRED2,CCND3,ACOXL,IL6R,RAB8A,CTSB,BRD3,PDGFRA,ABCC2,DUSP1,TRPC1,TLR1,PIK3CA,ZSCAN26,DNASE2,PPARG,BLK,EPAS1,TYMP,PSMB5,BCL2L11,TERT,NLRP3,APOE,ZKSCAN4,APOB,SH2B3,HSPA8,GADD45A,IL37,MYO9B,ASXL1,MSRA,TF,FAM167A,KITLG,PTPRC,IL2RB,TRIM38,ANP32B,PDE7A",DisGeNET
136,Hemochromatosis,0.0025055872783048406,4.881258023106547,29.234987384299,0.0812841990579482,"TF,TFRC,ALDH2,TMPRSS6,HFE,APOE",DisGeNET
137,Serum gamma-glutamyl transferase measurement,0.0026575592727179514,8.212525252525252,48.70312567681633,0.08228261093080441,"GCKR,ALDH2,ZNF827,DLG5",DisGeNET
138,Adenoid cystic carcinoma of salivary gland,0.0026575592727179514,8.212525252525252,48.70312567681633,0.08228261093080441,"PIK3CA,KIT,MYB,LONP1",DisGeNET
139,Childhood Burkitt Lymphoma,0.0026575592727179514,8.212525252525252,48.70312567681633,0.08228261093080441,"RTEL1,PIK3CA,KIT,RHOA",DisGeNET
140,Lipid Metabolism Disorders,0.0026575592727179514,8.212525252525252,48.70312567681633,0.08228261093080441,"TFEB,LPL,APOE,APOB",DisGeNET
141,Myxoma,0.0026575592727179514,8.212525252525252,48.70312567681633,0.08228261093080441,"PIK3CA,KIT,NLRP3,TYMP",DisGeNET
142,Epithelioma,0.0026808182449708545,2.515373563218391,14.895119642026197,0.08228261093080441,"RTEL1,CD82,KITLG,RAD50,BCL2L11,TERT,PIK3CA,CDH1,PSD4,MYB,KIT,PPARG,FBXO7,CTSB",DisGeNET
143,Abetalipoproteinemia,0.0027042109213432997,5.934065934065934,35.08780620889682,0.08228261093080441,"PDGFRA,PTPN1,HADHA,APOE,APOB",DisGeNET
144,Alcoholic Steatohepatitis,0.0027042109213432997,5.934065934065934,35.08780620889682,0.08228261093080441,"IL1RN,HFE,LEPR,APOE,APOB",DisGeNET
145,Proliferative retinopathy,0.0027042109213432997,5.934065934065934,35.08780620889682,0.08228261093080441,"GYPA,ALDH2,GYPE,LPL,EPHB4",DisGeNET
146,Refractory Hodgkin Lymphoma,0.0029561858566416093,61.30722891566265,357.04443639417775,0.08637510882144252,"PTPN1,BCL2L11",DisGeNET
147,Dementia in Parkinson's disease,0.0029561858566416093,61.30722891566265,357.04443639417775,0.08637510882144252,"APOE,MAPT",DisGeNET
148,Generalized hypopigmentation of hair,0.0029561858566416093,61.30722891566265,357.04443639417775,0.08637510882144252,"RTEL1,TERT",DisGeNET
149,Mediastinal Neoplasms,0.0029561858566416093,61.30722891566265,357.04443639417775,0.08637510882144252,"PTPN1,KIT",DisGeNET
150,White Blood Cell Count procedure,0.0029836456915449346,3.595269849737708,20.90508964727025,0.08637510882144252,"AHI1,SPRED2,GCKR,TERT,LEPR,NLRP3,SH2B3,KLF3",DisGeNET
151,Malignant neoplasm of ovary,0.003040422690999363,1.5628673651929466,9.058002175864335,0.08637510882144252,"IL1RN,TFRC,CD82,MPG,SPPL3,ETS2,LAPTM4B,CCND2,ALDH2,CDH1,PSD4,LEPR,JARID2,JAK2,IL6R,EPHB4,CTSB,MAP2K2,ABCC2,BTN3A1,DUSP1,TRPC1,NCOA4,ATP11B,BTN3A2,DDB2,TLR1,DOK2,ALDH5A1,PIK3CA,KIT,PPARG,EPAS1,HSD17B13,TYMP,HDAC7,BCL2L11,TERT,APOE,SH2B3,RBM38,CD164,PTPN1,MAP3K1,GADD45A,SLC25A37,RAD50,KITLG,PTPRC,AXL,ZNF217,RPL22L1,MUC20,ATR",DisGeNET
152,Systemic onset juvenile chronic arthritis,0.0031229749912561515,5.713722841382416,32.962291138617424,0.08637510882144252,"IL1RN,IL2RB,NLRP3,IL6R,UBE2L3",DisGeNET
153,Myeloid Leukemia,0.0031549698951151397,2.090060731743445,12.036192259765505,0.08637510882144252,"CEBPA,PDGFRA,MEF2C,TFRC,GADD45A,MPG,DUSP1,EPAS1,BCL11A,ASXL1,AHI1,BCL2L11,PIK3CA,AXL,KIT,PRDM16,IL2RB,MYB,JAK2,TRIB1",DisGeNET
154,Coronary heart disease,0.003164458007452982,1.790987098709871,10.3085160524401,0.08637510882144252,"FTO,IL1RN,TOMM40,CITED2,HFE,LPL,AGAP1,ETS2,FADS2,ALDH2,MYB,LEPR,NLRP3,APOE,APOB,SH2B3,PLTP,IL6R,SLC17A3,HSPA8,PTPN1,MEF2C,GCKR,GALNT2,QKI,RAD50,PTPRC,PPARG,BUD13,ANP32B,TRIB1",DisGeNET
155,Infection,0.003197740035569669,2.132222222222222,12.250279697297131,0.08637510882144252,"HSPA8,PDGFRA,IL1RN,HFE,LPL,ADAR,RHOA,TLR1,BCL2L11,PTPRC,PIK3CA,TERT,CDH1,NLRP3,PPARG,APOE,MAPT,APOB,RAB8A",DisGeNET
156,MYELODYSPLASTIC SYNDROME,0.003199741504682597,1.9770363685746077,11.35745166966501,0.08637510882144252,"CEBPA,GYPA,TFRC,GADD45A,HFE,WIPI2,TM9SF4,ASXL1,TLR1,SLC25A37,CCND3,KITLG,PTPRC,PIK3CA,TERT,CDH1,AXL,KIT,PRDM16,MYB,JAK2,TRIB1,SH2B3",DisGeNET
157,"Familial Partial Lipodystrophy, Type 2",0.0032302567895598406,13.169184290030211,75.52782203020769,0.08637510882144252,"CCND3,LPL,PPARG",DisGeNET
158,"Nuchal bleb, familial",0.0032302567895598406,13.169184290030211,75.52782203020769,0.08637510882144252,"LEPR,LPL,APOB",DisGeNET
159,Amyloid nephropathy,0.0032302567895598406,13.169184290030211,75.52782203020769,0.08637510882144252,"IL1RN,NLRP3,APOE",DisGeNET
160,Esophageal Stenosis,0.0032302567895598406,13.169184290030211,75.52782203020769,0.08637510882144252,"RTEL1,TERT,KIT",DisGeNET
161,Hyperkeratosis lenticularis perstans,0.0032302567895598406,13.169184290030211,75.52782203020769,0.08637510882144252,"LPL,APOE,APOB",DisGeNET
162,Hyperlipoproteinemia Type III,0.0032302567895598406,13.169184290030211,75.52782203020769,0.08637510882144252,"LPL,APOE,APOB",DisGeNET
163,Hypochondroplasia (disorder),0.0032302567895598406,13.169184290030211,75.52782203020769,0.08637510882144252,"GALNT2,DOCK7,BUD13",DisGeNET
164,Niemann-Pick Diseases,0.0032302567895598406,13.169184290030211,75.52782203020769,0.08637510882144252,"SMPD2,APOE,CTSB",DisGeNET
165,Prostate specific antigen measurement,0.0032302567895598406,13.169184290030211,75.52782203020769,0.08637510882144252,"TERT,BCL11A,ZBTB38",DisGeNET
166,Endometrial Carcinoma,0.0032580762683258897,1.8664921838328379,10.688688407842568,0.08659417166177003,"FTO,IL1RN,CD82,MAX,HFE,TYMP,CCND3,TERT,CDH1,LEPR,APOE,SH2B3,IL6R,EPHB4,MAP3K1,TNK2,SIRT3,TLR1,RAD50,ELF1,KITLG,PIK3CA,KIT,PPARG,PDE7A,MUC20,ATR",DisGeNET
167,Myeloproliferative disease,0.003308639364141897,2.5519112835282822,14.57452227531988,0.08741147829098234,"NFE2,HBS1L,PDGFRA,CEBPA,ASXL1,KITLG,TERT,PIK3CA,MYB,KIT,IL2RB,JAK2,SH2B3",DisGeNET
168,beta^+^ Thalassemia,0.0033671942882351224,3.9400055601890465,22.43311287892136,0.08790568757215006,"HBS1L,TFRC,BCL11A,TMPRSS6,HFE,MYB,APOE",DisGeNET
169,Merkel cell carcinoma,0.0033671942882351224,3.9400055601890465,22.43311287892136,0.08790568757215006,"PDGFRA,HSPA8,KITLG,PTPRC,TERT,PIK3CA,KIT",DisGeNET
170,mixed gliomas,0.0035196777683653355,4.522754312908983,25.550784157952677,0.09081180300601088,"PDGFRA,RTEL1,TFRC,TERT,MYB,QKI",DisGeNET
171,Polycythemia,0.0035196777683653355,4.522754312908983,25.550784157952677,0.09081180300601088,"ASXL1,NFE2,GYPA,EPAS1,JAK2,APOB",DisGeNET
172,Fatigue,0.0036539798424254396,2.5197074360016254,14.14044275968155,0.0937288317719828,"PDGFRA,MEF2C,MAX,HFE,DDB2,FIG4,RPS28,PIK3CA,KIT,NLRP3,JAK2,IL6R,SH2B3",DisGeNET
173,melanoma,0.003743964670080905,1.500936701674709,8.38664915902351,0.09548191979420204,"IL1RN,TFRC,CD82,MPG,TRRAP,ADAR,CCND3,CDH1,PSD4,MYB,LEPR,LONP1,SNIP1,FLOT2,JAK2,IL6R,EPHB4,RAB8A,CTSB,PDGFRA,MAP2K2,ABCC2,DUSP1,TRPC1,TFEB,RHOA,DDB2,TLR1,PIK3CA,KIT,PPARG,KANK2,FTO,RTEL1,TAGLN,GYPA,EPAS1,GMPR,LPL,PLD1,TM9SF4,TYMP,HMGCL,BCL2L11,TERT,MICAL1,PRDM16,NLRP3,APOE,MPST,HSPA8,MAP3K1,GADD45A,TF,KITLG,PTPRC,TP53I3,AXL,IL2RB,HIST1H4H,HIST1H4J,HIST1H4C,ATR",DisGeNET
174,Atrial Septal Defects,0.0038909441840610185,3.139187554019015,17.419676423311646,0.09729415468706087,"CEP57,ASXL1,MAP2K2,KLF13,KANSL1,CITED2,KIAA0586,LONP1,NPHP3",DisGeNET
175,"Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative",0.00390323331360149,7.244919786096257,40.17996299313587,0.09729415468706087,"ASXL1,CEBPA,PDGFRA,JAK2",DisGeNET
176,Chronic viral hepatitis,0.00390323331360149,7.244919786096257,40.17996299313587,0.09729415468706087,"TFRC,TERT,HFE,LEPR",DisGeNET
177,Cognitive changes,0.00390323331360149,7.244919786096257,40.17996299313587,0.09729415468706087,"FTO,TOMM40,APOE,MAPT",DisGeNET
178,Periodontitis,0.00400569137036787,2.7388978328173375,15.118823091223312,0.09928713666327552,"IL1RN,RTEL1,LEPROT,TERT,ALDH2,LEPR,PPARG,APOE,ANP32B,IL6R,ZNF410",DisGeNET
179,Delirium,0.004097480403703544,5.318624882087832,29.238518168972206,0.10043379745077799,"IL1RN,PIK3CA,NLRP3,APOE,IL6R",DisGeNET
180,Female Breast Carcinoma,0.004097480403703544,5.318624882087832,29.238518168972206,0.10043379745077799,"BCL2L11,ALDH2,PIK3CA,HFE,ZNF217",DisGeNET
181,Hereditary hemochromatosis,0.004163735146169601,3.104,17.014087852169148,0.10148206821401874,"PDGFRA,TF,TFRC,TERT,PIK3CA,TMPRSS6,HFE,APOE,PCSK7",DisGeNET
182,Secondary polycythemia,0.004337836661678677,11.52190332326284,62.683526873555344,0.10148206821401874,"NFE2,EPAS1,JAK2",DisGeNET
183,Benign neoplasm of stomach,0.004337836661678677,11.52190332326284,62.683526873555344,0.10148206821401874,"PIK3CA,CDH1,ATR",DisGeNET
184,Carcinoma in situ of stomach,0.004337836661678677,11.52190332326284,62.683526873555344,0.10148206821401874,"PIK3CA,CDH1,ATR",DisGeNET
185,Fibrosis of pancreas,0.004337836661678677,11.52190332326284,62.683526873555344,0.10148206821401874,"ALDH2,NPHP3,NLRP3",DisGeNET
186,Neoplasm of uncertain or unknown behavior of stomach,0.004337836661678677,11.52190332326284,62.683526873555344,0.10148206821401874,"PIK3CA,CDH1,ATR",DisGeNET
187,Primary Progressive Aphasia (disorder),0.004337836661678677,11.52190332326284,62.683526873555344,0.10148206821401874,"TOMM40,APOE,MAPT",DisGeNET
188,Gestational Diabetes,0.004347259948424647,4.311542824730573,23.447073275278882,0.10148206821401874,"GCKR,HFE,LEPR,LPL,PPARG,SIRT3",DisGeNET
189,Hurthle Cell Tumor,0.004347259948424647,4.311542824730573,23.447073275278882,0.10148206821401874,"CD82,TERT,CDH1,MAX,KIT,TFEB",DisGeNET
190,Other specified transient cerebral ischemias,0.004451245253555445,3.069585798816568,16.620491444471163,0.10336260030887696,"HSPA8,CEBPA,IL1RN,TERT,DUSP1,MYB,PPARG,APOE,JAK2",DisGeNET
191,Ulcerative Colitis,0.0045492551795759,1.776763801249326,9.581717180119599,0.1043284827257087,"IL1RN,MAST3,LPL,UBE2L3,HDAC7,TERT,CDH1,LEPR,NLRP3,APOE,JAK2,SH2B3,IL6R,NKX2-3,RTEL1-TNFRSF6B,GCKR,NDFIP1,MAP2K2,SMOX,IL37,DUSP1,MYO9B,ZFP90,TLR1,PTPRC,DLG5,TMBIM1,PPARG,MUC20",DisGeNET
192,Severe Combined Immunodeficiency,0.004551905067068795,2.8511156416355194,15.373812670484488,0.1043284827257087,"CCND2,PTPRC,THRB,TFRC,CD82,PIK3CA,IL2RB,NLRP3,PPARG,JAK2",DisGeNET
193,Dyskeratosis Congenita,0.004652898830980776,6.841750841750842,36.74201405180106,0.1043284827257087,"RTEL1-TNFRSF6B,RTEL1,TERT,ATR",DisGeNET
194,"Bulbo-Spinal Atrophy, X-Linked",0.0046583660691216265,5.1408308004052685,27.601585921924936,0.1043284827257087,"MPG,TFEB,ZKSCAN3,PPARG,MAPT",DisGeNET
195,Thrombocytosis,0.0046583660691216265,5.1408308004052685,27.601585921924936,0.1043284827257087,"NFE2,TFRC,JAK2,SH2B3,TYMP",DisGeNET
196,Carotid Artery Diseases,0.0046583660691216265,5.1408308004052685,27.601585921924936,0.1043284827257087,"IL1RN,PPARG,APOE,APOB,PLTP",DisGeNET
197,Malignant neoplasm of female breast,0.0046583660691216265,5.1408308004052685,27.601585921924936,0.1043284827257087,"BCL2L11,ALDH2,PIK3CA,HFE,ZNF217",DisGeNET
198,"Leukemia, Myelomonocytic, Chronic",0.004787580583957579,3.6714352355776705,19.61181608039877,0.1066653311782169,"ASXL1,PDGFRA,KITLG,BCL11A,MYB,KIT,JAK2",DisGeNET
199,"Liver Cirrhosis, Alcoholic",0.004811060948428187,4.2131374722838135,22.4848306773905,0.1066653311782169,"IL1RN,ALDH2,HFE,PPARG,APOE,APOB",DisGeNET
200,Erythema,0.005204253828084146,3.609887869520897,18.9817973743148,0.11400699132054974,"IL1RN,ALDH2,KIT,SERPING1,NLRP3,CTSB,DDB2",DisGeNET
201,Sparse scalp hair,0.005271738753936638,4.97450730463771,26.09325592483884,0.11400699132054974,"KANK2,FIG4,RTEL1,TERT,ATR",DisGeNET
202,Adenosquamous carcinoma,0.005271738753936638,4.97450730463771,26.09325592483884,0.11400699132054974,"PDGFRA,CD82,PIK3CA,KIT,IL2RB",DisGeNET
203,Acute myelomonocytic leukemia,0.005310239064643768,4.119105691056911,21.57636340723367,0.11400699132054974,"CEBPA,CCND3,TFRC,MYB,KIT,PRDM16",DisGeNET
204,Low density lipoprotein cholesterol measurement,0.005339542871063239,2.398514258327342,12.550502247915258,0.11400699132054974,"GCKR,LEPROT,TOMM40,HFE,DOCK7,MSRA,FADS2,TF,LEPR,PPARG,APOE,APOB,SH2B3",DisGeNET
205,Cystic Fibrosis,0.005426294650936128,1.9813538548092187,10.335729932069363,0.11400699132054974,"HSPA8,GYPA,IL1RN,SMOX,GYPE,HFE,TMC6,RHOA,MSRA,TF,PIK3CA,NLRP3,HIST1H4H,PPARG,APOE,HIST1H4J,PDE7A,HIST1H4C,MUC20,CTSB",DisGeNET
206,Serum triglycerides raised,0.0054936260994018216,6.481020733652312,33.72831260680547,0.11400699132054974,"NSMCE2,LEPR,PPARG,APOE",DisGeNET
207,Atherosclerosis of aorta,0.0054936260994018216,6.481020733652312,33.72831260680547,0.11400699132054974,"MSRA,LPL,APOE,APOB",DisGeNET
208,Lipodystrophy,0.0056475836663041476,3.5503584498922143,18.378528132905984,0.11400699132054974,"PTPRC,PIK3CA,HFE,LEPR,LONP1,PPARG,APOE",DisGeNET
209,"Cafe au lait spots, multiple",0.005648876859712258,10.240684793554884,53.00884174011179,0.11400699132054974,"MAP2K2,TMC8,TMC6",DisGeNET
210,Seborrheic dermatitis,0.005648876859712258,10.240684793554884,53.00884174011179,0.11400699132054974,"TMC8,TMC6,ANP32B",DisGeNET
211,Glycogen Storage Disease Type I,0.005648876859712258,10.240684793554884,53.00884174011179,0.11400699132054974,"GYPE,LPL,APOB",DisGeNET
212,Pdgfra-Associated Chronic Eosinophilic Leukemia,0.005648876859712258,10.240684793554884,53.00884174011179,0.11400699132054974,"PDGFRA,KIT,JAK2",DisGeNET
213,"LEUKEMIA, ACUTE MYELOID, SUSCEPTIBILITY TO",0.005788206268314402,30.650602409638555,157.9098449242407,0.11400699132054974,"CEBPA,JAK2",DisGeNET
214,Abnormality of the pancreas,0.005788206268314402,30.650602409638555,157.9098449242407,0.11400699132054974,"ASXL1,NPHP3",DisGeNET
215,Xanthelasma of periocular region,0.005788206268314402,30.650602409638555,157.9098449242407,0.11400699132054974,"APOE,APOB",DisGeNET
216,Xanthoma of periocular region,0.005788206268314402,30.650602409638555,157.9098449242407,0.11400699132054974,"APOE,APOB",DisGeNET
217,Arcus juvenilis,0.005788206268314402,30.650602409638555,157.9098449242407,0.11400699132054974,"APOE,APOB",DisGeNET
218,Arcus Senilis,0.005788206268314402,30.650602409638555,157.9098449242407,0.11400699132054974,"APOE,APOB",DisGeNET
219,Epiglottitis,0.005788206268314402,30.650602409638555,157.9098449242407,0.11400699132054974,"GYPA,GYPE",DisGeNET
220,HMG CoA lyase deficiency,0.005788206268314402,30.650602409638555,157.9098449242407,0.11400699132054974,"HMGCL,APOB",DisGeNET
221,Hyperimmunoglobulinemia D,0.005788206268314402,30.650602409638555,157.9098449242407,0.11400699132054974,"IL1RN,NLRP3",DisGeNET
222,Hyperlipoproteinemia Type IV,0.005788206268314402,30.650602409638555,157.9098449242407,0.11400699132054974,"LPL,APOB",DisGeNET
223,Ovarian papillary adenocarcinoma,0.005788206268314402,30.650602409638555,157.9098449242407,0.11400699132054974,"PIK3CA,CDH1",DisGeNET
224,Prominent superficial veins,0.005788206268314402,30.650602409638555,157.9098449242407,0.11400699132054974,"PPARG,SLC39A13",DisGeNET
225,IGA Glomerulonephritis,0.005842677176264713,2.5918472652218782,13.328746055102341,0.11413264440616479,"BLK,IL1RN,ACOXL,TFRC,PIK3CA,PRC1,PPARG,APOE,MUC20,RHOA,UBE2L3",DisGeNET
226,Endometrial Hyperplasia,0.005846323126879701,4.02916224814422,20.71771996113338,0.11413264440616479,"TLR1,CCND3,PIK3CA,HFE,APOE,EPHB4",DisGeNET
227,Myeloid neoplasm,0.005940112430561495,4.818579027355623,24.700167246707654,0.11494638615630402,"PDGFRA,CEBPA,TERT,KIT,JAK2",DisGeNET
228,Nausea,0.005940112430561495,4.818579027355623,24.700167246707654,0.11494638615630402,"ALDH2,MAX,SERPING1,LPL,TYMP",DisGeNET
229,Squamous cell carcinoma,0.006090784596830213,1.5303092361253328,7.806074315832101,0.11734734341141877,"IL1RN,TFRC,CD82,MPG,ICAM5,DMKN,ETS2,HK1,CCND3,CCND2,ALDH2,CDH1,LEPR,LONP1,JAK2,IL6R,EPHB4,CTSB,ABCC2,DUSP1,TMC8,TMC6,RHOA,DDB2,SIRT3,TLR1,XRN1,PIK3CA,KIT,PPARG,CEBPA,EPAS1,TYMP,TERT,HEATR3,APOE,HSPA8,RRM1,GADD45A,GALNT2,RAD50,KITLG,AXL,IL2RB,HIST1H4H,HIST1H4J,ANP32B,HIST1H4C,ATR",DisGeNET
230,Cardiovascular Diseases,0.006368797709070713,1.765330689704008,8.926120246964913,0.12123657299393505,"FTO,CEBPA,TAGLN,IL1RN,HFE,LPL,AGAP1,PCSK7,FADS2,SPRED2,ALDH2,LEPR,NLRP3,APOE,APOB,SH2B3,PLTP,IL6R,DUSP1,KLF3,RHOA,SIRT3,MSRA,PIK3CA,PPARG,MAPT,TRIB1",DisGeNET
231,"Glioblastoma, IDH-Wildtype",0.006420839015200227,3.943046185781007,19.90531131425283,0.12123657299393505,"PDGFRA,RTEL1,PIK3CA,TERT,KIT,SPPL3",DisGeNET
232,Cholecystolithiasis,0.006420839015200227,3.943046185781007,19.90531131425283,0.12123657299393505,"GCKR,ABCC2,PPARG,ATP11A,APOE,APOB",DisGeNET
233,Maturity onset diabetes mellitus in young,0.006420839015200227,3.943046185781007,19.90531131425283,0.12123657299393505,"BLK,GCKR,LEPR,APOB,IL6R,HK1",DisGeNET
234,Hypereosinophilia,0.006430044895870535,6.156363636363636,31.06977444782373,0.12123657299393505,"ASXL1,PDGFRA,KIT,JAK2",DisGeNET
235,Biliary cirrhosis,0.006515332564058162,2.878001586042823,14.486700218011535,0.12232190328776428,"ELF1,ABCC2,KANSL1,PRDM16,NPHP3,PPARG,MAPT,JAK2,SH2B3",DisGeNET
236,"Mastocytosis, Systemic",0.006665964546229144,4.672100948696693,23.41068599366763,0.12461964227950417,"ASXL1,PDGFRA,PTPRC,KIT,JAK2",DisGeNET
237,Multiple Myeloma,0.006780907358839554,1.6257245271507017,8.118290111443665,0.12623360028354477,"CEBPA,RTEL1,IL1RN,TFRC,CD82,MPG,EPAS1,HFE,CCND3,ACOXL,BCL2L11,CCND2,TERT,CDH1,ZKSCAN3,LEPR,LONP1,JAK2,IL6R,HSPA8,RRM1,ABCC2,GADD45A,DENND4A,ASXL1,TLR1,SLC25A37,RAD50,KITLG,PTPRC,PIK3CA,KIT,IL2RB,PPARG,ANP32B,ATR",DisGeNET
238,Sporadic Breast Carcinoma,0.0069209501095483465,2.8483516483516484,14.165428740095726,0.12760165367450502,"PIK3CA,CDH1,GADD45A,MYB,LEPR,HSD17B13,EPHB4,ZNF410,ATR",DisGeNET
239,"Hyperlipidemia, Familial Combined",0.0070353066130038775,3.8605182926829267,19.13587114137991,0.12760165367450502,"IL2RB,LEPR,LPL,PPARG,APOE,APOB",DisGeNET
240,Sweating,0.0070353066130038775,3.8605182926829267,19.13587114137991,0.12760165367450502,"RTEL1,MAP2K2,TERT,NLRP3,PPARG,JAK2",DisGeNET
241,Hyperhidrosis disorder,0.0070353066130038775,3.8605182926829267,19.13587114137991,0.12760165367450502,"RTEL1,MAP2K2,TERT,NLRP3,PPARG,JAK2",DisGeNET
242,Increased sweating,0.0070353066130038775,3.8605182926829267,19.13587114137991,0.12760165367450502,"RTEL1,MAP2K2,TERT,NLRP3,PPARG,JAK2",DisGeNET
243,Trisomy,0.007167680592692736,2.6540571910942283,13.106193998039581,0.12760165367450502,"CCND2,BCL2L11,PTPRC,TERT,TRRAP,KIT,LONP1,LPL,JAK2,ETS2",DisGeNET
244,"Chromosome 10, monosomy 10q",0.0071725317568624766,9.21570996978852,45.50253648143959,0.12760165367450502,"RTEL1,PIK3CA,TERT",DisGeNET
245,Bronchitis,0.0071725317568624766,9.21570996978852,45.50253648143959,0.12760165367450502,"GYPA,IL1RN,GYPE",DisGeNET
246,Hypoalphalipoproteinemias,0.0071725317568624766,9.21570996978852,45.50253648143959,0.12760165367450502,"PPARG,APOE,PLTP",DisGeNET
247,Neurofibrillary degeneration (morphologic abnormality),0.0071725317568624766,9.21570996978852,45.50253648143959,0.12760165367450502,"TOMM40,APOE,MAPT",DisGeNET
248,Non-infiltrating lobular carcinoma,0.0071725317568624766,9.21570996978852,45.50253648143959,0.12760165367450502,"MAP3K1,PIK3CA,CDH1",DisGeNET
249,"Carcinoma, Papillary",0.007562888915075302,2.631303620004185,12.852607873879567,0.13346986357324894,"THRB,TERT,CD82,PIK3CA,DUSP1,CDH1,NCOA4,KIT,PPARG,CTSB",DisGeNET
250,Polycythemia Vera,0.007562888915075302,2.631303620004185,12.852607873879567,0.13346986357324894,"ASXL1,NFE2,HBS1L,GYPA,KITLG,TERT,MYB,KIT,JAK2,SH2B3",DisGeNET
251,Gynecomastia,0.007691236810663684,3.7813588850174216,18.406421099421237,0.1349115388510162,"MAP3K1,PIK3CA,AXL,HFE,KIT,LEPR",DisGeNET
252,Periodontal Diseases,0.007713105758027033,3.0213975759389498,14.698598713839871,0.1349115388510162,"IL1RN,RTEL1,TERT,ALDH2,NLRP3,PPARG,APOE,CTSB",DisGeNET
253,Serum total cholesterol measurement,0.007736314444539234,2.2051767676767677,10.721194288177,0.1349115388510162,"KANK2,FTO,GCKR,TOMM40,HFE,DOCK7,LPL,FADS2,SAMM50,PPARG,BUD13,APOE,APOB,SH2B3",DisGeNET
254,Hashimoto Disease,0.007790001319229297,2.7908307692307694,13.549244070180388,0.13492801969006182,"IL1RN,THRB,TERT,PIK3CA,IL37,NCOA4,PPARG,IL6R,CTSB",DisGeNET
255,Liver carcinoma,0.007798423622159059,1.3964646464646464,6.778207113599453,0.13492801969006182,"IL1RN,THRB,TFRC,CD82,MPG,HFE,PDCD5,ADAR,SPPL3,ETS2,HK1,LAPTM4B,FADS2,SPRED2,CCND3,CCND2,SLC22A16,ALDH2,CDH1,LEPR,JAK2,IL6R,EPHB4,RAB8A,CTSB,PDGFRA,MEF2C,MAP2K2,ABCC2,DUSP1,TRPC1,RHOA,SIRT3,TLR1,ELF1,PIK3CA,TST,KIT,SERPING1,DNASE2,PPARG,FTO,CEBPA,GYPA,TMPRSS6,EPAS1,LPL,TYMP,BCL2L11,SAMM50,TERT,SERTAD2,NLRP3,APOE,ZKSCAN4,APOB,MPST,RBM38,HSPA8,PTPN1,RRM1,MAP3K1,GADD45A,IL37,GALNT2,TNK2,TEX35,SLC25A37,MSRA,AHI1,TF,KITLG,PTPRC,TFAP4,AXL,HIST1H4H,HIST1H4J,CRLF3,HIST1H4C",DisGeNET
256,Undifferentiated carcinoma,0.00789591699386487,2.477677569883789,11.99545169834705,0.13608119444113986,"TF,KITLG,TP53I3,TERT,PIK3CA,CDH1,NCOA4,LPL,PPARG,RHOA,TYMP",DisGeNET
257,Anaplastic carcinoma,0.00797472318619059,2.6089324618736383,12.605000682959131,0.1369045863714898,"TF,KITLG,TP53I3,TERT,CDH1,NCOA4,LPL,PPARG,RHOA,TYMP",DisGeNET
258,Hepatitis B,0.008144157115339019,1.789818070631402,8.609838440735949,0.1392713999723866,"FTO,HSPA8,IL1RN,GCKR,TFRC,IL37,HFE,PDCD5,ETS2,UBE2L3,DDB2,LAPTM4B,MSRA,CCND2,ALDH2,TERT,CDH1,TDP2,KIT,LEPR,PPARG,APOE,APOB,IL6R",DisGeNET
259,VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding),0.008229961722466988,2.9846995343336538,14.326479909750017,0.14016907442366666,"PDGFRA,NFE2,MSRA,KITLG,CDH1,TRPC1,KIT,ZNF410",DisGeNET
260,Hematologic Neoplasms,0.008260190242555152,1.932900432900433,9.270785152198764,0.14016907442366666,"CEBPA,PDGFRA,RTEL1,IL37,HFE,ASXL1,MFHAS1,RPS28,PTPRC,CCND2,PIK3CA,TERT,CDH1,KIT,PRDM16,LEPR,ANP32B,JAK2,SH2B3",DisGeNET
261,Coronary Arteriosclerosis,0.00833019730082003,1.7436308372478586,8.34827452924109,0.140815442495088,"FTO,IL1RN,HFE,LPL,PLD1,FADS2,ALDH2,TERT,MYB,LEPR,LONP1,NLRP3,APOE,APOB,JAK2,SH2B3,PLTP,IL6R,HSPA8,PTPN1,GALNT2,PIK3CA,PPARG,BUD13,ANP32B,TRIB1",DisGeNET
262,"Anemia, Sickle Cell",0.008403630046986407,2.586934156378601,12.36319508445457,0.1415145639973436,"SPTA1,HBS1L,TFRC,EPAS1,BCL11A,HFE,MYB,NPRL3,APOB,QKI",DisGeNET
263,Congenital chromosomal disease,0.00860680410514846,2.006082971251711,9.539330185399677,0.14270912479579376,"CEBPA,PDGFRA,RTEL1,GYPA,TFRC,MPG,EPAS1,BCL11A,DDB2,ASXL1,KITLG,CCND2,PIK3CA,TERT,CDH1,KIT,JAK2",DisGeNET
264,Dislocations,0.008607365490275446,5.595592286501377,26.60780786200401,0.14270912479579376,"GCDH,HFE,IL2RB,NLRP3",DisGeNET
265,PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA,0.008607365490275446,5.595592286501377,26.60780786200401,0.14270912479579376,"PDGFRA,PIK3CA,MAX,KIT",DisGeNET
266,Acute lymphocytic leukemia,0.008779520402301767,1.6994972347913524,8.04768618347466,0.14270912479579376,"TRABD,RTEL1,GYPA,IL1RN,MPG,HFE,HDAC7,PSMB5,BCL2L11,CCND2,TERT,MYB,LONP1,JAK2,SH2B3,EPHB4,MPST,PDGFRA,MEF2C,ABCC2,BCL11A,ATP11A,KITLG,PTPRC,PIK3CA,KIT,MAPT,ATR",DisGeNET
267,Spider Veins,0.008916446427890624,8.377094204888767,39.53869337643822,0.14270912479579376,"HFE,DDB2,ATR",DisGeNET
268,Behavioral variant of frontotemporal dementia,0.008916446427890624,8.377094204888767,39.53869337643822,0.14270912479579376,"TOMM40,APOE,MAPT",DisGeNET
269,Clubbed Fingers,0.008916446427890624,8.377094204888767,39.53869337643822,0.14270912479579376,"RTEL1,TERT,ATP11A",DisGeNET
270,Lobular carcinoma in situ of breast,0.008916446427890624,8.377094204888767,39.53869337643822,0.14270912479579376,"MAP3K1,PIK3CA,CDH1",DisGeNET
271,Macule,0.008916446427890624,8.377094204888767,39.53869337643822,0.14270912479579376,"PIK3CA,KIT,ADAR",DisGeNET
272,Hamman-Rich syndrome,0.009113501315287155,2.4242364358957467,11.389058664275893,0.14270912479579376,"CEBPA,IL1RN,RTEL1,TAGLN,PTPRC,TERT,PIK3CA,HFE,NLRP3,ATP11A,ETS2",DisGeNET
273,Eczema,0.009149479330752042,2.03989218328841,9.57537284438527,0.14270912479579376,"IL1RN,IL37,DUSP1,FADS2,RAD50,PTPRC,KANSL1,CDH1,IL2RB,CLDN23,NLRP3,PPARG,ANP32B,PDE7A,IL6R,CTSB",DisGeNET
274,"Histiocytosis, Langerhans-Cell",0.009212477677974914,4.281492738939548,20.068197543043876,0.14270912479579376,"PDGFRA,IL1RN,KITLG,MAP3K1,KIT",DisGeNET
275,Refractory cancer,0.009246614105936983,2.70873786407767,12.686367927595093,0.14270912479579376,"ASXL1,PDGFRA,ABCC2,PIK3CA,KIT,HIST1H4H,HIST1H4J,HIST1H4C,TYMP",DisGeNET
276,Multiple malignancy,0.009246614105936983,2.70873786407767,12.686367927595093,0.14270912479579376,"CCND2,TERT,ALDH2,PIK3CA,TDP2,APOB,IL6R,QKI,SIRT3",DisGeNET
277,"Leukemia, T-Cell",0.009406585766622379,2.1497844827586206,10.031636548484652,0.14270912479579376,"HBZ,MEF2C,CCND2,PIK3CA,TERT,PRDM16,IL2RB,MYB,LONP1,TAF8,JARID2,JAK2,FBXO7,ATR",DisGeNET
278,"AXENFELD-RIEGER SYNDROME, TYPE 3",0.009444937543148634,20.431726907630523,95.25835798349146,0.14270912479579376,"GYPA,GYPE",DisGeNET
279,Sensory denervation disorder,0.009444937543148634,20.431726907630523,95.25835798349146,0.14270912479579376,"APOE,MAPT",DisGeNET
280,Angiosarcoma of Soft Tissue,0.009444937543148634,20.431726907630523,95.25835798349146,0.14270912479579376,"PIK3CA,KIT",DisGeNET
281,Argyrophilic grain disease,0.009444937543148634,20.431726907630523,95.25835798349146,0.14270912479579376,"APOE,MAPT",DisGeNET
282,Aspartylglucosaminuria,0.009444937543148634,20.431726907630523,95.25835798349146,0.14270912479579376,"GYPA,GYPE",DisGeNET
283,Dementia of frontal lobe type,0.009444937543148634,20.431726907630523,95.25835798349146,0.14270912479579376,"APOE,MAPT",DisGeNET
284,Epstein-Barr virus associated gastric carcinoma,0.009444937543148634,20.431726907630523,95.25835798349146,0.14270912479579376,"PIK3CA,JAK2",DisGeNET
285,Eyelid Xanthoma,0.009444937543148634,20.431726907630523,95.25835798349146,0.14270912479579376,"APOE,APOB",DisGeNET
286,eyelids (symptom),0.009444937543148634,20.431726907630523,95.25835798349146,0.14270912479579376,"APOE,APOB",DisGeNET
287,Fatty Liver Disease,0.009444937543148634,20.431726907630523,95.25835798349146,0.14270912479579376,"FTO,NLRP3",DisGeNET
288,Glycogen storage disease type Ia,0.009444937543148634,20.431726907630523,95.25835798349146,0.14270912479579376,"APOE,APOB",DisGeNET
289,Hemoglobin H Disease,0.009444937543148634,20.431726907630523,95.25835798349146,0.14270912479579376,"HBZ,HFE",DisGeNET
290,HEPATIC LIPASE DEFICIENCY (disorder),0.009444937543148634,20.431726907630523,95.25835798349146,0.14270912479579376,"HMGCL,APOB",DisGeNET
291,Increased megakaryocyte count,0.009444937543148634,20.431726907630523,95.25835798349146,0.14270912479579376,"JAK2,SH2B3",DisGeNET
292,Macrocytosis,0.009444937543148634,20.431726907630523,95.25835798349146,0.14270912479579376,"ALDH2,TERT",DisGeNET
293,Psoriasis,0.009768318892490236,1.7593503270922626,8.143348093957684,0.14543932125853276,"RTEL1-TNFRSF6B,IL1RN,GCKR,NDFIP1,USP49,KLF13,IL37,DUSP1,EPAS1,ICAM5,UBE2L3,HDAC7,RAD50,PIK3CA,BLOC1S2,NLRP3,PPARG,APOE,ANP32B,PDE7A,APOB,JAK2,SH2B3,IL6R",DisGeNET
294,Anaplastic astrocytoma,0.009775239756132993,2.6824260355029588,12.414006547215301,0.14543932125853276,"ASXL1,PDGFRA,IL1RN,RTEL1,CCND2,TERT,PIK3CA,KIT,TYMP",DisGeNET
295,Tapering fingers (finding),0.009856381925725589,5.351778656126482,24.723269998721616,0.14543932125853276,"FIG4,ASXL1,SNIP1,SLC39A13",DisGeNET
296,Biparietal narrowing,0.009856381925725589,5.351778656126482,24.723269998721616,0.14543932125853276,"ASXL1,AHI1,MAP2K2,KIAA0586",DisGeNET
297,Carcinoma in situ of uterine cervix,0.009856381925725589,5.351778656126482,24.723269998721616,0.14543932125853276,"TERT,CDH1,TMC8,TMC6",DisGeNET
298,Decreased width of the skull,0.009856381925725589,5.351778656126482,24.723269998721616,0.14543932125853276,"ASXL1,AHI1,MAP2K2,KIAA0586",DisGeNET
299,Familial Mediterranean Fever,0.009856381925725589,5.351778656126482,24.723269998721616,0.14543932125853276,"IL1RN,NLRP3,TRIM38,JAK2",DisGeNET
300,Acquired Hypogammaglobulinemia,0.00992271576705608,3.5621482176360226,16.431935491424944,0.14593007321417142,"BLK,RTEL1,PTPRC,TERT,HFE,ANP32B",DisGeNET
301,Malignant neoplasm of stomach,0.010104686978721546,1.4479936565630842,6.653177404586537,0.14721264510167154,"IL1RN,THRB,CD82,CITED2,HFE,PDCD5,ETS2,HK1,LAPTM4B,CCND2,ALDH2,CDH1,CLDN23,LEPR,FLOT2,JAK2,IL6R,EPHB4,CTSB,PDGFRA,BTN3A2,RHOA,DDB2,SIRT3,TLR1,DOK2,PIK3CA,KIT,PPARG,MAPT,TRABD,KANK2,FTO,GTF2A1,TAGLN,EPAS1,PLD1,TYMP,HDAC7,TERT,APOE,HSPA8,PTPN1,RRM1,MAP3K1,GADD45A,SMOX,TNK2,SLC25A37,KITLG,PTPRC,IL2RB,ZNF217,ANP32B,FBXL5,ATR",DisGeNET
302,Thyroid Nodule,0.010192056889596663,4.165365973876612,19.10297899209617,0.14721264510167154,"TERT,NCOA4,KIT,PPARG,IL6R",DisGeNET
303,Coronary Artery Disease,0.010246969448238026,1.6332123212321232,7.481375362812338,0.14721264510167154,"KANK2,FTO,IL1RN,TOMM40,HFE,LPL,FADS2,ZNF827,ALDH2,TERT,PRDM16,MYB,LEPR,NLRP3,APOE,APOB,SH2B3,PLTP,IL6R,HSPA8,PTPN1,MAP2K2,GALNT2,MYO9B,RHOA,TLR1,PPARG,BUD13,ANP32B,TRIB1,ATR",DisGeNET
304,Adult Acute Myeloblastic Leukemia,0.010276857364305267,3.1362407481274652,14.357273484727603,0.14721264510167154,"ASXL1,CEBPA,KITLG,TERT,MPG,BCL11A,PRDM16",DisGeNET
305,Carotid Atherosclerosis,0.010276857364305267,3.1362407481274652,14.357273484727603,0.14721264510167154,"IL1RN,AXL,HFE,NLRP3,PPARG,APOE,APOB",DisGeNET
306,Chronic liver disease,0.010276857364305267,3.1362407481274652,14.357273484727603,0.14721264510167154,"PDGFRA,TERT,ALDH2,HFE,HSD17B13,APOE,CPEB4",DisGeNET
307,Dystonia Disorders,0.010276857364305267,3.1362407481274652,14.357273484727603,0.14721264510167154,"ASXL1,GCDH,HSPA8,ALDH5A1,ADAR,APOE,KCTD17",DisGeNET
308,Hormone refractory prostate cancer,0.010276857364305267,3.1362407481274652,14.357273484727603,0.14721264510167154,"PIK3CA,TNK2,HIST1H4H,HIST1H4J,HIST1H4C,JAK2,IL6R",DisGeNET
309,"Thrombocythemia, Essential",0.010560400568703937,2.846343699315986,12.952697073004542,0.15057319790098758,"ASXL1,NFE2,HBS1L,TERT,HFE,MYB,JAK2,SH2B3",DisGeNET
310,Hyperlipidemia,0.010820019067672298,2.482222222222222,11.235424535044688,0.15057319790098758,"HELZ2,GALNT2,HFE,DOCK7,LEPR,LPL,PPARG,BUD13,APOE,APOB",DisGeNET
311,"Polyarticular Juvenile Idiopathic Arthritis, Rheumatoid Factor Negative",0.010886865396739583,7.6782477341389725,34.70720178532406,0.15057319790098758,"IL2RB,IL6R,UBE2L3",DisGeNET
312,Brain hemorrhage,0.010886865396739583,7.6782477341389725,34.70720178532406,0.15057319790098758,"MAX,JAK2,SH2B3",DisGeNET
313,Familial erythrocytosis,0.010886865396739583,7.6782477341389725,34.70720178532406,0.15057319790098758,"EPAS1,JAK2,SH2B3",DisGeNET
314,Generalized hyperpigmentation,0.010886865396739583,7.6782477341389725,34.70720178532406,0.15057319790098758,"RTEL1,MAP2K2,TERT",DisGeNET
315,Insulin-resistant diabetes mellitus,0.010886865396739583,7.6782477341389725,34.70720178532406,0.15057319790098758,"NSMCE2,LEPR,PPARG",DisGeNET
316,Macroangiopathy,0.010886865396739583,7.6782477341389725,34.70720178532406,0.15057319790098758,"LPL,APOE,APOB",DisGeNET
317,Neutrophil abnormality,0.010886865396739583,7.6782477341389725,34.70720178532406,0.15057319790098758,"RTEL1,TERT,NLRP3",DisGeNET
318,Occlusive vascular disease,0.010886865396739583,7.6782477341389725,34.70720178532406,0.15057319790098758,"TRPC1,APOB,JAK2",DisGeNET
319,Pseudomonas aeruginosa infection,0.010886865396739583,7.6782477341389725,34.70720178532406,0.15057319790098758,"NLRP3,PPARG,TMC6",DisGeNET
320,Juvenile Myelomonocytic Leukemia,0.011006179902388192,3.091131498470948,13.938834180004697,0.15174770540417717,"ASXL1,IL1RN,PIK3CA,BCL11A,KIT,JAK2,SH2B3",DisGeNET
321,Hematological Disease,0.011212488637299664,2.8137200223089796,12.635648657497132,0.15259721254224135,"FIG4,PDGFRA,AHI1,TFRC,HFE,KIT,JAK2,SH2B3",DisGeNET
322,Hyperpigmentation,0.011217301193070883,5.1282828282828286,23.027517835974916,0.15259721254224135,"PDGFRA,KITLG,HFE,KIT",DisGeNET
323,Malignant neoplasm of stomach stage IV,0.011217301193070883,5.1282828282828286,23.027517835974916,0.15259721254224135,"IL1RN,GCKR,PIK3CA,TYMP",DisGeNET
324,"Fatty Liver, Alcoholic",0.011240728485092574,4.055351143816989,18.2012741462273,0.15259721254224135,"ABCC2,HFE,PPARG,APOB,CTSB",DisGeNET
325,Angina Pectoris,0.011240728485092574,4.055351143816989,18.2012741462273,0.15259721254224135,"APOE,JAK2,APOB,IL6R,RHOA",DisGeNET
326,Myelodysplasia,0.011644713896391084,3.4295392953929538,15.27140562756331,0.15759655739532963,"ASXL1,KITLG,TFRC,HFE,KIT,JAK2",DisGeNET
327,Celiac Disease,0.011784023961073907,2.234016439171347,9.921290612021597,0.15899423154818984,"GTF2A1,PTPRC,TFRC,PIK3CA,HFE,DLG5,IL2RB,NLRP3,MYO9B,APOB,SH2B3,CTSB",DisGeNET
328,Polyp of large intestine,0.012360620760466344,3.9509780999142703,17.35759346653731,0.166265423156029,"ALDH2,PIK3CA,TERT,HFE,PPARG",DisGeNET
329,Precursor Cell Lymphoblastic Leukemia Lymphoma,0.012472267690804681,1.7885296568967912,7.841357006220278,0.16725727979279711,"CEBPA,PDGFRA,RTEL1,IL1RN,MEF2C,GADD45A,MPG,BCL11A,HFE,ATP11A,PSMB5,BCL2L11,PTPRC,PIK3CA,TERT,KIT,MYB,LEPR,JAK2,SH2B3,ATR",DisGeNET
330,Cholelithiasis,0.012576354069320313,3.0046721032959565,13.14825549713713,0.16814204289042795,"GCKR,ABCC2,PPARG,ATP11A,APOE,APOB,HK1",DisGeNET
331,Antisocial behavior,0.012693553917064063,4.922666666666666,21.495616450673804,0.16859705706944828,"GYPA,PTPRC,ALDH2,PIK3CA",DisGeNET
332,Autosomal dominant retinitis pigmentosa,0.012693553917064063,4.922666666666666,21.495616450673804,0.16859705706944828,"MAP3K1,TST,LONP1,HK1",DisGeNET
333,Hypersensitivity,0.012767241522057772,2.5581086803105153,11.155586165982118,0.16859705706944828,"TLR1,RTEL1-TNFRSF6B,RTEL1,NDFIP1,IL2RB,ZNF217,JAK2,IL6R,HDAC7",DisGeNET
334,"Anemia, Macrocytic",0.013088735319820933,7.086916105042993,30.72889174550526,0.16859705706944828,"RPS28,ALDH2,KIT",DisGeNET
335,"Leukemia, Mast-Cell",0.013088735319820933,7.086916105042993,30.72889174550526,0.16859705706944828,"KITLG,PIK3CA,KIT",DisGeNET
336,Basal cell nevus,0.013088735319820933,7.086916105042993,30.72889174550526,0.16859705706944828,"TMC8,TMC6,DDB2",DisGeNET
337,Complications of Diabetes Mellitus,0.013088735319820933,7.086916105042993,30.72889174550526,0.16859705706944828,"FTO,ALDH2,NLRP3",DisGeNET
338,Klatskin Tumor,0.013088735319820933,7.086916105042993,30.72889174550526,0.16859705706944828,"PIK3CA,DUSP1,HK1",DisGeNET
339,Stomach Neoplasms,0.013159519245136931,1.6899815568778926,7.318650836150891,0.16859705706944828,"IL1RN,PGAP3,CITED2,PDCD5,TYMP,LAPTM4B,CCND2,ALDH2,TERT,CDH1,CLDN23,LEPR,APOE,IL6R,HSPA8,PDGFRA,GADD45A,DUSP1,TNK2,RHOA,SIRT3,PIK3CA,KIT,PPARG,ATR",DisGeNET
340,Breast Carcinoma,0.013421492846385583,1.315568956065471,5.671283467385372,0.16859705706944828,"IL1RN,TFRC,CD82,MPG,HFE,PPP2R2A,ICAM5,ETS2,LAPTM4B,CCND3,CCND2,CDH1,MYB,LEPR,LONP1,SLC12A7,IL6R,EPHB4,PDGFRA,ZBTB38,NSMCE2,VRK2,ATP11A,FRS3,FTO,RTEL1,EPAS1,PLD1,BCL2L11,TERT,ZKSCAN3,NLRP3,APOE,MPST,NFE2,HSPA8,GADD45A,BTN2A1,TNK2,MSRA,TF,PTPRC,TP53I3,DLG5,ANP32B,CNOT8,ZNF410,CPEB4,ATR,CEP57,THRB,CITED2,MAST2,ADAR,PCSK7,SPPL3,HK1,SMPD2,AKAP10,SLC22A16,ALDH2,PSD4,FLOT2,JAK2,RAB8A,CTSB,BRD3,ABCC2,DUSP1,TRPC1,NCOA4,RHOA,DDB2,SIRT3,TLR1,GIGYF1,ELF1,PIK3CA,KIT,PPARG,MAPT,KANK2,CEBPA,LEPROT,TAGLN,TMPRSS6,HIST1H2BK,HSD17B13,TYMP,HDAC7,KDELC2,SH2B3,SLC17A3,RBM38,PTPN1,RRM1,MAP3K1,MYO9B,BYSL,ASXL1,SLC25A37,RAD50,KITLG,KANSL1,AXL,PRC1,ZNF217,CRLF3",DisGeNET
341,Familial Alzheimer Disease (FAD),0.013439406445656861,2.5346013986013984,10.9230272158336,0.16859705706944828,"TF,TOMM40,PIK3CA,HFE,NLRP3,PPARG,APOE,MAPT,CTSB",DisGeNET
342,Colorectal Cancer,0.013481379230286044,1.3589977870171674,5.852450396292742,0.16859705706944828,"IL1RN,TFRC,CD82,MPG,HFE,PDCD5,PPP2R2A,ICAM5,DMKN,ETS2,SCGN,FADS2,AKAP10,CCND3,CCND2,ALDH2,CDH1,MYB,LEPR,LONP1,JAK2,IL6R,EPHB4,HIST1H1B,CTSB,PDGFRA,MAP2K2,ABCC2,DUSP1,TFEB,RHOA,PIK3CA,KIT,TMBIM1,PPARG,TRIB1,MDFI,FTO,GCDH,MACF1,TAGLN,GYPA,MAX,EPAS1,HSD17B13,PLD1,TYMP,HDAC7,BCL2L11,LARP1,TERT,ZKSCAN3,NLRP3,APOE,APOB,SH2B3,NKX2-3,PTPN1,RRM1,KLF3,QKI,RAD50,KITLG,PTPRC,TFAP4,TP53I3,AXL,TDP2,IL2RB,ZNF217,HIST1H4H,HIST1H4J,ANP32B,HIST1H4C,CNOT8,ZNF410,CPEB4,ATR",DisGeNET
343,Down Syndrome,0.013482453024534487,1.9027283108894995,8.193844914223641,0.16859705706944828,"GYPA,EPAS1,TRRAP,GYPE,PABPC4,ITSN1,ADAR,CPT1B,ETS2,KIT,PRDM16,TAF8,APOE,MAPT,JAK2,TRIB1,PLTP",DisGeNET
344,Refractory anemia with ring sideroblasts associated with marked thrombocytosis,0.013871426046285067,15.322289156626505,65.54759211542967,0.16859705706944828,"ASXL1,JAK2",DisGeNET
345,"Cardiomyopathy, Alcoholic",0.013871426046285067,15.322289156626505,65.54759211542967,0.16859705706944828,"ALDH2,PPARG",DisGeNET
346,Schnitzler Syndrome,0.013871426046285067,15.322289156626505,65.54759211542967,0.16859705706944828,"IL1RN,HFE",DisGeNET
347,Thalassemia Minor,0.013871426046285067,15.322289156626505,65.54759211542967,0.16859705706944828,"TFRC,HFE",DisGeNET
348,"Thrombocytosis, Autosomal Dominant",0.013871426046285067,15.322289156626505,65.54759211542967,0.16859705706944828,"JAK2,SH2B3",DisGeNET
349,"XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP E",0.013871426046285067,15.322289156626505,65.54759211542967,0.16859705706944828,"CRLF3,DDB2",DisGeNET
350,Abnormality of the lymphatic system,0.013871426046285067,15.322289156626505,65.54759211542967,0.16859705706944828,"MAP2K2,TERT",DisGeNET
351,Vulvar Vestibulitis,0.013871426046285067,15.322289156626505,65.54759211542967,0.16859705706944828,"IL1RN,NLRP3",DisGeNET
352,Wernicke-Korsakoff Syndrome,0.013871426046285067,15.322289156626505,65.54759211542967,0.16859705706944828,"ALDH2,APOE",DisGeNET
353,Adenoid cystic breast carcinoma,0.013871426046285067,15.322289156626505,65.54759211542967,0.16859705706944828,"PIK3CA,MYB",DisGeNET
354,alpha^0^ Thalassemia,0.013871426046285067,15.322289156626505,65.54759211542967,0.16859705706944828,"HBZ,NPRL3",DisGeNET
355,Aplastic/hypoplastic toenail,0.013871426046285067,15.322289156626505,65.54759211542967,0.16859705706944828,"RTEL1,TERT",DisGeNET
356,Bilateral pheochromocytoma and islet cell adenoma of the pancreas,0.013871426046285067,15.322289156626505,65.54759211542967,0.16859705706944828,"EPAS1,MAX",DisGeNET
357,Collapsing glomerulopathy,0.013871426046285067,15.322289156626505,65.54759211542967,0.16859705706944828,"TAGLN,TERT",DisGeNET
358,cortex bone disorders,0.013871426046285067,15.322289156626505,65.54759211542967,0.16859705706944828,"APOE,MAPT",DisGeNET
359,Decreased circulating high-density lipoprotein levels,0.013871426046285067,15.322289156626505,65.54759211542967,0.16859705706944828,"PPARG,APOE",DisGeNET
360,HOYERAAL-HREIDARSSON SYNDROME,0.013871426046285067,15.322289156626505,65.54759211542967,0.16859705706944828,"RTEL1,TERT",DisGeNET
361,Memory performance,0.013871426046285067,15.322289156626505,65.54759211542967,0.16859705706944828,"TOMM40,APOE",DisGeNET
362,obsolete Combined hyperlipidemia,0.013871426046285067,15.322289156626505,65.54759211542967,0.16859705706944828,"LPL,APOE",DisGeNET
363,Peripheral hypomyelination,0.013871426046285067,15.322289156626505,65.54759211542967,0.16859705706944828,"FIG4,HK1",DisGeNET
364,Autoimmune Diseases,0.013955726795002694,1.6037020517395182,6.850799197710562,0.1689738929630754,"BLK,GYPA,IL1RN,PDCD5,LPL,ADAR,PLD1,UBE2L3,HELZ2,TERT,NLRP3,APOE,JAK2,SH2B3,IL6R,PTPN1,PDGFRA,GADD45A,IL37,DUSP1,MYO9B,ATP11A,PTPRC,PIK3CA,IL2RB,SERPING1,DNASE2,PPARG,ANP32B,ZNF410",DisGeNET
365,Mammary Neoplasms,0.013979027862992413,1.404298754392587,5.996632443672929,0.1689738929630754,"THRB,TFRC,CD82,CITED2,HFE,ADAR,ICAM5,ETS2,FADS2,CCND3,CCND2,SLC22A16,CDH1,PSD4,MYB,LEPR,LONP1,FLOT2,JAK2,SLC12A7,EPHB4,CTSB,PDGFRA,ABCC2,DUSP1,RHOA,DDB2,PIK3CA,KIT,PPARG,MAPT,FTO,CEBPA,TMPRSS6,EPAS1,HIST1H2BK,LPL,HSD17B13,PLD1,TYMP,BCL2L11,TERT,APOE,APOB,RBM38,PTPN1,RRM1,MAP3K1,GADD45A,SMOX,TNK2,RAD50,KITLG,PRC1,IL2RB,ZNF217,HIST1H4H,HIST1H4J,HIST1H4C,CNOT8",DisGeNET
366,Alcohol consumption,0.014288310223592657,4.732867132867133,20.1067035373349,0.1700427954024308,"GCKR,TF,ALDH2,HFE",DisGeNET
367,Apraxias,0.014288310223592657,4.732867132867133,20.1067035373349,0.1700427954024308,"BCL11A,IL2RB,APOE,MAPT",DisGeNET
368,Isochromosomes,0.014288310223592657,4.732867132867133,20.1067035373349,0.1700427954024308,"ASXL1,TERT,JAK2,ATR",DisGeNET
369,Malignant Central Nervous System Neoplasm,0.014288310223592657,4.732867132867133,20.1067035373349,0.1700427954024308,"RTEL1-TNFRSF6B,RTEL1,TERT,HEATR3",DisGeNET
370,Paresthesia,0.014288310223592657,4.732867132867133,20.1067035373349,0.1700427954024308,"SERPING1,JAK2,SH2B3,TYMP",DisGeNET
371,Ventricular Septal Defects,0.014377653993793428,2.367119027424371,10.041508481948132,0.1700427954024308,"CEP57,FIG4,FTO,ASXL1,CCND2,PIK3CA,KANSL1,CITED2,LONP1,APOE",DisGeNET
372,Dyslipidemias,0.014377653993793428,2.367119027424371,10.041508481948132,0.1700427954024308,"MSRA,FADS2,PTPN1,GCKR,LEPR,LPL,PPARG,APOE,APOB,PLTP",DisGeNET
373,Kidney Neoplasm,0.014377653993793428,2.367119027424371,10.041508481948132,0.1700427954024308,"TERT,CD82,PIK3CA,EPAS1,AXL,CDH1,FIGNL1,KIT,TFEB,PPARG",DisGeNET
374,Senile Plaques,0.014414325811538784,2.167990755452838,9.191267742036688,0.1700427954024308,"IL1RN,TF,PTPRC,PABPC4,TFEB,SERPING1,LPL,PPARG,APOE,MAPT,APOB,CTSB",DisGeNET
375,Colorectal Carcinoma,0.01455766247525386,1.3714234522300017,5.800624464285481,0.17094930405310074,"IL1RN,TFRC,CD82,MPG,HFE,PDCD5,PPP2R2A,ICAM5,ETS2,SCGN,FADS2,AKAP10,CCND3,CCND2,ALDH2,CDH1,PSD4,MYB,LEPR,LONP1,JAK2,IL6R,EPHB4,CTSB,PDGFRA,MAP2K2,ABCC2,DUSP1,RHOA,PIK3CA,KIT,PPARG,TRIB1,MDFI,FTO,GCDH,TAGLN,MAX,EPAS1,HSD17B13,PLD1,TYMP,HDAC7,BCL2L11,LARP1,TERT,SERTAD2,ZKSCAN3,NLRP3,APOE,SH2B3,NKX2-3,PTPN1,RRM1,MAP3K1,IL37,KLF3,RAD50,KITLG,PTPRC,TFAP4,TP53I3,AXL,IL2RB,ZNF217,ANP32B,CNOT8,ZNF410,CPEB4,ATR",DisGeNET
376,Malignant Testicular Germ Cell Tumor,0.014607408800548272,3.248074454428755,13.727098095799386,0.17094930405310074,"KITLG,TERT,MPG,KIT,APOE,JAK2",DisGeNET
377,Polymicrogyria,0.014607408800548272,3.248074454428755,13.727098095799386,0.17094930405310074,"FIG4,AHI1,CCND2,PIK3CA,KIAA0586,CTSB",DisGeNET
378,"Niemann-Pick Disease, Type C",0.014822194710170926,3.7575061160945955,15.825223901719527,0.17300402926262998,"PIK3CA,TERT,MAPT,APOE,TYMP",DisGeNET
379,Transient Ischemic Attack,0.014862028360166653,2.4888461538461537,10.475418444161178,0.1730112641822039,"HSPA8,CEBPA,IL1RN,TERT,DUSP1,MYB,PPARG,APOE,JAK2",DisGeNET
380,"Cholangitis, Sclerosing",0.014926661160353703,2.661125404050399,11.188984706474978,0.1733063922091593,"RTEL1-TNFRSF6B,GCKR,BCL2L11,NDFIP1,IL6R,SH2B3,UBE2L3,HDAC7",DisGeNET
381,Myocardial Infarction,0.015145078012778607,1.5922381711855396,6.671604812310627,0.1753807984051948,"FTO,IL1RN,EPAS1,HFE,LPL,FADS2,ALDH2,NLRP3,APOE,APOB,JAK2,SH2B3,IL6R,CTSB,MEF2C,GCKR,BTN2A1,RHOA,QKI,SIRT3,MSRA,RAD50,PTPRC,PIK3CA,KIT,PPARG,MAPT,ANP32B,TRIB1,ATR",DisGeNET
382,Colon Carcinoma,0.015206340895797824,1.4279690965367648,5.977539717940899,0.17562925662895287,"IL1RN,TFRC,CD82,MPG,PGAP3,CITED2,UBXN2A,HFE,ETS2,SMPD2,LAPTM4B,AKAP10,CDH1,MYB,LEPR,LONP1,JARID2,JAK2,EPHB4,CTSB,MAP2K2,TRPC1,RHOA,DDB2,SIRT3,PIK3CA,KIT,PPARG,KANK2,CEBPA,TAGLN,MAX,EPAS1,PLD1,TYMP,BCL2L11,TERT,ZKSCAN3,APOE,RBM38,HSPA8,PTPN1,RRM1,GADD45A,IL37,SLC25A37,RAD50,KITLG,PRC1,ZNF217,ZNF410,ATR",DisGeNET
383,"Hydrocephalus, Normal Pressure",0.015525801931861961,6.580060422960725,27.407609825477234,0.17654597454478085,"TRPC1,NPHP3,APOE",DisGeNET
384,Tangier Disease,0.015525801931861961,6.580060422960725,27.407609825477234,0.17654597454478085,"TERT,APOE,APOB",DisGeNET
385,Gastric lymphoma,0.015525801931861961,6.580060422960725,27.407609825477234,0.17654597454478085,"CCND3,CDH1,JAK2",DisGeNET
386,Hyperlipoproteinemia Type IIb,0.015525801931861961,6.580060422960725,27.407609825477234,0.17654597454478085,"LPL,APOE,APOB",DisGeNET
387,Increased gastric cancer,0.015525801931861961,6.580060422960725,27.407609825477234,0.17654597454478085,"PDGFRA,PIK3CA,KIT",DisGeNET
388,Plexiform Neurofibroma,0.015525801931861961,6.580060422960725,27.407609825477234,0.17654597454478085,"PDGFRA,AXL,KIT",DisGeNET
389,Invasive Carcinoma,0.01576531125442151,2.6325544968019843,10.924951745300199,0.1788086201915365,"TAGLN,CCND2,CD82,PIK3CA,CDH1,MAST2,LPL,EPHB4",DisGeNET
390,Telangiectasia of the skin,0.016004476752385043,4.5571268237934905,18.843203544407974,0.18013201895796638,"RTEL1,TERT,PIK3CA,DDB2",DisGeNET
391,Factor V Leiden mutation,0.016004476752385043,4.5571268237934905,18.843203544407974,0.18013201895796638,"HFE,LPL,APOE,JAK2",DisGeNET
392,Oncocytic Neoplasm,0.016004476752385043,4.5571268237934905,18.843203544407974,0.18013201895796638,"CD82,CDH1,KIT,TFEB",DisGeNET
393,Overweight,0.016140268541171305,2.21671826625387,9.147150440485241,0.18058746013288096,"BLK,FTO,IL1RN,GCKR,HFE,LEPR,LPL,PPARG,APOE,PCSK7,APOB",DisGeNET
394,"Multiple Sclerosis, Relapsing-Remitting",0.016167734984698093,3.667679837892604,15.128217263537808,0.18058746013288096,"IL1RN,LEPR,NLRP3,APOE,PLD1",DisGeNET
395,Pediatric Obesity,0.016167734984698093,3.667679837892604,15.128217263537808,0.18058746013288096,"FTO,MSRA,GCKR,PPARG,APOE",DisGeNET
396,Osteosarcoma,0.016391464013259503,1.5938259949074471,6.552210005248025,0.1818444454405508,"CEBPA,RTEL1,CITED2,EPAS1,UBXN2A,ARPC1A,PDCD5,LPL,ETS2,THBS3,CCND3,BCL2L11,TERT,P4HTM,IL6R,CTSB,MPST,PDGFRA,GADD45A,DUSP1,RHOA,KITLG,PIK3CA,AXL,TDP2,KIT,PPARG,SNRNP25,ATR",DisGeNET
397,Nonalcoholic Steatohepatitis,0.016392763855116965,2.4446963562753035,10.049939581203736,0.1818444454405508,"IL1RN,GCKR,SAMM50,TFRC,HFE,LEPR,NLRP3,APOE,JAK2",DisGeNET
398,"Diabetes Mellitus, Insulin-Dependent",0.016403918695679788,1.6373916664497827,6.730064581729045,0.1818444454405508,"FTO,BLK,IL1RN,HFE,LPL,ACOXL,PSMB5,ALDH2,NLRP3,APOE,JAK2,SH2B3,IL6R,EPHB4,CTSB,PTPN1,MAP3K1,ABCC2,IL37,DUSP1,TLR1,FAM167A,PTPRC,IL2RB,PPARG,ZNF410",DisGeNET
399,Cutaneous Melanoma,0.016822716857929524,2.117871259175607,8.651557277798979,0.1858696262690597,"FTO,PDGFRA,MAP2K2,TERT,PIK3CA,TRRAP,CDH1,MYB,PRDM16,KIT,CNOT8,DDB2",DisGeNET
400,"Leukemia, B-Cell",0.016851280713423365,3.1373501446878875,12.810831631559623,0.1858696262690597,"CCND2,BCL2L11,PIK3CA,LONP1,JAK2,ATR",DisGeNET
401,Atherosclerosis,0.01698872252413166,1.5532144676515538,6.329668197159346,0.18691831365702963,"FTO,TAGLN,IL1RN,PCOLCE2,MPG,HFE,LPL,TYMP,FADS2,ALDH2,TERT,CDH1,LEPR,NLRP3,APOE,APOB,JAK2,PLTP,IL6R,CTSB,NFE2,PTPN1,MEF2C,IL37,DUSP1,RHOA,SIRT3,MSRA,PIK3CA,KIT,PPARG,ATR",DisGeNET
402,Colonic Neoplasms,0.017044458553899234,1.6658863831001998,6.783372972464629,0.18706505258657566,"HSPA8,PTPN1,TAGLN,IL1RN,ABCC2,GADD45A,MPG,CITED2,EPAS1,LPL,RHOA,TYMP,LAPTM4B,KITLG,CCND2,PIK3CA,CDH1,KIT,TRIP6,MYB,ZKSCAN3,PPARG,JAK2,ATR",DisGeNET
403,Gastric Adenocarcinoma,0.017181996216849307,2.041285125397275,8.295564689223513,0.18810661863210706,"BRD3,IL1RN,MAP2K2,TRRAP,TNK2,RHOA,DOK2,PIK3CA,AXL,KIT,PPARG,IL6R,EPHB4",DisGeNET
404,Hepatitis,0.017469649922953023,2.1056953363511948,8.522360085927286,0.19078241450512065,"IL1RN,TF,ABCC2,TERT,IL37,HFE,LEPR,NLRP3,PPARG,ADAR,APOE,APOB",DisGeNET
405,Malignant neoplasm of prostate,0.01777274514979712,1.346474358974359,5.426411727051936,0.1914231868184865,"CEP57,IL1RN,TFRC,CD82,TRRAP,HFE,ITSN1,PPP2R2A,ICAM5,ETS2,UBE2L3,HK1,LAPTM4B,SPRED2,CCND3,ACOXL,CCND2,CDH1,MYB,LEPR,LONP1,FLOT2,JAK2,EPHB4,ZNF322,CTSB,PDGFRA,ABCC2,DUSP1,TRPC1,NCOA4,FRS3,RHOA,SIRT3,TLR1,SLC7A6,XRN1,PIK3CA,TST,KIT,PPARG,TRIB1,FTO,CEBPA,TAGLN,TMPRSS6,EPAS1,LPL,HSD17B13,ARHGAP21,BCL2L11,LARP1,TERT,ZKSCAN3,NLRP3,STX4,APOE,HSPA8,PTPN1,MAP3K1,GADD45A,TNK2,QKI,TF,KITLG,PTPRC,TP53I3,AXL,DLG5,ZNF217,HIST1H4H,BUD13,ZNF410,ATR",DisGeNET
406,Restless Legs Syndrome,0.017844695030163935,4.393939393939394,17.690215356276155,0.1914231868184865,"TF,TMPRSS6,HFE,CPT1B",DisGeNET
407,Cutaneous Mastocytosis,0.017844695030163935,4.393939393939394,17.690215356276155,0.1914231868184865,"KITLG,FAM167A,CD82,KIT",DisGeNET
408,Fibrinogen assay,0.017844695030163935,4.393939393939394,17.690215356276155,0.1914231868184865,"GALNT2,NLRP3,IL6R,SH2B3",DisGeNET
409,gallbladder neoplasm,0.017844695030163935,4.393939393939394,17.690215356276155,0.1914231868184865,"IL1RN,CDH1,AXL,APOB",DisGeNET
410,Inclusion Body Myositis (disorder),0.017844695030163935,4.393939393939394,17.690215356276155,0.1914231868184865,"PTPRC,MAPT,APOE,HK1",DisGeNET
411,Glioma,0.017859444397449856,1.4084710535821081,5.669409816023318,0.1914231868184865,"TFRC,MPG,HFE,ITSN1,PDCD5,ADAR,HK1,SMPD2,CCND3,CCND2,CDH1,PSD4,MYB,LEPR,JARID2,JAK2,IL6R,EPHB4,RAB8A,CTSB,PDGFRA,DUSP1,TRPC1,RHOA,SIRT3,PIK3CA,KIT,SERPING1,PPARG,TRIB1,KANK2,RTEL1,EPAS1,PLD1,TYMP,TERT,HEATR3,RTEL1-TNFRSF6B,CD164,HSPA8,GADD45A,TNK2,QKI,AXL,TRIP6,IL2RB,ZNF217,HIST1H4H,HIST1H4J,ANP32B,CRLF3,HIST1H4C,ATR",DisGeNET
412,Hepatomegaly,0.017875419983956583,1.9711255656108597,7.932457175278047,0.1914231868184865,"GCDH,PDGFRA,IL1RN,HFE,SLC25A15,HADHA,HMGCL,PTPRC,LEPR,NPHP3,NLRP3,PPARG,APOE,JAK2",DisGeNET
413,Basal cell carcinoma,0.018057652701852788,3.084756097560976,12.382783850761681,0.19210883979137952,"TERT,PIK3CA,TMC8,TMC6,DDB2,TYMP",DisGeNET
414,Serum cholesterol raised,0.018200701503353726,6.140785498489426,24.601799107603384,0.19210883979137952,"LPL,APOE,APOB",DisGeNET
415,Excessive wrinkled skin,0.018200701503353726,6.140785498489426,24.601799107603384,0.19210883979137952,"RTEL1,MAP2K2,TERT",DisGeNET
416,Large hand,0.018200701503353726,6.140785498489426,24.601799107603384,0.19210883979137952,"PDGFRA,KIT,PPARG",DisGeNET
417,Lymphomatoid Papulosis,0.018200701503353726,6.140785498489426,24.601799107603384,0.19210883979137952,"PDGFRA,IL1RN,KIT",DisGeNET
418,Pregnancy in Diabetics,0.018200701503353726,6.140785498489426,24.601799107603384,0.19210883979137952,"ABCC2,TFRC,LEPR",DisGeNET
419,Brain Neoplasms,0.018336174443557656,1.7158551539468965,6.861497871013641,0.19307685356796273,"MPST,PDGFRA,RTEL1,TFRC,EPAS1,TRRAP,HFE,ADAR,TF,CCND2,PIK3CA,TERT,CDH1,AXL,PSD4,KIT,PPARG,APOE,MAPT,JAK2,CTSB",DisGeNET
420,Hyperactive behavior,0.018776123097770245,1.6684381326664286,6.63232398441448,0.1932508218357733,"MEF2C,PGAP3,DUSP1,LPL,HK1,FADS2,ALDH5A1,PIK3CA,CDH1,KIT,NPHP3,NLRP3,HIST1H4H,FLOT2,APOE,MAPT,HIST1H4J,APOB,JAK2,HIST1H4C,PLTP,RAB8A,ATR",DisGeNET
421,"Malignant melanoma, metastatic",0.019015359602025866,12.256626506024096,48.56698335666549,0.1932508218357733,"MPG,KIT",DisGeNET
422,Total iron binding capacity function,0.019015359602025866,12.256626506024096,48.56698335666549,0.1932508218357733,"TF,HFE",DisGeNET
423,Amaurosis Fugax,0.019015359602025866,12.256626506024096,48.56698335666549,0.1932508218357733,"JAK2,SH2B3",DisGeNET
424,beta^0^ Thalassemia,0.019015359602025866,12.256626506024096,48.56698335666549,0.1932508218357733,"HBZ,APOB",DisGeNET
425,Bone Sarcoma,0.019015359602025866,12.256626506024096,48.56698335666549,0.1932508218357733,"PDGFRA,KIT",DisGeNET
426,Chronic active hepatitis C,0.019015359602025866,12.256626506024096,48.56698335666549,0.1932508218357733,"IL1RN,HFE",DisGeNET
427,Constitutional Symptom,0.019015359602025866,12.256626506024096,48.56698335666549,0.1932508218357733,"IL1RN,JAK2",DisGeNET
428,Iron binding capacity total measurement,0.019015359602025866,12.256626506024096,48.56698335666549,0.1932508218357733,"TF,HFE",DisGeNET
429,Lecithin Acyltransferase Deficiency,0.019015359602025866,12.256626506024096,48.56698335666549,0.1932508218357733,"APOE,APOB",DisGeNET
430,Monogenic Obesity,0.019015359602025866,12.256626506024096,48.56698335666549,0.1932508218357733,"FTO,LEPR",DisGeNET
431,Primary gout,0.019015359602025866,12.256626506024096,48.56698335666549,0.1932508218357733,"NLRP3,SLC17A1",DisGeNET
432,Primary Progressive Nonfluent Aphasia,0.019015359602025866,12.256626506024096,48.56698335666549,0.1932508218357733,"APOE,MAPT",DisGeNET
433,Pulmonary Pathology,0.019015359602025866,12.256626506024096,48.56698335666549,0.1932508218357733,"EPAS1,AXL",DisGeNET
434,Precursor B-cell lymphoblastic leukemia,0.019083342491790525,2.0102137288634707,7.958314424674879,0.1932508218357733,"CEBPA,PDGFRA,RTEL1,TFRC,MPG,BCL11A,HDAC7,AHI1,BCL2L11,PTPRC,KIT,LONP1,JAK2",DisGeNET
435,"Carcinoma, Neuroendocrine",0.019097316029101804,3.5002763194252555,13.854819895055655,0.1932508218357733,"PIK3CA,TERT,MAX,KIT,NKX2-3",DisGeNET
436,Traditional Serrated Adenoma,0.019097316029101804,3.5002763194252555,13.854819895055655,0.1932508218357733,"BCL2L11,PIK3CA,HIST1H4H,HIST1H4J,HIST1H4C",DisGeNET
437,Waist Circumference,0.01932192344824079,3.0338864454218313,11.973278055063167,0.1950762614499734,"FTO,GCKR,TOMM40,ZBTB38,SLC39A13,CPEB4",DisGeNET
438,"FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder)",0.019558841129554277,2.2454821971730183,8.83446317440124,0.19701736772509926,"SPTA1,GYPA,RAD50,ALDH2,MPG,CDH1,KIT,JAK2,ATR,CTSB",DisGeNET
439,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,0.01972283750383522,1.944140625,7.632653420858591,0.1982032585795075,"MPST,RTEL1,MEF2C,TFRC,DUSP1,CCND3,TF,PTPRC,CCND2,PIK3CA,TERT,KIT,MYB,JAK2",DisGeNET
440,"Anemia, Diamond-Blackfan",0.019811341122747687,4.242006269592476,16.635030645892297,0.1982032585795075,"KITLG,RPS28,TFRC,LONP1",DisGeNET
441,ATRICHIA WITH PAPULAR LESIONS,0.019811341122747687,4.242006269592476,16.635030645892297,0.1982032585795075,"MPST,KIT,PPARG,HK1",DisGeNET
442,Virus Diseases,0.019955858312303353,1.6393000210837023,6.416601467338171,0.199197391117381,"BRD3,HSPA8,RTEL1,RRM1,ABCC2,DUSP1,HFE,ADAR,PLD1,PIK3CA,TERT,CDH1,AXL,TDP2,LEPR,NLRP3,SERPING1,PPARG,APOE,MAPT,APOB,CNOT8,IL6R,CTSB",DisGeNET
443,"Dermatitis, Atopic",0.02029043457421136,1.84635453063126,7.196361956151625,0.20207990370523818,"RTEL1-TNFRSF6B,RTEL1,IL1RN,IL37,DUSP1,TLR1,SMPD2,RAD50,KITLG,IL2RB,CLDN23,NLRP3,PPARG,ANP32B,PDE7A,IL6R",DisGeNET
444,Fanconi Anemia,0.020497751432833774,2.132314241486068,8.289243856290803,0.20368486333707794,"ASXL1,GYPA,RAD50,ABCC2,ALDH2,MPG,CDH1,KIT,JAK2,ATR,CTSB",DisGeNET
445,Cholera,0.02064524868725465,2.9846577498033047,11.581278147197382,0.2041628854936207,"TRPC1,KIT,NLRP3,ARFIP1,APOE,APOB",DisGeNET
446,Mixed Salivary Gland Tumor,0.02064524868725465,2.9846577498033047,11.581278147197382,0.2041628854936207,"PDGFRA,TERT,PIK3CA,MYB,NLRP3,JAK2",DisGeNET
447,Pregnancy Complications,0.020684680375260302,3.4221546774738263,13.272354423771738,0.2041628854936207,"HADHA,IL1RN,LEPR,PPARG,JAK2",DisGeNET
448,Tropical Spastic Paraparesis,0.02111504710387186,5.7564199395770395,22.20694046489024,0.20610528279266074,"HBZ,IL2RB,IL6R",DisGeNET
449,Disease of capillaries,0.02111504710387186,5.7564199395770395,22.20694046489024,0.20610528279266074,"APOE,APOB,EPHB4",DisGeNET
450,Iron deficiency anemia,0.02111504710387186,5.7564199395770395,22.20694046489024,0.20610528279266074,"TFRC,TMPRSS6,HFE",DisGeNET
451,Pathological accumulation of air in tissues,0.02111504710387186,5.7564199395770395,22.20694046489024,0.20610528279266074,"CEBPA,PPP2R2A,APOE",DisGeNET
452,Premature canities,0.02111504710387186,5.7564199395770395,22.20694046489024,0.20610528279266074,"RTEL1,KITLG,TERT",DisGeNET
453,Pancreatic carcinoma,0.02166546622804726,1.416123652096372,5.426636396322994,0.21011216196288413,"KANK2,FTO,CEBPA,TAGLN,IL1RN,TFRC,CD82,EPAS1,HFE,ARPC1A,PPP2R2A,ADAR,DMKN,ETS2,TYMP,LAPTM4B,CCND3,BCL2L11,CCND2,ALDH2,TERT,CDH1,MYB,LONP1,JAK2,EPHB4,CTSB,NFE2,PDGFRA,RRM1,GCKR,MAP3K1,MAP2K2,ABCC2,GADD45A,DUSP1,BCL11A,TFEB,SIRT3,TF,KITLG,PTPRC,PIK3CA,AXL,IL2RB,PPARG,ATR",DisGeNET
454,Abdominal Pain,0.021671354294248633,2.6684411220598783,10.224836545208754,0.21011216196288413,"PIK3CA,HFE,SERPING1,LPL,NLRP3,JAK2,TYMP",DisGeNET
455,Impaired glucose tolerance,0.021859985371661277,1.9701998328394499,7.532265987293287,0.21011216196288413,"FTO,PTPN1,GCKR,HFE,NSMCE2,LPL,ALDH2,PIK3CA,LEPR,PPARG,APOE,APOB,CTSB",DisGeNET
456,Dysmorphic features,0.021906526405921736,4.10020202020202,15.666751689594776,0.21011216196288413,"MEF2C,KANSL1,JARID2,ATR",DisGeNET
457,Hallucinations,0.021906526405921736,4.10020202020202,15.666751689594776,0.21011216196288413,"ALDH5A1,TOMM40,MAPT,APOE",DisGeNET
458,Invasive Lobular Breast Carcinoma,0.021906526405921736,4.10020202020202,15.666751689594776,0.21011216196288413,"CCND2,PIK3CA,CDH1,KIT",DisGeNET
459,Malignant neoplasm of nasopharynx,0.021906526405921736,4.10020202020202,15.666751689594776,0.21011216196288413,"PIK3CA,TERT,CDH1,TRIP6",DisGeNET
460,Pancreatic Diseases,0.021906526405921736,4.10020202020202,15.666751689594776,0.21011216196288413,"ASXL1,ABCC2,LEPR,NPHP3",DisGeNET
461,Skin Erosion,0.02202874179593662,2.936991869918699,11.205820023782435,0.21036971602526486,"ASXL1,IL1RN,TERT,MPG,IL2RB,CTSB",DisGeNET
462,Hyperkeratosis,0.02202874179593662,2.936991869918699,11.205820023782435,0.21036971602526486,"IL1RN,KITLG,PIK3CA,TMPRSS6,TRPC1,DDB2",DisGeNET
463,Malignant tumor of colon,0.022147201258040206,1.4045582424529792,5.351428907285659,0.2110441726792082,"IL1RN,TFRC,CD82,MPG,CITED2,UBXN2A,HFE,ETS2,SMPD2,LAPTM4B,AKAP10,CCND2,CDH1,MYB,LEPR,JARID2,JAK2,EPHB4,CTSB,TRPC1,RHOA,DDB2,SIRT3,PIK3CA,KIT,PPARG,KANK2,TAGLN,MAX,EPAS1,LPL,PLD1,TYMP,BCL2L11,TERT,ZKSCAN3,APOE,RBM38,HSPA8,PTPN1,RRM1,GADD45A,IL37,SLC25A37,RAD50,PRC1,ZNF217,ZNF410,ATR",DisGeNET
464,Acute leukemia,0.022765767297182438,1.8186659321489236,6.879098988208703,0.21600551680681487,"CEBPA,PDGFRA,RTEL1,TFRC,IL37,HFE,ETS2,ASXL1,TF,PTPRC,PIK3CA,KIT,IL2RB,MYB,LEPR,JAK2",DisGeNET
465,Acute Promyelocytic Leukemia,0.022765767297182438,1.8186659321489236,6.879098988208703,0.21600551680681487,"MPST,CEBPA,TFRC,BCL11A,HFE,WIPI2,HK1,ASXL1,TF,PTPRC,PIK3CA,TERT,KIT,PPARG,JAK2,RAB8A",DisGeNET
466,Tetralogy of Fallot,0.022904917795890396,2.635638099500261,9.953233314165592,0.21685943629928847,"FIG4,ALDH2,CITED2,APOE,JARID2,SH2B3,EPHB4",DisGeNET
467,Lupus Nephritis,0.02368375299800479,2.282572509457755,8.543591280445002,0.21911293465559037,"BLK,PDGFRA,FAM167A,DUSP1,AXL,SERPING1,NLRP3,ANP32B,MUC20",DisGeNET
468,B-Cell Lymphomas,0.02373135652147062,1.6464237516869096,6.159202179905434,0.21911293465559037,"CEBPA,PTPN1,RTEL1,IL1RN,ABCC2,BCL11A,RHOA,MFHAS1,AHI1,CCND3,BCL2L11,PTPRC,CCND2,PIK3CA,TERT,CDH1,PRC1,KIT,LONP1,PPARG,ANP32B,JAK2",DisGeNET
469,Xeroderma Pigmentosum,0.024112149987976932,3.2758843691392356,12.202798399421988,0.21911293465559037,"RTEL1,KIT,CRLF3,ATR,DDB2",DisGeNET
470,Gastrointestinal Hemorrhage,0.024132099380993526,3.9675464320625613,14.775985620607484,0.21911293465559037,"PDGFRA,PIK3CA,KIT,JAK2",DisGeNET
471,Heartburn,0.024186156641564278,2.603625511219189,9.69062866923648,0.21911293465559037,"ASXL1,RTEL1,TERT,PIK3CA,PRDM16,ATP11A,TYMP",DisGeNET
472,Platelet distribution width measurement,0.024186156641564278,2.603625511219189,9.69062866923648,0.21911293465559037,"BRD3,MEF2C,ERI1,PRDM16,DOCK7,TMCC2,SLC12A7",DisGeNET
473,Platelet distribution width result,0.024186156641564278,2.603625511219189,9.69062866923648,0.21911293465559037,"BRD3,MEF2C,ERI1,PRDM16,DOCK7,TMCC2,SLC12A7",DisGeNET
474,Progressive Neoplastic Disease,0.024186156641564278,2.603625511219189,9.69062866923648,0.21911293465559037,"IL1RN,RTEL1,KITLG,BCL2L11,PTPRC,PIK3CA,APOE",DisGeNET
475,Malignant neoplasm of pancreas,0.024198328751694777,1.4094406906906907,5.245193654582056,0.21911293465559037,"KANK2,FTO,CEBPA,TAGLN,IL1RN,TFRC,CD82,EPAS1,HFE,ARPC1A,ADAR,DMKN,ETS2,TYMP,CCND3,BCL2L11,CCND2,ALDH2,TERT,CDH1,MYB,LONP1,JAK2,EPHB4,CTSB,NFE2,PDGFRA,RRM1,GCKR,MAP3K1,MAP2K2,ABCC2,GADD45A,DUSP1,BCL11A,TFEB,SIRT3,TF,KITLG,PTPRC,PIK3CA,AXL,IL2RB,PPARG,MUC20,ATR",DisGeNET
476,Chronic Lymphocytic Leukemia,0.024260865566331603,1.536864512205236,5.715431137540637,0.21911293465559037,"KANK2,BLK,RTEL1,IL1RN,TFRC,MPG,AK3,LPL,ETS2,ACOXL,BCL2L11,CCND2,TERT,CDH1,LONP1,APOE,JAK2,IL6R,GADD45A,DUSP1,BCL11A,SIRT3,TF,PTPRC,PIK3CA,IL2RB,ANP32B,PDE7A,ATR",DisGeNET
477,Endometriosis of ovary,0.024269509920487396,5.417273858183757,20.14431947897334,0.21911293465559037,"TERT,CDH1,TYMP",DisGeNET
478,Restrictive behavior,0.024826956027899184,10.21285140562249,37.74491440057724,0.21911293465559037,"APOE,MAPT",DisGeNET
479,Rough bone trabeculation,0.024826956027899184,10.21285140562249,37.74491440057724,0.21911293465559037,"RTEL1,TERT",DisGeNET
480,Semantic Dementia,0.024826956027899184,10.21285140562249,37.74491440057724,0.21911293465559037,"APOE,MAPT",DisGeNET
481,"Hallucinations, Visual",0.024826956027899184,10.21285140562249,37.74491440057724,0.21911293465559037,"FIG4,APOE",DisGeNET
482,Abdominal obesity metabolic syndrome,0.024826956027899184,10.21285140562249,37.74491440057724,0.21911293465559037,"PPARG,SIRT3",DisGeNET
483,Abnormal platelet morphology,0.024826956027899184,10.21285140562249,37.74491440057724,0.21911293465559037,"JAK2,SH2B3",DisGeNET
484,Urticaria Pigmentosa,0.024826956027899184,10.21285140562249,37.74491440057724,0.21911293465559037,"KITLG,KIT",DisGeNET
485,AIDS-Related Non-Hodgkin Lymphoma,0.024826956027899184,10.21285140562249,37.74491440057724,0.21911293465559037,"RTEL1,TFRC",DisGeNET
486,Anterior segment mesenchymal dysgenesis,0.024826956027899184,10.21285140562249,37.74491440057724,0.21911293465559037,"GYPA,GYPE",DisGeNET
487,Arterial thrombosis,0.024826956027899184,10.21285140562249,37.74491440057724,0.21911293465559037,"JAK2,SH2B3",DisGeNET
488,Autoinflammatory Syndrome,0.024826956027899184,10.21285140562249,37.74491440057724,0.21911293465559037,"IL1RN,NLRP3",DisGeNET
489,Bile Duct Neoplasms,0.024826956027899184,10.21285140562249,37.74491440057724,0.21911293465559037,"APOE,APOB",DisGeNET
490,Cutaneous plaque,0.024826956027899184,10.21285140562249,37.74491440057724,0.21911293465559037,"TMC8,TMC6",DisGeNET
491,Deep palmar crease,0.024826956027899184,10.21285140562249,37.74491440057724,0.21911293465559037,"ASXL1,MAP2K2",DisGeNET
492,Fetal Distress,0.024826956027899184,10.21285140562249,37.74491440057724,0.21911293465559037,"IL1RN,PTPRC",DisGeNET
493,Glutaric aciduria,0.024826956027899184,10.21285140562249,37.74491440057724,0.21911293465559037,"GCDH,HMGCL",DisGeNET
494,Hyperlipoproteinemia Type I,0.024826956027899184,10.21285140562249,37.74491440057724,0.21911293465559037,"LPL,APOB",DisGeNET
495,Leukokeratosis,0.024826956027899184,10.21285140562249,37.74491440057724,0.21911293465559037,"RTEL1,TERT",DisGeNET
496,myeloblastosis,0.024826956027899184,10.21285140562249,37.74491440057724,0.21911293465559037,"RRM1,MYB",DisGeNET
497,Nicolaides Baraitser syndrome,0.024826956027899184,10.21285140562249,37.74491440057724,0.21911293465559037,"RAD50,TERT",DisGeNET
498,Psychotic episodes,0.024826956027899184,10.21285140562249,37.74491440057724,0.21911293465559037,"HSPA8,IL1RN",DisGeNET
499,Malignant neoplasm of endometrium,0.024893443578002872,1.7324191279887482,6.398085123642051,0.21911293465559037,"FTO,IL1RN,MAP3K1,CD82,MAX,TNK2,SIRT3,TYMP,PIK3CA,TERT,CDH1,KIT,LEPR,PDE7A,SH2B3,MUC20,IL6R,ATR",DisGeNET
500,Dilated ventricles (finding),0.024906201346451166,2.4003812019774853,8.863739936588173,0.21911293465559037,"FIG4,MEF2C,RTEL1,CCND2,TERT,PIK3CA,PRDM16,SNIP1",DisGeNET
501,"Carcinoma, Endometrioid",0.0249804637651319,2.8460600375234524,10.500997318933656,0.21911293465559037,"TERT,PIK3CA,CDH1,KIT,SPPL3,TYMP",DisGeNET
502,Disease Exacerbation,0.0249804637651319,2.8460600375234524,10.500997318933656,0.21911293465559037,"RRM1,TERT,PIK3CA,CDH1,APOE,CTSB",DisGeNET
503,Myelofibrosis,0.0249804637651319,2.8460600375234524,10.500997318933656,0.21911293465559037,"ASXL1,NFE2,MYB,KIT,JAK2,SH2B3",DisGeNET
504,Metabolic Diseases,0.02535540611208238,1.875592672413793,6.892359142384199,0.2219604201716418,"FTO,GCDH,HSPA8,PTPN1,IL1RN,IL37,DUSP1,LPL,SIRT3,HADHA,LEPR,NLRP3,PPARG,APOE",DisGeNET
505,Primary malignant neoplasm,0.025415995573076482,1.5544989988943012,5.708705680165768,0.2220502425117098,"FTO,MACF1,CD82,EPAS1,HFE,ADAR,HSD17B13,TERT,CDH1,MYB,APOB,JARID2,JAK2,RAB8A,RBM38,DUSP1,GPN1,SIRT3,TF,PIK3CA,AXL,PRC1,KIT,TAF8,PPARG,TRIB1,ATR",DisGeNET
506,Carcinoma,0.02581936840722973,2.2453101736972703,8.210269338071646,0.22512856405671458,"TF,KITLG,TP53I3,TERT,PIK3CA,CDH1,LPL,RHOA,TYMP",DisGeNET
507,Malignant Glioma,0.025920312413768746,1.7537343054714103,6.405915023978182,0.2255629553639994,"PDGFRA,RTEL1,TFRC,EPAS1,ITSN1,PDCD5,QKI,HK1,FIG4,CCND3,CCND2,PIK3CA,TERT,PSD4,MYB,ANP32B,CTSB",DisGeNET
508,Aplasia Cutis Congenita,0.02611078641457797,2.3770646531382726,8.665367596958308,0.2267732079943268,"RRM1,TERT,PIK3CA,MYB,KIT,LONP1,PPARG,SLC12A7",DisGeNET
509,Gastrointestinal Stromal Tumors,0.026766628185860834,1.9696342305037957,7.131256482332377,0.23201250207469154,"PDGFRA,KITLG,CCND3,BCL2L11,TFRC,TERT,PIK3CA,AXL,CDH1,MAX,KIT,RHOA",DisGeNET
510,Progressive cGVHD,0.02689471683597508,2.541860046771002,9.190922150386779,0.23266566800063146,"IL1RN,RTEL1,KITLG,BCL2L11,PTPRC,PIK3CA,APOE",DisGeNET
511,Embryonal Carcinoma,0.02735540093714466,2.354192229038855,8.472364209667752,0.23471751633890786,"PDGFRA,GTF2A1,CCND2,TRRAP,KIT,HIST1H4H,HIST1H4J,HIST1H4C",DisGeNET
512,Fibrosis,0.02735540093714466,2.354192229038855,8.472364209667752,0.23471751633890786,"PDGFRA,IL1RN,CCND2,HFE,LEPR,NPHP3,RHOA,TYMP",DisGeNET
513,Heart failure,0.027501447061172076,1.584973458554512,5.695628521504682,0.23471751633890786,"FTO,RTEL1,MEF2C,GCKR,TFRC,DUSP1,HFE,TRPC1,NSMCE2,SIRT3,GIGYF1,HADHA,TF,ALDH2,PIK3CA,AXL,PRDM16,LONP1,MLEC,PPARG,APOE,JARID2,IL6R,CTSB",DisGeNET
514,Tumor Progression,0.027586651139905147,1.3741929687967898,4.93393442309432,0.23471751633890786,"IL1RN,TFRC,CD82,ETS2,HK1,CCND3,CCND2,CDH1,MYB,LEPR,LONP1,FLOT2,JAK2,IL6R,EPHB4,RAB8A,CTSB,PDGFRA,MAP2K2,DUSP1,RHOA,ELF1,PIK3CA,KIT,PPARG,CEBPA,RTEL1,TAGLN,TMPRSS6,MAX,EPAS1,PLD1,THBS3,TYMP,HDAC7,ARHGAP21,LARP1,TERT,ZKSCAN3,IL37,TNK2,KITLG,AXL,DLG5,TRIP6,ZNF217,RPL22L1,ANP32B,CNOT8,CPEB4,ATR",DisGeNET
515,"Anemia, severe",0.0276638958513672,5.115810674723061,18.35362109091987,0.23471751633890786,"KITLG,TFRC,TYMP",DisGeNET
516,Extraskeletal Myxoid Chondrosarcoma,0.0276638958513672,5.115810674723061,18.35362109091987,0.23471751633890786,"HSPA8,BCL2L11,PPARG",DisGeNET
517,Granulocytic Sarcoma,0.0276638958513672,5.115810674723061,18.35362109091987,0.23471751633890786,"PDGFRA,KIT,JAK2",DisGeNET
518,Hand deformities,0.0276638958513672,5.115810674723061,18.35362109091987,0.23471751633890786,"RPS28,TYMP,HK1",DisGeNET
519,Protein C antigen measurement,0.0276638958513672,5.115810674723061,18.35362109091987,0.23471751633890786,"GCKR,SLC4A1AP,GPN1",DisGeNET
520,Protein C measurement,0.0276638958513672,5.115810674723061,18.35362109091987,0.23471751633890786,"GCKR,SLC4A1AP,GPN1",DisGeNET
521,"PARKINSON DISEASE, LATE-ONSET",0.027885581145800687,3.141554494138081,11.245651497651558,0.23569192340090542,"TOMM40,PIK3CA,HFE,MAPT,APOE",DisGeNET
522,Lipoma,0.027885581145800687,3.141554494138081,11.245651497651558,0.23569192340090542,"PDGFRA,PIK3CA,KIT,LEPR,PPARG",DisGeNET
523,"Lymphoma, T-Cell, Cutaneous",0.02808189798506571,2.106114050558495,7.524366472220482,0.23649700671856203,"CD164,AHI1,CCND2,PTPRC,PIK3CA,MYB,KIT,JAK2,RHOA,HDAC7",DisGeNET
524,synovial sarcoma,0.028088039782530938,2.209230769230769,7.892281237730329,0.23649700671856203,"PTPN1,RTEL1,KITLG,TERT,PIK3CA,CDH1,KIT,HEATR3,EPHB4",DisGeNET
525,Presenile dementia,0.028303091998445468,1.8946806487941146,6.75412768331838,0.23785379408979318,"FTO,IL1RN,MEF2C,TOMM40,HFE,TF,ALDH2,PPARG,APOE,MAPT,APOB,IL6R,CTSB",DisGeNET
526,Adult T-Cell Lymphoma/Leukemia,0.028394542284593864,1.7656452116508319,6.288448403187515,0.23816867026545271,"HBZ,TFRC,RHOA,ETS2,AHI1,PTPRC,PIK3CA,TERT,KIT,PRDM16,IL2RB,MYB,NLRP3,APOB,JAK2,IL6R",DisGeNET
527,Agenesis of corpus callosum,0.028581520672663587,2.016945426566765,7.170230705658385,0.23908485258458043,"FIG4,ASXL1,RRM1,TERT,PIK3CA,MYB,PRDM16,KIT,LONP1,PPARG,SLC12A7",DisGeNET
528,Heart Diseases,0.0286121491760332,1.9486195570875744,6.925245528237408,0.23908485258458043,"IL1RN,ABCC2,KLF13,ALDH2,PIK3CA,HFE,PRDM16,LPL,NLRP3,APOE,APOB,JAK2",DisGeNET
529,Cytogenetically normal acute myeloid leukemia,0.028980505186219998,3.726354453627181,13.195512663727806,0.2407947059917187,"ASXL1,CEBPA,CDH1,JAK2",DisGeNET
530,Insulin Sensitivity,0.028980505186219998,3.726354453627181,13.195512663727806,0.2407947059917187,"PTPN1,LEPR,PPARG,PLTP",DisGeNET
531,Mycoplasma Infections,0.028980505186219998,3.726354453627181,13.195512663727806,0.2407947059917187,"TLR1,CDH1,NLRP3,CRLF3",DisGeNET
532,Lymphoid leukemia,0.029273433178961628,2.1916172016959417,7.738764473164945,0.24277140448417048,"PDGFRA,CEBPA,CCND2,PTPRC,TERT,MPG,MYB,ATP11A,JAK2",DisGeNET
533,"Adenocarcinoma, Clear Cell",0.029884534304649265,2.7196915351506457,9.547243729512196,0.2469111710713718,"RRM1,ABCC2,TERT,PIK3CA,ZNF217,IL6R",DisGeNET
534,Arthralgia,0.029884534304649265,2.7196915351506457,9.547243729512196,0.2469111710713718,"IL1RN,HFE,IL2RB,NLRP3,JAK2,DDB2",DisGeNET
535,Adrenocortical carcinoma,0.02996697402437404,2.3097299466773693,8.10174588864409,0.24701846922520215,"RRM1,ABCC2,TERT,PIK3CA,CITED2,LPL,PPARG,SLC12A7",DisGeNET
536,Small cell carcinoma of lung,0.030893160981748286,1.6378287109015832,5.695091482274013,0.24701846922520215,"RRM1,ABCC2,THRB,MAX,EPAS1,LPL,SPTA1,SCGN,LAPTM4B,BCL2L11,CCND2,PIK3CA,TERT,CDH1,AXL,FIGNL1,KIT,MYB,NLRP3,JAK2",DisGeNET
537,"Cerebral Amyloid Angiopathy, Hereditary",0.03125885600520284,8.75301204819277,30.333147929428307,0.24701846922520215,"PTPRC,APOE",DisGeNET
538,"Liposarcoma, Pleomorphic",0.03125885600520284,8.75301204819277,30.333147929428307,0.24701846922520215,"PIK3CA,LEPR",DisGeNET
539,Bacteroides fragilis infection in conditions classified elsewhere and of unspecified site,0.03125885600520284,8.75301204819277,30.333147929428307,0.24701846922520215,"TLR1,PGAP3",DisGeNET
540,Disseminated eosinophilic collagen disease,0.03125885600520284,8.75301204819277,30.333147929428307,0.24701846922520215,"PDGFRA,JAK2",DisGeNET
541,Dysseborrheic dermatitis,0.03125885600520284,8.75301204819277,30.333147929428307,0.24701846922520215,"TMC8,TMC6",DisGeNET
542,Familial hypobetalipoproteinemia,0.03125885600520284,8.75301204819277,30.333147929428307,0.24701846922520215,"APOE,APOB",DisGeNET
543,Helicobacter Infections,0.03125885600520284,8.75301204819277,30.333147929428307,0.24701846922520215,"TFRC,CDH1",DisGeNET
544,Hereditary Paraganglioma,0.03125885600520284,8.75301204819277,30.333147929428307,0.24701846922520215,"KIT,LONP1",DisGeNET
545,Hereditary sideroblastic anemia,0.03125885600520284,8.75301204819277,30.333147929428307,0.24701846922520215,"GYPA,HFE",DisGeNET
546,Juvenile hemochromatosis,0.03125885600520284,8.75301204819277,30.333147929428307,0.24701846922520215,"TMPRSS6,HFE",DisGeNET
547,Low grade B-cell lymphoma,0.03125885600520284,8.75301204819277,30.333147929428307,0.24701846922520215,"RTEL1,PTPRC",DisGeNET
548,Meleda Disease,0.03125885600520284,8.75301204819277,30.333147929428307,0.24701846922520215,"PIK3CA,CTSB",DisGeNET
549,Menstrual spotting,0.03125885600520284,8.75301204819277,30.333147929428307,0.24701846922520215,"KITLG,KIT",DisGeNET
550,Metastatic hepatocellular carcinoma,0.03125885600520284,8.75301204819277,30.333147929428307,0.24701846922520215,"PDGFRA,CD82",DisGeNET
551,Multiple lentigines,0.03125885600520284,8.75301204819277,30.333147929428307,0.24701846922520215,"KITLG,MAP2K2",DisGeNET
552,Ophthalmoparesis,0.03125885600520284,8.75301204819277,30.333147929428307,0.24701846922520215,"MAPT,TYMP",DisGeNET
553,Post-transplant lymphoproliferative disorder,0.03125885600520284,8.75301204819277,30.333147929428307,0.24701846922520215,"RTEL1,PIK3CA",DisGeNET
554,Premature arteriosclerosis,0.03125885600520284,8.75301204819277,30.333147929428307,0.24701846922520215,"LPL,APOB",DisGeNET
555,Pseudopelade,0.03125885600520284,8.75301204819277,30.333147929428307,0.24701846922520215,"ABCC2,PPARG",DisGeNET
556,Bulimia,0.03129721765568631,4.846080457942439,16.78791829934718,0.24701846922520215,"FTO,LEPR,APOB",DisGeNET
557,Childhood T Acute Lymphoblastic Leukemia,0.03129721765568631,4.846080457942439,16.78791829934718,0.24701846922520215,"CCND3,CCND2,JAK2",DisGeNET
558,Gerstmann-Straussler-Scheinker Disease,0.03129721765568631,4.846080457942439,16.78791829934718,0.24701846922520215,"APOE,MAPT,APOB",DisGeNET
559,Malignant neoplasm of vulva,0.03129721765568631,4.846080457942439,16.78791829934718,0.24701846922520215,"IL1RN,TERT,KIT",DisGeNET
560,Drug-Induced Liver Disease,0.03143505700715566,2.0633744855967078,7.138928131641751,0.24766334199209067,"HADHA,FADS2,TF,KITLG,ABCC2,GADD45A,SERPING1,PPARG,APOE,ATR",DisGeNET
561,Phyllodes Tumor,0.031605749230535475,3.616399286987522,12.492548417395126,0.2476724632954303,"PDGFRA,PIK3CA,TERT,KIT",DisGeNET
562,Ischemic cardiomyopathy,0.031649853899842206,2.6800106044538707,9.254134898087006,0.2476724632954303,"CITED2,AXL,HFE,APOE,IL6R,RHOA",DisGeNET
563,Peripheral T-Cell Lymphoma,0.031649853899842206,2.6800106044538707,9.254134898087006,0.2476724632954303,"PDGFRA,DOK2,RTEL1,TERT,IL2RB,RHOA",DisGeNET
564,Hepatoblastoma,0.03174856786172286,2.1572093023255814,7.44217289928927,0.2476724632954303,"CEBPA,RRM1,ABCC2,TERT,PIK3CA,NLRP3,PPARG,APOE,APOB",DisGeNET
565,Thenar muscle atrophy,0.031773031329377505,inf,inf,0.2476724632954303,SLC39A13,DisGeNET
566,Beta-2-microglobulin measurement,0.031773031329377505,inf,inf,0.2476724632954303,SH2B3,DisGeNET
567,Severe Sepsis,0.03201432412229803,3.0177602956076046,10.385838875916175,0.2491132240345307,"TLR1,IL1RN,BCL2L11,PGAP3,APOE",DisGeNET
568,Childhood Leukemia,0.03274526644746352,2.2668993077052964,7.750521622467053,0.254352316137692,"CEBPA,RAD50,PSMB5,DUSP1,PRC1,HFE,LONP1,JAK2",DisGeNET
569,Familial (FPAH),0.03348182721014227,2.6414634146341465,8.97239734817435,0.25956669506380226,"FTO,PDGFRA,CEBPA,CDH1,KIT,APOB",DisGeNET
570,Congestive heart failure,0.033534228510056045,1.5368989261258512,5.218061736710997,0.25956669506380226,"RTEL1,TFRC,HFE,ALDH2,PRDM16,LONP1,MLEC,APOE,JARID2,IL6R,CTSB,MEF2C,ABCC2,TRPC1,NSMCE2,ATP11A,RHOA,ZFP90,SIRT3,GIGYF1,HADHA,TF,PIK3CA,AXL,PPARG",DisGeNET
571,Brain Ischemia,0.033821589298560766,2.0358187134502925,6.894617546313645,0.2613324903419441,"HSPA8,IL1RN,TF,EPAS1,CITED2,LONP1,APOE,MAPT,JAK2,CTSB",DisGeNET
572,Spina Bifida,0.03421440946050897,2.959434182838438,9.988411153152123,0.26390554989469506,"PDGFRA,ABCC2,LEPR,JARID2,HK1",DisGeNET
573,Cancer of Nasopharynx,0.03436621263241387,3.5127272727272727,11.840284439957147,0.2645241770653624,"PIK3CA,TERT,CDH1,TRIP6",DisGeNET
574,Prostate carcinoma,0.034414523489464645,1.3011352644260363,4.383884611888736,0.2645241770653624,"CEP57,IL1RN,TFRC,CD82,TRRAP,HFE,ADAR,ICAM5,ETS2,UBE2L3,HK1,LAPTM4B,SPRED2,CCND3,ACOXL,CCND2,CDH1,MYB,LEPR,LONP1,FLOT2,JAK2,EPHB4,ZNF322,RAB8A,CTSB,PDGFRA,ABCC2,DUSP1,ZBTB38,TRPC1,NCOA4,FRS3,RHOA,SIRT3,TLR1,SLC7A6,XRN1,PIK3CA,KIT,PPARG,TRIB1,FTO,CEBPA,TAGLN,TMPRSS6,EPAS1,LPL,HSD17B13,ARHGAP21,BCL2L11,LARP1,TERT,ZKSCAN3,NLRP3,APOE,HSPA8,PTPN1,MAP3K1,GADD45A,TNK2,QKI,TF,PTPRC,TP53I3,AXL,DLG5,ZNF217,BUD13,ZNF410",DisGeNET
575,High Grade Lymphoma (neoplasm),0.0351677628365098,4.603323262839879,15.410202084003604,0.26797956759012304,"RTEL1,TFRC,CDH1",DisGeNET
576,Idiopathic Hypereosinophilic Syndrome,0.0351677628365098,4.603323262839879,15.410202084003604,0.26797956759012304,"PDGFRA,KIT,JAK2",DisGeNET
577,Melanoderma (disorder),0.0351677628365098,4.603323262839879,15.410202084003604,0.26797956759012304,"PDGFRA,HFE,KIT",DisGeNET
578,Ovarian Mucinous Adenocarcinoma,0.0351677628365098,4.603323262839879,15.410202084003604,0.26797956759012304,"TRRAP,MAST2,TNK2",DisGeNET
579,Overfolded helix,0.0351677628365098,4.603323262839879,15.410202084003604,0.26797956759012304,"KANSL1,BCL11A,LONP1",DisGeNET
580,Acid reflux,0.0353811798732087,2.604002061147372,8.701468818203969,0.26867773769465886,"ASXL1,RTEL1,TERT,PRDM16,ATP11A,TYMP",DisGeNET
581,Polyhydramnios,0.0353811798732087,2.604002061147372,8.701468818203969,0.26867773769465886,"CEP57,FIG4,ASXL1,KIAA0586,LONP1,NPHP3",DisGeNET
582,Monosomy,0.03623931855380113,2.372853446247942,7.872203749522203,0.2747214320607742,"ASXL1,PDGFRA,SLC25A15,CEBPA,TERT,PIK3CA,KIT",DisGeNET
583,Ovarian Serous Adenocarcinoma,0.036506081508650444,2.9033090554567873,9.610755493468831,0.27626900791795156,"ACOXL,TERT,PIK3CA,TRRAP,JAK2",DisGeNET
584,Developmental delay (disorder),0.03723412466092187,2.205521472392638,7.257333707306683,0.2795193393189518,"FTO,ASXL1,MACF1,AHI1,MEF2C,ALDH5A1,MAPT,SH2B3",DisGeNET
585,Geographic Atrophy,0.037262485697505315,3.414814814814815,11.23394919967304,0.2795193393189518,"ARHGAP21,TST,NLRP3,APOE",DisGeNET
586,Precursor cell lymphoblastic lymphoma,0.037262485697505315,3.414814814814815,11.23394919967304,0.2795193393189518,"PDGFRA,RTEL1,GADD45A,JAK2",DisGeNET
587,Abdominal discomfort,0.03734858459681566,2.567581300813008,8.44082150047032,0.2795193393189518,"PIK3CA,HFE,SERPING1,NLRP3,JAK2,TYMP",DisGeNET
588,Barrett Esophagus,0.03750057607434242,1.9242448094313551,6.318063452526084,0.2795193393189518,"MSRA,TERT,PIK3CA,MAX,HFE,LEPR,ZNF217,PPARG,APOB,EPHB4,TYMP",DisGeNET
589,Dementia,0.037964313512875845,1.7663617886178862,5.777961376270002,0.2795193393189518,"FTO,IL1RN,MEF2C,TOMM40,HFE,ASXL1,ALDH2,PIK3CA,PPARG,APOE,MAPT,APOB,IL6R,CTSB",DisGeNET
590,Ankylosing spondylitis,0.03806943033675365,1.859254658385093,6.076683197877521,0.2795193393189518,"RTEL1-TNFRSF6B,IL1RN,GCKR,NDFIP1,IL37,IL2RB,NLRP3,JAK2,SH2B3,IL6R,UBE2L3,HDAC7",DisGeNET
591,"Atrophy, Muscular, Spinobulbar",0.03826602016061806,7.658132530120482,24.989964301974165,0.2795193393189518,"TFEB,ZKSCAN3",DisGeNET
592,Senile dementia,0.03826602016061806,7.658132530120482,24.989964301974165,0.2795193393189518,"APOE,MAPT",DisGeNET
593,Abnormality of female internal genitalia,0.03826602016061806,7.658132530120482,24.989964301974165,0.2795193393189518,"RTEL1,TERT",DisGeNET
594,Urethral Stricture,0.03826602016061806,7.658132530120482,24.989964301974165,0.2795193393189518,"RTEL1,TERT",DisGeNET
595,Aplastic clavicles,0.03826602016061806,7.658132530120482,24.989964301974165,0.2795193393189518,"FIG4,KIAA0586",DisGeNET
596,Decreased number of large peripheral myelinated nerve fibers,0.03826602016061806,7.658132530120482,24.989964301974165,0.2795193393189518,"TYMP,HK1",DisGeNET
597,Deficiency of mevalonate kinase,0.03826602016061806,7.658132530120482,24.989964301974165,0.2795193393189518,"NLRP3,RHOA",DisGeNET
598,Familial cold urticaria,0.03826602016061806,7.658132530120482,24.989964301974165,0.2795193393189518,"IL1RN,NLRP3",DisGeNET
599,Gastric Gastrointestinal Stromal Tumor,0.03826602016061806,7.658132530120482,24.989964301974165,0.2795193393189518,"PDGFRA,KIT",DisGeNET
600,Heterochromia iridis,0.03826602016061806,7.658132530120482,24.989964301974165,0.2795193393189518,"KITLG,KIT",DisGeNET
601,Hormone measurement,0.03826602016061806,7.658132530120482,24.989964301974165,0.2795193393189518,"TRIM4,ARPC1A",DisGeNET
602,Papillon-Lefevre Disease,0.03826602016061806,7.658132530120482,24.989964301974165,0.2795193393189518,"FIG4,PLS1",DisGeNET
603,Pimples,0.03826602016061806,7.658132530120482,24.989964301974165,0.2795193393189518,"TMC8,TMC6",DisGeNET
604,pustule,0.03826602016061806,7.658132530120482,24.989964301974165,0.2795193393189518,"TMC8,TMC6",DisGeNET
605,Huntington Disease,0.03848901993688679,1.6382411725516322,5.336377757332224,0.28068356357280083,"HSPA8,MAP3K1,MAP2K2,TOMM40,TFRC,IL37,DUSP1,TRPC1,LPL,VRK2,KITLG,BCL2L11,PIK3CA,IL2RB,NLRP3,PPARG,APOE,MAPT",DisGeNET
606,"Plaque, Amyloid",0.038564613671876816,2.075683122847302,6.757220698896577,0.2807707516836972,"TF,PTPRC,TFEB,SERPING1,PPARG,APOE,MAPT,APOB,CTSB",DisGeNET
607,"Fibrosis, Liver",0.038695572546406355,1.6915244085055405,5.500888274390086,0.2812600759056752,"PDGFRA,IL1RN,GCKR,HFE,PCSK7,ALDH2,PIK3CA,TERT,LEPR,NPHP3,NLRP3,SERPING1,PPARG,APOE,APOB,CTSB",DisGeNET
608,Lymphoproliferative Disorders,0.03881799139196975,2.185786416200662,7.101339070621037,0.2816858191140963,"RTEL1,BCL2L11,PTPRC,PIK3CA,KIT,IL2RB,LPL,JAK2",DisGeNET
609,Bacterial Infections,0.038969681496197464,1.982826843937955,6.4342162663185025,0.2821571391880575,"IL1RN,TF,PTPRC,TERT,PIK3CA,IL37,HFE,NLRP3,DNASE2,SH2B3",DisGeNET
610,Septicemia,0.039010846533253644,1.7590334008097166,5.7061558111478865,0.2821571391880575,"MPST,NFE2,IL1RN,SMOX,DUSP1,ADAR,SIRT3,TLR1,PIK3CA,NLRP3,SERPING1,PPARG,APOB,CTSB",DisGeNET
611,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome,0.03927315749651936,4.38368580060423,14.1909290839985,0.2822038613593541,"RTEL1,PRDM16,TRIB1",DisGeNET
612,Anaphylaxis (non medication),0.03927315749651936,4.38368580060423,14.1909290839985,0.2822038613593541,"TRPC1,NLRP3,RHOA",DisGeNET
613,Lymphatic Diseases,0.03927315749651936,4.38368580060423,14.1909290839985,0.2822038613593541,"MAP2K2,TERT,EPHB4",DisGeNET
614,Prolonged bleeding time,0.03927315749651936,4.38368580060423,14.1909290839985,0.2822038613593541,"MAP2K2,JAK2,SH2B3",DisGeNET
615,Gastrointestinal pain,0.03938466053295185,2.5321583695289007,8.189959513389933,0.2825449142624123,"PIK3CA,HFE,SERPING1,NLRP3,JAK2,TYMP",DisGeNET
616,Familial multiple trichoepitheliomata,0.03977703261631736,2.3213639801387655,7.485158306470615,0.28489653880388344,"PTPRC,TERT,PIK3CA,CDH1,AXL,PPARG,APOB",DisGeNET
617,Amnesia,0.04029492295605065,3.3221949221949223,10.66932799139733,0.2875050213728447,"ALDH2,MAPT,APOE,CTSB",DisGeNET
618,Human papilloma virus infection,0.04029492295605065,3.3221949221949223,10.66932799139733,0.2875050213728447,"CD82,PIK3CA,TERT,TMC8",DisGeNET
619,Neuropathy,0.04033671990702423,1.9700007863489817,6.324673854622456,0.2875050213728447,"FIG4,HADHA,ALDH2,TMPRSS6,HFE,SERPING1,APOE,MAPT,TYMP,HK1",DisGeNET
620,Malignant neoplasm of breast,0.041601619533507606,1.2414985353755827,3.9474888322382613,0.2960424925513477,"IL1RN,TFRC,CD82,MPG,HFE,PPP2R2A,ICAM5,ETS2,LAPTM4B,CCND3,CCND2,CDH1,MYB,LEPR,LONP1,SLC12A7,IL6R,EPHB4,PDGFRA,NSMCE2,VRK2,FRS3,FTO,MACF1,EPAS1,LPL,PLD1,BCL2L11,TERT,MICAL1,PRDM16,APOE,PLTP,MPST,HSPA8,GADD45A,BCL11A,TNK2,MSRA,TF,PTPRC,TP53I3,DLG5,ANP32B,CNOT8,ZNF410,CPEB4,ATR,CEP57,THRB,CITED2,ADAR,PCSK7,SPPL3,HK1,SMPD2,AKAP10,SLC22A16,ALDH2,PSD4,FLOT2,JAK2,RAB8A,CTSB,BRD3,ABCC2,DUSP1,TRPC1,NCOA4,RHOA,DDB2,SIRT3,TLR1,GIGYF1,HADHA,ELF1,PIK3CA,KIT,PPARG,MAPT,KANK2,GTF2A1,CEBPA,LEPROT,TMPRSS6,HIST1H2BK,WBP4,HSD17B13,LMF2,THBS3,TYMP,HDAC7,SH2B3,RBM38,PTPN1,RRM1,MAP3K1,SMOX,BYSL,SLC25A37,RAD50,KITLG,AXL,PRC1,TAF8,ZNF217",DisGeNET
621,Arteriosclerosis,0.04195636423505715,1.4557902480033627,4.616493065019625,0.29808611756050263,"FTO,TAGLN,IL1RN,PCOLCE2,MPG,HFE,LPL,TYMP,FADS2,ALDH2,TERT,LEPR,NLRP3,APOE,APOB,JAK2,PLTP,IL6R,NFE2,PTPN1,MEF2C,IL37,DUSP1,RHOA,SIRT3,MSRA,PIK3CA,KIT,PPARG",DisGeNET
622,Neurofibromatosis 1,0.04211966683527374,2.1473459589223793,6.801161092135017,0.2983821599364303,"PDGFRA,KITLG,PIK3CA,EPAS1,BCL11A,KIT,APOB,JAK2",DisGeNET
623,Triple Negative Breast Neoplasms,0.04213329230290029,1.6186434477207874,5.126109548258186,0.2983821599364303,"PDGFRA,RRM1,THRB,TFRC,TMPRSS6,EPAS1,ADAR,PIK3CA,TERT,CDH1,AXL,PSD4,KIT,MYB,LEPR,PPARG,JAK2,ATR",DisGeNET
624,Trichohepatoenteric Syndrome,0.04316893162304578,1.9448326733442038,6.111897707254318,0.302536587279707,"THRB,TFRC,KANSL1,KIT,LPL,NLRP3,PPARG,BUD13,APOE,ATR",DisGeNET
625,Acute Coronary Syndrome,0.04316893162304578,1.9448326733442038,6.111897707254318,0.302536587279707,"FTO,HSPA8,IL1RN,ALDH2,ARPC1A,NLRP3,PPARG,APOE,APOB,JAK2",DisGeNET
626,"Neoplastic Syndromes, Hereditary",0.04346364963671163,3.2344497607655502,10.142685663144357,0.302536587279707,"RAD50,PIK3CA,CDH1,MAX",DisGeNET
627,Allergic rhinitis (disorder),0.04353323765474594,2.2720424915499757,7.121104984810285,0.302536587279707,"BLK,FTO,IL1RN,PIK3CA,PRDM16,IL2RB,NLRP3",DisGeNET
628,Somatotropin deficiency,0.04361042637875409,4.184015380390003,13.106256718491624,0.302536587279707,"PTPN1,LEPR,LPL",DisGeNET
629,TNF receptor-associated periodic fever syndrome (TRAPS),0.04361042637875409,4.184015380390003,13.106256718491624,0.302536587279707,"IL1RN,IL2RB,NLRP3",DisGeNET
630,Airway Obstruction,0.04361042637875409,4.184015380390003,13.106256718491624,0.302536587279707,"TFRC,ALDH2,SERPING1",DisGeNET
631,Leukoaraiosis,0.04361042637875409,4.184015380390003,13.106256718491624,0.302536587279707,"APOE,MAPT,TYMP",DisGeNET
632,Mesenchymal Cell Neoplasm,0.04361042637875409,4.184015380390003,13.106256718491624,0.302536587279707,"PDGFRA,PIK3CA,KIT",DisGeNET
633,Non-small cell lung cancer metastatic,0.04361042637875409,4.184015380390003,13.106256718491624,0.302536587279707,"CCND2,ABCC2,PIK3CA",DisGeNET
634,High forehead,0.04366503175061294,2.464146341463415,7.715753963759093,0.302536587279707,"FIG4,MEF2C,CCND2,MAP2K2,PIK3CA,KANSL1",DisGeNET
635,Primary Myelofibrosis,0.043838262228024366,2.1286228051618363,6.656731997882507,0.302536587279707,"ASXL1,NFE2,CD164,MYB,KIT,JAK2,JARID2,SH2B3",DisGeNET
636,"Alzheimer's Disease, Focal Onset",0.04393713030581615,2.7469604863221884,8.584239223095436,0.302536587279707,"TF,HFE,PPARG,MAPT,APOE",DisGeNET
637,Acute Confusional Senile Dementia,0.04393713030581615,2.7469604863221884,8.584239223095436,0.302536587279707,"TF,HFE,PPARG,MAPT,APOE",DisGeNET
638,Hydrops Fetalis,0.04393713030581615,2.7469604863221884,8.584239223095436,0.302536587279707,"FIG4,HBZ,HADHA,MAP2K2,PLD1",DisGeNET
639,Liver diseases,0.0440464104657013,1.609013531209079,5.024163122346511,0.302536587279707,"PTPN1,PDGFRA,IL1RN,ABCC2,HFE,TFEB,HADHA,TF,ALDH2,PIK3CA,TERT,IL2RB,LEPR,NLRP3,PPARG,APOE,ZNF410,CPEB4",DisGeNET
640,Liver neoplasms,0.044880728544054206,1.4126853190592523,4.384617516884026,0.302536587279707,"FTO,CEBPA,IL1RN,TFRC,TMPRSS6,MPG,HFE,LPL,TYMP,HK1,LAPTM4B,ALDH2,TERT,LEPR,APOE,APOB,IL6R,EPHB4,PLS1,CTSB,PTPN1,PDGFRA,ABCC2,DUSP1,TNK2,TRPC1,CPT1B,TF,PIK3CA,KIT,SERPING1,PPARG,CRLF3",DisGeNET
641,Monocyte count procedure,0.04549438272243329,2.2481523955147806,6.947165033584341,0.302536587279707,"SPTA1,CCND3,GYPA,ACOXL,BCL2L11,THRB,SH2B3",DisGeNET
642,Monocyte count result,0.04549438272243329,2.2481523955147806,6.947165033584341,0.302536587279707,"SPTA1,CCND3,GYPA,ACOXL,BCL2L11,THRB,SH2B3",DisGeNET
643,"Hepatitis, Toxic",0.04560251935025568,2.1102197053117298,6.515920189189505,0.302536587279707,"HADHA,FADS2,TF,KITLG,ABCC2,GADD45A,SERPING1,APOE",DisGeNET
644,Chemical and Drug Induced Liver Injury,0.04560251935025568,2.1102197053117298,6.515920189189505,0.302536587279707,"HADHA,FADS2,TF,KITLG,ABCC2,GADD45A,SERPING1,APOE",DisGeNET
645,Chemically-Induced Liver Toxicity,0.04560251935025568,2.1102197053117298,6.515920189189505,0.302536587279707,"HADHA,FADS2,TF,KITLG,ABCC2,GADD45A,SERPING1,APOE",DisGeNET
646,Drug-Induced Acute Liver Injury,0.04560251935025568,2.1102197053117298,6.515920189189505,0.302536587279707,"HADHA,FADS2,TF,KITLG,ABCC2,GADD45A,SERPING1,APOE",DisGeNET
647,Pulmonary Fibrosis,0.045726234832707234,1.7162796442687747,5.294865290110307,0.302536587279707,"CEBPA,PDGFRA,RTEL1,TAGLN,IL1RN,ATP11A,ETS2,SIRT3,PTPRC,PIK3CA,TERT,CDH1,NLRP3,PPARG",DisGeNET
648,"B-CELL MALIGNANCY, LOW-GRADE",0.045805630168369055,6.806559571619813,20.986993652421944,0.302536587279707,"BCL2L11,BCL11A",DisGeNET
649,Self-Injurious Behavior,0.045805630168369055,6.806559571619813,20.986993652421944,0.302536587279707,"ALDH5A1,PRDM16",DisGeNET
650,Thrombosis of cerebral veins,0.045805630168369055,6.806559571619813,20.986993652421944,0.302536587279707,"APOE,JAK2",DisGeNET
651,White forelock,0.045805630168369055,6.806559571619813,20.986993652421944,0.302536587279707,"KITLG,KIT",DisGeNET
652,Anorectal Malformations,0.045805630168369055,6.806559571619813,20.986993652421944,0.302536587279707,"RTEL1,TERT",DisGeNET
653,Cellular immunodeficiency,0.045805630168369055,6.806559571619813,20.986993652421944,0.302536587279707,"RTEL1,TERT",DisGeNET
654,Chronic Neutrophilic Leukemia,0.045805630168369055,6.806559571619813,20.986993652421944,0.302536587279707,"ASXL1,JAK2",DisGeNET
655,Core binding factor acute myeloid leukemia,0.045805630168369055,6.806559571619813,20.986993652421944,0.302536587279707,"KIT,JAK2",DisGeNET
656,Corticobasal degeneration,0.045805630168369055,6.806559571619813,20.986993652421944,0.302536587279707,"APOE,MAPT",DisGeNET
657,Elevated circulating luteinizing hormone level,0.045805630168369055,6.806559571619813,20.986993652421944,0.302536587279707,"MAP3K1,NSMCE2",DisGeNET
658,Hypereosinophilic syndrome,0.045805630168369055,6.806559571619813,20.986993652421944,0.302536587279707,"PDGFRA,JAK2",DisGeNET
659,Increased number of platelets,0.045805630168369055,6.806559571619813,20.986993652421944,0.302536587279707,"JAK2,SH2B3",DisGeNET
660,Left ventricular systolic dysfunction,0.045805630168369055,6.806559571619813,20.986993652421944,0.302536587279707,"IL1RN,APOE",DisGeNET
661,Malignant neoplasm tonsil,0.045805630168369055,6.806559571619813,20.986993652421944,0.302536587279707,"PIK3CA,CDH1",DisGeNET
662,Mastocytoma,0.045805630168369055,6.806559571619813,20.986993652421944,0.302536587279707,"KITLG,KIT",DisGeNET
663,Microcytic hypochromic anemia (disorder),0.045805630168369055,6.806559571619813,20.986993652421944,0.302536587279707,"TF,TMPRSS6",DisGeNET
664,Morphological abnormality of the pyramidal tract,0.045805630168369055,6.806559571619813,20.986993652421944,0.302536587279707,"SLC25A15,MAPT",DisGeNET
665,Other Creutzfeldt-Jakob disease,0.045805630168369055,6.806559571619813,20.986993652421944,0.302536587279707,"ZBTB38,MAPT",DisGeNET
666,Pigmented lesions,0.045805630168369055,6.806559571619813,20.986993652421944,0.302536587279707,"KITLG,KIT",DisGeNET
667,Pulmonary Infiltrate,0.045805630168369055,6.806559571619813,20.986993652421944,0.302536587279707,"PDGFRA,APOE",DisGeNET
668,Pyramidal tract disease,0.045805630168369055,6.806559571619813,20.986993652421944,0.302536587279707,"SLC25A15,MAPT",DisGeNET
669,Childhood asthma,0.04591029324806036,2.4314826700898586,7.491558422190064,0.30277460958212604,"PDGFRA,IL1RN,CDH1,IL37,MYB,PPARG",DisGeNET
670,Asthma,0.046250412427841246,1.4085429520645467,4.329417199529238,0.30453896635012373,"FTO,CEBPA,TAGLN,IL1RN,PGAP3,ETS2,FADS2,ALDH2,CDH1,MYB,LEPR,NLRP3,APOE,IL6R,PDGFRA,NDFIP1,IL37,DUSP1,RHOA,TLR1,RAD50,KITLG,PIK3CA,AXL,KIT,IL2RB,HIST1H4H,SERPING1,PPARG,HIST1H4J,ANP32B,PDE7A,HIST1H4C",DisGeNET
671,Gastroesophageal reflux disease,0.046315876342006575,2.000022136137244,6.144608958424954,0.30453896635012373,"ASXL1,IL1RN,RTEL1,MAP2K2,TERT,PIK3CA,PRDM16,ATP11A,TYMP",DisGeNET
672,Chronic kidney disease stage 5,0.04642669948886497,1.7516456724908573,5.377343007134734,0.3048133900965361,"FTO,NUP205,IL1RN,GCKR,ABCC2,LPL,AHI1,DSTYK,NPHP3,PPARG,APOE,APOB,ZNF410",DisGeNET
673,Hyperhomocysteinemia,0.04660114439579063,2.69850157308164,8.273957114819368,0.3055040848056883,"MEF2C,TERT,NLRP3,APOE,SLC17A1",DisGeNET
674,Exophthalmos,0.047511415429740696,2.2247548787792804,6.778350398426541,0.31100944343622544,"FIG4,ASXL1,THRB,CITED2,NLRP3,SLC39A13,PPARG",DisGeNET
675,"Lymphoma, Non-Hodgkin",0.048028461251597106,1.639786620171451,4.978329048783539,0.3134996004990862,"CEBPA,RTEL1,IL1RN,TFRC,RHOA,ASXL1,TLR1,CCND3,RAD50,BCL2L11,CCND2,PIK3CA,TERT,KIT,LEPR,NLRP3",DisGeNET
676,Autosomal Recessive Polycystic Kidney Disease,0.04817604921540808,4.001707605411796,12.136752127660227,0.3134996004990862,"PIK3CA,NPHP3,APOE",DisGeNET
677,heavy drinking,0.04817604921540808,4.001707605411796,12.136752127660227,0.3134996004990862,"ALDH2,HFE,APOE",DisGeNET
678,Primary Carcinoma,0.04817604921540808,4.001707605411796,12.136752127660227,0.3134996004990862,"ALDH2,KIT,ZNF217",DisGeNET
679,"Hepatitis B, Chronic",0.04926936170841408,2.0743413929989174,6.244706973952022,0.3195645420073056,"IL1RN,ALDH2,CDH1,HFE,LEPR,PPARG,ADAR,UBE2L3",DisGeNET
680,"Hepatitis, Drug-Induced",0.04926936170841408,2.0743413929989174,6.244706973952022,0.3195645420073056,"HADHA,FADS2,TF,KITLG,ABCC2,GADD45A,SERPING1,APOE",DisGeNET
681,"Neoplasms, Intracranial",0.049359227855598736,2.651713656849387,7.978026698299047,0.3195645420073056,"PDGFRA,MPG,MYB,LEPR,CTSB",DisGeNET
682,Cardiomyopathies,0.049401613166743845,1.6622257053291536,4.999596266820845,0.3195645420073056,"HSPA8,IL1RN,MEF2C,HFE,LPL,SIRT3,FIG4,HADHA,PTPRC,ALDH2,PIK3CA,PRDM16,LONP1,PPARG,APOB",DisGeNET
683,Ataxia Telangiectasia,0.04954567875138735,1.7775862581354571,5.341398255790089,0.3195645420073056,"GYPA,RAD50,TFRC,PIK3CA,TERT,GADD45A,KIT,HIST1H4H,PPARG,HIST1H4J,HIST1H4C,ATR",DisGeNET
684,Deglutition Disorders,0.04958468884367571,2.2018348623853212,6.614473069154802,0.3195645420073056,"PDGFRA,MAP2K2,PRDM16,KIT,SERPING1,MAPT,TYMP",DisGeNET
685,Cerebral atrophy,0.04967965743952257,1.8294883318352808,5.492416208635667,0.3195645420073056,"ASXL1,FTO,SLC25A15,RTEL1,TOMM40,ALDH2,TERT,HFE,PRDM16,APOE,MAPT",DisGeNET
686,Intelligence,0.04968750585154389,1.9712602291325696,5.9177266946223925,0.3195645420073056,"CEP57,MEF2C,BTN3A1,BCL11A,DENND4A,BTN2A1,ZMIZ2,HFE,SLC17A1",DisGeNET
687,Adenocarcinoma of lung (disorder),0.050133829397413364,1.4289247450626048,4.276856441893578,0.3219657282407391,"TAGLN,TOMM40,TFRC,CD82,MPG,EPAS1,PDCD5,HK1,LAPTM4B,BCL2L11,TERT,CDH1,NLRP3,APOE,JAK2,PLS1,NOP58,RRM1,GADD45A,TNK2,PABPC4,RHOA,RCL1,TF,DOK2,PIK3CA,KIT,PPARG,ATR",DisGeNET
688,Congenital arteriovenous malformation,0.05020936719113392,3.0721212121212123,9.190415493744885,0.32198216285942277,"PIK3CA,MYB,APOE,EPHB4",DisGeNET
689,Polycystic Ovary Syndrome,0.05060281457095596,1.6561429734825244,4.941513417837001,0.3240342785008094,"FTO,IL1RN,MAP3K1,TFRC,BCL11A,NCOA4,HSD17B13,FADS2,RAD50,KITLG,CCND2,LEPR,PPARG,APOE,APOB",DisGeNET
690,Photophobia,0.051714522578328134,2.179377876625583,6.45535352664794,0.3271143132889907,"AHI1,HADHA,ALDH2,NLRP3,MAPT,HK1,DDB2",DisGeNET
691,Chronic inflammatory disorder,0.052966013709009704,3.834592145015106,11.266433671260492,0.3271143132889907,"IL1RN,NLRP3,ETS2",DisGeNET
692,Decreased motor nerve conduction velocity,0.052966013709009704,3.834592145015106,11.266433671260492,0.3271143132889907,"FIG4,TYMP,HK1",DisGeNET
693,Malignant hyperpyrexia due to anesthesia,0.052966013709009704,3.834592145015106,11.266433671260492,0.3271143132889907,"GYPA,TRPC1,GYPE",DisGeNET
694,"Lung Diseases, Interstitial",0.0530710224662085,2.338453226304415,6.865989145639425,0.3271143132889907,"BLK,IL1RN,TERT,KANSL1,KIT,MAPT",DisGeNET
695,Monoclonal Gammopathy of Undetermined Significance,0.0530710224662085,2.338453226304415,6.865989145639425,0.3271143132889907,"CCND3,RAD50,PTPRC,CDH1,KIT,ANP32B",DisGeNET
696,Hypercholesterolemia,0.05321743225713806,1.9433028509951586,5.700424850452238,0.3271143132889907,"PTPRC,MPG,LEPR,LPL,NLRP3,BUD13,APOE,TRIB1,APOB",DisGeNET
697,Glioblastoma,0.05350373272276247,1.3268067365613498,3.884895242138715,0.3271143132889907,"RTEL1,IL1RN,MPG,EPAS1,HFE,MAST2,ITSN1,DOCK7,SPPL3,ETS2,TYMP,HDAC7,HK1,ARHGAP21,CCND3,BCL2L11,CCND2,TERT,MYB,LEPR,APOE,JAK2,RAB8A,CTSB,HSPA8,PDGFRA,DUSP1,TFEB,RHOA,DDB2,AHI1,TF,KITLG,PIK3CA,AXL,KIT,TRIP6,ZNF217,HIST1H4H,PPARG,HIST1H4J,ANP32B,CRLF3,HIST1H4C,ATR",DisGeNET
698,Anaplastic Oligodendroglioma,0.053785525323632795,2.9968957871396897,8.759179841215941,0.3271143132889907,"PDGFRA,PIK3CA,TERT,KIT",DisGeNET
699,Papule,0.053785525323632795,2.9968957871396897,8.759179841215941,0.3271143132889907,"PIK3CA,TMC8,NLRP3,TMC6",DisGeNET
700,"46, XY Disorders of Sex Development",0.05383699378683079,6.125301204819277,17.89687095002477,0.3271143132889907,"MAP3K1,HSD17B13",DisGeNET
701,"ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, NONDELETION TYPE, X-LINKED",0.05383699378683079,6.125301204819277,17.89687095002477,0.3271143132889907,"TERT,ATR",DisGeNET
702,Salivary gland carcinoma,0.05383699378683079,6.125301204819277,17.89687095002477,0.3271143132889907,"CDH1,KIT",DisGeNET
703,Self-harm,0.05383699378683079,6.125301204819277,17.89687095002477,0.3271143132889907,"ALDH5A1,PRDM16",DisGeNET
704,"Glioblastoma, IDH-Mutant",0.05383699378683079,6.125301204819277,17.89687095002477,0.3271143132889907,"PDGFRA,KIT",DisGeNET
705,Skin tag,0.05383699378683079,6.125301204819277,17.89687095002477,0.3271143132889907,"PIK3CA,NSMCE2",DisGeNET
706,Staphylococcal toxic shock syndrome,0.05383699378683079,6.125301204819277,17.89687095002477,0.3271143132889907,"IL1RN,TST",DisGeNET
707,Systolic hypertension,0.05383699378683079,6.125301204819277,17.89687095002477,0.3271143132889907,"PPARG,APOE",DisGeNET
708,Taurodontism,0.05383699378683079,6.125301204819277,17.89687095002477,0.3271143132889907,"RTEL1,TERT",DisGeNET
709,Xanthoma,0.05383699378683079,6.125301204819277,17.89687095002477,0.3271143132889907,"APOE,APOB",DisGeNET
710,Xanthomatosis,0.05383699378683079,6.125301204819277,17.89687095002477,0.3271143132889907,"PPARG,APOE",DisGeNET
711,Arterial disease of legs,0.05383699378683079,6.125301204819277,17.89687095002477,0.3271143132889907,"APOB,JAK2",DisGeNET
712,Atrophy of testis,0.05383699378683079,6.125301204819277,17.89687095002477,0.3271143132889907,"ALDH2,HFE",DisGeNET
713,Benign neoplasm of adrenal gland,0.05383699378683079,6.125301204819277,17.89687095002477,0.3271143132889907,"EPAS1,MAX",DisGeNET
714,Benign neoplasm of aortic body and other paraganglia,0.05383699378683079,6.125301204819277,17.89687095002477,0.3271143132889907,"EPAS1,MAX",DisGeNET
715,Compensatory Hyperinsulinemia,0.05383699378683079,6.125301204819277,17.89687095002477,0.3271143132889907,"PTPN1,LEPR",DisGeNET
716,Cryoglobulinemia,0.05383699378683079,6.125301204819277,17.89687095002477,0.3271143132889907,"IL1RN,RTEL1",DisGeNET
717,Endogenous Hyperinsulinism,0.05383699378683079,6.125301204819277,17.89687095002477,0.3271143132889907,"PTPN1,LEPR",DisGeNET
718,Eosinophilic granulomatosis with polyangiitis,0.05383699378683079,6.125301204819277,17.89687095002477,0.3271143132889907,"GYPA,LEPR",DisGeNET
719,Erythrophagocytosis,0.05383699378683079,6.125301204819277,17.89687095002477,0.3271143132889907,"TF,HFE",DisGeNET
720,Exogenous Hyperinsulinism,0.05383699378683079,6.125301204819277,17.89687095002477,0.3271143132889907,"PTPN1,LEPR",DisGeNET
721,Large elongated pulp chamber,0.05383699378683079,6.125301204819277,17.89687095002477,0.3271143132889907,"RTEL1,TERT",DisGeNET
722,Macroencephaly,0.05383699378683079,6.125301204819277,17.89687095002477,0.3271143132889907,"CCND2,PIK3CA",DisGeNET
723,Malignant Adrenal Medulla Neoplasm,0.05383699378683079,6.125301204819277,17.89687095002477,0.3271143132889907,"EPAS1,MAX",DisGeNET
724,Malignant neoplasm of aortic body and other paraganglia,0.05383699378683079,6.125301204819277,17.89687095002477,0.3271143132889907,"EPAS1,MAX",DisGeNET
725,Molar tooth sign on MRI,0.05383699378683079,6.125301204819277,17.89687095002477,0.3271143132889907,"AHI1,KIAA0586",DisGeNET
726,insulinoma,0.05390120257504448,2.1573700305810397,6.300820283362168,0.3271143132889907,"CCND3,GCKR,CCND2,TRPC1,LEPR,HK1,CTSB",DisGeNET
727,Profound Mental Retardation,0.05390120257504448,2.1573700305810397,6.300820283362168,0.3271143132889907,"ASXL1,AHI1,MEF2C,ALDH5A1,KANSL1,ADAR,HIST1H4C",DisGeNET
728,Global developmental delay,0.05441969643838938,1.4253049754103595,4.149104293671672,0.3298072811623268,"CEP57,FTO,MACF1,RTEL1,PGAP3,DOCK7,ADAR,CCND2,TERT,PRDM16,LONP1,NPHP3,SNIP1,SH2B3,MEF2C,MAP2K2,BCL11A,ASXL1,FIG4,SLC25A15,HADHA,AHI1,RPS28,ALDH5A1,KANSL1,PIK3CA,KIAA0586,MAPT",DisGeNET
729,Skin Neoplasms,0.055042364428860194,1.9296153846153845,5.595213356041209,0.33312333588495363,"CEBPA,GYPA,TERT,PIK3CA,AXL,KIT,LONP1,DDB2,TYMP",DisGeNET
730,Rett Syndrome,0.05515826466515336,2.562816616008105,7.425885919645624,0.33336748452418713,"PTPN1,GYPE,HIST1H4H,HIST1H4J,HIST1H4C",DisGeNET
731,Hyperinsulinism,0.05533543312748138,1.7435045052926252,5.046298023821114,0.33398075370512703,"FTO,AHI1,PTPN1,ALDH2,TFRC,PIK3CA,LEPR,LPL,PPARG,APOE,JAK2,PLTP",DisGeNET
732,Cholangiocarcinoma,0.05588940502321747,1.6623323754789272,4.794799007317032,0.33686346306343645,"MAP2K2,ABCC2,TFRC,GADD45A,LAPTM4B,PIK3CA,TERT,CDH1,KIT,NLRP3,PPARG,APOE,APOB,IL6R",DisGeNET
733,Male infertility,0.05716454180029111,2.0060850915257618,5.741057388402455,0.34046608343879553,"IL1RN,KITLG,MAP3K1,THRB,ALDH2,HFE,KIT,APOB",DisGeNET
734,Osteosarcoma of bone,0.05735618245294479,1.4468541167570295,4.1357957991886645,0.34046608343879553,"CEBPA,RTEL1,EPAS1,UBXN2A,ARPC1A,PDCD5,LPL,THBS3,CCND3,BCL2L11,TERT,P4HTM,IL6R,CTSB,MPST,PDGFRA,GADD45A,DUSP1,KITLG,PIK3CA,AXL,TDP2,PPARG,SNRNP25,ATR",DisGeNET
735,Thrombophilia,0.05749632249994679,2.9252525252525254,8.354621518289637,0.34046608343879553,"BLOC1S2,AK3,APOE,JAK2",DisGeNET
736,Alcoholic Liver Diseases,0.05749632249994679,2.9252525252525254,8.354621518289637,0.34046608343879553,"IL1RN,ALDH2,HFE,PPARG",DisGeNET
737,Pituitary Neoplasms,0.057585031980204614,1.838991769547325,5.2493884095962215,0.34046608343879553,"SCGN,BCL2L11,THRB,PIK3CA,GADD45A,CDH1,LEPR,PPARG,IL6R,CTSB",DisGeNET
738,Renal tubular acidosis,0.057975865160158006,3.680845921450151,10.482049735111122,0.34046608343879553,"ATP11A,SLC12A7,CTSB",DisGeNET
739,"Obesity, Visceral",0.057975865160158006,3.680845921450151,10.482049735111122,0.34046608343879553,"LPL,APOE,APOB",DisGeNET
740,X-linked agammaglobulinemia,0.057975865160158006,3.680845921450151,10.482049735111122,0.34046608343879553,"TLR1,PTPRC,PIK3CA",DisGeNET
741,Arteriovenous hemangioma,0.057975865160158006,3.680845921450151,10.482049735111122,0.34046608343879553,"MYB,APOE,EPHB4",DisGeNET
742,Glucocorticoid Receptor Deficiency,0.057975865160158006,3.680845921450151,10.482049735111122,0.34046608343879553,"BCL2L11,PIK3CA,NLRP3",DisGeNET
743,Lipoatrophy,0.057975865160158006,3.680845921450151,10.482049735111122,0.34046608343879553,"HFE,PPARG,APOE",DisGeNET
744,Muscle Hypertonia,0.05819930117046132,2.5205540883950373,7.168158229852214,0.34046608343879553,"FTO,RTEL1,TOMM40,TERT,PIK3CA",DisGeNET
745,Intestinal Neoplasms,0.058446075531169844,2.114648917671044,6.004864354689299,0.34046608343879553,"PDGFRA,MAP2K2,TERT,PIK3CA,KIT,PPARG,EPHB4",DisGeNET
746,Squamous cell carcinoma of esophagus,0.05929009339502705,1.441206204499638,4.07185869160686,0.34046608343879553,"CEBPA,TAGLN,IL1RN,TFRC,CD82,ADAR,ETS2,TYMP,LAPTM4B,ALDH2,TERT,CDH1,LONP1,EPHB4,CTSB,PTPN1,ABCC2,GADD45A,TLR1,PIK3CA,IL2RB,HIST1H4H,HIST1H4J,HIST1H4C,MUC20",DisGeNET
747,Epithelial ovarian cancer,0.05976370872017417,1.3795267546020105,3.88661891709508,0.34046608343879553,"IL1RN,CD82,MPG,HFE,HSD17B13,ETS2,TYMP,HDAC7,ACOXL,CCND2,ALDH2,TERT,CDH1,JARID2,JAK2,IL6R,PTPN1,PDGFRA,ABCC2,BTN3A1,GADD45A,DUSP1,BTN3A2,ARHGAP27,RHOA,PTPRC,ALDH5A1,PIK3CA,KIT,PPARG,MAPT,MUC20",DisGeNET
748,Congenital Epicanthus,0.060759579007503825,1.8896703296703297,5.292646351081007,0.34046608343879553,"CEP57,AHI1,RPS28,MAP2K2,PIK3CA,KANSL1,BCL11A,PRDM16,LONP1",DisGeNET
749,Spontaneous abortion,0.060874681727052966,2.252230814991077,6.303854245950367,0.34046608343879553,"CD164,IL1RN,CD82,TFRC,APOE,JAK2",DisGeNET
750,Childhood Osteosarcoma,0.060874681727052966,2.252230814991077,6.303854245950367,0.34046608343879553,"CEBPA,PIK3CA,EPAS1,DUSP1,KIT,IL6R",DisGeNET
751,Diastolic blood pressure,0.060874681727052966,2.252230814991077,6.303854245950367,0.34046608343879553,"FTO,GCKR,HFE,PSD4,SH2B3,CPEB4",DisGeNET
752,Gastritis,0.060874681727052966,2.252230814991077,6.303854245950367,0.34046608343879553,"IL1RN,KITLG,TERT,CDH1,SMOX,PPARG",DisGeNET
753,"Alzheimer Disease, Late Onset",0.061170681675805,1.8169934640522876,5.0768382927432,0.34046608343879553,"TF,TOMM40,DNMBP,ALDH2,HFE,LEPR,NLRP3,PPARG,APOE,MAPT",DisGeNET
754,Pituitary Adenoma,0.061170681675805,1.8169934640522876,5.0768382927432,0.34046608343879553,"SCGN,IL1RN,TFRC,PIK3CA,CDH1,MYB,KIT,LEPR,PPARG,IL6R",DisGeNET
755,"Cystadenocarcinoma, Serous",0.06134084599917283,2.8569415081042986,7.974607482337523,0.34046608343879553,"LAPTM4B,PIK3CA,PSD4,TYMP",DisGeNET
756,Eosinophilic esophagitis,0.06134084599917283,2.8569415081042986,7.974607482337523,0.34046608343879553,"HBS1L,KITLG,BCL11A,MYB",DisGeNET
757,"Breast cancer, lobular",0.06232145365055438,5.567907995618839,15.453447752602834,0.34046608343879553,"PIK3CA,CDH1",DisGeNET
758,"Dystonia, Primary",0.06232145365055438,5.567907995618839,15.453447752602834,0.34046608343879553,"ALDH5A1,APOE",DisGeNET
759,"Gonadal Dysgenesis, Mixed",0.06232145365055438,5.567907995618839,15.453447752602834,0.34046608343879553,"MAP3K1,KIT",DisGeNET
760,"Lymphoma, Intermediate-Grade",0.06232145365055438,5.567907995618839,15.453447752602834,0.34046608343879553,"RTEL1,TFRC",DisGeNET
761,Smoldering myeloma,0.06232145365055438,5.567907995618839,15.453447752602834,0.34046608343879553,"CCND3,KIT",DisGeNET
762,"Melanoma, Amelanotic",0.06232145365055438,5.567907995618839,15.453447752602834,0.34046608343879553,"RAB8A,CTSB",DisGeNET
763,Tonsillar Carcinoma,0.06232145365055438,5.567907995618839,15.453447752602834,0.34046608343879553,"PIK3CA,CDH1",DisGeNET
764,Abnormality of the pharynx,0.06232145365055438,5.567907995618839,15.453447752602834,0.34046608343879553,"RTEL1,TERT",DisGeNET
765,Benign Mastocytoma,0.06232145365055438,5.567907995618839,15.453447752602834,0.34046608343879553,"KITLG,KIT",DisGeNET
766,Death in early adulthood,0.06232145365055438,5.567907995618839,15.453447752602834,0.34046608343879553,"PIK3CA,TYMP",DisGeNET
767,Distal Renal Tubular Acidosis,0.06232145365055438,5.567907995618839,15.453447752602834,0.34046608343879553,"GYPA,GYPE",DisGeNET
768,Elevated circulating follicle stimulating hormone level,0.06232145365055438,5.567907995618839,15.453447752602834,0.34046608343879553,"MAP3K1,NSMCE2",DisGeNET
769,Lobular Neoplasia,0.06232145365055438,5.567907995618839,15.453447752602834,0.34046608343879553,"CDH1,APOE",DisGeNET
770,Memory dysfunction,0.06232145365055438,5.567907995618839,15.453447752602834,0.34046608343879553,"APOE,PLTP",DisGeNET
771,Ovarian Diseases,0.06232145365055438,5.567907995618839,15.453447752602834,0.34046608343879553,"BCL2L11,CTSB",DisGeNET
772,Overnutrition,0.06232145365055438,5.567907995618839,15.453447752602834,0.34046608343879553,"FTO,LPL",DisGeNET
773,Pancolitis,0.06232145365055438,5.567907995618839,15.453447752602834,0.34046608343879553,"TLR1,MYO9B",DisGeNET
774,Peripheral arterial stenosis,0.06232145365055438,5.567907995618839,15.453447752602834,0.34046608343879553,"APOB,JAK2",DisGeNET
775,Pure gonadal dysgenesis,0.06232145365055438,5.567907995618839,15.453447752602834,0.34046608343879553,"MAP3K1,KIT",DisGeNET
776,Reticular hyperpigmentation,0.06253956201413506,30.56156156156156,84.71530180884244,0.34046608343879553,TERT,DisGeNET
777,Retinitis Pigmentosa 7,0.06253956201413506,30.56156156156156,84.71530180884244,0.34046608343879553,TST,DisGeNET
778,"Cataract, total congenital with posterior sutural opacities in Heterozygotes",0.06253956201413506,30.56156156156156,84.71530180884244,0.34046608343879553,AK3,DisGeNET
779,"Fibromatosis, Abdominal",0.06253956201413506,30.56156156156156,84.71530180884244,0.34046608343879553,KIT,DisGeNET
780,"STRIATONIGRAL DEGENERATION, INFANTILE (disorder)",0.06253956201413506,30.56156156156156,84.71530180884244,0.34046608343879553,ADAR,DisGeNET
781,"TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS",0.06253956201413506,30.56156156156156,84.71530180884244,0.34046608343879553,ETS2,DisGeNET
782,Tumor necrosis factor receptor associated periodic syndrome [TRAPS],0.06253956201413506,30.56156156156156,84.71530180884244,0.34046608343879553,NLRP3,DisGeNET
783,Alpha-thalassemia/mental retardation syndrome (301040) is an allelic disorder,0.06253956201413506,30.56156156156156,84.71530180884244,0.34046608343879553,ATR,DisGeNET
784,Asymmetric growth,0.06253956201413506,30.56156156156156,84.71530180884244,0.34046608343879553,PIK3CA,DisGeNET
785,Beta thalassemia minor,0.06253956201413506,30.56156156156156,84.71530180884244,0.34046608343879553,HFE,DisGeNET
786,Bulbar signs,0.06253956201413506,30.56156156156156,84.71530180884244,0.34046608343879553,FIG4,DisGeNET
787,Compensated liver disease,0.06253956201413506,30.56156156156156,84.71530180884244,0.34046608343879553,HFE,DisGeNET
788,Congenital Generalized Lipodystrophy Type 2,0.06253956201413506,30.56156156156156,84.71530180884244,0.34046608343879553,PPARG,DisGeNET
789,Cyanotic congenital heart disease,0.06253956201413506,30.56156156156156,84.71530180884244,0.34046608343879553,ALDH2,DisGeNET
790,Early Inflammatory Arthritis,0.06253956201413506,30.56156156156156,84.71530180884244,0.34046608343879553,CTSB,DisGeNET
791,Embolism and Thrombosis,0.06253956201413506,30.56156156156156,84.71530180884244,0.34046608343879553,JAK2,DisGeNET
792,Focal Neurologic Deficits,0.06253956201413506,30.56156156156156,84.71530180884244,0.34046608343879553,ALDH5A1,DisGeNET
793,Headache associated with sexual activity,0.06253956201413506,30.56156156156156,84.71530180884244,0.34046608343879553,KIT,DisGeNET
794,Hemoglobin E disease,0.06253956201413506,30.56156156156156,84.71530180884244,0.34046608343879553,BCL11A,DisGeNET
795,Hereditary Paraganglioma-Pheochromocytoma Syndrome,0.06253956201413506,30.56156156156156,84.71530180884244,0.34046608343879553,MAX,DisGeNET
796,Hereditary systemic amyloidosis,0.06253956201413506,30.56156156156156,84.71530180884244,0.34046608343879553,NLRP3,DisGeNET
797,Increased circulating very-low-density lipoprotein levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.34046608343879553,LPL,DisGeNET
798,Inherited bone marrow failure syndrome,0.06253956201413506,30.56156156156156,84.71530180884244,0.34046608343879553,TERT,DisGeNET
799,Malignant Cystosarcoma Phyllodes,0.06253956201413506,30.56156156156156,84.71530180884244,0.34046608343879553,KIT,DisGeNET
800,Malignant melanoma of conjunctiva,0.06253956201413506,30.56156156156156,84.71530180884244,0.34046608343879553,TERT,DisGeNET
801,MiT family translocation renal cell carcinoma,0.06253956201413506,30.56156156156156,84.71530180884244,0.34046608343879553,TFEB,DisGeNET
802,Neurologic Deficits,0.06253956201413506,30.56156156156156,84.71530180884244,0.34046608343879553,ALDH5A1,DisGeNET
803,Neurologic Dysfunction,0.06253956201413506,30.56156156156156,84.71530180884244,0.34046608343879553,ALDH5A1,DisGeNET
804,Neurological observations,0.06253956201413506,30.56156156156156,84.71530180884244,0.34046608343879553,ALDH5A1,DisGeNET
805,Normochromic anemia,0.06253956201413506,30.56156156156156,84.71530180884244,0.34046608343879553,HK1,DisGeNET
806,Normocytic anemia,0.06253956201413506,30.56156156156156,84.71530180884244,0.34046608343879553,HK1,DisGeNET
807,Ovarian Small Cell Carcinoma,0.06253956201413506,30.56156156156156,84.71530180884244,0.34046608343879553,KIT,DisGeNET
808,Pain in lower limb,0.06253956201413506,30.56156156156156,84.71530180884244,0.34046608343879553,PIK3CA,DisGeNET
809,Primary Cutaneous B-Cell Non-Hodgkin Lymphoma,0.06253956201413506,30.56156156156156,84.71530180884244,0.34046608343879553,APOE,DisGeNET
810,Ewings sarcoma,0.06254668527661521,1.752641154128499,4.858044426181435,0.34046608343879553,"CCND3,PTPRC,CCND2,TP53I3,PIK3CA,TERT,CD82,AXL,KIT,TRIP6,IL6R",DisGeNET
811,Essential Hypertension,0.06301671805588882,1.8061872788968305,4.99294323601674,0.34046608343879553,"FTO,PTPN1,ALDH2,LEPR,LPL,NLRP3,PPARG,APOE,APOB,ZNF410",DisGeNET
812,Colorectal Neoplasms,0.0630942743774346,1.3937553593947036,3.8511206292390847,0.34046608343879553,"IL1RN,TFRC,CD82,MPG,ICAM5,PLD1,TYMP,FADS2,AKAP10,BCL2L11,CCND2,ALDH2,TERT,CDH1,ZKSCAN3,LEPR,APOE,IL6R,EPHB4,CTSB,PDGFRA,MAP2K2,ABCC2,RHOA,RAD50,KITLG,PTPRC,PIK3CA,PPARG",DisGeNET
813,"Amaurosis congenita of Leber, type 1",0.06320075302275012,3.538926330467116,9.772529409972307,0.34046608343879553,"AHI1,MEF2C,PTPRC",DisGeNET
814,Transient Cerebral Ischemia,0.06320075302275012,3.538926330467116,9.772529409972307,0.34046608343879553,"APOE,JAK2,SH2B3",DisGeNET
815,Abnormality of vision,0.06320075302275012,3.538926330467116,9.772529409972307,0.34046608343879553,"CEP57,MAP2K2,CDH1",DisGeNET
816,Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,0.06320075302275012,3.538926330467116,9.772529409972307,0.34046608343879553,"IL1RN,CCND2,DUSP1",DisGeNET
817,Drusen,0.06320075302275012,3.538926330467116,9.772529409972307,0.34046608343879553,"SERPING1,APOE,APOB",DisGeNET
818,Malignant neoplasm of oropharynx,0.06320075302275012,3.538926330467116,9.772529409972307,0.34046608343879553,"ALDH2,PIK3CA,ATR",DisGeNET
819,Osteoarthritis of the hand,0.06320075302275012,3.538926330467116,9.772529409972307,0.34046608343879553,"IL1RN,HFE,TRIB1",DisGeNET
820,Alzheimer's Disease,0.06452757361906418,1.2983250809951707,3.5582710551742385,0.34696210188513915,"FTO,GYPA,IL1RN,TOMM40,TFRC,GYPE,HFE,ITSN1,LPL,PLD1,ETS2,LMF2,HK1,SMPD2,BCL2L11,ALDH2,TERT,CDH1,NLRP3,APOE,APOB,JAK2,SH2B3,PLTP,FBXO7,IL6R,CTSB,HSPA8,PTPN1,MEF2C,MAP2K2,ABCC2,GADD45A,PABPC4,TFEB,RHOA,SIRT3,MSRA,TF,DNMBP,PTPRC,PIK3CA,IL2RB,SERPING1,PPARG,MAPT,PDE7A",DisGeNET
821,Waldenstrom Macroglobulinemia,0.06456389067264262,2.440054035798717,6.685992044923583,0.34696210188513915,"CCND3,RTEL1,CCND2,PTPRC,ANP32B",DisGeNET
822,Malignant Fibrous Histiocytoma,0.06531799876695644,2.7917355371900827,7.617215931715123,0.3497366633007425,"PDGFRA,MFHAS1,PIK3CA,EPAS1",DisGeNET
823,Philadelphia chromosome-positive acute lymphoblastic leukemia,0.06531799876695644,2.7917355371900827,7.617215931715123,0.3497366633007425,"PIK3CA,MPG,JAK2,EPHB4",DisGeNET
824,Prediabetes syndrome,0.06531799876695644,2.7917355371900827,7.617215931715123,0.3497366633007425,"FTO,PIK3CA,PPARG,SIRT3",DisGeNET
825,Cardiomegaly,0.0656949255706966,2.05361875637105,5.591456774860482,0.35090316176502834,"FIG4,CCND2,THRB,HFE,TRPC1,PLD1,CPT1B",DisGeNET
826,Classical Hodgkin's Lymphoma,0.0656949255706966,2.05361875637105,5.591456774860482,0.35090316176502834,"PTPN1,DOK2,PTPRC,BCL11A,DUSP1,LPL,JAK2",DisGeNET
827,Pulmonary Emphysema,0.06582069930929134,1.9421283995942225,5.284183561369617,0.351149849277622,"SMPD2,PTPN1,TERT,EPAS1,TFEB,SERPING1,PPARG,PLTP",DisGeNET
828,Juvenile arthritis,0.06607523987097964,1.7344095532950021,4.712323440771686,0.35208207525454366,"IL1RN,SLC22A16,GADD45A,DUSP1,FAXDC2,HFE,IL2RB,GMPR,NLRP3,IL6R,SH2B3",DisGeNET
829,Diabetic Nephropathy,0.06694732892588813,1.5376939419300844,4.157692387409399,0.3562986914608184,"PTPN1,IL1RN,MAP2K2,HFE,TRPC1,LPL,ALDH2,PIK3CA,AXL,NLRP3,PPARG,APOE,APOB,JAK2,IL6R,ZNF410,CTSB",DisGeNET
830,Squamous cell carcinoma of the head and neck,0.06765068592937717,1.4292234626534264,3.849467308626519,0.3592167420616638,"CEBPA,PDGFRA,MAP2K2,ABCC2,TFRC,GADD45A,DUSP1,TMC8,TMC6,PCSK7,RHOA,SIRT3,ARHGAP21,BCL2L11,TP53I3,ALDH2,PIK3CA,TERT,CDH1,AXL,NLRP3,FLOT2,JAK2,EPHB4",DisGeNET
831,"Gastritis, Atrophic",0.067886951826869,2.4016907294832825,6.460335345480222,0.3592167420616638,"TLR1,IL1RN,CDH1,SMOX,DDB2",DisGeNET
832,Carcinomatosis,0.0682267826758351,2.0340430442559576,5.46123895186653,0.3592167420616638,"TF,KITLG,TP53I3,CDH1,LPL,RHOA,TYMP",DisGeNET
833,Neoplasm Invasiveness,0.0682267826758351,2.0340430442559576,5.46123895186653,0.3592167420616638,"IL1RN,TF,CD82,CDH1,AXL,RHOA,CTSB",DisGeNET
834,Systemic Scleroderma,0.06835316229651864,1.5550166597661719,4.172214585047743,0.3592167420616638,"BLK,PTPN1,PDGFRA,TAGLN,IL1RN,FAM167A,PTPRC,PIK3CA,IL2RB,MYB,NLRP3,HIST1H4H,PPARG,APOE,HIST1H4J,HIST1H4C",DisGeNET
835,"Inclusion Body Myopathy, Sporadic",0.06863547451450196,3.4075193017791205,9.128559374404292,0.3592167420616638,"TOMM40,MAPT,APOE",DisGeNET
836,Sparse and thin eyebrow,0.06863547451450196,3.4075193017791205,9.128559374404292,0.3592167420616638,"KANK2,FIG4,RPS28",DisGeNET
837,Telangiectasis,0.06863547451450196,3.4075193017791205,9.128559374404292,0.3592167420616638,"HFE,DDB2,ATR",DisGeNET
838,Thrombocytopenia due to platelet alloimmunization,0.06863547451450196,3.4075193017791205,9.128559374404292,0.3592167420616638,"IL1RN,NLRP3,ANP32B",DisGeNET
839,Cerebellar vermis hypoplasia,0.06863547451450196,3.4075193017791205,9.128559374404292,0.3592167420616638,"AHI1,KIAA0586,ATR",DisGeNET
840,Chronic eosinophilic leukemia,0.06863547451450196,3.4075193017791205,9.128559374404292,0.3592167420616638,"PDGFRA,KIT,JAK2",DisGeNET
841,Endometrioid carcinoma ovary,0.06863547451450196,3.4075193017791205,9.128559374404292,0.3592167420616638,"TERT,PIK3CA,TNK2",DisGeNET
842,Oligoarticular Juvenile Idiopathic Arthritis,0.06863547451450196,3.4075193017791205,9.128559374404292,0.3592167420616638,"IL2RB,IL6R,UBE2L3",DisGeNET
843,Peripheral arterial occlusive disease,0.06863547451450196,3.4075193017791205,9.128559374404292,0.3592167420616638,"APOE,APOB,JAK2",DisGeNET
844,Chest Pain,0.06942650750229386,2.7294276094276095,7.28071138797702,0.3620143782379869,"MAX,PPARG,JAK2,SH2B3",DisGeNET
845,Hyperglycemia,0.06960185444446791,1.5753148079273152,4.198157358409962,0.3620143782379869,"NFE2,IL1RN,GCKR,GALNT2,EPAS1,LPL,ALDH2,PIK3CA,LEPR,NLRP3,PPARG,APOE,APOB,JAK2,PLTP",DisGeNET
846,Adenoid Cystic Carcinoma,0.07043739878840909,1.9116374185570932,5.071633187065065,0.3620143782379869,"MAP2K2,PIK3CA,KANSL1,BCL11A,CDH1,MYB,KIT,ICAM5",DisGeNET
847,Malignant neoplasm of skin,0.07075882595216634,1.7641975308641975,4.672438351321439,0.3620143782379869,"CEBPA,GYPA,PTPRC,TERT,KIT,PDCD5,TMC8,NLRP3,RAB8A,DDB2",DisGeNET
848,Small chin,0.07122229964072589,5.103413654618474,13.482960195706973,0.3620143782379869,"FIG4,MEF2C",DisGeNET
849,Thymus Neoplasms,0.07122229964072589,5.103413654618474,13.482960195706973,0.3620143782379869,"RRM1,KIT",DisGeNET
850,ABLEPHARON-MACROSTOMIA SYNDROME,0.07122229964072589,5.103413654618474,13.482960195706973,0.3620143782379869,"EPAS1,SMOX",DisGeNET
851,Abnormal nasal morphology,0.07122229964072589,5.103413654618474,13.482960195706973,0.3620143782379869,"CCND2,CITED2",DisGeNET
852,Aplasia/Hypoplasia of the skin,0.07122229964072589,5.103413654618474,13.482960195706973,0.3620143782379869,"RTEL1,TERT",DisGeNET
853,Arhinencephaly,0.07122229964072589,5.103413654618474,13.482960195706973,0.3620143782379869,"FIG4,ADAR",DisGeNET
854,Carcinoma in situ of endometrium,0.07122229964072589,5.103413654618474,13.482960195706973,0.3620143782379869,"MAX,ATR",DisGeNET
855,Congenital anomaly of neck,0.07122229964072589,5.103413654618474,13.482960195706973,0.3620143782379869,"FIG4,PPARG",DisGeNET
856,Deformity of neck,0.07122229964072589,5.103413654618474,13.482960195706973,0.3620143782379869,"FIG4,PPARG",DisGeNET
857,Episodic tachypnea,0.07122229964072589,5.103413654618474,13.482960195706973,0.3620143782379869,"AHI1,KIAA0586",DisGeNET
858,Glucose measurement,0.07122229964072589,5.103413654618474,13.482960195706973,0.3620143782379869,"FTO,GCKR",DisGeNET
859,Ichthyosis linearis circumflexa,0.07122229964072589,5.103413654618474,13.482960195706973,0.3620143782379869,"GYPA,GYPE",DisGeNET
860,Malformation of the neck,0.07122229964072589,5.103413654618474,13.482960195706973,0.3620143782379869,"FIG4,PPARG",DisGeNET
861,Massive Osteolyses,0.07122229964072589,5.103413654618474,13.482960195706973,0.3620143782379869,"APOE,APOB",DisGeNET
862,Myoma,0.07122229964072589,5.103413654618474,13.482960195706973,0.3620143782379869,"TERT,LEPR",DisGeNET
863,Omenn Syndrome,0.07122229964072589,5.103413654618474,13.482960195706973,0.3620143782379869,"IL1RN,TFRC",DisGeNET
864,Peri-Implantitis,0.07122229964072589,5.103413654618474,13.482960195706973,0.3620143782379869,"IL1RN,TERT",DisGeNET
865,"Abortion, Tubal",0.0713033759494131,2.364507832592939,6.244219722447332,0.3620143782379869,"CD164,CD82,TFRC,APOE,JAK2",DisGeNET
866,Testicular Germ Cell Tumor,0.0713033759494131,2.364507832592939,6.244219722447332,0.3620143782379869,"KITLG,CCND2,TERT,PIK3CA,KIT",DisGeNET
867,Adult Hepatocellular Carcinoma,0.0713033759494131,2.364507832592939,6.244219722447332,0.3620143782379869,"TFRC,TERT,PIK3CA,CDH1,CTSB",DisGeNET
868,Memory Loss,0.0713033759494131,2.364507832592939,6.244219722447332,0.3620143782379869,"TOMM40,ALDH2,APOE,MAPT,CTSB",DisGeNET
869,Neurologic Symptoms,0.0713033759494131,2.364507832592939,6.244219722447332,0.3620143782379869,"GCDH,AHI1,ALDH5A1,PIK3CA,NLRP3",DisGeNET
870,Burkitt Lymphoma,0.07175514155593572,1.663649277219174,4.3828769795941245,0.3638892925802165,"PDGFRA,RTEL1,CCND3,BCL2L11,CCND2,TFRC,PIK3CA,MAX,BCL11A,KIT,RHOA,HDAC7",DisGeNET
871,Abnormality of metabolism/homeostasis,0.07228487917791347,2.1466250709018717,5.639485257853791,0.36573496207907596,"ALDH5A1,PIK3CA,CDH1,KIT,TMC8,TMC6",DisGeNET
872,Aplastic Anemia,0.07228487917791347,2.1466250709018717,5.639485257853791,0.36573496207907596,"GYPA,RTEL1,TFRC,TERT,HFE,KIT",DisGeNET
873,Dandy-Walker Syndrome,0.07366493077681577,2.669828722002635,6.963523177361515,0.3718646162326215,"CEP57,FTO,ASXL1,NPHP3",DisGeNET
874,Meningitis,0.07366493077681577,2.669828722002635,6.963523177361515,0.3718646162326215,"IL1RN,GYPA,GYPE,NLRP3",DisGeNET
875,Renal carcinoma,0.07386917419600399,1.5873397435897436,4.135749679203931,0.3719627266527974,"KANK2,RBM38,ABCC2,THRB,MPG,EPAS1,TNK2,TFEB,KITLG,BCL2L11,PIK3CA,CDH1,LEPR,PPARG",DisGeNET
876,Papillary thyroid carcinoma,0.0742191134450639,1.5589825587511308,4.054498273064715,0.3719627266527974,"PDGFRA,THRB,CD82,NCOA4,SIRT3,TYMP,TLR1,PIK3CA,TERT,CDH1,KIT,LEPR,PPARG,EPHB4,CTSB",DisGeNET
877,Alopecia Areata,0.07427451545356177,3.285498489425982,8.542254613906618,0.3719627266527974,"TLR1,IL1RN,ACOXL",DisGeNET
878,Atypical Ductal Breast Hyperplasia,0.07427451545356177,3.285498489425982,8.542254613906618,0.3719627266527974,"PIK3CA,APOE,APOB",DisGeNET
879,Convex nasal ridge,0.07427451545356177,3.285498489425982,8.542254613906618,0.3719627266527974,"ASXL1,THRB,ATR",DisGeNET
880,Hemorrhagic Disorders,0.07427451545356177,3.285498489425982,8.542254613906618,0.3719627266527974,"RTEL1,TERT,AK3",DisGeNET
881,Insulin resistance syndrome,0.07427451545356177,3.285498489425982,8.542254613906618,0.3719627266527974,"LPL,PPARG,APOB",DisGeNET
882,Hypogonadotropic hypogonadism,0.0748126900406105,2.328451690153818,6.037134462334783,0.37355367891450325,"MAP3K1,AXL,HFE,LEPR,TYMP",DisGeNET
883,Adenocarcinoma Of Esophagus,0.0748462040254807,1.7439143474925018,4.520783838692434,0.37355367891450325,"RBM38,MSRA,PIK3CA,AXL,CDH1,MAX,PPARG,JAK2,CTSB,TYMP",DisGeNET
884,Fibrosarcoma,0.0748462040254807,1.7439143474925018,4.520783838692434,0.37355367891450325,"AHI1,KITLG,MAP3K1,ABCC2,PIK3CA,IL2RB,ARFIP1,EPHB4,ATR,HK1",DisGeNET
885,Fetal Growth Retardation,0.07694427409233075,1.7339436815092246,4.446999986513043,0.37660426468712893,"CEP57,FIG4,FTO,ASXL1,RTEL1,TERT,KANSL1,CITED2,APOE,ATR",DisGeNET
886,Adenoma,0.07709794519974773,1.386786159046433,3.5538872817286977,0.37660426468712893,"FTO,IL1RN,TFRC,CD82,MPG,HFE,TYMP,CCND3,BCL2L11,ALDH2,TERT,CDH1,MYB,LEPR,NLRP3,APOE,EPHB4,RAB8A,CTSB,ABCC2,TF,PIK3CA,KIT,ZNF217,PPARG,ANP32B",DisGeNET
887,Uterine Corpus Cancer,0.0772787499355014,1.525379777455249,3.905485162103419,0.37660426468712893,"FTO,IL1RN,MAP3K1,CD82,TNK2,SIRT3,TYMP,PIK3CA,TERT,CDH1,KIT,LEPR,PDE7A,SH2B3,MUC20,IL6R",DisGeNET
888,Head and Neck Carcinoma,0.0784143340918938,2.293471850474073,5.838602604630274,0.37660426468712893,"PTPRC,PIK3CA,AXL,LONP1,NLRP3",DisGeNET
889,Chromophobe Renal Cell Carcinoma,0.07841991658117532,2.0974223946784925,5.33936067483829,0.37660426468712893,"CD82,PIK3CA,EPAS1,KIT,IL6R,CTSB",DisGeNET
890,Common Variable Immunodeficiency,0.07841991658117532,2.0974223946784925,5.33936067483829,0.37660426468712893,"BLK,RTEL1,PTPRC,TERT,HFE,ANP32B",DisGeNET
891,Parkinson Disease,0.0787444608047328,1.3746886376700518,3.4938362541621903,0.37660426468712893,"MACF1,IL1RN,TOMM40,TFRC,HFE,AGAP1,HSD17B13,UBE2L3,ALDH2,APOE,FBXO7,EPHB4,CTSB,HSPA8,MEF2C,NDFIP1,TNK2,TRPC1,TFEB,ZFP90,SIRT3,MSRA,TF,KANSL1,PIK3CA,PPARG,MAPT",DisGeNET
892,Cognitive delay,0.079288786559868,1.4009562428130484,3.5509457409301426,0.37660426468712893,"CEP57,FTO,RTEL1,MAP2K2,PGAP3,BCL11A,DOCK7,ADAR,ASXL1,FIG4,SLC25A15,HADHA,AHI1,RPS28,CCND2,ALDH5A1,KANSL1,PIK3CA,TERT,KIAA0586,PRDM16,LONP1,NPHP3,SNIP1",DisGeNET
893,Impaired cognition,0.07964755751138969,1.463035172712592,3.7016895299616897,0.37660426468712893,"FTO,MEF2C,TOMM40,HFE,LPL,DDB2,TYMP,AHI1,DSTYK,ALDH2,PIK3CA,NLRP3,PPARG,APOE,MAPT,JARID2,FBXO7,IL6R,ATR",DisGeNET
894,Autoimmune thyroiditis,0.08011208835267787,3.171892905510991,8.00689972545036,0.37660426468712893,"PIK3CA,TERT,NCOA4",DisGeNET
895,Carcinosarcoma,0.08011208835267787,3.171892905510991,8.00689972545036,0.37660426468712893,"PDGFRA,PIK3CA,KIT",DisGeNET
896,keratoacanthoma,0.08011208835267787,3.171892905510991,8.00689972545036,0.37660426468712893,"TERT,PIK3CA,DMKN",DisGeNET
897,Ketosis,0.08011208835267787,3.171892905510991,8.00689972545036,0.37660426468712893,"GCDH,ALDH2,LPL",DisGeNET
898,Neuroblastic tumors,0.08011208835267787,3.171892905510991,8.00689972545036,0.37660426468712893,"KITLG,TERT,KIT",DisGeNET
899,Pyramidal sign,0.08011208835267787,3.171892905510991,8.00689972545036,0.37660426468712893,"SLC25A15,MAPT,FBXO7",DisGeNET
900,QRS complex feature,0.08011208835267787,3.171892905510991,8.00689972545036,0.37660426468712893,"FADS2,PRDM16,MAPT",DisGeNET
901,"Infant, Small for Gestational Age",0.08012841131852502,1.7790532544378699,4.490552421704231,0.37660426468712893,"CEP57,FIG4,FTO,ASXL1,RTEL1,TERT,KANSL1,CITED2,ATR",DisGeNET
902,Recurrent skin infections,0.08050468484980135,4.710379981464319,11.86751926644335,0.37660426468712893,"TMC8,TMC6",DisGeNET
903,"alpha-1-Antitrypsin Deficiency, Autosomal Recessive",0.08050468484980135,4.710379981464319,11.86751926644335,0.37660426468712893,"MPG,HFE",DisGeNET
904,Short lower third of face,0.08050468484980135,4.710379981464319,11.86751926644335,0.37660426468712893,"FIG4,MEF2C",DisGeNET
905,Sideroblastic anemia,0.08050468484980135,4.710379981464319,11.86751926644335,0.37660426468712893,"HFE,JAK2",DisGeNET
906,"Infarction, Lacunar",0.08050468484980135,4.710379981464319,11.86751926644335,0.37660426468712893,"ALDH2,APOE",DisGeNET
907,"Meningitis, Pneumococcal",0.08050468484980135,4.710379981464319,11.86751926644335,0.37660426468712893,"NLRP3,CTSB",DisGeNET
908,Stage IV Bladder Cancer AJCC v6,0.08050468484980135,4.710379981464319,11.86751926644335,0.37660426468712893,"RRM1,PIK3CA",DisGeNET
909,Staphylococcus aureus infection,0.08050468484980135,4.710379981464319,11.86751926644335,0.37660426468712893,"NLRP3,APOB",DisGeNET
910,Stomach Diseases,0.08050468484980135,4.710379981464319,11.86751926644335,0.37660426468712893,"TLR1,SMOX",DisGeNET
911,Tooth Attrition,0.08050468484980135,4.710379981464319,11.86751926644335,0.37660426468712893,"TERT,APOE",DisGeNET
912,Acquired CJD,0.08050468484980135,4.710379981464319,11.86751926644335,0.37660426468712893,"ZBTB38,APOE",DisGeNET
913,Yellow Fever,0.08050468484980135,4.710379981464319,11.86751926644335,0.37660426468712893,"IL1RN,RAB8A",DisGeNET
914,Congenital malrotation of intestine,0.08050468484980135,4.710379981464319,11.86751926644335,0.37660426468712893,"ASXL1,NPHP3",DisGeNET
915,Cryopyrin-Associated Periodic Syndromes,0.08050468484980135,4.710379981464319,11.86751926644335,0.37660426468712893,"IL1RN,NLRP3",DisGeNET
916,Epidermodysplasia Verruciformis,0.08050468484980135,4.710379981464319,11.86751926644335,0.37660426468712893,"TMC8,TMC6",DisGeNET
917,Episodic abdominal pain,0.08050468484980135,4.710379981464319,11.86751926644335,0.37660426468712893,"MAX,LPL",DisGeNET
918,ESR raised,0.08050468484980135,4.710379981464319,11.86751926644335,0.37660426468712893,"IL2RB,NLRP3",DisGeNET
919,Fatty acid measurement,0.08050468484980135,4.710379981464319,11.86751926644335,0.37660426468712893,"FADS2,GCKR",DisGeNET
920,Hepatic Veno-Occlusive Disease,0.08050468484980135,4.710379981464319,11.86751926644335,0.37660426468712893,"HFE,TYMP",DisGeNET
921,Hereditary macular dystrophy,0.08050468484980135,4.710379981464319,11.86751926644335,0.37660426468712893,"RP1L1,TST",DisGeNET
922,Hunger,0.08050468484980135,4.710379981464319,11.86751926644335,0.37660426468712893,"FTO,PPARG",DisGeNET
923,Intermittent abdominal pain,0.08050468484980135,4.710379981464319,11.86751926644335,0.37660426468712893,"MAX,LPL",DisGeNET
924,Porphyria Cutanea Tarda,0.08050468484980135,4.710379981464319,11.86751926644335,0.37660426468712893,"TFRC,HFE",DisGeNET
925,Pseudomyxoma Peritonei,0.08050468484980135,4.710379981464319,11.86751926644335,0.37660426468712893,"PIK3CA,CDH1",DisGeNET
926,Rare Diseases,0.08050468484980135,4.710379981464319,11.86751926644335,0.37660426468712893,"PDGFRA,KIT",DisGeNET
927,Retinal Diseases,0.08146631628906648,1.6650579736538578,4.1752421653950575,0.37660426468712893,"ASXL1,RP1L1,AHI1,MEF2C,PTPRC,ALDH2,TST,IL37,PPARG,APOE,EPHB4",DisGeNET
928,Nerve Degeneration,0.0815942806951269,2.073650315154837,5.196559621181762,0.37660426468712893,"FIG4,CDH1,PPARG,APOE,ETS2,CTSB",DisGeNET
929,Renal glomerular disease,0.08210766330015962,2.259520829608439,5.6481782786841706,0.37660426468712893,"TAGLN,PTPRC,EPAS1,NLRP3,APOE",DisGeNET
930,Teratoma,0.08210766330015962,2.259520829608439,5.6481782786841706,0.37660426468712893,"KITLG,ABCC2,TERT,TRRAP,KIT",DisGeNET
931,Biliary Tract Cancer,0.08210766330015962,2.259520829608439,5.6481782786841706,0.37660426468712893,"RRM1,CCND2,PIK3CA,CDH1,PRC1",DisGeNET
932,Congenital anomaly of face,0.08210766330015962,2.259520829608439,5.6481782786841706,0.37660426468712893,"GCDH,KLF13,SNIP1,PPARG,MAPT",DisGeNET
933,IMMUNE SUPPRESSION,0.08252496370555697,2.558080808080808,6.381527648423984,0.37660426468712893,"PIK3CA,DUSP1,ANP32B,JAK2",DisGeNET
934,Addictive Behavior,0.08282584267193191,1.8393919970698653,4.581953343855261,0.37660426468712893,"FTO,RTEL1,RAD50,BCL2L11,ALDH2,PIK3CA,KIT,LEPR",DisGeNET
935,Leukopenia,0.08282584267193191,1.8393919970698653,4.581953343855261,0.37660426468712893,"FTO,ASXL1,CEBPA,RTEL1,RRM1,ABCC2,ALDH2,FLOT2",DisGeNET
936,Kaposi Sarcoma,0.08345666121001587,1.704692722188118,4.233481312579051,0.37660426468712893,"CEBPA,IL1RN,RTEL1,RAD50,TERT,PIK3CA,AXL,KIT,EPHB4,CTSB",DisGeNET
937,Nephrotic Syndrome,0.08463297997022308,1.9239296636085628,4.751012042143918,0.37660426468712893,"KANK2,TF,LEPR,LPL,NLRP3,APOE,APOB",DisGeNET
938,Intrauterine retardation,0.08488884393376389,1.7561830574488801,4.331472015052309,0.37660426468712893,"CEP57,FIG4,FTO,ASXL1,RTEL1,TERT,KANSL1,CITED2,ATR",DisGeNET
939,Multiple Sclerosis,0.08579342853443421,1.3604882831030012,3.3411046295902547,0.37660426468712893,"FTO,BLK,IL1RN,TMPRSS6,HFE,DUSP15,SPRED2,NLRP3,APOE,JAK2,IL6R,PDGFRA,NDFIP1,ZBTB38,MYO9B,ZFP90,TLR1,SLC25A37,AHI1,FAM167A,PTPRC,AXL,IL2RB,PPARG,MAPT,ANP32B,PDE7A",DisGeNET
940,Upward slant of palpebral fissure,0.08589195044138019,2.2265538963041274,5.465444282499133,0.37660426468712893,"FIG4,ASXL1,MEF2C,KANSL1,PGAP3",DisGeNET
941,Primary sclerosing cholangitis,0.08589195044138019,2.2265538963041274,5.465444282499133,0.37660426468712893,"IL1RN,BCL2L11,DLG5,NLRP3,SH2B3",DisGeNET
942,"Bronchitis, Chronic",0.08614216815905654,3.065861027190332,7.516743872182359,0.37660426468712893,"GYPA,PTPRC,GYPE",DisGeNET
943,Body fluid retention,0.08614216815905654,3.065861027190332,7.516743872182359,0.37660426468712893,"NLRP3,APOE,PLD1",DisGeNET
944,Neuro-degenerative disease,0.08614216815905654,3.065861027190332,7.516743872182359,0.37660426468712893,"SPTA1,FIG4,APOE",DisGeNET
945,Adverse reaction to drug,0.08714292340085301,2.5056277056277056,6.1142470357417364,0.37660426468712893,"TLR1,KITLG,TF,ABCC2",DisGeNET
946,Broad forehead,0.08714292340085301,2.5056277056277056,6.1142470357417364,0.37660426468712893,"MEF2C,PIK3CA,KANSL1,CITED2",DisGeNET
947,Cardiac Hypertrophy,0.08714292340085301,2.5056277056277056,6.1142470357417364,0.37660426468712893,"CCND2,TRPC1,PLD1,CPT1B",DisGeNET
948,Central Serous Chorioretinopathy,0.08714292340085301,2.5056277056277056,6.1142470357417364,0.37660426468712893,"PIK3CA,HIST1H4H,HIST1H4J,HIST1H4C",DisGeNET
949,Drug toxicity,0.08714292340085301,2.5056277056277056,6.1142470357417364,0.37660426468712893,"TLR1,KITLG,TF,ABCC2",DisGeNET
950,Malabsorption,0.08714292340085301,2.5056277056277056,6.1142470357417364,0.37660426468712893,"RTEL1,TERT,PIK3CA,TYMP",DisGeNET
951,Influenza,0.08775376134751486,1.540903024911032,3.7493569106949,0.37660426468712893,"HSPA8,GYPA,NDFIP1,GYPE,ADAR,ARHGAP21,PIK3CA,TERT,NLRP3,SERPING1,PPARG,CRLF3,IL6R,PLS1",DisGeNET
952,"Breast Cancer, Familial",0.08815521037246316,2.0276735459662287,4.9245220584728715,0.37660426468712893,"AKAP10,RAD50,PIK3CA,CDH1,GADD45A,JAK2",DisGeNET
953,Cervical Squamous Cell Carcinoma,0.08815521037246316,2.0276735459662287,4.9245220584728715,0.37660426468712893,"TLR1,HSPA8,CEBPA,PIK3CA,CDH1,APOE",DisGeNET
954,Pulmonary Hypertension,0.08815521037246316,2.0276735459662287,4.9245220584728715,0.37660426468712893,"TERT,EPAS1,PPARG,APOE,RHOA,HK1",DisGeNET
955,Premature Birth,0.08976638828382552,2.1945288753799392,5.290009881558194,0.37660426468712893,"FIG4,IL1RN,MAP2K2,PPARG,IL6R",DisGeNET
956,"Arteriovenous Malformations, Cerebral",0.09013554473473162,4.373493975903615,10.524553856726516,0.37660426468712893,"IL1RN,EPHB4",DisGeNET
957,"Chronic Infantile Neurological, Cutaneous, and Articular Syndrome",0.09013554473473162,4.373493975903615,10.524553856726516,0.37660426468712893,"IL1RN,NLRP3",DisGeNET
958,"Delirium, Dementia, Amnestic, Cognitive Disorders",0.09013554473473162,4.373493975903615,10.524553856726516,0.37660426468712893,"SMOX,APOE",DisGeNET
959,Stomatitis,0.09013554473473162,4.373493975903615,10.524553856726516,0.37660426468712893,"IL1RN,ABCC2",DisGeNET
960,Adrenal Cancer,0.09013554473473162,4.373493975903615,10.524553856726516,0.37660426468712893,"RRM1,TERT",DisGeNET
961,Adult Non-Hodgkin Lymphoma,0.09013554473473162,4.373493975903615,10.524553856726516,0.37660426468712893,"CCND3,NLRP3",DisGeNET
962,Alcohol Withdrawal Delirium,0.09013554473473162,4.373493975903615,10.524553856726516,0.37660426468712893,"ALDH2,MAPT",DisGeNET
963,Apathy,0.09013554473473162,4.373493975903615,10.524553856726516,0.37660426468712893,"APOE,MAPT",DisGeNET
964,CNS metastases,0.09013554473473162,4.373493975903615,10.524553856726516,0.37660426468712893,"TERT,PIK3CA",DisGeNET
965,Elevated C-reactive protein,0.09013554473473162,4.373493975903615,10.524553856726516,0.37660426468712893,"IL2RB,NLRP3",DisGeNET
966,Elevated C-reactive protein level,0.09013554473473162,4.373493975903615,10.524553856726516,0.37660426468712893,"IL2RB,NLRP3",DisGeNET
967,Fetal Alcohol Spectrum Disorders,0.09013554473473162,4.373493975903615,10.524553856726516,0.37660426468712893,"PDGFRA,PIK3CA",DisGeNET
968,Goiter,0.09013554473473162,4.373493975903615,10.524553856726516,0.37660426468712893,"THRB,PIK3CA",DisGeNET
969,Hypobetalipoproteinemias,0.09013554473473162,4.373493975903615,10.524553856726516,0.37660426468712893,"APOE,APOB",DisGeNET
970,Idiopathic Interstitial Pneumonias,0.09013554473473162,4.373493975903615,10.524553856726516,0.37660426468712893,"PTPRC,PPARG",DisGeNET
971,Invasive Skin Melanoma,0.09013554473473162,4.373493975903615,10.524553856726516,0.37660426468712893,"CD82,RAB8A",DisGeNET
972,Keratosis Follicularis,0.09013554473473162,4.373493975903615,10.524553856726516,0.37660426468712893,"TRPC1,APOE",DisGeNET
973,Longevity,0.09013554473473162,4.373493975903615,10.524553856726516,0.37660426468712893,"TOMM40,APOE",DisGeNET
974,Loss of speech,0.09013554473473162,4.373493975903615,10.524553856726516,0.37660426468712893,"ADAR,MAPT",DisGeNET
975,Low serum estradiol levels,0.09013554473473162,4.373493975903615,10.524553856726516,0.37660426468712893,"MAP3K1,LEPR",DisGeNET
976,Mucinous neoplasm,0.09013554473473162,4.373493975903615,10.524553856726516,0.37660426468712893,"PIK3CA,LONP1",DisGeNET
977,Neoplastic disease,0.09013554473473162,4.373493975903615,10.524553856726516,0.37660426468712893,"PDGFRA,KIT",DisGeNET
978,Anoxia,0.09029685873777261,1.6763955984970478,4.031149044816355,0.37660426468712893,"KITLG,MAP2K2,TERT,EPAS1,DUSP1,APOE,VRK2,JAK2,P4HTM,ATR",DisGeNET
979,"Carcinoma, Spindle-Cell",0.09056269025038409,1.8898009549868555,4.538759441897385,0.37660426468712893,"TF,KITLG,TP53I3,CDH1,LPL,RHOA,TYMP",DisGeNET
980,Hepatocarcinogenesis,0.09146680730071961,1.5297040636042403,3.6587142609142984,0.37660426468712893,"CEBPA,PDGFRA,IL1RN,TFRC,DUSP1,SPPL3,ETS2,CCND2,ALDH2,PIK3CA,TERT,CDH1,NLRP3,PPARG",DisGeNET
981,Papillary Renal Cell Carcinoma,0.09154103127020842,2.005434782608696,4.794930347249706,0.37660426468712893,"CD82,PIK3CA,CDH1,EPAS1,IL6R,CTSB",DisGeNET
982,Werner Syndrome,0.09188351396770704,2.4552727272727273,5.861309690938717,0.37660426468712893,"GYPA,TAGLN,TFRC,ATR",DisGeNET
983,Gaucher Disease,0.09188351396770704,2.4552727272727273,5.861309690938717,0.37660426468712893,"HFE,TFEB,CTSB,THBS3",DisGeNET
984,Long face,0.09188351396770704,2.4552727272727273,5.861309690938717,0.37660426468712893,"ASXL1,AHI1,MAP2K2,KIAA0586",DisGeNET
985,"Amyloidosis, familial visceral",0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,PTPRC,DisGeNET
986,"Amyotrophic Lateral Sclerosis 4, Juvenile",0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,BRD3,DisGeNET
987,"Anemia, hereditary spherocytic hemolytic",0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,SPTA1,DisGeNET
988,"Aphasia, Progressive",0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,APOE,DisGeNET
989,"Candidiasis, Vulvovaginal",0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,NLRP3,DisGeNET
990,Retinitis punctata albescens (disorder),0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,TST,DisGeNET
991,Round cell tumor,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,PTPRC,DisGeNET
992,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36",0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,GYPA,DisGeNET
993,Serum albumin measurement,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,GCKR,DisGeNET
994,Serum iron raised,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,HFE,DisGeNET
995,Serum zinc measurement,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,MAX,DisGeNET
996,Small anterior fontanelle,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,ATR,DisGeNET
997,Snowflake vitreoretinal degeneration,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,IL1RN,DisGeNET
998,Spherocytosis,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,SPTA1,DisGeNET
999,"Myositis, Focal",0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,IL1RN,DisGeNET
1000,"Myositis, Infectious",0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,IL1RN,DisGeNET
1001,"Myositis, Proliferative",0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,IL1RN,DisGeNET
1002,STOMATOCYTOSIS I,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,TFRC,DisGeNET
1003,Subcortical Vascular Dementia,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,APOE,DisGeNET
1004,Subsarcolemmal accumulations of abnormally shaped mitochondria,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,TYMP,DisGeNET
1005,"Rett Syndrome, Atypical",0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,MEF2C,DisGeNET
1006,"Schwannomatosis, Plexiform",0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,AXL,DisGeNET
1007,Tension Headache,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,APOE,DisGeNET
1008,"THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT",0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,THRB,DisGeNET
1009,"Thyroid Hormone Resistance, Generalized, Autosomal Recessive",0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,THRB,DisGeNET
1010,Aase Smith syndrome 2,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,RPS28,DisGeNET
1011,Transient hyperphenylalaninemia,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,HADHA,DisGeNET
1012,Absent bone maturation in sternum,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,FIG4,DisGeNET
1013,Absent sternal ossification,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,FIG4,DisGeNET
1014,Vocal cord paresis in severe cases,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,LONP1,DisGeNET
1015,Warburton Anyane Yeboa syndrome,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,CEP57,DisGeNET
1016,Weakness of vocal cord,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,LONP1,DisGeNET
1017,X-Linked Dyskeratosis Congenita,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,TERT,DisGeNET
1018,Young adult onset,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,FBXO7,DisGeNET
1019,Zoonoses,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,AHI1,DisGeNET
1020,Aggressive Systemic Mastocytosis,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,KIT,DisGeNET
1021,Aicardi-Goutieres Syndrome 2,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,ADAR,DisGeNET
1022,Alcohol-Induced Disorders,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,ALDH2,DisGeNET
1023,Bile duct adenoma,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,PPARG,DisGeNET
1024,Blood Sedimentation,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,RSRP1,DisGeNET
1025,Broad alveolar processes of jaw,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,ASXL1,DisGeNET
1026,Broad alveolar ridges,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,ASXL1,DisGeNET
1027,Broad neck,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,RPS28,DisGeNET
1028,Cervical lymphadenitis,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,NLRP3,DisGeNET
1029,Chronic osteomyelitis,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,TERT,DisGeNET
1030,Congenital macrodactylia,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,PIK3CA,DisGeNET
1031,Deficiency of oxidase,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,MSRA,DisGeNET
1032,Drinking behavior processes,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,ALDH2,DisGeNET
1033,Dyschromatosis universalis hereditaria,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,ADAR,DisGeNET
1034,Dysmenorrhea,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,IL1RN,DisGeNET
1035,Elliptocytosis found,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,SPTA1,DisGeNET
1036,Epithelial tumor of ovary,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,PIK3CA,DisGeNET
1037,Erythroleukemia,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,JAK2,DisGeNET
1038,Familial hyperchylomicronemia syndrome,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,LPL,DisGeNET
1039,Familial Nonmedullary Thyroid Gland Carcinoma,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,TERT,DisGeNET
1040,Fat redistribution,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,APOE,DisGeNET
1041,Gastrointestinal dysmotility,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,TYMP,DisGeNET
1042,hazardous drinking,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,ALDH2,DisGeNET
1043,HHH syndrome,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,SLC25A15,DisGeNET
1044,Hoarse voice due to vocal cord paresis,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,LONP1,DisGeNET
1045,Hypotriglyceridemia,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,LPL,DisGeNET
1046,Idiopathic normal pressure hydrocephalus (INPH),0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,APOE,DisGeNET
1047,IgG Deficiency disorder,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,HFE,DisGeNET
1048,Immunodeficiency congenital,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,CEBPA,DisGeNET
1049,Inappropriate laughter,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,MAPT,DisGeNET
1050,Infected ascites,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,PIK3CA,DisGeNET
1051,Infection by Wuchereria bancrofti,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,HSPA8,DisGeNET
1052,Joubert syndrome with ocular defect,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,AHI1,DisGeNET
1053,Lead Poisoning,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,HFE,DisGeNET
1054,Lichen planus follicularis,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,PPARG,DisGeNET
1055,Lipidemia retinalis,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,LPL,DisGeNET
1056,LIPOPROTEIN GLOMERULOPATHY,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,APOE,DisGeNET
1057,Localized amyloidosis,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,APOE,DisGeNET
1058,Loss of gluteal subcutaneous adipose tissue,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,PPARG,DisGeNET
1059,Mixed phenotype acute leukemia B/myeloid,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,KIT,DisGeNET
1060,MOSAIC VARIEGATED ANEUPLOIDY SYNDROME,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,CEP57,DisGeNET
1061,Multiple pancreatic cysts,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,NPHP3,DisGeNET
1062,Myeloid Metaplasia,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,JAK2,DisGeNET
1063,Neurofibromatosis-Noonan syndrome,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,MAP2K2,DisGeNET
1064,Neurologic Signs,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,ALDH5A1,DisGeNET
1065,Neuropathy ataxia and retinis pigmentosa,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,ATP11A,DisGeNET
1066,Numerous nevi,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,PIK3CA,DisGeNET
1067,Orthostatic hypotension due to autonomic dysfunction,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,LEPR,DisGeNET
1068,Pancreatic Pseudocyst,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,ALDH2,DisGeNET
1069,Periodic syndrome,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,NLRP3,DisGeNET
1070,Pineal germinoma,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,KIT,DisGeNET
1071,Poikilocytosis,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,TMPRSS6,DisGeNET
1072,Postpartum Thyroiditis,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,THRB,DisGeNET
1073,Protein avoidance,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,SLC25A15,DisGeNET
1074,Pycnodysostosis,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,IL6R,DisGeNET
1075,Pyramidal tract dysfunction,0.09233130434472851,15.27927927927928,36.400927689928544,0.37660426468712893,FIG4,DisGeNET
1076,Regional enteritis,0.09235852547404205,2.9666699152129423,7.066836941790966,0.37660426468712893,"NLRP3,PPARG,NKX2-3",DisGeNET
1077,Severe Dengue,0.09235852547404205,2.9666699152129423,7.066836941790966,0.37660426468712893,"TLR1,IL1RN,NLRP3",DisGeNET
1078,"Multiple Sclerosis, Acute Fulminating",0.09235852547404205,2.9666699152129423,7.066836941790966,0.37660426468712893,"IL1RN,NLRP3,APOE",DisGeNET
1079,Bradykinesia,0.09235852547404205,2.9666699152129423,7.066836941790966,0.37660426468712893,"MAPT,APOE,FBXO7",DisGeNET
1080,Idiopathic Inflammatory Myopathies,0.09235852547404205,2.9666699152129423,7.066836941790966,0.37660426468712893,"BLK,IL1RN,FAM167A",DisGeNET
1081,Neutrophilia (disorder),0.09235852547404205,2.9666699152129423,7.066836941790966,0.37660426468712893,"IL1RN,PPARG,JAK2",DisGeNET
1082,Noonan Syndrome,0.09235852547404205,2.9666699152129423,7.066836941790966,0.37660426468712893,"PTPN1,MAP2K2,ATR",DisGeNET
1083,Promyelocytic leukemia,0.093606775161625,1.7853649862185472,4.228909262858464,0.3804389754618027,"TF,TFRC,TERT,NSMCE2,SNIP1,PPARG,JAK2,RAB8A",DisGeNET
1084,Pancreatitis,0.09361325033604508,1.8731817577449807,4.436787108117476,0.3804389754618027,"TF,ALDH2,DUSP1,LEPR,LPL,PPARG,CTSB",DisGeNET
1085,Papilloma,0.09361325033604508,1.8731817577449807,4.436787108117476,0.3804389754618027,"TERT,PIK3CA,NCOA4,KIT,PPARG,APOE,DDB2",DisGeNET
1086,Urticaria,0.09373009209587024,2.163405967721221,5.1215088033019605,0.3804389754618027,"PDGFRA,PIK3CA,KIT,SERPING1,NLRP3",DisGeNET
1087,Nausea and vomiting,0.09373009209587024,2.163405967721221,5.1215088033019605,0.3804389754618027,"PDGFRA,RRM1,PIK3CA,KIT,NLRP3",DisGeNET
1088,"Pancreatitis, Chronic",0.0949082986861674,1.712136752136752,4.0318151814667305,0.3845179933086107,"ABCC2,ALDH2,DUSP1,HFE,IL2RB,LPL,NLRP3,APOE,TYMP",DisGeNET
1089,Prominent eyes,0.09499651239945277,1.9836742722265932,4.669400822161943,0.3845179933086107,"FIG4,ASXL1,THRB,CITED2,NLRP3,SLC39A13",DisGeNET
1090,Protruding eyes,0.09499651239945277,1.9836742722265932,4.669400822161943,0.3845179933086107,"FIG4,ASXL1,THRB,CITED2,NLRP3,SLC39A13",DisGeNET
1091,Age related macular degeneration,0.09524847085559293,1.5767939738337517,3.7074625628567754,0.3851844669247259,"RP1L1,FADS2,ARHGAP21,TF,TOMM40,ALDH5A1,TST,NLRP3,SERPING1,LPL,APOE,APOB",DisGeNET
1092,Prostatic Neoplasms,0.09542765709196518,1.2826746833226315,3.0134990157639017,0.38555569880013774,"TAGLN,IL1RN,CD82,TMPRSS6,EPAS1,ITSN1,LPL,PPP2R2A,TYMP,CCND3,CCND2,TERT,CDH1,LEPR,LONP1,STX4,APOE,JAK2,IL6R,EPHB4,CTSB,CD164,PTPN1,PDGFRA,MAP3K1,GADD45A,SMOX,TNK2,NCOA4,RHOA,SIRT3,TLR1,PTPRC,PIK3CA,TST,HIST1H4H,PPARG,ATR",DisGeNET
1093,Sarcoma,0.09630501265766965,1.4372634738353125,3.363534154918416,0.38874447927322825,"PDGFRA,ABCC2,CD82,GADD45A,EPAS1,KLF3,TLR1,CCND3,KITLG,BCL2L11,PIK3CA,TERT,PSD4,KIT,PPARG,MAPT,EPHB4,RAB8A",DisGeNET
1094,Acute Cerebrovascular Accidents,0.09674457554585714,2.4068924539512775,5.621733010691669,0.38944987893095045,"IL1RN,SMOX,APOE,SH2B3",DisGeNET
1095,Coughing,0.09674457554585714,2.4068924539512775,5.621733010691669,0.38944987893095045,"IL1RN,RTEL1,TERT,ATP11A",DisGeNET
1096,Paroxysmal kinesigenic choreoathetosis,0.09674457554585714,2.4068924539512775,5.621733010691669,0.38944987893095045,"PIK3CA,TRPC1,PPARG,JAK2",DisGeNET
1097,Prominent globes,0.09852116184004087,1.9623767514270887,4.547776552409568,0.3905346452789208,"FIG4,ASXL1,THRB,CITED2,NLRP3,SLC39A13",DisGeNET
1098,Reticulosarcoma,0.09875475759999416,2.873678247734139,6.652897622714506,0.3905346452789208,"RTEL1,PTPRC,TFRC",DisGeNET
1099,"Epilepsies, Partial",0.09875475759999416,2.873678247734139,6.652897622714506,0.3905346452789208,"ABCC2,KANSL1,NPRL3",DisGeNET
1100,Skin blisters,0.09875475759999416,2.873678247734139,6.652897622714506,0.3905346452789208,"RTEL1,TERT,KIT",DisGeNET
1101,SVEINSSON CHORIORETINAL ATROPHY,0.09875475759999416,2.873678247734139,6.652897622714506,0.3905346452789208,"IL1RN,TERT,APOB",DisGeNET
1102,Abnormal blistering of the skin,0.09875475759999416,2.873678247734139,6.652897622714506,0.3905346452789208,"RTEL1,TERT,KIT",DisGeNET
1103,Underdeveloped brows,0.09875475759999416,2.873678247734139,6.652897622714506,0.3905346452789208,"ASXL1,MAP2K2,CITED2",DisGeNET
1104,Underdeveloped supraorbital ridges,0.09875475759999416,2.873678247734139,6.652897622714506,0.3905346452789208,"ASXL1,MAP2K2,CITED2",DisGeNET
1105,Androgenetic Alopecia,0.09875475759999416,2.873678247734139,6.652897622714506,0.3905346452789208,"ABCC2,KANSL1,MAPT",DisGeNET
1106,Extrapyramidal sign,0.09875475759999416,2.873678247734139,6.652897622714506,0.3905346452789208,"GCDH,APOE,FBXO7",DisGeNET
1107,Hydatidiform Mole,0.09875475759999416,2.873678247734139,6.652897622714506,0.3905346452789208,"TERT,PPARG,APOB",DisGeNET
1108,IIeocolitis,0.09875475759999416,2.873678247734139,6.652897622714506,0.3905346452789208,"NLRP3,PPARG,NKX2-3",DisGeNET
1109,Premature coronary artery disease,0.09875475759999416,2.873678247734139,6.652897622714506,0.3905346452789208,"LPL,APOE,APOB",DisGeNET
1110,Nephroblastoma,0.09892407284972293,1.600940475495064,3.7036199609302374,0.3905346452789208,"ASXL1,CEBPA,RRM1,CCND2,PIK3CA,TERT,CDH1,MPG,MAX,KIT,ADAR",DisGeNET
1111,Malignant neoplasm of kidney,0.09957191628355262,1.5631732054406793,3.6060453745933345,0.3905346452789208,"RBM38,ABCC2,THRB,PIK3CA,CDH1,MPG,AXL,EPAS1,TNK2,FIGNL1,LEPR,TFEB",DisGeNET
1112,Cardiac Arrest,0.09988452666058059,1.8407956297864554,4.240715432793,0.3905346452789208,"HBS1L,TFRC,GADD45A,BCL11A,MYB,APOE,ATR",DisGeNET
1113,Sacral dimples,0.10008351964589496,4.08152610441767,9.394653711297185,0.3905346452789208,"ASXL1,KANSL1",DisGeNET
1114,Seborrheic keratosis,0.10008351964589496,4.08152610441767,9.394653711297185,0.3905346452789208,"PIK3CA,APOE",DisGeNET
1115,"Hemangioma, Cavernous",0.10008351964589496,4.08152610441767,9.394653711297185,0.3905346452789208,"MAP2K2,PIK3CA",DisGeNET
1116,"Human immunodeficiency virus, type 2 [HIV-2] infection in conditions classified elsewhere and of unspecified site",0.10008351964589496,4.08152610441767,9.394653711297185,0.3905346452789208,"RCL1,IL6R",DisGeNET
1117,"Pneumonia, Interstitial",0.10008351964589496,4.08152610441767,9.394653711297185,0.3905346452789208,"RTEL1,TERT",DisGeNET
1118,"POLYARTERITIS NODOSA, CHILDHOOD-ONSET",0.10008351964589496,4.08152610441767,9.394653711297185,0.3905346452789208,"TERT,AXL",DisGeNET
1119,Abnormal ocular motility,0.10008351964589496,4.08152610441767,9.394653711297185,0.3905346452789208,"ALDH5A1,KIAA0586",DisGeNET
1120,Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,0.10008351964589496,4.08152610441767,9.394653711297185,0.3905346452789208,"IL1RN,LEPR",DisGeNET
1121,Autoinflammatory disorder,0.10008351964589496,4.08152610441767,9.394653711297185,0.3905346452789208,"IL1RN,NLRP3",DisGeNET
1122,Bilateral Wilms Tumor,0.10008351964589496,4.08152610441767,9.394653711297185,0.3905346452789208,"ASXL1,MAX",DisGeNET
1123,Bone marrow hypocellularity,0.10008351964589496,4.08152610441767,9.394653711297185,0.3905346452789208,"RTEL1,TERT",DisGeNET
1124,Congenital malformation syndrome,0.10008351964589496,4.08152610441767,9.394653711297185,0.3905346452789208,"FTO,ASXL1",DisGeNET
1125,Delusions,0.10008351964589496,4.08152610441767,9.394653711297185,0.3905346452789208,"APOE,MAPT",DisGeNET
1126,Increased appetite (finding),0.10008351964589496,4.08152610441767,9.394653711297185,0.3905346452789208,"LEPR,MAPT",DisGeNET
1127,Malignant melanoma of eye,0.10008351964589496,4.08152610441767,9.394653711297185,0.3905346452789208,"TERT,KIT",DisGeNET
1128,Mast Cell Neoplasm,0.10008351964589496,4.08152610441767,9.394653711297185,0.3905346452789208,"KITLG,KIT",DisGeNET
1129,Paranoid Schizophrenia,0.10008351964589496,4.08152610441767,9.394653711297185,0.3905346452789208,"IL1RN,TERT",DisGeNET
1130,Pheochromocytoma,0.10016641331127732,1.690919324577861,3.8906740541595917,0.3905346452789208,"TERT,PIK3CA,EPAS1,DUSP1,MPG,MAX,ZAN,KIT,HSD17B13",DisGeNET
1131,Rectal Carcinoma,0.10016641331127732,1.690919324577861,3.8906740541595917,0.3905346452789208,"RRM1,TERT,ALDH2,PIK3CA,SMOX,KIT,PPARG,APOE,TYMP",DisGeNET
1132,Chordoma,0.10172382864973903,2.36037296037296,5.394617530657723,0.3905346452789208,"PDGFRA,PIK3CA,KIT,ETS2",DisGeNET
1133,Macroglossia,0.10172382864973903,2.36037296037296,5.394617530657723,0.3905346452789208,"FTO,THRB,PIK3CA,SNIP1",DisGeNET
1134,Polymyositis,0.10172382864973903,2.36037296037296,5.394617530657723,0.3905346452789208,"BLK,FAM167A,PTPRC,EXOSC9",DisGeNET
1135,"Alzheimer Disease, Early Onset",0.10192138639887453,2.1037181996086107,4.803953024987878,0.3905346452789208,"TF,HFE,PPARG,APOE,MAPT",DisGeNET
1136,Retrognathia,0.10192138639887453,2.1037181996086107,4.803953024987878,0.3905346452789208,"FTO,ASXL1,DSTYK,BCL11A,ATR",DisGeNET
1137,"Mental Retardation, Psychosocial",0.10192138639887453,2.1037181996086107,4.803953024987878,0.3905346452789208,"AHI1,MEF2C,ALDH5A1,KANSL1,HIST1H4C",DisGeNET
1138,Anaplastic thyroid carcinoma,0.10211444155579133,1.941527599486521,4.429908034447698,0.3905346452789208,"TERT,PIK3CA,NCOA4,KIT,PPARG,CTSB",DisGeNET
1139,Melanocytic nevus,0.10310464717528052,1.8250142538744623,4.146452121474241,0.3905346452789208,"HSPA8,TERT,PIK3CA,MYB,KIT,PPARG,RAB8A",DisGeNET
1140,Inflammation,0.1038232830006357,1.5208392334560559,3.4447997594497393,0.3905346452789208,"GTF2A1,PTPN1,IL1RN,TFRC,ADAR,TF,CDH1,NLRP3,SERPING1,PPARG,JAK2,SH2B3,CTSB",DisGeNET
1141,Sepsis,0.10522896327518423,1.4917241379310344,3.3587909811570213,0.3905346452789208,"MPST,NFE2,IL1RN,SMOX,DUSP1,ADAR,SIRT3,TLR1,PIK3CA,NLRP3,SERPING1,PPARG,APOB,CTSB",DisGeNET
1142,"Mammary Neoplasms, Human",0.10522896327518423,1.4917241379310344,3.3587909811570213,0.3905346452789208,"FTO,MAP3K1,TFRC,HIST1H2BK,ADAR,ICAM5,ETS2,PIK3CA,TERT,CDH1,PRC1,KIT,LEPR,EPHB4",DisGeNET
1143,"Carcinoma, Lobular",0.10532431745183514,2.786322438890415,6.271206427727801,0.3905346452789208,"PIK3CA,CDH1,MYB",DisGeNET
1144,Skin bullae,0.10532431745183514,2.786322438890415,6.271206427727801,0.3905346452789208,"RTEL1,TERT,KIT",DisGeNET
1145,Angioimmunoblastic Lymphadenopathy,0.10532431745183514,2.786322438890415,6.271206427727801,0.3905346452789208,"PDGFRA,AHI1,RHOA",DisGeNET
1146,Ascites,0.10532431745183514,2.786322438890415,6.271206427727801,0.3905346452789208,"CEP57,HFE,JAK2",DisGeNET
1147,Laryngeal Diseases,0.10532431745183514,2.786322438890415,6.271206427727801,0.3905346452789208,"RAD50,TERT,SERPING1",DisGeNET
1148,Nodular glomerulosclerosis,0.10532431745183514,2.786322438890415,6.271206427727801,0.3905346452789208,"AXL,PPARG,APOE",DisGeNET
1149,Anaplasia,0.10558907218440308,1.6702131603336423,3.7549738887453734,0.3905346452789208,"TAGLN,KITLG,TERT,PIK3CA,DUSP1,CDH1,KIT,PPARG,EPHB4",DisGeNET
1150,Malignant neoplasm of brain,0.10577576850455202,1.9211128048780488,4.31565277102966,0.3905346452789208,"TFRC,TERT,PIK3CA,MPG,PPARG,HK1",DisGeNET
1151,Muscle Rigidity,0.10614684299927872,2.0750842027437773,4.654272412859632,0.3905346452789208,"GCDH,ADAR,APOE,MAPT,FBXO7",DisGeNET
1152,Thymoma,0.10638064081237299,1.809498111171074,4.054599717053129,0.3905346452789208,"MPST,AHI1,PTPRC,PIK3CA,CDH1,KIT,JAK2",DisGeNET
1153,Insulin Resistance,0.10681888205563034,2.3156089193825045,5.179138540724848,0.3905346452789208,"PTPN1,LEPR,PPARG,PLTP",DisGeNET
1154,Primary physiologic amenorrhea,0.10681888205563034,2.3156089193825045,5.179138540724848,0.3905346452789208,"MAP3K1,AXL,LEPR,PPARG",DisGeNET
1155,Malignant neoplasm of mouth,0.10729233027186266,1.4864475945017182,3.318045512834465,0.3905346452789208,"HSPA8,TFRC,CD82,GADD45A,GPN1,SIRT3,ALDH2,PIK3CA,TERT,CDH1,LEPR,PPARG,JAK2,CTSB",DisGeNET
1156,Infection caused by Helicobacter pylori,0.10836176799578698,1.6600460617227084,3.6890870723254086,0.3905346452789208,"TLR1,IL1RN,ALDH2,PIK3CA,CDH1,HFE,LONP1,PPARG,JAK2",DisGeNET
1157,"Aggressive periodontitis, generalized",0.11031888038918752,3.82605421686747,8.434078137999961,0.3905346452789208,"IL1RN,NLRP3",DisGeNET
1158,Retinal Vein Occlusion,0.11031888038918752,3.82605421686747,8.434078137999961,0.3905346452789208,"APOE,JAK2",DisGeNET
1159,Salivary duct carcinoma,0.11031888038918752,3.82605421686747,8.434078137999961,0.3905346452789208,"CCND3,PIK3CA",DisGeNET
1160,Abnormality of coagulation,0.11031888038918752,3.82605421686747,8.434078137999961,0.3905346452789208,"RTEL1,TERT",DisGeNET
1161,Upper Respiratory Infections,0.11031888038918752,3.82605421686747,8.434078137999961,0.3905346452789208,"RRM1,LEPR",DisGeNET
1162,Uterine Carcinosarcoma,0.11031888038918752,3.82605421686747,8.434078137999961,0.3905346452789208,"PIK3CA,FLOT2",DisGeNET
1163,Achondroplasia,0.11031888038918752,3.82605421686747,8.434078137999961,0.3905346452789208,"SPRED2,NLRP3",DisGeNET
1164,Anemia of chronic disease,0.11031888038918752,3.82605421686747,8.434078137999961,0.3905346452789208,"IL1RN,TFRC",DisGeNET
1165,Anthracosis,0.11031888038918752,3.82605421686747,8.434078137999961,0.3905346452789208,"IL1RN,NLRP3",DisGeNET
1166,Camurati-Engelmann Syndrome,0.11031888038918752,3.82605421686747,8.434078137999961,0.3905346452789208,"APOE,MAPT",DisGeNET
1167,Childhood Brain Neoplasm,0.11031888038918752,3.82605421686747,8.434078137999961,0.3905346452789208,"TERT,KIT",DisGeNET
1168,Cholesterol gallstones,0.11031888038918752,3.82605421686747,8.434078137999961,0.3905346452789208,"APOE,APOB",DisGeNET
1169,Chronic arthritis,0.11031888038918752,3.82605421686747,8.434078137999961,0.3905346452789208,"DUSP1,PLD1",DisGeNET
1170,Hyperphagia,0.11031888038918752,3.82605421686747,8.434078137999961,0.3905346452789208,"LEPR,MAPT",DisGeNET
1171,Iron-Refractory Iron Deficiency Anemia,0.11031888038918752,3.82605421686747,8.434078137999961,0.3905346452789208,"TFRC,TMPRSS6",DisGeNET
1172,Melioidosis,0.11031888038918752,3.82605421686747,8.434078137999961,0.3905346452789208,"TLR1,NLRP3",DisGeNET
1173,Muckle-Wells Syndrome,0.11031888038918752,3.82605421686747,8.434078137999961,0.3905346452789208,"IL1RN,NLRP3",DisGeNET
1174,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0.11031888038918752,3.82605421686747,8.434078137999961,0.3905346452789208,"PTPN1,JAK2",DisGeNET
1175,Overlap syndrome,0.11031888038918752,3.82605421686747,8.434078137999961,0.3905346452789208,"ASXL1,JAK2",DisGeNET
1176,Paget Disease Extramammary,0.11031888038918752,3.82605421686747,8.434078137999961,0.3905346452789208,"PIK3CA,CDH1",DisGeNET
1177,Pigmented Basal Cell Carcinoma,0.11031888038918752,3.82605421686747,8.434078137999961,0.3905346452789208,"TERT,PIK3CA",DisGeNET
1178,Polyarteritis Nodosa,0.11031888038918752,3.82605421686747,8.434078137999961,0.3905346452789208,"TERT,AXL",DisGeNET
1179,Protein Misfolding Disorders,0.11031888038918752,3.82605421686747,8.434078137999961,0.3905346452789208,"NLRP3,MAPT",DisGeNET
1180,Uterine Cervical Neoplasm,0.11045730310699718,2.047213779128673,4.510270375045306,0.3905346452789208,"TERT,PIK3CA,CDH1,EPAS1,JAK2",DisGeNET
1181,Acute Megakaryocytic Leukemias,0.11045730310699718,2.047213779128673,4.510270375045306,0.3905346452789208,"TFRC,TRIB1,JAK2,IL6R,ETS2",DisGeNET
1182,Kidney Diseases,0.11198460025047069,1.40338934413162,3.0725720902834195,0.3905346452789208,"BLK,TAGLN,IL1RN,GCKR,IL37,HFE,LPL,SIRT3,TLR1,FADS2,AHI1,TERT,PSD4,LEPR,NLRP3,PPARG,APOE,APOB",DisGeNET
1183,Salivary Gland Neoplasms,0.11202724044647587,2.272502805836139,4.974538682161959,0.3905346452789208,"CDH1,BCL11A,MYB,PPARG",DisGeNET
1184,Aggressive behavior,0.11202724044647587,2.272502805836139,4.974538682161959,0.3905346452789208,"FIG4,ALDH5A1,LEPR,MAPT",DisGeNET
1185,Aggressive reaction,0.11202724044647587,2.272502805836139,4.974538682161959,0.3905346452789208,"FIG4,ALDH5A1,LEPR,MAPT",DisGeNET
1186,Bronchiectasis,0.11202724044647587,2.272502805836139,4.974538682161959,0.3905346452789208,"RTEL1,TERT,ATP11A,CTSB",DisGeNET
1187,Edema,0.11202724044647587,2.272502805836139,4.974538682161959,0.3905346452789208,"IL1RN,NLRP3,APOE,PLD1",DisGeNET
1188,Luminal A Breast Carcinoma,0.11202724044647587,2.272502805836139,4.974538682161959,0.3905346452789208,"MAP3K1,PIK3CA,LEPR,ZNF217",DisGeNET
1189,Physical aggression,0.11202724044647587,2.272502805836139,4.974538682161959,0.3905346452789208,"FIG4,ALDH5A1,LEPR,MAPT",DisGeNET
1190,"Large, late-closing fontanelle",0.11206054043565694,2.7041052070374976,5.918518370513306,0.3905346452789208,"FIG4,GCDH,THRB",DisGeNET
1191,"MYELOPROLIFERATIVE SYNDROME, TRANSIENT",0.11206054043565694,2.7041052070374976,5.918518370513306,0.3905346452789208,"KANSL1,KIT,SH2B3",DisGeNET
1192,"Neoplasms, Experimental",0.11206054043565694,2.7041052070374976,5.918518370513306,0.3905346452789208,"CDH1,EPAS1,AXL",DisGeNET
1193,Wide bregma sutures,0.11206054043565694,2.7041052070374976,5.918518370513306,0.3905346452789208,"FIG4,GCDH,THRB",DisGeNET
1194,Friedreich Ataxia,0.11206054043565694,2.7041052070374976,5.918518370513306,0.3905346452789208,"TFRC,HFE,PPARG",DisGeNET
1195,Heart valve disease,0.11206054043565694,2.7041052070374976,5.918518370513306,0.3905346452789208,"MAP2K2,APOE,JAK2",DisGeNET
1196,Hepatolenticular Degeneration,0.11206054043565694,2.7041052070374976,5.918518370513306,0.3905346452789208,"HFE,PPARG,APOE",DisGeNET
1197,Hip Dislocation,0.11206054043565694,2.7041052070374976,5.918518370513306,0.3905346452789208,"FIG4,KANSL1,ATR",DisGeNET
1198,Large bregma sutures,0.11206054043565694,2.7041052070374976,5.918518370513306,0.3905346452789208,"FIG4,GCDH,THRB",DisGeNET
1199,Large fontanelle,0.11206054043565694,2.7041052070374976,5.918518370513306,0.3905346452789208,"FIG4,GCDH,THRB",DisGeNET
1200,Narrow forehead,0.11206054043565694,2.7041052070374976,5.918518370513306,0.3905346452789208,"ASXL1,MAP2K2,DOCK7",DisGeNET
1201,Necrosis,0.11206054043565694,2.7041052070374976,5.918518370513306,0.3905346452789208,"IL1RN,LPL,CTSB",DisGeNET
1202,Astrocytoma,0.1131960120756634,1.3875861036238395,3.0230427390124097,0.3905346452789208,"FTO,PDGFRA,RTEL1,IL1RN,EPAS1,HFE,PDCD5,ADAR,PLD1,RHOA,PIK3CA,TERT,CDH1,AXL,PRDM16,MYB,APOE,JAK2,CPEB4",DisGeNET
1203,Fever,0.11330001324615506,1.8815331010452963,4.097444727454417,0.3905346452789208,"HMGCL,IL1RN,NLRP3,JAK2,IL6R,DDB2",DisGeNET
1204,Hereditary Diffuse Gastric Cancer,0.11692331255300042,1.6302624434389141,3.4989295878005495,0.3905346452789208,"HSPA8,IL1RN,PIK3CA,GADD45A,CDH1,PPARG,IL6R,RHOA,TYMP",DisGeNET
1205,Abnormality of the skeletal system,0.11734631201844407,2.2309641873278236,4.780121391787701,0.3905346452789208,"FIG4,PIK3CA,SH2B3,ETS2",DisGeNET
1206,Cholestasis in newborn,0.11734631201844407,2.2309641873278236,4.780121391787701,0.3905346452789208,"HADHA,ABCC2,HFE,NPHP3",DisGeNET
1207,Headache,0.11734631201844407,2.2309641873278236,4.780121391787701,0.3905346452789208,"NLRP3,APOE,JAK2,SH2B3",DisGeNET
1208,Peripheral Vascular Diseases,0.11734631201844407,2.2309641873278236,4.780121391787701,0.3905346452789208,"PPARG,APOE,JAK2,APOB",DisGeNET
1209,Liver Cirrhosis,0.11754061155936794,1.3924367088607594,2.9811671349219906,0.3905346452789208,"PDGFRA,IL1RN,DENND4A,HFE,ADAR,PCSK7,TYMP,RAD50,ALDH2,TERT,CDH1,NPHP3,SERPING1,PPARG,APOE,APOB,JAK2,CPEB4",DisGeNET
1210,Deformity of face,0.11895666942785178,2.6265861027190334,5.591991239719249,0.3905346452789208,"GCDH,KLF13,SNIP1",DisGeNET
1211,Distortion of face,0.11895666942785178,2.6265861027190334,5.591991239719249,0.3905346452789208,"GCDH,KLF13,SNIP1",DisGeNET
1212,Funny looking face,0.11895666942785178,2.6265861027190334,5.591991239719249,0.3905346452789208,"GCDH,KLF13,SNIP1",DisGeNET
1213,Psychotic symptom,0.11895666942785178,2.6265861027190334,5.591991239719249,0.3905346452789208,"TOMM40,APOE,MAPT",DisGeNET
1214,"Obesity, Morbid",0.11932823938519083,1.9936446532191212,4.2382438504965565,0.3905346452789208,"FTO,LEPR,LPL,PPARG,CPT1B",DisGeNET
1215,"Chromosome 5, trisomy 5q",0.12081345678782915,3.6006378454996457,7.6099754600801,0.3905346452789208,"KITLG,JAK2",DisGeNET
1216,"COLORBLINDNESS, PARTIAL, DEUTAN SERIES",0.12081345678782915,3.6006378454996457,7.6099754600801,0.3905346452789208,"APOE,MAPT",DisGeNET
1217,Rubella,0.12081345678782915,3.6006378454996457,7.6099754600801,0.3905346452789208,"TFRC,BTN2A1",DisGeNET
1218,"HYDATIDIFORM MOLE, RECURRENT, 1",0.12081345678782915,3.6006378454996457,7.6099754600801,0.3905346452789208,"PPARG,APOB",DisGeNET
1219,"Pancreatitis, Alcoholic",0.12081345678782915,3.6006378454996457,7.6099754600801,0.3905346452789208,"ALDH2,LPL",DisGeNET
1220,Superinfection,0.12081345678782915,3.6006378454996457,7.6099754600801,0.3905346452789208,"TFRC,NLRP3",DisGeNET
1221,Ventricular hypertrophy,0.12081345678782915,3.6006378454996457,7.6099754600801,0.3905346452789208,"NSMCE2,NLRP3",DisGeNET
1222,Broad foot,0.12081345678782915,3.6006378454996457,7.6099754600801,0.3905346452789208,"NLRP3,PPARG",DisGeNET
1223,Childhood Non-Hodgkin Lymphoma,0.12081345678782915,3.6006378454996457,7.6099754600801,0.3905346452789208,"CCND3,NLRP3",DisGeNET
1224,Congenital dislocation of radial head,0.12081345678782915,3.6006378454996457,7.6099754600801,0.3905346452789208,"ASXL1,ATR",DisGeNET
1225,Coronary Microvascular Disease,0.12081345678782915,3.6006378454996457,7.6099754600801,0.3905346452789208,"PPARG,JAK2",DisGeNET
1226,Cortical white matter abnormalities seen on MRI,0.12081345678782915,3.6006378454996457,7.6099754600801,0.3905346452789208,"MAPT,TYMP",DisGeNET
1227,Costello syndrome (disorder),0.12081345678782915,3.6006378454996457,7.6099754600801,0.3905346452789208,"MAP2K2,PIK3CA",DisGeNET
1228,Gall Bladder Diseases,0.12081345678782915,3.6006378454996457,7.6099754600801,0.3905346452789208,"APOE,APOB",DisGeNET
1229,Intestinal Obstruction,0.12081345678782915,3.6006378454996457,7.6099754600801,0.3905346452789208,"PDGFRA,KIT",DisGeNET
1230,Lower limb muscle weakness,0.12081345678782915,3.6006378454996457,7.6099754600801,0.3905346452789208,"PDGFRA,DSTYK",DisGeNET
1231,Macular dystrophy,0.12081345678782915,3.6006378454996457,7.6099754600801,0.3905346452789208,"RP1L1,TST",DisGeNET
1232,Malignant transformation,0.12081345678782915,3.6006378454996457,7.6099754600801,0.3905346452789208,"TERT,PIK3CA",DisGeNET
1233,Myelodysplastic Syndrome with Isolated del(5q),0.12081345678782915,3.6006378454996457,7.6099754600801,0.3905346452789208,"KITLG,JAK2",DisGeNET
1234,Periodic Fever Syndrome,0.12081345678782915,3.6006378454996457,7.6099754600801,0.3905346452789208,"IL1RN,NLRP3",DisGeNET
1235,Pharyngeal Carcinoma,0.12081345678782915,3.6006378454996457,7.6099754600801,0.3905346452789208,"ALDH2,PIK3CA",DisGeNET
1236,Plasmablastic lymphoma,0.12081345678782915,3.6006378454996457,7.6099754600801,0.3905346452789208,"RTEL1,PTPRC",DisGeNET
1237,Port-Wine Stain,0.12081345678782915,3.6006378454996457,7.6099754600801,0.3905346452789208,"ASXL1,PIK3CA",DisGeNET
1238,Dyschezia,0.1210883727907655,1.8435365853658536,3.8921383107849565,0.3905346452789208,"PDGFRA,THRB,PIK3CA,PRDM16,KIT,TYMP",DisGeNET
1239,"Abnormalities, Drug-Induced",0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,RHOA,DisGeNET
1240,Recurrent opportunistic infections,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,PTPRC,DisGeNET
1241,Reticulate acropigmentation of Kitamura,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,ADAR,DisGeNET
1242,Rosacea,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,NLRP3,DisGeNET
1243,Sea-Blue Histiocyte Syndrome,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,APOE,DisGeNET
1244,SECKEL SYNDROME 2,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,ATR,DisGeNET
1245,"Dystonias, Sporadic",0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,ALDH5A1,DisGeNET
1246,Secondary malignant neoplasm of ovary,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,CDH1,DisGeNET
1247,"Ehlers-Danlos Syndrome, Type IV",0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,SLC39A13,DisGeNET
1248,Selective tooth agenesis,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,ATR,DisGeNET
1249,Severe dementia,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,APOE,DisGeNET
1250,Severe short-limb dwarfism,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,NSMCE2,DisGeNET
1251,"Hyperbilirubinemia, Hereditary",0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,ABCC2,DisGeNET
1252,"Leukemia, Megakaryoblastic, of Down Syndrome",0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,KANSL1,DisGeNET
1253,Sleep-wake cycle disturbance,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,APOE,DisGeNET
1254,"MELORHEOSTOSIS, ISOLATED",0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,PRDM16,DisGeNET
1255,Speech Sound Disorders,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,APOE,DisGeNET
1256,Spindle cell rhabdomyosarcoma,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,CITED2,DisGeNET
1257,"Neoplasms, Bone Tissue",0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,CITED2,DisGeNET
1258,"NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE",0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,NUP205,DisGeNET
1259,Struma Ovarii,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,NCOA4,DisGeNET
1260,"PHEOCHROMOCYTOMA, SUSCEPTIBILITY TO",0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,MAX,DisGeNET
1261,"stage, bladder cancer",0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,CD82,DisGeNET
1262,"Sterility, Reproductive",0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,LEPR,DisGeNET
1263,Thyroid cancer metastatic,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,MAP2K2,DisGeNET
1264,"Xeroderma pigmentosum, group F",0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,ATR,DisGeNET
1265,Abnormal amniotic fluid,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,HADHA,DisGeNET
1266,Tricuspid Valve Prolapse,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,PLD1,DisGeNET
1267,Abnormal platelets,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,NLRP3,DisGeNET
1268,TROPICAL CALCIFIC PANCREATITIS,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,CTSB,DisGeNET
1269,Unilateral Hypotonia,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,KANSL1,DisGeNET
1270,Abnormality of the larynx,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,SERPING1,DisGeNET
1271,Abnormality of the mitochondrion,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,TYMP,DisGeNET
1272,Urine color abnormal,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,ABCC2,DisGeNET
1273,Absence of a tooth,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,ATR,DisGeNET
1274,Absent axillary hair,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,APOE,DisGeNET
1275,Acrocyanosis,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,SH2B3,DisGeNET
1276,Acute and subacute liver necrosis (disorder),0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,TF,DisGeNET
1277,Acylcarnitines measurement,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,SLC22A16,DisGeNET
1278,Writer's Cramp,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,ALDH5A1,DisGeNET
1279,Adult-Onset Idiopathic Focal Dystonias,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,ALDH5A1,DisGeNET
1280,Adult-Onset Idiopathic Torsion Dystonias,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,ALDH5A1,DisGeNET
1281,Advanced breast cancer,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,PIK3CA,DisGeNET
1282,Alcohol-Related Disorders,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,ALDH2,DisGeNET
1283,Anaplastic Oligoastrocytoma,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,PDGFRA,DisGeNET
1284,Apocrine Carcinoma,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,CDH1,DisGeNET
1285,aspirin sensitivity,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,PIK3CA,DisGeNET
1286,Astler-Coller B1 Rectal Carcinoma,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,PTPRC,DisGeNET
1287,Autosomal Dominant Familial Dystonia,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,ALDH5A1,DisGeNET
1288,Autosomal Recessive Familial Dystonia,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,ALDH5A1,DisGeNET
1289,Axonal regeneration,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,HK1,DisGeNET
1290,Blood platelet disease,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,NLRP3,DisGeNET
1291,Bone marrow toxicity,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,ABCC2,DisGeNET
1292,Broad jaw,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,SNIP1,DisGeNET
1293,carotid disease,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,IL1RN,DisGeNET
1294,Cat eye syndrome,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,PIK3CA,DisGeNET
1295,CD4+ T-cell lymphopenia,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,LEPR,DisGeNET
1296,Cerebral Thrombosis,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,APOE,DisGeNET
1297,Childhood Acute Promyelocytic Leukemia with PML-RARA,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,KIT,DisGeNET
1298,Chronic intestinal pseudo-obstruction,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,APOB,DisGeNET
1299,Chylomicron retention disease,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,APOB,DisGeNET
1300,Cigarette-paper scars,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,SLC39A13,DisGeNET
1301,Cleft palate and bilateral cleft lip,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,CDH1,DisGeNET
1302,colon (non-specific) lesion,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,KIT,DisGeNET
1303,Common ventricle,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,APOE,DisGeNET
1304,Congenital disorder of glycosylation type 1A,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,GYPA,DisGeNET
1305,Congenital malformation syndromes associated with short stature,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,ATR,DisGeNET
1306,Decreased facial muscle movement,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,FBXO7,DisGeNET
1307,Decreased number of CD4+ T cells,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,LEPR,DisGeNET
1308,Decreased T cell activation,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,LEPR,DisGeNET
1309,Deficiency of lyase,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,HMGCL,DisGeNET
1310,Delayed maturation of wrist bone,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,LONP1,DisGeNET
1311,Delayed ossification of carpal bones,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,LONP1,DisGeNET
1312,Diffuse Cerebral Sclerosis of Schilder,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,TYMP,DisGeNET
1313,Distichiasis,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,CDH1,DisGeNET
1314,Dysphoric mood,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,APOE,DisGeNET
1315,Elongated superior cerebellar peduncle,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,AHI1,DisGeNET
1316,Episodic vomiting,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,SLC25A15,DisGeNET
1317,Eruptive xanthoma,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,LPL,DisGeNET
1318,Expressionless face,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,FBXO7,DisGeNET
1319,Familial neurocardiogenic syncope,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,NLRP3,DisGeNET
1320,Flat Ductal Epithelial Atypia of the Breast,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,PIK3CA,DisGeNET
1321,Floppy Muscles,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,KANSL1,DisGeNET
1322,Food Allergy,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,NLRP3,DisGeNET
1323,Frequent vomiting,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,SLC25A15,DisGeNET
1324,Generalized periodontitis,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,IL1RN,DisGeNET
1325,Glutaric acidemia,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,GCDH,DisGeNET
1326,Granulomatous disorder,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,PPARG,DisGeNET
1327,Hemoglobin SC Disease,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,SPTA1,DisGeNET
1328,Hidradenoma Papilliferum,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,PIK3CA,DisGeNET
1329,Hip pain,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,PDGFRA,DisGeNET
1330,Histiocytic syndrome,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,PTPRC,DisGeNET
1331,Hyperphosphatasia with Mental Retardation,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,PGAP3,DisGeNET
1332,Hypertriglyceridemic Waist,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,APOB,DisGeNET
1333,Hypochromic anemia,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,TF,DisGeNET
1334,Immune dysregulation,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,LEPR,DisGeNET
1335,Infant length,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,ZBTB38,DisGeNET
1336,Infantile Colic,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,PPARG,DisGeNET
1337,Infectious colitis,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,PPARG,DisGeNET
1338,Intermittent diarrhea,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,TYMP,DisGeNET
1339,Iodine deficiency syndrome,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,APOE,DisGeNET
1340,Krukenberg Tumor,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,CDH1,DisGeNET
1341,LEPTIN RECEPTOR DEFICIENCY,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,LEPR,DisGeNET
1342,Long cerebellar peduncles,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,AHI1,DisGeNET
1343,Male Germ Cell Tumor,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,KIT,DisGeNET
1344,Mature T ALL,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,JAK2,DisGeNET
1345,Megakaryocytic hyperplasia,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,JAK2,DisGeNET
1346,Mesenchymal Glioblastoma,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,AXL,DisGeNET
1347,metabolic disturbance,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,PPARG,DisGeNET
1348,Mild dementia,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,APOE,DisGeNET
1349,Mixed dementia,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,APOE,DisGeNET
1350,Multiple mitochondrial DNA deletions,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,TYMP,DisGeNET
1351,Muscle Tone Atonic,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,KANSL1,DisGeNET
1352,Mydriasis,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,APOE,DisGeNET
1353,Nephropathia Epidemica,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,IL1RN,DisGeNET
1354,Nonspherocytic hemolytic anemia,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,HK1,DisGeNET
1355,Ornithine carbamoyltransferase deficiency,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,SLC25A15,DisGeNET
1356,Oropharyngeal Neoplasms,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,ATR,DisGeNET
1357,OTOFACIOCERVICAL SYNDROME 1,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,CDH1,DisGeNET
1358,Overriding aorta,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,MEF2C,DisGeNET
1359,Patau syndrome,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,MYB,DisGeNET
1360,Pathological Dilatation,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,PTPRC,DisGeNET
1361,Philadelphia chromosome negative chronic myelogenous leukemia,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,JAK2,DisGeNET
1362,Pitting of nails,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,TERT,DisGeNET
1363,Polymorphous low grade adenocarcinoma,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,MYB,DisGeNET
1364,Polysplenia,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,NPHP3,DisGeNET
1365,Poxviridae Infections,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,DUSP1,DisGeNET
1366,Primary gonadal insufficiency,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,NSMCE2,DisGeNET
1367,Prominent fingertip pads,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,KANSL1,DisGeNET
1368,Pseudodystonia,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,ALDH5A1,DisGeNET
1369,Reactive thrombocytosis,0.12117904111215834,10.185185185185185,21.49569225240779,0.3905346452789208,JAK2,DisGeNET
1370,"Ichthyosis, X-Linked",0.12277341585362123,2.190909090909091,4.595245086959867,0.39480780666630966,"EPAS1,GADD45A,KIT,EPHB4",DisGeNET
1371,Venous Thromboembolism,0.12277341585362123,2.190909090909091,4.595245086959867,0.39480780666630966,"FTO,NUP205,LPL,JAK2",DisGeNET
1372,Chronic graft-versus-host disease,0.12277341585362123,2.190909090909091,4.595245086959867,0.39480780666630966,"IL1RN,TF,PIK3CA,TYMP",DisGeNET
1373,Uveal melanoma,0.12358458780352394,1.7356713031468876,3.628992651631285,0.39712687646696837,"IL1RN,CCND2,TERT,PIK3CA,MPG,KIT,RAB8A",DisGeNET
1374,Malignant neoplasm of gastrointestinal tract,0.12388542932097439,1.663074117061847,3.4731608222023023,0.3975166019682948,"SPRED2,MAP2K2,TERT,CD82,ALDH2,CDH1,PPARG,TYMP",DisGeNET
1375,Premature Menopause,0.12388606702321063,1.9678902657626063,4.109728157539198,0.3975166019682948,"KITLG,CITED2,SPO11,NPHP3,PPARG",DisGeNET
1376,Proteinuria,0.12507969132909547,1.825102632214441,3.7940310431645843,0.40105494051160556,"IL1RN,MAX,LEPR,APOE,RHOA,CTSB",DisGeNET
1377,Adenocarcinoma of large intestine,0.12584577998470942,1.6015117830146732,3.319450413874378,0.4022705742472718,"FADS2,CCND2,ABCC2,PIK3CA,TRRAP,CDH1,SMOX,KIT,ANP32B",DisGeNET
1378,Noninfiltrating Intraductal Carcinoma,0.12584577998470942,1.6015117830146732,3.319450413874378,0.4022705742472718,"ALDH5A1,CCND2,TERT,CD82,PIK3CA,CDH1,KIT,LEPR,FLOT2",DisGeNET
1379,Carotid Stenosis,0.12600587797138024,2.5533736153071502,5.289126339407087,0.4022705742472718,"LPL,APOE,APOB",DisGeNET
1380,Intermittent migraine headaches,0.12600587797138024,2.5533736153071502,5.289126339407087,0.4022705742472718,"RPS28,PIK3CA,NLRP3",DisGeNET
1381,Multiple Chronic Conditions,0.12600587797138024,2.5533736153071502,5.289126339407087,0.4022705742472718,"PIK3CA,MAX,JAK2",DisGeNET
1382,Nijmegen Breakage Syndrome,0.12600587797138024,2.5533736153071502,5.289126339407087,0.4022705742472718,"RAD50,TERT,ATR",DisGeNET
1383,"Genetic Diseases, Inborn",0.12695133756833712,1.4405416666666666,2.9732080396685676,0.4033628228179445,"MEF2C,MAP3K1,ITSN1,LPL,ADAR,PLD1,ASXL1,FIG4,HADHA,HMGCL,CCND2,ALDH5A1,PIK3CA,NPHP3",DisGeNET
1384,Mental and motor retardation,0.12700201187901014,1.3147611991337056,2.7130785635837653,0.4033628228179445,"CEP57,FTO,RTEL1,MAP2K2,PGAP3,BCL11A,DOCK7,ADAR,ASXL1,FIG4,SLC25A15,HADHA,AHI1,RPS28,CCND2,ALDH5A1,KANSL1,PIK3CA,TERT,KIAA0586,PRDM16,LONP1,NPHP3,SNIP1",DisGeNET
1385,Steroid Sulfatase Deficiency Disease,0.12830578924427197,2.1522594364699628,4.419317992941132,0.4033628228179445,"EPAS1,GADD45A,KIT,EPHB4",DisGeNET
1386,Head and Neck Neoplasms,0.12830578924427197,2.1522594364699628,4.419317992941132,0.4033628228179445,"CEBPA,PIK3CA,EPAS1,ICAM5",DisGeNET
1387,Otitis Media,0.12830578924427197,2.1522594364699628,4.419317992941132,0.4033628228179445,"PTPRC,DUSP1,IL6R,CTSB",DisGeNET
1388,Electroencephalogram abnormal,0.12852360658365375,1.9427878881151168,3.985906554683842,0.4033628228179445,"MAP2K2,ALDH5A1,PRDM16,SNIP1,DDB2",DisGeNET
1389,cervical cancer,0.12882322010761638,1.3379876148779237,2.7419570202282064,0.4033628228179445,"CEBPA,IL1RN,TFRC,CD82,GADD45A,PABPC4,NSMCE2,TMC8,HSD17B13,TMC6,TYMP,LAPTM4B,ELF1,KITLG,PIK3CA,TERT,CDH1,PPARG,JAK2,EPHB4,ATR",DisGeNET
1390,Muscle hypotonia,0.13049761748958613,1.4799503105590062,3.0137712699798214,0.4033628228179445,"GCDH,HADHA,AHI1,MEF2C,MAP2K2,ALDH5A1,THRB,KANSL1,PIK3CA,KIAA0586,PRDM16,LONP1",DisGeNET
1391,"CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT",0.1315405690685488,3.4002677376171353,6.897238970399704,0.4033628228179445,"PPARG,JAK2",DisGeNET
1392,Short toe,0.1315405690685488,3.4002677376171353,6.897238970399704,0.4033628228179445,"FIG4,ASXL1",DisGeNET
1393,Social disinhibition,0.1315405690685488,3.4002677376171353,6.897238970399704,0.4033628228179445,"TOMM40,MAPT",DisGeNET
1394,Stage II Colon Cancer,0.1315405690685488,3.4002677376171353,6.897238970399704,0.4033628228179445,"IL1RN,PIK3CA",DisGeNET
1395,Stage II Colon Cancer AJCC v7,0.1315405690685488,3.4002677376171353,6.897238970399704,0.4033628228179445,"IL1RN,PIK3CA",DisGeNET
1396,"Optic Atrophy, Autosomal Dominant",0.1315405690685488,3.4002677376171353,6.897238970399704,0.4033628228179445,"TOMM40,CDH1",DisGeNET
1397,"Sterility, Postpartum",0.1315405690685488,3.4002677376171353,6.897238970399704,0.4033628228179445,"CEBPA,LEPR",DisGeNET
1398,"Subfertility, Female",0.1315405690685488,3.4002677376171353,6.897238970399704,0.4033628228179445,"CEBPA,LEPR",DisGeNET
1399,Unable to walk,0.1315405690685488,3.4002677376171353,6.897238970399704,0.4033628228179445,"MEF2C,PGAP3",DisGeNET
1400,Welts,0.1315405690685488,3.4002677376171353,6.897238970399704,0.4033628228179445,"PIK3CA,SERPING1",DisGeNET
1401,Adult Learning Disorders,0.1315405690685488,3.4002677376171353,6.897238970399704,0.4033628228179445,"IL1RN,MAPT",DisGeNET
1402,Brucellosis,0.1315405690685488,3.4002677376171353,6.897238970399704,0.4033628228179445,"IL1RN,NLRP3",DisGeNET
1403,Developmental Academic Disorder,0.1315405690685488,3.4002677376171353,6.897238970399704,0.4033628228179445,"IL1RN,MAPT",DisGeNET
1404,Female sterility,0.1315405690685488,3.4002677376171353,6.897238970399704,0.4033628228179445,"CEBPA,LEPR",DisGeNET
1405,Follicular neoplasm,0.1315405690685488,3.4002677376171353,6.897238970399704,0.4033628228179445,"TERT,PPARG",DisGeNET
1406,Germ Cell Cancer,0.1315405690685488,3.4002677376171353,6.897238970399704,0.4033628228179445,"KITLG,KIT",DisGeNET
1407,Gilbert Disease (disorder),0.1315405690685488,3.4002677376171353,6.897238970399704,0.4033628228179445,"ABCC2,HFE",DisGeNET
1408,Learning Disturbance,0.1315405690685488,3.4002677376171353,6.897238970399704,0.4033628228179445,"IL1RN,MAPT",DisGeNET
1409,LEOPARD Syndrome,0.1315405690685488,3.4002677376171353,6.897238970399704,0.4033628228179445,"MAP2K2,PIK3CA",DisGeNET
1410,Leukocytosis,0.1315405690685488,3.4002677376171353,6.897238970399704,0.4033628228179445,"NLRP3,JAK2",DisGeNET
1411,Neurocognitive Disorders,0.1315405690685488,3.4002677376171353,6.897238970399704,0.4033628228179445,"SMOX,APOE",DisGeNET
1412,Pallor,0.1315405690685488,3.4002677376171353,6.897238970399704,0.4033628228179445,"RPS28,TMPRSS6",DisGeNET
1413,Pelvic Inflammatory Disease,0.1315405690685488,3.4002677376171353,6.897238970399704,0.4033628228179445,"TLR1,CTSB",DisGeNET
1414,"AURAL ATRESIA, CONGENITAL",0.13320129173871514,2.4841185596472606,5.007719260451559,0.4033628228179445,"TOMM40,PTPRC,APOE",DisGeNET
1415,Cardiac defects,0.13320129173871514,2.4841185596472606,5.007719260451559,0.4033628228179445,"KLF13,ALDH2,CITED2",DisGeNET
1416,Crohn's disease of the ileum,0.13320129173871514,2.4841185596472606,5.007719260451559,0.4033628228179445,"NLRP3,PPARG,NKX2-3",DisGeNET
1417,Drug Resistant Epilepsy,0.13320129173871514,2.4841185596472606,5.007719260451559,0.4033628228179445,"ABCC2,PIK3CA,APOE",DisGeNET
1418,Large cell carcinoma of lung,0.13320129173871514,2.4841185596472606,5.007719260451559,0.4033628228179445,"TRRAP,TRIB1,ATR",DisGeNET
1419,Anxiety disease,0.13323939484694647,1.9183130699088147,3.866566800926283,0.4033628228179445,"FIG4,ALDH5A1,PIK3CA,MAPT,KCTD17",DisGeNET
1420,Cachexia,0.13323939484694647,1.9183130699088147,3.866566800926283,0.4033628228179445,"IL1RN,KITLG,LPL,ATR,TYMP",DisGeNET
1421,Rotting teeth,0.1339405946825831,2.1149425287356323,4.251793536884953,0.4033628228179445,"RTEL1,TERT,CDH1,ATR",DisGeNET
1422,"Osteoarthritis, Knee",0.1339405946825831,2.1149425287356323,4.251793536884953,0.4033628228179445,"IL1RN,EPAS1,HFE,ZNF410",DisGeNET
1423,Teratocarcinoma,0.1339405946825831,2.1149425287356323,4.251793536884953,0.4033628228179445,"PDGFRA,TRRAP,ADAR,APOE",DisGeNET
1424,Endometriosis,0.1341756045079645,1.3395097471530593,2.6905471217110692,0.4033628228179445,"CEBPA,PDGFRA,TAGLN,IL1RN,KLF13,CD82,IL37,DUSP1,HSD17B13,HK1,KITLG,PIK3CA,TERT,CDH1,AXL,IL2RB,LEPR,ZNF217,PPARG,APOE",DisGeNET
1425,"Aortic Aneurysm, Abdominal",0.1351226471075955,1.5737412587412587,3.149957093235248,0.4033628228179445,"SLC25A37,IL1RN,TAGLN,PTPRC,NLRP3,PPARG,APOE,IL6R,CTSB",DisGeNET
1426,Graves Disease,0.1351226471075955,1.5737412587412587,3.149957093235248,0.4033628228179445,"TLR1,GYPA,IL1RN,THRB,PIK3CA,IL37,GYPE,PPARG,SH2B3",DisGeNET
1427,"Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse",0.13518492160486678,1.532000491370309,3.0657040283048103,0.4033628228179445,"RTEL1,CCND3,BCL2L11,PTPRC,CCND2,PIK3CA,TERT,MPG,KIT,ATR",DisGeNET
1428,Mesothelioma,0.1371929187406133,1.4929010788178012,2.9654497025167172,0.4033628228179445,"KITLG,ABCC2,PIK3CA,TERT,CDH1,AXL,KIT,NLRP3,PPARG,EPHB4,ETS2",DisGeNET
1429,Hypoplasia of corpus callosum,0.1374321411679599,1.7719277673545966,3.516612149670679,0.4033628228179445,"ASXL1,MEF2C,MAP2K2,DOCK7,LONP1,SNIP1",DisGeNET
1430,Thyroid Diseases,0.13803191798387332,1.8944425682014334,3.751508411270816,0.4033628228179445,"THRB,NCOA4,KIT,SH2B3,CTSB",DisGeNET
1431,"Anemia, Hemolytic",0.13967492688331473,2.0788906009244994,4.092166232047201,0.4033628228179445,"SPTA1,TFRC,HFE,HK1",DisGeNET
1432,Pancytopenia,0.13967492688331473,2.0788906009244994,4.092166232047201,0.4033628228179445,"RTEL1,TERT,ALDH2,ATR",DisGeNET
1433,Duodenal Ulcer,0.14053600842899536,2.418508506916839,4.745818771158417,0.4033628228179445,"IL1RN,TFRC,ALDH2",DisGeNET
1434,Dystrophia myotonica 2,0.14053600842899536,2.418508506916839,4.745818771158417,0.4033628228179445,"PTPN1,LPL,APOB",DisGeNET
1435,FRIEDREICH ATAXIA 1,0.14053600842899536,2.418508506916839,4.745818771158417,0.4033628228179445,"HFE,PPARG,SIRT3",DisGeNET
1436,gliosarcoma,0.14053600842899536,2.418508506916839,4.745818771158417,0.4033628228179445,"PDGFRA,KIT,PPARG",DisGeNET
1437,Joint swelling,0.14053600842899536,2.418508506916839,4.745818771158417,0.4033628228179445,"IL1RN,IL2RB,IL6R",DisGeNET
1438,Libman-Sacks Disease,0.14053600842899536,2.418508506916839,4.745818771158417,0.4033628228179445,"BLK,TERT,SH2B3",DisGeNET
1439,Machado-Joseph Disease,0.14053600842899536,2.418508506916839,4.745818771158417,0.4033628228179445,"IL1RN,KITLG,APOE",DisGeNET
1440,Marginal Zone B-Cell Lymphoma,0.14053600842899536,2.418508506916839,4.745818771158417,0.4033628228179445,"TLR1,CDH1,LONP1",DisGeNET
1441,Secondary malignant neoplasm of lymph node,0.14091163752345703,1.2700760616137292,2.4888693340220334,0.4033628228179445,"CEP57,TAGLN,CD82,CITED2,EPAS1,LPL,TYMP,LAPTM4B,TERT,CDH1,ZKSCAN3,LEPR,LONP1,FLOT2,APOE,EPHB4,CTSB,RBM38,PTPN1,PDGFRA,NCOA4,SIRT3,MFHAS1,PIK3CA,KIT,ZNF217,RPL22L1,PPARG",DisGeNET
1442,Increase in blood pressure,0.14167278394259328,1.7548780487804878,3.4294444877782575,0.4033628228179445,"NSMCE2,NPHP3,PPARG,APOB,JAK2,SH2B3",DisGeNET
1443,Juvenile-Onset Still Disease,0.14167278394259328,1.7548780487804878,3.4294444877782575,0.4033628228179445,"IL1RN,SLC22A16,GADD45A,DUSP1,FAXDC2,GMPR",DisGeNET
1444,Juvenile psoriatic arthritis,0.14167278394259328,1.7548780487804878,3.4294444877782575,0.4033628228179445,"IL1RN,SLC22A16,GADD45A,DUSP1,FAXDC2,GMPR",DisGeNET
1445,Colitis,0.14192601578271646,1.3761496820307983,2.6868625835205213,0.4033628228179445,"FTO,CEBPA,IL1RN,TFRC,IL37,PLD1,ETS2,TLR1,PTPRC,FNDC4,PIK3CA,TST,DLG5,NLRP3,PPARG,ANP32B",DisGeNET
1446,Exanthema,0.1421170885913041,1.6675675034966693,3.2535976156791664,0.4033628228179445,"PDGFRA,HSPA8,IL1RN,MAP2K2,PIK3CA,SERPING1,NLRP3",DisGeNET
1447,"Albinism, Oculocutaneous",0.14247496211786,3.2209892200380468,6.276384160538291,0.4033628228179445,"PIK3CA,KIT",DisGeNET
1448,"Neoplasms, Germ Cell and Embryonal",0.14247496211786,3.2209892200380468,6.276384160538291,0.4033628228179445,"KITLG,KIT",DisGeNET
1449,Subfertility,0.14247496211786,3.2209892200380468,6.276384160538291,0.4033628228179445,"IL1RN,LEPR",DisGeNET
1450,"Sarcoma, Spindle Cell",0.14247496211786,3.2209892200380468,6.276384160538291,0.4033628228179445,"PIK3CA,CDH1",DisGeNET
1451,"stage, neuroblastoma",0.14247496211786,3.2209892200380468,6.276384160538291,0.4033628228179445,"PTPRC,TERT",DisGeNET
1452,Toxic Shock Syndrome,0.14247496211786,3.2209892200380468,6.276384160538291,0.4033628228179445,"IL1RN,TST",DisGeNET
1453,Atypical Lipoma,0.14247496211786,3.2209892200380468,6.276384160538291,0.4033628228179445,"CEBPA,TERT",DisGeNET
1454,Carotid Artery Plaque,0.14247496211786,3.2209892200380468,6.276384160538291,0.4033628228179445,"LPL,APOE",DisGeNET
1455,Female infertility,0.14247496211786,3.2209892200380468,6.276384160538291,0.4033628228179445,"CEBPA,LEPR",DisGeNET
1456,Gonadal Dysgenesis,0.14247496211786,3.2209892200380468,6.276384160538291,0.4033628228179445,"MAP3K1,KIT",DisGeNET
1457,Hereditary Motor and Sensory Neuropathies,0.14247496211786,3.2209892200380468,6.276384160538291,0.4033628228179445,"FIG4,HK1",DisGeNET
1458,Male Pseudohermaphroditism,0.14247496211786,3.2209892200380468,6.276384160538291,0.4033628228179445,"MAP3K1,HSD17B13",DisGeNET
1459,Nonnuclear polymorphic congenital cataract,0.14247496211786,3.2209892200380468,6.276384160538291,0.4033628228179445,"MAX,DUSP1",DisGeNET
1460,Parathyroid Gland Adenocarcinoma,0.14247496211786,3.2209892200380468,6.276384160538291,0.4033628228179445,"TERT,APOB",DisGeNET
1461,Malaria,0.14367018499726322,1.4502009499451955,2.8137306231586257,0.4033628228179445,"TLR1,SPTA1,GYPA,IL1RN,TFRC,TMPRSS6,GYPE,NLRP3,PPARG,APOE,SPPL3,HK1",DisGeNET
1462,nervous system disorder,0.14367018499726322,1.4502009499451955,2.8137306231586257,0.4033628228179445,"FTO,GCDH,MEF2C,TOMM40,ABCC2,ADAR,PPARG,APOE,MAPT,SH2B3,CTSB,HK1",DisGeNET
1463,Secondary malignant neoplasm of liver,0.14387080528643942,1.4263810822496426,2.7655240807827735,0.4033628228179445,"RRM1,CD82,TYMP,SLC25A37,CCND3,PIK3CA,AXL,KIT,ZKSCAN3,ZNF217,PPARG,NKX2-3,RAB8A",DisGeNET
1464,Secondary Neoplasm,0.14550581939240548,2.044040404040404,3.9399679997474655,0.4033628228179445,"PDGFRA,PTPRC,PIK3CA,IL6R",DisGeNET
1465,"Hypogonadism, Isolated Hypogonadotropic",0.14550581939240548,2.044040404040404,3.9399679997474655,0.4033628228179445,"MAP3K1,AXL,HFE,LEPR",DisGeNET
1466,Childhood Acute Myeloid Leukemia,0.14550581939240548,2.044040404040404,3.9399679997474655,0.4033628228179445,"CEBPA,MEF2C,PRDM16,KIT",DisGeNET
1467,Oral Cavity Carcinoma,0.14550581939240548,2.044040404040404,3.9399679997474655,0.4033628228179445,"ALDH2,PIK3CA,GPN1,CTSB",DisGeNET
1468,Attention deficit hyperactivity disorder,0.14568902260590555,1.4729842509086015,2.8373814448222423,0.4033628228179445,"FTO,FADS2,IL1RN,MEF2C,ACOXL,THRB,ALDH2,PIK3CA,HFE,APOE,HK1",DisGeNET
1469,Pneumonia,0.14645776174009215,1.4211793818077374,2.730111469092552,0.4033628228179445,"TAGLN,IL1RN,SMOX,DUSP1,ETS2,SMPD2,PIK3CA,TERT,IL2RB,NLRP3,PPARG,APOE,PDE7A",DisGeNET
1470,"Mammary Carcinoma, Animal",0.1478408767813434,1.8484271432233492,3.5334879674283712,0.4033628228179445,"TF,KITLG,TP53I3,CDH1,LPL",DisGeNET
1471,Animal Mammary Neoplasms,0.1478408767813434,1.8484271432233492,3.5334879674283712,0.4033628228179445,"TF,KITLG,TP53I3,CDH1,LPL",DisGeNET
1472,Malignant neoplasm of testis,0.1478408767813434,1.8484271432233492,3.5334879674283712,0.4033628228179445,"KITLG,MPG,KIT,APOE,JAK2",DisGeNET
1473,Malignant neoplasm of urinary bladder,0.14797165096644088,1.2729016638969246,2.432177214805379,0.4033628228179445,"TFRC,CD82,MPG,EPAS1,PPP2R2A,ETS2,TYMP,HK1,CCND3,ALDH2,TERT,CDH1,JARID2,SLC12A7,IL6R,EPHB4,PDGFRA,ABCC2,GADD45A,RHOA,PIK3CA,AXL,PRC1,DLG5,PPARG,ATR",DisGeNET
1474,Simple ear,0.14800311609084355,2.3562630722751567,4.501692321374702,0.4033628228179445,"KIAA0586,DOCK7,ATR",DisGeNET
1475,Stereotyped Behavior,0.14800311609084355,2.3562630722751567,4.501692321374702,0.4033628228179445,"MEF2C,PRDM16,MAPT",DisGeNET
1476,Abnormality of the pinna,0.14800311609084355,2.3562630722751567,4.501692321374702,0.4033628228179445,"KIAA0586,DOCK7,ATR",DisGeNET
1477,Atrophic,0.14800311609084355,2.3562630722751567,4.501692321374702,0.4033628228179445,"IL1RN,MAPT,APOE",DisGeNET
1478,Autoimmune thrombocytopenia,0.14800311609084355,2.3562630722751567,4.501692321374702,0.4033628228179445,"IL1RN,NLRP3,ANP32B",DisGeNET
1479,Limitation of joint mobility,0.14800311609084355,2.3562630722751567,4.501692321374702,0.4033628228179445,"ASXL1,HFE,IL2RB",DisGeNET
1480,Malignancy,0.14800311609084355,2.3562630722751567,4.501692321374702,0.4033628228179445,"CD82,TERT,SIRT3",DisGeNET
1481,Monocytic leukemia,0.14800311609084355,2.3562630722751567,4.501692321374702,0.4033628228179445,"CEBPA,LPL,PPARG",DisGeNET
1482,Oropharyngeal Carcinoma,0.14800311609084355,2.3562630722751567,4.501692321374702,0.4033628228179445,"ALDH2,PIK3CA,ATR",DisGeNET
1483,Recurrent tumor,0.14802955510219715,1.5381538461538462,2.938401938234724,0.4033628228179445,"PDGFRA,IL1RN,PIK3CA,TERT,GADD45A,PSD4,KIT,ETS2,HK1",DisGeNET
1484,Central neuroblastoma,0.14822913652950293,1.224321226448886,2.3372243028017086,0.4033628228179445,"FTO,BLK,CEBPA,RTEL1,TFRC,CD82,MAX,EPAS1,HFE,ITSN1,TYMP,BCL2L11,CCND2,TERT,PSD4,MYB,LEPR,APOE,JAK2,IL6R,CTSB,HSPA8,PDGFRA,SMOX,TRPC1,PABPC4,MSRA,KITLG,PTPRC,XRN1,PIK3CA,KIT,IL2RB,SERPING1,PPARG,MAPT,ATR",DisGeNET
1485,"Amyloidosis, Primary Cutaneous",0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,APOE,DisGeNET
1486,REM Sleep Behavior Disorder,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,FBXO7,DisGeNET
1487,Renal corticomedullary cysts,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,NPHP3,DisGeNET
1488,"Aplastic anemia, idiopathic",0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,TERT,DisGeNET
1489,"DEAFNESS, AUTOSOMAL DOMINANT 1 (disorder)",0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,CD164,DisGeNET
1490,"Decreased visual acuity, slowly progressive",0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,RP1L1,DisGeNET
1491,Scimitar Syndrome,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,PDGFRA,DisGeNET
1492,"DIARRHEA 5, WITH TUFTING ENTEROPATHY, CONGENITAL",0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,MAPT,DisGeNET
1493,"Dystonia, Secondary",0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,ALDH5A1,DisGeNET
1494,Secondary malignant neoplasm of prostate,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,CD82,DisGeNET
1495,Secondary Peritonitis,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,LEPR,DisGeNET
1496,"Gait, Scissors",0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,FBXO7,DisGeNET
1497,Severe failure to thrive,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,FIG4,DisGeNET
1498,"HEMIHYPERPLASIA, ISOLATED",0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,PIK3CA,DisGeNET
1499,Short upper lip,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,FIG4,DisGeNET
1500,"Keratitis, Herpetic",0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,APOE,DisGeNET
1501,"Macular Degeneration, Age-Related, 1",0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,APOE,DisGeNET
1502,Somatostatinoma,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,EPAS1,DisGeNET
1503,Spindle Cell Neoplasm,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,KIT,DisGeNET
1504,"Pheochromocytoma, malignant",0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,MAX,DisGeNET
1505,"Polycystic Kidney, Type 1 Autosomal Dominant Disease",0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,PPARG,DisGeNET
1506,Supranuclear gaze palsy,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,MAPT,DisGeNET
1507,Supratentorial Neoplasms,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,PDGFRA,DisGeNET
1508,Swyer Syndrome,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,MAP3K1,DisGeNET
1509,"Pyogenic Arthritis, Pyoderma Gangrenosum and Acne",0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,NLRP3,DisGeNET
1510,T-cell/histiocyte rich large B-cell lymphoma,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,PTPRC,DisGeNET
1511,Thick hair,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,ASXL1,DisGeNET
1512,"Synovial sarcoma, biphasic",0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,HEATR3,DisGeNET
1513,"Thyroid cancer, follicular",0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,PPARG,DisGeNET
1514,Thrombocytopenia-Absent Radius Syndrome,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,JAK2,DisGeNET
1515,"Urea Cycle Disorders, Inborn",0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,SLC25A15,DisGeNET
1516,"Vertigo, Paroxysmal",0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,MAX,DisGeNET
1517,11 pairs of ribs,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,ATR,DisGeNET
1518,Toxic multinodular goiter,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,THRB,DisGeNET
1519,Transitional Cell Neoplasm,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,CCND2,DisGeNET
1520,Triple vessel disease,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,APOB,DisGeNET
1521,Tumor of Rete Testis,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,KITLG,DisGeNET
1522,Abnormality of hair consistency,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,KANSL1,DisGeNET
1523,Abnormality of hair curl pattern,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,KANSL1,DisGeNET
1524,Abnormality of hair texture,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,KANSL1,DisGeNET
1525,Abnormality of hair volume,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,KANSL1,DisGeNET
1526,Abnormality of skull shape,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,FTO,DisGeNET
1527,Underdevelopment of facial bones,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,FIG4,DisGeNET
1528,Absent palmar crease,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,SLC39A13,DisGeNET
1529,Vasculitic neuropathy,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,SERPING1,DisGeNET
1530,Accessory oral frenulum,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,ASXL1,DisGeNET
1531,Ventricular Dysfunction,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,ALDH2,DisGeNET
1532,ACTIVATED PI3K-DELTA SYNDROME,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,PIK3CA,DisGeNET
1533,acute aortic dissection,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,JAK2,DisGeNET
1534,Vitamin Deficiency,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,APOB,DisGeNET
1535,Acute encephalopathy,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,SLC25A15,DisGeNET
1536,Acute glaucoma,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,NLRP3,DisGeNET
1537,Adult-Onset Vitelliform Macular Dystrophy,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,TST,DisGeNET
1538,Adult Classical Hodgkin Lymphoma,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,PTPN1,DisGeNET
1539,Alcoholic Neuropathy,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,ALDH2,DisGeNET
1540,Alopecia totalis,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,IL1RN,DisGeNET
1541,Amebiasis,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,LEPR,DisGeNET
1542,Amputation Stumps,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,TERT,DisGeNET
1543,Aplasia/Hypoplasia of the distal phalanges of the hand,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,FIG4,DisGeNET
1544,Aplasia/Hypoplasia of the middle phalanges of the hand,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,FIG4,DisGeNET
1545,Asymmetrical skull,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,FTO,DisGeNET
1546,ATAXIA-TELANGIECTASIA-LIKE DISORDER,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,RAD50,DisGeNET
1547,Avitaminosis,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,APOB,DisGeNET
1548,Breast cancer stage II,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,IL6R,DisGeNET
1549,Broad femoral neck,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,SLC39A13,DisGeNET
1550,Bruxism,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,PGAP3,DisGeNET
1551,Carcinoma in situ of fallopian tube,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,PSD4,DisGeNET
1552,Centrocytic lymphoma,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,IL6R,DisGeNET
1553,Childhood Onset Dystonias,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,ALDH5A1,DisGeNET
1554,Chordee,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,MAP3K1,DisGeNET
1555,Chronic cholecystitis,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,CDH1,DisGeNET
1556,Chronic mountain sickness,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,EPAS1,DisGeNET
1557,Chronic skin ulcer,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,PDGFRA,DisGeNET
1558,Circadian Rhythm Disorders,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,PPARG,DisGeNET
1559,Collagenous Sprue,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,HFE,DisGeNET
1560,Congenital amegakaryocytic thrombocytopenia,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,GYPA,DisGeNET
1561,COWDEN-LIKE SYNDROME (disorder),0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,PIK3CA,DisGeNET
1562,Cri-du-Chat Syndrome,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,TERT,DisGeNET
1563,Cutaneous anaphylaxis,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,RHOA,DisGeNET
1564,Decreased facial expression,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,FBXO7,DisGeNET
1565,Decreased LDL,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,APOB,DisGeNET
1566,Decreased size of facial bones,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,FIG4,DisGeNET
1567,Deep plantar creases,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,ASXL1,DisGeNET
1568,Defective DNA repair after ultraviolet radiation damage,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,DDB2,DisGeNET
1569,Elevated immunoglobulin levels,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,TERT,DisGeNET
1570,Elevated urinary epinephrine,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,MAX,DisGeNET
1571,Elevated urinary norepinephrine,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,MAX,DisGeNET
1572,Enuresis,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,NPHP3,DisGeNET
1573,Episodic paroxysmal anxiety,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,MAX,DisGeNET
1574,Epithelioid and spindle cell nevus,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,MYB,DisGeNET
1575,Erythroid hyperplasia,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,APOB,DisGeNET
1576,Extra-Adrenal Paraganglioma,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,TERT,DisGeNET
1577,Fenestration (morphologic abnormality),0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,MEF2C,DisGeNET
1578,Flat capital femoral epiphysis,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,SLC39A13,DisGeNET
1579,Flattening of facial bones,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,FIG4,DisGeNET
1580,Folliculitis,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,PPARG,DisGeNET
1581,Ganglioneuromatosis,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,PIK3CA,DisGeNET
1582,Globulin gamma serum plasma increased result,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,TERT,DisGeNET
1583,Hepatoblastoma Caused By Somatic Mutation,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,PIK3CA,DisGeNET
1584,Hyperglobulinemia,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,TERT,DisGeNET
1585,Hyperplasia of malar bones,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,NSMCE2,DisGeNET
1586,Hypertensive Retinopathy,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,MAX,DisGeNET
1587,Hypointensity of cerebral white matter on MRI,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,TYMP,DisGeNET
1588,Hypoplastic facial bones,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,FIG4,DisGeNET
1589,Hypotrophic facial bones,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,FIG4,DisGeNET
1590,Ileal Pouches,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,IL1RN,DisGeNET
1591,Increased antibody level in blood,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,TERT,DisGeNET
1592,Increased nuchal translucency,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,CEP57,DisGeNET
1593,Infantile encephalopathy,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,GCDH,DisGeNET
1594,Intolerant of heat,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,MAP2K2,DisGeNET
1595,Intracranial Atherosclerosis,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,APOE,DisGeNET
1596,Klippel-Trenaunay-Weber Syndrome,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,PIK3CA,DisGeNET
1597,LEPTIN DEFICIENCY OR DYSFUNCTION,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,PPARG,DisGeNET
1598,Loss of subcutaneous adipose tissue in limbs,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,PPARG,DisGeNET
1599,Malar prominence,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,NSMCE2,DisGeNET
1600,Malformation of skull shape,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,FTO,DisGeNET
1601,Malignant melanoma of iris,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,KIT,DisGeNET
1602,Malignant neoplasm of thymus,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,PDGFRA,DisGeNET
1603,Malignant tumor of eye,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,TRPC1,DisGeNET
1604,Metastatic Endometrial Carcinoma,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,PIK3CA,DisGeNET
1605,Motor disturbances,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,MAPT,DisGeNET
1606,Myelofibrosis due to another disorder,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,JAK2,DisGeNET
1607,Myelolipoma,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,KIT,DisGeNET
1608,Myocardial rupture,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,MSRA,DisGeNET
1609,Myxopapillary ependymoma,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,PDGFRA,DisGeNET
1610,Narrow palm,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,KANSL1,DisGeNET
1611,Necrotizing fasciitis,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,CTSB,DisGeNET
1612,Neonatal breathing dysregulation,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,AHI1,DisGeNET
1613,Nodular thyroid disease,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,PPARG,DisGeNET
1614,Non-small cell lung cancer stage III,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,CCND2,DisGeNET
1615,Obstruction of pelviureteric junction,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,DSTYK,DisGeNET
1616,Old myocardial infarction,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,APOE,DisGeNET
1617,Papillary cystic tumor,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,CDH1,DisGeNET
1618,Parkinsonism with favorable response to dopaminergic medication,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,FBXO7,DisGeNET
1619,Partial Paralysis (Paresis) Vocal Cords,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,LONP1,DisGeNET
1620,Pediatric follicular lymphoma,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,RTEL1,DisGeNET
1621,Penile Neoplasms,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,PIK3CA,DisGeNET
1622,Pityriasis Rubra Pilaris,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,IL37,DisGeNET
1623,Polio and Post-Polio Syndrome,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,FBXO7,DisGeNET
1624,Positive regitine blocking test,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,MAX,DisGeNET
1625,Postherpetic neuralgia,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,APOE,DisGeNET
1626,Postoperative confusion,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,APOE,DisGeNET
1627,Processing speed,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,SH2B3,DisGeNET
1628,Proximal spinal muscular atrophy,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,APOE,DisGeNET
1629,Pseudo-TORCH syndrome,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,ADAR,DisGeNET
1630,pseudohermaphrodite (non-specific),0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,HSD17B13,DisGeNET
1631,Pulsatile Tinnitus,0.14911259383863723,7.638138138138138,14.535786243348012,0.4033628228179445,MAX,DisGeNET
1632,"Hypercholesterolemia, Familial",0.15033304431816796,1.721734670617734,3.262518730193559,0.4061661919974017,"PTPRC,HFE,LPL,APOE,TRIB1,APOB",DisGeNET
1633,Ulcer,0.15033304431816796,1.721734670617734,3.262518730193559,0.4061661919974017,"PDGFRA,TERT,CDH1,HFE,BLOC1S2,KIT",DisGeNET
1634,Plasmacytoma,0.15143025121536938,2.0103328365623447,3.794764869932429,0.4088802131959668,"RTEL1,PSMB5,KIT,IL6R",DisGeNET
1635,Encephalitis,0.1528540562776754,1.826241134751773,3.4301770286563236,0.408962691091878,"IL1RN,NLRP3,PPARG,APOE,CTSB",DisGeNET
1636,Mouth Neoplasms,0.1528540562776754,1.826241134751773,3.4301770286563236,0.408962691091878,"HSPA8,PIK3CA,GPN1,SIRT3,TYMP",DisGeNET
1637,Right Middle Cerebral Artery Infarction,0.15359274232530412,3.0596385542168676,5.7320820213469,0.408962691091878,"PLD1,IL6R",DisGeNET
1638,"Embolic Infarction, Middle Cerebral Artery",0.15359274232530412,3.0596385542168676,5.7320820213469,0.408962691091878,"PLD1,IL6R",DisGeNET
1639,Sessile Serrated Adenoma/Polyp,0.15359274232530412,3.0596385542168676,5.7320820213469,0.408962691091878,"PIK3CA,MAPT",DisGeNET
1640,"Hallucinations, Sensory",0.15359274232530412,3.0596385542168676,5.7320820213469,0.408962691091878,"ALDH5A1,TOMM40",DisGeNET
1641,"Neoplasm Recurrence, Local",0.15359274232530412,3.0596385542168676,5.7320820213469,0.408962691091878,"ASXL1,KIT",DisGeNET
1642,"Thrombotic Infarction, Middle Cerebral Artery",0.15359274232530412,3.0596385542168676,5.7320820213469,0.408962691091878,"PLD1,IL6R",DisGeNET
1643,5q-syndrome,0.15359274232530412,3.0596385542168676,5.7320820213469,0.408962691091878,"KITLG,JAK2",DisGeNET
1644,Acanthosis Nigricans,0.15359274232530412,3.0596385542168676,5.7320820213469,0.408962691091878,"NSMCE2,PPARG",DisGeNET
1645,Cholestasis of pregnancy,0.15359274232530412,3.0596385542168676,5.7320820213469,0.408962691091878,"ABCC2,PPARG",DisGeNET
1646,Hereditary non-polyposis colorectal cancer syndrome,0.15359274232530412,3.0596385542168676,5.7320820213469,0.408962691091878,"PIK3CA,CDH1",DisGeNET
1647,Intrahepatic Cholestasis,0.15359274232530412,3.0596385542168676,5.7320820213469,0.408962691091878,"ABCC2,TMPRSS6",DisGeNET
1648,Keratosis,0.15359274232530412,3.0596385542168676,5.7320820213469,0.408962691091878,"PIK3CA,TRPC1",DisGeNET
1649,Left Middle Cerebral Artery Infarction,0.15359274232530412,3.0596385542168676,5.7320820213469,0.408962691091878,"PLD1,IL6R",DisGeNET
1650,Malignant neoplasm of adrenal cortex,0.15359274232530412,3.0596385542168676,5.7320820213469,0.408962691091878,"RRM1,CITED2",DisGeNET
1651,Middle Cerebral Artery Embolus,0.15359274232530412,3.0596385542168676,5.7320820213469,0.408962691091878,"PLD1,IL6R",DisGeNET
1652,Middle Cerebral Artery Syndrome,0.15359274232530412,3.0596385542168676,5.7320820213469,0.408962691091878,"PLD1,IL6R",DisGeNET
1653,Middle Cerebral Artery Thrombosis,0.15359274232530412,3.0596385542168676,5.7320820213469,0.408962691091878,"PLD1,IL6R",DisGeNET
1654,Narrow palate,0.15359274232530412,3.0596385542168676,5.7320820213469,0.408962691091878,"ASXL1,KANSL1",DisGeNET
1655,Plasma Cell Neoplasm,0.15359274232530412,3.0596385542168676,5.7320820213469,0.408962691091878,"PTPRC,KIT",DisGeNET
1656,Progressive intrahepatic cholestasis (disorder),0.15359274232530412,3.0596385542168676,5.7320820213469,0.408962691091878,"ABCC2,APOE",DisGeNET
1657,Prolymphocytic Leukemia,0.15359274232530412,3.0596385542168676,5.7320820213469,0.408962691091878,"TFRC,ATR",DisGeNET
1658,Cirrhosis,0.15470232201190323,1.4272284707067315,2.663568718287033,0.4113010703765078,"IL1RN,CCND2,ALDH2,TERT,CDH1,DENND4A,HFE,LEPR,APOE,PCSK7,APOB,CPEB4",DisGeNET
1659,Diarrhea,0.1547074820465961,1.5209467455621302,2.8384199544016924,0.4113010703765078,"IL1RN,PTPRC,ABCC2,KIT,LEPR,SERPING1,APOE,CTSB,TYMP",DisGeNET
1660,MIXED LINEAGE LEUKEMIA,0.1547506293801004,1.7056233062330624,3.1825912643149867,0.4113010703765078,"GTF2A1,MEF2C,MPG,MYB,P4HTM,ETS2",DisGeNET
1661,Adenoma of large intestine,0.1550147030396647,1.5663319135633622,2.9200112576898842,0.411754888507526,"FTO,ABCC2,ALDH2,CDH1,HFE,LEPR,PPARG,APOE",DisGeNET
1662,Inborn Errors of Metabolism,0.15559571008477832,2.297129909365559,4.273796959777195,0.41280112621409615,"GCDH,LEPR,TYMP",DisGeNET
1663,MYOTONIC DYSTROPHY 1,0.15559571008477832,2.297129909365559,4.273796959777195,0.41280112621409615,"CEBPA,ALDH2,HFE",DisGeNET
1664,Amyloidosis,0.15617172054882375,1.3068770956491294,2.426608220748868,0.4140803071282514,"CEBPA,IL1RN,TOMM40,HFE,LPL,PLD1,ETS2,SIRT3,TLR1,MSRA,PTPRC,PIK3CA,IL2RB,NLRP3,PPARG,APOE,MAPT,APOB,PLTP,CTSB",DisGeNET
1665,Xerosis,0.1574451531052338,1.9777126099706746,3.6561540210316963,0.4157074025671033,"MAP2K2,TERT,KANSL1,DDB2",DisGeNET
1666,Ki-1+ Anaplastic Large Cell Lymphoma,0.15785036154875876,1.6167712860131982,2.984734039117728,0.4157074025671033,"PDGFRA,RTEL1,DOK2,BCL2L11,PTPRC,PIK3CA,KIT",DisGeNET
1667,Squamous cell carcinoma of tongue,0.15793746364548836,1.8045771500089398,3.3304484104595113,0.4157074025671033,"PIK3CA,CDH1,EPAS1,GADD45A,SNIP1",DisGeNET
1668,Neurilemmoma,0.15793746364548836,1.8045771500089398,3.3304484104595113,0.4157074025671033,"PIK3CA,AXL,TNK2,KIT,IL2RB",DisGeNET
1669,Cholestasis,0.15810127904201246,1.512484237074401,2.789806585111886,0.4157074025671033,"HADHA,PTPRC,ABCC2,MAX,KIAA0586,HFE,NPHP3,PPARG,ALDH8A1",DisGeNET
1670,Refractory anemias,0.16240006356470635,1.5463209476405448,2.8107359270286745,0.4157074025671033,"GYPA,CCND3,TERT,PIK3CA,TMPRSS6,KIT,APOE,JAK2",DisGeNET
1671,Retinoblastoma,0.16249858947755774,1.390727760470751,2.527071884101236,0.4157074025671033,"CEP57,NUP205,RTEL1,TFEB,CCND3,ELF1,PIK3CA,TERT,KIT,PRDM16,IL2RB,PPARG,ATR",DisGeNET
1672,"Multiple, subcutaneous nodules",0.16330690860836444,2.2408812909881366,4.060754709535732,0.4157074025671033,"PIK3CA,KIT,APOE",DisGeNET
1673,Subcutaneous nodule,0.16330690860836444,2.2408812909881366,4.060754709535732,0.4157074025671033,"PIK3CA,KIT,APOE",DisGeNET
1674,Uterine Cancer,0.16330690860836444,2.2408812909881366,4.060754709535732,0.4157074025671033,"PDGFRA,HSPA8,PIK3CA",DisGeNET
1675,Bipolar I disorder,0.16330690860836444,2.2408812909881366,4.060754709535732,0.4157074025671033,"MSRA,ALDH2,SLC22A16",DisGeNET
1676,Brain Infarction,0.16330690860836444,2.2408812909881366,4.060754709535732,0.4157074025671033,"HFE,LPL,CTSB",DisGeNET
1677,Difficulty speaking,0.16330690860836444,2.2408812909881366,4.060754709535732,0.4157074025671033,"KANSL1,PRDM16,MAPT",DisGeNET
1678,Distal muscle weakness,0.16330690860836444,2.2408812909881366,4.060754709535732,0.4157074025671033,"FIG4,HK1,TYMP",DisGeNET
1679,Problems speaking,0.16330690860836444,2.2408812909881366,4.060754709535732,0.4157074025671033,"KANSL1,PRDM16,MAPT",DisGeNET
1680,Subclinical abnormal liver function tests,0.16354741372376325,1.9461279461279462,3.5237611166576324,0.4157074025671033,"HADHA,HFE,JAK2,TYMP",DisGeNET
1681,Transaminases increased,0.16354741372376325,1.9461279461279462,3.5237611166576324,0.4157074025671033,"HADHA,HFE,JAK2,TYMP",DisGeNET
1682,Elevated liver enzymes,0.16354741372376325,1.9461279461279462,3.5237611166576324,0.4157074025671033,"HADHA,HFE,JAK2,TYMP",DisGeNET
1683,Increased liver function tests,0.16354741372376325,1.9461279461279462,3.5237611166576324,0.4157074025671033,"HADHA,HFE,JAK2,TYMP",DisGeNET
1684,Liver enzymes abnormal,0.16354741372376325,1.9461279461279462,3.5237611166576324,0.4157074025671033,"HADHA,HFE,JAK2,TYMP",DisGeNET
1685,Liver function tests abnormal finding,0.16354741372376325,1.9461279461279462,3.5237611166576324,0.4157074025671033,"HADHA,HFE,JAK2,TYMP",DisGeNET
1686,"Conjunctivitis, recurrent",0.16487131692197854,2.9136546184738954,5.252124698534515,0.4157074025671033,"NLRP3,DDB2",DisGeNET
1687,Small Lymphocytic Lymphoma,0.16487131692197854,2.9136546184738954,5.252124698534515,0.4157074025671033,"KIT,ETS2",DisGeNET
1688,Sparse axillary hair,0.16487131692197854,2.9136546184738954,5.252124698534515,0.4157074025671033,"MAP3K1,AXL",DisGeNET
1689,Streptococcal pneumonia,0.16487131692197854,2.9136546184738954,5.252124698534515,0.4157074025671033,"IL37,NLRP3",DisGeNET
1690,X-Linked Lymphoproliferative Disorder,0.16487131692197854,2.9136546184738954,5.252124698534515,0.4157074025671033,"IL1RN,RTEL1",DisGeNET
1691,AIDS-Associated Nephropathy,0.16487131692197854,2.9136546184738954,5.252124698534515,0.4157074025671033,"TERT,APOE",DisGeNET
1692,alpha 1-Antitrypsin Deficiency,0.16487131692197854,2.9136546184738954,5.252124698534515,0.4157074025671033,"HFE,TFEB",DisGeNET
1693,Clear Cell Sarcoma of Soft Tissue,0.16487131692197854,2.9136546184738954,5.252124698534515,0.4157074025671033,"KIT,PPARG",DisGeNET
1694,CREST Syndrome,0.16487131692197854,2.9136546184738954,5.252124698534515,0.4157074025671033,"GADD45A,JAK2",DisGeNET
1695,Decreased testosterone in males,0.16487131692197854,2.9136546184738954,5.252124698534515,0.4157074025671033,"MAP3K1,LEPR",DisGeNET
1696,Hepatitis E,0.16487131692197854,2.9136546184738954,5.252124698534515,0.4157074025671033,"AHI1,APOE",DisGeNET
1697,Hereditary Breast and Ovarian Cancer Syndrome,0.16487131692197854,2.9136546184738954,5.252124698534515,0.4157074025671033,"RAD50,HSD17B13",DisGeNET
1698,Increased hepatocellular carcinoma risk,0.16487131692197854,2.9136546184738954,5.252124698534515,0.4157074025671033,"PIK3CA,HFE",DisGeNET
1699,Increased incidence of hepatocellular carcinoma,0.16487131692197854,2.9136546184738954,5.252124698534515,0.4157074025671033,"PIK3CA,HFE",DisGeNET
1700,Learning Disorders,0.16487131692197854,2.9136546184738954,5.252124698534515,0.4157074025671033,"IL1RN,MAPT",DisGeNET
1701,Micronychia (disorder),0.16487131692197854,2.9136546184738954,5.252124698534515,0.4157074025671033,"FTO,CDH1",DisGeNET
1702,Motor symptoms,0.16487131692197854,2.9136546184738954,5.252124698534515,0.4157074025671033,"APOE,MAPT",DisGeNET
1703,Neuronal loss in central nervous system,0.16487131692197854,2.9136546184738954,5.252124698534515,0.4157074025671033,"FIG4,MAPT",DisGeNET
1704,Malignant tumor of cervix,0.16740385475912972,1.3009045155386618,2.325166604458973,0.4157074025671033,"CEBPA,IL1RN,TFRC,CD82,GADD45A,PABPC4,NSMCE2,TMC8,HSD17B13,TMC6,TYMP,LAPTM4B,ELF1,PIK3CA,TERT,CDH1,PPARG,JAK2,ATR",DisGeNET
1705,Bladder Neoplasm,0.16821530717498479,1.2440960912052117,2.217614382640742,0.4157074025671033,"TFRC,CD82,EPAS1,PPP2R2A,ETS2,TYMP,HK1,CCND3,ALDH2,TERT,CDH1,LEPR,JARID2,SLC12A7,IL6R,EPHB4,PDGFRA,ABCC2,GADD45A,RHOA,PIK3CA,AXL,PRC1,DLG5,ZNF217,PPARG,ATR",DisGeNET
1706,Mental impairment,0.16830802307557988,1.762743248436572,3.1411370910914576,0.4157074025671033,"MEF2C,DSTYK,PIK3CA,ATR,DDB2",DisGeNET
1707,Obesity,0.16952766490332097,1.1890920198549064,2.1103281614343556,0.4157074025671033,"FTO,BLK,CEBPA,LEPROT,IL1RN,TFRC,CD82,EPAS1,HFE,LPL,PPP2R2A,PCSK7,PLD1,MRPL33,HK1,HELZ2,FADS2,CCND2,PRDM16,LEPR,NLRP3,APOE,APOB,JAK2,PLTP,IL6R,PTPN1,GCKR,IL37,GALNT2,DUSP1,TFEB,CPT1B,RHOA,SIRT3,MSRA,AHI1,TF,KITLG,PIK3CA,KIT,PPARG,TRIB1",DisGeNET
1708,"Condition, Preneoplastic",0.16973388555725094,1.915530303030303,3.39723790680724,0.4157074025671033,"CEBPA,ALDH2,CDH1,TNK2",DisGeNET
1709,Elevated hepatic transaminases,0.16973388555725094,1.915530303030303,3.39723790680724,0.4157074025671033,"HADHA,HFE,JAK2,TYMP",DisGeNET
1710,Experimental Organism Basal Cell Carcinoma,0.16994668460514456,1.5268071485729529,2.7059152855382305,0.4157074025671033,"TLR1,PDGFRA,TERT,PIK3CA,APOE,ATR,SIRT3,TYMP",DisGeNET
1711,Spondylarthritis,0.1711298670427318,2.187311178247734,3.8613316294113096,0.4157074025671033,"IL37,HFE,IL6R",DisGeNET
1712,"Pleural Effusion, Malignant",0.1711298670427318,2.187311178247734,3.8613316294113096,0.4157074025671033,"TLR1,TERT,APOE",DisGeNET
1713,Thin skin,0.1711298670427318,2.187311178247734,3.8613316294113096,0.4157074025671033,"SLC39A13,PPARG,DDB2",DisGeNET
1714,Distal limb muscle weakness due to peripheral neuropathy,0.1711298670427318,2.187311178247734,3.8613316294113096,0.4157074025671033,"FIG4,HK1,TYMP",DisGeNET
1715,Poor speech,0.1711298670427318,2.187311178247734,3.8613316294113096,0.4157074025671033,"KANSL1,PRDM16,MAPT",DisGeNET
1716,Rectal Neoplasms,0.1711298670427318,2.187311178247734,3.8613316294113096,0.4157074025671033,"PIK3CA,CDH1,PPARG",DisGeNET
1717,Pancreatic Ductal Adenocarcinoma,0.17280220603696558,1.3143505451325475,2.307483880065296,0.4157074025671033,"CEBPA,GADD45A,DUSP1,EPAS1,PPP2R2A,CCND3,KITLG,PTPRC,PIK3CA,TERT,CDH1,AXL,DLG5,LONP1,PPARG,CPEB4,ATR",DisGeNET
1718,Carcinoma breast stage IV,0.17284991986074386,1.4439517765026373,2.5346141478763524,0.4157074025671033,"FTO,RRM1,PIK3CA,CD82,CDH1,MPG,MAPT,CTSB,TYMP,HK1",DisGeNET
1719,Germ cell tumor,0.1729789426683207,1.6440548780487805,2.8846347032056068,0.4157074025671033,"KITLG,CCND2,TERT,KIT,LPL,PPP2R2A",DisGeNET
1720,Peripheral Arterial Diseases,0.17359162212964624,1.742539375518099,3.0512731161580446,0.4157074025671033,"BMP8A,LPL,APOE,APOB,JAK2",DisGeNET
1721,Reperfusion Injury,0.17600139071984627,1.8858741258741258,3.2762600622401497,0.4157074025671033,"HSPA8,TERT,PPARG,IL6R",DisGeNET
1722,Psoriasis vulgaris,0.17600139071984627,1.8858741258741258,3.2762600622401497,0.4157074025671033,"IL1RN,IL37,APOE,UBE2L3",DisGeNET
1723,"46,XY partial gonadal dysgenesis",0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,MAP3K1,DisGeNET
1724,Recurrent paroxysmal headache,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,MAX,DisGeNET
1725,"Charcot-Marie-Tooth Disease, Type Ib",0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,FIG4,DisGeNET
1726,Ridged nails,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,TERT,DisGeNET
1727,Secondary malignant neoplasm of skin,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,KIT,DisGeNET
1728,Senile Paranoid Dementia,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,MAPT,DisGeNET
1729,"Familial Partial Lipodystrophy, Type 3",0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,PPARG,DisGeNET
1730,"Gonadal Dysgenesis, 45,X",0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,BCL2L11,DisGeNET
1731,Sex reversal,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,MAP3K1,DisGeNET
1732,"Hypoalphalipoproteinemia, Familial",0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,APOB,DisGeNET
1733,Sinus Tachycardia,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,MAX,DisGeNET
1734,Slow decrease in visual acuity,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,RP1L1,DisGeNET
1735,Splanchnic vein thrombosis,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,JAK2,DisGeNET
1736,Spoken Word Recognition Deficit,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,MAPT,DisGeNET
1737,"Nevus, Blue",0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,KIT,DisGeNET
1738,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Gastric-Type",0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,CDH1,DisGeNET
1739,Strudwick syndrome,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,MAPT,DisGeNET
1740,Subacute Bacterial Endocarditis,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,JAK2,DisGeNET
1741,Subglottic stenosis,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,SNIP1,DisGeNET
1742,"Primitive reflexes (palmomental, snout, glabellar)",0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,MAPT,DisGeNET
1743,Supraventricular tachycardia,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,JAK2,DisGeNET
1744,Temporal cortical atrophy,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,MAPT,DisGeNET
1745,Testicular regression syndrome,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,MAP3K1,DisGeNET
1746,"Xeroderma pigmentosum, group G",0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,RRM1,DisGeNET
1747,Abdominal Neoplasms,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,PIK3CA,DisGeNET
1748,Abdominal wall muscle weakness,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,MAP2K2,DisGeNET
1749,Abnormality of internal carotid artery,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,APOB,DisGeNET
1750,Ubiquinone dehydrogenase deficiency,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,HK1,DisGeNET
1751,Abnormality of the genital system,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,RPS28,DisGeNET
1752,Abnormality of the intestine,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,TMPRSS6,DisGeNET
1753,Abnormality of the labia,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,MAP3K1,DisGeNET
1754,Abnormality of the optic nerve,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,ASXL1,DisGeNET
1755,Abnormality of the penis,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,PIK3CA,DisGeNET
1756,Abnormality of the reproductive system,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,RPS28,DisGeNET
1757,Abnormality of the scrotum,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,MAP3K1,DisGeNET
1758,Abnormality of the ulna,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,MAP2K2,DisGeNET
1759,Variegate Porphyria,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,HFE,DisGeNET
1760,Vaso-Occlusive Crisis,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,TERT,DisGeNET
1761,Very Low Birth Weight,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,HSPA8,DisGeNET
1762,Acute lymphoblastic leukemia with lymphomatous features,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,JAK2,DisGeNET
1763,Acute Myeloid Leukemia with Myelodysplasia-Related Changes,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,ASXL1,DisGeNET
1764,Acute recurrent pancreatitis,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,LPL,DisGeNET
1765,White eyebrow,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,KIT,DisGeNET
1766,Wide cranial sutures,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,FIG4,DisGeNET
1767,Adult-Onset Dystonias,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,ALDH5A1,DisGeNET
1768,Alcohol Withdrawal Seizures,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,APOE,DisGeNET
1769,ALZHEIMER DISEASE 5,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,NLRP3,DisGeNET
1770,anaphylaxis,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,NLRP3,DisGeNET
1771,Anisocytosis,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,TMPRSS6,DisGeNET
1772,Apparent mineralocorticoid excess,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,CEBPA,DisGeNET
1773,Asymmetric overgrowth,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,PIK3CA,DisGeNET
1774,B Lymphoblastic Lymphoma,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,PTPRC,DisGeNET
1775,Blonde eyebrow,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,KIT,DisGeNET
1776,body fat percentage (physical finding),0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,FTO,DisGeNET
1777,Central areolar choroidal sclerosis,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,TST,DisGeNET
1778,Cerebral artery atherosclerosis,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,APOB,DisGeNET
1779,Cerebral Atherosclerosis,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,APOE,DisGeNET
1780,Cerebral Vasospasm,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,APOE,DisGeNET
1781,Childhood Hodgkin Lymphoma,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,GYPA,DisGeNET
1782,Chromosome 1p36 Deletion Syndrome,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,PRDM16,DisGeNET
1783,CHROMOSOME 8p11 MYELOPROLIFERATIVE SYNDROME,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,PDGFRA,DisGeNET
1784,clinical depression,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,APOE,DisGeNET
1785,Conjunctival hamartoma,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,PIK3CA,DisGeNET
1786,Constitutional delay of growth and puberty,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,LEPR,DisGeNET
1787,Cystadenofibroma,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,PIK3CA,DisGeNET
1788,Cytochrome C oxidase-negative muscle fibers,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,TYMP,DisGeNET
1789,Decreased serum leptin,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,LEPR,DisGeNET
1790,Dementia due to Alzheimer's disease (disorder),0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,APOE,DisGeNET
1791,Dengue Shock Syndrome,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,IL1RN,DisGeNET
1792,Deposits immunoreactive to beta-amyloid protein,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,TOMM40,DisGeNET
1793,Diabetes mellitus autosomal dominant type II (disorder),0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,GCKR,DisGeNET
1794,Digestive System Disorders,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,PPARG,DisGeNET
1795,Dilation of lateral ventricles,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,GCDH,DisGeNET
1796,Disorder of vein,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,BLOC1S2,DisGeNET
1797,Dubowitz syndrome,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,ATR,DisGeNET
1798,Elevated urinary dopamine,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,MAX,DisGeNET
1799,Enterochromaffin-like cell carcinoid,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,PIK3CA,DisGeNET
1800,Erythrocytosis,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,JAK2,DisGeNET
1801,Extravasation of Contrast Media,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,IL1RN,DisGeNET
1802,Extravasation of Diagnostic and Therapeutic Materials,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,IL1RN,DisGeNET
1803,Familial hypercholesterolemia - homozygous,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,APOB,DisGeNET
1804,Female Pseudo-Turner Syndrome,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,MAP2K2,DisGeNET
1805,Genital ulcers,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,APOE,DisGeNET
1806,Glycogen Storage Disease Type VI,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,JAK2,DisGeNET
1807,Grammar-specific speech disorder,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,MAPT,DisGeNET
1808,Grey eyebrow,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,KIT,DisGeNET
1809,Hallermann's Syndrome,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,APOE,DisGeNET
1810,Hereditary Neurodegenerative Disorder,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,MAPT,DisGeNET
1811,HIV-Associated Lipodystrophy Syndrome,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,PPARG,DisGeNET
1812,Horizontal eyebrow,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,PRDM16,DisGeNET
1813,Hyaline Membrane Disease,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,EPAS1,DisGeNET
1814,Hypersensitive syndrome,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,APOE,DisGeNET
1815,Hypopharyngeal Cancer,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,ETS2,DisGeNET
1816,Idiopathic familial dystonia,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,ALDH5A1,DisGeNET
1817,INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE AND FRONTOTEMPORAL DEMENTIA,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,APOE,DisGeNET
1818,Indolent Systemic Mastocytosis,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,KIT,DisGeNET
1819,Intestinal adenocarcinoma,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,CDH1,DisGeNET
1820,Isovaleryl-CoA dehydrogenase deficiency,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,PIK3CA,DisGeNET
1821,Juvenile pauciarticular chronic arthritis,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,IL2RB,DisGeNET
1822,Laryngeal dystonia,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,KCTD17,DisGeNET
1823,Liquid Tumor,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,PIK3CA,DisGeNET
1824,Loss of ability to walk,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,ADAR,DisGeNET
1825,Lymphohistiocytosis,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,PTPRC,DisGeNET
1826,Malignant neoplasm of body of pancreas,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,APOE,DisGeNET
1827,malignant neoplasm of head of pancreas,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,APOE,DisGeNET
1828,Malignant neoplasm of other specified sites of pancreas,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,APOE,DisGeNET
1829,Malignant neoplasm of tail of pancreas,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,APOE,DisGeNET
1830,Marek Disease,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,TERT,DisGeNET
1831,Medullary cystic disease,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,NPHP3,DisGeNET
1832,Medullary cystic kidney disease 1,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,NPHP3,DisGeNET
1833,Megalencephaly cutis marmorata telangiectatica congenita,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,PIK3CA,DisGeNET
1834,Melanosis,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,ALDH2,DisGeNET
1835,Melanosis coli,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,ALDH2,DisGeNET
1836,Merkel Cell Polyomavirus Infection,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,KIT,DisGeNET
1837,Microvillus inclusion disease,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,RAB8A,DisGeNET
1838,Mixed sensory-motor polyneuropathy,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,TYMP,DisGeNET
1839,Mowat-Wilson syndrome,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,MEF2C,DisGeNET
1840,Myocardial steatosis,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,APOB,DisGeNET
1841,Myotonic Disorders,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,MAPT,DisGeNET
1842,NEPHRONOPHTHISIS 2,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,NPHP3,DisGeNET
1843,Neurologic Manifestations,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,ALDH5A1,DisGeNET
1844,Non-Hereditary Clear Cell Renal Cell Carcinoma,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,EPAS1,DisGeNET
1845,Oligoarticular Arthritis,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,IL1RN,DisGeNET
1846,Overweight and obesity,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,FTO,DisGeNET
1847,Pediatric Crohn's disease,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,DLG5,DisGeNET
1848,Pharyngeal Neoplasms,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,PIK3CA,DisGeNET
1849,Popliteal pterygium syndrome,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,FBXO7,DisGeNET
1850,Potassium aggravated myotonia,0.17616084684518224,6.10990990990991,10.608989721849268,0.4157074025671033,PIK3CA,DisGeNET
1851,Rheumatic Heart Disease,0.1762893359481075,2.7809419496166483,4.8266826037987975,0.4157074025671033,"IL1RN,DUSP1",DisGeNET
1852,Salmonella infections,0.1762893359481075,2.7809419496166483,4.8266826037987975,0.4157074025671033,"ABCC2,ADAR",DisGeNET
1853,Sandal gap,0.1762893359481075,2.7809419496166483,4.8266826037987975,0.4157074025671033,"PIK3CA,ATR",DisGeNET
1854,"Epilepsy, Rolandic",0.1762893359481075,2.7809419496166483,4.8266826037987975,0.4157074025671033,"SNIP1,CTSB",DisGeNET
1855,Sparse eyelashes,0.1762893359481075,2.7809419496166483,4.8266826037987975,0.4157074025671033,"KANK2,FIG4",DisGeNET
1856,Thyroiditis,0.1762893359481075,2.7809419496166483,4.8266826037987975,0.4157074025671033,"THRB,PIK3CA",DisGeNET
1857,Toxoplasmosis,0.1762893359481075,2.7809419496166483,4.8266826037987975,0.4157074025671033,"TFRC,CTSB",DisGeNET
1858,ACTH-Secreting Pituitary Adenoma,0.1762893359481075,2.7809419496166483,4.8266826037987975,0.4157074025671033,"CDH1,PPARG",DisGeNET
1859,Carcinoma testes,0.1762893359481075,2.7809419496166483,4.8266826037987975,0.4157074025671033,"KITLG,TERT",DisGeNET
1860,Cone-shaped epiphysis,0.1762893359481075,2.7809419496166483,4.8266826037987975,0.4157074025671033,"NSMCE2,ATR",DisGeNET
1861,Conjunctivitis,0.1762893359481075,2.7809419496166483,4.8266826037987975,0.4157074025671033,"NLRP3,DDB2",DisGeNET
1862,Defective or absent horizontal voluntary eye movements,0.1762893359481075,2.7809419496166483,4.8266826037987975,0.4157074025671033,"AHI1,KIAA0586",DisGeNET
1863,Early gastric cancer,0.1762893359481075,2.7809419496166483,4.8266826037987975,0.4157074025671033,"IL1RN,RHOA",DisGeNET
1864,End Stage Liver Disease,0.1762893359481075,2.7809419496166483,4.8266826037987975,0.4157074025671033,"IL1RN,HFE",DisGeNET
1865,Ewings sarcoma-primitive neuroectodermal tumor (PNET),0.1762893359481075,2.7809419496166483,4.8266826037987975,0.4157074025671033,"PDGFRA,KIT",DisGeNET
1866,Flushing,0.1762893359481075,2.7809419496166483,4.8266826037987975,0.4157074025671033,"ALDH2,MAX",DisGeNET
1867,Large cell neuroendocrine carcinoma,0.1762893359481075,2.7809419496166483,4.8266826037987975,0.4157074025671033,"KITLG,KIT",DisGeNET
1868,Mediastinal (Thymic) Large B-Cell Lymphoma,0.1762893359481075,2.7809419496166483,4.8266826037987975,0.4157074025671033,"PIK3CA,JAK2",DisGeNET
1869,Mitochondrial abnormalities,0.1762893359481075,2.7809419496166483,4.8266826037987975,0.4157074025671033,"HADHA,TYMP",DisGeNET
1870,Oestrogen deficiency,0.1762893359481075,2.7809419496166483,4.8266826037987975,0.4157074025671033,"TERT,APOE",DisGeNET
1871,Pulmonary Cystic Fibrosis,0.1762893359481075,2.7809419496166483,4.8266826037987975,0.4157074025671033,"TLR1,PPARG",DisGeNET
1872,Simple Partial Status Epilepticus,0.1790577909998144,2.136232698658048,3.674419940740421,0.4197677863396287,"IL1RN,MEF2C,ABCC2",DisGeNET
1873,Situs Inversus,0.1790577909998144,2.136232698658048,3.674419940740421,0.4197677863396287,"TLR1,CITED2,NPHP3",DisGeNET
1874,Testicular Neoplasms,0.1790577909998144,2.136232698658048,3.674419940740421,0.4197677863396287,"KITLG,CCND2,KIT",DisGeNET
1875,"Status Epilepticus, Subclinical",0.1790577909998144,2.136232698658048,3.674419940740421,0.4197677863396287,"IL1RN,MEF2C,ABCC2",DisGeNET
1876,Comatose,0.1790577909998144,2.136232698658048,3.674419940740421,0.4197677863396287,"SLC25A15,HMGCL,APOE",DisGeNET
1877,Complex Partial Status Epilepticus,0.1790577909998144,2.136232698658048,3.674419940740421,0.4197677863396287,"IL1RN,MEF2C,ABCC2",DisGeNET
1878,Creutzfeldt-Jakob disease,0.1790577909998144,2.136232698658048,3.674419940740421,0.4197677863396287,"ZBTB38,MAPT,APOE",DisGeNET
1879,Grand Mal Status Epilepticus,0.1790577909998144,2.136232698658048,3.674419940740421,0.4197677863396287,"IL1RN,MEF2C,ABCC2",DisGeNET
1880,Motor neuron atrophy,0.1790577909998144,2.136232698658048,3.674419940740421,0.4197677863396287,"FIG4,PIK3CA,MAPT",DisGeNET
1881,MRSA - Methicillin resistant Staphylococcus aureus infection,0.1790577909998144,2.136232698658048,3.674419940740421,0.4197677863396287,"MSRA,TST,MAX",DisGeNET
1882,Non-Convulsive Status Epilepticus,0.1790577909998144,2.136232698658048,3.674419940740421,0.4197677863396287,"IL1RN,MEF2C,ABCC2",DisGeNET
1883,Rhabdomyosarcoma,0.1823084287109651,1.3982549957782155,2.3799074143776213,0.42679774889275457,"PDGFRA,MEF2C,KITLG,PTPRC,CCND2,TFRC,PIK3CA,TERT,KIT,JARID2,P4HTM",DisGeNET
1884,Alcohol abuse,0.1823467263515055,1.8571166207529843,3.1605252194047115,0.42679774889275457,"TF,ALDH2,HFE,APOE",DisGeNET
1885,liposarcoma,0.1823467263515055,1.8571166207529843,3.1605252194047115,0.42679774889275457,"PIK3CA,LEPR,PPARG,SPPL3",DisGeNET
1886,Encephalomyelitis,0.18284298177847144,1.4557408906882592,2.473489405749922,0.4277323624637413,"SLC25A37,IL1RN,PTPRC,DUSP1,KIT,IL2RB,NLRP3,PPARG,APOE",DisGeNET
1887,Choriocarcinoma,0.18550525840911902,1.4891987358245027,2.508811487313782,0.42901299041708935,"CCND2,TERT,PIK3CA,PPARG,HSD17B13,MAPT,JAK2,ETS2",DisGeNET
1888,Generalized hypotonia,0.1858827334289556,1.3203761755485894,2.2217168035319594,0.42901299041708935,"CEP57,GCDH,MEF2C,PGAP3,ASXL1,FIG4,SLC25A15,HADHA,AHI1,ALDH5A1,KANSL1,PIK3CA,KIAA0586,LONP1,SNIP1",DisGeNET
1889,Retinitis Pigmentosa,0.18641287636912035,1.4167662285941856,2.3798715847606027,0.42901299041708935,"RP1L1,HADHA,AHI1,PTPRC,TST,ZBTB38,NPHP3,APOB,RAB8A,HK1",DisGeNET
1890,Shy-Drager Syndrome,0.18708394837205428,2.0874759681406205,3.499022711118496,0.42901299041708935,"MAPT,APOE,FBXO7",DisGeNET
1891,"Myoclonic Epilepsies, Progressive",0.18708394837205428,2.0874759681406205,3.499022711118496,0.42901299041708935,"SLC25A15,ALDH5A1,CTSB",DisGeNET
1892,Bloom Syndrome,0.18708394837205428,2.0874759681406205,3.499022711118496,0.42901299041708935,"GYPA,NSMCE2,ATR",DisGeNET
1893,Chagas Disease,0.18708394837205428,2.0874759681406205,3.499022711118496,0.42901299041708935,"PIK3CA,PPARG,CTSB",DisGeNET
1894,Chronic granulomatous disease,0.18708394837205428,2.0874759681406205,3.499022711118496,0.42901299041708935,"ELF1,PRDM16,PPARG",DisGeNET
1895,Dysmorphic facies,0.18708394837205428,2.0874759681406205,3.499022711118496,0.42901299041708935,"GCDH,KLF13,SNIP1",DisGeNET
1896,Mucoepidermoid Carcinoma,0.18708394837205428,2.0874759681406205,3.499022711118496,0.42901299041708935,"IL1RN,CDH1,KIT",DisGeNET
1897,Alopecia,0.18720416157333328,1.6006892895015907,2.682043718099178,0.42901299041708935,"TLR1,IL1RN,ABCC2,TERT,HFE,ATR",DisGeNET
1898,Cerebrovascular Disorders,0.18720416157333328,1.6006892895015907,2.682043718099178,0.42901299041708935,"IL1RN,MEF2C,PIK3CA,LPL,APOE,APOB",DisGeNET
1899,Sparse pubic hair,0.187826636372978,2.6597695128339445,4.447762034614779,0.42901299041708935,"MAP3K1,AXL",DisGeNET
1900,"Sleep Apnea, Central",0.187826636372978,2.6597695128339445,4.447762034614779,0.42901299041708935,"AHI1,APOE",DisGeNET
1901,Tracheoesophageal Fistula,0.187826636372978,2.6597695128339445,4.447762034614779,0.42901299041708935,"RTEL1,TERT",DisGeNET
1902,Varicella zoster,0.187826636372978,2.6597695128339445,4.447762034614779,0.42901299041708935,"TFRC,APOE",DisGeNET
1903,AIDS Dementia Complex,0.187826636372978,2.6597695128339445,4.447762034614779,0.42901299041708935,"PTPRC,APOE",DisGeNET
1904,Anti-Basement Membrane Glomerulonephritis,0.187826636372978,2.6597695128339445,4.447762034614779,0.42901299041708935,"IL1RN,DUSP1",DisGeNET
1905,Candidiasis,0.187826636372978,2.6597695128339445,4.447762034614779,0.42901299041708935,"TLR1,PLD1",DisGeNET
1906,Defective tooth enamel,0.187826636372978,2.6597695128339445,4.447762034614779,0.42901299041708935,"LONP1,ATR",DisGeNET
1907,Drug Allergy,0.187826636372978,2.6597695128339445,4.447762034614779,0.42901299041708935,"ABCC2,NLRP3",DisGeNET
1908,Dystrophic tooth enamel,0.187826636372978,2.6597695128339445,4.447762034614779,0.42901299041708935,"LONP1,ATR",DisGeNET
1909,Embryonal Neoplasm,0.187826636372978,2.6597695128339445,4.447762034614779,0.42901299041708935,"KITLG,PIK3CA",DisGeNET
1910,Facial asymmetry,0.187826636372978,2.6597695128339445,4.447762034614779,0.42901299041708935,"PIK3CA,ATR",DisGeNET
1911,Growth Disorders,0.187826636372978,2.6597695128339445,4.447762034614779,0.42901299041708935,"PIK3CA,HIST1H4C",DisGeNET
1912,Hematopoetic Myelodysplasia,0.187826636372978,2.6597695128339445,4.447762034614779,0.42901299041708935,"ASXL1,HFE",DisGeNET
1913,Infectious Otitis Media,0.187826636372978,2.6597695128339445,4.447762034614779,0.42901299041708935,"DUSP1,PLS1",DisGeNET
1914,Influenza due to Influenza A virus subtype H1N1,0.187826636372978,2.6597695128339445,4.447762034614779,0.42901299041708935,"SPRED2,BUD13",DisGeNET
1915,Metaphyseal widening,0.187826636372978,2.6597695128339445,4.447762034614779,0.42901299041708935,"NSMCE2,SLC39A13",DisGeNET
1916,Neuroblastoma,0.1887193284710295,1.188015419899478,1.9810090624381642,0.42901299041708935,"FTO,BLK,CEBPA,RTEL1,TFRC,CD82,MAX,EPAS1,HFE,ITSN1,TYMP,BCL2L11,CCND2,TERT,PSD4,MYB,LEPR,APOE,JAK2,IL6R,CTSB,HSPA8,PDGFRA,SMOX,TRPC1,PABPC4,MSRA,KITLG,PTPRC,XRN1,PIK3CA,KIT,IL2RB,SERPING1,PPARG,MAPT,ATR",DisGeNET
1917,Dry skin,0.1887666700976493,1.8292175486205338,3.049751207692878,0.42901299041708935,"MAP2K2,TERT,KANSL1,DDB2",DisGeNET
1918,Glomerulosclerosis (disorder),0.1887666700976493,1.8292175486205338,3.049751207692878,0.42901299041708935,"MAX,NLRP3,PPARG,APOE",DisGeNET
1919,Medulloblastoma,0.19132101356981002,1.3126068680535765,2.170792601826205,0.42901299041708935,"BRD3,PDGFRA,MAP2K2,TFRC,MPG,MAX,TF,CCND2,PIK3CA,TERT,CDH1,KIT,IL2RB,PPARG,CTSB",DisGeNET
1920,Acute myocardial infarction,0.1915419633074469,1.5238250157242934,2.518346920514666,0.42901299041708935,"PIK3CA,HFE,LPL,NLRP3,PPARG,APOE,APOB",DisGeNET
1921,Diabetes,0.19241134446854283,1.2109156877060243,1.9957340962812138,0.42901299041708935,"FTO,BLK,TAGLN,GYPA,IL1RN,TOMM40,GYPE,HFE,LPL,ALDH2,LEPR,LONP1,NLRP3,STX4,APOE,APOB,SH2B3,PLTP,IL6R,PTPN1,GCKR,BTN2A1,BCL11A,KITLG,PIK3CA,IL2RB,PPARG,MAPT,ZNF410",DisGeNET
1922,Osteoporosis,0.1934326024449667,1.3572341980270368,2.229699811785034,0.42901299041708935,"FTO,IL1RN,MAP3K1,ALDH2,TERT,IL37,HFE,KIT,LEPR,PPARG,APOE,IL6R",DisGeNET
1923,Rhabdomyolysis,0.19520168016594044,2.040886203423968,3.3342406851988353,0.42901299041708935,"HADHA,CPT1B,TYMP",DisGeNET
1924,Stereotypic Movement Disorder,0.19520168016594044,2.040886203423968,3.3342406851988353,0.42901299041708935,"MEF2C,PRDM16,MAPT",DisGeNET
1925,Cockayne Syndrome,0.19520168016594044,2.040886203423968,3.3342406851988353,0.42901299041708935,"GYPA,RTEL1,ATR",DisGeNET
1926,Learning Disabilities,0.19520168016594044,2.040886203423968,3.3342406851988353,0.42901299041708935,"IL1RN,ALDH5A1,MAPT",DisGeNET
1927,Weight Gain,0.19525798515487663,1.8021390374331552,2.943674444835606,0.42901299041708935,"FTO,RPS28,PIK3CA,MAPT",DisGeNET
1928,polyps,0.19756197636581185,1.4621676891615543,2.371201639530944,0.42901299041708935,"TLR1,PDGFRA,ALDH2,PIK3CA,CDH1,HFE,KIT,PPARG",DisGeNET
1929,Metastatic melanoma,0.19873513931685796,1.3692608515812035,2.212427446665653,0.42901299041708935,"PDGFRA,KITLG,PIK3CA,CD82,KIT,FLOT2,ADAR,JAK2,EPHB4,TM9SF4,CTSB",DisGeNET
1930,Rotavirus Infections,0.1994641886930714,2.548694779116466,4.108803264933942,0.42901299041708935,"HSPA8,NLRP3",DisGeNET
1931,"Dysautonomia, Familial",0.1994641886930714,2.548694779116466,4.108803264933942,0.42901299041708935,"BCL2L11,APOE",DisGeNET
1932,Skin lesion,0.1994641886930714,2.548694779116466,4.108803264933942,0.42901299041708935,"HFE,DMKN",DisGeNET
1933,Stage IV Ovarian Carcinoma,0.1994641886930714,2.548694779116466,4.108803264933942,0.42901299041708935,"PIK3CA,AXL",DisGeNET
1934,Tooth Abnormalities,0.1994641886930714,2.548694779116466,4.108803264933942,0.42901299041708935,"LONP1,SLC39A13",DisGeNET
1935,Cancer of Urinary Tract,0.1994641886930714,2.548694779116466,4.108803264933942,0.42901299041708935,"PIK3CA,ATR",DisGeNET
1936,Cleft Lip with or without Cleft Palate,0.1994641886930714,2.548694779116466,4.108803264933942,0.42901299041708935,"CDH1,JARID2",DisGeNET
1937,Decreased nerve conduction velocity,0.1994641886930714,2.548694779116466,4.108803264933942,0.42901299041708935,"FIG4,SLC25A15",DisGeNET
1938,exudative macular degeneration,0.1994641886930714,2.548694779116466,4.108803264933942,0.42901299041708935,"ARHGAP21,APOE",DisGeNET
1939,Freckles,0.1994641886930714,2.548694779116466,4.108803264933942,0.42901299041708935,"TERT,DDB2",DisGeNET
1940,Hyperlipoproteinemias,0.1994641886930714,2.548694779116466,4.108803264933942,0.42901299041708935,"LPL,APOE",DisGeNET
1941,Intracranial Hypertension,0.1994641886930714,2.548694779116466,4.108803264933942,0.42901299041708935,"PIK3CA,NLRP3",DisGeNET
1942,Laryngeal neoplasm,0.1994641886930714,2.548694779116466,4.108803264933942,0.42901299041708935,"TERT,CDH1",DisGeNET
1943,Macrocephaly,0.1994641886930714,2.548694779116466,4.108803264933942,0.42901299041708935,"CCND2,PIK3CA",DisGeNET
1944,Malignant neoplasm of pharynx,0.1994641886930714,2.548694779116466,4.108803264933942,0.42901299041708935,"ALDH2,PIK3CA",DisGeNET
1945,Neoplasm of uncertain or unknown behavior of ovary,0.1994641886930714,2.548694779116466,4.108803264933942,0.42901299041708935,"PIK3CA,ATR",DisGeNET
1946,Polydactyly,0.20091920579805864,1.6480373892865314,2.644856780803274,0.42901299041708935,"AHI1,CCND2,PIK3CA,KIAA0586,NPHP3",DisGeNET
1947,Thrombocytopenia,0.2015118673704414,1.4177041420118344,2.2710301949593252,0.42901299041708935,"ASXL1,NFE2,PDGFRA,RTEL1,RRM1,TERT,FLOT2,APOE,JAK2",DisGeNET
1948,"Neuroectodermal Tumor, Primitive",0.2018174251552911,1.7758454106280193,2.842048479678181,0.42901299041708935,"PDGFRA,KIT,IL2RB,CTSB",DisGeNET
1949,Tauopathies,0.2018174251552911,1.7758454106280193,2.842048479678181,0.42901299041708935,"HSPA8,LEPR,APOE,MAPT",DisGeNET
1950,M5b Acute differentiated monocytic leukemia,0.2018174251552911,1.7758454106280193,2.842048479678181,0.42901299041708935,"CEBPA,TFRC,LPL,PPARG",DisGeNET
1951,Colorectal cancer metastatic,0.20186819977294337,1.5595287308805292,2.4954647259197373,0.42901299041708935,"RRM1,PTPRC,PIK3CA,DUSP1,CDH1,TYMP",DisGeNET
1952,Recurrent hepatitis,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,APOE,DisGeNET
1953,Recurrent seizures,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,IL1RN,DisGeNET
1954,Redundant neck skin,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,FIG4,DisGeNET
1955,Relapsing Fever,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,NLRP3,DisGeNET
1956,"Arterial Diseases, Common Carotid",0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,APOE,DisGeNET
1957,response to anticoagulant,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,STX4,DisGeNET
1958,"Breast Cancer, Familial Male",0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,PIK3CA,DisGeNET
1959,"Cirrhosis, Cryptogenic",0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,HFE,DisGeNET
1960,"Clinically Isolated Syndrome, CNS Demyelinating",0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,QKI,DisGeNET
1961,Round cell liposarcoma,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,PIK3CA,DisGeNET
1962,"Congenital dyserythropoietic anemia, type II",0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,TFRC,DisGeNET
1963,Sendai virus infection,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,NLRP3,DisGeNET
1964,"Familial Partial Lipodystrophy, Type 1",0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,PPARG,DisGeNET
1965,Sensory polyneuropathy,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,TYMP,DisGeNET
1966,"Gaucher Disease, Type 1",0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,HFE,DisGeNET
1967,"Gonadal Dysgenesis, 46,XY",0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,MAP3K1,DisGeNET
1968,Sex hormone binding globulin measurement,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,GCKR,DisGeNET
1969,"Hyper-Immunoglobulin E Syndrome, Autosomal Dominant",0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,IL1RN,DisGeNET
1970,Sick Headaches,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,PRDM16,DisGeNET
1971,Sinonasal undifferentiated carcinoma,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,KIT,DisGeNET
1972,SPINOCEREBELLAR ATAXIA 17,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,HSPA8,DisGeNET
1973,Status Migrainosus,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,PRDM16,DisGeNET
1974,"Pemphigoid, Benign Mucous Membrane",0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,IL1RN,DisGeNET
1975,Subaortic stenosis,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,CEP57,DisGeNET
1976,Subependymal Glioma,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,PDGFRA,DisGeNET
1977,"Post-transplant lymphoproliferative disorder, polymorphic",0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,RTEL1,DisGeNET
1978,"Restrictive behavior, interests, and activities",0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,MAPT,DisGeNET
1979,Thick skull bones,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,PIK3CA,DisGeNET
1980,Abdominal Migraine,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,PRDM16,DisGeNET
1981,Abnormal social behavior,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,TOMM40,DisGeNET
1982,Abnormal social interactions,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,TOMM40,DisGeNET
1983,Tumor thrombus,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,TYMP,DisGeNET
1984,Abnormality of the cerebral vasculature,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,PIK3CA,DisGeNET
1985,Absent earlobe,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,ATR,DisGeNET
1986,Vascular Endothelial Growth Factor Measurement,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,MEF2C,DisGeNET
1987,Acanthocytosis,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,APOB,DisGeNET
1988,Acute blood cancer,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,JAK2,DisGeNET
1989,Acute Confusional Migraine,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,PRDM16,DisGeNET
1990,Waardenburg Syndrome Type 2,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,KITLG,DisGeNET
1991,Wernicke Encephalopathy,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,MAPT,DisGeNET
1992,White eyelashes,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,KIT,DisGeNET
1993,Wooly hair,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,KANK2,DisGeNET
1994,Adenosquamous cell lung cancer,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,PIK3CA,DisGeNET
1995,Xanthoma tendinosum,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,APOE,DisGeNET
1996,Afro-textured hair,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,KANK2,DisGeNET
1997,Alexia,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,MAPT,DisGeNET
1998,Alpers Syndrome (disorder),0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,TYMP,DisGeNET
1999,Altitude Sickness,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,EPAS1,DisGeNET
2000,Angioedema,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,SERPING1,DisGeNET
2001,Aplasia/Hypoplasia of the nipples,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,FIG4,DisGeNET
2002,Autoinflammatory disease,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,NLRP3,DisGeNET
2003,Axonal loss,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,FIG4,DisGeNET
2004,Blunted affect,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,MAPT,DisGeNET
2005,Bone marrow myeloid dysplasia,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,TFRC,DisGeNET
2006,Breast size,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,FTO,DisGeNET
2007,Brenner Tumor,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,PIK3CA,DisGeNET
2008,Cardio-facio-cutaneous syndrome,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,MAP2K2,DisGeNET
2009,Central Precocious Puberty,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,LEPR,DisGeNET
2010,Cervical Migraine Syndrome,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,PRDM16,DisGeNET
2011,Childhood Ependymoma,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,PIK3CA,DisGeNET
2012,Chromosomal Instability,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,PPP2R2A,DisGeNET
2013,Citrullinemia,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,SLC25A37,DisGeNET
2014,Complex Regional Pain Syndromes,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,IL1RN,DisGeNET
2015,Congenital euryblepharon,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,CDH1,DisGeNET
2016,Coronal cleft vertebrae,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,LONP1,DisGeNET
2017,Cranial hyperostosis,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,PIK3CA,DisGeNET
2018,De Toni-Debre-Fanconi Syndrome,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,ABCC2,DisGeNET
2019,Decreased vibratory sense,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,SLC25A15,DisGeNET
2020,Demyelination,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,QKI,DisGeNET
2021,Desmoplastic melanoma,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,KIT,DisGeNET
2022,Disorder of endocrine ovary,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,PPARG,DisGeNET
2023,Ductal Carcinoma In Situ with Microinvasion,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,PIK3CA,DisGeNET
2024,Dysglycemia,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,ALDH2,DisGeNET
2025,Dysthymic Disorder,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,IL1RN,DisGeNET
2026,Eccrine dermal cylindroma,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,MYB,DisGeNET
2027,EEG with continuous slow activity,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,MAPT,DisGeNET
2028,Enlargement of skull bones,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,PIK3CA,DisGeNET
2029,Entropion,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,DDB2,DisGeNET
2030,Erosive esophagitis,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,IL1RN,DisGeNET
2031,Excessive growth of skull bones,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,PIK3CA,DisGeNET
2032,External Carotid Artery Diseases,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,APOE,DisGeNET
2033,extranodal lymphoma,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,RTEL1,DisGeNET
2034,Familial Epilepsies,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,FIG4,DisGeNET
2035,Fibromatosis,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,KIT,DisGeNET
2036,Flaccid Muscle Tone,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,KANSL1,DisGeNET
2037,Gastroparesis,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,TYMP,DisGeNET
2038,Generalized neonatal hypotonia,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,FIG4,DisGeNET
2039,Genital Herpes,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,APOE,DisGeNET
2040,Grey eyelashes,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,KIT,DisGeNET
2041,Hashimoto's encephalitis,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,NLRP3,DisGeNET
2042,Head circumference small for gestational age,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,FIG4,DisGeNET
2043,Hemicrania migraine,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,PRDM16,DisGeNET
2044,Hemoglobin F Disease,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,TFRC,DisGeNET
2045,Hereditary Autoinflammatory Diseases,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,NLRP3,DisGeNET
2046,Hereditary Connective Tissue Disorder,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,SLC39A13,DisGeNET
2047,Histiocytosis,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,PTPRC,DisGeNET
2048,HODGKIN'S AND NON-HODGKIN'S LYMPHOMA,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,RTEL1,DisGeNET
2049,Homozygous alpha thalassemia,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,HBZ,DisGeNET
2050,Hypertrophy of cranial bones,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,PIK3CA,DisGeNET
2051,Hypoadiponectinemia,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,PPARG,DisGeNET
2052,Hypocupremia,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,TMPRSS6,DisGeNET
2053,Hypoplasia of the pons,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,DOCK7,DisGeNET
2054,Hypoplastic anemia,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,TERT,DisGeNET
2055,Increased size of palpebral fissures,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,ATR,DisGeNET
2056,Infection in children,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,LEPR,DisGeNET
2057,Internal Carotid Artery Diseases,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,APOE,DisGeNET
2058,Kabuki syndrome eyelids,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,CDH1,DisGeNET
2059,Kinky hair texture,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,KANK2,DisGeNET
2060,Lack of insight,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,MAPT,DisGeNET
2061,Large eyes,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,ATR,DisGeNET
2062,Lentivirus Infections,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,APOB,DisGeNET
2063,Leukostasis,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,PPARG,DisGeNET
2064,Lipoatrophic Diabetes Mellitus,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,PPARG,DisGeNET
2065,Lymphoepithelial carcinoma,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,PIK3CA,DisGeNET
2066,Malignant tumor of parathyroid gland,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,TERT,DisGeNET
2067,Metastases to adrenals,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,PIK3CA,DisGeNET
2068,Nappy hair texture,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,KANK2,DisGeNET
2069,Nasopharyngeal Angiofibroma,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,KIT,DisGeNET
2070,Paraganglioma of head and neck,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,MAX,DisGeNET
2071,Parainfluenza,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,TLR1,DisGeNET
2072,Pediatric Neoplasm,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,PDGFRA,DisGeNET
2073,Persistent cavum septum pellucidum,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,PIK3CA,DisGeNET
2074,Phosphate Diabetes,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,SLC17A1,DisGeNET
2075,Pineal Gland Neoplasm,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,MAPT,DisGeNET
2076,Placental dysfunction,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,PPARG,DisGeNET
2077,Polygenic hypercholesterolemia,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,APOE,DisGeNET
2078,Precocious atherosclerosis,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,APOB,DisGeNET
2079,Premature plaque build-up in arteries,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,APOB,DisGeNET
2080,Prodrome,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,APOE,DisGeNET
2081,Proportionate short stature,0.20235177539845034,5.091091091091091,8.134278744250102,0.42901299041708935,ATR,DisGeNET
2082,Short philtrum,0.2034044104295907,1.9963220806515172,3.1792609201776654,0.4297989745284263,"FIG4,MEF2C,DOCK7",DisGeNET
2083,Stable angina,0.2034044104295907,1.9963220806515172,3.1792609201776654,0.4297989745284263,"ALDH2,TERT,APOE",DisGeNET
2084,Varicosity,0.2034044104295907,1.9963220806515172,3.1792609201776654,0.4297989745284263,"EPAS1,HFE,BLOC1S2",DisGeNET
2085,Angle class 2 malocclusion,0.2034044104295907,1.9963220806515172,3.1792609201776654,0.4297989745284263,"IL2RB,SLC39A13,ATR",DisGeNET
2086,Angle class 3 malocclusion,0.2034044104295907,1.9963220806515172,3.1792609201776654,0.4297989745284263,"IL2RB,SLC39A13,ATR",DisGeNET
2087,Hereditary gingival fibromatosis,0.2034044104295907,1.9963220806515172,3.1792609201776654,0.4297989745284263,"SLC25A37,PIK3CA,CTSB",DisGeNET
2088,Irritation - emotion,0.2034044104295907,1.9963220806515172,3.1792609201776654,0.4297989745284263,"GCDH,PIK3CA,MAPT",DisGeNET
2089,Peritonitis,0.2084417389278875,1.7503030303030302,2.744642666705652,0.4402321455959022,"DUSP1,NLRP3,PPARG,APOE",DisGeNET
2090,Renal tubular disorder,0.21118404556912293,2.4465060240963856,3.8043786951207514,0.4428441107656703,"ABCC2,SIRT3",DisGeNET
2091,"Carcinoma of urinary bladder, superficial",0.21118404556912293,2.4465060240963856,3.8043786951207514,0.4428441107656703,"TERT,CDH1",DisGeNET
2092,Rhabdoid Tumor of the Kidney,0.21118404556912293,2.4465060240963856,3.8043786951207514,0.4428441107656703,"PDGFRA,KIT",DisGeNET
2093,"Liposarcoma, Dedifferentiated",0.21118404556912293,2.4465060240963856,3.8043786951207514,0.4428441107656703,"CEBPA,EPAS1",DisGeNET
2094,"MYELOPROLIFERATIVE DISORDER, CHRONIC, WITH EOSINOPHILIA",0.21118404556912293,2.4465060240963856,3.8043786951207514,0.4428441107656703,"KIT,APOE",DisGeNET
2095,"Parkinsonism, Juvenile",0.21118404556912293,2.4465060240963856,3.8043786951207514,0.4428441107656703,"MAPT,FBXO7",DisGeNET
2096,"stage, ovarian epithelial cancer",0.21118404556912293,2.4465060240963856,3.8043786951207514,0.4428441107656703,"ABCC2,PIK3CA",DisGeNET
2097,Varicose Ulcer,0.21118404556912293,2.4465060240963856,3.8043786951207514,0.4428441107656703,"HFE,BLOC1S2",DisGeNET
2098,Antiphospholipid Syndrome,0.21118404556912293,2.4465060240963856,3.8043786951207514,0.4428441107656703,"PPARG,SH2B3",DisGeNET
2099,Cleft uvula,0.21118404556912293,2.4465060240963856,3.8043786951207514,0.4428441107656703,"FTO,SLC39A13",DisGeNET
2100,Clostridium; difficile (disorder),0.21118404556912293,2.4465060240963856,3.8043786951207514,0.4428441107656703,"MAX,IL37",DisGeNET
2101,Gastrointestinal Diseases,0.21118404556912293,2.4465060240963856,3.8043786951207514,0.4428441107656703,"ABCC2,MYB",DisGeNET
2102,Immunoblastic Large-Cell Lymphoma,0.21118404556912293,2.4465060240963856,3.8043786951207514,0.4428441107656703,"RTEL1,PTPRC",DisGeNET
2103,Mammary adenocarcinoma,0.21118404556912293,2.4465060240963856,3.8043786951207514,0.4428441107656703,"TFRC,PIK3CA",DisGeNET
2104,Memory Disorders,0.21118404556912293,2.4465060240963856,3.8043786951207514,0.4428441107656703,"APOE,MAPT",DisGeNET
2105,"Hip Dislocation, Congenital",0.2116856551833833,1.953654303528958,3.0333469481816007,0.44347441152378303,"KANSL1,LONP1,ATR",DisGeNET
2106,Attention Deficit Disorder,0.2116856551833833,1.953654303528958,3.0333469481816007,0.44347441152378303,"THRB,PIK3CA,APOE",DisGeNET
2107,Icterus,0.21223929978254336,1.613021916493361,2.500249892085898,0.4444232513718943,"SPTA1,THRB,ABCC2,LPL,HK1",DisGeNET
2108,Pediatric failure to thrive,0.2124941932163712,1.3109544967059905,2.0304595715785023,0.44474591103919814,"FTO,GCDH,RTEL1,SLC39A13,DDB2,ASXL1,SLC25A15,HADHA,KANSL1,PIK3CA,TERT,PRDM16,APOB",DisGeNET
2109,Neurodegenerative Disorders,0.21369278270161873,1.2616092128767435,1.9469353846175086,0.44704246433359024,"MPG,TRRAP,HFE,PABPC4,LPL,SIRT3,FIG4,MSRA,KITLG,PIK3CA,TDP2,PPARG,APOE,MAPT,FBXO7,CTSB,ATR",DisGeNET
2110,Hepatitis A,0.2139545757607968,1.4709061203971345,2.26812480745314,0.4473780039130974,"ABCC2,TFRC,TERT,IL37,HFE,LEPR,APOB",DisGeNET
2111,Turner Syndrome,0.2151276749735801,1.7254801536491677,2.6512409601924607,0.4489979342829885,"PTPN1,MAP3K1,KIT,MYO9B",DisGeNET
2112,CNS disorder,0.2151276749735801,1.7254801536491677,2.6512409601924607,0.4489979342829885,"MEF2C,NLRP3,PPARG,APOE",DisGeNET
2113,leiomyosarcoma,0.2151276749735801,1.7254801536491677,2.6512409601924607,0.4489979342829885,"PIK3CA,CDH1,AXL,KIT",DisGeNET
2114,Renal Cell Carcinoma,0.2159967899679889,1.1901029760738466,1.8238229718564103,0.4489979342829885,"KANK2,MACF1,THRB,TFRC,CD82,EPAS1,HFE,PCSK7,BCL2L11,TERT,CDH1,KDELC2,APOE,JAK2,IL6R,AP1M2,CTSB,RBM38,ABCC2,DUSP1,TNK2,TFEB,TLR1,KITLG,PIK3CA,AXL,KIT,PPARG,CNOT8",DisGeNET
2115,androgen independent prostate cancer,0.21797497000660154,1.5960612968591692,2.431399940777681,0.4489979342829885,"MEF2C,PIK3CA,TNK2,NCOA4,PPARG",DisGeNET
2116,Focal glomerulosclerosis,0.21797497000660154,1.5960612968591692,2.431399940777681,0.4489979342829885,"NUP205,TAGLN,LPL,PPARG,APOE",DisGeNET
2117,Memory impairment,0.2185497119482116,1.4607543323139653,2.2214301371654694,0.4489979342829885,"IL1RN,TOMM40,PTPRC,PPARG,APOE,MAPT,CTSB",DisGeNET
2118,"Cardiomyopathy, Dilated",0.21927458913857628,1.335980616502894,2.0272577387287734,0.4489979342829885,"HADHA,IL1RN,KITLG,ALDH2,PIK3CA,AXL,HFE,PRDM16,LPL,PPARG,CTSB",DisGeNET
2119,Conduction disorder of the heart,0.22003903062749322,1.9127643504531722,2.89583023186509,0.4489979342829885,"AKAP10,HFE,PRDM16",DisGeNET
2120,Crohn's disease of large bowel,0.22003903062749322,1.9127643504531722,2.89583023186509,0.4489979342829885,"NLRP3,PPARG,NKX2-3",DisGeNET
2121,Mucinous Adenocarcinoma,0.22003903062749322,1.9127643504531722,2.89583023186509,0.4489979342829885,"PIK3CA,TERT,TYMP",DisGeNET
2122,Paraganglioma,0.22003903062749322,1.9127643504531722,2.89583023186509,0.4489979342829885,"EPAS1,MAX,KIT",DisGeNET
2123,Chronic Obstructive Airway Disease,0.22090625326394667,1.2627640703112402,1.9067950374274298,0.4489979342829885,"FTO,PTPN1,GYPA,RRM1,IL1RN,EPAS1,TFEB,MYO1D,TOX2,ALDH2,PIK3CA,LEPR,PPARG,PDE7A,IL6R,ZNF410",DisGeNET
2124,Diabetes Mellitus,0.22153143064749886,1.1729636842708213,1.7678800742276413,0.4489979342829885,"FTO,BLK,CEBPA,TAGLN,GYPA,IL1RN,TOMM40,GYPE,HFE,LPL,ALDH2,TERT,LEPR,LONP1,NLRP3,STX4,APOE,APOB,SH2B3,PLTP,IL6R,CTSB,NFE2,PTPN1,GCKR,BTN2A1,BCL11A,KITLG,PIK3CA,IL2RB,PPARG,MAPT,ZNF410",DisGeNET
2125,Constipation,0.22204377839495104,1.507796881247501,2.269054451099722,0.4489979342829885,"PDGFRA,THRB,PIK3CA,PRDM16,KIT,TYMP",DisGeNET
2126,Thyroid Neoplasm,0.22261185643343878,1.3125704560022988,1.9719081691847253,0.4489979342829885,"CCND3,TF,CCND2,THRB,PIK3CA,TERT,CD82,CDH1,NCOA4,KIT,PPARG,CTSB",DisGeNET
2127,Tumors of Adrenal Cortex,0.22296929257000844,2.3521779425393885,3.529963348017771,0.4489979342829885,"CCND2,PPARG",DisGeNET
2128,Adult Lymphoma,0.22296929257000844,2.3521779425393885,3.529963348017771,0.4489979342829885,"PDGFRA,BCL2L11",DisGeNET
2129,Fasting blood glucose measurement,0.22296929257000844,2.3521779425393885,3.529963348017771,0.4489979342829885,"GCKR,MRPL33",DisGeNET
2130,Hemangioblastoma,0.22296929257000844,2.3521779425393885,3.529963348017771,0.4489979342829885,"PTPRC,EPAS1",DisGeNET
2131,Hypertrophy of clitoris,0.22296929257000844,2.3521779425393885,3.529963348017771,0.4489979342829885,"MAP3K1,ATR",DisGeNET
2132,Intracranial Hemorrhages,0.22296929257000844,2.3521779425393885,3.529963348017771,0.4489979342829885,"APOE,EPHB4",DisGeNET
2133,Lafora Disease,0.22296929257000844,2.3521779425393885,3.529963348017771,0.4489979342829885,"MAPT,APOE",DisGeNET
2134,Malignant Meningioma,0.22296929257000844,2.3521779425393885,3.529963348017771,0.4489979342829885,"TERT,CTSB",DisGeNET
2135,Myxoid/Round Cell Liposarcoma,0.22296929257000844,2.3521779425393885,3.529963348017771,0.4489979342829885,"PIK3CA,PPARG",DisGeNET
2136,PITUITARY ADENOMA PREDISPOSITION (disorder),0.22296929257000844,2.3521779425393885,3.529963348017771,0.4489979342829885,"SLC7A6,PPARG",DisGeNET
2137,Aneurysm,0.2237584344416632,1.5794503807225895,2.3647345146888767,0.4489979342829885,"BLK,FAM167A,PTPRC,NLRP3,APOE",DisGeNET
2138,Photodysphoria,0.2237584344416632,1.5794503807225895,2.3647345146888767,0.4489979342829885,"AHI1,HADHA,MAPT,HK1,DDB2",DisGeNET
2139,"Alport Syndrome, X-Linked",0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,APOE,DisGeNET
2140,Refractory anemia with excess blasts I,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,ASXL1,DisGeNET
2141,"Apraxia, Verbal",0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,BCL11A,DisGeNET
2142,"Asthma, Aspirin-Induced",0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,NLRP3,DisGeNET
2143,"Cancer, Embryonal and Mixed",0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,KITLG,DisGeNET
2144,Rhinosinusitis,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,ANP32B,DisGeNET
2145,"Creutzfeldt-Jakob Disease, Sporadic",0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,MAPT,DisGeNET
2146,"Elliptocytosis, Hereditary",0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,SPTA1,DisGeNET
2147,"Female external genitalia in individual with 46,XY karyotype",0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,MAP3K1,DisGeNET
2148,Serous cystadenocarcinoma ovary,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,PIK3CA,DisGeNET
2149,Short Bowel Syndrome,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,LEPR,DisGeNET
2150,"Hodgkin lymphoma, lymphocyte depletion",0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,PTPN1,DisGeNET
2151,Short middle phalanx of finger,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,FIG4,DisGeNET
2152,SHORT syndrome,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,PIK3CA,DisGeNET
2153,Slender finger,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,KANSL1,DisGeNET
2154,Slowed saccades,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,FBXO7,DisGeNET
2155,Small earlobe,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,FIG4,DisGeNET
2156,Smoker's lung,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,LAPTM4B,DisGeNET
2157,Somnolence,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,APOE,DisGeNET
2158,"Neoplasms, Embryonal and Mixed",0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,KITLG,DisGeNET
2159,"Neoplasms, Vascular Tissue",0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,P4HTM,DisGeNET
2160,"NEVUS, EPIDERMAL (disorder)",0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,PIK3CA,DisGeNET
2161,Status Dysraphicus,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,PDGFRA,DisGeNET
2162,Subacute progressive viral hepatitis,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,PIK3CA,DisGeNET
2163,Subcutaneous lipoma,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,PIK3CA,DisGeNET
2164,"Polyneuropathy, Motor",0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,TYMP,DisGeNET
2165,"Pyloric Stenosis, Hypertrophic",0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,PCSK7,DisGeNET
2166,Symptomatic dermographism,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,SERPING1,DisGeNET
2167,"RETINOSCHISIS 1, X-LINKED, JUVENILE",0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,GADD45A,DisGeNET
2168,"Rickets, X-Linked Hypophosphatemic",0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,SLC17A1,DisGeNET
2169,Testicular dysgenesis,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,MAP3K1,DisGeNET
2170,"stage, pancreatic cancer",0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,PIK3CA,DisGeNET
2171,"Vasculitis, Leukocytoclastic, Cutaneous",0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,IL1RN,DisGeNET
2172,Abnormal sex determination,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,MAP3K1,DisGeNET
2173,Trisomy 4,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,KIT,DisGeNET
2174,Abnormality of aortic valve,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,MAP2K2,DisGeNET
2175,Abnormality of the corpus callosum,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,ASXL1,DisGeNET
2176,Abnormality of the face,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,PPARG,DisGeNET
2177,Uterine Polyp,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,KIT,DisGeNET
2178,Acidosis,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,SLC12A7,DisGeNET
2179,Acute mountain sickness,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,EPAS1,DisGeNET
2180,Amebic colitis,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,LEPR,DisGeNET
2181,Angioid Streaks,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,PIK3CA,DisGeNET
2182,Ankle contracture,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,FIG4,DisGeNET
2183,Aspergillosis,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,TLR1,DisGeNET
2184,Ataxia with vitamin E deficiency,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,APOB,DisGeNET
2185,Bannayan-Riley-Ruvalcaba Syndrome,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,PIK3CA,DisGeNET
2186,Bare Lymphocyte Syndrome,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,TFRC,DisGeNET
2187,Blepharospasm,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,KCTD17,DisGeNET
2188,Bone Marrow failure syndromes,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,TERT,DisGeNET
2189,Cancer Relapse,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,PIK3CA,DisGeNET
2190,Carnitine deficiency,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,HMGCL,DisGeNET
2191,Cholera Infantum,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,ABCC2,DisGeNET
2192,Codependency,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,PDGFRA,DisGeNET
2193,Compression of spinal cord,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,APOE,DisGeNET
2194,Congenital dyserythropoietic anemia,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,HFE,DisGeNET
2195,Congenital hypoplasia of adrenal gland,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,CTSB,DisGeNET
2196,Congenital microcephaly,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,FIG4,DisGeNET
2197,Dedifferentiated chondrosarcoma,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,PIK3CA,DisGeNET
2198,Difficulty making arithmetical calculations,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,MAPT,DisGeNET
2199,Diffuse Intrinsic Pontine Glioma,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,PDGFRA,DisGeNET
2200,Disorder of face,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,PPARG,DisGeNET
2201,Episodic hyperhidrosis,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,MAX,DisGeNET
2202,Epithelioid hemangioendothelioma,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,KIT,DisGeNET
2203,Esophageal Varices,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,JAK2,DisGeNET
2204,Exudative retinopathy,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,TERT,DisGeNET
2205,Familial Atypical Mole Melanoma Syndrome,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,TERT,DisGeNET
2206,Female pattern alopecia (disorder),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,ABCC2,DisGeNET
2207,Focal Dystonia,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,ALDH5A1,DisGeNET
2208,Hepatic Vein Thrombosis,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,JAK2,DisGeNET
2209,Horizontal Nystagmus,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,SNIP1,DisGeNET
2210,Hyperorality,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,MAPT,DisGeNET
2211,Intestinal infectious disease (disorder),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,LEPR,DisGeNET
2212,Keratoderma,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,KANK2,DisGeNET
2213,Ketonemia,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,GCDH,DisGeNET
2214,Lateral Sclerosis,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,FIG4,DisGeNET
2215,Limbal stem cell deficiency,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,NLRP3,DisGeNET
2216,LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 2,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,APOE,DisGeNET
2217,Lymphocyte Rich Classical Hodgkin Lymphoma,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,PTPN1,DisGeNET
2218,Malignant melanoma of ciliary body,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,KIT,DisGeNET
2219,Malignant tumor of peritoneum,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,ABCC2,DisGeNET
2220,Mast-Cell Sarcoma,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,KIT,DisGeNET
2221,Mediastinal lymphadenopathy,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,APOE,DisGeNET
2222,Mixed Cellularity Hodgkin Lymphoma,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,PTPN1,DisGeNET
2223,Mucosal Melanoma,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,KIT,DisGeNET
2224,Neuropil Threads,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,MAPT,DisGeNET
2225,Oral Mucositis,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,ABCC2,DisGeNET
2226,OROFACIAL CLEFT 1,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,CDH1,DisGeNET
2227,Pancreatic Cyst,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,NPHP3,DisGeNET
2228,Perseveration,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,MAPT,DisGeNET
2229,Premature hardening of arteries,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,APOB,DisGeNET
2230,Progressive multiple sclerosis,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,APOE,DisGeNET
2231,PTEN Hamartoma Tumor Syndrome,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,PIK3CA,DisGeNET
2232,Pulmonary Blastoma,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,KIT,DisGeNET
2233,Raised TSH level,0.22771247374454687,4.363363363363363,6.4563445260378325,0.4489979342829885,THRB,DisGeNET
2234,Sudden infant death syndrome,0.22845826020082471,1.873543375053949,2.766102725198173,0.4489979342829885,"HADHA,IL1RN,APOE",DisGeNET
2235,Demyelinating Diseases,0.22845826020082471,1.873543375053949,2.766102725198173,0.4489979342829885,"FIG4,PPARG,QKI",DisGeNET
2236,Gout,0.22845826020082471,1.873543375053949,2.766102725198173,0.4489979342829885,"IL1RN,GCKR,SLC17A1",DisGeNET
2237,Lobar Pneumonia,0.22845826020082471,1.873543375053949,2.766102725198173,0.4489979342829885,"IL37,IL2RB,NLRP3",DisGeNET
2238,Malignant neoplasm of salivary gland,0.22845826020082471,1.873543375053949,2.766102725198173,0.4489979342829885,"CDH1,BCL11A,PPARG",DisGeNET
2239,Malocclusion,0.22845826020082471,1.873543375053949,2.766102725198173,0.4489979342829885,"IL2RB,SLC39A13,ATR",DisGeNET
2240,Petit mal status,0.22845826020082471,1.873543375053949,2.766102725198173,0.4489979342829885,"IL1RN,MEF2C,ABCC2",DisGeNET
2241,Prader-Willi Syndrome,0.22845826020082471,1.873543375053949,2.766102725198173,0.4489979342829885,"PIK3CA,LEPR,ATR",DisGeNET
2242,"Carcinoma, Cribriform",0.22867143207930082,1.6778746367787463,2.475652180483332,0.4489979342829885,"HSPA8,PIK3CA,PPARG,APOE",DisGeNET
2243,"Carcinoma, Granular Cell",0.22867143207930082,1.6778746367787463,2.475652180483332,0.4489979342829885,"HSPA8,PIK3CA,PPARG,APOE",DisGeNET
2244,"Diabetes Mellitus, Experimental",0.22867143207930082,1.6778746367787463,2.475652180483332,0.4489979342829885,"LEPR,PPARG,CPT1B,HK1",DisGeNET
2245,Streptozotocin Diabetes,0.22867143207930082,1.6778746367787463,2.475652180483332,0.4489979342829885,"LEPR,PPARG,CPT1B,HK1",DisGeNET
2246,Alloxan Diabetes,0.22867143207930082,1.6778746367787463,2.475652180483332,0.4489979342829885,"LEPR,PPARG,CPT1B,HK1",DisGeNET
2247,Hyperthyroidism,0.22867143207930082,1.6778746367787463,2.475652180483332,0.4489979342829885,"THRB,PIK3CA,PPARG,APOB",DisGeNET
2248,Blood Coagulation Disorders,0.22958771637869083,1.5631784628745116,2.3001703941895704,0.4503961781515269,"RTEL1,TERT,AK3,APOE,JAK2",DisGeNET
2249,Mild cognitive disorder,0.22958771637869083,1.5631784628745116,2.3001703941895704,0.4503961781515269,"TOMM40,HFE,APOE,MAPT,CTSB",DisGeNET
2250,Squamous cell carcinoma of skin,0.23237521970172767,1.4831825334382376,2.1645593887756425,0.45566198636623223,"TERT,PIK3CA,TMC8,PPARG,TMC6,DDB2",DisGeNET
2251,Adenomatous Polyposis Coli,0.23357259314447124,1.3349436392914653,1.9413582857128875,0.45576561934680243,"BCL2L11,PIK3CA,TERT,CD82,CDH1,KIT,NLRP3,PPARG,MAPT,EPHB4",DisGeNET
2252,Single transverse palmar crease,0.2348040010823395,2.2648371262829095,3.2817583968441295,0.45576561934680243,"FIG4,ATR",DisGeNET
2253,Thin dental enamel,0.2348040010823395,2.2648371262829095,3.2817583968441295,0.45576561934680243,"LONP1,ATR",DisGeNET
2254,Abnormality of dental enamel,0.2348040010823395,2.2648371262829095,3.2817583968441295,0.45576561934680243,"LONP1,ATR",DisGeNET
2255,Vertical Talus,0.2348040010823395,2.2648371262829095,3.2817583968441295,0.45576561934680243,"FIG4,JAK2",DisGeNET
2256,Cone-Rod Dystrophies,0.2348040010823395,2.2648371262829095,3.2817583968441295,0.45576561934680243,"AHI1,TST",DisGeNET
2257,Cystadenoma,0.2348040010823395,2.2648371262829095,3.2817583968441295,0.45576561934680243,"PIK3CA,DUSP1",DisGeNET
2258,Decreased antibody level in blood,0.2348040010823395,2.2648371262829095,3.2817583968441295,0.45576561934680243,"RTEL1,TFRC",DisGeNET
2259,Defective enamel matrix,0.2348040010823395,2.2648371262829095,3.2817583968441295,0.45576561934680243,"LONP1,ATR",DisGeNET
2260,Dysplasia of tooth enamel,0.2348040010823395,2.2648371262829095,3.2817583968441295,0.45576561934680243,"LONP1,ATR",DisGeNET
2261,Fibromyalgia,0.2348040010823395,2.2648371262829095,3.2817583968441295,0.45576561934680243,"HFE,NLRP3",DisGeNET
2262,Forgetful,0.2348040010823395,2.2648371262829095,3.2817583968441295,0.45576561934680243,"TOMM40,MAPT",DisGeNET
2263,Generalized myoclonic seizures,0.2348040010823395,2.2648371262829095,3.2817583968441295,0.45576561934680243,"SLC25A15,ALDH5A1",DisGeNET
2264,HER2 gene amplification,0.2348040010823395,2.2648371262829095,3.2817583968441295,0.45576561934680243,"PTPRC,PIK3CA",DisGeNET
2265,Hyperextensible skin,0.2348040010823395,2.2648371262829095,3.2817583968441295,0.45576561934680243,"MAP2K2,SLC39A13",DisGeNET
2266,Muscular Atrophy,0.2348040010823395,2.2648371262829095,3.2817583968441295,0.45576561934680243,"TFRC,CITED2",DisGeNET
2267,Neurobehavioral Manifestations,0.2348040010823395,2.2648371262829095,3.2817583968441295,0.45576561934680243,"APOE,MAPT",DisGeNET
2268,Obsessive compulsive behavior,0.2348040010823395,2.2648371262829095,3.2817583968441295,0.45576561934680243,"MAPT,KCTD17",DisGeNET
2269,Peripheral axonal neuropathy,0.2348040010823395,2.2648371262829095,3.2817583968441295,0.45576561934680243,"SERPING1,TYMP",DisGeNET
2270,Peripheral demyelinating neuropathy,0.2348040010823395,2.2648371262829095,3.2817583968441295,0.45576561934680243,"FIG4,TYMP",DisGeNET
2271,Phospholipid measurement,0.2348040010823395,2.2648371262829095,3.2817583968441295,0.45576561934680243,"FADS2,GCKR",DisGeNET
2272,Polyarthritis,0.2348040010823395,2.2648371262829095,3.2817583968441295,0.45576561934680243,"IL2RB,HK1",DisGeNET
2273,Range of joint movement increased,0.2348040010823395,2.2648371262829095,3.2817583968441295,0.45576561934680243,"KANSL1,BCL11A",DisGeNET
2274,Neoplastic Cell Transformation,0.2355227863487793,1.655036855036855,2.3930965897800434,0.45695977720792186,"CCND2,TFRC,CDH1,EPAS1",DisGeNET
2275,"Lymphoma, Large-Cell, Follicular",0.2369371811649995,1.835891238670695,2.64361037278202,0.4593000190245949,"TLR1,RTEL1,KIT",DisGeNET
2276,Bronchioloalveolar Adenocarcinoma,0.2369371811649995,1.835891238670695,2.64361037278202,0.4593000190245949,"PIK3CA,TERT,ATR",DisGeNET
2277,Tumor Angiogenesis,0.23956737629790703,1.28897189766755,1.8418384729530108,0.462790699932783,"IL1RN,ELF1,PIK3CA,AXL,IL37,EPAS1,PPARG,JAK2,P4HTM,ETS2,CTSB,TYMP",DisGeNET
2278,"Adenocarcinoma, Basal Cell",0.24242283699095532,1.6328080808080807,2.3138063142352823,0.462790699932783,"HSPA8,PIK3CA,PPARG,APOE",DisGeNET
2279,"Infarction, Middle Cerebral Artery",0.24242283699095532,1.6328080808080807,2.3138063142352823,0.462790699932783,"PDGFRA,APOE,PLD1,IL6R",DisGeNET
2280,Hypodontia,0.24242283699095532,1.6328080808080807,2.3138063142352823,0.462790699932783,"RTEL1,TERT,CDH1,SLC39A13",DisGeNET
2281,Left-Sided Heart Failure,0.24242283699095532,1.6328080808080807,2.3138063142352823,0.462790699932783,"PPARG,APOE,APOB,JARID2",DisGeNET
2282,Syndactyly,0.24546975040118685,1.7997156566554113,2.527847416712688,0.462790699932783,"FIG4,ASXL1,PIK3CA",DisGeNET
2283,Acromegaly,0.24546975040118685,1.7997156566554113,2.527847416712688,0.462790699932783,"LPL,PPARG,APOE",DisGeNET
2284,Dyskinetic syndrome,0.24546975040118685,1.7997156566554113,2.527847416712688,0.462790699932783,"GCDH,MEF2C,APOE",DisGeNET
2285,Frontotemporal Lobar Degeneration,0.24546975040118685,1.7997156566554113,2.527847416712688,0.462790699932783,"HFE,APOE,MAPT",DisGeNET
2286,Lysosomal Storage Diseases,0.24546975040118685,1.7997156566554113,2.527847416712688,0.462790699932783,"FIG4,TFEB,CTSB",DisGeNET
2287,Adenocarcinoma,0.24579869903941487,1.1480873522139339,1.6110448223975289,0.462790699932783,"TAGLN,IL1RN,THRB,CD82,MAX,EPAS1,LPL,ETS2,TYMP,LAPTM4B,CCND3,BCL2L11,CCND2,ALDH2,TERT,CDH1,NLRP3,APOE,CTSB,HSPA8,RRM1,MAP2K2,ABCC2,SMOX,DUSP1,TNK2,TFEB,RHOA,TLR1,KITLG,PTPRC,PIK3CA,AXL,KIT,PPARG,CPEB4",DisGeNET
2288,Young onset Parkinson disease,0.24667318295277238,2.183734939759036,3.0565540638795885,0.462790699932783,"HSD17B13,APOE",DisGeNET
2289,Adult Cholangiocarcinoma,0.24667318295277238,2.183734939759036,3.0565540638795885,0.462790699932783,"TFRC,PPARG",DisGeNET
2290,Arterial Occlusive Diseases,0.24667318295277238,2.183734939759036,3.0565540638795885,0.462790699932783,"APOB,JAK2",DisGeNET
2291,Bleeding tendency,0.24667318295277238,2.183734939759036,3.0565540638795885,0.462790699932783,"AK3,JAK2",DisGeNET
2292,CARCINOMA OF VULVA,0.24667318295277238,2.183734939759036,3.0565540638795885,0.462790699932783,"IL1RN,KIT",DisGeNET
2293,Cerebral Amyloid Angiopathy,0.24667318295277238,2.183734939759036,3.0565540638795885,0.462790699932783,"PTPRC,APOE",DisGeNET
2294,Childhood Lymphoma,0.24667318295277238,2.183734939759036,3.0565540638795885,0.462790699932783,"PDGFRA,BCL2L11",DisGeNET
2295,Congenital Bilateral Cataracts,0.24667318295277238,2.183734939759036,3.0565540638795885,0.462790699932783,"MAP2K2,LONP1",DisGeNET
2296,Endometrial Stromal Sarcoma,0.24667318295277238,2.183734939759036,3.0565540638795885,0.462790699932783,"PDGFRA,KIT",DisGeNET
2297,Medullomyoblastoma,0.24667318295277238,2.183734939759036,3.0565540638795885,0.462790699932783,"BRD3,PDGFRA",DisGeNET
2298,Melanotic medulloblastoma,0.24667318295277238,2.183734939759036,3.0565540638795885,0.462790699932783,"BRD3,PDGFRA",DisGeNET
2299,Oculomotor apraxia,0.24667318295277238,2.183734939759036,3.0565540638795885,0.462790699932783,"AHI1,KIAA0586",DisGeNET
2300,Pemphigus Vulgaris,0.24667318295277238,2.183734939759036,3.0565540638795885,0.462790699932783,"IL1RN,CDH1",DisGeNET
2301,Glioblastoma Multiforme,0.24683514207936202,1.217234664070107,1.7029534188592776,0.462790699932783,"RTEL1-TNFRSF6B,PDGFRA,RTEL1,GADD45A,MPG,EPAS1,HFE,DOCK7,HK1,PIK3CA,TERT,AXL,ZNF217,HEATR3,PPARG,JAK2,EPHB4,CTSB",DisGeNET
2302,Respiratory Failure,0.24733062049078025,1.5162960065003461,2.1183099378021266,0.462790699932783,"FIG4,HADHA,IL1RN,CEBPG,MAPT",DisGeNET
2303,Eosinophilic disorder,0.24733062049078025,1.5162960065003461,2.1183099378021266,0.462790699932783,"PDGFRA,MYB,KIT,JAK2,SH2B3",DisGeNET
2304,Epileptic encephalopathy,0.2479344682400378,1.2939871653440567,1.8045826073678757,0.462790699932783,"FIG4,HMGCL,MEF2C,CCND2,MAP2K2,ALDH5A1,PIK3CA,TNK2,NPRL3,DOCK7,ADAR",DisGeNET
2305,Malignant Head and Neck Neoplasm,0.2479344682400378,1.2939871653440567,1.8045826073678757,0.462790699932783,"CEBPA,RAD50,BCL2L11,PTPRC,ALDH2,PIK3CA,AXL,NLRP3,TMC8,CTSB,TYMP",DisGeNET
2306,Dystonia,0.24814674528382072,1.447714614941425,2.0177305186594885,0.462790699932783,"GCDH,HSPA8,ADAR,APOE,KCTD17,FBXO7",DisGeNET
2307,"Adenocarcinoma, Tubular",0.24936839163977695,1.611164274322169,2.2376235982317674,0.462790699932783,"HSPA8,PIK3CA,PPARG,APOE",DisGeNET
2308,Bone Density,0.24936839163977695,1.611164274322169,2.2376235982317674,0.462790699932783,"MEF2C,GCKR,MAPT,DDB2",DisGeNET
2309,Hereditary Nonpolyposis Colorectal Cancer,0.24936839163977695,1.611164274322169,2.2376235982317674,0.462790699932783,"RAD50,PIK3CA,CDH1,HFE",DisGeNET
2310,precancerous lesions,0.24936839163977695,1.611164274322169,2.2376235982317674,0.462790699932783,"IL1RN,CD82,TERT,CDH1",DisGeNET
2311,Small head,0.25136483252396113,1.2597953949114067,1.739588318817846,0.462790699932783,"CEP57,FTO,RTEL1,PGAP3,BCL11A,NSMCE2,ASXL1,FIG4,DSTYK,RAD50,TERT,PRDM16,ATR",DisGeNET
2312,"Kidney Failure, Chronic",0.2516104511667165,1.288918299340628,1.7785438391303625,0.462790699932783,"FTO,IL1RN,GCKR,ABCC2,TERT,NPHP3,LPL,PPARG,APOE,APOB,ZNF410",DisGeNET
2313,Metastatic Neoplasm,0.2516104511667165,1.288918299340628,1.7785438391303625,0.462790699932783,"MACF1,PTPRC,PIK3CA,CD82,AXL,EPAS1,KIT,ZNF217,JARID2,EPHB4,HDAC7",DisGeNET
2314,Lupus Vulgaris,0.25165066524093543,1.3933833750347513,1.9224697170032272,0.462790699932783,"BLK,IL1RN,FAM167A,PTPRC,GADD45A,NLRP3,PDE7A",DisGeNET
2315,Reduced subcutaneous adipose tissue,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,PPARG,DisGeNET
2316,Refractory anemia with ringed sideroblasts,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,JAK2,DisGeNET
2317,"Auditory Processing Disorder, Central",0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,BCL11A,DisGeNET
2318,"Colitis, Collagenous",0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,IL37,DisGeNET
2319,Rudimentary vagina,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,MAP3K1,DisGeNET
2320,Saldino-Noonan Syndrome,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,KIAA0586,DisGeNET
2321,Semantic-Pragmatic Disorder,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,BCL11A,DisGeNET
2322,Severe hereditary factor VIII deficiency disease,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,AK3,DisGeNET
2323,Skeletal muscle hypertrophy,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,PPARG,DisGeNET
2324,Spade-like hand,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,ASXL1,DisGeNET
2325,"PNEUMOTHORAX, PRIMARY SPONTANEOUS",0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,MAPT,DisGeNET
2326,Subcortical Infarction,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,APOE,DisGeNET
2327,"Polycystic kidney disease, type 2",0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,PPARG,DisGeNET
2328,Syphilis,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,TLR1,DisGeNET
2329,"SPHEROCYTOSIS, TYPE 1 (disorder)",0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,SPTA1,DisGeNET
2330,"SYNOVITIS, GRANULOMATOUS, WITH UVEITIS AND CRANIAL NEUROPATHIES (disorder)",0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,NLRP3,DisGeNET
2331,Thromboembolism,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,JAK2,DisGeNET
2332,Aarskog syndrome,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,ATR,DisGeNET
2333,Abnormal brain FDG positron emission tomography,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,MAPT,DisGeNET
2334,Tricuspid Valve Insufficiency,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,PLD1,DisGeNET
2335,Tubular atrophy,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,NPHP3,DisGeNET
2336,Tubulointerstitial scarring,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,NPHP3,DisGeNET
2337,Ulnar deviation of the wrist,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,ASXL1,DisGeNET
2338,Abnormality of the helix,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,MAP2K2,DisGeNET
2339,Abnormality of the hypothalamus-pituitary axis,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,HFE,DisGeNET
2340,Urologic Neoplasms,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,ATR,DisGeNET
2341,Adrenal Gland Diseases,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,CITED2,DisGeNET
2342,Adult B Acute Lymphoblastic Leukemia,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,PIK3CA,DisGeNET
2343,AICARDI-GOUTIERES SYNDROME,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,ADAR,DisGeNET
2344,Akathisia,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,MAPT,DisGeNET
2345,Alopecia universalis,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,IL1RN,DisGeNET
2346,ALZHEIMER DISEASE 2,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,APOE,DisGeNET
2347,Anterior chamber anomalies,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,ASXL1,DisGeNET
2348,Atrophoderma maculatum,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,HK1,DisGeNET
2349,Bagassosis,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,ATR,DisGeNET
2350,Blurred vision,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,MAPT,DisGeNET
2351,Brain and/or spinal cord issue,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,PDGFRA,DisGeNET
2352,Budd-Chiari Syndrome,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,JAK2,DisGeNET
2353,CAMPOMELIC DYSPLASIA,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,JAK2,DisGeNET
2354,Candidemia,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,TLR1,DisGeNET
2355,Cellulitis of eyelid,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,APOE,DisGeNET
2356,Childhood B Acute Lymphoblastic Leukemia,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,IL37,DisGeNET
2357,Clostridium difficile infection,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,MAX,DisGeNET
2358,Colon diverticulum anatomic structure,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,PIK3CA,DisGeNET
2359,Congenital hemihypertrophy,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,PIK3CA,DisGeNET
2360,Congenital Intestinal Aganglionosis,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,VRK2,DisGeNET
2361,Conjunctival telangiectasis,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,DDB2,DisGeNET
2362,Contralateral breast cancer,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,RAD50,DisGeNET
2363,Curling Ulcer,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,TFRC,DisGeNET
2364,Dental Plaque,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,APOE,DisGeNET
2365,Developmental arithmetic disorder,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,MAPT,DisGeNET
2366,Diplopia,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,MAPT,DisGeNET
2367,Disorders of Porphyrin Metabolism,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,HFE,DisGeNET
2368,Diverticular disease of colon,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,PIK3CA,DisGeNET
2369,Falls,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,MAPT,DisGeNET
2370,Filariasis,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,HSPA8,DisGeNET
2371,Frontotemporal cerebral atrophy,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,MAPT,DisGeNET
2372,Gastroschisis,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,KIT,DisGeNET
2373,Germinoma,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,KIT,DisGeNET
2374,Granulocytosis,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,JAK2,DisGeNET
2375,Group B streptococcal pneumonia,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,IL1RN,DisGeNET
2376,Hamartomatous polyposis,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,PIK3CA,DisGeNET
2377,Hyper-beta-alaninemia,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,TYMP,DisGeNET
2378,Hypoplasia of vagina,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,MAP3K1,DisGeNET
2379,Impaired platelet aggregation,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,SH2B3,DisGeNET
2380,Inappropriate behavior,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,MAPT,DisGeNET
2381,Increased blood alanine,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,TYMP,DisGeNET
2382,Increased serum alanine,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,TYMP,DisGeNET
2383,Iridocyclitis,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,IL2RB,DisGeNET
2384,Language Development Disorders,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,BCL11A,DisGeNET
2385,Lean body mass,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,FTO,DisGeNET
2386,Lymphatic Abnormalities,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,PIK3CA,DisGeNET
2387,Lysinuric Protein Intolerance,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,SLC7A6,DisGeNET
2388,Macular retinal edema,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,APOE,DisGeNET
2389,Mastitis,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,NLRP3,DisGeNET
2390,Mastitis-metritis-agalactia syndrome,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,PIK3CA,DisGeNET
2391,Mature B-Cell Non-Hodgkin Lymphoma,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,CEBPA,DisGeNET
2392,Meningothelial meningioma,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,TERT,DisGeNET
2393,Mesenchymal Chondrosarcoma,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,PDGFRA,DisGeNET
2394,Migraine Variant,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,PRDM16,DisGeNET
2395,Mirror movements disorder,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,MEF2C,DisGeNET
2396,Monoblastic leukemia,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,KIT,DisGeNET
2397,Mucolipidosis Type IV,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,APOB,DisGeNET
2398,Multiple System Atrophy,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,MAPT,DisGeNET
2399,Odontome,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,SLC39A13,DisGeNET
2400,Peg-shaped teeth,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,CDH1,DisGeNET
2401,Periorbital fullness,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,DOCK7,DisGeNET
2402,Pointed tooth,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,CDH1,DisGeNET
2403,Primary antiphospholipid syndrome,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,IL37,DisGeNET
2404,Psychological symptom,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,APOE,DisGeNET
2405,Pulmonary Fibrosis - from Asbestos Exposure,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.462790699932783,NLRP3,DisGeNET
2406,Immune thrombocytopenic purpura,0.2533233131479587,1.5012813636092734,2.0613924586509373,0.46441730178048457,"IL1RN,PTPRC,IL2RB,NLRP3,ANP32B",DisGeNET
2407,Psychotic Disorders,0.25342843985247493,1.3273668639053255,1.8220416963006436,0.46441730178048457,"FTO,AHI1,ALDH5A1,TOMM40,PTPRC,ALDH2,LEPR,APOE,MAPT",DisGeNET
2408,Downward slant of palpebral fissure,0.2534716370551693,1.4362614329268293,1.9712736247129226,0.46441730178048457,"RPS28,MAP2K2,PIK3CA,BCL11A,SLC39A13,ATR",DisGeNET
2409,Sparse hair,0.25405004934325137,1.7649314431791774,2.4183513983531832,0.46470514830117127,"RTEL1,MAP2K2,TERT",DisGeNET
2410,"Thin, sparse hair",0.25405004934325137,1.7649314431791774,2.4183513983531832,0.46470514830117127,"RTEL1,MAP2K2,TERT",DisGeNET
2411,Nevus,0.25405004934325137,1.7649314431791774,2.4183513983531832,0.46470514830117127,"TERT,KIT,PPARG",DisGeNET
2412,Postnatal growth retardation,0.25405004934325137,1.7649314431791774,2.4183513983531832,0.46470514830117127,"FIG4,RTEL1,ATR",DisGeNET
2413,Mental Retardation,0.25449741841246964,1.1773166221491678,1.6111161048684974,0.46533054705172655,"CEP57,LEPROT,RTEL1,MAP2K2,TMPRSS6,PGAP3,BCL11A,ETS2,SLC25A15,AHI1,RAD50,ALDH5A1,KANSL1,PIK3CA,TERT,KIAA0586,TDP2,PRDM16,LEPR,NLRP3,PPARG,APOE,MAPT,ATR",DisGeNET
2414,Schizophrenia,0.25491447035511733,1.1328343505140803,1.5483888038963152,0.4659000178984166,"FTO,IL1RN,TRRAP,HFE,ZSCAN9,LPL,AGAP1,HK1,FADS2,CCND2,SLC22A16,ALDH2,TERT,ZKSCAN3,LEPR,APOE,ZKSCAN4,SLC17A1,JARID2,IL6R,HIST1H1B,SLC17A3,HSPA8,PTPN1,CHURC1,BTN3A1,GALNT2,BTN2A1,BCL11A,MYO9B,VRK2,QKI,TLR1,MYO1D,GIGYF1,MSRA,AHI1,TF,PIK3CA,KIT,PPARG",DisGeNET
2415,"Adenocarcinoma, Oxyphilic",0.25635628048071935,1.5900826446280991,2.164399954258425,0.46814731352687655,"HSPA8,PIK3CA,PPARG,APOE",DisGeNET
2416,PACHYONYCHIA CONGENITA 3,0.25635628048071935,1.5900826446280991,2.164399954258425,0.46814731352687655,"TFRC,LONP1,PPARG,EPHB4",DisGeNET
2417,Short phalanx of finger,0.2585627471976888,2.1082260074781884,2.851622081860491,0.4708125632010743,"LONP1,SLC39A13",DisGeNET
2418,Silicosis,0.2585627471976888,2.1082260074781884,2.851622081860491,0.4708125632010743,"IL1RN,NLRP3",DisGeNET
2419,Thromboangiitis Obliterans,0.2585627471976888,2.1082260074781884,2.851622081860491,0.4708125632010743,"IL1RN,PTPRC",DisGeNET
2420,Advanced bone age,0.2585627471976888,2.1082260074781884,2.851622081860491,0.4708125632010743,"LEPR,PPARG",DisGeNET
2421,Alcohol withdrawal syndrome,0.2585627471976888,2.1082260074781884,2.851622081860491,0.4708125632010743,"PPARG,APOE",DisGeNET
2422,Cutis marmorata,0.2585627471976888,2.1082260074781884,2.851622081860491,0.4708125632010743,"FTO,PIK3CA",DisGeNET
2423,Lymphocytic infiltration,0.2585627471976888,2.1082260074781884,2.851622081860491,0.4708125632010743,"PDGFRA,MAPT",DisGeNET
2424,Immune System Diseases,0.2588281021180633,1.4249858196256382,1.9259982027512719,0.4711013145812274,"SPRED2,PIK3CA,IL2RB,NLRP3,SH2B3,UBE2L3",DisGeNET
2425,Amyotrophic Lateral Sclerosis,0.25893996495769545,1.2292163009404389,1.6608667167394908,0.47111056717251637,"HSPA8,HFE,ADAR,ETS2,SIRT3,FIG4,SLC25A37,KITLG,XRN1,IL2RB,NLRP3,PPARG,APOE,MAPT,SH2B3",DisGeNET
2426,DOSAGE-SENSITIVE SEX REVERSAL,0.262672288407135,1.731459841532235,2.314698756882004,0.47750726677061384,"IL1RN,TRRAP,IL37",DisGeNET
2427,Malignant Childhood Neoplasm,0.262672288407135,1.731459841532235,2.314698756882004,0.47750726677061384,"TAGLN,PIK3CA,LEPR",DisGeNET
2428,Waist-Hip Ratio,0.2633833594910324,1.5695415695415695,2.093995515393584,0.4784056739705373,"FTO,KLF13,TOMM40,CPEB4",DisGeNET
2429,Ependymoma,0.2633833594910324,1.5695415695415695,2.093995515393584,0.4784056739705373,"PDGFRA,PIK3CA,KIT,JAK2",DisGeNET
2430,Vascular Diseases,0.2646223494213961,1.2890341321713872,1.7137084455586227,0.4804583562334155,"MSRA,ALDH2,LPL,PPARG,APOE,APOB,RHOA,CTSB,DDB2,HDAC7",DisGeNET
2431,Adenocarcinoma of pancreas,0.26600487852478794,1.3081006197593876,1.7322399888787943,0.480821459351257,"MAP3K1,CCND2,MAP2K2,ABCC2,PIK3CA,TERT,CD82,HFE,HDAC7",DisGeNET
2432,"Cardiomyopathy, Familial Idiopathic",0.26859616585372664,1.2835115450178212,1.6872353134312073,0.480821459351257,"IL1RN,KITLG,PTPRC,PIK3CA,CDH1,AXL,HFE,NCOA4,PRDM16,NLRP3",DisGeNET
2433,Feeding difficulties in infancy,0.26963024485654563,1.4029510333271271,1.8388531412359839,0.480821459351257,"GCDH,AHI1,MAP2K2,KANSL1,KIAA0586,PRDM16",DisGeNET
2434,Thyroid Gland Follicular Adenoma,0.2704465134065228,1.5495205216724204,2.0262784408178804,0.480821459351257,"TERT,PIK3CA,NCOA4,PPARG",DisGeNET
2435,Differentiated Thyroid Gland Carcinoma,0.2704465134065228,1.5495205216724204,2.0262784408178804,0.480821459351257,"THRB,TERT,PIK3CA,PPARG",DisGeNET
2436,Barrett Epithelium,0.27045945831080337,2.0377510040160645,2.664630598797084,0.480821459351257,"LEPR,PPARG",DisGeNET
2437,Disorder of macula of retina,0.27045945831080337,2.0377510040160645,2.664630598797084,0.480821459351257,"FADS2,TST",DisGeNET
2438,Epiretinal Membrane,0.27045945831080337,2.0377510040160645,2.664630598797084,0.480821459351257,"PTPRC,IL2RB",DisGeNET
2439,granulosa cell tumor,0.27045945831080337,2.0377510040160645,2.664630598797084,0.480821459351257,"CCND2,LEPR",DisGeNET
2440,Hyperparathyroidism,0.27045945831080337,2.0377510040160645,2.664630598797084,0.480821459351257,"LEPR,IL6R",DisGeNET
2441,Low anterior hairline,0.27045945831080337,2.0377510040160645,2.664630598797084,0.480821459351257,"ASXL1,DOCK7",DisGeNET
2442,Lymphocytosis,0.27045945831080337,2.0377510040160645,2.664630598797084,0.480821459351257,"PTPRC,LONP1",DisGeNET
2443,Malignant neoplasm of male breast,0.27045945831080337,2.0377510040160645,2.664630598797084,0.480821459351257,"PIK3CA,HFE",DisGeNET
2444,NONAKA MYOPATHY,0.27045945831080337,2.0377510040160645,2.664630598797084,0.480821459351257,"TLR1,MAPT",DisGeNET
2445,Specific learning disability,0.2713308110068603,1.6992279288351795,2.2165009437837093,0.480821459351257,"SLC25A15,MAP2K2,TERT",DisGeNET
2446,Venous Thrombosis,0.2713308110068603,1.6992279288351795,2.2165009437837093,0.480821459351257,"PDGFRA,JAK2,SH2B3",DisGeNET
2447,Chubby cheeks,0.2713308110068603,1.6992279288351795,2.2165009437837093,0.480821459351257,"ASXL1,MAP2K2,PIK3CA",DisGeNET
2448,Full cheeks,0.2713308110068603,1.6992279288351795,2.2165009437837093,0.480821459351257,"ASXL1,MAP2K2,PIK3CA",DisGeNET
2449,High-Grade Prostatic Intraepithelial Neoplasia,0.2713308110068603,1.6992279288351795,2.2165009437837093,0.480821459351257,"PIK3CA,DUSP1,LONP1",DisGeNET
2450,Hyperplasia of cheeks,0.2713308110068603,1.6992279288351795,2.2165009437837093,0.480821459351257,"ASXL1,MAP2K2,PIK3CA",DisGeNET
2451,Hypertrophy of cheeks,0.2713308110068603,1.6992279288351795,2.2165009437837093,0.480821459351257,"ASXL1,MAP2K2,PIK3CA",DisGeNET
2452,Puffy cheeks,0.2713308110068603,1.6992279288351795,2.2165009437837093,0.480821459351257,"ASXL1,MAP2K2,PIK3CA",DisGeNET
2453,Decreased tendon reflex,0.2715087513490271,1.457953394123607,1.9008226391916403,0.480821459351257,"FIG4,ALDH5A1,KIAA0586,SNIP1,HK1",DisGeNET
2454,Invasive Ductal Breast Carcinoma,0.2750731648579639,1.3921840354767183,1.7969172203727788,0.480821459351257,"CCND2,CD82,CDH1,NCOA4,KIT,HSD17B13",DisGeNET
2455,Cerebrovascular accident,0.27516319562094615,1.1898325847284605,1.5353491621176736,0.480821459351257,"FTO,IL1RN,GCKR,SMOX,GALNT2,HFE,LPL,SIRT3,ALDH2,PIK3CA,AXL,NLRP3,PPARG,APOE,APOB,JAK2,SH2B3,IL6R",DisGeNET
2456,"Affective Disorders, Psychotic",0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,IL1RN,DisGeNET
2457,Renal glomerular fibrosis,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,MAX,DisGeNET
2458,"Cancer, Embryonal",0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,KITLG,DisGeNET
2459,"Carcinoma of urinary bladder, invasive",0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,PIK3CA,DisGeNET
2460,Retinal depigmentation,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,SLC25A15,DisGeNET
2461,Robinow Syndrome,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,ATR,DisGeNET
2462,"Colitis, Lymphocytic",0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,IL37,DisGeNET
2463,Schistosomiasis mansoni,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,APOE,DisGeNET
2464,"Hearing Loss, Mixed Conductive-Sensorineural",0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,RPS28,DisGeNET
2465,Short Rib-Polydactyly Syndrome,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,KIAA0586,DisGeNET
2466,Sparse or absent eyelashes,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,MAP2K2,DisGeNET
2467,Sparse to absent eyelashes,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,MAP2K2,DisGeNET
2468,"Neoplasms, Radiation-Induced",0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,CEBPA,DisGeNET
2469,Streak ovary,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,MAP3K1,DisGeNET
2470,Symmetrical dyschromatosis of extremities,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,ADAR,DisGeNET
2471,Thrombocytopenic purpura,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,IL1RN,DisGeNET
2472,Trifunctional Protein Deficiency With Myopathy And Neuropathy,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,HADHA,DisGeNET
2473,Abnormality of blood and blood-forming tissues,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,FIG4,DisGeNET
2474,Abnormality of the fallopian tube,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,RAD50,DisGeNET
2475,Urogenital sinus anomaly,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,MAP3K1,DisGeNET
2476,Abnormality of the thyroid gland,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,THRB,DisGeNET
2477,Abnormally small eyeball on both sides,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,FIG4,DisGeNET
2478,Valgus deformities of feet,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,LONP1,DisGeNET
2479,Vulval intraepithelial neoplasia,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,PIK3CA,DisGeNET
2480,Anti-Glomerular Basement Membrane Disease,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,IL1RN,DisGeNET
2481,Aortic Rupture,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,APOE,DisGeNET
2482,ARTERIAL TORTUOSITY SYNDROME,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,APOE,DisGeNET
2483,Balkan Nephropathy,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,IL1RN,DisGeNET
2484,Basaloid squamous cell carcinoma,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,PIK3CA,DisGeNET
2485,Benign symmetrical lipomatosis,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,PIK3CA,DisGeNET
2486,Bilateral nanophthalmos,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,FIG4,DisGeNET
2487,Blepharitis,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,APOE,DisGeNET
2488,Calcium measurement,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,GCKR,DisGeNET
2489,Chronic Q Fever,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,TLR1,DisGeNET
2490,Completed Suicide,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,FTO,DisGeNET
2491,Compulsive hoarding,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,MAPT,DisGeNET
2492,Cone-shaped epiphyses of the phalanges of the hand,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,ATR,DisGeNET
2493,Cranial nerve palsies,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,NLRP3,DisGeNET
2494,Decreased sensory nerve conduction velocity,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,TYMP,DisGeNET
2495,Distal arthrogryposis syndrome,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,FIG4,DisGeNET
2496,Endomyocardial Fibrosis,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,PDGFRA,DisGeNET
2497,Enlarged kidney,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,NPHP3,DisGeNET
2498,Enteropathy-Associated T-Cell Lymphoma,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,MYO9B,DisGeNET
2499,Epidermolysis Bullosa Acquisita,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,IL1RN,DisGeNET
2500,Familial Dystonia,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,ALDH5A1,DisGeNET
2501,Familial partial lipodystrophy,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,PPARG,DisGeNET
2502,Fanconi Syndrome,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,ABCC2,DisGeNET
2503,Filarial Elephantiases,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,TLR1,DisGeNET
2504,Fissured tongue,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,PIK3CA,DisGeNET
2505,Gastric dysplasia,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,SMOX,DisGeNET
2506,Gastrointestinal hamartomatous polyps,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,PIK3CA,DisGeNET
2507,Generalized hyperkeratosis,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,PIK3CA,DisGeNET
2508,Glucose tolerance test,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,GCKR,DisGeNET
2509,Growth hormone excess,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,PPARG,DisGeNET
2510,growth hormone treatment,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,LPL,DisGeNET
2511,Hand polydactyly,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,PIK3CA,DisGeNET
2512,Hematological abnormality,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,FIG4,DisGeNET
2513,Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,PIK3CA,DisGeNET
2514,Hypoketotic hypoglycemia,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,HADHA,DisGeNET
2515,Inflammatory disease of mucous membrane,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,IL1RN,DisGeNET
2516,Large earlobe,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,PIK3CA,DisGeNET
2517,Leukaemia recurrent,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,CEBPA,DisGeNET
2518,Little's Disease,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,GCDH,DisGeNET
2519,Low Back Pain,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,NLRP3,DisGeNET
2520,Meconium ileus,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,MSRA,DisGeNET
2521,Mild global developmental delay,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,ATR,DisGeNET
2522,Mucopolysaccharidosis I,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,PTPRC,DisGeNET
2523,Myoglobinuria,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,HADHA,DisGeNET
2524,Neonatal thrombocytopenia (disorder),0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,PGAP3,DisGeNET
2525,Nesidioblastosis,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,PPARG,DisGeNET
2526,Optic Nerve Glioma,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,PIK3CA,DisGeNET
2527,Overriding toe,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,ASXL1,DisGeNET
2528,Partial to total absence of eyelashes,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,MAP2K2,DisGeNET
2529,Portal vein thrombosis,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,JAK2,DisGeNET
2530,Potter's facies,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,NPHP3,DisGeNET
2531,Pyle metaphyseal dysplasia,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,LONP1,DisGeNET
2532,Rachischisis,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,PDGFRA,DisGeNET
2533,Reading Disabilities,0.2760473156248264,3.3930597263930595,4.367488779253821,0.480821459351257,TDP2,DisGeNET
2534,Depressive disorder,0.2762486570899822,1.1953959098816853,1.5378217152191398,0.4809822711448309,"FTO,GYPA,TOMM40,DUSP1,GYPE,ETS2,FIG4,AHI1,ALDH2,PIK3CA,KIT,SERPING1,APOE,MAPT,KCTD17,SLC12A7,IL6R",DisGeNET
2535,"Acute Myeloid Leukemia, M1",0.2775426585130613,1.53,1.9611243688551132,0.48225086196110817,"CEBPA,CCND2,KIT,JAK2",DisGeNET
2536,Sarcomatoid Renal Cell Carcinoma,0.2775426585130613,1.53,1.9611243688551132,0.48225086196110817,"PIK3CA,EPAS1,IL6R,CTSB",DisGeNET
2537,Systolic Pressure,0.2775426585130613,1.53,1.9611243688551132,0.48225086196110817,"FTO,GCKR,HFE,SH2B3",DisGeNET
2538,Interstitial lung fibrosis,0.2775426585130613,1.53,1.9611243688551132,0.48225086196110817,"ALDH2,NLRP3,PPARG,SIRT3",DisGeNET
2539,"Respiratory Distress Syndrome, Adult",0.2776330891616534,1.4440557435338648,1.8504922509291213,0.48225086196110817,"HADHA,IL1RN,MAP3K1,EPAS1,NLRP3",DisGeNET
2540,Follicular thyroid carcinoma,0.2776330891616534,1.4440557435338648,1.8504922509291213,0.48225086196110817,"CCND2,THRB,TERT,PIK3CA,PPARG",DisGeNET
2541,"Muscular Dystrophy, Facioscapulohumeral",0.28002009647924414,1.6681680856907444,2.1234009892054697,0.48506033202450927,"HIST1H4H,HIST1H4J,HIST1H4C",DisGeNET
2542,Vascular lesions,0.28002009647924414,1.6681680856907444,2.1234009892054697,0.48506033202450927,"ALDH2,PPARG,APOE",DisGeNET
2543,Adenovirus Infections,0.28002009647924414,1.6681680856907444,2.1234009892054697,0.48506033202450927,"HBS1L,TERT,APOB",DisGeNET
2544,Cakut,0.28002009647924414,1.6681680856907444,2.1234009892054697,0.48506033202450927,"DSTYK,KIT,NPHP3",DisGeNET
2545,Hemangiosarcoma,0.28002009647924414,1.6681680856907444,2.1234009892054697,0.48506033202450927,"PIK3CA,TERT,KIT",DisGeNET
2546,Myalgia,0.28002009647924414,1.6681680856907444,2.1234009892054697,0.48506033202450927,"PDGFRA,HADHA,NLRP3",DisGeNET
2547,Nephrolithiasis,0.28002009647924414,1.6681680856907444,2.1234009892054697,0.48506033202450927,"FADS2,IL1RN,CDH1",DisGeNET
2548,Craniofacial Abnormalities,0.2805421448292483,1.381578947368421,1.7560301081289498,0.48558334365894207,"PDGFRA,THRB,KANSL1,KIAA0586,HIST1H4C,ETS2",DisGeNET
2549,Malnutrition,0.2805421448292483,1.381578947368421,1.7560301081289498,0.48558334365894207,"LEPROT,LEPR,APOE,APOB,DDB2,TYMP",DisGeNET
2550,Undergrowth,0.28213237535411806,1.235566301221393,1.5634595296321616,0.4875664013703177,"ASXL1,FTO,GCDH,SLC25A15,HADHA,RTEL1,KANSL1,PIK3CA,TERT,PRDM16,SLC39A13,DDB2",DisGeNET
2551,Arrhythmogenic Right Ventricular Dysplasia,0.28235089653244827,1.9718227749708512,2.493576284940006,0.4875664013703177,"MEF2C,PPARG",DisGeNET
2552,Colonic Polyps,0.28235089653244827,1.9718227749708512,2.493576284940006,0.4875664013703177,"TERT,PPARG",DisGeNET
2553,Dental Enamel Hypoplasia,0.28235089653244827,1.9718227749708512,2.493576284940006,0.4875664013703177,"LONP1,ATR",DisGeNET
2554,Dizziness,0.28235089653244827,1.9718227749708512,2.493576284940006,0.4875664013703177,"JAK2,SH2B3",DisGeNET
2555,Mental deterioration,0.28235089653244827,1.9718227749708512,2.493576284940006,0.4875664013703177,"MAPT,APOE",DisGeNET
2556,Hypertensive disease,0.28285583385878693,1.1367498543406487,1.4355081004092907,0.4882472374745571,"FTO,TAGLN,GYPA,IL1RN,CD82,EPAS1,GYPE,HFE,LPL,AGAP1,ALDH2,TERT,LEPR,NPHP3,NLRP3,APOE,APOB,JAK2,SH2B3,PTPN1,PDGFRA,ABCC2,GALNT2,DUSP1,BTN2A1,NSMCE2,RHOA,SIRT3,PIK3CA,PPARG",DisGeNET
2557,Middle Cerebral Artery Occlusion,0.2846687452653117,1.5109614665170221,1.8984159132332938,0.4911843973838699,"IL1RN,APOE,PLD1,IL6R",DisGeNET
2558,Atrial Fibrillation,0.2849942117495389,1.3040073097506852,1.6369026526065795,0.4915537381700413,"FTO,MSRA,PDGFRA,HSPA8,GCKR,TERT,KIT,IL6R",DisGeNET
2559,Visual seizure,0.28603580642203297,1.3711321441572624,1.7161614768092526,0.4931574747690541,"RRM1,ABCC2,DUSP1,APOE,PLD1,IL6R",DisGeNET
2560,Childhood Medulloblastoma,0.28873476314902763,1.6382175226586102,2.0350704536897366,0.4956812156694352,"BRD3,PDGFRA,TFRC",DisGeNET
2561,Palmoplantar Keratosis,0.28873476314902763,1.6382175226586102,2.0350704536897366,0.4956812156694352,"KANK2,MAP2K2,PIK3CA",DisGeNET
2562,"Lymphoma, Follicular",0.2896245539407356,1.2969779595546467,1.607175965900902,0.4956812156694352,"RTEL1,CCND3,KITLG,BCL2L11,PIK3CA,BCL11A,KIT,LONP1",DisGeNET
2563,Ciliopathies,0.2899637597154422,1.4170325340538106,1.7542853281847621,0.4956812156694352,"AHI1,KIAA0586,NPHP3,RAB8A,ATR",DisGeNET
2564,Language Delay,0.2899637597154422,1.4170325340538106,1.7542853281847621,0.4956812156694352,"MEF2C,ALDH5A1,THRB,KANSL1,BCL11A",DisGeNET
2565,Vasculitis,0.2918217607684129,1.4923872875092388,1.8380421985244855,0.4956812156694352,"IL1RN,GYPA,RTEL1,SERPING1",DisGeNET
2566,Mental Depression,0.2918564024806276,1.2035539215686275,1.4821686748494354,0.4956812156694352,"FTO,GYPA,TOMM40,DUSP1,GYPE,ETS2,AHI1,PTPRC,ALDH2,KIT,SERPING1,APOE,SLC12A7,IL6R",DisGeNET
2567,Sleep Apnea Syndromes,0.294225419472405,1.9100150602409638,2.3367297533746547,0.4956812156694352,"LEPR,APOE",DisGeNET
2568,Thin face,0.294225419472405,1.9100150602409638,2.3367297533746547,0.4956812156694352,"DSTYK,ATR",DisGeNET
2569,Viral hepatitis,0.294225419472405,1.9100150602409638,2.3367297533746547,0.4956812156694352,"ALDH2,APOE",DisGeNET
2570,Cytokine Measurement,0.294225419472405,1.9100150602409638,2.3367297533746547,0.4956812156694352,"BLK,ZNF827",DisGeNET
2571,Gingivitis,0.294225419472405,1.9100150602409638,2.3367297533746547,0.4956812156694352,"IL1RN,NLRP3",DisGeNET
2572,Hereditary Malignant Neoplasm,0.294225419472405,1.9100150602409638,2.3367297533746547,0.4956812156694352,"RAD50,CDH1",DisGeNET
2573,High-Grade Squamous Intraepithelial Lesions,0.294225419472405,1.9100150602409638,2.3367297533746547,0.4956812156694352,"TERT,MPG",DisGeNET
2574,Hypocholesterolemia,0.294225419472405,1.9100150602409638,2.3367297533746547,0.4956812156694352,"PIK3CA,APOB",DisGeNET
2575,Narrow face,0.294225419472405,1.9100150602409638,2.3367297533746547,0.4956812156694352,"DSTYK,ATR",DisGeNET
2576,Nerve Sheath Tumors,0.294225419472405,1.9100150602409638,2.3367297533746547,0.4956812156694352,"PDGFRA,KIT",DisGeNET
2577,Profound intellectual disabilities,0.294225419472405,1.9100150602409638,2.3367297533746547,0.4956812156694352,"ASXL1,ADAR",DisGeNET
2578,Pulmonary Stenosis,0.294225419472405,1.9100150602409638,2.3367297533746547,0.4956812156694352,"MAP2K2,KANSL1",DisGeNET
2579,Degenerative polyarthritis,0.2960094801878209,1.152109815227362,1.402536779813028,0.4956812156694352,"FTO,NFE2,PTPN1,PDGFRA,IL1RN,CD82,DUSP1,EPAS1,HFE,PDCD5,TLR1,HADHA,MFHAS1,PIK3CA,LEPR,NLRP3,PPARG,APOE,ANP32B,IL6R,EPHB4,CTSB",DisGeNET
2580,Delayed speech and language development,0.2961661964033936,1.4038928083433255,1.7083052145707955,0.4956812156694352,"ASXL1,MEF2C,ALDH5A1,THRB,KANSL1",DisGeNET
2581,Sciatic Neuropathy,0.29746957034264254,1.6093178565749722,1.9512067232473926,0.4956812156694352,"PDGFRA,APOE,IL6R",DisGeNET
2582,Skin carcinoma,0.29746957034264254,1.6093178565749722,1.9512067232473926,0.4956812156694352,"PIK3CA,TERT,DMKN",DisGeNET
2583,Small for gestational age (disorder),0.29746957034264254,1.6093178565749722,1.9512067232473926,0.4956812156694352,"CEP57,HADHA,THRB",DisGeNET
2584,Inflammatory Breast Carcinoma,0.29746957034264254,1.6093178565749722,1.9512067232473926,0.4956812156694352,"PDGFRA,PIK3CA,CTSB",DisGeNET
2585,Low Birth Weights,0.29746957034264254,1.6093178565749722,1.9512067232473926,0.4956812156694352,"CEP57,HADHA,THRB",DisGeNET
2586,Pruritus,0.2989987311231301,1.4742606790799562,1.7798984313318675,0.4956812156694352,"PDGFRA,KIT,NLRP3,JAK2",DisGeNET
2587,"Angina Pectoris, Variant",0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,APOE,DisGeNET
2588,Restrictive cardiomyopathy,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,PDGFRA,DisGeNET
2589,"DISORGANIZATION, MOUSE, HOMOLOG OF",0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,ETS2,DisGeNET
2590,Severe periodontitis,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,IL1RN,DisGeNET
2591,Sexually Transmitted Diseases,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,KIT,DisGeNET
2592,"Hereditary motor and sensory neuropathy, types I-IV",0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,FIG4,DisGeNET
2593,Shock,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,IL1RN,DisGeNET
2594,Short humerus,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,LONP1,DisGeNET
2595,"Jaundice, Chronic Idiopathic",0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,ABCC2,DisGeNET
2596,"Lymphoma, Mixed-Cell",0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,TFRC,DisGeNET
2597,"Myopathies, Nemaline",0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,HK1,DisGeNET
2598,Sprengel deformity,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,THRB,DisGeNET
2599,"Opitz GBBB Syndrome, X-Linked",0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,GADD45A,DisGeNET
2600,Stenosis,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,APOE,DisGeNET
2601,"Papillary renal cell carcinoma, sporadic",0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,PIK3CA,DisGeNET
2602,"Psychomotor retardation, mild",0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,ATR,DisGeNET
2603,TDP-43 Proteinopathies,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,RRM1,DisGeNET
2604,Thumb aplasia,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,FIG4,DisGeNET
2605,Thyroid Lymphoma,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,LONP1,DisGeNET
2606,Tinnitus,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,JAK2,DisGeNET
2607,Uterine Corpus Carcinosarcoma,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,FLOT2,DisGeNET
2608,Accessory nipple,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,ASXL1,DisGeNET
2609,Acquired partial lipodystrophy,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,PPARG,DisGeNET
2610,Viral myocarditis,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,IL1RN,DisGeNET
2611,Acute hepatitis,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,SLC25A15,DisGeNET
2612,Age-related cognitive decline,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,APOE,DisGeNET
2613,Agranulocytosis,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,ALDH2,DisGeNET
2614,Akinesia,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,MAPT,DisGeNET
2615,Alcohol problem,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,ALDH2,DisGeNET
2616,Alkaline phosphatase measurement,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,FADS2,DisGeNET
2617,Alveolar Soft Part Sarcoma,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,TFEB,DisGeNET
2618,Alveolitis,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,IL2RB,DisGeNET
2619,Amyloid angiopathy,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,APOE,DisGeNET
2620,Anal squamous cell carcinoma,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,PIK3CA,DisGeNET
2621,Autosome Abnormalities,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,EPAS1,DisGeNET
2622,Bipolar II disorder,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,ALDH2,DisGeNET
2623,Bone Cysts,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,PPARG,DisGeNET
2624,Carotid artery occlusion,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,APOE,DisGeNET
2625,Cholecystitis,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,HK1,DisGeNET
2626,Chromosome Aberrations,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,EPAS1,DisGeNET
2627,Chronic venous insufficiency,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,BLOC1S2,DisGeNET
2628,Complement deficiency disease,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,IL1RN,DisGeNET
2629,Congenital cystic kidney disease,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,NPHP3,DisGeNET
2630,de novo myelodysplastic syndromes,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,ASXL1,DisGeNET
2631,Delayed closure of the soft spot on the skull,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,NLRP3,DisGeNET
2632,Dysesthesia,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,NLRP3,DisGeNET
2633,Dystrophic fingernails,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,MAP2K2,DisGeNET
2634,Erythema Chronicum Migrans,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,TLR1,DisGeNET
2635,Eye Color,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,HK1,DisGeNET
2636,Familial Dementia,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,MAPT,DisGeNET
2637,First myocardial infarction,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,IL1RN,DisGeNET
2638,Fish-Eye Disease,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,PPARG,DisGeNET
2639,Hereditary Motor and Sensory Neuropathy Type I,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,FIG4,DisGeNET
2640,Herpes zoster disease,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,APOE,DisGeNET
2641,Hyperferritinaemia,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,HFE,DisGeNET
2642,Hypertrophic neuropathy of infancy,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,FIG4,DisGeNET
2643,Hypopharyngeal Carcinoma,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,ETS2,DisGeNET
2644,Hypoxic-Ischemic Encephalopathy,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,APOE,DisGeNET
2645,Increased ferritin,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,HFE,DisGeNET
2646,Increased serum ferritin,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,HFE,DisGeNET
2647,Infection by Candida albicans,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,NLRP3,DisGeNET
2648,Intermittent fever,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,NLRP3,DisGeNET
2649,Late closure of anterior fontanel,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,NLRP3,DisGeNET
2650,Liver cyst,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,NPHP3,DisGeNET
2651,Micronodular cirrhosis,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,PIK3CA,DisGeNET
2652,Multiple renal cysts,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,EPAS1,DisGeNET
2653,Myeloid and Lymphoid Neoplasms with FGFR1 Rearrangement,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,KIT,DisGeNET
2654,Nephropathic cystinosis,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,TFEB,DisGeNET
2655,Nevi and Melanomas,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,KIT,DisGeNET
2656,Organic writer's cramp,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,KCTD17,DisGeNET
2657,Oropharynx (excludes nasopharynx),0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,SERPING1,DisGeNET
2658,Parvovirus B19 (disease),0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,RBM38,DisGeNET
2659,Peroneal muscular atrophy (axonal type) (hypertrophic type),0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,FIG4,DisGeNET
2660,Poor eye contact,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,MEF2C,DisGeNET
2661,Protrusion of tongue,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,FTO,DisGeNET
2662,Pyothorax-Associated Lymphoma,0.29907148597280975,3.0534534534534536,3.685740153685031,0.4956812156694352,ATR,DisGeNET
2663,Failure to gain weight,0.3005334007042109,1.2145624500338232,1.4601425816299358,0.4979171475429886,"ASXL1,FTO,GCDH,SLC25A15,HADHA,RTEL1,KANSL1,PIK3CA,TERT,PRDM16,SLC39A13,DDB2",DisGeNET
2664,Vomiting,0.30239079049710293,1.3909919867366676,1.6636752258314622,0.500618449408337,"GCDH,RRM1,SERPING1,LPL,TYMP",DisGeNET
2665,Prostatic Intraepithelial Neoplasias,0.30239079049710293,1.3909919867366676,1.6636752258314622,0.500618449408337,"PIK3CA,CDH1,DUSP1,SMOX,LONP1",DisGeNET
2666,Diffuse Large B-Cell Lymphoma,0.303274703639325,1.2010471793716924,1.432988932579696,0.5017052840107619,"CEBPA,RTEL1,BCL11A,BYSL,CCND3,PTPRC,CCND2,SLC22A16,PIK3CA,CDH1,LEPR,LONP1,JAK2",DisGeNET
2667,Liver and Intrahepatic Biliary Tract Carcinoma,0.303274703639325,1.2010471793716924,1.432988932579696,0.5017052840107619,"CEBPA,PDGFRA,CD82,EPAS1,HFE,KITLG,ALDH2,PIK3CA,TERT,CDH1,NLRP3,PPARG,CPEB4",DisGeNET
2668,"Leukoplakia, Oral",0.3060721256646625,1.8519532676159183,2.192591365950232,0.5037435058788271,"RTEL1,TERT",DisGeNET
2669,Tooth problem,0.3060721256646625,1.8519532676159183,2.192591365950232,0.5037435058788271,"KANSL1,DDB2",DisGeNET
2670,Vertigo,0.3060721256646625,1.8519532676159183,2.192591365950232,0.5037435058788271,"JAK2,SH2B3",DisGeNET
2671,Bicuspid aortic valve,0.3060721256646625,1.8519532676159183,2.192591365950232,0.5037435058788271,"KANSL1,SNIP1",DisGeNET
2672,Drug usage,0.3060721256646625,1.8519532676159183,2.192591365950232,0.5037435058788271,"PPARG,APOE",DisGeNET
2673,Dystrophia unguium,0.3060721256646625,1.8519532676159183,2.192591365950232,0.5037435058788271,"RTEL1,TERT",DisGeNET
2674,Early Rheumatoid Arthritis,0.3060721256646625,1.8519532676159183,2.192591365950232,0.5037435058788271,"TLR1,IL2RB",DisGeNET
2675,Gastrointestinal Stromal Sarcoma,0.3060721256646625,1.8519532676159183,2.192591365950232,0.5037435058788271,"PDGFRA,KIT",DisGeNET
2676,Hepatocellular Adenoma,0.3060721256646625,1.8519532676159183,2.192591365950232,0.5037435058788271,"IL1RN,TERT",DisGeNET
2677,Skin Carcinogenesis,0.30619672351044575,1.4565656565656566,1.7238855047178703,0.5037435058788271,"CEBPA,KIT,PPARG,DDB2",DisGeNET
2678,Delayed Puberty,0.3062194203914357,1.5814147307011146,1.8715305985704085,0.5037435058788271,"RPS28,MAP3K1,LEPR",DisGeNET
2679,Hairy Cell Leukemia,0.3062194203914357,1.5814147307011146,1.8715305985704085,0.5037435058788271,"HMGCL,DOK2,PIK3CA",DisGeNET
2680,Pleural effusion disorder,0.3062194203914357,1.5814147307011146,1.8715305985704085,0.5037435058788271,"TERT,HFE,NLRP3",DisGeNET
2681,Premature Obstetric Labor,0.3062194203914357,1.5814147307011146,1.8715305985704085,0.5037435058788271,"IL1RN,IL6R,RHOA",DisGeNET
2682,Rash and Dermatitis Adverse Event Associated with Chemoradiation,0.3062194203914357,1.5814147307011146,1.8715305985704085,0.5037435058788271,"SAMM50,PIK3CA,TYMP",DisGeNET
2683,Malignant neoplasm of liver,0.3066468370109683,1.1674535458965836,1.3799984592190362,0.5042586078614953,"CEBPA,PDGFRA,TAGLN,CD82,EPAS1,TNK2,HFE,CPT1B,KITLG,ALDH2,PIK3CA,TERT,CDH1,NLRP3,PPARG,CPEB4,PLS1",DisGeNET
2684,Epilepsy,0.3069320314748375,1.1336407289667878,1.338975885870243,0.5045395390711561,"FTO,LEPROT,IL1RN,TOMM40,PGAP3,NPRL3,SEZ6,CCND2,ALDH2,PRDM16,LEPR,SNIP1,APOE,MEF2C,ABCC2,TNK2,VRK2,ASXL1,FIG4,ALDH5A1,KANSL1,PIK3CA,TDP2,MAPT,ATR",DisGeNET
2685,Acute Myeloid Leukemia (AML-M2),0.3134128482502873,1.4392869875222816,1.6699096318534767,0.5081952407938299,"CEBPA,CCND2,KIT,JAK2",DisGeNET
2686,Neoplasm Metastasis,0.3142717259781572,1.0753918382087395,1.2447631469456917,0.5081952407938299,"IL1RN,TFRC,CD82,CITED2,ADAR,ETS2,UBE2L3,LAPTM4B,FADS2,CCND2,CDH1,MYB,LEPR,LONP1,SNIP1,FLOT2,JARID2,JAK2,IL6R,EPHB4,RAB8A,CTSB,PDGFRA,MAP2K2,DUSP1,TFEB,ATP11A,RHOA,DDB2,PIK3CA,KIT,PPARG,MAPT,TRIB1,FTO,CEBPA,MACF1,TAGLN,TMPRSS6,EPAS1,LPL,PLD1,THBS3,TYMP,HDAC7,BCL2L11,TERT,ZKSCAN3,APOE,RBM38,CD164,HSPA8,PTPN1,RRM1,MAP3K1,GADD45A,IL37,TNK2,MYO9B,MSRA,RAD50,TF,KITLG,PTPRC,AXL,DLG5,TRIP6,IL2RB,ZNF217,RPL22L1,ANP32B,FBXL5,MUC20,CPEB4",DisGeNET
2687,Speech Delay,0.3148988061137183,1.3658814589665653,1.5782814104152814,0.5081952407938299,"MEF2C,ALDH5A1,THRB,KANSL1,BCL11A",DisGeNET
2688,Renal failure in adulthood,0.31497935978187597,1.5544574735009473,1.7957841466387816,0.5081952407938299,"NPHP3,NLRP3,APOE",DisGeNET
2689,Small testicle,0.31497935978187597,1.5544574735009473,1.7957841466387816,0.5081952407938299,"MAP3K1,AXL,LEPR",DisGeNET
2690,Tumor Immunity,0.31497935978187597,1.5544574735009473,1.7957841466387816,0.5081952407938299,"TERT,BTN3A1,BTN3A2",DisGeNET
2691,Age at menarche,0.31497935978187597,1.5544574735009473,1.7957841466387816,0.5081952407938299,"FTO,SIRT3,BYSL",DisGeNET
2692,Bulging forehead,0.31497935978187597,1.5544574735009473,1.7957841466387816,0.5081952407938299,"ASXL1,GCDH,CCND2",DisGeNET
2693,Cystic kidney,0.31497935978187597,1.5544574735009473,1.7957841466387816,0.5081952407938299,"AHI1,NPHP3,EPHB4",DisGeNET
2694,Prominent forehead,0.31497935978187597,1.5544574735009473,1.7957841466387816,0.5081952407938299,"ASXL1,GCDH,CCND2",DisGeNET
2695,Migraine Disorders,0.3165517274223231,1.283250013734,1.4760822159690061,0.5081952407938299,"RPS28,PTPRC,PIK3CA,HFE,PRDM16,NLRP3,APOE",DisGeNET
2696,Cervix carcinoma,0.3175701681546668,1.1393896973323248,1.306944338993927,0.5081952407938299,"CEBPA,IL1RN,TFRC,CD82,GADD45A,PABPC4,NSMCE2,TMC8,HSD17B13,TMC6,ETS2,TYMP,LAPTM4B,ELF1,PIK3CA,TERT,CDH1,PPARG,JAK2,IL6R,ATR",DisGeNET
2697,Precancerous Conditions,0.3176010969491332,1.2206728640991589,1.4000618444076967,0.5081952407938299,"LAPTM4B,CEBPA,IL1RN,ALDH2,PIK3CA,TERT,CDH1,TNK2,KIT,ATR",DisGeNET
2698,Syndactyly of the toes,0.31788081930037987,1.7973068745570517,2.0598552135069905,0.5081952407938299,"FIG4,PIK3CA",DisGeNET
2699,"stage, non-small cell lung cancer",0.31788081930037987,1.7973068745570517,2.0598552135069905,0.5081952407938299,"RRM1,ABCC2",DisGeNET
2700,Desmoplastic Medulloblastoma,0.31788081930037987,1.7973068745570517,2.0598552135069905,0.5081952407938299,"BRD3,PDGFRA",DisGeNET
2701,Extrapyramidal Disorders,0.31788081930037987,1.7973068745570517,2.0598552135069905,0.5081952407938299,"GCDH,FBXO7",DisGeNET
2702,Familial aplasia of the vermis,0.31788081930037987,1.7973068745570517,2.0598552135069905,0.5081952407938299,"AHI1,KIAA0586",DisGeNET
2703,Hyperandrogenism,0.31788081930037987,1.7973068745570517,2.0598552135069905,0.5081952407938299,"FTO,PPARG",DisGeNET
2704,Moyamoya disease 1,0.31788081930037987,1.7973068745570517,2.0598552135069905,0.5081952407938299,"APOE,ATP11A",DisGeNET
2705,"Carcinoma, Transitional Cell",0.3180202467685295,1.2362193859951707,1.4162626606453992,0.5081952407938299,"CEBPA,CCND2,PIK3CA,TERT,CD82,CDH1,DUSP1,CRLF3,ATR",DisGeNET
2706,Refractory Neoplasm,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,KIT,DisGeNET
2707,"Congenital Myasthenic Syndromes, Postsynaptic",0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,AK9,DisGeNET
2708,Sebaceous adenoma,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,PIK3CA,DisGeNET
2709,"Glossitis, Benign Migratory",0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,TLR1,DisGeNET
2710,"HYPERCHOLESTEROLEMIA, AUTOSOMAL RECESSIVE",0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,APOB,DisGeNET
2711,"Jaundice, Obstructive",0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,ABCC2,DisGeNET
2712,Smith-Lemli-Opitz Syndrome,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,APOE,DisGeNET
2713,"Lymphoma, Undifferentiated",0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,TFRC,DisGeNET
2714,Smooth Muscle Tumor,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,KIT,DisGeNET
2715,Sparse eyebrow,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,FIG4,DisGeNET
2716,"Nephronophthisis, familial juvenile",0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,NPHP3,DisGeNET
2717,Symmetric Diabetic Proximal Motor Neuropathy,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,LEPR,DisGeNET
2718,T-Lymphocytopenia,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,PTPRC,DisGeNET
2719,Testicular Hydrocele,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,PIK3CA,DisGeNET
2720,"Teratoma, Malignant",0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,KIT,DisGeNET
2721,AA amyloidosis,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,NLRP3,DisGeNET
2722,Trachoma,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,IL1RN,DisGeNET
2723,Tubulointerstitial fibrosis,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,NPHP3,DisGeNET
2724,Tumor Necrosis Factor Receptor 1-Associated Periodic Syndrome,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,NLRP3,DisGeNET
2725,Abnormality of the heart valves,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,MAP2K2,DisGeNET
2726,Abnormality of the musculature,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,PPARG,DisGeNET
2727,Varicocele,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,PIK3CA,DisGeNET
2728,Absent eyebrow,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,MAP2K2,DisGeNET
2729,Venous malformation,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,PIK3CA,DisGeNET
2730,Vital Capacity Adverse Event,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,KANSL1,DisGeNET
2731,Acute pyelonephritis,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,NLRP3,DisGeNET
2732,Adult Burkitt Lymphoma,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,PIK3CA,DisGeNET
2733,Agenesis of eyebrows,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,MAP2K2,DisGeNET
2734,Alagille Syndrome,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,APOE,DisGeNET
2735,Aplasia of eyebrows,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,MAP2K2,DisGeNET
2736,Appendicitis,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,LEPR,DisGeNET
2737,Asymmetric Diabetic Proximal Motor Neuropathy,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,LEPR,DisGeNET
2738,BREAST CANCER 3,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,PIK3CA,DisGeNET
2739,Childhood Myelodysplastic Syndrome,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,PPARG,DisGeNET
2740,Chronic myocardial ischemia,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,TYMP,DisGeNET
2741,Clonus,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,SLC25A15,DisGeNET
2742,CNS hypomyelination,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,SNIP1,DisGeNET
2743,Coloboma of eyelid,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,ADAR,DisGeNET
2744,Cone dysfunction syndrome,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,RP1L1,DisGeNET
2745,Dermatitis Herpetiformis,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,MYO9B,DisGeNET
2746,Diabetic Amyotrophy,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,LEPR,DisGeNET
2747,Diabetic Asymmetric Polyneuropathy,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,LEPR,DisGeNET
2748,Diabetic Autonomic Neuropathy,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,LEPR,DisGeNET
2749,Diabetic Mononeuropathy,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,LEPR,DisGeNET
2750,Diastrophic dysplasia,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,APOE,DisGeNET
2751,Diffuse Mixed-Cell Lymphoma,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,TFRC,DisGeNET
2752,Disease due to Papilloma virus,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,TERT,DisGeNET
2753,Dysgraphia,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,MAPT,DisGeNET
2754,Dystonia Musculorum Deformans,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,ADAR,DisGeNET
2755,Endocarditis,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,SMOX,DisGeNET
2756,Enthesitis-Related Arthritis,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,TLR1,DisGeNET
2757,Executive dysfunction,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,APOE,DisGeNET
2758,Fetal overgrowth,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,PIK3CA,DisGeNET
2759,Fibrolamellar Hepatocellular Carcinoma,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,CDH1,DisGeNET
2760,Fibrous skin tumor of tuberous sclerosis,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,PIK3CA,DisGeNET
2761,Generalized overgrowth,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,PIK3CA,DisGeNET
2762,Granuloma,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,TLR1,DisGeNET
2763,Hepatic Form of Wilson Disease,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,APOE,DisGeNET
2764,HER2-positive carcinoma of breast,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,PIK3CA,DisGeNET
2765,Homocysteine measurement,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,SLC17A3,DisGeNET
2766,Hyperplasia of supraorbital margins,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,PPARG,DisGeNET
2767,Hyperplasia of supraorbital ridge,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,PPARG,DisGeNET
2768,Hypertrophy of supraorbital margins,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,PPARG,DisGeNET
2769,Hypertrophy of supraorbital ridge,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,PPARG,DisGeNET
2770,Ileal Diseases,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,TLR1,DisGeNET
2771,Irregular vertebral endplates,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,SLC39A13,DisGeNET
2772,Kashin-Beck Disease,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,PIK3CA,DisGeNET
2773,Laryngitis,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,MUC20,DisGeNET
2774,Lower limb spasticity,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,FBXO7,DisGeNET
2775,Madarosis of eyebrow,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,MAP2K2,DisGeNET
2776,Malignant neoplasm of other specified sites of female breast,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,PIK3CA,DisGeNET
2777,Microretrognathia,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,NSMCE2,DisGeNET
2778,MOHR-TRANEBJAERG SYNDROME,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,GYPA,DisGeNET
2779,Mucosal telangiectasiae,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,PIK3CA,DisGeNET
2780,Myoclonic dystonia,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,KCTD17,DisGeNET
2781,Neurodegeneration with brain iron accumulation (NBIA),0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,FBXO7,DisGeNET
2782,Norrie disease,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,APOE,DisGeNET
2783,Oligomenorrhea,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,PPARG,DisGeNET
2784,Overgrowth,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,PIK3CA,DisGeNET
2785,Petechiae,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,APOE,DisGeNET
2786,PITUITARY DWARFISM I,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,NSMCE2,DisGeNET
2787,Poor coordination,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,SLC25A15,DisGeNET
2788,Porencephalic cyst,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,ADAR,DisGeNET
2789,Primary chondrosarcoma of bone,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,KIT,DisGeNET
2790,Prominent supraorbital ridges,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5081952407938299,PPARG,DisGeNET
2791,Thyroid carcinoma,0.32150578028451837,1.1603253192976195,1.3166672701112196,0.5082348629936564,"THRB,MPG,IL37,TRPC1,NCOA4,SIRT3,TYMP,CCND3,KITLG,CCND2,PIK3CA,TERT,CDH1,KIT,PPARG,CTSB",DisGeNET
2792,Lupus Erythematosus,0.3216785728590722,1.2754841997961264,1.446657308077901,0.5083258823260124,"BLK,IL1RN,FAM167A,PTPRC,GADD45A,NLRP3,PDE7A",DisGeNET
2793,Schizoaffective Disorder,0.32374458038296294,1.5283987915407855,1.7237287779939032,0.5112244411773917,"GIGYF1,TF,HFE",DisGeNET
2794,Childhood Neuroblastoma,0.32374458038296294,1.5283987915407855,1.7237287779939032,0.5112244411773917,"TERT,MAX,ITSN1",DisGeNET
2795,Liver Dysfunction,0.32747267975456223,1.3416520023462912,1.4977540821873454,0.516822712360453,"HADHA,SLC25A15,HFE,JAK2,TYMP",DisGeNET
2796,"Ovarian Failure, Premature",0.32788816248201164,1.4059212817833509,1.5677184943562388,0.516822712360453,"KITLG,CITED2,SPO11,KIT",DisGeNET
2797,Collecting Duct Carcinoma of the Kidney,0.32788816248201164,1.4059212817833509,1.5677184943562388,0.516822712360453,"PIK3CA,EPAS1,IL6R,CTSB",DisGeNET
2798,Hemoglobin low,0.32788816248201164,1.4059212817833509,1.5677184943562388,0.516822712360453,"RTEL1,TF,TERT,NLRP3",DisGeNET
2799,Irritable Bowel Syndrome,0.32788816248201164,1.4059212817833509,1.5677184943562388,0.516822712360453,"IL1RN,CDH1,DLG5,NKX2-3",DisGeNET
2800,HIV Infections,0.3279926551698251,1.154628190899001,1.2871380140609807,0.516822712360453,"FTO,RTEL1,IL1RN,ABCC2,TFRC,GADD45A,DUSP1,HFE,ADAR,FADS2,PTPRC,LEPR,PPARG,APOE,APOB,CTSB",DisGeNET
2801,"Liver Neoplasms, Experimental",0.32964197679430984,1.7457831325301205,1.9373795706862602,0.5179417384674128,"CDH1,JAK2",DisGeNET
2802,Essential Tremor,0.32964197679430984,1.7457831325301205,1.9373795706862602,0.5179417384674128,"MAPT,APOB",DisGeNET
2803,Experimental Hepatoma,0.32964197679430984,1.7457831325301205,1.9373795706862602,0.5179417384674128,"CDH1,JAK2",DisGeNET
2804,Febrile Convulsions,0.32964197679430984,1.7457831325301205,1.9373795706862602,0.5179417384674128,"SEZ6,APOE",DisGeNET
2805,Fetal Alcohol Syndrome,0.32964197679430984,1.7457831325301205,1.9373795706862602,0.5179417384674128,"PDGFRA,PIK3CA",DisGeNET
2806,GRN-related frontotemporal dementia,0.32964197679430984,1.7457831325301205,1.9373795706862602,0.5179417384674128,"MAPT,APOE",DisGeNET
2807,Neck Neoplasms,0.32964197679430984,1.7457831325301205,1.9373795706862602,0.5179417384674128,"CEBPA,PIK3CA",DisGeNET
2808,Paroxysmal nocturnal hemoglobinuria,0.32964197679430984,1.7457831325301205,1.9373795706862602,0.5179417384674128,"GYPA,PTPRC",DisGeNET
2809,Hypoglycemia,0.33070930030826856,1.2928546891102715,1.4305637996692064,0.5194337603987472,"GCDH,HADHA,HMGCL,KIT,LPL,APOE",DisGeNET
2810,"Leukoencephalopathy, Progressive Multifocal",0.3325104198689481,1.503194492595711,1.6551435270836612,0.5218622189513185,"TERT,SNIP1,PPARG",DisGeNET
2811,Myotonic Dystrophy,0.3325104198689481,1.503194492595711,1.6551435270836612,0.5218622189513185,"MEF2C,APOE,MAPT",DisGeNET
2812,Lip and Oral Cavity Carcinoma,0.33261028098166534,1.1907470817971972,1.31075509962577,0.5218622189513185,"TFRC,PIK3CA,TERT,CD82,CDH1,GADD45A,LEPR,PPARG,JAK2,CTSB,SIRT3",DisGeNET
2813,Eosinophilia,0.33377966393278913,1.3298533104268535,1.4592137173684585,0.5232042143827801,"PDGFRA,MYB,KIT,JAK2,SH2B3",DisGeNET
2814,oligodendroglioma,0.33377966393278913,1.3298533104268535,1.4592137173684585,0.5232042143827801,"PDGFRA,TERT,PIK3CA,CDH1,IL2RB",DisGeNET
2815,Weight decreased,0.335141804094657,1.3898071625344353,1.5193393316594606,0.5232042143827801,"PIK3CA,MAX,MAPT,JAK2",DisGeNET
2816,Decreased platelet count,0.335141804094657,1.3898071625344353,1.5193393316594606,0.5232042143827801,"RTEL1,TERT,APOE,JAK2",DisGeNET
2817,Strabismus,0.33583490283973494,1.2139478143002371,1.3245816771769314,0.5232042143827801,"ASXL1,MAP2K2,ALDH5A1,KANSL1,BCL11A,PRDM16,SNIP1,DDB2,ATR",DisGeNET
2818,Primary biliary cirrhosis,0.3368320981709533,1.2305700280543823,1.33907024611614,0.5232042143827801,"ABCC2,IL37,NPHP3,PPARG,APOE,MAPT,JAK2,HK1",DisGeNET
2819,Malignant neoplasm of gallbladder,0.3400975725074432,1.3182580442301646,1.4217712575615131,0.5232042143827801,"PIK3CA,AXL,CDH1,APOE,APOB",DisGeNET
2820,"Dermatitis, Allergic Contact",0.34127236212840595,1.4788032355520904,1.5898235079571046,0.5232042143827801,"IL1RN,PPARG,ETS2",DisGeNET
2821,Telecanthus,0.34127236212840595,1.4788032355520904,1.5898235079571046,0.5232042143827801,"CCND2,MAP2K2,DOCK7",DisGeNET
2822,Vesico-Ureteral Reflux,0.34127236212840595,1.4788032355520904,1.5898235079571046,0.5232042143827801,"ASXL1,DSTYK,KANSL1",DisGeNET
2823,Hip circumference,0.34127236212840595,1.4788032355520904,1.5898235079571046,0.5232042143827801,"FTO,ZBTB38,SLC39A13",DisGeNET
2824,Ischemia of kidney,0.34127236212840595,1.4788032355520904,1.5898235079571046,0.5232042143827801,"PTPRC,EPAS1,IL37",DisGeNET
2825,"Epilepsy, Generalized",0.3413467144841261,1.6971218206157965,1.8241625223966422,0.5232042143827801,"ABCC2,ALDH5A1",DisGeNET
2826,Abnormality of the dentition,0.3413467144841261,1.6971218206157965,1.8241625223966422,0.5232042143827801,"KANSL1,DDB2",DisGeNET
2827,Wide spaced nipples,0.3413467144841261,1.6971218206157965,1.8241625223966422,0.5232042143827801,"ASXL1,KANSL1",DisGeNET
2828,Broad nasal tip,0.3413467144841261,1.6971218206157965,1.8241625223966422,0.5232042143827801,"PGAP3,DOCK7",DisGeNET
2829,Carcinoma of Male Breast,0.3413467144841261,1.6971218206157965,1.8241625223966422,0.5232042143827801,"PIK3CA,HFE",DisGeNET
2830,Isolated somatotropin deficiency,0.3413467144841261,1.6971218206157965,1.8241625223966422,0.5232042143827801,"LEPR,LPL",DisGeNET
2831,Language Disorders,0.3413467144841261,1.6971218206157965,1.8241625223966422,0.5232042143827801,"TOMM40,MAPT",DisGeNET
2832,Open mouth (finding),0.3413467144841261,1.6971218206157965,1.8241625223966422,0.5232042143827801,"AHI1,KANSL1",DisGeNET
2833,Carcinoma of bladder,0.3417978156278961,1.1151663847447209,1.19717114750563,0.5232042143827801,"PDGFRA,ABCC2,TFRC,CD82,GADD45A,MPG,EPAS1,PPP2R2A,ETS2,TYMP,CCND3,ALDH2,PIK3CA,TERT,CDH1,AXL,PRC1,DLG5,PPARG,JARID2,IL6R,EPHB4,ATR",DisGeNET
2834,Brain Diseases,0.3420292307214306,1.2746443089430894,1.3675137150448489,0.5232042143827801,"AHI1,PTPRC,PIK3CA,APOE,MAPT,ATR",DisGeNET
2835,Squamous cell carcinoma of lung,0.3423165819980647,1.2453239456653153,1.3350112942172658,0.5232042143827801,"SCGN,TERT,PIK3CA,SERPING1,ZNF322,ATR,CTSB",DisGeNET
2836,Myoclonus,0.34240248525329164,1.3740551583248213,1.4726688661323915,0.5232042143827801,"TOMM40,APOE,MAPT,KCTD17",DisGeNET
2837,Anxiety,0.34283208201622156,1.1914541000144112,1.2754689002680302,0.5232042143827801,"MPST,FIG4,FTO,ALDH5A1,ALDH2,PIK3CA,APOE,MAPT,KCTD17,FBXO7",DisGeNET
2838,Respiratory Depression,0.3429525358102901,2.544044044044044,2.7225423684214074,0.5232042143827801,MAPT,DisGeNET
2839,Roussy-Levy Syndrome (disorder),0.3429525358102901,2.544044044044044,2.7225423684214074,0.5232042143827801,FIG4,DisGeNET
2840,"Erythroblastosis, Fetal",0.3429525358102901,2.544044044044044,2.7225423684214074,0.5232042143827801,GYPA,DisGeNET
2841,Short finger,0.3429525358102901,2.544044044044044,2.7225423684214074,0.5232042143827801,FIG4,DisGeNET
2842,"Lymphoma, Follicular, Grade 3",0.3429525358102901,2.544044044044044,2.7225423684214074,0.5232042143827801,RTEL1,DisGeNET
2843,Squamous cell carcinoma of penis,0.3429525358102901,2.544044044044044,2.7225423684214074,0.5232042143827801,CD82,DisGeNET
2844,"Pheochromocytoma, Extra-Adrenal",0.3429525358102901,2.544044044044044,2.7225423684214074,0.5232042143827801,MAX,DisGeNET
2845,Superficial spreading malignant melanoma of skin,0.3429525358102901,2.544044044044044,2.7225423684214074,0.5232042143827801,PLD1,DisGeNET
2846,"SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1",0.3429525358102901,2.544044044044044,2.7225423684214074,0.5232042143827801,FTO,DisGeNET
2847,Thickened helices,0.3429525358102901,2.544044044044044,2.7225423684214074,0.5232042143827801,MAP2K2,DisGeNET
2848,"Thymoma, type C",0.3429525358102901,2.544044044044044,2.7225423684214074,0.5232042143827801,KIT,DisGeNET
2849,Thyrotoxicosis,0.3429525358102901,2.544044044044044,2.7225423684214074,0.5232042143827801,PGAP3,DisGeNET
2850,Tobacco Use Disorder,0.3429525358102901,2.544044044044044,2.7225423684214074,0.5232042143827801,RHOA,DisGeNET
2851,Adult Myelodysplastic Syndrome,0.3429525358102901,2.544044044044044,2.7225423684214074,0.5232042143827801,ASXL1,DisGeNET
2852,Carcinoma ex pleomorphic adenoma,0.3429525358102901,2.544044044044044,2.7225423684214074,0.5232042143827801,JAK2,DisGeNET
2853,Carcinoma of ampulla of Vater,0.3429525358102901,2.544044044044044,2.7225423684214074,0.5232042143827801,APOE,DisGeNET
2854,Chediak-Higashi Syndrome,0.3429525358102901,2.544044044044044,2.7225423684214074,0.5232042143827801,TLR1,DisGeNET
2855,Choroid Plexus Papilloma,0.3429525358102901,2.544044044044044,2.7225423684214074,0.5232042143827801,LEPR,DisGeNET
2856,Choroidal Neovascularization,0.3429525358102901,2.544044044044044,2.7225423684214074,0.5232042143827801,EPAS1,DisGeNET
2857,Chronic ulcerative colitis,0.3429525358102901,2.544044044044044,2.7225423684214074,0.5232042143827801,PIK3CA,DisGeNET
2858,Chronic urticaria,0.3429525358102901,2.544044044044044,2.7225423684214074,0.5232042143827801,SERPING1,DisGeNET
2859,Complex partial seizure with impairment of consciousness,0.3429525358102901,2.544044044044044,2.7225423684214074,0.5232042143827801,FIG4,DisGeNET
2860,Congenital absence of spleen,0.3429525358102901,2.544044044044044,2.7225423684214074,0.5232042143827801,NPHP3,DisGeNET
2861,Decreased fertility in females,0.3429525358102901,2.544044044044044,2.7225423684214074,0.5232042143827801,MAP3K1,DisGeNET
2862,Early onset periodontitis,0.3429525358102901,2.544044044044044,2.7225423684214074,0.5232042143827801,IL1RN,DisGeNET
2863,Eosinophilic leukemia,0.3429525358102901,2.544044044044044,2.7225423684214074,0.5232042143827801,PDGFRA,DisGeNET
2864,Gallbladder adenocarcinoma,0.3429525358102901,2.544044044044044,2.7225423684214074,0.5232042143827801,JAK2,DisGeNET
2865,Generalized pustular psoriasis,0.3429525358102901,2.544044044044044,2.7225423684214074,0.5232042143827801,APOE,DisGeNET
2866,Gingival Hemorrhage,0.3429525358102901,2.544044044044044,2.7225423684214074,0.5232042143827801,JAK2,DisGeNET
2867,Gonadoblastoma,0.3429525358102901,2.544044044044044,2.7225423684214074,0.5232042143827801,MAP3K1,DisGeNET
2868,Healing ulcer,0.3429525358102901,2.544044044044044,2.7225423684214074,0.5232042143827801,HFE,DisGeNET
2869,Heat Stroke,0.3429525358102901,2.544044044044044,2.7225423684214074,0.5232042143827801,IL6R,DisGeNET
2870,High Grade Intraepithelial Neoplasia,0.3429525358102901,2.544044044044044,2.7225423684214074,0.5232042143827801,ALDH2,DisGeNET
2871,Hypomyelination,0.3429525358102901,2.544044044044044,2.7225423684214074,0.5232042143827801,SNIP1,DisGeNET
2872,Hypoplasia of the odontoid process,0.3429525358102901,2.544044044044044,2.7225423684214074,0.5232042143827801,LONP1,DisGeNET
2873,Hypoplastic finger,0.3429525358102901,2.544044044044044,2.7225423684214074,0.5232042143827801,FIG4,DisGeNET
2874,Lipoprotein (a) measurement,0.3429525358102901,2.544044044044044,2.7225423684214074,0.5232042143827801,APOE,DisGeNET
2875,Majewski Syndrome,0.3429525358102901,2.544044044044044,2.7225423684214074,0.5232042143827801,KIAA0586,DisGeNET
2876,malignant neoplasm of breast staging,0.3429525358102901,2.544044044044044,2.7225423684214074,0.5232042143827801,ZNF217,DisGeNET
2877,maternal hyperglycemia,0.3429525358102901,2.544044044044044,2.7225423684214074,0.5232042143827801,PPARG,DisGeNET
2878,Maternal hypertension,0.3429525358102901,2.544044044044044,2.7225423684214074,0.5232042143827801,LPL,DisGeNET
2879,Meckel-Gruber syndrome,0.3429525358102901,2.544044044044044,2.7225423684214074,0.5232042143827801,KIAA0586,DisGeNET
2880,Myelodysplastic-Myeloproliferative Diseases,0.3429525358102901,2.544044044044044,2.7225423684214074,0.5232042143827801,JAK2,DisGeNET
2881,Non-Functioning Pituitary Gland Neoplasm,0.3429525358102901,2.544044044044044,2.7225423684214074,0.5232042143827801,BCL2L11,DisGeNET
2882,Nonketotic Hyperglycinemia,0.3429525358102901,2.544044044044044,2.7225423684214074,0.5232042143827801,PTPRC,DisGeNET
2883,Nuclear non-senile cataract,0.3429525358102901,2.544044044044044,2.7225423684214074,0.5232042143827801,FTO,DisGeNET
2884,Panic Attacks,0.3429525358102901,2.544044044044044,2.7225423684214074,0.5232042143827801,KCTD17,DisGeNET
2885,Ph-Like Acute Lymphoblastic Leukemia,0.3429525358102901,2.544044044044044,2.7225423684214074,0.5232042143827801,JAK2,DisGeNET
2886,Polydactyly of toes,0.3429525358102901,2.544044044044044,2.7225423684214074,0.5232042143827801,PIK3CA,DisGeNET
2887,Polydipsia,0.3429525358102901,2.544044044044044,2.7225423684214074,0.5232042143827801,NPHP3,DisGeNET
2888,Pouchitis,0.3429525358102901,2.544044044044044,2.7225423684214074,0.5232042143827801,IL1RN,DisGeNET
2889,Precocious exfoliation of primary tooth,0.3429525358102901,2.544044044044044,2.7225423684214074,0.5232042143827801,FIG4,DisGeNET
2890,Primary HIV infection,0.3429525358102901,2.544044044044044,2.7225423684214074,0.5232042143827801,IL1RN,DisGeNET
2891,Progressive macrocephaly,0.3429525358102901,2.544044044044044,2.7225423684214074,0.5232042143827801,PIK3CA,DisGeNET
2892,Ragged-red muscle fibers,0.3429525358102901,2.544044044044044,2.7225423684214074,0.5232042143827801,TYMP,DisGeNET
2893,Intellectual Disability,0.3434147661620371,1.0772085057799343,1.1513380434662392,0.5237282918447659,"CEP57,FTO,GCDH,LEPROT,RTEL1,THRB,TMPRSS6,PGAP3,DOCK7,ADAR,ETS2,HK1,HMGCL,CCND2,TERT,PRDM16,LEPR,LONP1,NPHP3,NLRP3,SNIP1,APOE,JARID2,FBXO7,MEF2C,MAP3K1,MAP2K2,BCL11A,SLC39A13,QKI,DDB2,ASXL1,FIG4,MYO1D,SLC25A15,HADHA,AHI1,RAD50,ALDH5A1,KANSL1,PIK3CA,KIAA0586,TDP2,KIT,PPARG,MAPT,HIST1H4C,ATR",DisGeNET
2894,"Lupus Erythematosus, Discoid",0.34750368710376406,1.2380018030439623,1.3085431503162521,0.5297810184871482,"BLK,IL1RN,FAM167A,PTPRC,GADD45A,NLRP3,PDE7A",DisGeNET
2895,Joint hyperflexibility,0.35002603721679515,1.4551863041289024,1.5275785270790472,0.5334420988602764,"PIK3CA,LONP1,ATR",DisGeNET
2896,"Hepatitis C, Chronic",0.35124154865097745,1.2119297819352488,1.2680192488819937,0.5351097074061162,"RTEL1,IL1RN,TFRC,AXL,HFE,NLRP3,APOE,APOB",DisGeNET
2897,"Leukemia, Myeloid, Chronic-Phase",0.3529867577805054,1.6510908498860306,1.7193217435712793,0.5368416323087177,"KITLG,MPG",DisGeNET
2898,Fibroadenoma,0.3529867577805054,1.6510908498860306,1.7193217435712793,0.5368416323087177,"TERT,KIT",DisGeNET
2899,Kidney Calculi,0.3529867577805054,1.6510908498860306,1.7193217435712793,0.5368416323087177,"IL1RN,CDH1",DisGeNET
2900,Leber Congenital Amaurosis,0.3529867577805054,1.6510908498860306,1.7193217435712793,0.5368416323087177,"MEF2C,PTPRC",DisGeNET
2901,neurofibroma,0.3529867577805054,1.6510908498860306,1.7193217435712793,0.5368416323087177,"PDGFRA,KIT",DisGeNET
2902,Myasthenia Gravis,0.35693442142411325,1.3435897435897435,1.3841704634990573,0.5393742670291768,"IL1RN,PTPRC,KIT,IL2RB",DisGeNET
2903,Cryptorchidism,0.35833485094295986,1.187188328912467,1.218396413782951,0.5393742670291768,"FIG4,FTO,MAP3K1,MAP2K2,AXL,CITED2,KIT,DDB2,ATR",DisGeNET
2904,Metastasis from malignant tumor of prostate,0.3590797200068191,1.2482578397212543,1.2784792278402295,0.5393742670291768,"TFRC,TERT,CD82,PIK3CA,CDH1,ZKSCAN3",DisGeNET
2905,Lung diseases,0.3628591992211809,1.1819742489270386,1.1982150489559733,0.5393742670291768,"PTPN1,PDGFRA,IL1RN,ALDH2,TERT,KIT,NLRP3,PPARG,CTSB",DisGeNET
2906,"Aganglionosis, Colonic",0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,PPARG,DisGeNET
2907,Renal dysplasia and retinal aplasia (disorder),0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,NPHP3,DisGeNET
2908,"Bone Cysts, Aneurysmal",0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,NLRP3,DisGeNET
2909,Retinal Dysplasia,0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,PTPRC,DisGeNET
2910,Rheumatoid Nodule,0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,IL1RN,DisGeNET
2911,"Disruptive, Impulse Control, and Conduct Disorders",0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,GADD45A,DisGeNET
2912,Secondary hypothyroidism,0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,LEPR,DisGeNET
2913,Severe Aplastic Anemia,0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,KIT,DisGeNET
2914,"Hemorrhagic Fevers, Viral",0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,TFRC,DisGeNET
2915,Spasm,0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,ALDH5A1,DisGeNET
2916,Spinal Cord Myelodysplasia,0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,RRM1,DisGeNET
2917,"Neoplasms, Neuroepithelial",0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,CDH1,DisGeNET
2918,"Neoplasms, Second Primary",0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,RTEL1,DisGeNET
2919,"stage, gastric cancer",0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,IL1RN,DisGeNET
2920,Ulnar deviation of the fingers,0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,ASXL1,DisGeNET
2921,Upper Aerodigestive Tract Neoplasms,0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,CEBPA,DisGeNET
2922,Abnormality of the urinary system,0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,RPS28,DisGeNET
2923,Visceral angiomatosis,0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,PIK3CA,DisGeNET
2924,Activated Protein C Resistance,0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,JAK2,DisGeNET
2925,Adenoma of lung,0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,TP53I3,DisGeNET
2926,allergic symptom,0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,SERPING1,DisGeNET
2927,Anencephaly,0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,KIAA0586,DisGeNET
2928,Angiolymphoid hyperplasia,0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,IL6R,DisGeNET
2929,Antibody Deficiency Syndrome,0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,LEPR,DisGeNET
2930,ATRIOVENTRICULAR CANAL DEFECT,0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,LONP1,DisGeNET
2931,Benign neoplasm of breast,0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,DUSP1,DisGeNET
2932,Bilateral microphthalmos,0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,FIG4,DisGeNET
2933,Bile duct proliferation,0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,NPHP3,DisGeNET
2934,Biliary tract abnormality,0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,ABCC2,DisGeNET
2935,Biliary Tract Diseases,0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,ABCC2,DisGeNET
2936,Brain Stem Glioma,0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,PIK3CA,DisGeNET
2937,CADASIL Syndrome,0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,APOE,DisGeNET
2938,Cerebral Small Vessel Diseases,0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,APOE,DisGeNET
2939,Cervix Diseases,0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,TLR1,DisGeNET
2940,Chronic small plaque psoriasis,0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,PPARG,DisGeNET
2941,Clear cell sarcoma of kidney,0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,TERT,DisGeNET
2942,Colonic Diseases,0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,TLR1,DisGeNET
2943,Congenital abnormality of vein,0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,PIK3CA,DisGeNET
2944,Congenital hypoplasia of clavicle,0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,FIG4,DisGeNET
2945,Death in childhood,0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,HMGCL,DisGeNET
2946,Diastematomyelia,0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,RRM1,DisGeNET
2947,Double Outlet Right Ventricle,0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,MEF2C,DisGeNET
2948,Dysphonia,0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,MAX,DisGeNET
2949,External Ophthalmoplegia,0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,TYMP,DisGeNET
2950,Familial generalized lipodystrophy,0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,PPARG,DisGeNET
2951,Frontal lobe hypoplasia,0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,FIG4,DisGeNET
2952,Gestational trophoblastic disease,0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,PPARG,DisGeNET
2953,Globe of eye large,0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,ATR,DisGeNET
2954,Head Neoplasms,0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,CEBPA,DisGeNET
2955,Hepatitis C Virus Infection,0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,LPL,DisGeNET
2956,Iniencephaly,0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,RRM1,DisGeNET
2957,Malignant neoplasm of penis,0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,PIK3CA,DisGeNET
2958,Meningomyelocele,0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,PDGFRA,DisGeNET
2959,Monoparesis - leg,0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,DSTYK,DisGeNET
2960,Neonatal Alloimmune Thrombocytopenia,0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,PGAP3,DisGeNET
2961,Neurenteric Cyst,0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,RRM1,DisGeNET
2962,Observation of Neuromuscular Block,0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,AXL,DisGeNET
2963,Orchitis,0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,IL6R,DisGeNET
2964,Ostium secundum atrial septal defect,0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,CITED2,DisGeNET
2965,Ovarian epithelial cancer recurrent,0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,PSD4,DisGeNET
2966,Pendred's syndrome,0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,THRB,DisGeNET
2967,Peritoneal adhesion,0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,IL1RN,DisGeNET
2968,Pneumoconiosis,0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,ATR,DisGeNET
2969,Poikiloderma,0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,DDB2,DisGeNET
2970,Reactive systemic amyloidosis,0.36385485898912845,2.348117348117348,2.373947178787745,0.5393742670291768,NLRP3,DisGeNET
2971,Penile hypospadias,0.36420053547322007,1.3288537549407116,1.3422095875276232,0.5393742670291768,"FIG4,MAP3K1,HSD17B13,ATR",DisGeNET
2972,"Hepatoma, Novikoff",0.3645544116684055,1.6074825618262525,1.62207763724789,0.5393742670291768,"CDH1,JAK2",DisGeNET
2973,Squamous cell carcinoma of mouth,0.3645544116684055,1.6074825618262525,1.62207763724789,0.5393742670291768,"PIK3CA,TERT",DisGeNET
2974,Sudden Cardiac Death,0.3645544116684055,1.6074825618262525,1.62207763724789,0.5393742670291768,"AKAP10,APOB",DisGeNET
2975,Abnormal heart beat,0.3645544116684055,1.6074825618262525,1.62207763724789,0.5393742670291768,"RPS28,HFE",DisGeNET
2976,Abnormality of cardiovascular system morphology,0.3645544116684055,1.6074825618262525,1.62207763724789,0.5393742670291768,"ASXL1,PIK3CA",DisGeNET
2977,Cardiac conduction abnormality,0.3645544116684055,1.6074825618262525,1.62207763724789,0.5393742670291768,"RPS28,HFE",DisGeNET
2978,Dry Eye Syndromes,0.3645544116684055,1.6074825618262525,1.62207763724789,0.5393742670291768,"NLRP3,PLTP",DisGeNET
2979,ECG abnormality,0.3645544116684055,1.6074825618262525,1.62207763724789,0.5393742670291768,"RPS28,HFE",DisGeNET
2980,Hereditary pancreatitis,0.3645544116684055,1.6074825618262525,1.62207763724789,0.5393742670291768,"CDH1,CTSB",DisGeNET
2981,Hirsutism,0.3645544116684055,1.6074825618262525,1.62207763724789,0.5393742670291768,"ASXL1,PPARG",DisGeNET
2982,Progressive supranuclear palsy,0.3645544116684055,1.6074825618262525,1.62207763724789,0.5393742670291768,"MAPT,APOE",DisGeNET
2983,Malignant mesothelioma,0.3657266990051957,1.1938351039952118,1.200841660794815,0.5409273201511644,"RRM1,TF,CCND2,PIK3CA,CDH1,KIT,IL2RB,NLRP3",DisGeNET
2984,Flexion contracture of proximal interphalangeal joint,0.36749183466707397,1.4101324657215897,1.4116189979925944,0.5431738608211492,"ASXL1,PRDM16,SLC39A13",DisGeNET
2985,Myositis,0.36749183466707397,1.4101324657215897,1.4116189979925944,0.5431738608211492,"IL1RN,APOE,MAPT",DisGeNET
2986,Concave bridge of nose,0.3683325863072092,1.209540593306726,1.2080516268537804,0.543869936675839,"MEF2C,CCND2,MAP2K2,PIK3CA,KIAA0586,PRDM16,LONP1",DisGeNET
2987,Depressed nasal bridge,0.3683325863072092,1.209540593306726,1.2080516268537804,0.543869936675839,"MEF2C,CCND2,MAP2K2,PIK3CA,KIAA0586,PRDM16,LONP1",DisGeNET
2988,Depressed nasal root/bridge,0.3683325863072092,1.209540593306726,1.2080516268537804,0.543869936675839,"MEF2C,CCND2,MAP2K2,PIK3CA,KIAA0586,PRDM16,LONP1",DisGeNET
2989,Cyst,0.3714634091495741,1.314434669273379,1.3016911128521154,0.5479426817679441,"TERT,CDH1,EPAS1,NPHP3",DisGeNET
2990,early pregnancy,0.3714634091495741,1.314434669273379,1.3016911128521154,0.5479426817679441,"MAP3K1,EPAS1,GADD45A,IL37",DisGeNET
2991,Neural Tube Defects,0.3714634091495741,1.314434669273379,1.3016911128521154,0.5479426817679441,"FTO,PDGFRA,RRM1,TRIP6",DisGeNET
2992,Microphthalmos,0.3717886349527635,1.263156572634329,1.2498047194073025,0.5482391234664413,"CEP57,PIK3CA,KIT,TFEB,ATR",DisGeNET
2993,Secondary malignant neoplasm of bone,0.375415032298757,1.1820633650454937,1.1580947988370027,0.5495155643706183,"CD82,PIK3CA,CITED2,AXL,CDH1,MYB,APOE,CTSB",DisGeNET
2994,Schistosomiasis,0.3760425324506758,1.5661105962310782,1.5317392042016418,0.5495155643706183,"THRB,APOE",DisGeNET
2995,Spinocerebellar Ataxia Type 7,0.3760425324506758,1.5661105962310782,1.5317392042016418,0.5495155643706183,"TRRAP,TDP2",DisGeNET
2996,Adult Medulloblastoma,0.3760425324506758,1.5661105962310782,1.5317392042016418,0.5495155643706183,"BRD3,PDGFRA",DisGeNET
2997,Axonal neuropathy,0.3760425324506758,1.5661105962310782,1.5317392042016418,0.5495155643706183,"SERPING1,TYMP",DisGeNET
2998,Congenital aneurysm of ascending aorta,0.3760425324506758,1.5661105962310782,1.5317392042016418,0.5495155643706183,"SLC39A13,PPARG",DisGeNET
2999,Electrocardiogram abnormal,0.3760425324506758,1.5661105962310782,1.5317392042016418,0.5495155643706183,"RPS28,HFE",DisGeNET
3000,Guillain-Barre Syndrome,0.3760425324506758,1.5661105962310782,1.5317392042016418,0.5495155643706183,"SERPING1,APOE",DisGeNET
3001,Hyperopia,0.3760425324506758,1.5661105962310782,1.5317392042016418,0.5495155643706183,"RAD50,KANSL1",DisGeNET
3002,Necrotizing Enterocolitis,0.3760425324506758,1.5661105962310782,1.5317392042016418,0.5495155643706183,"TLR1,ALDH2",DisGeNET
3003,Oligohydramnios,0.3760425324506758,1.5661105962310782,1.5317392042016418,0.5495155643706183,"PDGFRA,NPHP3",DisGeNET
3004,Osteoarthritis of hip,0.3760425324506758,1.5661105962310782,1.5317392042016418,0.5495155643706183,"FTO,IL1RN",DisGeNET
3005,Congenital diaphragmatic hernia,0.37619594380196947,1.3886294973908266,1.3575868852155466,0.5495155643706183,"RPS28,KIAA0586,RHOA",DisGeNET
3006,Carcinoid Tumor,0.37813501288213097,1.2526782600029898,1.2182345812338706,0.5495155643706183,"PDGFRA,BCL2L11,TERT,PIK3CA,KIT",DisGeNET
3007,Parkinsonian Disorders,0.37813501288213097,1.2526782600029898,1.2182345812338706,0.5495155643706183,"TOMM40,APOE,MAPT,FBXO7,SIRT3",DisGeNET
3008,Sezary Syndrome,0.3787206076273476,1.3003223726627982,1.2625564972739005,0.5495155643706183,"CD164,AHI1,RTEL1,JAK2",DisGeNET
3009,"Mammary Neoplasms, Experimental",0.3787206076273476,1.3003223726627982,1.2625564972739005,0.5495155643706183,"TF,KITLG,CDH1,LPL",DisGeNET
3010,Myoclonic Seizures,0.3787206076273476,1.3003223726627982,1.2625564972739005,0.5495155643706183,"SLC25A15,ABCC2,ALDH5A1,APOE",DisGeNET
3011,Congenital Heart Defects,0.38401136557938154,1.189024804621135,1.1379955804290796,0.5495155643706183,"ASXL1,MEF2C,ALDH2,PIK3CA,CITED2,APOE,JARID2",DisGeNET
3012,Reduced tensile strength of hair,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,MAP2K2,DisGeNET
3013,"Aneurysm, Dissecting",0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,APOE,DisGeNET
3014,"Angioedemas, Hereditary",0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,SERPING1,DisGeNET
3015,Renal Artery Stenosis,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,APOB,DisGeNET
3016,"Arthritis, Gouty",0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,NLRP3,DisGeNET
3017,Restlessness,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,MAPT,DisGeNET
3018,Schizophreniform Disorders,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,APOE,DisGeNET
3019,Severe Congenital Microcephaly,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,HIST1H4C,DisGeNET
3020,Severe diarrhea,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,ABCC2,DisGeNET
3021,Short femoral neck,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,SLC39A13,DisGeNET
3022,Small cheekbone,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,MAP2K2,DisGeNET
3023,"Lymphoma, Small Noncleaved-Cell",0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,TFRC,DisGeNET
3024,Solitary fibrous tumor,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,TERT,DisGeNET
3025,"MICROPHTHALMIA, SYNDROMIC 7",0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,TERT,DisGeNET
3026,Stippled epiphyses,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,THRB,DisGeNET
3027,Triangular head shape,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,ASXL1,DisGeNET
3028,Abnormality of the liver,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,TF,DisGeNET
3029,Abnormality of the thorax,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,MAP2K2,DisGeNET
3030,Wedge shaped head,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,ASXL1,DisGeNET
3031,Adult Hodgkin Lymphoma,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,PTPN1,DisGeNET
3032,Alcohol or Other Drugs use,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,ALDH2,DisGeNET
3033,Brittle hair,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,MAP2K2,DisGeNET
3034,Cancer of Head,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,CEBPA,DisGeNET
3035,Cancer of Neck,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,CEBPA,DisGeNET
3036,Capillary malformation (disorder),0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,PIK3CA,DisGeNET
3037,Community acquired pneumonia,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,IL1RN,DisGeNET
3038,Congenital hernia of foramen of Bochdalek,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,RHOA,DisGeNET
3039,Congenital hernia of foramen of Morgagni,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,RHOA,DisGeNET
3040,Conotruncal defect,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,CITED2,DisGeNET
3041,Depressed cheekbone,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,MAP2K2,DisGeNET
3042,Diabetes Insipidus,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,LEPR,DisGeNET
3043,Diabetic Neuralgia,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,LEPR,DisGeNET
3044,Diabetic Polyneuropathies,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,LEPR,DisGeNET
3045,Early tooth exfoliation,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,TERT,DisGeNET
3046,Echinococcosis,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,TF,DisGeNET
3047,Endemic Cretinism,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,APOE,DisGeNET
3048,Failure to thrive in infant,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,APOB,DisGeNET
3049,Flattening of the zygomatic bone,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,MAP2K2,DisGeNET
3050,Fluid overload,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,DUSP1,DisGeNET
3051,Fractured hair,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,MAP2K2,DisGeNET
3052,Fragile hair,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,MAP2K2,DisGeNET
3053,Frequent falls,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,FIG4,DisGeNET
3054,Gait imbalance,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,MAPT,DisGeNET
3055,Hallervorden-Spatz Syndrome,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,APOE,DisGeNET
3056,Heart murmur,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,APOB,DisGeNET
3057,Helminthiasis,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,CTSB,DisGeNET
3058,Hereditary Melanoma,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,TERT,DisGeNET
3059,Holt-Oram syndrome,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,KLF13,DisGeNET
3060,Human anaplasmosis due to Anaplasma phagocytophilum,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,TF,DisGeNET
3061,Hypergammaglobulinemia,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,TERT,DisGeNET
3062,Hypoplasia of the zygomatic bone,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,MAP2K2,DisGeNET
3063,Hypotrophic cheekbone,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,MAP2K2,DisGeNET
3064,Idiopathic Nephrotic Syndrome,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,APOE,DisGeNET
3065,Jeune thoracic dystrophy,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,KIAA0586,DisGeNET
3066,Ketonuria,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,GCDH,DisGeNET
3067,Listeriosis,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,IL37,DisGeNET
3068,Long palpebral fissure,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,MAP2K2,DisGeNET
3069,Malignant Mesothelioma of Peritoneum,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,PIK3CA,DisGeNET
3070,Microlissencephaly,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,HIST1H4C,DisGeNET
3071,Motion Sickness,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,PRDM16,DisGeNET
3072,Mutism,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,MAPT,DisGeNET
3073,Neonatal Jaundice,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,SPTA1,DisGeNET
3074,Neurocysticercosis,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,CTSB,DisGeNET
3075,Nongerminomatous Germ Cell Tumor,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,KIT,DisGeNET
3076,Nuclear cataract,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,FTO,DisGeNET
3077,Opportunistic Infections,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,APOE,DisGeNET
3078,Other specified manifestations of hyperkinetic syndrome,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,THRB,DisGeNET
3079,Pancreatic Intraductal Papillary-Mucinous Neoplasm,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,PIK3CA,DisGeNET
3080,Perianal Squamous Intraepithelial Neoplasia,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,APOE,DisGeNET
3081,Personality change,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,MAPT,DisGeNET
3082,Premature tooth loss,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,TERT,DisGeNET
3083,Prematurely aged appearance,0.38409415344077596,2.18018018018018,2.0861437006994428,0.5495155643706183,ATR,DisGeNET
3084,Glomerulonephritis,0.38448018353010854,1.2423703264388266,1.1875358641743234,0.5495155643706183,"IL1RN,KITLG,AXL,KIT,PPARG",DisGeNET
3085,Microstomia,0.38487575739039553,1.3677684087117283,1.3059927448391158,0.5495155643706183,"CCND2,PIK3CA,PRDM16",DisGeNET
3086,Pseudohyperkalemia Cardiff,0.38487575739039553,1.3677684087117283,1.3059927448391158,0.5495155643706183,"RTEL1,HFE,APOE",DisGeNET
3087,Ischemic stroke,0.38556724333990317,1.1565610859728508,1.1022485953620955,0.5495155643706183,"IL1RN,GALNT2,HFE,LPL,PPARG,APOE,APOB,TRIB1,SLC17A3",DisGeNET
3088,Vascular inflammations,0.38596975174404835,1.2865071770334928,1.2247500415127373,0.5495155643706183,"DUSP1,PPARG,APOE,SH2B3",DisGeNET
3089,Acquired Immunodeficiency Syndrome,0.38596975174404835,1.2865071770334928,1.2247500415127373,0.5495155643706183,"IL1RN,RTEL1,ABCC2,APOE",DisGeNET
3090,"Adenocarcinoma, Endometrioid",0.38744450052350976,1.5268072289156627,1.4476921471045792,0.5495155643706183,"PIK3CA,EPHB4",DisGeNET
3091,RESTING HEART RATE,0.38744450052350976,1.5268072289156627,1.4476921471045792,0.5495155643706183,"GCKR,UFSP1",DisGeNET
3092,"Brain Injuries, Focal",0.38744450052350976,1.5268072289156627,1.4476921471045792,0.5495155643706183,"TLR1,IL1RN",DisGeNET
3093,"Hepatoma, Morris",0.38744450052350976,1.5268072289156627,1.4476921471045792,0.5495155643706183,"CDH1,JAK2",DisGeNET
3094,Short metacarpal,0.38744450052350976,1.5268072289156627,1.4476921471045792,0.5495155643706183,"LONP1,SLC39A13",DisGeNET
3095,"Injuries, Acute Brain",0.38744450052350976,1.5268072289156627,1.4476921471045792,0.5495155643706183,"TLR1,IL1RN",DisGeNET
3096,"Polyendocrinopathies, Autoimmune",0.38744450052350976,1.5268072289156627,1.4476921471045792,0.5495155643706183,"BLK,NLRP3",DisGeNET
3097,Syndactyly of fingers,0.38744450052350976,1.5268072289156627,1.4476921471045792,0.5495155643706183,"PIK3CA,CDH1",DisGeNET
3098,Varying degree of multiple fractures,0.38744450052350976,1.5268072289156627,1.4476921471045792,0.5495155643706183,"RTEL1,TERT",DisGeNET
3099,Angiogenic Switch,0.38744450052350976,1.5268072289156627,1.4476921471045792,0.5495155643706183,"PIK3CA,EPAS1",DisGeNET
3100,Apnea,0.38744450052350976,1.5268072289156627,1.4476921471045792,0.5495155643706183,"AHI1,KIAA0586",DisGeNET
3101,Brain Injuries,0.38744450052350976,1.5268072289156627,1.4476921471045792,0.5495155643706183,"TLR1,IL1RN",DisGeNET
3102,Brain Lacerations,0.38744450052350976,1.5268072289156627,1.4476921471045792,0.5495155643706183,"TLR1,IL1RN",DisGeNET
3103,Cervical Adenocarcinoma,0.38744450052350976,1.5268072289156627,1.4476921471045792,0.5495155643706183,"PIK3CA,CDH1",DisGeNET
3104,Frequent fractures,0.38744450052350976,1.5268072289156627,1.4476921471045792,0.5495155643706183,"RTEL1,TERT",DisGeNET
3105,Granulomatosis with polyangiitis,0.38744450052350976,1.5268072289156627,1.4476921471045792,0.5495155643706183,"GYPA,ANP32B",DisGeNET
3106,Hemophilia A,0.38744450052350976,1.5268072289156627,1.4476921471045792,0.5495155643706183,"HFE,AK3",DisGeNET
3107,Increased fracture rate,0.38744450052350976,1.5268072289156627,1.4476921471045792,0.5495155643706183,"RTEL1,TERT",DisGeNET
3108,Kallmann Syndrome,0.38744450052350976,1.5268072289156627,1.4476921471045792,0.5495155643706183,"AXL,LEPR",DisGeNET
3109,Primary hypogonadism,0.38744450052350976,1.5268072289156627,1.4476921471045792,0.5495155643706183,"MAP3K1,LEPR",DisGeNET
3110,Pustulosis of Palms and Soles,0.38744450052350976,1.5268072289156627,1.4476921471045792,0.5495155643706183,"PPARG,APOE",DisGeNET
3111,Behcet Syndrome,0.3876002802178976,1.2065949935815148,1.1435874186862398,0.5495155643706183,"TLR1,IL1RN,IL37,NLRP3,APOB,JAK2",DisGeNET
3112,Metastatic Prostate Carcinoma,0.3876002802178976,1.2065949935815148,1.1435874186862398,0.5495155643706183,"TFRC,TERT,CD82,PIK3CA,CDH1,ZKSCAN3",DisGeNET
3113,Idiopathic pulmonary arterial hypertension,0.38924337428852585,1.182337337591025,1.1155949744075941,0.5514906125115531,"FIG4,PDGFRA,TERT,ITSN1,PPARG,JAK2,SIRT3",DisGeNET
3114,Kidney Failure,0.38924337428852585,1.182337337591025,1.1155949744075941,0.5514906125115531,"HBS1L,IL1RN,MYB,NPHP3,NLRP3,PPARG,APOE",DisGeNET
3115,Synovitis,0.3935276266124674,1.3475208814643682,1.2567033724751988,0.5572027883871007,"IL1RN,KITLG,TYMP",DisGeNET
3116,Prolactinoma,0.3935276266124674,1.3475208814643682,1.2567033724751988,0.5572027883871007,"BCL2L11,CDH1,PPARG",DisGeNET
3117,Mental deficiency,0.3939974081777697,1.0877804301342897,1.0131706015763584,0.5576889845621815,"CEP57,RTEL1,MEF2C,MAP2K2,TMPRSS6,PGAP3,BCL11A,SLC25A15,AHI1,RAD50,ALDH5A1,KANSL1,PIK3CA,TERT,KIAA0586,TDP2,PRDM16,PPARG,HIST1H4C,ATR",DisGeNET
3118,Tremor,0.39716040592786417,1.2222492401215805,1.128643324528863,0.5586845703717661,"FIG4,ADAR,APOE,MAPT,FBXO7",DisGeNET
3119,Bronchopulmonary Dysplasia,0.39716040592786417,1.2222492401215805,1.128643324528863,0.5586845703717661,"PDGFRA,IL1RN,NLRP3,PPARG,ZNF410",DisGeNET
3120,"Fractures, Multiple",0.39875419464729916,1.4894210990302674,1.3693888097140368,0.5586845703717661,"RTEL1,TERT",DisGeNET
3121,Thin lips,0.39875419464729916,1.4894210990302674,1.3693888097140368,0.5586845703717661,"FIG4,CITED2",DisGeNET
3122,Abnormality of the fingernails,0.39875419464729916,1.4894210990302674,1.3693888097140368,0.5586845703717661,"RTEL1,TERT",DisGeNET
3123,Benign Neoplasm,0.39875419464729916,1.4894210990302674,1.3693888097140368,0.5586845703717661,"TERT,CITED2",DisGeNET
3124,Bile duct carcinoma,0.39875419464729916,1.4894210990302674,1.3693888097140368,0.5586845703717661,"APOE,APOB",DisGeNET
3125,Electrocardiographic changes,0.39875419464729916,1.4894210990302674,1.3693888097140368,0.5586845703717661,"RPS28,HFE",DisGeNET
3126,Generalized muscle weakness,0.39875419464729916,1.4894210990302674,1.3693888097140368,0.5586845703717661,"FIG4,HADHA",DisGeNET
3127,Hepatic methionine adenosyltransferase deficiency,0.39875419464729916,1.4894210990302674,1.3693888097140368,0.5586845703717661,"PIK3CA,CNOT8",DisGeNET
3128,Idiopathic hypogonadotropic hypogonadism,0.39875419464729916,1.4894210990302674,1.3693888097140368,0.5586845703717661,"AXL,HFE",DisGeNET
3129,Leigh Disease,0.39875419464729916,1.4894210990302674,1.3693888097140368,0.5586845703717661,"KITLG,ATP11A",DisGeNET
3130,Leishmaniasis,0.39875419464729916,1.4894210990302674,1.3693888097140368,0.5586845703717661,"PTPN1,CTSB",DisGeNET
3131,Leukoencephalopathies,0.39875419464729916,1.4894210990302674,1.3693888097140368,0.5586845703717661,"APOE,TYMP",DisGeNET
3132,Macular degeneration,0.39875419464729916,1.4894210990302674,1.3693888097140368,0.5586845703717661,"TST,APOE",DisGeNET
3133,Hypothyroidism,0.39901568957174915,1.1906873614190687,1.0939494197750141,0.5586845703717661,"THRB,PIK3CA,PGAP3,APOE,APOB,SH2B3",DisGeNET
3134,Low set ears,0.3997103720286855,1.1691816647449074,1.072157199202806,0.5586845703717661,"FIG4,ASXL1,AHI1,MEF2C,BCL11A,KIAA0586,ATR",DisGeNET
3135,Peripheral Neuropathy,0.3997103720286855,1.1691816647449074,1.072157199202806,0.5586845703717661,"FIG4,HADHA,TMPRSS6,HFE,APOE,TYMP,HK1",DisGeNET
3136,"Hepatitis, Autoimmune",0.40214804341935495,1.3278602390647576,1.2095943548480383,0.5586845703717661,"IL1RN,PTPRC,SH2B3",DisGeNET
3137,"Hypertension, Portal",0.40214804341935495,1.3278602390647576,1.2095943548480383,0.5586845703717661,"DUSP1,JAK2,CPEB4",DisGeNET
3138,Motor Neuron Disease,0.40214804341935495,1.3278602390647576,1.2095943548480383,0.5586845703717661,"FIG4,APOE,MAPT",DisGeNET
3139,Precursor B-Cell Lymphoblastic Leukemia-Lymphoma,0.40214804341935495,1.3278602390647576,1.2095943548480383,0.5586845703717661,"RTEL1,PTPRC,DUSP1",DisGeNET
3140,Herpes Simplex Infections,0.40277865953517006,1.1283085053072752,1.0260477615059531,0.5586845703717661,"SLC25A37,HSPA8,HBZ,PTPRC,PIK3CA,TERT,PSD4,APOE,MAPT,ATR",DisGeNET
3141,Big calvaria,0.4034922786333819,1.2124282337048295,1.1003973520705164,0.5586845703717661,"GCDH,CCND2,MAP2K2,PIK3CA,NLRP3",DisGeNET
3142,Increased size of skull,0.4034922786333819,1.2124282337048295,1.1003973520705164,0.5586845703717661,"GCDH,CCND2,MAP2K2,PIK3CA,NLRP3",DisGeNET
3143,"Acute myeloid leukemia, minimal differentiation",0.4036913894708047,2.0346346346346347,1.8456263964772202,0.5586845703717661,BCL11A,DisGeNET
3144,"Carcinoma, Signet Ring Cell",0.4036913894708047,2.0346346346346347,1.8456263964772202,0.5586845703717661,CDH1,DisGeNET
3145,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",0.4036913894708047,2.0346346346346347,1.8456263964772202,0.5586845703717661,PDGFRA,DisGeNET
3146,Saethre-Chotzen Syndrome,0.4036913894708047,2.0346346346346347,1.8456263964772202,0.5586845703717661,PIK3CA,DisGeNET
3147,Sclerocornea,0.4036913894708047,2.0346346346346347,1.8456263964772202,0.5586845703717661,FIG4,DisGeNET
3148,Severe depression,0.4036913894708047,2.0346346346346347,1.8456263964772202,0.5586845703717661,APOE,DisGeNET
3149,"Hearing Loss, High-Frequency",0.4036913894708047,2.0346346346346347,1.8456263964772202,0.5586845703717661,ZAN,DisGeNET
3150,Shared Paranoid Disorder,0.4036913894708047,2.0346346346346347,1.8456263964772202,0.5586845703717661,APOE,DisGeNET
3151,"Liposarcoma, well differentiated",0.4036913894708047,2.0346346346346347,1.8456263964772202,0.5586845703717661,CEBPA,DisGeNET
3152,Spasmodic torticollis,0.4036913894708047,2.0346346346346347,1.8456263964772202,0.5586845703717661,KCTD17,DisGeNET
3153,"Schizophrenia, Childhood",0.4036913894708047,2.0346346346346347,1.8456263964772202,0.5586845703717661,SEZ6,DisGeNET
3154,Temporomandibular Joint Disorders,0.4036913894708047,2.0346346346346347,1.8456263964772202,0.5586845703717661,IL1RN,DisGeNET
3155,Acrania,0.4036913894708047,2.0346346346346347,1.8456263964772202,0.5586845703717661,RRM1,DisGeNET
3156,Acute Lung Injury,0.4036913894708047,2.0346346346346347,1.8456263964772202,0.5586845703717661,PPARG,DisGeNET
3157,Aphasia,0.4036913894708047,2.0346346346346347,1.8456263964772202,0.5586845703717661,APOE,DisGeNET
3158,Benign Rolandic Epilepsy,0.4036913894708047,2.0346346346346347,1.8456263964772202,0.5586845703717661,SNIP1,DisGeNET
3159,Cluster Headache,0.4036913894708047,2.0346346346346347,1.8456263964772202,0.5586845703717661,HFE,DisGeNET
3160,Decreased calcification of skull,0.4036913894708047,2.0346346346346347,1.8456263964772202,0.5586845703717661,FIG4,DisGeNET
3161,Defect of skull ossification,0.4036913894708047,2.0346346346346347,1.8456263964772202,0.5586845703717661,FIG4,DisGeNET
3162,Disorder of Achilles tendon,0.4036913894708047,2.0346346346346347,1.8456263964772202,0.5586845703717661,IL1RN,DisGeNET
3163,Functional Gastrointestinal Disorders,0.4036913894708047,2.0346346346346347,1.8456263964772202,0.5586845703717661,ABCC2,DisGeNET
3164,Hemimegalencephaly,0.4036913894708047,2.0346346346346347,1.8456263964772202,0.5586845703717661,PIK3CA,DisGeNET
3165,Hepatitis B Virus-Related Hepatocellular Carcinoma,0.4036913894708047,2.0346346346346347,1.8456263964772202,0.5586845703717661,CDH1,DisGeNET
3166,Hereditary Leiomyomatosis and Renal Cell Cancer,0.4036913894708047,2.0346346346346347,1.8456263964772202,0.5586845703717661,KIT,DisGeNET
3167,Hyperphosphaturia,0.4036913894708047,2.0346346346346347,1.8456263964772202,0.5586845703717661,SLC17A1,DisGeNET
3168,Hyperprolactinemia,0.4036913894708047,2.0346346346346347,1.8456263964772202,0.5586845703717661,LPL,DisGeNET
3169,Hypersomnia,0.4036913894708047,2.0346346346346347,1.8456263964772202,0.5586845703717661,CPT1B,DisGeNET
3170,Invasive Pulmonary Aspergillosis,0.4036913894708047,2.0346346346346347,1.8456263964772202,0.5586845703717661,IL1RN,DisGeNET
3171,Invasive Streptococcus pneumoniae disease,0.4036913894708047,2.0346346346346347,1.8456263964772202,0.5586845703717661,IL1RN,DisGeNET
3172,Involuntary Movements,0.4036913894708047,2.0346346346346347,1.8456263964772202,0.5586845703717661,PGAP3,DisGeNET
3173,Job Syndrome,0.4036913894708047,2.0346346346346347,1.8456263964772202,0.5586845703717661,IL37,DisGeNET
3174,Menkes Kinky Hair Syndrome,0.4036913894708047,2.0346346346346347,1.8456263964772202,0.5586845703717661,GYPA,DisGeNET
3175,Mixed cryoglobulinemia,0.4036913894708047,2.0346346346346347,1.8456263964772202,0.5586845703717661,RTEL1,DisGeNET
3176,Multi-infarct dementia,0.4036913894708047,2.0346346346346347,1.8456263964772202,0.5586845703717661,APOE,DisGeNET
3177,Narcolepsy-Cataplexy Syndrome,0.4036913894708047,2.0346346346346347,1.8456263964772202,0.5586845703717661,CPT1B,DisGeNET
3178,Odontogenic Tumors,0.4036913894708047,2.0346346346346347,1.8456263964772202,0.5586845703717661,IL1RN,DisGeNET
3179,Oral Ulcer,0.4036913894708047,2.0346346346346347,1.8456263964772202,0.5586845703717661,PTPRC,DisGeNET
3180,Oropharyngeal disorders,0.4036913894708047,2.0346346346346347,1.8456263964772202,0.5586845703717661,PIK3CA,DisGeNET
3181,Paratuberculosis,0.4036913894708047,2.0346346346346347,1.8456263964772202,0.5586845703717661,TF,DisGeNET
3182,Platelet Storage Pool Deficiency,0.4036913894708047,2.0346346346346347,1.8456263964772202,0.5586845703717661,DOCK7,DisGeNET
3183,Poorly differentiated carcinoma,0.4036913894708047,2.0346346346346347,1.8456263964772202,0.5586845703717661,PPARG,DisGeNET
3184,Precursor T-cell lymphoblastic lymphoma,0.4036913894708047,2.0346346346346347,1.8456263964772202,0.5586845703717661,JAK2,DisGeNET
3185,Primary Malignant Liver Neoplasm,0.4036913894708047,2.0346346346346347,1.8456263964772202,0.5586845703717661,LAPTM4B,DisGeNET
3186,Primary peritoneal carcinoma,0.4036913894708047,2.0346346346346347,1.8456263964772202,0.5586845703717661,RAD50,DisGeNET
3187,Pulmonary Alveolar Proteinosis,0.4036913894708047,2.0346346346346347,1.8456263964772202,0.5586845703717661,PPARG,DisGeNET
3188,Quadriplegia,0.4036913894708047,2.0346346346346347,1.8456263964772202,0.5586845703717661,APOE,DisGeNET
3189,Conventional (Clear Cell) Renal Cell Carcinoma,0.406364136105394,1.1044825199030806,0.9945927322514608,0.5622071396980239,"BRD3,THRB,CD82,EPAS1,SLC7A6,PIK3CA,TERT,CDH1,KIT,PPARG,ATP6V1G3,IL6R,CTSB",DisGeNET
3190,Dental caries,0.4076459142486928,1.2467532467532467,1.1187819286662053,0.5636270052225737,"RTEL1,TERT,CDH1,ATR",DisGeNET
3191,Mammary Tumorigenesis,0.4076459142486928,1.2467532467532467,1.1187819286662053,0.5636270052225737,"PIK3CA,FLOT2,PPARG,JAK2",DisGeNET
3192,Brachydactyly,0.40981658706778007,1.2027618888064524,1.0729184122561113,0.5645349082863661,"FTO,CITED2,PRDM16,LONP1,NLRP3",DisGeNET
3193,Increased head circumference,0.40981658706778007,1.2027618888064524,1.0729184122561113,0.5645349082863661,"GCDH,CCND2,MAP2K2,PIK3CA,NLRP3",DisGeNET
3194,Stromal Neoplasm,0.40996596694232024,1.4538152610441768,1.29633963505076,0.5645349082863661,"KIT,LEPR",DisGeNET
3195,Abdomen distended,0.40996596694232024,1.4538152610441768,1.29633963505076,0.5645349082863661,"THRB,TYMP",DisGeNET
3196,Atherogenesis,0.40996596694232024,1.4538152610441768,1.29633963505076,0.5645349082863661,"PPARG,APOE",DisGeNET
3197,Cleft palate with cleft lip,0.40996596694232024,1.4538152610441768,1.29633963505076,0.5645349082863661,"TERT,CDH1",DisGeNET
3198,Cortical Dysplasia,0.40996596694232024,1.4538152610441768,1.29633963505076,0.5645349082863661,"PIK3CA,NPRL3",DisGeNET
3199,Dysplastic Nevus,0.40996596694232024,1.4538152610441768,1.29633963505076,0.5645349082863661,"RTEL1,CD82",DisGeNET
3200,Eating Disorders,0.40996596694232024,1.4538152610441768,1.29633963505076,0.5645349082863661,"FTO,IL2RB",DisGeNET
3201,Klinefelter Syndrome,0.40996596694232024,1.4538152610441768,1.29633963505076,0.5645349082863661,"AXL,LEPR",DisGeNET
3202,Metabolic acidosis,0.40996596694232024,1.4538152610441768,1.29633963505076,0.5645349082863661,"GCDH,HMGCL",DisGeNET
3203,Migraine with Aura,0.40996596694232024,1.4538152610441768,1.29633963505076,0.5645349082863661,"PRDM16,APOE",DisGeNET
3204,Neurofibromatoses,0.40996596694232024,1.4538152610441768,1.29633963505076,0.5645349082863661,"PDGFRA,KIT",DisGeNET
3205,"Liver Cirrhosis, Experimental",0.41022947509467994,1.0820546616597448,0.9641524497507963,0.5647215114251881,"PTPN1,PDGFRA,ABCC2,DOCK7,SEZ6,LPL,U2SURP,TF,PTPRC,ALDH2,AXL,BLOC1S2,IL2RB,TMBIM1,RSRP1,SLC17A1,JAK2,PLTP",DisGeNET
3206,Chondrosarcoma,0.41042087175665704,1.175187617260788,1.0465893386449088,0.5648087605085373,"TERT,PIK3CA,EPAS1,KIT,PDCD5,PPARG",DisGeNET
3207,Ischemia,0.41073363884372144,1.308761329305136,1.1645493833706129,0.5650629293977234,"LONP1,PPARG,APOE",DisGeNET
3208,Arthritis,0.4138785072328193,1.0981566582330768,0.9687749254987544,0.5692119619423937,"IL1RN,IL37,HFE,PDCD5,PLD1,HK1,TLR1,KITLG,PIK3CA,NLRP3,PPARG,JAK2,CTSB",DisGeNET
3209,Hypospadias,0.414840182742797,1.2340373431282523,1.0857824842745936,0.5695804083093555,"FIG4,MAP3K1,HSD17B13,ATR",DisGeNET
3210,Keloid,0.414840182742797,1.2340373431282523,1.0857824842745936,0.5695804083093555,"TAGLN,PIK3CA,TAF8,PPARG",DisGeNET
3211,Primary Effusion Lymphoma,0.414840182742797,1.2340373431282523,1.0857824842745936,0.5695804083093555,"RTEL1,PTPRC,MPG,IL6R",DisGeNET
3212,Gallbladder Carcinoma,0.4161318134282889,1.1932465805471124,1.0461827694672174,0.5695804083093555,"LAPTM4B,PIK3CA,AXL,APOB,CPEB4",DisGeNET
3213,Malignant neoplasm of thyroid,0.4179819630311238,1.1061389929933192,0.9649038457736747,0.5695804083093555,"KITLG,CCND2,THRB,PIK3CA,TERT,IL37,TRPC1,NCOA4,KIT,PPARG,SIRT3",DisGeNET
3214,Pancreatic intraepithelial neoplasia,0.41928118129141106,1.2902004170035317,1.1214596292787138,0.5695804083093555,"PIK3CA,EPAS1,PPP2R2A",DisGeNET
3215,"ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 1",0.4210746192897417,1.4198655085458112,1.228105881872269,0.5695804083093555,"PIK3CA,CDH1",DisGeNET
3216,Meningococcal Infections,0.4210746192897417,1.4198655085458112,1.228105881872269,0.5695804083093555,"IL1RN,SERPING1",DisGeNET
3217,Osteitis Deformans,0.4210746192897417,1.4198655085458112,1.228105881872269,0.5695804083093555,"NUP205,TRIP6",DisGeNET
3218,Renal Insufficiency,0.42180662115222206,1.1600802716887928,1.0013909350660122,0.5695804083093555,"AHI1,IL1RN,NPHP3,NLRP3,PPARG,APOE",DisGeNET
3219,Cerebral Ischemia,0.42180662115222206,1.1600802716887928,1.0013909350660122,0.5695804083093555,"IL1RN,ALDH2,PIK3CA,PPARG,APOE,JAK2",DisGeNET
3220,Recurrent aphthous ulcer,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5695804083093555,NLRP3,DisGeNET
3221,"Apraxia, Developmental Verbal",0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5695804083093555,BCL11A,DisGeNET
3222,Reticulocytosis,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5695804083093555,HK1,DisGeNET
3223,Sclerosis,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5695804083093555,IL1RN,DisGeNET
3224,"Dystonia, Limb",0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5695804083093555,ADAR,DisGeNET
3225,"Hypophosphatemic Rickets, X-Linked Dominant",0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5695804083093555,SLC17A1,DisGeNET
3226,"Liver dysfunction, mild",0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5695804083093555,SLC25A15,DisGeNET
3227,Stage III Colon Cancer AJCC v7,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5695804083093555,PIK3CA,DisGeNET
3228,Steroid resistant nephrotic syndrome of childhood,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5695804083093555,NUP205,DisGeNET
3229,"POLYDACTYLY, POSTAXIAL",0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5695804083093555,KIAA0586,DisGeNET
3230,Tethered Cord Syndrome,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5695804083093555,RRM1,DisGeNET
3231,"Vitamin D-Resistant Rickets, X-Linked",0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5695804083093555,SLC17A1,DisGeNET
3232,Torticollis,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5695804083093555,KCTD17,DisGeNET
3233,Abnormal pigmentation,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5695804083093555,PPARG,DisGeNET
3234,Type II Mucolipidosis,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5695804083093555,GADD45A,DisGeNET
3235,Anaplastic large B-cell lymphoma,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5695804083093555,PIK3CA,DisGeNET
3236,Angiomyolipoma of kidney,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5695804083093555,KIT,DisGeNET
3237,Aortic valve calcification,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5695804083093555,APOE,DisGeNET
3238,Aphthous Stomatitis,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5695804083093555,NLRP3,DisGeNET
3239,Carpal Tunnel Syndrome,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5695804083093555,IL1RN,DisGeNET
3240,Cataplexy,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5695804083093555,CPT1B,DisGeNET
3241,Common acute lymphoblastic leukemia,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5695804083093555,TFRC,DisGeNET
3242,Complete hydatidiform mole,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5695804083093555,APOB,DisGeNET
3243,Conduct Disorder,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5695804083093555,ALDH2,DisGeNET
3244,Decreased liver function,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5695804083093555,SLC25A15,DisGeNET
3245,Dupuytren's Disease,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5695804083093555,HFE,DisGeNET
3246,Ectopic Tissue,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5695804083093555,ASXL1,DisGeNET
3247,Excessive daytime somnolence,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5695804083093555,HMGCL,DisGeNET
3248,Exfoliation Syndrome,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5695804083093555,APOE,DisGeNET
3249,Exotropia,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5695804083093555,HADHA,DisGeNET
3250,Fatigable weakness of respiratory muscles,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5695804083093555,FIG4,DisGeNET
3251,Fatigable weakness of swallowing muscles,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5695804083093555,FIG4,DisGeNET
3252,Folic Acid Deficiency,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5695804083093555,TAGLN,DisGeNET
3253,genetic hypertension,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5695804083093555,LPL,DisGeNET
3254,Granulomatous Slack Skin,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5695804083093555,RHOA,DisGeNET
3255,Hemophilia B,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5695804083093555,AK3,DisGeNET
3256,Hereditary nonpolyposis colorectal carcinoma,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5695804083093555,PIK3CA,DisGeNET
3257,Incontinentia Pigmenti Achromians,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5695804083093555,IL1RN,DisGeNET
3258,Increased CSF protein,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5695804083093555,TYMP,DisGeNET
3259,Increased drug resistance,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5695804083093555,PIK3CA,DisGeNET
3260,Infection of bone,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5695804083093555,IL1RN,DisGeNET
3261,Infectious Mononucleosis,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5695804083093555,RTEL1,DisGeNET
3262,Intestinal Pseudo-Obstruction,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5695804083093555,PIK3CA,DisGeNET
3263,Invasive aspergillosis,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5695804083093555,TLR1,DisGeNET
3264,Lipomatosis,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5695804083093555,PIK3CA,DisGeNET
3265,Low Grade Squamous Intraepithelial Neoplasia,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5695804083093555,TERT,DisGeNET
3266,Lyme Arthritis,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5695804083093555,TLR1,DisGeNET
3267,Myelomonocytic leukemia,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5695804083093555,MEF2C,DisGeNET
3268,Onion bulb formation,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5695804083093555,FIG4,DisGeNET
3269,Osteophyte,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5695804083093555,CTSB,DisGeNET
3270,Ovarian Clear Cell Adenocarcinoma,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5695804083093555,PIK3CA,DisGeNET
3271,Penis carcinoma,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5695804083093555,PIK3CA,DisGeNET
3272,Plasma cell dyscrasia,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5695804083093555,CCND2,DisGeNET
3273,Postural instability,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5695804083093555,FBXO7,DisGeNET
3274,Progressive sensorineural hearing impairment,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5695804083093555,NLRP3,DisGeNET
3275,Umbilical hernia,0.427787574578638,1.2721550855991943,1.0802231748235642,0.5761290534313037,"FTO,THRB,SNIP1",DisGeNET
3276,Von Hippel-Lindau Syndrome,0.427787574578638,1.2721550855991943,1.0802231748235642,0.5761290534313037,"THRB,PIK3CA,EPAS1",DisGeNET
3277,Restenosis,0.42872909706284934,1.1746551321019405,0.9948507120226207,0.5772208654993259,"IL1RN,SERPING1,LPL,PPARG,APOE",DisGeNET
3278,Secondary malignant neoplasm of lung,0.42892007382994835,1.0857123401937252,0.919038868832709,0.5772851727981642,"KANK2,PTPN1,IL1RN,TFRC,CD82,PCSK7,ETS2,SLC25A37,PIK3CA,TERT,FLOT2,EPHB4,CTSB",DisGeNET
3279,Gait abnormality,0.4291693941019897,1.2093609360936093,1.023002745285343,0.5772851727981642,"FIG4,AHI1,KIAA0586,PRDM16",DisGeNET
3280,Neutropenia,0.4291693941019897,1.2093609360936093,1.023002745285343,0.5772851727981642,"ASXL1,RRM1,ABCC2,FLOT2",DisGeNET
3281,"Glaucoma, Open-Angle",0.4320753805020225,1.387458926615553,1.1642933925595615,0.5801328602479986,"CDH1,APOE",DisGeNET
3282,Skin Ulcer,0.4320753805020225,1.387458926615553,1.1642933925595615,0.5801328602479986,"RTEL1,TERT",DisGeNET
3283,Tracheal Diseases,0.4320753805020225,1.387458926615553,1.1642933925595615,0.5801328602479986,"SLC25A37,NLRP3",DisGeNET
3284,Benign melanocytic nevus,0.4320753805020225,1.387458926615553,1.1642933925595615,0.5801328602479986,"KIT,PPARG",DisGeNET
3285,Lesion of brain,0.4320753805020225,1.387458926615553,1.1642933925595615,0.5801328602479986,"MAPT,APOE",DisGeNET
3286,Mitral Valve Stenosis,0.4320753805020225,1.387458926615553,1.1642933925595615,0.5801328602479986,"IL1RN,PLD1",DisGeNET
3287,Mycosis Fungoides,0.4362498561764909,1.2546041468360716,1.0407444935223196,0.5855595879071123,"MEF2C,PTPRC,PIK3CA",DisGeNET
3288,Sensorineural Hearing Loss (disorder),0.44026972609750953,1.099716923076923,0.902172271459231,0.5866354301553198,"FTO,CD164,AHI1,KITLG,THRB,LONP1,NLRP3,DDB2,TYMP",DisGeNET
3289,Repeated speech,0.4410402814653663,1.7949125596184419,1.4693496440315028,0.5866354301553198,MAPT,DisGeNET
3290,"Blindness, Cortical",0.4410402814653663,1.7949125596184419,1.4693496440315028,0.5866354301553198,DOCK7,DisGeNET
3291,Sebaceous Adenocarcinoma,0.4410402814653663,1.7949125596184419,1.4693496440315028,0.5866354301553198,CDH1,DisGeNET
3292,Slender long bone,0.4410402814653663,1.7949125596184419,1.4693496440315028,0.5866354301553198,NSMCE2,DisGeNET
3293,"Major depression, single episode",0.4410402814653663,1.7949125596184419,1.4693496440315028,0.5866354301553198,APOE,DisGeNET
3294,ST segment elevation myocardial infarction,0.4410402814653663,1.7949125596184419,1.4693496440315028,0.5866354301553198,ALDH2,DisGeNET
3295,Stage III Colon Cancer,0.4410402814653663,1.7949125596184419,1.4693496440315028,0.5866354301553198,PIK3CA,DisGeNET
3296,Steroid-resistant nephrotic syndrome,0.4410402814653663,1.7949125596184419,1.4693496440315028,0.5866354301553198,NUP205,DisGeNET
3297,Sudden death,0.4410402814653663,1.7949125596184419,1.4693496440315028,0.5866354301553198,HADHA,DisGeNET
3298,Tachypnea,0.4410402814653663,1.7949125596184419,1.4693496440315028,0.5866354301553198,KIAA0586,DisGeNET
3299,Thymic Carcinoma,0.4410402814653663,1.7949125596184419,1.4693496440315028,0.5866354301553198,KIT,DisGeNET
3300,Uroureter,0.4410402814653663,1.7949125596184419,1.4693496440315028,0.5866354301553198,PLD1,DisGeNET
3301,Vitamin D Deficiency,0.4410402814653663,1.7949125596184419,1.4693496440315028,0.5866354301553198,APOE,DisGeNET
3302,Acute Chest Syndrome,0.4410402814653663,1.7949125596184419,1.4693496440315028,0.5866354301553198,NLRP3,DisGeNET
3303,Adult T Acute Lymphoblastic Leukemia,0.4410402814653663,1.7949125596184419,1.4693496440315028,0.5866354301553198,KIT,DisGeNET
3304,Anterior uveitis,0.4410402814653663,1.7949125596184419,1.4693496440315028,0.5866354301553198,SERPING1,DisGeNET
3305,Anti-nuclear factor positive,0.4410402814653663,1.7949125596184419,1.4693496440315028,0.5866354301553198,IL2RB,DisGeNET
3306,Avellino corneal dystrophy,0.4410402814653663,1.7949125596184419,1.4693496440315028,0.5866354301553198,GCDH,DisGeNET
3307,Body Weight,0.4410402814653663,1.7949125596184419,1.4693496440315028,0.5866354301553198,FTO,DisGeNET
3308,Corneal Diseases,0.4410402814653663,1.7949125596184419,1.4693496440315028,0.5866354301553198,APOE,DisGeNET
3309,Cornelia De Lange Syndrome,0.4410402814653663,1.7949125596184419,1.4693496440315028,0.5866354301553198,ATR,DisGeNET
3310,Cortical visual impairment,0.4410402814653663,1.7949125596184419,1.4693496440315028,0.5866354301553198,DOCK7,DisGeNET
3311,Echolalia,0.4410402814653663,1.7949125596184419,1.4693496440315028,0.5866354301553198,MAPT,DisGeNET
3312,Fetal Death,0.4410402814653663,1.7949125596184419,1.4693496440315028,0.5866354301553198,PDGFRA,DisGeNET
3313,Gastric Cardia Adenocarcinoma,0.4410402814653663,1.7949125596184419,1.4693496440315028,0.5866354301553198,GADD45A,DisGeNET
3314,High grade serous carcinoma,0.4410402814653663,1.7949125596184419,1.4693496440315028,0.5866354301553198,RHOA,DisGeNET
3315,Infiltrating duct carcinoma of female breast,0.4410402814653663,1.7949125596184419,1.4693496440315028,0.5866354301553198,ATR,DisGeNET
3316,Pericardial effusion,0.4410402814653663,1.7949125596184419,1.4693496440315028,0.5866354301553198,NLRP3,DisGeNET
3317,Polyuria,0.4410402814653663,1.7949125596184419,1.4693496440315028,0.5866354301553198,NPHP3,DisGeNET
3318,secondary acute myeloid leukemia,0.44296388473656995,1.3564926372155288,1.1045472398168368,0.5875997172151974,"ASXL1,JAK2",DisGeNET
3319,Chronic active hepatitis,0.44296388473656995,1.3564926372155288,1.1045472398168368,0.5875997172151974,"IL1RN,HFE",DisGeNET
3320,Curvature of digit,0.44296388473656995,1.3564926372155288,1.1045472398168368,0.5875997172151974,"CEP57,CDH1",DisGeNET
3321,Distal sensory impairment,0.44296388473656995,1.3564926372155288,1.1045472398168368,0.5875997172151974,"FIG4,TYMP",DisGeNET
3322,Extrahepatic Cholangiocarcinoma,0.44296388473656995,1.3564926372155288,1.1045472398168368,0.5875997172151974,"PIK3CA,CDH1",DisGeNET
3323,Hypogammaglobulinemia,0.44296388473656995,1.3564926372155288,1.1045472398168368,0.5875997172151974,"RTEL1,TFRC",DisGeNET
3324,Platyspondyly,0.44296388473656995,1.3564926372155288,1.1045472398168368,0.5875997172151974,"ASXL1,SLC39A13",DisGeNET
3325,Prion Diseases,0.44296388473656995,1.3564926372155288,1.1045472398168368,0.5875997172151974,"MAPT,APOE",DisGeNET
3326,Pulmonary arterial hypertension,0.44296388473656995,1.3564926372155288,1.1045472398168368,0.5875997172151974,"FIG4,TERT",DisGeNET
3327,Congenital Abnormality,0.44396065606640145,1.0735370884903594,0.8717328704815274,0.5887449397550235,"FTO,MEF2C,THRB,CITED2,FIG4,AHI1,ALDH2,KANSL1,PIK3CA,KIT,NPHP3,NLRP3,PPARG",DisGeNET
3328,Sclerocystic Ovaries,0.4446651946803041,1.2375275577692497,1.0029339774677757,0.5891479996785289,"MAP3K1,TFRC,BCL11A",DisGeNET
3329,Congenital heart disease,0.4446651946803041,1.2375275577692497,1.0029339774677757,0.5891479996785289,"MEF2C,ALDH2,CITED2",DisGeNET
3330,Convulsive Seizures,0.4446651946803041,1.2375275577692497,1.0029339774677757,0.5891479996785289,"ABCC2,ALDH5A1,APOE",DisGeNET
3331,Gastrointestinal Carcinoid Tumor,0.44752068141029655,1.1478163493840985,0.9228816798045378,0.5927533012255264,"KITLG,CCND2,PIK3CA,KIT,PPARG",DisGeNET
3332,Dull intelligence,0.44849497782658776,1.055820112247625,0.8466175873949264,0.5936873213834098,"CEP57,RTEL1,MAP2K2,TMPRSS6,PGAP3,BCL11A,SLC25A15,AHI1,RAD50,ALDH5A1,KANSL1,PIK3CA,TERT,KIAA0586,TDP2,PRDM16,PPARG,ATR",DisGeNET
3333,Low intelligence,0.44849497782658776,1.055820112247625,0.8466175873949264,0.5936873213834098,"CEP57,RTEL1,MAP2K2,TMPRSS6,PGAP3,BCL11A,SLC25A15,AHI1,RAD50,ALDH5A1,KANSL1,PIK3CA,TERT,KIAA0586,TDP2,PRDM16,PPARG,ATR",DisGeNET
3334,Carcinoma of larynx,0.450485235309106,1.1741258741258742,0.9362831681881303,0.595964275317474,"RAD50,PIK3CA,IL2RB,LONP1",DisGeNET
3335,Hyperlipoproteinemia Type IIa,0.450485235309106,1.1741258741258742,0.9362831681881303,0.595964275317474,"LPL,APOE,TRIB1,APOB",DisGeNET
3336,"Kidney Failure, Acute",0.4518706191197313,1.1074931469949771,0.8797475707199659,0.5968044946228716,"HSPA8,SLC25A37,TF,EPAS1,PPARG,APOE,SIRT3",DisGeNET
3337,Dystonic disease,0.45303088787577833,1.220906344410876,0.9667075031604053,0.5968044946228716,"GCDH,ADAR,FBXO7",DisGeNET
3338,Hyperplasia,0.45303088787577833,1.220906344410876,0.9667075031604053,0.5968044946228716,"TERT,PIK3CA,CDH1",DisGeNET
3339,Pilocytic Astrocytoma,0.45303088787577833,1.220906344410876,0.9667075031604053,0.5968044946228716,"PIK3CA,MYB,KIT",DisGeNET
3340,Rhabdoid Tumor,0.4537361503852823,1.3268727082242011,1.048547114631643,0.5968044946228716,"TAGLN,PIK3CA",DisGeNET
3341,Adult type dermatomyositis,0.4537361503852823,1.3268727082242011,1.048547114631643,0.5968044946228716,"BLK,FAM167A",DisGeNET
3342,Chronic gastritis,0.4537361503852823,1.3268727082242011,1.048547114631643,0.5968044946228716,"IL1RN,TERT",DisGeNET
3343,Congenital small ears,0.4537361503852823,1.3268727082242011,1.048547114631643,0.5968044946228716,"RPS28,ATR",DisGeNET
3344,Cystic Kidney Diseases,0.4537361503852823,1.3268727082242011,1.048547114631643,0.5968044946228716,"AHI1,NPHP3",DisGeNET
3345,Dyslexia,0.4537361503852823,1.3268727082242011,1.048547114631643,0.5968044946228716,"TDP2,MAPT",DisGeNET
3346,Peptic Ulcer,0.4537361503852823,1.3268727082242011,1.048547114631643,0.5968044946228716,"IL1RN,PPARG",DisGeNET
3347,Photoreceptor degeneration,0.4537361503852823,1.3268727082242011,1.048547114631643,0.5968044946228716,"TFRC,RAB8A",DisGeNET
3348,Pituitary Diseases,0.45375122162860704,1.1391371410425077,0.9001532327690693,0.5968044946228716,"LEPROT,PIK3CA,LEPR,PPARG,APOB",DisGeNET
3349,Speech impairment,0.4575355517558093,1.1628282828282828,0.9092162349854322,0.5968044946228716,"MEF2C,ALDH5A1,THRB,KANSL1",DisGeNET
3350,"AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED",0.4588306540708931,1.6950283616950284,1.320552665492241,0.5968044946228716,NLRP3,DisGeNET
3351,"Charcot-Marie-Tooth Disease, Type Ia (disorder)",0.4588306540708931,1.6950283616950284,1.320552665492241,0.5968044946228716,FIG4,DisGeNET
3352,Sarcopenia,0.4588306540708931,1.6950283616950284,1.320552665492241,0.5968044946228716,GADD45A,DisGeNET
3353,Slow-growing hair,0.4588306540708931,1.6950283616950284,1.320552665492241,0.5968044946228716,MAP2K2,DisGeNET
3354,"Parkinsonism, Experimental",0.4588306540708931,1.6950283616950284,1.320552665492241,0.5968044946228716,MAPT,DisGeNET
3355,Thickened nuchal skin fold,0.4588306540708931,1.6950283616950284,1.320552665492241,0.5968044946228716,MAPT,DisGeNET
3356,Tires quickly,0.4588306540708931,1.6950283616950284,1.320552665492241,0.5968044946228716,TYMP,DisGeNET
3357,Absence of secondary sex characteristics,0.4588306540708931,1.6950283616950284,1.320552665492241,0.5968044946228716,LEPR,DisGeNET
3358,Verrucous carcinoma,0.4588306540708931,1.6950283616950284,1.320552665492241,0.5968044946228716,CDH1,DisGeNET
3359,Adrenal gland hypofunction,0.4588306540708931,1.6950283616950284,1.320552665492241,0.5968044946228716,CITED2,DisGeNET
3360,Albuminuria,0.4588306540708931,1.6950283616950284,1.320552665492241,0.5968044946228716,LEPR,DisGeNET
3361,Amino acids measurement,0.4588306540708931,1.6950283616950284,1.320552665492241,0.5968044946228716,GCKR,DisGeNET
3362,Asbestosis,0.4588306540708931,1.6950283616950284,1.320552665492241,0.5968044946228716,NLRP3,DisGeNET
3363,Autoimmune Lymphoproliferative Syndrome,0.4588306540708931,1.6950283616950284,1.320552665492241,0.5968044946228716,BCL2L11,DisGeNET
3364,Autosomal Dominant Juvenile Parkinson Disease,0.4588306540708931,1.6950283616950284,1.320552665492241,0.5968044946228716,MAPT,DisGeNET
3365,Bacterial Vaginosis,0.4588306540708931,1.6950283616950284,1.320552665492241,0.5968044946228716,IL1RN,DisGeNET
3366,Bowen's Disease,0.4588306540708931,1.6950283616950284,1.320552665492241,0.5968044946228716,APOE,DisGeNET
3367,Breast cancer recurrent,0.4588306540708931,1.6950283616950284,1.320552665492241,0.5968044946228716,CITED2,DisGeNET
3368,Bright Disease,0.4588306540708931,1.6950283616950284,1.320552665492241,0.5968044946228716,PPARG,DisGeNET
3369,Calcium pyrophosphate deposition disease,0.4588306540708931,1.6950283616950284,1.320552665492241,0.5968044946228716,HFE,DisGeNET
3370,Capuchin ears,0.4588306540708931,1.6950283616950284,1.320552665492241,0.5968044946228716,BCL11A,DisGeNET
3371,Cardiac Lymphoma,0.4588306540708931,1.6950283616950284,1.320552665492241,0.5968044946228716,IL6R,DisGeNET
3372,Contiguous gene syndrome,0.4588306540708931,1.6950283616950284,1.320552665492241,0.5968044946228716,KANSL1,DisGeNET
3373,Craniorachischisis,0.4588306540708931,1.6950283616950284,1.320552665492241,0.5968044946228716,RRM1,DisGeNET
3374,Cupped ears (finding),0.4588306540708931,1.6950283616950284,1.320552665492241,0.5968044946228716,BCL11A,DisGeNET
3375,Early infantile epileptic encephalopathy with suppression bursts,0.4588306540708931,1.6950283616950284,1.320552665492241,0.5968044946228716,GADD45A,DisGeNET
3376,Easy fatigability,0.4588306540708931,1.6950283616950284,1.320552665492241,0.5968044946228716,TYMP,DisGeNET
3377,ESTROGEN RESISTANCE,0.4588306540708931,1.6950283616950284,1.320552665492241,0.5968044946228716,PIK3CA,DisGeNET
3378,Exencephaly,0.4588306540708931,1.6950283616950284,1.320552665492241,0.5968044946228716,RRM1,DisGeNET
3379,Familial Juvenile Parkinsonism,0.4588306540708931,1.6950283616950284,1.320552665492241,0.5968044946228716,MAPT,DisGeNET
3380,Gross motor development delay,0.4588306540708931,1.6950283616950284,1.320552665492241,0.5968044946228716,ASXL1,DisGeNET
3381,Impaired left ventricular function,0.4588306540708931,1.6950283616950284,1.320552665492241,0.5968044946228716,APOB,DisGeNET
3382,Increased bilirubin level (finding),0.4588306540708931,1.6950283616950284,1.320552665492241,0.5968044946228716,HK1,DisGeNET
3383,Keratoconjunctivitis Sicca,0.4588306540708931,1.6950283616950284,1.320552665492241,0.5968044946228716,NLRP3,DisGeNET
3384,Loss of appetite (finding),0.4588306540708931,1.6950283616950284,1.320552665492241,0.5968044946228716,TYMP,DisGeNET
3385,Malignant Uterine Corpus Neoplasm,0.4588306540708931,1.6950283616950284,1.320552665492241,0.5968044946228716,PIK3CA,DisGeNET
3386,Megacolon,0.4588306540708931,1.6950283616950284,1.320552665492241,0.5968044946228716,KIT,DisGeNET
3387,Opisthotonus,0.4588306540708931,1.6950283616950284,1.320552665492241,0.5968044946228716,GCDH,DisGeNET
3388,Optic Neuritis,0.4588306540708931,1.6950283616950284,1.320552665492241,0.5968044946228716,APOE,DisGeNET
3389,Optic Neuropathy,0.4588306540708931,1.6950283616950284,1.320552665492241,0.5968044946228716,APOE,DisGeNET
3390,Personality Disorders,0.4588306540708931,1.6950283616950284,1.320552665492241,0.5968044946228716,KCTD17,DisGeNET
3391,Premenopausal breast cancer,0.4588306540708931,1.6950283616950284,1.320552665492241,0.5968044946228716,LEPR,DisGeNET
3392,Ramsay Hunt Paralysis Syndrome,0.4588306540708931,1.6950283616950284,1.320552665492241,0.5968044946228716,MAPT,DisGeNET
3393,Epstein-Barr Virus Infections,0.45996290143142454,1.1305865135652369,0.8780241612216876,0.5981008903965355,"IL1RN,RTEL1,PIK3CA,CDH1,ATR",DisGeNET
3394,Clear-cell metastatic renal cell carcinoma,0.461344360344615,1.2047225314040388,0.9319860351516344,0.599367290294594,"ABCC2,CD82,KIT",DisGeNET
3395,Juvenile rheumatoid arthritis,0.461344360344615,1.2047225314040388,0.9319860351516344,0.599367290294594,"IL1RN,IL2RB,NLRP3",DisGeNET
3396,Lymphatic Metastasis,0.461344360344615,1.2047225314040388,0.9319860351516344,0.599367290294594,"MAP3K1,CD82,CDH1",DisGeNET
3397,Osteopenia,0.4622195264818432,1.0959146867403748,0.8457341698401579,0.6003275098139218,"IL1RN,HFE,NLRP3,SLC39A13,PPARG,APOE,ANP32B",DisGeNET
3398,Orbital separation excessive,0.4627069087873585,1.085535105657805,0.8365800604180645,0.6007836614390305,"ASXL1,FIG4,MEF2C,CCND2,MAP2K2,PIK3CA,CDH1,PGAP3",DisGeNET
3399,"Leishmaniasis, Visceral",0.4643885605952292,1.2985132017431429,0.9960033364394497,0.601727556342482,"IL2RB,LPL",DisGeNET
3400,Congenital cataract,0.4643885605952292,1.2985132017431429,0.9960033364394497,0.601727556342482,"MAP2K2,LONP1",DisGeNET
3401,Congenital clinodactyly,0.4643885605952292,1.2985132017431429,0.9960033364394497,0.601727556342482,"CEP57,CDH1",DisGeNET
3402,Diaphragmatic Hernia,0.4643885605952292,1.2985132017431429,0.9960033364394497,0.601727556342482,"PDGFRA,THRB",DisGeNET
3403,Intraepithelial Neoplasia,0.4643885605952292,1.2985132017431429,0.9960033364394497,0.601727556342482,"CCND2,CTSB",DisGeNET
3404,Mood swings,0.4643885605952292,1.2985132017431429,0.9960033364394497,0.601727556342482,"FIG4,LEPR",DisGeNET
3405,Nephronophthisis,0.4643885605952292,1.2985132017431429,0.9960033364394497,0.601727556342482,"AHI1,NPHP3",DisGeNET
3406,Coinfection,0.46960316096530463,1.1889590771765999,0.8986952628694377,0.6083056800290441,"RTEL1,TP53I3,LPL",DisGeNET
3407,Inflammatory disorder,0.471543176548593,1.1408666100254885,0.8576403229418544,0.6088002949213643,"IL1RN,IL37,NLRP3,HDAC7",DisGeNET
3408,Retrusion of lower jaw,0.47231233763776986,1.0757547093321802,0.8069395070831887,0.6088002949213643,"ASXL1,CEP57,FIG4,DSTYK,RPS28,PIK3CA,NSMCE2,ATR",DisGeNET
3409,Decreased projection of lower jaw,0.47231233763776986,1.0757547093321802,0.8069395070831887,0.6088002949213643,"ASXL1,CEP57,FIG4,DSTYK,RPS28,PIK3CA,NSMCE2,ATR",DisGeNET
3410,Decreased projection of mandible,0.47231233763776986,1.0757547093321802,0.8069395070831887,0.6088002949213643,"ASXL1,CEP57,FIG4,DSTYK,RPS28,PIK3CA,NSMCE2,ATR",DisGeNET
3411,Hypoplastic mandible condyle,0.47231233763776986,1.0757547093321802,0.8069395070831887,0.6088002949213643,"ASXL1,CEP57,FIG4,DSTYK,RPS28,PIK3CA,NSMCE2,ATR",DisGeNET
3412,Tumor Initiation,0.4723246198728904,1.1138597386461961,0.8354936877996214,0.6088002949213643,"CEBPA,PIK3CA,CDH1,PSD4,CTSB",DisGeNET
3413,Anteverted nostril,0.47256918190945557,1.0965751423981305,0.8219610642601851,0.6088002949213643,"FIG4,FTO,AHI1,MEF2C,MAP2K2,LONP1",DisGeNET
3414,Retinal Degeneration,0.47491784384475805,1.2713353413654618,0.946653394938154,0.6088002949213643,"AHI1,APOB",DisGeNET
3415,"Spastic Paraplegia, Hereditary",0.47491784384475805,1.2713353413654618,0.946653394938154,0.6088002949213643,"DSTYK,ADAR",DisGeNET
3416,Abnormal skeletal development,0.47491784384475805,1.2713353413654618,0.946653394938154,0.6088002949213643,"NLRP3,SLC39A13",DisGeNET
3417,Connective Tissue Diseases,0.47491784384475805,1.2713353413654618,0.946653394938154,0.6088002949213643,"ABCC2,SLC39A13",DisGeNET
3418,Early-Stage Breast Carcinoma,0.47491784384475805,1.2713353413654618,0.946653394938154,0.6088002949213643,"PIK3CA,APOE",DisGeNET
3419,Hypopigmentation disorder,0.47491784384475805,1.2713353413654618,0.946653394938154,0.6088002949213643,"KITLG,KIT",DisGeNET
3420,Pulmonary Embolism,0.47491784384475805,1.2713353413654618,0.946653394938154,0.6088002949213643,"FTO,APOE",DisGeNET
3421,Seckel syndrome,0.47605644095165617,1.605658289868816,1.191749862810084,0.6088002949213643,ATR,DisGeNET
3422,"Hyperglycemia, Postprandial",0.47605644095165617,1.605658289868816,1.191749862810084,0.6088002949213643,LEPR,DisGeNET
3423,Short thorax,0.47605644095165617,1.605658289868816,1.191749862810084,0.6088002949213643,ASXL1,DisGeNET
3424,Spinocerebellar Ataxia Type 4,0.47605644095165617,1.605658289868816,1.191749862810084,0.6088002949213643,TDP2,DisGeNET
3425,"Preauricular Fistulae, Congenital",0.47605644095165617,1.605658289868816,1.191749862810084,0.6088002949213643,CITED2,DisGeNET
3426,Abnormality of the sternum,0.47605644095165617,1.605658289868816,1.191749862810084,0.6088002949213643,MAP2K2,DisGeNET
3427,Andersen Syndrome,0.47605644095165617,1.605658289868816,1.191749862810084,0.6088002949213643,APOE,DisGeNET
3428,Antisocial Personality Disorder,0.47605644095165617,1.605658289868816,1.191749862810084,0.6088002949213643,ALDH2,DisGeNET
3429,Autoimmune state,0.47605644095165617,1.605658289868816,1.191749862810084,0.6088002949213643,SERPING1,DisGeNET
3430,Autosomal Dominant Parkinsonism,0.47605644095165617,1.605658289868816,1.191749862810084,0.6088002949213643,MAPT,DisGeNET
3431,Blood Platelet Disorders,0.47605644095165617,1.605658289868816,1.191749862810084,0.6088002949213643,CEBPA,DisGeNET
3432,Chronic Persistent Hepatitis,0.47605644095165617,1.605658289868816,1.191749862810084,0.6088002949213643,TF,DisGeNET
3433,Congenital preauricular sinus,0.47605644095165617,1.605658289868816,1.191749862810084,0.6088002949213643,CITED2,DisGeNET
3434,Cyanosis,0.47605644095165617,1.605658289868816,1.191749862810084,0.6088002949213643,ALDH2,DisGeNET
3435,Dermatofibrosarcoma Protuberans,0.47605644095165617,1.605658289868816,1.191749862810084,0.6088002949213643,PDGFRA,DisGeNET
3436,Diffusely thickened skin,0.47605644095165617,1.605658289868816,1.191749862810084,0.6088002949213643,KIT,DisGeNET
3437,Extramedullary Hematopoiesis (disorder),0.47605644095165617,1.605658289868816,1.191749862810084,0.6088002949213643,JAK2,DisGeNET
3438,Failure to thrive in infancy,0.47605644095165617,1.605658289868816,1.191749862810084,0.6088002949213643,MAP2K2,DisGeNET
3439,Giant Cell Fibroblastoma,0.47605644095165617,1.605658289868816,1.191749862810084,0.6088002949213643,PDGFRA,DisGeNET
3440,Harlequin Fetus,0.47605644095165617,1.605658289868816,1.191749862810084,0.6088002949213643,EPAS1,DisGeNET
3441,Hereditary hemorrhagic telangiectasia,0.47605644095165617,1.605658289868816,1.191749862810084,0.6088002949213643,PIK3CA,DisGeNET
3442,Hypoplasia of the optic nerve,0.47605644095165617,1.605658289868816,1.191749862810084,0.6088002949213643,MAP2K2,DisGeNET
3443,Islet Cell Tumor,0.47605644095165617,1.605658289868816,1.191749862810084,0.6088002949213643,KIT,DisGeNET
3444,Left ventricular noncompaction,0.47605644095165617,1.605658289868816,1.191749862810084,0.6088002949213643,PRDM16,DisGeNET
3445,Methylmalonic acidemia,0.47605644095165617,1.605658289868816,1.191749862810084,0.6088002949213643,PIK3CA,DisGeNET
3446,Oculocerebrorenal Syndrome,0.47605644095165617,1.605658289868816,1.191749862810084,0.6088002949213643,ABCC2,DisGeNET
3447,Pleural Tuberculosis,0.47605644095165617,1.605658289868816,1.191749862810084,0.6088002949213643,IL1RN,DisGeNET
3448,Preauricular dimple,0.47605644095165617,1.605658289868816,1.191749862810084,0.6088002949213643,CITED2,DisGeNET
3449,Prominent metopic ridge,0.47605644095165617,1.605658289868816,1.191749862810084,0.6088002949213643,ASXL1,DisGeNET
3450,Radial polydactyly,0.47605644095165617,1.605658289868816,1.191749862810084,0.6088002949213643,KIAA0586,DisGeNET
3451,Acute GVH disease,0.47780496063662703,1.1735998140831978,0.8667652666957798,0.6106823540929311,"IL1RN,NLRP3,JAK2",DisGeNET
3452,Congenital hypoplasia of lung,0.47780496063662703,1.1735998140831978,0.8667652666957798,0.6106823540929311,"KIAA0586,NPHP3,APOE",DisGeNET
3453,Malignant Peripheral Nerve Sheath Tumor,0.4784971650487183,1.1301907968574636,0.8330692791460639,0.6113899485070794,"PDGFRA,TERT,AXL,KIT",DisGeNET
3454,Aplasia/Hypoplasia of the mandible,0.48187951506881194,1.066145149623597,0.7783511699035688,0.615355259184833,"ASXL1,CEP57,FIG4,DSTYK,RPS28,PIK3CA,NSMCE2,ATR",DisGeNET
3455,Micrognathism,0.48187951506881194,1.066145149623597,0.7783511699035688,0.615355259184833,"ASXL1,CEP57,FIG4,DSTYK,RPS28,PIK3CA,NSMCE2,ATR",DisGeNET
3456,Pneumonitis,0.482782520752255,1.073455964839488,0.7816788194877073,0.6163300004510848,"SMPD2,TAGLN,IL2RB,NLRP3,PPARG,PDE7A,ETS2",DisGeNET
3457,"Dementia, Vascular",0.4853210560706859,1.2452667814113598,0.9002589397254492,0.6186756715931425,"APOE,APOB",DisGeNET
3458,Sicca Syndrome,0.4853210560706859,1.2452667814113598,0.9002589397254492,0.6186756715931425,"BLK,FAM167A",DisGeNET
3459,Contact Dermatitis,0.4853210560706859,1.2452667814113598,0.9002589397254492,0.6186756715931425,"DUSP1,IL37",DisGeNET
3460,Ichthyoses,0.4853210560706859,1.2452667814113598,0.9002589397254492,0.6186756715931425,"MAP2K2,TMPRSS6",DisGeNET
3461,Neuromuscular Diseases,0.4853210560706859,1.2452667814113598,0.9002589397254492,0.6186756715931425,"MEF2C,APOE",DisGeNET
3462,Physical Activity Measurement,0.4859475495128385,1.1586293930934262,0.836130212357224,0.6192953750579558,"FTO,KLF13,ZBTB38",DisGeNET
3463,Smoking Behaviors,0.4906949500700555,1.0896656534954408,0.7757685314810167,0.6227296071635378,"FTO,KLF13,ZBTB38,TNK2,CPEB4",DisGeNET
3464,Status Epilepticus,0.4906949500700555,1.0896656534954408,0.7757685314810167,0.6227296071635378,"FIG4,IL1RN,MEF2C,ALDH5A1,ABCC2",DisGeNET
3465,Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site,0.49229762070841715,1.1094214876033057,0.7862157505816472,0.6227296071635378,"TLR1,BCL2L11,NLRP3,PPARG",DisGeNET
3466,"Alopecia, Male Pattern",0.4927355073907322,1.5252252252252252,1.0795280967596923,0.6227296071635378,ABCC2,DisGeNET
3467,Refractory anaemia with excess blasts,0.4927355073907322,1.5252252252252252,1.0795280967596923,0.6227296071635378,ASXL1,DisGeNET
3468,Stage IV Breast Cancer AJCC v6 and v7,0.4927355073907322,1.5252252252252252,1.0795280967596923,0.6227296071635378,PIK3CA,DisGeNET
3469,"Refractory anemia, without ringed sideroblasts, without excess blasts",0.4927355073907322,1.5252252252252252,1.0795280967596923,0.6227296071635378,JAK2,DisGeNET
3470,Thyroid Hormone Resistance Syndrome,0.4927355073907322,1.5252252252252252,1.0795280967596923,0.6227296071635378,THRB,DisGeNET
3471,Ulnohumeral dislocation,0.4927355073907322,1.5252252252252252,1.0795280967596923,0.6227296071635378,ASXL1,DisGeNET
3472,Anastomosis,0.4927355073907322,1.5252252252252252,1.0795280967596923,0.6227296071635378,IL1RN,DisGeNET
3473,Angiomyolipoma,0.4927355073907322,1.5252252252252252,1.0795280967596923,0.6227296071635378,KIT,DisGeNET
3474,Atrioventricular Block,0.4927355073907322,1.5252252252252252,1.0795280967596923,0.6227296071635378,TDP2,DisGeNET
3475,Cervical Dystonia,0.4927355073907322,1.5252252252252252,1.0795280967596923,0.6227296071635378,KCTD17,DisGeNET
3476,Choreoathetoid movements,0.4927355073907322,1.5252252252252252,1.0795280967596923,0.6227296071635378,GCDH,DisGeNET
3477,Columnar Cell Change of the Breast,0.4927355073907322,1.5252252252252252,1.0795280967596923,0.6227296071635378,PIK3CA,DisGeNET
3478,Congenital vascular anomaly,0.4927355073907322,1.5252252252252252,1.0795280967596923,0.6227296071635378,PIK3CA,DisGeNET
3479,Conjugated hyperbilirubinemia,0.4927355073907322,1.5252252252252252,1.0795280967596923,0.6227296071635378,ABCC2,DisGeNET
3480,Dilatation of ureter,0.4927355073907322,1.5252252252252252,1.0795280967596923,0.6227296071635378,PLD1,DisGeNET
3481,Dislocation of elbow joint,0.4927355073907322,1.5252252252252252,1.0795280967596923,0.6227296071635378,ASXL1,DisGeNET
3482,Ectropion,0.4927355073907322,1.5252252252252252,1.0795280967596923,0.6227296071635378,DDB2,DisGeNET
3483,Familial medullary thyroid carcinoma,0.4927355073907322,1.5252252252252252,1.0795280967596923,0.6227296071635378,KIT,DisGeNET
3484,HIV encephalitis,0.4927355073907322,1.5252252252252252,1.0795280967596923,0.6227296071635378,APOE,DisGeNET
3485,Infective endocarditis,0.4927355073907322,1.5252252252252252,1.0795280967596923,0.6227296071635378,TLR1,DisGeNET
3486,Intermittent Claudication,0.4927355073907322,1.5252252252252252,1.0795280967596923,0.6227296071635378,EPAS1,DisGeNET
3487,Lichen Sclerosus et Atrophicus,0.4927355073907322,1.5252252252252252,1.0795280967596923,0.6227296071635378,IL1RN,DisGeNET
3488,Lymphoid neoplasm,0.4927355073907322,1.5252252252252252,1.0795280967596923,0.6227296071635378,PDGFRA,DisGeNET
3489,Paget Disease,0.4927355073907322,1.5252252252252252,1.0795280967596923,0.6227296071635378,TRIP6,DisGeNET
3490,Prostate cancer recurrent,0.4927355073907322,1.5252252252252252,1.0795280967596923,0.6227296071635378,PIK3CA,DisGeNET
3491,Radiohumeral dislocation,0.4927355073907322,1.5252252252252252,1.0795280967596923,0.6227296071635378,ASXL1,DisGeNET
3492,"Sleep Apnea, Obstructive",0.4940288347139516,1.1440332326283988,0.8067280686808431,0.6233089009342015,"LEPR,LPL,APOE",DisGeNET
3493,Complex partial seizures,0.4940288347139516,1.1440332326283988,0.8067280686808431,0.6233089009342015,"FIG4,ABCC2,APOE",DisGeNET
3494,Follicular adenoma,0.4940288347139516,1.1440332326283988,0.8067280686808431,0.6233089009342015,"CCND2,TERT,PPARG",DisGeNET
3495,Nicotine Dependence,0.4940288347139516,1.1440332326283988,0.8067280686808431,0.6233089009342015,"TERT,ALDH2,RHOA",DisGeNET
3496,Body mass index,0.4944343369299679,1.0480798590722256,0.738205535873302,0.6233089009342015,"FTO,GCKR,TOMM40,KLF13,ALDH2,ZBTB38,PPARG,CPEB4,MRPL33",DisGeNET
3497,Finding of body mass index,0.4944343369299679,1.0480798590722256,0.738205535873302,0.6233089009342015,"FTO,GCKR,TOMM40,KLF13,ALDH2,ZBTB38,PPARG,CPEB4,MRPL33",DisGeNET
3498,Soft Tissue Neoplasms,0.49559556311812764,1.2202409638554217,0.856603155253718,0.6233089009342015,"TERT,KIT",DisGeNET
3499,Anorexia Nervosa,0.49559556311812764,1.2202409638554217,0.856603155253718,0.6233089009342015,"FTO,LEPR",DisGeNET
3500,Bulbous nasal tip,0.49559556311812764,1.2202409638554217,0.856603155253718,0.6233089009342015,"KANSL1,SNIP1",DisGeNET
3501,Bulbous nose,0.49559556311812764,1.2202409638554217,0.856603155253718,0.6233089009342015,"KANSL1,SNIP1",DisGeNET
3502,Giant Cell Glioblastoma,0.49559556311812764,1.2202409638554217,0.856603155253718,0.6233089009342015,"PPARG,CTSB",DisGeNET
3503,Glomerular filtration rate finding,0.49559556311812764,1.2202409638554217,0.856603155253718,0.6233089009342015,"SLC7A6,GCKR",DisGeNET
3504,Hamartoma,0.49559556311812764,1.2202409638554217,0.856603155253718,0.6233089009342015,"PIK3CA,KIT",DisGeNET
3505,Membranous glomerulonephritis,0.49559556311812764,1.2202409638554217,0.856603155253718,0.6233089009342015,"APOE,RHOA",DisGeNET
3506,Narrow thorax,0.49559556311812764,1.2202409638554217,0.856603155253718,0.6233089009342015,"ASXL1,KIAA0586",DisGeNET
3507,Potato nose,0.49559556311812764,1.2202409638554217,0.856603155253718,0.6233089009342015,"KANSL1,SNIP1",DisGeNET
3508,Protein Deficiency,0.49559556311812764,1.2202409638554217,0.856603155253718,0.6233089009342015,"PIK3CA,AK3",DisGeNET
3509,Uterine Fibroids,0.49614787159931534,1.0520414639306115,0.7373561557165914,0.6238257080353888,"PDGFRA,IL1RN,KANSL1,PIK3CA,TERT,KIT,PPARG,ATR",DisGeNET
3510,Bone Diseases,0.4991411069945305,1.0993174993174992,0.7638788412007249,0.6274104171110736,"IL1RN,PRDM16,SLC39A13,PPARG",DisGeNET
3511,Cerebral Infarction,0.5002488761627956,1.0641661939875213,0.7370942375955697,0.6286237657733563,"IL1RN,ALDH2,PIK3CA,LPL,PPARG,APOE",DisGeNET
3512,"Amyotrophic Lateral Sclerosis, Sporadic",0.502046837453479,1.1297974711871992,0.7785003491142737,0.6305239529874037,"HFE,APOE,MAPT",DisGeNET
3513,Lewy Body Disease,0.502046837453479,1.1297974711871992,0.7785003491142737,0.6305239529874037,"TOMM40,APOE,MAPT",DisGeNET
3514,Anorexia,0.5057390240908062,1.1961965509095205,0.8154884640102932,0.6333431039900291,"IL1RN,LEPR",DisGeNET
3515,Mycobacterium Infections,0.5057390240908062,1.1961965509095205,0.8154884640102932,0.6333431039900291,"TLR1,PIK3CA",DisGeNET
3516,Seminoma,0.5059448710187313,1.0893939393939394,0.7422341213451401,0.6333431039900291,"KITLG,KIT,LPL,SIRT3",DisGeNET
3517,Well Differentiated Oligodendroglioma,0.5059448710187313,1.0893939393939394,0.7422341213451401,0.6333431039900291,"PDGFRA,TERT,CDH1,IL2RB",DisGeNET
3518,Liver Failure,0.5059448710187313,1.0893939393939394,0.7422341213451401,0.6333431039900291,"PTPN1,IL1RN,PIK3CA,PPARG",DisGeNET
3519,Urothelial Carcinoma,0.5088312636889708,1.0664867047845772,0.7205598218744743,0.6333431039900291,"CEBPA,TERT,PIK3CA,DUSP1,ATR",DisGeNET
3520,Hydrocephalus,0.5088312636889708,1.0664867047845772,0.7205598218744743,0.6333431039900291,"FTO,CCND2,PIK3CA,KIAA0586,DLG5",DisGeNET
3521,Nonorganic psychosis,0.5088312636889708,1.0664867047845772,0.7205598218744743,0.6333431039900291,"AHI1,TOMM40,PTPRC,APOE,MAPT",DisGeNET
3522,Reduced number of teeth,0.5088851549511907,1.4524524524524525,0.981179441528542,0.6333431039900291,ATR,DisGeNET
3523,"EAR, PATELLA, SHORT STATURE SYNDROME",0.5088851549511907,1.4524524524524525,0.981179441528542,0.6333431039900291,ATR,DisGeNET
3524,Thick skin,0.5088851549511907,1.4524524524524525,0.981179441528542,0.6333431039900291,KIT,DisGeNET
3525,Toeing-in,0.5088851549511907,1.4524524524524525,0.981179441528542,0.6333431039900291,FIG4,DisGeNET
3526,Unverricht-Lundborg Syndrome,0.5088851549511907,1.4524524524524525,0.981179441528542,0.6333431039900291,CTSB,DisGeNET
3527,X-Linked Emery-Dreifuss Muscular Dystrophy,0.5088851549511907,1.4524524524524525,0.981179441528542,0.6333431039900291,HSPA8,DisGeNET
3528,Agitation,0.5088851549511907,1.4524524524524525,0.981179441528542,0.6333431039900291,TOMM40,DisGeNET
3529,Anthrax disease,0.5088851549511907,1.4524524524524525,0.981179441528542,0.6333431039900291,RAB8A,DisGeNET
3530,Autosomal Recessive Parkinsonism,0.5088851549511907,1.4524524524524525,0.981179441528542,0.6333431039900291,MAPT,DisGeNET
3531,Birthmark,0.5088851549511907,1.4524524524524525,0.981179441528542,0.6333431039900291,KITLG,DisGeNET
3532,Decrease in appetite,0.5088851549511907,1.4524524524524525,0.981179441528542,0.6333431039900291,TYMP,DisGeNET
3533,Disorder of the optic nerve,0.5088851549511907,1.4524524524524525,0.981179441528542,0.6333431039900291,APOE,DisGeNET
3534,Erythrokeratoderma,0.5088851549511907,1.4524524524524525,0.981179441528542,0.6333431039900291,KANK2,DisGeNET
3535,Fundus coloboma,0.5088851549511907,1.4524524524524525,0.981179441528542,0.6333431039900291,KIAA0586,DisGeNET
3536,Gastrinoma,0.5088851549511907,1.4524524524524525,0.981179441528542,0.6333431039900291,CDH1,DisGeNET
3537,Hereditary Diseases,0.5088851549511907,1.4524524524524525,0.981179441528542,0.6333431039900291,LPL,DisGeNET
3538,Hereditary Motor and Sensory-Neuropathy Type II,0.5088851549511907,1.4524524524524525,0.981179441528542,0.6333431039900291,FIG4,DisGeNET
3539,High-grade hypermetropia,0.5088851549511907,1.4524524524524525,0.981179441528542,0.6333431039900291,PRDM16,DisGeNET
3540,HIV Encephalopathy,0.5088851549511907,1.4524524524524525,0.981179441528542,0.6333431039900291,APOE,DisGeNET
3541,Infant Acute Lymphoblastic Leukemia,0.5088851549511907,1.4524524524524525,0.981179441528542,0.6333431039900291,TERT,DisGeNET
3542,Metatarsus Varus,0.5088851549511907,1.4524524524524525,0.981179441528542,0.6333431039900291,FIG4,DisGeNET
3543,Noncancerous mole,0.5088851549511907,1.4524524524524525,0.981179441528542,0.6333431039900291,PIK3CA,DisGeNET
3544,Primary Lesion,0.5088851549511907,1.4524524524524525,0.981179441528542,0.6333431039900291,KIT,DisGeNET
3545,Prostatic Diseases,0.5088851549511907,1.4524524524524525,0.981179441528542,0.6333431039900291,GADD45A,DisGeNET
3546,Absence Seizures,0.5099996906644908,1.1159089234396875,0.7513918723803886,0.6345512225639406,"ABCC2,ALDH5A1,APOE",DisGeNET
3547,Hypogonadism,0.5127075604010686,1.079646017699115,0.7212571486244082,0.6377405572285071,"AHI1,HFE,LEPR,DDB2",DisGeNET
3548,Fibroid Tumor,0.5132014764060744,1.0414112031028566,0.6947116350759267,0.637995745184696,"PDGFRA,IL1RN,TERT,KANSL1,KIT,PPARG,ATR",DisGeNET
3549,Immunologic Deficiency Syndromes,0.5132019264869643,1.022242270724175,0.6819233973904907,0.637995745184696,"PTPN1,RTEL1,BCL2L11,PTPRC,PIK3CA,TERT,IL2RB,LEPR,PPARG,JAK2,PLD1,CTSB",DisGeNET
3550,Chronic Kidney Diseases,0.51499396486088,1.0337943225538109,0.6860260128320695,0.6400432036524514,"FTO,IL1RN,GCKR,CITED2,NLRP3,PPARG,APOE,APOB",DisGeNET
3551,Rheumatism,0.5157493756746305,1.1730769230769231,0.7767345113577714,0.6404408233820631,"SPTA1,ANP32B",DisGeNET
3552,Death in infancy,0.5157493756746305,1.1730769230769231,0.7767345113577714,0.6404408233820631,"ASXL1,PIK3CA",DisGeNET
3553,Luminal B Breast Carcinoma,0.5157493756746305,1.1730769230769231,0.7767345113577714,0.6404408233820631,"PIK3CA,CDH1",DisGeNET
3554,Neoplasms,0.5159875249551894,1.0099878050009574,0.6682813480407993,0.6405562633940055,"BLK,PDGFRA,CITED2,EPAS1,TFEB,ADAR,SIRT3,TLR1,PIK3CA,TERT,AXL,KIT,TAF8,PPARG,ZKSCAN4,JARID2,JAK2,IL6R,ZNF410,CTSB,ATR",DisGeNET
3555,Ureteral obstruction,0.5178856359622828,1.1023550394933208,0.725350543170526,0.6423703755596265,"PIK3CA,NLRP3,MUC20",DisGeNET
3556,Cerebellar Hypoplasia,0.5178856359622828,1.1023550394933208,0.725350543170526,0.6423703755596265,"RTEL1,MAP2K2,TERT",DisGeNET
3557,Complete atrioventricular block,0.5178856359622828,1.1023550394933208,0.725350543170526,0.6423703755596265,"TLR1,ADAR,PPARG",DisGeNET
3558,Poor school performance,0.5182260853520742,1.0107350164347157,0.6644002688749883,0.6426119979126901,"CEP57,RTEL1,MAP2K2,TMPRSS6,PGAP3,BCL11A,SLC25A15,AHI1,RAD50,ALDH5A1,KANSL1,PIK3CA,TERT,KIAA0586,TDP2,PRDM16,PPARG,ATR",DisGeNET
3559,"Neoplasm, Residual",0.5194278769433858,1.0700691121743753,0.7009244918034175,0.6439212680736774,"RTEL1,PTPRC,KIT,JAK2",DisGeNET
3560,Recurrent upper respiratory tract infection,0.5245221393688277,1.3862953862953864,0.8945315544894749,0.6444421272334357,LEPR,DisGeNET
3561,Secondary physiologic amenorrhea,0.5245221393688277,1.3862953862953864,0.8945315544894749,0.6444421272334357,PPARG,DisGeNET
3562,Single tumor,0.5245221393688277,1.3862953862953864,0.8945315544894749,0.6444421272334357,PIK3CA,DisGeNET
3563,Tendinopathy,0.5245221393688277,1.3862953862953864,0.8945315544894749,0.6444421272334357,TRABD,DisGeNET
3564,Tented mouth,0.5245221393688277,1.3862953862953864,0.8945315544894749,0.6444421272334357,PGAP3,DisGeNET
3565,Tented upper lip,0.5245221393688277,1.3862953862953864,0.8945315544894749,0.6444421272334357,PGAP3,DisGeNET
3566,Tented upper lip vermilion,0.5245221393688277,1.3862953862953864,0.8945315544894749,0.6444421272334357,PGAP3,DisGeNET
3567,Terminal tremor,0.5245221393688277,1.3862953862953864,0.8945315544894749,0.6444421272334357,PIK3CA,DisGeNET
3568,Abnormality of the hair,0.5245221393688277,1.3862953862953864,0.8945315544894749,0.6444421272334357,TERT,DisGeNET
3569,Abnormality of the hair shaft,0.5245221393688277,1.3862953862953864,0.8945315544894749,0.6444421272334357,TERT,DisGeNET
3570,Vascular anomaly,0.5245221393688277,1.3862953862953864,0.8945315544894749,0.6444421272334357,PIK3CA,DisGeNET
3571,Acanthosis,0.5245221393688277,1.3862953862953864,0.8945315544894749,0.6444421272334357,IL1RN,DisGeNET
3572,Acinar Cell Carcinoma,0.5245221393688277,1.3862953862953864,0.8945315544894749,0.6444421272334357,PIK3CA,DisGeNET
3573,African Burkitt's lymphoma,0.5245221393688277,1.3862953862953864,0.8945315544894749,0.6444421272334357,RHOA,DisGeNET
3574,Cafe-au-Lait Spots,0.5245221393688277,1.3862953862953864,0.8945315544894749,0.6444421272334357,KITLG,DisGeNET
3575,Central visual impairment,0.5245221393688277,1.3862953862953864,0.8945315544894749,0.6444421272334357,DOCK7,DisGeNET
3576,Cerebellar Diseases,0.5245221393688277,1.3862953862953864,0.8945315544894749,0.6444421272334357,AHI1,DisGeNET
3577,Cholangitis,0.5245221393688277,1.3862953862953864,0.8945315544894749,0.6444421272334357,PPARG,DisGeNET
3578,Chronic leukemia (category),0.5245221393688277,1.3862953862953864,0.8945315544894749,0.6444421272334357,JAK2,DisGeNET
3579,Combined immunodeficiency,0.5245221393688277,1.3862953862953864,0.8945315544894749,0.6444421272334357,TFRC,DisGeNET
3580,Gastro-esophageal reflux disease with esophagitis,0.5245221393688277,1.3862953862953864,0.8945315544894749,0.6444421272334357,IL1RN,DisGeNET
3581,Generalized osteoarthritis,0.5245221393688277,1.3862953862953864,0.8945315544894749,0.6444421272334357,HFE,DisGeNET
3582,heart rate,0.5245221393688277,1.3862953862953864,0.8945315544894749,0.6444421272334357,FTO,DisGeNET
3583,Hereditary pyropoikilocytosis,0.5245221393688277,1.3862953862953864,0.8945315544894749,0.6444421272334357,SPTA1,DisGeNET
3584,Hypoplasia of the brainstem,0.5245221393688277,1.3862953862953864,0.8945315544894749,0.6444421272334357,ASXL1,DisGeNET
3585,Inflammatory Myofibroblastic Tumor,0.5245221393688277,1.3862953862953864,0.8945315544894749,0.6444421272334357,PDGFRA,DisGeNET
3586,Juvenile polyposis syndrome,0.5245221393688277,1.3862953862953864,0.8945315544894749,0.6444421272334357,PIK3CA,DisGeNET
3587,Low Grade Lymphoma (neoplasm),0.5245221393688277,1.3862953862953864,0.8945315544894749,0.6444421272334357,TFRC,DisGeNET
3588,Monocytosis,0.5245221393688277,1.3862953862953864,0.8945315544894749,0.6444421272334357,JAK2,DisGeNET
3589,Neck webbing,0.5245221393688277,1.3862953862953864,0.8945315544894749,0.6444421272334357,MAP2K2,DisGeNET
3590,Oral cleft,0.5245221393688277,1.3862953862953864,0.8945315544894749,0.6444421272334357,JARID2,DisGeNET
3591,Psychiatric symptom,0.5245221393688277,1.3862953862953864,0.8945315544894749,0.6444421272334357,APOE,DisGeNET
3592,"Malaria, Falciparum",0.5256248166650371,1.1508297340304614,0.7401763946491501,0.6445404922529583,"TLR1,IL1RN",DisGeNET
3593,Turridolichocephaly,0.5256248166650371,1.1508297340304614,0.7401763946491501,0.6445404922529583,"FIG4,CITED2",DisGeNET
3594,Death in early childhood,0.5256248166650371,1.1508297340304614,0.7401763946491501,0.6445404922529583,"ASXL1,PIK3CA",DisGeNET
3595,Diabetic Neuropathies,0.5256248166650371,1.1508297340304614,0.7401763946491501,0.6445404922529583,"LEPR,APOE",DisGeNET
3596,Narrow cranium shape,0.5256248166650371,1.1508297340304614,0.7401763946491501,0.6445404922529583,"FIG4,CITED2",DisGeNET
3597,Narrow head shape,0.5256248166650371,1.1508297340304614,0.7401763946491501,0.6445404922529583,"FIG4,CITED2",DisGeNET
3598,Narrow skull shape,0.5256248166650371,1.1508297340304614,0.7401763946491501,0.6445404922529583,"FIG4,CITED2",DisGeNET
3599,Allergic asthma,0.5261045761260449,1.0606587615283267,0.681213681466712,0.6449495387241205,"TLR1,IL1RN,MYB,PPARG",DisGeNET
3600,Byzanthine arch palate,0.5267051764026424,1.0442603156097765,0.6694902468970543,0.6455064550801273,"MAP2K2,PIK3CA,KANSL1,SLC39A13,ATR",DisGeNET
3601,Feeding difficulties,0.532600297252464,1.0370531191199883,0.6533269214418981,0.6525356160819547,"ASXL1,AHI1,RPS28,THRB,SNIP1",DisGeNET
3602,Nasal Polyps,0.5327364662572984,1.05141065830721,0.6621031640882299,0.6525356160819547,"KITLG,PTPRC,TERT,LEPR",DisGeNET
3603,Intracranial Aneurysm,0.5334502983754498,1.0762040163497424,0.6762751681445156,0.6532286196037981,"AKAP10,APOE,CTSB",DisGeNET
3604,"Creatinine measurement, serum (procedure)",0.5353637937478779,1.1294065149486836,0.7056631009235845,0.6548447624107672,"SLC7A6,GCKR",DisGeNET
3605,Everted lower lip vermilion,0.5353637937478779,1.1294065149486836,0.7056631009235845,0.6548447624107672,"KANSL1,BCL11A",DisGeNET
3606,Increased tendency to bruise,0.5353637937478779,1.1294065149486836,0.7056631009235845,0.6548447624107672,"SLC39A13,JAK2",DisGeNET
3607,Protruding lower lip,0.5353637937478779,1.1294065149486836,0.7056631009235845,0.6548447624107672,"KANSL1,BCL11A",DisGeNET
3608,Cytomegalovirus Infections,0.5384624759465659,1.0299433171773598,0.6375735025940699,0.6550183706110161,"PDGFRA,PTPRC,CDH1,ADAR,APOE",DisGeNET
3609,Disseminated Malignant Neoplasm,0.5393224078772868,1.0423206423206424,0.6435722580784767,0.6550183706110161,"PTPRC,CD82,AXL,CTSB",DisGeNET
3610,"ALBINOIDISM, OCULOCUTANEOUS, AUTOSOMAL DOMINANT",0.5396626874821041,1.3258911084998042,0.8178242038340053,0.6550183706110161,KITLG,DisGeNET
3611,"Amyotrophic Lateral Sclerosis, Guam Form",0.5396626874821041,1.3258911084998042,0.8178242038340053,0.6550183706110161,APOE,DisGeNET
3612,"Biliary Cirrhosis, Secondary",0.5396626874821041,1.3258911084998042,0.8178242038340053,0.6550183706110161,ABCC2,DisGeNET
3613,"CATARACT, ANTERIOR POLAR",0.5396626874821041,1.3258911084998042,0.8178242038340053,0.6550183706110161,IL1RN,DisGeNET
3614,Soluble Interleukin 6 Receptor Measurement,0.5396626874821041,1.3258911084998042,0.8178242038340053,0.6550183706110161,IL6R,DisGeNET
3615,Spastic,0.5396626874821041,1.3258911084998042,0.8178242038340053,0.6550183706110161,APOE,DisGeNET
3616,Spinocerebellar Ataxia Type 6 (disorder),0.5396626874821041,1.3258911084998042,0.8178242038340053,0.6550183706110161,TDP2,DisGeNET
3617,"Sarcoidosis, Pulmonary",0.5396626874821041,1.3258911084998042,0.8178242038340053,0.6550183706110161,PPARG,DisGeNET
3618,Talipes foot deformities,0.5396626874821041,1.3258911084998042,0.8178242038340053,0.6550183706110161,ATR,DisGeNET
3619,"Skin Diseases, Genetic",0.5396626874821041,1.3258911084998042,0.8178242038340053,0.6550183706110161,ADAR,DisGeNET
3620,"Xeroderma pigmentosum, group A",0.5396626874821041,1.3258911084998042,0.8178242038340053,0.6550183706110161,ATR,DisGeNET
3621,Abnormality of the eye,0.5396626874821041,1.3258911084998042,0.8178242038340053,0.6550183706110161,APOE,DisGeNET
3622,Active tuberculosis,0.5396626874821041,1.3258911084998042,0.8178242038340053,0.6550183706110161,NLRP3,DisGeNET
3623,Breast Diseases,0.5396626874821041,1.3258911084998042,0.8178242038340053,0.6550183706110161,CCND2,DisGeNET
3624,Erythroblastosis,0.5396626874821041,1.3258911084998042,0.8178242038340053,0.6550183706110161,ETS2,DisGeNET
3625,Fibrillary Astrocytoma,0.5396626874821041,1.3258911084998042,0.8178242038340053,0.6550183706110161,TERT,DisGeNET
3626,Genitourinary Cancer,0.5396626874821041,1.3258911084998042,0.8178242038340053,0.6550183706110161,TERT,DisGeNET
3627,Hallopeau-Siemens Disease,0.5396626874821041,1.3258911084998042,0.8178242038340053,0.6550183706110161,PIK3CA,DisGeNET
3628,Hypopituitarism,0.5396626874821041,1.3258911084998042,0.8178242038340053,0.6550183706110161,APOE,DisGeNET
3629,Left ventricular noncompaction cardiomyopathy,0.5396626874821041,1.3258911084998042,0.8178242038340053,0.6550183706110161,PRDM16,DisGeNET
3630,Leiomyosarcoma of uterus,0.5396626874821041,1.3258911084998042,0.8178242038340053,0.6550183706110161,PIK3CA,DisGeNET
3631,Nodular Sclerosis Classical Hodgkin Lymphoma,0.5396626874821041,1.3258911084998042,0.8178242038340053,0.6550183706110161,AHI1,DisGeNET
3632,Non-medullary thyroid carcinoma,0.5396626874821041,1.3258911084998042,0.8178242038340053,0.6550183706110161,PIK3CA,DisGeNET
3633,Pre-renal acute kidney injury,0.5396626874821041,1.3258911084998042,0.8178242038340053,0.6550183706110161,PPARG,DisGeNET
3634,Pyelonephritis,0.5396626874821041,1.3258911084998042,0.8178242038340053,0.6550183706110161,TLR1,DisGeNET
3635,Pyloric Stenosis,0.5396626874821041,1.3258911084998042,0.8178242038340053,0.6550183706110161,FIG4,DisGeNET
3636,Azoospermia,0.5411260191812659,1.0635846272746434,0.6531506058443203,0.6564333232410627,"MAP3K1,HFE,MAST2",DisGeNET
3637,Kyphosis deformity of spine,0.5411260191812659,1.0635846272746434,0.6531506058443203,0.6564333232410627,"PIK3CA,KANSL1,SLC39A13",DisGeNET
3638,Acute Kidney Insufficiency,0.5449649876065206,1.108762322015334,0.6730561272473623,0.6603640552924935,"TF,PPARG",DisGeNET
3639,Blepharophimosis,0.5449649876065206,1.108762322015334,0.6730561272473623,0.6603640552924935,"KANSL1,ATR",DisGeNET
3640,Dejerine-Sottas Disease (disorder),0.5449649876065206,1.108762322015334,0.6730561272473623,0.6603640552924935,"FIG4,IL1RN",DisGeNET
3641,Embryonal Rhabdomyosarcoma,0.5449649876065206,1.108762322015334,0.6730561272473623,0.6603640552924935,"PIK3CA,TERT",DisGeNET
3642,"Foramen Ovale, Patent",0.5543225141392293,1.2705205205205206,0.7496180413790507,0.6641686791257742,PLD1,DisGeNET
3643,"Glomerulonephritis, Membranoproliferative",0.5543225141392293,1.2705205205205206,0.7496180413790507,0.6641686791257742,TAGLN,DisGeNET
3644,"Hemophilia, NOS",0.5543225141392293,1.2705205205205206,0.7496180413790507,0.6641686791257742,AK3,DisGeNET
3645,"Memory Disorder, Semantic",0.5543225141392293,1.2705205205205206,0.7496180413790507,0.6641686791257742,MAPT,DisGeNET
3646,"Memory Disorder, Spatial",0.5543225141392293,1.2705205205205206,0.7496180413790507,0.6641686791257742,MAPT,DisGeNET
3647,"Mental Retardation, X-Linked",0.5543225141392293,1.2705205205205206,0.7496180413790507,0.6641686791257742,ATR,DisGeNET
3648,"Mitral regurgitation, mild",0.5543225141392293,1.2705205205205206,0.7496180413790507,0.6641686791257742,CCND2,DisGeNET
3649,Spinocerebellar Ataxia Type 5,0.5543225141392293,1.2705205205205206,0.7496180413790507,0.6641686791257742,TDP2,DisGeNET
3650,Talipes,0.5543225141392293,1.2705205205205206,0.7496180413790507,0.6641686791257742,ATR,DisGeNET
3651,Widely spaced teeth,0.5543225141392293,1.2705205205205206,0.7496180413790507,0.6641686791257742,KANSL1,DisGeNET
3652,Age-Related Memory Disorders,0.5543225141392293,1.2705205205205206,0.7496180413790507,0.6641686791257742,MAPT,DisGeNET
3653,Aortic coarctation,0.5543225141392293,1.2705205205205206,0.7496180413790507,0.6641686791257742,CEP57,DisGeNET
3654,Bacterial Endocarditis,0.5543225141392293,1.2705205205205206,0.7496180413790507,0.6641686791257742,TLR1,DisGeNET
3655,Bone necrosis,0.5543225141392293,1.2705205205205206,0.7496180413790507,0.6641686791257742,PPARG,DisGeNET
3656,Chikungunya Fever,0.5543225141392293,1.2705205205205206,0.7496180413790507,0.6641686791257742,PIK3CA,DisGeNET
3657,Cone dystrophy,0.5543225141392293,1.2705205205205206,0.7496180413790507,0.6641686791257742,TST,DisGeNET
3658,Congenital anomaly of brain,0.5543225141392293,1.2705205205205206,0.7496180413790507,0.6641686791257742,AHI1,DisGeNET
3659,Dysphasia,0.5543225141392293,1.2705205205205206,0.7496180413790507,0.6641686791257742,MAPT,DisGeNET
3660,Enteritis,0.5543225141392293,1.2705205205205206,0.7496180413790507,0.6641686791257742,DUSP1,DisGeNET
3661,FRAGILE X TREMOR/ATAXIA SYNDROME,0.5543225141392293,1.2705205205205206,0.7496180413790507,0.6641686791257742,APOE,DisGeNET
3662,Glycosuria,0.5543225141392293,1.2705205205205206,0.7496180413790507,0.6641686791257742,NSMCE2,DisGeNET
3663,Hemorrhage,0.5543225141392293,1.2705205205205206,0.7496180413790507,0.6641686791257742,APOE,DisGeNET
3664,Hepatitis D Infection,0.5543225141392293,1.2705205205205206,0.7496180413790507,0.6641686791257742,ADAR,DisGeNET
3665,Hyperemia,0.5543225141392293,1.2705205205205206,0.7496180413790507,0.6641686791257742,APOE,DisGeNET
3666,Hyperplasia of nose,0.5543225141392293,1.2705205205205206,0.7496180413790507,0.6641686791257742,ATR,DisGeNET
3667,Hypertrophy of nose,0.5543225141392293,1.2705205205205206,0.7496180413790507,0.6641686791257742,ATR,DisGeNET
3668,Infiltrating Cervical Carcinoma,0.5543225141392293,1.2705205205205206,0.7496180413790507,0.6641686791257742,CD82,DisGeNET
3669,Japanese Encephalitis,0.5543225141392293,1.2705205205205206,0.7496180413790507,0.6641686791257742,NLRP3,DisGeNET
3670,Large nose,0.5543225141392293,1.2705205205205206,0.7496180413790507,0.6641686791257742,ATR,DisGeNET
3671,Malabsorption Syndrome,0.5543225141392293,1.2705205205205206,0.7496180413790507,0.6641686791257742,APOB,DisGeNET
3672,Monoclonal B-Cell Lymphocytosis,0.5543225141392293,1.2705205205205206,0.7496180413790507,0.6641686791257742,JAK2,DisGeNET
3673,Palpitations,0.5543225141392293,1.2705205205205206,0.7496180413790507,0.6641686791257742,MAX,DisGeNET
3674,Paranoia,0.5543225141392293,1.2705205205205206,0.7496180413790507,0.6641686791257742,ICE2,DisGeNET
3675,Protein measurement,0.5543225141392293,1.2705205205205206,0.7496180413790507,0.6641686791257742,GCKR,DisGeNET
3676,Sleep disturbances,0.5544272994606133,1.088855421686747,0.6422282593330724,0.6641686791257742,"THRB,APOE",DisGeNET
3677,Thyroid associated opthalmopathies,0.5544272994606133,1.088855421686747,0.6422282593330724,0.6641686791257742,"IL1RN,PPARG",DisGeNET
3678,Acute kidney injury,0.5544272994606133,1.088855421686747,0.6422282593330724,0.6641686791257742,"TF,PPARG",DisGeNET
3679,Gastric ulcer,0.5544272994606133,1.088855421686747,0.6422282593330724,0.6641686791257742,"TLR1,IL1RN",DisGeNET
3680,Gilles de la Tourette syndrome,0.5544272994606133,1.088855421686747,0.6422282593330724,0.6641686791257742,"PSD4,HK1",DisGeNET
3681,Long narrow head,0.5544272994606133,1.088855421686747,0.6422282593330724,0.6641686791257742,"FIG4,CITED2",DisGeNET
3682,Malformations of Cortical Development,0.5544272994606133,1.088855421686747,0.6422282593330724,0.6641686791257742,"CCND2,PIK3CA",DisGeNET
3683,Pick Disease of the Brain,0.5544272994606133,1.088855421686747,0.6422282593330724,0.6641686791257742,"APOE,MAPT",DisGeNET
3684,Adenocarcinoma of colon,0.5558428725623387,1.0091789287223978,0.5926601340325657,0.6656381994394519,"PIK3CA,EPAS1,CDH1,PPARG,HSD17B13",DisGeNET
3685,Curvature of little finger,0.5562574889694604,1.0392062620159297,0.6095193952041892,0.6656381994394519,"CITED2,PRDM16,ATR",DisGeNET
3686,Familial lichen amyloidosis,0.5562574889694604,1.0392062620159297,0.6095193952041892,0.6656381994394519,"PSMB5,CDH1,APOE",DisGeNET
3687,Hyperammonemia,0.5562574889694604,1.0392062620159297,0.6095193952041892,0.6656381994394519,"HADHA,SLC25A15,HMGCL",DisGeNET
3688,Dermatologic disorders,0.5575876508339106,0.9967132527365744,0.5822156608034988,0.6670490009433877,"IL1RN,PIK3CA,NLRP3,ADAR,PPARG,JAK2,DMKN",DisGeNET
3689,Autistic Disorder,0.5581610565006131,0.9870081018518518,0.5755320503330027,0.6675539661915709,"IL1RN,MEF2C,CHURC1,AGAP1,DUSP15,MYO1D,AHI1,TF,ALDH5A1,ZNF827,ALDH2,PIK3CA,PRDM16,APOE",DisGeNET
3690,"Tuberculosis, Pulmonary",0.5637108221940834,1.027427950711158,0.588935967780174,0.6724153254701869,"FTO,TLR1,ZNF410",DisGeNET
3691,Clinodactyly of the 5th finger,0.5637108221940834,1.027427950711158,0.588935967780174,0.6724153254701869,"CITED2,PRDM16,ATR",DisGeNET
3692,Mucosa-Associated Lymphoid Tissue Lymphoma,0.5637108221940834,1.027427950711158,0.588935967780174,0.6724153254701869,"IL1RN,PIK3CA,CDH1",DisGeNET
3693,Nephritis,0.5637108221940834,1.027427950711158,0.588935967780174,0.6724153254701869,"IL1RN,CCND2,NLRP3",DisGeNET
3694,"Brain Tumor, Primary",0.5637498388291526,1.0696470090889876,0.6130624863792062,0.6724153254701869,"PDGFRA,CTSB",DisGeNET
3695,Acquired flat foot,0.5637498388291526,1.0696470090889876,0.6130624863792062,0.6724153254701869,"SLC39A13,ATR",DisGeNET
3696,Cerebral Palsy,0.5637498388291526,1.0696470090889876,0.6130624863792062,0.6724153254701869,"WIPI2,APOE",DisGeNET
3697,Intervertebral Disc Degeneration,0.5637498388291526,1.0696470090889876,0.6130624863792062,0.6724153254701869,"IL1RN,NLRP3",DisGeNET
3698,Late tooth eruption,0.5637498388291526,1.0696470090889876,0.6130624863792062,0.6724153254701869,"LONP1,SLC39A13",DisGeNET
3699,Pachygyria,0.5637498388291526,1.0696470090889876,0.6130624863792062,0.6724153254701869,"FIG4,ATR",DisGeNET
3700,Congenital contractural arachnodactyly,0.5651856869928412,1.0074630603556223,0.5748593816301495,0.6735489499471101,"PDGFRA,ABCC2,PIK3CA,CDH1",DisGeNET
3701,Charcot-Marie-Tooth Disease,0.5672500645220853,0.9957883862764965,0.5645672459430656,0.6735489499471101,"FIG4,HADHA,MAP2K2,TYMP,HK1",DisGeNET
3702,Diabetic Retinopathy,0.5672500645220853,0.9957883862764965,0.5645672459430656,0.6735489499471101,"PTPN1,ALDH2,SERPING1,PPARG,APOE",DisGeNET
3703,Sensorimotor neuropathy,0.5685168380786577,1.2195795795795796,0.6887262826658954,0.6735489499471101,TYMP,DisGeNET
3704,"Leishmaniasis, Cutaneous",0.5685168380786577,1.2195795795795796,0.6887262826658954,0.6735489499471101,NLRP3,DisGeNET
3705,Spinal Cord Diseases,0.5685168380786577,1.2195795795795796,0.6887262826658954,0.6735489499471101,IL2RB,DisGeNET
3706,Spondylarthropathies,0.5685168380786577,1.2195795795795796,0.6887262826658954,0.6735489499471101,IL37,DisGeNET
3707,"Nephrotic Syndrome, Minimal Change",0.5685168380786577,1.2195795795795796,0.6887262826658954,0.6735489499471101,APOE,DisGeNET
3708,Tooth agenesis,0.5685168380786577,1.2195795795795796,0.6887262826658954,0.6735489499471101,ATR,DisGeNET
3709,Trigonocephaly,0.5685168380786577,1.2195795795795796,0.6887262826658954,0.6735489499471101,ASXL1,DisGeNET
3710,Acute anterior uveitis,0.5685168380786577,1.2195795795795796,0.6887262826658954,0.6735489499471101,SERPING1,DisGeNET
3711,Behavioral Symptoms,0.5685168380786577,1.2195795795795796,0.6887262826658954,0.6735489499471101,ALDH5A1,DisGeNET
3712,Bone Marrow Diseases,0.5685168380786577,1.2195795795795796,0.6887262826658954,0.6735489499471101,IL2RB,DisGeNET
3713,Broad thumbs,0.5685168380786577,1.2195795795795796,0.6887262826658954,0.6735489499471101,SNIP1,DisGeNET
3714,Chronic progressive external ophthalmoplegia,0.5685168380786577,1.2195795795795796,0.6887262826658954,0.6735489499471101,TYMP,DisGeNET
3715,Delayed myelination,0.5685168380786577,1.2195795795795796,0.6887262826658954,0.6735489499471101,GCDH,DisGeNET
3716,DOWN SYNDROME CRITICAL REGION,0.5685168380786577,1.2195795795795796,0.6887262826658954,0.6735489499471101,ETS2,DisGeNET
3717,Dropped beats - heart,0.5685168380786577,1.2195795795795796,0.6887262826658954,0.6735489499471101,MAX,DisGeNET
3718,Exfoliative dermatitis,0.5685168380786577,1.2195795795795796,0.6887262826658954,0.6735489499471101,KIT,DisGeNET
3719,Foot-drop,0.5685168380786577,1.2195795795795796,0.6887262826658954,0.6735489499471101,TYMP,DisGeNET
3720,Foot dorsiflexor weakness,0.5685168380786577,1.2195795795795796,0.6887262826658954,0.6735489499471101,TYMP,DisGeNET
3721,Gastrointestinal mucositis,0.5685168380786577,1.2195795795795796,0.6887262826658954,0.6735489499471101,IL1RN,DisGeNET
3722,Hyperbilirubinemia,0.5685168380786577,1.2195795795795796,0.6887262826658954,0.6735489499471101,ABCC2,DisGeNET
3723,Idiopathic osteoarthritis,0.5685168380786577,1.2195795795795796,0.6887262826658954,0.6735489499471101,HFE,DisGeNET
3724,Low Tension Glaucoma,0.5685168380786577,1.2195795795795796,0.6887262826658954,0.6735489499471101,APOE,DisGeNET
3725,Severe mental retardation (I.Q. 20-34),0.5715265701690226,0.9991058122205663,0.5589440565830338,0.67693294700288,"ASXL1,MEF2C,ITSN1,ATR",DisGeNET
3726,Uranostaphyloschisis,0.5728975088702359,0.9892235424150317,0.5510454369077702,0.6778695606983534,"FTO,ASXL1,RPS28,KIAA0586,ATR",DisGeNET
3727,Desmoplastic,0.5729319111160833,1.0511009555463233,0.585451037466751,0.6778695606983534,"PIK3CA,PPARG",DisGeNET
3728,Limb ischemia,0.5729319111160833,1.0511009555463233,0.585451037466751,0.6778695606983534,"IL2RB,EPHB4",DisGeNET
3729,Lyme Disease,0.5729319111160833,1.0511009555463233,0.585451037466751,0.6778695606983534,"TLR1,IL37",DisGeNET
3730,Thickened facial skin with coarse facial features,0.5783873248096287,1.004647920055775,0.5500563123939457,0.6837740828135268,"FTO,MAP2K2,THRB",DisGeNET
3731,Transitional cell carcinoma of bladder,0.5783873248096287,1.004647920055775,0.5500563123939457,0.6837740828135268,"PIK3CA,CDH1,EPHB4",DisGeNET
3732,Dengue Fever,0.5783873248096287,1.004647920055775,0.5500563123939457,0.6837740828135268,"IL1RN,NLRP3,ADAR",DisGeNET
3733,Alcohol Use Disorder,0.5819730064684353,1.033183581784766,0.5592945215428038,0.6852314950412092,"TF,ALDH2",DisGeNET
3734,Flatfoot,0.5819730064684353,1.033183581784766,0.5592945215428038,0.6852314950412092,"SLC39A13,ATR",DisGeNET
3735,"Cockayne Syndrome, Type I",0.5822603977582713,1.1725571725571726,0.634162904451109,0.6852314950412092,APOE,DisGeNET
3736,Rous Sarcoma,0.5822603977582713,1.1725571725571726,0.634162904451109,0.6852314950412092,PIK3CA,DisGeNET
3737,"Degenerative Diseases, Spinal Cord",0.5822603977582713,1.1725571725571726,0.634162904451109,0.6852314950412092,MAPT,DisGeNET
3738,"Intellectual disability, progressive",0.5822603977582713,1.1725571725571726,0.634162904451109,0.6852314950412092,DDB2,DisGeNET
3739,Acquired aplastic anemia,0.5822603977582713,1.1725571725571726,0.634162904451109,0.6852314950412092,TERT,DisGeNET
3740,Agyria,0.5822603977582713,1.1725571725571726,0.634162904451109,0.6852314950412092,FTO,DisGeNET
3741,Blue sclera,0.5822603977582713,1.1725571725571726,0.634162904451109,0.6852314950412092,SLC39A13,DisGeNET
3742,Chloracne,0.5822603977582713,1.1725571725571726,0.634162904451109,0.6852314950412092,GADD45A,DisGeNET
3743,Choreoathetosis,0.5822603977582713,1.1725571725571726,0.634162904451109,0.6852314950412092,GCDH,DisGeNET
3744,Depressive Syndrome,0.5822603977582713,1.1725571725571726,0.634162904451109,0.6852314950412092,APOE,DisGeNET
3745,Endocrine System Diseases,0.5822603977582713,1.1725571725571726,0.634162904451109,0.6852314950412092,LEPR,DisGeNET
3746,Kidney damage,0.5822603977582713,1.1725571725571726,0.634162904451109,0.6852314950412092,NLRP3,DisGeNET
3747,Microcalcification,0.5822603977582713,1.1725571725571726,0.634162904451109,0.6852314950412092,JAK2,DisGeNET
3748,Milroy Disease,0.5822603977582713,1.1725571725571726,0.634162904451109,0.6852314950412092,IL6R,DisGeNET
3749,Nervous System Neoplasms,0.5822603977582713,1.1725571725571726,0.634162904451109,0.6852314950412092,TERT,DisGeNET
3750,Lens Opacities,0.5848996776088131,0.9720420342501297,0.5213206630635558,0.688153967362689,"CEP57,FIG4,AHI1,PIK3CA,LONP1,DDB2",DisGeNET
3751,Coarse facial features,0.5856086104582441,0.9936293182713779,0.5316946379828277,0.6888043693259859,"FTO,MAP2K2,THRB",DisGeNET
3752,Congenital hypoplasia of penis,0.5896071080694392,0.9700307823359727,0.5124661782317345,0.6931379058892527,"FIG4,AHI1,MAP3K1,AXL,KIAA0586",DisGeNET
3753,Endometrioma,0.5896071080694392,0.9700307823359727,0.5124661782317345,0.6931379058892527,"TAGLN,KLF13,DUSP1,LEPR,TYMP",DisGeNET
3754,Muscular Dystrophy,0.5902356998792261,0.9748363636363636,0.5139662227286381,0.6934926527010472,"CEP57,HSPA8,KITLG,IL2RB",DisGeNET
3755,Deep Vein Thrombosis,0.5908727885267967,1.015863453815261,0.5345011607121284,0.6934926527010472,"FTO,JAK2",DisGeNET
3756,Dermatomyositis,0.5908727885267967,1.015863453815261,0.5345011607121284,0.6934926527010472,"BLK,FAM167A",DisGeNET
3757,Joint laxity,0.5908727885267967,1.015863453815261,0.5345011607121284,0.6934926527010472,"PIK3CA,SLC39A13",DisGeNET
3758,Lymphadenopathy,0.5908727885267967,1.015863453815261,0.5345011607121284,0.6934926527010472,"PTPRC,NLRP3",DisGeNET
3759,Benign Prostatic Hyperplasia,0.5920734610296802,0.9626809573462014,0.5045647353260727,0.6934926527010472,"THRB,CD82,DUSP1,KIT,LPL,PPARG,JAK2,IL6R",DisGeNET
3760,Depressive Symptoms,0.5927508016664805,0.9828476756651399,0.5140108583939823,0.6934926527010472,"FTO,AHI1,APOE",DisGeNET
3761,Metastatic malignant neoplasm to brain,0.5927508016664805,0.9828476756651399,0.5140108583939823,0.6934926527010472,"PIK3CA,CDH1,KIT",DisGeNET
3762,Malignant neoplasm of large intestine,0.5935167920975412,0.9612631578947368,0.501481157666646,0.6934926527010472,"RRM1,ABCC2,PIK3CA,TERT,CDH1,AXL,TRIB1,KLF3,MDFI",DisGeNET
3763,Neuroendocrine Tumors,0.5950973061507945,0.9637951598630295,0.5002389363169527,0.6934926527010472,"PDGFRA,BCL2L11,TERT,PIK3CA,KIT",DisGeNET
3764,Patent ductus arteriosus,0.5950973061507945,0.9637951598630295,0.5002389363169527,0.6934926527010472,"FTO,SMPD2,PIK3CA,AXL,NPHP3",DisGeNET
3765,Russell-Silver syndrome,0.5955674662475675,1.1290179067956845,0.5851029209930787,0.6934926527010472,ATR,DisGeNET
3766,"Hyperparathyroidism, Secondary",0.5955674662475675,1.1290179067956845,0.5851029209930787,0.6934926527010472,PIK3CA,DisGeNET
3767,"Leukemia, Plasma Cell",0.5955674662475675,1.1290179067956845,0.5851029209930787,0.6934926527010472,PSMB5,DisGeNET
3768,"Sarcoma, Epithelioid",0.5955674662475675,1.1290179067956845,0.5851029209930787,0.6934926527010472,PIK3CA,DisGeNET
3769,"Sensorineural hearing loss, bilateral",0.5955674662475675,1.1290179067956845,0.5851029209930787,0.6934926527010472,CD164,DisGeNET
3770,Thrombasthenia,0.5955674662475675,1.1290179067956845,0.5851029209930787,0.6934926527010472,NLRP3,DisGeNET
3771,"Turner Syndrome, Male",0.5955674662475675,1.1290179067956845,0.5851029209930787,0.6934926527010472,MAP2K2,DisGeNET
3772,"Xeroderma Pigmentosum, Complementation Group D",0.5955674662475675,1.1290179067956845,0.5851029209930787,0.6934926527010472,RRM1,DisGeNET
3773,Turcot syndrome (disorder),0.5955674662475675,1.1290179067956845,0.5851029209930787,0.6934926527010472,PIK3CA,DisGeNET
3774,Unilateral agenesis of kidney,0.5955674662475675,1.1290179067956845,0.5851029209930787,0.6934926527010472,DSTYK,DisGeNET
3775,Aortic aneurysm without mention of rupture NOS,0.5955674662475675,1.1290179067956845,0.5851029209930787,0.6934926527010472,APOE,DisGeNET
3776,Bronchogenic Carcinoma,0.5955674662475675,1.1290179067956845,0.5851029209930787,0.6934926527010472,CEBPG,DisGeNET
3777,Cervical Squamous Intraepithelial Neoplasia,0.5955674662475675,1.1290179067956845,0.5851029209930787,0.6934926527010472,TERT,DisGeNET
3778,Congenital hypoplasia of ovary,0.5955674662475675,1.1290179067956845,0.5851029209930787,0.6934926527010472,LEPR,DisGeNET
3779,Endocardial Cushion Defects,0.5955674662475675,1.1290179067956845,0.5851029209930787,0.6934926527010472,LONP1,DisGeNET
3780,Foot Deformities,0.5955674662475675,1.1290179067956845,0.5851029209930787,0.6934926527010472,HK1,DisGeNET
3781,Hereditary Nonpolyposis Colorectal Neoplasms,0.5955674662475675,1.1290179067956845,0.5851029209930787,0.6934926527010472,CDH1,DisGeNET
3782,Hypoplastic ovary,0.5955674662475675,1.1290179067956845,0.5851029209930787,0.6934926527010472,LEPR,DisGeNET
3783,Inherited neuropathies,0.5955674662475675,1.1290179067956845,0.5851029209930787,0.6934926527010472,FIG4,DisGeNET
3784,intracranial glioma,0.5955674662475675,1.1290179067956845,0.5851029209930787,0.6934926527010472,CDH1,DisGeNET
3785,Mitral Valve Insufficiency,0.5955674662475675,1.1290179067956845,0.5851029209930787,0.6934926527010472,CCND2,DisGeNET
3786,Monoclonal Gammapathies,0.5955674662475675,1.1290179067956845,0.5851029209930787,0.6934926527010472,KIT,DisGeNET
3787,Neuroectodermal Tumors,0.5955674662475675,1.1290179067956845,0.5851029209930787,0.6934926527010472,CD82,DisGeNET
3788,Peroxisomal Disorders,0.5955674662475675,1.1290179067956845,0.5851029209930787,0.6934926527010472,EPAS1,DisGeNET
3789,Radial club hand,0.5955674662475675,1.1290179067956845,0.5851029209930787,0.6934926527010472,FIG4,DisGeNET
3790,Esophageal carcinoma,0.5985063674718939,0.9582823886144667,0.4919037093516161,0.6967308953261203,"LAPTM4B,THRB,ALDH2,PIK3CA,TERT,CDH1,GADD45A,AXL,HEATR3,PPARG,EPHB4,RHOA",DisGeNET
3791,"Ataxia, Spinocerebellar",0.5996310841894394,0.9991111988939364,0.5109861035185408,0.6969368660284001,"HSPA8,TDP2",DisGeNET
3792,Retinal Detachment,0.5996310841894394,0.9991111988939364,0.5109861035185408,0.6969368660284001,"NSMCE2,JAK2",DisGeNET
3793,Retroviridae Infections,0.5996310841894394,0.9991111988939364,0.5109861035185408,0.6969368660284001,"TERT,ZNF217",DisGeNET
3794,Kartagener Syndrome,0.5996310841894394,0.9991111988939364,0.5109861035185408,0.6969368660284001,"PTPRC,PPARG",DisGeNET
3795,Osteoarthrosis Deformans,0.5996310841894394,0.9991111988939364,0.5109861035185408,0.6969368660284001,"HADHA,PPARG",DisGeNET
3796,Primary microcephaly,0.5996310841894394,0.9991111988939364,0.5109861035185408,0.6969368660284001,"NSMCE2,ATR",DisGeNET
3797,Adrenoleukodystrophy,0.5998131604191327,0.9722954297100983,0.4969762386353951,0.6969648837948942,"TFRC,HFE,PCSK7",DisGeNET
3798,Nasopharyngeal carcinoma,0.6002797825955581,0.9575479169966735,0.4886936073217958,0.6973234335996847,"BRD3,ABCC2,TYMP,RAD50,KITLG,PIK3CA,TERT,CDH1,KIT,TRIP6,FLOT2,MAPT,JAK2",DisGeNET
3799,"Alcoholic Intoxication, Chronic",0.6057739696933591,0.9509615384615384,0.47666790187195807,0.7001798729779047,"FTO,GYPA,IL1RN,TF,ALDH2,PIK3CA,GYPE,PPARG,APOE",DisGeNET
3800,Cognition Disorders,0.6059547321336486,0.9515577507598785,0.4766828506303805,0.7001798729779047,"AHI1,NLRP3,APOE,MAPT,ETS2",DisGeNET
3801,Tuberculosis,0.6067373238718746,0.9508101851851852,0.475081176702487,0.7001798729779047,"TLR1,FTO,IL1RN,TF,BCL2L11,PIK3CA,TST,IL2RB,NLRP3,ZNF410",DisGeNET
3802,"PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE",0.6082478734799617,0.9828993392926545,0.48867081019915476,0.7001798729779047,"MAPT,UBE2L3",DisGeNET
3803,Idiopathic pulmonary hypertension,0.6082478734799617,0.9828993392926545,0.48867081019915476,0.7001798729779047,"TRPC1,PPARG",DisGeNET
3804,"Degenerative Diseases, Central Nervous System",0.6084518660465291,1.0885885885885886,0.5408516027490681,0.7001798729779047,MAPT,DisGeNET
3805,Sense of smell impaired,0.6084518660465291,1.0885885885885886,0.5408516027490681,0.7001798729779047,APOE,DisGeNET
3806,"Liposarcoma, Myxoid",0.6084518660465291,1.0885885885885886,0.5408516027490681,0.7001798729779047,TERT,DisGeNET
3807,"Lymphoma, Diffuse",0.6084518660465291,1.0885885885885886,0.5408516027490681,0.7001798729779047,TFRC,DisGeNET
3808,Sparse body hair,0.6084518660465291,1.0885885885885886,0.5408516027490681,0.7001798729779047,KANK2,DisGeNET
3809,Sparse or absent eyebrows,0.6084518660465291,1.0885885885885886,0.5408516027490681,0.7001798729779047,MAP2K2,DisGeNET
3810,Sparse/absent eyebrows,0.6084518660465291,1.0885885885885886,0.5408516027490681,0.7001798729779047,MAP2K2,DisGeNET
3811,Spinocerebellar Ataxia Type 2,0.6084518660465291,1.0885885885885886,0.5408516027490681,0.7001798729779047,TDP2,DisGeNET
3812,Thick vermilion border,0.6084518660465291,1.0885885885885886,0.5408516027490681,0.7001798729779047,DOCK7,DisGeNET
3813,Tumoral calcinosis,0.6084518660465291,1.0885885885885886,0.5408516027490681,0.7001798729779047,JAK2,DisGeNET
3814,Absence of eyebrow,0.6084518660465291,1.0885885885885886,0.5408516027490681,0.7001798729779047,MAP2K2,DisGeNET
3815,Vascular Neoplasms,0.6084518660465291,1.0885885885885886,0.5408516027490681,0.7001798729779047,PPARG,DisGeNET
3816,Visual field constriction,0.6084518660465291,1.0885885885885886,0.5408516027490681,0.7001798729779047,HK1,DisGeNET
3817,Well Differentiated Pancreatic Endocrine Tumor,0.6084518660465291,1.0885885885885886,0.5408516027490681,0.7001798729779047,KIT,DisGeNET
3818,AIDS related complex,0.6084518660465291,1.0885885885885886,0.5408516027490681,0.7001798729779047,RTEL1,DisGeNET
3819,Alkaline phosphatase raised,0.6084518660465291,1.0885885885885886,0.5408516027490681,0.7001798729779047,PGAP3,DisGeNET
3820,Aplasia/Hypoplasia of the eyebrow,0.6084518660465291,1.0885885885885886,0.5408516027490681,0.7001798729779047,MAP2K2,DisGeNET
3821,Basal Cell Nevus Syndrome,0.6084518660465291,1.0885885885885886,0.5408516027490681,0.7001798729779047,TERT,DisGeNET
3822,contracture of elbow,0.6084518660465291,1.0885885885885886,0.5408516027490681,0.7001798729779047,ATR,DisGeNET
3823,Gemistocytic astrocytoma,0.6084518660465291,1.0885885885885886,0.5408516027490681,0.7001798729779047,TERT,DisGeNET
3824,Growth Hormone-Secreting Pituitary Adenoma,0.6084518660465291,1.0885885885885886,0.5408516027490681,0.7001798729779047,BCL2L11,DisGeNET
3825,hiv-infection/aids,0.6084518660465291,1.0885885885885886,0.5408516027490681,0.7001798729779047,APOE,DisGeNET
3826,Hypoalbuminemia,0.6084518660465291,1.0885885885885886,0.5408516027490681,0.7001798729779047,LPL,DisGeNET
3827,Juvenile Pilocytic Astrocytoma,0.6084518660465291,1.0885885885885886,0.5408516027490681,0.7001798729779047,KIT,DisGeNET
3828,Leukocyte adhesion deficiency type 1,0.6084518660465291,1.0885885885885886,0.5408516027490681,0.7001798729779047,PIK3CA,DisGeNET
3829,Male sterility,0.6084518660465291,1.0885885885885886,0.5408516027490681,0.7001798729779047,ALDH2,DisGeNET
3830,Myocardial Reperfusion Injury,0.6084518660465291,1.0885885885885886,0.5408516027490681,0.7001798729779047,TFRC,DisGeNET
3831,Neoplasm of uncertain or unknown behavior of breast,0.6084518660465291,1.0885885885885886,0.5408516027490681,0.7001798729779047,PIK3CA,DisGeNET
3832,Non-arthropod borne lymphocytic choriomeningitis,0.6084518660465291,1.0885885885885886,0.5408516027490681,0.7001798729779047,ADAR,DisGeNET
3833,Paralysed,0.6084518660465291,1.0885885885885886,0.5408516027490681,0.7001798729779047,FIG4,DisGeNET
3834,Pointed chin,0.6084518660465291,1.0885885885885886,0.5408516027490681,0.7001798729779047,PRDM16,DisGeNET
3835,Graft-vs-Host Disease,0.6144229091729643,0.9442330279539581,0.45990929072235176,0.7068667210615693,"IL1RN,PTPRC,JAK2,TYMP",DisGeNET
3836,Thrombosis,0.6167232800625455,0.9672021419009371,0.4674825005165326,0.7078888501269639,"LEPR,JAK2",DisGeNET
3837,Infectious disease of lung,0.6167232800625455,0.9672021419009371,0.4674825005165326,0.7078888501269639,"SMOX,NLRP3",DisGeNET
3838,Macrostomia,0.6167232800625455,0.9672021419009371,0.4674825005165326,0.7078888501269639,"PIK3CA,SNIP1",DisGeNET
3839,Retinal Dystrophies,0.6205149999954452,0.9419441243342573,0.4495009173749175,0.7078888501269639,"AHI1,TST,NPHP3",DisGeNET
3840,Small midface,0.6205149999954452,0.9419441243342573,0.4495009173749175,0.7078888501269639,"RPS28,BCL11A,PRDM16",DisGeNET
3841,Decreased projection of midface,0.6205149999954452,0.9419441243342573,0.4495009173749175,0.7078888501269639,"RPS28,BCL11A,PRDM16",DisGeNET
3842,Hypotrophic midface,0.6205149999954452,0.9419441243342573,0.4495009173749175,0.7078888501269639,"RPS28,BCL11A,PRDM16",DisGeNET
3843,Intrahepatic Cholangiocarcinoma,0.6205149999954452,0.9419441243342573,0.4495009173749175,0.7078888501269639,"TERT,PIK3CA,CDH1",DisGeNET
3844,Midface retrusion,0.6205149999954452,0.9419441243342573,0.4495009173749175,0.7078888501269639,"RPS28,BCL11A,PRDM16",DisGeNET
3845,Reduced tendon reflexes,0.6209269832256007,1.0509474992233614,0.50082039544352,0.7078888501269639,APOB,DisGeNET
3846,"Lymphohistiocytosis, Hemophagocytic",0.6209269832256007,1.0509474992233614,0.50082039544352,0.7078888501269639,PTPRC,DisGeNET
3847,"Paraparesis, Spastic",0.6209269832256007,1.0509474992233614,0.50082039544352,0.7078888501269639,SLC25A15,DisGeNET
3848,Alcoholic Intoxication,0.6209269832256007,1.0509474992233614,0.50082039544352,0.7078888501269639,ALDH2,DisGeNET
3849,Amenorrhea,0.6209269832256007,1.0509474992233614,0.50082039544352,0.7078888501269639,HFE,DisGeNET
3850,Angelman Syndrome,0.6209269832256007,1.0509474992233614,0.50082039544352,0.7078888501269639,MEF2C,DisGeNET
3851,Anosmia,0.6209269832256007,1.0509474992233614,0.50082039544352,0.7078888501269639,APOE,DisGeNET
3852,Aplasia/Hypoplasia of the cerebellum,0.6209269832256007,1.0509474992233614,0.50082039544352,0.7078888501269639,PIK3CA,DisGeNET
3853,Atypical Teratoid Rhabdoid Tumor,0.6209269832256007,1.0509474992233614,0.50082039544352,0.7078888501269639,PIK3CA,DisGeNET
3854,Chronic pain,0.6209269832256007,1.0509474992233614,0.50082039544352,0.7078888501269639,NLRP3,DisGeNET
3855,Confusion,0.6209269832256007,1.0509474992233614,0.50082039544352,0.7078888501269639,TOMM40,DisGeNET
3856,Congenital anomaly of the kidney,0.6209269832256007,1.0509474992233614,0.50082039544352,0.7078888501269639,AHI1,DisGeNET
3857,Epistaxis,0.6209269832256007,1.0509474992233614,0.50082039544352,0.7078888501269639,JAK2,DisGeNET
3858,Eye Abnormalities,0.6209269832256007,1.0509474992233614,0.50082039544352,0.7078888501269639,MAPT,DisGeNET
3859,Frequent nosebleeds,0.6209269832256007,1.0509474992233614,0.50082039544352,0.7078888501269639,JAK2,DisGeNET
3860,Heart Septal Defects,0.6209269832256007,1.0509474992233614,0.50082039544352,0.7078888501269639,CITED2,DisGeNET
3861,Hypernasal voice,0.6209269832256007,1.0509474992233614,0.50082039544352,0.7078888501269639,KANSL1,DisGeNET
3862,Hypoplastic Left Heart Syndrome,0.6209269832256007,1.0509474992233614,0.50082039544352,0.7078888501269639,APOE,DisGeNET
3863,Immunoglobulin A deficiency (disorder),0.6209269832256007,1.0509474992233614,0.50082039544352,0.7078888501269639,AHI1,DisGeNET
3864,Impulsive character (finding),0.6209269832256007,1.0509474992233614,0.50082039544352,0.7078888501269639,MAPT,DisGeNET
3865,Late fontanel closure,0.6209269832256007,1.0509474992233614,0.50082039544352,0.7078888501269639,PRDM16,DisGeNET
3866,Microscopic Polyarteritis,0.6209269832256007,1.0509474992233614,0.50082039544352,0.7078888501269639,GYPA,DisGeNET
3867,Mixed anxiety and depressive disorder,0.6209269832256007,1.0509474992233614,0.50082039544352,0.7078888501269639,ALDH2,DisGeNET
3868,Nasal voice,0.6209269832256007,1.0509474992233614,0.50082039544352,0.7078888501269639,KANSL1,DisGeNET
3869,Parasitic Diseases,0.6209269832256007,1.0509474992233614,0.50082039544352,0.7078888501269639,PIK3CA,DisGeNET
3870,Rabies (disorder),0.6209269832256007,1.0509474992233614,0.50082039544352,0.7078888501269639,HSPA8,DisGeNET
3871,Major Depressive Disorder,0.6220014458437017,0.9386907483615302,0.44570244051661717,0.7089306068360661,"FTO,FADS2,TOMM40,SLC22A16,TERT,DUSP1,IL2RB,ADAR,APOE,QKI",DisGeNET
3872,Respiratory Syncytial Virus Infections,0.6250575623548842,0.9519954819277109,0.4473536570060607,0.711862148969992,"NLRP3,PPARG",DisGeNET
3873,Cardiac Arrhythmia,0.6250575623548842,0.9519954819277109,0.4473536570060607,0.711862148969992,"RPS28,HFE",DisGeNET
3874,Hydronephrosis,0.6250575623548842,0.9519954819277109,0.4473536570060607,0.711862148969992,"KANSL1,PLD1",DisGeNET
3875,TARSAL-CARPAL COALITION SYNDROME,0.627252148673819,0.9322399654725939,0.4348029362546004,0.7141771561158424,"CD82,TERT,EPHB4",DisGeNET
3876,Cataract,0.6297304759682993,0.930989010989011,0.43054831271712435,0.7168139473612323,"CEP57,FIG4,FTO,AHI1,PIK3CA,LONP1,APOE,DDB2,ATR",DisGeNET
3877,RENAL ADYSPLASIA,0.6330057811196118,1.015815815815816,0.46450791261694185,0.7176737410429057,NPHP3,DisGeNET
3878,Sleep Disorders,0.6330057811196118,1.015815815815816,0.46450791261694185,0.7176737410429057,APOE,DisGeNET
3879,Autistic behavior,0.6330057811196118,1.015815815815816,0.46450791261694185,0.7176737410429057,MEF2C,DisGeNET
3880,Bullous pemphigoid,0.6330057811196118,1.015815815815816,0.46450791261694185,0.7176737410429057,NFE2,DisGeNET
3881,Congenital neurologic anomalies,0.6330057811196118,1.015815815815816,0.46450791261694185,0.7176737410429057,PDGFRA,DisGeNET
3882,Corneal Neovascularization,0.6330057811196118,1.015815815815816,0.46450791261694185,0.7176737410429057,APOE,DisGeNET
3883,Endometriosis of uterus,0.6330057811196118,1.015815815815816,0.46450791261694185,0.7176737410429057,PIK3CA,DisGeNET
3884,Fabry Disease,0.6330057811196118,1.015815815815816,0.46450791261694185,0.7176737410429057,APOE,DisGeNET
3885,Flexion contracture - elbow,0.6330057811196118,1.015815815815816,0.46450791261694185,0.7176737410429057,ATR,DisGeNET
3886,Gonorrhea,0.6330057811196118,1.015815815815816,0.46450791261694185,0.7176737410429057,TFRC,DisGeNET
3887,HELLP Syndrome,0.6330057811196118,1.015815815815816,0.46450791261694185,0.7176737410429057,HADHA,DisGeNET
3888,Hernia,0.6330057811196118,1.015815815815816,0.46450791261694185,0.7176737410429057,PIK3CA,DisGeNET
3889,Li-Fraumeni Syndrome,0.6330057811196118,1.015815815815816,0.46450791261694185,0.7176737410429057,CDH1,DisGeNET
3890,Lymphocytic Choriomeningitis,0.6330057811196118,1.015815815815816,0.46450791261694185,0.7176737410429057,ADAR,DisGeNET
3891,Peptic Esophagitis,0.6330057811196118,1.015815815815816,0.46450791261694185,0.7176737410429057,IL1RN,DisGeNET
3892,Atrial Premature Complexes,0.6332511046872239,0.93725671918443,0.42822157813249745,0.7176737410429057,"BCL2L11,CDH1",DisGeNET
3893,Cocaine-Related Disorders,0.6332511046872239,0.93725671918443,0.42822157813249745,0.7176737410429057,"KLHL5,ICE2",DisGeNET
3894,Keratoconus,0.6339068778621321,0.9227318502242974,0.420630281131896,0.7182324461036792,"AHI1,IL1RN,CTSB",DisGeNET
3895,Craniosynostosis,0.6377090541341621,0.9154704944178629,0.4118455745974548,0.7223549029114052,"ASXL1,PDGFRA,MYB,ATR",DisGeNET
3896,Deafness,0.6426130734610279,0.9110350727117195,0.4028710860448144,0.7271012243560496,"FIG4,THRB,PIK3CA,NLRP3,SLC12A7",DisGeNET
3897,"Arthritis, Adjuvant-Induced",0.6447008136176033,0.982950692628112,0.43148480853355703,0.7271012243560496,DNASE2,DisGeNET
3898,"Arthritis, Collagen-Induced",0.6447008136176033,0.982950692628112,0.43148480853355703,0.7271012243560496,DNASE2,DisGeNET
3899,"Arthritis, Experimental",0.6447008136176033,0.982950692628112,0.43148480853355703,0.7271012243560496,DNASE2,DisGeNET
3900,"Carcinoma, Pancreatic Ductal",0.6447008136176033,0.982950692628112,0.43148480853355703,0.7271012243560496,PPARG,DisGeNET
3901,Right Ventricular Hypertrophy,0.6447008136176033,0.982950692628112,0.43148480853355703,0.7271012243560496,PPARG,DisGeNET
3902,Short ribs,0.6447008136176033,0.982950692628112,0.43148480853355703,0.7271012243560496,KIAA0586,DisGeNET
3903,Adult Diffuse Large B-Cell Lymphoma,0.6447008136176033,0.982950692628112,0.43148480853355703,0.7271012243560496,JAK2,DisGeNET
3904,AICARDI-GOUTIERES SYNDROME 1,0.6447008136176033,0.982950692628112,0.43148480853355703,0.7271012243560496,ADAR,DisGeNET
3905,Childhood Diffuse Large B-Cell Lymphoma,0.6447008136176033,0.982950692628112,0.43148480853355703,0.7271012243560496,JAK2,DisGeNET
3906,Common Migraine,0.6447008136176033,0.982950692628112,0.43148480853355703,0.7271012243560496,PRDM16,DisGeNET
3907,Diabetic Cardiomyopathies,0.6447008136176033,0.982950692628112,0.43148480853355703,0.7271012243560496,LONP1,DisGeNET
3908,Dryness of eye,0.6447008136176033,0.982950692628112,0.43148480853355703,0.7271012243560496,NLRP3,DisGeNET
3909,Generalized hirsutism,0.6447008136176033,0.982950692628112,0.43148480853355703,0.7271012243560496,PPARG,DisGeNET
3910,Neutrophil count decreased,0.6447008136176033,0.982950692628112,0.43148480853355703,0.7271012243560496,TFRC,DisGeNET
3911,Pneumocystis jiroveci pneumonia,0.6447008136176033,0.982950692628112,0.43148480853355703,0.7271012243560496,MAX,DisGeNET
3912,Progressive visual loss,0.6447008136176033,0.982950692628112,0.43148480853355703,0.7271012243560496,NPHP3,DisGeNET
3913,Childhood Glioblastoma,0.6469678836147785,0.9042804582573061,0.3937767246410513,0.7294715825475091,"PDGFRA,PIK3CA,KIT",DisGeNET
3914,Thin upper lip vermilion,0.649218087917489,0.9090990828987592,0.39271860540526976,0.7316347902661461,"PGAP3,BCL11A",DisGeNET
3915,Lactic acidemia,0.649218087917489,0.9090990828987592,0.39271860540526976,0.7316347902661461,"HADHA,TYMP",DisGeNET
3916,"Hepatitis, Chronic",0.6533737162176463,0.8953261062733251,0.38105616887358496,0.7348004415555573,"TF,CDH1,HFE",DisGeNET
3917,Renal dysplasia,0.656024238279089,0.9521396396396397,0.401381646245754,0.7348004415555573,NPHP3,DisGeNET
3918,"Decreased visual acuity, progressive",0.656024238279089,0.9521396396396397,0.401381646245754,0.7348004415555573,NPHP3,DisGeNET
3919,Sentinel node (disorder),0.656024238279089,0.9521396396396397,0.401381646245754,0.7348004415555573,PIK3CA,DisGeNET
3920,"Pain, Crushing",0.656024238279089,0.9521396396396397,0.401381646245754,0.7348004415555573,IL1RN,DisGeNET
3921,"Pain, Migratory",0.656024238279089,0.9521396396396397,0.401381646245754,0.7348004415555573,IL1RN,DisGeNET
3922,"Pain, Splitting",0.656024238279089,0.9521396396396397,0.401381646245754,0.7348004415555573,IL1RN,DisGeNET
3923,"Prostate cancer, familial",0.656024238279089,0.9521396396396397,0.401381646245754,0.7348004415555573,CDH1,DisGeNET
3924,"Suffering, Physical",0.656024238279089,0.9521396396396397,0.401381646245754,0.7348004415555573,IL1RN,DisGeNET
3925,Ache,0.656024238279089,0.9521396396396397,0.401381646245754,0.7348004415555573,IL1RN,DisGeNET
3926,Adenoviral infections,0.656024238279089,0.9521396396396397,0.401381646245754,0.7348004415555573,PIK3CA,DisGeNET
3927,Ambiguous Genitalia,0.656024238279089,0.9521396396396397,0.401381646245754,0.7348004415555573,MAP3K1,DisGeNET
3928,Anophthalmos,0.656024238279089,0.9521396396396397,0.401381646245754,0.7348004415555573,ASXL1,DisGeNET
3929,Autoimmune arthritis,0.656024238279089,0.9521396396396397,0.401381646245754,0.7348004415555573,PLD1,DisGeNET
3930,Calcinosis,0.656024238279089,0.9521396396396397,0.401381646245754,0.7348004415555573,JAK2,DisGeNET
3931,Difficulty walking,0.656024238279089,0.9521396396396397,0.401381646245754,0.7348004415555573,HK1,DisGeNET
3932,Dissection of aorta,0.656024238279089,0.9521396396396397,0.401381646245754,0.7348004415555573,APOE,DisGeNET
3933,Dupuytren Contracture,0.656024238279089,0.9521396396396397,0.401381646245754,0.7348004415555573,HFE,DisGeNET
3934,Hemiplegia/hemiparesis,0.656024238279089,0.9521396396396397,0.401381646245754,0.7348004415555573,ADAR,DisGeNET
3935,Hypsarrhythmia,0.656024238279089,0.9521396396396397,0.401381646245754,0.7348004415555573,DOCK7,DisGeNET
3936,Idiopathic crescentic glomerulonephritis,0.656024238279089,0.9521396396396397,0.401381646245754,0.7348004415555573,TAGLN,DisGeNET
3937,Pallor of optic disc,0.656024238279089,0.9521396396396397,0.401381646245754,0.7348004415555573,HK1,DisGeNET
3938,Pituitary-dependent Cushing's disease,0.656024238279089,0.9521396396396397,0.401381646245754,0.7348004415555573,PPARG,DisGeNET
3939,Radiating pain,0.656024238279089,0.9521396396396397,0.401381646245754,0.7348004415555573,IL1RN,DisGeNET
3940,Autoimmune thyroid disease,0.6569928554628606,0.8956413890857547,0.3762429469594908,0.7351388481618414,"THRB,IL37",DisGeNET
3941,Class III malocclusion,0.6569928554628606,0.8956413890857547,0.3762429469594908,0.7351388481618414,"ARHGAP21,PPARG",DisGeNET
3942,Forced expiratory volume function,0.6569928554628606,0.8956413890857547,0.3762429469594908,0.7351388481618414,"KANSL1,ZKSCAN3",DisGeNET
3943,Nodule,0.6569928554628606,0.8956413890857547,0.3762429469594908,0.7351388481618414,"CDH1,KIT",DisGeNET
3944,Tonic - clonic seizures,0.6596962368068422,0.8865456252016543,0.36878152317110574,0.7376025840830684,"ABCC2,ALDH5A1,APOE",DisGeNET
3945,Adult Glioblastoma,0.6596962368068422,0.8865456252016543,0.36878152317110574,0.7376025840830684,"PDGFRA,PIK3CA,KIT",DisGeNET
3946,Osteochondrodysplasias,0.6596962368068422,0.8865456252016543,0.36878152317110574,0.7376025840830684,"PDGFRA,NLRP3,SLC39A13",DisGeNET
3947,Single Seizure,0.664629521774859,0.8825737733542867,0.36055389529676907,0.7390131338747822,"ABCC2,APOE",DisGeNET
3948,"Seizures, Auditory",0.664629521774859,0.8825737733542867,0.36055389529676907,0.7390131338747822,"ABCC2,APOE",DisGeNET
3949,"Seizures, Clonic",0.664629521774859,0.8825737733542867,0.36055389529676907,0.7390131338747822,"ABCC2,APOE",DisGeNET
3950,"Seizures, Sensory",0.664629521774859,0.8825737733542867,0.36055389529676907,0.7390131338747822,"ABCC2,APOE",DisGeNET
3951,"Seizures, Somatosensory",0.664629521774859,0.8825737733542867,0.36055389529676907,0.7390131338747822,"ABCC2,APOE",DisGeNET
3952,Tumor Promotion,0.664629521774859,0.8825737733542867,0.36055389529676907,0.7390131338747822,"PIK3CA,IL37",DisGeNET
3953,Vertiginous seizure,0.664629521774859,0.8825737733542867,0.36055389529676907,0.7390131338747822,"ABCC2,APOE",DisGeNET
3954,Arthropathy,0.664629521774859,0.8825737733542867,0.36055389529676907,0.7390131338747822,"IL1RN,HFE",DisGeNET
3955,Atonic Absence Seizures,0.664629521774859,0.8825737733542867,0.36055389529676907,0.7390131338747822,"ABCC2,APOE",DisGeNET
3956,Generalized Absence Seizures,0.664629521774859,0.8825737733542867,0.36055389529676907,0.7390131338747822,"ABCC2,APOE",DisGeNET
3957,Gustatory seizure,0.664629521774859,0.8825737733542867,0.36055389529676907,0.7390131338747822,"ABCC2,APOE",DisGeNET
3958,Hyperalgesia,0.664629521774859,0.8825737733542867,0.36055389529676907,0.7390131338747822,"IL1RN,NLRP3",DisGeNET
3959,Jacksonian Seizure,0.664629521774859,0.8825737733542867,0.36055389529676907,0.7390131338747822,"ABCC2,APOE",DisGeNET
3960,Measles,0.664629521774859,0.8825737733542867,0.36055389529676907,0.7390131338747822,"TRIP6,ADAR",DisGeNET
3961,Non-epileptic convulsion,0.664629521774859,0.8825737733542867,0.36055389529676907,0.7390131338747822,"ABCC2,APOE",DisGeNET
3962,Nonepileptic Seizures,0.664629521774859,0.8825737733542867,0.36055389529676907,0.7390131338747822,"ABCC2,APOE",DisGeNET
3963,Olfactory seizure,0.664629521774859,0.8825737733542867,0.36055389529676907,0.7390131338747822,"ABCC2,APOE",DisGeNET
3964,Ductal Carcinoma,0.6655080090755185,0.8818620992534036,0.3590983091538088,0.7390131338747822,"CD82,PIK3CA,CDH1,MYB",DisGeNET
3965,Small nose,0.6659353663225122,0.877933999535208,0.3569351827831633,0.7390131338747822,"MEF2C,MAP2K2,LONP1",DisGeNET
3966,Mood Disorders,0.6661140991239044,0.8899167162403331,0.36156809205034457,0.7390131338747822,"FTO,IL1RN,PIK3CA,SMOX,PPARG,APOE",DisGeNET
3967,Meningioma,0.6666777363977462,0.8971090937903244,0.36373153968755617,0.7390131338747822,"PDGFRA,PTPRC,PIK3CA,TERT,CDH1,LEPR,JAK2,CTSB",DisGeNET
3968,"Hyperparathyroidism, Primary",0.6669878284427431,0.9231959231959231,0.3738790990315251,0.7390131338747822,ZNF410,DisGeNET
3969,"Optic Atrophy, Hereditary, Leber",0.6669878284427431,0.9231959231959231,0.3738790990315251,0.7390131338747822,MAPT,DisGeNET
3970,"Osteoporosis, Postmenopausal",0.6669878284427431,0.9231959231959231,0.3738790990315251,0.7390131338747822,IL1RN,DisGeNET
3971,"Pain, Burning",0.6669878284427431,0.9231959231959231,0.3738790990315251,0.7390131338747822,IL1RN,DisGeNET
3972,Tongue Carcinoma,0.6669878284427431,0.9231959231959231,0.3738790990315251,0.7390131338747822,PIK3CA,DisGeNET
3973,Action Tremor,0.6669878284427431,0.9231959231959231,0.3738790990315251,0.7390131338747822,PIK3CA,DisGeNET
3974,Xerostomia,0.6669878284427431,0.9231959231959231,0.3738790990315251,0.7390131338747822,FIG4,DisGeNET
3975,Astigmatism,0.6669878284427431,0.9231959231959231,0.3738790990315251,0.7390131338747822,PDGFRA,DisGeNET
3976,Bone pain,0.6669878284427431,0.9231959231959231,0.3738790990315251,0.7390131338747822,MEF2C,DisGeNET
3977,Experimental Lung Inflammation,0.6669878284427431,0.9231959231959231,0.3738790990315251,0.7390131338747822,IL2RB,DisGeNET
3978,Hematuria,0.6669878284427431,0.9231959231959231,0.3738790990315251,0.7390131338747822,IL1RN,DisGeNET
3979,LATERAL MENINGOCELE SYNDROME,0.6669878284427431,0.9231959231959231,0.3738790990315251,0.7390131338747822,KIT,DisGeNET
3980,Low posterior hairline,0.6669878284427431,0.9231959231959231,0.3738790990315251,0.7390131338747822,MAP2K2,DisGeNET
3981,Metaplasia,0.6669878284427431,0.9231959231959231,0.3738790990315251,0.7390131338747822,CDH1,DisGeNET
3982,Moderate mental retardation (I.Q. 35-49),0.6669878284427431,0.9231959231959231,0.3738790990315251,0.7390131338747822,TFRC,DisGeNET
3983,Cleft upper lip,0.6720910788252232,0.8694864048338369,0.3455003469975142,0.7439621385186826,"ASXL1,KANSL1,CDH1",DisGeNET
3984,Carcinoid tumor no ICD-O subtype,0.6721289855248117,0.8698795180722891,0.34560749422118214,0.7439621385186826,"BCL2L11,PIK3CA",DisGeNET
3985,Epileptic Seizures,0.6721289855248117,0.8698795180722891,0.34560749422118214,0.7439621385186826,"ABCC2,APOE",DisGeNET
3986,Posteriorly rotated ear,0.6721289855248117,0.8698795180722891,0.34560749422118214,0.7439621385186826,"ASXL1,RPS28",DisGeNET
3987,Severe global developmental delay,0.6776029857475239,0.8959547783077195,0.34869998145102127,0.7473960932795188,FIG4,DisGeNET
3988,Synophrys,0.6776029857475239,0.8959547783077195,0.34869998145102127,0.7473960932795188,ASXL1,DisGeNET
3989,"Subfertility, Male",0.6776029857475239,0.8959547783077195,0.34869998145102127,0.7473960932795188,ALDH2,DisGeNET
3990,Treatment related acute myeloid leukaemia,0.6776029857475239,0.8959547783077195,0.34869998145102127,0.7473960932795188,ASXL1,DisGeNET
3991,Abnormality of epiphysis morphology,0.6776029857475239,0.8959547783077195,0.34869998145102127,0.7473960932795188,LONP1,DisGeNET
3992,Waddling gait,0.6776029857475239,0.8959547783077195,0.34869998145102127,0.7473960932795188,SLC39A13,DisGeNET
3993,Acute periodontitis,0.6776029857475239,0.8959547783077195,0.34869998145102127,0.7473960932795188,IL1RN,DisGeNET
3994,Allergic sensitization,0.6776029857475239,0.8959547783077195,0.34869998145102127,0.7473960932795188,FADS2,DisGeNET
3995,Bardet-Biedl Syndrome,0.6776029857475239,0.8959547783077195,0.34869998145102127,0.7473960932795188,RAB8A,DisGeNET
3996,Birth Weight,0.6776029857475239,0.8959547783077195,0.34869998145102127,0.7473960932795188,HFE,DisGeNET
3997,Chlamydia Infections,0.6776029857475239,0.8959547783077195,0.34869998145102127,0.7473960932795188,NLRP3,DisGeNET
3998,Disorders of Sex Development,0.6776029857475239,0.8959547783077195,0.34869998145102127,0.7473960932795188,MAP3K1,DisGeNET
3999,Hippocampal sclerosis,0.6776029857475239,0.8959547783077195,0.34869998145102127,0.7473960932795188,APOE,DisGeNET
4000,Holoprosencephaly,0.6776029857475239,0.8959547783077195,0.34869998145102127,0.7473960932795188,PLTP,DisGeNET
4001,Body Height,0.6793621670699448,0.8768175422138836,0.338978460252166,0.7483573910251334,"GCKR,CCND2,MICAL1,ZBTB38,PPP2R2A,MYO9B",DisGeNET
4002,Erectile dysfunction,0.6794922276624399,0.8575428474461225,0.3313626889966528,0.7483573910251334,"CCND2,HFE",DisGeNET
4003,Large auricle,0.6794922276624399,0.8575428474461225,0.3313626889966528,0.7483573910251334,"MAP2K2,KANSL1",DisGeNET
4004,Large pinnae,0.6794922276624399,0.8575428474461225,0.3313626889966528,0.7483573910251334,"MAP2K2,KANSL1",DisGeNET
4005,Macrotia,0.6794922276624399,0.8575428474461225,0.3313626889966528,0.7483573910251334,"MAP2K2,KANSL1",DisGeNET
4006,Pectus excavatum,0.6794922276624399,0.8575428474461225,0.3313626889966528,0.7483573910251334,"MAP2K2,PIK3CA",DisGeNET
4007,Short nose,0.6841524024687822,0.8530649123302368,0.32380175201546796,0.7529260163861977,"MEF2C,MAP2K2,LONP1",DisGeNET
4008,Delayed bone age,0.6841524024687822,0.8530649123302368,0.32380175201546796,0.7529260163861977,"THRB,LONP1,ATR",DisGeNET
4009,Dyspnea,0.6841524024687822,0.8530649123302368,0.32380175201546796,0.7529260163861977,"FIG4,RPS28,APOB",DisGeNET
4010,hearing impairment,0.6865163943260593,0.8636709035645206,0.3248483680448444,0.7532712521295711,"FIG4,THRB,PIK3CA,NLRP3,APOE",DisGeNET
4011,Narcolepsy,0.6865163943260593,0.8636709035645206,0.3248483680448444,0.7532712521295711,"TF,RAD50,ERI1,SERPING1,CPT1B",DisGeNET
4012,Tonic Seizures,0.6867203051250215,0.8455488621151271,0.3177811023435499,0.7532712521295711,"ABCC2,APOE",DisGeNET
4013,Babinski Reflex,0.6867203051250215,0.8455488621151271,0.3177811023435499,0.7532712521295711,"DSTYK,FBXO7",DisGeNET
4014,Autism Spectrum Disorders,0.6867381163087013,0.8876615406829832,0.33358521168614763,0.7532712521295711,"AHI1,MEF2C,BTN3A1,PIK3CA,BTN2A1,HFE,ZSCAN9,ZKSCAN3,VRK2,JARID2",DisGeNET
4015,Refractive Errors,0.6878807513214057,0.8702702702702703,0.3256027297563665,0.7532712521295711,MYO1D,DisGeNET
4016,"Carcinoma, Large Cell",0.6878807513214057,0.8702702702702703,0.3256027297563665,0.7532712521295711,PPARG,DisGeNET
4017,Rheumatic Fever,0.6878807513214057,0.8702702702702703,0.3256027297563665,0.7532712521295711,IL1RN,DisGeNET
4018,"Hepatitis, Alcoholic",0.6878807513214057,0.8702702702702703,0.3256027297563665,0.7532712521295711,UFSP1,DisGeNET
4019,"Hypertrophic disorder of skin, unspecified",0.6878807513214057,0.8702702702702703,0.3256027297563665,0.7532712521295711,PIK3CA,DisGeNET
4020,Skin Abnormalities,0.6878807513214057,0.8702702702702703,0.3256027297563665,0.7532712521295711,NLRP3,DisGeNET
4021,"stage, prostate cancer",0.6878807513214057,0.8702702702702703,0.3256027297563665,0.7532712521295711,CD82,DisGeNET
4022,Carcinomatosis of peritoneal cavity,0.6878807513214057,0.8702702702702703,0.3256027297563665,0.7532712521295711,TERT,DisGeNET
4023,Chronic schizophrenia,0.6878807513214057,0.8702702702702703,0.3256027297563665,0.7532712521295711,FTO,DisGeNET
4024,Epithelial hyperplasia of skin,0.6878807513214057,0.8702702702702703,0.3256027297563665,0.7532712521295711,PTPRC,DisGeNET
4025,Fine hair,0.6878807513214057,0.8702702702702703,0.3256027297563665,0.7532712521295711,MAP2K2,DisGeNET
4026,Idiopathic generalized epilepsy,0.6878807513214057,0.8702702702702703,0.3256027297563665,0.7532712521295711,VRK2,DisGeNET
4027,LIMB-MAMMARY SYNDROME,0.6878807513214057,0.8702702702702703,0.3256027297563665,0.7532712521295711,KIT,DisGeNET
4028,Lissencephaly,0.6878807513214057,0.8702702702702703,0.3256027297563665,0.7532712521295711,FTO,DisGeNET
4029,Maternal oligohydramnios,0.6878807513214057,0.8702702702702703,0.3256027297563665,0.7532712521295711,NPHP3,DisGeNET
4030,Spasmodic movement,0.6938143452384443,0.8338834791219674,0.3048268298784471,0.7588271916688191,"TOMM40,KCTD17",DisGeNET
4031,Cocaine Abuse,0.6938143452384443,0.8338834791219674,0.3048268298784471,0.7588271916688191,"KLHL5,ICE2",DisGeNET
4032,Gastrointestinal Neoplasms,0.6938143452384443,0.8338834791219674,0.3048268298784471,0.7588271916688191,"PDGFRA,CDH1",DisGeNET
4033,Involuntary jerking movements,0.6938143452384443,0.8338834791219674,0.3048268298784471,0.7588271916688191,"TOMM40,KCTD17",DisGeNET
4034,Myocarditis,0.6938143452384443,0.8338834791219674,0.3048268298784471,0.7588271916688191,"IL1RN,PTPRC",DisGeNET
4035,Mental disorders,0.6964930567442468,0.8599286700414174,0.31103401108523127,0.7609574838874373,"FTO,IL1RN,SLC22A16,ALDH2,APOE,QKI",DisGeNET
4036,Respiratory Tract Infections,0.6978318177263308,0.8460126793460127,0.30437603408117725,0.7609574838874373,LEPR,DisGeNET
4037,Shigella Infections,0.6978318177263308,0.8460126793460127,0.30437603408117725,0.7609574838874373,MYO9B,DisGeNET
4038,"Leukemia, Large Granular Lymphocytic",0.6978318177263308,0.8460126793460127,0.30437603408117725,0.7609574838874373,IL2RB,DisGeNET
4039,Systemic Inflammatory Response Syndrome,0.6978318177263308,0.8460126793460127,0.30437603408117725,0.7609574838874373,PIK3CA,DisGeNET
4040,Tardive Dyskinesia,0.6978318177263308,0.8460126793460127,0.30437603408117725,0.7609574838874373,APOE,DisGeNET
4041,Tumor-Associated Vasculature,0.6978318177263308,0.8460126793460127,0.30437603408117725,0.7609574838874373,IL6R,DisGeNET
4042,Cerebral Aneurysm,0.6978318177263308,0.8460126793460127,0.30437603408117725,0.7609574838874373,APOE,DisGeNET
4043,Chronic Fatigue Syndrome,0.6978318177263308,0.8460126793460127,0.30437603408117725,0.7609574838874373,CTSB,DisGeNET
4044,Drug-induced tardive dyskinesia,0.6978318177263308,0.8460126793460127,0.30437603408117725,0.7609574838874373,APOE,DisGeNET
4045,Mitochondrial Myopathies,0.6978318177263308,0.8460126793460127,0.30437603408117725,0.7609574838874373,TYMP,DisGeNET
4046,Polycystic Kidney - body part,0.6978318177263308,0.8460126793460127,0.30437603408117725,0.7609574838874373,NPHP3,DisGeNET
4047,Adult Acute Lymphocytic Leukemia,0.7007755403646384,0.8225333767502442,0.2924662535801967,0.7636013050355112,"KIT,JAK2",DisGeNET
4048,Frontotemporal dementia,0.7007755403646384,0.8225333767502442,0.2924662535801967,0.7636013050355112,"APOE,MAPT",DisGeNET
4049,Post-Traumatic Stress Disorder,0.7007755403646384,0.8225333767502442,0.2924662535801967,0.7636013050355112,"APOE,CPT1B",DisGeNET
4050,Malignant neoplasm of esophagus,0.7038027416196613,0.8781000488838194,0.3084389281808885,0.766161603377313,"LAPTM4B,THRB,ALDH2,PIK3CA,TERT,CD82,CDH1,GADD45A,AXL,MAX,JAK2",DisGeNET
4051,Hypertrophic Cardiomyopathy,0.7048210350395028,0.8441404930766633,0.29528993341050835,0.766161603377313,"FTO,HADHA,MAP2K2,PIK3CA,PPARG",DisGeNET
4052,Medullary carcinoma of thyroid,0.7068911882041147,0.8328767123287671,0.2889070507178015,0.766161603377313,"TERT,PIK3CA,KIT,TYMP",DisGeNET
4053,"Muscular Dystrophy, Duchenne",0.7072783183928419,0.8219972238099126,0.28468314473258277,0.766161603377313,"PDGFRA,TERT,CTSB",DisGeNET
4054,"Cholestasis, Extrahepatic",0.707466539473974,0.823066309552796,0.2848343968281003,0.766161603377313,ABCC2,DisGeNET
4055,"High, narrow palate",0.707466539473974,0.823066309552796,0.2848343968281003,0.766161603377313,FIG4,DisGeNET
4056,Splenic Marginal Zone B-Cell Lymphoma,0.707466539473974,0.823066309552796,0.2848343968281003,0.766161603377313,TERT,DisGeNET
4057,Substance Withdrawal Syndrome,0.707466539473974,0.823066309552796,0.2848343968281003,0.766161603377313,NCOA4,DisGeNET
4058,Tooth Crowding,0.707466539473974,0.823066309552796,0.2848343968281003,0.766161603377313,ATR,DisGeNET
4059,Tooth mass arch size discrepancy,0.707466539473974,0.823066309552796,0.2848343968281003,0.766161603377313,ATR,DisGeNET
4060,Tooth size discrepancy,0.707466539473974,0.823066309552796,0.2848343968281003,0.766161603377313,ATR,DisGeNET
4061,Absence Epilepsy,0.707466539473974,0.823066309552796,0.2848343968281003,0.766161603377313,MEF2C,DisGeNET
4062,Williams Syndrome,0.707466539473974,0.823066309552796,0.2848343968281003,0.766161603377313,ATR,DisGeNET
4063,Ameloblastoma,0.707466539473974,0.823066309552796,0.2848343968281003,0.766161603377313,TERT,DisGeNET
4064,Beckwith-Wiedemann Syndrome,0.707466539473974,0.823066309552796,0.2848343968281003,0.766161603377313,TERT,DisGeNET
4065,Bronchiolitis,0.707466539473974,0.823066309552796,0.2848343968281003,0.766161603377313,TLR1,DisGeNET
4066,Congenital pectus carinatum,0.707466539473974,0.823066309552796,0.2848343968281003,0.766161603377313,THRB,DisGeNET
4067,Distal amyotrophy,0.707466539473974,0.823066309552796,0.2848343968281003,0.766161603377313,TYMP,DisGeNET
4068,Inadequate arch length for tooth size,0.707466539473974,0.823066309552796,0.2848343968281003,0.766161603377313,ATR,DisGeNET
4069,Moyamoya Disease,0.707466539473974,0.823066309552796,0.2848343968281003,0.766161603377313,APOE,DisGeNET
4070,Muscle biopsy shows dystrophic changes,0.707466539473974,0.823066309552796,0.2848343968281003,0.766161603377313,CEP57,DisGeNET
4071,NEUROTICISM,0.707466539473974,0.823066309552796,0.2848343968281003,0.766161603377313,APOE,DisGeNET
4072,Osteomyelitis,0.707466539473974,0.823066309552796,0.2848343968281003,0.766161603377313,IL1RN,DisGeNET
4073,Precocious Puberty,0.707466539473974,0.823066309552796,0.2848343968281003,0.766161603377313,PPARG,DisGeNET
4074,Primary central nervous system lymphoma,0.707466539473974,0.823066309552796,0.2848343968281003,0.766161603377313,RTEL1,DisGeNET
4075,Leprosy,0.7143044572440648,0.8007292327203551,0.2694021448885474,0.7733769976345555,"TLR1,IL1RN",DisGeNET
4076,Endothelial dysfunction,0.7166372777305133,0.8214578214578214,0.2736977981595675,0.7743631959846538,"PTPN1,NLRP3,PPARG,APOE",DisGeNET
4077,"Other specified types of schizophrenia, unspecified",0.7167949438806269,0.8013276434329066,0.2668144362884767,0.7743631959846538,APOE,DisGeNET
4078,"Stress, Psychological",0.7167949438806269,0.8013276434329066,0.2668144362884767,0.7743631959846538,APOE,DisGeNET
4079,West Nile viral infection,0.7167949438806269,0.8013276434329066,0.2668144362884767,0.7743631959846538,NLRP3,DisGeNET
4080,Allergic Reaction,0.7167949438806269,0.8013276434329066,0.2668144362884767,0.7743631959846538,IL2RB,DisGeNET
4081,Chorea,0.7167949438806269,0.8013276434329066,0.2668144362884767,0.7743631959846538,FBXO7,DisGeNET
4082,Congenital defects,0.7167949438806269,0.8013276434329066,0.2668144362884767,0.7743631959846538,ALDH2,DisGeNET
4083,Melanocytic nevus of skin,0.7167949438806269,0.8013276434329066,0.2668144362884767,0.7743631959846538,HSPA8,DisGeNET
4084,Parasitemia,0.7167949438806269,0.8013276434329066,0.2668144362884767,0.7743631959846538,APOE,DisGeNET
4085,Blepharoptosis,0.7180549062247449,0.8300529838723072,0.2749212194360084,0.7755344544096877,"AHI1,MAP2K2,KANSL1,LONP1,TYMP",DisGeNET
4086,Abnormally small eyeball,0.7208748419032562,0.7902519167579408,0.25864134939531713,0.7776283135640994,"CEP57,PIK3CA",DisGeNET
4087,Chronic Periodontitis,0.7208748419032562,0.7902519167579408,0.25864134939531713,0.7776283135640994,"NLRP3,PPARG",DisGeNET
4088,Convulsions,0.7208748419032562,0.7902519167579408,0.25864134939531713,0.7776283135640994,"ABCC2,APOE",DisGeNET
4089,Decreased size of eyeball,0.7208748419032562,0.7902519167579408,0.25864134939531713,0.7776283135640994,"CEP57,PIK3CA",DisGeNET
4090,Laryngeal Squamous Cell Carcinoma,0.7208748419032562,0.7902519167579408,0.25864134939531713,0.7776283135640994,"CCND3,CTSB",DisGeNET
4091,"Arsenic Poisoning, Inorganic",0.7258267414612338,0.7807037807037807,0.2501717960575722,0.7797291413019147,IL1RN,DisGeNET
4092,"Nervous System, Organic Arsenic Poisoning",0.7258267414612338,0.7807037807037807,0.2501717960575722,0.7797291413019147,IL1RN,DisGeNET
4093,Arsenic Encephalopathy,0.7258267414612338,0.7807037807037807,0.2501717960575722,0.7797291413019147,IL1RN,DisGeNET
4094,Arsenic Induced Polyneuropathy,0.7258267414612338,0.7807037807037807,0.2501717960575722,0.7797291413019147,IL1RN,DisGeNET
4095,Arsenic Poisoning,0.7258267414612338,0.7807037807037807,0.2501717960575722,0.7797291413019147,IL1RN,DisGeNET
4096,Aura,0.7258267414612338,0.7807037807037807,0.2501717960575722,0.7797291413019147,MEF2C,DisGeNET
4097,Awakening Epilepsy,0.7258267414612338,0.7807037807037807,0.2501717960575722,0.7797291413019147,MEF2C,DisGeNET
4098,Central Nervous System Neoplasms,0.7258267414612338,0.7807037807037807,0.2501717960575722,0.7797291413019147,TF,DisGeNET
4099,Conn Syndrome,0.7258267414612338,0.7807037807037807,0.2501717960575722,0.7797291413019147,NLRP3,DisGeNET
4100,Esophagitis,0.7258267414612338,0.7807037807037807,0.2501717960575722,0.7797291413019147,IL1RN,DisGeNET
4101,Familial primary gastric lymphoma,0.7258267414612338,0.7807037807037807,0.2501717960575722,0.7797291413019147,CDH1,DisGeNET
4102,Hepatosplenomegaly,0.7258267414612338,0.7807037807037807,0.2501717960575722,0.7797291413019147,LPL,DisGeNET
4103,Hypertrichosis,0.7258267414612338,0.7807037807037807,0.2501717960575722,0.7797291413019147,ASXL1,DisGeNET
4104,Infertility,0.7258267414612338,0.7807037807037807,0.2501717960575722,0.7797291413019147,LEPR,DisGeNET
4105,Mitral Valve Prolapse Syndrome,0.7258267414612338,0.7807037807037807,0.2501717960575722,0.7797291413019147,PLD1,DisGeNET
4106,Persistent infection,0.7258267414612338,0.7807037807037807,0.2501717960575722,0.7797291413019147,TMC6,DisGeNET
4107,Photosensitivity of skin,0.7258267414612338,0.7807037807037807,0.2501717960575722,0.7797291413019147,DDB2,DisGeNET
4108,Muscle Spasticity,0.7266414099197857,0.8209151400640763,0.26213640346968486,0.7804142893296238,"FIG4,GCDH,RAD50,ADAR,APOE",DisGeNET
4109,"Low-set, posteriorly rotated ears",0.7273176979850559,0.780043249922768,0.24835945109961277,0.7807605069367559,"MAP2K2,PRDM16",DisGeNET
4110,Lymphopenia,0.7273176979850559,0.780043249922768,0.24835945109961277,0.7807605069367559,"TERT,ALDH2",DisGeNET
4111,Seizures,0.7277618585892761,0.8868632908082261,0.2818286596005064,0.7810472683278731,"FTO,IL1RN,MEF2C,TOMM40,ABCC2,PGAP3,PLD1,ASXL1,FIG4,CCND2,ALDH5A1,KANSL1,PIK3CA,TDP2,PRDM16,SNIP1,APOE,MAPT,JAK2,ATR",DisGeNET
4112,Eclampsia,0.7290884522465833,0.7930907657953501,0.25058513336587696,0.7821219469330093,"LEPR,LPL,APOE",DisGeNET
4113,Pain,0.7291177624060442,0.842706203135651,0.2662277608588256,0.7821219469330093,"FIG4,IL1RN,ABCC2,MYB,NLRP3,SERPING1,MAPT,ZNF410",DisGeNET
4114,Uveitis,0.7336344685650344,0.770093030349245,0.23853198333053405,0.785679692899258,"IL1RN,NLRP3",DisGeNET
4115,Epileptic drop attack,0.7336344685650344,0.770093030349245,0.23853198333053405,0.785679692899258,"ABCC2,APOE",DisGeNET
4116,Hyperkyphosis,0.7336344685650344,0.770093030349245,0.23853198333053405,0.785679692899258,"PIK3CA,KANSL1",DisGeNET
4117,Recurrent infections,0.734571335722901,0.7611111111111111,0.23477854903083212,0.785679692899258,TF,DisGeNET
4118,"Epilepsy, Cryptogenic",0.734571335722901,0.7611111111111111,0.23477854903083212,0.785679692899258,MEF2C,DisGeNET
4119,Severe psychomotor retardation,0.734571335722901,0.7611111111111111,0.23477854903083212,0.785679692899258,FIG4,DisGeNET
4120,Abnormality of brain morphology,0.734571335722901,0.7611111111111111,0.23477854903083212,0.785679692899258,ARHGAP21,DisGeNET
4121,Bronchial Hyperreactivity,0.734571335722901,0.7611111111111111,0.23477854903083212,0.785679692899258,IL1RN,DisGeNET
4122,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.734571335722901,0.7611111111111111,0.23477854903083212,0.785679692899258,PIK3CA,DisGeNET
4123,Flat face,0.734571335722901,0.7611111111111111,0.23477854903083212,0.785679692899258,LONP1,DisGeNET
4124,Low grade glioma,0.734571335722901,0.7611111111111111,0.23477854903083212,0.785679692899258,CDH1,DisGeNET
4125,Post-Traumatic Osteoporosis,0.734571335722901,0.7611111111111111,0.23477854903083212,0.785679692899258,IL6R,DisGeNET
4126,"Meningioma, benign, no ICD-O subtype",0.7354120942950738,0.7995215311004785,0.24571236639910934,0.786388308296138,"TERT,CDH1,LEPR,CTSB",DisGeNET
4127,"Melanoma, B16",0.7398266338960455,0.7603915662650602,0.22913593739309557,0.7903426413436689,"TERT,TRPC1",DisGeNET
4128,Electroretinogram abnormal,0.7398266338960455,0.7603915662650602,0.22913593739309557,0.7903426413436689,"AHI1,HADHA",DisGeNET
4129,Hirschsprung Disease,0.7398266338960455,0.7603915662650602,0.22913593739309557,0.7903426413436689,"KIT,VRK2",DisGeNET
4130,Mycoses,0.7398266338960455,0.7603915662650602,0.22913593739309557,0.7903426413436689,"IL1RN,NLRP3",DisGeNET
4131,SCHIZOPHRENIA 1 (disorder),0.7430378328370436,0.7424741814985717,0.2205210067166506,0.7912823843777544,APOE,DisGeNET
4132,Smooth philtrum,0.7430378328370436,0.7424741814985717,0.2205210067166506,0.7912823843777544,PIK3CA,DisGeNET
4133,Alveolar rhabdomyosarcoma,0.7430378328370436,0.7424741814985717,0.2205210067166506,0.7912823843777544,PDGFRA,DisGeNET
4134,Cardiovascular Abnormalities,0.7430378328370436,0.7424741814985717,0.2205210067166506,0.7912823843777544,PIK3CA,DisGeNET
4135,Chronic heart failure,0.7430378328370436,0.7424741814985717,0.2205210067166506,0.7912823843777544,ZFP90,DisGeNET
4136,Congenital Camptodactyly,0.7430378328370436,0.7424741814985717,0.2205210067166506,0.7912823843777544,ASXL1,DisGeNET
4137,Coronary Stenosis,0.7430378328370436,0.7424741814985717,0.2205210067166506,0.7912823843777544,APOE,DisGeNET
4138,Knee joint valgus deformity,0.7430378328370436,0.7424741814985717,0.2205210067166506,0.7912823843777544,LONP1,DisGeNET
4139,Malignant neoplasm of tongue,0.7430378328370436,0.7424741814985717,0.2205210067166506,0.7912823843777544,PIK3CA,DisGeNET
4140,Non-obstructive azoospermia,0.7430378328370436,0.7424741814985717,0.2205210067166506,0.7912823843777544,KITLG,DisGeNET
4141,Nonverbal,0.7430378328370436,0.7424741814985717,0.2205210067166506,0.7912823843777544,PRDM16,DisGeNET
4142,Oligospermia,0.7430378328370436,0.7424741814985717,0.2205210067166506,0.7912823843777544,KITLG,DisGeNET
4143,Pterygium,0.7430378328370436,0.7424741814985717,0.2205210067166506,0.7912823843777544,TERT,DisGeNET
4144,Abnormal behavior,0.7441626757774314,0.8128810975609756,0.24020280213069808,0.7922890264309912,"MPST,AHI1,ALDH5A1,APOE,MAPT,QKI",DisGeNET
4145,Cervical Intraepithelial Neoplasia,0.7445967342727591,0.772697014696093,0.22787801100036778,0.792368738931841,"LAPTM4B,TERT,PIK3CA",DisGeNET
4146,Neurodevelopmental Disorders,0.7445967342727591,0.772697014696093,0.22787801100036778,0.792368738931841,"AHI1,MEF2C,BCL11A",DisGeNET
4147,Absent tendon reflex,0.7458957076995787,0.7509296445039417,0.22014966132778285,0.793368337119224,"FIG4,TYMP",DisGeNET
4148,Pervasive Development Disorder,0.7458957076995787,0.7509296445039417,0.22014966132778285,0.793368337119224,"APOE,MAPT",DisGeNET
4149,Mitochondrial Diseases,0.7472826811201144,0.7989121740521516,0.2327324983946276,0.7946520099064702,"HMGCL,ALDH2,LONP1,SIRT3,TYMP",DisGeNET
4150,Myopia,0.7488699803865357,0.7838123167155425,0.22667060664411384,0.7961480369796134,"ASXL1,MAP2K2,PIK3CA,APOE",DisGeNET
4151,Short neck,0.7496068648798186,0.7661275990758841,0.22080286964156576,0.796168399221043,"FTO,MAP2K2,KIAA0586",DisGeNET
4152,"Fibromatosis, Aggressive",0.7512350512142344,0.7247247247247247,0.20729786278448545,0.796168399221043,KIT,DisGeNET
4153,Spinocerebellar Ataxia Type 1,0.7512350512142344,0.7247247247247247,0.20729786278448545,0.796168399221043,TDP2,DisGeNET
4154,Squamous cell carcinoma of oropharynx,0.7512350512142344,0.7247247247247247,0.20729786278448545,0.796168399221043,ATR,DisGeNET
4155,"Osteoporosis, Senile",0.7512350512142344,0.7247247247247247,0.20729786278448545,0.796168399221043,IL6R,DisGeNET
4156,Abnormal vision,0.7512350512142344,0.7247247247247247,0.20729786278448545,0.796168399221043,HADHA,DisGeNET
4157,Ulnar polydactyly of fingers,0.7512350512142344,0.7247247247247247,0.20729786278448545,0.796168399221043,CCND2,DisGeNET
4158,bone destruction,0.7512350512142344,0.7247247247247247,0.20729786278448545,0.796168399221043,TYMP,DisGeNET
4159,Congenital anomaly of testis,0.7512350512142344,0.7247247247247247,0.20729786278448545,0.796168399221043,AHI1,DisGeNET
4160,Keratitis,0.7512350512142344,0.7247247247247247,0.20729786278448545,0.796168399221043,DDB2,DisGeNET
4161,Metastatic Renal Cell Cancer,0.7512350512142344,0.7247247247247247,0.20729786278448545,0.796168399221043,PIK3CA,DisGeNET
4162,Nonsyndromic Deafness,0.7512350512142344,0.7247247247247247,0.20729786278448545,0.796168399221043,CD164,DisGeNET
4163,Progressive night blindness,0.7512350512142344,0.7247247247247247,0.20729786278448545,0.796168399221043,AHI1,DisGeNET
4164,"Hamartoma Syndrome, Multiple",0.7576707808820571,0.7326897953258819,0.20332604418630593,0.8022182589996726,"PIK3CA,JAK2",DisGeNET
4165,"Reflex, Deep Tendon, Absent",0.7576707808820571,0.7326897953258819,0.20332604418630593,0.8022182589996726,"FIG4,TYMP",DisGeNET
4166,Absent reflex,0.7576707808820571,0.7326897953258819,0.20332604418630593,0.8022182589996726,"FIG4,TYMP",DisGeNET
4167,Malignant Squamous Cell Neoplasm,0.7576707808820571,0.7326897953258819,0.20332604418630593,0.8022182589996726,"XRN1,PIK3CA",DisGeNET
4168,Uremia,0.7591715303401266,0.7078008240798939,0.19501861416491995,0.8026515197365537,CITED2,DisGeNET
4169,Uveomeningoencephalitic Syndrome,0.7591715303401266,0.7078008240798939,0.19501861416491995,0.8026515197365537,JAK2,DisGeNET
4170,Bowed and upward slanting eyebrows,0.7591715303401266,0.7078008240798939,0.19501861416491995,0.8026515197365537,AHI1,DisGeNET
4171,Contact hypersensitivity,0.7591715303401266,0.7078008240798939,0.19501861416491995,0.8026515197365537,DUSP1,DisGeNET
4172,Failure to Thrive,0.7591715303401266,0.7078008240798939,0.19501861416491995,0.8026515197365537,APOB,DisGeNET
4173,Highly arched eyebrow,0.7591715303401266,0.7078008240798939,0.19501861416491995,0.8026515197365537,AHI1,DisGeNET
4174,"Arthritis, Psoriatic",0.7593913853480194,0.753314523981923,0.20734076432451556,0.8026916128786444,"FADS2,PIK3CA,PPARG",DisGeNET
4175,Esophageal Neoplasms,0.761871765961752,0.8274303447345341,0.22504204239442802,0.8051205344726347,"LAPTM4B,THRB,ALDH2,PIK3CA,TERT,CDH1,GADD45A,AXL,PPARG,CTSB",DisGeNET
4176,Anxiety Disorders,0.7623670058859093,0.7947331984236873,0.2156327368319234,0.8054509650308026,"MPST,FTO,ALDH2,APOE,FBXO7,QKI",DisGeNET
4177,"Acidosis, Lactic",0.7633799431613524,0.7238955823293173,0.19545138161887624,0.8063280606243445,"HADHA,TYMP",DisGeNET
4178,"Hearing Loss, Partial",0.7659935450090588,0.76378883171336,0.20361200005860636,0.8080646385707576,"FIG4,THRB,PIK3CA,NLRP3",DisGeNET
4179,Dwarfism,0.7659935450090588,0.76378883171336,0.20361200005860636,0.8080646385707576,"ASXL1,SPRED2,ZBTB38,NSMCE2",DisGeNET
4180,"Angina, Unstable",0.766855539822249,0.6916461916461917,0.18360221228292864,0.8080646385707576,APOE,DisGeNET
4181,Retinopathy of Prematurity,0.766855539822249,0.6916461916461917,0.18360221228292864,0.8080646385707576,EPAS1,DisGeNET
4182,Skeletal dysplasia,0.766855539822249,0.6916461916461917,0.18360221228292864,0.8080646385707576,PDGFRA,DisGeNET
4183,Abnormality of the retinal vasculature,0.766855539822249,0.6916461916461917,0.18360221228292864,0.8080646385707576,AHI1,DisGeNET
4184,Absent speech,0.766855539822249,0.6916461916461917,0.18360221228292864,0.8080646385707576,PRDM16,DisGeNET
4185,Bacteremia,0.766855539822249,0.6916461916461917,0.18360221228292864,0.8080646385707576,XRN1,DisGeNET
4186,Degenerative disorder,0.766855539822249,0.6916461916461917,0.18360221228292864,0.8080646385707576,MAPT,DisGeNET
4187,Proliferative diabetic retinopathy,0.766855539822249,0.6916461916461917,0.18360221228292864,0.8080646385707576,PPARG,DisGeNET
4188,Unipolar Depression,0.7674898363280387,0.8161768770152004,0.21598492138907682,0.8085399135337408,"FTO,TOMM40,SLC22A16,TERT,DUSP1,IL2RB,ADAR,APOE,QKI",DisGeNET
4189,tumor vasculature,0.768972333491036,0.7153082919914954,0.1879116938704039,0.8099083159136908,"TFRC,PIK3CA",DisGeNET
4190,Encephalopathies,0.7734876332643493,0.7348698957216645,0.18874809717188237,0.8141223628212032,"GCDH,PTPRC,APOE",DisGeNET
4191,Wheezing,0.7742950875876043,0.6762095428762095,0.17297590761971335,0.8141223628212032,FTO,DisGeNET
4192,aggressive cancer,0.7742950875876043,0.6762095428762095,0.17297590761971335,0.8141223628212032,PIK3CA,DisGeNET
4193,Arteriopathic disease,0.7742950875876043,0.6762095428762095,0.17297590761971335,0.8141223628212032,APOE,DisGeNET
4194,Bone neoplasms,0.7742950875876043,0.6762095428762095,0.17297590761971335,0.8141223628212032,CTSB,DisGeNET
4195,Multicystic Dysplastic Kidney,0.7742950875876043,0.6762095428762095,0.17297590761971335,0.8141223628212032,NPHP3,DisGeNET
4196,Ovarian Cysts,0.7742950875876043,0.6762095428762095,0.17297590761971335,0.8141223628212032,PIK3CA,DisGeNET
4197,"Seizures, Focal",0.7744495822213485,0.7069207060801345,0.18069085419601622,0.8141223628212032,"ABCC2,APOE",DisGeNET
4198,Glaucoma,0.7762330473536095,0.7807756725635926,0.1977724181901214,0.8158028120352847,"CEP57,AHI1,CCND2,TFRC,APOE,ATR",DisGeNET
4199,Cerebellar Ataxia,0.7772632846199892,0.799773228856628,0.20152376977549144,0.8166910244685383,"AHI1,RAD50,ALDH5A1,PIK3CA,TERT,KIAA0586,TDP2,APOB",DisGeNET
4200,No development of motor milestones,0.7780340738197148,0.7289184290030212,0.18294756207551038,0.8173062699268052,"AHI1,MEF2C,ALDH5A1",DisGeNET
4201,Generalized seizures,0.7798133344113339,0.6987259382357014,0.17377363190110687,0.8189803454945979,"ABCC2,APOE",DisGeNET
4202,Sensory neuropathy,0.7814979285728179,0.6614440527484006,0.16307425538242756,0.8201638584356024,APOE,DisGeNET
4203,Clouding of corneal stroma,0.7814979285728179,0.6614440527484006,0.16307425538242756,0.8201638584356024,CEP57,DisGeNET
4204,Heroin Dependence,0.7814979285728179,0.6614440527484006,0.16307425538242756,0.8201638584356024,ALDH2,DisGeNET
4205,Frontal bossing,0.7869024680768291,0.7172966672217332,0.17190083991883945,0.825443102509503,"MAP2K2,PIK3CA,NLRP3",DisGeNET
4206,Motor delay,0.7869024680768291,0.7172966672217332,0.17190083991883945,0.825443102509503,"AHI1,MEF2C,ALDH5A1",DisGeNET
4207,Abnormality of the skull,0.7884715720346978,0.6473068813494346,0.15383825850563562,0.825518883677524,ATR,DisGeNET
4208,Adrenal Gland Neoplasms,0.7884715720346978,0.6473068813494346,0.15383825850563562,0.825518883677524,TERT,DisGeNET
4209,Diffuse Astrocytoma,0.7884715720346978,0.6473068813494346,0.15383825850563562,0.825518883677524,PDGFRA,DisGeNET
4210,Familial dilated cardiomyopathy,0.7884715720346978,0.6473068813494346,0.15383825850563562,0.825518883677524,PRDM16,DisGeNET
4211,Muscle Cramp,0.7884715720346978,0.6473068813494346,0.15383825850563562,0.825518883677524,FIG4,DisGeNET
4212,Non-small cell lung cancer stage I,0.7884715720346978,0.6473068813494346,0.15383825850563562,0.825518883677524,TERT,DisGeNET
4213,PANIC DISORDER 1,0.7884715720346978,0.6473068813494346,0.15383825850563562,0.825518883677524,APOE,DisGeNET
4214,Polyneuropathy,0.7884715720346978,0.6473068813494346,0.15383825850563562,0.825518883677524,ALDH2,DisGeNET
4215,Inflammatory dermatosis,0.7902069862572116,0.6828888588060106,0.16079325647888557,0.8269433641761901,"IL1RN,NLRP3",DisGeNET
4216,Movement Disorders,0.7902069862572116,0.6828888588060106,0.16079325647888557,0.8269433641761901,"MAPT,SIRT3",DisGeNET
4217,Osteogenesis Imperfecta,0.7912258054877616,0.7116219788519638,0.16664185918032387,0.8278131974892112,"THRB,TDP2,SLC39A13",DisGeNET
4218,"Malaria, Cerebral",0.7952232900338203,0.6337587587587588,0.1452146247260491,0.830291204703354,IL1RN,DisGeNET
4219,Subarachnoid Hemorrhage,0.7952232900338203,0.6337587587587588,0.1452146247260491,0.830291204703354,APOE,DisGeNET
4220,Androgen-Insensitivity Syndrome,0.7952232900338203,0.6337587587587588,0.1452146247260491,0.830291204703354,NLRP3,DisGeNET
4221,Diabetic Angiopathies,0.7952232900338203,0.6337587587587588,0.1452146247260491,0.830291204703354,APOE,DisGeNET
4222,Hay fever,0.7952232900338203,0.6337587587587588,0.1452146247260491,0.830291204703354,TLR1,DisGeNET
4223,Herpes NOS,0.7952232900338203,0.6337587587587588,0.1452146247260491,0.830291204703354,APOE,DisGeNET
4224,Ovarian adenocarcinoma,0.7952232900338203,0.6337587587587588,0.1452146247260491,0.830291204703354,CDH1,DisGeNET
4225,Primary immune deficiency disorder,0.7952232900338203,0.6337587587587588,0.1452146247260491,0.830291204703354,TFRC,DisGeNET
4226,Sarcoidosis,0.795476183653916,0.7060352701468419,0.16155101588312337,0.830291204703354,"IL1RN,TERT,PPARG",DisGeNET
4227,Myxoid cyst,0.795476183653916,0.7060352701468419,0.16155101588312337,0.830291204703354,"APOE,MAPT,APOB",DisGeNET
4228,Renal fibrosis,0.799654329772283,0.7005345108064142,0.15662251637803745,0.8344548020234893,"PIK3CA,EPAS1,TRPC1",DisGeNET
4229,Superficial ulcer,0.8017601244090331,0.6207636207636208,0.1371551226226436,0.8360590094286585,IL2RB,DisGeNET
4230,Triangular face,0.8017601244090331,0.6207636207636208,0.1371551226226436,0.8360590094286585,CEP57,DisGeNET
4231,Mammary Ductal Carcinoma,0.8017601244090331,0.6207636207636208,0.1371551226226436,0.8360590094286585,CDH1,DisGeNET
4232,Bipolar Disorder,0.8037217354262615,0.8158783783783784,0.17827119607119085,0.837906497330025,"FTO,IL1RN,TLR1,GIGYF1,FADS2,AHI1,AKAP10,SLC22A16,ALDH2,PIK3CA,IL2RB,APOE,MAPT,APOB",DisGeNET
4233,Cocaine Dependence,0.8049879276172716,0.6604243059193295,0.14326452279413956,0.8390282864746993,"KLHL5,ICE2",DisGeNET
4234,Adenocarcinoma of prostate,0.8077968948312512,0.6897830266410326,0.14723047589508226,0.840077333127229,"ARHGAP21,XRN1,PIK3CA",DisGeNET
4235,Short palm,0.8080888943318133,0.6082882882882883,0.12961602032881586,0.840077333127229,SNIP1,DisGeNET
4236,Abnormality of the metaphysis,0.8080888943318133,0.6082882882882883,0.12961602032881586,0.840077333127229,SLC39A13,DisGeNET
4237,Atypical scarring of skin,0.8080888943318133,0.6082882882882883,0.12961602032881586,0.840077333127229,AHI1,DisGeNET
4238,Convex nasal bridge,0.8080888943318133,0.6082882882882883,0.12961602032881586,0.840077333127229,KANSL1,DisGeNET
4239,Corneal Opacity,0.8080888943318133,0.6082882882882883,0.12961602032881586,0.840077333127229,CEP57,DisGeNET
4240,Depressed nasal ridge,0.8080888943318133,0.6082882882882883,0.12961602032881586,0.840077333127229,PRDM16,DisGeNET
4241,Downturned corners of mouth,0.8080888943318133,0.6082882882882883,0.12961602032881586,0.840077333127229,MEF2C,DisGeNET
4242,Fragile X Syndrome,0.8080888943318133,0.6082882882882883,0.12961602032881586,0.840077333127229,PIK3CA,DisGeNET
4243,Henoch-Schoenlein Purpura,0.8080888943318133,0.6082882882882883,0.12961602032881586,0.840077333127229,IL1RN,DisGeNET
4244,Prominent nasal bridge,0.8080888943318133,0.6082882882882883,0.12961602032881586,0.840077333127229,KANSL1,DisGeNET
4245,"Epilepsy, Temporal Lobe",0.8117628254296716,0.6845285418985531,0.14275642064593472,0.8436979000696612,"IL1RN,APOE,PLD1",DisGeNET
4246,Invasive carcinoma of breast,0.8141894421591093,0.7416376306620209,0.15245267047580335,0.8451629784871669,"HSPA8,KITLG,TFRC,PIK3CA,CDH1,AXL",DisGeNET
4247,"Myocardial Diseases, Secondary",0.8142162030729391,0.5963021845374786,0.12255759592278734,0.8451629784871669,LPL,DisGeNET
4248,HIV Coinfection,0.8142162030729391,0.5963021845374786,0.12255759592278734,0.8451629784871669,GADD45A,DisGeNET
4249,Marfan Syndrome,0.8142162030729391,0.5963021845374786,0.12255759592278734,0.8451629784871669,PPARG,DisGeNET
4250,Retinal pigment epithelial abnormality,0.8143218090546117,0.6462445526788003,0.13273840382829052,0.8451629784871669,"AHI1,NPHP3",DisGeNET
4251,Abnormality of retinal pigmentation,0.8143218090546117,0.6462445526788003,0.13273840382829052,0.8451629784871669,"AHI1,NPHP3",DisGeNET
4252,"Osteoporosis, Age-Related",0.8201484449397144,0.5847770847770848,0.11594370856128416,0.8504100914392526,IL6R,DisGeNET
4253,Thick eyebrow,0.8201484449397144,0.5847770847770848,0.11594370856128416,0.8504100914392526,DOCK7,DisGeNET
4254,Prostatic Hyperplasia,0.8201484449397144,0.5847770847770848,0.11594370856128416,0.8504100914392526,LEPR,DisGeNET
4255,Pulmonary Edema,0.8201484449397144,0.5847770847770848,0.11594370856128416,0.8504100914392526,EPAS1,DisGeNET
4256,Mucocutaneous Lymph Node Syndrome,0.8232553215296023,0.6326556224899599,0.1230444921086398,0.853230556398545,"BLK,TFRC",DisGeNET
4257,Pre-Eclampsia,0.8232553215296023,0.6326556224899599,0.1230444921086398,0.853230556398545,"LEPR,PPARG",DisGeNET
4258,"Cardiomyopathies, Primary",0.8258918121257055,0.5736868944416115,0.1097414220334155,0.8545578506328829,LPL,DisGeNET
4259,"Cicatrix, Hypertrophic",0.8258918121257055,0.5736868944416115,0.1097414220334155,0.8545578506328829,PIK3CA,DisGeNET
4260,Sloping forehead,0.8258918121257055,0.5736868944416115,0.1097414220334155,0.8545578506328829,ATR,DisGeNET
4261,Actinic keratosis,0.8258918121257055,0.5736868944416115,0.1097414220334155,0.8545578506328829,TYMP,DisGeNET
4262,Gliosis,0.8258918121257055,0.5736868944416115,0.1097414220334155,0.8545578506328829,MAPT,DisGeNET
4263,Kyphoscoliosis deformity of spine,0.8258918121257055,0.5736868944416115,0.1097414220334155,0.8545578506328829,MAPT,DisGeNET
4264,Marinesco-Sjogren syndrome,0.8258918121257055,0.5736868944416115,0.1097414220334155,0.8545578506328829,PIK3CA,DisGeNET
4265,Breast adenocarcinoma,0.8275761280180568,0.6260712954912433,0.11848660862143386,0.8560998538840954,"PIK3CA,CDH1",DisGeNET
4266,Allergic disposition,0.8305699955534792,0.6593983974779981,0.12241274435108729,0.8589013227841628,"RTEL1,KIT,NLRP3",DisGeNET
4267,"Hyperalgesia, Secondary",0.8314523004558384,0.5630074518963408,0.10392067420918301,0.8589013227841628,IL1RN,DisGeNET
4268,Acute monocytic leukemia,0.8314523004558384,0.5630074518963408,0.10392067420918301,0.8589013227841628,TFRC,DisGeNET
4269,Allodynia,0.8314523004558384,0.5630074518963408,0.10392067420918301,0.8589013227841628,IL1RN,DisGeNET
4270,Enterovirus Infections,0.8314523004558384,0.5630074518963408,0.10392067420918301,0.8589013227841628,TDP2,DisGeNET
4271,Premature aging syndrome,0.8314523004558384,0.5630074518963408,0.10392067420918301,0.8589013227841628,APOE,DisGeNET
4272,Congenital deafness,0.8351477644750774,0.6809669731018045,0.12267388923681181,0.8625168391535677,"FIG4,THRB,PIK3CA,NLRP3",DisGeNET
4273,invasive cancer,0.8359341663070862,0.6133016916149446,0.10990698565929824,0.8631269697511967,"PIK3CA,CTSB",DisGeNET
4274,Myopathy,0.8362487329207464,0.7009174828323764,0.12534450061803074,0.8632497448868351,"LPL,PPARG,APOE,MAPT,CTSB",DisGeNET
4275,Respiratory distress,0.8368357162387334,0.5527163527163527,0.09845398469009083,0.8634516323772901,RPS28,DisGeNET
4276,"Hyperalgesia, Primary",0.8368357162387334,0.5527163527163527,0.09845398469009083,0.8634516323772901,IL1RN,DisGeNET
4277,"Polycystic Kidney, Autosomal Dominant",0.8399747038416917,0.6071084337349397,0.1058696948123909,0.8661959368013661,"PPARG,APOE",DisGeNET
4278,Retrusion of upper jaw bones,0.8420476819902674,0.5427927927927928,0.09331619705666398,0.8661959368013661,PIK3CA,DisGeNET
4279,Spastic Paraplegia,0.8420476819902674,0.5427927927927928,0.09331619705666398,0.8661959368013661,DSTYK,DisGeNET
4280,Adrenal Cortical Adenoma,0.8420476819902674,0.5427927927927928,0.09331619705666398,0.8661959368013661,HSD17B13,DisGeNET
4281,airway disease,0.8420476819902674,0.5427927927927928,0.09331619705666398,0.8661959368013661,IL2RB,DisGeNET
4282,Cardiac fibrosis,0.8420476819902674,0.5427927927927928,0.09331619705666398,0.8661959368013661,KITLG,DisGeNET
4283,Congenital ear anomaly NOS (disorder),0.8420476819902674,0.5427927927927928,0.09331619705666398,0.8661959368013661,KIT,DisGeNET
4284,Decreased projection of maxilla,0.8420476819902674,0.5427927927927928,0.09331619705666398,0.8661959368013661,PIK3CA,DisGeNET
4285,Deficiency of upper jaw bones,0.8420476819902674,0.5427927927927928,0.09331619705666398,0.8661959368013661,PIK3CA,DisGeNET
4286,Hypoplasia of the maxilla,0.8420476819902674,0.5427927927927928,0.09331619705666398,0.8661959368013661,PIK3CA,DisGeNET
4287,Hypoplastic feet,0.8420476819902674,0.5427927927927928,0.09331619705666398,0.8661959368013661,PRDM16,DisGeNET
4288,Hypotrophic maxilla,0.8420476819902674,0.5427927927927928,0.09331619705666398,0.8661959368013661,PIK3CA,DisGeNET
4289,Maxillary retrognathia,0.8420476819902674,0.5427927927927928,0.09331619705666398,0.8661959368013661,PIK3CA,DisGeNET
4290,Reduced visual acuity,0.8470936420048437,0.5332174279542701,0.08848425055363685,0.8699667477945462,HK1,DisGeNET
4291,Rhinitis,0.8470936420048437,0.5332174279542701,0.08848425055363685,0.8699667477945462,IL2RB,DisGeNET
4292,"Muscular Dystrophies, Limb-Girdle",0.8470936420048437,0.5332174279542701,0.08848425055363685,0.8699667477945462,RTEL1,DisGeNET
4293,Amphetamine-Related Disorders,0.8470936420048437,0.5332174279542701,0.08848425055363685,0.8699667477945462,PCOLCE2,DisGeNET
4294,Amphetamine Abuse,0.8470936420048437,0.5332174279542701,0.08848425055363685,0.8699667477945462,PCOLCE2,DisGeNET
4295,Heart Decompensation,0.8470936420048437,0.5332174279542701,0.08848425055363685,0.8699667477945462,PPARG,DisGeNET
4296,Multiple Endocrine Neoplasia Type 1,0.8470936420048437,0.5332174279542701,0.08848425055363685,0.8699667477945462,PIK3CA,DisGeNET
4297,Short stature,0.8494943462219583,0.7505681469197224,0.12242816769598439,0.8722292426184034,"CEP57,FIG4,RTEL1,RAD50,RPS28,MAP2K2,TERT,LONP1,NPHP3,ATR",DisGeNET
4298,"Carcinoma, Lewis Lung",0.851978868417745,0.5239722481101792,0.08393697703450269,0.87376354427222,TERT,DisGeNET
4299,Tactile Allodynia,0.851978868417745,0.5239722481101792,0.08393697703450269,0.87376354427222,IL1RN,DisGeNET
4300,Amphetamine Addiction,0.851978868417745,0.5239722481101792,0.08393697703450269,0.87376354427222,PCOLCE2,DisGeNET
4301,Hypercalcemia,0.851978868417745,0.5239722481101792,0.08393697703450269,0.87376354427222,MAX,DisGeNET
4302,Panic Disorder,0.851978868417745,0.5239722481101792,0.08393697703450269,0.87376354427222,APOE,DisGeNET
4303,Cerebral arterial aneurysm,0.856708466255799,0.5150404641930065,0.0796549208880451,0.8775940917391652,APOE,DisGeNET
4304,Congenital ocular coloboma (disorder),0.856708466255799,0.5150404641930065,0.0796549208880451,0.8775940917391652,AHI1,DisGeNET
4305,Micromelia,0.856708466255799,0.5150404641930065,0.0796549208880451,0.8775940917391652,KIAA0586,DisGeNET
4306,Neonatal Hypotonia,0.856708466255799,0.5150404641930065,0.0796549208880451,0.8775940917391652,KANSL1,DisGeNET
4307,Obsessive-Compulsive Disorder,0.856708466255799,0.5150404641930065,0.0796549208880451,0.8775940917391652,KCTD17,DisGeNET
4308,Conductive hearing loss,0.8588577493044754,0.5779116465863454,0.08793039612384887,0.879591548266329,"AHI1,CDH1",DisGeNET
4309,"Heart Failure, Right-Sided",0.861287378964621,0.5064064064064064,0.0756201781962719,0.8810572492445881,PPARG,DisGeNET
4310,Sunken eyes,0.861287378964621,0.5064064064064064,0.0756201781962719,0.8810572492445881,PRDM16,DisGeNET
4311,Dehydration,0.861287378964621,0.5064064064064064,0.0756201781962719,0.8810572492445881,PPARG,DisGeNET
4312,Difficulties with night vision,0.861287378964621,0.5064064064064064,0.0756201781962719,0.8810572492445881,HK1,DisGeNET
4313,Myocardial Failure,0.861287378964621,0.5064064064064064,0.0756201781962719,0.8810572492445881,PPARG,DisGeNET
4314,Respiratory Insufficiency,0.8623816404449286,0.5724028188224597,0.0847484547694314,0.881972136681276,"MAPT,JAK2",DisGeNET
4315,"Periodontitis, Juvenile",0.8657203934049079,0.498055432481662,0.07181625335969878,0.8848783275991414,IL1RN,DisGeNET
4316,Enophthalmos,0.8657203934049079,0.498055432481662,0.07181625335969878,0.8848783275991414,PRDM16,DisGeNET
4317,Dermatitis,0.8658249637909097,0.5669969598018241,0.08168867583154392,0.8848783275991414,"IL1RN,NLRP3",DisGeNET
4318,Scleroderma,0.8691892622547542,0.5616912092815707,0.07874595323606286,0.8881047410843208,"PIK3CA,MYB",DisGeNET
4319,Broad flat nasal bridge,0.8693844915555715,0.6371929824561403,0.08918777347907733,0.8881047410843208,"ASXL1,AHI1,PGAP3,PRDM16",DisGeNET
4320,Ductal Breast Carcinoma,0.870012144883489,0.4899738448125545,0.06822793075906583,0.8884405614486037,PIK3CA,DisGeNET
4321,Curvature of spine,0.8701159714459239,0.660264663330723,0.0918618142502631,0.8884405614486037,"MAP2K2,KANSL1,PIK3CA,LONP1,ATR",DisGeNET
4322,Nasal bridge wide,0.8719415919244703,0.6337934316991909,0.08685051331985157,0.8900986357174372,"ASXL1,AHI1,PGAP3,PRDM16",DisGeNET
4323,Leukodystrophy,0.8724760622615371,0.5564828119818724,0.07591541920349727,0.8904382111260472,"ADAR,TYMP",DisGeNET
4324,Hypertrophy of lower jaw,0.8741671217257349,0.48214881548214883,0.06484115994329588,0.8915453862815401,PPARG,DisGeNET
4325,mandibular excess (physical finding),0.8741671217257349,0.48214881548214883,0.06484115994329588,0.8915453862815401,PPARG,DisGeNET
4326,Mandibular hyperplasia,0.8741671217257349,0.48214881548214883,0.06484115994329588,0.8915453862815401,PPARG,DisGeNET
4327,Renal cyst,0.8781896701457171,0.4745683183183183,0.061642952348711706,0.8946139054913194,DLG5,DisGeNET
4328,"Diabetes, Autoimmune",0.8781896701457171,0.4745683183183183,0.061642952348711706,0.8946139054913194,SH2B3,DisGeNET
4329,Increased size of the mandible,0.8781896701457171,0.4745683183183183,0.061642952348711706,0.8946139054913194,PPARG,DisGeNET
4330,Lethargy,0.8781896701457171,0.4745683183183183,0.061642952348711706,0.8946139054913194,SLC25A15,DisGeNET
4331,Night Blindness,0.8781896701457171,0.4745683183183183,0.061642952348711706,0.8946139054913194,HK1,DisGeNET
4332,Recurrent respiratory infections,0.8788231885174614,0.5463475523716488,0.07057256140788375,0.8950526102814035,"RTEL1,TERT",DisGeNET
4333,"Hyperalgesia, Thermal",0.8820839987011834,0.4672210672210672,0.058621288604497945,0.8979590683593958,IL1RN,DisGeNET
4334,Biliary Atresia,0.8820839987011834,0.4672210672210672,0.058621288604497945,0.8979590683593958,EPAS1,DisGeNET
4335,Malignant Pleural Mesothelioma,0.8829231734617216,0.5860832277555794,0.07297737710103895,0.8986060072233254,"PTPRC,TERT,PIK3CA",DisGeNET
4336,Acquired scoliosis,0.8836417157752727,0.643018819116601,0.07954374111872071,0.8991299008303744,"MAP2K2,KANSL1,PIK3CA,LONP1,ATR",DisGeNET
4337,Hemangioma,0.8858541824970396,0.4600964600964601,0.05576503513375435,0.9009655724243749,PTPRC,DisGeNET
4338,Paresis,0.8858541824970396,0.4600964600964601,0.05576503513375435,0.9009655724243749,CCND3,DisGeNET
4339,Long philtrum,0.8877998085352549,0.5318114563517227,0.06329035080247986,0.9027362883746358,"MAP2K2,PRDM16",DisGeNET
4340,Sjogren's Syndrome,0.8905058893645801,0.5747829744923324,0.06665503108243863,0.9052792589577253,"BLK,NLRP3,CTSB",DisGeNET
4341,"Psychomotor regression, progressive",0.893037774879375,0.44647588765235824,0.050508208920914614,0.9061827651259896,DDB2,DisGeNET
4342,Agenesis,0.893037774879375,0.44647588765235824,0.050508208920914614,0.9061827651259896,CITED2,DisGeNET
4343,Loss of developmental milestones,0.893037774879375,0.44647588765235824,0.050508208920914614,0.9061827651259896,DDB2,DisGeNET
4344,Mechanical Allodynia,0.893037774879375,0.44647588765235824,0.050508208920914614,0.9061827651259896,IL1RN,DisGeNET
4345,Mental deterioration in childhood,0.893037774879375,0.44647588765235824,0.050508208920914614,0.9061827651259896,DDB2,DisGeNET
4346,Neurodevelopmental regression,0.893037774879375,0.44647588765235824,0.050508208920914614,0.9061827651259896,DDB2,DisGeNET
4347,Psychomotor regression,0.893037774879375,0.44647588765235824,0.050508208920914614,0.9061827651259896,DDB2,DisGeNET
4348,Psychomotor regression beginning in infancy,0.893037774879375,0.44647588765235824,0.050508208920914614,0.9061827651259896,DDB2,DisGeNET
4349,Aortic Valve Insufficiency,0.8961579358999663,0.5180208011533313,0.05679508255544845,0.9086091897822013,"CEP57,PIK3CA",DisGeNET
4350,"Encephalitis, St. Louis",0.8964587042434095,0.43996170083126607,0.048089155919102886,0.9086091897822013,PPARG,DisGeNET
4351,Aortic Aneurysm,0.8964587042434095,0.43996170083126607,0.048089155919102886,0.9086091897822013,APOE,DisGeNET
4352,Developmental regression,0.8964587042434095,0.43996170083126607,0.048089155919102886,0.9086091897822013,DDB2,DisGeNET
4353,Psychomotor regression in infants,0.8964587042434095,0.43996170083126607,0.048089155919102886,0.9086091897822013,DDB2,DisGeNET
4354,Dysarthria,0.8976470604188529,0.5639038486798896,0.06088938820472257,0.9096046923674733,"MAPT,KCTD17,FBXO7",DisGeNET
4355,Congenital Disorders of Glycosylation,0.8997705381698449,0.4336336336336336,0.045798435528203923,0.9113378361812111,PGAP3,DisGeNET
4356,Giant Cell Arteritis,0.8997705381698449,0.4336336336336336,0.045798435528203923,0.9113378361812111,GADD45A,DisGeNET
4357,"Liver Failure, Acute",0.9060806859763385,0.42150483817150486,0.04157172375816611,0.9170042048940577,IL1RN,DisGeNET
4358,Ehlers-Danlos Syndrome,0.9060806859763385,0.42150483817150486,0.04157172375816611,0.9170042048940577,SLC39A13,DisGeNET
4359,Ophthalmoplegia,0.9060806859763385,0.42150483817150486,0.04157172375816611,0.9170042048940577,AHI1,DisGeNET
4360,Substance Dependence,0.9064042016189904,0.5006970028875833,0.04920346131615983,0.9170042048940577,"MSRA,ALDH2",DisGeNET
4361,Tuberous Sclerosis,0.9064042016189904,0.5006970028875833,0.04920346131615983,0.9170042048940577,"TFRC,PIK3CA",DisGeNET
4362,Left Ventricular Hypertrophy,0.9088142396065093,0.49654355125419714,0.047476794443617173,0.9192316426281337,"KITLG,LPL",DisGeNET
4363,Wide skull shape,0.911994671007507,0.4100316532748965,0.03777258010406282,0.9218145448992258,PRDM16,DisGeNET
4364,Broad cranium shape,0.911994671007507,0.4100316532748965,0.03777258010406282,0.9218145448992258,PRDM16,DisGeNET
4365,Mild Mental Retardation,0.911994671007507,0.4100316532748965,0.03777258010406282,0.9218145448992258,AHI1,DisGeNET
4366,Neurogenic Muscular Atrophy,0.9134613854476583,0.4884376214535562,0.04421052836963273,0.9230855777817379,"FIG4,CITED2",DisGeNET
4367,Disorder of eye,0.9175372951671965,0.3991623202149518,0.03435272803783502,0.9269921104368379,APOE,DisGeNET
4368,Vesicular Stomatitis,0.9201766713623399,0.3939393939393939,0.03277165796104778,0.9292331137675999,APOE,DisGeNET
4369,Polycystic Kidney Diseases,0.9201766713623399,0.3939393939393939,0.03277165796104778,0.9292331137675999,NPHP3,DisGeNET
4370,Microcephaly,0.9241270513795892,0.4692724385915756,0.037028277437575474,0.9330088216674479,"HIST1H4C,ATR",DisGeNET
4371,"Hernia, Inguinal",0.9252053969341675,0.3838902193332573,0.029843439609969522,0.933456714217596,PLD1,DisGeNET
4372,Cleft Palate,0.9252053969341675,0.3838902193332573,0.029843439609969522,0.933456714217596,PDGFRA,DisGeNET
4373,Primary Sj??gren's syndrome,0.9252053969341675,0.3838902193332573,0.029843439609969522,0.933456714217596,APOE,DisGeNET
4374,Brachycephaly,0.9299182011776355,0.3743373002632262,0.027198843789965167,0.9379970515765268,PRDM16,DisGeNET
4375,Malignant neoplasm of larynx,0.9321623668296658,0.3697355892477844,0.02597328407245882,0.9400457971319968,RAD50,DisGeNET
4376,"Blindness, Legal",0.9404449130033864,0.3523989105384454,0.021638069790386794,0.9481816627447305,AHI1,DisGeNET
4377,Blindness,0.9459879432258,0.3404190707561494,0.01890192379983075,0.9533345832599885,AHI1,DisGeNET
4378,Generalized osteopenia,0.9459879432258,0.3404190707561494,0.01890192379983075,0.9533345832599885,SLC39A13,DisGeNET
4379,Muscle degeneration,0.9463561919366785,0.4257593755302902,0.023474778158556895,0.9534879010789279,"FIG4,ARIH2",DisGeNET
4380,Visual Impairment,0.9505251593917352,0.416825924387204,0.021150017408697156,0.9574696354420859,"AHI1,NPHP3",DisGeNET
4381,"Glaucoma, Primary Open Angle",0.9525866290675595,0.32564822887403533,0.015818110979950964,0.9593271416220207,APOE,DisGeNET
4382,"Cleft palate, isolated",0.954106627802011,0.3221519391732158,0.0151346480383557,0.9606386220589852,PDGFRA,DisGeNET
4383,Spinal Muscular Atrophy,0.9570024037123258,0.31537787787787785,0.013860660878976227,0.9631146453418754,APOE,DisGeNET
4384,Degenerative brain disorder,0.9570024037123258,0.31537787787787785,0.013860660878976227,0.9631146453418754,MAPT,DisGeNET
4385,Respiratory function loss,0.9597159647552134,0.3088803088803089,0.012700512230142218,0.9656252762827826,JAK2,DisGeNET
4386,Developmental Disabilities,0.9610080161949572,0.30572997239663907,0.012159654050425945,0.9667048261404814,ASXL1,DisGeNET
4387,Low Vision,0.9612584461017714,0.39211391018619934,0.015493193690719026,0.9667363264647858,"AHI1,NPHP3",DisGeNET
4388,"Organic Mental Disorders, Substance-Induced",0.9646414605998339,0.29664959076723785,0.010679026351983768,0.9696965423026811,MSRA,DisGeNET
4389,Prescription Drug Abuse,0.9646414605998339,0.29664959076723785,0.010679026351983768,0.9696965423026811,MSRA,DisGeNET
4390,Drug Use Disorders,0.966874160759827,0.29088704088704087,0.009799090118213625,0.9712770485592799,MSRA,DisGeNET
4391,Growth retardation,0.966874160759827,0.29088704088704087,0.009799090118213625,0.9712770485592799,NLRP3,DisGeNET
4392,Poor growth,0.966874160759827,0.29088704088704087,0.009799090118213625,0.9712770485592799,NLRP3,DisGeNET
4393,Growth delay,0.9679372215045617,0.2880880880880881,0.009388228335173176,0.9721236105800425,NLRP3,DisGeNET
4394,Substance-Related Disorders,0.969962371263813,0.28264713311442285,0.008620172477338879,0.9737142166134114,MSRA,DisGeNET
4395,Very poor growth,0.969962371263813,0.28264713311442285,0.008620172477338879,0.9737142166134114,NLRP3,DisGeNET
4396,Arthrogryposis,0.97291000700753,0.3611211312315129,0.009917719270865285,0.9764510807364019,"ASXL1,HADHA",DisGeNET
4397,Cerebellar atrophy,0.9753039846120579,0.26747986924978073,0.0066886223369401355,0.978631153083557,MAPT,DisGeNET
4398,Drug abuse,0.9757576634453883,0.3525329387726344,0.008651517566076499,0.9786412391727786,"MSRA,KITLG",DisGeNET
4399,Hyperreflexia,0.9757576634453883,0.3525329387726344,0.008651517566076499,0.9786412391727786,"DSTYK,FBXO7",DisGeNET
4400,Skeletal muscle atrophy,0.9776081773854197,0.26048462255358806,0.005899019639657574,0.9800516424959036,FIG4,DisGeNET
4401,"Neurogenic muscle atrophy, especially in the lower limbs",0.9776081773854197,0.26048462255358806,0.005899019639657574,0.9800516424959036,FIG4,DisGeNET
4402,Substance Use Disorders,0.9790239124127462,0.2560187305950018,0.00542739519350514,0.9812479558303128,MSRA,DisGeNET
4403,Ataxia,0.9796979442560414,0.2538420773714891,0.0052065484963168115,0.9814775953809388,APOB,DisGeNET
4404,Drug habituation,0.9796979442560414,0.2538420773714891,0.0052065484963168115,0.9814775953809388,MSRA,DisGeNET
4405,Congenital clubfoot,0.9833119576553575,0.24151351351351352,0.004064396269037212,0.9848745419240493,FBXO7,DisGeNET
4406,Substance abuse problem,0.9853572492260116,0.23393160602462928,0.0034507283946828026,0.986475194823046,MSRA,DisGeNET
4407,Growth failure,0.9853572492260116,0.23393160602462928,0.0034507283946828026,0.986475194823046,NLRP3,DisGeNET
4408,Optic Atrophy,0.9869363187245468,0.3116611523815469,0.0040982698743940215,0.987831905220667,"AHI1,DDB2",DisGeNET
4409,Drug Dependence,0.9897820626122419,0.2153153153153153,0.0022113957011564555,0.9904555364584285,MSRA,DisGeNET
4410,Nystagmus,0.9949807196339852,0.3180561804975252,0.0016004330215404134,0.9954319580555879,"AHI1,MAP2K2,KIAA0586",DisGeNET
4411,"Infant, Premature",0.9959173823835045,0.17892892892892892,0.0007319936412190861,0.9961431627921156,TST,DisGeNET
4412,Muscle Weakness,0.9970594243858162,0.1687080338765732,0.0004968295713291162,0.9970594243858162,CCND3,DisGeNET
1,Negative Regulation Of Blood Vessel Endothelial Cell Migration (GO:0043537),0.0002530059070628862,11.033434650455927,91.37998397813934,0.218548360772521,"MEF2C,GADD45A,PPARG,APOE,RHOA",GO_Biological_Process_2023
2,Erythrocyte Differentiation (GO:0030218),0.0003696098968189728,7.429024390243902,58.712043635135004,0.218548360772521,"MFHAS1,MYB,KIT,CEBPG,JAK2,SH2B3",GO_Biological_Process_2023
3,Hemopoiesis (GO:0030097),0.0005308922078947015,4.308497041420118,32.4901674669861,0.218548360772521,"CD164,CEBPA,KITLG,PTPRC,MYB,KIT,ARIH2,SH2B3,KLF3",GO_Biological_Process_2023
4,Negative Regulation Of Protein Serine/Threonine Kinase Activity (GO:0071901),0.0005782186924429975,4.778669183577159,35.627647173511235,0.218548360772521,"CEBPA,PTPN1,TFAP4,DUSP1,GADD45A,PPARG,APOE,SH2B3",GO_Biological_Process_2023
5,Regulation Of Receptor Signaling Pathway Via JAK-STAT (GO:0046425),0.0006230844235638044,6.6310975609756095,48.94299410980775,0.218548360772521,"LEPROT,PTPRC,KIT,JAK2,CRLF3,SH2B3",GO_Biological_Process_2023
6,Negative Regulation Of Endothelial Cell Migration (GO:0010596),0.0006594573572003917,8.578183046268153,62.82741252228215,0.218548360772521,"MEF2C,GADD45A,DNAJA4,PPARG,APOE",GO_Biological_Process_2023
7,Regulation Of Gene Expression (GO:0010468),0.0009912281643653848,1.8686176142697881,12.924416709625469,0.218548360772521,"CEBPA,TFRC,TRRAP,CITED2,HFE,PDCD5,UBE2L3,LARP1,TERT,TRIM4,ZNF827,CDH1,MYB,FLOT2,APOE,RBM38,MEF2C,MAP2K2,NDFIP1,BTN3A1,DENND4A,BTN2A1,IL37,ZBTB38,TFEB,BTN3A2,LGALS9B,PTPRC,KANSL1,DNAJA4,ZNF217,PPARG,ZSCAN26,MAPT,ZNF410",GO_Biological_Process_2023
8,Telomere Maintenance (GO:0000723),0.0009941592348822398,5.987608182533438,41.396006776061505,0.218548360772521,"RTEL1,RAD50,TERT,ZNF827,NSMCE2,ATR",GO_Biological_Process_2023
9,TORC1 Signaling (GO:0038202),0.0010116319550177567,23.052870090634443,158.97698268116935,0.218548360772521,"LARP1,NPRL3,LAMTOR4",GO_Biological_Process_2023
10,rRNA Metabolic Process (GO:0016072),0.0011495013777876424,5.799923780487805,39.25636080174819,0.218548360772521,"NOP58,RPS28,XRN1,EXOSC9,MAPT,BYSL",GO_Biological_Process_2023
11,Antigen Receptor-Mediated Signaling Pathway (GO:0050851),0.0013409602288911682,4.138241308793456,27.371856405113093,0.218548360772521,"BLK,MEF2C,PTPRC,BTN3A1,PIK3CA,BTN2A1,BTN3A2,SPPL3",GO_Biological_Process_2023
12,Positive Regulation Of Protein Targeting To Mitochondrion (GO:1903955),0.0013454554683839503,10.268686868686869,67.88652183456014,0.218548360772521,"LEPROT,PDCD5,ARIH2,UBE2L3",GO_Biological_Process_2023
13,"Protein Localization To Chromosome, Telomeric Region (GO:0070198)",0.0015806168266557857,18.4404833836858,118.94001345207991,0.218548360772521,"TERT,ZNF827,ATR",GO_Biological_Process_2023
14,Regulation Of DNA Binding (GO:0051101),0.0016908866802507084,6.710056825690498,42.82695261826485,0.218548360772521,"TFAP4,CEBPG,PPARG,JAK2,MDFI",GO_Biological_Process_2023
15,Regulation Of Supramolecular Fiber Organization (GO:1902903),0.0017157869344260725,9.477855477855478,60.353879036205086,0.218548360772521,"HSPA8,PIK3CA,APOE,MAPT",GO_Biological_Process_2023
16,Endosome Transport Via Multivesicular Body Sorting Pathway (GO:0032509),0.0017157869344260725,9.477855477855478,60.353879036205086,0.218548360772521,"LAPTM4B,LEPROT,TMEM50B,UBXN6",GO_Biological_Process_2023
17,Transmembrane Receptor Protein Tyrosine Kinase Signaling Pathway (GO:0007169),0.0018746941955765691,2.526039033269289,15.861781476314503,0.22474275121088516,"CEP57,BLK,PDGFRA,CHURC1,PILRB,FRS3,AHI1,GIGYF1,DOK2,PIK3CA,AXL,KIT,JAK2,MUC20,EPHB4",GO_Biological_Process_2023
18,Positive Regulation Of Binding (GO:0051099),0.0020717738615938937,4.336146788990826,26.79456909719397,0.23457084055157532,"BLK,TERT,HFE,CEBPG,PPARG,APOE,SPPL3",GO_Biological_Process_2023
19,Embryonic Hemopoiesis (GO:0035162),0.002315358484185784,15.365558912386707,93.24114247074891,0.2359350295385314,"KITLG,KIT,SH2B3",GO_Biological_Process_2023
20,Negative Regulation Of Receptor Signaling Pathway Via STAT (GO:1904893),0.002315358484185784,15.365558912386707,93.24114247074891,0.2359350295385314,"LEPROT,PPARG,SH2B3",GO_Biological_Process_2023
21,Intracellular Iron Ion Homeostasis (GO:0006879),0.0027042109213432997,5.934065934065934,35.08780620889682,0.2619437728624174,"NDFIP1,TFRC,TMPRSS6,HFE,FBXL5",GO_Biological_Process_2023
22,Axo-Dendritic Transport (GO:0008088),0.0029561858566416093,61.30722891566265,357.04443639417775,0.2619437728624174,"HSPA8,MAPT",GO_Biological_Process_2023
23,Establishment Of Protein Localization To Telomere (GO:0070200),0.0029561858566416093,61.30722891566265,357.04443639417775,0.2619437728624174,"TERT,ZNF827",GO_Biological_Process_2023
24,Regulation Of Protein Localization To Cell Surface (GO:2000008),0.00390323331360149,7.244919786096257,40.17996299313587,0.3164184205317654,"LEPROT,HFE,STX4,TM9SF4",GO_Biological_Process_2023
25,Telomere Organization (GO:0032200),0.004097480403703544,5.318624882087832,29.238518168972206,0.3164184205317654,"RTEL1,RAD50,TERT,ZNF827,ATR",GO_Biological_Process_2023
26,Regulation Of Megakaryocyte Differentiation (GO:0045652),0.004337836661678677,11.52190332326284,62.683526873555344,0.3164184205317654,"MEF2C,FAXDC2,MYB",GO_Biological_Process_2023
27,Response To Chemokine (GO:1990868),0.004337836661678677,11.52190332326284,62.683526873555344,0.3164184205317654,"DUSP1,SH2B3,RHOA",GO_Biological_Process_2023
28,T Cell Receptor Signaling Pathway (GO:0050852),0.004347259948424647,4.311542824730573,23.447073275278882,0.3164184205317654,"PTPRC,BTN3A1,PIK3CA,BTN2A1,BTN3A2,SPPL3",GO_Biological_Process_2023
29,Myeloid Cell Differentiation (GO:0030099),0.0046583660691216265,5.1408308004052685,27.601585921924936,0.3273706913403405,"CEBPA,MFHAS1,MYB,KIT,JAK2",GO_Biological_Process_2023
30,Sulfur Amino Acid Metabolic Process (GO:0000096),0.005648876859712258,10.240684793554884,53.00884174011179,0.34588426095669506,"MPST,MSRA,TST",GO_Biological_Process_2023
31,Regulation Of Growth Hormone Receptor Signaling Pathway (GO:0060398),0.005788206268314402,30.650602409638555,157.9098449242407,0.34588426095669506,"LEPROT,JAK2",GO_Biological_Process_2023
32,Regulation Of Interleukin-1-Mediated Signaling Pathway (GO:2000659),0.005788206268314402,30.650602409638555,157.9098449242407,0.34588426095669506,"IL1RN,VRK2",GO_Biological_Process_2023
33,Positive Regulation Of Toll-Like Receptor 2 Signaling Pathway (GO:0034137),0.005788206268314402,30.650602409638555,157.9098449242407,0.34588426095669506,"TLR1,MFHAS1",GO_Biological_Process_2023
34,Negative Regulation Of MAP Kinase Activity (GO:0043407),0.005940112430561495,4.818579027355623,24.700167246707654,0.34588426095669506,"PTPN1,DUSP1,PPARG,APOE,SH2B3",GO_Biological_Process_2023
35,Positive Regulation Of Protein Binding (GO:0032092),0.005940112430561495,4.818579027355623,24.700167246707654,0.34588426095669506,"BLK,TERT,HFE,APOE,SPPL3",GO_Biological_Process_2023
36,Regulation Of MAP Kinase Activity (GO:0043405),0.006308410630019351,3.1370660868214646,15.891973730824853,0.35712613511054,"PTPN1,MEF2C,DUSP1,KIT,PPARG,APOE,TRIB1,SH2B3",GO_Biological_Process_2023
37,Regulation Of Kinase Activity (GO:0043549),0.0070353066130038775,3.8605182926829267,19.13587114137991,0.3748107620637366,"PDGFRA,DSTYK,RAD50,AXL,MAPT,EPHB4",GO_Biological_Process_2023
38,Negative Regulation Of MAPK Cascade (GO:0043409),0.007147752795627278,3.3829319571865444,16.714922234227185,0.3748107620637366,"SPRED2,PTPN1,PTPRC,DUSP1,PPARG,APOE,SH2B3",GO_Biological_Process_2023
39,Regulation Of Receptor Signaling Pathway Via STAT (GO:1904892),0.0071725317568624766,9.21570996978852,45.50253648143959,0.3748107620637366,"PTPRC,PPARG,JAK2",GO_Biological_Process_2023
40,Regulation Of Cytokine-Mediated Signaling Pathway (GO:0001959),0.008607365490275446,5.595592286501377,26.60780786200401,0.38725981208669813,"PTPN1,PTPRC,AXL,VRK2",GO_Biological_Process_2023
41,Negative Regulation Of Platelet Activation (GO:0010544),0.008916446427890624,8.377094204888767,39.53869337643822,0.38725981208669813,"PDGFRA,APOE,SH2B3",GO_Biological_Process_2023
42,Positive Regulation Of Cholesterol Efflux (GO:0010875),0.008916446427890624,8.377094204888767,39.53869337643822,0.38725981208669813,"PPARG,APOE,PLTP",GO_Biological_Process_2023
43,Regulation Of Behavior (GO:0050795),0.008916446427890624,8.377094204888767,39.53869337643822,0.38725981208669813,"AHI1,LEPR,APOE",GO_Biological_Process_2023
44,Erythrocyte Development (GO:0048821),0.009444937543148634,20.431726907630523,95.25835798349146,0.38725981208669813,"HEATR3,SH2B3",GO_Biological_Process_2023
45,Sulfur Amino Acid Catabolic Process (GO:0000098),0.009444937543148634,20.431726907630523,95.25835798349146,0.38725981208669813,"MPST,TST",GO_Biological_Process_2023
46,Histone mRNA Catabolic Process (GO:0071044),0.009444937543148634,20.431726907630523,95.25835798349146,0.38725981208669813,"XRN1,ERI1",GO_Biological_Process_2023
47,Histone mRNA Metabolic Process (GO:0008334),0.009444937543148634,20.431726907630523,95.25835798349146,0.38725981208669813,"XRN1,ERI1",GO_Biological_Process_2023
48,Positive Regulation Of Receptor Catabolic Process (GO:2000646),0.009444937543148634,20.431726907630523,95.25835798349146,0.38725981208669813,"PTPN1,APOE",GO_Biological_Process_2023
49,DNA Metabolic Process (GO:0006259),0.009550067957458943,2.4069245192517332,11.195104192995775,0.38725981208669813,"RTEL1,RRM1,RAD50,TERT,ZNF827,TRRAP,GADD45A,LONP1,DNASE2,ATR,DDB2",GO_Biological_Process_2023
50,Stem Cell Differentiation (GO:0048863),0.009856381925725589,5.351778656126482,24.723269998721616,0.38725981208669813,"MEF2C,PTPRC,KIT,JARID2",GO_Biological_Process_2023
51,Liver Development (GO:0001889),0.009856381925725589,5.351778656126482,24.723269998721616,0.38725981208669813,"CEBPA,CITED2,CEBPG,NPHP3",GO_Biological_Process_2023
52,Long-Chain Fatty Acid Transport (GO:0015909),0.010886865396739583,7.6782477341389725,34.70720178532406,0.38725981208669813,"PPARG,APOE,CPT1B",GO_Biological_Process_2023
53,Membrane Assembly (GO:0071709),0.011217301193070883,5.1282828282828286,23.027517835974916,0.38725981208669813,"UBXN2A,STX4,TLCD1,DMKN",GO_Biological_Process_2023
54,Lymphocyte Differentiation (GO:0030098),0.012360620760466344,3.9509780999142703,17.35759346653731,0.38725981208669813,"PTPRC,AXL,KIT,CEBPG,LEPR",GO_Biological_Process_2023
55,Negative Regulation Of Smooth Muscle Cell Proliferation (GO:0048662),0.012693553917064063,4.922666666666666,21.495616450673804,0.38725981208669813,"MEF2C,PPARG,APOE,TRIB1",GO_Biological_Process_2023
56,Regulation Of Lipid Storage (GO:0010883),0.013088735319820933,7.086916105042993,30.72889174550526,0.38725981208669813,"FTO,PPARG,APOB",GO_Biological_Process_2023
57,Integrated Stress Response Signaling (GO:0140467),0.013088735319820933,7.086916105042993,30.72889174550526,0.38725981208669813,"CEBPA,NFE2,CEBPG",GO_Biological_Process_2023
58,Myeloid Cell Development (GO:0061515),0.013088735319820933,7.086916105042993,30.72889174550526,0.38725981208669813,"MYB,KIT,SH2B3",GO_Biological_Process_2023
59,Positive Regulation Of Establishment Of Protein Localization To Mitochondrion (GO:1903749),0.013088735319820933,7.086916105042993,30.72889174550526,0.38725981208669813,"LEPROT,ARIH2,UBE2L3",GO_Biological_Process_2023
60,Positive Regulation Of Immunoglobulin Production (GO:0002639),0.013088735319820933,7.086916105042993,30.72889174550526,0.38725981208669813,"PTPRC,TFRC,STX4",GO_Biological_Process_2023
61,Regulation Of DNA Recombination (GO:0000018),0.013088735319820933,7.086916105042993,30.72889174550526,0.38725981208669813,"RTEL1,RAD50,FIGNL1",GO_Biological_Process_2023
62,Positive Regulation Of DNA-templated Transcription (GO:0045893),0.013231787425858451,1.5452610901947945,6.68346005311909,0.38725981208669813,"CEBPA,GTF2A1,THRB,EPAS1,TMPRSS6,ICE2,TRRAP,CITED2,MAX,CEBPG,ETS2,HELZ2,TERT,CDH1,ZMIZ2,PRDM16,MYB,ZKSCAN3,NLRP3,APOE,NFE2,MEF2C,MAP2K2,ZBTB38,TFEB,ZFP90,ASXL1,AHI1,TOX2,ELF1,TFAP4,KANSL1,PPARG,RBM23,CRLF3,ZNF410",GO_Biological_Process_2023
63,DNA Dealkylation (GO:0035510),0.013871426046285067,15.322289156626505,65.54759211542967,0.38725981208669813,"FTO,MPG",GO_Biological_Process_2023
64,DNA Dealkylation Involved In DNA Repair (GO:0006307),0.013871426046285067,15.322289156626505,65.54759211542967,0.38725981208669813,"FTO,MPG",GO_Biological_Process_2023
65,L-arginine Transmembrane Transport (GO:1903826),0.013871426046285067,15.322289156626505,65.54759211542967,0.38725981208669813,"SLC25A15,SLC7A6",GO_Biological_Process_2023
66,Amino-Acid Betaine Transport (GO:0015838),0.013871426046285067,15.322289156626505,65.54759211542967,0.38725981208669813,"SLC7A6,SLC22A16",GO_Biological_Process_2023
67,Regulation Of Nitrogen Compound Metabolic Process (GO:0051171),0.013871426046285067,15.322289156626505,65.54759211542967,0.38725981208669813,"ALDH2,APOE",GO_Biological_Process_2023
68,Basic Amino Acid Transmembrane Transport (GO:1990822),0.013871426046285067,15.322289156626505,65.54759211542967,0.38725981208669813,"SLC25A15,SLC7A6",GO_Biological_Process_2023
69,Telomere Maintenance Via Recombination (GO:0000722),0.013871426046285067,15.322289156626505,65.54759211542967,0.38725981208669813,"RAD50,NSMCE2",GO_Biological_Process_2023
70,Lipoprotein Transport (GO:0042953),0.013871426046285067,15.322289156626505,65.54759211542967,0.38725981208669813,"UNC119B,PPARG",GO_Biological_Process_2023
71,Nuclear RNA Surveillance (GO:0071027),0.013871426046285067,15.322289156626505,65.54759211542967,0.38725981208669813,"XRN1,EXOSC9",GO_Biological_Process_2023
72,Nuclear mRNA Surveillance (GO:0071028),0.013871426046285067,15.322289156626505,65.54759211542967,0.38725981208669813,"XRN1,EXOSC9",GO_Biological_Process_2023
73,Positive Regulation Of IRE1-mediated Unfolded Protein Response (GO:1903896),0.013871426046285067,15.322289156626505,65.54759211542967,0.38725981208669813,"PTPN1,BCL2L11",GO_Biological_Process_2023
74,Hepaticobiliary System Development (GO:0061008),0.015525801931861961,6.580060422960725,27.407609825477234,0.4218877911617957,"CEBPA,CITED2,CEBPG",GO_Biological_Process_2023
75,Negative Regulation Of DNA Binding (GO:0043392),0.015525801931861961,6.580060422960725,27.407609825477234,0.4218877911617957,"TFAP4,JAK2,MDFI",GO_Biological_Process_2023
76,Epithelial Cell Migration (GO:0010631),0.016004476752385043,4.5571268237934905,18.843203544407974,0.4291726792284305,"KANK2,PIK3CA,KIT,RHOA",GO_Biological_Process_2023
77,Enzyme-Linked Receptor Protein Signaling Pathway (GO:0007167),0.01719761661026338,2.8081734778982486,11.409565240816796,0.4403784416923718,"BLK,PDGFRA,AHI1,DOK2,AXL,PILRB,JAK2",GO_Biological_Process_2023
78,Positive Regulation Of Nucleic Acid-Templated Transcription (GO:1903508),0.01796693204201013,1.7722530206112295,7.123078896095023,0.4403784416923718,"NFE2,MEF2C,MAP2K2,TRRAP,CITED2,MAX,TFEB,ZFP90,ELF1,TFAP4,KANSL1,CDH1,PRDM16,MYB,ZKSCAN3,PPARG,APOE,RBM23,CRLF3",GO_Biological_Process_2023
79,Regulation Of Protein Transport (GO:0051223),0.018200701503353726,6.140785498489426,24.601799107603384,0.4403784416923718,"HSPA8,PTPN1,NDFIP1",GO_Biological_Process_2023
80,DNA Strand Elongation (GO:0022616),0.019015359602025866,12.256626506024096,48.56698335666549,0.4403784416923718,"RAD50,TERT",GO_Biological_Process_2023
81,Brown Fat Cell Differentiation (GO:0050873),0.019015359602025866,12.256626506024096,48.56698335666549,0.4403784416923718,"PRDM16,SLC39A13",GO_Biological_Process_2023
82,Regulation Of Toll-Like Receptor 2 Signaling Pathway (GO:0034135),0.019015359602025866,12.256626506024096,48.56698335666549,0.4403784416923718,"TLR1,MFHAS1",GO_Biological_Process_2023
83,Lipoprotein Localization (GO:0044872),0.019015359602025866,12.256626506024096,48.56698335666549,0.4403784416923718,"UNC119B,PPARG",GO_Biological_Process_2023
84,Megakaryocyte Development (GO:0035855),0.019015359602025866,12.256626506024096,48.56698335666549,0.4403784416923718,"KIT,SH2B3",GO_Biological_Process_2023
85,Multicellular Organismal-Level Iron Ion Homeostasis (GO:0060586),0.019015359602025866,12.256626506024096,48.56698335666549,0.4403784416923718,"TMPRSS6,HFE",GO_Biological_Process_2023
86,Negative Regulation Of T Cell Mediated Immunity (GO:0002710),0.019015359602025866,12.256626506024096,48.56698335666549,0.4403784416923718,"PTPRC,HFE",GO_Biological_Process_2023
87,Negative Regulation Of Establishment Of Protein Localization (GO:1904950),0.019015359602025866,12.256626506024096,48.56698335666549,0.4403784416923718,"NDFIP1,MAPT",GO_Biological_Process_2023
88,Positive Regulation Of Protein Localization To Cell Surface (GO:2000010),0.019015359602025866,12.256626506024096,48.56698335666549,0.4403784416923718,"STX4,TM9SF4",GO_Biological_Process_2023
89,Regulation Of Cyclin-Dependent Protein Serine/Threonine Kinase Activity (GO:0000079),0.020684680375260302,3.4221546774738263,13.272354423771738,0.443516697597749,"CEBPA,CCND3,CCND2,TFAP4,GADD45A",GO_Biological_Process_2023
90,Negative Regulation Of Macromolecule Metabolic Process (GO:0010605),0.020721343367757293,2.3408144796380093,9.074380413116906,0.443516697597749,"MEF2C,NDFIP1,TERT,CITED2,FLOT2,PPARG,APOE,MAPT,ZNF410",GO_Biological_Process_2023
91,Regulation Of Cholesterol Efflux (GO:0010874),0.02111504710387186,5.7564199395770395,22.20694046489024,0.443516697597749,"PPARG,APOE,PLTP",GO_Biological_Process_2023
92,TOR Signaling (GO:0031929),0.02111504710387186,5.7564199395770395,22.20694046489024,0.443516697597749,"LARP1,NPRL3,LAMTOR4",GO_Biological_Process_2023
93,Response To Glucocorticoid (GO:0051384),0.02111504710387186,5.7564199395770395,22.20694046489024,0.443516697597749,"IL1RN,BCL2L11,UBE2L3",GO_Biological_Process_2023
94,Positive Regulation Of B Cell Proliferation (GO:0030890),0.02111504710387186,5.7564199395770395,22.20694046489024,0.443516697597749,"MEF2C,PTPRC,TFRC",GO_Biological_Process_2023
95,Positive Regulation Of Cysteine-Type Endopeptidase Activity Involved In Apoptotic Process (GO:0043280),0.02202874179593662,2.936991869918699,11.205820023782435,0.443516697597749,"PDCD5,NLRP3,PPARG,ANP32B,MAPT,JAK2",GO_Biological_Process_2023
96,Nuclear-Transcribed mRNA Catabolic Process (GO:0000956),0.02235581800673843,3.3474296286507204,12.722470942418289,0.443516697597749,"HBS1L,XRN1,ERI1,EXOSC9,CNOT8",GO_Biological_Process_2023
97,Cellular Response To Hormone Stimulus (GO:0032870),0.023473472179624935,2.8908155487804876,10.846005584048363,0.443516697597749,"HSPA8,MEF2C,THRB,NCOA4,UBE2L3,CTSB",GO_Biological_Process_2023
98,Ribosome Biogenesis (GO:0042254),0.023473472179624935,2.8908155487804876,10.846005584048363,0.443516697597749,"RCL1,RPS28,NOP58,EXOSC9,HEATR3,BYSL",GO_Biological_Process_2023
99,Positive Regulation Of Intracellular Protein Transport (GO:0090316),0.023473472179624935,2.8908155487804876,10.846005584048363,0.443516697597749,"LEPROT,CDH1,ARIH2,ANP32B,TM9SF4,UBE2L3",GO_Biological_Process_2023
100,Regulation Of Secretion By Cell (GO:1903530),0.024132099380993526,3.9675464320625613,14.775985620607484,0.443516697597749,"MEF2C,ARFIP1,STX4,RAB8A",GO_Biological_Process_2023
101,Regulation Of Telomere Maintenance (GO:0032204),0.024269509920487396,5.417273858183757,20.14431947897334,0.443516697597749,"RTEL1,RAD50,NSMCE2",GO_Biological_Process_2023
102,Embryonic Heart Tube Morphogenesis (GO:0003143),0.024269509920487396,5.417273858183757,20.14431947897334,0.443516697597749,"AHI1,MEF2C,NPHP3",GO_Biological_Process_2023
103,Negative Regulation Of Endothelial Cell Proliferation (GO:0001937),0.024269509920487396,5.417273858183757,20.14431947897334,0.443516697597749,"MEF2C,PPARG,APOE",GO_Biological_Process_2023
104,Nucleobase-Containing Compound Catabolic Process (GO:0034655),0.024269509920487396,5.417273858183757,20.14431947897334,0.443516697597749,"EXOSC9,PABPC4,SIDT2",GO_Biological_Process_2023
105,Positive Regulation Of Cholesterol Transport (GO:0032376),0.024269509920487396,5.417273858183757,20.14431947897334,0.443516697597749,"PPARG,APOE,PLTP",GO_Biological_Process_2023
106,Regulation Of Stem Cell Proliferation (GO:0072091),0.024826956027899184,10.21285140562249,37.74491440057724,0.443516697597749,"PTPRC,TERT",GO_Biological_Process_2023
107,Establishment Of Protein Localization To Chromosome (GO:0070199),0.024826956027899184,10.21285140562249,37.74491440057724,0.443516697597749,"TERT,ZNF827",GO_Biological_Process_2023
108,Melanocyte Differentiation (GO:0030318),0.024826956027899184,10.21285140562249,37.74491440057724,0.443516697597749,"MEF2C,KIT",GO_Biological_Process_2023
109,Mitochondrial Genome Maintenance (GO:0000002),0.024826956027899184,10.21285140562249,37.74491440057724,0.443516697597749,"LONP1,TYMP",GO_Biological_Process_2023
110,Negative Regulation Of Response To Cytokine Stimulus (GO:0060761),0.024826956027899184,10.21285140562249,37.74491440057724,0.443516697597749,"PTPRC,SH2B3",GO_Biological_Process_2023
111,Negative Regulation Of Cell Adhesion (GO:0007162),0.02595499764346597,3.207320162107396,11.711180296360382,0.443516697597749,"CD164,PTPRC,CDH1,DUSP1,RHOA",GO_Biological_Process_2023
112,Positive Regulation Of Kinase Activity (GO:0033674),0.026550693606772917,2.802660753880266,10.170013415870047,0.443516697597749,"PDGFRA,DSTYK,RAD50,PTPRC,AXL,EPHB4",GO_Biological_Process_2023
113,Epithelium Development (GO:0060429),0.02689471683597508,2.541860046771002,9.190922150386779,0.443516697597749,"KANK2,AHI1,TAGLN,TST,PPARG,JAK2,CTSB",GO_Biological_Process_2023
114,Fatty Acid Transport (GO:0015908),0.0276638958513672,5.115810674723061,18.35362109091987,0.443516697597749,"PPARG,APOE,CPT1B",GO_Biological_Process_2023
115,Lysosome Localization (GO:0032418),0.0276638958513672,5.115810674723061,18.35362109091987,0.443516697597749,"BLOC1S2,KIT,TFEB",GO_Biological_Process_2023
116,Organelle Transport Along Microtubule (GO:0072384),0.0276638958513672,5.115810674723061,18.35362109091987,0.443516697597749,"ARHGAP21,BLOC1S2,MAPT",GO_Biological_Process_2023
117,Positive Regulation Of Lipid Kinase Activity (GO:0090218),0.0276638958513672,5.115810674723061,18.35362109091987,0.443516697597749,"PDGFRA,KIT,MAPT",GO_Biological_Process_2023
118,Positive Regulation Of Transferase Activity (GO:0051347),0.02832350246648102,2.512054619159377,8.953121784111,0.443516697597749,"PDGFRA,DSTYK,RAD50,AXL,APOE,EPHB4,UBE2L3",GO_Biological_Process_2023
119,Positive Regulation Of Protein Phosphorylation (GO:0001934),0.02858356121168778,1.8430614406779662,6.551942444394531,0.443516697597749,"TFRC,HFE,FAXDC2,TNK2,DOCK7,BMP8A,RAD50,CCND3,PTPRC,CCND2,LEPR,PPARG,JAK2,IL6R",GO_Biological_Process_2023
120,Regulation Of Tyrosine Phosphorylation Of STAT Protein (GO:0042509),0.028980505186219998,3.726354453627181,13.195512663727806,0.443516697597749,"KIT,JAK2,IL6R,SH2B3",GO_Biological_Process_2023
121,Negative Regulation Of Cytokine-Mediated Signaling Pathway (GO:0001960),0.028980505186219998,3.726354453627181,13.195512663727806,0.443516697597749,"IL1RN,PTPRC,PPARG,SH2B3",GO_Biological_Process_2023
122,Positive Regulation Of Phosphorylation (GO:0042327),0.029169880141752053,2.091675008341675,7.393273398146476,0.443516697597749,"PDGFRA,DSTYK,CCND3,RAD50,CCND2,TFRC,AXL,FAXDC2,LEPR,EPHB4",GO_Biological_Process_2023
123,Ribonucleoprotein Complex Biogenesis (GO:0022613),0.029905018384531586,3.078419452887538,10.804417947066764,0.443516697597749,"RCL1,RPS28,NOP58,HEATR3,BYSL",GO_Biological_Process_2023
124,Regulation Of Peroxisome Proliferator Activated Receptor Signaling Pathway (GO:0035358),0.03125885600520284,8.75301204819277,30.333147929428307,0.443516697597749,"ASXL1,CITED2",GO_Biological_Process_2023
125,Retinoic Acid Receptor Signaling Pathway (GO:0048384),0.03125885600520284,8.75301204819277,30.333147929428307,0.443516697597749,"THRB,PPARG",GO_Biological_Process_2023
126,Exonucleolytic Catabolism Of Deadenylated mRNA (GO:0043928),0.03125885600520284,8.75301204819277,30.333147929428307,0.443516697597749,"EXOSC9,CNOT8",GO_Biological_Process_2023
127,High-Density Lipoprotein Particle Remodeling (GO:0034375),0.03125885600520284,8.75301204819277,30.333147929428307,0.443516697597749,"APOE,PLTP",GO_Biological_Process_2023
128,Maintenance Of Protein Localization In Organelle (GO:0072595),0.03125885600520284,8.75301204819277,30.333147929428307,0.443516697597749,"TAF8,HK1",GO_Biological_Process_2023
129,Mitochondrial DNA Metabolic Process (GO:0032042),0.03125885600520284,8.75301204819277,30.333147929428307,0.443516697597749,"RRM1,LONP1",GO_Biological_Process_2023
130,Mitotic Recombination (GO:0006312),0.03125885600520284,8.75301204819277,30.333147929428307,0.443516697597749,"RAD50,NSMCE2",GO_Biological_Process_2023
131,Negative Regulation Of Cellular Senescence (GO:2000773),0.03125885600520284,8.75301204819277,30.333147929428307,0.443516697597749,"TERT,ZKSCAN3",GO_Biological_Process_2023
132,Negative Regulation Of Receptor Signaling Pathway Via JAK-STAT (GO:0046426),0.03125885600520284,8.75301204819277,30.333147929428307,0.443516697597749,"LEPROT,SH2B3",GO_Biological_Process_2023
133,Outer Mitochondrial Membrane Organization (GO:0007008),0.03125885600520284,8.75301204819277,30.333147929428307,0.443516697597749,"TOMM40,SAMM50",GO_Biological_Process_2023
134,Positive Regulation Of Nitric-Oxide Synthase Activity (GO:0051000),0.03125885600520284,8.75301204819277,30.333147929428307,0.443516697597749,"TERT,APOE",GO_Biological_Process_2023
135,Protein Insertion Into Mitochondrial Outer Membrane (GO:0045040),0.03125885600520284,8.75301204819277,30.333147929428307,0.443516697597749,"TOMM40,SAMM50",GO_Biological_Process_2023
136,Regulation Of Amyloid Precursor Protein Catabolic Process (GO:1902991),0.03125885600520284,8.75301204819277,30.333147929428307,0.443516697597749,"FLOT2,APOE",GO_Biological_Process_2023
137,Regulation Of Extrinsic Apoptotic Signaling Pathway Via Death Domain Receptors (GO:1902041),0.03129721765568631,4.846080457942439,16.78791829934718,0.443516697597749,"TMBIM1,TMC8,STX4",GO_Biological_Process_2023
138,Regulation Of Protein Targeting To Mitochondrion (GO:1903214),0.03129721765568631,4.846080457942439,16.78791829934718,0.443516697597749,"LEPROT,ARIH2,UBE2L3",GO_Biological_Process_2023
139,Negative Regulation Of Mitochondrion Organization (GO:0010823),0.03129721765568631,4.846080457942439,16.78791829934718,0.443516697597749,"TFRC,PPARG,MAPT",GO_Biological_Process_2023
140,Response To Lipopolysaccharide (GO:0032496),0.03133354461567158,2.4544759521823742,8.500012321766551,0.443516697597749,"MEF2C,IL37,AXL,NLRP3,TRIB1,JAK2,RHOA",GO_Biological_Process_2023
141,Cellular Response To Fibroblast Growth Factor Stimulus (GO:0044344),0.031605749230535475,3.616399286987522,12.492548417395126,0.443516697597749,"CEP57,DSTYK,CHURC1,FRS3",GO_Biological_Process_2023
142,Phospholipid Transport (GO:0015914),0.031605749230535475,3.616399286987522,12.492548417395126,0.443516697597749,"ATP11B,ATP11A,APOE,PLTP",GO_Biological_Process_2023
143,Regulation Of Endosome Size (GO:0051036),0.031773031329377505,inf,inf,0.443516697597749,BLOC1S2,GO_Biological_Process_2023
144,Regulation Of Lysosome Size (GO:0062196),0.031773031329377505,inf,inf,0.443516697597749,BLOC1S2,GO_Biological_Process_2023
145,Meiotic DNA Double-Strand Break Formation (GO:0042138),0.031773031329377505,inf,inf,0.443516697597749,SPO11,GO_Biological_Process_2023
146,Negative Regulation Of miRNA-mediated Gene Silencing (GO:0060965),0.031773031329377505,inf,inf,0.443516697597749,PPARG,GO_Biological_Process_2023
147,Regulation Of Vesicle-Mediated Transport (GO:0060627),0.03201432412229803,3.0177602956076046,10.385838875916175,0.4438448473553972,"PTPN1,MAP2K2,STX4,PLD1,RAB8A",GO_Biological_Process_2023
148,Regulation Of Protein Serine/Threonine Kinase Activity (GO:0071900),0.03348182721014227,2.6414634146341465,8.97239734817435,0.4610538098261483,"CCND3,CCND2,MAP2K2,GADD45A,TRIB1,RHOA",GO_Biological_Process_2023
149,Regulation Of Type II Interferon Production (GO:0032649),0.03421440946050897,2.959434182838438,9.988411153152123,0.46797964080884086,"BTN3A1,CEBPG,BTN3A2,JAK2,LGALS9B",GO_Biological_Process_2023
150,Replication Fork Processing (GO:0031297),0.0351677628365098,4.603323262839879,15.410202084003604,0.4715256622421511,"RTEL1,RAD50,ATR",GO_Biological_Process_2023
151,mRNA Transcription By RNA Polymerase II (GO:0042789),0.0351677628365098,4.603323262839879,15.410202084003604,0.4715256622421511,"THRB,TAF8,PPARG",GO_Biological_Process_2023
152,Positive Regulation Of Receptor Signaling Pathway Via STAT (GO:1904894),0.0351677628365098,4.603323262839879,15.410202084003604,0.4715256622421511,"KIT,JAK2,CRLF3",GO_Biological_Process_2023
153,RNA Metabolic Process (GO:0016070),0.036506081508650444,2.9033090554567873,9.610755493468831,0.4755252993130464,"FTO,PABPC4,EXOSC9,ADAR,SIDT2",GO_Biological_Process_2023
154,Regulation Of Blood Vessel Endothelial Cell Migration (GO:0043535),0.037262485697505315,3.414814814814815,11.23394919967304,0.4755252993130464,"MEF2C,GADD45A,PPARG,APOE",GO_Biological_Process_2023
155,Cellular Response To Oxidative Stress (GO:0034599),0.03734858459681566,2.567581300813008,8.44082150047032,0.4755252993130464,"PDGFRA,MSRA,LONP1,STX4,VRK2,MAPT",GO_Biological_Process_2023
156,Positive Regulation Of Peptidyl-Tyrosine Phosphorylation (GO:0050731),0.03734858459681566,2.567581300813008,8.44082150047032,0.4755252993130464,"PTPN1,PTPRC,TNK2,KIT,JAK2,IL6R",GO_Biological_Process_2023
157,Regulation Of Hematopoietic Progenitor Cell Differentiation (GO:1901532),0.03826602016061806,7.658132530120482,24.989964301974165,0.4755252993130464,"KITLG,MYB",GO_Biological_Process_2023
158,Regulation Of Phospholipase C Activity (GO:1900274),0.03826602016061806,7.658132530120482,24.989964301974165,0.4755252993130464,"PDGFRA,KIT",GO_Biological_Process_2023
159,Cellular Response To Thyroid Hormone Stimulus (GO:0097067),0.03826602016061806,7.658132530120482,24.989964301974165,0.4755252993130464,"THRB,CTSB",GO_Biological_Process_2023
160,Transport Along Microtubule (GO:0010970),0.03826602016061806,7.658132530120482,24.989964301974165,0.4755252993130464,"ARHGAP21,BLOC1S2",GO_Biological_Process_2023
161,Intracellular Zinc Ion Homeostasis (GO:0006882),0.03826602016061806,7.658132530120482,24.989964301974165,0.4755252993130464,"TMC8,SLC39A13",GO_Biological_Process_2023
162,Megakaryocyte Differentiation (GO:0030219),0.03826602016061806,7.658132530120482,24.989964301974165,0.4755252993130464,"KIT,SH2B3",GO_Biological_Process_2023
163,Negative Regulation Of Smooth Muscle Cell Migration (GO:0014912),0.03826602016061806,7.658132530120482,24.989964301974165,0.4755252993130464,"MEF2C,TRIB1",GO_Biological_Process_2023
164,Regulation Of IRE1-mediated Unfolded Protein Response (GO:1903894),0.03826602016061806,7.658132530120482,24.989964301974165,0.4755252993130464,"PTPN1,BCL2L11",GO_Biological_Process_2023
165,Response To Amino Acid Starvation (GO:1990928),0.03927315749651936,4.38368580060423,14.1909290839985,0.47642080343991944,"LARP1,NPRL3,TFEB",GO_Biological_Process_2023
166,Macrophage Activation (GO:0042116),0.03927315749651936,4.38368580060423,14.1909290839985,0.47642080343991944,"TLR1,MAPT,JAK2",GO_Biological_Process_2023
167,Positive Regulation Of Receptor Signaling Pathway Via JAK-STAT (GO:0046427),0.03927315749651936,4.38368580060423,14.1909290839985,0.47642080343991944,"KIT,JAK2,CRLF3",GO_Biological_Process_2023
168,Regulation Of Axon Extension (GO:0030516),0.03927315749651936,4.38368580060423,14.1909290839985,0.47642080343991944,"MACF1,APOE,MAPT",GO_Biological_Process_2023
169,Neuron Development (GO:0048666),0.03977703261631736,2.3213639801387655,7.485158306470615,0.47958419075255115,"RP1L1,MEF2C,TDP2,BLOC1S2,DOCK7,APOE,MAPT",GO_Biological_Process_2023
170,Cellular Response To Cytokine Stimulus (GO:0071345),0.040004569395453236,1.9023643565041424,6.123257333277721,0.47958419075255115,"CEBPA,DUSP1,IL37,AXL,KIT,IL2RB,LEPR,JAK2,IL6R,SH2B3,RHOA",GO_Biological_Process_2023
171,Regulation Of Smooth Muscle Cell Proliferation (GO:0048660),0.04029492295605065,3.3221949221949223,10.66932799139733,0.48024007593234636,"PPARG,APOE,TRIB1,IL6R",GO_Biological_Process_2023
172,Positive Regulation Of Intracellular Signal Transduction (GO:1902533),0.04055617691467709,1.652070189274448,5.294995945457911,0.4805435380936739,"PDGFRA,NDFIP1,TFRC,RHOA,MFHAS1,DOK2,PTPRC,PIK3CA,AXL,DLG5,TRIP6,KIT,NLRP3,PPARG,TRIM38,JAK2,LAMTOR4",GO_Biological_Process_2023
173,Positive Regulation Of Signal Transduction (GO:0009967),0.04316893162304578,1.9448326733442038,6.111897707254318,0.4848551506912862,"ASXL1,MACF1,DSTYK,PTPRC,THRB,TERT,CITED2,AXL,DLG5,JAK2",GO_Biological_Process_2023
174,Activation Of Cysteine-Type Endopeptidase Activity Involved In Apoptotic Process (GO:0006919),0.04346364963671163,3.2344497607655502,10.142685663144357,0.4848551506912862,"PPARG,MAPT,ANP32B,JAK2",GO_Biological_Process_2023
175,ncRNA Processing (GO:0034470),0.04346364963671163,3.2344497607655502,10.142685663144357,0.4848551506912862,"RPS28,NOP58,EXOSC9,BYSL",GO_Biological_Process_2023
176,Establishment Of Protein Localization To Mitochondrion (GO:0072655),0.04361042637875409,4.184015380390003,13.106256718491624,0.4848551506912862,"TOMM40,FBXO7,HK1",GO_Biological_Process_2023
177,Cellular Response To Chemical Stress (GO:0062197),0.04393713030581615,2.7469604863221884,8.584239223095436,0.4848551506912862,"MSRA,PIK3CA,LONP1,STX4,VRK2",GO_Biological_Process_2023
178,Negative Regulation Of Protein Kinase Activity (GO:0006469),0.04393713030581615,2.7469604863221884,8.584239223095436,0.4848551506912862,"PTPN1,PTPRC,GADD45A,ADAR,TRIB1",GO_Biological_Process_2023
179,Regulation Of Cholesterol Storage (GO:0010885),0.045805630168369055,6.806559571619813,20.986993652421944,0.4848551506912862,"PPARG,APOB",GO_Biological_Process_2023
180,B Cell Proliferation (GO:0042100),0.045805630168369055,6.806559571619813,20.986993652421944,0.4848551506912862,"MEF2C,PTPRC",GO_Biological_Process_2023
181,Cellular Response To Corticosteroid Stimulus (GO:0071384),0.045805630168369055,6.806559571619813,20.986993652421944,0.4848551506912862,"BCL2L11,UBE2L3",GO_Biological_Process_2023
182,Response To Thyroid Hormone (GO:0097066),0.045805630168369055,6.806559571619813,20.986993652421944,0.4848551506912862,"THRB,CTSB",GO_Biological_Process_2023
183,Determination Of Bilateral Symmetry (GO:0009855),0.045805630168369055,6.806559571619813,20.986993652421944,0.4848551506912862,"CITED2,NPHP3",GO_Biological_Process_2023
184,Interleukin-6-Mediated Signaling Pathway (GO:0070102),0.045805630168369055,6.806559571619813,20.986993652421944,0.4848551506912862,"JAK2,IL6R",GO_Biological_Process_2023
185,Negative Regulation Of Amyloid Precursor Protein Catabolic Process (GO:1902992),0.045805630168369055,6.806559571619813,20.986993652421944,0.4848551506912862,"FLOT2,APOE",GO_Biological_Process_2023
186,Negative Regulation Of Telomere Maintenance (GO:0032205),0.045805630168369055,6.806559571619813,20.986993652421944,0.4848551506912862,"RTEL1,RAD50",GO_Biological_Process_2023
187,"Nuclear-Transcribed mRNA Catabolic Process, Exonucleolytic (GO:0000291)",0.045805630168369055,6.806559571619813,20.986993652421944,0.4848551506912862,"EXOSC9,CNOT8",GO_Biological_Process_2023
188,Phosphate Ion Transport (GO:0006817),0.045805630168369055,6.806559571619813,20.986993652421944,0.4848551506912862,"SLC17A1,SLC17A3",GO_Biological_Process_2023
189,"Positive Regulation Of DNA Damage Response, Signal Transduction By P53 Class Mediator (GO:0043517)",0.045805630168369055,6.806559571619813,20.986993652421944,0.4848551506912862,"SPRED2,ATR",GO_Biological_Process_2023
190,Positive Regulation Of Endoplasmic Reticulum Unfolded Protein Response (GO:1900103),0.045805630168369055,6.806559571619813,20.986993652421944,0.4848551506912862,"PTPN1,BCL2L11",GO_Biological_Process_2023
191,Positive Regulation Of Stem Cell Proliferation (GO:2000648),0.045805630168369055,6.806559571619813,20.986993652421944,0.4848551506912862,"PTPRC,TERT",GO_Biological_Process_2023
192,Positive Regulation Of Striated Muscle Cell Differentiation (GO:0051155),0.045805630168369055,6.806559571619813,20.986993652421944,0.4848551506912862,"MEF2C,ATP11A",GO_Biological_Process_2023
193,Positive Regulation Of Transmembrane Receptor Protein Serine/Threonine Kinase Signaling Pathway (GO:0090100),0.04660114439579063,2.69850157308164,8.273957114819368,0.4848551506912862,"CITED2,HFE,BMP8A,PPARG,JAK2",GO_Biological_Process_2023
194,Regulation Of Double-Strand Break Repair (GO:2000779),0.046768568540565984,3.1512043512043513,9.650701707778818,0.4848551506912862,"RTEL1,TRRAP,FIGNL1,ATR",GO_Biological_Process_2023
195,B Cell Receptor Signaling Pathway (GO:0050853),0.04817604921540808,4.001707605411796,12.136752127660227,0.4848551506912862,"BLK,MEF2C,PTPRC",GO_Biological_Process_2023
196,mRNA Transcription (GO:0009299),0.04817604921540808,4.001707605411796,12.136752127660227,0.4848551506912862,"THRB,TAF8,PPARG",GO_Biological_Process_2023
197,DNA Repair (GO:0006281),0.05143255655920343,1.9571830985915493,5.807909355830609,0.4848551506912862,"FTO,RRM1,RAD50,TRRAP,GADD45A,TDP2,MPG,ATR,DDB2",GO_Biological_Process_2023
198,Regulation Of Protein Binding (GO:0043393),0.052211571037431126,2.6065117716758537,7.6955986550295075,0.4848551506912862,"BLK,TERT,HFE,TMC8,SPPL3",GO_Biological_Process_2023
199,Negative Regulation Of Developmental Process (GO:0051093),0.052211571037431126,2.6065117716758537,7.6955986550295075,0.4848551506912862,"TFRC,BCL11A,PPARG,ANP32B,MAPT",GO_Biological_Process_2023
200,Negative Regulation Of Signal Transduction (GO:0009968),0.05247009745283525,1.8729891507669285,5.52065770553052,0.4848551506912862,"KANK2,ASXL1,MFHAS1,PTPN1,LEPROT,PTPRC,TMBIM1,PPARG,TRIB1,MDFI",GO_Biological_Process_2023
201,Response To Transforming Growth Factor Beta (GO:0071559),0.052966013709009704,3.834592145015106,11.266433671260492,0.4848551506912862,"MEF2C,FNDC4,PDCD5",GO_Biological_Process_2023
202,Development Of Primary Male Sexual Characteristics (GO:0046546),0.052966013709009704,3.834592145015106,11.266433671260492,0.4848551506912862,"KITLG,NCOA4,KIT",GO_Biological_Process_2023
203,Male Gonad Development (GO:0008584),0.052966013709009704,3.834592145015106,11.266433671260492,0.4848551506912862,"KITLG,NCOA4,KIT",GO_Biological_Process_2023
204,Regulation Of Cellular Response To Heat (GO:1900034),0.05383699378683079,6.125301204819277,17.89687095002477,0.4848551506912862,"MAPT,ATR",GO_Biological_Process_2023
205,Regulation Of Endoplasmic Reticulum Stress-Induced Intrinsic Apoptotic Signaling Pathway (GO:1902235),0.05383699378683079,6.125301204819277,17.89687095002477,0.4848551506912862,"PTPN1,BCL2L11",GO_Biological_Process_2023
206,RNA-templated DNA Biosynthetic Process (GO:0006278),0.05383699378683079,6.125301204819277,17.89687095002477,0.4848551506912862,"RAD50,TERT",GO_Biological_Process_2023
207,Amyloid Precursor Protein Metabolic Process (GO:0042982),0.05383699378683079,6.125301204819277,17.89687095002477,0.4848551506912862,"TMCC2,APOE",GO_Biological_Process_2023
208,Regulation Of Vascular Associated Smooth Muscle Cell Migration (GO:1904752),0.05383699378683079,6.125301204819277,17.89687095002477,0.4848551506912862,"MEF2C,DOCK7",GO_Biological_Process_2023
209,Telomere Maintenance Via Telomerase (GO:0007004),0.05383699378683079,6.125301204819277,17.89687095002477,0.4848551506912862,"RAD50,TERT",GO_Biological_Process_2023
210,Growth Hormone Receptor Signaling Pathway (GO:0060396),0.05383699378683079,6.125301204819277,17.89687095002477,0.4848551506912862,"PTPN1,JAK2",GO_Biological_Process_2023
211,Left/Right Pattern Formation (GO:0060972),0.05383699378683079,6.125301204819277,17.89687095002477,0.4848551506912862,"CITED2,NPHP3",GO_Biological_Process_2023
212,Lipoprotein Biosynthetic Process (GO:0042158),0.05383699378683079,6.125301204819277,17.89687095002477,0.4848551506912862,"WIPI2,APOE",GO_Biological_Process_2023
213,"Maturation Of 5.8S rRNA From Tricistronic rRNA Transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.05383699378683079,6.125301204819277,17.89687095002477,0.4848551506912862,"ERI1,EXOSC9",GO_Biological_Process_2023
214,Microglial Cell Activation (GO:0001774),0.05383699378683079,6.125301204819277,17.89687095002477,0.4848551506912862,"MAPT,JAK2",GO_Biological_Process_2023
215,Nucleic Acid Phosphodiester Bond Hydrolysis (GO:0090305),0.05383699378683079,6.125301204819277,17.89687095002477,0.4848551506912862,"RAD50,SPO11",GO_Biological_Process_2023
216,Positive Regulation Of Hormone Secretion (GO:0046887),0.05383699378683079,6.125301204819277,17.89687095002477,0.4848551506912862,"HFE,PPARG",GO_Biological_Process_2023
217,Positive Regulation Of Natural Killer Cell Activation (GO:0032816),0.05383699378683079,6.125301204819277,17.89687095002477,0.4848551506912862,"AXL,JAK2",GO_Biological_Process_2023
218,rRNA Catabolic Process (GO:0016075),0.05383699378683079,6.125301204819277,17.89687095002477,0.4848551506912862,"XRN1,EXOSC9",GO_Biological_Process_2023
219,Glucose Homeostasis (GO:0042593),0.05515826466515336,2.562816616008105,7.425885919645624,0.4848551506912862,"CEBPA,GCKR,LEPR,PPARG,HK1",GO_Biological_Process_2023
220,rRNA Processing (GO:0006364),0.05749632249994679,2.9252525252525254,8.354621518289637,0.4848551506912862,"RPS28,NOP58,ERI1,EXOSC9",GO_Biological_Process_2023
221,Triglyceride Metabolic Process (GO:0006641),0.057975865160158006,3.680845921450151,10.482049735111122,0.4848551506912862,"GK5,APOE,APOB",GO_Biological_Process_2023
222,Positive Regulation Of Autophagy (GO:0010508),0.05819930117046132,2.5205540883950373,7.168158229852214,0.4848551506912862,"LARP1,NPRL3,TFEB,TRIM38,FBXO7",GO_Biological_Process_2023
223,Mitochondrion Organization (GO:0007005),0.05820172560691982,2.2802619692863595,6.484700825991727,0.4848551506912862,"TOMM40,SAMM50,TERT,LONP1,FBXO7,TYMP",GO_Biological_Process_2023
224,Positive Regulation Of Cellular Catabolic Process (GO:0031331),0.060874681727052966,2.252230814991077,6.303854245950367,0.4848551506912862,"PTPN1,NPRL3,TFEB,APOE,TRIM38,CNOT8",GO_Biological_Process_2023
225,Positive Regulation Of Protein Serine/Threonine Kinase Activity (GO:0071902),0.060874681727052966,2.252230814991077,6.303854245950367,0.4848551506912862,"CCND3,MEF2C,CCND2,MAP2K2,KIT,RHOA",GO_Biological_Process_2023
226,Positive Regulation Of Cold-Induced Thermogenesis (GO:0120162),0.061334576279301785,2.479654868124326,6.921737226059301,0.4848551506912862,"HADHA,EPAS1,PRDM16,LEPR,JAK2",GO_Biological_Process_2023
227,B Cell Activation (GO:0042113),0.06134084599917283,2.8569415081042986,7.974607482337523,0.4848551506912862,"MEF2C,PTPRC,KIT,CEBPG",GO_Biological_Process_2023
228,Negative Regulation Of Cellular Component Organization (GO:0051129),0.06134084599917283,2.8569415081042986,7.974607482337523,0.4848551506912862,"HSPA8,RTEL1,DNAJA4,TMC8",GO_Biological_Process_2023
229,DNA Biosynthetic Process (GO:0071897),0.06232145365055438,5.567907995618839,15.453447752602834,0.4848551506912862,"RRM1,TERT",GO_Biological_Process_2023
230,Cellular Response To Glucocorticoid Stimulus (GO:0071385),0.06232145365055438,5.567907995618839,15.453447752602834,0.4848551506912862,"BCL2L11,UBE2L3",GO_Biological_Process_2023
231,Regulation Of Telomere Capping (GO:1904353),0.06232145365055438,5.567907995618839,15.453447752602834,0.4848551506912862,"RTEL1,RAD50",GO_Biological_Process_2023
232,Regulation Of Vascular Endothelial Cell Proliferation (GO:1905562),0.06232145365055438,5.567907995618839,15.453447752602834,0.4848551506912862,"MEF2C,PPARG",GO_Biological_Process_2023
233,Late Endosome To Vacuole Transport (GO:0045324),0.06232145365055438,5.567907995618839,15.453447752602834,0.4848551506912862,"LEPROT,TMEM50B",GO_Biological_Process_2023
234,ncRNA-mediated Post-Transcriptional Gene Silencing (GO:0035194),0.06232145365055438,5.567907995618839,15.453447752602834,0.4848551506912862,"HELZ2,CNOT8",GO_Biological_Process_2023
235,Negative Regulation Of Cyclin-Dependent Protein Serine/Threonine Kinase Activity (GO:0045736),0.06232145365055438,5.567907995618839,15.453447752602834,0.4848551506912862,"CEBPA,TFAP4",GO_Biological_Process_2023
236,Positive Regulation Of Cyclin-Dependent Protein Serine/Threonine Kinase Activity (GO:0045737),0.06232145365055438,5.567907995618839,15.453447752602834,0.4848551506912862,"CCND3,CCND2",GO_Biological_Process_2023
237,T-helper 2 Cell Differentiation (GO:0045064),0.06253956201413506,30.56156156156156,84.71530180884244,0.4848551506912862,MYB,GO_Biological_Process_2023
238,Regulation Of Lysosome Organization (GO:1905671),0.06253956201413506,30.56156156156156,84.71530180884244,0.4848551506912862,LAPTM4B,GO_Biological_Process_2023
239,Auditory Receptor Cell Morphogenesis (GO:0002093),0.06253956201413506,30.56156156156156,84.71530180884244,0.4848551506912862,PLS1,GO_Biological_Process_2023
240,Auditory Receptor Cell Stereocilium Organization (GO:0060088),0.06253956201413506,30.56156156156156,84.71530180884244,0.4848551506912862,PLS1,GO_Biological_Process_2023
241,Regulation Of T-Circle Formation (GO:1904429),0.06253956201413506,30.56156156156156,84.71530180884244,0.4848551506912862,RTEL1,GO_Biological_Process_2023
242,Sequestering Of Actin Monomers (GO:0042989),0.06253956201413506,30.56156156156156,84.71530180884244,0.4848551506912862,PFN4,GO_Biological_Process_2023
243,Inclusion Body Assembly (GO:0070841),0.06253956201413506,30.56156156156156,84.71530180884244,0.4848551506912862,MAPT,GO_Biological_Process_2023
244,Negative Regulation Of PERK-mediated Unfolded Protein Response (GO:1903898),0.06253956201413506,30.56156156156156,84.71530180884244,0.4848551506912862,PTPN1,GO_Biological_Process_2023
245,Negative Regulation Of T Cell Cytokine Production (GO:0002725),0.06253956201413506,30.56156156156156,84.71530180884244,0.4848551506912862,HFE,GO_Biological_Process_2023
246,Negative Regulation Of Meiotic Cell Cycle (GO:0051447),0.06253956201413506,30.56156156156156,84.71530180884244,0.4848551506912862,DUSP1,GO_Biological_Process_2023
247,Negative Regulation Of Transcription By RNA Polymerase I (GO:0016479),0.06253956201413506,30.56156156156156,84.71530180884244,0.4848551506912862,BEND3,GO_Biological_Process_2023
248,Negative Regulation Of Transcription From RNA Polymerase II Promoter In Response To Stress (GO:0097201),0.06253956201413506,30.56156156156156,84.71530180884244,0.4848551506912862,CITED2,GO_Biological_Process_2023
249,Osmosensory Signaling Pathway (GO:0007231),0.06253956201413506,30.56156156156156,84.71530180884244,0.4848551506912862,NLRP3,GO_Biological_Process_2023
250,Polyamine Biosynthetic Process (GO:0006596),0.06253956201413506,30.56156156156156,84.71530180884244,0.4848551506912862,SMOX,GO_Biological_Process_2023
251,Positive Regulation Of Amyloid-Beta Clearance (GO:1900223),0.06253956201413506,30.56156156156156,84.71530180884244,0.4848551506912862,APOE,GO_Biological_Process_2023
252,rDNA Heterochromatin Formation (GO:0000183),0.06253956201413506,30.56156156156156,84.71530180884244,0.4848551506912862,BEND3,GO_Biological_Process_2023
253,RNA Catabolic Process (GO:0006401),0.06320075302275012,3.538926330467116,9.772529409972307,0.4848551506912862,"PABPC4,EXOSC9,SIDT2",GO_Biological_Process_2023
254,Cellular Response To Ionizing Radiation (GO:0071479),0.06320075302275012,3.538926330467116,9.772529409972307,0.4848551506912862,"GADD45A,FIGNL1,ATR",GO_Biological_Process_2023
255,Positive Regulation Of NIK/NF-kappaB Signaling (GO:1901224),0.06320075302275012,3.538926330467116,9.772529409972307,0.4848551506912862,"TRIP6,NLRP3,RHOA",GO_Biological_Process_2023
256,Positive Regulation Of miRNA Transcription (GO:1902895),0.06320075302275012,3.538926330467116,9.772529409972307,0.4848551506912862,"TERT,MYB,PPARG",GO_Biological_Process_2023
257,Regulation Of Protein-Containing Complex Assembly (GO:0043254),0.06456389067264262,2.440054035798717,6.685992044923583,0.4848551506912862,"HSPA8,BCL2L11,TFRC,TMC8,APOE",GO_Biological_Process_2023
258,Cellular Response To Decreased Oxygen Levels (GO:0036294),0.06531799876695644,2.7917355371900827,7.617215931715123,0.4848551506912862,"TERT,EPAS1,PPARG,CPEB4",GO_Biological_Process_2023
259,Positive Regulation Of Protein Localization (GO:1903829),0.06531799876695644,2.7917355371900827,7.617215931715123,0.4848551506912862,"TFRC,STX4,MAPT,TM9SF4",GO_Biological_Process_2023
260,Cellular Response To Molecule Of Bacterial Origin (GO:0071219),0.067886951826869,2.4016907294832825,6.460335345480222,0.4848551506912862,"MEF2C,IL37,AXL,NLRP3,RHOA",GO_Biological_Process_2023
261,B Cell Differentiation (GO:0030183),0.06863547451450196,3.4075193017791205,9.128559374404292,0.4848551506912862,"PTPRC,KIT,CEBPG",GO_Biological_Process_2023
262,T Cell Differentiation (GO:0030217),0.06863547451450196,3.4075193017791205,9.128559374404292,0.4848551506912862,"PTPRC,KIT,LEPR",GO_Biological_Process_2023
263,Regulation Of Nervous System Development (GO:0051960),0.06863547451450196,3.4075193017791205,9.128559374404292,0.4848551506912862,"DOCK7,NPHP3,TYMP",GO_Biological_Process_2023
264,Regulation Of Protein Localization To Nucleus (GO:1900180),0.06863547451450196,3.4075193017791205,9.128559374404292,0.4848551506912862,"MFHAS1,TFRC,BYSL",GO_Biological_Process_2023
265,Positive Regulation Of Pathway-Restricted SMAD Protein Phosphorylation (GO:0010862),0.06863547451450196,3.4075193017791205,9.128559374404292,0.4848551506912862,"HFE,BMP8A,PPARG",GO_Biological_Process_2023
266,Protein Targeting To Mitochondrion (GO:0006626),0.06863547451450196,3.4075193017791205,9.128559374404292,0.4848551506912862,"TOMM40,SAMM50,FBXO7",GO_Biological_Process_2023
267,Regulation Of Cell-Cell Adhesion (GO:0022407),0.06863547451450196,3.4075193017791205,9.128559374404292,0.4848551506912862,"CITED2,CDH1,FLOT2",GO_Biological_Process_2023
268,Negative Regulation Of Response To External Stimulus (GO:0032102),0.06932464928767217,2.1720946915351504,5.797222436715981,0.4848551506912862,"MFHAS1,FNDC4,NLRP3,PPARG,APOE,TRIB1",GO_Biological_Process_2023
269,Regulation Of DNA-templated Transcription (GO:0006355),0.06937458235039662,1.3039379585771338,3.479212543069982,0.4848551506912862,"CEBPA,EPAS1,TMPRSS6,TRRAP,CITED2,MAX,CEBPG,ZSCAN9,ETS2,UBE2L3,ZNF827,CDH1,ZMIZ2,PRDM16,MYB,ZKSCAN3,APOE,ZKSCAN4,ZNF322,NKX2-3,BRD3,NFE2,HSPA8,MEF2C,KLF13,MAP2K2,DENND4A,BCL11A,ZBTB38,TFEB,ZFP91,KLF3,ZFP90,TOX2,ELF1,TFAP4,KANSL1,ZNF217,PPARG,ZSCAN26,RBM23,CRLF3,ZNF410",GO_Biological_Process_2023
270,Negative Regulation Of Binding (GO:0051100),0.06942650750229386,2.7294276094276095,7.28071138797702,0.4848551506912862,"TFAP4,TMC8,JAK2,MDFI",GO_Biological_Process_2023
271,Positive Regulation Of Lymphocyte Proliferation (GO:0050671),0.06942650750229386,2.7294276094276095,7.28071138797702,0.4848551506912862,"MEF2C,PTPRC,TFRC,JAK2",GO_Biological_Process_2023
272,Intracellular Monoatomic Cation Homeostasis (GO:0030003),0.07081653378791945,2.014833233301895,5.334598954618809,0.4848551506912862,"NDFIP1,TFRC,TMPRSS6,HFE,TMC8,SLC39A13,FBXL5",GO_Biological_Process_2023
273,Protein Autophosphorylation (GO:0046777),0.07081653378791945,2.014833233301895,5.334598954618809,0.4848551506912862,"PDGFRA,MAP2K2,KIT,VRK2,JAK2,EPHB4,ATR",GO_Biological_Process_2023
274,Regulation Of Heterotypic Cell-Cell Adhesion (GO:0034114),0.07122229964072589,5.103413654618474,13.482960195706973,0.4848551506912862,"IL1RN,FLOT2",GO_Biological_Process_2023
275,Acylglycerol Homeostasis (GO:0055090),0.07122229964072589,5.103413654618474,13.482960195706973,0.4848551506912862,"GCKR,APOE",GO_Biological_Process_2023
276,Carboxylic Acid Catabolic Process (GO:0046395),0.07122229964072589,5.103413654618474,13.482960195706973,0.4848551506912862,"MPST,TST",GO_Biological_Process_2023
277,Vasculature Development (GO:0001944),0.07122229964072589,5.103413654618474,13.482960195706973,0.4848551506912862,"PDGFRA,PIK3CA",GO_Biological_Process_2023
278,Lymphocyte Proliferation (GO:0046651),0.07122229964072589,5.103413654618474,13.482960195706973,0.4848551506912862,"MEF2C,PTPRC",GO_Biological_Process_2023
279,Negative Regulation Of Cyclin-Dependent Protein Kinase Activity (GO:1904030),0.07122229964072589,5.103413654618474,13.482960195706973,0.4848551506912862,"CEBPA,TFAP4",GO_Biological_Process_2023
280,Negative Regulation Of Vascular Associated Smooth Muscle Cell Proliferation (GO:1904706),0.07122229964072589,5.103413654618474,13.482960195706973,0.4848551506912862,"MEF2C,PPARG",GO_Biological_Process_2023
281,Placenta Development (GO:0001890),0.07122229964072589,5.103413654618474,13.482960195706973,0.4848551506912862,"TFEB,PPARG",GO_Biological_Process_2023
282,Platelet-Derived Growth Factor Receptor Signaling Pathway (GO:0048008),0.07122229964072589,5.103413654618474,13.482960195706973,0.4848551506912862,"PDGFRA,PTPN1",GO_Biological_Process_2023
283,Positive Regulation Of SMAD Protein Signal Transduction (GO:0060391),0.07122229964072589,5.103413654618474,13.482960195706973,0.4848551506912862,"PPARG,JAK2",GO_Biological_Process_2023
284,Positive Regulation Of Axon Extension (GO:0045773),0.07122229964072589,5.103413654618474,13.482960195706973,0.4848551506912862,"MACF1,MAPT",GO_Biological_Process_2023
285,Positive Regulation Of Signal Transduction By P53 Class Mediator (GO:1901798),0.07122229964072589,5.103413654618474,13.482960195706973,0.4848551506912862,"SPRED2,ATR",GO_Biological_Process_2023
286,Protein Insertion Into Mitochondrial Membrane (GO:0051204),0.07122229964072589,5.103413654618474,13.482960195706973,0.4848551506912862,"TOMM40,SAMM50",GO_Biological_Process_2023
287,Regulation Of AMPA Receptor Activity (GO:2000311),0.07122229964072589,5.103413654618474,13.482960195706973,0.4848551506912862,"MEF2C,CNIH4",GO_Biological_Process_2023
288,Cytoskeleton Organization (GO:0007010),0.0713033759494131,2.364507832592939,6.244219722447332,0.4848551506912862,"ARHGAP21,MAST3,MICAL1,MAST2,APOE",GO_Biological_Process_2023
289,Negative Regulation Of Inflammatory Response (GO:0050728),0.0713033759494131,2.364507832592939,6.244219722447332,0.4848551506912862,"MFHAS1,FNDC4,NLRP3,PPARG,APOE",GO_Biological_Process_2023
290,Regulation Of T Cell Proliferation (GO:0042129),0.07366493077681577,2.669828722002635,6.963523177361515,0.4848551506912862,"PTPRC,TFRC,DLG5,JAK2",GO_Biological_Process_2023
291,Cellular Response To Chemokine (GO:1990869),0.07427451545356177,3.285498489425982,8.542254613906618,0.4848551506912862,"DUSP1,SH2B3,RHOA",GO_Biological_Process_2023
292,Positive Regulation Of B Cell Activation (GO:0050871),0.07427451545356177,3.285498489425982,8.542254613906618,0.4848551506912862,"MEF2C,PTPRC,TFRC",GO_Biological_Process_2023
293,Regulation Of B Cell Proliferation (GO:0030888),0.07427451545356177,3.285498489425982,8.542254613906618,0.4848551506912862,"MEF2C,PTPRC,TFRC",GO_Biological_Process_2023
294,Positive Regulation Of Metabolic Process (GO:0009893),0.0748126900406105,2.328451690153818,6.037134462334783,0.4848551506912862,"HADHA,EPAS1,PRDM16,LEPR,JAK2",GO_Biological_Process_2023
295,Protein Transport (GO:0015031),0.07694427409233075,1.7339436815092246,4.446999986513043,0.4848551506912862,"MACF1,UNC119B,TFRC,SNX13,ARFIP1,PPARG,STX4,APOE,APOB,RAB8A",GO_Biological_Process_2023
296,Embryonic Organ Development (GO:0048568),0.07803166722629232,2.6127659574468085,6.664226784623739,0.4848551506912862,"KITLG,KIT,TFEB,SH2B3",GO_Biological_Process_2023
297,Regulation Of RNA Splicing (GO:0043484),0.07803166722629232,2.6127659574468085,6.664226784623739,0.4848551506912862,"RBM38,TRRAP,RBM23,QKI",GO_Biological_Process_2023
298,Regulation Of Transcription By RNA Polymerase II (GO:0006357),0.0780535793700938,1.2861234187375585,3.2800774304022915,0.4848551506912862,"KANK2,CEBPA,GTF2A1,THRB,EPAS1,TMPRSS6,TRRAP,CITED2,MAX,CEBPG,ZSCAN9,ETS2,HELZ2,ZMIZ2,PRDM16,MYB,ZKSCAN3,BEND3,NLRP3,ZKSCAN4,ZNF322,NKX2-3,BRD3,NFE2,MEF2C,KLF13,GADD45A,BCL11A,ZBTB38,TFEB,ZFP91,KLF3,ZFP90,ASXL1,AHI1,TOX2,ELF1,TFAP4,ZNF217,PPARG,ZSCAN26,CRLF3,ZNF410,MDFI",GO_Biological_Process_2023
299,Cellular Response To Starvation (GO:0009267),0.0784143340918938,2.293471850474073,5.838602604630274,0.4848551506912862,"HSPA8,NPRL3,TFEB,WIPI2,CPEB4",GO_Biological_Process_2023
300,Negative Regulation Of Defense Response (GO:0031348),0.0784143340918938,2.293471850474073,5.838602604630274,0.4848551506912862,"MFHAS1,FNDC4,NLRP3,PPARG,APOE",GO_Biological_Process_2023
301,Negative Regulation Of Apoptotic Process (GO:0043066),0.07889523994280723,1.5696105072463769,3.9862368124445915,0.4848551506912862,"MEF2C,TFRC,CITED2,AHI1,ARHGAP21,DSTYK,CCND2,PIK3CA,AXL,FIGNL1,IL2RB,TMBIM1,APOE,CPEB4",GO_Biological_Process_2023
302,Regulation Of Cyclin-Dependent Protein Kinase Activity (GO:1904029),0.08011208835267787,3.171892905510991,8.00689972545036,0.4848551506912862,"CCND3,CCND2,GADD45A",GO_Biological_Process_2023
303,Regulation Of p38MAPK Cascade (GO:1900744),0.08011208835267787,3.171892905510991,8.00689972545036,0.4848551506912862,"MFHAS1,DUSP1,GADD45A",GO_Biological_Process_2023
304,Positive Regulation Of miRNA Metabolic Process (GO:2000630),0.08011208835267787,3.171892905510991,8.00689972545036,0.4848551506912862,"TERT,MYB,PPARG",GO_Biological_Process_2023
305,Positive Regulation Of Tyrosine Phosphorylation Of STAT Protein (GO:0042531),0.08011208835267787,3.171892905510991,8.00689972545036,0.4848551506912862,"KIT,JAK2,IL6R",GO_Biological_Process_2023
306,Regulation Of Dendritic Spine Development (GO:0060998),0.08050468484980135,4.710379981464319,11.86751926644335,0.4848551506912862,"MEF2C,DLG5",GO_Biological_Process_2023
307,RNA Transport (GO:0050658),0.08050468484980135,4.710379981464319,11.86751926644335,0.4848551506912862,"TST,SIDT2",GO_Biological_Process_2023
308,Regulation Of Immunoglobulin Production (GO:0002637),0.08050468484980135,4.710379981464319,11.86751926644335,0.4848551506912862,"PTPRC,STX4",GO_Biological_Process_2023
309,Regulation Of Mitochondrial Fission (GO:0090140),0.08050468484980135,4.710379981464319,11.86751926644335,0.4848551506912862,"PPARG,MAPT",GO_Biological_Process_2023
310,Fatty Acid Derivative Biosynthetic Process (GO:1901570),0.08050468484980135,4.710379981464319,11.86751926644335,0.4848551506912862,"GCDH,HMGCL",GO_Biological_Process_2023
311,Positive Regulation Of Cyclin-Dependent Protein Kinase Activity (GO:1904031),0.08050468484980135,4.710379981464319,11.86751926644335,0.4848551506912862,"CCND3,CCND2",GO_Biological_Process_2023
312,Positive Regulation Of Monooxygenase Activity (GO:0032770),0.08050468484980135,4.710379981464319,11.86751926644335,0.4848551506912862,"TERT,APOE",GO_Biological_Process_2023
313,Positive Regulation Of Phospholipase Activity (GO:0010518),0.08050468484980135,4.710379981464319,11.86751926644335,0.4848551506912862,"PDGFRA,KIT",GO_Biological_Process_2023
314,Regulation Of Cell-Substrate Junction Assembly (GO:0090109),0.08050468484980135,4.710379981464319,11.86751926644335,0.4848551506912862,"MACF1,RHOA",GO_Biological_Process_2023
315,Regulation Of Fat Cell Differentiation (GO:0045598),0.08252496370555697,2.558080808080808,6.381527648423984,0.4848551506912862,"FTO,ASXL1,TAF8,PPARG",GO_Biological_Process_2023
316,Fat Cell Differentiation (GO:0045444),0.08252496370555697,2.558080808080808,6.381527648423984,0.4848551506912862,"CEBPA,PRDM16,SLC39A13,PPARG",GO_Biological_Process_2023
317,Gene Expression (GO:0010467),0.08544873167344505,1.8255850942967506,4.490644887803608,0.4848551506912862,"HBS1L,RPS28,GALNT2,PABPC4,EXOSC9,NLRP3,ADAR,LMF2",GO_Biological_Process_2023
318,Regulation Of Double-Strand Break Repair Via Homologous Recombination (GO:0010569),0.08614216815905654,3.065861027190332,7.516743872182359,0.4848551506912862,"RTEL1,TRRAP,FIGNL1",GO_Biological_Process_2023
319,Gonad Development (GO:0008406),0.08614216815905654,3.065861027190332,7.516743872182359,0.4848551506912862,"KITLG,NCOA4,KIT",GO_Biological_Process_2023
320,Negative Regulation Of Protein-Containing Complex Assembly (GO:0031333),0.08614216815905654,3.065861027190332,7.516743872182359,0.4848551506912862,"HSPA8,ZNF827,TMC8",GO_Biological_Process_2023
321,Positive Regulation Of Endocytosis (GO:0045807),0.08714292340085301,2.5056277056277056,6.1142470357417364,0.4848551506912862,"AXL,HFE,IL2RB,APOE",GO_Biological_Process_2023
322,Cellular Response To Organonitrogen Compound (GO:0071417),0.08976638828382552,2.1945288753799392,5.290009881558194,0.4848551506912862,"MEF2C,LARP1,CDH1,LAMTOR4,CPEB4",GO_Biological_Process_2023
323,ATP Metabolic Process (GO:0046034),0.09013554473473162,4.373493975903615,10.524553856726516,0.4848551506912862,"HSPA8,FIGNL1",GO_Biological_Process_2023
324,Telomere Maintenance Via Telomere Lengthening (GO:0010833),0.09013554473473162,4.373493975903615,10.524553856726516,0.4848551506912862,"RAD50,TERT",GO_Biological_Process_2023
325,Negative Regulation Of Protein Transport (GO:0051224),0.09013554473473162,4.373493975903615,10.524553856726516,0.4848551506912862,"NDFIP1,APOE",GO_Biological_Process_2023
326,Positive Regulation Of Chromosome Organization (GO:2001252),0.09013554473473162,4.373493975903615,10.524553856726516,0.4848551506912862,"RTEL1,RAD50",GO_Biological_Process_2023
327,Cellular Component Assembly (GO:0022607),0.09083930058184314,1.7985759706237965,4.314178103258706,0.4848551506912862,"RP1L1,TFAP4,MICAL1,HFE,IL2RB,TLCD1,RHOA,PLS1",GO_Biological_Process_2023
328,Regulation Of Cold-Induced Thermogenesis (GO:0120161),0.09154103127020842,2.005434782608696,4.794930347249706,0.4848551506912862,"HADHA,EPAS1,PRDM16,DOCK7,LEPR,JAK2",GO_Biological_Process_2023
329,Negative Regulation Of Neuron Death (GO:1901215),0.09188351396770704,2.4552727272727273,5.861309690938717,0.4848551506912862,"MEF2C,APOE,FBXO7,CPEB4",GO_Biological_Process_2023
330,Regulation Of Mitotic Sister Chromatid Segregation (GO:0033047),0.09233130434472851,15.27927927927928,36.400927689928544,0.4848551506912862,DUSP1,GO_Biological_Process_2023
331,Regulation Of Mitotic Spindle Checkpoint (GO:1903504),0.09233130434472851,15.27927927927928,36.400927689928544,0.4848551506912862,DUSP1,GO_Biological_Process_2023
332,Cellular Response To Bacterial Lipopeptide (GO:0071221),0.09233130434472851,15.27927927927928,36.400927689928544,0.4848551506912862,TLR1,GO_Biological_Process_2023
333,Regulation Of Transmission Of Nerve Impulse (GO:0051969),0.09233130434472851,15.27927927927928,36.400927689928544,0.4848551506912862,TYMP,GO_Biological_Process_2023
334,Regulation Of Type 2 Immune Response (GO:0002828),0.09233130434472851,15.27927927927928,36.400927689928544,0.4848551506912862,NLRP3,GO_Biological_Process_2023
335,Cholesterol Catabolic Process (GO:0006707),0.09233130434472851,15.27927927927928,36.400927689928544,0.4848551506912862,APOE,GO_Biological_Process_2023
336,Determination Of Digestive Tract Left/Right Asymmetry (GO:0071907),0.09233130434472851,15.27927927927928,36.400927689928544,0.4848551506912862,NPHP3,GO_Biological_Process_2023
337,Determination Of Liver Left/Right Asymmetry (GO:0071910),0.09233130434472851,15.27927927927928,36.400927689928544,0.4848551506912862,NPHP3,GO_Biological_Process_2023
338,Sterol Catabolic Process (GO:0016127),0.09233130434472851,15.27927927927928,36.400927689928544,0.4848551506912862,APOE,GO_Biological_Process_2023
339,Telomeric Loop Disassembly (GO:0090657),0.09233130434472851,15.27927927927928,36.400927689928544,0.4848551506912862,RTEL1,GO_Biological_Process_2023
340,Transferrin Transport (GO:0033572),0.09233130434472851,15.27927927927928,36.400927689928544,0.4848551506912862,TFRC,GO_Biological_Process_2023
341,Glycolipid Transport (GO:0046836),0.09233130434472851,15.27927927927928,36.400927689928544,0.4848551506912862,PLTP,GO_Biological_Process_2023
342,Urea Cycle (GO:0000050),0.09233130434472851,15.27927927927928,36.400927689928544,0.4848551506912862,SLC25A15,GO_Biological_Process_2023
343,Negative Regulation Of Acute Inflammatory Response (GO:0002674),0.09233130434472851,15.27927927927928,36.400927689928544,0.4848551506912862,NLRP3,GO_Biological_Process_2023
344,Negative Regulation Of Sequestering Of Triglyceride (GO:0010891),0.09233130434472851,15.27927927927928,36.400927689928544,0.4848551506912862,PPARG,GO_Biological_Process_2023
345,Negative Regulation Of Toll-Like Receptor 2 Signaling Pathway (GO:0034136),0.09233130434472851,15.27927927927928,36.400927689928544,0.4848551506912862,MFHAS1,GO_Biological_Process_2023
346,Nucleic Acid Transport (GO:0050657),0.09233130434472851,15.27927927927928,36.400927689928544,0.4848551506912862,SIDT2,GO_Biological_Process_2023
347,Nucleolar Chromatin Organization (GO:1990700),0.09233130434472851,15.27927927927928,36.400927689928544,0.4848551506912862,BEND3,GO_Biological_Process_2023
348,Photoreceptor Cell Differentiation (GO:0046530),0.09233130434472851,15.27927927927928,36.400927689928544,0.4848551506912862,RP1L1,GO_Biological_Process_2023
349,Podocyte Cell Migration (GO:0090521),0.09233130434472851,15.27927927927928,36.400927689928544,0.4848551506912862,KANK2,GO_Biological_Process_2023
350,Positive Regulation Of Cardiac Muscle Cell Differentiation (GO:2000727),0.09233130434472851,15.27927927927928,36.400927689928544,0.4848551506912862,MEF2C,GO_Biological_Process_2023
351,Positive Regulation Of Receptor Binding (GO:1900122),0.09233130434472851,15.27927927927928,36.400927689928544,0.4848551506912862,HFE,GO_Biological_Process_2023
352,Positive Regulation Of Skeletal Muscle Tissue Development (GO:0048643),0.09233130434472851,15.27927927927928,36.400927689928544,0.4848551506912862,MEF2C,GO_Biological_Process_2023
353,Protein Localization To Membrane Raft (GO:1903044),0.09233130434472851,15.27927927927928,36.400927689928544,0.4848551506912862,FLOT2,GO_Biological_Process_2023
354,Protein Targeting To Vacuole Involved In Autophagy (GO:0071211),0.09233130434472851,15.27927927927928,36.400927689928544,0.4848551506912862,HSPA8,GO_Biological_Process_2023
355,Proton-Transporting V-type ATPase Complex Assembly (GO:0070070),0.09233130434472851,15.27927927927928,36.400927689928544,0.4848551506912862,TM9SF4,GO_Biological_Process_2023
356,Negative Regulation Of Response To Stimulus (GO:0048585),0.09235852547404205,2.9666699152129423,7.066836941790966,0.4848551506912862,"PTPN1,RTEL1,SH2B3",GO_Biological_Process_2023
357,Cellular Response To Lipopolysaccharide (GO:0071222),0.09373009209587024,2.163405967721221,5.1215088033019605,0.4848551506912862,"MEF2C,IL37,AXL,NLRP3,RHOA",GO_Biological_Process_2023
358,Peptidyl-Lysine Modification (GO:0018205),0.09674457554585714,2.4068924539512775,5.621733010691669,0.4848551506912862,"BCL11A,ZMIZ2,NSMCE2,SIRT3",GO_Biological_Process_2023
359,Macromolecule Biosynthetic Process (GO:0009059),0.09778210216435339,2.133147585275245,4.959597409254698,0.4848551506912862,"HBS1L,RPS28,TERT,PABPC4,APOE",GO_Biological_Process_2023
360,Regulation Of Cellular Senescence (GO:2000772),0.10008351964589496,4.08152610441767,9.394653711297185,0.4848551506912862,"TERT,ZKSCAN3",GO_Biological_Process_2023
361,RNA Stabilization (GO:0043489),0.10008351964589496,4.08152610441767,9.394653711297185,0.4848551506912862,"RBM38,LARP1",GO_Biological_Process_2023
362,Cellular Response To Acid Chemical (GO:0071229),0.10008351964589496,4.08152610441767,9.394653711297185,0.4848551506912862,"LAMTOR4,CPEB4",GO_Biological_Process_2023
363,Cellular Response To Steroid Hormone Stimulus (GO:0071383),0.10008351964589496,4.08152610441767,9.394653711297185,0.4848551506912862,"HSPA8,UBE2L3",GO_Biological_Process_2023
364,Response To Amino Acid (GO:0043200),0.10008351964589496,4.08152610441767,9.394653711297185,0.4848551506912862,"LAMTOR4,CPEB4",GO_Biological_Process_2023
365,Determination Of Left/Right Symmetry (GO:0007368),0.10008351964589496,4.08152610441767,9.394653711297185,0.4848551506912862,"CITED2,NPHP3",GO_Biological_Process_2023
366,Sulfur Compound Catabolic Process (GO:0044273),0.10008351964589496,4.08152610441767,9.394653711297185,0.4848551506912862,"MPST,TST",GO_Biological_Process_2023
367,Transition Metal Ion Transport (GO:0000041),0.10008351964589496,4.08152610441767,9.394653711297185,0.4848551506912862,"TFRC,SLC39A13",GO_Biological_Process_2023
368,Heart Looping (GO:0001947),0.10008351964589496,4.08152610441767,9.394653711297185,0.4848551506912862,"MEF2C,NPHP3",GO_Biological_Process_2023
369,Lipid Translocation (GO:0034204),0.10008351964589496,4.08152610441767,9.394653711297185,0.4848551506912862,"ATP11B,ATP11A",GO_Biological_Process_2023
370,Negative Regulation Of mRNA Catabolic Process (GO:1902373),0.10008351964589496,4.08152610441767,9.394653711297185,0.4848551506912862,"RBM38,LARP1",GO_Biological_Process_2023
371,Positive Regulation Of Release Of Cytochrome C From Mitochondria (GO:0090200),0.10008351964589496,4.08152610441767,9.394653711297185,0.4848551506912862,"BCL2L11,PDCD5",GO_Biological_Process_2023
372,Protein Targeting To Lysosome (GO:0006622),0.10008351964589496,4.08152610441767,9.394653711297185,0.4848551506912862,"HSPA8,NCOA4",GO_Biological_Process_2023
373,Regulation Of Protein Localization (GO:0032880),0.10172382864973903,2.36037296037296,5.394617530657723,0.4848551506912862,"KIAA0586,HFE,MAPT,TRIM38",GO_Biological_Process_2023
374,"mRNA Splicing, Via Spliceosome (GO:0000398)",0.10211444155579133,1.941527599486521,4.429908034447698,0.4848551506912862,"HSPA8,USP49,WBP4,RSRP1,SNIP1,BUD13",GO_Biological_Process_2023
375,Regulation Of Inflammatory Response (GO:0050727),0.10219625352971619,1.7468563721011183,3.9843352792391085,0.4848551506912862,"MFHAS1,CEBPA,FNDC4,IL37,NLRP3,PPARG,APOE,JAK2",GO_Biological_Process_2023
376,Cilium Assembly (GO:0060271),0.10310464717528052,1.8250142538744623,4.146452121474241,0.4848551506912862,"RP1L1,UNC119B,AHI1,DNMBP,KIAA0586,NPHP3,RAB8A",GO_Biological_Process_2023
377,DNA Damage Response (GO:0006974),0.10495903421553801,1.6224821312540612,3.657375134982012,0.4848551506912862,"RAD50,RTEL1,RRM1,BCL2L11,GADD45A,TRRAP,ZBTB38,MAPT,ATR,DDB2",GO_Biological_Process_2023
378,Cellular Response To Lipid (GO:0071396),0.10515449404856755,1.734381750626458,3.9063907492240606,0.4848551506912862,"HSPA8,MEF2C,IL37,AXL,NCOA4,NLRP3,RHOA,UBE2L3",GO_Biological_Process_2023
379,Ribosomal Small Subunit Biogenesis (GO:0042274),0.10532431745183514,2.786322438890415,6.271206427727801,0.4848551506912862,"RCL1,NOP58,RPS28",GO_Biological_Process_2023
380,Negative Regulation Of Supramolecular Fiber Organization (GO:1902904),0.10532431745183514,2.786322438890415,6.271206427727801,0.4848551506912862,"HSPA8,PIK3CA,APOE",GO_Biological_Process_2023
381,Positive Regulation Of Mitochondrion Organization (GO:0010822),0.10532431745183514,2.786322438890415,6.271206427727801,0.4848551506912862,"BCL2L11,PDCD5,FBXO7",GO_Biological_Process_2023
382,Negative Regulation Of Gene Expression (GO:0010629),0.10752933929707896,1.6138258677525694,3.5988180401220244,0.4848551506912862,"MEF2C,LARP1,NDFIP1,TERT,CITED2,FLOT2,PPARG,MAPT,APOE,ZNF410",GO_Biological_Process_2023
383,DNA Geometric Change (GO:0032392),0.11031888038918752,3.82605421686747,8.434078137999961,0.4848551506912862,"RTEL1,RAD50",GO_Biological_Process_2023
384,Regulation Of Long-Term Synaptic Potentiation (GO:1900271),0.11031888038918752,3.82605421686747,8.434078137999961,0.4848551506912862,"SCGN,APOE",GO_Biological_Process_2023
385,Regulation Of Nitric-Oxide Synthase Activity (GO:0050999),0.11031888038918752,3.82605421686747,8.434078137999961,0.4848551506912862,"TERT,APOE",GO_Biological_Process_2023
386,Cellular Response To Interleukin-6 (GO:0071354),0.11031888038918752,3.82605421686747,8.434078137999961,0.4848551506912862,"JAK2,IL6R",GO_Biological_Process_2023
387,Determination Of Heart Left/Right Asymmetry (GO:0061371),0.11031888038918752,3.82605421686747,8.434078137999961,0.4848551506912862,"MEF2C,NPHP3",GO_Biological_Process_2023
388,Histone H4 Acetylation (GO:0043967),0.11031888038918752,3.82605421686747,8.434078137999961,0.4848551506912862,"KANSL1,TRRAP",GO_Biological_Process_2023
389,Late Endosome To Vacuole Transport Via Multivesicular Body Sorting Pathway (GO:0032511),0.11031888038918752,3.82605421686747,8.434078137999961,0.4848551506912862,"LEPROT,TMEM50B",GO_Biological_Process_2023
390,Morphogenesis Of An Epithelium (GO:0002009),0.11031888038918752,3.82605421686747,8.434078137999961,0.4848551506912862,"AHI1,NPHP3",GO_Biological_Process_2023
391,Negative Regulation Of G1/S Transition Of Mitotic Cell Cycle (GO:2000134),0.11031888038918752,3.82605421686747,8.434078137999961,0.4848551506912862,"KANK2,CRLF3",GO_Biological_Process_2023
392,Nucleic Acid Metabolic Process (GO:0090304),0.11031888038918752,3.82605421686747,8.434078137999961,0.4848551506912862,"RAD50,DNASE2",GO_Biological_Process_2023
393,Positive Regulation Of Phosphatidylinositol 3-Kinase Activity (GO:0043552),0.11031888038918752,3.82605421686747,8.434078137999961,0.4848551506912862,"PDGFRA,KIT",GO_Biological_Process_2023
394,Purine Ribonucleoside Triphosphate Metabolic Process (GO:0009205),0.11031888038918752,3.82605421686747,8.434078137999961,0.4848551506912862,"HSPA8,FIGNL1",GO_Biological_Process_2023
395,Regulation Of T Cell Mediated Cytotoxicity (GO:0001914),0.11031888038918752,3.82605421686747,8.434078137999961,0.4848551506912862,"PTPRC,HFE",GO_Biological_Process_2023
396,Regulation Of Proteasomal Ubiquitin-Dependent Protein Catabolic Process (GO:0032434),0.11202724044647587,2.272502805836139,4.974538682161959,0.4848551506912862,"CEBPA,HFE,ARIH2,TRIB1",GO_Biological_Process_2023
397,Regulation Of mRNA Stability (GO:0043488),0.11206054043565694,2.7041052070374976,5.918518370513306,0.4848551506912862,"FTO,RBM38,LARP1",GO_Biological_Process_2023
398,Positive Regulation Of Transcription By RNA Polymerase II (GO:0045944),0.1188377474997482,1.3271692254614456,2.826865383930725,0.4848551506912862,"CEBPA,GTF2A1,MEF2C,THRB,EPAS1,TMPRSS6,CITED2,MAX,ZBTB38,CEBPG,TFEB,ETS2,HELZ2,ASXL1,AHI1,TOX2,ELF1,ZMIZ2,MYB,TAF8,NLRP3,PPARG,CRLF3,ZNF410",GO_Biological_Process_2023
399,Response To Reactive Oxygen Species (GO:0000302),0.11895666942785178,2.6265861027190334,5.591991239719249,0.4848551506912862,"PDGFRA,MAPT,APOE",GO_Biological_Process_2023
400,Sterol Metabolic Process (GO:0016125),0.11895666942785178,2.6265861027190334,5.591991239719249,0.4848551506912862,"FAXDC2,APOE,APOB",GO_Biological_Process_2023
401,Fatty Acid Beta-Oxidation (GO:0006635),0.11895666942785178,2.6265861027190334,5.591991239719249,0.4848551506912862,"HADHA,GCDH,ACOXL",GO_Biological_Process_2023
402,Negative Regulation Of ERK1 And ERK2 Cascade (GO:0070373),0.11895666942785178,2.6265861027190334,5.591991239719249,0.4848551506912862,"SPRED2,PTPN1,PTPRC",GO_Biological_Process_2023
403,Positive Regulation Of Mitotic Cell Cycle Phase Transition (GO:1901992),0.11895666942785178,2.6265861027190334,5.591991239719249,0.4848551506912862,"RRM1,CCND2,NSMCE2",GO_Biological_Process_2023
404,Regulation Of Chemotaxis (GO:0050920),0.12081345678782915,3.6006378454996457,7.6099754600801,0.4848551506912862,"PDGFRA,STX4",GO_Biological_Process_2023
405,DNA-templated DNA Replication Maintenance Of Fidelity (GO:0045005),0.12081345678782915,3.6006378454996457,7.6099754600801,0.4848551506912862,"RTEL1,ATR",GO_Biological_Process_2023
406,Regulation Of mRNA Processing (GO:0050684),0.12081345678782915,3.6006378454996457,7.6099754600801,0.4848551506912862,"RBM23,QKI",GO_Biological_Process_2023
407,Carbohydrate Derivative Biosynthetic Process (GO:1901137),0.12081345678782915,3.6006378454996457,7.6099754600801,0.4848551506912862,"GK5,RRM1",GO_Biological_Process_2023
408,Triglyceride Homeostasis (GO:0070328),0.12081345678782915,3.6006378454996457,7.6099754600801,0.4848551506912862,"GCKR,APOE",GO_Biological_Process_2023
409,Phospholipid Catabolic Process (GO:0009395),0.12081345678782915,3.6006378454996457,7.6099754600801,0.4848551506912862,"SMPD2,PLD1",GO_Biological_Process_2023
410,Positive Regulation Of Lipid Metabolic Process (GO:0045834),0.12081345678782915,3.6006378454996457,7.6099754600801,0.4848551506912862,"HSD17B13,APOE",GO_Biological_Process_2023
411,Regulation Of SMAD Protein Signal Transduction (GO:0060390),0.12081345678782915,3.6006378454996457,7.6099754600801,0.4848551506912862,"PPARG,JAK2",GO_Biological_Process_2023
412,DNA Strand Resection Involved In Replication Fork Processing (GO:0110025),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,RAD50,GO_Biological_Process_2023
413,Regulation Of Dosage Compensation By Inactivation Of X Chromosome (GO:1900095),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,KANSL1,GO_Biological_Process_2023
414,Regulation Of Establishment Of T Cell Polarity (GO:1903903),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,FLOT2,GO_Biological_Process_2023
415,Regulation Of Hemoglobin Biosynthetic Process (GO:0046984),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,SLC25A37,GO_Biological_Process_2023
416,U4 snRNA 3'-End Processing (GO:0034475),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,EXOSC9,GO_Biological_Process_2023
417,Activation Of Transmembrane Receptor Protein Tyrosine Kinase Activity (GO:0007171),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,PILRB,GO_Biological_Process_2023
418,Adenosine To Inosine Editing (GO:0006382),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,ADAR,GO_Biological_Process_2023
419,Regulation Of Macrophage Apoptotic Process (GO:2000109),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,MEF2C,GO_Biological_Process_2023
420,Amino-Acid Betaine Metabolic Process (GO:0006577),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,CPT1B,GO_Biological_Process_2023
421,Regulation Of Microvillus Organization (GO:0032530),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,PLD1,GO_Biological_Process_2023
422,Apoptotic DNA Fragmentation (GO:0006309),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,DNASE2,GO_Biological_Process_2023
423,Cardiac Atrium Development (GO:0003230),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,NPHP3,GO_Biological_Process_2023
424,Regulation Of Protein Localization To Nucleolus (GO:1904749),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,TERT,GO_Biological_Process_2023
425,Cellular Biogenic Amine Catabolic Process (GO:0042402),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,SMOX,GO_Biological_Process_2023
426,Cellular Response To Iron Ion (GO:0071281),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,HFE,GO_Biological_Process_2023
427,Regulation Of Toll-Like Receptor 3 Signaling Pathway (GO:0034139),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,FLOT2,GO_Biological_Process_2023
428,Regulation Of Transforming Growth Factor Beta1 Production (GO:0032908),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,LAPTM4B,GO_Biological_Process_2023
429,Regulation Of Viral-Induced Cytoplasmic Pattern Recognition Receptor Signaling Pathway (GO:0039531),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,FLOT2,GO_Biological_Process_2023
430,Regulation Of Vitamin D Receptor Signaling Pathway (GO:0070562),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,KANK2,GO_Biological_Process_2023
431,Clathrin Coat Disassembly (GO:0072318),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,HSPA8,GO_Biological_Process_2023
432,Cristae Formation (GO:0042407),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,SAMM50,GO_Biological_Process_2023
433,Response To Lithium Ion (GO:0010226),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,CDH1,GO_Biological_Process_2023
434,Response To Testosterone (GO:0033574),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,NCOA4,GO_Biological_Process_2023
435,siRNA Processing (GO:0030422),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,TERT,GO_Biological_Process_2023
436,snoRNA Localization (GO:0048254),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,NOP58,GO_Biological_Process_2023
437,Sphingomyelin Metabolic Process (GO:0006684),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,SMPD2,GO_Biological_Process_2023
438,Epithelial Cilium Movement Involved In Determination Of Left/Right Asymmetry (GO:0060287),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,NPHP3,GO_Biological_Process_2023
439,Telomere Maintenance In Response To DNA Damage (GO:0043247),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,RTEL1,GO_Biological_Process_2023
440,Gamma-Aminobutyric Acid Metabolic Process (GO:0009448),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,ALDH5A1,GO_Biological_Process_2023
441,Glycerol-3-Phosphate Metabolic Process (GO:0006072),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,GK5,GO_Biological_Process_2023
442,Very-Low-Density Lipoprotein Particle Remodeling (GO:0034372),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,APOE,GO_Biological_Process_2023
443,Hemostasis (GO:0007599),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,NFE2,GO_Biological_Process_2023
444,High-Density Lipoprotein Particle Assembly (GO:0034380),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,APOE,GO_Biological_Process_2023
445,Histone H4-K16 Acetylation (GO:0043984),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,KANSL1,GO_Biological_Process_2023
446,Interleukin-3-Mediated Signaling Pathway (GO:0038156),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,JAK2,GO_Biological_Process_2023
447,Interleukin-5-Mediated Signaling Pathway (GO:0038043),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,JAK2,GO_Biological_Process_2023
448,Ketone Body Biosynthetic Process (GO:0046951),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,HMGCL,GO_Biological_Process_2023
449,Kidney Morphogenesis (GO:0060993),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,NPHP3,GO_Biological_Process_2023
450,Lipoprotein Metabolic Process (GO:0042157),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,APOE,GO_Biological_Process_2023
451,Methionine Metabolic Process (GO:0006555),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,MSRA,GO_Biological_Process_2023
452,"Negative Regulation Of CD4-positive, Alpha-Beta T Cell Proliferation (GO:2000562)",0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,LGALS9B,GO_Biological_Process_2023
453,"Negative Regulation Of CD8-positive, Alpha-Beta T Cell Activation (GO:2001186)",0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,HFE,GO_Biological_Process_2023
454,Negative Regulation Of NLRP3 Inflammasome Complex Assembly (GO:1900226),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,HSPA8,GO_Biological_Process_2023
455,Negative Regulation Of Actin Filament Depolymerization (GO:0030835),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,PIK3CA,GO_Biological_Process_2023
456,Negative Regulation Of Alpha-Beta T Cell Proliferation (GO:0046642),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,LGALS9B,GO_Biological_Process_2023
457,Negative Regulation Of Chemokine-Mediated Signaling Pathway (GO:0070100),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,SH2B3,GO_Biological_Process_2023
458,Negative Regulation Of Establishment Of Protein Localization To Mitochondrion (GO:1903748),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,MAPT,GO_Biological_Process_2023
459,Negative Regulation Of Lens Fiber Cell Differentiation (GO:1902747),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,SPRED2,GO_Biological_Process_2023
460,Negative Regulation Of Lipopolysaccharide-Mediated Signaling Pathway (GO:0031665),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,TRIB1,GO_Biological_Process_2023
461,Negative Regulation Of Microglial Cell Activation (GO:1903979),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,PTPRC,GO_Biological_Process_2023
462,Negative Regulation Of Mitochondrial Fusion (GO:0010637),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,TFRC,GO_Biological_Process_2023
463,Negative Regulation Of Monocyte Chemotaxis (GO:0090027),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,DUSP1,GO_Biological_Process_2023
464,Negative Regulation Of p38MAPK Cascade (GO:1903753),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,DUSP1,GO_Biological_Process_2023
465,Negative Regulation Of Response To Type II Interferon (GO:0060331),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,PPARG,GO_Biological_Process_2023
466,Negative Regulation Of Type II Interferon-Mediated Signaling Pathway (GO:0060336),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,PPARG,GO_Biological_Process_2023
467,Neurotransmitter Receptor Transport To Postsynaptic Membrane (GO:0098969),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,RAB8A,GO_Biological_Process_2023
468,"Nuclear-Transcribed mRNA Catabolic Process, Exonucleolytic, 3'-5' (GO:0034427)",0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,EXOSC9,GO_Biological_Process_2023
469,Ornithine Transport (GO:0015822),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,SLC7A6,GO_Biological_Process_2023
470,Plus-End-Directed Organelle Transport Along Microtubule (GO:0072386),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,MAPT,GO_Biological_Process_2023
471,Polyamine Metabolic Process (GO:0006595),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,SMOX,GO_Biological_Process_2023
472,Positive Regulation By Symbiont Of Entry Into Host (GO:0075294),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,TRIM38,GO_Biological_Process_2023
473,Positive Regulation Of NK T Cell Proliferation (GO:0051142),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,JAK2,GO_Biological_Process_2023
474,Positive Regulation Of Activation Of Janus Kinase Activity (GO:0010536),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,IL6R,GO_Biological_Process_2023
475,Positive Regulation Of Cysteine-Type Endopeptidase Activity Involved In Apoptotic Signaling Pathway (GO:2001269),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,JAK2,GO_Biological_Process_2023
476,Positive Regulation Of Hemoglobin Biosynthetic Process (GO:0046985),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,SLC25A37,GO_Biological_Process_2023
477,Positive Regulation Of Mitochondrial Membrane Permeability Involved In Apoptotic Process (GO:1902110),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,BLOC1S2,GO_Biological_Process_2023
478,Positive Regulation Of Peptide Secretion (GO:0002793),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,HFE,GO_Biological_Process_2023
479,Positive Regulation Of Peroxisome Proliferator Activated Receptor Signaling Pathway (GO:0035360),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,CITED2,GO_Biological_Process_2023
480,Positive Regulation Of Steroid Metabolic Process (GO:0045940),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,APOE,GO_Biological_Process_2023
481,Positive Regulation Of Viral Entry Into Host Cell (GO:0046598),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,TRIM38,GO_Biological_Process_2023
482,Protein Repair (GO:0030091),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,MSRA,GO_Biological_Process_2023
483,Pyrimidine-Containing Compound Metabolic Process (GO:0072527),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,TYMP,GO_Biological_Process_2023
484,Regulation Of NK T Cell Proliferation (GO:0051140),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,JAK2,GO_Biological_Process_2023
485,Regulation Of Adiponectin Secretion (GO:0070163),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,PPARG,GO_Biological_Process_2023
486,Regulation Of Antigen Receptor-Mediated Signaling Pathway (GO:0050854),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,PTPRC,GO_Biological_Process_2023
487,Regulation Of Blood Vessel Remodeling (GO:0060312),0.12117904111215834,10.185185185185185,21.49569225240779,0.4848551506912862,TMBIM1,GO_Biological_Process_2023
488,Negative Regulation Of Transcription By RNA Polymerase II (GO:0000122),0.12133592404576442,1.3852257698847534,2.9217075943924375,0.4848551506912862,"KANK2,CEBPA,MEF2C,THRB,GADD45A,TMPRSS6,BCL11A,CITED2,MAX,ZFP90,ETS2,PRDM16,MYB,ZKSCAN3,BEND3,ZNF217,PPARG,MDFI",GO_Biological_Process_2023
489,Protein Catabolic Process (GO:0030163),0.12277341585362123,2.190909090909091,4.595245086959867,0.4848551506912862,"HSPA8,LONP1,APOE,CTSB",GO_Biological_Process_2023
490,Regulation Of G1/S Transition Of Mitotic Cell Cycle (GO:2000045),0.12277341585362123,2.190909090909091,4.595245086959867,0.4848551506912862,"KANK2,RRM1,CCND2,CRLF3",GO_Biological_Process_2023
491,Regulation Of Pathway-Restricted SMAD Protein Phosphorylation (GO:0060393),0.12600587797138024,2.5533736153071502,5.289126339407087,0.4848551506912862,"HFE,BMP8A,PPARG",GO_Biological_Process_2023
492,Negative Regulation Of Autophagy (GO:0010507),0.12600587797138024,2.5533736153071502,5.289126339407087,0.4848551506912862,"PIK3CA,LEPR,ZKSCAN3",GO_Biological_Process_2023
493,Positive Regulation Of Type II Interferon Production (GO:0032729),0.12600587797138024,2.5533736153071502,5.289126339407087,0.4848551506912862,"CEBPG,BTN3A2,JAK2",GO_Biological_Process_2023
494,Regulation Of MAPK Cascade (GO:0043408),0.13084195913808852,1.707781175671084,3.4732257584406563,0.4848551506912862,"SPRED2,DOK2,MAP2K2,PTPRC,DUSP1,KIT,VRK2",GO_Biological_Process_2023
495,Regulation Of Platelet Aggregation (GO:0090330),0.1315405690685488,3.4002677376171353,6.897238970399704,0.4848551506912862,"JAK2,SH2B3",GO_Biological_Process_2023
496,Regulation Of Primary Metabolic Process (GO:0080090),0.1315405690685488,3.4002677376171353,6.897238970399704,0.4848551506912862,"PPARG,APOE",GO_Biological_Process_2023
497,Cellular Response To Amino Acid Stimulus (GO:0071230),0.1315405690685488,3.4002677376171353,6.897238970399704,0.4848551506912862,"LAMTOR4,CPEB4",GO_Biological_Process_2023
498,Response To Steroid Hormone (GO:0048545),0.1315405690685488,3.4002677376171353,6.897238970399704,0.4848551506912862,"HSPA8,UBE2L3",GO_Biological_Process_2023
499,mRNA Stabilization (GO:0048255),0.1315405690685488,3.4002677376171353,6.897238970399704,0.4848551506912862,"RBM38,LARP1",GO_Biological_Process_2023
500,Mitochondrion Disassembly (GO:0061726),0.1315405690685488,3.4002677376171353,6.897238970399704,0.4848551506912862,"WIPI2,FBXO7",GO_Biological_Process_2023
501,Modified Amino Acid Transport (GO:0072337),0.1315405690685488,3.4002677376171353,6.897238970399704,0.4848551506912862,"SLC25A15,SLC7A6",GO_Biological_Process_2023
502,Natural Killer Cell Activation (GO:0030101),0.1315405690685488,3.4002677376171353,6.897238970399704,0.4848551506912862,"PTPRC,IL2RB",GO_Biological_Process_2023
503,Negative Regulation Of DNA Metabolic Process (GO:0051053),0.1315405690685488,3.4002677376171353,6.897238970399704,0.4848551506912862,"RTEL1,ATR",GO_Biological_Process_2023
504,Negative Regulation Of Cell Cycle G1/S Phase Transition (GO:1902807),0.1315405690685488,3.4002677376171353,6.897238970399704,0.4848551506912862,"KANK2,CRLF3",GO_Biological_Process_2023
505,Negative Regulation Of Peptidyl-Tyrosine Phosphorylation (GO:0050732),0.1315405690685488,3.4002677376171353,6.897238970399704,0.4848551506912862,"PTPRC,SH2B3",GO_Biological_Process_2023
506,Negative Regulation Of Signaling Receptor Activity (GO:2000272),0.1315405690685488,3.4002677376171353,6.897238970399704,0.4848551506912862,"HFE,PPARG",GO_Biological_Process_2023
507,Peptidyl-Tyrosine Dephosphorylation (GO:0035335),0.1315405690685488,3.4002677376171353,6.897238970399704,0.4848551506912862,"PTPN1,DUSP1",GO_Biological_Process_2023
508,Positive Regulation Of G1/S Transition Of Mitotic Cell Cycle (GO:1900087),0.1315405690685488,3.4002677376171353,6.897238970399704,0.4848551506912862,"RRM1,CCND2",GO_Biological_Process_2023
509,Actin Cytoskeleton Reorganization (GO:0031532),0.13320129173871514,2.4841185596472606,5.007719260451559,0.4848551506912862,"PTPN1,KIT,RHOA",GO_Biological_Process_2023
510,Regulation Of miRNA Transcription (GO:1902893),0.13320129173871514,2.4841185596472606,5.007719260451559,0.4848551506912862,"TERT,MYB,PPARG",GO_Biological_Process_2023
511,"RNA Splicing, Via Transesterification Reactions With Bulged Adenosine As Nucleophile (GO:0000377)",0.13323939484694647,1.9183130699088147,3.866566800926283,0.4848551506912862,"HSPA8,USP49,WBP4,SNIP1,BUD13",GO_Biological_Process_2023
512,Regulation Of Peptidyl-Tyrosine Phosphorylation (GO:0050730),0.1339405946825831,2.1149425287356323,4.251793536884953,0.4848551506912862,"PTPRC,TNK2,JAK2,IL6R",GO_Biological_Process_2023
513,Positive Regulation Of T Cell Activation (GO:0050870),0.1339405946825831,2.1149425287356323,4.251793536884953,0.4848551506912862,"PTPRC,TFRC,FLOT2,JAK2",GO_Biological_Process_2023
514,Cellular Response To Organic Cyclic Compound (GO:0071407),0.1374321411679599,1.7719277673545966,3.516612149670679,0.4848551506912862,"HSPA8,MEF2C,LARP1,CDH1,NCOA4,UBE2L3",GO_Biological_Process_2023
515,Extrinsic Apoptotic Signaling Pathway (GO:0097191),0.14053600842899536,2.418508506916839,4.745818771158417,0.4848551506912862,"BLOC1S2,JAK2,IL6R",GO_Biological_Process_2023
516,Macromolecule Catabolic Process (GO:0009057),0.14053600842899536,2.418508506916839,4.745818771158417,0.4848551506912862,"PABPC4,EXOSC9,SIDT2",GO_Biological_Process_2023
517,Negative Regulation Of Kinase Activity (GO:0033673),0.14053600842899536,2.418508506916839,4.745818771158417,0.4848551506912862,"PTPRC,MAPT,TRIB1",GO_Biological_Process_2023
518,Positive Regulation Of Proteasomal Ubiquitin-Dependent Protein Catabolic Process (GO:0032436),0.14053600842899536,2.418508506916839,4.745818771158417,0.4848551506912862,"CEBPA,ARIH2,TRIB1",GO_Biological_Process_2023
519,Fc Receptor Signaling Pathway (GO:0038093),0.14247496211786,3.2209892200380468,6.276384160538291,0.4848551506912862,"MAP3K1,KIT",GO_Biological_Process_2023
520,Regulation Of Macrophage Activation (GO:0043030),0.14247496211786,3.2209892200380468,6.276384160538291,0.4848551506912862,"CEBPA,MFHAS1",GO_Biological_Process_2023
521,Axonal Transport (GO:0098930),0.14247496211786,3.2209892200380468,6.276384160538291,0.4848551506912862,"BLOC1S2,MAPT",GO_Biological_Process_2023
522,Regulation Of Receptor-Mediated Endocytosis (GO:0048259),0.14247496211786,3.2209892200380468,6.276384160538291,0.4848551506912862,"HFE,TNK2",GO_Biological_Process_2023
523,Regulatory ncRNA Processing (GO:0070918),0.14247496211786,3.2209892200380468,6.276384160538291,0.4848551506912862,"TERT,SNIP1",GO_Biological_Process_2023
524,Response To Estrogen (GO:0043627),0.14247496211786,3.2209892200380468,6.276384160538291,0.4848551506912862,"CITED2,NCOA4",GO_Biological_Process_2023
525,Lamellipodium Organization (GO:0097581),0.14247496211786,3.2209892200380468,6.276384160538291,0.4848551506912862,"KIT,MYO9B",GO_Biological_Process_2023
526,Membrane Protein Proteolysis (GO:0033619),0.14247496211786,3.2209892200380468,6.276384160538291,0.4848551506912862,"TMPRSS6,SPPL3",GO_Biological_Process_2023
527,Mitotic Spindle Assembly (GO:0090307),0.14247496211786,3.2209892200380468,6.276384160538291,0.4848551506912862,"PRC1,RHOA",GO_Biological_Process_2023
528,Negative Regulation Of Blood Coagulation (GO:0030195),0.14247496211786,3.2209892200380468,6.276384160538291,0.4848551506912862,"PDGFRA,APOE",GO_Biological_Process_2023
529,Phospholipid Translocation (GO:0045332),0.14247496211786,3.2209892200380468,6.276384160538291,0.4848551506912862,"ATP11B,ATP11A",GO_Biological_Process_2023
530,Positive Regulation Of p38MAPK Cascade (GO:1900745),0.14247496211786,3.2209892200380468,6.276384160538291,0.4848551506912862,"MFHAS1,GADD45A",GO_Biological_Process_2023
531,"Regulation Of DNA Damage Response, Signal Transduction By P53 Class Mediator (GO:0043516)",0.14247496211786,3.2209892200380468,6.276384160538291,0.4848551506912862,"SPRED2,ATR",GO_Biological_Process_2023
532,Positive Regulation Of Macromolecule Metabolic Process (GO:0010604),0.14568902260590555,1.4729842509086015,2.8373814448222423,0.4848551506912862,"PTPN1,MEF2C,MAP2K2,TFRC,IL37,CITED2,DNAJA4,HFE,PDCD5,PPARG,LGALS9B",GO_Biological_Process_2023
533,Regulation Of Macromolecule Metabolic Process (GO:0060255),0.1478408767813434,1.8484271432233492,3.5334879674283712,0.4848551506912862,"PTPRC,ZNF827,TRIM4,CDH1,APOE",GO_Biological_Process_2023
534,Response To Metal Ion (GO:0010038),0.14800311609084355,2.3562630722751567,4.501692321374702,0.4848551506912862,"HFE,TRPC1,MAPT",GO_Biological_Process_2023
535,Regulation Of Ceramide Biosynthetic Process (GO:2000303),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,SIRT3,GO_Biological_Process_2023
536,Regulation Of Digestive System Process (GO:0044058),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,TYMP,GO_Biological_Process_2023
537,Regulation Of Establishment Of Protein Localization To Mitochondrion (GO:1903747),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,MAPT,GO_Biological_Process_2023
538,IRE1-mediated Unfolded Protein Response (GO:0036498),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,PTPN1,GO_Biological_Process_2023
539,Regulation Of Extent Of Cell Growth (GO:0061387),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,APOE,GO_Biological_Process_2023
540,Regulation Of Generation Of Precursor Metabolites And Energy (GO:0043467),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,PRDM16,GO_Biological_Process_2023
541,Regulation Of Histone H3-K4 Methylation (GO:0051569),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,KANSL1,GO_Biological_Process_2023
542,UV-damage Excision Repair (GO:0070914),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,DDB2,GO_Biological_Process_2023
543,Acid Secretion (GO:0046717),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,SLC22A16,GO_Biological_Process_2023
544,Regulation Of Isotype Switching (GO:0045191),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,TFRC,GO_Biological_Process_2023
545,Actin Filament Network Formation (GO:0051639),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,PLS1,GO_Biological_Process_2023
546,Regulation Of Lens Fiber Cell Differentiation (GO:1902746),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,SPRED2,GO_Biological_Process_2023
547,Regulation Of Leukocyte Proliferation (GO:0070663),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,JAK2,GO_Biological_Process_2023
548,acyl-CoA Biosynthetic Process (GO:0071616),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,GCDH,GO_Biological_Process_2023
549,Regulation Of Lysosomal Protein Catabolic Process (GO:1905165),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,LAPTM4B,GO_Biological_Process_2023
550,Alcohol Catabolic Process (GO:0046164),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,APOE,GO_Biological_Process_2023
551,Aldehyde Catabolic Process (GO:0046185),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,ALDH2,GO_Biological_Process_2023
552,Alditol Metabolic Process (GO:0019400),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,GK5,GO_Biological_Process_2023
553,Regulation Of Nitric Oxide Metabolic Process (GO:0080164),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,JAK2,GO_Biological_Process_2023
554,Axonal Transport Of Mitochondrion (GO:0019896),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,MAPT,GO_Biological_Process_2023
555,Regulation Of Pinocytosis (GO:0048548),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,AXL,GO_Biological_Process_2023
556,Regulation Of Vesicle Size (GO:0097494),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,BLOC1S2,GO_Biological_Process_2023
557,Detection Of Mechanical Stimulus Involved In Sensory Perception Of Sound (GO:0050910),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,KIT,GO_Biological_Process_2023
558,"Endonucleolytic Cleavage Of Tricistronic rRNA Transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,RCL1,GO_Biological_Process_2023
559,Foam Cell Differentiation (GO:0090077),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,PPARG,GO_Biological_Process_2023
560,Triglyceride-Rich Lipoprotein Particle Remodeling (GO:0034370),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,APOE,GO_Biological_Process_2023
561,Heme Catabolic Process (GO:0042167),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,ABCC2,GO_Biological_Process_2023
562,Very-Low-Density Lipoprotein Particle Assembly (GO:0034379),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,APOB,GO_Biological_Process_2023
563,Hepatocyte Growth Factor Receptor Signaling Pathway (GO:0048012),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,MUC20,GO_Biological_Process_2023
564,Xenobiotic Transport Across Blood-Brain Barrier (GO:1990962),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,ABCC2,GO_Biological_Process_2023
565,Internal Protein Amino Acid Acetylation (GO:0006475),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,MAPT,GO_Biological_Process_2023
566,Ketone Body Metabolic Process (GO:1902224),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,HMGCL,GO_Biological_Process_2023
567,Leucine Metabolic Process (GO:0006551),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,HMGCL,GO_Biological_Process_2023
568,Leukotriene Transport (GO:0071716),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,ABCC2,GO_Biological_Process_2023
569,Macrophage Derived Foam Cell Differentiation (GO:0010742),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,PPARG,GO_Biological_Process_2023
570,Membrane Biogenesis (GO:0044091),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,TLCD1,GO_Biological_Process_2023
571,Mitotic Spindle Elongation (GO:0000022),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,PRC1,GO_Biological_Process_2023
572,Mitotic Spindle Midzone Assembly (GO:0051256),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,PRC1,GO_Biological_Process_2023
573,Negative Regulation Of SMAD Protein Signal Transduction (GO:0060392),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,PPARG,GO_Biological_Process_2023
574,Negative Regulation Of T Cell Mediated Cytotoxicity (GO:0001915),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,PTPRC,GO_Biological_Process_2023
575,Negative Regulation Of Cell Size (GO:0045792),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,RHOA,GO_Biological_Process_2023
576,Negative Regulation Of Cytoplasmic Translation (GO:2000766),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,CPEB4,GO_Biological_Process_2023
577,Negative Regulation Of Hematopoietic Progenitor Cell Differentiation (GO:1901533),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,MYB,GO_Biological_Process_2023
578,Negative Regulation Of Long-Term Synaptic Potentiation (GO:1900272),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,APOE,GO_Biological_Process_2023
579,Negative Regulation Of Oxidative Stress-Induced Neuron Death (GO:1903204),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,FBXO7,GO_Biological_Process_2023
580,Negative Regulation Of Telomere Capping (GO:1904354),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,RAD50,GO_Biological_Process_2023
581,Negative Regulation Of Toll-Like Receptor 4 Signaling Pathway (GO:0034144),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,MFHAS1,GO_Biological_Process_2023
582,Nephron Tubule Development (GO:0072080),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,MEF2C,GO_Biological_Process_2023
583,Nuclear Polyadenylation-Dependent ncRNA Catabolic Process (GO:0071046),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,EXOSC9,GO_Biological_Process_2023
584,Nuclear Polyadenylation-Dependent rRNA Catabolic Process (GO:0071035),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,EXOSC9,GO_Biological_Process_2023
585,Nuclear Polyadenylation-Dependent tRNA Catabolic Process (GO:0071038),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,EXOSC9,GO_Biological_Process_2023
586,Nucleoside Diphosphate Metabolic Process (GO:0009132),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,RRM1,GO_Biological_Process_2023
587,Nucleoside Metabolic Process (GO:0009116),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,TYMP,GO_Biological_Process_2023
588,Peptidyl-Lysine Deacetylation (GO:0034983),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,SIRT3,GO_Biological_Process_2023
589,Peptidyl-Proline Hydroxylation To 4-hydroxy-L-proline (GO:0018401),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,P4HTM,GO_Biological_Process_2023
590,Peptidyl-Serine Autophosphorylation (GO:0036289),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,MAP2K2,GO_Biological_Process_2023
591,Positive Regulation Of T-helper 2 Cell Cytokine Production (GO:2000553),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,NLRP3,GO_Biological_Process_2023
592,Positive Regulation Of T-helper 2 Cell Differentiation (GO:0045630),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,NLRP3,GO_Biological_Process_2023
593,Positive Regulation Of Autophagy Of Mitochondrion (GO:1903599),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,FBXO7,GO_Biological_Process_2023
594,Positive Regulation Of Histone H3-K4 Methylation (GO:0051571),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,KANSL1,GO_Biological_Process_2023
595,Positive Regulation Of Isotype Switching (GO:0045830),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,TFRC,GO_Biological_Process_2023
596,Positive Regulation Of mRNA Metabolic Process (GO:1903313),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,CNOT8,GO_Biological_Process_2023
597,Positive Regulation Of Natural Killer Cell Proliferation (GO:0032819),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,JAK2,GO_Biological_Process_2023
598,Positive Regulation Of Vascular Associated Smooth Muscle Cell Differentiation (GO:1905065),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,KIT,GO_Biological_Process_2023
599,Regulation Of Cdc42 Protein Signal Transduction (GO:0032489),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,APOE,GO_Biological_Process_2023
600,Regulation Of PERK-mediated Unfolded Protein Response (GO:1903897),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,PTPN1,GO_Biological_Process_2023
601,Regulation Of T-helper 2 Cell Cytokine Production (GO:2000551),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,NLRP3,GO_Biological_Process_2023
602,Regulation Of Activation Of Janus Kinase Activity (GO:0010533),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,IL6R,GO_Biological_Process_2023
603,Regulation Of Cardiac Muscle Hypertrophy In Response To Stress (GO:1903242),0.14911259383863723,7.638138138138138,14.535786243348012,0.4848551506912862,PPARG,GO_Biological_Process_2023
604,Regulation Of Small GTPase Mediated Signal Transduction (GO:0051056),0.1528540562776754,1.826241134751773,3.4301770286563236,0.4848551506912862,"ARHGAP21,DNMBP,ITSN1,MYO9B,ARHGAP27",GO_Biological_Process_2023
605,Translation (GO:0006412),0.1528540562776754,1.826241134751773,3.4301770286563236,0.4848551506912862,"HBS1L,RPS28,PABPC4,RPL22L1,MRPL33",GO_Biological_Process_2023
606,Regulation Of Chromosome Organization (GO:0033044),0.15359274232530412,3.0596385542168676,5.7320820213469,0.4848551506912862,"NSMCE2,MAPT",GO_Biological_Process_2023
607,Regulation Of Establishment Of Planar Polarity (GO:0090175),0.15359274232530412,3.0596385542168676,5.7320820213469,0.4848551506912862,"NPHP3,RHOA",GO_Biological_Process_2023
608,Actin Filament Bundle Organization (GO:0061572),0.15359274232530412,3.0596385542168676,5.7320820213469,0.4848551506912862,"MICAL1,PLS1",GO_Biological_Process_2023
609,Regulation Of Platelet Activation (GO:0010543),0.15359274232530412,3.0596385542168676,5.7320820213469,0.4848551506912862,"PDGFRA,JAK2",GO_Biological_Process_2023
610,Lytic Vacuole Organization (GO:0080171),0.15359274232530412,3.0596385542168676,5.7320820213469,0.4848551506912862,"ZKSCAN3,TFEB",GO_Biological_Process_2023
611,Negative Regulation Of Protein Localization (GO:1903828),0.15359274232530412,3.0596385542168676,5.7320820213469,0.4848551506912862,"MFHAS1,LEPROT",GO_Biological_Process_2023
612,Positive Regulation Of Phospholipase C Activity (GO:0010863),0.15359274232530412,3.0596385542168676,5.7320820213469,0.4848551506912862,"PDGFRA,KIT",GO_Biological_Process_2023
613,Positive Regulation Of Production Of Molecular Mediator Of Immune Response (GO:0002702),0.15359274232530412,3.0596385542168676,5.7320820213469,0.4848551506912862,"PTPRC,STX4",GO_Biological_Process_2023
614,Positive Regulation Of Telomere Maintenance Via Telomere Lengthening (GO:1904358),0.15359274232530412,3.0596385542168676,5.7320820213469,0.4848551506912862,"RTEL1,ATR",GO_Biological_Process_2023
615,Positive Regulation Of Viral Process (GO:0048524),0.15359274232530412,3.0596385542168676,5.7320820213469,0.4848551506912862,"LARP1,AXL",GO_Biological_Process_2023
616,Negative Regulation Of Nucleic Acid-Templated Transcription (GO:1903507),0.15470232201190323,1.4272284707067315,2.663568718287033,0.4848551506912862,"CEBPA,HSPA8,TFAP4,ZNF827,TMPRSS6,CITED2,ZBTB38,PRDM16,MYB,ZKSCAN3,ZNF217,PPARG",GO_Biological_Process_2023
617,Transcription By RNA Polymerase II (GO:0006366),0.1547506293801004,1.7056233062330624,3.1825912643149867,0.4848551506912862,"GTF2A1,THRB,KLF13,ICE2,TAF8,PPARG",GO_Biological_Process_2023
618,Peptidyl-Tyrosine Modification (GO:0018212),0.15559571008477832,2.297129909365559,4.273796959777195,0.4848551506912862,"BLK,PDGFRA,JAK2",GO_Biological_Process_2023
619,Positive Regulation Of T Cell Proliferation (GO:0042102),0.15559571008477832,2.297129909365559,4.273796959777195,0.4848551506912862,"PTPRC,TFRC,JAK2",GO_Biological_Process_2023
620,Regulation Of Autophagy (GO:0010506),0.15785036154875876,1.6167712860131982,2.984734039117728,0.4848551506912862,"NPRL3,TFEB,LEPR,ZKSCAN3,MAPT,TRIM38,RAB8A",GO_Biological_Process_2023
621,RNA Processing (GO:0006396),0.15793746364548836,1.8045771500089398,3.3304484104595113,0.4848551506912862,"PABPC4,EXOSC9,WBP4,ADAR,SNRNP25",GO_Biological_Process_2023
622,Positive Regulation Of Gene Expression (GO:0010628),0.15976410734971105,1.395714611351721,2.5598199864502917,0.4848551506912862,"MEF2C,MAP2K2,BTN3A1,TFRC,IL37,CITED2,HFE,PDCD5,PLD1,LGALS9B,LARP1,DNAJA4,PPARG",GO_Biological_Process_2023
623,Regulation Of Endocytosis (GO:0030100),0.16330690860836444,2.2408812909881366,4.060754709535732,0.4848551506912862,"PTPN1,PTPRC,APOE",GO_Biological_Process_2023
624,Myeloid Leukocyte Differentiation (GO:0002573),0.16330690860836444,2.2408812909881366,4.060754709535732,0.4848551506912862,"CEBPA,KIT,PPARG",GO_Biological_Process_2023
625,Positive Regulation Of Cell Cycle (GO:0045787),0.16330690860836444,2.2408812909881366,4.060754709535732,0.4848551506912862,"CCND3,CCND2,CITED2",GO_Biological_Process_2023
626,Positive Regulation Of Immune Response (GO:0050778),0.16330690860836444,2.2408812909881366,4.060754709535732,0.4848551506912862,"PTPRC,NLRP3,STX4",GO_Biological_Process_2023
627,Positive Regulation Of Protein Localization To Nucleus (GO:1900182),0.16330690860836444,2.2408812909881366,4.060754709535732,0.4848551506912862,"TFRC,TERT,CDH1",GO_Biological_Process_2023
628,DNA Duplex Unwinding (GO:0032508),0.16487131692197854,2.9136546184738954,5.252124698534515,0.4848551506912862,"RTEL1,RAD50",GO_Biological_Process_2023
629,Actin Filament Bundle Assembly (GO:0051017),0.16487131692197854,2.9136546184738954,5.252124698534515,0.4848551506912862,"MICAL1,PLS1",GO_Biological_Process_2023
630,Regulation Of Lipid Biosynthetic Process (GO:0046890),0.16487131692197854,2.9136546184738954,5.252124698534515,0.4848551506912862,"HSD17B13,APOE",GO_Biological_Process_2023
631,Regulation Of Macrophage Derived Foam Cell Differentiation (GO:0010743),0.16487131692197854,2.9136546184738954,5.252124698534515,0.4848551506912862,"PPARG,APOB",GO_Biological_Process_2023
632,Autophagy Of Mitochondrion (GO:0000422),0.16487131692197854,2.9136546184738954,5.252124698534515,0.4848551506912862,"WIPI2,FBXO7",GO_Biological_Process_2023
633,Regulation Of Release Of Cytochrome C From Mitochondria (GO:0090199),0.16487131692197854,2.9136546184738954,5.252124698534515,0.4848551506912862,"BCL2L11,PDCD5",GO_Biological_Process_2023
634,Cellular Response To Xenobiotic Stimulus (GO:0071466),0.16487131692197854,2.9136546184738954,5.252124698534515,0.4848551506912862,"MEF2C,TFRC",GO_Biological_Process_2023
635,Hematopoietic Progenitor Cell Differentiation (GO:0002244),0.16487131692197854,2.9136546184738954,5.252124698534515,0.4848551506912862,"PTPRC,KIT",GO_Biological_Process_2023
636,mRNA Catabolic Process (GO:0006402),0.16487131692197854,2.9136546184738954,5.252124698534515,0.4848551506912862,"XRN1,EXOSC9",GO_Biological_Process_2023
637,Negative Regulation Of Epithelial Cell Migration (GO:0010633),0.16487131692197854,2.9136546184738954,5.252124698534515,0.4848551506912862,"DNAJA4,APOE",GO_Biological_Process_2023
638,"Nuclear-Transcribed mRNA Catabolic Process, Deadenylation-Dependent Decay (GO:0000288)",0.16487131692197854,2.9136546184738954,5.252124698534515,0.4848551506912862,"EXOSC9,CNOT8",GO_Biological_Process_2023
639,Organic Cation Transport (GO:0015695),0.16487131692197854,2.9136546184738954,5.252124698534515,0.4848551506912862,"SLC7A6,SLC22A16",GO_Biological_Process_2023
640,Regulation Of Cell Size (GO:0008361),0.16487131692197854,2.9136546184738954,5.252124698534515,0.4848551506912862,"LAMTOR4,RHOA",GO_Biological_Process_2023
641,Positive Regulation Of DNA-binding Transcription Factor Activity (GO:0051091),0.16600439589850724,1.5925019821044286,2.8597211172296126,0.4848551506912862,"TFRC,KIT,CEBPG,NLRP3,FLOT2,PPARG,TRIM38",GO_Biological_Process_2023
642,Organelle Assembly (GO:0070925),0.16615349557587475,1.5365030674846625,2.7577821527147424,0.4848551506912862,"UNC119B,AHI1,DNMBP,UBXN2A,KIAA0586,NPHP3,WIPI2,RAB8A",GO_Biological_Process_2023
643,Negative Regulation Of DNA-binding Transcription Factor Activity (GO:0043433),0.16830802307557988,1.762743248436572,3.1411370910914576,0.4848551506912862,"CEBPG,NLRP3,TRIB1,COMMD6,MDFI",GO_Biological_Process_2023
644,Negative Regulation Of Neuron Apoptotic Process (GO:0043524),0.1711298670427318,2.187311178247734,3.8613316294113096,0.4848551506912862,"MEF2C,APOE,CPEB4",GO_Biological_Process_2023
645,Modification-Dependent Protein Catabolic Process (GO:0019941),0.1729789426683207,1.6440548780487805,2.8846347032056068,0.4848551506912862,"NDFIP1,C18ORF25,LONP1,ARIH2,FBXO7,UBE2L3",GO_Biological_Process_2023
646,Phosphate-Containing Compound Metabolic Process (GO:0006796),0.1729789426683207,1.6440548780487805,2.8846347032056068,0.4848551506912862,"GK5,PTPRC,PIK3CA,TNK2,DUSP15,HK1",GO_Biological_Process_2023
647,Negative Regulation Of Intracellular Signal Transduction (GO:1902532),0.17434199601046263,1.5689412710105137,2.7405268503036524,0.4848551506912862,"SPRED2,DUSP1,DLG5,NPRL3,NLRP3,PPARG,SH2B3",GO_Biological_Process_2023
648,Monoatomic Ion Transport (GO:0006811),0.17600139071984627,1.8858741258741258,3.2762600622401497,0.4848551506912862,"ATP11B,SLC17A1,SLC12A7,SLC17A3",GO_Biological_Process_2023
649,Regulation Of Cellular Response To Insulin Stimulus (GO:1900076),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,PPARG,GO_Biological_Process_2023
650,Regulation Of Chemokine-Mediated Signaling Pathway (GO:0070099),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,SH2B3,GO_Biological_Process_2023
651,DNA Catabolic Process (GO:0006308),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,DNASE2,GO_Biological_Process_2023
652,"DNA Damage Response, Signal Transduction By P53 Class Mediator Resulting In Transcription Of P21 Class Mediator (GO:0006978)",0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,TFAP4,GO_Biological_Process_2023
653,"DNA Damage Response, Signal Transduction Resulting In Transcription (GO:0042772)",0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,TFAP4,GO_Biological_Process_2023
654,Regulation Of Inclusion Body Assembly (GO:0090083),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,DNAJA4,GO_Biological_Process_2023
655,Regulation Of Lipase Activity (GO:0060191),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,RHOA,GO_Biological_Process_2023
656,Regulation Of Long-Term Synaptic Depression (GO:1900452),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,MAPT,GO_Biological_Process_2023
657,Ammonium Transmembrane Transport (GO:0072488),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,SLC12A7,GO_Biological_Process_2023
658,Antigen Processing And Presentation Of Endogenous Peptide Antigen (GO:0002483),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,HFE,GO_Biological_Process_2023
659,Regulation Of Natural Killer Cell Proliferation (GO:0032817),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,JAK2,GO_Biological_Process_2023
660,"Base-Excision Repair, AP Site Formation (GO:0006285)",0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,MPG,GO_Biological_Process_2023
661,Biogenic Amine Biosynthetic Process (GO:0042401),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,SMOX,GO_Biological_Process_2023
662,Regulation Of Receptor Binding (GO:1900120),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,HFE,GO_Biological_Process_2023
663,Cell Proliferation In Forebrain (GO:0021846),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,DOCK7,GO_Biological_Process_2023
664,Regulation Of Skeletal Muscle Cell Differentiation (GO:2001014),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,MEF2C,GO_Biological_Process_2023
665,Cellular Response To Growth Hormone Stimulus (GO:0071378),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,JAK2,GO_Biological_Process_2023
666,Cellular Response To Interleukin-2 (GO:0071352),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,IL2RB,GO_Biological_Process_2023
667,Cellular Response To Leptin Stimulus (GO:0044320),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,LEPR,GO_Biological_Process_2023
668,Regulation Of Type II Interferon-Mediated Signaling Pathway (GO:0060334),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,PPARG,GO_Biological_Process_2023
669,Regulation Of Vascular Associated Smooth Muscle Cell Apoptotic Process (GO:1905459),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,PPARG,GO_Biological_Process_2023
670,Regulation Of Vascular Associated Smooth Muscle Cell Differentiation (GO:1905063),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,KIT,GO_Biological_Process_2023
671,Chloride Ion Homeostasis (GO:0055064),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,SLC12A7,GO_Biological_Process_2023
672,Cleavage Furrow Formation (GO:0036089),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,RHOA,GO_Biological_Process_2023
673,Collagen-Activated Signaling Pathway (GO:0038065),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,JAK2,GO_Biological_Process_2023
674,Ribosomal Small Subunit Assembly (GO:0000028),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,RPS28,GO_Biological_Process_2023
675,Epithelial Cell Differentiation Involved In Kidney Development (GO:0035850),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,MEF2C,GO_Biological_Process_2023
676,Exonucleolytic Trimming Involved In rRNA Processing (GO:0000459),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,EXOSC9,GO_Biological_Process_2023
677,"Exonucleolytic Trimming To Generate Mature 3'-End Of 5.8S rRNA From Tricistronic rRNA Transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)",0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,EXOSC9,GO_Biological_Process_2023
678,Facultative Heterochromatin Formation (GO:0140718),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,BEND3,GO_Biological_Process_2023
679,tRNA Surveillance (GO:0106354),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,EXOSC9,GO_Biological_Process_2023
680,Tyrosine Phosphorylation Of STAT Protein (GO:0007260),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,JAK2,GO_Biological_Process_2023
681,Ureter Development (GO:0072189),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,NPHP3,GO_Biological_Process_2023
682,White Fat Cell Differentiation (GO:0050872),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,PPARG,GO_Biological_Process_2023
683,Homologous Recombination (GO:0035825),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,RAD50,GO_Biological_Process_2023
684,Inner Ear Receptor Cell Stereocilium Organization (GO:0060122),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,PLS1,GO_Biological_Process_2023
685,Interleukin-2-Mediated Signaling Pathway (GO:0038110),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,IL2RB,GO_Biological_Process_2023
686,Iron Ion Transmembrane Transport (GO:0034755),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,SLC25A37,GO_Biological_Process_2023
687,Lipoprotein Catabolic Process (GO:0042159),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,APOE,GO_Biological_Process_2023
688,Melanin Biosynthetic Process (GO:0042438),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,TRPC1,GO_Biological_Process_2023
689,Mitochondrial DNA Replication (GO:0006264),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,RRM1,GO_Biological_Process_2023
690,Mitochondrion Distribution (GO:0048311),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,MAPT,GO_Biological_Process_2023
691,Monoatomic Anion Homeostasis (GO:0055081),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,SLC12A7,GO_Biological_Process_2023
692,Muscle Cell Fate Commitment (GO:0042693),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,MEF2C,GO_Biological_Process_2023
693,Natural Killer Cell Differentiation (GO:0001779),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,PTPRC,GO_Biological_Process_2023
694,ncRNA Metabolic Process (GO:0034660),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,MAPT,GO_Biological_Process_2023
695,Negative Regulation Of Alpha-Beta T Cell Activation (GO:0046636),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,HFE,GO_Biological_Process_2023
696,Negative Regulation Of Cholesterol Storage (GO:0010887),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,PPARG,GO_Biological_Process_2023
697,Negative Regulation Of Dephosphorylation (GO:0035305),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,MFHAS1,GO_Biological_Process_2023
698,Negative Regulation Of Heterotypic Cell-Cell Adhesion (GO:0034115),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,IL1RN,GO_Biological_Process_2023
699,Negative Regulation Of Lipid Localization (GO:1905953),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,PPARG,GO_Biological_Process_2023
700,Negative Regulation Of Membrane Potential (GO:0045837),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,MAPT,GO_Biological_Process_2023
701,Negative Regulation Of Mitochondrial Membrane Potential (GO:0010917),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,MAPT,GO_Biological_Process_2023
702,Negative Regulation Of Transforming Growth Factor Beta Production (GO:0071635),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,LAPTM4B,GO_Biological_Process_2023
703,Negative Regulation Of Translational Initiation (GO:0045947),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,LARP1,GO_Biological_Process_2023
704,Negative Regulation Of Tyrosine Phosphorylation Of STAT Protein (GO:0042532),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,SH2B3,GO_Biological_Process_2023
705,Nucleobase-Containing Compound Biosynthetic Process (GO:0034654),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,TERT,GO_Biological_Process_2023
706,Peptidyl-Tyrosine Dephosphorylation Involved In Inactivation Of Protein Kinase Activity (GO:1990264),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,PTPN1,GO_Biological_Process_2023
707,Peroxisome Proliferator Activated Receptor Signaling Pathway (GO:0035357),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,PPARG,GO_Biological_Process_2023
708,Phenol-Containing Compound Biosynthetic Process (GO:0046189),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,TRPC1,GO_Biological_Process_2023
709,Phospholipid Efflux (GO:0033700),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,APOE,GO_Biological_Process_2023
710,Positive Regulation Of CoA-transferase Activity (GO:1905920),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,APOE,GO_Biological_Process_2023
711,Positive Regulation Of MHC Class II Biosynthetic Process (GO:0045348),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,JAK2,GO_Biological_Process_2023
712,Positive Regulation Of NK T Cell Activation (GO:0051135),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,JAK2,GO_Biological_Process_2023
713,Positive Regulation Of Dendritic Cell Cytokine Production (GO:0002732),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,KIT,GO_Biological_Process_2023
714,Positive Regulation Of Immunoglobulin Mediated Immune Response (GO:0002891),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,TFRC,GO_Biological_Process_2023
715,Positive Regulation Of Myeloid Cell Apoptotic Process (GO:0033034),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,MEF2C,GO_Biological_Process_2023
716,Positive Regulation Of Pinocytosis (GO:0048549),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,AXL,GO_Biological_Process_2023
717,Positive Regulation Of Protein Exit From Endoplasmic Reticulum (GO:0070863),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,TM9SF4,GO_Biological_Process_2023
718,rRNA 3'-End Processing (GO:0031125),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,EXOSC9,GO_Biological_Process_2023
719,"Regulation Of CD4-positive, Alpha-Beta T Cell Proliferation (GO:2000561)",0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,LGALS9B,GO_Biological_Process_2023
720,"Regulation Of CD8-positive, Alpha-Beta T Cell Activation (GO:2001185)",0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,HFE,GO_Biological_Process_2023
721,Regulation Of CoA-transferase Activity (GO:1905918),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,APOE,GO_Biological_Process_2023
722,Regulation Of Rab Protein Signal Transduction (GO:0032483),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,DENND4A,GO_Biological_Process_2023
723,"Regulation Of Wnt Signaling Pathway, Planar Cell Polarity Pathway (GO:2000095)",0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,NPHP3,GO_Biological_Process_2023
724,Regulation Of Actin Filament Organization (GO:0110053),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,PIK3CA,GO_Biological_Process_2023
725,Regulation Of Actin Nucleation (GO:0051125),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,ARFIP1,GO_Biological_Process_2023
726,Regulation Of Amyloid-Beta Clearance (GO:1900221),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,APOE,GO_Biological_Process_2023
727,Regulation Of Cell Projection Organization (GO:0031344),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,MACF1,GO_Biological_Process_2023
728,Regulation Of Cell-Cell Adhesion Involved In Gastrulation (GO:0070587),0.17616084684518224,6.10990990990991,10.608989721849268,0.4848551506912862,IL1RN,GO_Biological_Process_2023
729,RNA Polymerase II Preinitiation Complex Assembly (GO:0051123),0.1762893359481075,2.7809419496166483,4.8266826037987975,0.4848551506912862,"GTF2A1,TAF8",GO_Biological_Process_2023
730,Acylglycerol Metabolic Process (GO:0006639),0.1762893359481075,2.7809419496166483,4.8266826037987975,0.4848551506912862,"GK5,APOE",GO_Biological_Process_2023
731,Regulation Of Phosphatidylinositol 3-Kinase Activity (GO:0043551),0.1762893359481075,2.7809419496166483,4.8266826037987975,0.4848551506912862,"PDGFRA,KIT",GO_Biological_Process_2023
732,Regulation Of Protein Dephosphorylation (GO:0035304),0.1762893359481075,2.7809419496166483,4.8266826037987975,0.4848551506912862,"MFHAS1,SPPL3",GO_Biological_Process_2023
733,Regulation Of Protein Tyrosine Kinase Activity (GO:0061097),0.1762893359481075,2.7809419496166483,4.8266826037987975,0.4848551506912862,"PTPN1,PTPRC",GO_Biological_Process_2023
734,Respiratory Tube Development (GO:0030323),0.1762893359481075,2.7809419496166483,4.8266826037987975,0.4848551506912862,"CEBPA,NPHP3",GO_Biological_Process_2023
735,Establishment Or Maintenance Of Epithelial Cell Apical/Basal Polarity (GO:0045197),0.1762893359481075,2.7809419496166483,4.8266826037987975,0.4848551506912862,"DLG5,RHOA",GO_Biological_Process_2023
736,Lysosome Organization (GO:0007040),0.1762893359481075,2.7809419496166483,4.8266826037987975,0.4848551506912862,"ZKSCAN3,TFEB",GO_Biological_Process_2023
737,Melanosome Organization (GO:0032438),0.1762893359481075,2.7809419496166483,4.8266826037987975,0.4848551506912862,"BLOC1S2,APOE",GO_Biological_Process_2023
738,Negative Regulation Of Mitotic Cell Cycle Phase Transition (GO:1901991),0.1762893359481075,2.7809419496166483,4.8266826037987975,0.4848551506912862,"KANK2,CRLF3",GO_Biological_Process_2023
739,Positive Regulation Of Pattern Recognition Receptor Signaling Pathway (GO:0062208),0.1762893359481075,2.7809419496166483,4.8266826037987975,0.4848551506912862,"TLR1,MFHAS1",GO_Biological_Process_2023
740,Positive Regulation Of Telomere Maintenance (GO:0032206),0.1762893359481075,2.7809419496166483,4.8266826037987975,0.4848551506912862,"RTEL1,RAD50",GO_Biological_Process_2023
741,Regulation Of Cellular Component Biogenesis (GO:0044087),0.1762893359481075,2.7809419496166483,4.8266826037987975,0.4848551506912862,"HSPA8,APOE",GO_Biological_Process_2023
742,Cytokine-Mediated Signaling Pathway (GO:0019221),0.17857764067052667,1.5574170101493596,2.6830118257401927,0.4859455722422895,"CEBPA,IL37,KIT,IL2RB,LEPR,JAK2,IL6R",GO_Biological_Process_2023
743,Cellular Response To Hypoxia (GO:0071456),0.1790577909998144,2.136232698658048,3.674419940740421,0.4859455722422895,"TERT,EPAS1,PPARG",GO_Biological_Process_2023
744,Positive Regulation Of Ubiquitin-Dependent Protein Catabolic Process (GO:2000060),0.1790577909998144,2.136232698658048,3.674419940740421,0.4859455722422895,"CEBPA,ARIH2,TRIB1",GO_Biological_Process_2023
745,Regulation Of Rho Protein Signal Transduction (GO:0035023),0.1790577909998144,2.136232698658048,3.674419940740421,0.4859455722422895,"KANK2,MYO9B,APOE",GO_Biological_Process_2023
746,Regulation Of TOR Signaling (GO:0032006),0.1790577909998144,2.136232698658048,3.674419940740421,0.4859455722422895,"PIK3CA,NPRL3,LAMTOR4",GO_Biological_Process_2023
747,Regulation Of Apoptotic Process (GO:0042981),0.1801391852727467,1.3041417518087794,2.2353321861090305,0.4859455722422895,"MEF2C,TFRC,GADD45A,TRRAP,CITED2,PDCD5,AHI1,ARHGAP21,DSTYK,TFAP4,BCL2L11,CCND2,AXL,FIGNL1,IL2RB,ANP32B,CTSB",GO_Biological_Process_2023
748,Cilium Organization (GO:0044782),0.18241202177541344,1.6148908857509627,2.747716324363243,0.4859455722422895,"UNC119B,AHI1,DNMBP,KIAA0586,NPHP3,RAB8A",GO_Biological_Process_2023
749,Monoatomic Cation Homeostasis (GO:0055080),0.18708394837205428,2.0874759681406205,3.499022711118496,0.4859455722422895,"TMPRSS6,HFE,SLC12A7",GO_Biological_Process_2023
750,Negative Regulation Of Transforming Growth Factor Beta Receptor Signaling Pathway (GO:0030512),0.18708394837205428,2.0874759681406205,3.499022711118496,0.4859455722422895,"SPRED2,PRDM16,PPARG",GO_Biological_Process_2023
751,Positive Regulation Of Proteasomal Protein Catabolic Process (GO:1901800),0.18708394837205428,2.0874759681406205,3.499022711118496,0.4859455722422895,"CEBPA,ARIH2,TRIB1",GO_Biological_Process_2023
752,Regulation Of Ras Protein Signal Transduction (GO:0046578),0.18708394837205428,2.0874759681406205,3.499022711118496,0.4859455722422895,"KANK2,DENND4A,MYO9B",GO_Biological_Process_2023
753,Regulation Of Cytosolic Calcium Ion Concentration (GO:0051480),0.187826636372978,2.6597695128339445,4.447762034614779,0.4859455722422895,"SCGN,TRPC1",GO_Biological_Process_2023
754,Regulation Of Mitotic Metaphase/Anaphase Transition (GO:0030071),0.187826636372978,2.6597695128339445,4.447762034614779,0.4859455722422895,"DUSP1,NSMCE2",GO_Biological_Process_2023
755,Cellular Response To Amino Acid Starvation (GO:0034198),0.187826636372978,2.6597695128339445,4.447762034614779,0.4859455722422895,"NPRL3,TFEB",GO_Biological_Process_2023
756,Endothelial Cell Migration (GO:0043542),0.187826636372978,2.6597695128339445,4.447762034614779,0.4859455722422895,"PIK3CA,RHOA",GO_Biological_Process_2023
757,Negative Regulation Of Cellular Metabolic Process (GO:0031324),0.187826636372978,2.6597695128339445,4.447762034614779,0.4859455722422895,"TERT,ZKSCAN3",GO_Biological_Process_2023
758,Positive Regulation Of DNA Recombination (GO:0045911),0.187826636372978,2.6597695128339445,4.447762034614779,0.4859455722422895,"TFRC,TRRAP",GO_Biological_Process_2023
759,Regulation Of Transforming Growth Factor Beta Receptor Signaling Pathway (GO:0017015),0.1887666700976493,1.8292175486205338,3.049751207692878,0.4859455722422895,"SPRED2,CITED2,PRDM16,PPARG",GO_Biological_Process_2023
760,Epithelial Cell Differentiation (GO:0030855),0.1887666700976493,1.8292175486205338,3.049751207692878,0.4859455722422895,"TAGLN,TST,PPARG,CTSB",GO_Biological_Process_2023
761,Regulation Of NIK/NF-kappaB Signaling (GO:1901222),0.19520168016594044,2.040886203423968,3.3342406851988353,0.4859455722422895,"TRIP6,NLRP3,RHOA",GO_Biological_Process_2023
762,Response To Lipid (GO:0033993),0.19525798515487663,1.8021390374331552,2.943674444835606,0.4859455722422895,"ASXL1,PPARG,TRIB1,JAK2",GO_Biological_Process_2023
763,Protein Dephosphorylation (GO:0006470),0.19525798515487663,1.8021390374331552,2.943674444835606,0.4859455722422895,"PTPN1,PTPRC,DUSP1,PPP2R2A",GO_Biological_Process_2023
764,Regulation Of Microtubule-Based Process (GO:0032886),0.1994641886930714,2.548694779116466,4.108803264933942,0.4859455722422895,"MACF1,MAPT",GO_Biological_Process_2023
765,Cellular Response To Radiation (GO:0071478),0.1994641886930714,2.548694779116466,4.108803264933942,0.4859455722422895,"GADD45A,FIGNL1",GO_Biological_Process_2023
766,Cellular Response To Virus (GO:0098586),0.1994641886930714,2.548694779116466,4.108803264933942,0.4859455722422895,"NLRP3,JAK2",GO_Biological_Process_2023
767,Response To Unfolded Protein (GO:0006986),0.1994641886930714,2.548694779116466,4.108803264933942,0.4859455722422895,"HSPA8,PTPN1",GO_Biological_Process_2023
768,Spliceosomal Complex Assembly (GO:0000245),0.1994641886930714,2.548694779116466,4.108803264933942,0.4859455722422895,"RSRP1,SNIP1",GO_Biological_Process_2023
769,Transcription Preinitiation Complex Assembly (GO:0070897),0.1994641886930714,2.548694779116466,4.108803264933942,0.4859455722422895,"GTF2A1,TAF8",GO_Biological_Process_2023
770,Positive Regulation Of Lipid Biosynthetic Process (GO:0046889),0.1994641886930714,2.548694779116466,4.108803264933942,0.4859455722422895,"HSD17B13,APOE",GO_Biological_Process_2023
771,Positive Regulation Of Signaling Receptor Activity (GO:2000273),0.1994641886930714,2.548694779116466,4.108803264933942,0.4859455722422895,"HFE,JAK2",GO_Biological_Process_2023
772,Negative Regulation Of DNA-templated Transcription (GO:0045892),0.2017378566008051,1.2367357900144786,1.9797495411468435,0.4859455722422895,"KANK2,CEBPA,HSPA8,MEF2C,THRB,GADD45A,TMPRSS6,BCL11A,CITED2,MAX,ZBTB38,ZFP90,ETS2,TFAP4,ZNF827,PRDM16,MYB,ZKSCAN3,BEND3,ZNF217,PPARG,MDFI",GO_Biological_Process_2023
773,B Cell Mediated Immunity (GO:0019724),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,IL2RB,GO_Biological_Process_2023
774,Regulation Of Cytoplasmic Transport (GO:1903649),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,MAP2K2,GO_Biological_Process_2023
775,Actin Filament Depolymerization (GO:0030042),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,MICAL1,GO_Biological_Process_2023
776,Regulation Of Leukocyte Adhesion To Vascular Endothelial Cell (GO:1904994),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,RHOA,GO_Biological_Process_2023
777,Regulation Of Mesenchymal Stem Cell Differentiation (GO:2000739),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,PDGFRA,GO_Biological_Process_2023
778,Regulation Of miRNA-mediated Gene Silencing (GO:0060964),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,PPARG,GO_Biological_Process_2023
779,Regulation Of Microglial Cell Activation (GO:1903978),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,PTPRC,GO_Biological_Process_2023
780,Anoikis (GO:0043276),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,PIK3CA,GO_Biological_Process_2023
781,Regulation Of Mitotic Sister Chromatid Separation (GO:0010965),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,DUSP1,GO_Biological_Process_2023
782,Carbohydrate Phosphorylation (GO:0046835),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,HK1,GO_Biological_Process_2023
783,Carbon Dioxide Transport (GO:0015670),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,HBZ,GO_Biological_Process_2023
784,Regulation Of Protein Exit From Endoplasmic Reticulum (GO:0070861),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,TM9SF4,GO_Biological_Process_2023
785,Cardiolipin Metabolic Process (GO:0032048),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,HADHA,GO_Biological_Process_2023
786,Carnitine Metabolic Process (GO:0009437),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,CPT1B,GO_Biological_Process_2023
787,Regulation Of Response To Cytokine Stimulus (GO:0060759),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,SH2B3,GO_Biological_Process_2023
788,Regulation Of Sequestering Of Triglyceride (GO:0010889),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,PPARG,GO_Biological_Process_2023
789,Regulation Of Stress-Activated Protein Kinase Signaling Cascade (GO:0070302),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,MAP2K2,GO_Biological_Process_2023
790,Cellular Response To Gamma Radiation (GO:0071480),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,ATR,GO_Biological_Process_2023
791,Cellular Response To Oxygen Levels (GO:0071453),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,CPEB4,GO_Biological_Process_2023
792,Ceramide Transport (GO:0035627),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,PLTP,GO_Biological_Process_2023
793,Response To Leptin (GO:0044321),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,LEPR,GO_Biological_Process_2023
794,Embryonic Placenta Development (GO:0001892),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,TFEB,GO_Biological_Process_2023
795,Endochondral Ossification (GO:0001958),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,MEF2C,GO_Biological_Process_2023
796,snRNA Transcription By RNA Polymerase III (GO:0042796),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,ICE2,GO_Biological_Process_2023
797,Spleen Development (GO:0048536),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,CITED2,GO_Biological_Process_2023
798,Establishment Of Epithelial Cell Apical/Basal Polarity (GO:0045198),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,RHOA,GO_Biological_Process_2023
799,Fatty Acid Homeostasis (GO:0055089),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,APOE,GO_Biological_Process_2023
800,Glycerol Metabolic Process (GO:0006071),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,GK5,GO_Biological_Process_2023
801,Growth Hormone Receptor Signaling Pathway Via JAK-STAT (GO:0060397),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,PTPN1,GO_Biological_Process_2023
802,Histone H4-K5 Acetylation (GO:0043981),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,KANSL1,GO_Biological_Process_2023
803,Histone H4-K8 Acetylation (GO:0043982),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,KANSL1,GO_Biological_Process_2023
804,Innate Immune Response-Activating Signaling Pathway (GO:0002758),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,NLRP3,GO_Biological_Process_2023
805,Interleukin-12-Mediated Signaling Pathway (GO:0035722),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,JAK2,GO_Biological_Process_2023
806,Kidney Epithelium Development (GO:0072073),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,KANK2,GO_Biological_Process_2023
807,Leptin-Mediated Signaling Pathway (GO:0033210),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,LEPR,GO_Biological_Process_2023
808,Mast Cell Activation Involved In Immune Response (GO:0002279),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,KIT,GO_Biological_Process_2023
809,Mast Cell Degranulation (GO:0043303),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,KIT,GO_Biological_Process_2023
810,Mitochondrion Transport Along Microtubule (GO:0047497),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,MAPT,GO_Biological_Process_2023
811,Monocyte Differentiation (GO:0030224),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,PPARG,GO_Biological_Process_2023
812,Negative Regulation Of Cell Migration Involved In Sprouting Angiogenesis (GO:0090051),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,RHOA,GO_Biological_Process_2023
813,Negative Regulation Of Endoplasmic Reticulum Stress-Induced Intrinsic Apoptotic Signaling Pathway (GO:1902236),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,PTPN1,GO_Biological_Process_2023
814,Negative Regulation Of Endoplasmic Reticulum Unfolded Protein Response (GO:1900102),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,PTPN1,GO_Biological_Process_2023
815,Negative Regulation Of Hemostasis (GO:1900047),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,APOE,GO_Biological_Process_2023
816,Negative Regulation Of Intracellular Estrogen Receptor Signaling Pathway (GO:0033147),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,KANK2,GO_Biological_Process_2023
817,Negative Regulation Of Leukocyte Mediated Cytotoxicity (GO:0001911),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,PTPRC,GO_Biological_Process_2023
818,Negative Regulation Of Pathway-Restricted SMAD Protein Phosphorylation (GO:0060394),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,PPARG,GO_Biological_Process_2023
819,Negative Regulation Of Protein Localization To Cell Surface (GO:2000009),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,LEPROT,GO_Biological_Process_2023
820,Negative Regulation Of Receptor Binding (GO:1900121),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,HFE,GO_Biological_Process_2023
821,Negative Regulation Of Vascular Endothelial Growth Factor Receptor Signaling Pathway (GO:0030948),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,PTPN1,GO_Biological_Process_2023
822,Oxygen Transport (GO:0015671),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,HBZ,GO_Biological_Process_2023
823,Peptidyl-Proline Hydroxylation (GO:0019511),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,P4HTM,GO_Biological_Process_2023
824,Porphyrin-Containing Compound Catabolic Process (GO:0006787),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,ABCC2,GO_Biological_Process_2023
825,Positive Regulation Of Adipose Tissue Development (GO:1904179),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,PPARG,GO_Biological_Process_2023
826,Positive Regulation Of Cardiocyte Differentiation (GO:1905209),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,MEF2C,GO_Biological_Process_2023
827,Positive Regulation Of Cholesterol Metabolic Process (GO:0090205),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,APOE,GO_Biological_Process_2023
828,Positive Regulation Of Hippo Signaling (GO:0035332),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,DLG5,GO_Biological_Process_2023
829,Positive Regulation Of Leukocyte Degranulation (GO:0043302),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,STX4,GO_Biological_Process_2023
830,Positive Regulation Of Lipid Transport (GO:0032370),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,APOE,GO_Biological_Process_2023
831,Positive Regulation Of Metaphase/Anaphase Transition Of Cell Cycle (GO:1902101),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,NSMCE2,GO_Biological_Process_2023
832,Positive Regulation Of Mitotic Metaphase/Anaphase Transition (GO:0045842),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,NSMCE2,GO_Biological_Process_2023
833,Positive Regulation Of Myeloid Leukocyte Mediated Immunity (GO:0002888),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,STX4,GO_Biological_Process_2023
834,Positive Regulation Of Nitric-Oxide Synthase Biosynthetic Process (GO:0051770),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,JAK2,GO_Biological_Process_2023
835,Positive Regulation Of Phospholipid Transport (GO:2001140),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,APOE,GO_Biological_Process_2023
836,Positive Regulation Of Platelet Activation (GO:0010572),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,JAK2,GO_Biological_Process_2023
837,Positive Regulation Of Tissue Remodeling (GO:0034105),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,TMBIM1,GO_Biological_Process_2023
838,Positive Regulation Of Vascular Associated Smooth Muscle Cell Migration (GO:1904754),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,DOCK7,GO_Biological_Process_2023
839,Post-Transcriptional Gene Silencing (GO:0016441),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,HELZ2,GO_Biological_Process_2023
840,Protein O-linked Glycosylation Via Serine (GO:0018242),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,GALNT2,GO_Biological_Process_2023
841,Protein Import Into Mitochondrial Matrix (GO:0030150),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,TOMM40,GO_Biological_Process_2023
842,Protein Localization To Phagophore Assembly Site (GO:0034497),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,WIPI2,GO_Biological_Process_2023
843,Protein Localization To Vacuole (GO:0072665),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,LAMTOR4,GO_Biological_Process_2023
844,Regulation Of T-helper 2 Cell Differentiation (GO:0045628),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,NLRP3,GO_Biological_Process_2023
845,Regulation Of Animal Organ Morphogenesis (GO:2000027),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,CITED2,GO_Biological_Process_2023
846,Regulation Of Cardiac Muscle Cell Differentiation (GO:2000725),0.20235177539845034,5.091091091091091,8.134278744250102,0.4859455722422895,MEF2C,GO_Biological_Process_2023
847,"Regulation Of mRNA Splicing, Via Spliceosome (GO:0048024)",0.2034044104295907,1.9963220806515172,3.1792609201776654,0.4859455722422895,"RBM38,RBM23,QKI",GO_Biological_Process_2023
848,Cell Morphogenesis Involved In Neuron Differentiation (GO:0048667),0.2034044104295907,1.9963220806515172,3.1792609201776654,0.4859455722422895,"MEF2C,DOCK7,RAB8A",GO_Biological_Process_2023
849,Peptidyl-Tyrosine Phosphorylation (GO:0018108),0.2034044104295907,1.9963220806515172,3.1792609201776654,0.4859455722422895,"BLK,PDGFRA,JAK2",GO_Biological_Process_2023
850,L-alpha-amino Acid Transmembrane Transport (GO:1902475),0.21118404556912293,2.4465060240963856,3.8043786951207514,0.4859455722422895,"SLC25A15,SLC7A6",GO_Biological_Process_2023
851,Regulation Of Neurotransmitter Receptor Activity (GO:0099601),0.21118404556912293,2.4465060240963856,3.8043786951207514,0.4859455722422895,"MEF2C,CNIH4",GO_Biological_Process_2023
852,Cyclic-Nucleotide-Mediated Signaling (GO:0019935),0.21118404556912293,2.4465060240963856,3.8043786951207514,0.4859455722422895,"APOE,PDE7A",GO_Biological_Process_2023
853,Cytoplasmic Microtubule Organization (GO:0031122),0.21118404556912293,2.4465060240963856,3.8043786951207514,0.4859455722422895,"MAPT,RHOA",GO_Biological_Process_2023
854,Fibroblast Growth Factor Receptor Signaling Pathway (GO:0008543),0.21118404556912293,2.4465060240963856,3.8043786951207514,0.4859455722422895,"CHURC1,FRS3",GO_Biological_Process_2023
855,Negative Regulation Of Cell-Cell Adhesion (GO:0022408),0.21118404556912293,2.4465060240963856,3.8043786951207514,0.4859455722422895,"IL1RN,CDH1",GO_Biological_Process_2023
856,Positive Regulation Of TOR Signaling (GO:0032008),0.21118404556912293,2.4465060240963856,3.8043786951207514,0.4859455722422895,"PIK3CA,LAMTOR4",GO_Biological_Process_2023
857,Positive Regulation Of Axonogenesis (GO:0050772),0.21118404556912293,2.4465060240963856,3.8043786951207514,0.4859455722422895,"MACF1,MAPT",GO_Biological_Process_2023
858,Positive Regulation Of Cell Cycle G1/S Phase Transition (GO:1902808),0.21118404556912293,2.4465060240963856,3.8043786951207514,0.4859455722422895,"RRM1,CCND2",GO_Biological_Process_2023
859,Protein Localization To Lysosome (GO:0061462),0.21118404556912293,2.4465060240963856,3.8043786951207514,0.4859455722422895,"NCOA4,LAMTOR4",GO_Biological_Process_2023
860,T Cell Activation (GO:0042110),0.2116856551833833,1.953654303528958,3.0333469481816007,0.4859455722422895,"PTPRC,KIT,LEPR",GO_Biological_Process_2023
861,Cellular Response To Nutrient Levels (GO:0031669),0.2116856551833833,1.953654303528958,3.0333469481816007,0.4859455722422895,"HSPA8,TFEB,WIPI2",GO_Biological_Process_2023
862,Plasma Membrane Organization (GO:0007009),0.2116856551833833,1.953654303528958,3.0333469481816007,0.4859455722422895,"STX4,TLCD1,DMKN",GO_Biological_Process_2023
863,Positive Regulation Of Protein Localization To Membrane (GO:1905477),0.2116856551833833,1.953654303528958,3.0333469481816007,0.4859455722422895,"PDCD5,STX4,PLS1",GO_Biological_Process_2023
864,mRNA Processing (GO:0006397),0.21223929978254336,1.613021916493361,2.500249892085898,0.4859455722422895,"HSPA8,USP49,WBP4,SNIP1,BUD13",GO_Biological_Process_2023
865,Plasma Membrane Bounded Cell Projection Assembly (GO:0120031),0.2139545757607968,1.4709061203971345,2.26812480745314,0.4859455722422895,"UNC119B,AHI1,DNMBP,KIAA0586,KIT,NPHP3,RAB8A",GO_Biological_Process_2023
866,Regulation Of Cytokine Production (GO:0001817),0.21797497000660154,1.5960612968591692,2.431399940777681,0.4859455722422895,"PTPRC,BTN3A1,BTN2A1,MAST2,BTN3A2",GO_Biological_Process_2023
867,Regulation Of Programmed Cell Death (GO:0043067),0.21797497000660154,1.5960612968591692,2.431399940777681,0.4859455722422895,"KANK2,BCL2L11,TRRAP,ANP32B,CTSB",GO_Biological_Process_2023
868,Establishment Of Protein Localization To Organelle (GO:0072594),0.22003903062749322,1.9127643504531722,2.89583023186509,0.4859455722422895,"GCKR,HEATR3,HK1",GO_Biological_Process_2023
869,Protein Maturation (GO:0051604),0.22187198583403833,1.7013468013468014,2.5616408142736593,0.4859455722422895,"GALNT2,NLRP3,PCSK7,LMF2",GO_Biological_Process_2023
870,Protein Targeting (GO:0006605),0.22187198583403833,1.7013468013468014,2.5616408142736593,0.4859455722422895,"TOMM40,SRP14,FBXO7,AP1M2",GO_Biological_Process_2023
871,Protein-Containing Complex Organization (GO:0043933),0.22187198583403833,1.7013468013468014,2.5616408142736593,0.4859455722422895,"NUP205,TFAP4,HFE,IL2RB",GO_Biological_Process_2023
872,DNA Recombination (GO:0006310),0.22296929257000844,2.3521779425393885,3.529963348017771,0.4859455722422895,"RTEL1,RAD50",GO_Biological_Process_2023
873,Autophagosome Organization (GO:1905037),0.22296929257000844,2.3521779425393885,3.529963348017771,0.4859455722422895,"UBXN2A,WIPI2",GO_Biological_Process_2023
874,Cell Cycle G1/S Phase Transition (GO:0044843),0.22296929257000844,2.3521779425393885,3.529963348017771,0.4859455722422895,"CCND3,CCND2",GO_Biological_Process_2023
875,Regulation Of Transport (GO:0051049),0.22296929257000844,2.3521779425393885,3.529963348017771,0.4859455722422895,"LEPR,PLD1",GO_Biological_Process_2023
876,Lung Development (GO:0030324),0.22296929257000844,2.3521779425393885,3.529963348017771,0.4859455722422895,"CEBPA,NPHP3",GO_Biological_Process_2023
877,Negative Regulation Of Protein Secretion (GO:0050709),0.22296929257000844,2.3521779425393885,3.529963348017771,0.4859455722422895,"BMP8A,APOE",GO_Biological_Process_2023
878,Nucleic Acid-Templated Transcription (GO:0097659),0.22296929257000844,2.3521779425393885,3.529963348017771,0.4859455722422895,"THRB,TERT",GO_Biological_Process_2023
879,Positive Regulation Of Insulin Secretion (GO:0032024),0.22296929257000844,2.3521779425393885,3.529963348017771,0.4859455722422895,"BLK,STX4",GO_Biological_Process_2023
880,Positive Regulation Of mRNA Catabolic Process (GO:0061014),0.22296929257000844,2.3521779425393885,3.529963348017771,0.4859455722422895,"FTO,CNOT8",GO_Biological_Process_2023
881,Positive Regulation Of Peptide Hormone Secretion (GO:0090277),0.22296929257000844,2.3521779425393885,3.529963348017771,0.4859455722422895,"BLK,HFE",GO_Biological_Process_2023
882,Protein Sumoylation (GO:0016925),0.22296929257000844,2.3521779425393885,3.529963348017771,0.4859455722422895,"ZMIZ2,NSMCE2",GO_Biological_Process_2023
883,Positive Regulation Of Protein Kinase Activity (GO:0045860),0.2237584344416632,1.5794503807225895,2.3647345146888767,0.4859455722422895,"PTPN1,MAP2K2,PTPRC,IL6R,RHOA",GO_Biological_Process_2023
884,Regulation Of Nucleic Acid-Templated Transcription (GO:1903506),0.22603432201703982,1.346924409789907,2.002968759190153,0.4859455722422895,"CEBPA,MEF2C,DENND4A,TRRAP,ZBTB38,MYB,TFEB,ZNF217,ZSCAN26,UBE2L3",GO_Biological_Process_2023
885,AMP Metabolic Process (GO:0046033),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,AK9,GO_Biological_Process_2023
886,Regulation Of Cholesterol Biosynthetic Process (GO:0045540),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,APOE,GO_Biological_Process_2023
887,B Cell Homeostasis (GO:0001782),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,MEF2C,GO_Biological_Process_2023
888,Regulation Of Clathrin-Dependent Endocytosis (GO:2000369),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,TNK2,GO_Biological_Process_2023
889,DNA Alkylation (GO:0006305),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,BEND3,GO_Biological_Process_2023
890,DNA Modification (GO:0006304),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,MPG,GO_Biological_Process_2023
891,Regulation Of Establishment Of Protein Localization (GO:0070201),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,KIAA0586,GO_Biological_Process_2023
892,Regulation Of Hair Cycle (GO:0042634),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,TERT,GO_Biological_Process_2023
893,Actin-Mediated Cell Contraction (GO:0070252),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,PIK3CA,GO_Biological_Process_2023
894,Regulation Of Mitochondrial Fusion (GO:0010635),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,TFRC,GO_Biological_Process_2023
895,Anterograde Synaptic Vesicle Transport (GO:0048490),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,BLOC1S2,GO_Biological_Process_2023
896,Apoptotic Nuclear Changes (GO:0030262),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,DNASE2,GO_Biological_Process_2023
897,Astrocyte Activation (GO:0048143),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,MAPT,GO_Biological_Process_2023
898,Regulation Of Neuron Projection Arborization (GO:0150011),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,MACF1,GO_Biological_Process_2023
899,Branched-Chain Amino Acid Transport (GO:0015803),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,SLC7A6,GO_Biological_Process_2023
900,Regulation Of Retinoic Acid Receptor Signaling Pathway (GO:0048385),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,ASXL1,GO_Biological_Process_2023
901,Regulation Of Telomere Maintenance In Response To DNA Damage (GO:1904505),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,RTEL1,GO_Biological_Process_2023
902,Cellular Response To Interleukin-15 (GO:0071350),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,IL2RB,GO_Biological_Process_2023
903,Regulation Of Vacuole Organization (GO:0044088),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,LAPTM4B,GO_Biological_Process_2023
904,Response To Corticosteroid (GO:0031960),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,IL1RN,GO_Biological_Process_2023
905,Cotranslational Protein Targeting To Membrane (GO:0006613),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,SRP14,GO_Biological_Process_2023
906,Response To Iron Ion (GO:0010039),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,HFE,GO_Biological_Process_2023
907,Ribosome Disassembly (GO:0032790),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,HBS1L,GO_Biological_Process_2023
908,Secretion (GO:0046903),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,SLC22A16,GO_Biological_Process_2023
909,Embryonic Digestive Tract Morphogenesis (GO:0048557),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,PDGFRA,GO_Biological_Process_2023
910,Endothelial Tube Morphogenesis (GO:0061154),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,RHOA,GO_Biological_Process_2023
911,Epithelial Cell-Cell Adhesion (GO:0090136),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,KIT,GO_Biological_Process_2023
912,Establishment Of Apical/Basal Cell Polarity (GO:0035089),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,RHOA,GO_Biological_Process_2023
913,Fatty Acid Beta-Oxidation Using acyl-CoA Dehydrogenase (GO:0033539),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,GCDH,GO_Biological_Process_2023
914,Synaptic Vesicle Transport Along Microtubule (GO:0099517),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,BLOC1S2,GO_Biological_Process_2023
915,Fatty Acid Transmembrane Transport (GO:1902001),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,CPT1B,GO_Biological_Process_2023
916,Telomere Capping (GO:0016233),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,RAD50,GO_Biological_Process_2023
917,Fructose 6-Phosphate Metabolic Process (GO:0006002),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,HK1,GO_Biological_Process_2023
918,Type II Interferon-Mediated Signaling Pathway (GO:0060333),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,JAK2,GO_Biological_Process_2023
919,Granulocyte Differentiation (GO:0030851),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,CEBPA,GO_Biological_Process_2023
920,Immune Response-Regulating Cell Surface Receptor Signaling Pathway (GO:0002768),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,KIT,GO_Biological_Process_2023
921,Interleukin-15-Mediated Signaling Pathway (GO:0035723),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,IL2RB,GO_Biological_Process_2023
922,Ionotropic Glutamate Receptor Signaling Pathway (GO:0035235),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,CPEB4,GO_Biological_Process_2023
923,Leucine Transport (GO:0015820),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,SLC7A6,GO_Biological_Process_2023
924,Mast Cell Mediated Immunity (GO:0002448),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,KIT,GO_Biological_Process_2023
925,Membrane Lipid Catabolic Process (GO:0046466),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,SMPD2,GO_Biological_Process_2023
926,Negative Regulation By Host Of Viral Transcription (GO:0043922),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,TFAP4,GO_Biological_Process_2023
927,"Negative Regulation Of CD4-positive, Alpha-Beta T Cell Activation (GO:2000515)",0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,LGALS9B,GO_Biological_Process_2023
928,Negative Regulation Of Coagulation (GO:0050819),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,APOE,GO_Biological_Process_2023
929,Negative Regulation Of Leukocyte Chemotaxis (GO:0002689),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,DUSP1,GO_Biological_Process_2023
930,Negative Regulation Of Neuroinflammatory Response (GO:0150079),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,PTPRC,GO_Biological_Process_2023
931,Negative Regulation Of Nitrogen Compound Metabolic Process (GO:0051172),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,APOE,GO_Biological_Process_2023
932,Negative Regulation Of Platelet Aggregation (GO:0090331),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,SH2B3,GO_Biological_Process_2023
933,Negative Regulation Of Protein Localization To Cell Periphery (GO:1904376),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,TMBIM1,GO_Biological_Process_2023
934,Negative Regulation Of Transporter Activity (GO:0032410),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,NDFIP1,GO_Biological_Process_2023
935,Nuclear Pore Complex Assembly (GO:0051292),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,NUP205,GO_Biological_Process_2023
936,Nucleotide Biosynthetic Process (GO:0009165),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,RRM1,GO_Biological_Process_2023
937,Organophosphate Catabolic Process (GO:0046434),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,PLD1,GO_Biological_Process_2023
938,Phospholipid Homeostasis (GO:0055091),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,TLCD1,GO_Biological_Process_2023
939,Positive Regulation Of T-helper 17 Type Immune Response (GO:2000318),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,JAK2,GO_Biological_Process_2023
940,Positive Regulation Of Behavior (GO:0048520),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,MEF2C,GO_Biological_Process_2023
941,Positive Regulation Of Cell Activation (GO:0050867),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,JAK2,GO_Biological_Process_2023
942,Positive Regulation Of Histone Methylation (GO:0031062),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,KANSL1,GO_Biological_Process_2023
943,Positive Regulation Of Leukocyte Apoptotic Process (GO:2000108),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,MEF2C,GO_Biological_Process_2023
944,Positive Regulation Of Lipase Activity (GO:0060193),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,RHOA,GO_Biological_Process_2023
945,Positive Regulation Of Lymphocyte Migration (GO:2000403),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,RHOA,GO_Biological_Process_2023
946,Positive Regulation Of Macrophage Activation (GO:0043032),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,CEBPA,GO_Biological_Process_2023
947,Positive Regulation Of Platelet Aggregation (GO:1901731),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,JAK2,GO_Biological_Process_2023
948,Positive Regulation Of Response To Cytokine Stimulus (GO:0060760),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,AXL,GO_Biological_Process_2023
949,Positive Regulation Of Smooth Muscle Cell Apoptotic Process (GO:0034393),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,PPARG,GO_Biological_Process_2023
950,Positive Regulation Of Superoxide Anion Generation (GO:0032930),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,MAPT,GO_Biological_Process_2023
951,Positive Regulation Of Translational Initiation (GO:0045948),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,LARP1,GO_Biological_Process_2023
952,Regulation Of Arp2/3 Complex-Mediated Actin Nucleation (GO:0034315),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,ARFIP1,GO_Biological_Process_2023
953,Regulation Of Golgi Organization (GO:1903358),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,MAP2K2,GO_Biological_Process_2023
954,Regulation Of MHC Class II Biosynthetic Process (GO:0045346),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,JAK2,GO_Biological_Process_2023
955,Regulation Of T-helper 17 Type Immune Response (GO:2000316),0.22771247374454687,4.363363363363363,6.4563445260378325,0.4859455722422895,JAK2,GO_Biological_Process_2023
956,Regulation Of Protein Localization To Plasma Membrane (GO:1903076),0.22845826020082471,1.873543375053949,2.766102725198173,0.4864638607281994,"TMBIM1,STX4,PLS1",GO_Biological_Process_2023
957,Positive Regulation Of Amide Metabolic Process (GO:0034250),0.22845826020082471,1.873543375053949,2.766102725198173,0.4864638607281994,"LARP1,PLD1,SIRT3",GO_Biological_Process_2023
958,Positive Regulation Of Macromolecule Biosynthetic Process (GO:0010557),0.22867143207930082,1.6778746367787463,2.475652180483332,0.4864638607281994,"SLC25A37,LARP1,PLD1,JAK2",GO_Biological_Process_2023
959,Negative Regulation Of Programmed Cell Death (GO:0043069),0.23357259314447124,1.3349436392914653,1.9413582857128875,0.49637220524341225,"KANK2,AHI1,ARHGAP21,DSTYK,CCND2,TFRC,AXL,CITED2,FIGNL1,IL2RB",GO_Biological_Process_2023
960,Respiratory System Development (GO:0060541),0.2348040010823395,2.2648371262829095,3.2817583968441295,0.4969164633497486,"CEBPA,NPHP3",GO_Biological_Process_2023
961,Secondary Alcohol Metabolic Process (GO:1902652),0.2348040010823395,2.2648371262829095,3.2817583968441295,0.4969164633497486,"APOE,APOB",GO_Biological_Process_2023
962,Positive Regulation Of Transcription Initiation By RNA Polymerase II (GO:0060261),0.2348040010823395,2.2648371262829095,3.2817583968441295,0.4969164633497486,"GTF2A1,TAF8",GO_Biological_Process_2023
963,Regulation Of Cellular Component Size (GO:0032535),0.2348040010823395,2.2648371262829095,3.2817583968441295,0.4969164633497486,"BLOC1S2,LAMTOR4",GO_Biological_Process_2023
964,Organonitrogen Compound Catabolic Process (GO:1901565),0.2369371811649995,1.835891238670695,2.64361037278202,0.4991500912655562,"MPST,SMPD2,TST",GO_Biological_Process_2023
965,Positive Regulation Of Phosphatidylinositol 3-Kinase Signaling (GO:0014068),0.2369371811649995,1.835891238670695,2.64361037278202,0.4991500912655562,"PDGFRA,KIT,JAK2",GO_Biological_Process_2023
966,Positive Regulation Of Tumor Necrosis Factor Production (GO:0032760),0.2369371811649995,1.835891238670695,2.64361037278202,0.4991500912655562,"TLR1,PTPRC,JAK2",GO_Biological_Process_2023
967,Organelle Organization (GO:0006996),0.2412044796070239,1.3231694338016178,1.8816928038867924,0.4991500912655562,"ARHGAP21,TERT,UBXN2A,MAST3,MAST2,MICAL1,LONP1,STX4,APOE,RAB8A",GO_Biological_Process_2023
968,Phosphatidylinositol Biosynthetic Process (GO:0006661),0.24546975040118685,1.7997156566554113,2.527847416712688,0.4991500912655562,"FIG4,PIK3CA,PGAP3",GO_Biological_Process_2023
969,Positive Regulation Of Tumor Necrosis Factor Superfamily Cytokine Production (GO:1903557),0.24546975040118685,1.7997156566554113,2.527847416712688,0.4991500912655562,"TLR1,PTPRC,JAK2",GO_Biological_Process_2023
970,Mitochondrial Transport (GO:0006839),0.24667318295277238,2.183734939759036,3.0565540638795885,0.4991500912655562,"TOMM40,FBXO7",GO_Biological_Process_2023
971,Positive Regulation Of Cell Death (GO:0010942),0.24667318295277238,2.183734939759036,3.0565540638795885,0.4991500912655562,"HBZ,MAPT",GO_Biological_Process_2023
972,Positive Regulation Of Neuron Differentiation (GO:0045666),0.24667318295277238,2.183734939759036,3.0565540638795885,0.4991500912655562,"MEF2C,RHOA",GO_Biological_Process_2023
973,Regulation Of Tumor Necrosis Factor Production (GO:0032680),0.24936839163977695,1.611164274322169,2.2376235982317674,0.4991500912655562,"TLR1,PTPRC,IL37,JAK2",GO_Biological_Process_2023
974,Regulation Of Cellular Respiration (GO:0043457),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.4991500912655562,PRDM16,GO_Biological_Process_2023
975,B Cell Activation Involved In Immune Response (GO:0002312),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.4991500912655562,C17ORF99,GO_Biological_Process_2023
976,DNA Double-Strand Break Processing (GO:0000729),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.4991500912655562,RAD50,GO_Biological_Process_2023
977,Regulation Of Early Endosome To Late Endosome Transport (GO:2000641),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.4991500912655562,MAP2K2,GO_Biological_Process_2023
978,Regulation Of Feeding Behavior (GO:0060259),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.4991500912655562,LEPR,GO_Biological_Process_2023
979,U2-type Prespliceosome Assembly (GO:1903241),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.4991500912655562,SNIP1,GO_Biological_Process_2023
980,Activation Of NF-kappaB-inducing Kinase Activity (GO:0007250),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.4991500912655562,ZFP91,GO_Biological_Process_2023
981,Amyloid Fibril Formation (GO:1990000),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.4991500912655562,MAPT,GO_Biological_Process_2023
982,Aspartate Family Amino Acid Metabolic Process (GO:0009066),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.4991500912655562,MSRA,GO_Biological_Process_2023
983,Astrocyte Development (GO:0014002),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.4991500912655562,MAPT,GO_Biological_Process_2023
984,Regulation Of Nitric-Oxide Synthase Biosynthetic Process (GO:0051769),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.4991500912655562,JAK2,GO_Biological_Process_2023
985,Base Conversion Or Substitution Editing (GO:0016553),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.4991500912655562,ADAR,GO_Biological_Process_2023
986,Branched-Chain Amino Acid Catabolic Process (GO:0009083),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.4991500912655562,HMGCL,GO_Biological_Process_2023
987,Calcium-Independent Cell-Cell Adhesion Via Plasma Membrane Cell-Adhesion Molecules (GO:0016338),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.4991500912655562,CLDN23,GO_Biological_Process_2023
988,Regulation Of Protein Neddylation (GO:2000434),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.4991500912655562,EPAS1,GO_Biological_Process_2023
989,Cellular Response To Fluid Shear Stress (GO:0071498),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.4991500912655562,MEF2C,GO_Biological_Process_2023
990,Regulation Of Superoxide Anion Generation (GO:0032928),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.4991500912655562,MAPT,GO_Biological_Process_2023
991,Cellular Response To Interleukin-12 (GO:0071349),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.4991500912655562,JAK2,GO_Biological_Process_2023
992,Chaperone Cofactor-Dependent Protein Refolding (GO:0051085),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.4991500912655562,HSPA8,GO_Biological_Process_2023
993,Relaxation Of Muscle (GO:0090075),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.4991500912655562,PIK3CA,GO_Biological_Process_2023
994,Cytoplasmic Sequestering Of Protein (GO:0051220),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.4991500912655562,MDFI,GO_Biological_Process_2023
995,Cytoplasmic Sequestering Of Transcription Factor (GO:0042994),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.4991500912655562,MDFI,GO_Biological_Process_2023
996,Detection Of Mechanical Stimulus Involved In Sensory Perception (GO:0050974),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.4991500912655562,KIT,GO_Biological_Process_2023
997,Self Proteolysis (GO:0097264),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.4991500912655562,TMPRSS6,GO_Biological_Process_2023
998,Endochondral Bone Morphogenesis (GO:0060350),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.4991500912655562,MEF2C,GO_Biological_Process_2023
999,Signal Peptide Processing (GO:0006465),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.4991500912655562,SPPL3,GO_Biological_Process_2023
1000,Smooth Muscle Cell Differentiation (GO:0051145),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.4991500912655562,MEF2C,GO_Biological_Process_2023
1001,snRNA 3'-End Processing (GO:0034472),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.4991500912655562,EXOSC9,GO_Biological_Process_2023
1002,snRNA Transcription By RNA Polymerase II (GO:0042795),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.4991500912655562,ICE2,GO_Biological_Process_2023
1003,Epiboly Involved In Wound Healing (GO:0090505),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.4991500912655562,RHOA,GO_Biological_Process_2023
1004,Excitatory Postsynaptic Potential (GO:0060079),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.4991500912655562,MEF2C,GO_Biological_Process_2023
1005,Icosanoid Transport (GO:0071715),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.4991500912655562,ABCC2,GO_Biological_Process_2023
1006,Insulin-Like Growth Factor Receptor Signaling Pathway (GO:0048009),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.4991500912655562,GIGYF1,GO_Biological_Process_2023
1007,Low-Density Lipoprotein Particle Remodeling (GO:0034374),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.4991500912655562,APOB,GO_Biological_Process_2023
1008,Lysosomal Membrane Organization (GO:0097212),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.4991500912655562,LAPTM4B,GO_Biological_Process_2023
1009,Negative Regulation Of Amyloid-Beta Formation (GO:1902430),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.4991500912655562,APOE,GO_Biological_Process_2023
1010,Negative Regulation Of Anoikis (GO:2000811),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.4991500912655562,PIK3CA,GO_Biological_Process_2023
1011,Negative Regulation Of Cell Activation (GO:0050866),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.4991500912655562,PDGFRA,GO_Biological_Process_2023
1012,Negative Regulation Of Complement Activation (GO:0045916),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.4991500912655562,SERPING1,GO_Biological_Process_2023
1013,Negative Regulation Of Hippo Signaling (GO:0035331),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.4991500912655562,DLG5,GO_Biological_Process_2023
1014,Negative Regulation Of Macrophage Activation (GO:0043031),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.4991500912655562,PTPRC,GO_Biological_Process_2023
1015,Negative Regulation Of Protein Localization To Plasma Membrane (GO:1903077),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.4991500912655562,TMBIM1,GO_Biological_Process_2023
1016,Neuron Projection Organization (GO:0106027),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.4991500912655562,PLS1,GO_Biological_Process_2023
1017,Nicotinamide Nucleotide Metabolic Process (GO:0046496),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.4991500912655562,TP53I3,GO_Biological_Process_2023
1018,Nitric Oxide Biosynthetic Process (GO:0006809),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.4991500912655562,SLC7A6,GO_Biological_Process_2023
1019,Phosphatidylinositol-3-Phosphate Biosynthetic Process (GO:0036092),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.4991500912655562,PIK3CA,GO_Biological_Process_2023
1020,Phospholipid Dephosphorylation (GO:0046839),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.4991500912655562,FIG4,GO_Biological_Process_2023
1021,Positive Regulation Of T-helper Cell Differentiation (GO:0045624),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.4991500912655562,NLRP3,GO_Biological_Process_2023
1022,Positive Regulation Of Insulin Secretion Involved In Cellular Response To Glucose Stimulus (GO:0035774),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.4991500912655562,STX4,GO_Biological_Process_2023
1023,Positive Regulation Of Leukocyte Adhesion To Vascular Endothelial Cell (GO:1904996),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.4991500912655562,RHOA,GO_Biological_Process_2023
1024,Positive Regulation Of Membrane Protein Ectodomain Proteolysis (GO:0051044),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.4991500912655562,APOE,GO_Biological_Process_2023
1025,Positive Regulation Of Telomere Capping (GO:1904355),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.4991500912655562,RTEL1,GO_Biological_Process_2023
1026,Positive Regulation Of Viral Life Cycle (GO:1903902),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.4991500912655562,TRIM38,GO_Biological_Process_2023
1027,Protein O-linked Glycosylation Via Threonine (GO:0018243),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.4991500912655562,GALNT2,GO_Biological_Process_2023
1028,Regulation Of Actin Filament Depolymerization (GO:0030834),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.4991500912655562,PIK3CA,GO_Biological_Process_2023
1029,Regulation Of Adipose Tissue Development (GO:1904177),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.4991500912655562,PPARG,GO_Biological_Process_2023
1030,Regulation Of Bone Remodeling (GO:0046850),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.4991500912655562,LEPR,GO_Biological_Process_2023
1031,Plasma Membrane Bounded Cell Projection Organization (GO:0120036),0.25635628048071935,1.5900826446280991,2.164399954258425,0.5067450044808012,"BLOC1S2,DOCK7,APOE,MAPT",GO_Biological_Process_2023
1032,Protein Modification By Small Protein Conjugation (GO:0032446),0.2576531501561841,1.3478055686644643,1.8278143617575835,0.5068328191381947,"TRIM4,BCL11A,ZMIZ2,NSMCE2,ARIH2,FBXL5,FBXO7,UBE2L3",GO_Biological_Process_2023
1033,Regulation Of Exocytosis (GO:0017157),0.2585627471976888,2.1082260074781884,2.851622081860491,0.5068328191381947,"STX4,RAB8A",GO_Biological_Process_2023
1034,SMAD Protein Signal Transduction (GO:0060395),0.2585627471976888,2.1082260074781884,2.851622081860491,0.5068328191381947,"ZMIZ2,BMP8A",GO_Biological_Process_2023
1035,Regulation Of Myoblast Differentiation (GO:0045661),0.2585627471976888,2.1082260074781884,2.851622081860491,0.5068328191381947,"MEF2C,FLOT2",GO_Biological_Process_2023
1036,Regulation Of Synapse Assembly (GO:0051963),0.2585627471976888,2.1082260074781884,2.851622081860491,0.5068328191381947,"MEF2C,DLG5",GO_Biological_Process_2023
1037,Cellular Response To Mechanical Stimulus (GO:0071260),0.2585627471976888,2.1082260074781884,2.851622081860491,0.5068328191381947,"MAP3K1,GADD45A",GO_Biological_Process_2023
1038,Cytoplasmic Translation (GO:0002181),0.2585627471976888,2.1082260074781884,2.851622081860491,0.5068328191381947,"RPS28,RPL22L1",GO_Biological_Process_2023
1039,Positive Regulation Of Reactive Oxygen Species Metabolic Process (GO:2000379),0.2585627471976888,2.1082260074781884,2.851622081860491,0.5068328191381947,"GADD45A,MAPT",GO_Biological_Process_2023
1040,Negative Regulation Of Cell Population Proliferation (GO:0008285),0.26066791596125793,1.2946033234359535,1.7406045697544648,0.5068328191381947,"KANK2,CEBPA,TFAP4,DLG5,PDCD5,PPARG,APOE,TRIB1,JAK2,SH2B3",GO_Biological_Process_2023
1041,Regulation Of ERK1 And ERK2 Cascade (GO:0070372),0.2613789323094081,1.375245040382655,1.8452818966675575,0.5068328191381947,"PDGFRA,MFHAS1,SPRED2,PTPN1,DSTYK,PTPRC,APOE",GO_Biological_Process_2023
1042,Positive Regulation Of Cytokine Production (GO:0001819),0.26215350710967766,1.3403064132220321,1.7944357897035648,0.5068328191381947,"TLR1,PTPRC,BTN3A1,CEBPG,NLRP3,BTN3A2,JAK2,IL6R",GO_Biological_Process_2023
1043,Gland Development (GO:0048732),0.262672288407135,1.731459841532235,2.314698756882004,0.5068328191381947,"CEBPA,CITED2,CEBPG",GO_Biological_Process_2023
1044,Negative Regulation Of Translation (GO:0017148),0.262672288407135,1.731459841532235,2.314698756882004,0.5068328191381947,"FTO,LARP1,CPEB4",GO_Biological_Process_2023
1045,Dephosphorylation (GO:0016311),0.2704465134065228,1.5495205216724204,2.0262784408178804,0.5068328191381947,"PTPN1,PTPRC,PPP2R2A,DUSP15",GO_Biological_Process_2023
1046,Regulation Of Dendrite Development (GO:0050773),0.27045945831080337,2.0377510040160645,2.664630598797084,0.5068328191381947,"BCL11A,SEZ6",GO_Biological_Process_2023
1047,Amide Biosynthetic Process (GO:0043604),0.27045945831080337,2.0377510040160645,2.664630598797084,0.5068328191381947,"SMPD2,SLC25A15",GO_Biological_Process_2023
1048,Autophagosome Assembly (GO:0000045),0.27045945831080337,2.0377510040160645,2.664630598797084,0.5068328191381947,"UBXN2A,WIPI2",GO_Biological_Process_2023
1049,Regulation Of Transcription Initiation By RNA Polymerase II (GO:0060260),0.27045945831080337,2.0377510040160645,2.664630598797084,0.5068328191381947,"GTF2A1,TAF8",GO_Biological_Process_2023
1050,Regulation Of Vascular Associated Smooth Muscle Cell Proliferation (GO:1904705),0.27045945831080337,2.0377510040160645,2.664630598797084,0.5068328191381947,"MEF2C,PPARG",GO_Biological_Process_2023
1051,Pattern Recognition Receptor Signaling Pathway (GO:0002221),0.27045945831080337,2.0377510040160645,2.664630598797084,0.5068328191381947,"TLR1,NLRP3",GO_Biological_Process_2023
1052,Positive Regulation Of Chemotaxis (GO:0050921),0.27045945831080337,2.0377510040160645,2.664630598797084,0.5068328191381947,"STX4,IL6R",GO_Biological_Process_2023
1053,Protein Polymerization (GO:0051258),0.27045945831080337,2.0377510040160645,2.664630598797084,0.5068328191381947,"MAPT,JAK2",GO_Biological_Process_2023
1054,Regulation Of Cell-Substrate Adhesion (GO:0010810),0.27045945831080337,2.0377510040160645,2.664630598797084,0.5068328191381947,"JAK2,RHOA",GO_Biological_Process_2023
1055,Negative Regulation Of Cell Cycle (GO:0045786),0.2713308110068603,1.6992279288351795,2.2165009437837093,0.5068328191381947,"CEBPA,TFAP4,DUSP1",GO_Biological_Process_2023
1056,Positive Regulation Of Cellular Component Organization (GO:0051130),0.2713308110068603,1.6992279288351795,2.2165009437837093,0.5068328191381947,"BCL2L11,TFRC,APOE",GO_Biological_Process_2023
1057,Positive Regulation Of Protein-Containing Complex Assembly (GO:0031334),0.2713308110068603,1.6992279288351795,2.2165009437837093,0.5068328191381947,"BCL2L11,TFRC,ATR",GO_Biological_Process_2023
1058,Peptidyl-Serine Phosphorylation (GO:0018105),0.2715087513490271,1.457953394123607,1.9008226391916403,0.5068328191381947,"MAP2K2,MAST3,MAST2,VRK2,ATR",GO_Biological_Process_2023
1059,Arp2/3 Complex-Mediated Actin Nucleation (GO:0034314),0.2760473156248264,3.3930597263930595,4.367488779253821,0.5068328191381947,ARPC1A,GO_Biological_Process_2023
1060,Regulation Of Chromatin Organization (GO:1902275),0.2760473156248264,3.3930597263930595,4.367488779253821,0.5068328191381947,KANSL1,GO_Biological_Process_2023
1061,Regulation Of Leukocyte Activation (GO:0002694),0.2760473156248264,3.3930597263930595,4.367488779253821,0.5068328191381947,MFHAS1,GO_Biological_Process_2023
1062,Acute-Phase Response (GO:0006953),0.2760473156248264,3.3930597263930595,4.367488779253821,0.5068328191381947,IL6R,GO_Biological_Process_2023
1063,Regulation Of Meiotic Cell Cycle (GO:0051445),0.2760473156248264,3.3930597263930595,4.367488779253821,0.5068328191381947,DUSP1,GO_Biological_Process_2023
1064,Antigen Processing And Presentation Of Peptide Antigen Via MHC Class I (GO:0002474),0.2760473156248264,3.3930597263930595,4.367488779253821,0.5068328191381947,HFE,GO_Biological_Process_2023
1065,Autophagy Of Nucleus (GO:0044804),0.2760473156248264,3.3930597263930595,4.367488779253821,0.5068328191381947,WIPI2,GO_Biological_Process_2023
1066,Regulation Of Viral Life Cycle (GO:1903900),0.2760473156248264,3.3930597263930595,4.367488779253821,0.5068328191381947,TRIM38,GO_Biological_Process_2023
1067,Relaxation Of Cardiac Muscle (GO:0055119),0.2760473156248264,3.3930597263930595,4.367488779253821,0.5068328191381947,PIK3CA,GO_Biological_Process_2023
1068,Response To Interferon-Alpha (GO:0035455),0.2760473156248264,3.3930597263930595,4.367488779253821,0.5068328191381947,AXL,GO_Biological_Process_2023
1069,Digestive System Development (GO:0055123),0.2760473156248264,3.3930597263930595,4.367488779253821,0.5068328191381947,KIT,GO_Biological_Process_2023
1070,Reverse Cholesterol Transport (GO:0043691),0.2760473156248264,3.3930597263930595,4.367488779253821,0.5068328191381947,APOE,GO_Biological_Process_2023
1071,Embryonic Heart Tube Development (GO:0035050),0.2760473156248264,3.3930597263930595,4.367488779253821,0.5068328191381947,CITED2,GO_Biological_Process_2023
1072,Endoderm Development (GO:0007492),0.2760473156248264,3.3930597263930595,4.367488779253821,0.5068328191381947,DUSP1,GO_Biological_Process_2023
1073,Sphingolipid Catabolic Process (GO:0030149),0.2760473156248264,3.3930597263930595,4.367488779253821,0.5068328191381947,SMPD2,GO_Biological_Process_2023
1074,Epithelial Cilium Movement Involved In Extracellular Fluid Movement (GO:0003351),0.2760473156248264,3.3930597263930595,4.367488779253821,0.5068328191381947,NPHP3,GO_Biological_Process_2023
1075,Fatty Acid Beta-Oxidation Using acyl-CoA Oxidase (GO:0033540),0.2760473156248264,3.3930597263930595,4.367488779253821,0.5068328191381947,ACOXL,GO_Biological_Process_2023
1076,fatty-acyl-CoA Metabolic Process (GO:0035337),0.2760473156248264,3.3930597263930595,4.367488779253821,0.5068328191381947,GCDH,GO_Biological_Process_2023
1077,Gas Transport (GO:0015669),0.2760473156248264,3.3930597263930595,4.367488779253821,0.5068328191381947,HBZ,GO_Biological_Process_2023
1078,Glucose 6-Phosphate Metabolic Process (GO:0051156),0.2760473156248264,3.3930597263930595,4.367488779253821,0.5068328191381947,HK1,GO_Biological_Process_2023
1079,Vascular Endothelial Growth Factor Signaling Pathway (GO:0038084),0.2760473156248264,3.3930597263930595,4.367488779253821,0.5068328191381947,PIK3CA,GO_Biological_Process_2023
1080,Hydrogen Peroxide Catabolic Process (GO:0042744),0.2760473156248264,3.3930597263930595,4.367488779253821,0.5068328191381947,HBZ,GO_Biological_Process_2023
1081,Immunoglobulin Mediated Immune Response (GO:0016064),0.2760473156248264,3.3930597263930595,4.367488779253821,0.5068328191381947,IL2RB,GO_Biological_Process_2023
1082,"mRNA Cis Splicing, Via Spliceosome (GO:0045292)",0.2760473156248264,3.3930597263930595,4.367488779253821,0.5068328191381947,WBP4,GO_Biological_Process_2023
1083,Modulation By Symbiont Of Entry Into Host (GO:0052372),0.2760473156248264,3.3930597263930595,4.367488779253821,0.5068328191381947,TRIM38,GO_Biological_Process_2023
1084,Morphogenesis Of A Polarized Epithelium (GO:0001738),0.2760473156248264,3.3930597263930595,4.367488779253821,0.5068328191381947,AHI1,GO_Biological_Process_2023
1085,Negative Regulation Of DNA Recombination (GO:0045910),0.2760473156248264,3.3930597263930595,4.367488779253821,0.5068328191381947,RTEL1,GO_Biological_Process_2023
1086,Negative Regulation Of Cardiac Muscle Hypertrophy (GO:0010614),0.2760473156248264,3.3930597263930595,4.367488779253821,0.5068328191381947,PPARG,GO_Biological_Process_2023
1087,Negative Regulation Of Cytokine Production Involved In Immune Response (GO:0002719),0.2760473156248264,3.3930597263930595,4.367488779253821,0.5068328191381947,HFE,GO_Biological_Process_2023
1088,Negative Regulation Of Homotypic Cell-Cell Adhesion (GO:0034111),0.2760473156248264,3.3930597263930595,4.367488779253821,0.5068328191381947,SH2B3,GO_Biological_Process_2023
1089,Negative Regulation Of Interleukin-2 Production (GO:0032703),0.2760473156248264,3.3930597263930595,4.367488779253821,0.5068328191381947,PTPRC,GO_Biological_Process_2023
1090,Negative Regulation Of Macrophage Derived Foam Cell Differentiation (GO:0010745),0.2760473156248264,3.3930597263930595,4.367488779253821,0.5068328191381947,PPARG,GO_Biological_Process_2023
1091,Negative Regulation Of Mononuclear Cell Migration (GO:0071676),0.2760473156248264,3.3930597263930595,4.367488779253821,0.5068328191381947,DUSP1,GO_Biological_Process_2023
1092,Negative Regulation Of Reproductive Process (GO:2000242),0.2760473156248264,3.3930597263930595,4.367488779253821,0.5068328191381947,DUSP1,GO_Biological_Process_2023
1093,Negative Regulation Of Response To Endoplasmic Reticulum Stress (GO:1903573),0.2760473156248264,3.3930597263930595,4.367488779253821,0.5068328191381947,PTPN1,GO_Biological_Process_2023
1094,Nitric Oxide Mediated Signal Transduction (GO:0007263),0.2760473156248264,3.3930597263930595,4.367488779253821,0.5068328191381947,APOE,GO_Biological_Process_2023
1095,Nitric Oxide Metabolic Process (GO:0046209),0.2760473156248264,3.3930597263930595,4.367488779253821,0.5068328191381947,SLC7A6,GO_Biological_Process_2023
1096,Nuclear Migration (GO:0007097),0.2760473156248264,3.3930597263930595,4.367488779253821,0.5068328191381947,DOCK7,GO_Biological_Process_2023
1097,Nucleosome Disassembly (GO:0006337),0.2760473156248264,3.3930597263930595,4.367488779253821,0.5068328191381947,NFE2,GO_Biological_Process_2023
1098,Pancreas Development (GO:0031016),0.2760473156248264,3.3930597263930595,4.367488779253821,0.5068328191381947,NPHP3,GO_Biological_Process_2023
1099,Photoreceptor Cell Development (GO:0042461),0.2760473156248264,3.3930597263930595,4.367488779253821,0.5068328191381947,RP1L1,GO_Biological_Process_2023
1100,Polarized Epithelial Cell Differentiation (GO:0030859),0.2760473156248264,3.3930597263930595,4.367488779253821,0.5068328191381947,RHOA,GO_Biological_Process_2023
1101,Positive Regulation By Host Of Viral Transcription (GO:0043923),0.2760473156248264,3.3930597263930595,4.367488779253821,0.5068328191381947,TFAP4,GO_Biological_Process_2023
1102,Positive Regulation Of Adaptive Immune Response Based On Somatic Recombination Of Immune Receptors Built From Immunoglobulin Superfamily Domains (GO:0002824),0.2760473156248264,3.3930597263930595,4.367488779253821,0.5068328191381947,JAK2,GO_Biological_Process_2023
1103,Positive Regulation Of Alpha-Beta T Cell Proliferation (GO:0046641),0.2760473156248264,3.3930597263930595,4.367488779253821,0.5068328191381947,JAK2,GO_Biological_Process_2023
1104,Positive Regulation Of Mitotic Sister Chromatid Separation (GO:1901970),0.2760473156248264,3.3930597263930595,4.367488779253821,0.5068328191381947,NSMCE2,GO_Biological_Process_2023
1105,Positive Regulation Of Smoothened Signaling Pathway (GO:0045880),0.2760473156248264,3.3930597263930595,4.367488779253821,0.5068328191381947,DLG5,GO_Biological_Process_2023
1106,Positive Regulation Of Transcription By RNA Polymerase III (GO:0045945),0.2760473156248264,3.3930597263930595,4.367488779253821,0.5068328191381947,ICE2,GO_Biological_Process_2023
1107,Positive Regulation Of Type 2 Immune Response (GO:0002830),0.2760473156248264,3.3930597263930595,4.367488779253821,0.5068328191381947,NLRP3,GO_Biological_Process_2023
1108,Protein Deacylation (GO:0035601),0.2760473156248264,3.3930597263930595,4.367488779253821,0.5068328191381947,SIRT3,GO_Biological_Process_2023
1109,Protein Localization To Mitochondrion (GO:0070585),0.2760473156248264,3.3930597263930595,4.367488779253821,0.5068328191381947,HK1,GO_Biological_Process_2023
1110,Regulation Of Brown Fat Cell Differentiation (GO:0090335),0.2760473156248264,3.3930597263930595,4.367488779253821,0.5068328191381947,FTO,GO_Biological_Process_2023
1111,Activation Of Protein Kinase Activity (GO:0032147),0.28002009647924414,1.6681680856907444,2.1234009892054697,0.5136642273849681,"ZFP91,PILRB,JAK2",GO_Biological_Process_2023
1112,Negative Regulation Of Cell Differentiation (GO:0045596),0.2805421448292483,1.381578947368421,1.7560301081289498,0.5137777920831514,"ASXL1,SPRED2,MYB,NPHP3,PPARG,ANP32B",GO_Biological_Process_2023
1113,Rho Protein Signal Transduction (GO:0007266),0.28235089653244827,1.9718227749708512,2.493576284940006,0.5137777920831514,"MYO9B,RHOA",GO_Biological_Process_2023
1114,Regulation Of Peptide Hormone Secretion (GO:0090276),0.28235089653244827,1.9718227749708512,2.493576284940006,0.5137777920831514,"HADHA,HFE",GO_Biological_Process_2023
1115,Cell Chemotaxis (GO:0060326),0.28235089653244827,1.9718227749708512,2.493576284940006,0.5137777920831514,"PDGFRA,KIT",GO_Biological_Process_2023
1116,Regulation Of Telomere Maintenance Via Telomerase (GO:0032210),0.28235089653244827,1.9718227749708512,2.493576284940006,0.5137777920831514,"XRN1,ATR",GO_Biological_Process_2023
1117,Response To Light Stimulus (GO:0009416),0.28235089653244827,1.9718227749708512,2.493576284940006,0.5137777920831514,"CPT1B,DDB2",GO_Biological_Process_2023
1118,Signal Transduction In Response To DNA Damage (GO:0042770),0.28235089653244827,1.9718227749708512,2.493576284940006,0.5137777920831514,"GADD45A,ATR",GO_Biological_Process_2023
1119,Positive Regulation Of DNA-templated Transcription Initiation (GO:2000144),0.28235089653244827,1.9718227749708512,2.493576284940006,0.5137777920831514,"GTF2A1,TAF8",GO_Biological_Process_2023
1120,Positive Regulation Of Biosynthetic Process (GO:0009891),0.28235089653244827,1.9718227749708512,2.493576284940006,0.5137777920831514,"HSD17B13,APOE",GO_Biological_Process_2023
1121,Response To Cytokine (GO:0034097),0.2846687452653117,1.5109614665170221,1.8984159132332938,0.5174089035760495,"ADAR,JAK2,IL6R,RHOA",GO_Biological_Process_2023
1122,Regulation Of Actin Cytoskeleton Organization (GO:0032956),0.28873476314902763,1.6382175226586102,2.0350704536897366,0.5174089035760495,"PDGFRA,PIK3CA,RHOA",GO_Biological_Process_2023
1123,Positive Regulation Of MAPK Cascade (GO:0043410),0.2896245539407356,1.2969779595546467,1.607175965900902,0.5174089035760495,"PDGFRA,MFHAS1,MEF2C,DSTYK,DOK2,PTPRC,KIT,APOE",GO_Biological_Process_2023
1124,Positive Regulation Of ERK1 And ERK2 Cascade (GO:0070374),0.2899637597154422,1.4170325340538106,1.7542853281847621,0.5174089035760495,"PDGFRA,MFHAS1,DSTYK,PTPRC,APOE",GO_Biological_Process_2023
1125,Protein Polyubiquitination (GO:0000209),0.2915527732240877,1.360840108401084,1.6772820415037608,0.5174089035760495,"ARIH2,ZFP91,TRIM38,FBXO7,UBE2L3,DDB2",GO_Biological_Process_2023
1126,G1/S Transition Of Mitotic Cell Cycle (GO:0000082),0.294225419472405,1.9100150602409638,2.3367297533746547,0.5174089035760495,"CCND3,CCND2",GO_Biological_Process_2023
1127,Actin Polymerization Or Depolymerization (GO:0008154),0.294225419472405,1.9100150602409638,2.3367297533746547,0.5174089035760495,"MICAL1,JAK2",GO_Biological_Process_2023
1128,Apical Junction Assembly (GO:0043297),0.294225419472405,1.9100150602409638,2.3367297533746547,0.5174089035760495,"CLDN23,RHOA",GO_Biological_Process_2023
1129,Cholesterol Transport (GO:0030301),0.294225419472405,1.9100150602409638,2.3367297533746547,0.5174089035760495,"APOE,APOB",GO_Biological_Process_2023
1130,Transcription Initiation At RNA Polymerase II Promoter (GO:0006367),0.294225419472405,1.9100150602409638,2.3367297533746547,0.5174089035760495,"GTF2A1,TAF8",GO_Biological_Process_2023
1131,Phospholipid Metabolic Process (GO:0006644),0.294225419472405,1.9100150602409638,2.3367297533746547,0.5174089035760495,"SMPD2,PLD1",GO_Biological_Process_2023
1132,Positive Regulation Of Developmental Growth (GO:0048639),0.294225419472405,1.9100150602409638,2.3367297533746547,0.5174089035760495,"MACF1,MAPT",GO_Biological_Process_2023
1133,Regulation Of Defense Response (GO:0031347),0.29746957034264254,1.6093178565749722,1.9512067232473926,0.5174089035760495,"IL37,APOE,JAK2",GO_Biological_Process_2023
1134,Positive Regulation Of DNA Metabolic Process (GO:0051054),0.29746957034264254,1.6093178565749722,1.9512067232473926,0.5174089035760495,"RTEL1,RAD50,CEBPG",GO_Biological_Process_2023
1135,Positive Regulation Of Cell Adhesion (GO:0045785),0.29746957034264254,1.6093178565749722,1.9512067232473926,0.5174089035760495,"CITED2,STX4,JAK2",GO_Biological_Process_2023
1136,RNA Destabilization (GO:0050779),0.29907148597280975,3.0534534534534536,3.685740153685031,0.5174089035760495,FTO,GO_Biological_Process_2023
1137,T Cell Differentiation In Thymus (GO:0033077),0.29907148597280975,3.0534534534534536,3.685740153685031,0.5174089035760495,PTPRC,GO_Biological_Process_2023
1138,Regulation Of Mitotic Cell Cycle Spindle Assembly Checkpoint (GO:0090266),0.29907148597280975,3.0534534534534536,3.685740153685031,0.5174089035760495,DUSP1,GO_Biological_Process_2023
1139,Atrial Septum Development (GO:0003283),0.29907148597280975,3.0534534534534536,3.685740153685031,0.5174089035760495,NPHP3,GO_Biological_Process_2023
1140,Regulation Of Neurotransmitter Transport (GO:0051588),0.29907148597280975,3.0534534534534536,3.685740153685031,0.5174089035760495,MEF2C,GO_Biological_Process_2023
1141,Regulation Of Non-Canonical Wnt Signaling Pathway (GO:2000050),0.29907148597280975,3.0534534534534536,3.685740153685031,0.5174089035760495,NPHP3,GO_Biological_Process_2023
1142,Calcium-Mediated Signaling Using Intracellular Calcium Source (GO:0035584),0.29907148597280975,3.0534534534534536,3.685740153685031,0.5174089035760495,PTPRC,GO_Biological_Process_2023
1143,Regulation Of Protein Deacetylation (GO:0090311),0.29907148597280975,3.0534534534534536,3.685740153685031,0.5174089035760495,SPRED2,GO_Biological_Process_2023
1144,Cardiac Myofibril Assembly (GO:0055003),0.29907148597280975,3.0534534534534536,3.685740153685031,0.5174089035760495,PDGFRA,GO_Biological_Process_2023
1145,Regulation Of Telomere Maintenance Via Telomere Lengthening (GO:1904356),0.29907148597280975,3.0534534534534536,3.685740153685031,0.5174089035760495,RTEL1,GO_Biological_Process_2023
1146,Regulation Of Transcription By RNA Polymerase I (GO:0006356),0.29907148597280975,3.0534534534534536,3.685740153685031,0.5174089035760495,BEND3,GO_Biological_Process_2023
1147,Regulation Of Tubulin Deacetylation (GO:0090043),0.29907148597280975,3.0534534534534536,3.685740153685031,0.5174089035760495,MAPT,GO_Biological_Process_2023
1148,Central Nervous System Neuron Development (GO:0021954),0.29907148597280975,3.0534534534534536,3.685740153685031,0.5174089035760495,MAPT,GO_Biological_Process_2023
1149,"Chemical Synaptic Transmission, Postsynaptic (GO:0099565)",0.29907148597280975,3.0534534534534536,3.685740153685031,0.5174089035760495,MEF2C,GO_Biological_Process_2023
1150,Contractile Actin Filament Bundle Assembly (GO:0030038),0.29907148597280975,3.0534534534534536,3.685740153685031,0.5174089035760495,RHOA,GO_Biological_Process_2023
1151,Response To Gamma Radiation (GO:0010332),0.29907148597280975,3.0534534534534536,3.685740153685031,0.5174089035760495,ATR,GO_Biological_Process_2023
1152,Response To Muscle Stretch (GO:0035994),0.29907148597280975,3.0534534534534536,3.685740153685031,0.5174089035760495,PIK3CA,GO_Biological_Process_2023
1153,Retinal Metabolic Process (GO:0042574),0.29907148597280975,3.0534534534534536,3.685740153685031,0.5174089035760495,ALDH8A1,GO_Biological_Process_2023
1154,Embryonic Cranial Skeleton Morphogenesis (GO:0048701),0.29907148597280975,3.0534534534534536,3.685740153685031,0.5174089035760495,PDGFRA,GO_Biological_Process_2023
1155,Endosome To Lysosome Transport Via Multivesicular Body Sorting Pathway (GO:0032510),0.29907148597280975,3.0534534534534536,3.685740153685031,0.5174089035760495,UBXN6,GO_Biological_Process_2023
1156,snRNA Transcription (GO:0009301),0.29907148597280975,3.0534534534534536,3.685740153685031,0.5174089035760495,ICE2,GO_Biological_Process_2023
1157,Stress Fiber Assembly (GO:0043149),0.29907148597280975,3.0534534534534536,3.685740153685031,0.5174089035760495,RHOA,GO_Biological_Process_2023
1158,Stress Granule Assembly (GO:0034063),0.29907148597280975,3.0534534534534536,3.685740153685031,0.5174089035760495,MAPT,GO_Biological_Process_2023
1159,Establishment Of Protein Localization To Endoplasmic Reticulum (GO:0072599),0.29907148597280975,3.0534534534534536,3.685740153685031,0.5174089035760495,SRP14,GO_Biological_Process_2023
1160,Substrate-Dependent Cell Migration (GO:0006929),0.29907148597280975,3.0534534534534536,3.685740153685031,0.5174089035760495,PTPRC,GO_Biological_Process_2023
1161,"Synaptic Transmission, Cholinergic (GO:0007271)",0.29907148597280975,3.0534534534534536,3.685740153685031,0.5174089035760495,APOE,GO_Biological_Process_2023
1162,Gastrulation (GO:0007369),0.29907148597280975,3.0534534534534536,3.685740153685031,0.5174089035760495,NPHP3,GO_Biological_Process_2023
1163,Histone H2A Acetylation (GO:0043968),0.29907148597280975,3.0534534534534536,3.685740153685031,0.5174089035760495,TRRAP,GO_Biological_Process_2023
1164,Mesoderm Development (GO:0007498),0.29907148597280975,3.0534534534534536,3.685740153685031,0.5174089035760495,JAK2,GO_Biological_Process_2023
1165,Negative Regulation Of Actin Filament Polymerization (GO:0030837),0.29907148597280975,3.0534534534534536,3.685740153685031,0.5174089035760495,PFN4,GO_Biological_Process_2023
1166,Negative Regulation Of Epithelial Cell Differentiation (GO:0030857),0.29907148597280975,3.0534534534534536,3.685740153685031,0.5174089035760495,SPRED2,GO_Biological_Process_2023
1167,Negative Regulation Of Extrinsic Apoptotic Signaling Pathway In Absence Of Ligand (GO:2001240),0.29907148597280975,3.0534534534534536,3.685740153685031,0.5174089035760495,TERT,GO_Biological_Process_2023
1168,Negative Regulation Of Peptidyl-Threonine Phosphorylation (GO:0010801),0.29907148597280975,3.0534534534534536,3.685740153685031,0.5174089035760495,SPRED2,GO_Biological_Process_2023
1169,Negative Regulation Of Protein Dephosphorylation (GO:0035308),0.29907148597280975,3.0534534534534536,3.685740153685031,0.5174089035760495,MFHAS1,GO_Biological_Process_2023
1170,Negative Regulation Of Protein Depolymerization (GO:1901880),0.29907148597280975,3.0534534534534536,3.685740153685031,0.5174089035760495,PIK3CA,GO_Biological_Process_2023
1171,Negative Regulation Of Signal Transduction In Absence Of Ligand (GO:1901099),0.29907148597280975,3.0534534534534536,3.685740153685031,0.5174089035760495,TERT,GO_Biological_Process_2023
1172,Negative Regulation Of Telomere Maintenance Via Telomerase (GO:0032211),0.29907148597280975,3.0534534534534536,3.685740153685031,0.5174089035760495,XRN1,GO_Biological_Process_2023
1173,Nuclear Pore Organization (GO:0006999),0.29907148597280975,3.0534534534534536,3.685740153685031,0.5174089035760495,NUP205,GO_Biological_Process_2023
1174,Positive Regulation Of Antigen Receptor-Mediated Signaling Pathway (GO:0050857),0.29907148597280975,3.0534534534534536,3.685740153685031,0.5174089035760495,PTPRC,GO_Biological_Process_2023
1175,Positive Regulation Of Cardiac Muscle Cell Proliferation (GO:0060045),0.29907148597280975,3.0534534534534536,3.685740153685031,0.5174089035760495,MEF2C,GO_Biological_Process_2023
1176,Positive Regulation Of Leukocyte Activation (GO:0002696),0.29907148597280975,3.0534534534534536,3.685740153685031,0.5174089035760495,CEBPA,GO_Biological_Process_2023
1177,Positive Regulation Of Smooth Muscle Cell Migration (GO:0014911),0.29907148597280975,3.0534534534534536,3.685740153685031,0.5174089035760495,DOCK7,GO_Biological_Process_2023
1178,Regulation Of Anoikis (GO:2000209),0.29907148597280975,3.0534534534534536,3.685740153685031,0.5174089035760495,PIK3CA,GO_Biological_Process_2023
1179,Muscle Organ Development (GO:0007517),0.3060721256646625,1.8519532676159183,2.192591365950232,0.5275360767182975,"MEF2C,TAGLN",GO_Biological_Process_2023
1180,Positive Regulation Of Interleukin-1 Beta Production (GO:0032731),0.3060721256646625,1.8519532676159183,2.192591365950232,0.5275360767182975,"NLRP3,JAK2",GO_Biological_Process_2023
1181,Positive Regulation Of Osteoblast Differentiation (GO:0045669),0.3060721256646625,1.8519532676159183,2.192591365950232,0.5275360767182975,"MEF2C,IL6R",GO_Biological_Process_2023
1182,Ras Protein Signal Transduction (GO:0007265),0.30619672351044575,1.4565656565656566,1.7238855047178703,0.5275360767182975,"DOK2,MYO9B,PLD1,RHOA",GO_Biological_Process_2023
1183,Vascular Transport (GO:0010232),0.3062194203914357,1.5814147307011146,1.8715305985704085,0.5275360767182975,"ABCC2,TFRC,LEPR",GO_Biological_Process_2023
1184,Positive Regulation Of Protein Modification Process (GO:0031401),0.30822978982455046,1.3308589607635206,1.5663008246758157,0.5305509389040827,"CCND3,CCND2,TFRC,FAXDC2,LEPR,SPPL3",GO_Biological_Process_2023
1185,Transmembrane Receptor Protein Serine/Threonine Kinase Signaling Pathway (GO:0007178),0.3134128482502873,1.4392869875222816,1.6699096318534767,0.5320413905246478,"HFE,ZMIZ2,BMP8A,PPARG",GO_Biological_Process_2023
1186,Peptidyl-Serine Modification (GO:0018209),0.3148988061137183,1.3658814589665653,1.5782814104152814,0.5320413905246478,"MAST3,GALNT2,MAST2,VRK2,ATR",GO_Biological_Process_2023
1187,Regulation Of Cellular Response To Stress (GO:0080135),0.31497935978187597,1.5544574735009473,1.7957841466387816,0.5320413905246478,"TRRAP,MAPT,ATR",GO_Biological_Process_2023
1188,Regulation Of Insulin Secretion (GO:0050796),0.31497935978187597,1.5544574735009473,1.7957841466387816,0.5320413905246478,"BLK,HADHA,BMP8A",GO_Biological_Process_2023
1189,Transport Across Blood-Brain Barrier (GO:0150104),0.31497935978187597,1.5544574735009473,1.7957841466387816,0.5320413905246478,"ABCC2,TFRC,LEPR",GO_Biological_Process_2023
1190,Regulation Of DNA Metabolic Process (GO:0051052),0.31497935978187597,1.5544574735009473,1.7957841466387816,0.5320413905246478,"TRRAP,ZBTB38,NSMCE2",GO_Biological_Process_2023
1191,Negative Regulation Of Neuron Projection Development (GO:0010977),0.31788081930037987,1.7973068745570517,2.0598552135069905,0.5320413905246478,"BCL11A,APOE",GO_Biological_Process_2023
1192,Positive Regulation Of Protein Localization To Plasma Membrane (GO:1903078),0.31788081930037987,1.7973068745570517,2.0598552135069905,0.5320413905246478,"STX4,PLS1",GO_Biological_Process_2023
1193,Protein Lipidation (GO:0006497),0.31788081930037987,1.7973068745570517,2.0598552135069905,0.5320413905246478,"PGAP3,WIPI2",GO_Biological_Process_2023
1194,Positive Regulation Of NF-kappaB Transcription Factor Activity (GO:0051092),0.3206442605929114,1.4224101479915434,1.6178820075698062,0.5320413905246478,"TFRC,NLRP3,FLOT2,TRIM38",GO_Biological_Process_2023
1195,Phosphorylation (GO:0016310),0.32067125791987283,1.2038699690402477,1.3692080250408862,0.5320413905246478,"GK5,MAP3K1,PIK3CA,MAST2,TNK2,TAF8,VRK2,TRIB1,JAK2,HK1,ATR",GO_Biological_Process_2023
1196,DNA Methylation (GO:0006306),0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5320413905246478,BEND3,GO_Biological_Process_2023
1197,RNA Phosphodiester Bond Hydrolysis (GO:0090501),0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5320413905246478,XRN1,GO_Biological_Process_2023
1198,Actin Nucleation (GO:0045010),0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5320413905246478,ARPC1A,GO_Biological_Process_2023
1199,Regulation Of Leukocyte Chemotaxis (GO:0002688),0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5320413905246478,IL6R,GO_Biological_Process_2023
1200,Carbohydrate Derivative Transport (GO:1901264),0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5320413905246478,PLTP,GO_Biological_Process_2023
1201,Cellular Response To Estrogen Stimulus (GO:0071391),0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5320413905246478,NCOA4,GO_Biological_Process_2023
1202,Regulation Of Transcription By RNA Polymerase III (GO:0006359),0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5320413905246478,ICE2,GO_Biological_Process_2023
1203,Cellular Response To Unfolded Protein (GO:0034620),0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5320413905246478,PTPN1,GO_Biological_Process_2023
1204,Rescue Of Stalled Ribosome (GO:0072344),0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5320413905246478,HBS1L,GO_Biological_Process_2023
1205,Response To Nerve Growth Factor (GO:1990089),0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5320413905246478,MAPT,GO_Biological_Process_2023
1206,Digestive Tract Morphogenesis (GO:0048546),0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5320413905246478,PDGFRA,GO_Biological_Process_2023
1207,Endoplasmic Reticulum Calcium Ion Homeostasis (GO:0032469),0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5320413905246478,KCTD17,GO_Biological_Process_2023
1208,Energy Reserve Metabolic Process (GO:0006112),0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5320413905246478,LEPR,GO_Biological_Process_2023
1209,Zinc Ion Transmembrane Transport (GO:0071577),0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5320413905246478,SLC39A13,GO_Biological_Process_2023
1210,Inner Mitochondrial Membrane Organization (GO:0007007),0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5320413905246478,SAMM50,GO_Biological_Process_2023
1211,Intracellular Estrogen Receptor Signaling Pathway (GO:0030520),0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5320413905246478,NCOA4,GO_Biological_Process_2023
1212,Maintenance Of Protein Location In Nucleus (GO:0051457),0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5320413905246478,TAF8,GO_Biological_Process_2023
1213,Mammary Gland Epithelium Development (GO:0061180),0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5320413905246478,JAK2,GO_Biological_Process_2023
1214,Mitotic Cell Cycle Checkpoint Signaling (GO:0007093),0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5320413905246478,RAD50,GO_Biological_Process_2023
1215,Mitotic Cytokinetic Process (GO:1902410),0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5320413905246478,RHOA,GO_Biological_Process_2023
1216,Natural Killer Cell Mediated Cytotoxicity (GO:0042267),0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5320413905246478,CEBPG,GO_Biological_Process_2023
1217,Negative Regulation Of miRNA Metabolic Process (GO:2000629),0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5320413905246478,PPARG,GO_Biological_Process_2023
1218,Negative Regulation Of miRNA Transcription (GO:1902894),0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5320413905246478,PPARG,GO_Biological_Process_2023
1219,Negative Regulation Of Oxidative Stress-Induced Cell Death (GO:1903202),0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5320413905246478,FBXO7,GO_Biological_Process_2023
1220,Negative Regulation Of Protein Localization To Membrane (GO:1905476),0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5320413905246478,TMBIM1,GO_Biological_Process_2023
1221,Negative Regulation Of Protein Localization To Nucleus (GO:1900181),0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5320413905246478,MFHAS1,GO_Biological_Process_2023
1222,Nuclear-Transcribed mRNA poly(A) Tail Shortening (GO:0000289),0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5320413905246478,CNOT8,GO_Biological_Process_2023
1223,Positive Regulation Of Homotypic Cell-Cell Adhesion (GO:0034112),0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5320413905246478,JAK2,GO_Biological_Process_2023
1224,Positive Regulation Of Leukocyte Proliferation (GO:0070665),0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5320413905246478,JAK2,GO_Biological_Process_2023
1225,Positive Regulation Of Macrophage Derived Foam Cell Differentiation (GO:0010744),0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5320413905246478,APOB,GO_Biological_Process_2023
1226,Positive Regulation Of Myeloid Leukocyte Cytokine Production Involved In Immune Response (GO:0061081),0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5320413905246478,KIT,GO_Biological_Process_2023
1227,Positive Regulation Of Ubiquitin-Protein Transferase Activity (GO:0051443),0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5320413905246478,UBE2L3,GO_Biological_Process_2023
1228,protein-DNA Complex Disassembly (GO:0032986),0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5320413905246478,NFE2,GO_Biological_Process_2023
1229,Regulation Of NMDA Receptor Activity (GO:2000310),0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5320413905246478,MEF2C,GO_Biological_Process_2023
1230,Regulation Of T Cell Cytokine Production (GO:0002724),0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5320413905246478,HFE,GO_Biological_Process_2023
1231,Regulation Of Autophagy Of Mitochondrion (GO:1903146),0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5320413905246478,FBXO7,GO_Biological_Process_2023
1232,Axon Development (GO:0061564),0.32374458038296294,1.5283987915407855,1.7237287779939032,0.5346770298383132,"DOCK7,MAPT,RAB8A",GO_Biological_Process_2023
1233,Peptide Biosynthetic Process (GO:0043043),0.32374458038296294,1.5283987915407855,1.7237287779939032,0.5346770298383132,"HBS1L,RPS28,PABPC4",GO_Biological_Process_2023
1234,protein-RNA Complex Assembly (GO:0022618),0.32374458038296294,1.5283987915407855,1.7237287779939032,0.5346770298383132,"RPS28,RSRP1,ADAR",GO_Biological_Process_2023
1235,Endomembrane System Organization (GO:0010256),0.32747267975456223,1.3416520023462912,1.4977540821873454,0.5400404732369802,"LAPTM4B,ARHGAP21,UBXN2A,TLCD1,RAB8A",GO_Biological_Process_2023
1236,Regulation Of Neuron Death (GO:1901214),0.32964197679430984,1.7457831325301205,1.9373795706862602,0.5400404732369802,"MEF2C,MAPT",GO_Biological_Process_2023
1237,Cellular Response To Ketone (GO:1901655),0.32964197679430984,1.7457831325301205,1.9373795706862602,0.5400404732369802,"LARP1,NCOA4",GO_Biological_Process_2023
1238,Inorganic Anion Transport (GO:0015698),0.32964197679430984,1.7457831325301205,1.9373795706862602,0.5400404732369802,"SLC17A1,SLC17A3",GO_Biological_Process_2023
1239,Memory (GO:0007613),0.32964197679430984,1.7457831325301205,1.9373795706862602,0.5400404732369802,"MAPT,APOE",GO_Biological_Process_2023
1240,Monoatomic Anion Transport (GO:0006820),0.32964197679430984,1.7457831325301205,1.9373795706862602,0.5400404732369802,"SLC17A1,SLC17A3",GO_Biological_Process_2023
1241,Phosphatidylinositol Metabolic Process (GO:0046488),0.32964197679430984,1.7457831325301205,1.9373795706862602,0.5400404732369802,"FIG4,PGAP3",GO_Biological_Process_2023
1242,Positive Regulation Of Protein Localization To Cell Periphery (GO:1904377),0.32964197679430984,1.7457831325301205,1.9373795706862602,0.5400404732369802,"STX4,PLS1",GO_Biological_Process_2023
1243,Protein-Containing Complex Disassembly (GO:0032984),0.32964197679430984,1.7457831325301205,1.9373795706862602,0.5400404732369802,"HSPA8,WIPI2",GO_Biological_Process_2023
1244,Regulation Of Cell Communication (GO:0010646),0.32964197679430984,1.7457831325301205,1.9373795706862602,0.5400404732369802,"PTPN1,TYMP",GO_Biological_Process_2023
1245,Regulation Of Protein Secretion (GO:0050708),0.3325104198689481,1.503194492595711,1.6551435270836612,0.5426531583706299,"HADHA,ARFIP1,APOE",GO_Biological_Process_2023
1246,Lipid Transport (GO:0006869),0.3325104198689481,1.503194492595711,1.6551435270836612,0.5426531583706299,"ABCC2,APOE,PLTP",GO_Biological_Process_2023
1247,Positive Regulation Of MAP Kinase Activity (GO:0043406),0.3325104198689481,1.503194492595711,1.6551435270836612,0.5426531583706299,"PTPN1,MEF2C,KIT",GO_Biological_Process_2023
1248,Cellular Response To Oxygen-Containing Compound (GO:1901701),0.33437943181324514,1.201040910191237,1.3157149840375324,0.5426531583706299,"PDGFRA,MEF2C,CDH1,IL37,AXL,NLRP3,MAPT,LAMTOR4,RHOA,CPEB4",GO_Biological_Process_2023
1249,Regulation Of Cell Population Proliferation (GO:0042127),0.3348124551183579,1.1433532569594334,1.2510396854980612,0.5426531583706299,"KANK2,PDGFRA,CEBPA,TFRC,PDCD5,RHOA,KITLG,TFAP4,CCND2,PRC1,DLG5,KIT,STX4,JAK2,CNOT8,IL6R,SH2B3",GO_Biological_Process_2023
1250,Protein Localization To Nucleus (GO:0034504),0.34127236212840595,1.4788032355520904,1.5898235079571046,0.5426531583706299,"GCKR,TAF8,HEATR3",GO_Biological_Process_2023
1251,BMP Signaling Pathway (GO:0030509),0.3413467144841261,1.6971218206157965,1.8241625223966422,0.5426531583706299,"HFE,PPARG",GO_Biological_Process_2023
1252,Cellular Response To Light Stimulus (GO:0071482),0.3413467144841261,1.6971218206157965,1.8241625223966422,0.5426531583706299,"DDB2,ATR",GO_Biological_Process_2023
1253,Cholesterol Metabolic Process (GO:0008203),0.3413467144841261,1.6971218206157965,1.8241625223966422,0.5426531583706299,"APOE,APOB",GO_Biological_Process_2023
1254,Negative Regulation Of Protein Binding (GO:0032091),0.3413467144841261,1.6971218206157965,1.8241625223966422,0.5426531583706299,"HFE,TMC8",GO_Biological_Process_2023
1255,Regulation Of DNA Replication (GO:0006275),0.3413467144841261,1.6971218206157965,1.8241625223966422,0.5426531583706299,"ZBTB38,ATR",GO_Biological_Process_2023
1256,'De Novo' Post-Translational Protein Folding (GO:0051084),0.3429525358102901,2.544044044044044,2.7225423684214074,0.5426531583706299,HSPA8,GO_Biological_Process_2023
1257,Regulation Of Cytoplasmic Translation (GO:2000765),0.3429525358102901,2.544044044044044,2.7225423684214074,0.5426531583706299,CPEB4,GO_Biological_Process_2023
1258,Regulation Of Fibroblast Growth Factor Receptor Signaling Pathway (GO:0040036),0.3429525358102901,2.544044044044044,2.7225423684214074,0.5426531583706299,DSTYK,GO_Biological_Process_2023
1259,NADP Metabolic Process (GO:0006739),0.3429525358102901,2.544044044044044,2.7225423684214074,0.5426531583706299,TP53I3,GO_Biological_Process_2023
1260,T-helper Cell Differentiation (GO:0042093),0.3429525358102901,2.544044044044044,2.7225423684214074,0.5426531583706299,MYB,GO_Biological_Process_2023
1261,Adaptive Immune Response Based On Somatic Recombination Of Immune Receptors Built From Immunoglobulin Superfamily Domains (GO:0002460),0.3429525358102901,2.544044044044044,2.7225423684214074,0.5426531583706299,BTN3A2,GO_Biological_Process_2023
1262,Regulation Of Osteoblast Proliferation (GO:0033688),0.3429525358102901,2.544044044044044,2.7225423684214074,0.5426531583706299,RHOA,GO_Biological_Process_2023
1263,Regulation Of Protein Kinase C Signaling (GO:0090036),0.3429525358102901,2.544044044044044,2.7225423684214074,0.5426531583706299,SEZ6,GO_Biological_Process_2023
1264,Cardiac Muscle Cell Contraction (GO:0086003),0.3429525358102901,2.544044044044044,2.7225423684214074,0.5426531583706299,PIK3CA,GO_Biological_Process_2023
1265,Regulation Of Smooth Muscle Cell Migration (GO:0014910),0.3429525358102901,2.544044044044044,2.7225423684214074,0.5426531583706299,TRIB1,GO_Biological_Process_2023
1266,Response To Fibroblast Growth Factor (GO:0071774),0.3429525358102901,2.544044044044044,2.7225423684214074,0.5426531583706299,DSTYK,GO_Biological_Process_2023
1267,Striated Muscle Cell Differentiation (GO:0051146),0.3429525358102901,2.544044044044044,2.7225423684214074,0.5426531583706299,MEF2C,GO_Biological_Process_2023
1268,Establishment Or Maintenance Of Apical/Basal Cell Polarity (GO:0035088),0.3429525358102901,2.544044044044044,2.7225423684214074,0.5426531583706299,DLG5,GO_Biological_Process_2023
1269,fatty-acyl-CoA Biosynthetic Process (GO:0046949),0.3429525358102901,2.544044044044044,2.7225423684214074,0.5426531583706299,GCDH,GO_Biological_Process_2023
1270,Female Gamete Generation (GO:0007292),0.3429525358102901,2.544044044044044,2.7225423684214074,0.5426531583706299,SPO11,GO_Biological_Process_2023
1271,Vesicle Transport Along Actin Filament (GO:0030050),0.3429525358102901,2.544044044044044,2.7225423684214074,0.5426531583706299,MYO1D,GO_Biological_Process_2023
1272,Zinc Ion Transport (GO:0006829),0.3429525358102901,2.544044044044044,2.7225423684214074,0.5426531583706299,SLC39A13,GO_Biological_Process_2023
1273,Iron Ion Transport (GO:0006826),0.3429525358102901,2.544044044044044,2.7225423684214074,0.5426531583706299,TFRC,GO_Biological_Process_2023
1274,Long-Term Synaptic Potentiation (GO:0060291),0.3429525358102901,2.544044044044044,2.7225423684214074,0.5426531583706299,STX4,GO_Biological_Process_2023
1275,Maturation Of SSU-rRNA (GO:0030490),0.3429525358102901,2.544044044044044,2.7225423684214074,0.5426531583706299,RPS28,GO_Biological_Process_2023
1276,Natural Killer Cell Mediated Immunity (GO:0002228),0.3429525358102901,2.544044044044044,2.7225423684214074,0.5426531583706299,CEBPG,GO_Biological_Process_2023
1277,Negative Regulation Of G2/M Transition Of Mitotic Cell Cycle (GO:0010972),0.3429525358102901,2.544044044044044,2.7225423684214074,0.5426531583706299,RAD50,GO_Biological_Process_2023
1278,Negative Regulation Of Lipid Storage (GO:0010888),0.3429525358102901,2.544044044044044,2.7225423684214074,0.5426531583706299,PPARG,GO_Biological_Process_2023
1279,Negative Regulation Of Myeloid Cell Differentiation (GO:0045638),0.3429525358102901,2.544044044044044,2.7225423684214074,0.5426531583706299,MYB,GO_Biological_Process_2023
1280,Positive Regulation Of G2/M Transition Of Mitotic Cell Cycle (GO:0010971),0.3429525358102901,2.544044044044044,2.7225423684214074,0.5426531583706299,RRM1,GO_Biological_Process_2023
1281,Positive Regulation Of calcineurin-NFAT Signaling Cascade (GO:0070886),0.3429525358102901,2.544044044044044,2.7225423684214074,0.5426531583706299,SPPL3,GO_Biological_Process_2023
1282,Positive Regulation Of Calcineurin-Mediated Signaling (GO:0106058),0.3429525358102901,2.544044044044044,2.7225423684214074,0.5426531583706299,SPPL3,GO_Biological_Process_2023
1283,Positive Regulation Of Cardiac Muscle Tissue Growth (GO:0055023),0.3429525358102901,2.544044044044044,2.7225423684214074,0.5426531583706299,MEF2C,GO_Biological_Process_2023
1284,Positive Regulation Of Cilium Assembly (GO:0045724),0.3429525358102901,2.544044044044044,2.7225423684214074,0.5426531583706299,KCTD17,GO_Biological_Process_2023
1285,Pyroptosis (GO:0070269),0.3429525358102901,2.544044044044044,2.7225423684214074,0.5426531583706299,NLRP3,GO_Biological_Process_2023
1286,Regulation Of NLRP3 Inflammasome Complex Assembly (GO:1900225),0.3429525358102901,2.544044044044044,2.7225423684214074,0.5426531583706299,HSPA8,GO_Biological_Process_2023
1287,Regulation Of T Cell Migration (GO:2000404),0.3429525358102901,2.544044044044044,2.7225423684214074,0.5426531583706299,RHOA,GO_Biological_Process_2023
1288,Regulation Of Cell Cycle Phase Transition (GO:1901987),0.3429525358102901,2.544044044044044,2.7225423684214074,0.5426531583706299,TFAP4,GO_Biological_Process_2023
1289,Regulation Of Interleukin-6 Production (GO:0032675),0.35002603721679515,1.4551863041289024,1.5275785270790472,0.5534158757547156,"TLR1,IL37,IL6R",GO_Biological_Process_2023
1290,Protein Localization (GO:0008104),0.35124154865097745,1.2119297819352488,1.2680192488819937,0.5549071908144899,"AHI1,AKAP10,ITSN1,SNX13,STX4,ARFIP1,WIPI2,TM9SF4",GO_Biological_Process_2023
1291,Regulation Of Extrinsic Apoptotic Signaling Pathway (GO:2001236),0.3529867577805054,1.6510908498860306,1.7193217435712793,0.5561091998354869,"TMC8,STX4",GO_Biological_Process_2023
1292,Positive Regulation Of Interleukin-1 Production (GO:0032732),0.3529867577805054,1.6510908498860306,1.7193217435712793,0.5561091998354869,"NLRP3,JAK2",GO_Biological_Process_2023
1293,Regulation Of Cellular Catabolic Process (GO:0031329),0.3529867577805054,1.6510908498860306,1.7193217435712793,0.5561091998354869,"MAPT,RAB8A",GO_Biological_Process_2023
1294,Regulation Of Neuron Apoptotic Process (GO:0043523),0.358767221010209,1.432307401812689,1.4682318345845138,0.5561091998354869,"MEF2C,APOE,CPEB4",GO_Biological_Process_2023
1295,Regulation Of Osteoblast Differentiation (GO:0045667),0.358767221010209,1.432307401812689,1.4682318345845138,0.5561091998354869,"MEF2C,PPARG,IL6R",GO_Biological_Process_2023
1296,Regulation Of Intracellular Signal Transduction (GO:1902531),0.3608912204648066,1.199807530374113,1.2228182723500978,0.5561091998354869,"ARHGAP21,DNMBP,ITSN1,SEZ6,MYO9B,MAPT,VRK2,ARHGAP27",GO_Biological_Process_2023
1297,GPI Anchor Metabolic Process (GO:0006505),0.36385485898912845,2.348117348117348,2.373947178787745,0.5561091998354869,PGAP3,GO_Biological_Process_2023
1298,T Cell Mediated Immunity (GO:0002456),0.36385485898912845,2.348117348117348,2.373947178787745,0.5561091998354869,BTN3A2,GO_Biological_Process_2023
1299,Regulation Of Intracellular Estrogen Receptor Signaling Pathway (GO:0033146),0.36385485898912845,2.348117348117348,2.373947178787745,0.5561091998354869,KANK2,GO_Biological_Process_2023
1300,Regulation Of Membrane Protein Ectodomain Proteolysis (GO:0051043),0.36385485898912845,2.348117348117348,2.373947178787745,0.5561091998354869,APOE,GO_Biological_Process_2023
1301,Regulation Of Nervous System Process (GO:0031644),0.36385485898912845,2.348117348117348,2.373947178787745,0.5561091998354869,TYMP,GO_Biological_Process_2023
1302,Regulation Of Peptidase Activity (GO:0052547),0.36385485898912845,2.348117348117348,2.373947178787745,0.5561091998354869,CTSB,GO_Biological_Process_2023
1303,Cellular Response To Topologically Incorrect Protein (GO:0035967),0.36385485898912845,2.348117348117348,2.373947178787745,0.5561091998354869,PTPN1,GO_Biological_Process_2023
1304,Regulation Of Vascular Endothelial Growth Factor Receptor Signaling Pathway (GO:0030947),0.36385485898912845,2.348117348117348,2.373947178787745,0.5561091998354869,PTPN1,GO_Biological_Process_2023
1305,Chaperone-Mediated Protein Complex Assembly (GO:0051131),0.36385485898912845,2.348117348117348,2.373947178787745,0.5561091998354869,LONP1,GO_Biological_Process_2023
1306,Response To Hexose (GO:0009746),0.36385485898912845,2.348117348117348,2.373947178787745,0.5561091998354869,GCKR,GO_Biological_Process_2023
1307,Establishment Of Epithelial Cell Polarity (GO:0090162),0.36385485898912845,2.348117348117348,2.373947178787745,0.5561091998354869,RHOA,GO_Biological_Process_2023
1308,Transcription By RNA Polymerase III (GO:0006383),0.36385485898912845,2.348117348117348,2.373947178787745,0.5561091998354869,ICE2,GO_Biological_Process_2023
1309,Membrane Protein Ectodomain Proteolysis (GO:0006509),0.36385485898912845,2.348117348117348,2.373947178787745,0.5561091998354869,SPPL3,GO_Biological_Process_2023
1310,miRNA-mediated Gene Silencing (GO:0035195),0.36385485898912845,2.348117348117348,2.373947178787745,0.5561091998354869,CNOT8,GO_Biological_Process_2023
1311,Mitochondrial Membrane Organization (GO:0007006),0.36385485898912845,2.348117348117348,2.373947178787745,0.5561091998354869,SAMM50,GO_Biological_Process_2023
1312,Monoubiquitinated Histone H2A Deubiquitination (GO:0035522),0.36385485898912845,2.348117348117348,2.373947178787745,0.5561091998354869,TRRAP,GO_Biological_Process_2023
1313,Monoubiquitinated Histone Deubiquitination (GO:0035521),0.36385485898912845,2.348117348117348,2.373947178787745,0.5561091998354869,TRRAP,GO_Biological_Process_2023
1314,Negative Regulation Of Extrinsic Apoptotic Signaling Pathway Via Death Domain Receptors (GO:1902042),0.36385485898912845,2.348117348117348,2.373947178787745,0.5561091998354869,TMBIM1,GO_Biological_Process_2023
1315,Negative Regulation Of Insulin Secretion (GO:0046676),0.36385485898912845,2.348117348117348,2.373947178787745,0.5561091998354869,BMP8A,GO_Biological_Process_2023
1316,Negative Regulation Of Interleukin-1 Beta Production (GO:0032691),0.36385485898912845,2.348117348117348,2.373947178787745,0.5561091998354869,NLRP3,GO_Biological_Process_2023
1317,Negative Regulation Of Peptide Hormone Secretion (GO:0090278),0.36385485898912845,2.348117348117348,2.373947178787745,0.5561091998354869,BMP8A,GO_Biological_Process_2023
1318,Negative Regulation Of Peptidyl-Serine Phosphorylation (GO:0033137),0.36385485898912845,2.348117348117348,2.373947178787745,0.5561091998354869,GADD45A,GO_Biological_Process_2023
1319,Negative Regulation Of Proteolysis Involved In Protein Catabolic Process (GO:1903051),0.36385485898912845,2.348117348117348,2.373947178787745,0.5561091998354869,HFE,GO_Biological_Process_2023
1320,Organelle Membrane Fusion (GO:0090174),0.36385485898912845,2.348117348117348,2.373947178787745,0.5561091998354869,STX4,GO_Biological_Process_2023
1321,Platelet Dense Granule Organization (GO:0060155),0.36385485898912845,2.348117348117348,2.373947178787745,0.5561091998354869,BLOC1S2,GO_Biological_Process_2023
1322,Pore Complex Assembly (GO:0046931),0.36385485898912845,2.348117348117348,2.373947178787745,0.5561091998354869,NUP205,GO_Biological_Process_2023
1323,Positive Regulation Of T Cell Mediated Cytotoxicity (GO:0001916),0.36385485898912845,2.348117348117348,2.373947178787745,0.5561091998354869,HFE,GO_Biological_Process_2023
1324,Positive Regulation Of Dendritic Spine Development (GO:0060999),0.36385485898912845,2.348117348117348,2.373947178787745,0.5561091998354869,DLG5,GO_Biological_Process_2023
1325,Positive Regulation Of Interleukin-4 Production (GO:0032753),0.36385485898912845,2.348117348117348,2.373947178787745,0.5561091998354869,NLRP3,GO_Biological_Process_2023
1326,Positive Regulation Of Lamellipodium Assembly (GO:0010592),0.36385485898912845,2.348117348117348,2.373947178787745,0.5561091998354869,PIK3CA,GO_Biological_Process_2023
1327,Positive Regulation Of Phosphoprotein Phosphatase Activity (GO:0032516),0.36385485898912845,2.348117348117348,2.373947178787745,0.5561091998354869,PTPRC,GO_Biological_Process_2023
1328,Positive Regulation Of Response To Endoplasmic Reticulum Stress (GO:1905898),0.36385485898912845,2.348117348117348,2.373947178787745,0.5561091998354869,BCL2L11,GO_Biological_Process_2023
1329,Protein Acetylation (GO:0006473),0.36385485898912845,2.348117348117348,2.373947178787745,0.5561091998354869,MAPT,GO_Biological_Process_2023
1330,Protein Quality Control For Misfolded Or Incompletely Synthesized Proteins (GO:0006515),0.36385485898912845,2.348117348117348,2.373947178787745,0.5561091998354869,LONP1,GO_Biological_Process_2023
1331,Regulation Of Acute Inflammatory Response (GO:0002673),0.36385485898912845,2.348117348117348,2.373947178787745,0.5561091998354869,NLRP3,GO_Biological_Process_2023
1332,Cell Junction Organization (GO:0034330),0.3645544116684055,1.6074825618262525,1.62207763724789,0.5561091998354869,"MAPT,RHOA",GO_Biological_Process_2023
1333,Cellular Response To Alcohol (GO:0097306),0.3645544116684055,1.6074825618262525,1.62207763724789,0.5561091998354869,"LARP1,CDH1",GO_Biological_Process_2023
1334,Negative Regulation Of Cellular Catabolic Process (GO:0031330),0.3645544116684055,1.6074825618262525,1.62207763724789,0.5561091998354869,"LEPR,ZKSCAN3",GO_Biological_Process_2023
1335,Negative Regulation Of Peptidase Activity (GO:0010466),0.3645544116684055,1.6074825618262525,1.62207763724789,0.5561091998354869,"SERPING1,CTSB",GO_Biological_Process_2023
1336,Phosphatidylinositol-Mediated Signaling (GO:0048015),0.3645544116684055,1.6074825618262525,1.62207763724789,0.5561091998354869,"PDGFRA,PIK3CA",GO_Biological_Process_2023
1337,Negative Regulation Of Cellular Process (GO:0048523),0.37295953215377986,1.1406967323791521,1.1250524851888046,0.5672346990668851,"KANK2,CEBPA,CD164,TFAP4,DUSP1,SERTAD2,DLG5,PDCD5,ANP32B,JAK2,CRLF3,SH2B3",GO_Biological_Process_2023
1338,Regulation Of Phagocytosis (GO:0050764),0.3760425324506758,1.5661105962310782,1.5317392042016418,0.5672346990668851,"PTPRC,IL2RB",GO_Biological_Process_2023
1339,Positive Regulation Of Cysteine-Type Endopeptidase Activity (GO:2001056),0.3760425324506758,1.5661105962310782,1.5317392042016418,0.5672346990668851,"PDCD5,NLRP3",GO_Biological_Process_2023
1340,Positive Regulation Of Phagocytosis (GO:0050766),0.3760425324506758,1.5661105962310782,1.5317392042016418,0.5672346990668851,"PTPRC,IL2RB",GO_Biological_Process_2023
1341,Negative Regulation Of Transmembrane Receptor Protein Serine/Threonine Kinase Signaling Pathway (GO:0090101),0.37619594380196947,1.3886294973908266,1.3575868852155466,0.5672346990668851,"SPRED2,PRDM16,PPARG",GO_Biological_Process_2023
1342,Positive Regulation Of Defense Response (GO:0031349),0.37619594380196947,1.3886294973908266,1.3575868852155466,0.5672346990668851,"CEBPA,MEF2C,NLRP3",GO_Biological_Process_2023
1343,Regulation Of Protein Kinase B Signaling (GO:0051896),0.3787206076273476,1.3003223726627982,1.2625564972739005,0.5672346990668851,"MFHAS1,PIK3CA,AXL,SH2B3",GO_Biological_Process_2023
1344,Regulation Of Cholesterol Metabolic Process (GO:0090181),0.38409415344077596,2.18018018018018,2.0861437006994428,0.5672346990668851,APOE,GO_Biological_Process_2023
1345,Regulation Of Extrinsic Apoptotic Signaling Pathway In Absence Of Ligand (GO:2001239),0.38409415344077596,2.18018018018018,2.0861437006994428,0.5672346990668851,TERT,GO_Biological_Process_2023
1346,RNA-mediated Gene Silencing (GO:0031047),0.38409415344077596,2.18018018018018,2.0861437006994428,0.5672346990668851,HELZ2,GO_Biological_Process_2023
1347,Actin Filament-Based Transport (GO:0099515),0.38409415344077596,2.18018018018018,2.0861437006994428,0.5672346990668851,MYO1D,GO_Biological_Process_2023
1348,Regulation Of Lipopolysaccharide-Mediated Signaling Pathway (GO:0031664),0.38409415344077596,2.18018018018018,2.0861437006994428,0.5672346990668851,TRIB1,GO_Biological_Process_2023
1349,Regulation Of Monocyte Chemotaxis (GO:0090025),0.38409415344077596,2.18018018018018,2.0861437006994428,0.5672346990668851,DUSP1,GO_Biological_Process_2023
1350,Bile Acid And Bile Salt Transport (GO:0015721),0.38409415344077596,2.18018018018018,2.0861437006994428,0.5672346990668851,ABCC2,GO_Biological_Process_2023
1351,Cell Morphogenesis Involved In Differentiation (GO:0000904),0.38409415344077596,2.18018018018018,2.0861437006994428,0.5672346990668851,MEF2C,GO_Biological_Process_2023
1352,Regulation Of Synapse Organization (GO:0050807),0.38409415344077596,2.18018018018018,2.0861437006994428,0.5672346990668851,MEF2C,GO_Biological_Process_2023
1353,Regulation Of Tissue Remodeling (GO:0034103),0.38409415344077596,2.18018018018018,2.0861437006994428,0.5672346990668851,LEPR,GO_Biological_Process_2023
1354,Regulation Of Toll-Like Receptor 4 Signaling Pathway (GO:0034143),0.38409415344077596,2.18018018018018,2.0861437006994428,0.5672346990668851,MFHAS1,GO_Biological_Process_2023
1355,Cholesterol Efflux (GO:0033344),0.38409415344077596,2.18018018018018,2.0861437006994428,0.5672346990668851,APOE,GO_Biological_Process_2023
1356,Stem Cell Development (GO:0048864),0.38409415344077596,2.18018018018018,2.0861437006994428,0.5672346990668851,PTPRC,GO_Biological_Process_2023
1357,Transepithelial Transport (GO:0070633),0.38409415344077596,2.18018018018018,2.0861437006994428,0.5672346990668851,ABCC2,GO_Biological_Process_2023
1358,Glutamate Metabolic Process (GO:0006536),0.38409415344077596,2.18018018018018,2.0861437006994428,0.5672346990668851,ALDH5A1,GO_Biological_Process_2023
1359,Glycolytic Process (GO:0006096),0.38409415344077596,2.18018018018018,2.0861437006994428,0.5672346990668851,HK1,GO_Biological_Process_2023
1360,Vesicle Docking (GO:0048278),0.38409415344077596,2.18018018018018,2.0861437006994428,0.5672346990668851,STX4,GO_Biological_Process_2023
1361,Intracellular Lipid Transport (GO:0032365),0.38409415344077596,2.18018018018018,2.0861437006994428,0.5672346990668851,CPT1B,GO_Biological_Process_2023
1362,Lamellipodium Assembly (GO:0030032),0.38409415344077596,2.18018018018018,2.0861437006994428,0.5672346990668851,KIT,GO_Biological_Process_2023
1363,Mammary Gland Development (GO:0030879),0.38409415344077596,2.18018018018018,2.0861437006994428,0.5672346990668851,JAK2,GO_Biological_Process_2023
1364,Microtubule Polymerization (GO:0046785),0.38409415344077596,2.18018018018018,2.0861437006994428,0.5672346990668851,MAPT,GO_Biological_Process_2023
1365,Microtubule Polymerization Or Depolymerization (GO:0031109),0.38409415344077596,2.18018018018018,2.0861437006994428,0.5672346990668851,MAPT,GO_Biological_Process_2023
1366,Negative Regulation Of NIK/NF-kappaB Signaling (GO:1901223),0.38409415344077596,2.18018018018018,2.0861437006994428,0.5672346990668851,NLRP3,GO_Biological_Process_2023
1367,Negative Regulation Of TORC1 Signaling (GO:1904262),0.38409415344077596,2.18018018018018,2.0861437006994428,0.5672346990668851,NPRL3,GO_Biological_Process_2023
1368,Negative Regulation Of Cell Communication (GO:0010648),0.38409415344077596,2.18018018018018,2.0861437006994428,0.5672346990668851,PTPN1,GO_Biological_Process_2023
1369,Negative Regulation Of Macroautophagy (GO:0016242),0.38409415344077596,2.18018018018018,2.0861437006994428,0.5672346990668851,PIK3CA,GO_Biological_Process_2023
1370,Negative Regulation Of Telomere Maintenance Via Telomere Lengthening (GO:1904357),0.38409415344077596,2.18018018018018,2.0861437006994428,0.5672346990668851,XRN1,GO_Biological_Process_2023
1371,Neural Crest Cell Differentiation (GO:0014033),0.38409415344077596,2.18018018018018,2.0861437006994428,0.5672346990668851,MEF2C,GO_Biological_Process_2023
1372,Organelle Fusion (GO:0048284),0.38409415344077596,2.18018018018018,2.0861437006994428,0.5672346990668851,STX4,GO_Biological_Process_2023
1373,Positive Regulation Of T Cell Cytokine Production (GO:0002726),0.38409415344077596,2.18018018018018,2.0861437006994428,0.5672346990668851,NLRP3,GO_Biological_Process_2023
1374,Positive Regulation Of T Cell Migration (GO:2000406),0.38409415344077596,2.18018018018018,2.0861437006994428,0.5672346990668851,RHOA,GO_Biological_Process_2023
1375,Positive Regulation Of Cell Cycle G2/M Phase Transition (GO:1902751),0.38409415344077596,2.18018018018018,2.0861437006994428,0.5672346990668851,RRM1,GO_Biological_Process_2023
1376,Positive Regulation Of Interleukin-17 Production (GO:0032740),0.38409415344077596,2.18018018018018,2.0861437006994428,0.5672346990668851,JAK2,GO_Biological_Process_2023
1377,Potassium Ion Homeostasis (GO:0055075),0.38409415344077596,2.18018018018018,2.0861437006994428,0.5672346990668851,SLC12A7,GO_Biological_Process_2023
1378,Protein K11-linked Ubiquitination (GO:0070979),0.38409415344077596,2.18018018018018,2.0861437006994428,0.5672346990668851,UBE2L3,GO_Biological_Process_2023
1379,Regulation Of Actin Cytoskeleton Reorganization (GO:2000249),0.38409415344077596,2.18018018018018,2.0861437006994428,0.5672346990668851,PDGFRA,GO_Biological_Process_2023
1380,Regulation Of Cell Morphogenesis (GO:0022604),0.38409415344077596,2.18018018018018,2.0861437006994428,0.5672346990668851,MACF1,GO_Biological_Process_2023
1381,Protein Phosphorylation (GO:0006468),0.38463810063397535,1.129823220258003,1.0794922905630506,0.5675664208115963,"BLK,PDGFRA,MAP3K1,MAST3,MAST2,KIT,TAF8,VRK2,TRIB1,JAK2,EPHB4,ATR",GO_Biological_Process_2023
1382,Positive Regulation Of Cell Growth (GO:0030307),0.38487575739039553,1.3677684087117283,1.3059927448391158,0.5675664208115963,"MACF1,EXOSC9,MAPT",GO_Biological_Process_2023
1383,Response To Molecule Of Bacterial Origin (GO:0002237),0.38744450052350976,1.5268072289156627,1.4476921471045792,0.5701168895789985,"JAK2,TRIB1",GO_Biological_Process_2023
1384,Mesenchymal Cell Differentiation (GO:0048762),0.38744450052350976,1.5268072289156627,1.4476921471045792,0.5701168895789985,"MEF2C,DLG5",GO_Biological_Process_2023
1385,Negative Regulation Of Extrinsic Apoptotic Signaling Pathway (GO:2001237),0.38744450052350976,1.5268072289156627,1.4476921471045792,0.5701168895789985,"TERT,TMBIM1",GO_Biological_Process_2023
1386,Proteasomal Protein Catabolic Process (GO:0010498),0.3908225157290855,1.232228649867634,1.1576809680440148,0.5746726457834604,"PSMB5,UBXN2A,KCTD17,FBXO7,UBXN6",GO_Biological_Process_2023
1387,Cellular Response To Transforming Growth Factor Beta Stimulus (GO:0071560),0.3935276266124674,1.3475208814643682,1.2567033724751988,0.576694251804054,"MEF2C,ZMIZ2,PDCD5",GO_Biological_Process_2023
1388,Regulation Of DNA Repair (GO:0006282),0.3935276266124674,1.3475208814643682,1.2567033724751988,0.576694251804054,"TRRAP,CEBPG,ATR",GO_Biological_Process_2023
1389,Ubiquitin-Dependent Protein Catabolic Process (GO:0006511),0.39483960742640245,1.1591893699299276,1.0772064594954842,0.576694251804054,"PSMB5,C18ORF25,NDFIP1,UBXN2A,ARIH2,KCTD17,FBXO7,UBE2L3",GO_Biological_Process_2023
1390,Response To Ionizing Radiation (GO:0010212),0.39875419464729916,1.4894210990302674,1.3693888097140368,0.576694251804054,"GADD45A,FIGNL1",GO_Biological_Process_2023
1391,Mitotic Spindle Organization (GO:0007052),0.39875419464729916,1.4894210990302674,1.3693888097140368,0.576694251804054,"PRC1,RHOA",GO_Biological_Process_2023
1392,Regulation Of RNA Metabolic Process (GO:0051252),0.39875419464729916,1.4894210990302674,1.3693888097140368,0.576694251804054,"RBM38,TRRAP",GO_Biological_Process_2023
1393,Negative Regulation Of Protein Phosphorylation (GO:0001933),0.4004346425124784,1.2597313339581382,1.1529120571296296,0.576694251804054,"SPRED2,PTPRC,PPARG,TRIB1",GO_Biological_Process_2023
1394,Positive Regulation Of I-kappaB kinase/NF-kappaB Signaling (GO:0043123),0.4004346425124784,1.2597313339581382,1.1529120571296296,0.576694251804054,"NDFIP1,TFRC,TRIM38,RHOA",GO_Biological_Process_2023
1395,Regulation Of Cellular Component Organization (GO:0051128),0.4004346425124784,1.2597313339581382,1.1529120571296296,0.576694251804054,"HSPA8,PTPN1,TFRC,APOE",GO_Biological_Process_2023
1396,Positive Regulation Of Cell Population Proliferation (GO:0008284),0.4015826599549473,1.1213415892672858,1.023046903698882,0.576694251804054,"PDGFRA,KITLG,MEF2C,PTPRC,CCND2,TERT,PRC1,STX4,JAK2,CNOT8,IL6R",GO_Biological_Process_2023
1397,Regulation Of Phosphatidylinositol 3-Kinase Signaling (GO:0014066),0.40214804341935495,1.3278602390647576,1.2095943548480383,0.576694251804054,"PDGFRA,KIT,JAK2",GO_Biological_Process_2023
1398,Positive Regulation Of Protein Kinase B Signaling (GO:0051897),0.40214804341935495,1.3278602390647576,1.2095943548480383,0.576694251804054,"MFHAS1,PIK3CA,AXL",GO_Biological_Process_2023
1399,Regulation Of Wnt Signaling Pathway (GO:0030111),0.40214804341935495,1.3278602390647576,1.2095943548480383,0.576694251804054,"MACF1,TERT,MDFI",GO_Biological_Process_2023
1400,ERK1 And ERK2 Cascade (GO:0070371),0.4036913894708047,2.0346346346346347,1.8456263964772202,0.576694251804054,MAP2K2,GO_Biological_Process_2023
1401,GPI Anchor Biosynthetic Process (GO:0006506),0.4036913894708047,2.0346346346346347,1.8456263964772202,0.576694251804054,PGAP3,GO_Biological_Process_2023
1402,Regulation Of Interleukin-4 Production (GO:0032673),0.4036913894708047,2.0346346346346347,1.8456263964772202,0.576694251804054,NLRP3,GO_Biological_Process_2023
1403,Regulation Of Myelination (GO:0031641),0.4036913894708047,2.0346346346346347,1.8456263964772202,0.576694251804054,TYMP,GO_Biological_Process_2023
1404,Regulation Of Myeloid Cell Differentiation (GO:0045637),0.4036913894708047,2.0346346346346347,1.8456263964772202,0.576694251804054,MEF2C,GO_Biological_Process_2023
1405,Regulation Of Protein Modification By Small Protein Conjugation Or Removal (GO:1903320),0.4036913894708047,2.0346346346346347,1.8456263964772202,0.576694251804054,EPAS1,GO_Biological_Process_2023
1406,Cell Migration Involved In Sprouting Angiogenesis (GO:0002042),0.4036913894708047,2.0346346346346347,1.8456263964772202,0.576694251804054,EPHB4,GO_Biological_Process_2023
1407,Regulation Of Steroid Metabolic Process (GO:0019218),0.4036913894708047,2.0346346346346347,1.8456263964772202,0.576694251804054,APOE,GO_Biological_Process_2023
1408,Skeletal Muscle Organ Development (GO:0060538),0.4036913894708047,2.0346346346346347,1.8456263964772202,0.576694251804054,MEF2C,GO_Biological_Process_2023
1409,Sterol Biosynthetic Process (GO:0016126),0.4036913894708047,2.0346346346346347,1.8456263964772202,0.576694251804054,FAXDC2,GO_Biological_Process_2023
1410,"Wound Healing, Spreading Of Cells (GO:0044319)",0.4036913894708047,2.0346346346346347,1.8456263964772202,0.576694251804054,RHOA,GO_Biological_Process_2023
1411,Mononuclear Cell Differentiation (GO:1903131),0.4036913894708047,2.0346346346346347,1.8456263964772202,0.576694251804054,PPARG,GO_Biological_Process_2023
1412,Multivesicular Body Sorting Pathway (GO:0071985),0.4036913894708047,2.0346346346346347,1.8456263964772202,0.576694251804054,LAPTM4B,GO_Biological_Process_2023
1413,Myoblast Differentiation (GO:0045445),0.4036913894708047,2.0346346346346347,1.8456263964772202,0.576694251804054,EPAS1,GO_Biological_Process_2023
1414,Myotube Differentiation (GO:0014902),0.4036913894708047,2.0346346346346347,1.8456263964772202,0.576694251804054,MEF2C,GO_Biological_Process_2023
1415,Negative Regulation Of Catalytic Activity (GO:0043086),0.4036913894708047,2.0346346346346347,1.8456263964772202,0.576694251804054,TMBIM1,GO_Biological_Process_2023
1416,Negative Regulation Of Ossification (GO:0030279),0.4036913894708047,2.0346346346346347,1.8456263964772202,0.576694251804054,MEF2C,GO_Biological_Process_2023
1417,Nuclear Membrane Organization (GO:0071763),0.4036913894708047,2.0346346346346347,1.8456263964772202,0.576694251804054,UBXN2A,GO_Biological_Process_2023
1418,Organophosphate Ester Transport (GO:0015748),0.4036913894708047,2.0346346346346347,1.8456263964772202,0.576694251804054,PLTP,GO_Biological_Process_2023
1419,Positive Regulation Of Intrinsic Apoptotic Signaling Pathway (GO:2001244),0.4036913894708047,2.0346346346346347,1.8456263964772202,0.576694251804054,BCL2L11,GO_Biological_Process_2023
1420,Positive Regulation Of Leukocyte Migration (GO:0002687),0.4036913894708047,2.0346346346346347,1.8456263964772202,0.576694251804054,IL6R,GO_Biological_Process_2023
1421,Positive Regulation Of Viral Genome Replication (GO:0045070),0.4036913894708047,2.0346346346346347,1.8456263964772202,0.576694251804054,LARP1,GO_Biological_Process_2023
1422,Protein Targeting To ER (GO:0045047),0.4036913894708047,2.0346346346346347,1.8456263964772202,0.576694251804054,SRP14,GO_Biological_Process_2023
1423,Protein Transmembrane Import Into Intracellular Organelle (GO:0044743),0.4036913894708047,2.0346346346346347,1.8456263964772202,0.576694251804054,TOMM40,GO_Biological_Process_2023
1424,Purine Nucleotide Metabolic Process (GO:0006163),0.4036913894708047,2.0346346346346347,1.8456263964772202,0.576694251804054,TP53I3,GO_Biological_Process_2023
1425,Regulation Of G0 To G1 Transition (GO:0070316),0.4036913894708047,2.0346346346346347,1.8456263964772202,0.576694251804054,RRM1,GO_Biological_Process_2023
1426,Regulation Of Cell Junction Assembly (GO:1901888),0.4036913894708047,2.0346346346346347,1.8456263964772202,0.576694251804054,MEF2C,GO_Biological_Process_2023
1427,Positive Regulation Of Multicellular Organismal Process (GO:0051240),0.4037991645360084,1.1369866497139225,1.031062292537096,0.576694251804054,"HADHA,TERT,BTN3A1,EPAS1,PRDM16,LEPR,PPARG,APOE,JAK2",GO_Biological_Process_2023
1428,Regulation Of Cytokinesis (GO:0032465),0.40996596694232024,1.4538152610441768,1.29633963505076,0.582237380228884,"PRC1,RHOA",GO_Biological_Process_2023
1429,Regulation Of Focal Adhesion Assembly (GO:0051893),0.40996596694232024,1.4538152610441768,1.29633963505076,0.582237380228884,"MACF1,RHOA",GO_Biological_Process_2023
1430,Regulation Of Monoatomic Ion Transmembrane Transporter Activity (GO:0032412),0.40996596694232024,1.4538152610441768,1.29633963505076,0.582237380228884,"MEF2C,CNIH4",GO_Biological_Process_2023
1431,Cellular Response To BMP Stimulus (GO:0071773),0.40996596694232024,1.4538152610441768,1.29633963505076,0.582237380228884,"HFE,PPARG",GO_Biological_Process_2023
1432,Negative Regulation Of Amide Metabolic Process (GO:0034249),0.40996596694232024,1.4538152610441768,1.29633963505076,0.582237380228884,"LARP1,APOE",GO_Biological_Process_2023
1433,Positive Regulation Of Interleukin-6 Production (GO:0032755),0.40996596694232024,1.4538152610441768,1.29633963505076,0.582237380228884,"TLR1,IL6R",GO_Biological_Process_2023
1434,Protein Secretion (GO:0009306),0.40996596694232024,1.4538152610441768,1.29633963505076,0.582237380228884,"RAB8A,AP1M2",GO_Biological_Process_2023
1435,Proteolysis Involved In Protein Catabolic Process (GO:0051603),0.40996596694232024,1.4538152610441768,1.29633963505076,0.582237380228884,"LONP1,CTSB",GO_Biological_Process_2023
1436,Golgi Organization (GO:0007030),0.41928118129141106,1.2902004170035317,1.1214596292787138,0.5895928085136863,"ARHGAP21,UBXN2A,RAB8A",GO_Biological_Process_2023
1437,Protein-Containing Complex Assembly (GO:0065003),0.4206306135177622,1.1437145333529575,0.9904570523843901,0.5895928085136863,"SAMM50,TFAP4,HFE,IL2RB,LONP1,PILRB,MAPT",GO_Biological_Process_2023
1438,Purine Ribonucleotide Metabolic Process (GO:0009150),0.4210746192897417,1.4198655085458112,1.228105881872269,0.5895928085136863,"HSPA8,FIGNL1",GO_Biological_Process_2023
1439,Regulation Of Cellular Response To Transforming Growth Factor Beta Stimulus (GO:1903844),0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5895928085136863,PPARG,GO_Biological_Process_2023
1440,DNA Damage Checkpoint Signaling (GO:0000077),0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5895928085136863,ATR,GO_Biological_Process_2023
1441,Golgi To Plasma Membrane Protein Transport (GO:0043001),0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5895928085136863,MACF1,GO_Biological_Process_2023
1442,JNK Cascade (GO:0007254),0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5895928085136863,TRIB1,GO_Biological_Process_2023
1443,Axoneme Assembly (GO:0035082),0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5895928085136863,RP1L1,GO_Biological_Process_2023
1444,Cellular Lipid Catabolic Process (GO:0044242),0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5895928085136863,PLD1,GO_Biological_Process_2023
1445,Cellular Response To Heat (GO:0034605),0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5895928085136863,MAPT,GO_Biological_Process_2023
1446,Cellular Response To Low-Density Lipoprotein Particle Stimulus (GO:0071404),0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5895928085136863,PPARG,GO_Biological_Process_2023
1447,Ribosome Assembly (GO:0042255),0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5895928085136863,RPS28,GO_Biological_Process_2023
1448,Secretory Granule Organization (GO:0033363),0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5895928085136863,BLOC1S2,GO_Biological_Process_2023
1449,Smoothened Signaling Pathway (GO:0007224),0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5895928085136863,KIAA0586,GO_Biological_Process_2023
1450,Extrinsic Apoptotic Signaling Pathway Via Death Domain Receptors (GO:0008625),0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5895928085136863,BLOC1S2,GO_Biological_Process_2023
1451,Vesicle-Mediated Transport Between Endosomal Compartments (GO:0098927),0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5895928085136863,MYO1D,GO_Biological_Process_2023
1452,Xenobiotic Transport (GO:0042908),0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5895928085136863,ABCC2,GO_Biological_Process_2023
1453,miRNA Processing (GO:0035196),0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5895928085136863,SNIP1,GO_Biological_Process_2023
1454,ncRNA Catabolic Process (GO:0034661),0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5895928085136863,XRN1,GO_Biological_Process_2023
1455,Negative Regulation Of Cytoskeleton Organization (GO:0051494),0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5895928085136863,PIK3CA,GO_Biological_Process_2023
1456,Negative Regulation Of Protein Tyrosine Kinase Activity (GO:0061099),0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5895928085136863,PTPRC,GO_Biological_Process_2023
1457,Negative Regulation Of Type II Interferon Production (GO:0032689),0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5895928085136863,LGALS9B,GO_Biological_Process_2023
1458,Negative Regulation Of Wound Healing (GO:0061045),0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5895928085136863,APOE,GO_Biological_Process_2023
1459,Nuclear Membrane Reassembly (GO:0031468),0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5895928085136863,UBXN2A,GO_Biological_Process_2023
1460,Regulation Of Cardiac Conduction (GO:1903779),0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5895928085136863,TRPC1,GO_Biological_Process_2023
1461,Regulation Of Cardiac Muscle Cell Proliferation (GO:0060043),0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5895928085136863,MEF2C,GO_Biological_Process_2023
1462,Negative Regulation Of Protein Metabolic Process (GO:0051248),0.427787574578638,1.2721550855991943,1.0802231748235642,0.5963276860405364,"LARP1,FLOT2,APOE",GO_Biological_Process_2023
1463,Regulation Of Interleukin-8 Production (GO:0032677),0.4320753805020225,1.387458926615553,1.1642933925595615,0.6006614089107243,"TLR1,PTPRC",GO_Biological_Process_2023
1464,Cellular Response To UV (GO:0034644),0.4320753805020225,1.387458926615553,1.1642933925595615,0.6006614089107243,"DDB2,ATR",GO_Biological_Process_2023
1465,Import Into Nucleus (GO:0051170),0.4320753805020225,1.387458926615553,1.1642933925595615,0.6006614089107243,"GCKR,HEATR3",GO_Biological_Process_2023
1466,Positive Regulation Of Protein Ubiquitination (GO:0031398),0.4320753805020225,1.387458926615553,1.1642933925595615,0.6006614089107243,"NDFIP1,UBE2L3",GO_Biological_Process_2023
1467,Small GTPase Mediated Signal Transduction (GO:0007264),0.4362498561764909,1.2546041468360716,1.0407444935223196,0.6008289395898506,"DOK2,TNK2,PLD1",GO_Biological_Process_2023
1468,DNA Synthesis Involved In DNA Repair (GO:0000731),0.4410402814653663,1.7949125596184419,1.4693496440315028,0.6008289395898506,RRM1,GO_Biological_Process_2023
1469,Regulation Of Hippo Signaling (GO:0035330),0.4410402814653663,1.7949125596184419,1.4693496440315028,0.6008289395898506,DLG5,GO_Biological_Process_2023
1470,Acute Inflammatory Response (GO:0002526),0.4410402814653663,1.7949125596184419,1.4693496440315028,0.6008289395898506,IL6R,GO_Biological_Process_2023
1471,Anterograde Axonal Transport (GO:0008089),0.4410402814653663,1.7949125596184419,1.4693496440315028,0.6008289395898506,BLOC1S2,GO_Biological_Process_2023
1472,Regulation Of Neuronal Synaptic Plasticity (GO:0048168),0.4410402814653663,1.7949125596184419,1.4693496440315028,0.6008289395898506,APOE,GO_Biological_Process_2023
1473,Regulation Of Postsynaptic Membrane Potential (GO:0060078),0.4410402814653663,1.7949125596184419,1.4693496440315028,0.6008289395898506,MEF2C,GO_Biological_Process_2023
1474,Cardiac Muscle Cell Differentiation (GO:0055007),0.4410402814653663,1.7949125596184419,1.4693496440315028,0.6008289395898506,MEF2C,GO_Biological_Process_2023
1475,Regulation Of Viral Entry Into Host Cell (GO:0046596),0.4410402814653663,1.7949125596184419,1.4693496440315028,0.6008289395898506,TRIM38,GO_Biological_Process_2023
1476,Embryonic Digestive Tract Development (GO:0048566),0.4410402814653663,1.7949125596184419,1.4693496440315028,0.6008289395898506,PDGFRA,GO_Biological_Process_2023
1477,Skeletal Muscle Tissue Development (GO:0007519),0.4410402814653663,1.7949125596184419,1.4693496440315028,0.6008289395898506,MEF2C,GO_Biological_Process_2023
1478,Focal Adhesion Assembly (GO:0048041),0.4410402814653663,1.7949125596184419,1.4693496440315028,0.6008289395898506,TRIP6,GO_Biological_Process_2023
1479,Toll-Like Receptor Signaling Pathway (GO:0002224),0.4410402814653663,1.7949125596184419,1.4693496440315028,0.6008289395898506,TLR1,GO_Biological_Process_2023
1480,Monocyte Chemotaxis (GO:0002548),0.4410402814653663,1.7949125596184419,1.4693496440315028,0.6008289395898506,IL6R,GO_Biological_Process_2023
1481,Monoubiquitinated Protein Deubiquitination (GO:0035520),0.4410402814653663,1.7949125596184419,1.4693496440315028,0.6008289395898506,TRRAP,GO_Biological_Process_2023
1482,Muscle Tissue Development (GO:0060537),0.4410402814653663,1.7949125596184419,1.4693496440315028,0.6008289395898506,MEF2C,GO_Biological_Process_2023
1483,Negative Regulation Of Interleukin-1 Production (GO:0032692),0.4410402814653663,1.7949125596184419,1.4693496440315028,0.6008289395898506,NLRP3,GO_Biological_Process_2023
1484,Negative Regulation Of Proteasomal Ubiquitin-Dependent Protein Catabolic Process (GO:0032435),0.4410402814653663,1.7949125596184419,1.4693496440315028,0.6008289395898506,HFE,GO_Biological_Process_2023
1485,Platelet Aggregation (GO:0070527),0.4410402814653663,1.7949125596184419,1.4693496440315028,0.6008289395898506,PDGFRA,GO_Biological_Process_2023
1486,Positive Regulation Of JUN Kinase Activity (GO:0043507),0.4410402814653663,1.7949125596184419,1.4693496440315028,0.6008289395898506,PTPN1,GO_Biological_Process_2023
1487,Positive Regulation Of Cellular Response To Transforming Growth Factor Beta Stimulus (GO:1903846),0.4410402814653663,1.7949125596184419,1.4693496440315028,0.6008289395898506,CITED2,GO_Biological_Process_2023
1488,Positive Regulation Of Interleukin-2 Production (GO:0032743),0.4410402814653663,1.7949125596184419,1.4693496440315028,0.6008289395898506,PTPRC,GO_Biological_Process_2023
1489,Positive Regulation Of Microtubule Polymerization Or Depolymerization (GO:0031112),0.4410402814653663,1.7949125596184419,1.4693496440315028,0.6008289395898506,MAPT,GO_Biological_Process_2023
1490,Positive Regulation Of Oxidoreductase Activity (GO:0051353),0.4410402814653663,1.7949125596184419,1.4693496440315028,0.6008289395898506,SIRT3,GO_Biological_Process_2023
1491,Positive Regulation Of Phosphatase Activity (GO:0010922),0.4410402814653663,1.7949125596184419,1.4693496440315028,0.6008289395898506,MEF2C,GO_Biological_Process_2023
1492,Positive Regulation Of Protein Autophosphorylation (GO:0031954),0.4410402814653663,1.7949125596184419,1.4693496440315028,0.6008289395898506,RAD50,GO_Biological_Process_2023
1493,Positive Regulation Of Protein Import Into Nucleus (GO:0042307),0.4410402814653663,1.7949125596184419,1.4693496440315028,0.6008289395898506,CDH1,GO_Biological_Process_2023
1494,Positive Regulation Of Transforming Growth Factor Beta Receptor Signaling Pathway (GO:0030511),0.4410402814653663,1.7949125596184419,1.4693496440315028,0.6008289395898506,CITED2,GO_Biological_Process_2023
1495,Regulation Of Calcium-Mediated Signaling (GO:0050848),0.4410402814653663,1.7949125596184419,1.4693496440315028,0.6008289395898506,MAPT,GO_Biological_Process_2023
1496,Regulation Of Cell Migration Involved In Sprouting Angiogenesis (GO:0090049),0.4410402814653663,1.7949125596184419,1.4693496440315028,0.6008289395898506,RHOA,GO_Biological_Process_2023
1497,Cholesterol Homeostasis (GO:0042632),0.44296388473656995,1.3564926372155288,1.1045472398168368,0.6018402647287531,"APOE,APOB",GO_Biological_Process_2023
1498,Sterol Homeostasis (GO:0055092),0.44296388473656995,1.3564926372155288,1.1045472398168368,0.6018402647287531,"APOE,APOB",GO_Biological_Process_2023
1499,Macromolecule Modification (GO:0043412),0.44296388473656995,1.3564926372155288,1.1045472398168368,0.6018402647287531,"MSRA,UBE2L3",GO_Biological_Process_2023
1500,Protein Import Into Nucleus (GO:0006606),0.44296388473656995,1.3564926372155288,1.1045472398168368,0.6018402647287531,"GCKR,HEATR3",GO_Biological_Process_2023
1501,Negative Regulation Of Cell Migration (GO:0030336),0.450485235309106,1.1741258741258742,0.9362831681881303,0.6107752273001176,"CDH1,CITED2,DLG5,TRIB1",GO_Biological_Process_2023
1502,Cellular Response To Reactive Oxygen Species (GO:0034614),0.4537361503852823,1.3268727082242011,1.048547114631643,0.6107752273001176,"PDGFRA,MAPT",GO_Biological_Process_2023
1503,Phagocytosis (GO:0006909),0.4537361503852823,1.3268727082242011,1.048547114631643,0.6107752273001176,"AXL,TM9SF4",GO_Biological_Process_2023
1504,Positive Regulation Of Protein Secretion (GO:0050714),0.4537361503852823,1.3268727082242011,1.048547114631643,0.6107752273001176,"BLK,PPARG",GO_Biological_Process_2023
1505,Fc-epsilon Receptor Signaling Pathway (GO:0038095),0.4588306540708931,1.6950283616950284,1.320552665492241,0.6107752273001176,MAP3K1,GO_Biological_Process_2023
1506,Actin Filament Polymerization (GO:0030041),0.4588306540708931,1.6950283616950284,1.320552665492241,0.6107752273001176,JAK2,GO_Biological_Process_2023
1507,Amide Transport (GO:0042886),0.4588306540708931,1.6950283616950284,1.320552665492241,0.6107752273001176,PLTP,GO_Biological_Process_2023
1508,Regulation Of Microtubule Polymerization Or Depolymerization (GO:0031110),0.4588306540708931,1.6950283616950284,1.320552665492241,0.6107752273001176,MAPT,GO_Biological_Process_2023
1509,Blood Vessel Endothelial Cell Migration (GO:0043534),0.4588306540708931,1.6950283616950284,1.320552665492241,0.6107752273001176,EPHB4,GO_Biological_Process_2023
1510,Regulation Of Plasma Membrane Bounded Cell Projection Organization (GO:0120035),0.4588306540708931,1.6950283616950284,1.320552665492241,0.6107752273001176,FBXO7,GO_Biological_Process_2023
1511,Cardiac Muscle Cell Development (GO:0055013),0.4588306540708931,1.6950283616950284,1.320552665492241,0.6107752273001176,PDGFRA,GO_Biological_Process_2023
1512,Cardiac Muscle Contraction (GO:0060048),0.4588306540708931,1.6950283616950284,1.320552665492241,0.6107752273001176,PIK3CA,GO_Biological_Process_2023
1513,Regulation Of Protein Polymerization (GO:0032271),0.4588306540708931,1.6950283616950284,1.320552665492241,0.6107752273001176,MAPT,GO_Biological_Process_2023
1514,Cellular Response To Nerve Growth Factor Stimulus (GO:1990090),0.4588306540708931,1.6950283616950284,1.320552665492241,0.6107752273001176,MAPT,GO_Biological_Process_2023
1515,Regulation Of Type I Interferon-Mediated Signaling Pathway (GO:0060338),0.4588306540708931,1.6950283616950284,1.320552665492241,0.6107752273001176,PTPN1,GO_Biological_Process_2023
1516,Regulation Of Ubiquitin-Protein Transferase Activity (GO:0051438),0.4588306540708931,1.6950283616950284,1.320552665492241,0.6107752273001176,UBE2L3,GO_Biological_Process_2023
1517,Clathrin-Dependent Endocytosis (GO:0072583),0.4588306540708931,1.6950283616950284,1.320552665492241,0.6107752273001176,ITSN1,GO_Biological_Process_2023
1518,Sterol Transport (GO:0015918),0.4588306540708931,1.6950283616950284,1.320552665492241,0.6107752273001176,APOB,GO_Biological_Process_2023
1519,Histone Deubiquitination (GO:0016578),0.4588306540708931,1.6950283616950284,1.320552665492241,0.6107752273001176,TRRAP,GO_Biological_Process_2023
1520,Negative Regulation Of Intracellular Steroid Hormone Receptor Signaling Pathway (GO:0033144),0.4588306540708931,1.6950283616950284,1.320552665492241,0.6107752273001176,KANK2,GO_Biological_Process_2023
1521,Negative Regulation Of Proteasomal Protein Catabolic Process (GO:1901799),0.4588306540708931,1.6950283616950284,1.320552665492241,0.6107752273001176,HFE,GO_Biological_Process_2023
1522,Positive Regulation Of Cytokine Production Involved In Immune Response (GO:0002720),0.4588306540708931,1.6950283616950284,1.320552665492241,0.6107752273001176,KIT,GO_Biological_Process_2023
1523,Positive Regulation Of Dephosphorylation (GO:0035306),0.4588306540708931,1.6950283616950284,1.320552665492241,0.6107752273001176,SPPL3,GO_Biological_Process_2023
1524,Positive Regulation Of Double-Strand Break Repair Via Homologous Recombination (GO:1905168),0.4588306540708931,1.6950283616950284,1.320552665492241,0.6107752273001176,TRRAP,GO_Biological_Process_2023
1525,Positive Regulation Of Fibroblast Proliferation (GO:0048146),0.4588306540708931,1.6950283616950284,1.320552665492241,0.6107752273001176,PDGFRA,GO_Biological_Process_2023
1526,Positive Regulation Of Lamellipodium Organization (GO:1902745),0.4588306540708931,1.6950283616950284,1.320552665492241,0.6107752273001176,PIK3CA,GO_Biological_Process_2023
1527,Positive Regulation Of Microtubule Polymerization (GO:0031116),0.4588306540708931,1.6950283616950284,1.320552665492241,0.6107752273001176,MAPT,GO_Biological_Process_2023
1528,Protein Deacetylation (GO:0006476),0.4588306540708931,1.6950283616950284,1.320552665492241,0.6107752273001176,SIRT3,GO_Biological_Process_2023
1529,Protein Depolymerization (GO:0051261),0.4588306540708931,1.6950283616950284,1.320552665492241,0.6107752273001176,MICAL1,GO_Biological_Process_2023
1530,Protein Localization To Cell Surface (GO:0034394),0.4588306540708931,1.6950283616950284,1.320552665492241,0.6107752273001176,STX4,GO_Biological_Process_2023
1531,Regulation Of G2/M Transition Of Mitotic Cell Cycle (GO:0010389),0.4588306540708931,1.6950283616950284,1.320552665492241,0.6107752273001176,RRM1,GO_Biological_Process_2023
1532,RNA Splicing (GO:0008380),0.4643885605952292,1.2985132017431429,0.9960033364394497,0.6165627925036333,"WBP4,SNRNP25",GO_Biological_Process_2023
1533,Vesicle Fusion (GO:0006906),0.4643885605952292,1.2985132017431429,0.9960033364394497,0.6165627925036333,"STX4,RAB8A",GO_Biological_Process_2023
1534,Negative Regulation Of Protein Modification Process (GO:0031400),0.4643885605952292,1.2985132017431429,0.9960033364394497,0.6165627925036333,"MFHAS1,MAPT",GO_Biological_Process_2023
1535,Positive Regulation Of Protein Modification By Small Protein Conjugation Or Removal (GO:1903322),0.4643885605952292,1.2985132017431429,0.9960033364394497,0.6165627925036333,"NDFIP1,UBE2L3",GO_Biological_Process_2023
1536,Regulation Of Response To External Stimulus (GO:0032101),0.46960316096530463,1.1889590771765999,0.8986952628694377,0.6219250170894073,"PDGFRA,IL37,JAK2",GO_Biological_Process_2023
1537,Negative Regulation Of Cellular Response To Growth Factor Stimulus (GO:0090288),0.47491784384475805,1.2713353413654618,0.946653394938154,0.6219250170894073,"PTPN1,PPARG",GO_Biological_Process_2023
1538,Protein K48-linked Ubiquitination (GO:0070936),0.47491784384475805,1.2713353413654618,0.946653394938154,0.6219250170894073,"ARIH2,FBXO7",GO_Biological_Process_2023
1539,Regulation Of Cell-Matrix Adhesion (GO:0001952),0.47491784384475805,1.2713353413654618,0.946653394938154,0.6219250170894073,"MACF1,RHOA",GO_Biological_Process_2023
1540,DNA Integrity Checkpoint Signaling (GO:0031570),0.47605644095165617,1.605658289868816,1.191749862810084,0.6219250170894073,ATR,GO_Biological_Process_2023
1541,Alpha-Amino Acid Catabolic Process (GO:1901606),0.47605644095165617,1.605658289868816,1.191749862810084,0.6219250170894073,HMGCL,GO_Biological_Process_2023
1542,Regulation Of Proteasomal Protein Catabolic Process (GO:0061136),0.47605644095165617,1.605658289868816,1.191749862810084,0.6219250170894073,APOE,GO_Biological_Process_2023
1543,Cell-Cell Adhesion Mediated By Cadherin (GO:0044331),0.47605644095165617,1.605658289868816,1.191749862810084,0.6219250170894073,CDH1,GO_Biological_Process_2023
1544,Cellular Response To Osmotic Stress (GO:0071470),0.47605644095165617,1.605658289868816,1.191749862810084,0.6219250170894073,NLRP3,GO_Biological_Process_2023
1545,Chondrocyte Differentiation (GO:0002062),0.47605644095165617,1.605658289868816,1.191749862810084,0.6219250170894073,MEF2C,GO_Biological_Process_2023
1546,Embryonic Skeletal System Morphogenesis (GO:0048704),0.47605644095165617,1.605658289868816,1.191749862810084,0.6219250170894073,PDGFRA,GO_Biological_Process_2023
1547,Energy Derivation By Oxidation Of Organic Compounds (GO:0015980),0.47605644095165617,1.605658289868816,1.191749862810084,0.6219250170894073,LEPR,GO_Biological_Process_2023
1548,Translational Elongation (GO:0006414),0.47605644095165617,1.605658289868816,1.191749862810084,0.6219250170894073,HBS1L,GO_Biological_Process_2023
1549,Histone H3 Acetylation (GO:0043966),0.47605644095165617,1.605658289868816,1.191749862810084,0.6219250170894073,TRRAP,GO_Biological_Process_2023
1550,mRNA Destabilization (GO:0061157),0.47605644095165617,1.605658289868816,1.191749862810084,0.6219250170894073,FTO,GO_Biological_Process_2023
1551,Mitotic G2/M Transition Checkpoint (GO:0044818),0.47605644095165617,1.605658289868816,1.191749862810084,0.6219250170894073,RAD50,GO_Biological_Process_2023
1552,Negative Regulation Of DNA Biosynthetic Process (GO:2000279),0.47605644095165617,1.605658289868816,1.191749862810084,0.6219250170894073,XRN1,GO_Biological_Process_2023
1553,Negative Regulation Of Signaling (GO:0023057),0.47605644095165617,1.605658289868816,1.191749862810084,0.6219250170894073,PTPN1,GO_Biological_Process_2023
1554,Organophosphate Biosynthetic Process (GO:0090407),0.47605644095165617,1.605658289868816,1.191749862810084,0.6219250170894073,GK5,GO_Biological_Process_2023
1555,Phosphatidylinositol 3-Kinase Signaling (GO:0014065),0.47605644095165617,1.605658289868816,1.191749862810084,0.6219250170894073,PIK3CA,GO_Biological_Process_2023
1556,Positive Regulation Of Leukocyte Cell-Cell Adhesion (GO:1903039),0.47605644095165617,1.605658289868816,1.191749862810084,0.6219250170894073,RHOA,GO_Biological_Process_2023
1557,Positive Regulation Of Myoblast Differentiation (GO:0045663),0.47605644095165617,1.605658289868816,1.191749862810084,0.6219250170894073,MEF2C,GO_Biological_Process_2023
1558,Positive Regulation Of Synapse Assembly (GO:0051965),0.47605644095165617,1.605658289868816,1.191749862810084,0.6219250170894073,DLG5,GO_Biological_Process_2023
1559,Positive Regulation Of Telomere Maintenance Via Telomerase (GO:0032212),0.47605644095165617,1.605658289868816,1.191749862810084,0.6219250170894073,ATR,GO_Biological_Process_2023
1560,Regulation Of Blood Coagulation (GO:0030193),0.47605644095165617,1.605658289868816,1.191749862810084,0.6219250170894073,APOE,GO_Biological_Process_2023
1561,Regulation Of Interleukin-1 Beta Production (GO:0032651),0.4853210560706859,1.2452667814113598,0.9002589397254492,0.633216589162649,"NLRP3,JAK2",GO_Biological_Process_2023
1562,Positive Regulation Of Plasma Membrane Bounded Cell Projection Assembly (GO:0120034),0.4853210560706859,1.2452667814113598,0.9002589397254492,0.633216589162649,"PIK3CA,KCTD17",GO_Biological_Process_2023
1563,Nitrogen Compound Transport (GO:0071705),0.49229762070841715,1.1094214876033057,0.7862157505816472,0.6355664329508305,"ABCC2,ATP11B,SLC17A1,SLC17A3",GO_Biological_Process_2023
1564,Regulation Of Developmental Growth (GO:0048638),0.4927355073907322,1.5252252252252252,1.0795280967596923,0.6355664329508305,APOE,GO_Biological_Process_2023
1565,NIK/NF-kappaB Signaling (GO:0038061),0.4927355073907322,1.5252252252252252,1.0795280967596923,0.6355664329508305,ZFP91,GO_Biological_Process_2023
1566,Regulation Of Insulin Secretion Involved In Cellular Response To Glucose Stimulus (GO:0061178),0.4927355073907322,1.5252252252252252,1.0795280967596923,0.6355664329508305,STX4,GO_Biological_Process_2023
1567,Regulation Of Interleukin-17 Production (GO:0032660),0.4927355073907322,1.5252252252252252,1.0795280967596923,0.6355664329508305,JAK2,GO_Biological_Process_2023
1568,"Wnt Signaling Pathway, Planar Cell Polarity Pathway (GO:0060071)",0.4927355073907322,1.5252252252252252,1.0795280967596923,0.6355664329508305,RHOA,GO_Biological_Process_2023
1569,Regulation Of Intracellular Protein Transport (GO:0033157),0.4927355073907322,1.5252252252252252,1.0795280967596923,0.6355664329508305,PTPN1,GO_Biological_Process_2023
1570,Regulation Of Lamellipodium Assembly (GO:0010591),0.4927355073907322,1.5252252252252252,1.0795280967596923,0.6355664329508305,PIK3CA,GO_Biological_Process_2023
1571,Regulation Of Neurotransmitter Secretion (GO:0046928),0.4927355073907322,1.5252252252252252,1.0795280967596923,0.6355664329508305,MEF2C,GO_Biological_Process_2023
1572,cAMP-mediated Signaling (GO:0019933),0.4927355073907322,1.5252252252252252,1.0795280967596923,0.6355664329508305,PDE7A,GO_Biological_Process_2023
1573,Central Nervous System Neuron Differentiation (GO:0021953),0.4927355073907322,1.5252252252252252,1.0795280967596923,0.6355664329508305,MAPT,GO_Biological_Process_2023
1574,Substantia Nigra Development (GO:0021762),0.4927355073907322,1.5252252252252252,1.0795280967596923,0.6355664329508305,RHOA,GO_Biological_Process_2023
1575,Internal Peptidyl-Lysine Acetylation (GO:0018393),0.4927355073907322,1.5252252252252252,1.0795280967596923,0.6355664329508305,TRRAP,GO_Biological_Process_2023
1576,Negative Regulation Of Epithelial To Mesenchymal Transition (GO:0010719),0.4927355073907322,1.5252252252252252,1.0795280967596923,0.6355664329508305,SPRED2,GO_Biological_Process_2023
1577,Negative Regulation Of Interleukin-6 Production (GO:0032715),0.4927355073907322,1.5252252252252252,1.0795280967596923,0.6355664329508305,IL37,GO_Biological_Process_2023
1578,Positive Regulation Of DNA Binding (GO:0043388),0.4927355073907322,1.5252252252252252,1.0795280967596923,0.6355664329508305,PPARG,GO_Biological_Process_2023
1579,Positive Regulation Of Protein Dephosphorylation (GO:0035307),0.4927355073907322,1.5252252252252252,1.0795280967596923,0.6355664329508305,SPPL3,GO_Biological_Process_2023
1580,Positive Regulation Of Release Of Sequestered Calcium Ion Into Cytosol (GO:0051281),0.4927355073907322,1.5252252252252252,1.0795280967596923,0.6355664329508305,TRPC1,GO_Biological_Process_2023
1581,Receptor-Mediated Endocytosis (GO:0006898),0.4940288347139516,1.1440332326283988,0.8067280686808431,0.6368316035085599,"TFRC,APOE,ARHGAP27",GO_Biological_Process_2023
1582,Regulation Of Cysteine-Type Endopeptidase Activity Involved In Apoptotic Process (GO:0043281),0.49559556311812764,1.2202409638554217,0.856603155253718,0.638044066730729,"PDCD5,NLRP3",GO_Biological_Process_2023
1583,Kidney Development (GO:0001822),0.49559556311812764,1.2202409638554217,0.856603155253718,0.638044066730729,"KANK2,NPHP3",GO_Biological_Process_2023
1584,Negative Regulation Of Cytokine Production (GO:0001818),0.4991411069945305,1.0993174993174992,0.7638788412007249,0.6405855131504179,"PTPRC,IL37,AXL,LGALS9B",GO_Biological_Process_2023
1585,Cell-Cell Junction Assembly (GO:0007043),0.5057390240908062,1.1961965509095205,0.8154884640102932,0.6405855131504179,"CDH1,RHOA",GO_Biological_Process_2023
1586,Vesicle Organization (GO:0016050),0.5057390240908062,1.1961965509095205,0.8154884640102932,0.6405855131504179,"LAPTM4B,STX4",GO_Biological_Process_2023
1587,Wound Healing (GO:0042060),0.5057390240908062,1.1961965509095205,0.8154884640102932,0.6405855131504179,"PDGFRA,MACF1",GO_Biological_Process_2023
1588,Negative Regulation Of NF-kappaB Transcription Factor Activity (GO:0032088),0.5057390240908062,1.1961965509095205,0.8154884640102932,0.6405855131504179,"NLRP3,COMMD6",GO_Biological_Process_2023
1589,Positive Regulation Of JNK Cascade (GO:0046330),0.5057390240908062,1.1961965509095205,0.8154884640102932,0.6405855131504179,"MFHAS1,GADD45A",GO_Biological_Process_2023
1590,Positive Regulation Of Protein Metabolic Process (GO:0051247),0.5059448710187313,1.0893939393939394,0.7422341213451401,0.6405855131504179,"SLC25A37,LARP1,APOE,PLD1",GO_Biological_Process_2023
1591,Apoptotic Process (GO:0006915),0.5088312636889708,1.0664867047845772,0.7205598218744743,0.6405855131504179,"BCL2L11,PIK3CA,GADD45A,NLRP3,JAK2",GO_Biological_Process_2023
1592,Regulation Of Intracellular Transport (GO:0032386),0.5088851549511907,1.4524524524524525,0.981179441528542,0.6405855131504179,PTPN1,GO_Biological_Process_2023
1593,Amino Acid Catabolic Process (GO:0009063),0.5088851549511907,1.4524524524524525,0.981179441528542,0.6405855131504179,ALDH5A1,GO_Biological_Process_2023
1594,Carbohydrate Catabolic Process (GO:0016052),0.5088851549511907,1.4524524524524525,0.981179441528542,0.6405855131504179,HK1,GO_Biological_Process_2023
1595,Regulation Of Stem Cell Differentiation (GO:2000736),0.5088851549511907,1.4524524524524525,0.981179441528542,0.6405855131504179,PDGFRA,GO_Biological_Process_2023
1596,Dorsal/Ventral Pattern Formation (GO:0009953),0.5088851549511907,1.4524524524524525,0.981179441528542,0.6405855131504179,MDFI,GO_Biological_Process_2023
1597,Double-Strand Break Repair Via Nonhomologous End Joining (GO:0006303),0.5088851549511907,1.4524524524524525,0.981179441528542,0.6405855131504179,NSMCE2,GO_Biological_Process_2023
1598,Embryonic Skeletal System Development (GO:0048706),0.5088851549511907,1.4524524524524525,0.981179441528542,0.6405855131504179,PDGFRA,GO_Biological_Process_2023
1599,Glutamine Family Amino Acid Metabolic Process (GO:0009064),0.5088851549511907,1.4524524524524525,0.981179441528542,0.6405855131504179,ALDH5A1,GO_Biological_Process_2023
1600,Glycolipid Metabolic Process (GO:0006664),0.5088851549511907,1.4524524524524525,0.981179441528542,0.6405855131504179,PGAP3,GO_Biological_Process_2023
1601,Homotypic Cell-Cell Adhesion (GO:0034109),0.5088851549511907,1.4524524524524525,0.981179441528542,0.6405855131504179,PDGFRA,GO_Biological_Process_2023
1602,Interferon-Mediated Signaling Pathway (GO:0140888),0.5088851549511907,1.4524524524524525,0.981179441528542,0.6405855131504179,JAK2,GO_Biological_Process_2023
1603,Membrane Fusion (GO:0061025),0.5088851549511907,1.4524524524524525,0.981179441528542,0.6405855131504179,UBXN2A,GO_Biological_Process_2023
1604,Negative Regulation Of T Cell Proliferation (GO:0042130),0.5088851549511907,1.4524524524524525,0.981179441528542,0.6405855131504179,DLG5,GO_Biological_Process_2023
1605,Negative Regulation Of Fat Cell Differentiation (GO:0045599),0.5088851549511907,1.4524524524524525,0.981179441528542,0.6405855131504179,ASXL1,GO_Biological_Process_2023
1606,Negative Regulation Of Insulin Receptor Signaling Pathway (GO:0046627),0.5088851549511907,1.4524524524524525,0.981179441528542,0.6405855131504179,PTPN1,GO_Biological_Process_2023
1607,Negative Regulation Of Proteolysis (GO:0045861),0.5088851549511907,1.4524524524524525,0.981179441528542,0.6405855131504179,CTSB,GO_Biological_Process_2023
1608,Negative Regulation Of Stress-Activated MAPK Cascade (GO:0032873),0.5088851549511907,1.4524524524524525,0.981179441528542,0.6405855131504179,DUSP1,GO_Biological_Process_2023
1609,Negative Regulation Of Ubiquitin-Dependent Protein Catabolic Process (GO:2000059),0.5088851549511907,1.4524524524524525,0.981179441528542,0.6405855131504179,HFE,GO_Biological_Process_2023
1610,Phosphatidic Acid Biosynthetic Process (GO:0006654),0.5088851549511907,1.4524524524524525,0.981179441528542,0.6405855131504179,PLD1,GO_Biological_Process_2023
1611,Plasma Membrane Invagination (GO:0099024),0.5088851549511907,1.4524524524524525,0.981179441528542,0.6405855131504179,RHOA,GO_Biological_Process_2023
1612,Positive Regulation Of T Cell Mediated Immunity (GO:0002711),0.5088851549511907,1.4524524524524525,0.981179441528542,0.6405855131504179,HFE,GO_Biological_Process_2023
1613,Positive Regulation Of Cytokinesis (GO:0032467),0.5088851549511907,1.4524524524524525,0.981179441528542,0.6405855131504179,RHOA,GO_Biological_Process_2023
1614,Positive Regulation Of Leukocyte Mediated Cytotoxicity (GO:0001912),0.5088851549511907,1.4524524524524525,0.981179441528542,0.6405855131504179,HFE,GO_Biological_Process_2023
1615,Positive Regulation Of Locomotion (GO:0040017),0.5088851549511907,1.4524524524524525,0.981179441528542,0.6405855131504179,STX4,GO_Biological_Process_2023
1616,Positive Regulation Of Myeloid Cell Differentiation (GO:0045639),0.5088851549511907,1.4524524524524525,0.981179441528542,0.6405855131504179,FAXDC2,GO_Biological_Process_2023
1617,Receptor Signaling Pathway Via STAT (GO:0097696),0.5088851549511907,1.4524524524524525,0.981179441528542,0.6405855131504179,JAK2,GO_Biological_Process_2023
1618,Regulation Of Amyloid-Beta Formation (GO:1902003),0.5088851549511907,1.4524524524524525,0.981179441528542,0.6405855131504179,APOE,GO_Biological_Process_2023
1619,Regulation Of calcineurin-NFAT Signaling Cascade (GO:0070884),0.5088851549511907,1.4524524524524525,0.981179441528542,0.6405855131504179,SPPL3,GO_Biological_Process_2023
1620,Cellular Response To Growth Factor Stimulus (GO:0071363),0.5127075604010686,1.079646017699115,0.7212571486244082,0.64499877043048,"MEF2C,DSTYK,PDCD5,MAPT",GO_Biological_Process_2023
1621,Organic Anion Transport (GO:0015711),0.5157493756746305,1.1730769230769231,0.7767345113577714,0.6472273569118825,"SLC17A1,SLC17A3",GO_Biological_Process_2023
1622,Positive Regulation Of Peptidyl-Serine Phosphorylation (GO:0033138),0.5157493756746305,1.1730769230769231,0.7767345113577714,0.6472273569118825,"TFRC,DOCK7",GO_Biological_Process_2023
1623,Positive Regulation Of Translation (GO:0045727),0.5157493756746305,1.1730769230769231,0.7767345113577714,0.6472273569118825,"LARP1,PLD1",GO_Biological_Process_2023
1624,Protein Complex Oligomerization (GO:0051259),0.5157493756746305,1.1730769230769231,0.7767345113577714,0.6472273569118825,"BEND3,NLRP3",GO_Biological_Process_2023
1625,SCF-dependent Proteasomal Ubiquitin-Dependent Protein Catabolic Process (GO:0031146),0.5245221393688277,1.3862953862953864,0.8945315544894749,0.650228783475469,FBXL5,GO_Biological_Process_2023
1626,Base-Excision Repair (GO:0006284),0.5245221393688277,1.3862953862953864,0.8945315544894749,0.650228783475469,MPG,GO_Biological_Process_2023
1627,Cellular Nitrogen Compound Biosynthetic Process (GO:0044271),0.5245221393688277,1.3862953862953864,0.8945315544894749,0.650228783475469,SLC7A6,GO_Biological_Process_2023
1628,Cellular Response To Vascular Endothelial Growth Factor Stimulus (GO:0035924),0.5245221393688277,1.3862953862953864,0.8945315544894749,0.650228783475469,PIK3CA,GO_Biological_Process_2023
1629,Establishment Of Protein Localization To Plasma Membrane (GO:0061951),0.5245221393688277,1.3862953862953864,0.8945315544894749,0.650228783475469,MACF1,GO_Biological_Process_2023
1630,Synaptic Vesicle Endocytosis (GO:0048488),0.5245221393688277,1.3862953862953864,0.8945315544894749,0.650228783475469,ITSN1,GO_Biological_Process_2023
1631,Tumor Necrosis Factor-Mediated Signaling Pathway (GO:0033209),0.5245221393688277,1.3862953862953864,0.8945315544894749,0.650228783475469,JAK2,GO_Biological_Process_2023
1632,Heart Contraction (GO:0060047),0.5245221393688277,1.3862953862953864,0.8945315544894749,0.650228783475469,PIK3CA,GO_Biological_Process_2023
1633,In Utero Embryonic Development (GO:0001701),0.5245221393688277,1.3862953862953864,0.8945315544894749,0.650228783475469,TFEB,GO_Biological_Process_2023
1634,Inositol Lipid-Mediated Signaling (GO:0048017),0.5245221393688277,1.3862953862953864,0.8945315544894749,0.650228783475469,PDGFRA,GO_Biological_Process_2023
1635,Intracellular Protein Transmembrane Transport (GO:0065002),0.5245221393688277,1.3862953862953864,0.8945315544894749,0.650228783475469,TOMM40,GO_Biological_Process_2023
1636,Muscle Cell Differentiation (GO:0042692),0.5245221393688277,1.3862953862953864,0.8945315544894749,0.650228783475469,MEF2C,GO_Biological_Process_2023
1637,Negative Regulation Of Cellular Response To Insulin Stimulus (GO:1900077),0.5245221393688277,1.3862953862953864,0.8945315544894749,0.650228783475469,PTPN1,GO_Biological_Process_2023
1638,Negative Regulation Of Protein Kinase B Signaling (GO:0051898),0.5245221393688277,1.3862953862953864,0.8945315544894749,0.650228783475469,SH2B3,GO_Biological_Process_2023
1639,Negative Regulation Of Sequestering Of Calcium Ion (GO:0051283),0.5245221393688277,1.3862953862953864,0.8945315544894749,0.650228783475469,PTPRC,GO_Biological_Process_2023
1640,Negative Regulation Of Transferase Activity (GO:0051348),0.5245221393688277,1.3862953862953864,0.8945315544894749,0.650228783475469,MAPT,GO_Biological_Process_2023
1641,Phosphatidic Acid Metabolic Process (GO:0046473),0.5245221393688277,1.3862953862953864,0.8945315544894749,0.650228783475469,PLD1,GO_Biological_Process_2023
1642,Positive Regulation Of Catalytic Activity (GO:0043085),0.5245221393688277,1.3862953862953864,0.8945315544894749,0.650228783475469,STX4,GO_Biological_Process_2023
1643,Positive Regulation Of Lymphocyte Differentiation (GO:0045621),0.5245221393688277,1.3862953862953864,0.8945315544894749,0.650228783475469,AXL,GO_Biological_Process_2023
1644,Protein Localization To Chromosome (GO:0034502),0.5245221393688277,1.3862953862953864,0.8945315544894749,0.650228783475469,ATR,GO_Biological_Process_2023
1645,Regulation Of Neuron Differentiation (GO:0045664),0.5256248166650371,1.1508297340304614,0.7401763946491501,0.6505056208927739,"MEF2C,RHOA",GO_Biological_Process_2023
1646,Positive Regulation Of Cellular Component Biogenesis (GO:0044089),0.5256248166650371,1.1508297340304614,0.7401763946491501,0.6505056208927739,"BCL2L11,TFRC",GO_Biological_Process_2023
1647,Double-Strand Break Repair (GO:0006302),0.5257030213986253,1.0891238670694865,0.7003271479661906,0.6505056208927739,"RAD50,TDP2,NSMCE2",GO_Biological_Process_2023
1648,Response To Insulin (GO:0032868),0.5353637937478779,1.1294065149486836,0.7056631009235845,0.6620578954236499,"PPARG,RAB8A",GO_Biological_Process_2023
1649,Positive Regulation Of Hydrolase Activity (GO:0051345),0.5393224078772868,1.0423206423206424,0.6435722580784767,0.6629491001136396,"DOCK7,SNX13,ARHGAP27,RHOA",GO_Biological_Process_2023
1650,Regulation Of Chemokine Production (GO:0032642),0.5396626874821041,1.3258911084998042,0.8178242038340053,0.6629491001136396,IL6R,GO_Biological_Process_2023
1651,Regulation Of mRNA Catabolic Process (GO:0061013),0.5396626874821041,1.3258911084998042,0.8178242038340053,0.6629491001136396,CNOT8,GO_Biological_Process_2023
1652,Calcium-Dependent Cell-Cell Adhesion Via Plasma Membrane Cell Adhesion Molecules (GO:0016339),0.5396626874821041,1.3258911084998042,0.8178242038340053,0.6629491001136396,CDH1,GO_Biological_Process_2023
1653,Cellular Response To Glucose Starvation (GO:0042149),0.5396626874821041,1.3258911084998042,0.8178242038340053,0.6629491001136396,CPEB4,GO_Biological_Process_2023
1654,Endoderm Formation (GO:0001706),0.5396626874821041,1.3258911084998042,0.8178242038340053,0.6629491001136396,DUSP1,GO_Biological_Process_2023
1655,Negative Chemotaxis (GO:0050919),0.5396626874821041,1.3258911084998042,0.8178242038340053,0.6629491001136396,RHOA,GO_Biological_Process_2023
1656,Positive Regulation Of Calcium Ion Transmembrane Transport (GO:1904427),0.5396626874821041,1.3258911084998042,0.8178242038340053,0.6629491001136396,TRPC1,GO_Biological_Process_2023
1657,Positive Regulation Of Cell Division (GO:0051781),0.5396626874821041,1.3258911084998042,0.8178242038340053,0.6629491001136396,RHOA,GO_Biological_Process_2023
1658,Positive Regulation Of Immune Effector Process (GO:0002699),0.5396626874821041,1.3258911084998042,0.8178242038340053,0.6629491001136396,PTPRC,GO_Biological_Process_2023
1659,Protein Targeting To Vacuole (GO:0006623),0.5396626874821041,1.3258911084998042,0.8178242038340053,0.6629491001136396,NCOA4,GO_Biological_Process_2023
1660,Cellular Response To Metal Ion (GO:0071248),0.5411260191812659,1.0635846272746434,0.6531506058443203,0.6643462813803734,"MEF2C,CDH1,HFE",GO_Biological_Process_2023
1661,Neuron Projection Development (GO:0031175),0.5458613130655067,1.0333846944016436,0.6256011124004627,0.669756385326612,"BLOC1S2,DOCK7,APOE,MAPT",GO_Biological_Process_2023
1662,Positive Regulation Of Response To External Stimulus (GO:0032103),0.548728834096336,1.0512553390978228,0.6309118236548311,0.6700529559998513,"CEBPA,NLRP3,STX4",GO_Biological_Process_2023
1663,Aerobic Respiration (GO:0009060),0.5543225141392293,1.2705205205205206,0.7496180413790507,0.6700529559998513,SIRT3,GO_Biological_Process_2023
1664,Regulation Of Mitochondrial Membrane Potential (GO:0051881),0.5543225141392293,1.2705205205205206,0.7496180413790507,0.6700529559998513,MAPT,GO_Biological_Process_2023
1665,Regulation Of Ossification (GO:0030278),0.5543225141392293,1.2705205205205206,0.7496180413790507,0.6700529559998513,MEF2C,GO_Biological_Process_2023
1666,Regulation Of Protein Autophosphorylation (GO:0031952),0.5543225141392293,1.2705205205205206,0.7496180413790507,0.6700529559998513,RAD50,GO_Biological_Process_2023
1667,Regulation Of Protein Import Into Nucleus (GO:0042306),0.5543225141392293,1.2705205205205206,0.7496180413790507,0.6700529559998513,CDH1,GO_Biological_Process_2023
1668,Cell-Substrate Junction Assembly (GO:0007044),0.5543225141392293,1.2705205205205206,0.7496180413790507,0.6700529559998513,TRIP6,GO_Biological_Process_2023
1669,Cellular Component Disassembly (GO:0022411),0.5543225141392293,1.2705205205205206,0.7496180413790507,0.6700529559998513,TMPRSS6,GO_Biological_Process_2023
1670,Digestive Tract Development (GO:0048565),0.5543225141392293,1.2705205205205206,0.7496180413790507,0.6700529559998513,KIT,GO_Biological_Process_2023
1671,Ribosomal Large Subunit Biogenesis (GO:0042273),0.5543225141392293,1.2705205205205206,0.7496180413790507,0.6700529559998513,HEATR3,GO_Biological_Process_2023
1672,Spermatid Development (GO:0007286),0.5543225141392293,1.2705205205205206,0.7496180413790507,0.6700529559998513,CEP57,GO_Biological_Process_2023
1673,Stress-Activated MAPK Cascade (GO:0051403),0.5543225141392293,1.2705205205205206,0.7496180413790507,0.6700529559998513,TRIB1,GO_Biological_Process_2023
1674,Extracellular Matrix Disassembly (GO:0022617),0.5543225141392293,1.2705205205205206,0.7496180413790507,0.6700529559998513,TMPRSS6,GO_Biological_Process_2023
1675,Glutamate Receptor Signaling Pathway (GO:0007215),0.5543225141392293,1.2705205205205206,0.7496180413790507,0.6700529559998513,CPEB4,GO_Biological_Process_2023
1676,Glycolipid Biosynthetic Process (GO:0009247),0.5543225141392293,1.2705205205205206,0.7496180413790507,0.6700529559998513,PGAP3,GO_Biological_Process_2023
1677,Ventricular Septum Morphogenesis (GO:0060412),0.5543225141392293,1.2705205205205206,0.7496180413790507,0.6700529559998513,CITED2,GO_Biological_Process_2023
1678,Heterochromatin Organization (GO:0070828),0.5543225141392293,1.2705205205205206,0.7496180413790507,0.6700529559998513,PRDM16,GO_Biological_Process_2023
1679,Modulation By Host Of Symbiont Process (GO:0051851),0.5543225141392293,1.2705205205205206,0.7496180413790507,0.6700529559998513,TFAP4,GO_Biological_Process_2023
1680,Negative Regulation Of Immune System Process (GO:0002683),0.5543225141392293,1.2705205205205206,0.7496180413790507,0.6700529559998513,MFHAS1,GO_Biological_Process_2023
1681,Negative Regulation Of Osteoblast Differentiation (GO:0045668),0.5543225141392293,1.2705205205205206,0.7496180413790507,0.6700529559998513,PPARG,GO_Biological_Process_2023
1682,Negative Regulation Of Transport (GO:0051051),0.5543225141392293,1.2705205205205206,0.7496180413790507,0.6700529559998513,NDFIP1,GO_Biological_Process_2023
1683,One-Carbon Compound Transport (GO:0019755),0.5543225141392293,1.2705205205205206,0.7496180413790507,0.6700529559998513,HBZ,GO_Biological_Process_2023
1684,Positive Regulation Of Neuron Death (GO:1901216),0.5543225141392293,1.2705205205205206,0.7496180413790507,0.6700529559998513,MAPT,GO_Biological_Process_2023
1685,Receptor Signaling Pathway Via JAK-STAT (GO:0007259),0.5543225141392293,1.2705205205205206,0.7496180413790507,0.6700529559998513,JAK2,GO_Biological_Process_2023
1686,Regulation Of JUN Kinase Activity (GO:0043506),0.5543225141392293,1.2705205205205206,0.7496180413790507,0.6700529559998513,PTPN1,GO_Biological_Process_2023
1687,Negative Regulation Of Cell Motility (GO:2000146),0.5562574889694604,1.0392062620159297,0.6095193952041892,0.6719933387787553,"CDH1,CITED2,DLG5",GO_Biological_Process_2023
1688,Negative Regulation Of Wnt Signaling Pathway (GO:0030178),0.5637108221940834,1.027427950711158,0.588935967780174,0.6798356044578776,"NPHP3,APOE,MDFI",GO_Biological_Process_2023
1689,Response To UV (GO:0009411),0.5637498388291526,1.0696470090889876,0.6130624863792062,0.6798356044578776,"ATR,DDB2",GO_Biological_Process_2023
1690,Mitotic Cell Cycle Phase Transition (GO:0044772),0.5637498388291526,1.0696470090889876,0.6130624863792062,0.6798356044578776,"CCND3,CCND2",GO_Biological_Process_2023
1691,Intracellular Protein Transport (GO:0006886),0.5643948258896289,0.9935710498409331,0.5683238591222358,0.6799514765283476,"GCKR,SNX13,HEATR3,ARFIP1,STX4,AP1M2",GO_Biological_Process_2023
1692,"DNA Damage Response, Signal Transduction By P53 Class Mediator (GO:0030330)",0.5685168380786577,1.2195795795795796,0.6887262826658954,0.6799514765283476,TFAP4,GO_Biological_Process_2023
1693,O-glycan Processing (GO:0016266),0.5685168380786577,1.2195795795795796,0.6887262826658954,0.6799514765283476,GALNT2,GO_Biological_Process_2023
1694,Regulation Of Metal Ion Transport (GO:0010959),0.5685168380786577,1.2195795795795796,0.6887262826658954,0.6799514765283476,HFE,GO_Biological_Process_2023
1695,Regulation Of Nitric Oxide Biosynthetic Process (GO:0045428),0.5685168380786577,1.2195795795795796,0.6887262826658954,0.6799514765283476,JAK2,GO_Biological_Process_2023
1696,Regulation Of Peptidyl-Threonine Phosphorylation (GO:0010799),0.5685168380786577,1.2195795795795796,0.6887262826658954,0.6799514765283476,SPRED2,GO_Biological_Process_2023
1697,Vesicle Cytoskeletal Trafficking (GO:0099518),0.5685168380786577,1.2195795795795796,0.6887262826658954,0.6799514765283476,MYO1D,GO_Biological_Process_2023
1698,Microtubule Bundle Formation (GO:0001578),0.5685168380786577,1.2195795795795796,0.6887262826658954,0.6799514765283476,RP1L1,GO_Biological_Process_2023
1699,Myofibril Assembly (GO:0030239),0.5685168380786577,1.2195795795795796,0.6887262826658954,0.6799514765283476,PDGFRA,GO_Biological_Process_2023
1700,Negative Regulation Of Lymphocyte Proliferation (GO:0050672),0.5685168380786577,1.2195795795795796,0.6887262826658954,0.6799514765283476,DLG5,GO_Biological_Process_2023
1701,Negative Regulation Of Response To Biotic Stimulus (GO:0002832),0.5685168380786577,1.2195795795795796,0.6887262826658954,0.6799514765283476,TRIB1,GO_Biological_Process_2023
1702,Positive Regulation Of Cytokine-Mediated Signaling Pathway (GO:0001961),0.5685168380786577,1.2195795795795796,0.6887262826658954,0.6799514765283476,AXL,GO_Biological_Process_2023
1703,Positive Regulation Of Nucleocytoplasmic Transport (GO:0046824),0.5685168380786577,1.2195795795795796,0.6887262826658954,0.6799514765283476,CDH1,GO_Biological_Process_2023
1704,"Regulation Of Alternative mRNA Splicing, Via Spliceosome (GO:0000381)",0.5685168380786577,1.2195795795795796,0.6887262826658954,0.6799514765283476,RBM38,GO_Biological_Process_2023
1705,Actin Filament Organization (GO:0007015),0.5710877622385485,1.0159113796576031,0.5691261338427972,0.68222559170115,"SPTA1,MYO1D,PLS1",GO_Biological_Process_2023
1706,Endosomal Transport (GO:0016197),0.5710877622385485,1.0159113796576031,0.5691261338427972,0.68222559170115,"LAPTM4B,BLOC1S2,ITSN1",GO_Biological_Process_2023
1707,Mitotic Sister Chromatid Segregation (GO:0000070),0.5729319111160833,1.0511009555463233,0.585451037466751,0.6840276712680596,"PRC1,RHOA",GO_Biological_Process_2023
1708,Chromatin Organization (GO:0006325),0.5778157226971848,0.9908844542990884,0.5435004006369398,0.6867168348561093,"HMGN4,ZNF827,ANP32B,JARID2",GO_Biological_Process_2023
1709,Protein Localization To Plasma Membrane (GO:0072659),0.5783873248096287,1.004647920055775,0.5500563123939457,0.6867168348561093,"CDH1,FLOT2,RAB8A",GO_Biological_Process_2023
1710,Positive Regulation Of Cell Differentiation (GO:0045597),0.5798191939199254,0.9773379418286161,0.5326872540749626,0.6867168348561093,"MEF2C,KITLG,PPARG,APOB,IL6R,RHOA",GO_Biological_Process_2023
1711,MAPK Cascade (GO:0000165),0.5819730064684353,1.033183581784766,0.5592945215428038,0.6867168348561093,"MEF2C,MAP2K2",GO_Biological_Process_2023
1712,RNA Modification (GO:0009451),0.5822603977582713,1.1725571725571726,0.634162904451109,0.6867168348561093,ADAR,GO_Biological_Process_2023
1713,Regulation Of Lipid Metabolic Process (GO:0019216),0.5822603977582713,1.1725571725571726,0.634162904451109,0.6867168348561093,PPARG,GO_Biological_Process_2023
1714,Regulation Of Microtubule Polymerization (GO:0031113),0.5822603977582713,1.1725571725571726,0.634162904451109,0.6867168348561093,MAPT,GO_Biological_Process_2023
1715,Autophagosome Maturation (GO:0097352),0.5822603977582713,1.1725571725571726,0.634162904451109,0.6867168348561093,WIPI2,GO_Biological_Process_2023
1716,Regulation Of Ubiquitin-Dependent Protein Catabolic Process (GO:2000058),0.5822603977582713,1.1725571725571726,0.634162904451109,0.6867168348561093,HFE,GO_Biological_Process_2023
1717,Release Of Sequestered Calcium Ion Into Cytosol (GO:0051209),0.5822603977582713,1.1725571725571726,0.634162904451109,0.6867168348561093,PTPRC,GO_Biological_Process_2023
1718,Connective Tissue Development (GO:0061448),0.5822603977582713,1.1725571725571726,0.634162904451109,0.6867168348561093,SLC39A13,GO_Biological_Process_2023
1719,Retinoid Metabolic Process (GO:0001523),0.5822603977582713,1.1725571725571726,0.634162904451109,0.6867168348561093,ALDH8A1,GO_Biological_Process_2023
1720,Establishment Of Protein Localization To Extracellular Region (GO:0035592),0.5822603977582713,1.1725571725571726,0.634162904451109,0.6867168348561093,RAB8A,GO_Biological_Process_2023
1721,Substrate Adhesion-Dependent Cell Spreading (GO:0034446),0.5822603977582713,1.1725571725571726,0.634162904451109,0.6867168348561093,RHOA,GO_Biological_Process_2023
1722,Negative Regulation Of Secretion By Cell (GO:1903531),0.5822603977582713,1.1725571725571726,0.634162904451109,0.6867168348561093,APOE,GO_Biological_Process_2023
1723,Neutral Amino Acid Transport (GO:0015804),0.5822603977582713,1.1725571725571726,0.634162904451109,0.6867168348561093,SLC7A6,GO_Biological_Process_2023
1724,Nuclear Transport (GO:0051169),0.5822603977582713,1.1725571725571726,0.634162904451109,0.6867168348561093,NUP205,GO_Biological_Process_2023
1725,Phosphatidylinositol Phosphate Biosynthetic Process (GO:0046854),0.5822603977582713,1.1725571725571726,0.634162904451109,0.6867168348561093,PIK3CA,GO_Biological_Process_2023
1726,Positive Regulation Of Mitotic Nuclear Division (GO:0045840),0.5822603977582713,1.1725571725571726,0.634162904451109,0.6867168348561093,NSMCE2,GO_Biological_Process_2023
1727,Protein Localization To Cilium (GO:0061512),0.5822603977582713,1.1725571725571726,0.634162904451109,0.6867168348561093,RAB8A,GO_Biological_Process_2023
1728,protein-DNA Complex Organization (GO:0071824),0.5822603977582713,1.1725571725571726,0.634162904451109,0.6867168348561093,HMGN4,GO_Biological_Process_2023
1729,Regulation Of Macroautophagy (GO:0016241),0.5908727885267967,1.015863453815261,0.5345011607121284,0.6951698145547209,"LARP1,PIK3CA",GO_Biological_Process_2023
1730,Response To Endoplasmic Reticulum Stress (GO:0034976),0.5908727885267967,1.015863453815261,0.5345011607121284,0.6951698145547209,"BCL2L11,UBXN6",GO_Biological_Process_2023
1731,Positive Regulation Of Supramolecular Fiber Organization (GO:1902905),0.5908727885267967,1.015863453815261,0.5345011607121284,0.6951698145547209,"MAPT,APOE",GO_Biological_Process_2023
1732,Circulatory System Development (GO:0072359),0.5927508016664805,0.9828476756651399,0.5140108583939823,0.6951698145547209,"MEF2C,PIK3CA,CITED2",GO_Biological_Process_2023
1733,Regulation Of Interleukin-2 Production (GO:0032663),0.5955674662475675,1.1290179067956845,0.5851029209930787,0.6951698145547209,PTPRC,GO_Biological_Process_2023
1734,Bicellular Tight Junction Assembly (GO:0070830),0.5955674662475675,1.1290179067956845,0.5851029209930787,0.6951698145547209,CLDN23,GO_Biological_Process_2023
1735,Bone Development (GO:0060348),0.5955674662475675,1.1290179067956845,0.5851029209930787,0.6951698145547209,PTPRC,GO_Biological_Process_2023
1736,Carboxylic Acid Transmembrane Transport (GO:1905039),0.5955674662475675,1.1290179067956845,0.5851029209930787,0.6951698145547209,SLC7A6,GO_Biological_Process_2023
1737,Skeletal System Morphogenesis (GO:0048705),0.5955674662475675,1.1290179067956845,0.5851029209930787,0.6951698145547209,PDGFRA,GO_Biological_Process_2023
1738,Epithelial Tube Morphogenesis (GO:0060562),0.5955674662475675,1.1290179067956845,0.5851029209930787,0.6951698145547209,MEF2C,GO_Biological_Process_2023
1739,Intracellular Steroid Hormone Receptor Signaling Pathway (GO:0030518),0.5955674662475675,1.1290179067956845,0.5851029209930787,0.6951698145547209,NCOA4,GO_Biological_Process_2023
1740,Intrinsic Apoptotic Signaling Pathway In Response To DNA Damage (GO:0008630),0.5955674662475675,1.1290179067956845,0.5851029209930787,0.6951698145547209,BCL2L11,GO_Biological_Process_2023
1741,Negative Regulation Of Hydrolase Activity (GO:0051346),0.5955674662475675,1.1290179067956845,0.5851029209930787,0.6951698145547209,CTSB,GO_Biological_Process_2023
1742,Negative Regulation Of Tumor Necrosis Factor Production (GO:0032720),0.5955674662475675,1.1290179067956845,0.5851029209930787,0.6951698145547209,IL37,GO_Biological_Process_2023
1743,Positive Regulation Of Bone Mineralization (GO:0030501),0.5955674662475675,1.1290179067956845,0.5851029209930787,0.6951698145547209,MEF2C,GO_Biological_Process_2023
1744,Positive Regulation Of Protein Tyrosine Kinase Activity (GO:0061098),0.5955674662475675,1.1290179067956845,0.5851029209930787,0.6951698145547209,PTPN1,GO_Biological_Process_2023
1745,Positive Regulation Of Transport (GO:0051050),0.5955674662475675,1.1290179067956845,0.5851029209930787,0.6951698145547209,APOE,GO_Biological_Process_2023
1746,Pyruvate Metabolic Process (GO:0006090),0.5955674662475675,1.1290179067956845,0.5851029209930787,0.6951698145547209,HK1,GO_Biological_Process_2023
1747,Protein Localization To Cell Periphery (GO:1990778),0.5998131604191327,0.9722954297100983,0.4969762386353951,0.6997247973292459,"CDH1,FLOT2,RAB8A",GO_Biological_Process_2023
1748,Cellular Response To Peptide Hormone Stimulus (GO:0071375),0.6082478734799617,0.9828993392926545,0.48867081019915476,0.7021744024245715,"PPARG,RAB8A",GO_Biological_Process_2023
1749,Adherens Junction Organization (GO:0034332),0.6084518660465291,1.0885885885885886,0.5408516027490681,0.7021744024245715,CDH1,GO_Biological_Process_2023
1750,Aortic Valve Morphogenesis (GO:0003180),0.6084518660465291,1.0885885885885886,0.5408516027490681,0.7021744024245715,RHOA,GO_Biological_Process_2023
1751,Regulation Of Protein Modification Process (GO:0031399),0.6084518660465291,1.0885885885885886,0.5408516027490681,0.7021744024245715,SPRED2,GO_Biological_Process_2023
1752,Regulation Of Release Of Sequestered Calcium Ion Into Cytosol (GO:0051279),0.6084518660465291,1.0885885885885886,0.5408516027490681,0.7021744024245715,TRPC1,GO_Biological_Process_2023
1753,Regulation Of Translational Initiation (GO:0006446),0.6084518660465291,1.0885885885885886,0.5408516027490681,0.7021744024245715,LARP1,GO_Biological_Process_2023
1754,Ceramide Biosynthetic Process (GO:0046513),0.6084518660465291,1.0885885885885886,0.5408516027490681,0.7021744024245715,SMPD2,GO_Biological_Process_2023
1755,Response To Organonitrogen Compound (GO:0010243),0.6084518660465291,1.0885885885885886,0.5408516027490681,0.7021744024245715,UBXN6,GO_Biological_Process_2023
1756,Striated Muscle Contraction (GO:0006941),0.6084518660465291,1.0885885885885886,0.5408516027490681,0.7021744024245715,PIK3CA,GO_Biological_Process_2023
1757,Monoatomic Cation Transport (GO:0006812),0.6084518660465291,1.0885885885885886,0.5408516027490681,0.7021744024245715,NDFIP1,GO_Biological_Process_2023
1758,Negative Regulation Of Cell-Substrate Adhesion (GO:0010812),0.6084518660465291,1.0885885885885886,0.5408516027490681,0.7021744024245715,RHOA,GO_Biological_Process_2023
1759,Neurogenesis (GO:0022008),0.6084518660465291,1.0885885885885886,0.5408516027490681,0.7021744024245715,MAPT,GO_Biological_Process_2023
1760,Organelle Disassembly (GO:1903008),0.6084518660465291,1.0885885885885886,0.5408516027490681,0.7021744024245715,HBS1L,GO_Biological_Process_2023
1761,Organic Hydroxy Compound Biosynthetic Process (GO:1901617),0.6084518660465291,1.0885885885885886,0.5408516027490681,0.7021744024245715,FAXDC2,GO_Biological_Process_2023
1762,Positive Regulation Of Receptor-Mediated Endocytosis (GO:0048260),0.6084518660465291,1.0885885885885886,0.5408516027490681,0.7021744024245715,HFE,GO_Biological_Process_2023
1763,Positive Regulation Of Small Molecule Metabolic Process (GO:0062013),0.6084518660465291,1.0885885885885886,0.5408516027490681,0.7021744024245715,APOE,GO_Biological_Process_2023
1764,Potassium Ion Import Across Plasma Membrane (GO:1990573),0.6084518660465291,1.0885885885885886,0.5408516027490681,0.7021744024245715,SLC12A7,GO_Biological_Process_2023
1765,Regulation Of Apoptotic Signaling Pathway (GO:2001233),0.6084518660465291,1.0885885885885886,0.5408516027490681,0.7021744024245715,TMBIM1,GO_Biological_Process_2023
1766,Endocytosis (GO:0006897),0.6084592711883186,0.9517045454545454,0.4728308981417899,0.7021744024245715,"AXL,APOE,ARHGAP27,TM9SF4",GO_Biological_Process_2023
1767,Protein Ubiquitination (GO:0016567),0.6138171899320196,0.9426537847419556,0.4600698447706351,0.707956668410558,"TRIM4,ARIH2,TRIM38,FBXL5,FBXO7,DDB2,UBE2L3",GO_Biological_Process_2023
1768,Regulation Of Peptidyl-Serine Phosphorylation (GO:0033135),0.6167232800625455,0.9672021419009371,0.4674825005165326,0.708141685402224,"TFRC,DOCK7",GO_Biological_Process_2023
1769,Regulation Of Protein Ubiquitination (GO:0031396),0.6167232800625455,0.9672021419009371,0.4674825005165326,0.708141685402224,"NDFIP1,UBE2L3",GO_Biological_Process_2023
1770,Cell Junction Assembly (GO:0034329),0.6167232800625455,0.9672021419009371,0.4674825005165326,0.708141685402224,"CDH1,RHOA",GO_Biological_Process_2023
1771,Regulation Of Cell Adhesion (GO:0030155),0.6205149999954452,0.9419441243342573,0.4495009173749175,0.708141685402224,"CD164,DUSP1,STX4",GO_Biological_Process_2023
1772,Regulation Of Microtubule Cytoskeleton Organization (GO:0070507),0.6209269832256007,1.0509474992233614,0.50082039544352,0.708141685402224,MAPT,GO_Biological_Process_2023
1773,Regulation Of Mitochondrion Organization (GO:0010821),0.6209269832256007,1.0509474992233614,0.50082039544352,0.708141685402224,MAPT,GO_Biological_Process_2023
1774,Cardiac Ventricle Morphogenesis (GO:0003208),0.6209269832256007,1.0509474992233614,0.50082039544352,0.708141685402224,MEF2C,GO_Biological_Process_2023
1775,Cartilage Development (GO:0051216),0.6209269832256007,1.0509474992233614,0.50082039544352,0.708141685402224,MEF2C,GO_Biological_Process_2023
1776,Regulation Of Small Molecule Metabolic Process (GO:0062012),0.6209269832256007,1.0509474992233614,0.50082039544352,0.708141685402224,APOE,GO_Biological_Process_2023
1777,Chemokine-Mediated Signaling Pathway (GO:0070098),0.6209269832256007,1.0509474992233614,0.50082039544352,0.708141685402224,SH2B3,GO_Biological_Process_2023
1778,Embryonic Organ Morphogenesis (GO:0048562),0.6209269832256007,1.0509474992233614,0.50082039544352,0.708141685402224,PDGFRA,GO_Biological_Process_2023
1779,Endosome Organization (GO:0007032),0.6209269832256007,1.0509474992233614,0.50082039544352,0.708141685402224,LAPTM4B,GO_Biological_Process_2023
1780,Heterophilic Cell-Cell Adhesion Via Plasma Membrane Cell Adhesion Molecules (GO:0007157),0.6209269832256007,1.0509474992233614,0.50082039544352,0.708141685402224,CD164,GO_Biological_Process_2023
1781,Negative Regulation Of T Cell Activation (GO:0050868),0.6209269832256007,1.0509474992233614,0.50082039544352,0.708141685402224,DLG5,GO_Biological_Process_2023
1782,Negative Regulation Of Cold-Induced Thermogenesis (GO:0120163),0.6209269832256007,1.0509474992233614,0.50082039544352,0.708141685402224,DOCK7,GO_Biological_Process_2023
1783,Negative Regulation Of Tumor Necrosis Factor Superfamily Cytokine Production (GO:1903556),0.6209269832256007,1.0509474992233614,0.50082039544352,0.708141685402224,IL37,GO_Biological_Process_2023
1784,Positive Regulation Of Biomineral Tissue Development (GO:0070169),0.6209269832256007,1.0509474992233614,0.50082039544352,0.708141685402224,MEF2C,GO_Biological_Process_2023
1785,Positive Regulation Of Cell-Cell Adhesion (GO:0022409),0.6209269832256007,1.0509474992233614,0.50082039544352,0.708141685402224,CITED2,GO_Biological_Process_2023
1786,Positive Regulation Of Ossification (GO:0045778),0.6209269832256007,1.0509474992233614,0.50082039544352,0.708141685402224,MEF2C,GO_Biological_Process_2023
1787,Post-Transcriptional Regulation Of Gene Expression (GO:0010608),0.6209269832256007,1.0509474992233614,0.50082039544352,0.708141685402224,LARP1,GO_Biological_Process_2023
1788,Activation Of GTPase Activity (GO:0090630),0.6250575623548842,0.9519954819277109,0.4473536570060607,0.7120555126211592,"DOCK7,AGAP1",GO_Biological_Process_2023
1789,Positive Regulation Of Inflammatory Response (GO:0050729),0.6250575623548842,0.9519954819277109,0.4473536570060607,0.7120555126211592,"CEBPA,NLRP3",GO_Biological_Process_2023
1790,Protein Localization To Membrane (GO:0072657),0.6261805905442279,0.9296321998612075,0.4351761402534704,0.7129363371671155,"CDH1,FLOT2,RAB8A,TM9SF4",GO_Biological_Process_2023
1791,Proteolysis (GO:0006508),0.6291558683355936,0.9267983162065123,0.4294563278851573,0.7142035148603001,"PSMB5,TMPRSS6,LONP1,PCSK7,SPPL3,CTSB",GO_Biological_Process_2023
1792,Regulation Of Cell Migration (GO:0030334),0.6297304759682993,0.930989010989011,0.43054831271712435,0.7142035148603001,"PDGFRA,MACF1,CDH1,CITED2,DLG5,TRIP6,KIT,STX4,RHOA",GO_Biological_Process_2023
1793,Golgi To Plasma Membrane Transport (GO:0006893),0.6330057811196118,1.015815815815816,0.46450791261694185,0.7142035148603001,MACF1,GO_Biological_Process_2023
1794,Regulation Of Insulin Receptor Signaling Pathway (GO:0046626),0.6330057811196118,1.015815815815816,0.46450791261694185,0.7142035148603001,PTPN1,GO_Biological_Process_2023
1795,Amino Acid Transmembrane Transport (GO:0003333),0.6330057811196118,1.015815815815816,0.46450791261694185,0.7142035148603001,SLC7A6,GO_Biological_Process_2023
1796,Regulation Of Smoothened Signaling Pathway (GO:0008589),0.6330057811196118,1.015815815815816,0.46450791261694185,0.7142035148603001,DLG5,GO_Biological_Process_2023
1797,Defense Response To Gram-negative Bacterium (GO:0050829),0.6330057811196118,1.015815815815816,0.46450791261694185,0.7142035148603001,IL6R,GO_Biological_Process_2023
1798,Epidermal Growth Factor Receptor Signaling Pathway (GO:0007173),0.6330057811196118,1.015815815815816,0.46450791261694185,0.7142035148603001,PIK3CA,GO_Biological_Process_2023
1799,Steroid Biosynthetic Process (GO:0006694),0.6330057811196118,1.015815815815816,0.46450791261694185,0.7142035148603001,FAXDC2,GO_Biological_Process_2023
1800,Tight Junction Assembly (GO:0120192),0.6330057811196118,1.015815815815816,0.46450791261694185,0.7142035148603001,CLDN23,GO_Biological_Process_2023
1801,Ventricular Septum Development (GO:0003281),0.6330057811196118,1.015815815815816,0.46450791261694185,0.7142035148603001,CITED2,GO_Biological_Process_2023
1802,Negative Regulation Of TOR Signaling (GO:0032007),0.6330057811196118,1.015815815815816,0.46450791261694185,0.7142035148603001,NPRL3,GO_Biological_Process_2023
1803,Nucleosome Organization (GO:0034728),0.6330057811196118,1.015815815815816,0.46450791261694185,0.7142035148603001,NFE2,GO_Biological_Process_2023
1804,Organic Hydroxy Compound Transport (GO:0015850),0.6330057811196118,1.015815815815816,0.46450791261694185,0.7142035148603001,ABCC2,GO_Biological_Process_2023
1805,Post-Translational Protein Modification (GO:0043687),0.6330057811196118,1.015815815815816,0.46450791261694185,0.7142035148603001,JAK2,GO_Biological_Process_2023
1806,Protein K63-linked Ubiquitination (GO:0070534),0.6330057811196118,1.015815815815816,0.46450791261694185,0.7142035148603001,ZFP91,GO_Biological_Process_2023
1807,Macroautophagy (GO:0016236),0.6332511046872239,0.93725671918443,0.42822157813249745,0.7142035148603001,"WIPI2,UBXN6",GO_Biological_Process_2023
1808,Positive Regulation Of Cellular Process (GO:0048522),0.6367634416396226,0.9287753697970417,0.4192093162118975,0.7177676405207694,"PDGFRA,HBZ,KITLG,CCND2,PRC1,CITED2,EXOSC9,STX4,MAPT,CNOT8,IL6R",GO_Biological_Process_2023
1809,Regulation Of Endothelial Cell Migration (GO:0010594),0.6413044091660259,0.922964585615188,0.4100279747303273,0.7199453469329729,"DNAJA4,APOE",GO_Biological_Process_2023
1810,Glycerophospholipid Biosynthetic Process (GO:0046474),0.6413044091660259,0.922964585615188,0.4100279747303273,0.7199453469329729,"FIG4,PLD1",GO_Biological_Process_2023
1811,Organic Substance Transport (GO:0071702),0.6433863146202877,0.9085481682496608,0.40067876845170397,0.7199453469329729,"SLC22A16,TRPC1,PLTP,SLC17A3",GO_Biological_Process_2023
1812,DNA-templated Transcription Initiation (GO:0006352),0.6447008136176033,0.982950692628112,0.43148480853355703,0.7199453469329729,TAF8,GO_Biological_Process_2023
1813,Regulation Of Interleukin-12 Production (GO:0032655),0.6447008136176033,0.982950692628112,0.43148480853355703,0.7199453469329729,MAST2,GO_Biological_Process_2023
1814,Regulation Of Stress-Activated MAPK Cascade (GO:0032872),0.6447008136176033,0.982950692628112,0.43148480853355703,0.7199453469329729,MAP2K2,GO_Biological_Process_2023
1815,Ceramide Metabolic Process (GO:0006672),0.6447008136176033,0.982950692628112,0.43148480853355703,0.7199453469329729,SMPD2,GO_Biological_Process_2023
1816,Hexose Metabolic Process (GO:0019318),0.6447008136176033,0.982950692628112,0.43148480853355703,0.7199453469329729,HK1,GO_Biological_Process_2023
1817,Intracellular Glucose Homeostasis (GO:0001678),0.6447008136176033,0.982950692628112,0.43148480853355703,0.7199453469329729,HK1,GO_Biological_Process_2023
1818,Negative Regulation Of Intrinsic Apoptotic Signaling Pathway (GO:2001243),0.6447008136176033,0.982950692628112,0.43148480853355703,0.7199453469329729,PTPN1,GO_Biological_Process_2023
1819,Non-Canonical Wnt Signaling Pathway (GO:0035567),0.6447008136176033,0.982950692628112,0.43148480853355703,0.7199453469329729,RHOA,GO_Biological_Process_2023
1820,Nucleus Organization (GO:0006997),0.6447008136176033,0.982950692628112,0.43148480853355703,0.7199453469329729,NUP205,GO_Biological_Process_2023
1821,Positive Regulation Of Fat Cell Differentiation (GO:0045600),0.6447008136176033,0.982950692628112,0.43148480853355703,0.7199453469329729,PPARG,GO_Biological_Process_2023
1822,Positive Regulation Of Leukocyte Chemotaxis (GO:0002690),0.6447008136176033,0.982950692628112,0.43148480853355703,0.7199453469329729,IL6R,GO_Biological_Process_2023
1823,Positive Regulation Of Stress Fiber Assembly (GO:0051496),0.6447008136176033,0.982950692628112,0.43148480853355703,0.7199453469329729,RHOA,GO_Biological_Process_2023
1824,Receptor Internalization (GO:0031623),0.6447008136176033,0.982950692628112,0.43148480853355703,0.7199453469329729,TFRC,GO_Biological_Process_2023
1825,Regulation Of TORC1 Signaling (GO:1903432),0.6447008136176033,0.982950692628112,0.43148480853355703,0.7199453469329729,NPRL3,GO_Biological_Process_2023
1826,Regulation Of Cell Cycle (GO:0051726),0.6476738997920356,0.9055217831813577,0.39332964096665307,0.7228693361315272,"PTPRC,TRRAP,GADD45A,CITED2,FIGNL1",GO_Biological_Process_2023
1827,Regulation Of Fibroblast Proliferation (GO:0048145),0.656024238279089,0.9521396396396397,0.401381646245754,0.7282011969568536,PDGFRA,GO_Biological_Process_2023
1828,Amino Acid Transport (GO:0006865),0.656024238279089,0.9521396396396397,0.401381646245754,0.7282011969568536,SLC7A6,GO_Biological_Process_2023
1829,Regulation Of Reactive Oxygen Species Metabolic Process (GO:2000377),0.656024238279089,0.9521396396396397,0.401381646245754,0.7282011969568536,GADD45A,GO_Biological_Process_2023
1830,Ephrin Receptor Signaling Pathway (GO:0048013),0.656024238279089,0.9521396396396397,0.401381646245754,0.7282011969568536,EPHB4,GO_Biological_Process_2023
1831,Glucose Metabolic Process (GO:0006006),0.656024238279089,0.9521396396396397,0.401381646245754,0.7282011969568536,HK1,GO_Biological_Process_2023
1832,Negative Regulation Of BMP Signaling Pathway (GO:0030514),0.656024238279089,0.9521396396396397,0.401381646245754,0.7282011969568536,PPARG,GO_Biological_Process_2023
1833,Negative Regulation Of Innate Immune Response (GO:0045824),0.656024238279089,0.9521396396396397,0.401381646245754,0.7282011969568536,SERPING1,GO_Biological_Process_2023
1834,Positive Regulation Of Cellular Metabolic Process (GO:0031325),0.656024238279089,0.9521396396396397,0.401381646245754,0.7282011969568536,GADD45A,GO_Biological_Process_2023
1835,Positive Regulation Of Chemokine Production (GO:0032722),0.656024238279089,0.9521396396396397,0.401381646245754,0.7282011969568536,IL6R,GO_Biological_Process_2023
1836,Regulation Of Cell Death (GO:0010941),0.656024238279089,0.9521396396396397,0.401381646245754,0.7282011969568536,HBZ,GO_Biological_Process_2023
1837,Positive Regulation Of Cell Cycle Process (GO:0090068),0.6569928554628606,0.8956413890857547,0.3762429469594908,0.7284828288538138,"RRM1,RHOA",GO_Biological_Process_2023
1838,Positive Regulation Of Stress-Activated MAPK Cascade (GO:0032874),0.6569928554628606,0.8956413890857547,0.3762429469594908,0.7284828288538138,"MFHAS1,GADD45A",GO_Biological_Process_2023
1839,Proteasome-Mediated Ubiquitin-Dependent Protein Catabolic Process (GO:0043161),0.6576600497141294,0.894689790809941,0.3749350765531486,0.7288260909828144,"PSMB5,UBXN2A,KCTD17,FBXL5,FBXO7",GO_Biological_Process_2023
1840,Protein Modification Process (GO:0036211),0.6629006568882809,0.9136523595246336,0.37563002139005575,0.7342345319229981,"PTPN1,MAP3K1,MAST2,PPP2R2A,WIPI2,VRK2,UBE2L3,MSRA,PTPRC,TAF8,TRIB1,JAK2,ATR",GO_Biological_Process_2023
1841,Regulation Of Cytoskeleton Organization (GO:0051493),0.664629521774859,0.8825737733542867,0.36055389529676907,0.7347682131709786,"MAPT,RHOA",GO_Biological_Process_2023
1842,Blood Circulation (GO:0008015),0.6669878284427431,0.9231959231959231,0.3738790990315251,0.7347682131709786,SERPING1,GO_Biological_Process_2023
1843,Dicarboxylic Acid Metabolic Process (GO:0043648),0.6669878284427431,0.9231959231959231,0.3738790990315251,0.7347682131709786,ALDH5A1,GO_Biological_Process_2023
1844,Spindle Assembly (GO:0051225),0.6669878284427431,0.9231959231959231,0.3738790990315251,0.7347682131709786,RHOA,GO_Biological_Process_2023
1845,Histone Acetylation (GO:0016573),0.6669878284427431,0.9231959231959231,0.3738790990315251,0.7347682131709786,TRRAP,GO_Biological_Process_2023
1846,Negative Regulation Of Cell Projection Organization (GO:0031345),0.6669878284427431,0.9231959231959231,0.3738790990315251,0.7347682131709786,APOE,GO_Biological_Process_2023
1847,Negative Regulation Of Metabolic Process (GO:0009892),0.6669878284427431,0.9231959231959231,0.3738790990315251,0.7347682131709786,DOCK7,GO_Biological_Process_2023
1848,Positive Regulation Of Interleukin-8 Production (GO:0032757),0.6669878284427431,0.9231959231959231,0.3738790990315251,0.7347682131709786,TLR1,GO_Biological_Process_2023
1849,Positive Regulation Of Proteolysis (GO:0045862),0.6669878284427431,0.9231959231959231,0.3738790990315251,0.7347682131709786,APOE,GO_Biological_Process_2023
1850,Regulation Of Cell Development (GO:0060284),0.6669878284427431,0.9231959231959231,0.3738790990315251,0.7347682131709786,DOCK7,GO_Biological_Process_2023
1851,Regulation Of Protein Phosphorylation (GO:0001932),0.6674637067905982,0.8841097052378596,0.35741926220439607,0.7348952103939704,"CCND3,CCND2,TFRC,FAXDC2,LEPR",GO_Biological_Process_2023
1852,Regulation Of I-kappaB kinase/NF-kappaB Signaling (GO:0043122),0.6708903297245468,0.8754305646391978,0.34942775830473455,0.7382691641353274,"NDFIP1,TFRC,TRIM38,RHOA",GO_Biological_Process_2023
1853,Cell-Cell Adhesion Via Plasma-Membrane Adhesion Molecules (GO:0098742),0.6720910788252232,0.8694864048338369,0.3455003469975142,0.7388343433115244,"CD164,CDH1,CLDN23",GO_Biological_Process_2023
1854,Cellular Response To Insulin Stimulus (GO:0032869),0.6721289855248117,0.8698795180722891,0.34560749422118214,0.7388343433115244,"PPARG,RAB8A",GO_Biological_Process_2023
1855,Inflammatory Response (GO:0006954),0.676213019312231,0.8690909090909091,0.3400293284557432,0.7412532930506998,"TLR1,MFHAS1,KIT,NLRP3",GO_Biological_Process_2023
1856,Positive Regulation Of Developmental Process (GO:0051094),0.676213019312231,0.8690909090909091,0.3400293284557432,0.7412532930506998,"TFRC,DLG5,PPARG,APOE",GO_Biological_Process_2023
1857,"Regulation Of Synaptic Transmission, Glutamatergic (GO:0051966)",0.6776029857475239,0.8959547783077195,0.34869998145102127,0.7412532930506998,MEF2C,GO_Biological_Process_2023
1858,Insulin Receptor Signaling Pathway (GO:0008286),0.6776029857475239,0.8959547783077195,0.34869998145102127,0.7412532930506998,PIK3CA,GO_Biological_Process_2023
1859,Nucleocytoplasmic Transport (GO:0006913),0.6776029857475239,0.8959547783077195,0.34869998145102127,0.7412532930506998,NUP205,GO_Biological_Process_2023
1860,Nucleotide-Excision Repair (GO:0006289),0.6776029857475239,0.8959547783077195,0.34869998145102127,0.7412532930506998,DDB2,GO_Biological_Process_2023
1861,Positive Regulation Of Nervous System Development (GO:0051962),0.6776029857475239,0.8959547783077195,0.34869998145102127,0.7412532930506998,DLG5,GO_Biological_Process_2023
1862,Positive Regulation Of Organelle Assembly (GO:1902117),0.6776029857475239,0.8959547783077195,0.34869998145102127,0.7412532930506998,KCTD17,GO_Biological_Process_2023
1863,Positive Regulation Of Smooth Muscle Cell Proliferation (GO:0048661),0.6776029857475239,0.8959547783077195,0.34869998145102127,0.7412532930506998,IL6R,GO_Biological_Process_2023
1864,Membrane Organization (GO:0061024),0.6781633995044333,0.8611981987117369,0.3344609762193773,0.7414683520332807,"HSPA8,UBXN2A,TLCD1",GO_Biological_Process_2023
1865,Positive Regulation Of Wnt Signaling Pathway (GO:0030177),0.6867203051250215,0.8455488621151271,0.3177811023435499,0.7484788954581019,"MACF1,TERT",GO_Biological_Process_2023
1866,Regulation Of Embryonic Development (GO:0045995),0.6878807513214057,0.8702702702702703,0.3256027297563665,0.7484788954581019,NPHP3,GO_Biological_Process_2023
1867,Cellular Response To Type II Interferon (GO:0071346),0.6878807513214057,0.8702702702702703,0.3256027297563665,0.7484788954581019,JAK2,GO_Biological_Process_2023
1868,Chloride Transmembrane Transport (GO:1902476),0.6878807513214057,0.8702702702702703,0.3256027297563665,0.7484788954581019,SLC12A7,GO_Biological_Process_2023
1869,Epidermis Development (GO:0008544),0.6878807513214057,0.8702702702702703,0.3256027297563665,0.7484788954581019,FLOT2,GO_Biological_Process_2023
1870,Epithelial To Mesenchymal Transition (GO:0001837),0.6878807513214057,0.8702702702702703,0.3256027297563665,0.7484788954581019,DLG5,GO_Biological_Process_2023
1871,Plasma Membrane Bounded Cell Projection Morphogenesis (GO:0120039),0.6878807513214057,0.8702702702702703,0.3256027297563665,0.7484788954581019,MYO9B,GO_Biological_Process_2023
1872,Positive Regulation Of Actin Filament Bundle Assembly (GO:0032233),0.6878807513214057,0.8702702702702703,0.3256027297563665,0.7484788954581019,RHOA,GO_Biological_Process_2023
1873,Protein Targeting To Membrane (GO:0006612),0.6878807513214057,0.8702702702702703,0.3256027297563665,0.7484788954581019,SRP14,GO_Biological_Process_2023
1874,Cellular Response To Salt (GO:1902075),0.6938143452384443,0.8338834791219674,0.3048268298784471,0.7545323562411684,"MEF2C,CDH1",GO_Biological_Process_2023
1875,Regulation Of Cell Growth (GO:0001558),0.6969051336195738,0.8446127946127946,0.3049947344666288,0.7568819821853445,"TFRC,SERTAD2,EXOSC9,CRLF3",GO_Biological_Process_2023
1876,Fatty Acid Oxidation (GO:0019395),0.6978318177263308,0.8460126793460127,0.30437603408117725,0.7568819821853445,HADHA,GO_Biological_Process_2023
1877,Mitochondrial Respiratory Chain Complex Assembly (GO:0033108),0.6978318177263308,0.8460126793460127,0.30437603408117725,0.7568819821853445,SAMM50,GO_Biological_Process_2023
1878,Negative Regulation Of Cell Death (GO:0060548),0.6978318177263308,0.8460126793460127,0.30437603408117725,0.7568819821853445,KANK2,GO_Biological_Process_2023
1879,Peptide Metabolic Process (GO:0006518),0.6978318177263308,0.8460126793460127,0.30437603408117725,0.7568819821853445,SPPL3,GO_Biological_Process_2023
1880,Organonitrogen Compound Biosynthetic Process (GO:1901566),0.7007755403646384,0.8225333767502442,0.2924662535801967,0.7596705059910283,"SLC25A15,APOE",GO_Biological_Process_2023
1881,Positive Regulation Of Programmed Cell Death (GO:0043068),0.7068911882041147,0.8328767123287671,0.2889070507178015,0.7646337644679629,"TFAP4,BCL2L11,GADD45A,PDCD5",GO_Biological_Process_2023
1882,Heart Development (GO:0007507),0.7072783183928419,0.8219972238099126,0.28468314473258277,0.7646337644679629,"MEF2C,CITED2,EPHB4",GO_Biological_Process_2023
1883,Metal Ion Transport (GO:0030001),0.7072783183928419,0.8219972238099126,0.28468314473258277,0.7646337644679629,"NDFIP1,TRPC1,SLC17A3",GO_Biological_Process_2023
1884,ERBB Signaling Pathway (GO:0038127),0.707466539473974,0.823066309552796,0.2848343968281003,0.7646337644679629,PIK3CA,GO_Biological_Process_2023
1885,Endosome To Lysosome Transport (GO:0008333),0.707466539473974,0.823066309552796,0.2848343968281003,0.7646337644679629,UBXN6,GO_Biological_Process_2023
1886,Regulation Of JNK Cascade (GO:0046328),0.7076051421916477,0.8114859437751004,0.2806678721653784,0.7646337644679629,"MFHAS1,GADD45A",GO_Biological_Process_2023
1887,Cell-Matrix Adhesion (GO:0007160),0.7143044572440648,0.8007292327203551,0.2694021448885474,0.7708855385903524,"TRIP6,THBS3",GO_Biological_Process_2023
1888,Regulation Of Cell Motility (GO:2000145),0.7143044572440648,0.8007292327203551,0.2694021448885474,0.7708855385903524,"MACF1,RHOA",GO_Biological_Process_2023
1889,Positive Regulation Of GTPase Activity (GO:0043547),0.7166372777305133,0.8214578214578214,0.2736977981595675,0.7708855385903524,"DOCK7,AGAP1,SNX13,ARHGAP27",GO_Biological_Process_2023
1890,Regulation Of Cellular Localization (GO:0060341),0.7167949438806269,0.8013276434329066,0.2668144362884767,0.7708855385903524,TRIM38,GO_Biological_Process_2023
1891,Regulation Of Endopeptidase Activity (GO:0052548),0.7167949438806269,0.8013276434329066,0.2668144362884767,0.7708855385903524,SERPING1,GO_Biological_Process_2023
1892,Regulation Of Mitotic Nuclear Division (GO:0007088),0.7167949438806269,0.8013276434329066,0.2668144362884767,0.7708855385903524,DUSP1,GO_Biological_Process_2023
1893,Cellular Respiration (GO:0045333),0.7167949438806269,0.8013276434329066,0.2668144362884767,0.7708855385903524,SIRT3,GO_Biological_Process_2023
1894,Regulation Of Viral Genome Replication (GO:0045069),0.7167949438806269,0.8013276434329066,0.2668144362884767,0.7708855385903524,LARP1,GO_Biological_Process_2023
1895,Response To Retinoic Acid (GO:0032526),0.7167949438806269,0.8013276434329066,0.2668144362884767,0.7708855385903524,ASXL1,GO_Biological_Process_2023
1896,Negative Regulation Of Canonical Wnt Signaling Pathway (GO:0090090),0.7208748419032562,0.7902519167579408,0.25864134939531713,0.7748644133960106,"NPHP3,APOE",GO_Biological_Process_2023
1897,Regulation Of Innate Immune Response (GO:0045088),0.7258267414612338,0.7807037807037807,0.2501717960575722,0.7785446837357866,PTPN1,GO_Biological_Process_2023
1898,Neuron Migration (GO:0001764),0.7258267414612338,0.7807037807037807,0.2501717960575722,0.7785446837357866,MEF2C,GO_Biological_Process_2023
1899,Positive Regulation Of Response To Stimulus (GO:0048584),0.7258267414612338,0.7807037807037807,0.2501717960575722,0.7785446837357866,CEBPG,GO_Biological_Process_2023
1900,Protein Autoubiquitination (GO:0051865),0.7258267414612338,0.7807037807037807,0.2501717960575722,0.7785446837357866,DDB2,GO_Biological_Process_2023
1901,Positive Regulation Of Cell Migration (GO:0030335),0.7266414099197857,0.8209151400640763,0.26213640346968486,0.7790085183674503,"PDGFRA,PTPRC,TRIP6,KIT,STX4",GO_Biological_Process_2023
1902,Protein Processing (GO:0016485),0.7273176979850559,0.780043249922768,0.24835945109961277,0.7793235901648495,"PCSK7,SPPL3",GO_Biological_Process_2023
1903,DNA-templated Transcription (GO:0006351),0.7290884522465833,0.7930907657953501,0.25058513336587696,0.7799906906449012,"GTF2A1,THRB,KLF13",GO_Biological_Process_2023
1904,Chromatin Remodeling (GO:0006338),0.7290884522465833,0.7930907657953501,0.25058513336587696,0.7799906906449012,"ZNF827,PRDM16,JARID2",GO_Biological_Process_2023
1905,Regulation Of Cell Differentiation (GO:0045595),0.7290884522465833,0.7930907657953501,0.25058513336587696,0.7799906906449012,"TAF8,FLOT2,ANP32B",GO_Biological_Process_2023
1906,Regulation Of Protein Kinase Activity (GO:0045859),0.7336344685650344,0.770093030349245,0.23853198333053405,0.7825699854695621,"PTPRC,TRIB1",GO_Biological_Process_2023
1907,Response To Calcium Ion (GO:0051592),0.7336344685650344,0.770093030349245,0.23853198333053405,0.7825699854695621,"MEF2C,TRPC1",GO_Biological_Process_2023
1908,Regulation Of Epithelial Cell Migration (GO:0010632),0.734571335722901,0.7611111111111111,0.23477854903083212,0.7825699854695621,MACF1,GO_Biological_Process_2023
1909,Monoatomic Anion Transmembrane Transport (GO:0098656),0.734571335722901,0.7611111111111111,0.23477854903083212,0.7825699854695621,SLC12A7,GO_Biological_Process_2023
1910,Monocarboxylic Acid Transport (GO:0015718),0.734571335722901,0.7611111111111111,0.23477854903083212,0.7825699854695621,ABCC2,GO_Biological_Process_2023
1911,Negative Regulation Of Catabolic Process (GO:0009895),0.734571335722901,0.7611111111111111,0.23477854903083212,0.7825699854695621,HFE,GO_Biological_Process_2023
1912,Positive Regulation Of Cell Junction Assembly (GO:1901890),0.734571335722901,0.7611111111111111,0.23477854903083212,0.7825699854695621,DLG5,GO_Biological_Process_2023
1913,Positive Regulation Of Double-Strand Break Repair (GO:2000781),0.734571335722901,0.7611111111111111,0.23477854903083212,0.7825699854695621,TRRAP,GO_Biological_Process_2023
1914,Regulation Of Neuron Projection Development (GO:0010975),0.7395072940711898,0.7793787280192114,0.2351940020729255,0.7866551186087766,"SEZ6,APOE,FBXO7",GO_Biological_Process_2023
1915,Negative Regulation Of Growth (GO:0045926),0.7398266338960455,0.7603915662650602,0.22913593739309557,0.7866551186087766,"SERTAD2,CRLF3",GO_Biological_Process_2023
1916,Protein Homooligomerization (GO:0051260),0.7398266338960455,0.7603915662650602,0.22913593739309557,0.7866551186087766,"BEND3,NLRP3",GO_Biological_Process_2023
1917,Positive Regulation Of Cell Motility (GO:2000147),0.7399571126838715,0.7942166765696177,0.239188716911683,0.7866551186087766,"PDGFRA,TRIP6,KIT,STX4",GO_Biological_Process_2023
1918,DNA-templated DNA Replication (GO:0006261),0.7430378328370436,0.7424741814985717,0.2205210067166506,0.7866551186087766,RRM1,GO_Biological_Process_2023
1919,Cytoskeleton-Dependent Cytokinesis (GO:0061640),0.7430378328370436,0.7424741814985717,0.2205210067166506,0.7866551186087766,RHOA,GO_Biological_Process_2023
1920,Homophilic Cell Adhesion Via Plasma Membrane Adhesion Molecules (GO:0007156),0.7430378328370436,0.7424741814985717,0.2205210067166506,0.7866551186087766,CDH1,GO_Biological_Process_2023
1921,Negative Regulation Of Blood Vessel Morphogenesis (GO:2000181),0.7430378328370436,0.7424741814985717,0.2205210067166506,0.7866551186087766,PPARG,GO_Biological_Process_2023
1922,Positive Regulation Of DNA Biosynthetic Process (GO:2000573),0.7430378328370436,0.7424741814985717,0.2205210067166506,0.7866551186087766,ATR,GO_Biological_Process_2023
1923,Positive Regulation Of Macroautophagy (GO:0016239),0.7430378328370436,0.7424741814985717,0.2205210067166506,0.7866551186087766,LARP1,GO_Biological_Process_2023
1924,Protein N-linked Glycosylation (GO:0006487),0.7430378328370436,0.7424741814985717,0.2205210067166506,0.7866551186087766,MLEC,GO_Biological_Process_2023
1925,Regulation Of Bone Mineralization (GO:0030500),0.7430378328370436,0.7424741814985717,0.2205210067166506,0.7866551186087766,MEF2C,GO_Biological_Process_2023
1926,Negative Regulation Of Cell Growth (GO:0030308),0.7458957076995787,0.7509296445039417,0.22014966132778285,0.7892707436613402,"SERTAD2,CRLF3",GO_Biological_Process_2023
1927,Sprouting Angiogenesis (GO:0002040),0.7512350512142344,0.7247247247247247,0.20729786278448545,0.7932730748054972,EPHB4,GO_Biological_Process_2023
1928,Synapse Assembly (GO:0007416),0.7512350512142344,0.7247247247247247,0.20729786278448545,0.7932730748054972,CDH1,GO_Biological_Process_2023
1929,Heart Morphogenesis (GO:0003007),0.7512350512142344,0.7247247247247247,0.20729786278448545,0.7932730748054972,EPHB4,GO_Biological_Process_2023
1930,Histone Modification (GO:0016570),0.7512350512142344,0.7247247247247247,0.20729786278448545,0.7932730748054972,TRRAP,GO_Biological_Process_2023
1931,Synapse Organization (GO:0050808),0.7518432333616928,0.7416985013223626,0.2115527670378549,0.7935041478980477,"CDH1,MAPT",GO_Biological_Process_2023
1932,ERAD Pathway (GO:0036503),0.7591715303401266,0.7078008240798939,0.19501861416491995,0.7991692039427573,UBXN6,GO_Biological_Process_2023
1933,Regulation Of Neurogenesis (GO:0050767),0.7591715303401266,0.7078008240798939,0.19501861416491995,0.7991692039427573,DOCK7,GO_Biological_Process_2023
1934,Sensory Organ Development (GO:0007423),0.7591715303401266,0.7078008240798939,0.19501861416491995,0.7991692039427573,AHI1,GO_Biological_Process_2023
1935,Fatty Acid Catabolic Process (GO:0009062),0.7591715303401266,0.7078008240798939,0.19501861416491995,0.7991692039427573,HADHA,GO_Biological_Process_2023
1936,Regulation Of Cell Division (GO:0051302),0.7591715303401266,0.7078008240798939,0.19501861416491995,0.7991692039427573,PRC1,GO_Biological_Process_2023
1937,Nervous System Development (GO:0007399),0.7599278548858628,0.8070254997034918,0.2215541453164214,0.7995523842320023,"AHI1,UNC119B,MEF2C,ALDH5A1,CDH1,AXL,JARID2",GO_Biological_Process_2023
1938,Renal System Development (GO:0072001),0.766855539822249,0.6916461916461917,0.18360221228292864,0.8047639496177875,NPHP3,GO_Biological_Process_2023
1939,Inorganic Anion Transmembrane Transport (GO:0098661),0.766855539822249,0.6916461916461917,0.18360221228292864,0.8047639496177875,SLC12A7,GO_Biological_Process_2023
1940,Negative Regulation Of Endopeptidase Activity (GO:0010951),0.766855539822249,0.6916461916461917,0.18360221228292864,0.8047639496177875,SERPING1,GO_Biological_Process_2023
1941,Negative Regulation Of Epithelial Cell Proliferation (GO:0050680),0.766855539822249,0.6916461916461917,0.18360221228292864,0.8047639496177875,APOE,GO_Biological_Process_2023
1942,Positive Regulation Of Protein Polymerization (GO:0032273),0.766855539822249,0.6916461916461917,0.18360221228292864,0.8047639496177875,MAPT,GO_Biological_Process_2023
1943,Defense Response To Bacterium (GO:0042742),0.768972333491036,0.7153082919914954,0.1879116938704039,0.8065700543771135,"TFEB,IL6R",GO_Biological_Process_2023
1944,Regulation Of Mitotic Cell Cycle Phase Transition (GO:1901990),0.7742950875876043,0.6762095428762095,0.17297590761971335,0.8106462499060649,TFAP4,GO_Biological_Process_2023
1945,Protein Deubiquitination (GO:0016579),0.7742950875876043,0.6762095428762095,0.17297590761971335,0.8106462499060649,USP49,GO_Biological_Process_2023
1946,Regulation Of Cellular Biosynthetic Process (GO:0031326),0.7742950875876043,0.6762095428762095,0.17297590761971335,0.8106462499060649,JAK2,GO_Biological_Process_2023
1947,Intracellular Calcium Ion Homeostasis (GO:0006874),0.7744495822213485,0.7069207060801345,0.18069085419601622,0.8106462499060649,"TRPC1,KCTD17",GO_Biological_Process_2023
1948,Second-Messenger-Mediated Signaling (GO:0019932),0.7814979285728179,0.6614440527484006,0.16307425538242756,0.8146766130083902,APOE,GO_Biological_Process_2023
1949,Sphingolipid Biosynthetic Process (GO:0030148),0.7814979285728179,0.6614440527484006,0.16307425538242756,0.8146766130083902,SMPD2,GO_Biological_Process_2023
1950,Mitochondrial Gene Expression (GO:0140053),0.7814979285728179,0.6614440527484006,0.16307425538242756,0.8146766130083902,MRPL33,GO_Biological_Process_2023
1951,Mitochondrial Translation (GO:0032543),0.7814979285728179,0.6614440527484006,0.16307425538242756,0.8146766130083902,MRPL33,GO_Biological_Process_2023
1952,Negative Regulation Of Angiogenesis (GO:0016525),0.7814979285728179,0.6614440527484006,0.16307425538242756,0.8146766130083902,PPARG,GO_Biological_Process_2023
1953,Negative Regulation Of Phosphorylation (GO:0042326),0.7814979285728179,0.6614440527484006,0.16307425538242756,0.8146766130083902,MAPT,GO_Biological_Process_2023
1954,Peptidyl-Threonine Modification (GO:0018210),0.7814979285728179,0.6614440527484006,0.16307425538242756,0.8146766130083902,GALNT2,GO_Biological_Process_2023
1955,Positive Regulation Of Synaptic Transmission (GO:0050806),0.7814979285728179,0.6614440527484006,0.16307425538242756,0.8146766130083902,STX4,GO_Biological_Process_2023
1956,Positive Regulation Of Apoptotic Process (GO:0043065),0.7821957903766881,0.7447480944413459,0.182947517193888,0.8149872294415595,"TFAP4,BCL2L11,GADD45A,PDCD5",GO_Biological_Process_2023
1957,Protein Glycosylation (GO:0006486),0.7850652468662721,0.6907174151150055,0.16714563503237886,0.8175590051678399,"GALNT2,MLEC",GO_Biological_Process_2023
1958,Regulation Of Cilium Assembly (GO:1902017),0.7884715720346978,0.6473068813494346,0.15383825850563562,0.8181797677223596,KCTD17,GO_Biological_Process_2023
1959,Regulation Of Heart Contraction (GO:0008016),0.7884715720346978,0.6473068813494346,0.15383825850563562,0.8181797677223596,TRPC1,GO_Biological_Process_2023
1960,Regulation Of Plasma Membrane Bounded Cell Projection Assembly (GO:0120032),0.7884715720346978,0.6473068813494346,0.15383825850563562,0.8181797677223596,PLD1,GO_Biological_Process_2023
1961,Cell-Cell Junction Organization (GO:0045216),0.7884715720346978,0.6473068813494346,0.15383825850563562,0.8181797677223596,CDH1,GO_Biological_Process_2023
1962,Positive Regulation Of Cell-Substrate Adhesion (GO:0010811),0.7884715720346978,0.6473068813494346,0.15383825850563562,0.8181797677223596,JAK2,GO_Biological_Process_2023
1963,Protein Modification By Small Protein Removal (GO:0070646),0.7884715720346978,0.6473068813494346,0.15383825850563562,0.8181797677223596,USP49,GO_Biological_Process_2023
1964,Regulation Of Actin Filament-Based Process (GO:0032970),0.7884715720346978,0.6473068813494346,0.15383825850563562,0.8181797677223596,RHOA,GO_Biological_Process_2023
1965,Regulation Of Anatomical Structure Morphogenesis (GO:0022603),0.7902069862572116,0.6828888588060106,0.16079325647888557,0.8195632763319071,"MEF2C,MAPT",GO_Biological_Process_2023
1966,Supramolecular Fiber Organization (GO:0097435),0.793755526508419,0.731069733479372,0.16886231616553876,0.822824904895299,"SPTA1,MYO1D,MAPT,RHOA",GO_Biological_Process_2023
1967,Actomyosin Structure Organization (GO:0031032),0.7952232900338203,0.6337587587587588,0.1452146247260491,0.8230904342757369,RHOA,GO_Biological_Process_2023
1968,Negative Regulation Of Apoptotic Signaling Pathway (GO:2001234),0.7952232900338203,0.6337587587587588,0.1452146247260491,0.8230904342757369,TMBIM1,GO_Biological_Process_2023
1969,Positive Regulation Of DNA Repair (GO:0045739),0.7952232900338203,0.6337587587587588,0.1452146247260491,0.8230904342757369,CEBPG,GO_Biological_Process_2023
1970,Positive Regulation Of Growth (GO:0045927),0.8017601244090331,0.6207636207636208,0.1371551226226436,0.8290142737420647,EXOSC9,GO_Biological_Process_2023
1971,Recombinational Repair (GO:0000725),0.8017601244090331,0.6207636207636208,0.1371551226226436,0.8290142737420647,NSMCE2,GO_Biological_Process_2023
1972,Cellular Response To Calcium Ion (GO:0071277),0.8080888943318133,0.6082882882882883,0.12961602032881586,0.8347111843123343,MEF2C,GO_Biological_Process_2023
1973,Positive Regulation Of Protein Catabolic Process (GO:0045732),0.8080888943318133,0.6082882882882883,0.12961602032881586,0.8347111843123343,APOE,GO_Biological_Process_2023
1974,Regulation Of Stress Fiber Assembly (GO:0051492),0.8142162030729391,0.5963021845374786,0.12255759592278734,0.8401886692975442,RHOA,GO_Biological_Process_2023
1975,Negative Regulation Of Macromolecule Biosynthetic Process (GO:0010558),0.8142162030729391,0.5963021845374786,0.12255759592278734,0.8401886692975442,LARP1,GO_Biological_Process_2023
1976,Calcium Ion Transmembrane Import Into Cytosol (GO:0097553),0.8201484449397144,0.5847770847770848,0.11594370856128416,0.8454539862352746,PTPRC,GO_Biological_Process_2023
1977,Sensory Perception Of Sound (GO:0007605),0.8201484449397144,0.5847770847770848,0.11594370856128416,0.8454539862352746,KIT,GO_Biological_Process_2023
1978,Regulation Of Hydrolase Activity (GO:0051336),0.8258918121257055,0.5736868944416115,0.1097414220334155,0.8487985441816379,ARHGAP27,GO_Biological_Process_2023
1979,Regulation Of Organelle Organization (GO:0033043),0.8258918121257055,0.5736868944416115,0.1097414220334155,0.8487985441816379,MAPT,GO_Biological_Process_2023
1980,Chloride Transport (GO:0006821),0.8258918121257055,0.5736868944416115,0.1097414220334155,0.8487985441816379,SLC12A7,GO_Biological_Process_2023
1981,Sulfur Compound Biosynthetic Process (GO:0044272),0.8258918121257055,0.5736868944416115,0.1097414220334155,0.8487985441816379,MPST,GO_Biological_Process_2023
1982,Exocytosis (GO:0006887),0.8258918121257055,0.5736868944416115,0.1097414220334155,0.8487985441816379,STX4,GO_Biological_Process_2023
1983,Transforming Growth Factor Beta Receptor Signaling Pathway (GO:0007179),0.8258918121257055,0.5736868944416115,0.1097414220334155,0.8487985441816379,ZMIZ2,GO_Biological_Process_2023
1984,Neuron Projection Morphogenesis (GO:0048812),0.8275761280180568,0.6260712954912433,0.11848660862143386,0.8501008815024191,"DOCK7,RAB8A",GO_Biological_Process_2023
1985,Sodium Ion Transport (GO:0006814),0.8314523004558384,0.5630074518963408,0.10392067420918301,0.8536522863118381,SLC17A3,GO_Biological_Process_2023
1986,Calcium Ion Transmembrane Transport (GO:0070588),0.8368357162387334,0.5527163527163527,0.09845398469009083,0.8574515785291797,TRPC1,GO_Biological_Process_2023
1987,Calcium-Mediated Signaling (GO:0019722),0.8368357162387334,0.5527163527163527,0.09845398469009083,0.8574515785291797,PTPRC,GO_Biological_Process_2023
1988,Cellular Response To Organic Substance (GO:0071310),0.8368357162387334,0.5527163527163527,0.09845398469009083,0.8574515785291797,RHOA,GO_Biological_Process_2023
1989,Regulation Of BMP Signaling Pathway (GO:0030510),0.8368357162387334,0.5527163527163527,0.09845398469009083,0.8574515785291797,PPARG,GO_Biological_Process_2023
1990,Double-Strand Break Repair Via Homologous Recombination (GO:0000724),0.8420476819902674,0.5427927927927928,0.09331619705666398,0.8619252515801933,NSMCE2,GO_Biological_Process_2023
1991,Non-Membrane-Bounded Organelle Assembly (GO:0140694),0.8420476819902674,0.5427927927927928,0.09331619705666398,0.8619252515801933,MAPT,GO_Biological_Process_2023
1992,Regulation Of Translation (GO:0006417),0.843925108085783,0.601037814624836,0.10199102203539363,0.8634133384933865,"LARP1,PLD1",GO_Biological_Process_2023
1993,Intrinsic Apoptotic Signaling Pathway (GO:0097193),0.8470936420048437,0.5332174279542701,0.08848425055363685,0.8662201918744966,BCL2L11,GO_Biological_Process_2023
1994,Sphingolipid Metabolic Process (GO:0006665),0.851978868417745,0.5239722481101792,0.08393697703450269,0.8703423227244934,SMPD2,GO_Biological_Process_2023
1995,Protein O-linked Glycosylation (GO:0006493),0.851978868417745,0.5239722481101792,0.08393697703450269,0.8703423227244934,GALNT2,GO_Biological_Process_2023
1996,Negative Regulation Of Multicellular Organismal Process (GO:0051241),0.854182570382413,0.6271278258151891,0.09884182068950197,0.8721563519235259,"SPRED2,MEF2C,DOCK7",GO_Biological_Process_2023
1997,Positive Regulation Of Cellular Biosynthetic Process (GO:0031328),0.8588577493044754,0.5779116465863454,0.08793039612384887,0.8764907827153335,"LARP1,PLD1",GO_Biological_Process_2023
1998,Positive Regulation Of Neuron Projection Development (GO:0010976),0.861287378964621,0.5064064064064064,0.0756201781962719,0.8785303695344833,APOE,GO_Biological_Process_2023
1999,Regulation Of Endothelial Cell Proliferation (GO:0001936),0.8657203934049079,0.498055432481662,0.07181625335969878,0.8817282167712156,APOE,GO_Biological_Process_2023
2000,Regulation Of Protein Metabolic Process (GO:0051246),0.8657203934049079,0.498055432481662,0.07181625335969878,0.8817282167712156,APOE,GO_Biological_Process_2023
2001,Endoplasmic Reticulum To Golgi Vesicle-Mediated Transport (GO:0006888),0.8657203934049079,0.498055432481662,0.07181625335969878,0.8817282167712156,CNIH4,GO_Biological_Process_2023
2002,Regulation Of GTPase Activity (GO:0043087),0.8663475526116662,0.6100488655487744,0.08752317387963696,0.8819262298814065,"DOCK7,SNX13,ARHGAP27",GO_Biological_Process_2023
2003,Regulation Of Epithelial To Mesenchymal Transition (GO:0010717),0.870012144883489,0.4899738448125545,0.06822793075906583,0.8852145538055669,SPRED2,GO_Biological_Process_2023
2004,Generation Of Neurons (GO:0048699),0.8724760622615371,0.5564828119818724,0.07591541920349727,0.8872785503438185,"MEF2C,MAPT",GO_Biological_Process_2023
2005,Response To Tumor Necrosis Factor (GO:0034612),0.8781896701457171,0.4745683183183183,0.061642952348711706,0.8926436647166941,JAK2,GO_Biological_Process_2023
2006,Golgi Vesicle Transport (GO:0048193),0.8818864814986092,0.5414156626506024,0.06805158338372229,0.895708614525666,"RAB8A,CNIH4",GO_Biological_Process_2023
2007,Inorganic Cation Import Across Plasma Membrane (GO:0098659),0.8820839987011834,0.4672210672210672,0.058621288604497945,0.895708614525666,SLC12A7,GO_Biological_Process_2023
2008,Regulation Of Protein Catabolic Process (GO:0042176),0.8858541824970396,0.4600964600964601,0.05576503513375435,0.8981944397656552,APOE,GO_Biological_Process_2023
2009,Cytosolic Transport (GO:0016482),0.8858541824970396,0.4600964600964601,0.05576503513375435,0.8981944397656552,MYO1D,GO_Biological_Process_2023
2010,Lysosomal Transport (GO:0007041),0.8858541824970396,0.4600964600964601,0.05576503513375435,0.8981944397656552,NCOA4,GO_Biological_Process_2023
2011,Monocarboxylic Acid Metabolic Process (GO:0032787),0.8895041675513641,0.45318452781139346,0.053063868797664594,0.9014467893931775,CPT1B,GO_Biological_Process_2023
2012,Regulation Of Cell Cycle Process (GO:0010564),0.893037774879375,0.44647588765235824,0.050508208920914614,0.9045341371648675,PRC1,GO_Biological_Process_2023
2013,Neuron Differentiation (GO:0030182),0.8934382817040619,0.5225384295803905,0.058878596416447826,0.9045341371648675,"MEF2C,TDP2",GO_Biological_Process_2023
2014,Cellular Response To Tumor Necrosis Factor (GO:0071356),0.8997705381698449,0.4336336336336336,0.045798435528203923,0.9104927292900415,JAK2,GO_Biological_Process_2023
2015,Protein Localization To Organelle (GO:0033365),0.9060806859763385,0.42150483817150486,0.04157172375816611,0.9164103438015687,RAB8A,GO_Biological_Process_2023
2016,Central Nervous System Development (GO:0007417),0.9065177885691671,0.5500137324910739,0.053980891865115746,0.9164103438015687,"AHI1,ALDH5A1,JARID2",GO_Biological_Process_2023
2017,Positive Regulation Of Cell Projection Organization (GO:0031346),0.9090856112988658,0.41568966226500476,0.03962187892145899,0.9185505581691069,APOE,GO_Biological_Process_2023
2018,Inorganic Cation Transmembrane Transport (GO:0098662),0.9146887265193646,0.5367811365952198,0.04786555828434995,0.9237540260884366,"TRPC1,SLC39A13,SLC12A7",GO_Biological_Process_2023
2019,Monoatomic Cation Transmembrane Transport (GO:0098655),0.9166275952238144,0.5335702861204905,0.046449428376364135,0.9251493318131216,"TRPC1,SLC39A13,SLC12A7",GO_Biological_Process_2023
2020,Defense Response To Symbiont (GO:0140546),0.9175372951671965,0.3991623202149518,0.03435272803783502,0.9251493318131216,PTPRC,GO_Biological_Process_2023
2021,Negative Regulation Of Cellular Biosynthetic Process (GO:0031327),0.9175372951671965,0.3991623202149518,0.03435272803783502,0.9251493318131216,LARP1,GO_Biological_Process_2023
2022,Axonogenesis (GO:0007409),0.9178861378440294,0.48058902275769744,0.0411777944799668,0.9251493318131216,"DOCK7,RAB8A",GO_Biological_Process_2023
2023,Vesicle-Mediated Transport (GO:0016192),0.9249018683189794,0.5843406140288872,0.045618090006167296,0.9317597665022639,"AHI1,BLOC1S2,ITSN1,STX4,AP1M2",GO_Biological_Process_2023
2024,Regulation Of Mitotic Cell Cycle (GO:0007346),0.9299182011776355,0.3743373002632262,0.027198843789965167,0.9363504416996152,TFAP4,GO_Biological_Process_2023
2025,Fatty Acid Metabolic Process (GO:0006631),0.9321623668296658,0.3697355892477844,0.02597328407245882,0.9372209687216867,CPT1B,GO_Biological_Process_2023
2026,Modulation Of Chemical Synaptic Transmission (GO:0050804),0.9321623668296658,0.3697355892477844,0.02597328407245882,0.9372209687216867,MEF2C,GO_Biological_Process_2023
2027,Potassium Ion Transport (GO:0006813),0.9321623668296658,0.3697355892477844,0.02597328407245882,0.9372209687216867,SLC12A7,GO_Biological_Process_2023
2028,Calcium Ion Transport (GO:0006816),0.9364380083947468,0.3608608608608609,0.02369843795441691,0.9410555528148391,TRPC1,GO_Biological_Process_2023
2029,Regulation Of Canonical Wnt Signaling Pathway (GO:0060828),0.9369966622373707,0.4448086463501063,0.028946171278141763,0.9411528820304393,"NPHP3,APOE",GO_Biological_Process_2023
2030,Potassium Ion Transmembrane Transport (GO:0071805),0.949394410368502,0.33287133287133286,0.01728632801340145,0.9531358661729099,SLC12A7,GO_Biological_Process_2023
2031,Defense Response To Virus (GO:0051607),0.9525866290675595,0.32564822887403533,0.015818110979950964,0.955869793224858,PTPRC,GO_Biological_Process_2023
2032,Chemical Synaptic Transmission (GO:0007268),0.963320828121133,0.3870095767686129,0.01446207101728389,0.9661652793852702,"APOE,SLC12A7",GO_Biological_Process_2023
2033,Protein Stabilization (GO:0050821),0.9657759597628154,0.2937403422840316,0.010229036665869731,0.9681512080652325,FLOT2,GO_Biological_Process_2023
2034,Skeletal System Development (GO:0001501),0.966874160759827,0.29088704088704087,0.009799090118213625,0.9687755848714491,ETS2,GO_Biological_Process_2023
2035,Anterograde Trans-Synaptic Signaling (GO:0098916),0.9736379911558556,0.2723534345155967,0.007276117212806822,0.9750733297177562,SLC12A7,GO_Biological_Process_2023
2036,Extracellular Matrix Organization (GO:0030198),0.980981901480639,0.24959670414215868,0.004792573367466923,0.9819455379261014,TMPRSS6,GO_Biological_Process_2023
2037,Regulation Of Signal Transduction (GO:0009966),0.9827575968901069,0.24348542090477573,0.004234889448201057,0.9832400503004604,PTPN1,GO_Biological_Process_2023
2038,Regulation Of Angiogenesis (GO:0045765),0.9887281591428336,0.2200960084171763,0.0024949752284516027,0.9887281591428336,PPARG,GO_Biological_Process_2023
1,Cytoplasmic Side Of Endoplasmic Reticulum Membrane (GO:0098554),0.0010116319550177567,23.052870090634443,158.97698268116935,0.1947368657116217,"PTPN1,RPS28,SPPL3",GO_Cellular_Component_2023
2,Chylomicron (GO:0042627),0.0029561858566416093,61.30722891566265,357.04443639417775,0.1947368657116217,"APOE,APOB",GO_Cellular_Component_2023
3,Low-Density Lipoprotein Particle (GO:0034362),0.0029561858566416093,61.30722891566265,357.04443639417775,0.1947368657116217,"APOE,APOB",GO_Cellular_Component_2023
4,Intracellular Membrane-Bounded Organelle (GO:0043231),0.005783263897969875,1.3648977507824518,7.0330274786154545,0.1947368657116217,"SLC4A1AP,TFRC,UBXN2A,TRRAP,PDCD5,ITSN1,SRP14,ETS2,UBE2L3,SCGN,CCND3,HMGN4,CCND2,ZMIZ2,MYB,SNIP1,FBXO7,PDGFRA,MEF2C,MAP2K2,ZBTB38,NSMCE2,VRK2,ATP11A,LGALS9B,XRN1,ZSCAN26,SNRNP25,TRIB1,FTO,RTEL1,MAX,EPAS1,PLD1,AK9,TERT,ZNF827,ERI1,FIGNL1,PRDM16,ZKSCAN3,NLRP3,APOE,APOB,PLTP,NKX2-3,AP1M2,NFE2,HSPA8,GADD45A,BCL11A,TNK2,TEX35,QKI,MSRA,TDP2,TRIP6,RSRP1,ANP32B,CNOT8,ZNF410,ATR,CPEB4,CEP57,THRB,CITED2,ARPC1A,ADAR,SPPL3,ARIH2,FLOT2,JAK2,JARID2,BRD3,DUSP1,PABPC4,NCOA4,TFEB,ZFP91,DDB2,SIRT3,ELF1,TOX2,TMBIM1,PPARG,MAPT,MDFI,GTF2A1,CEBPA,WBP4,CEBPG,PSMB5,SERTAD2,EXOSC9,SPRYD4,SMOX,IL37,U2SURP,BYSL,FIG4,RAD50,TFAP4,KANSL1,AXL,PRC1,TAF8,ZNF217,BUD13,CRLF3,LAMTOR4",GO_Cellular_Component_2023
5,Triglyceride-Rich Plasma Lipoprotein Particle (GO:0034385),0.005788206268314402,30.650602409638555,157.9098449242407,0.1947368657116217,"APOE,APOB",GO_Cellular_Component_2023
6,Very-Low-Density Lipoprotein Particle (GO:0034361),0.005788206268314402,30.650602409638555,157.9098449242407,0.1947368657116217,"APOE,APOB",GO_Cellular_Component_2023
7,Lysosomal Membrane (GO:0005765),0.00631091694435811,2.2634391191709846,11.465392680811291,0.1947368657116217,"HSPA8,HFE,NPRL3,TFEB,ATP11B,ATP11A,PLD1,LAPTM4B,BLOC1S2,TMBIM1,LAMTOR4,AP1M2,UBXN6,SIDT2",GO_Cellular_Component_2023
8,HFE-transferrin Receptor Complex (GO:1990712),0.009444937543148634,20.431726907630523,95.25835798349146,0.22667850103556722,"TFRC,HFE",GO_Cellular_Component_2023
9,Flotillin Complex (GO:0016600),0.009444937543148634,20.431726907630523,95.25835798349146,0.22667850103556722,"CDH1,FLOT2",GO_Cellular_Component_2023
10,Endosome Lumen (GO:0031904),0.013088735319820933,7.086916105042993,30.72889174550526,0.2715383076129834,"APOB,JAK2,CTSB",GO_Cellular_Component_2023
11,Nucleus (GO:0005634),0.013828339739550081,1.3314712237851685,5.70007516118877,0.2715383076129834,"CEP57,THRB,CITED2,UBXN2A,TRRAP,PDCD5,ARPC1A,ADAR,SRP14,ETS2,UBE2L3,SCGN,CCND3,HMGN4,CCND2,ZMIZ2,MYB,ARIH2,SNIP1,JAK2,JARID2,FBXO7,BRD3,PDGFRA,MEF2C,MAP2K2,DUSP1,PABPC4,ZBTB38,NCOA4,NSMCE2,TFEB,ZFP91,VRK2,DDB2,SIRT3,LGALS9B,ELF1,TOX2,XRN1,ZSCAN26,PPARG,MAPT,SNRNP25,TRIB1,MDFI,FTO,GTF2A1,CEBPA,RTEL1,MAX,EPAS1,WBP4,CEBPG,AK9,PSMB5,TERT,ZNF827,SERTAD2,ERI1,FIGNL1,EXOSC9,PRDM16,ZKSCAN3,NLRP3,APOE,PLTP,NKX2-3,NFE2,HSPA8,SPRYD4,GADD45A,BCL11A,TNK2,TEX35,QKI,U2SURP,RAD50,TFAP4,KANSL1,PRC1,TDP2,TRIP6,RSRP1,TAF8,ZNF217,BUD13,ANP32B,CRLF3,CNOT8,ZNF410,ATR,CPEB4",GO_Cellular_Component_2023
12,Lytic Vacuole Membrane (GO:0098852),0.017507196474746283,2.187862189410177,8.850215979357614,0.29337983385982763,"LAPTM4B,HSPA8,NPRL3,TMBIM1,TFEB,ATP11A,LAMTOR4,PLD1,UBXN6,AP1M2,SIDT2",GO_Cellular_Component_2023
13,High-Density Lipoprotein Particle (GO:0034364),0.019015359602025866,12.256626506024096,48.56698335666549,0.29337983385982763,"APOE,PLTP",GO_Cellular_Component_2023
14,Lumenal Side Of Endoplasmic Reticulum Membrane (GO:0098553),0.019015359602025866,12.256626506024096,48.56698335666549,0.29337983385982763,"HFE,SPPL3",GO_Cellular_Component_2023
15,Cytoplasmic Side Of Plasma Membrane (GO:0009898),0.020484671449267734,2.702064220183486,10.505837548045788,0.29497926886945536,"BLK,SPTA1,MAP2K2,PTPRC,CDH1,JAK2,RHOA",GO_Cellular_Component_2023
16,Nuclear Chromosome (GO:0000228),0.024112149987976932,3.2758843691392356,12.202798399421988,0.3255140248376886,"RAD50,SPO11,TRRAP,EXOSC9,FIGNL1",GO_Cellular_Component_2023
17,MHC Class I Protein Complex (GO:0042612),0.031773031329377505,inf,inf,0.36120919827081793,HFE,GO_Cellular_Component_2023
18,Box C/D RNP Complex (GO:0031428),0.031773031329377505,inf,inf,0.36120919827081793,NOP58,GO_Cellular_Component_2023
19,Rough Endoplasmic Reticulum Membrane (GO:0030867),0.031773031329377505,inf,inf,0.36120919827081793,RPS28,GO_Cellular_Component_2023
20,Specific Granule Membrane (GO:0035579),0.03889004337682268,2.849262636496679,9.251604262170583,0.4114755709246619,"TMBIM1,MLEC,ATP11A,TMC6,PLD1",GO_Cellular_Component_2023
21,Early Endosome (GO:0005769),0.040004569395453236,1.9023643565041424,6.123257333277721,0.4114755709246619,"FIG4,LAPTM4B,PTPN1,MAP2K2,HFE,SNX13,ATP11B,APOE,APOB,UBXN6,TM9SF4",GO_Cellular_Component_2023
22,Endocytic Vesicle Lumen (GO:0071682),0.045805630168369055,6.806559571619813,20.986993652421944,0.41225067151532147,"APOE,APOB",GO_Cellular_Component_2023
23,Mitochondrial Outer Membrane Translocase Complex (GO:0005742),0.045805630168369055,6.806559571619813,20.986993652421944,0.41225067151532147,"TOMM40,SAMM50",GO_Cellular_Component_2023
24,Polysomal Ribosome (GO:0042788),0.045805630168369055,6.806559571619813,20.986993652421944,0.41225067151532147,"RPS28,LARP1",GO_Cellular_Component_2023
25,Caveola (GO:0005901),0.053785525323632795,2.9968957871396897,8.759179841215941,0.4306959502946463,"SMPD2,CDH1,FLOT2,JAK2",GO_Cellular_Component_2023
26,MLL1 Complex (GO:0071339),0.05383699378683079,6.125301204819277,17.89687095002477,0.4306959502946463,"KANSL1,MAX",GO_Cellular_Component_2023
27,MLL1/2 Complex (GO:0044665),0.05383699378683079,6.125301204819277,17.89687095002477,0.4306959502946463,"KANSL1,MAX",GO_Cellular_Component_2023
28,Small-Subunit Processome (GO:0032040),0.057975865160158006,3.680845921450151,10.482049735111122,0.4472423883783618,"RCL1,NOP58,RPS28",GO_Cellular_Component_2023
29,Actin Cytoskeleton (GO:0015629),0.06156538644053553,1.7106792226006813,4.768784300518353,0.4502848465017725,"SPTA1,MYO1D,MACF1,MSRA,ARHGAP21,AXL,CDH1,MICAL1,ARPC1A,FLOT2,MYO9B,PLS1",GO_Cellular_Component_2023
30,MHC Protein Complex (GO:0042611),0.06253956201413506,30.56156156156156,84.71530180884244,0.4502848465017725,HFE,GO_Cellular_Component_2023
31,Lysosome (GO:0005764),0.06810638851626788,1.5808329601433049,4.247199030781531,0.47454773933915684,"HSPA8,CD164,NPRL3,TFEB,ATP11A,PLD1,MFHAS1,LAPTM4B,TMBIM1,APOB,LAMTOR4,AP1M2,UBXN6,CTSB,SIDT2",GO_Cellular_Component_2023
32,Chromosome (GO:0005694),0.0713033759494131,2.364507832592939,6.244219722447332,0.4766285542596791,"SPO11,FIGNL1,EXOSC9,ATR,BYSL",GO_Cellular_Component_2023
33,Nuclear Membrane (GO:0031965),0.07281825134522875,1.8967437470504955,4.9690677403091605,0.4766285542596791,"NUP205,RTEL1,CCND2,SMOX,TMC8,ATP11B,TMC6,AK9",GO_Cellular_Component_2023
34,Late Endosome Membrane (GO:0031902),0.07803166722629232,2.6127659574468085,6.664226784623739,0.4830281090988081,"FIG4,LAPTM4B,LAMTOR4,UBXN6",GO_Cellular_Component_2023
35,Cortical Actin Cytoskeleton (GO:0030864),0.08011208835267787,3.171892905510991,8.00689972545036,0.4830281090988081,"SPTA1,CDH1,FLOT2",GO_Cellular_Component_2023
36,Transcription Factor TFIID Complex (GO:0005669),0.08050468484980135,4.710379981464319,11.86751926644335,0.4830281090988081,"GTF2A1,TAF8",GO_Cellular_Component_2023
37,BLOC-1 Complex (GO:0031083),0.09233130434472851,15.27927927927928,36.400927689928544,0.5230399125332332,BLOC1S2,GO_Cellular_Component_2023
38,Secretory Granule Membrane (GO:0030667),0.09751672857910869,1.7014629542236903,3.9605486432892922,0.5230399125332332,"PTPRC,HFE,TMBIM1,MLEC,ATP11B,TMC6,ATP11A,PLD1,RHOA",GO_Cellular_Component_2023
39,Clathrin-Coated Vesicle Membrane (GO:0030665),0.10681888205563034,2.3156089193825045,5.179138540724848,0.5230399125332332,"HSPA8,TFRC,APOE,APOB",GO_Cellular_Component_2023
40,Specific Granule (GO:0042581),0.10950451568250577,1.9011189338697512,4.2048748799606335,0.5230399125332332,"TMBIM1,MLEC,STX4,ATP11A,TMC6,PLD1",GO_Cellular_Component_2023
41,Cyclin-Dependent Protein Kinase Holoenzyme Complex (GO:0000307),0.11031888038918752,3.82605421686747,8.434078137999961,0.5230399125332332,"CCND3,CCND2",GO_Cellular_Component_2023
42,Endosome Membrane (GO:0010008),0.11816861875529197,1.5800886356441912,3.3745047632639595,0.5230399125332332,"FIG4,LAPTM4B,TFRC,HFE,TMBIM1,ATP11B,APOB,LAMTOR4,RAB8A,UBXN6",GO_Cellular_Component_2023
43,Clathrin-Sculpted Gamma-Aminobutyric Acid Transport Vesicle (GO:0061200),0.12117904111215834,10.185185185185185,21.49569225240779,0.5230399125332332,HSPA8,GO_Cellular_Component_2023
44,Clathrin-Sculpted Gamma-Aminobutyric Acid Transport Vesicle Membrane (GO:0061202),0.12117904111215834,10.185185185185185,21.49569225240779,0.5230399125332332,HSPA8,GO_Cellular_Component_2023
45,"Multivesicular Body, Internal Vesicle (GO:0097487)",0.12117904111215834,10.185185185185185,21.49569225240779,0.5230399125332332,LAPTM4B,GO_Cellular_Component_2023
46,Early Endosome Membrane (GO:0031901),0.12830578924427197,2.1522594364699628,4.419317992941132,0.5230399125332332,"FIG4,HFE,ATP11B,UBXN6",GO_Cellular_Component_2023
47,Cytoskeleton (GO:0005856),0.13091764545184115,1.396297480723448,2.838933626429306,0.5230399125332332,"MACF1,MAST2,ARPC1A,TEX35,MYO9B,MYO1D,SPTA1,ARHGAP21,MFHAS1,MSRA,AXL,PRC1,CDH1,MICAL1,TRIP6,MAPT",GO_Cellular_Component_2023
48,Phagocytic Vesicle Membrane (GO:0030670),0.1315405690685488,3.4002677376171353,6.897238970399704,0.5230399125332332,"HFE,STX4",GO_Cellular_Component_2023
49,Recycling Endosome (GO:0055037),0.13803191798387332,1.8944425682014334,3.751508411270816,0.5230399125332332,"TFRC,HFE,ATP11B,ATP11A,RAB8A",GO_Cellular_Component_2023
50,U2-type Spliceosomal Complex (GO:0005684),0.14053600842899536,2.418508506916839,4.745818771158417,0.5230399125332332,"WBP4,SNIP1,BUD13",GO_Cellular_Component_2023
51,Clathrin-Coated Endocytic Vesicle Membrane (GO:0030669),0.14800311609084355,2.3562630722751567,4.501692321374702,0.5230399125332332,"TFRC,APOE,APOB",GO_Cellular_Component_2023
52,Tertiary Granule Membrane (GO:0070821),0.14800311609084355,2.3562630722751567,4.501692321374702,0.5230399125332332,"ATP11A,TMC6,PLD1",GO_Cellular_Component_2023
53,MIB Complex (GO:0140275),0.14911259383863723,7.638138138138138,14.535786243348012,0.5230399125332332,SAMM50,GO_Cellular_Component_2023
54,NSL Complex (GO:0044545),0.14911259383863723,7.638138138138138,14.535786243348012,0.5230399125332332,KANSL1,GO_Cellular_Component_2023
55,SAM Complex (GO:0001401),0.14911259383863723,7.638138138138138,14.535786243348012,0.5230399125332332,SAMM50,GO_Cellular_Component_2023
56,Smc5-Smc6 Complex (GO:0030915),0.14911259383863723,7.638138138138138,14.535786243348012,0.5230399125332332,NSMCE2,GO_Cellular_Component_2023
57,Aggresome (GO:0016235),0.15359274232530412,3.0596385542168676,5.7320820213469,0.5230399125332332,"TDP2,PRDM16",GO_Cellular_Component_2023
58,Lytic Vacuole (GO:0000323),0.15785036154875876,1.6167712860131982,2.984734039117728,0.5230399125332332,"LAPTM4B,CD164,HSPA8,MFHAS1,LAMTOR4,CTSB,SIDT2",GO_Cellular_Component_2023
59,Polymeric Cytoskeletal Fiber (GO:0099513),0.16190404389288915,1.6045460769546762,2.9214795815901935,0.5230399125332332,"CEP57,MACF1,MAP2K2,MICAL1,MYO9B,MAPT,PLS1",GO_Cellular_Component_2023
60,Mitochondrial Matrix (GO:0005759),0.1649965579208556,1.4958336798336798,2.69523899613566,0.5230399125332332,"MPST,GCDH,HADHA,HMGCL,ALDH5A1,ALDH2,TST,LONP1,SIRT3",GO_Cellular_Component_2023
61,Endocytic Vesicle Membrane (GO:0030666),0.16830802307557988,1.762743248436572,3.1411370910914576,0.5230399125332332,"TFRC,HFE,STX4,APOE,APOB",GO_Cellular_Component_2023
62,Cortical Cytoskeleton (GO:0030863),0.1711298670427318,2.187311178247734,3.8613316294113096,0.5230399125332332,"SPTA1,CDH1,FLOT2",GO_Cellular_Component_2023
63,Cul4A-RING E3 Ubiquitin Ligase Complex (GO:0031464),0.17616084684518224,6.10990990990991,10.608989721849268,0.5230399125332332,DDB2,GO_Cellular_Component_2023
64,H4 Histone Acetyltransferase Complex (GO:1902562),0.17616084684518224,6.10990990990991,10.608989721849268,0.5230399125332332,KANSL1,GO_Cellular_Component_2023
65,Autolysosome (GO:0044754),0.17616084684518224,6.10990990990991,10.608989721849268,0.5230399125332332,NCOA4,GO_Cellular_Component_2023
66,Cytoplasmic Side Of Lysosomal Membrane (GO:0098574),0.17616084684518224,6.10990990990991,10.608989721849268,0.5230399125332332,BLOC1S2,GO_Cellular_Component_2023
67,Nucleolar Exosome (RNase Complex) (GO:0101019),0.17616084684518224,6.10990990990991,10.608989721849268,0.5230399125332332,EXOSC9,GO_Cellular_Component_2023
68,Spectrin-Associated Cytoskeleton (GO:0014731),0.17616084684518224,6.10990990990991,10.608989721849268,0.5230399125332332,SPTA1,GO_Cellular_Component_2023
69,"Transferase Complex, Transferring Phosphorus-Containing Groups (GO:0061695)",0.17616084684518224,6.10990990990991,10.608989721849268,0.5230399125332332,TERT,GO_Cellular_Component_2023
70,Endoplasmic reticulum-Golgi Intermediate Compartment Membrane (GO:0033116),0.1762893359481075,2.7809419496166483,4.8266826037987975,0.5230399125332332,"SPPL3,CNIH4",GO_Cellular_Component_2023
71,Ribosome (GO:0005840),0.1762893359481075,2.7809419496166483,4.8266826037987975,0.5230399125332332,"RPS28,LARP1",GO_Cellular_Component_2023
72,Clathrin-Coated Vesicle (GO:0030136),0.18708394837205428,2.0874759681406205,3.499022711118496,0.5230399125332332,"TNK2,RAB8A,AP1M2",GO_Cellular_Component_2023
73,U2-type Precatalytic Spliceosome (GO:0071005),0.187826636372978,2.6597695128339445,4.447762034614779,0.5230399125332332,"WBP4,SNIP1",GO_Cellular_Component_2023
74,Coated Vesicle Membrane (GO:0030662),0.187826636372978,2.6597695128339445,4.447762034614779,0.5230399125332332,"HFE,CNIH4",GO_Cellular_Component_2023
75,Intermediate Filament (GO:0005882),0.187826636372978,2.6597695128339445,4.447762034614779,0.5230399125332332,"MACF1,MICAL1",GO_Cellular_Component_2023
76,Precatalytic Spliceosome (GO:0071011),0.187826636372978,2.6597695128339445,4.447762034614779,0.5230399125332332,"WBP4,SNIP1",GO_Cellular_Component_2023
77,Spliceosomal snRNP Complex (GO:0097525),0.187826636372978,2.6597695128339445,4.447762034614779,0.5230399125332332,"SNIP1,BUD13",GO_Cellular_Component_2023
78,Actin Filament (GO:0005884),0.19520168016594044,2.040886203423968,3.3342406851988353,0.5230399125332332,"MICAL1,MYO9B,PLS1",GO_Cellular_Component_2023
79,Coated Vesicle (GO:0030135),0.19520168016594044,2.040886203423968,3.3342406851988353,0.5230399125332332,"TNK2,AP1M2,CNIH4",GO_Cellular_Component_2023
80,Glutamatergic Synapse (GO:0098978),0.19520168016594044,2.040886203423968,3.3342406851988353,0.5230399125332332,"STX4,APOE,RHOA",GO_Cellular_Component_2023
81,ER To Golgi Transport Vesicle Membrane (GO:0012507),0.1994641886930714,2.548694779116466,4.108803264933942,0.5230399125332332,"HFE,CNIH4",GO_Cellular_Component_2023
82,AP-1 Adaptor Complex (GO:0030121),0.20235177539845034,5.091091091091091,8.134278744250102,0.5230399125332332,AP1M2,GO_Cellular_Component_2023
83,Apical Dendrite (GO:0097440),0.20235177539845034,5.091091091091091,8.134278744250102,0.5230399125332332,MYO1D,GO_Cellular_Component_2023
84,Phagocytic Vesicle (GO:0045335),0.2034044104295907,1.9963220806515172,3.1792609201776654,0.5230399125332332,"HFE,STX4,RAB8A",GO_Cellular_Component_2023
85,Golgi-associated Vesicle (GO:0005798),0.21118404556912293,2.4465060240963856,3.8043786951207514,0.5366559275638888,"SPPL3,RAB8A",GO_Cellular_Component_2023
86,Clathrin-Coated Endocytic Vesicle (GO:0045334),0.22003903062749322,1.9127643504531722,2.89583023186509,0.5433917680927157,"TFRC,APOE,APOB",GO_Cellular_Component_2023
87,Extrinsic Component Of Cytoplasmic Side Of Plasma Membrane (GO:0031234),0.22003903062749322,1.9127643504531722,2.89583023186509,0.5433917680927157,"BLK,JAK2,RHOA",GO_Cellular_Component_2023
88,SUMO Ligase Complex (GO:0106068),0.22771247374454687,4.363363363363363,6.4563445260378325,0.5433917680927157,NSMCE2,GO_Cellular_Component_2023
89,Clathrin Coat Of trans-Golgi Network Vesicle (GO:0030130),0.22771247374454687,4.363363363363363,6.4563445260378325,0.5433917680927157,AP1M2,GO_Cellular_Component_2023
90,Autophagosome (GO:0005776),0.22845826020082471,1.873543375053949,2.766102725198173,0.5433917680927157,"HSPA8,NCOA4,WIPI2",GO_Cellular_Component_2023
91,Microtubule (GO:0005874),0.22958771637869083,1.5631784628745116,2.3001703941895704,0.5433917680927157,"CEP57,MACF1,MAP2K2,PRC1,MAPT",GO_Cellular_Component_2023
92,Transport Vesicle Membrane (GO:0030658),0.2348040010823395,2.2648371262829095,3.2817583968441295,0.5433917680927157,"HFE,CNIH4",GO_Cellular_Component_2023
93,Plasma Membrane Raft (GO:0044853),0.2369371811649995,1.835891238670695,2.64361037278202,0.5433917680927157,"SMPD2,FLOT2,JAK2",GO_Cellular_Component_2023
94,trans-Golgi Network Membrane (GO:0032588),0.2369371811649995,1.835891238670695,2.64361037278202,0.5433917680927157,"ARFIP1,AP1M2,RAB8A",GO_Cellular_Component_2023
95,Swr1 Complex (GO:0000812),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.5433917680927157,TRRAP,GO_Cellular_Component_2023
96,U2 snRNP (GO:0005686),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.5433917680927157,SNIP1,GO_Cellular_Component_2023
97,trans-Golgi Network Transport Vesicle (GO:0030140),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.5433917680927157,RAB8A,GO_Cellular_Component_2023
98,Transcription Factor TFTC Complex (GO:0033276),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.5433917680927157,TRRAP,GO_Cellular_Component_2023
99,Condensed Chromosome (GO:0000793),0.27045945831080337,2.0377510040160645,2.664630598797084,0.5433917680927157,"RAD50,NSMCE2",GO_Cellular_Component_2023
100,Multivesicular Body (GO:0005771),0.27045945831080337,2.0377510040160645,2.664630598797084,0.5433917680927157,"LAPTM4B,APOE",GO_Cellular_Component_2023
101,Endocytic Vesicle (GO:0030139),0.2715087513490271,1.457953394123607,1.9008226391916403,0.5433917680927157,"FLOT2,APOE,APOB,PLD1,RAB8A",GO_Cellular_Component_2023
102,Germ Plasm (GO:0060293),0.2760473156248264,3.3930597263930595,4.367488779253821,0.5433917680927157,HELZ2,GO_Cellular_Component_2023
103,Glial Cell Projection (GO:0097386),0.2760473156248264,3.3930597263930595,4.367488779253821,0.5433917680927157,MAPT,GO_Cellular_Component_2023
104,Intracellular Vesicle (GO:0097708),0.2760473156248264,3.3930597263930595,4.367488779253821,0.5433917680927157,ITSN1,GO_Cellular_Component_2023
105,SCF Ubiquitin Ligase Complex (GO:0019005),0.28235089653244827,1.9718227749708512,2.493576284940006,0.5433917680927157,"FBXL5,FBXO7",GO_Cellular_Component_2023
106,Dendrite (GO:0030425),0.29116449113053816,1.3235171971155661,1.6330440741963452,0.5433917680927157,"MYO1D,SCGN,HSPA8,APOE,MAPT,CNIH4,CPEB4",GO_Cellular_Component_2023
107,Cell-Cell Contact Zone (GO:0044291),0.294225419472405,1.9100150602409638,2.3367297533746547,0.5433917680927157,"PIK3CA,FLOT2",GO_Cellular_Component_2023
108,Lysosomal Lumen (GO:0043202),0.29746957034264254,1.6093178565749722,1.9512067232473926,0.5433917680927157,"HSPA8,APOB,CTSB",GO_Cellular_Component_2023
109,Golgi-associated Vesicle Membrane (GO:0030660),0.29907148597280975,3.0534534534534536,3.685740153685031,0.5433917680927157,SPPL3,GO_Cellular_Component_2023
110,SAGA Complex (GO:0000124),0.29907148597280975,3.0534534534534536,3.685740153685031,0.5433917680927157,TRRAP,GO_Cellular_Component_2023
111,U12-type Spliceosomal Complex (GO:0005689),0.29907148597280975,3.0534534534534536,3.685740153685031,0.5433917680927157,SNRNP25,GO_Cellular_Component_2023
112,Protein Phosphatase Type 2A Complex (GO:0000159),0.29907148597280975,3.0534534534534536,3.685740153685031,0.5433917680927157,PPP2R2A,GO_Cellular_Component_2023
113,Proton-Transporting V-type ATPase Complex (GO:0033176),0.29907148597280975,3.0534534534534536,3.685740153685031,0.5433917680927157,ATP6V1G3,GO_Cellular_Component_2023
114,Smooth Endoplasmic Reticulum (GO:0005790),0.29907148597280975,3.0534534534534536,3.685740153685031,0.5433917680927157,MYO1D,GO_Cellular_Component_2023
115,Azurophil Granule Membrane (GO:0035577),0.3060721256646625,1.8519532676159183,2.192591365950232,0.5433917680927157,"HFE,ATP11B",GO_Cellular_Component_2023
116,Extracellular Membrane-Bounded Organelle (GO:0065010),0.3060721256646625,1.8519532676159183,2.192591365950232,0.5433917680927157,"TFRC,APOE",GO_Cellular_Component_2023
117,Mitochondrial Outer Membrane (GO:0005741),0.3134128482502873,1.4392869875222816,1.6699096318534767,0.5433917680927157,"BCL2L11,TOMM40,SAMM50,CPT1B",GO_Cellular_Component_2023
118,Basolateral Plasma Membrane (GO:0016323),0.3148988061137183,1.3658814589665653,1.5782814104152814,0.5433917680927157,"MYO1D,DSTYK,TFRC,FLOT2,STX4",GO_Cellular_Component_2023
119,Apical Junction Complex (GO:0043296),0.31497935978187597,1.5544574735009473,1.7957841466387816,0.5433917680927157,"CDH1,CLDN23,RHOA",GO_Cellular_Component_2023
120,Extracellular Vesicle (GO:1903561),0.31788081930037987,1.7973068745570517,2.0598552135069905,0.5433917680927157,"TFRC,APOE",GO_Cellular_Component_2023
121,Serine/Threonine Protein Kinase Complex (GO:1902554),0.31788081930037987,1.7973068745570517,2.0598552135069905,0.5433917680927157,"CCND3,CCND2",GO_Cellular_Component_2023
122,Late Endosome (GO:0005770),0.32117844528113787,1.3536595206713828,1.5374301794740215,0.5433917680927157,"FIG4,LAPTM4B,MAP2K2,LAMTOR4,UBXN6",GO_Cellular_Component_2023
123,Secondary Lysosome (GO:0005767),0.3213655307830429,2.7755937755937756,3.1507876577626246,0.5433917680927157,NCOA4,GO_Cellular_Component_2023
124,cullin-RING Ubiquitin Ligase Complex (GO:0031461),0.32788816248201164,1.4059212817833509,1.5677184943562388,0.5433917680927157,"KCTD17,FBXL5,FBXO7,DDB2",GO_Cellular_Component_2023
125,Cytoplasmic Vesicle Membrane (GO:0030659),0.33583490283973494,1.2139478143002371,1.3245816771769314,0.5433917680927157,"FIG4,PTPRC,TFRC,TMBIM1,SLC39A13,APOB,SPPL3,AP1M2,RHOA",GO_Cellular_Component_2023
126,Intracellular Organelle Lumen (GO:0070013),0.3410915739063466,1.1335092142541523,1.2192073765200044,0.5433917680927157,"MPST,GCDH,HSPA8,COL26A1,SRP14,SIRT3,HADHA,HMGCL,ALDH5A1,ALDH2,TST,LONP1,SERPING1,APOE,APOB,JAK2,MUC20,CTSB",GO_Cellular_Component_2023
127,COPII-coated ER To Golgi Transport Vesicle (GO:0030134),0.3413467144841261,1.6971218206157965,1.8241625223966422,0.5433917680927157,"HFE,CNIH4",GO_Cellular_Component_2023
128,Microbody Lumen (GO:0031907),0.3413467144841261,1.6971218206157965,1.8241625223966422,0.5433917680927157,"HMGCL,ACOXL",GO_Cellular_Component_2023
129,Peroxisomal Matrix (GO:0005782),0.3413467144841261,1.6971218206157965,1.8241625223966422,0.5433917680927157,"HMGCL,ACOXL",GO_Cellular_Component_2023
130,Microtubule Cytoskeleton (GO:0015630),0.3423165819980647,1.2453239456653153,1.3350112942172658,0.5433917680927157,"CEP57,MACF1,MAP2K2,PRC1,MAST2,TEX35,MAPT",GO_Cellular_Component_2023
131,AMPA Glutamate Receptor Complex (GO:0032281),0.3429525358102901,2.544044044044044,2.7225423684214074,0.5433917680927157,CNIH4,GO_Cellular_Component_2023
132,Cul4-RING E3 Ubiquitin Ligase Complex (GO:0080008),0.3429525358102901,2.544044044044044,2.7225423684214074,0.5433917680927157,DDB2,GO_Cellular_Component_2023
133,Clathrin Adaptor Complex (GO:0030131),0.3429525358102901,2.544044044044044,2.7225423684214074,0.5433917680927157,AP1M2,GO_Cellular_Component_2023
134,Cytosolic Small Ribosomal Subunit (GO:0022627),0.3429525358102901,2.544044044044044,2.7225423684214074,0.5433917680927157,RPS28,GO_Cellular_Component_2023
135,Vacuolar Proton-Transporting V-type ATPase Complex (GO:0016471),0.3429525358102901,2.544044044044044,2.7225423684214074,0.5433917680927157,ATP6V1G3,GO_Cellular_Component_2023
136,Tertiary Granule (GO:0070820),0.34966755669618294,1.3586531986531987,1.4276353011903056,0.5433917680927157,"ATP11A,TMC6,PLD1,RHOA",GO_Cellular_Component_2023
137,trans-Golgi Network (GO:0005802),0.35275896869127504,1.295657101643398,1.3500361716161209,0.5433917680927157,"CDH1,ARFIP1,PCSK7,RAB8A,AP1M2",GO_Cellular_Component_2023
138,Cytoplasmic Stress Granule (GO:0010494),0.3529867577805054,1.6510908498860306,1.7193217435712793,0.5433917680927157,"LARP1,PABPC4",GO_Cellular_Component_2023
139,Intermediate Filament Cytoskeleton (GO:0045111),0.3529867577805054,1.6510908498860306,1.7193217435712793,0.5433917680927157,"MACF1,MICAL1",GO_Cellular_Component_2023
140,Endoplasmic Reticulum Membrane (GO:0005789),0.35783977536838657,1.1346801346801347,1.166076674550521,0.5433917680927157,"PDGFRA,PTPN1,GALNT2,PGAP3,HFE,SLC39A13,VRK2,PLD1,SPPL3,LMF2,RHOA,MLEC,APOB,CNIH4,SLC17A3",GO_Cellular_Component_2023
141,H4/H2A Histone Acetyltransferase Complex (GO:0043189),0.36385485898912845,2.348117348117348,2.373947178787745,0.5433917680927157,TRRAP,GO_Cellular_Component_2023
142,NuA4 Histone Acetyltransferase Complex (GO:0035267),0.36385485898912845,2.348117348117348,2.373947178787745,0.5433917680927157,TRRAP,GO_Cellular_Component_2023
143,Histone Acetyltransferase Complex (GO:0000123),0.36385485898912845,2.348117348117348,2.373947178787745,0.5433917680927157,KANSL1,GO_Cellular_Component_2023
144,Small Ribosomal Subunit (GO:0015935),0.36385485898912845,2.348117348117348,2.373947178787745,0.5433917680927157,RPS28,GO_Cellular_Component_2023
145,Vesicle (GO:0031982),0.36477688135853603,1.239700065919578,1.2501995770202452,0.5433917680927157,"MYO1D,TFRC,ITSN1,FLOT2,APOE,RHOA",GO_Cellular_Component_2023
146,Organelle Outer Membrane (GO:0031968),0.3787206076273476,1.3003223726627982,1.2625564972739005,0.5494326963126331,"BCL2L11,TOMM40,SAMM50,CPT1B",GO_Cellular_Component_2023
147,INO80-type Complex (GO:0097346),0.38409415344077596,2.18018018018018,2.0861437006994428,0.5494326963126331,TRRAP,GO_Cellular_Component_2023
148,P Granule (GO:0043186),0.38409415344077596,2.18018018018018,2.0861437006994428,0.5494326963126331,HELZ2,GO_Cellular_Component_2023
149,SWI/SNF Complex (GO:0016514),0.38409415344077596,2.18018018018018,2.0861437006994428,0.5494326963126331,BCL11A,GO_Cellular_Component_2023
150,Condensed Nuclear Chromosome (GO:0000794),0.38409415344077596,2.18018018018018,2.0861437006994428,0.5494326963126331,RAD50,GO_Cellular_Component_2023
151,Multivesicular Body Membrane (GO:0032585),0.38409415344077596,2.18018018018018,2.0861437006994428,0.5494326963126331,LAPTM4B,GO_Cellular_Component_2023
152,Recycling Endosome Membrane (GO:0055038),0.38744450052350976,1.5268072289156627,1.4476921471045792,0.5495200578190953,"HFE,RAB8A",GO_Cellular_Component_2023
153,Cell-Cell Junction (GO:0005911),0.38924337428852585,1.182337337591025,1.1155949744075941,0.5495200578190953,"AHI1,MAP2K2,DNMBP,CDH1,DLG5,FLOT2,RHOA",GO_Cellular_Component_2023
154,Protein Serine/Threonine Phosphatase Complex (GO:0008287),0.4036913894708047,2.0346346346346347,1.8456263964772202,0.5662164943226871,PPP2R2A,GO_Cellular_Component_2023
155,Lipid Droplet (GO:0005811),0.40996596694232024,1.4538152610441768,1.29633963505076,0.5713074119970398,"FIG4,HSD17B13",GO_Cellular_Component_2023
156,Golgi Membrane (GO:0000139),0.4174851486979347,1.1227252747252747,0.9807076088431761,0.5778230709541343,"FIG4,GALNT2,HFE,NLRP3,SLC39A13,ARFIP1,PCSK7,AP1M2,RAB8A",GO_Cellular_Component_2023
157,Adherens Junction (GO:0005912),0.42201535451176975,1.2215757575757575,1.0538699956812572,0.5778230709541343,"AHI1,CDH1,DLG5,FLOT2",GO_Cellular_Component_2023
158,Non-Motile Cilium (GO:0097730),0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5778230709541343,RAB8A,GO_Cellular_Component_2023
159,Cilium (GO:0005929),0.4350082680604736,1.1655722870600247,0.9702109969737047,0.584446017156559,"UNC119B,PDGFRA,AHI1,NPHP3,RAB8A",GO_Cellular_Component_2023
160,Ficolin-1-Rich Granule Lumen (GO:1904813),0.4362498561764909,1.2546041468360716,1.0407444935223196,0.584446017156559,"HSPA8,SRP14,CTSB",GO_Cellular_Component_2023
161,Endolysosome (GO:0036019),0.4410402814653663,1.7949125596184419,1.4693496440315028,0.584446017156559,CTSB,GO_Cellular_Component_2023
162,Rough Endoplasmic Reticulum (GO:0005791),0.4410402814653663,1.7949125596184419,1.4693496440315028,0.584446017156559,SPPL3,GO_Cellular_Component_2023
163,Supramolecular Fiber (GO:0099512),0.4410402814653663,1.7949125596184419,1.4693496440315028,0.584446017156559,TNK2,GO_Cellular_Component_2023
164,Ficolin-1-Rich Granule (GO:0101002),0.450485235309106,1.1741258741258742,0.9362831681881303,0.5870795837178732,"HSPA8,SRP14,RHOA,CTSB",GO_Cellular_Component_2023
165,Asymmetric Synapse (GO:0032279),0.45303088787577833,1.220906344410876,0.9667075031604053,0.5870795837178732,"DLG5,CNIH4,CPEB4",GO_Cellular_Component_2023
166,Vesicle Membrane (GO:0012506),0.4537361503852823,1.3268727082242011,1.048547114631643,0.5870795837178732,"SLC39A13,AP1M2",GO_Cellular_Component_2023
167,Mitochondrial Membrane (GO:0031966),0.4538994929670594,1.086348434174521,0.8580843434317079,0.5870795837178732,"HADHA,SLC25A37,SLC25A15,SAMM50,TOMM40,BCL2L11,VRK2,CPT1B,MRPL33",GO_Cellular_Component_2023
168,Membrane Raft (GO:0045121),0.4575355517558093,1.1628282828282828,0.9092162349854322,0.588259995114612,"TLR1,PTPRC,MAPT,JAK2",GO_Cellular_Component_2023
169,Bounding Membrane Of Organelle (GO:0098588),0.4754201220024707,1.0415845301792923,0.7744768419774505,0.6013344517284077,"TFRC,GALNT2,HFE,SLC39A13,PCSK7,SPPL3,RHOA,FIG4,PTPRC,TMBIM1,NLRP3,ARFIP1,APOB,CNIH4,AP1M2,RAB8A",GO_Cellular_Component_2023
170,Golgi Stack (GO:0005795),0.47605644095165617,1.605658289868816,1.191749862810084,0.6013344517284077,GALNT2,GO_Cellular_Component_2023
171,SAGA-type Complex (GO:0070461),0.47605644095165617,1.605658289868816,1.191749862810084,0.6013344517284077,TRRAP,GO_Cellular_Component_2023
172,Cul3-RING Ubiquitin Ligase Complex (GO:0031463),0.4927355073907322,1.5252252252252252,1.0795280967596923,0.6152073387075038,KCTD17,GO_Cellular_Component_2023
173,Nuclear Inner Membrane (GO:0005637),0.4927355073907322,1.5252252252252252,1.0795280967596923,0.6152073387075038,ATP11B,GO_Cellular_Component_2023
174,Peroxisome (GO:0005777),0.502046837453479,1.1297974711871992,0.7785003491142737,0.6232305568388016,"HMGCL,ACOXL,MAP2K2",GO_Cellular_Component_2023
175,Nuclear Lumen (GO:0031981),0.5073875343978811,1.0246001271865215,0.6951708989291558,0.626261185313956,"NOP58,SPO11,ZFP91,ADAR,BYSL,RCL1,CCND2,TERT,ERI1,FIGNL1,EXOSC9,BEND3,ANP32B",GO_Cellular_Component_2023
176,Euchromatin (GO:0000791),0.5245221393688277,1.3862953862953864,0.8945315544894749,0.6329429167802615,ICE2,GO_Cellular_Component_2023
177,Intercalated Disc (GO:0014704),0.5245221393688277,1.3862953862953864,0.8945315544894749,0.6329429167802615,PIK3CA,GO_Cellular_Component_2023
178,Ionotropic Glutamate Receptor Complex (GO:0008328),0.5245221393688277,1.3862953862953864,0.8945315544894749,0.6329429167802615,CNIH4,GO_Cellular_Component_2023
179,Melanosome (GO:0042470),0.5245221393688277,1.3862953862953864,0.8945315544894749,0.6329429167802615,APOE,GO_Cellular_Component_2023
180,Actin-Based Cell Projection (GO:0098858),0.5353637937478779,1.1294065149486836,0.7056631009235845,0.6424365524974535,"MYO1D,KITLG",GO_Cellular_Component_2023
181,Catenin Complex (GO:0016342),0.5396626874821041,1.3258911084998042,0.8178242038340053,0.6440173508073729,CDH1,GO_Cellular_Component_2023
182,Brush Border Membrane (GO:0031526),0.5543225141392293,1.2705205205205206,0.7496180413790507,0.6529979218337144,SLC17A3,GO_Cellular_Component_2023
183,Heterochromatin (GO:0000792),0.5543225141392293,1.2705205205205206,0.7496180413790507,0.6529979218337144,BEND3,GO_Cellular_Component_2023
184,Postsynaptic Density (GO:0014069),0.5562574889694604,1.0392062620159297,0.6095193952041892,0.6529979218337144,"DLG5,CNIH4,CPEB4",GO_Cellular_Component_2023
185,Monoatomic Ion Channel Complex (GO:0034702),0.5822603977582713,1.1725571725571726,0.634162904451109,0.6798283563015493,TRPC1,GO_Cellular_Component_2023
186,Focal Adhesion (GO:0005925),0.6050606748810773,0.9511119631901841,0.4778638898890885,0.7026511063135091,"HSPA8,MAP2K2,PTPRC,DOCK7,TRIP6,FLOT2,JAK2,RHOA",GO_Cellular_Component_2023
187,Cell-Substrate Junction (GO:0030055),0.6178371159759223,0.9398109766207926,0.4525475767797221,0.7134054700889881,"HSPA8,MAP2K2,PTPRC,DOCK7,TRIP6,FLOT2,JAK2,RHOA",GO_Cellular_Component_2023
188,Cation Channel Complex (GO:0034703),0.6209269832256007,1.0509474992233614,0.50082039544352,0.7134054700889881,TRPC1,GO_Cellular_Component_2023
189,Cytoplasmic Vesicle Lumen (GO:0060205),0.6413044091660259,0.922964585615188,0.4100279747303273,0.7329193247611725,"HSPA8,SRP14",GO_Cellular_Component_2023
190,Ficolin-1-Rich Granule Membrane (GO:0101003),0.6447008136176033,0.982950692628112,0.43148480853355703,0.732923030217907,RHOA,GO_Cellular_Component_2023
191,Microbody Membrane (GO:0031903),0.6669878284427431,0.9231959231959231,0.3738790990315251,0.7503613069980859,MAP2K2,GO_Cellular_Component_2023
192,Peroxisomal Membrane (GO:0005778),0.6669878284427431,0.9231959231959231,0.3738790990315251,0.7503613069980859,MAP2K2,GO_Cellular_Component_2023
193,Mitochondrial Envelope (GO:0005740),0.6721289855248117,0.8698795180722891,0.34560749422118214,0.7522272584111882,"SLC25A37,VRK2",GO_Cellular_Component_2023
194,Vacuolar Membrane (GO:0005774),0.6776029857475239,0.8959547783077195,0.34869998145102127,0.7544445614508514,ATP6V1G3,GO_Cellular_Component_2023
195,Organelle Inner Membrane (GO:0019866),0.6911629958949534,0.8587055449659128,0.3171883098216631,0.76559593391441,"HADHA,SLC25A15,TOMM40,ATP11B,MRPL33",GO_Cellular_Component_2023
196,Intracellular Non-Membrane-Bounded Organelle (GO:0043232),0.7025111577572759,0.8981606990177883,0.3171351493429109,0.7679033795295396,"MACF1,NOP58,ZFP91,ADAR,HSD17B13,BYSL,RCL1,FIG4,MFHAS1,CCND2,TERT,PRC1,ERI1,EXOSC9,TRIP6,BEND3,ANP32B,ATR",GO_Cellular_Component_2023
197,Nucleolus (GO:0005730),0.7038027416196613,0.8781000488838194,0.3084389281808885,0.7679033795295396,"RCL1,NOP58,CCND2,TERT,ERI1,EXOSC9,BEND3,ZFP91,ADAR,ANP32B,BYSL",GO_Cellular_Component_2023
198,Neuron Projection (GO:0043005),0.7067649343419684,0.8718248900241238,0.30257306304386605,0.7679033795295396,"MYO1D,MPST,HSPA8,SCGN,DOCK7,MAPT,APOE,FBXO7,CNIH4,CPEB4",GO_Cellular_Component_2023
199,Microvillus (GO:0005902),0.707466539473974,0.823066309552796,0.2848343968281003,0.7679033795295396,MYO1D,GO_Cellular_Component_2023
200,Filopodium (GO:0030175),0.734571335722901,0.7611111111111111,0.23477854903083212,0.7893900921201324,KITLG,GO_Cellular_Component_2023
201,Platelet Alpha Granule Lumen (GO:0031093),0.734571335722901,0.7611111111111111,0.23477854903083212,0.7893900921201324,SERPING1,GO_Cellular_Component_2023
202,Spindle Microtubule (GO:0005876),0.7430378328370436,0.7424741814985717,0.2205210067166506,0.794535504419809,PRC1,GO_Cellular_Component_2023
203,Mitochondrial Inner Membrane (GO:0005743),0.7701297110539558,0.7589393939393939,0.19823217862698228,0.8194483625007608,"HADHA,SLC25A15,TOMM40,MRPL33",GO_Cellular_Component_2023
204,P-body (GO:0000932),0.7742950875876043,0.6762095428762095,0.17297590761971335,0.8198418574456987,CNOT8,GO_Cellular_Component_2023
205,Bicellular Tight Junction (GO:0005923),0.8017601244090331,0.6207636207636208,0.1371551226226436,0.8447813993773228,CLDN23,GO_Cellular_Component_2023
206,Axon (GO:0030424),0.8117628254296716,0.6845285418985531,0.14275642064593472,0.8511687878291702,"MYO1D,DOCK7,MAPT",GO_Cellular_Component_2023
207,Azurophil Granule (GO:0042582),0.8232553215296023,0.6326556224899599,0.1230444921086398,0.8590490311613241,"HFE,ATP11B",GO_Cellular_Component_2023
208,Golgi Lumen (GO:0005796),0.8420476819902674,0.5427927927927928,0.09331619705666398,0.8643528861494327,MUC20,GO_Cellular_Component_2023
209,Tight Junction (GO:0070160),0.8420476819902674,0.5427927927927928,0.09331619705666398,0.8643528861494327,CLDN23,GO_Cellular_Component_2023
210,Vacuolar Lumen (GO:0005775),0.843925108085783,0.601037814624836,0.10199102203539363,0.8643528861494327,"HSPA8,APOB",GO_Cellular_Component_2023
211,Endoplasmic Reticulum Lumen (GO:0005788),0.8443447174885663,0.66947932362297,0.11327217572309216,0.8643528861494327,"COL26A1,SERPING1,APOE,APOB",GO_Cellular_Component_2023
212,Platelet Alpha Granule (GO:0031091),0.851978868417745,0.5239722481101792,0.08393697703450269,0.868053941406759,SERPING1,GO_Cellular_Component_2023
213,Cell Projection Membrane (GO:0031253),0.8820839987011834,0.4672210672210672,0.058621288604497945,0.8945077169927493,SLC17A3,GO_Cellular_Component_2023
214,Collagen-Containing Extracellular Matrix (GO:0062023),0.8939785827258435,0.629305977710233,0.07052849881032568,0.9023335227513186,"COL26A1,SERPING1,APOE,CTSB,THBS3",GO_Cellular_Component_2023
215,Secretory Granule Lumen (GO:0034774),0.9439964101340531,0.48423994700874035,0.0279081600290138,0.9483870911114209,"HSPA8,SERPING1,SRP14",GO_Cellular_Component_2023
216,Spindle (GO:0005819),0.9783275688630425,0.2582325915659249,0.005658063955383662,0.9783275688630425,PRC1,GO_Cellular_Component_2023
1,Cytokine Receptor Binding (GO:0005126),0.0005782186924429975,4.778669183577159,35.627647173511235,0.093653069095259,"SPRED2,IL1RN,KITLG,IL37,TRIP6,JAK2,IL6R,SH2B3",GO_Molecular_Function_2023
2,G-quadruplex DNA Binding (GO:0051880),0.0005919929148545868,30.740181268882175,228.46151569186478,0.093653069095259,"RAD50,XRN1,LONP1",GO_Molecular_Function_2023
3,Interleukin-1 Receptor Binding (GO:0005149),0.0010116319550177567,23.052870090634443,158.97698268116935,0.093653069095259,"IL1RN,IL37,TRIP6",GO_Molecular_Function_2023
4,DNA Binding (GO:0003677),0.0010152094210868184,2.0433224755700325,14.083927833280539,0.093653069095259,"GTF2A1,CEBPA,THRB,MAX,MPG,EPAS1,SPO11,CEBPG,ETS2,TERT,PRDM16,ZKSCAN3,LONP1,NLRP3,NFE2,DENND4A,DDB2,SIRT3,RAD50,TOX2,TFAP4,XRN1,TDP2,PPARG,DNASE2,MAPT,CRLF3",GO_Molecular_Function_2023
5,"RNA Exonuclease Activity, Producing 5'-Phosphomonoesters (GO:0016896)",0.0026575592727179514,8.212525252525252,48.70312567681633,0.1961278743265848,"XRN1,ERI1,EXOSC9,CNOT8",GO_Molecular_Function_2023
6,Sequence-Specific DNA Binding (GO:0043565),0.0035826297544379057,1.9276040384141837,10.855607050647626,0.21337440695145,"NFE2,MEF2C,THRB,KLF13,MAX,EPAS1,ZBTB38,CEBPG,ZSCAN9,TFEB,KLF3,ETS2,SIRT3,ELF1,TFAP4,TERT,PRDM16,ZKSCAN3,LONP1,NLRP3,PPARG,MAPT,NKX2-3,ZNF410",GO_Molecular_Function_2023
7,Kinase Binding (GO:0019900),0.004332112923252782,2.114421846110084,11.506049112484737,0.21337440695145,"CEBPA,PTPN1,MAP3K1,TFRC,GADD45A,VRK2,SPRED2,LAPTM4B,CCND3,PTPRC,CCND2,PRC1,TRIP6,MAPT,TRIM38,JAK2,FBXO7,SLC12A7",GO_Molecular_Function_2023
8,3'-5' Exonuclease Activity (GO:0008408),0.004652898830980776,6.841750841750842,36.74201405180106,0.21337440695145,"RAD50,ERI1,EXOSC9,CNOT8",GO_Molecular_Function_2023
9,Protein Tyrosine Kinase Activity (GO:0004713),0.005204253828084146,3.609887869520897,18.9817973743148,0.21337440695145,"BLK,PDGFRA,AXL,TNK2,KIT,JAK2,EPHB4",GO_Molecular_Function_2023
10,Growth Factor Receptor Binding (GO:0070851),0.006118592679216405,3.4927493341225215,17.80052860994537,0.22577606986308535,"PDGFRA,IL37,TNK2,TRIP6,JAK2,IL6R,FRS3",GO_Molecular_Function_2023
11,WW Domain Binding (GO:0050699),0.008916446427890624,8.377094204888767,39.53869337643822,0.26809091949398817,"NFE2,NDFIP1,TNK2",GO_Molecular_Function_2023
12,LBD Domain Binding (GO:0050693),0.009444937543148634,20.431726907630523,95.25835798349146,0.26809091949398817,"CITED2,PPARG",GO_Molecular_Function_2023
13,Minor Groove Of Adenine-Thymine-Rich DNA Binding (GO:0003680),0.009444937543148634,20.431726907630523,95.25835798349146,0.26809091949398817,"MEF2C,MAPT",GO_Molecular_Function_2023
14,ADP Binding (GO:0043531),0.010886865396739583,7.6782477341389725,34.70720178532406,0.2759456093495437,"LONP1,NLRP3,MYO9B",GO_Molecular_Function_2023
15,Transmembrane Receptor Protein Kinase Activity (GO:0019199),0.011217301193070883,5.1282828282828286,23.027517835974916,0.2759456093495437,"PDGFRA,AXL,KIT,EPHB4",GO_Molecular_Function_2023
16,Sulfurtransferase Activity (GO:0016783),0.013871426046285067,15.322289156626505,65.54759211542967,0.30109154182818765,"MPST,TST",GO_Molecular_Function_2023
17,Sodium:Phosphate Symporter Activity (GO:0005436),0.013871426046285067,15.322289156626505,65.54759211542967,0.30109154182818765,"SLC17A1,SLC17A3",GO_Molecular_Function_2023
18,L-arginine Transmembrane Transporter Activity (GO:0061459),0.019015359602025866,12.256626506024096,48.56698335666549,0.3895726190664358,"SLC25A15,SLC7A6",GO_Molecular_Function_2023
19,Protein Kinase Binding (GO:0019901),0.02030454741381055,1.8092505463980793,7.050487284012874,0.3895726190664358,"PTPN1,MAP3K1,TFRC,DUSP1,VRK2,SPRED2,CCND3,PTPRC,CCND2,PRC1,MAPT,TRIM38,JAK2,TRIB1,SH2B3,FBXO7,SLC12A7",GO_Molecular_Function_2023
20,NAD Binding (GO:0051287),0.02111504710387186,5.7564199395770395,22.20694046489024,0.3895726190664358,"HADHA,ALDH2,SIRT3",GO_Molecular_Function_2023
21,Cyclin-Dependent Protein Serine/Threonine Kinase Activator Activity (GO:0061575),0.024826956027899184,10.21285140562249,37.74491440057724,0.4232503625112088,"CCND3,CCND2",GO_Molecular_Function_2023
22,Phosphatidylinositol Phosphate Binding (GO:1901981),0.026550693606772917,2.802660753880266,10.170013415870047,0.4232503625112088,"LAPTM4B,NLRP3,SNX13,ARFIP1,WIPI2,MAPT",GO_Molecular_Function_2023
23,NAD+ Binding (GO:0070403),0.03125885600520284,8.75301204819277,30.333147929428307,0.4232503625112088,"HADHA,SIRT3",GO_Molecular_Function_2023
24,SUMO Ligase Activity (GO:0061665),0.03125885600520284,8.75301204819277,30.333147929428307,0.4232503625112088,"ZMIZ2,NSMCE2",GO_Molecular_Function_2023
25,Basic Amino Acid Transmembrane Transporter Activity (GO:0015174),0.03125885600520284,8.75301204819277,30.333147929428307,0.4232503625112088,"SLC25A15,SLC7A6",GO_Molecular_Function_2023
26,3'-5'-RNA Exonuclease Activity (GO:0000175),0.03129721765568631,4.846080457942439,16.78791829934718,0.4232503625112088,"ERI1,EXOSC9,CNOT8",GO_Molecular_Function_2023
27,High-Density Lipoprotein Particle Binding (GO:0008035),0.031773031329377505,inf,inf,0.4232503625112088,PLTP,GO_Molecular_Function_2023
28,2-Oxoglutarate-Dependent Dioxygenase Activity (GO:0016706),0.0351677628365098,4.603323262839879,15.410202084003604,0.4232503625112088,"FTO,JARID2,P4HTM",GO_Molecular_Function_2023
29,RNA Polymerase II Cis-Regulatory Region Sequence-Specific DNA Binding (GO:0000978),0.03691152590627248,1.4963592862702142,4.93683557515318,0.4232503625112088,"CEBPA,THRB,MAX,EPAS1,CEBPG,ZSCAN9,ETS2,PRDM16,MYB,ZKSCAN3,ZKSCAN4,NKX2-3,ZNF322,NFE2,MEF2C,KLF13,BCL11A,ZBTB38,TFEB,KLF3,ELF1,TFAP4,ZNF217,PPARG,ZSCAN26,ZNF410,ZNF211",GO_Molecular_Function_2023
30,Transmembrane Receptor Protein Tyrosine Kinase Adaptor Activity (GO:0005068),0.03826602016061806,7.658132530120482,24.989964301974165,0.4232503625112088,"FRS3,SH2B3",GO_Molecular_Function_2023
31,Mechanosensitive Monoatomic Ion Channel Activity (GO:0008381),0.03826602016061806,7.658132530120482,24.989964301974165,0.4232503625112088,"TMC8,TMC6",GO_Molecular_Function_2023
32,Sequence-Specific Double-Stranded DNA Binding (GO:1990837),0.038484176974584484,1.5943114991773502,5.193482638181562,0.4232503625112088,"CEBPA,NFE2,MEF2C,THRB,KLF13,MAX,EPAS1,CEBPG,ZSCAN9,TFEB,KLF3,ETS2,ELF1,TFAP4,PRDM16,BEND3,ZNF217,PPARG,NKX2-3,ZNF410",GO_Molecular_Function_2023
33,Transmembrane Receptor Protein Tyrosine Kinase Activity (GO:0004714),0.04029492295605065,3.3221949221949223,10.66932799139733,0.4232503625112088,"PDGFRA,AXL,KIT,EPHB4",GO_Molecular_Function_2023
34,Double-Stranded DNA Binding (GO:0003690),0.04213329230290029,1.6186434477207874,5.126109548258186,0.4232503625112088,"NFE2,MEF2C,THRB,KLF13,MAX,EPAS1,CEBPG,ZSCAN9,TFEB,KLF3,ETS2,RAD50,ELF1,TFAP4,PPARG,MAPT,NKX2-3,ZNF410",GO_Molecular_Function_2023
35,RNA Binding (GO:0003723),0.04480544967840422,1.4459120810274617,4.490172250581627,0.4232503625112088,"MACF1,SLC4A1AP,TFRC,WBP4,ADAR,SRP14,UBE2L3,HELZ2,LARP1,TERT,ERI1,EXOSC9,LONP1,SNIP1,RBM38,HSPA8,PTPN1,NOP58,PABPC4,QKI,U2SURP,BYSL,RPS28,XRN1,TRIP6,BUD13,RPL22L1,MAPT,CPEB4",GO_Molecular_Function_2023
36,Cis-Regulatory Region Sequence-Specific DNA Binding (GO:0000987),0.04532213208684689,1.4748980601975157,4.563275305527008,0.4232503625112088,"CEBPA,THRB,EPAS1,CEBPG,ZSCAN9,ETS2,PRDM16,MYB,ZKSCAN3,ZKSCAN4,NKX2-3,ZNF322,NFE2,MEF2C,KLF13,BCL11A,ZBTB38,TFEB,KLF3,ELF1,TFAP4,ZNF217,PPARG,ZSCAN26,ZNF410,ZNF211",GO_Molecular_Function_2023
37,Histone Acetyltransferase Binding (GO:0035035),0.045805630168369055,6.806559571619813,20.986993652421944,0.4232503625112088,"KANSL1,CITED2",GO_Molecular_Function_2023
38,DNA-binding Transcription Factor Binding (GO:0140297),0.05247009745283525,1.8729891507669285,5.52065770553052,0.4232503625112088,"CEBPA,MEF2C,EPAS1,MAX,PRDM16,CEBPG,NLRP3,PPARG,TRIB1,ETS2",GO_Molecular_Function_2023
39,RNA Polymerase II Transcription Regulatory Region Sequence-Specific DNA Binding (GO:0000977),0.052719971730643723,1.4302618650946217,4.208918729125159,0.4232503625112088,"GTF2A1,CEBPA,THRB,MAX,EPAS1,CEBPG,ZSCAN9,ETS2,PRDM16,MYB,ZKSCAN3,ZKSCAN4,NKX2-3,ZNF322,NFE2,MEF2C,KLF13,BCL11A,ZBTB38,TFEB,KLF3,ELF1,TFAP4,ZNF217,PPARG,ZSCAN26,ZNF410,ZNF211",GO_Molecular_Function_2023
40,Signaling Receptor Complex Adaptor Activity (GO:0030159),0.052966013709009704,3.834592145015106,11.266433671260492,0.4232503625112088,"DLG5,SH2B3,FRS3",GO_Molecular_Function_2023
41,Exonuclease Activity (GO:0004527),0.052966013709009704,3.834592145015106,11.266433671260492,0.4232503625112088,"RAD50,ERI1,EXOSC9",GO_Molecular_Function_2023
42,DNA Polymerase Binding (GO:0070182),0.05383699378683079,6.125301204819277,17.89687095002477,0.4232503625112088,"RTEL1,LONP1",GO_Molecular_Function_2023
43,Nuclear Retinoic Acid Receptor Binding (GO:0042974),0.05383699378683079,6.125301204819277,17.89687095002477,0.4232503625112088,"ASXL1,PPARG",GO_Molecular_Function_2023
44,Transcription Coactivator Binding (GO:0001223),0.057975865160158006,3.680845921450151,10.482049735111122,0.4232503625112088,"THRB,TERT,EPAS1",GO_Molecular_Function_2023
45,Low-Density Lipoprotein Particle Receptor Binding (GO:0050750),0.06232145365055438,5.567907995618839,15.453447752602834,0.4232503625112088,"APOE,APOB",GO_Molecular_Function_2023
46,Ankyrin Binding (GO:0030506),0.06232145365055438,5.567907995618839,15.453447752602834,0.4232503625112088,"PTPRC,CDH1",GO_Molecular_Function_2023
47,snoRNA Binding (GO:0030515),0.06232145365055438,5.567907995618839,15.453447752602834,0.4232503625112088,"NOP58,BYSL",GO_Molecular_Function_2023
48,Histone Deubiquitinase Activity (GO:0140934),0.06253956201413506,30.56156156156156,84.71530180884244,0.4232503625112088,USP49,GO_Molecular_Function_2023
49,Acetyltransferase Activator Activity (GO:0010698),0.06253956201413506,30.56156156156156,84.71530180884244,0.4232503625112088,PDCD5,GO_Molecular_Function_2023
50,Phosphatidic Acid Transfer Activity (GO:1990050),0.06253956201413506,30.56156156156156,84.71530180884244,0.4232503625112088,PLTP,GO_Molecular_Function_2023
51,Phosphatidylethanolamine Binding (GO:0008429),0.06253956201413506,30.56156156156156,84.71530180884244,0.4232503625112088,PLTP,GO_Molecular_Function_2023
52,rDNA Binding (GO:0000182),0.06253956201413506,30.56156156156156,84.71530180884244,0.4232503625112088,BEND3,GO_Molecular_Function_2023
53,Ubiquitin-Like Protein Transferase Activity (GO:0019787),0.06582069930929134,1.9421283995942225,5.284183561369617,0.4232503625112088,"TRIM4,NSMCE2,ARIH2,ZFP91,FBXL5,FBXO7,UBE2L3,DDB2",GO_Molecular_Function_2023
54,Phosphoric Diester Hydrolase Activity (GO:0008081),0.06863547451450196,3.4075193017791205,9.128559374404292,0.4232503625112088,"SMPD2,TDP2,PLD1",GO_Molecular_Function_2023
55,Telomerase RNA Binding (GO:0070034),0.07122229964072589,5.103413654618474,13.482960195706973,0.4232503625112088,"TERT,XRN1",GO_Molecular_Function_2023
56,"Oxidoreductase Activity, Acting On The Aldehyde Or Oxo Group Of Donors, NAD Or NADP As Acceptor (GO:0016620)",0.07122229964072589,5.103413654618474,13.482960195706973,0.4232503625112088,"ALDH2,ALDH8A1",GO_Molecular_Function_2023
57,mRNA 3'-UTR Binding (GO:0003730),0.07366493077681577,2.669828722002635,6.963523177361515,0.4232503625112088,"LARP1,PABPC4,EXOSC9,CPEB4",GO_Molecular_Function_2023
58,Protein Tyrosine Phosphatase Activity (GO:0004725),0.07803166722629232,2.6127659574468085,6.664226784623739,0.4232503625112088,"PTPN1,PTPRC,DUSP1,DUSP15",GO_Molecular_Function_2023
59,Lipoprotein Particle Receptor Binding (GO:0070325),0.08050468484980135,4.710379981464319,11.86751926644335,0.4232503625112088,"APOE,APOB",GO_Molecular_Function_2023
60,E-box Binding (GO:0070888),0.08614216815905654,3.065861027190332,7.516743872182359,0.4232503625112088,"TFAP4,MAX,PPARG",GO_Molecular_Function_2023
61,Manganese Ion Binding (GO:0030145),0.08614216815905654,3.065861027190332,7.516743872182359,0.4232503625112088,"HMGCL,GALNT2,TDP2",GO_Molecular_Function_2023
62,Sterol Transfer Activity (GO:0120015),0.09013554473473162,4.373493975903615,10.524553856726516,0.4232503625112088,"APOB,PLTP",GO_Molecular_Function_2023
63,Histone H3 Methyltransferase Activity (GO:0140938),0.09013554473473162,4.373493975903615,10.524553856726516,0.4232503625112088,"PRDM16,JARID2",GO_Molecular_Function_2023
64,Lipoprotein Particle Binding (GO:0071813),0.09013554473473162,4.373493975903615,10.524553856726516,0.4232503625112088,"MAPT,PLTP",GO_Molecular_Function_2023
65,Protein Phosphatase 2A Binding (GO:0051721),0.09013554473473162,4.373493975903615,10.524553856726516,0.4232503625112088,"MFHAS1,MAPT",GO_Molecular_Function_2023
66,Cholesterol Transfer Activity (GO:0120020),0.09013554473473162,4.373493975903615,10.524553856726516,0.4232503625112088,"APOB,PLTP",GO_Molecular_Function_2023
67,Protein Serine/Threonine/Tyrosine Kinase Activity (GO:0004712),0.09013554473473162,4.373493975903615,10.524553856726516,0.4232503625112088,"MAP2K2,TNK2",GO_Molecular_Function_2023
68,C3HC4-type RING Finger Domain Binding (GO:0055131),0.09233130434472851,15.27927927927928,36.400927689928544,0.4232503625112088,HSPA8,GO_Molecular_Function_2023
69,Histone H3K9 Methyltransferase Activity (GO:0046974),0.09233130434472851,15.27927927927928,36.400927689928544,0.4232503625112088,PRDM16,GO_Molecular_Function_2023
70,Icosatetraenoic Acid Binding (GO:0050543),0.09233130434472851,15.27927927927928,36.400927689928544,0.4232503625112088,PPARG,GO_Molecular_Function_2023
71,Urate Transmembrane Transporter Activity (GO:0015143),0.09233130434472851,15.27927927927928,36.400927689928544,0.4232503625112088,SLC17A3,GO_Molecular_Function_2023
72,G-quadruplex RNA Binding (GO:0002151),0.09233130434472851,15.27927927927928,36.400927689928544,0.4232503625112088,XRN1,GO_Molecular_Function_2023
73,NAD(P)H Oxidase H2O2-forming Activity (GO:0016174),0.09233130434472851,15.27927927927928,36.400927689928544,0.4232503625112088,MICAL1,GO_Molecular_Function_2023
74,NAD-dependent Protein Deacetylase Activity (GO:0034979),0.09233130434472851,15.27927927927928,36.400927689928544,0.4232503625112088,SIRT3,GO_Molecular_Function_2023
75,Phosphatidylcholine-Sterol O-acyltransferase Activator Activity (GO:0060228),0.09233130434472851,15.27927927927928,36.400927689928544,0.4232503625112088,APOE,GO_Molecular_Function_2023
76,Arachidonic Acid Binding (GO:0050544),0.09233130434472851,15.27927927927928,36.400927689928544,0.4232503625112088,PPARG,GO_Molecular_Function_2023
77,"Aspartic Endopeptidase Activity, Intramembrane Cleaving (GO:0042500)",0.09233130434472851,15.27927927927928,36.400927689928544,0.4232503625112088,SPPL3,GO_Molecular_Function_2023
78,Ceramide Transfer Activity (GO:0120017),0.09233130434472851,15.27927927927928,36.400927689928544,0.4232503625112088,PLTP,GO_Molecular_Function_2023
79,SH3 Domain Binding (GO:0017124),0.09875475759999416,2.873678247734139,6.652897622714506,0.4232503625112088,"MICAL1,MAPT,ARHGAP27",GO_Molecular_Function_2023
80,SUMO Transferase Activity (GO:0019789),0.10008351964589496,4.08152610441767,9.394653711297185,0.4232503625112088,"ZMIZ2,NSMCE2",GO_Molecular_Function_2023
81,DNA Secondary Structure Binding (GO:0000217),0.11031888038918752,3.82605421686747,8.434078137999961,0.4232503625112088,"MEF2C,MAPT",GO_Molecular_Function_2023
82,Flavin Adenine Dinucleotide Binding (GO:0050660),0.11895666942785178,2.6265861027190334,5.591991239719249,0.4232503625112088,"GCDH,ACOXL,MICAL1",GO_Molecular_Function_2023
83,Ribosome Binding (GO:0043022),0.11895666942785178,2.6265861027190334,5.591991239719249,0.4232503625112088,"LARP1,ERI1,CPEB4",GO_Molecular_Function_2023
84,3-hydroxyacyl-CoA Dehydrogenase Activity (GO:0003857),0.12117904111215834,10.185185185185185,21.49569225240779,0.4232503625112088,HADHA,GO_Molecular_Function_2023
85,tRNA-specific Adenosine Deaminase Activity (GO:0008251),0.12117904111215834,10.185185185185185,21.49569225240779,0.4232503625112088,ADAR,GO_Molecular_Function_2023
86,5'-3' RNA Polymerase Activity (GO:0034062),0.12117904111215834,10.185185185185185,21.49569225240779,0.4232503625112088,TERT,GO_Molecular_Function_2023
87,5S rRNA Binding (GO:0008097),0.12117904111215834,10.185185185185185,21.49569225240779,0.4232503625112088,TST,GO_Molecular_Function_2023
88,Telomerase Activity (GO:0003720),0.12117904111215834,10.185185185185185,21.49569225240779,0.4232503625112088,TERT,GO_Molecular_Function_2023
89,Growth Hormone Receptor Binding (GO:0005131),0.12117904111215834,10.185185185185185,21.49569225240779,0.4232503625112088,JAK2,GO_Molecular_Function_2023
90,Icosanoid Binding (GO:0050542),0.12117904111215834,10.185185185185185,21.49569225240779,0.4232503625112088,PPARG,GO_Molecular_Function_2023
91,L-lysine Transmembrane Transporter Activity (GO:0015189),0.12117904111215834,10.185185185185185,21.49569225240779,0.4232503625112088,SLC7A6,GO_Molecular_Function_2023
92,RNA Polymerase II Core Promoter Sequence-Specific DNA Binding (GO:0000979),0.12117904111215834,10.185185185185185,21.49569225240779,0.4232503625112088,GTF2A1,GO_Molecular_Function_2023
93,RNA-directed DNA Polymerase Activity (GO:0003964),0.12117904111215834,10.185185185185185,21.49569225240779,0.4232503625112088,TERT,GO_Molecular_Function_2023
94,Roundabout Binding (GO:0048495),0.12117904111215834,10.185185185185185,21.49569225240779,0.4232503625112088,MYO9B,GO_Molecular_Function_2023
95,STAT Family Protein Binding (GO:0097677),0.12117904111215834,10.185185185185185,21.49569225240779,0.4232503625112088,PPARG,GO_Molecular_Function_2023
96,Toll-like Receptor Binding (GO:0035325),0.12117904111215834,10.185185185185185,21.49569225240779,0.4232503625112088,TLR1,GO_Molecular_Function_2023
97,Non-Membrane Spanning Protein Tyrosine Phosphatase Activity (GO:0004726),0.12117904111215834,10.185185185185185,21.49569225240779,0.4232503625112088,PTPN1,GO_Molecular_Function_2023
98,"Oxidoreductase Activity, Acting On A Sulfur Group Of Donors, Disulfide As Acceptor (GO:0016671)",0.12117904111215834,10.185185185185185,21.49569225240779,0.4232503625112088,MSRA,GO_Molecular_Function_2023
99,"Oxidoreductase Activity, Acting On Paired Donors, With Incorporation Or Reduction Of Molecular Oxygen, Another Compound As One Donor, And Incorporation Of One Atom Of Oxygen (GO:0016716)",0.12117904111215834,10.185185185185185,21.49569225240779,0.4232503625112088,FAXDC2,GO_Molecular_Function_2023
100,"Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Activity (GO:0046934)",0.12117904111215834,10.185185185185185,21.49569225240779,0.4232503625112088,PIK3CA,GO_Molecular_Function_2023
101,Phospholipase D Activity (GO:0004630),0.12117904111215834,10.185185185185185,21.49569225240779,0.4232503625112088,PLD1,GO_Molecular_Function_2023
102,Carnitine O-acyltransferase Activity (GO:0016406),0.12117904111215834,10.185185185185185,21.49569225240779,0.4232503625112088,CPT1B,GO_Molecular_Function_2023
103,Single-Stranded DNA Endodeoxyribonuclease Activity (GO:0000014),0.12117904111215834,10.185185185185185,21.49569225240779,0.4232503625112088,RAD50,GO_Molecular_Function_2023
104,Eukaryotic Initiation Factor 4E Binding (GO:0008190),0.12117904111215834,10.185185185185185,21.49569225240779,0.4232503625112088,LARP1,GO_Molecular_Function_2023
105,Protein Serine/Threonine Kinase Activator Activity (GO:0043539),0.12600587797138024,2.5533736153071502,5.289126339407087,0.4232503625112088,"CCND3,CCND2,MAP2K2",GO_Molecular_Function_2023
106,Receptor Tyrosine Kinase Binding (GO:0030971),0.12600587797138024,2.5533736153071502,5.289126339407087,0.4232503625112088,"PTPN1,FRS3,SH2B3",GO_Molecular_Function_2023
107,Transcription Regulatory Region Nucleic Acid Binding (GO:0001067),0.13084195913808852,1.707781175671084,3.4732257584406563,0.4232503625112088,"CEBPA,MEF2C,TFAP4,PRDM16,TFEB,ZNF217,PPARG",GO_Molecular_Function_2023
108,rRNA Binding (GO:0019843),0.1315405690685488,3.4002677376171353,6.897238970399704,0.4232503625112088,"TST,ERI1",GO_Molecular_Function_2023
109,Telomeric DNA Binding (GO:0042162),0.14247496211786,3.2209892200380468,6.276384160538291,0.4232503625112088,"RAD50,TERT",GO_Molecular_Function_2023
110,Protein-Lysine N-methyltransferase Activity (GO:0016279),0.14247496211786,3.2209892200380468,6.276384160538291,0.4232503625112088,"PRDM16,JARID2",GO_Molecular_Function_2023
111,Solute:Sodium Symporter Activity (GO:0015370),0.14247496211786,3.2209892200380468,6.276384160538291,0.4232503625112088,"SLC17A1,SLC17A3",GO_Molecular_Function_2023
112,1-Phosphatidylinositol-4-Phosphate 3-Kinase Activity (GO:0035005),0.14911259383863723,7.638138138138138,14.535786243348012,0.4232503625112088,PIK3CA,GO_Molecular_Function_2023
113,ABC-type Glutathione S-conjugate Transporter Activity (GO:0015431),0.14911259383863723,7.638138138138138,14.535786243348012,0.4232503625112088,ABCC2,GO_Molecular_Function_2023
114,DNA N-glycosylase Activity (GO:0019104),0.14911259383863723,7.638138138138138,14.535786243348012,0.4232503625112088,MPG,GO_Molecular_Function_2023
115,Interleukin-6 Receptor Binding (GO:0005138),0.14911259383863723,7.638138138138138,14.535786243348012,0.4232503625112088,IL6R,GO_Molecular_Function_2023
116,Iron Ion Transmembrane Transporter Activity (GO:0005381),0.14911259383863723,7.638138138138138,14.535786243348012,0.4232503625112088,SLC25A37,GO_Molecular_Function_2023
117,Microtubule Minus-End Binding (GO:0051011),0.14911259383863723,7.638138138138138,14.535786243348012,0.4232503625112088,MACF1,GO_Molecular_Function_2023
118,RNA Polymerase II General Transcription Initiation Factor Binding (GO:0001091),0.14911259383863723,7.638138138138138,14.535786243348012,0.4232503625112088,GTF2A1,GO_Molecular_Function_2023
119,acetyl-CoA C-acyltransferase Activity (GO:0003988),0.14911259383863723,7.638138138138138,14.535786243348012,0.4232503625112088,HADHA,GO_Molecular_Function_2023
120,acyl-CoA Oxidase Activity (GO:0003997),0.14911259383863723,7.638138138138138,14.535786243348012,0.4232503625112088,ACOXL,GO_Molecular_Function_2023
121,Adenylate Kinase Activity (GO:0004017),0.14911259383863723,7.638138138138138,14.535786243348012,0.4232503625112088,AK9,GO_Molecular_Function_2023
122,Peptidyl-Proline 4-Dioxygenase Activity (GO:0031545),0.14911259383863723,7.638138138138138,14.535786243348012,0.4232503625112088,P4HTM,GO_Molecular_Function_2023
123,Arginine Binding (GO:0034618),0.14911259383863723,7.638138138138138,14.535786243348012,0.4232503625112088,SLC7A6,GO_Molecular_Function_2023
124,Potassium:Chloride Symporter Activity (GO:0015379),0.14911259383863723,7.638138138138138,14.535786243348012,0.4232503625112088,SLC12A7,GO_Molecular_Function_2023
125,Procollagen-Proline Dioxygenase Activity (GO:0019798),0.14911259383863723,7.638138138138138,14.535786243348012,0.4232503625112088,P4HTM,GO_Molecular_Function_2023
126,Chloride:Monoatomic Cation Symporter Activity (GO:0015377),0.14911259383863723,7.638138138138138,14.535786243348012,0.4232503625112088,SLC12A7,GO_Molecular_Function_2023
127,Retinal Dehydrogenase Activity (GO:0001758),0.14911259383863723,7.638138138138138,14.535786243348012,0.4232503625112088,ALDH8A1,GO_Molecular_Function_2023
128,Double-Stranded Telomeric DNA Binding (GO:0003691),0.14911259383863723,7.638138138138138,14.535786243348012,0.4232503625112088,RAD50,GO_Molecular_Function_2023
129,enoyl-CoA Hydratase Activity (GO:0004300),0.14911259383863723,7.638138138138138,14.535786243348012,0.4232503625112088,HADHA,GO_Molecular_Function_2023
130,Single-Stranded Telomeric DNA Binding (GO:0043047),0.14911259383863723,7.638138138138138,14.535786243348012,0.4232503625112088,RAD50,GO_Molecular_Function_2023
131,ATP Binding (GO:0005524),0.1550147030396647,1.5663319135633622,2.9200112576898842,0.43664446886745245,"HSPA8,RTEL1,RRM1,MAST2,LONP1,NLRP3,MYO9B,TRIB1",GO_Molecular_Function_2023
132,"DNA-binding Transcription Repressor Activity, RNA Polymerase II-specific (GO:0001227)",0.15785036154875876,1.6167712860131982,2.984734039117728,0.43953219570845725,"BCL11A,MAX,PRDM16,ZKSCAN3,ZNF217,ETS2,ZFP90",GO_Molecular_Function_2023
133,Cyclin-Dependent Protein Serine/Threonine Kinase Regulator Activity (GO:0016538),0.16487131692197854,2.9136546184738954,5.252124698534515,0.43953219570845725,"CCND3,CCND2",GO_Molecular_Function_2023
134,Protein Homodimerization Activity (GO:0042803),0.1703918065710965,1.3177876765531125,2.3320292203099684,0.43953219570845725,"CEP57,CEBPA,PDGFRA,TFRC,GADD45A,ZBTB38,SLC39A13,MYO9B,SPPL3,TYMP,TP53I3,TFAP4,TERT,KIT,APOE,TRIM38,IL6R",GO_Molecular_Function_2023
135,Transcription Coregulator Binding (GO:0001221),0.17600139071984627,1.8858741258741258,3.2762600622401497,0.43953219570845725,"THRB,TERT,EPAS1,PPARG",GO_Molecular_Function_2023
136,Store-Operated Calcium Channel Activity (GO:0015279),0.17616084684518224,6.10990990990991,10.608989721849268,0.43953219570845725,TRPC1,GO_Molecular_Function_2023
137,5'-3' Exonuclease Activity (GO:0008409),0.17616084684518224,6.10990990990991,10.608989721849268,0.43953219570845725,XRN1,GO_Molecular_Function_2023
138,Vascular Endothelial Growth Factor Receptor Activity (GO:0005021),0.17616084684518224,6.10990990990991,10.608989721849268,0.43953219570845725,PDGFRA,GO_Molecular_Function_2023
139,MHC Class I Protein Binding (GO:0042288),0.17616084684518224,6.10990990990991,10.608989721849268,0.43953219570845725,PILRB,GO_Molecular_Function_2023
140,RNA 7-Methylguanosine Cap Binding (GO:0000340),0.17616084684518224,6.10990990990991,10.608989721849268,0.43953219570845725,LARP1,GO_Molecular_Function_2023
141,Mitogen-Activated Protein Kinase Kinase Binding (GO:0031434),0.17616084684518224,6.10990990990991,10.608989721849268,0.43953219570845725,TRIB1,GO_Molecular_Function_2023
142,acyl-CoA Dehydrogenase Activity (GO:0003995),0.17616084684518224,6.10990990990991,10.608989721849268,0.43953219570845725,GCDH,GO_Molecular_Function_2023
143,"Oxidoreductase Activity, Acting On NAD(P)H, Oxygen As Acceptor (GO:0050664)",0.17616084684518224,6.10990990990991,10.608989721849268,0.43953219570845725,MICAL1,GO_Molecular_Function_2023
144,Adenosine Deaminase Activity (GO:0004000),0.17616084684518224,6.10990990990991,10.608989721849268,0.43953219570845725,ADAR,GO_Molecular_Function_2023
145,Peptidoglycan Binding (GO:0042834),0.17616084684518224,6.10990990990991,10.608989721849268,0.43953219570845725,NLRP3,GO_Molecular_Function_2023
146,Ammonium Transmembrane Transporter Activity (GO:0008519),0.17616084684518224,6.10990990990991,10.608989721849268,0.43953219570845725,SLC12A7,GO_Molecular_Function_2023
147,Endopeptidase Activator Activity (GO:0061133),0.17616084684518224,6.10990990990991,10.608989721849268,0.43953219570845725,NLRP3,GO_Molecular_Function_2023
148,Non-Membrane Spanning Protein Tyrosine Kinase Activity (GO:0004715),0.1762893359481075,2.7809419496166483,4.8266826037987975,0.43953219570845725,"BLK,JAK2",GO_Molecular_Function_2023
149,Actin Binding (GO:0003779),0.18241202177541344,1.6148908857509627,2.747716324363243,0.4441196890444909,"MACF1,MICAL1,ARPC1A,PFN4,MYO9B,MAPT",GO_Molecular_Function_2023
150,Pentosyltransferase Activity (GO:0016763),0.187826636372978,2.6597695128339445,4.447762034614779,0.4441196890444909,"TYMP,SIRT3",GO_Molecular_Function_2023
151,ATPase Binding (GO:0051117),0.19520168016594044,2.040886203423968,3.3342406851988353,0.4441196890444909,"NOP58,TRPC1,ATP6V1G3",GO_Molecular_Function_2023
152,RNA Polymerase II-specific DNA-binding Transcription Factor Binding (GO:0061629),0.19594632982419735,1.5129431020373003,2.4659678765023845,0.4441196890444909,"CEBPA,MEF2C,EPAS1,PPARG,TRIB1,COMMD6,ETS2",GO_Molecular_Function_2023
153,Protein Kinase Inhibitor Activity (GO:0004860),0.1994641886930714,2.548694779116466,4.108803264933942,0.4441196890444909,"SPRED2,TRIB1",GO_Molecular_Function_2023
154,mRNA Binding (GO:0003729),0.20186819977294337,1.5595287308805292,2.4954647259197373,0.4441196890444909,"SLC4A1AP,LARP1,PABPC4,SNIP1,QKI,CPEB4",GO_Molecular_Function_2023
155,Histone H3 Kinase Activity (GO:0140996),0.20235177539845034,5.091091091091091,8.134278744250102,0.4441196890444909,JAK2,GO_Molecular_Function_2023
156,Interleukin-1 Binding (GO:0019966),0.20235177539845034,5.091091091091091,8.134278744250102,0.4441196890444909,IL1RN,GO_Molecular_Function_2023
157,MAP-kinase Scaffold Activity (GO:0005078),0.20235177539845034,5.091091091091091,8.134278744250102,0.4441196890444909,MAP2K2,GO_Molecular_Function_2023
158,MHC Class II Protein Complex Binding (GO:0023026),0.20235177539845034,5.091091091091091,8.134278744250102,0.4441196890444909,HSPA8,GO_Molecular_Function_2023
159,Myosin V Binding (GO:0031489),0.20235177539845034,5.091091091091091,8.134278744250102,0.4441196890444909,RAB8A,GO_Molecular_Function_2023
160,Nucleoside Diphosphate Kinase Activity (GO:0004550),0.20235177539845034,5.091091091091091,8.134278744250102,0.4441196890444909,AK9,GO_Molecular_Function_2023
161,Phosphatidylglycerol Binding (GO:1901611),0.20235177539845034,5.091091091091091,8.134278744250102,0.4441196890444909,PLTP,GO_Molecular_Function_2023
162,Phosphatidylinositol Bisphosphate Kinase Activity (GO:0052813),0.20235177539845034,5.091091091091091,8.134278744250102,0.4441196890444909,PIK3CA,GO_Molecular_Function_2023
163,Phosphatidylinositol Transfer Activity (GO:0008526),0.20235177539845034,5.091091091091091,8.134278744250102,0.4441196890444909,PLTP,GO_Molecular_Function_2023
164,Phospholipase Activator Activity (GO:0016004),0.20235177539845034,5.091091091091091,8.134278744250102,0.4441196890444909,STX4,GO_Molecular_Function_2023
165,poly(A)-specific Ribonuclease Activity (GO:0004535),0.20235177539845034,5.091091091091091,8.134278744250102,0.4441196890444909,CNOT8,GO_Molecular_Function_2023
166,Prostaglandin Receptor Activity (GO:0004955),0.20235177539845034,5.091091091091091,8.134278744250102,0.4441196890444909,PPARG,GO_Molecular_Function_2023
167,Ribosomal Small Subunit Binding (GO:0043024),0.20235177539845034,5.091091091091091,8.134278744250102,0.4441196890444909,LARP1,GO_Molecular_Function_2023
168,Dynactin Binding (GO:0034452),0.20235177539845034,5.091091091091091,8.134278744250102,0.4441196890444909,MAPT,GO_Molecular_Function_2023
169,Single-Stranded DNA Binding (GO:0003697),0.2034044104295907,1.9963220806515172,3.1792609201776654,0.4441196890444909,"TDP2,LONP1,MAPT",GO_Molecular_Function_2023
170,Damaged DNA Binding (GO:0003684),0.21118404556912293,2.4465060240963856,3.8043786951207514,0.44841009581970387,"MPG,DDB2",GO_Molecular_Function_2023
171,Purine Ribonucleoside Triphosphate Binding (GO:0035639),0.21579161395878968,1.3414172686618506,2.0569856962089648,0.44841009581970387,"MFHAS1,HSPA8,RRM1,RTEL1,MAST2,LONP1,NLRP3,MYO9B,TRIB1,RHOA,RAB8A",GO_Molecular_Function_2023
172,Phosphatidylinositol-3-Phosphate Binding (GO:0032266),0.22296929257000844,2.3521779425393885,3.529963348017771,0.44841009581970387,"SNX13,WIPI2",GO_Molecular_Function_2023
173,Adenyl Ribonucleotide Binding (GO:0032559),0.22687839199448434,1.4026993865030675,2.0806816833961093,0.44841009581970387,"HSPA8,RTEL1,RRM1,MAST2,LONP1,NLRP3,MYO9B,TRIB1",GO_Molecular_Function_2023
174,1-Phosphatidylinositol-3-Kinase Activity (GO:0016303),0.22771247374454687,4.363363363363363,6.4563445260378325,0.44841009581970387,PIK3CA,GO_Molecular_Function_2023
175,Glycerophospholipid Flippase Activity (GO:0140333),0.22771247374454687,4.363363363363363,6.4563445260378325,0.44841009581970387,ATP11A,GO_Molecular_Function_2023
176,ABC-type Xenobiotic Transporter Activity (GO:0008559),0.22771247374454687,4.363363363363363,6.4563445260378325,0.44841009581970387,ABCC2,GO_Molecular_Function_2023
177,Transferrin Receptor Binding (GO:1990459),0.22771247374454687,4.363363363363363,6.4563445260378325,0.44841009581970387,HFE,GO_Molecular_Function_2023
178,Ubiquitin-Protein Transferase Activator Activity (GO:0097027),0.22771247374454687,4.363363363363363,6.4563445260378325,0.44841009581970387,UBE2L3,GO_Molecular_Function_2023
179,"Inositol 1,4,5 Trisphosphate Binding (GO:0070679)",0.22771247374454687,4.363363363363363,6.4563445260378325,0.44841009581970387,TRPC1,GO_Molecular_Function_2023
180,Voltage-Gated Monoatomic Anion Channel Activity (GO:0008308),0.22771247374454687,4.363363363363363,6.4563445260378325,0.44841009581970387,SLC17A3,GO_Molecular_Function_2023
181,MAP Kinase Kinase Activity (GO:0004708),0.22771247374454687,4.363363363363363,6.4563445260378325,0.44841009581970387,MAP2K2,GO_Molecular_Function_2023
182,Nuclear Retinoid X Receptor Binding (GO:0046965),0.22771247374454687,4.363363363363363,6.4563445260378325,0.44841009581970387,PPARG,GO_Molecular_Function_2023
183,Nucleotidyltransferase Activity (GO:0016779),0.22771247374454687,4.363363363363363,6.4563445260378325,0.44841009581970387,TERT,GO_Molecular_Function_2023
184,Peptidase Activator Activity (GO:0016504),0.22771247374454687,4.363363363363363,6.4563445260378325,0.44841009581970387,PCOLCE2,GO_Molecular_Function_2023
185,Aspartic-Type Endopeptidase Activity (GO:0004190),0.22771247374454687,4.363363363363363,6.4563445260378325,0.44841009581970387,SPPL3,GO_Molecular_Function_2023
186,Death Receptor Binding (GO:0005123),0.22771247374454687,4.363363363363363,6.4563445260378325,0.44841009581970387,TMBIM1,GO_Molecular_Function_2023
187,fatty-acyl-CoA Binding (GO:0000062),0.22771247374454687,4.363363363363363,6.4563445260378325,0.44841009581970387,GCDH,GO_Molecular_Function_2023
188,Cytokine Receptor Activity (GO:0004896),0.22845826020082471,1.873543375053949,2.766102725198173,0.44841009581970387,"IL2RB,LEPR,IL6R",GO_Molecular_Function_2023
189,Ubiquitin Protein Ligase Binding (GO:0031625),0.23727398828481838,1.4214917876744233,2.0448724222005414,0.46324921522274065,"LAPTM4B,HSPA8,MFHAS1,TNK2,TRIB1,FBXO7,UBE2L3",GO_Molecular_Function_2023
190,Monoatomic Ion Gated Channel Activity (GO:0022839),0.24667318295277238,2.183734939759036,3.0565540638795885,0.46543664177453375,"TMC8,TMC6",GO_Molecular_Function_2023
191,DNA Endonuclease Activity (GO:0004520),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.46543664177453375,RAD50,GO_Molecular_Function_2023
192,Hormone Receptor Binding (GO:0051427),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.46543664177453375,JAK2,GO_Molecular_Function_2023
193,GTPase Inhibitor Activity (GO:0005095),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.46543664177453375,TNK2,GO_Molecular_Function_2023
194,MHC Protein Binding (GO:0042287),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.46543664177453375,PILRB,GO_Molecular_Function_2023
195,NADPH Binding (GO:0070402),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.46543664177453375,TP53I3,GO_Molecular_Function_2023
196,RNA Cap Binding (GO:0000339),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.46543664177453375,LARP1,GO_Molecular_Function_2023
197,RNA Exonuclease Activity (GO:0004532),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.46543664177453375,EXOSC9,GO_Molecular_Function_2023
198,Platelet-Derived Growth Factor Binding (GO:0048407),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.46543664177453375,PDGFRA,GO_Molecular_Function_2023
199,Platelet-Derived Growth Factor Receptor Binding (GO:0005161),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.46543664177453375,PDGFRA,GO_Molecular_Function_2023
200,Carbohydrate Kinase Activity (GO:0019200),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.46543664177453375,HK1,GO_Molecular_Function_2023
201,Antiporter Activity (GO:0015297),0.2585627471976888,2.1082260074781884,2.851622081860491,0.47232501839577806,"SLC25A15,SLC7A6",GO_Molecular_Function_2023
202,Double-Stranded RNA Binding (GO:0003725),0.2585627471976888,2.1082260074781884,2.851622081860491,0.47232501839577806,"TFRC,ADAR",GO_Molecular_Function_2023
203,Ubiquitin-Protein Transferase Activity (GO:0004842),0.2702397218463651,1.301799709724238,1.7033344344982324,0.4739792202141376,"C18ORF25,TRIM4,ARIH2,ZFP91,TRIM38,FBXL5,FBXO7,DDB2,UBE2L3",GO_Molecular_Function_2023
204,GTPase Regulator Activity (GO:0030695),0.2702728024373751,1.2641435048294896,1.653908592387892,0.4739792202141376,"ARHGAP21,DNMBP,DENND4A,TNK2,ITSN1,DOCK7,NPRL3,AGAP1,MYO9B,ARHGAP27,LAMTOR4",GO_Molecular_Function_2023
205,Transcription Cis-Regulatory Region Binding (GO:0000976),0.2740587356501977,1.2592994778429831,1.630053403299522,0.4739792202141376,"CEBPA,NFE2,MEF2C,TFAP4,MAX,EPAS1,PRDM16,LONP1,TFEB,ZNF217,PPARG",GO_Molecular_Function_2023
206,Histone Deacetylase Activity (GO:0004407),0.2760473156248264,3.3930597263930595,4.367488779253821,0.4739792202141376,SIRT3,GO_Molecular_Function_2023
207,"Hydrolase Activity, Hydrolyzing N-glycosyl Compounds (GO:0016799)",0.2760473156248264,3.3930597263930595,4.367488779253821,0.4739792202141376,MPG,GO_Molecular_Function_2023
208,mRNA 5'-UTR Binding (GO:0048027),0.2760473156248264,3.3930597263930595,4.367488779253821,0.4739792202141376,LARP1,GO_Molecular_Function_2023
209,Nucleobase-Containing Compound Kinase Activity (GO:0019205),0.2760473156248264,3.3930597263930595,4.367488779253821,0.4739792202141376,AK9,GO_Molecular_Function_2023
210,Aldehyde Dehydrogenase (NAD+) Activity (GO:0004029),0.2760473156248264,3.3930597263930595,4.367488779253821,0.4739792202141376,ALDH2,GO_Molecular_Function_2023
211,Aldehyde Dehydrogenase [NAD(P)+] Activity (GO:0004030),0.2760473156248264,3.3930597263930595,4.367488779253821,0.4739792202141376,ALDH2,GO_Molecular_Function_2023
212,Phosphatidylinositol 3-Kinase Activity (GO:0035004),0.2760473156248264,3.3930597263930595,4.367488779253821,0.4739792202141376,PIK3CA,GO_Molecular_Function_2023
213,Phosphatidylinositol Phosphate Kinase Activity (GO:0016307),0.2760473156248264,3.3930597263930595,4.367488779253821,0.4739792202141376,PIK3CA,GO_Molecular_Function_2023
214,"Phosphotransferase Activity, Phosphate Group As Acceptor (GO:0016776)",0.2760473156248264,3.3930597263930595,4.367488779253821,0.4739792202141376,AK9,GO_Molecular_Function_2023
215,Ubiquitin-Like Protein Ligase Binding (GO:0044389),0.2761667543253105,1.348893120227723,1.7356887800470915,0.4739792202141376,"LAPTM4B,HSPA8,MFHAS1,TNK2,TRIB1,FBXO7,UBE2L3",GO_Molecular_Function_2023
216,Myosin Binding (GO:0017022),0.28235089653244827,1.9718227749708512,2.493576284940006,0.4801266397256839,"RAB8A,RHOA",GO_Molecular_Function_2023
217,Phosphoric Ester Hydrolase Activity (GO:0042578),0.28235089653244827,1.9718227749708512,2.493576284940006,0.4801266397256839,"SMPD2,DUSP15",GO_Molecular_Function_2023
218,Protein Kinase Regulator Activity (GO:0019887),0.29746957034264254,1.6093178565749722,1.9512067232473926,0.4883069837343664,"CCND3,CCND2,TRIB1",GO_Molecular_Function_2023
219,"3',5'-cyclic-AMP Phosphodiesterase Activity (GO:0004115)",0.29907148597280975,3.0534534534534536,3.685740153685031,0.4883069837343664,PDE7A,GO_Molecular_Function_2023
220,Lysine-Acetylated Histone Binding (GO:0070577),0.29907148597280975,3.0534534534534536,3.685740153685031,0.4883069837343664,BRD3,GO_Molecular_Function_2023
221,Acetylation-Dependent Protein Binding (GO:0140033),0.29907148597280975,3.0534534534534536,3.685740153685031,0.4883069837343664,BRD3,GO_Molecular_Function_2023
222,Actin Monomer Binding (GO:0003785),0.29907148597280975,3.0534534534534536,3.685740153685031,0.4883069837343664,PFN4,GO_Molecular_Function_2023
223,Phosphatidylinositol Kinase Activity (GO:0052742),0.29907148597280975,3.0534534534534536,3.685740153685031,0.4883069837343664,PIK3CA,GO_Molecular_Function_2023
224,Phospholipid Transfer Activity (GO:0120014),0.29907148597280975,3.0534534534534536,3.685740153685031,0.4883069837343664,PLTP,GO_Molecular_Function_2023
225,Clathrin Adaptor Activity (GO:0035615),0.29907148597280975,3.0534534534534536,3.685740153685031,0.4883069837343664,AP1M2,GO_Molecular_Function_2023
226,Quaternary Ammonium Group Transmembrane Transporter Activity (GO:0015651),0.29907148597280975,3.0534534534534536,3.685740153685031,0.4883069837343664,SLC22A16,GO_Molecular_Function_2023
227,RNA Nuclease Activity (GO:0004540),0.3060721256646625,1.8519532676159183,2.192591365950232,0.49535357179938805,"RCL1,EXOSC9",GO_Molecular_Function_2023
228,Nuclear Receptor Coactivator Activity (GO:0030374),0.3060721256646625,1.8519532676159183,2.192591365950232,0.49535357179938805,"HELZ2,ZMIZ2",GO_Molecular_Function_2023
229,"DNA-binding Transcription Activator Activity, RNA Polymerase II-specific (GO:0001228)",0.3083264608191771,1.2695889888426206,1.4937934777861974,0.4968229870841762,"CEBPA,MEF2C,ELF1,TFAP4,EPAS1,PRDM16,CEBPG,MYB",GO_Molecular_Function_2023
230,Iron Ion Binding (GO:0005506),0.31788081930037987,1.7973068745570517,2.0598552135069905,0.49825160024765897,"FTO,FBXL5",GO_Molecular_Function_2023
231,Gamma-Tubulin Binding (GO:0043015),0.3213655307830429,2.7755937755937756,3.1507876577626246,0.49825160024765897,BLOC1S2,GO_Molecular_Function_2023
232,Histone Demethylase Activity (GO:0032452),0.3213655307830429,2.7755937755937756,3.1507876577626246,0.49825160024765897,JARID2,GO_Molecular_Function_2023
233,MAP Kinase Kinase Kinase Activity (GO:0004709),0.3213655307830429,2.7755937755937756,3.1507876577626246,0.49825160024765897,MAP3K1,GO_Molecular_Function_2023
234,Low-Density Lipoprotein Particle Binding (GO:0030169),0.3213655307830429,2.7755937755937756,3.1507876577626246,0.49825160024765897,PLTP,GO_Molecular_Function_2023
235,mRNA 3'-UTR AU-rich Region Binding (GO:0035925),0.3213655307830429,2.7755937755937756,3.1507876577626246,0.49825160024765897,EXOSC9,GO_Molecular_Function_2023
236,TBP-class Protein Binding (GO:0017025),0.3213655307830429,2.7755937755937756,3.1507876577626246,0.49825160024765897,GTF2A1,GO_Molecular_Function_2023
237,Nucleoside Monophosphate Kinase Activity (GO:0050145),0.3213655307830429,2.7755937755937756,3.1507876577626246,0.49825160024765897,AK9,GO_Molecular_Function_2023
238,"Oxidoreductase Activity, Acting On NAD(P)H, Quinone Or Similar Compound As Acceptor (GO:0016655)",0.3213655307830429,2.7755937755937756,3.1507876577626246,0.49825160024765897,TP53I3,GO_Molecular_Function_2023
239,Phosphatidylinositol Bisphosphate Binding (GO:1902936),0.3325104198689481,1.503194492595711,1.6551435270836612,0.5133738281658654,"LAPTM4B,WIPI2,MAPT",GO_Molecular_Function_2023
240,Voltage-Gated Monoatomic Ion Channel Activity (GO:0005244),0.3429525358102901,2.544044044044044,2.7225423684214074,0.5186454332540863,SLC17A3,GO_Molecular_Function_2023
241,Phosphatidic Acid Binding (GO:0070300),0.3429525358102901,2.544044044044044,2.7225423684214074,0.5186454332540863,PLTP,GO_Molecular_Function_2023
242,poly(A) Binding (GO:0008143),0.3429525358102901,2.544044044044044,2.7225423684214074,0.5186454332540863,PABPC4,GO_Molecular_Function_2023
243,poly(U) RNA Binding (GO:0008266),0.3429525358102901,2.544044044044044,2.7225423684214074,0.5186454332540863,PABPC4,GO_Molecular_Function_2023
244,Ephrin Receptor Activity (GO:0005003),0.3429525358102901,2.544044044044044,2.7225423684214074,0.5186454332540863,EPHB4,GO_Molecular_Function_2023
245,Protein Heterodimerization Activity (GO:0046982),0.3464246013881534,1.3068609877120516,1.3853903750790189,0.5217578690295045,"GTF2A1,MEF2C,EPAS1,GADD45A,FBXO7",GO_Molecular_Function_2023
246,"3',5'-Cyclic-Nucleotide Phosphodiesterase Activity (GO:0004114)",0.36385485898912845,2.348117348117348,2.373947178787745,0.5224219570699937,PDE7A,GO_Molecular_Function_2023
247,Transmembrane Receptor Protein Phosphatase Activity (GO:0019198),0.36385485898912845,2.348117348117348,2.373947178787745,0.5224219570699937,PTPRC,GO_Molecular_Function_2023
248,Transmembrane Receptor Protein Tyrosine Phosphatase Activity (GO:0005001),0.36385485898912845,2.348117348117348,2.373947178787745,0.5224219570699937,PTPRC,GO_Molecular_Function_2023
249,DNA Polymerase Activity (GO:0034061),0.36385485898912845,2.348117348117348,2.373947178787745,0.5224219570699937,TERT,GO_Molecular_Function_2023
250,Zinc Ion Transmembrane Transporter Activity (GO:0005385),0.36385485898912845,2.348117348117348,2.373947178787745,0.5224219570699937,SLC39A13,GO_Molecular_Function_2023
251,methyl-CpG Binding (GO:0008327),0.36385485898912845,2.348117348117348,2.373947178787745,0.5224219570699937,ZBTB38,GO_Molecular_Function_2023
252,Phosphatidylcholine Transporter Activity (GO:0008525),0.36385485898912845,2.348117348117348,2.373947178787745,0.5224219570699937,PLTP,GO_Molecular_Function_2023
253,Poly-Pyrimidine Tract Binding (GO:0008187),0.36385485898912845,2.348117348117348,2.373947178787745,0.5224219570699937,PABPC4,GO_Molecular_Function_2023
254,pre-mRNA Binding (GO:0036002),0.36385485898912845,2.348117348117348,2.373947178787745,0.5224219570699937,ERI1,GO_Molecular_Function_2023
255,Protein Tyrosine/Serine/Threonine Phosphatase Activity (GO:0008138),0.36385485898912845,2.348117348117348,2.373947178787745,0.5224219570699937,DUSP15,GO_Molecular_Function_2023
256,Ephrin Receptor Binding (GO:0046875),0.36385485898912845,2.348117348117348,2.373947178787745,0.5224219570699937,PTPN1,GO_Molecular_Function_2023
257,Fibroblast Growth Factor Receptor Binding (GO:0005104),0.36385485898912845,2.348117348117348,2.373947178787745,0.5224219570699937,FRS3,GO_Molecular_Function_2023
258,Tumor Necrosis Factor Receptor Superfamily Binding (GO:0032813),0.38409415344077596,2.18018018018018,2.0861437006994428,0.5451182408447937,TMBIM1,GO_Molecular_Function_2023
259,Receptor Antagonist Activity (GO:0048019),0.38409415344077596,2.18018018018018,2.0861437006994428,0.5451182408447937,IL1RN,GO_Molecular_Function_2023
260,Fibroblast Growth Factor Binding (GO:0017134),0.38409415344077596,2.18018018018018,2.0861437006994428,0.5451182408447937,CEP57,GO_Molecular_Function_2023
261,L-amino Acid Transmembrane Transporter Activity (GO:0015179),0.38744450052350976,1.5268072289156627,1.4476921471045792,0.5477663628091,"SLC25A15,SLC7A6",GO_Molecular_Function_2023
262,CCR Chemokine Receptor Binding (GO:0048020),0.4036913894708047,2.0346346346346347,1.8456263964772202,0.564250464828511,CNIH4,GO_Molecular_Function_2023
263,R-SMAD Binding (GO:0070412),0.4036913894708047,2.0346346346346347,1.8456263964772202,0.564250464828511,PPARG,GO_Molecular_Function_2023
264,Poly-Purine Tract Binding (GO:0070717),0.4036913894708047,2.0346346346346347,1.8456263964772202,0.564250464828511,PABPC4,GO_Molecular_Function_2023
265,GTPase Activator Activity (GO:0005096),0.40981658706778007,1.2027618888064524,1.0729184122561113,0.5706502665207956,"ARHGAP21,NPRL3,AGAP1,MYO9B,ARHGAP27",GO_Molecular_Function_2023
266,GTPase Activity (GO:0003924),0.4161318134282889,1.1932465805471124,1.0461827694672174,0.5712969862089259,"HBS1L,AGAP1,GPN1,RAB8A,RHOA",GO_Molecular_Function_2023
267,Phosphatidylinositol Binding (GO:0035091),0.41928118129141106,1.2902004170035317,1.1214596292787138,0.5712969862089259,"NLRP3,SNX13,MAPT",GO_Molecular_Function_2023
268,General Transcription Initiation Factor Binding (GO:0140296),0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5712969862089259,GTF2A1,GO_Molecular_Function_2023
269,Ubiquitin Conjugating Enzyme Activity (GO:0061631),0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5712969862089259,UBE2L3,GO_Molecular_Function_2023
270,Lipid Kinase Activity (GO:0001727),0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5712969862089259,PIK3CA,GO_Molecular_Function_2023
271,Mitogen-Activated Protein Kinase Binding (GO:0051019),0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5712969862089259,DUSP1,GO_Molecular_Function_2023
272,Actinin Binding (GO:0042805),0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5712969862089259,PPARG,GO_Molecular_Function_2023
273,Adenyl Nucleotide Binding (GO:0030554),0.4226668759757094,1.9072822822822824,1.6424960710005596,0.5712969862089259,ALDH2,GO_Molecular_Function_2023
274,Ribonucleoside Triphosphate Phosphatase Activity (GO:0017111),0.42872909706284934,1.1746551321019405,0.9948507120226207,0.5750666567516614,"HBS1L,AGAP1,GPN1,RAB8A,RHOA",GO_Molecular_Function_2023
275,Magnesium Ion Binding (GO:0000287),0.4291693941019897,1.2093609360936093,1.023002745285343,0.5750666567516614,"HMGCL,TDP2,FIGNL1,MAST2",GO_Molecular_Function_2023
276,Histone Deacetylase Binding (GO:0042826),0.4320753805020225,1.387458926615553,1.1642933925595615,0.5750666567516614,"MEF2C,TFAP4",GO_Molecular_Function_2023
277,Phospholipase Activity (GO:0004620),0.4320753805020225,1.387458926615553,1.1642933925595615,0.5750666567516614,"SMPD2,PLD1",GO_Molecular_Function_2023
278,FAD Binding (GO:0071949),0.4410402814653663,1.7949125596184419,1.4693496440315028,0.5750666567516614,MICAL1,GO_Molecular_Function_2023
279,Inorganic Cation Transmembrane Transporter Activity (GO:0022890),0.4410402814653663,1.7949125596184419,1.4693496440315028,0.5750666567516614,SLC12A7,GO_Molecular_Function_2023
280,Kinesin Binding (GO:0019894),0.4410402814653663,1.7949125596184419,1.4693496440315028,0.5750666567516614,PRC1,GO_Molecular_Function_2023
281,NF-kappaB Binding (GO:0051059),0.4410402814653663,1.7949125596184419,1.4693496440315028,0.5750666567516614,COMMD6,GO_Molecular_Function_2023
282,Basal RNA Polymerase II Transcription Machinery Binding (GO:0001099),0.4410402814653663,1.7949125596184419,1.4693496440315028,0.5750666567516614,GTF2A1,GO_Molecular_Function_2023
283,Phosphatidylinositol-4-Phosphate Binding (GO:0070273),0.4410402814653663,1.7949125596184419,1.4693496440315028,0.5750666567516614,NLRP3,GO_Molecular_Function_2023
284,Ubiquitin Binding (GO:0043130),0.4537361503852823,1.3268727082242011,1.048547114631643,0.5773003762863798,"UBXN2A,FBXO7",GO_Molecular_Function_2023
285,Microtubule Binding (GO:0008017),0.45375122162860704,1.1391371410425077,0.9001532327690693,0.5773003762863798,"CEP57,MACF1,PRC1,MAST2,MAPT",GO_Molecular_Function_2023
286,Ubiquitin Conjugating Enzyme Binding (GO:0031624),0.4588306540708931,1.6950283616950284,1.320552665492241,0.5773003762863798,ARIH2,GO_Molecular_Function_2023
287,Ubiquitin-Like Protein Conjugating Enzyme Activity (GO:0061650),0.4588306540708931,1.6950283616950284,1.320552665492241,0.5773003762863798,UBE2L3,GO_Molecular_Function_2023
288,Hsp90 Protein Binding (GO:0051879),0.4588306540708931,1.6950283616950284,1.320552665492241,0.5773003762863798,MAPT,GO_Molecular_Function_2023
289,NAD+ ADP-ribosyltransferase Activity (GO:0003950),0.4588306540708931,1.6950283616950284,1.320552665492241,0.5773003762863798,SIRT3,GO_Molecular_Function_2023
290,Monoatomic Ion Channel Activity (GO:0005216),0.4588306540708931,1.6950283616950284,1.320552665492241,0.5773003762863798,TRPC1,GO_Molecular_Function_2023
291,Alpha-Actinin Binding (GO:0051393),0.4588306540708931,1.6950283616950284,1.320552665492241,0.5773003762863798,PPARG,GO_Molecular_Function_2023
292,"Phosphatidylinositol-3,5-Bisphosphate Binding (GO:0080025)",0.4588306540708931,1.6950283616950284,1.320552665492241,0.5773003762863798,WIPI2,GO_Molecular_Function_2023
293,Beta-Tubulin Binding (GO:0048487),0.4588306540708931,1.6950283616950284,1.320552665492241,0.5773003762863798,PDCD5,GO_Molecular_Function_2023
294,Guanyl-Nucleotide Exchange Factor Activity (GO:0005085),0.45996290143142454,1.1305865135652369,0.8780241612216876,0.5773003762863798,"DNMBP,DENND4A,ITSN1,DOCK7,LAMTOR4",GO_Molecular_Function_2023
295,Transition Metal Ion Transmembrane Transporter Activity (GO:0046915),0.47605644095165617,1.605658289868816,1.191749862810084,0.5816716116263613,SLC39A13,GO_Molecular_Function_2023
296,Kinase Inhibitor Activity (GO:0019210),0.47605644095165617,1.605658289868816,1.191749862810084,0.5816716116263613,TRIB1,GO_Molecular_Function_2023
297,NADP Binding (GO:0050661),0.47605644095165617,1.605658289868816,1.191749862810084,0.5816716116263613,TP53I3,GO_Molecular_Function_2023
298,Monoatomic Cation Transmembrane Transporter Activity (GO:0008324),0.47605644095165617,1.605658289868816,1.191749862810084,0.5816716116263613,TRPC1,GO_Molecular_Function_2023
299,SH2 Domain Binding (GO:0042169),0.47605644095165617,1.605658289868816,1.191749862810084,0.5816716116263613,JAK2,GO_Molecular_Function_2023
300,"Oxidoreductase Activity, Acting On Paired Donors, With Incorporation Or Reduction Of Molecular Oxygen, NAD(P)H As One Donor, And Incorporation Of One Atom Of Oxygen (GO:0016709)",0.47605644095165617,1.605658289868816,1.191749862810084,0.5816716116263613,MICAL1,GO_Molecular_Function_2023
301,Protein Serine/Threonine Kinase Inhibitor Activity (GO:0030291),0.47605644095165617,1.605658289868816,1.191749862810084,0.5816716116263613,SPRED2,GO_Molecular_Function_2023
302,Ferrous Iron Binding (GO:0008198),0.47605644095165617,1.605658289868816,1.191749862810084,0.5816716116263613,FTO,GO_Molecular_Function_2023
303,Ubiquitin-Like Protein Ligase Activity (GO:0061659),0.47814123173956247,1.0899390243902438,0.8042105568025735,0.5822908069699622,"C18ORF25,TRIM4,ZMIZ2,NSMCE2,ARIH2,TRIM38",GO_Molecular_Function_2023
304,Heme Binding (GO:0020037),0.4853210560706859,1.2452667814113598,0.9002589397254492,0.5880536774498327,"HBZ,JAK2",GO_Molecular_Function_2023
305,RNA Endonuclease Activity (GO:0004521),0.4927355073907322,1.5252252252252252,1.0795280967596923,0.5880536774498327,RCL1,GO_Molecular_Function_2023
306,Nuclear Thyroid Hormone Receptor Binding (GO:0046966),0.4927355073907322,1.5252252252252252,1.0795280967596923,0.5880536774498327,TRIP6,GO_Molecular_Function_2023
307,Potassium Ion Transmembrane Transporter Activity (GO:0015079),0.4927355073907322,1.5252252252252252,1.0795280967596923,0.5880536774498327,SLC12A7,GO_Molecular_Function_2023
308,"Catalytic Activity, Acting On A tRNA (GO:0140101)",0.4927355073907322,1.5252252252252252,1.0795280967596923,0.5880536774498327,FTO,GO_Molecular_Function_2023
309,Epidermal Growth Factor Receptor Binding (GO:0005154),0.4927355073907322,1.5252252252252252,1.0795280967596923,0.5880536774498327,TNK2,GO_Molecular_Function_2023
310,Cytokine Activity (GO:0005125),0.4940288347139516,1.1440332326283988,0.8067280686808431,0.5880536774498327,"KITLG,IL37,BMP8A",GO_Molecular_Function_2023
311,Protein Tyrosine Kinase Binding (GO:1990782),0.5057390240908062,1.1961965509095205,0.8154884640102932,0.6000569128279983,"PTPN1,SH2B3",GO_Molecular_Function_2023
312,Core Promoter Sequence-Specific DNA Binding (GO:0001046),0.5088851549511907,1.4524524524524525,0.981179441528542,0.6018545582595813,GTF2A1,GO_Molecular_Function_2023
313,Ubiquitin Ligase-Substrate Adaptor Activity (GO:1990756),0.5245221393688277,1.3862953862953864,0.8945315544894749,0.6124957893262577,FBXO7,GO_Molecular_Function_2023
314,Ubiquitin-Like Protein Conjugating Enzyme Binding (GO:0044390),0.5245221393688277,1.3862953862953864,0.8945315544894749,0.6124957893262577,ARIH2,GO_Molecular_Function_2023
315,Endonuclease Activity (GO:0004519),0.5245221393688277,1.3862953862953864,0.8945315544894749,0.6124957893262577,RCL1,GO_Molecular_Function_2023
316,Single-Stranded RNA Binding (GO:0003727),0.5245221393688277,1.3862953862953864,0.8945315544894749,0.6124957893262577,LONP1,GO_Molecular_Function_2023
317,Tubulin Binding (GO:0015631),0.5274133761891774,1.0335882596114097,0.6612594253164531,0.6139291350593264,"CEP57,PRC1,BLOC1S2,MAST2,PDCD5,MAPT",GO_Molecular_Function_2023
318,tRNA Binding (GO:0000049),0.5396626874821041,1.3258911084998042,0.8178242038340053,0.6242493156140954,TERT,GO_Molecular_Function_2023
319,Amino Acid Binding (GO:0016597),0.5396626874821041,1.3258911084998042,0.8178242038340053,0.6242493156140954,SLC7A6,GO_Molecular_Function_2023
320,"Oxidoreductase Activity, Acting On The CH-OH Group Of Donors, NAD Or NADP As Acceptor (GO:0016616)",0.5449649876065206,1.108762322015334,0.6730561272473623,0.6284127513337691,"HADHA,HSD17B13",GO_Molecular_Function_2023
321,Cysteine-Type Endopeptidase Activity (GO:0004197),0.5729319111160833,1.0511009555463233,0.585451037466751,0.6586039725913855,"USP49,CTSB",GO_Molecular_Function_2023
322,Tau Protein Binding (GO:0048156),0.5822603977582713,1.1725571725571726,0.634162904451109,0.6672487166857209,APOE,GO_Molecular_Function_2023
323,Hydro-Lyase Activity (GO:0016836),0.6084518660465291,1.0885885885885886,0.5408516027490681,0.6951044537807098,HADHA,GO_Molecular_Function_2023
324,Kinase Activity (GO:0016301),0.6167232800625455,0.9672021419009371,0.4674825005165326,0.7014827562926625,"PIK3CA,TRRAP",GO_Molecular_Function_2023
325,Transition Metal Ion Binding (GO:0046914),0.6178371159759223,0.9398109766207926,0.4525475767797221,0.7014827562926625,"HMGCL,PTPN1,GALNT2,TDP2,ARIH2,PPARG,FBXL5,SIRT3",GO_Molecular_Function_2023
326,Monoatomic Anion Channel Activity (GO:0005253),0.6330057811196118,1.015815815815816,0.46450791261694185,0.7131452375948986,SLC17A3,GO_Molecular_Function_2023
327,Channel Activity (GO:0015267),0.6330057811196118,1.015815815815816,0.46450791261694185,0.7131452375948986,SLC12A7,GO_Molecular_Function_2023
328,GTP Binding (GO:0005525),0.6339068778621321,0.9227318502242974,0.420630281131896,0.7131452375948986,"MFHAS1,RAB8A,RHOA",GO_Molecular_Function_2023
329,Serine-Type Endopeptidase Inhibitor Activity (GO:0004867),0.6669878284427431,0.9231959231959231,0.3738790990315251,0.746345781229487,SERPING1,GO_Molecular_Function_2023
330,Endopeptidase Activity (GO:0004175),0.6674637067905982,0.8841097052378596,0.35741926220439607,0.746345781229487,"PSMB5,USP49,TMPRSS6,PCSK7,CTSB",GO_Molecular_Function_2023
331,Protein Serine/Threonine Phosphatase Activity (GO:0004722),0.6776029857475239,0.8959547783077195,0.34869998145102127,0.755218771106748,DUSP1,GO_Molecular_Function_2023
332,Cysteine-Type Peptidase Activity (GO:0008234),0.6794922276624399,0.8575428474461225,0.3313626889966528,0.755218771106748,"USP49,CTSB",GO_Molecular_Function_2023
333,Carboxylic Acid Transmembrane Transporter Activity (GO:0046943),0.6878807513214057,0.8702702702702703,0.3256027297563665,0.7599640635856248,SLC7A6,GO_Molecular_Function_2023
334,Protein Phosphatase Regulator Activity (GO:0019888),0.6878807513214057,0.8702702702702703,0.3256027297563665,0.7599640635856248,PPP2R2A,GO_Molecular_Function_2023
335,Protein Serine/Threonine Kinase Activity (GO:0004674),0.6964930567442468,0.8599286700414174,0.31103401108523127,0.7651023555692846,"MAP2K2,MAP3K1,MAST3,MAST2,VRK2,ATR",GO_Molecular_Function_2023
336,Metal Ion Binding (GO:0046872),0.6966785676728445,0.8756804733727811,0.316498191813548,0.7651023555692846,"SCGN,HMGCL,CDH1,TDP2,FIGNL1,MAST2,ITSN1,APOE,THBS3",GO_Molecular_Function_2023
337,Chromatin DNA Binding (GO:0031490),0.707466539473974,0.823066309552796,0.2848343968281003,0.7746443711154195,TOX2,GO_Molecular_Function_2023
338,Nuclear Receptor Binding (GO:0016922),0.7143044572440648,0.8007292327203551,0.2694021448885474,0.779817587938047,"ASXL1,TRIP6",GO_Molecular_Function_2023
339,Protein Phosphatase Binding (GO:0019903),0.7208748419032562,0.7902519167579408,0.25864134939531713,0.7846690757000045,"MFHAS1,MAPT",GO_Molecular_Function_2023
340,GDP Binding (GO:0019003),0.7258267414612338,0.7807037807037807,0.2501717960575722,0.7854254181794582,RAB8A,GO_Molecular_Function_2023
341,Amino Acid Transmembrane Transporter Activity (GO:0015171),0.7258267414612338,0.7807037807037807,0.2501717960575722,0.7854254181794582,SLC7A6,GO_Molecular_Function_2023
342,Cysteine-Type Deubiquitinase Activity (GO:0004843),0.734571335722901,0.7611111111111111,0.23477854903083212,0.7902531279351325,USP49,GO_Molecular_Function_2023
343,Secondary Active Transmembrane Transporter Activity (GO:0015291),0.734571335722901,0.7611111111111111,0.23477854903083212,0.7902531279351325,SLC25A15,GO_Molecular_Function_2023
344,Guanyl Ribonucleotide Binding (GO:0032561),0.7395072940711898,0.7793787280192114,0.2351940020729255,0.7932505567217122,"MFHAS1,RAB8A,RHOA",GO_Molecular_Function_2023
345,Small GTPase Binding (GO:0031267),0.7496068648798186,0.7661275990758841,0.22080286964156576,0.8017534293931974,"DOCK7,MYO9B,RAB8A",GO_Molecular_Function_2023
346,Calcium Ion Transmembrane Transporter Activity (GO:0015085),0.7742950875876043,0.6762095428762095,0.17297590761971335,0.8257655702885145,TRPC1,GO_Molecular_Function_2023
347,Ubiquitin Protein Ligase Activity (GO:0061630),0.7782305002319155,0.749420127197905,0.1879040014467823,0.8275707624944577,"C18ORF25,TRIM4,ARIH2,TRIM38",GO_Molecular_Function_2023
348,Phosphatase Activity (GO:0016791),0.7814979285728179,0.6614440527484006,0.16307425538242756,0.8286572863315224,DUSP15,GO_Molecular_Function_2023
349,Cadherin Binding (GO:0045296),0.7850700207005499,0.7582066869300912,0.1834726486519622,0.8300597067005815,"MACF1,HSPA8,PTPN1,LARP1,CDH1",GO_Molecular_Function_2023
350,Deubiquitinase Activity (GO:0101005),0.7952232900338203,0.6337587587587588,0.1452146247260491,0.8357330110365346,USP49,GO_Molecular_Function_2023
351,GTPase Binding (GO:0051020),0.795476183653916,0.7060352701468419,0.16155101588312337,0.8357330110365346,"DOCK7,MYO9B,RAB8A",GO_Molecular_Function_2023
352,PDZ Domain Binding (GO:0030165),0.8017601244090331,0.6207636207636208,0.1371551226226436,0.8357330110365346,MAP2K2,GO_Molecular_Function_2023
353,Olfactory Receptor Activity (GO:0004984),0.8017601244090331,0.6207636207636208,0.1371551226226436,0.8357330110365346,OR13A1,GO_Molecular_Function_2023
354,"Phosphotransferase Activity, Alcohol Group As Acceptor (GO:0016773)",0.8017601244090331,0.6207636207636208,0.1371551226226436,0.8357330110365346,HK1,GO_Molecular_Function_2023
355,Amyloid-Beta Binding (GO:0001540),0.8080888943318133,0.6082882882882883,0.12961602032881586,0.8399571887561664,APOE,GO_Molecular_Function_2023
356,Carboxylic Ester Hydrolase Activity (GO:0052689),0.856708466255799,0.5150404641930065,0.0796549208880451,0.8877515163071095,ALDH2,GO_Molecular_Function_2023
357,Metalloendopeptidase Activity (GO:0004222),0.861287378964621,0.5064064064064064,0.0756201781962719,0.8877515163071095,TMPRSS6,GO_Molecular_Function_2023
358,Serine-Type Endopeptidase Activity (GO:0004252),0.861287378964621,0.5064064064064064,0.0756201781962719,0.8877515163071095,PCSK7,GO_Molecular_Function_2023
359,Calcium Channel Activity (GO:0005262),0.870012144883489,0.4899738448125545,0.06822793075906583,0.8917624485055762,TRPC1,GO_Molecular_Function_2023
360,Protein Kinase Activator Activity (GO:0030295),0.870012144883489,0.4899738448125545,0.06822793075906583,0.8917624485055762,MAP2K2,GO_Molecular_Function_2023
361,Monoatomic Cation Channel Activity (GO:0005261),0.8895041675513641,0.45318452781139346,0.053063868797664594,0.9081172472614109,TRPC1,GO_Molecular_Function_2023
362,Zinc Ion Binding (GO:0008270),0.8908900908092974,0.6078270138571646,0.07022481628902258,0.9081172472614109,"PTPN1,ARIH2,PPARG,SIRT3",GO_Molecular_Function_2023
363,Serine-Type Peptidase Activity (GO:0008236),0.8997705381698449,0.4336336336336336,0.045798435528203923,0.9122946678261034,PCSK7,GO_Molecular_Function_2023
364,Receptor Ligand Activity (GO:0048018),0.899932951459896,0.560367013539219,0.05908230549275985,0.9122946678261034,"KITLG,IL37,BMP8A",GO_Molecular_Function_2023
365,G Protein-Coupled Receptor Binding (GO:0001664),0.9090856112988658,0.41568966226500476,0.03962187892145899,0.9166928139569362,HSPA8,GO_Molecular_Function_2023
366,Calcium Ion Binding (GO:0005509),0.9092400268515954,0.581002331002331,0.055280142906635535,0.9166928139569362,"SCGN,CDH1,ITSN1,THBS3",GO_Molecular_Function_2023
367,Endopeptidase Inhibitor Activity (GO:0004866),0.9175372951671965,0.3991623202149518,0.03435272803783502,0.9201766713623399,SERPING1,GO_Molecular_Function_2023
368,Metallopeptidase Activity (GO:0008237),0.9201766713623399,0.3939393939393939,0.03277165796104778,0.9201766713623399,TMPRSS6,GO_Molecular_Function_2023
369,Phosphatase Binding (GO:0019902),0.9201766713623399,0.3939393939393939,0.03277165796104778,0.9201766713623399,MAST2,GO_Molecular_Function_2023
1,Mean Corpuscular Hemoglobin,1.637611406446941e-66,11.673931623931624,1768.3365465376385,3.9073408157824014e-63,"IL1RN,TFRC,TRRAP,MPG,ZAN,HFE,PDCD5,ITSN1,UBE2L3,CCND3,CDH1,MYB,LONP1,LEPR,SLC12A7,FBXO7,IL6R,EPHB4,PLS1,MEF2C,ZBTB38,ATP11B,ATP11A,FRS3,SNRNP25,FTO,UNC119B,GCDH,GYPA,RTEL1,MAX,NPRL3,GMPR,PLD1,AK9,SPTA1,LARP1,BCL2L11,TERT,ERI1,PRDM16,NLRP3,NPHP3,APOE,NKX2-3,MPST,RTEL1-TNFRSF6B,HSPA8,NDFIP1,BCL11A,DENND4A,RCL1,AHI1,TF,PTPRC,RSRP1,TMCC2,ANP32B,CNIH4,ATR,CPEB4,CEP57,HBS1L,THRB,MAST2,DOCK7,ADAR,HK1,SPRED2,ACOXL,DSTYK,SLC22A16,ALDH2,JAK2,RAB8A,UBXN6,BRD3,HBZ,KLF13,USP49,PABPC4,NCOA4,TFEB,TMC8,TMC6,WIPI2,SIRT3,GIGYF1,ELF1,TOX2,TST,PIK3CA,KIT,TMPRSS6,TYMP,HDAC7,PSMB5,C18ORF25,SERTAD2,EXOSC9,BEND3,HEATR3,SH2B3,SLC17A3,NOP58,RRM1,SMOX,SUSD1,KLF3,MYO1D,FIG4,RP1L1,SLC25A37,KANSL1,AXL,IL2RB,ZNF217,CRLF3",GWAS_Catalog_2023
2,Mean Corpuscular Volume,2.405743094168599e-52,9.755721634667804,1159.5315723582044,2.870051511343139e-49,"TFRC,UBXN2A,TRRAP,MPG,HFE,PDCD5,ITSN1,UBE2L3,FADS2,CCND3,CDH1,LONP1,LEPR,SLC12A7,FBXO7,IL6R,EPHB4,PLS1,MEF2C,ZBTB38,ATP11A,SNRNP25,KCTD17,MACF1,UNC119B,GCDH,GYPA,RTEL1,MAX,NPRL3,GMPR,PLD1,SPTA1,LARP1,TERT,ERI1,PRDM16,NPHP3,NKX2-3,AP1M2,RTEL1-TNFRSF6B,BCL11A,GADD45A,DENND4A,RCL1,MSRA,TF,PTPRC,RSRP1,TMCC2,ANP32B,ATR,CPEB4,CEP57,HBS1L,THRB,MAST2,HK1,SPRED2,ACOXL,ALDH2,JAK2,RAB8A,UBXN6,BRD3,HBZ,KLF13,USP49,PABPC4,NCOA4,TMC8,TMC6,WIPI2,SIRT3,ELF1,TOX2,PIK3CA,PPARG,TMPRSS6,TYMP,HDAC7,PSMB5,C18ORF25,SERTAD2,EXOSC9,BEND3,HEATR3,RRM1,SMOX,SUSD1,BMP8A,MYO9B,FIG4,SLC25A37,FAM167A,KITLG,KANSL1,DNAJA4,AXL,ZNF217,CRLF3",GWAS_Catalog_2023
3,Red Cell Distribution Width,3.119759014638206e-46,9.226306351131429,966.7430683115562,2.48124833630892e-43,"CEP57,HBS1L,IL1RN,THRB,CD82,TFRC,MAST3,UBXN2A,HFE,PDCD5,ARPC1A,ITSN1,UBE2L3,HK1,FADS2,CCND3,ACOXL,SLC22A16,CDH1,LONP1,ARFIP1,SLC12A7,FBXO7,IL6R,RAB8A,BRD3,KLF13,PABPC4,NCOA4,NSMCE2,TMC8,ATP11B,ATP11A,TMC6,TOX2,TMBIM1,PPARG,RBM23,FTO,KANK2,UNC119B,GCDH,GYPA,TMPRSS6,LPL,GMPR,PLD1,TYMP,AK9,SPTA1,HELZ2,PSMB5,C18ORF25,SERTAD2,ERI1,SEC14L4,HEATR3,NLRP3,APOE,APOB,AP1M2,MPST,HSPA8,GCKR,RRM1,BCL11A,SMOX,GALNT2,SUSD1,BMP8A,MYO9B,KLF3,ASXL1,MYO1D,FIG4,RCL1,RP1L1,SLC25A37,AHI1,TF,KANSL1,DNAJA4,PRC1,IL2RB,RSRP1,ZNF217,TMCC2,BUD13,ZNF211,ATR,CPEB4",GWAS_Catalog_2023
4,Mean Spheric Corpuscular Volume,1.4767105533995928e-39,9.568498168498168,855.5290051649978,8.80857845102857e-37,"HBS1L,THRB,TFRC,UBXN2A,TRRAP,CITED2,MAST2,HFE,PDCD5,ITSN1,UBE2L3,HK1,SPRED2,FADS2,CCND3,ACOXL,LONP1,LEPR,JAK2,SLC12A7,FBXO7,HBZ,MEF2C,USP49,ZBTB38,TMC8,ATP11A,TMC6,SIRT3,ELF1,TOX2,PIK3CA,XRN1,MAPT,KCTD17,KANK2,UNC119B,GCDH,GYPA,RTEL1,TMPRSS6,MAX,NPRL3,LPL,GMPR,TYMP,SPTA1,PSMB5,C18ORF25,TERT,SERTAD2,SEC14L4,PRDM16,BEND3,APOE,NKX2-3,AP1M2,RTEL1-TNFRSF6B,NFE2,GCKR,RRM1,CHURC1,BCL11A,SMOX,GALNT2,MYO9B,RCL1,TF,PTPRC,DNAJA4,AXL,RSRP1,TMCC2,ATR",GWAS_Catalog_2023
5,Reticulocyte Fraction Of Red Cells,8.093569703361803e-30,9.524469589816125,638.0107193783849,3.862251462444252e-27,"HBS1L,THRB,CD82,TFRC,UBXN2A,HFE,SRP14,UBE2L3,HK1,CCND3,SLC22A16,CDH1,ARFIP1,SLC12A7,BRD3,KLF13,TMC8,ATP11A,TMC6,PIK3CA,TMBIM1,KANK2,TMPRSS6,MAX,NPRL3,LPL,GMPR,PLD1,SPTA1,PSMB5,C18ORF25,LARP1,BCL2L11,ZNF827,SERTAD2,SEC14L4,BEND3,APOE,SH2B3,RBM38,NFE2,GCKR,SMOX,DENND4A,SUSD1,MYO9B,KLF3,MYO1D,SLC25A37,KANSL1,DNAJA4,TMCC2,CNIH4,ATR",GWAS_Catalog_2023
6,Red Blood Cell Count,1.724650735640092e-29,5.636757932807776,373.32215737781075,6.858361092062099e-27,"HBS1L,THRB,UBXN2A,TRRAP,MAST2,ZAN,HFE,ITSN1,MRPL33,HK1,SPRED2,FADS2,CCND3,ACOXL,TRIM4,ZMIZ2,PSD4,MYB,LONP1,JAK2,SLC12A7,FBXO7,UBXN6,PLS1,BRD3,HBZ,MEF2C,KLF13,ABCC2,USP49,ZBTB38,NCOA4,TMC8,ATP11A,TMC6,WIPI2,TOX2,PIK3CA,PPARG,MAPT,MDFI,MACF1,UNC119B,GCDH,GYPA,NUP205,TMPRSS6,MAX,EPAS1,NPRL3,GMPR,TYMP,THBS3,SPTA1,C18ORF25,ZNF827,TERT,SERTAD2,EXOSC9,PRDM16,MLEC,APOE,SH2B3,GCKR,BCL11A,DENND4A,SUSD1,QKI,FIG4,RCL1,SLC25A37,AHI1,TF,PTPRC,KANSL1,AXL,TAF8,ZNF217,TMCC2,ANP32B,FBXL5,ATR,CPEB4",GWAS_Catalog_2023
7,Mean Corpuscular Hemoglobin Concentration,4.225971690243707e-28,11.912715517241379,750.871960728246,1.4404526361316406e-25,"MACF1,HBS1L,IL1RN,THRB,TFRC,TMPRSS6,MPG,MAX,HFE,ITSN1,NPRL3,GMPR,LPL,UBE2L3,THBS3,SPTA1,FADS2,CCND3,ACOXL,C18ORF25,PSMB5,BCL2L11,ALDH2,CDH1,NPHP3,ARFIP1,SLC12A7,RAB8A,NFE2,HBZ,GCKR,USP49,DENND4A,SMOX,GALNT2,PABPC4,SUSD1,MYO9B,ATP11B,WIPI2,SLC25A37,TF,RSRP1,TMCC2",GWAS_Catalog_2023
8,Mean Reticulocyte Volume,2.4463754247427423e-27,8.093841642228739,495.95168445889425,7.296314704295229e-25,"HBS1L,THRB,CD82,TFRC,TRRAP,CITED2,PDCD5,ITSN1,HK1,SPRED2,FADS2,CCND3,ACOXL,JAK2,SLC12A7,FBXO7,MEF2C,USP49,TMC6,SIRT3,ELF1,PIK3CA,MAPT,UNC119B,GYPA,MAX,NPRL3,LPL,TYMP,HDAC7,SPTA1,HELZ2,C18ORF25,BCL2L11,TERT,SERTAD2,PRDM16,HEATR3,APOE,AP1M2,RBM38,GCKR,RRM1,BCL11A,SMOX,MYO9B,RCL1,PTPRC,TFAP4,KANSL1,RSRP1,ZNF217,TMCC2,ZNF211,ATR",GWAS_Catalog_2023
9,Reticulocyte Count,1.1285651468442147e-26,8.194330914233321,489.58066936030815,2.9919516004114402e-24,"HBS1L,THRB,CD82,TFRC,UBXN2A,MAST2,HFE,SRP14,UBE2L3,HK1,CCND3,SLC22A16,CDH1,BRD3,KLF13,USP49,TMC8,ATP11A,TMC6,TMBIM1,KANK2,TMPRSS6,MAX,NPRL3,LPL,GMPR,PROCA1,SPTA1,PSMB5,C18ORF25,LARP1,BCL2L11,SERTAD2,SEC14L4,BEND3,APOE,SH2B3,RBM38,NFE2,GCKR,SMOX,DENND4A,SUSD1,MYO9B,KLF3,MYO1D,SLC25A37,KANSL1,DNAJA4,ZNF217,TMCC2,CNIH4,ATR",GWAS_Catalog_2023
10,High Light Scatter Reticulocyte Percentage Of Red Cells,1.2202924172725232e-24,7.658240463894174,421.68532488942367,2.9116177076122403e-22,"HBS1L,THRB,CD82,TFRC,UBXN2A,HFE,UBE2L3,HK1,CCND3,ACOXL,SLC22A16,CDH1,ARFIP1,SLC12A7,KLF13,TMC8,ATP11B,ATP11A,TMC6,TMBIM1,KANK2,GCDH,TMPRSS6,MAX,NPRL3,LPL,GMPR,SPTA1,PSMB5,C18ORF25,LARP1,BCL2L11,SEC14L4,APOE,SH2B3,RBM38,GCKR,BCL11A,SMOX,DENND4A,MYO9B,U2SURP,MYO1D,RCL1,KANSL1,DNAJA4,RSRP1,ZNF217,TMCC2,CNIH4,ATR",GWAS_Catalog_2023
11,High Light Scatter Reticulocyte Count,1.1574120744288205e-20,6.611767372029121,303.5165883717978,2.5105320087156053e-18,"KANK2,HBS1L,GCDH,THRB,CD82,TFRC,UBXN2A,TMPRSS6,MAX,HFE,NPRL3,LPL,GMPR,UBE2L3,HK1,SPTA1,CCND3,PSMB5,C18ORF25,BCL2L11,SLC22A16,CDH1,ARFIP1,APOE,SH2B3,RBM38,NFE2,GCKR,KLF13,BCL11A,SMOX,TMC8,ATP11B,MYO9B,ATP11A,TMC6,WIPI2,U2SURP,MYO1D,RCL1,KANSL1,DNAJA4,TMBIM1,ZNF217,TMCC2,MAPT,CNIH4",GWAS_Catalog_2023
12,Red Blood Cell Traits,1.7428262865228643e-20,52.64844649021864,2395.303922777159,3.465319599702962e-18,"GCDH,HBS1L,NUP205,THRB,TMPRSS6,MAX,DENND4A,HFE,NPRL3,UBE2L3,HK1,RCL1,ACOXL,CCND3,SLC17A1,FBXO7,SH2B3,SLC17A3",GWAS_Catalog_2023
13,Immature Fraction Of Reticulocytes,3.004460567206496e-18,8.043249186787007,324.51641951453416,5.514340702580539e-16,"KANK2,HBS1L,THRB,TFRC,TMPRSS6,UBXN2A,MAX,GMPR,SPPL3,HK1,SPTA1,ARHGAP21,HMGCL,C18ORF25,PSMB5,BCL2L11,SLC22A16,CDH1,PRDM16,APOE,SH2B3,BRD3,RBM38,GCKR,BCL11A,SMOX,TMC6,WIPI2,U2SURP,RCL1,MYO1D,TMCC2,DNASE2,ANP32B,MAPT",GWAS_Catalog_2023
14,Glycated Hemoglobin Levels,9.762677439330372e-16,6.952773455570041,240.30728221698507,1.663839169303019e-13,"FTO,MACF1,HBS1L,DHRS13,GYPA,TOMM40,TMPRSS6,HFE,NPRL3,ARPC1A,SEZ6,PLD1,HK1,SPTA1,FADS2,C18ORF25,CCND2,CDH1,APOE,GCKR,BCL11A,ZBTB38,TEX33,TMC8,MYO9B,TMC6,ATP11A,SIRT3,FIG4,SLC25A37,TMBIM1,RSRP1,PPARG",GWAS_Catalog_2023
15,Hemoglobin A1c Levels,1.9856114943376776e-15,6.516015325670498,220.58568596811563,3.1584460169931325e-13,"FTO,MACF1,HBS1L,TFRC,TMPRSS6,MAST2,ITSN1,PDCD5,PLD1,HK1,THBS3,SPTA1,FADS2,C18ORF25,PSMB5,CCND2,SLC22A16,CDH1,FIGNL1,SLC12A7,SH2B3,BCL11A,ZBTB38,TMC8,MYO9B,TMC6,ATP11A,RCL1,SLC25A37,ELF1,AXL,PRC1,DLG5,RSRP1",GWAS_Catalog_2023
16,Platelet Count,1.7791006318903535e-14,3.745902867652067,118.59559692952223,2.6530838173064897e-12,"HBS1L,CD82,UBXN2A,HFE,DOCK7,HK1,FADS2,CCND3,AKAP10,ALDH2,MYB,LEPR,JAK2,SLC12A7,IL6R,RAB8A,BRD3,MEF2C,NSMCE2,ATP11A,TMC6,SIRT3,ELF1,SERPING1,MAPT,TRABD,GYPA,TMPRSS6,MAX,AK3,HSD17B13,HDAC7,C18ORF25,BCL2L11,TERT,SERTAD2,PRDM16,NLRP3,APOE,APOB,SH2B3,NFE2,HSPA8,GCKR,NDFIP1,GALNT2,MYO9B,RCL1,SLC25A37,TFAP4,DNAJA4,PRC1,TAF8,RSRP1,ZNF217,TMCC2,BUD13",GWAS_Catalog_2023
17,Hemoglobin Levels,3.0075091090655785e-14,6.275481014146322,195.3875977927984,4.221127490723806e-12,"HBS1L,UBXN2A,TRRAP,TMPRSS6,MAX,EPAS1,MAST2,HFE,NPRL3,GMPR,THBS3,HK1,SPTA1,FADS2,AKAP10,TRIM4,PSD4,SH2B3,COL26A1,BTN3A1,DENND4A,GALNT2,ZBTB38,SUSD1,ARHGAP27,TMC6,SLC7A6,KANSL1,TAF8,PPARG,MAPT,KCTD17",GWAS_Catalog_2023
18,HDL Cholesterol,6.60618905787737e-13,5.511037527593819,154.56035002361708,8.756870606719669e-11,"FTO,MACF1,GTF2A1,THRB,TOMM40,DOCK7,SNX13,LPL,PCSK7,UBE2L3,FADS2,CCND3,ACOXL,BCL2L11,TERT,LEPR,APOE,APOB,JAK2,PLTP,KLF13,GALNT2,PABPC4,TEX35,DDB2,TF,AXL,KIT,PPARG,MAPT,CNIH4,SIDT2",GWAS_Catalog_2023
19,Apolipoprotein A1 Levels,1.2884183208671497e-12,5.03625,137.880466997192,1.6179821650468523e-10,"KANK2,MACF1,TAGLN,NUP205,TOMM40,HFE,DOCK7,SNX13,LPL,ADAR,PCSK7,UBE2L3,FADS2,CCND3,ACOXL,CDH1,LEPR,APOE,APOB,SH2B3,BRD3,GCKR,GALNT2,PABPC4,ZBTB38,NCOA4,TEX35,SLC39A13,DDB2,TF,PPARG,BUD13,TRIB1,CNIH4",GWAS_Catalog_2023
20,Plateletcrit,2.4999753885677155e-12,4.232279662653705,113.06425176290124,2.9824706385612847e-10,"TRABD,HBS1L,GYPA,RTEL1,UBXN2A,TMPRSS6,MAX,HK1,HDAC7,SCGN,FADS2,CCND3,ALDH2,TERT,SERTAD2,PRDM16,ARIH2,LEPR,NLRP3,APOE,APOB,JAK2,SLC12A7,SH2B3,RTEL1-TNFRSF6B,GCKR,MEF2C,NDFIP1,GALNT2,NSMCE2,MYO9B,TMC6,RCL1,SLC25A37,ELF1,PTPRC,KANSL1,DNAJA4,RSRP1,PPARG",GWAS_Catalog_2023
21,Triglyceride Levels,5.429083979915841e-12,3.6925355450236967,95.78160519282574,6.168473512418665e-10,"FTO,BLK,KANK2,MACF1,IL1RN,TAGLN,THRB,SLC4A1AP,TOMM40,PGAP3,TMPRSS6,DOCK7,SNX13,LPL,PPP2R2A,HSD17B13,PCSK7,UBE2L3,MRPL33,FADS2,CCND2,BEND3,STX4,APOE,APOB,PLTP,CTSB,GCKR,NOP58,KLF13,MAP3K1,GALNT2,PABPC4,TEX35,GPN1,DDB2,MSRA,XRN1,AXL,KIT,TMBIM1,PPARG,BUD13,TRIB1,SIDT2,CPEB4",GWAS_Catalog_2023
22,Eosinophil Percentage Of White Cells,7.2336187755141216e-12,4.8278011348602,123.84411461986049,7.845188362898497e-10,"TRABD,HBS1L,NUP205,MAST3,MAX,ICE2,SPPL3,UBE2L3,SPRED2,FADS2,ACOXL,BCL2L11,TERT,ERI1,MYB,LEPR,JAK2,BRD3,PTPN1,NDFIP1,NSMCE2,KLF3,ZFP90,RCL1,MSRA,ELF1,TOX2,RAD50,PTPRC,KANSL1,IL2RB,PPARG,BUD13",GWAS_Catalog_2023
23,Hemoglobin Concentration,9.162966852671633e-12,4.308869581596855,109.51358768428872,9.50558213498892e-10,"HBS1L,UBXN2A,TMPRSS6,MAX,MAST2,HFE,NPRL3,ITSN1,GMPR,THBS3,HK1,SPTA1,FADS2,C18ORF25,MICAL1,PSD4,ZKSCAN3,LEPR,SH2B3,GCKR,MEF2C,BCL11A,SMOX,DENND4A,GALNT2,ZBTB38,TNK2,SUSD1,TMC6,GPN1,QKI,SLC25A37,GIGYF1,DNAJA4,ZSCAN26,PPARG,MAPT",GWAS_Catalog_2023
24,Total Cholesterol Levels,1.6276559463003968e-11,3.507559594161077,87.1323230045861,1.6181612866136445e-09,"FTO,KANK2,HBS1L,IL1RN,TAGLN,THRB,SLC4A1AP,TOMM40,ZAN,HFE,WBP4,DOCK7,SNX13,PROCA1,PCSK7,UBE2L3,MRPL33,HK1,C12ORF43,SPTA1,SPRED2,FADS2,ACOXL,CCND2,SERTAD2,NPHP3,APOE,APOB,JAK2,SH2B3,EPHB4,AP1M2,CTSB,GCKR,TNK2,MYO9B,GIGYF1,ELF1,TF,XRN1,AXL,RSRP1,PPARG,BUD13,TRIB1,CNIH4,SIDT2",GWAS_Catalog_2023
25,HDL Cholesterol Levels,3.620543345407356e-11,4.178345144788098,100.4549880783566,3.455446568856781e-09,"FTO,MACF1,PGAP3,HFE,DOCK7,SNX13,LPL,PCSK7,UBE2L3,HK1,FADS2,CCND3,ACOXL,BCL2L11,ALDH2,TERT,LEPR,APOE,APOB,PLTP,SH2B3,BRD3,KLF13,GALNT2,PABPC4,ZFP91,TEX35,QKI,TF,KIT,PPARG,BUD13,MAPT,TRIB1,CNIH4,SIDT2",GWAS_Catalog_2023
26,Aspartate Aminotransferase Levels,6.746055596221247e-11,4.389802807844818,102.80689048006066,6.190803327916883e-09,"FTO,BLK,HBS1L,HFE,WBP4,SNX13,HSD17B13,SRP14,SPPL3,ACOXL,SAMM50,ZNF827,ALDH2,LEPR,NLRP3,NPHP3,SH2B3,BRD3,RTEL1-TNFRSF6B,GCKR,ABCC2,GALNT2,MFHAS1,MSRA,ELF1,PTPRC,DNMBP,AXL,DLG5,TMCC2,PPARG,BUD13,MAPT",GWAS_Catalog_2023
27,Serum Alkaline Phosphatase Levels,1.3629037249332045e-10,3.8753146608036197,88.03255238905871,1.2044030695150465e-08,"BLK,MACF1,SLC4A1AP,TOMM40,PGAP3,LPL,C12ORF43,FADS2,ZNF827,SERTAD2,ERI1,LEPR,NLRP3,NPHP3,APOE,APOB,SLC17A1,IL6R,CTSB,GCKR,TMEM50B,BMP8A,KLF3,U2SURP,RP1L1,MFHAS1,MSRA,FAM167A,ALDH5A1,TDP2,DLG5,TRIP6,TMBIM1,SERPING1,PPARG,MAPT,TRIB1",GWAS_Catalog_2023
28,High Density Lipoprotein Cholesterol Levels,1.4497852177842774e-10,3.4064516129032256,77.17123838294785,1.2354241177261735e-08,"FTO,KANK2,MACF1,HBS1L,TAGLN,THRB,TOMM40,PGAP3,DOCK7,SNX13,LPL,ADAR,PCSK7,UBE2L3,FADS2,CCND3,ACOXL,CCND2,ALDH2,TERT,CDH1,SEC14L4,LEPR,APOE,APOB,JAK2,SH2B3,GCKR,KLF13,GALNT2,PABPC4,TEX35,SLC39A13,DDB2,RP1L1,MFHAS1,ELF1,TF,KIT,PPARG,TRIB1,CNIH4,SIDT2,CPEB4",GWAS_Catalog_2023
29,Cholesteryl Esters To Total Lipids Ratio In Very Large VLDL,2.962559476929156e-10,14.17305833064776,310.95402756275837,2.4374713489492988e-08,"MACF1,GCKR,GALNT2,DOCK7,LPL,PCSK7,FADS2,MFHAS1,MSRA,PPARG,APOE,TRIB1,SH2B3",GWAS_Catalog_2023
30,C-reactive Protein Levels (MTAG),5.490641656946567e-10,4.345598509548207,92.66035312057427,4.3668903311581696e-08,"FTO,BLK,KANK2,MACF1,IL1RN,LEPROT,THRB,TOMM40,DOCK7,ADAR,SPPL3,MRPL33,C12ORF43,FADS2,ERI1,ZMIZ2,LEPR,NLRP3,IL6R,BRD3,GCKR,GALNT2,PABPC4,NSMCE2,TFEB,DDB2,MFHAS1,MSRA,FAM167A,TMCC2",GWAS_Catalog_2023
31,Triglycerides,6.522496268623877e-10,4.588498045784478,97.04945815324704,5.020218095785991e-08,"FTO,MACF1,TAGLN,THRB,TOMM40,DOCK7,SNX13,LPL,PCSK7,FADS2,ACOXL,DSTYK,CCND2,ALDH2,APOE,APOB,CTSB,GCKR,NOP58,SPRYD4,GALNT2,TEX35,KLF3,RP1L1,AXL,KIT,PPARG,BUD13",GWAS_Catalog_2023
32,Alanine Aminotransferase Levels,9.386844918914976e-10,4.364569011105235,90.72429574120761,6.999066242665979e-08,"FTO,BLK,TOMM40,MAST3,HFE,WBP4,HSD17B13,SRP14,C12ORF43,FADS2,SAMM50,CCND2,ZNF827,LEPR,NLRP3,APOE,APOB,JARID2,SH2B3,BRD3,KLF13,ABCC2,MAP3K1,KLF3,MSRA,ELF1,DNMBP,DLG5,PPARG",GWAS_Catalog_2023
33,Mean Platelet Volume,1.9630098243175344e-09,3.4775979491888585,69.72162026599857,1.4193155881277686e-07,"TRABD,MAX,DOCK7,PDCD5,SNX13,LPL,PROCA1,HDAC7,SPTA1,FADS2,AKAP10,C18ORF25,TERT,MICAL1,PRDM16,MYB,ARFIP1,JAK2,SLC12A7,IL6R,BRD3,NFE2,GCKR,MEF2C,GADD45A,GALNT2,ZBTB38,MYO9B,KLF3,U2SURP,SIRT3,DOK2,PTPRC,PRC1,SERPING1,ZNF217,TMCC2",GWAS_Catalog_2023
34,Hemoglobin,2.051929886245937e-09,3.778381006401426,75.584566464268,1.4399719731125897e-07,"HBS1L,TMPRSS6,MAX,EPAS1,SPO11,MAST2,HFE,NPRL3,GMPR,UBE2L3,THBS3,MRPL33,HK1,SPTA1,FADS2,C18ORF25,ZMIZ2,PSD4,PRDM16,LEPR,SH2B3,HBZ,MEF2C,SMOX,DENND4A,GALNT2,ZBTB38,SUSD1,PILRB,TMC6,QKI,SLC25A37,PPARG",GWAS_Catalog_2023
35,Lymphocyte Percentage Of White Cells,4.113241445786349e-09,4.180608023025724,80.72358793539544,2.772023426235206e-07,"IL1RN,UBXN2A,ICAM5,UBE2L3,HDAC7,SPTA1,FADS2,ACOXL,C18ORF25,TERT,PRDM16,MYB,LEPR,BEND3,AP1M2,PTPN1,MEF2C,NDFIP1,ZBTB38,KLF3,DDB2,SIRT3,RCL1,ELF1,PTPRC,KANSL1,TAF8,CRLF3",GWAS_Catalog_2023
36,Eosinophil Counts,4.1824326632216016e-09,3.1021929957780277,59.84866371888142,2.772023426235206e-07,"TRABD,HBS1L,NUP205,MAX,ICE2,LPL,PLD1,SPPL3,SPRED2,FADS2,CCND3,ACOXL,C18ORF25,BCL2L11,TERT,BEND3,APOE,JAK2,SH2B3,BRD3,PTPN1,NDFIP1,NSMCE2,KLF3,ZFP90,RCL1,GIGYF1,TOX2,DOK2,RAD50,PTPRC,KANSL1,XRN1,KIT,IL2RB,ZSCAN26,PPARG,BUD13,ANP32B,MAPT,ATR,CPEB4",GWAS_Catalog_2023
37,Platelet Distribution Width,6.604091123439709e-09,3.8556775797762124,72.62391006242552,4.2587463298722014e-07,"MACF1,THRB,DOCK7,LPL,HDAC7,SPTA1,FADS2,CCND3,ACOXL,ERI1,PRDM16,SLC12A7,SH2B3,NKX2-3,EPHB4,BRD3,NFE2,MEF2C,USP49,GALNT2,MYO9B,QKI,AHI1,DOK2,RSRP1,TMCC2,PPARG,CRLF3,ZNF211,SIDT2",GWAS_Catalog_2023
38,Neutrophil Percentage Of White Cells,7.72962454961059e-09,4.174592833876222,77.97390302233923,4.853390572466018e-07,"IL1RN,ICAM5,UBE2L3,HDAC7,SPTA1,FADS2,ACOXL,BCL2L11,TERT,MYB,LEPR,BEND3,NLRP3,BRD3,GCKR,USP49,DENND4A,ZBTB38,KLF3,RCL1,ELF1,DOK2,RAD50,KANSL1,KIT,TAF8,MAPT",GWAS_Catalog_2023
39,Serum Metabolite Levels,1.6217592897113822e-08,4.630506430868167,83.05817734446846,9.921840167311174e-07,"GCDH,UNC119B,HSPA8,GCKR,TOMM40,ABCC2,SPRYD4,GALNT2,NPRL3,ARPC1A,DOCK7,LPL,SPPL3,MSRA,FADS2,SLC7A6,SLC22A16,TRIM4,DNAJA4,APOB,SLC17A1,PLTP,SLC17A3",GWAS_Catalog_2023
40,Total Bilirubin Levels,1.9534922870771573e-08,5.5718945682248435,98.90704625398007,1.1652581492415242e-06,"TOMM40,TMPRSS6,PABPC4,HFE,DOCK7,MYO9B,TMC6,UBE2L3,HK1,SPTA1,FADS2,SLC25A37,CCND2,SLC22A16,SERTAD2,RSRP1,NLRP3,IL6R,SH2B3",GWAS_Catalog_2023
41,Free Cholesterol Levels In Very Large HDL,2.13639461420726e-08,12.345201238390093,218.03552590730993,1.2432774510972005e-06,"FADS2,MSRA,GCKR,BCL2L11,GALNT2,DOCK7,LPL,PPARG,PCSK7,APOE,PLTP",GWAS_Catalog_2023
42,Red Blood Cell Traits (Multivariate Analysis),2.6116462605160127e-08,93.07317073170732,1625.1227094310448,1.4836638041883825e-06,"HBS1L,HBZ,CCND3,USP49,HFE,NPRL3",GWAS_Catalog_2023
43,C-reactive Protein Levels,4.7449150349587814e-08,3.584554011095182,60.44851089580687,2.632876110095733e-06,"FTO,MACF1,IL1RN,THRB,SLC4A1AP,TOMM40,DOCK7,ADAR,SPPL3,MRPL33,C12ORF43,GK5,ZMIZ2,LEPR,NLRP3,APOE,IL6R,RTEL1-TNFRSF6B,GCKR,NOP58,MAP3K1,SPRYD4,DUSP1,PABPC4,NSMCE2,TFEB,DDB2,MSRA,TMCC2",GWAS_Catalog_2023
44,Free Cholesterol To Total Lipids Ratio In Medium LDL,5.0092882256853734e-08,11.147208628782582,187.37774280401925,2.7164003878375684e-06,"FADS2,MACF1,MFHAS1,GCKR,GALNT2,DOCK7,SNX13,LPL,PCSK7,APOE,APOB",GWAS_Catalog_2023
45,White Blood Cell Count,5.6892230457052564e-08,2.6097219853317415,43.53566153647635,3.0165524860117207e-06,"FTO,GTF2A1,HBS1L,GYPA,IL1RN,MAX,MAST2,SNX13,HDAC7,SPTA1,SPRED2,FADS2,CCND3,ACOXL,AKAP10,C18ORF25,BCL2L11,ALDH2,TERT,PSD4,MYB,LEPR,NLRP3,JAK2,SLC12A7,SH2B3,IL6R,RBM38,PTPN1,HSPA8,GCKR,NDFIP1,MAP2K2,SMOX,NSMCE2,TFEB,ARHGAP27,KLF3,RP1L1,MSRA,AHI1,TOX2,PTPRC,KLHL5,KANSL1,DLG5,TAF8,TMCC2",GWAS_Catalog_2023
46,Low Density Lipoprotein Cholesterol Levels,9.549983991867531e-08,2.945557267591166,47.612403779568716,4.953535174912159e-06,"KANK2,HBS1L,TAGLN,THRB,TOMM40,TMPRSS6,HFE,DOCK7,LPL,PCSK7,UBE2L3,HK1,C12ORF43,SPTA1,FADS2,CCND2,ALDH2,SERTAD2,NPHP3,APOE,APOB,PLTP,SH2B3,EPHB4,AP1M2,GCKR,TNK2,GIGYF1,ELF1,TF,XRN1,RSRP1,PPARG,BUD13,TRIB1,CNIH4,SIDT2",GWAS_Catalog_2023
47,Neutrophil Count,1.031742114656735e-07,2.984136668700427,48.00534973007063,5.2377376288744035e-06,"FTO,GTF2A1,HBS1L,IL1RN,MAX,MAST2,ZNF391,SNX13,SPPL3,SPRED2,FADS2,CCND3,ACOXL,AKAP10,DSTYK,C18ORF25,BCL2L11,TERT,MYB,LEPR,NLRP3,JAK2,SLC12A7,SH2B3,BRD3,RBM38,GCKR,NDFIP1,DENND4A,NSMCE2,RP1L1,AHI1,TOX2,DOK2,TMCC2,MAPT",GWAS_Catalog_2023
48,Monocyte Percentage Of White Cells,1.131266143779975e-07,3.717273876565912,59.45689668608009,5.6233354563729595e-06,"IL1RN,THRB,UBXN2A,SPPL3,FADS2,CCND3,ACOXL,BCL2L11,TERT,SERTAD2,PRDM16,MYB,LEPR,NLRP3,JAK2,SH2B3,IL6R,GCKR,MEF2C,DENND4A,KLF3,BYSL,DDB2,AHI1,PTPRC,KANSL1",GWAS_Catalog_2023
49,Cholesterol To Total Lipids Ratio In Very Large VLDL,1.4875618113365521e-07,11.603795153177868,182.42276741954078,7.240026946566038e-06,"MFHAS1,GCKR,CCND2,GALNT2,DOCK7,LPL,PPARG,PCSK7,TRIB1,SH2B3",GWAS_Catalog_2023
50,Triglyceride Levels (MTAG),1.5171892176374765e-07,4.811992945326279,75.55423795675337,7.240026946566038e-06,"KANK2,GCKR,TOMM40,THRB,GALNT2,DOCK7,SNX13,LPL,HSD17B13,PCSK7,MRPL33,MSRA,FADS2,CCND2,BCL2L11,PPARG,BUD13,TRIB1,PLTP",GWAS_Catalog_2023
51,Iron Status Biomarkers (Iron Levels),1.5866750104889828e-07,27.21330275229358,426.0638502878718,7.423150147111201e-06,"FIG4,HBS1L,SCGN,TF,TMPRSS6,HFE,IL6R",GWAS_Catalog_2023
52,Hematocrit,1.7060597979031437e-07,3.2034470113678033,49.92222719512542,7.828189764994041e-06,"HBS1L,GCDH,RTEL1,TMPRSS6,EPAS1,SPO11,MAST2,HFE,UBE2L3,THBS3,MRPL33,HK1,FADS2,TERT,ZMIZ2,PSD4,PRDM16,SH2B3,SLC17A3,RTEL1-TNFRSF6B,NFE2,GCKR,MEF2C,BCL11A,ZBTB38,SUSD1,TMC6,SLC25A37,DNAJA4,PPARG,MAPT",GWAS_Catalog_2023
53,Serum Metabolite Levels (CMS),1.962476992814675e-07,11.188271604938272,172.7904158599596,8.834849254444933e-06,"FADS2,GCKR,TOMM40,SPRYD4,GALNT2,DOCK7,LPL,APOE,APOB,PLTP",GWAS_Catalog_2023
54,Sex Hormone-Binding Globulin Levels In Postmenopausal Women,2.1632880069722447e-07,6.602332089552239,101.32246731793582,9.558528119695881e-06,"BRD3,GCKR,MAST3,SMOX,TFEB,ADAR,UBE2L3,SLC25A37,ACOXL,CCND2,BCL2L11,SERTAD2,TRIP6,PPARG",GWAS_Catalog_2023
55,Triglycerides To Total Lipids Ratio In Small VLDL,2.5655317275513736e-07,10.801404853128991,163.92136279299783,1.0930997682031388e-05,"HELZ2,MFHAS1,MSRA,GCKR,TOMM40,GALNT2,LPL,BUD13,PCSK7,APOB",GWAS_Catalog_2023
56,Phospholipids To Total Lipids Ratio In Small VLDL,2.5655317275513736e-07,10.801404853128991,163.92136279299783,1.0930997682031388e-05,"FADS2,MACF1,MFHAS1,MSRA,GCKR,GALNT2,LPL,BUD13,PCSK7,TRIB1",GWAS_Catalog_2023
57,Phospholipids To Total Lipids Ratio In Chylomicrons And Extremely Large VLDL,2.7441746276101654e-07,24.187223921168876,365.4354614801993,1.128896665772044e-05,"FADS2,GCKR,GALNT2,DOCK7,LPL,PCSK7,DDB2",GWAS_Catalog_2023
58,Glycated Haemoglobin HbA1c Levels Adjusted For BMI,2.7441746276101654e-07,24.187223921168876,365.4354614801993,1.128896665772044e-05,"SPTA1,GCKR,TMPRSS6,HFE,PPARG,TMC6,HK1",GWAS_Catalog_2023
59,Apolipoprotein B Levels,2.89308401827303e-07,3.6283856672206185,54.628149450783205,1.1699827911185508e-05,"KANK2,HBS1L,TAGLN,SLC4A1AP,TOMM40,HFE,DOCK7,LPL,PCSK7,HK1,FADS2,CCND2,SERTAD2,NPHP3,APOE,APOB,AP1M2,GCKR,GALNT2,FIG4,GIGYF1,RSRP1,PPARG,TRIB1,SIDT2",GWAS_Catalog_2023
60,Ratio Of Polyunsaturated Fatty Acids To Total Fatty Acids,3.0867812537665396e-07,16.626584867075664,249.24858121442824,1.2275100119144939e-05,"MACF1,FADS2,GCKR,GALNT2,DOCK7,LPL,PCSK7,APOB",GWAS_Catalog_2023
61,Triglyceride Levels In Medium LDL,3.3252520766052154e-07,10.440329218106996,155.7336945440947,1.3006641729147613e-05,"FADS2,GCKR,CCND2,TOMM40,GALNT2,DOCK7,LPL,PCSK7,APOE,APOB",GWAS_Catalog_2023
62,Lymphocyte Count,3.721225992577199e-07,2.813698322948535,41.65410946808604,1.4320718094014834e-05,"HBS1L,GYPA,THRB,CD82,UBXN2A,ARPC1A,SPPL3,UBE2L3,HDAC7,SPTA1,FADS2,CCND3,ACOXL,CCND2,BCL2L11,FIGNL1,PSD4,LEPR,BEND3,JARID2,SH2B3,BRD3,PTPN1,GCKR,RRM1,MAP2K2,SMOX,ZBTB38,KLF3,SIRT3,ELF1,DOK2,PTPRC,TAF8,ZNF217,CRLF3",GWAS_Catalog_2023
63,Total Triglycerides Levels,4.275209921246204e-07,10.102548785344485,148.15652930443386,1.569330903398991e-05,"FADS2,GCKR,CCND2,GALNT2,DOCK7,LPL,BUD13,PCSK7,APOE,APOB",GWAS_Catalog_2023
64,Triglyceride Levels In Very Large VLDL,4.275209921246204e-07,10.102548785344485,148.15652930443386,1.569330903398991e-05,"FADS2,MACF1,GCKR,CCND2,GALNT2,DOCK7,LPL,PPARG,PCSK7,APOB",GWAS_Catalog_2023
65,Cholesteryl Esters To Total Lipids Ratio In Medium VLDL,4.275209921246204e-07,10.102548785344485,148.15652930443386,1.569330903398991e-05,"MFHAS1,MSRA,GCKR,GALNT2,DOCK7,LPL,PPARG,PCSK7,APOE,TRIB1",GWAS_Catalog_2023
66,C-reactive Protein,4.753305743605356e-07,5.650470219435737,82.26663865338016,1.71839204609733e-05,"FTO,IL1RN,GCKR,NOP58,THRB,TOMM40,PABPC4,NSMCE2,TFEB,C12ORF43,GK5,LEPR,NLRP3,APOE,IL6R",GWAS_Catalog_2023
67,Platelet-to-lymphocyte Ratio,5.082491313084702e-07,4.908402638371093,71.13401456517902,1.8099737720925523e-05,"TRABD,NFE2,HBS1L,MEF2C,GALNT2,ICAM5,HDAC7,SPTA1,RCL1,FADS2,AHI1,PTPRC,MYB,TMCC2,JAK2,ATP6V1G3,SH2B3",GWAS_Catalog_2023
68,Sex Hormone-Binding Globulin Levels,5.675441590370368e-07,2.7587193310595226,39.675755972268526,1.9914122992093672e-05,"FTO,MACF1,THRB,SLC4A1AP,MAST3,SNX13,HSD17B13,ADAR,UBE2L3,FADS2,CCND3,ACOXL,CCND2,BCL2L11,TERT,SERTAD2,ZMIZ2,STX4,JARID2,SLC17A3,BRD3,GCKR,KLF13,SMOX,PABPC4,TFEB,BMP8A,MYO9B,RHOA,DDB2,SLC25A37,XRN1,TRIP6,ZNF217,PPARG,CPEB4",GWAS_Catalog_2023
69,Triglycerides To Total Lipids Ratio In Very Large VLDL,5.825557162716291e-07,11.716153846153846,168.19524181521683,2.014460781194358e-05,"HELZ2,MFHAS1,MSRA,GCKR,SAMM50,GALNT2,LPL,PCSK7,SH2B3",GWAS_Catalog_2023
70,Cholesterol To Total Lipids Ratio In Medium VLDL,6.90938755671213e-07,9.488402543958099,134.59502675791404,2.355114101473592e-05,"MFHAS1,MSRA,GCKR,GALNT2,DOCK7,LPL,PPARG,PCSK7,APOE,TRIB1",GWAS_Catalog_2023
71,Lipid Metabolism Phenotypes,7.225132567280435e-07,19.785654712260218,279.7796453879409,2.4280515923283267e-05,"FADS2,GCKR,DOCK7,LPL,APOE,APOB,PLTP",GWAS_Catalog_2023
72,"Cholesterol, Total",7.698246253005649e-07,7.119418727294035,100.22079148879926,2.4604880119856274e-05,"KANK2,FADS2,HBS1L,GCKR,TOMM40,SAMM50,HFE,DOCK7,PPARG,APOE,APOB,C12ORF43",GWAS_Catalog_2023
73,Triglyceride Levels In Medium HDL,7.703304913481746e-07,11.2464,158.30934459585953,2.4604880119856274e-05,"FADS2,MFHAS1,MSRA,GCKR,CCND2,DOCK7,LPL,PCSK7,APOE",GWAS_Catalog_2023
74,Iron Status Biomarkers,7.734140859133364e-07,31.01219512195122,436.41760385303235,2.4604880119856274e-05,"TF,TMPRSS6,HFE,PCSK7,SLC17A1,SLC17A3",GWAS_Catalog_2023
75,Triacylglyceride Levels,7.734140859133364e-07,31.01219512195122,436.41760385303235,2.4604880119856274e-05,"FADS2,GCKR,DOCK7,LPL,BUD13,APOE",GWAS_Catalog_2023
76,Low-density Lipoprotein Levels (MTAG),7.950625551635983e-07,4.734296308594831,66.49245802598847,2.4960779692372967e-05,"HBS1L,GCKR,THRB,PGAP3,NSMCE2,DOCK7,ADAR,PCSK7,SPPL3,UBE2L3,MRPL33,FADS2,CCND2,LEPR,TRIB1,IL6R,CTSB",GWAS_Catalog_2023
77,Iron Status Biomarkers (Transferrin Levels),1.0014373000701344e-06,inf,inf,3.063371023035052e-05,"FADS2,TF,TMPRSS6,HFE",GWAS_Catalog_2023
78,Apolipoprotein E Levels,1.0014373000701344e-06,inf,inf,3.063371023035052e-05,"GCKR,DOCK7,BUD13,APOE",GWAS_Catalog_2023
79,Sum Basophil Neutrophil Counts,1.0825687435864645e-06,6.859175607001694,94.21882877431527,3.240229731033105e-05,"BRD3,FADS2,AHI1,HBS1L,GCKR,C18ORF25,TERT,MAST2,LEPR,NLRP3,SLC12A7,SH2B3",GWAS_Catalog_2023
80,Triglyceride Levels In LDL,1.0864139919641593e-06,8.944444444444445,122.83073002026788,3.240229731033105e-05,"FADS2,GCKR,CCND2,TOMM40,GALNT2,DOCK7,LPL,PCSK7,APOE,APOB",GWAS_Catalog_2023
81,Cholesteryl Esters To Total Lipids Ratio In Very Large HDL,1.1129544617020705e-06,18.13506625891947,248.60441800965825,3.278406599532272e-05,"MACF1,FADS2,DOCK7,SNX13,PCSK7,APOE,DDB2",GWAS_Catalog_2023
82,Total Concentration Of Lipoprotein Particles,1.2503741723691757e-06,13.121084920891185,178.34267471995835,3.638283872283967e-05,"FADS2,GCKR,GALNT2,PABPC4,DOCK7,LPL,PLTP,UBE2L3",GWAS_Catalog_2023
83,Cholesterol Levels In Medium HDL,1.307135368751853e-06,10.41128205128205,141.04864012488744,3.7576204696890617e-05,"FADS2,GCKR,GALNT2,PABPC4,DOCK7,LPL,BUD13,APOE,APOB",GWAS_Catalog_2023
84,Hematology Traits,1.3980291225498093e-06,26.579268292682926,358.30041971876204,3.9710684361950536e-05,"HBS1L,FADS2,TMPRSS6,GALNT2,HFE,NPRL3",GWAS_Catalog_2023
85,Triglycerides To Total Lipids Ratio In Small LDL,1.6794753836818039e-06,10.038461538461538,133.48171504491455,4.659567750540447e-05,"FADS2,MACF1,MFHAS1,GCKR,GALNT2,DOCK7,LPL,PCSK7,TRIB1",GWAS_Catalog_2023
86,Cholesteryl Ester Levels In Medium HDL,1.6794753836818039e-06,10.038461538461538,133.48171504491455,4.659567750540447e-05,"FADS2,GCKR,GALNT2,PABPC4,DOCK7,LPL,BUD13,APOE,APOB",GWAS_Catalog_2023
87,High-density Lipoprotein Levels (MTAG),1.963916054336783e-06,4.174859096368844,54.86002857645367,5.386096213388004e-05,"FTO,MACF1,GALNT2,TEX35,SNX13,LPL,PCSK7,SPPL3,UBE2L3,FADS2,CCND3,ARIH2,LEPR,PPARG,BUD13,APOE,TRIB1,IL6R",GWAS_Catalog_2023
88,Phospholipid Levels In Medium HDL,2.1397920348635623e-06,9.691352785145888,126.51869088511901,5.736566062005011e-05,"FADS2,GCKR,GALNT2,PABPC4,DOCK7,LPL,APOB,SLC17A3,UBE2L3",GWAS_Catalog_2023
89,Phospholipids To Total Lipids Ratio In Medium HDL,2.1397920348635623e-06,9.691352785145888,126.51869088511901,5.736566062005011e-05,"FADS2,GCKR,GALNT2,PABPC4,DOCK7,SNX13,LPL,PCSK7,APOB",GWAS_Catalog_2023
90,Ratio Of Polyunsaturated Fatty Acids To Monounsaturated Fatty Acids,2.286591390429662e-06,11.869120654396728,154.16146028369596,6.062007841739082e-05,"FADS2,MFHAS1,GCKR,GALNT2,DOCK7,LPL,PCSK7,APOB",GWAS_Catalog_2023
91,Granulocyte Count,2.4045824013041177e-06,6.284472049689441,81.30934342869321,6.304762208254533e-05,"FADS2,AHI1,HBS1L,GCKR,NDFIP1,C18ORF25,TERT,MAST2,LEPR,NLRP3,SLC12A7,SH2B3",GWAS_Catalog_2023
92,Triglyceride Levels In VLDL,3.393491669322421e-06,9.064317617866005,114.152854225139,8.635002016910021e-05,"FADS2,GCKR,CCND2,GALNT2,DOCK7,LPL,PPARG,PCSK7,APOB",GWAS_Catalog_2023
93,Triglyceride Levels In Large VLDL,3.393491669322421e-06,9.064317617866005,114.152854225139,8.635002016910021e-05,"FADS2,GCKR,CCND2,GALNT2,DOCK7,LPL,PPARG,PCSK7,APOB",GWAS_Catalog_2023
94,Sex Hormone-Binding Globulin Levels Adjusted For BMI,3.4018867962679876e-06,2.8463899546564355,35.839409237572006,8.635002016910021e-05,"MACF1,THRB,MAST3,SNX13,HSD17B13,ADAR,UBE2L3,ACOXL,CCND2,BCL2L11,TERT,SERTAD2,ZMIZ2,STX4,JARID2,SLC17A3,BRD3,GCKR,KLF13,SMOX,TFEB,BMP8A,DDB2,SLC25A37,XRN1,TRIP6,ZNF217,PPARG,CPEB4",GWAS_Catalog_2023
95,Triglyceride Levels X Short Total Sleep Time Interaction (2Df Test),3.468897075264347e-06,14.503771661569827,182.3366870731448,8.712408864821823e-05,"FADS2,GCKR,GALNT2,DOCK7,LPL,MYO9B,MRPL33",GWAS_Catalog_2023
96,Triglyceride Levels In Type 2 Diabetes,3.565423785734558e-06,38.65501519756839,484.8973099571099,8.861563700794434e-05,"BLK,FADS2,GALNT2,LPL,APOB",GWAS_Catalog_2023
97,Lipid Traits,3.863115329804982e-06,20.66869918699187,257.61542354908426,9.391318466988261e-05,"GCKR,TOMM40,DOCK7,LPL,BUD13,APOE",GWAS_Catalog_2023
98,Cardiovascular Disease Risk Factors,3.863115329804982e-06,20.66869918699187,257.61542354908426,9.391318466988261e-05,"GCKR,TAGLN,TOMM40,HFE,PCSK7,APOB",GWAS_Catalog_2023
99,Non-HDL Cholesterol Levels,3.961041021167348e-06,3.271439799928546,40.693451720392645,9.391318466988261e-05,"HBS1L,GCKR,THRB,GALNT2,DOCK7,LPL,UBE2L3,THBS3,HK1,SPTA1,FADS2,GIGYF1,DSTYK,CCND2,SERTAD2,TMBIM1,STX4,PPARG,APOE,APOB,PLTP,SH2B3,CNIH4",GWAS_Catalog_2023
100,Medication Use (HMG CoA Reductase Inhibitors),3.965890017055396e-06,6.63169802333889,82.48360276300711,9.391318466988261e-05,"FTO,HBS1L,GCKR,CCND2,TOMM40,ALDH2,DOCK7,LPL,PPARG,APOE,APOB",GWAS_Catalog_2023
101,Triglyceride Levels In HDL,3.975369510334511e-06,10.83488930381435,134.73610503990926,9.391318466988261e-05,"FADS2,MFHAS1,MSRA,GCKR,CCND2,DOCK7,LPL,PCSK7",GWAS_Catalog_2023
102,Free Cholesterol To Total Lipids Ratio In Medium VLDL,4.2276785583973674e-06,8.780192307692309,108.64484861108745,9.889452000329527e-05,"MFHAS1,MSRA,GCKR,GALNT2,LPL,PPARG,PCSK7,APOE,APOB",GWAS_Catalog_2023
103,Phospholipids To Total Lipids Ratio In IDL,4.851507420611792e-06,13.595948012232416,166.36302584568836,0.00010885245969885286,"MACF1,GALNT2,LPL,SNX13,PCSK7,APOE,APOB",GWAS_Catalog_2023
104,Nonalcoholic Steatohepatitis,4.881480799571356e-06,123.35757575757576,1508.6707924799618,0.00010885245969885286,"GCKR,LEPROT,LEPR,HSD17B13",GWAS_Catalog_2023
105,Hematological Parameters,4.881480799571356e-06,123.35757575757576,1508.6707924799618,0.00010885245969885286,"FIG4,CCND3,TMPRSS6,HFE",GWAS_Catalog_2023
106,Diacylglycerol 34:2 [M+H-H2O]1+ Levels,4.881480799571356e-06,123.35757575757576,1508.6707924799618,0.00010885245969885286,"FADS2,GCKR,LPL,BUD13",GWAS_Catalog_2023
107,Transferrin Receptor Protein 1 Levels,4.881480799571356e-06,123.35757575757576,1508.6707924799618,0.00010885245969885286,"TAGLN,TFRC,TMPRSS6,HFE",GWAS_Catalog_2023
108,Serum Albumin Levels,5.063107567006881e-06,3.706008374720031,45.18932474025572,0.0001104723610423748,"FTO,MACF1,HBS1L,GCKR,THRB,KLF13,TMEM50B,TFEB,SNX13,PILRB,RHOA,FADS2,TF,DOK2,CCND2,NLRP3,PPARG,SH2B3,CPEB4",GWAS_Catalog_2023
109,HDL Cholesterol Levels X Short Total Sleep Time Interaction (2Df Test),5.155254125163043e-06,10.38241308793456,126.41100976186802,0.0001104723610423748,"FADS2,GALNT2,LPL,SNX13,PCSK7,APOE,APOB,DDB2",GWAS_Catalog_2023
110,Phospholipids To Total Lipids Ratio In Very Small VLDL,5.155254125163043e-06,10.38241308793456,126.41100976186802,0.0001104723610423748,"FADS2,GCKR,GALNT2,BMP8A,LPL,PCSK7,APOE,APOB",GWAS_Catalog_2023
111,Free Cholesterol To Total Lipids Ratio In Small VLDL,5.231926570741136e-06,8.513286713286714,103.52778946356209,0.0001104723610423748,"MACF1,MFHAS1,MSRA,GCKR,GALNT2,LPL,BUD13,PCSK7,TRIB1",GWAS_Catalog_2023
112,Triglyceride Levels In Small VLDL,5.231926570741136e-06,8.513286713286714,103.52778946356209,0.0001104723610423748,"TRABD,FADS2,MSRA,GCKR,CCND2,GALNT2,DOCK7,LPL,PCSK7",GWAS_Catalog_2023
113,Triglycerides To Total Lipids Ratio In Medium VLDL,5.231926570741136e-06,8.513286713286714,103.52778946356209,0.0001104723610423748,"MFHAS1,MSRA,GCKR,GALNT2,LPL,PPARG,PCSK7,APOE,TRIB1",GWAS_Catalog_2023
114,Iron Status Biomarkers (Total Iron Binding Capacity),6.0163587297226565e-06,18.6,223.59112719502937,0.00012592133271156368,"HBS1L,FADS2,TF,TFRC,TMPRSS6,HFE",GWAS_Catalog_2023
115,Triglycerides To Total Lipids Ratio In IDL,6.433963144236644e-06,8.262081447963801,98.76425948464552,0.00013233996605300545,"FADS2,MACF1,GCKR,GALNT2,SNX13,LPL,PCSK7,TRIB1,APOB",GWAS_Catalog_2023
116,Concentration Of Very Large HDL Particles,6.433963144236644e-06,8.262081447963801,98.76425948464552,0.00013233996605300545,"RP1L1,FADS2,GCKR,BCL2L11,GALNT2,LPL,PPARG,PCSK7,PLTP",GWAS_Catalog_2023
117,Concentration Of HDL Particles,6.6185311138789194e-06,9.966134969325154,118.85250892140087,0.0001336117384409999,"FADS2,GCKR,GALNT2,PABPC4,DOCK7,LPL,APOB,PLTP",GWAS_Catalog_2023
118,Triglyceride Levels In Chylomicrons And Extremely Large VLDL,6.6185311138789194e-06,9.966134969325154,118.85250892140087,0.0001336117384409999,"FADS2,GCKR,GALNT2,DOCK7,LPL,PPARG,PCSK7,APOB",GWAS_Catalog_2023
119,Free Cholesterol To Total Lipids Ratio In IDL,6.663787457870489e-06,12.794927145169995,152.50046615384434,0.0001336117384409999,"FADS2,MFHAS1,GCKR,DOCK7,LPL,SNX13,TRIB1",GWAS_Catalog_2023
120,Free Cholesterol To Total Lipids Ratio In Large LDL,7.864908489752472e-06,8.025230769230769,94.32133699834603,0.00015638059713791164,"FADS2,MACF1,GCKR,GALNT2,SNX13,LPL,PCSK7,APOE,APOB",GWAS_Catalog_2023
121,Total Lipid Levels In Medium HDL,8.41799349153648e-06,9.581878244454932,111.96557974988497,0.00016329538594151251,"FADS2,GCKR,GALNT2,PABPC4,DOCK7,LPL,APOB,SLC17A3",GWAS_Catalog_2023
122,Phospholipids To Total Lipids Ratio In Large HDL,8.41799349153648e-06,9.581878244454932,111.96557974988497,0.00016329538594151251,"FADS2,MACF1,ACOXL,GCKR,DOCK7,LPL,PCSK7,PLTP",GWAS_Catalog_2023
123,Total Lipid Levels In Very Large VLDL,8.41799349153648e-06,9.581878244454932,111.96557974988497,0.00016329538594151251,"FADS2,GCKR,CCND2,GALNT2,DOCK7,LPL,PCSK7,APOB",GWAS_Catalog_2023
124,Asthma,9.49184658867877e-06,3.529805996472663,40.822479491565886,0.00018264149968215762,"RTEL1-TNFRSF6B,RTEL1,NDFIP1,THRB,TFRC,ZBTB38,MYO9B,SPPL3,HDAC7,TLR1,FADS2,AHI1,RAD50,BCL2L11,PTPRC,PRDM16,IL2RB,ZNF217,IL6R",GWAS_Catalog_2023
125,Sum Eosinophil Basophil Counts,9.964250469426148e-06,4.925684044589573,56.726673909639594,0.0001901976129604063,"BRD3,HBS1L,NDFIP1,KLF3,FADS2,SPRED2,RAD50,BCL2L11,PTPRC,KANSL1,ARIH2,BUD13,JAK2",GWAS_Catalog_2023
126,A Body Shape Index,1.018143730462356e-05,3.2639756876801993,37.51921894756867,0.0001904043616050117,"BLK,MAP3K1,BTN3A1,MAST3,MYO9B,VRK2,HDAC7,RP1L1,MFHAS1,MSRA,ACOXL,FAM167A,BCL2L11,KANSL1,ERI1,PPARG,TRIM38,MAPT,TRIB1,CPEB4,CTSB",GWAS_Catalog_2023
127,Metabolic Syndrome,1.0479030783292027e-05,6.652876280535855,76.28277335205672,0.0001904043616050117,"FTO,FADS2,GCKR,TOMM40,ALDH2,GALNT2,SNX13,LPL,BUD13,APOB",GWAS_Catalog_2023
128,Total Lipid Levels In HDL,1.0613487046716913e-05,9.226084980686208,105.66990335157608,0.0001904043616050117,"FADS2,GCKR,GALNT2,PABPC4,DOCK7,LPL,APOB,UBE2L3",GWAS_Catalog_2023
129,Phospholipid Levels In HDL,1.0613487046716913e-05,9.226084980686208,105.66990335157608,0.0001904043616050117,"FADS2,GCKR,GALNT2,PABPC4,DOCK7,LPL,APOB,UBE2L3",GWAS_Catalog_2023
130,Average Diameter For VLDL Particles,1.0613487046716913e-05,9.226084980686208,105.66990335157608,0.0001904043616050117,"FADS2,GCKR,GALNT2,DOCK7,LPL,PPARG,PCSK7,APOB",GWAS_Catalog_2023
131,Phospholipid Levels In Large VLDL,1.0613487046716913e-05,9.226084980686208,105.66990335157608,0.0001904043616050117,"FADS2,GCKR,CCND2,GALNT2,DOCK7,LPL,PCSK7,APOB",GWAS_Catalog_2023
132,Triglyceride Levels In Medium VLDL,1.0613487046716913e-05,9.226084980686208,105.66990335157608,0.0001904043616050117,"FADS2,GCKR,CCND2,GALNT2,DOCK7,LPL,PCSK7,APOB",GWAS_Catalog_2023
133,Concentration Of Large VLDL Particles,1.0613487046716913e-05,9.226084980686208,105.66990335157608,0.0001904043616050117,"FADS2,GCKR,CCND2,GALNT2,DOCK7,LPL,PCSK7,APOB",GWAS_Catalog_2023
134,Cholesterol Levels In Very Large HDL,1.1556599954315399e-05,7.58993762993763,86.28433775551979,0.00020577647381340704,"FADS2,MSRA,GCKR,BCL2L11,GALNT2,DOCK7,LPL,PCSK7,PLTP",GWAS_Catalog_2023
135,LDL Cholesterol,1.1831032302828178e-05,3.9819739513692864,45.174636850059215,0.0002091025412929484,"HBS1L,GCKR,TOMM40,TMPRSS6,HFE,DOCK7,C12ORF43,HK1,RP1L1,FADS2,GIGYF1,SERTAD2,BUD13,APOE,APOB,JAK2",GWAS_Catalog_2023
136,Degree Of Unsaturation,1.1989107451977517e-05,11.445839369064863,129.69866653527376,0.0002103383116207232,"MACF1,FADS2,GCKR,KANSL1,GALNT2,LPL,PCSK7",GWAS_Catalog_2023
137,Iron Status Biomarkers (Transferrin Saturation),1.2402105303297582e-05,25.76494427558257,291.08317627905893,0.00021599579017275933,"HBS1L,TF,TFRC,TMPRSS6,HFE",GWAS_Catalog_2023
138,Cholesteryl Esters To Total Lipids Ratio In Medium LDL,1.3214516754766828e-05,15.496951219512194,174.09576537367067,0.00022301482970533227,"GCKR,DOCK7,LPL,PCSK7,APOE,APOB",GWAS_Catalog_2023
139,Nonalcoholic Fatty Liver Disease (Imputed),1.3272466813980377e-05,8.895705521472392,99.89716139652793,0.00022301482970533227,"SAMM50,ZNF827,DOCK7,LPL,PPARG,BUD13,TRIB1,HK1",GWAS_Catalog_2023
140,Free Cholesterol Levels In Large VLDL,1.3272466813980377e-05,8.895705521472392,99.89716139652793,0.00022301482970533227,"FADS2,GCKR,CCND2,GALNT2,DOCK7,LPL,PCSK7,APOB",GWAS_Catalog_2023
141,Triglyceride Levels In Small HDL,1.3272466813980377e-05,8.895705521472392,99.89716139652793,0.00022301482970533227,"FADS2,MSRA,GCKR,CCND2,GALNT2,DOCK7,LPL,PCSK7",GWAS_Catalog_2023
142,Concentration Of Medium HDL Particles,1.3272466813980377e-05,8.895705521472392,99.89716139652793,0.00022301482970533227,"FADS2,GCKR,GALNT2,PABPC4,DOCK7,LPL,APOB,SLC17A3",GWAS_Catalog_2023
143,1-stearoyl-2-linoleoyl-GPE (18:0/18:2) Levels,1.4277051926215603e-05,61.67272727272727,688.0738033056999,0.00023656281872187795,"FADS2,BUD13,APOE,SIDT2",GWAS_Catalog_2023
144,Major Depressive Disorder Or Stress-Related Disorder,1.4277051926215603e-05,61.67272727272727,688.0738033056999,0.00023656281872187795,"ZSCAN9,ZKSCAN3,ZSCAN26,ZKSCAN4",GWAS_Catalog_2023
145,Concentration Of Chylomicrons And Extremely Large VLDL Particles,1.6470559190684425e-05,8.588110852549185,94.58890382571128,0.00026375002838236936,"FADS2,GCKR,GALNT2,DOCK7,LPL,PPARG,PCSK7,APOB",GWAS_Catalog_2023
146,Cholesterol To Total Lipids Ratio In Large HDL,1.6470559190684425e-05,8.588110852549185,94.58890382571128,0.00026375002838236936,"FADS2,MACF1,MSRA,GCKR,BCL2L11,DOCK7,LPL,PCSK7",GWAS_Catalog_2023
147,Free Cholesterol To Total Lipids Ratio In Small LDL,1.6470559190684425e-05,8.588110852549185,94.58890382571128,0.00026375002838236936,"FADS2,GCKR,GALNT2,DOCK7,SNX13,LPL,PCSK7,APOB",GWAS_Catalog_2023
148,Concentration Of Very Large VLDL Particles,1.6470559190684425e-05,8.588110852549185,94.58890382571128,0.00026375002838236936,"FADS2,GCKR,CCND2,GALNT2,DOCK7,LPL,PCSK7,APOB",GWAS_Catalog_2023
149,Free Cholesterol To Total Lipids Ratio In Very Large VLDL,1.6470559190684425e-05,8.588110852549185,94.58890382571128,0.00026375002838236936,"MFHAS1,MSRA,GCKR,CCND2,SAMM50,GALNT2,LPL,SH2B3",GWAS_Catalog_2023
150,Average Diameter For HDL Particles,1.6634274361108136e-05,7.199289940828402,79.2213124254763,0.0002645958575040267,"FADS2,GCKR,KANSL1,GALNT2,PABPC4,LPL,PCSK7,APOB,PLTP",GWAS_Catalog_2023
151,Very Low Density Lipoprotein Cholesterol Levels,1.8799906265301198e-05,14.303470919324578,155.64548839799036,0.0002970634195298587,"FADS2,GCKR,TOMM40,DOCK7,LPL,APOB",GWAS_Catalog_2023
152,Waist-hip Index,1.9167456716779933e-05,2.6748099891422368,29.054579663815062,0.00030087862977787446,"BLK,NUP205,TOMM40,MAST3,CEBPG,ZSCAN9,HDAC7,BCL2L11,ERI1,LEPR,APOE,CTSB,KLF13,MAP3K1,BTN2A1,NSMCE2,MYO9B,RP1L1,MFHAS1,MSRA,FAM167A,KANSL1,KIAA0586,PPARG,MAPT,TRIB1,CPEB4",GWAS_Catalog_2023
153,Waist-to-hip Ratio Adjusted For BMI,1.974690558208323e-05,2.3445230658669396,25.39707836761038,0.0003069982461106489,"BLK,LEPROT,NUP205,TOMM40,MAST3,CEBPG,ZSCAN9,LPL,HDAC7,ARHGAP21,ACOXL,DSTYK,BCL2L11,ALDH2,ERI1,LEPR,APOE,P4HTM,KLF13,MAP3K1,BTN2A1,NSMCE2,MYO9B,VRK2,RHOA,RP1L1,MFHAS1,MSRA,FAM167A,KANSL1,KIAA0586,PPARG,MAPT,TRIB1,CPEB4",GWAS_Catalog_2023
154,General Factor Of Neuroticism,1.9814639522648756e-05,7.0186153846153845,76.00521433194264,0.0003069982461106489,"BLK,RP1L1,MFHAS1,MSRA,FAM167A,KANSL1,ERI1,MAPT,ARHGAP27",GWAS_Catalog_2023
155,Total Lipid Levels In Large VLDL,2.0292126923345703e-05,8.301022494887526,89.69485228358016,0.00031236783767163125,"FADS2,GCKR,CCND2,GALNT2,DOCK7,LPL,PCSK7,APOB",GWAS_Catalog_2023
156,Sex Hormone-Binding Globulin Levels In Premenopausal Women,2.0429469115500247e-05,10.353720693170235,111.8049856220996,0.00031246611095886917,"GCKR,CCND2,MAST3,SERTAD2,TRIP6,TFEB,ADAR",GWAS_Catalog_2023
157,Direct Bilirubin Levels,2.349750595301848e-05,6.846754221388368,72.97692595519435,0.00035710222422867576,"SPTA1,GCKR,ABCC2,DNMBP,RSRP1,TMC6,APOE,APOB,HK1",GWAS_Catalog_2023
158,Myeloid White Cell Count,2.5511084522585603e-05,5.298547273160276,56.03954220283561,0.0003852496688030965,"FADS2,AHI1,HBS1L,GCKR,C18ORF25,TERT,MAST2,LEPR,NLRP3,SLC12A7,SH2B3",GWAS_Catalog_2023
159,Cholesteryl Esters To Total Lipids Ratio In Small LDL,2.620224976677274e-05,9.882123992215735,104.25310039233625,0.0003931985405252815,"FADS2,GCKR,DOCK7,LPL,PCSK7,APOE,APOB",GWAS_Catalog_2023
160,Gamma Glutamyl Transferase Levels,2.8031115662169224e-05,3.513845075359271,36.83281065413787,0.0004180140123120985,"UNC119B,RTEL1-TNFRSF6B,GCKR,ABCC2,ICE2,TEX35,HSD17B13,SPPL3,C12ORF43,DNMBP,ZNF827,ALDH2,AXL,DLG5,PPARG,APOE,TRIB1",GWAS_Catalog_2023
161,Cholesterol To Total Lipids Ratio In Medium HDL,3.0190209105648375e-05,7.780674846625767,80.98120846711639,0.00043351772627691113,"FADS2,GCKR,GALNT2,DOCK7,LPL,PCSK7,APOB,DDB2",GWAS_Catalog_2023
162,Ratio Of Monounsaturated Fatty Acids To Total Fatty Acids,3.0190209105648375e-05,7.780674846625767,80.98120846711639,0.00043351772627691113,"MFHAS1,GCKR,GALNT2,DOCK7,BMP8A,LPL,PCSK7,APOB",GWAS_Catalog_2023
163,Postprandial Linoleic Acid (18:2),3.179614505383883e-05,inf,inf,0.00043351772627691113,"FADS2,DOCK7,APOE",GWAS_Catalog_2023
164,Postprandial Phospholipid Levels In Medium VLDL,3.179614505383883e-05,inf,inf,0.00043351772627691113,"GCKR,LPL,APOE",GWAS_Catalog_2023
165,Fasting Free Cholesterol In Medium VLDL,3.179614505383883e-05,inf,inf,0.00043351772627691113,"GCKR,LPL,APOE",GWAS_Catalog_2023
166,Waist Circumference - Triglycerides (WC-TG),3.179614505383883e-05,inf,inf,0.00043351772627691113,"GCKR,BUD13,GPN1",GWAS_Catalog_2023
167,Triglycerides-Blood Pressure (TG-BP),3.179614505383883e-05,inf,inf,0.00043351772627691113,"GCKR,LPL,BUD13",GWAS_Catalog_2023
168,Glioma (High-Grade),3.179614505383883e-05,inf,inf,0.00043351772627691113,"RTEL1-TNFRSF6B,RTEL1,TERT",GWAS_Catalog_2023
169,Diacylglycerol 34:1 [M+H-H2O]1+ Levels,3.179614505383883e-05,inf,inf,0.00043351772627691113,"GCKR,LPL,BUD13",GWAS_Catalog_2023
170,Dehydrocholesteryl Ester (18:2) Levels,3.179614505383883e-05,inf,inf,0.00043351772627691113,"FADS2,APOE,SIDT2",GWAS_Catalog_2023
171,Liver Iron Content,3.179614505383883e-05,inf,inf,0.00043351772627691113,"SCGN,TMPRSS6,BTN3A2",GWAS_Catalog_2023
172,Phosphatidylinositol (15-MHDA 20:4) levels/Phosphatidylinositol (17:0 20:4) Levels,3.179614505383883e-05,inf,inf,0.00043351772627691113,"FADS2,GALNT2,DOCK7",GWAS_Catalog_2023
173,Phosphatidylcholine Diacyl C38:5 Levels,3.179614505383883e-05,inf,inf,0.00043351772627691113,"FADS2,GCKR,DOCK7",GWAS_Catalog_2023
174,Oleoyl-linoleoyl-glycerol (18:1/18:2) [1] Levels,3.179614505383883e-05,inf,inf,0.00043351772627691113,"FADS2,LPL,BUD13",GWAS_Catalog_2023
175,Oleoyl-linoleoyl-glycerol (18:1/18:2) [2] Levels,3.179614505383883e-05,inf,inf,0.00043351772627691113,"FADS2,DOCK7,LPL",GWAS_Catalog_2023
176,Systemic Lupus Erythematosus,3.260495885557038e-05,3.4678131678029915,35.82613794212703,0.0004420194990306302,"BLK,PDCD5,SPPL3,ZFP90,UBE2L3,MSRA,AHI1,MFHAS1,SPRED2,ACOXL,ELF1,BCL2L11,PTPRC,TERT,KIT,JAK2,IL6R",GWAS_Catalog_2023
177,Fibrinogen Levels Or Factor VII Levels (Pleiotropy),3.562808939027565e-05,12.39390243902439,126.94301140882828,0.0004802746965265407,"GCKR,LEPR,SNX13,NLRP3,IL6R,SH2B3",GWAS_Catalog_2023
178,Triglyceride Levels In Very Small VLDL,3.6484200622710324e-05,7.544153188324968,77.09091953057512,0.0004863201267362393,"FADS2,MACF1,GCKR,CCND2,GALNT2,DOCK7,LPL,PCSK7",GWAS_Catalog_2023
179,Monounsaturated Fatty Acid Levels,3.6484200622710324e-05,7.544153188324968,77.09091953057512,0.0004863201267362393,"FADS2,MSRA,GCKR,CCND2,GALNT2,DOCK7,LPL,PCSK7",GWAS_Catalog_2023
180,Phospholipid Levels In Chylomicrons And Extremely Large VLDL,4.1793588022027755e-05,9.056829765545363,91.31790996149964,0.0005304228777689268,"FADS2,GCKR,GALNT2,DOCK7,LPL,PCSK7,APOB",GWAS_Catalog_2023
181,Concentration Of Small LDL Particles,4.1793588022027755e-05,9.056829765545363,91.31790996149964,0.0005304228777689268,"GCKR,GALNT2,HFE,DOCK7,RSRP1,LPL,APOB",GWAS_Catalog_2023
182,Metabolic Traits,4.1793588022027755e-05,9.056829765545363,91.31790996149964,0.0005304228777689268,"FADS2,UNC119B,SLC7A6,GCKR,TRIM4,SPRYD4,APOB",GWAS_Catalog_2023
183,Phospholipid Levels In Medium VLDL,4.1793588022027755e-05,9.056829765545363,91.31790996149964,0.0005304228777689268,"GCKR,GALNT2,DOCK7,RSRP1,LPL,PCSK7,APOB",GWAS_Catalog_2023
184,Free Cholesterol Levels In Small VLDL,4.1793588022027755e-05,9.056829765545363,91.31790996149964,0.0005304228777689268,"GCKR,GALNT2,DOCK7,LPL,PCSK7,APOE,APOB",GWAS_Catalog_2023
185,Cholesteryl Esters To Total Lipids Ratio In IDL,4.1793588022027755e-05,9.056829765545363,91.31790996149964,0.0005304228777689268,"MACF1,GCKR,GALNT2,SNX13,LPL,PCSK7,APOB",GWAS_Catalog_2023
186,Phospholipids To Total Lipids Ratio In Small LDL,4.1793588022027755e-05,9.056829765545363,91.31790996149964,0.0005304228777689268,"KANK2,FADS2,GCKR,DOCK7,LPL,PCSK7,APOE",GWAS_Catalog_2023
187,Phospholipids To Total Lipids Ratio In Very Large HDL,4.1793588022027755e-05,9.056829765545363,91.31790996149964,0.0005304228777689268,"GCKR,KANSL1,GALNT2,LPL,PCSK7,APOB,PLTP",GWAS_Catalog_2023
188,Linoleic Acid Levels,4.1793588022027755e-05,9.056829765545363,91.31790996149964,0.0005304228777689268,"FADS2,MSRA,TAGLN,GCKR,DOCK7,RSRP1,APOB",GWAS_Catalog_2023
189,Phospholipids To Total Lipids Ratio In Medium LDL,4.7687883988284956e-05,11.618140243902438,115.6101756237892,0.0006020279957462852,"GCKR,DOCK7,LPL,PCSK7,APOE,APOB",GWAS_Catalog_2023
190,Feeling Guilty,4.966443069489874e-05,17.17156366092536,170.17400043315652,0.0006236806928317283,"KANSL1,UBXN2A,MAPT,ZKSCAN4,SLC17A1",GWAS_Catalog_2023
191,Free Cholesterol Levels In HDL,5.205239565490629e-05,8.693700305810397,85.74822419994334,0.0006443087568835326,"FADS2,GALNT2,PABPC4,LPL,PCSK7,APOB,UBE2L3",GWAS_Catalog_2023
192,Phosphatidylcholine Levels,5.205239565490629e-05,8.693700305810397,85.74822419994334,0.0006443087568835326,"BLK,FADS2,GCKR,GALNT2,DOCK7,UBE2L3,CTSB",GWAS_Catalog_2023
193,Cholesteryl Esters To Total Lipids Ratio In Very Small VLDL,5.238721661165353e-05,7.111656441717791,70.09851624846729,0.0006443087568835326,"MACF1,GCKR,GALNT2,SNX13,LPL,PCSK7,TRIB1,APOB",GWAS_Catalog_2023
194,Ratio Of Triglycerides To Phosphoglycerides,5.238721661165353e-05,7.111656441717791,70.09851624846729,0.0006443087568835326,"FADS2,GCKR,GALNT2,DOCK7,LPL,PPARG,PCSK7,APOB",GWAS_Catalog_2023
195,Triglycerides To Total Lipids Ratio In Very Small VLDL,6.228112710477124e-05,6.913428766189503,66.94862177095322,0.0007620654834460727,"MACF1,MFHAS1,GCKR,GALNT2,LPL,PCSK7,TRIB1,APOB",GWAS_Catalog_2023
196,Serum Glutamic-Oxaloacetic Transaminase Levels,6.332956811216239e-05,30.830303030303032,298.0414175833727,0.0007709405587531605,"GCKR,ALDH2,ZNF827,HSD17B13",GWAS_Catalog_2023
197,Triglycerides To Total Lipids Ratio In Medium LDL,6.428467514654747e-05,8.358503881439661,80.67786163459866,0.0007746628025235468,"FADS2,MACF1,GCKR,GALNT2,DOCK7,SNX13,LPL",GWAS_Catalog_2023
198,Concentration Of Medium VLDL Particles,6.428467514654747e-05,8.358503881439661,80.67786163459866,0.0007746628025235468,"GCKR,GALNT2,DOCK7,RSRP1,LPL,PCSK7,APOB",GWAS_Catalog_2023
199,Nonalcoholic Fatty Liver Disease,7.256528337475818e-05,15.45288753799392,147.28184108117077,0.0008700541011666986,"FTO,GCKR,SAMM50,LPL,APOE",GWAS_Catalog_2023
200,HDL Cholesterol Levels X Alcohol Consumption (Regular Vs Non-Regular Drinkers) Interaction (2Df),7.36804597823611e-05,6.725916100149229,64.0022903268452,0.0008746347116453411,"FADS2,CCND3,GALNT2,DOCK7,SNX13,LPL,SH2B3,UBE2L3",GWAS_Catalog_2023
201,Cholesteryl Ester Levels In Very Large HDL,7.36804597823611e-05,6.725916100149229,64.0022903268452,0.0008746347116453411,"FADS2,MSRA,GCKR,BCL2L11,GALNT2,LPL,PCSK7,PLTP",GWAS_Catalog_2023
202,Sum Neutrophil Eosinophil Counts,7.553988985080087e-05,5.118903056061526,48.58273952800389,0.0008878727940099058,"FADS2,HBS1L,GCKR,NDFIP1,C18ORF25,TERT,LEPR,NLRP3,SLC12A7,SH2B3",GWAS_Catalog_2023
203,Albumin Levels,7.553988985080087e-05,5.118903056061526,48.58273952800389,0.0008878727940099058,"GCKR,TERT,SPRYD4,PABPC4,NLRP3,TEX35,SNX13,ADAR,PPARG,SRP14",GWAS_Catalog_2023
204,Phospholipid Levels In Very Large VLDL,7.876872694470607e-05,8.048136821837128,76.04680061353085,0.0009035681850484071,"FADS2,GCKR,GALNT2,DOCK7,LPL,PCSK7,APOB",GWAS_Catalog_2023
205,Free Cholesterol Levels In Medium HDL,7.876872694470607e-05,8.048136821837128,76.04680061353085,0.0009035681850484071,"FADS2,GCKR,GALNT2,PABPC4,DOCK7,LPL,APOB",GWAS_Catalog_2023
206,Phospholipids To Total Lipids Ratio In Large VLDL,7.876872694470607e-05,8.048136821837128,76.04680061353085,0.0009035681850484071,"FADS2,GCKR,GALNT2,DOCK7,BMP8A,LPL,PCSK7",GWAS_Catalog_2023
207,Cholesteryl Esters To Total Lipids Ratio In Large HDL,7.876872694470607e-05,8.048136821837128,76.04680061353085,0.0009035681850484071,"FADS2,MACF1,GCKR,BCL2L11,DOCK7,LPL,PCSK7",GWAS_Catalog_2023
208,Free Cholesterol Levels In Very Large VLDL,7.876872694470607e-05,8.048136821837128,76.04680061353085,0.0009035681850484071,"FADS2,GCKR,GALNT2,DOCK7,LPL,PCSK7,APOB",GWAS_Catalog_2023
209,HDL Cholesterol Levels X Long Total Sleep Time Interaction (2Df Test),8.152116984816158e-05,10.325203252032521,97.2081522744769,0.000926235767893874,"MACF1,FADS2,GALNT2,LPL,PCSK7,DDB2",GWAS_Catalog_2023
210,Cholesteryl Ester Levels In Medium LDL,8.152116984816158e-05,10.325203252032521,97.2081522744769,0.000926235767893874,"GCKR,GALNT2,HFE,DOCK7,APOE,APOB",GWAS_Catalog_2023
211,Crohn's Disease,8.390142173404591e-05,3.9228971962616823,36.819795257979315,0.0009487620486134292,"RTEL1-TNFRSF6B,GCKR,NDFIP1,ZBTB38,DOCK7,UBE2L3,FADS2,CCND3,ELF1,TMBIM1,JAK2,EPHB4,CPEB4",GWAS_Catalog_2023
212,Colorectal Cancer,9.314704706250586e-05,3.2967484687795454,30.598214297564112,0.0010483436523166933,"BRD3,MACF1,RTEL1-TNFRSF6B,RTEL1,THRB,TFEB,HK1,FADS2,DSTYK,TOX2,CCND2,TERT,TRIM4,CDH1,TMBIM1,SH2B3",GWAS_Catalog_2023
213,Triglycerides To Total Lipids Ratio In Medium HDL,9.580764736618172e-05,7.759938837920489,71.80401812347971,0.0010732255709657726,"FADS2,GCKR,GALNT2,DOCK7,LPL,PCSK7,DDB2",GWAS_Catalog_2023
214,HDL Cholesterol Levels X Alcohol Consumption (Drinkers Vs Non-Drinkers) Interaction (2Df),0.00010170502373614971,6.379738870536417,58.65170734095362,0.0011339634889460431,"FADS2,CCND3,GALNT2,DOCK7,SNX13,LPL,SH2B3,UBE2L3",GWAS_Catalog_2023
215,Free Cholesterol Levels In Chylomicrons And Extremely Large VLDL,0.00011573005702438655,7.491616577032585,67.90588685717405,0.0012666601654136985,"FADS2,GCKR,GALNT2,DOCK7,LPL,PCSK7,APOB",GWAS_Catalog_2023
216,Triglycerides To Total Lipids Ratio In Large LDL,0.00011573005702438655,7.491616577032585,67.90588685717405,0.0012666601654136985,"FADS2,MACF1,GCKR,GALNT2,DOCK7,SNX13,LPL",GWAS_Catalog_2023
217,Free Cholesterol To Total Lipids Ratio In Medium HDL,0.00011573005702438655,7.491616577032585,67.90588685717405,0.0012666601654136985,"FADS2,GALNT2,PABPC4,LPL,PCSK7,APOB,UBE2L3",GWAS_Catalog_2023
218,Cholesteryl Ester Levels In Very Large VLDL,0.00011573005702438655,7.491616577032585,67.90588685717405,0.0012666601654136985,"FADS2,GCKR,GALNT2,DOCK7,LPL,PCSK7,APOB",GWAS_Catalog_2023
219,Fasting Mean Diameter Of VLDLD Particles,0.00012418164855074857,92.23867069486406,829.5729425886379,0.0012826727854635762,"FADS2,GCKR,LPL",GWAS_Catalog_2023
220,Fasting Linoleic Acid (18:2),0.00012418164855074857,92.23867069486406,829.5729425886379,0.0012826727854635762,"FADS2,DOCK7,APOE",GWAS_Catalog_2023
221,Postprandial Mean Diameter Of VLDLD Particles,0.00012418164855074857,92.23867069486406,829.5729425886379,0.0012826727854635762,"FADS2,GCKR,LPL",GWAS_Catalog_2023
222,Vaginal Microbiome MetaCyc Pathway (RHAMCAT-PWY|L-rhamnose Degradation I),0.00012418164855074857,92.23867069486406,829.5729425886379,0.0012826727854635762,"RTEL1-TNFRSF6B,RTEL1,AGAP1",GWAS_Catalog_2023
223,Hemoglobin Subunit Zeta Levels,0.00012418164855074857,92.23867069486406,829.5729425886379,0.0012826727854635762,"HBZ,BCL11A,NPRL3",GWAS_Catalog_2023
224,Integral Membrane Protein 2B Levels,0.00012418164855074857,92.23867069486406,829.5729425886379,0.0012826727854635762,"BUD13,APOE,APOB",GWAS_Catalog_2023
225,Tumor Protein P53-Inducible Protein 11 Levels,0.00012418164855074857,92.23867069486406,829.5729425886379,0.0012826727854635762,"GCKR,DOCK7,APOE",GWAS_Catalog_2023
226,Phosphatidylcholine-O 34:3 [M+H]1+/Phosphatidylcholine-P 34:2 [M+H]1+/Phosphatidylethanolamine-P 37:2 [M+H]1+ Levels,0.00012418164855074857,92.23867069486406,829.5729425886379,0.0012826727854635762,"GCKR,LPL,BUD13",GWAS_Catalog_2023
227,Diacylglycerol(36:2) [M+H-H2O]1+ Levels,0.00012418164855074857,92.23867069486406,829.5729425886379,0.0012826727854635762,"FADS2,LPL,BUD13",GWAS_Catalog_2023
228,Diacylglycerol 36:2 [M+H-H2O]1+ Levels,0.00012418164855074857,92.23867069486406,829.5729425886379,0.0012826727854635762,"FADS2,LPL,BUD13",GWAS_Catalog_2023
229,Diacylglycerol 36:3 [M+H-H2O]1+ Levels,0.00012418164855074857,92.23867069486406,829.5729425886379,0.0012826727854635762,"FADS2,LPL,BUD13",GWAS_Catalog_2023
230,Sphingomyelin 34:0 [M+H]1+ Levels,0.00012418164855074857,92.23867069486406,829.5729425886379,0.0012826727854635762,"GCKR,LPL,BUD13",GWAS_Catalog_2023
231,Sphingomyelin 34:1 [M+H]1+ Levels,0.00012418164855074857,92.23867069486406,829.5729425886379,0.0012826727854635762,"GCKR,LPL,BUD13",GWAS_Catalog_2023
232,Concentration Of Small HDL Particles,0.00013215104818705081,9.290853658536586,82.98186321871815,0.001359105176613376,"MSRA,GCKR,CCND2,PABPC4,DOCK7,UBE2L3",GWAS_Catalog_2023
233,Eosinophil Percentage Of Granulocytes,0.0001356901503013896,4.7287691732136174,42.11033533389396,0.0013895137279790369,"BRD3,MSRA,HBS1L,RAD50,BCL2L11,NDFIP1,KANSL1,PPARG,JAK2,KLF3",GWAS_Catalog_2023
234,Liver Enzyme Levels (Alkaline Phosphatase),0.00013878729815473698,3.3233255331361207,29.519665120400038,0.0014101843460410048,"GCKR,NOP58,PGAP3,BMP8A,U2SURP,FADS2,MFHAS1,ELF1,ZNF827,KANSL1,SERTAD2,DLG5,PPARG,APOE,IL6R",GWAS_Catalog_2023
235,Total Lipid Levels In Chylomicrons And Extremely Large VLDL,0.00013889074657151554,7.241182466870541,64.31490047296214,0.0014101843460410048,"FADS2,GCKR,GALNT2,DOCK7,LPL,PCSK7,APOB",GWAS_Catalog_2023
236,Fibrinogen Levels Or Plasminogen Activator Inhibitor 1 Levels (Pleiotropy),0.00014188388628955093,12.874873353596758,114.07783513886903,0.00143447013850368,"LEPR,SNX13,NLRP3,PPARG,IL6R",GWAS_Catalog_2023
237,LDL Cholesterol Levels,0.00015028451232252437,3.150314465408805,27.732156214367087,0.00151299091308668,"FTO,HBS1L,GCKR,TOMM40,HFE,MAST2,DOCK7,SPPL3,HK1,FADS2,ALDH2,SERTAD2,RSRP1,APOE,APOB,PLTP",GWAS_Catalog_2023
238,Hay Fever And/Or Eczema,0.0001543975830742845,5.191794871794872,45.56308574810084,0.0015478682067867346,"TLR1,RTEL1-TNFRSF6B,AHI1,RTEL1,ZBTB38,PRDM16,ZNF217,IL6R,SPPL3",GWAS_Catalog_2023
239,Idiopathic Pulmonary Fibrosis,0.00016540936110046592,8.847560975609756,77.03648474710761,0.0016267142817646787,"RTEL1-TNFRSF6B,RTEL1,TERT,KANSL1,NPRL3,ATP11A",GWAS_Catalog_2023
240,Total Cholines Levels,0.00016540936110046592,8.847560975609756,77.03648474710761,0.0016267142817646787,"GCKR,GALNT2,PABPC4,DOCK7,UBE2L3,CTSB",GWAS_Catalog_2023
241,Triglyceride Levels In Small LDL,0.00016567123657536332,7.0069053960737895,60.99865161335654,0.0016267142817646787,"FADS2,GCKR,CCND2,GALNT2,DOCK7,LPL,PCSK7",GWAS_Catalog_2023
242,Cholesterol Levels In Chylomicrons And Extremely Large VLDL,0.00016567123657536332,7.0069053960737895,60.99865161335654,0.0016267142817646787,"FADS2,GCKR,GALNT2,DOCK7,LPL,PCSK7,APOB",GWAS_Catalog_2023
243,Cholesteryl Ester Levels In Chylomicrons And Extremely Large VLDL,0.00016567123657536332,7.0069053960737895,60.99865161335654,0.0016267142817646787,"FADS2,GCKR,GALNT2,DOCK7,LPL,PCSK7,APOB",GWAS_Catalog_2023
244,Liver Enzyme Levels (Alanine Transaminase),0.0001678982581377524,4.193007626670694,36.44626117262286,0.0016418247701503164,"FTO,MSRA,MFHAS1,ZNF827,MAST3,DLG5,NLRP3,PPARG,APOE,SRP14,SH2B3",GWAS_Catalog_2023
245,Glioblastoma,0.00018060592056913158,20.54949494949495,177.12006579114168,0.0017517305954388128,"RTEL1-TNFRSF6B,RTEL1,TERT,HEATR3",GWAS_Catalog_2023
246,Lysine Levels,0.00018060592056913158,20.54949494949495,177.12006579114168,0.0017517305954388128,"MPST,SLC7A6,SPRYD4,TST",GWAS_Catalog_2023
247,Spleen Volume,0.00019137245059493605,11.883329436520926,101.7366178923672,0.0018486423770020949,"SPTA1,HBS1L,ELF1,TERT,MYO9B",GWAS_Catalog_2023
248,Triglyceride Levels In Large LDL,0.0001964802487586898,6.787270642201835,57.92900638400762,0.001867736547961091,"GCKR,CCND2,GALNT2,DOCK7,LPL,PCSK7,APOE",GWAS_Catalog_2023
249,Cholesterol Levels In Large VLDL,0.0001964802487586898,6.787270642201835,57.92900638400762,0.001867736547961091,"FADS2,GCKR,GALNT2,DOCK7,LPL,PCSK7,APOB",GWAS_Catalog_2023
250,Cholesterol To Total Lipids Ratio In IDL,0.0001964802487586898,6.787270642201835,57.92900638400762,0.001867736547961091,"MACF1,GCKR,GALNT2,SNX13,LPL,PCSK7,APOB",GWAS_Catalog_2023
251,Cholesterol Levels In Very Large VLDL,0.0001964802487586898,6.787270642201835,57.92900638400762,0.001867736547961091,"FADS2,GCKR,GALNT2,DOCK7,LPL,PCSK7,APOB",GWAS_Catalog_2023
252,Phospholipid Levels In Small HDL,0.00020494957373037238,8.444567627494457,71.71757292992177,0.0019405146147645576,"MSRA,GCKR,CCND2,GALNT2,DOCK7,APOB",GWAS_Catalog_2023
253,Inflammatory Bowel Disease,0.00020974844126541545,3.543789787349316,30.01448780905568,0.0019781019006295704,"RTEL1-TNFRSF6B,GCKR,NDFIP1,TM9SF4,UBE2L3,HDAC7,FADS2,CCND3,TMBIM1,JAK2,SH2B3,EPHB4,CPEB4",GWAS_Catalog_2023
254,Appendicular Lean Mass,0.00022107145045609767,2.0713383838383836,17.43450613887363,0.002076679058221453,"FTO,CEP57,MACF1,RTEL1,THRB,UBXN2A,MAX,EPAS1,SNX13,SPPL3,AK9,SPRED2,ARHGAP21,FADS2,CCND3,CCND2,ERI1,HEATR3,JARID2,SH2B3,RTEL1-TNFRSF6B,PTPN1,GCKR,KLF13,SMOX,ZBTB38,MYO9B,FRS3,FIG4,RP1L1,MFHAS1,MSRA,PPARG,MAPT",GWAS_Catalog_2023
255,Concentration Of Large HDL Particles,0.00023175408643573702,6.580947085534241,55.08143283081537,0.0021295924518885713,"FADS2,GCKR,GALNT2,LPL,PCSK7,APOB,UBE2L3",GWAS_Catalog_2023
256,Total Lipid Levels In Large HDL,0.00023175408643573702,6.580947085534241,55.08143283081537,0.0021295924518885713,"FADS2,GCKR,GALNT2,LPL,PCSK7,APOB,UBE2L3",GWAS_Catalog_2023
257,Cholesteryl Esters To Total Lipids Ratio In Small VLDL,0.00023175408643573702,6.580947085534241,55.08143283081537,0.0021295924518885713,"HELZ2,MFHAS1,MSRA,GCKR,LPL,PPARG,APOE",GWAS_Catalog_2023
258,Total Lipid Levels In VLDL,0.00023175408643573702,6.580947085534241,55.08143283081537,0.0021295924518885713,"FADS2,GCKR,GALNT2,DOCK7,LPL,PCSK7,APOB",GWAS_Catalog_2023
259,Cholesteryl Esters To Total Lipids Ratio In Medium HDL,0.00023175408643573702,6.580947085534241,55.08143283081537,0.0021295924518885713,"FADS2,GCKR,GALNT2,DOCK7,LPL,PCSK7,DDB2",GWAS_Catalog_2023
260,Alzheimer's Disease Or Educational Attainment (Pleiotropy),0.00023205952954359957,4.39358372456964,36.76777844833031,0.0021295924518885713,"CEP57,SPRED2,MEF2C,KANSL1,BCL11A,DENND4A,ARIH2,MAPT,RBM23,RHOA",GWAS_Catalog_2023
261,Coronary Artery Disease Or Fibrinogen Levels (Pleiotropy),0.00024289672439518534,5.525835037491479,45.99082990817145,0.0022205041548157556,"SCGN,LEPR,SNX13,NLRP3,ZSCAN26,APOE,IL6R,SH2B3",GWAS_Catalog_2023
262,Age Of Onset Of Adult Onset Asthma,0.000251579584085909,8.07661717921527,66.93699356361212,0.0022651656136942603,"TLR1,NDFIP1,PTPRC,PABPC4,BTN3A2,HDAC7",GWAS_Catalog_2023
263,Free Cholesterol To Total Lipids Ratio In Large VLDL,0.000251579584085909,8.07661717921527,66.93699356361212,0.0022651656136942603,"FADS2,GALNT2,LPL,PCSK7,APOE,UBE2L3",GWAS_Catalog_2023
264,Phospholipids To Total Lipids Ratio In Medium VLDL,0.000251579584085909,8.07661717921527,66.93699356361212,0.0022651656136942603,"HELZ2,MFHAS1,MSRA,GCKR,LPL,APOB",GWAS_Catalog_2023
265,Cholesterol To Total Lipids Ratio In Small HDL,0.000251579584085909,8.07661717921527,66.93699356361212,0.0022651656136942603,"FADS2,GCKR,DOCK7,SNX13,PCSK7,APOE",GWAS_Catalog_2023
266,"Allergic Disease (Asthma, Hay Fever Or Eczema)",0.00025698060059419696,4.332133058984911,35.81162108008942,0.002305096665480278,"TLR1,RTEL1-TNFRSF6B,RTEL1,NDFIP1,ZBTB38,ZNF217,JAK2,IL6R,SPPL3,HDAC7",GWAS_Catalog_2023
267,Cholesterol To Total Lipids Ratio In Very Small VLDL,0.00027195692277912764,6.3867602086706246,52.43445108432981,0.0024032933990777725,"MACF1,GCKR,GALNT2,LPL,PCSK7,TRIB1,APOB",GWAS_Catalog_2023
268,Triglyceride Levels In IDL,0.00027195692277912764,6.3867602086706246,52.43445108432981,0.0024032933990777725,"GCKR,CCND2,GALNT2,DOCK7,LPL,PCSK7,APOB",GWAS_Catalog_2023
269,Phospholipid Levels In Very Large HDL,0.00027195692277912764,6.3867602086706246,52.43445108432981,0.0024032933990777725,"FADS2,MSRA,GCKR,GALNT2,LPL,PCSK7,PLTP",GWAS_Catalog_2023
270,Total Lipid Levels In Very Large HDL,0.00027195692277912764,6.3867602086706246,52.43445108432981,0.0024032933990777725,"RP1L1,FADS2,GCKR,GALNT2,LPL,PCSK7,PLTP",GWAS_Catalog_2023
271,Aspartate Aminotransferase To Alanine Aminotransferase Ratio,0.0002841045539529788,4.272365973279215,34.88885931992763,0.0025013781023313923,"FTO,DNMBP,ABCC2,TOMM40,SAMM50,ZNF827,PPARG,HSD17B13,APOE,JARID2",GWAS_Catalog_2023
272,Protein Wnt-5a Levels,0.000303133778816608,46.11480362537765,373.59153422151684,0.002527684662049555,"DOCK7,LPL,BUD13",GWAS_Catalog_2023
273,Hepcidin Levels,0.000303133778816608,46.11480362537765,373.59153422151684,0.002527684662049555,"TF,TMPRSS6,HFE",GWAS_Catalog_2023
274,Prion Diseases,0.000303133778816608,46.11480362537765,373.59153422151684,0.002527684662049555,"MFHAS1,ZBTB38,CPEB4",GWAS_Catalog_2023
275,1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4) Levels,0.000303133778816608,46.11480362537765,373.59153422151684,0.002527684662049555,"FADS2,BUD13,SIDT2",GWAS_Catalog_2023
276,IDP SWI T2star Left Putamen,0.000303133778816608,46.11480362537765,373.59153422151684,0.002527684662049555,"SLC25A37,TF,HFE",GWAS_Catalog_2023
277,IDP SWI T2star Right Putamen,0.000303133778816608,46.11480362537765,373.59153422151684,0.002527684662049555,"SLC25A37,TF,HFE",GWAS_Catalog_2023
278,IDP SWI T2star Left Caudate,0.000303133778816608,46.11480362537765,373.59153422151684,0.002527684662049555,"SLC25A37,TF,HFE",GWAS_Catalog_2023
279,Glioblastoma (Age-Stratified),0.000303133778816608,46.11480362537765,373.59153422151684,0.002527684662049555,"RTEL1-TNFRSF6B,RTEL1,TERT",GWAS_Catalog_2023
280,Diacylglycerol 44:7 [M+H-H2O]1+ Levels,0.000303133778816608,46.11480362537765,373.59153422151684,0.002527684662049555,"GCKR,LPL,BUD13",GWAS_Catalog_2023
281,Fasting Blood Insulin Adjusted For BMI,0.000303133778816608,46.11480362537765,373.59153422151684,0.002527684662049555,"GCKR,PPARG,GPN1",GWAS_Catalog_2023
282,Total Lysophosphatidylethanolamine Levels,0.000303133778816608,46.11480362537765,373.59153422151684,0.002527684662049555,"FADS2,APOE,SIDT2",GWAS_Catalog_2023
283,Sphingomyelin 34:2 [M+H]1+ Levels,0.000303133778816608,46.11480362537765,373.59153422151684,0.002527684662049555,"FADS2,GCKR,LPL",GWAS_Catalog_2023
284,1-stearoyl-2-linoleoyl-GPI (18:0/18:2) Levels,0.000303133778816608,46.11480362537765,373.59153422151684,0.002527684662049555,"FADS2,DOCK7,BUD13",GWAS_Catalog_2023
285,1-stearoyl-2-arachidonoyl-GPI (18:0/20:4) Levels,0.000303133778816608,46.11480362537765,373.59153422151684,0.002527684662049555,"FADS2,DOCK7,BUD13",GWAS_Catalog_2023
286,1-stearoyl-2-oleoyl-GPE (18:0/18:1) Levels,0.000303133778816608,46.11480362537765,373.59153422151684,0.002527684662049555,"FADS2,GCKR,BUD13",GWAS_Catalog_2023
287,Free Cholesterol To Total Lipids Ratio In Very Small VLDL,0.0003061613023186594,7.739329268292683,62.62199694717237,0.002527684662049555,"FADS2,MFHAS1,MSRA,GCKR,DOCK7,APOE",GWAS_Catalog_2023
288,Cutaneous Melanoma (MTAG),0.0003061613023186594,7.739329268292683,62.62199694717237,0.002527684662049555,"FTO,RTEL1-TNFRSF6B,RTEL1,DSTYK,CDH1,ATP11A",GWAS_Catalog_2023
289,Phospholipids To Total Lipids Ratio In Small HDL,0.0003061613023186594,7.739329268292683,62.62199694717237,0.002527684662049555,"KANSL1,GALNT2,DOCK7,NPHP3,HSD17B13,APOB",GWAS_Catalog_2023
290,HDL Cholesterol Levels In Current Drinkers,0.0003175809956479513,6.203669724770642,49.96918035725459,0.002612925019365558,"FADS2,GALNT2,DOCK7,SNX13,LPL,SH2B3,UBE2L3",GWAS_Catalog_2023
291,Iron Status Biomarkers (Ferritin Levels),0.00032862729414395416,10.296859169199594,82.58684752269625,0.002685290150094091,"RP1L1,GCKR,TMPRSS6,HFE,HK1",GWAS_Catalog_2023
292,Pyruvate Levels,0.00032862729414395416,10.296859169199594,82.58684752269625,0.002685290150094091,"HBS1L,GCKR,C18ORF25,BCL11A,RSRP1",GWAS_Catalog_2023
293,Eczema,0.00034929861025445103,3.8172686618507052,30.383868216254417,0.0028444589899901717,"TLR1,RTEL1-TNFRSF6B,AHI1,RTEL1,PTPRC,ZBTB38,PRDM16,ZNF217,ICAM5,IL6R,SPPL3",GWAS_Catalog_2023
294,Triglycerides To Total Lipids Ratio In Very Large HDL,0.00036914670867321223,6.030750934420659,47.668963566272254,0.002989454962068031,"FADS2,GCKR,CCND2,GALNT2,DOCK7,LPL,PCSK7",GWAS_Catalog_2023
295,Free Cholesterol Levels In Medium VLDL,0.0003696098968189728,7.429024390243902,58.712043635135004,0.002989454962068031,"GCKR,DOCK7,LPL,PCSK7,APOE,APOB",GWAS_Catalog_2023
296,Dyslipidemia,0.0004047313640015722,15.409090909090908,120.38024074036545,0.0032624629544180783,"GCKR,BUD13,APOE,APOB",GWAS_Catalog_2023
297,Triglyceride Levels In Non-Type 2 Diabetes,0.0004099297755175138,3.283639835192443,25.610829974748444,0.003293240553484134,"MACF1,IL1RN,THRB,GALNT2,DOCK7,TEX35,SNX13,FADS2,CCND2,AXL,PPARG,STX4,APOB",GWAS_Catalog_2023
298,LDL Cholesterol Levels X Long Total Sleep Time Interaction (2Df Test),0.000420190082639675,9.652355623100304,75.04516704000488,0.0033530887531045637,"KANK2,FADS2,TOMM40,DOCK7,APOB",GWAS_Catalog_2023
299,Circulating Docosahexaenoic Acid Levels,0.000420190082639675,9.652355623100304,75.04516704000488,0.0033530887531045637,"GCKR,KANSL1,GALNT2,LPL,APOE",GWAS_Catalog_2023
300,Cholesterol Levels In Large HDL,0.0004272026385051014,5.867179105711216,45.519054583117196,0.003397684984910573,"FADS2,GCKR,GALNT2,LPL,PCSK7,APOB,UBE2L3",GWAS_Catalog_2023
301,Cholesterol To Total Lipids Ratio In Large VLDL,0.0004428927778560465,7.142589118198874,55.156379219272544,0.0035107713221412856,"HELZ2,MSRA,GCKR,SAMM50,LPL,PPARG",GWAS_Catalog_2023
302,Cholesteryl Ester Levels In Large HDL,0.0004923254486984088,5.712216320618059,43.50635632558076,0.0038896970880609384,"FADS2,GCKR,GALNT2,LPL,PCSK7,APOB,UBE2L3",GWAS_Catalog_2023
303,Cholesterol Levels In Small VLDL,0.0005270283321468798,6.877371273712737,51.91216069816133,0.004136478949021234,"GCKR,GALNT2,DOCK7,LPL,PCSK7,APOB",GWAS_Catalog_2023
304,Phospholipid Levels In Small VLDL,0.0005270283321468798,6.877371273712737,51.91216069816133,0.004136478949021234,"GCKR,GALNT2,DOCK7,LPL,PCSK7,APOB",GWAS_Catalog_2023
305,Free Cholesterol Levels In Small HDL,0.0005297501617941013,9.08367602360093,68.51912253523957,0.004144209462428609,"GCKR,CCND2,DOCK7,UBE2L3,CTSB",GWAS_Catalog_2023
306,Mean Sphered Cell Volume,0.0005700452404067419,13.695622895622895,102.3034931151118,0.004444862560818582,"SPTA1,TF,NPRL3,NKX2-3",GWAS_Catalog_2023
307,Lamb Consumption,0.0005919929148545868,30.740181268882175,228.46151569186478,0.004556435789816271,"MEF2C,VRK2,APOE",GWAS_Catalog_2023
308,Phosphatidylcholine-O 32:1 [M+H]1+/Phosphatidylcholine-P 32:0 [M+H]1+/Phosphatidylethanolamine-O 35:1 [M+H]1+ Levels,0.0005919929148545868,30.740181268882175,228.46151569186478,0.004556435789816271,"GCKR,LPL,BUD13",GWAS_Catalog_2023
309,Phosphatidylcholine-O 34:1 [M+H]1+/Phosphatidylcholine-P 34:0 [M+H]1+/Phosphatidylethanolamine-O 37:1 [M+H]1+ Levels,0.0005919929148545868,30.740181268882175,228.46151569186478,0.004556435789816271,"GCKR,LPL,BUD13",GWAS_Catalog_2023
310,Sphingomyelin 36:2 [M+H]1+ Levels,0.0005919929148545868,30.740181268882175,228.46151569186478,0.004556435789816271,"FADS2,LPL,BUD13",GWAS_Catalog_2023
311,Total Fatty Acid Levels,0.0006230844235638044,6.6310975609756095,48.94299410980775,0.004734647880965724,"MSRA,GCKR,CCND2,DOCK7,LPL,APOB",GWAS_Catalog_2023
312,VLDL Cholesterol Levels,0.0006230844235638044,6.6310975609756095,48.94299410980775,0.004734647880965724,"GCKR,GALNT2,DOCK7,LPL,PCSK7,APOB",GWAS_Catalog_2023
313,Concentration Of VLDL Particles,0.0006230844235638044,6.6310975609756095,48.94299410980775,0.004734647880965724,"GCKR,GALNT2,DOCK7,LPL,PCSK7,APOB",GWAS_Catalog_2023
314,Sphingomyelin Levels,0.0006230844235638044,6.6310975609756095,48.94299410980775,0.004734647880965724,"FADS2,GCKR,GALNT2,PABPC4,LPL,APOE",GWAS_Catalog_2023
315,Blood Glucose Levels,0.0006462176371549506,5.425535168195719,39.847160571792095,0.004894842165878451,"FTO,FADS2,GIGYF1,GCKR,CCND2,ZBTB38,PRDM16",GWAS_Catalog_2023
316,Triglyceride Levels X Long Total Sleep Time Interaction (2Df Test),0.0006594573572003917,8.578183046268153,62.82741252228215,0.004936902084170858,"GCKR,TOMM40,GALNT2,DOCK7,LPL",GWAS_Catalog_2023
317,Concentration Of Medium LDL Particles,0.0006594573572003917,8.578183046268153,62.82741252228215,0.004936902084170858,"GCKR,HFE,DOCK7,APOE,APOB",GWAS_Catalog_2023
318,Cholesteryl Ester Levels In Small HDL,0.0006594573572003917,8.578183046268153,62.82741252228215,0.004936902084170858,"MSRA,GCKR,PABPC4,DOCK7,LEPR",GWAS_Catalog_2023
319,Basophil Count,0.0006614031477739053,3.1060141257045015,22.73958599267172,0.004936902084170858,"PTPN1,NDFIP1,HELZ2,SPRED2,SLC25A15,DSTYK,ELF1,ERI1,MYB,NLRP3,JAK2,SH2B3,CTSB",GWAS_Catalog_2023
320,Monocyte Count,0.0006621159542894696,2.1414440481797996,15.675520033590281,0.004936902084170858,"HBS1L,GYPA,THRB,MAST2,ZNF391,UBE2L3,SPTA1,CCND3,ACOXL,C18ORF25,BCL2L11,SERTAD2,ZMIZ2,MYB,SH2B3,IL6R,GCKR,MEF2C,DENND4A,NSMCE2,U2SURP,DDB2,ASXL1,AHI1,KIT,TMCC2",GWAS_Catalog_2023
321,Ulcerative Colitis,0.000713236609164597,3.7539045069165553,27.199655909536343,0.005301503269366755,"RTEL1-TNFRSF6B,RTEL1,NDFIP1,PTPRC,PRDM16,TMBIM1,EPHB4,ZFP90,UBE2L3,HDAC7",GWAS_Catalog_2023
322,Autism Spectrum Disorder Or Schizophrenia,0.0007362787166883879,5.2926829268292686,38.18089499730918,0.005455779559063644,"BTN3A1,BTN2A1,HFE,ZSCAN9,ZKSCAN3,VRK2,BTN3A2",GWAS_Catalog_2023
323,Ratio Of Docosahexaenoic Acid To Total Fatty Acid Levels,0.0007781987854220331,12.324848484848484,88.22777985388169,0.005748552018628393,"KANSL1,GALNT2,LPL,APOB",GWAS_Catalog_2023
324,Neuroticism,0.0007890250905237159,2.67362505018065,19.10228214847189,0.0058105366234246485,"BLK,MEF2C,UBXN2A,BTN2A1,GALNT2,HFE,BTN3A2,VRK2,ARHGAP27,RP1L1,MSRA,MFHAS1,FAM167A,KANSL1,ERI1,MAPT",GWAS_Catalog_2023
325,HDL Cholesterol X Physical Activity Interaction (2Df Test),0.0008115465901635193,8.125899856023036,57.82852506434653,0.005885562808906252,"GALNT2,PABPC4,SNX13,UBE2L3,DDB2",GWAS_Catalog_2023
326,Fibrinogen Levels Or Factor VII Levels Or Factor XI Levels Or Tissue Plasminogen Activator Levels (Pleiotropy),0.0008115465901635193,8.125899856023036,57.82852506434653,0.005885562808906252,"GCKR,LEPR,SNX13,NLRP3,IL6R",GWAS_Catalog_2023
327,Triglyceride Levels In Very Large HDL,0.0008115465901635193,8.125899856023036,57.82852506434653,0.005885562808906252,"GCKR,THRB,DOCK7,LPL,CTSB",GWAS_Catalog_2023
328,Total Lipid Levels In Medium LDL,0.0008115465901635193,8.125899856023036,57.82852506434653,0.005885562808906252,"GCKR,GALNT2,HFE,DOCK7,APOB",GWAS_Catalog_2023
329,Ratio Of Omega-6 Fatty Acids To Total Fatty Acids,0.0008115465901635193,8.125899856023036,57.82852506434653,0.005885562808906252,"GCKR,GALNT2,DOCK7,LPL,PCSK7",GWAS_Catalog_2023
330,Cognitive Aspects Of Educational Attainment,0.0008435387280215076,3.6648511256354395,25.939467166542954,0.006092964729825978,"CEP57,MEF2C,KANSL1,BCL11A,DENND4A,ZMIZ2,PPARG,BTN3A2,SLC17A1,RHOA",GWAS_Catalog_2023
331,White Matter Microstructure (Mean Diusivities),0.0008554665484038988,6.18780487804878,43.70980943901454,0.006092964729825978,"SCGN,CD82,KANSL1,ZSCAN9,MAPT,ARHGAP27",GWAS_Catalog_2023
332,Cholesteryl Ester Levels In HDL,0.0008554665484038988,6.18780487804878,43.70980943901454,0.006092964729825978,"FADS2,GALNT2,PABPC4,LPL,PCSK7,APOB",GWAS_Catalog_2023
333,Cholesteryl Ester Levels In Large VLDL,0.0008554665484038988,6.18780487804878,43.70980943901454,0.006092964729825978,"GCKR,GALNT2,DOCK7,LPL,PCSK7,APOB",GWAS_Catalog_2023
334,Cholesteryl Ester Levels In Small VLDL,0.0008554665484038988,6.18780487804878,43.70980943901454,0.006092964729825978,"GCKR,GALNT2,DOCK7,LPL,PCSK7,APOB",GWAS_Catalog_2023
335,Asthma (Adult Onset),0.0008554665484038988,6.18780487804878,43.70980943901454,0.006092964729825978,"FADS2,ACOXL,NDFIP1,PTPRC,TFRC,HDAC7",GWAS_Catalog_2023
336,Non-albumin Protein Levels,0.0008686356597537613,3.177176544899463,22.394604606144924,0.006168347274322841,"BLK,FADS2,TF,GCKR,ACOXL,TERT,MAST2,NLRP3,IL6R,SH2B3,UBE2L3,BYSL",GWAS_Catalog_2023
337,Cholesteryl Ester Levels In Small LDL,0.000988328774481877,7.718844984802431,53.41051041955582,0.006916200128001053,"GCKR,GALNT2,HFE,DOCK7,APOB",GWAS_Catalog_2023
338,Phosphoglycerides Levels,0.000988328774481877,7.718844984802431,53.41051041955582,0.006916200128001053,"GCKR,GALNT2,DOCK7,UBE2L3,CTSB",GWAS_Catalog_2023
339,Free Cholesterol To Total Lipids Ratio In Large HDL,0.0009941592348822398,5.987608182533438,41.396006776061505,0.006916200128001053,"MSRA,GCKR,BCL2L11,PPARG,PCSK7,PLTP",GWAS_Catalog_2023
340,Triacylglycerol 52:3 [M+NH4]1+ Levels,0.0010065873059180376,inf,inf,0.006916200128001053,"LPL,BUD13",GWAS_Catalog_2023
341,Triacylglycerol 52:2 [M+NH4]1+ Levels,0.0010065873059180376,inf,inf,0.006916200128001053,"LPL,BUD13",GWAS_Catalog_2023
342,Cholesteryl Ester (16:0) Levels,0.0010065873059180376,inf,inf,0.006916200128001053,"FADS2,APOE",GWAS_Catalog_2023
343,Phosphatidylcholine Acyl-Alkyl C36:2 Levels,0.0010065873059180376,inf,inf,0.006916200128001053,"FADS2,DOCK7",GWAS_Catalog_2023
344,1-myristoyl-2-arachidonoyl-GPC (14:0/20:4) Levels,0.0010065873059180376,inf,inf,0.006916200128001053,"FADS2,GCKR",GWAS_Catalog_2023
345,High IL-1beta Levels In Gingival Crevicular Fluid,0.0010116319550177567,23.052870090634443,158.97698268116935,0.006916200128001053,"IL1RN,IL37,PSD4",GWAS_Catalog_2023
346,Alcohol Use Disorder (Total Score),0.0010116319550177567,23.052870090634443,158.97698268116935,0.006916200128001053,"GCKR,SLC39A13,MAPT",GWAS_Catalog_2023
347,Cholesteryl Ester (18:3) Levels,0.0010116319550177567,23.052870090634443,158.97698268116935,0.006916200128001053,"FADS2,APOB,SIDT2",GWAS_Catalog_2023
348,Total Cholesteryl Ester Levels,0.0010116319550177567,23.052870090634443,158.97698268116935,0.006916200128001053,"FADS2,APOE,SIDT2",GWAS_Catalog_2023
349,Proprotein Convertase Subtilisin/Kexin Type 7 Levels,0.0010116319550177567,23.052870090634443,158.97698268116935,0.006916200128001053,"TAGLN,PCSK7,SIDT2",GWAS_Catalog_2023
350,Cholesteryl Esters To Total Lipids Ratio In Large VLDL,0.0011495013777876424,5.799923780487805,39.25636080174819,0.00776971752804905,"HELZ2,MSRA,GCKR,GALNT2,LPL,PPARG",GWAS_Catalog_2023
351,Cholesterol To Total Lipids Ratio In Small VLDL,0.0011495013777876424,5.799923780487805,39.25636080174819,0.00776971752804905,"HELZ2,MFHAS1,MSRA,GCKR,LPL,APOB",GWAS_Catalog_2023
352,Phospholipid Levels In VLDL,0.0011495013777876424,5.799923780487805,39.25636080174819,0.00776971752804905,"GCKR,GALNT2,DOCK7,LPL,PCSK7,APOB",GWAS_Catalog_2023
353,Phospholipid Levels In Large HDL,0.0011495013777876424,5.799923780487805,39.25636080174819,0.00776971752804905,"FADS2,GALNT2,LPL,PCSK7,APOB,UBE2L3",GWAS_Catalog_2023
354,Total Lipid Levels In Large LDL,0.0011921815408100036,7.350557244174265,49.483733957395316,0.0080128032573878,"GCKR,HFE,DOCK7,APOE,APOB",GWAS_Catalog_2023
355,Cholesterol Levels In Small LDL,0.0011921815408100036,7.350557244174265,49.483733957395316,0.0080128032573878,"GCKR,GALNT2,DOCK7,RSRP1,APOB",GWAS_Catalog_2023
356,Triglycerides To Total Lipids Ratio In Large HDL,0.0013227786389526186,5.623614190687362,37.273431407217736,0.008865589417249855,"FADS2,GCKR,GALNT2,DOCK7,LPL,PCSK7",GWAS_Catalog_2023
357,Serum 25-Hydroxyvitamin D Levels,0.0013564094043361226,3.4211775878442543,22.589742124869332,0.009065526158952349,"FTO,SCGN,GCKR,GALNT2,MAST2,DOCK7,ADAR,APOE,APOB,RHOA",GWAS_Catalog_2023
358,LDL Cholesterol Levels X Short Total Sleep Time Interaction (2Df Test),0.0014255398662648474,7.015750207239569,45.97564711627271,0.00944816144696646,"KANK2,ZNF827,DOCK7,APOE,APOB",GWAS_Catalog_2023
359,Saturated Fatty Acid Levels,0.0014255398662648474,7.015750207239569,45.97564711627271,0.00944816144696646,"MSRA,GCKR,CCND2,DOCK7,APOB",GWAS_Catalog_2023
360,Principal Component-Derived Dietary Pattern 1,0.0014255398662648474,7.015750207239569,45.97564711627271,0.00944816144696646,"FTO,AKAP10,BCL11A,ZBTB38,AGAP1",GWAS_Catalog_2023
361,Liver Enzyme Levels (Gamma-Glutamyl Transferase),0.0014947842201232507,3.145936887550771,20.466752574343438,0.00987965415294758,"GCKR,ABCC2,ZNF827,ALDH2,SERTAD2,ZMIZ2,DLG5,CEBPG,ZFP91,PPARG,HSD17B13",GWAS_Catalog_2023
362,Free Cholesterol Levels In Large HDL,0.0015153131256205193,5.457675753228121,35.431957831201494,0.009932794279479558,"FADS2,GCKR,GALNT2,LPL,PCSK7,APOB",GWAS_Catalog_2023
363,Cognitive Ability (MTAG),0.0015153131256205193,5.457675753228121,35.431957831201494,0.009932794279479558,"CEP57,MEF2C,DENND4A,BCL11A,MAPT,RBM23",GWAS_Catalog_2023
364,Triglycerides To Total Lipids Ratio In Small HDL,0.0015153131256205193,5.457675753228121,35.431957831201494,0.009932794279479558,"FADS2,GCKR,GALNT2,DOCK7,LPL,PCSK7",GWAS_Catalog_2023
365,C-reactive Protein Levels Or Triglyceride Levels (Pleiotropy),0.0015806168266557857,18.4404833836858,118.94001345207991,0.010332470543563574,"FADS2,GCKR,ADAR",GWAS_Catalog_2023
366,Diastolic Blood Pressure,0.0016429760350875771,1.921051912568306,12.316336440391172,0.010710767266991692,"FTO,RTEL1,MAST3,HFE,HDAC7,SCGN,ALDH2,TERT,PSD4,PRDM16,CLDN23,MYB,SLC17A1,SH2B3,SLC17A3,RTEL1-TNFRSF6B,MEF2C,BTN3A1,SMOX,DUSP1,PABPC4,ZBTB38,ZFP91,MYO9B,MFHAS1,MSRA,SLC25A37,MAPT,CPEB4",GWAS_Catalog_2023
367,Cholesterol Levels In Large LDL,0.0016908866802507084,6.710056825690498,42.82695261826485,0.0109631946170603,"GCKR,HFE,DOCK7,APOE,APOB",GWAS_Catalog_2023
368,Total Lipid Levels In Small LDL,0.0016908866802507084,6.710056825690498,42.82695261826485,0.0109631946170603,"GCKR,GALNT2,DOCK7,RSRP1,LPL",GWAS_Catalog_2023
369,Blood Urea Nitrogen Levels,0.0019565130302500863,2.7258985134541804,17.00031537990291,0.012628488041911507,"FTO,GCKR,TNK2,SUSD1,TFEB,C12ORF43,MRPL33,DDB2,THBS3,CCND3,APOE,PDE7A,SH2B3",GWAS_Catalog_2023
370,Cutaneous Malignant Melanoma,0.0019636081573969695,5.153455284552845,32.12134043812593,0.012628488041911507,"FTO,RTEL1-TNFRSF6B,RTEL1,TERT,CDH1,ATP11A",GWAS_Catalog_2023
371,Mitochondrial DNA Levels,0.0019636081573969695,5.153455284552845,32.12134043812593,0.012628488041911507,"TRABD,RCL1,HBS1L,MEF2C,TERT,PRDM16",GWAS_Catalog_2023
372,Medication Use For Hyperlipidemia (Number Of Purchases),0.001990743510949224,6.42983789260385,39.988750579813484,0.012768586067539915,"HBS1L,FADS2,DOCK7,APOE,APOB",GWAS_Catalog_2023
373,Hematological And Biochemical Traits,0.002151335854860353,8.8,54.04666345711396,0.013579596163219054,"HBS1L,GCKR,ALDH2,TMPRSS6",GWAS_Catalog_2023
374,Fibrinogen Levels Or Tissue Plasminogen Activator Levels (Pleiotropy),0.002151335854860353,8.8,54.04666345711396,0.013579596163219054,"LEPR,SNX13,NLRP3,IL6R",GWAS_Catalog_2023
375,Glioma,0.002151335854860353,8.8,54.04666345711396,0.013579596163219054,"RTEL1-TNFRSF6B,RTEL1,TERT,HEATR3",GWAS_Catalog_2023
376,Systolic Blood Pressure X Alcohol Consumption (Light Vs Heavy) Interaction (2Df Test),0.002151335854860353,8.8,54.04666345711396,0.013579596163219054,"RP1L1,MSRA,FAM167A,SH2B3",GWAS_Catalog_2023
377,Aspartate Aminotransferase Platelet Ratio Index In High Alcohol Intake,0.002151335854860353,8.8,54.04666345711396,0.013579596163219054,"TRABD,HBS1L,FADS2,HSD17B13",GWAS_Catalog_2023
378,Cholesterol To Total Lipids Ratio In Medium LDL,0.002151335854860353,8.8,54.04666345711396,0.013579596163219054,"GCKR,GALNT2,PABPC4,LPL",GWAS_Catalog_2023
379,Respiratory Diseases,0.0022933161621878006,4.250704563170834,25.83474687671529,0.014437605179366998,"TLR1,RTEL1-TNFRSF6B,AHI1,RTEL1,PTPRC,TFRC,IL6R",GWAS_Catalog_2023
380,Myeloproliferative Neoplasms,0.002315358484185784,15.365558912386707,93.24114247074891,0.0144512882317325,"TERT,JAK2,SH2B3",GWAS_Catalog_2023
381,Hemolysis Of Donated Blood (Osmotic),0.002315358484185784,15.365558912386707,93.24114247074891,0.0144512882317325,"SPTA1,MYO9B,HK1",GWAS_Catalog_2023
382,Sphingomyeline C16:0 Levels,0.002315358484185784,15.365558912386707,93.24114247074891,0.0144512882317325,"FADS2,APOE,APOB",GWAS_Catalog_2023
383,Neutrophil Percentage Of Granulocytes,0.0023197164261330875,3.759806655512177,22.80815395648128,0.0144512882317325,"BRD3,HBS1L,BCL2L11,NDFIP1,KANSL1,PPARG,JAK2,KLF3",GWAS_Catalog_2023
384,Waist Circumference Adjusted For Body Mass Index,0.002471868557674713,1.8062091963740547,10.842278089352623,0.015359058277635068,"BLK,MACF1,MAST3,ZAN,DMKN,SPPL3,THBS3,HDAC7,SCGN,ACOXL,CCND2,BCL2L11,ERI1,ARIH2,CTSB,MAP2K2,PABPC4,ZBTB38,NSMCE2,TFEB,MYO9B,VRK2,RHOA,RP1L1,MFHAS1,MSRA,FAM167A,PPARG,MAPT,CRLF3,TRIB1,CPEB4",GWAS_Catalog_2023
385,Cholesterol To Total Lipids Ratio In Large LDL,0.0027042109213432997,5.934065934065934,35.08780620889682,0.016480045453146915,"FADS2,GCKR,PABPC4,SNX13,LPL",GWAS_Catalog_2023
386,Venous Thromboembolism Or Fibrinogen Levels (Pleiotropy),0.0027042109213432997,5.934065934065934,35.08780620889682,0.016480045453146915,"LEPR,SNX13,NLRP3,IL6R,SH2B3",GWAS_Catalog_2023
387,Triglyceride Levels In Current Drinkers,0.0027042109213432997,5.934065934065934,35.08780620889682,0.016480045453146915,"FADS2,GALNT2,DOCK7,LPL,SNX13",GWAS_Catalog_2023
388,Nevus Count Or Cutaneous Melanoma,0.0028153208707267564,4.75562851782364,27.92827990836662,0.016480045453146915,"FTO,RTEL1-TNFRSF6B,RTEL1,TMCC2,ATP11A,JARID2",GWAS_Catalog_2023
389,Pancreatic Cancer,0.0028153208707267564,4.75562851782364,27.92827990836662,0.016480045453146915,"MYO1D,DOK2,TERT,TEX33,SNRNP25,APOB",GWAS_Catalog_2023
390,Medication Use (Agents Acting On The Renin-Angiotensin System),0.0029366667197651426,3.288217194570136,19.17188494905479,0.016480045453146915,"FTO,MSRA,MFHAS1,HFE,PRDM16,MYO9B,APOE,SH2B3,HDAC7",GWAS_Catalog_2023
391,Dehydroepiandrosterone Sulphate Levels,0.0029561858566416093,61.30722891566265,357.04443639417775,0.016480045453146915,"TRIM4,ARPC1A",GWAS_Catalog_2023
392,Uterine Fibroids And Heavy Menstrual Bleeding,0.0029561858566416093,61.30722891566265,357.04443639417775,0.016480045453146915,"TERT,SIRT3",GWAS_Catalog_2023
393,Nonatopic Asthma Or Type 2 Diabetes,0.0029561858566416093,61.30722891566265,357.04443639417775,0.016480045453146915,"FADS2,PABPC4",GWAS_Catalog_2023
394,G Ruminococcus Prevalence,0.0029561858566416093,61.30722891566265,357.04443639417775,0.016480045453146915,"ACOXL,SEZ6",GWAS_Catalog_2023
395,Cooked Vegetable Consumption,0.0029561858566416093,61.30722891566265,357.04443639417775,0.016480045453146915,"MSRA,MFHAS1",GWAS_Catalog_2023
396,Non-oily Fish Consumption,0.0029561858566416093,61.30722891566265,357.04443639417775,0.016480045453146915,"FTO,GCKR",GWAS_Catalog_2023
397,Fasting Total Lipids In Very Small VLDL,0.0029561858566416093,61.30722891566265,357.04443639417775,0.016480045453146915,"DOCK7,APOE",GWAS_Catalog_2023
398,"Fasting Monounsaturated Fatty Acids (16:1, 18:1)",0.0029561858566416093,61.30722891566265,357.04443639417775,0.016480045453146915,"LPL,APOE",GWAS_Catalog_2023
399,Fasting Omega-3 Fatty Acids,0.0029561858566416093,61.30722891566265,357.04443639417775,0.016480045453146915,"FADS2,APOE",GWAS_Catalog_2023
400,Postprandial Very Small VLDL Particle Concentration,0.0029561858566416093,61.30722891566265,357.04443639417775,0.016480045453146915,"LPL,APOE",GWAS_Catalog_2023
401,Medication Use (Anilides),0.0029561858566416093,61.30722891566265,357.04443639417775,0.016480045453146915,"KANSL1,MAPT",GWAS_Catalog_2023
402,Myeloid Clonal Hematopoiesis,0.0029561858566416093,61.30722891566265,357.04443639417775,0.016480045453146915,"TERT,JAK2",GWAS_Catalog_2023
403,Apolipoprotein C-III Levels,0.0029561858566416093,61.30722891566265,357.04443639417775,0.016480045453146915,"GCKR,DOCK7",GWAS_Catalog_2023
404,Postprandial Triglyceride Levels,0.0029561858566416093,61.30722891566265,357.04443639417775,0.016480045453146915,"GCKR,LPL",GWAS_Catalog_2023
405,Inactive Gamma-Glutamyltranspeptidase 2 Levels,0.0029561858566416093,61.30722891566265,357.04443639417775,0.016480045453146915,"GCKR,APOE",GWAS_Catalog_2023
406,X-24870 Levels,0.0029561858566416093,61.30722891566265,357.04443639417775,0.016480045453146915,"FADS2,APOE",GWAS_Catalog_2023
407,Transmembrane And Coiled-Coil Domains Protein 3 Levels,0.0029561858566416093,61.30722891566265,357.04443639417775,0.016480045453146915,"GCKR,APOE",GWAS_Catalog_2023
408,Phosphatidylcholine-O 31:0 [M+H]1+/Phosphatidylethanolamine-O 34:0 [M+H]1+ Levels,0.0029561858566416093,61.30722891566265,357.04443639417775,0.016480045453146915,"GCKR,BUD13",GWAS_Catalog_2023
409,5-Methyluridine (Ribothymidine) Levels,0.0029561858566416093,61.30722891566265,357.04443639417775,0.016480045453146915,"CPT1B,TYMP",GWAS_Catalog_2023
410,Phosphatidylcholine(32:0) [M+H]1+/Phosphatidylethanolamine(35:0) [M+H]1+/Phosphatidate(37:1) [M+NH4]1+ Levels,0.0029561858566416093,61.30722891566265,357.04443639417775,0.016480045453146915,"FADS2,BUD13",GWAS_Catalog_2023
411,Phosphatidylcholine-2O 32:0 [M+H]1+ Levels,0.0029561858566416093,61.30722891566265,357.04443639417775,0.016480045453146915,"GCKR,BUD13",GWAS_Catalog_2023
412,Diacylglycerol(36:3) [M+H-H2O]1+ Levels,0.0029561858566416093,61.30722891566265,357.04443639417775,0.016480045453146915,"FADS2,BUD13",GWAS_Catalog_2023
413,Cholesteryl Ester(16:0) [M+NH4]1+ Levels,0.0029561858566416093,61.30722891566265,357.04443639417775,0.016480045453146915,"FADS2,BUD13",GWAS_Catalog_2023
414,Cholesteryl Ester(18:3) [M+NH4]1+ Levels,0.0029561858566416093,61.30722891566265,357.04443639417775,0.016480045453146915,"FADS2,BUD13",GWAS_Catalog_2023
415,Cholesteryl Ester(20:4) [M+NH4]1+ Levels,0.0029561858566416093,61.30722891566265,357.04443639417775,0.016480045453146915,"FADS2,BUD13",GWAS_Catalog_2023
416,Triacylglycerol 52:6 [M+NH4]1+ Levels,0.0029561858566416093,61.30722891566265,357.04443639417775,0.016480045453146915,"FADS2,GCKR",GWAS_Catalog_2023
417,Triacylglycerol(54:3) [M+NH4]1+ Levels,0.0029561858566416093,61.30722891566265,357.04443639417775,0.016480045453146915,"FADS2,BUD13",GWAS_Catalog_2023
418,Phosphatidylinositol (36:2) Levels,0.0029561858566416093,61.30722891566265,357.04443639417775,0.016480045453146915,"FADS2,DOCK7",GWAS_Catalog_2023
419,Phosphatidylinositol (15-MHDA 18:2) levels/Phosphatidylinositol (17:0 18:2) Levels,0.0029561858566416093,61.30722891566265,357.04443639417775,0.016480045453146915,"FADS2,DOCK7",GWAS_Catalog_2023
420,Alkylphosphatidylcholine (O-38:5) Levels,0.0029561858566416093,61.30722891566265,357.04443639417775,0.016480045453146915,"MACF1,FADS2",GWAS_Catalog_2023
421,Phosphatidylcholine Diacyl C36:4 Levels,0.0029561858566416093,61.30722891566265,357.04443639417775,0.016480045453146915,"FADS2,DOCK7",GWAS_Catalog_2023
422,Phosphatidylcholine Diacyl C38:4 Levels,0.0029561858566416093,61.30722891566265,357.04443639417775,0.016480045453146915,"FADS2,DOCK7",GWAS_Catalog_2023
423,Sphingomyelin 36:1 [M+H]1+ Levels,0.0029561858566416093,61.30722891566265,357.04443639417775,0.016480045453146915,"LPL,BUD13",GWAS_Catalog_2023
424,lysoPhosphatidylcholine Acyl C20:3 Levels,0.0029561858566416093,61.30722891566265,357.04443639417775,0.016480045453146915,"FADS2,GCKR",GWAS_Catalog_2023
425,Phosphatidylcholine Diacyl C34:4 Levels,0.0029561858566416093,61.30722891566265,357.04443639417775,0.016480045453146915,"FADS2,GCKR",GWAS_Catalog_2023
426,1-palmitoyl-2-linoleoyl-GPI (16:0/18:2) Levels,0.0029561858566416093,61.30722891566265,357.04443639417775,0.016480045453146915,"FADS2,DOCK7",GWAS_Catalog_2023
427,1-stearoyl-2-oleoyl-GPI (18:0/18:1) Levels,0.0029561858566416093,61.30722891566265,357.04443639417775,0.016480045453146915,"FADS2,DOCK7",GWAS_Catalog_2023
428,2'-Deoxyuridine Levels,0.0029561858566416093,61.30722891566265,357.04443639417775,0.016480045453146915,"CPT1B,TYMP",GWAS_Catalog_2023
429,Systolic Blood Pressure,0.0029973634220529675,1.7358275641459089,10.085196745641406,0.016670650641068485,"FTO,KANK2,RTEL1,TAGLN,NUP205,HFE,ITSN1,HDAC7,CCND2,ZNF827,ALDH2,TERT,PRDM16,CLDN23,STX4,APOE,SH2B3,SLC17A3,RTEL1-TNFRSF6B,PDGFRA,SMOX,ZBTB38,ZFP91,MYO9B,ARHGAP27,GPN1,RP1L1,MFHAS1,MSRA,SLC25A37,KANSL1,TMBIM1,PPARG,MAPT,CPEB4",GWAS_Catalog_2023
430,Familial Combined Hyperlipidemia Defined By Consensus Criteria,0.0031229749912561515,5.713722841382416,32.962291138617424,0.01724865353966939,"GCKR,GALNT2,DOCK7,APOE,PLTP",GWAS_Catalog_2023
431,Cholesteryl Ester Levels In VLDL,0.0031229749912561515,5.713722841382416,32.962291138617424,0.01724865353966939,"GCKR,DOCK7,LPL,PCSK7,APOB",GWAS_Catalog_2023
432,Total Lipid Levels In Medium VLDL,0.0031229749912561515,5.713722841382416,32.962291138617424,0.01724865353966939,"GCKR,GALNT2,DOCK7,LPL,PCSK7",GWAS_Catalog_2023
433,Number Of Sexual Partners,0.003152852101623455,4.6362804878048784,26.70241548678687,0.01733342192275015,"FTO,BLK,MAST3,BCL11A,HFE,MAPT",GWAS_Catalog_2023
434,Allergic Rhinitis,0.003152852101623455,4.6362804878048784,26.70241548678687,0.01733342192275015,"TLR1,FTO,RAD50,PRDM16,ZNF217,SPPL3",GWAS_Catalog_2023
435,Triglycerides X Physical Activity Interaction (2Df Test),0.0032302567895598406,13.169184290030211,75.52782203020769,0.017449548000719017,"GCKR,DOCK7,LPL",GWAS_Catalog_2023
436,3-Hydroxybutyrate Levels,0.0032302567895598406,13.169184290030211,75.52782203020769,0.017449548000719017,"MSRA,GALNT2,APOE",GWAS_Catalog_2023
437,Hepcidin/ferritin Ratio,0.0032302567895598406,13.169184290030211,75.52782203020769,0.017449548000719017,"TMPRSS6,HFE,SLC17A3",GWAS_Catalog_2023
438,C-reactive Protein Levels Or HDL-cholesterol Levels (Pleiotropy),0.0032302567895598406,13.169184290030211,75.52782203020769,0.017449548000719017,"FTO,FADS2,PABPC4",GWAS_Catalog_2023
439,Medication Use (Calcium Channel Blockers),0.003235045685482462,3.543558282208589,20.317743456440752,0.017449548000719017,"FTO,MFHAS1,TAGLN,ALDH2,ZFP91,APOE,SH2B3,THBS3",GWAS_Catalog_2023
440,Ischemic Stroke Or Fibrinogen Levels (Pleiotropy),0.0032397945365961966,7.698484848484848,44.12960409655887,0.017449548000719017,"LEPR,NLRP3,IL6R,SH2B3",GWAS_Catalog_2023
441,Phospholipids To Total Lipids Ratio In Large LDL,0.0032397945365961966,7.698484848484848,44.12960409655887,0.017449548000719017,"GCKR,GALNT2,LPL,APOE",GWAS_Catalog_2023
442,Total Omega-3 Fatty Acid Levels,0.0032397945365961966,7.698484848484848,44.12960409655887,0.017449548000719017,"FADS2,GCKR,KANSL1,DOCK7",GWAS_Catalog_2023
443,Feeling Miserable,0.0032397945365961966,7.698484848484848,44.12960409655887,0.017449548000719017,"KANSL1,UBXN2A,VRK2,MAPT",GWAS_Catalog_2023
444,Polyunsaturated Fatty Acid Levels,0.00358653843266451,5.509118541033435,31.019465279137517,0.01910151942039625,"MSRA,GCKR,DOCK7,APOB,UBE2L3",GWAS_Catalog_2023
445,White Matter Microstructure (Axial Diusivities),0.00358653843266451,5.509118541033435,31.019465279137517,0.01910151942039625,"CD82,KANSL1,ZKSCAN3,MAPT,ARHGAP27",GWAS_Catalog_2023
446,Omega-6 Fatty Acid Levels,0.00358653843266451,5.509118541033435,31.019465279137517,0.01910151942039625,"MSRA,GCKR,DOCK7,RSRP1,UBE2L3",GWAS_Catalog_2023
447,Free Cholesterol To Total Lipids Ratio In Small HDL,0.00358653843266451,5.509118541033435,31.019465279137517,0.01910151942039625,"FADS2,DOCK7,LPL,PPARG,PCSK7",GWAS_Catalog_2023
448,Glycoprotein Acetyls Levels,0.00358653843266451,5.509118541033435,31.019465279137517,0.01910151942039625,"GCKR,DOCK7,LPL,NLRP3,APOB",GWAS_Catalog_2023
449,Mean Arterial Pressure,0.004028017936254663,2.48829386694188,13.721648881514712,0.021405012908471327,"FTO,PABPC4,HFE,SEZ6,MYO9B,HDAC7,THBS3,SLC25A37,TERT,ALDH2,PRDM16,RBM23,CPEB4",GWAS_Catalog_2023
450,Triglyceride Levels X Alcohol Consumption (Regular Vs Non-Regular Drinkers) Interaction (2Df),0.004097480403703544,5.318624882087832,29.238518168972206,0.021677579253296355,"FADS2,GALNT2,DOCK7,LPL,SNX13",GWAS_Catalog_2023
451,Fibrinogen Levels,0.004097480403703544,5.318624882087832,29.238518168972206,0.021677579253296355,"GALNT2,LEPR,NLRP3,IL6R,SH2B3",GWAS_Catalog_2023
452,Alzheimer's Disease Or HDL Levels (Pleiotropy),0.004337836661678677,11.52190332326284,62.683526873555344,0.022847053385333056,"TOMM40,APOB,UBE2L3",GWAS_Catalog_2023
453,COVID-19 (Critical Illness Vs Population Or Mild Symptoms),0.004337836661678677,11.52190332326284,62.683526873555344,0.022847053385333056,"KANSL1,BCL11A,THBS3",GWAS_Catalog_2023
454,Uterine Fibroids,0.004347259948424647,4.311542824730573,23.447073275278882,0.022847053385333056,"RTEL1-TNFRSF6B,RTEL1,THRB,TERT,HEATR3,SIRT3",GWAS_Catalog_2023
455,Cholesteryl Esters To Total Lipids Ratio In Large LDL,0.004652898830980776,6.841750841750842,36.74201405180106,0.024321359826967617,"GCKR,DOCK7,APOB,UBE2L3",GWAS_Catalog_2023
456,Cholesterol Levels In Small HDL,0.004652898830980776,6.841750841750842,36.74201405180106,0.024321359826967617,"MSRA,GCKR,PABPC4,DOCK7",GWAS_Catalog_2023
457,Free Cholesterol Levels In VLDL,0.0046583660691216265,5.1408308004052685,27.601585921924936,0.024321359826967617,"GCKR,GALNT2,DOCK7,LPL,PCSK7",GWAS_Catalog_2023
458,Body Composition (MOSTest),0.005271738753936638,4.97450730463771,26.09325592483884,0.0267130757373272,"FTO,GCKR,ZBTB38,PPARG,APOE",GWAS_Catalog_2023
459,Phospholipid Levels In Medium LDL,0.0054936260994018216,6.481020733652312,33.72831260680547,0.0267130757373272,"GCKR,GALNT2,HFE,DOCK7",GWAS_Catalog_2023
460,Irritable Mood,0.0054936260994018216,6.481020733652312,33.72831260680547,0.0267130757373272,"MSRA,KANSL1,VRK2,MAPT",GWAS_Catalog_2023
461,Cholesterol Levels In Medium LDL,0.0054936260994018216,6.481020733652312,33.72831260680547,0.0267130757373272,"GCKR,HFE,DOCK7,APOB",GWAS_Catalog_2023
462,Free Cholesterol To Total Lipids Ratio In Chylomicrons And Extremely Large VLDL,0.005648876859712258,10.240684793554884,53.00884174011179,0.0267130757373272,"FADS2,GCKR,MAST3",GWAS_Catalog_2023
463,Interstitial Lung Disease,0.005648876859712258,10.240684793554884,53.00884174011179,0.0267130757373272,"TERT,ATP11A,MAPT",GWAS_Catalog_2023
464,Age-related Disease Endophenotypes,0.005648876859712258,10.240684793554884,53.00884174011179,0.0267130757373272,"FTO,FADS2,GCKR",GWAS_Catalog_2023
465,Glutaroyl Carnitine Levels,0.005788206268314402,30.650602409638555,157.9098449242407,0.0267130757373272,"GCDH,SLC7A6",GWAS_Catalog_2023
466,Wg Lh Intensity-Contrast Lateralorbitofrontal,0.005788206268314402,30.650602409638555,157.9098449242407,0.0267130757373272,"CD82,KLF3",GWAS_Catalog_2023
467,1-stearoyl-2-dihomo-linolenoyl-GPI (18:0/20:3N3 Or 6) Levels,0.005788206268314402,30.650602409638555,157.9098449242407,0.0267130757373272,"FADS2,DOCK7",GWAS_Catalog_2023
468,Phosphatidylcholine Diacyl C36:3 Levels,0.005788206268314402,30.650602409638555,157.9098449242407,0.0267130757373272,"FADS2,DOCK7",GWAS_Catalog_2023
469,Phosphatidylcholine Diacyl C40:6 Levels,0.005788206268314402,30.650602409638555,157.9098449242407,0.0267130757373272,"FADS2,GCKR",GWAS_Catalog_2023
470,Serum Omega-3 Polyunsaturated Fatty Acid Concentration In Metabolic Syndrome,0.005788206268314402,30.650602409638555,157.9098449242407,0.0267130757373272,"AHI1,FADS2",GWAS_Catalog_2023
471,Alcohol Consumption (Drinkers Vs Non-Drinkers),0.005788206268314402,30.650602409638555,157.9098449242407,0.0267130757373272,"GCKR,ALDH2",GWAS_Catalog_2023
472,Postprandial Phospholipid Levels In IDL,0.005788206268314402,30.650602409638555,157.9098449242407,0.0267130757373272,"FADS2,APOE",GWAS_Catalog_2023
473,Fasting Phospholipid Levels In Very Small VLDL,0.005788206268314402,30.650602409638555,157.9098449242407,0.0267130757373272,"DOCK7,APOE",GWAS_Catalog_2023
474,Fasting Triglycerides Levels In Very Small VLDL,0.005788206268314402,30.650602409638555,157.9098449242407,0.0267130757373272,"LPL,APOB",GWAS_Catalog_2023
475,Fasting Free Cholesterol In Very Small VLDL,0.005788206268314402,30.650602409638555,157.9098449242407,0.0267130757373272,"DOCK7,APOE",GWAS_Catalog_2023
476,Fasting Phospholipid Levels In Large HDL,0.005788206268314402,30.650602409638555,157.9098449242407,0.0267130757373272,"FADS2,LPL",GWAS_Catalog_2023
477,Postprandial Total Lipids In Very Small VLDL,0.005788206268314402,30.650602409638555,157.9098449242407,0.0267130757373272,"LPL,APOE",GWAS_Catalog_2023
478,Ethylmalonate Levels In Elite Athletes,0.005788206268314402,30.650602409638555,157.9098449242407,0.0267130757373272,"UNC119B,SPPL3",GWAS_Catalog_2023
479,Phosphatidylinositol (18:1 18:2) Levels,0.005788206268314402,30.650602409638555,157.9098449242407,0.0267130757373272,"FADS2,DOCK7",GWAS_Catalog_2023
480,Acetate Levels,0.005788206268314402,30.650602409638555,157.9098449242407,0.0267130757373272,"GCKR,SH2B3",GWAS_Catalog_2023
481,Lysophosphatidylcholine Levels,0.005788206268314402,30.650602409638555,157.9098449242407,0.0267130757373272,"FADS2,COL26A1",GWAS_Catalog_2023
482,tRNA (guanine-N(7)-)-methyltransferase Levels,0.005788206268314402,30.650602409638555,157.9098449242407,0.0267130757373272,"GCKR,APOE",GWAS_Catalog_2023
483,Reaction Time (Standard GWA),0.005788206268314402,30.650602409638555,157.9098449242407,0.0267130757373272,"MAPT,SH2B3",GWAS_Catalog_2023
484,Alzheimer's Disease Biomarkers,0.005788206268314402,30.650602409638555,157.9098449242407,0.0267130757373272,"TOMM40,APOE",GWAS_Catalog_2023
485,Phosphatidylcholine-O(36:5) [M+H]1+/Phosphatidylcholine-P(36:4) [M+H]1+ Levels,0.005788206268314402,30.650602409638555,157.9098449242407,0.0267130757373272,"FADS2,BUD13",GWAS_Catalog_2023
486,1-stearoyl-2-arachidonoyl-GPE (18:0/20:4) Levels,0.005788206268314402,30.650602409638555,157.9098449242407,0.0267130757373272,"FADS2,SIDT2",GWAS_Catalog_2023
487,1-oleoyl-2-linoleoyl-GPE (18:1/18:2) Levels,0.005788206268314402,30.650602409638555,157.9098449242407,0.0267130757373272,"FADS2,BUD13",GWAS_Catalog_2023
488,1-palmitoyl-2-linoleoyl-GPE (16:0/18:2) Levels,0.005788206268314402,30.650602409638555,157.9098449242407,0.0267130757373272,"FADS2,SIDT2",GWAS_Catalog_2023
489,Serum Levels Of Protein LRP1B,0.005788206268314402,30.650602409638555,157.9098449242407,0.0267130757373272,"APOE,APOB",GWAS_Catalog_2023
490,Wg Lh Intensity-Contrast Rostralmiddlefrontal,0.005788206268314402,30.650602409638555,157.9098449242407,0.0267130757373272,"CD82,KLF3",GWAS_Catalog_2023
491,IDP dMRI TBSS ICVF Anterior Limb Of Internal Capsule R,0.005788206268314402,30.650602409638555,157.9098449242407,0.0267130757373272,"TF,CD82",GWAS_Catalog_2023
492,IDP dMRI TBSS MD Anterior Corona Radiata R,0.005788206268314402,30.650602409638555,157.9098449242407,0.0267130757373272,"CD82,MAPT",GWAS_Catalog_2023
493,IDP dMRI TBSS MD Anterior Limb Of Internal Capsule L,0.005788206268314402,30.650602409638555,157.9098449242407,0.0267130757373272,"CD82,KANSL1",GWAS_Catalog_2023
494,Dehydrocholesteryl Ester (20:4) Levels,0.005788206268314402,30.650602409638555,157.9098449242407,0.0267130757373272,"FADS2,SIDT2",GWAS_Catalog_2023
495,Lysoalkenylphosphatidylcholine (P-16:0) Levels,0.005788206268314402,30.650602409638555,157.9098449242407,0.0267130757373272,"FADS2,APOE",GWAS_Catalog_2023
496,Leukotriene B4 Levels In Elite Athletes,0.005788206268314402,30.650602409638555,157.9098449242407,0.0267130757373272,"MACF1,THRB",GWAS_Catalog_2023
497,Sphingomyelin(37:1) [M+H]1+ Levels,0.005788206268314402,30.650602409638555,157.9098449242407,0.0267130757373272,"GCKR,BUD13",GWAS_Catalog_2023
498,Total Lysoalkenylphosphatidylcholine Levels,0.005788206268314402,30.650602409638555,157.9098449242407,0.0267130757373272,"FADS2,APOE",GWAS_Catalog_2023
499,Phosphatidylethanolamine (18:0 18:1) Levels,0.005788206268314402,30.650602409638555,157.9098449242407,0.0267130757373272,"FADS2,SIDT2",GWAS_Catalog_2023
500,Phosphatidylethanolamine (18:0 20:4) Levels,0.005788206268314402,30.650602409638555,157.9098449242407,0.0267130757373272,"FADS2,SIDT2",GWAS_Catalog_2023
501,Phosphatidylethanolamine (16:0 18:3) (B) Levels,0.005788206268314402,30.650602409638555,157.9098449242407,0.0267130757373272,"FADS2,SIDT2",GWAS_Catalog_2023
502,Phosphatidylethanolamine (17:0 18:1) Levels,0.005788206268314402,30.650602409638555,157.9098449242407,0.0267130757373272,"FADS2,SIDT2",GWAS_Catalog_2023
503,Total Phosphatidylinositol Levels,0.005788206268314402,30.650602409638555,157.9098449242407,0.0267130757373272,"FADS2,DOCK7",GWAS_Catalog_2023
504,Phosphatidylethanolamine (18:1 18:1) Levels,0.005788206268314402,30.650602409638555,157.9098449242407,0.0267130757373272,"FADS2,SIDT2",GWAS_Catalog_2023
505,Alkenylphosphatidylethanolamine (P-18:1/20:3) (B) Levels,0.005788206268314402,30.650602409638555,157.9098449242407,0.0267130757373272,"FADS2,APOE",GWAS_Catalog_2023
506,Alkenylphosphatidylcholine (P-38:5) (B) Levels,0.005788206268314402,30.650602409638555,157.9098449242407,0.0267130757373272,"FADS2,APOE",GWAS_Catalog_2023
507,Phosphatidylinositol (18:0 20:2) Levels,0.005788206268314402,30.650602409638555,157.9098449242407,0.0267130757373272,"FADS2,DOCK7",GWAS_Catalog_2023
508,Alkenylphosphatidylcholine (P-18:0/22:5) Levels,0.005788206268314402,30.650602409638555,157.9098449242407,0.0267130757373272,"FADS2,APOE",GWAS_Catalog_2023
509,Liver Liking,0.005788206268314402,30.650602409638555,157.9098449242407,0.0267130757373272,"FTO,APOE",GWAS_Catalog_2023
510,Sphingomyelin 36:0 [M+H]1+ Levels,0.005788206268314402,30.650602409638555,157.9098449242407,0.0267130757373272,"LPL,BUD13",GWAS_Catalog_2023
511,F-fatty Food Liking (Derived Food-Liking Factor),0.005788206268314402,30.650602409638555,157.9098449242407,0.0267130757373272,"FTO,APOE",GWAS_Catalog_2023
512,Beta-endorphin Levels,0.005788206268314402,30.650602409638555,157.9098449242407,0.0267130757373272,"BUD13,APOE",GWAS_Catalog_2023
513,1-palmitoyl-2-oleoyl-GPE (16:0/18:1) Levels,0.005788206268314402,30.650602409638555,157.9098449242407,0.0267130757373272,"FADS2,GCKR",GWAS_Catalog_2023
514,1-oleoyl-2-arachidonoyl-GPE (18:1/20:4) Levels,0.005788206268314402,30.650602409638555,157.9098449242407,0.0267130757373272,"FADS2,BUD13",GWAS_Catalog_2023
515,X-21471 Levels,0.005788206268314402,30.650602409638555,157.9098449242407,0.0267130757373272,"ABCC2,DNMBP",GWAS_Catalog_2023
516,Threonine Levels,0.005788206268314402,30.650602409638555,157.9098449242407,0.0267130757373272,"GCKR,SPRYD4",GWAS_Catalog_2023
517,Dietary Approaches To Stop Hypertension (DASH) Diet,0.005788206268314402,30.650602409638555,157.9098449242407,0.0267130757373272,"FTO,MSRA",GWAS_Catalog_2023
518,Ratio Of Apolipoprotein B To Apolipoprotein A1 Levels,0.005940112430561495,4.818579027355623,24.700167246707654,0.027255977421768704,"TOMM40,GALNT2,LPL,PCSK7,APOB",GWAS_Catalog_2023
519,Phospholipid Levels In Very Small VLDL,0.005940112430561495,4.818579027355623,24.700167246707654,0.027255977421768704,"GCKR,DOCK7,LPL,PCSK7,APOB",GWAS_Catalog_2023
520,Free Cholesterol To Total Lipids Ratio In Very Large HDL,0.005940112430561495,4.818579027355623,24.700167246707654,0.027255977421768704,"FADS2,GALNT2,LPL,PCSK7,UBE2L3",GWAS_Catalog_2023
521,Gamma Glutamyl Transpeptidase,0.006056098598300428,2.4581562602157567,12.553040718876826,0.027734839262082187,"GCKR,ACOXL,THRB,ABCC2,ZNF827,ALDH2,SERTAD2,MAST3,DLG5,WBP4,PPARG,UBE2L3",GWAS_Catalog_2023
522,Mitochondrial DNA Copy Number,0.006420839015200227,3.943046185781007,19.90531131425283,0.029278792216692932,"MEF2C,NUP205,TERT,PRDM16,LONP1,RSRP1",GWAS_Catalog_2023
523,Total Lipid Levels In Small HDL,0.006430044895870535,6.156363636363636,31.06977444782373,0.029278792216692932,"MSRA,GCKR,CCND2,DOCK7",GWAS_Catalog_2023
524,Docosahexaenoic Acid Levels,0.006430044895870535,6.156363636363636,31.06977444782373,0.029278792216692932,"GCKR,KANSL1,GALNT2,LPL",GWAS_Catalog_2023
525,"Chronic Inflammatory Diseases (Ankylosing Spondylitis, Crohn's Disease, Psoriasis, Primary Sclerosing Cholangitis, Ulcerative Colitis) (Pleiotropy)",0.00675307477104331,3.0975460122699388,15.480783368928535,0.03069111695944636,"RTEL1-TNFRSF6B,GCKR,NDFIP1,IL6R,SH2B3,UBE2L3,CPEB4,HDAC7",GWAS_Catalog_2023
526,Intelligence,0.006973267280182516,2.3148909657320873,11.494987864384697,0.03163158884128419,"CEP57,MEF2C,THRB,BTN3A1,BCL11A,MAST3,HFE,BTN3A2,RHOA,ZMIZ2,ARIH2,APOE,MAPT",GWAS_Catalog_2023
527,Medication Use (Drugs Used In Diabetes),0.007147752795627278,3.3829319571865444,16.714922234227185,0.03228992598466768,"FTO,GCKR,ACOXL,CCND2,PRC1,PABPC4,PPARG",GWAS_Catalog_2023
528,Visceral Adipose Tissue Volumes To Abdominal Adipose Tissue Volumes Ratio,0.0071725317568624766,9.21570996978852,45.50253648143959,0.03228992598466768,"PPARG,SPPL3,CPEB4",GWAS_Catalog_2023
529,Participation In An Health Questionnaire (Not Invited Vs Invited),0.0071725317568624766,9.21570996978852,45.50253648143959,0.03228992598466768,"ZMIZ2,AGAP1,RHOA",GWAS_Catalog_2023
530,Alcohol Use Disorder (Consumption Score),0.0071725317568624766,9.21570996978852,45.50253648143959,0.03228992598466768,"FTO,GCKR,MAPT",GWAS_Catalog_2023
531,Cholesteryl Ester Levels In Large LDL,0.007466565284857296,5.862626262626263,28.711157943637104,0.03342443671607787,"GCKR,HFE,DOCK7,APOB",GWAS_Catalog_2023
532,Snoring,0.007466565284857296,5.862626262626263,28.711157943637104,0.03342443671607787,"FTO,MACF1,STX4,MAPT",GWAS_Catalog_2023
533,Cholesterol To Total Lipids Ratio In Very Large HDL,0.007466565284857296,5.862626262626263,28.711157943637104,0.03342443671607787,"GALNT2,DOCK7,APOE,PLTP",GWAS_Catalog_2023
534,Cancer (Pleiotropy),0.007691236810663684,3.7813588850174216,18.406421099421237,0.034365713539781934,"FTO,RTEL1-TNFRSF6B,RTEL1,TERT,ZBTB38,SH2B3",GWAS_Catalog_2023
535,Glucose Levels,0.007707958871342327,3.330557515878617,16.204833802614615,0.03437605582621083,"FTO,FADS2,GCKR,CCND2,ALDH2,ZBTB38,PRDM16",GWAS_Catalog_2023
536,Type 1 Diabetes,0.008299951103925817,3.279770178852748,15.715037360025132,0.03694717039919217,"FTO,FADS2,ACOXL,IL2RB,MAPT,IL6R,SH2B3",GWAS_Catalog_2023
537,Alanine Levels,0.008607365490275446,5.595592286501377,26.60780786200401,0.03824427199217358,"GCKR,SLC7A6,SPRYD4,APOE",GWAS_Catalog_2023
538,JT Interval,0.00877237295329815,2.948875255623722,13.966309446580714,0.03826081660093827,"KANK2,LAPTM4B,FADS2,THRB,EPAS1,SERTAD2,GMPR,SLC12A7",GWAS_Catalog_2023
539,Total Lipid Levels In Small VLDL,0.009212477677974914,4.281492738939548,20.068197543043876,0.03826081660093827,"GCKR,GALNT2,DOCK7,LPL,PCSK7",GWAS_Catalog_2023
540,Concentration Of Small VLDL Particles,0.009212477677974914,4.281492738939548,20.068197543043876,0.03826081660093827,"GCKR,GALNT2,DOCK7,LPL,PCSK7",GWAS_Catalog_2023
541,Liver Proton Density Fat Fraction,0.009444937543148634,20.431726907630523,95.25835798349146,0.03826081660093827,"GCKR,APOE",GWAS_Catalog_2023
542,IDP dMRI TBSS ICVF Cerebral Peduncle R,0.009444937543148634,20.431726907630523,95.25835798349146,0.03826081660093827,"TF,HFE",GWAS_Catalog_2023
543,Wg Lh Intensity-Contrast Middletemporal,0.009444937543148634,20.431726907630523,95.25835798349146,0.03826081660093827,"CD82,KLF3",GWAS_Catalog_2023
544,Wg Lh Intensity-Contrast Inferiortemporal,0.009444937543148634,20.431726907630523,95.25835798349146,0.03826081660093827,"CD82,KLF3",GWAS_Catalog_2023
545,Wg Lh Intensity-Contrast Parsopercularis,0.009444937543148634,20.431726907630523,95.25835798349146,0.03826081660093827,"CD82,KLF3",GWAS_Catalog_2023
546,Serum Glutamic-Pyruvic Transaminase Levels,0.009444937543148634,20.431726907630523,95.25835798349146,0.03826081660093827,"ZNF827,HSD17B13",GWAS_Catalog_2023
547,Interleukin-6 Receptor Subunit Alpha Levels,0.009444937543148634,20.431726907630523,95.25835798349146,0.03826081660093827,"ADAR,IL6R",GWAS_Catalog_2023
548,Fasting Insulin Adjusted For BMI,0.009444937543148634,20.431726907630523,95.25835798349146,0.03826081660093827,"GCKR,PPARG",GWAS_Catalog_2023
549,Fasting Mean Diameter Of HDL Particles,0.009444937543148634,20.431726907630523,95.25835798349146,0.03826081660093827,"FADS2,LPL",GWAS_Catalog_2023
550,Fasting Blood Insulin,0.009444937543148634,20.431726907630523,95.25835798349146,0.03826081660093827,"GCKR,PPARG",GWAS_Catalog_2023
551,Sodium-coupled Monocarboxylate Transporter 1 Levels,0.009444937543148634,20.431726907630523,95.25835798349146,0.03826081660093827,"FADS2,APOB",GWAS_Catalog_2023
552,Circulating Leptin Levels,0.009444937543148634,20.431726907630523,95.25835798349146,0.03826081660093827,"FTO,GCKR",GWAS_Catalog_2023
553,Dihydroorotate Levels,0.009444937543148634,20.431726907630523,95.25835798349146,0.03826081660093827,"HSPA8,DNAJA4",GWAS_Catalog_2023
554,Diabetic Retinopathy (All NPDR And PDR),0.009444937543148634,20.431726907630523,95.25835798349146,0.03826081660093827,"UBXN2A,AGAP1",GWAS_Catalog_2023
555,Metabolic Syndrome (Bivariate Traits),0.009444937543148634,20.431726907630523,95.25835798349146,0.03826081660093827,"LPL,BUD13",GWAS_Catalog_2023
556,Clinical Laboratory Measurements,0.009444937543148634,20.431726907630523,95.25835798349146,0.03826081660093827,"C18ORF25,TMPRSS6",GWAS_Catalog_2023
557,Arachidonoylcarnitine (C20:4) Levels,0.009444937543148634,20.431726907630523,95.25835798349146,0.03826081660093827,"FADS2,SLC22A16",GWAS_Catalog_2023
558,1-(1-enyl-palmitoyl)-2-palmitoleoyl-GPC (P-16:0/16:1) Levels,0.009444937543148634,20.431726907630523,95.25835798349146,0.03826081660093827,"FADS2,GCKR",GWAS_Catalog_2023
559,Androsterone Sulfate Levels,0.009444937543148634,20.431726907630523,95.25835798349146,0.03826081660093827,"SLC17A1,SLC17A3",GWAS_Catalog_2023
560,Phosphatidylcholine-O 36:4 [M+H]1+/Phosphatidylcholine-P 36:3 [M+H]1+ Levels,0.009444937543148634,20.431726907630523,95.25835798349146,0.03826081660093827,"FADS2,LPL",GWAS_Catalog_2023
561,White Blood Cell Count (Lymphocyte),0.009444937543148634,20.431726907630523,95.25835798349146,0.03826081660093827,"KLF3,UBE2L3",GWAS_Catalog_2023
562,Body Mass Index And LDL-C (Pairwise),0.009444937543148634,20.431726907630523,95.25835798349146,0.03826081660093827,"GCKR,TOMM40",GWAS_Catalog_2023
563,IDP SWI T2star Right Caudate,0.009444937543148634,20.431726907630523,95.25835798349146,0.03826081660093827,"TF,HFE",GWAS_Catalog_2023
564,IDP dMRI TBSS ICVF Cerebral Peduncle L,0.009444937543148634,20.431726907630523,95.25835798349146,0.03826081660093827,"TF,HFE",GWAS_Catalog_2023
565,IDP dMRI TBSS ICVF Anterior Limb Of Internal Capsule L,0.009444937543148634,20.431726907630523,95.25835798349146,0.03826081660093827,"TF,CD82",GWAS_Catalog_2023
566,Cholesteryl Ester(20:3) [M+NH4]1+ Levels,0.009444937543148634,20.431726907630523,95.25835798349146,0.03826081660093827,"LPL,BUD13",GWAS_Catalog_2023
567,Phosphatidylcholine 32:0 [M+H]1+/Phosphatidylethanolamine 35:0 [M+H]1+/Phosphatidate 37:1 [M+NH4]1+ Levels,0.009444937543148634,20.431726907630523,95.25835798349146,0.03826081660093827,"FADS2,BUD13",GWAS_Catalog_2023
568,Executive Function (Trail Making Test B),0.009444937543148634,20.431726907630523,95.25835798349146,0.03826081660093827,"APOE,RHOA",GWAS_Catalog_2023
569,Alzheimer's Disease (Age Of Onset),0.009444937543148634,20.431726907630523,95.25835798349146,0.03826081660093827,"TOMM40,APOE",GWAS_Catalog_2023
570,Cholesteryl Ester (20:3) Levels,0.009444937543148634,20.431726907630523,95.25835798349146,0.03826081660093827,"FADS2,APOB",GWAS_Catalog_2023
571,Cholesteryl Ester (20:4) Levels,0.009444937543148634,20.431726907630523,95.25835798349146,0.03826081660093827,"FADS2,SIDT2",GWAS_Catalog_2023
572,Diacylglycerol (18:1 20:4) Levels,0.009444937543148634,20.431726907630523,95.25835798349146,0.03826081660093827,"FADS2,APOE",GWAS_Catalog_2023
573,Phosphatidylcholine (16:1 18:2) Levels,0.009444937543148634,20.431726907630523,95.25835798349146,0.03826081660093827,"FADS2,APOE",GWAS_Catalog_2023
574,Phosphatidylcholine (15:0 20:3) Levels,0.009444937543148634,20.431726907630523,95.25835798349146,0.03826081660093827,"FADS2,SEZ6",GWAS_Catalog_2023
575,Lysophosphatidylethanolamine (18:1) [Sn1] Levels,0.009444937543148634,20.431726907630523,95.25835798349146,0.03826081660093827,"FADS2,SIDT2",GWAS_Catalog_2023
576,Lysophosphatidylethanolamine (18:1) [Sn2] Levels,0.009444937543148634,20.431726907630523,95.25835798349146,0.03826081660093827,"FADS2,SIDT2",GWAS_Catalog_2023
577,Triacylglycerol 58:7 [M+NH4]1+ Levels,0.009444937543148634,20.431726907630523,95.25835798349146,0.03826081660093827,"FADS2,SAMM50",GWAS_Catalog_2023
578,Triacylglycerol 56:7 [M+NH4]1+ Levels,0.009444937543148634,20.431726907630523,95.25835798349146,0.03826081660093827,"FADS2,SAMM50",GWAS_Catalog_2023
579,Phosphatidylethanolamine (15-MHDA 18:1) Levels,0.009444937543148634,20.431726907630523,95.25835798349146,0.03826081660093827,"FADS2,SIDT2",GWAS_Catalog_2023
580,Phosphatidylinositol (16:0 20:3) (A) Levels,0.009444937543148634,20.431726907630523,95.25835798349146,0.03826081660093827,"FADS2,DOCK7",GWAS_Catalog_2023
581,Phosphatidylinositol (18:0 18:1) Levels,0.009444937543148634,20.431726907630523,95.25835798349146,0.03826081660093827,"FADS2,DOCK7",GWAS_Catalog_2023
582,Phosphatidylinositol (18:0 20:4) Levels,0.009444937543148634,20.431726907630523,95.25835798349146,0.03826081660093827,"FADS2,DOCK7",GWAS_Catalog_2023
583,Alkenylphosphatidylcholine (P-17:0/20:4) (B) Levels,0.009444937543148634,20.431726907630523,95.25835798349146,0.03826081660093827,"FADS2,APOE",GWAS_Catalog_2023
584,Alkenylphosphatidylcholine (P-18:0/20:4) Levels,0.009444937543148634,20.431726907630523,95.25835798349146,0.03826081660093827,"FADS2,APOE",GWAS_Catalog_2023
585,Salami Liking,0.009444937543148634,20.431726907630523,95.25835798349146,0.03826081660093827,"FTO,MEF2C",GWAS_Catalog_2023
586,Crisps Liking,0.009444937543148634,20.431726907630523,95.25835798349146,0.03826081660093827,"FTO,MFHAS1",GWAS_Catalog_2023
587,"Androstenediol (3Beta,17Beta) Monosulfate (2) Levels",0.009444937543148634,20.431726907630523,95.25835798349146,0.03826081660093827,"SLC17A1,SLC17A3",GWAS_Catalog_2023
588,COVID-19 Or Coronary Artery Disease (Pleiotropy),0.009444937543148634,20.431726907630523,95.25835798349146,0.03826081660093827,"AXL,IL6R",GWAS_Catalog_2023
589,X-21410 Levels,0.009444937543148634,20.431726907630523,95.25835798349146,0.03826081660093827,"SLC17A1,SLC17A3",GWAS_Catalog_2023
590,Cardiovascular Disease,0.009550067957458943,2.4069245192517332,11.195104192995775,0.03862112228219837,"KANK2,FTO,GCKR,CCND2,PRDM16,DOCK7,TMBIM1,MYO9B,APOE,APOB,SH2B3",GWAS_Catalog_2023
591,Mosaic Loss Of Chromosome Y (Y Chromosome Dosage),0.009856381925725589,5.351778656126482,24.723269998721616,0.039408783269008624,"CD164,TERT,PRDM16,TAF8",GWAS_Catalog_2023
592,Neurofibrillary Tangles,0.009856381925725589,5.351778656126482,24.723269998721616,0.039408783269008624,"BLK,MYO1D,TFRC,APOE",GWAS_Catalog_2023
593,Cognitive Ability,0.009856381925725589,5.351778656126482,24.723269998721616,0.039408783269008624,"MEF2C,KANSL1,BCL11A,MAPT",GWAS_Catalog_2023
594,Total Lipid Levels In LDL,0.009856381925725589,5.351778656126482,24.723269998721616,0.039408783269008624,"GCKR,HFE,DOCK7,APOB",GWAS_Catalog_2023
595,Cholesteryl Esters To Total Lipids Ratio In Small HDL,0.009856381925725589,5.351778656126482,24.723269998721616,0.039408783269008624,"GCKR,DOCK7,APOE,PLTP",GWAS_Catalog_2023
596,Phospholipids To Total Lipids Ratio In Very Large VLDL,0.009856381925725589,5.351778656126482,24.723269998721616,0.039408783269008624,"DOCK7,LPL,PCSK7,APOE",GWAS_Catalog_2023
597,Body Mass Index (MTAG),0.009860454154064606,1.6824400871459695,7.771566032771213,0.039408783269008624,"FTO,MACF1,MAST3,AGAP1,CCND2,ERI1,FIGNL1,ZMIZ2,PSD4,LEPR,APOE,P4HTM,UBXN6,GCKR,SPRYD4,DENND4A,GALNT2,PABPC4,GPN1,FRS3,KLF3,DDB2,RP1L1,MSRA,SLC25A37,KANSL1,PPARG,CPEB4",GWAS_Catalog_2023
598,Atopic Dermatitis,0.010192056889596663,4.165365973876612,19.10297899209617,0.040665966118022805,"TLR1,RTEL1-TNFRSF6B,RTEL1,ZBTB38,IL6R",GWAS_Catalog_2023
599,Alcohol-associated Liver Disease In Light Drinkers,0.010886865396739583,7.6782477341389725,34.70720178532406,0.04314960271863894,"ZNF827,DLG5,SPPL3",GWAS_Catalog_2023
600,"Parental Longevity (Combined Parental Attained Age, Martingale Residuals)",0.010886865396739583,7.6782477341389725,34.70720178532406,0.04314960271863894,"BCL11A,APOE,IL6R",GWAS_Catalog_2023
601,Mean Arterial Pressure X Alcohol Consumption (Light Vs Heavy) Interaction (2Df Test),0.010886865396739583,7.6782477341389725,34.70720178532406,0.04314960271863894,"RP1L1,MSRA,SH2B3",GWAS_Catalog_2023
602,Average Diameter For LDL Particles,0.010886865396739583,7.6782477341389725,34.70720178532406,0.04314960271863894,"GCKR,LPL,APOE",GWAS_Catalog_2023
603,Angina Pectoris,0.011217301193070883,5.1282828282828286,23.027517835974916,0.04438554004422409,"APOE,APOB,IL6R,SIRT3",GWAS_Catalog_2023
604,Gallstone Disease,0.011240728485092574,4.055351143816989,18.2012741462273,0.04440459961164053,"FADS2,GCKR,TMBIM1,ADAR,APOE",GWAS_Catalog_2023
605,Creatinine Levels,0.011348996920510059,2.0970552884615383,9.391926162205014,0.044758192813780164,"BLK,RTEL1-TNFRSF6B,GCKR,TOMM40,TNK2,TRPC1,DOCK7,TFEB,RHOA,THBS3,MSRA,APOE,PDE7A,CTSB",GWAS_Catalog_2023
606,Age At Menopause,0.011772349464574833,3.0472929319033466,13.536080575794728,0.04635119772685734,"FTO,FNDC4,BCL2L11,PGAP3,PPARG,UBE2L3,MRPL33",GWAS_Catalog_2023
607,Total Testosterone Levels,0.011986857500621138,1.9737986924205135,8.73197574638356,0.04711802635334767,"FTO,GCKR,THRB,PABPC4,SUSD1,TFEB,BMP8A,HSD17B13,ADAR,SLC25A37,BCL2L11,SERTAD2,LEPR,PPARG,MAPT,SLC17A3",GWAS_Catalog_2023
608,Serum Total Protein Level,0.012333515154205653,2.140417676243221,9.408066582308782,0.048400932825550476,"BLK,MACF1,GCKR,ZBTB38,SNX13,FADS2,TF,CCND3,ACOXL,CCND2,TERT,PPARG,SH2B3",GWAS_Catalog_2023
609,Protein Quantitative Trait Loci,0.012580283249542058,3.366851441241685,14.732077694901285,0.04920746857935632,"TAGLN,LEPR,ICAM5,IL6R,RHOA,ZNF410",GWAS_Catalog_2023
610,Cigarettes Smoked Per Day (MTAG),0.012580283249542058,3.366851441241685,14.732077694901285,0.04920746857935632,"FTO,BCL11A,ARIH2,SEZ6,BMP8A,APOE",GWAS_Catalog_2023
611,Total Omega-6 Fatty Acid Levels,0.012693553917064063,4.922666666666666,21.495616450673804,0.04948826739561251,"GCKR,DOCK7,RSRP1,UBE2L3",GWAS_Catalog_2023
612,Concentration Of LDL Particles,0.012693553917064063,4.922666666666666,21.495616450673804,0.04948826739561251,"GALNT2,HFE,DOCK7,APOB",GWAS_Catalog_2023
613,QT Interval,0.013073803467610817,2.2922475949051466,9.941809704950211,0.05069760141735836,"KANK2,LAPTM4B,FADS2,FAM167A,THRB,MAST2,ITSN1,ARIH2,BEND3,GMPR,SLC12A7",GWAS_Catalog_2023
614,Non-glioblastoma Glioma,0.013088735319820933,7.086916105042993,30.72889174550526,0.05069760141735836,"RTEL1-TNFRSF6B,RTEL1,TERT",GWAS_Catalog_2023
615,Abdominal Aortic Aneurysm,0.013088735319820933,7.086916105042993,30.72889174550526,0.05069760141735836,"APOE,JAK2,IL6R",GWAS_Catalog_2023
616,Occupational Attainment,0.013088735319820933,7.086916105042993,30.72889174550526,0.05069760141735836,"BCL11A,AGAP1,MAPT",GWAS_Catalog_2023
617,Chronic Elevation Of Alanine Aminotransferase (cALT) Levels,0.013553785684800401,3.851823708206687,16.56703806173767,0.0514731299322491,"FTO,MFHAS1,PPARG,HSD17B13,APOE",GWAS_Catalog_2023
618,Relative Carbohydrate Intake,0.013871426046285067,15.322289156626505,65.54759211542967,0.0514731299322491,"FTO,APOE",GWAS_Catalog_2023
619,Phosphatidylglycerol (36:2) Levels,0.013871426046285067,15.322289156626505,65.54759211542967,0.0514731299322491,"FADS2,SIDT2",GWAS_Catalog_2023
620,Triglyceride Levels In HIV Infection,0.013871426046285067,15.322289156626505,65.54759211542967,0.0514731299322491,"DOCK7,SNX13",GWAS_Catalog_2023
621,Liver Fibrosis And Steatohepatitis Severity (MRI cT1 Measure),0.013871426046285067,15.322289156626505,65.54759211542967,0.0514731299322491,"TMPRSS6,HFE",GWAS_Catalog_2023
622,"Advanced Glycosylation End Product-Specific Receptor, Soluble Levels",0.013871426046285067,15.322289156626505,65.54759211542967,0.0514731299322491,"KANSL1,PRDM16",GWAS_Catalog_2023
623,Waist Circumference Variance,0.013871426046285067,15.322289156626505,65.54759211542967,0.0514731299322491,"FTO,PPARG",GWAS_Catalog_2023
624,Cerebrospinal Fluid p-Tau181p:AB1-42 Ratio,0.013871426046285067,15.322289156626505,65.54759211542967,0.0514731299322491,"TOMM40,APOE",GWAS_Catalog_2023
625,C-C Motif Chemokine 3 Levels,0.013871426046285067,15.322289156626505,65.54759211542967,0.0514731299322491,"TLR1,SH2B3",GWAS_Catalog_2023
626,Cholesteryl Ester 18:3 [M+NH4]1+ Levels,0.013871426046285067,15.322289156626505,65.54759211542967,0.0514731299322491,"FADS2,BUD13",GWAS_Catalog_2023
627,Phosphatidylinositol(36:2) [M-H]1- Levels,0.013871426046285067,15.322289156626505,65.54759211542967,0.0514731299322491,"FADS2,DOCK7",GWAS_Catalog_2023
628,Carboplatin Disposition In Epthelial Ovarian Cancer,0.013871426046285067,15.322289156626505,65.54759211542967,0.0514731299322491,"ABCC2,ZNF827",GWAS_Catalog_2023
629,Triacylglycerol 56:6 [M+NH4]1+ Levels,0.013871426046285067,15.322289156626505,65.54759211542967,0.0514731299322491,"FADS2,SAMM50",GWAS_Catalog_2023
630,Familial Combined Hyperlipidemia Defined By Goldstein Criteria,0.013871426046285067,15.322289156626505,65.54759211542967,0.0514731299322491,"GCKR,DOCK7",GWAS_Catalog_2023
631,Phosphatidylethanolamine (16:0 18:3) (A) Levels,0.013871426046285067,15.322289156626505,65.54759211542967,0.0514731299322491,"FADS2,SIDT2",GWAS_Catalog_2023
632,Phosphatidylethanolamine (17:0 18:2) Levels,0.013871426046285067,15.322289156626505,65.54759211542967,0.0514731299322491,"FADS2,SIDT2",GWAS_Catalog_2023
633,Alkenylphosphatidylethanolamine (P-18:1/20:3) (A) Levels,0.013871426046285067,15.322289156626505,65.54759211542967,0.0514731299322491,"FADS2,APOE",GWAS_Catalog_2023
634,Phosphatidylethanolamine (16:0 18:2) Levels,0.013871426046285067,15.322289156626505,65.54759211542967,0.0514731299322491,"FADS2,SIDT2",GWAS_Catalog_2023
635,Alkenylphosphatidylcholine (P-17:0/20:4) (A) Levels,0.013871426046285067,15.322289156626505,65.54759211542967,0.0514731299322491,"FADS2,APOE",GWAS_Catalog_2023
636,Smoked Fish Liking,0.013871426046285067,15.322289156626505,65.54759211542967,0.0514731299322491,"FTO,MEF2C",GWAS_Catalog_2023
637,F-savour/caloric Food Liking (Derived Food-Liking Factor),0.013871426046285067,15.322289156626505,65.54759211542967,0.0514731299322491,"MFHAS1,APOE",GWAS_Catalog_2023
638,Herring Liking,0.013871426046285067,15.322289156626505,65.54759211542967,0.0514731299322491,"FTO,MAPT",GWAS_Catalog_2023
639,Mackerel Liking,0.013871426046285067,15.322289156626505,65.54759211542967,0.0514731299322491,"FTO,MAPT",GWAS_Catalog_2023
640,Avocado Liking,0.013871426046285067,15.322289156626505,65.54759211542967,0.0514731299322491,"KANSL1,SLC17A3",GWAS_Catalog_2023
641,Tumor Necrosis Factor Receptor Superfamily Member EDAR Levels,0.013871426046285067,15.322289156626505,65.54759211542967,0.0514731299322491,"BRD3,MEF2C",GWAS_Catalog_2023
642,Lactate Levels,0.013871426046285067,15.322289156626505,65.54759211542967,0.0514731299322491,"HBS1L,GCKR",GWAS_Catalog_2023
643,3-Methoxytyrosine Levels,0.013871426046285067,15.322289156626505,65.54759211542967,0.0514731299322491,"FIGNL1,SLC17A3",GWAS_Catalog_2023
644,Rheumatoid Arthritis (ACPA-positive),0.014288310223592657,4.732867132867133,20.1067035373349,0.05293774564206844,"BLK,SPRED2,IL2RB,IL6R",GWAS_Catalog_2023
645,Lymphocyte-to-monocyte Ratio,0.014926661160353703,2.661125404050399,11.188984706474978,0.05521707523814564,"ASXL1,CCND3,ACOXL,BCL2L11,UBXN2A,IL6R,KLF3,NKX2-3",GWAS_Catalog_2023
646,Alanine Transaminase Levels,0.015525801931861961,6.580060422960725,27.407609825477234,0.05716753612565222,"FADS2,ZNF827,DLG5",GWAS_Catalog_2023
647,Endometrial Cancer (Endometrioid Histology),0.015525801931861961,6.580060422960725,27.407609825477234,0.05716753612565222,"BCL11A,PPARG,SH2B3",GWAS_Catalog_2023
648,Forns Index In High Alcohol Intake,0.015525801931861961,6.580060422960725,27.407609825477234,0.05716753612565222,"TRABD,HBS1L,APOE",GWAS_Catalog_2023
649,Alzheimer?s Disease Polygenic Risk Score (Upper Quantile Vs Lower Quantile),0.01573876751267887,2.331059129304743,9.677691147955052,0.057862402596689955,"HADHA,GIGYF1,AKAP10,TOMM40,KANSL1,ZAN,MAST2,PILRB,SLC17A1,EPHB4",GWAS_Catalog_2023
650,Depressive Symptoms,0.01576531125442151,2.6325544968019843,10.924951745300199,0.057870819466230336,"MSRA,MEF2C,UBXN2A,BTN2A1,GALNT2,HFE,VRK2,SPPL3",GWAS_Catalog_2023
651,Breast Cancer,0.015961501723537278,1.9042680877622546,7.87905317280068,0.05850098788380944,"FTO,BTN2A1,MAST2,ZBTB38,MYO9B,ARHGAP27,PCSK7,TLR1,BCL2L11,ZNF827,TERT,KANSL1,PRC1,ZKSCAN3,MAPT,SLC17A3",GWAS_Catalog_2023
652,Familial Combined Hyperlipidemia Defined By Dutch Criteria,0.016004476752385043,4.5571268237934905,18.843203544407974,0.05856852995581398,"GCKR,GALNT2,DOCK7,PLTP",GWAS_Catalog_2023
653,Alcohol Consumption,0.017592205900682403,3.5820315261186115,14.472479544839654,0.06428025004445362,"TLR1,FTO,GCKR,KIT,MAPT",GWAS_Catalog_2023
654,Triglyceride Levels X Alcohol Consumption (Drinkers Vs Non-Drinkers) Interaction (2Df),0.017844695030163935,4.393939393939394,17.690215356276155,0.06510312284705068,"FADS2,GALNT2,DOCK7,LPL",GWAS_Catalog_2023
655,Bioavailable Testosterone Levels,0.018135135590367647,2.093656221648405,8.395360519685477,0.06589813928224884,"SLC25A37,CCND2,DNMBP,THRB,SERTAD2,ICE2,DENND4A,TFEB,LEPR,PPARG,MAPT,SLC17A3",GWAS_Catalog_2023
656,Maximum Habitual Alcohol Consumption (MTAG),0.018200701503353726,6.140785498489426,24.601799107603384,0.06589813928224884,"FTO,GCKR,MAPT",GWAS_Catalog_2023
657,Educational Attainment (College Completion),0.018200701503353726,6.140785498489426,24.601799107603384,0.06589813928224884,"BCL11A,MAPT,RHOA",GWAS_Catalog_2023
658,Juvenile Idiopathic Arthritis (Oligoarticular Or Rheumatoid Factor-Negative Polyarticular),0.018200701503353726,6.140785498489426,24.601799107603384,0.06589813928224884,"IL2RB,IL6R,UBE2L3",GWAS_Catalog_2023
659,Ratio Of Omega-3 Fatty Acids To Total Fatty Acids,0.018200701503353726,6.140785498489426,24.601799107603384,0.06589813928224884,"FADS2,GCKR,KANSL1",GWAS_Catalog_2023
660,Hip Circumference Adjusted For BMI,0.01828009420548173,1.6203102453102454,6.48438853029556,0.06608531026405971,"GYPA,SRP14,SPPL3,AK9,CCND3,ACOXL,HMGN4,BCL2L11,ZKSCAN3,ZKSCAN4,SLC17A1,JARID2,SH2B3,ZNF322,KLF13,USP49,ZBTB38,VRK2,FIG4,MFHAS1,SLC25A37,TMBIM1,PPARG,MAPT,CRLF3,CPEB4",GWAS_Catalog_2023
661,Wg Rh Intensity-Contrast Fusiform,0.019015359602025866,12.256626506024096,48.56698335666549,0.06652587684814328,"CD82,KLF3",GWAS_Catalog_2023
662,Eye Color (Saturation),0.019015359602025866,12.256626506024096,48.56698335666549,0.06652587684814328,"MPST,DSTYK",GWAS_Catalog_2023
663,Cortical Amyloid Beta Load,0.019015359602025866,12.256626506024096,48.56698335666549,0.06652587684814328,"APOE,RBM23",GWAS_Catalog_2023
664,Dementia And Core Alzheimer's Disease Neuropathologic Changes,0.019015359602025866,12.256626506024096,48.56698335666549,0.06652587684814328,"GALNT2,SMOX",GWAS_Catalog_2023
665,White Blood Cell Types,0.019015359602025866,12.256626506024096,48.56698335666549,0.06652587684814328,"HBS1L,ACOXL",GWAS_Catalog_2023
666,Lipoprotein-associated Phospholipase A2 Activity And Mass,0.019015359602025866,12.256626506024096,48.56698335666549,0.06652587684814328,"GCKR,APOB",GWAS_Catalog_2023
667,Plasma Omega-3 Polyunsaturated Fatty Acid Levels (Docosapentaenoic Acid),0.019015359602025866,12.256626506024096,48.56698335666549,0.06652587684814328,"FADS2,GCKR",GWAS_Catalog_2023
668,IgA Levels,0.019015359602025866,12.256626506024096,48.56698335666549,0.06652587684814328,"FADS2,SH2B3",GWAS_Catalog_2023
669,Direct Low Density Lipoprotein Cholesterol Levels,0.019015359602025866,12.256626506024096,48.56698335666549,0.06652587684814328,"DOCK7,APOB",GWAS_Catalog_2023
670,Dihomo-linolenoylcarnitine (C20:3n3 Or 6) Levels,0.019015359602025866,12.256626506024096,48.56698335666549,0.06652587684814328,"FADS2,SLC22A16",GWAS_Catalog_2023
671,C-X-C Motif Chemokine 16 Levels,0.019015359602025866,12.256626506024096,48.56698335666549,0.06652587684814328,"TOX2,ACOXL",GWAS_Catalog_2023
672,Body Mass Index And Triglycerides (Pairwise),0.019015359602025866,12.256626506024096,48.56698335666549,0.06652587684814328,"GCKR,TOMM40",GWAS_Catalog_2023
673,IDP SWI T2star Right Pallidum,0.019015359602025866,12.256626506024096,48.56698335666549,0.06652587684814328,"TF,CD82",GWAS_Catalog_2023
674,Phosphatidylethanolamine (16:0 20:3) Levels,0.019015359602025866,12.256626506024096,48.56698335666549,0.06652587684814328,"FADS2,SIDT2",GWAS_Catalog_2023
675,Alkenylphosphatidylethanolamine (P-16:0/20:3) (A) Levels,0.019015359602025866,12.256626506024096,48.56698335666549,0.06652587684814328,"FADS2,APOE",GWAS_Catalog_2023
676,Alkenylphosphatidylethanolamine (P-18:0/20:3) (A) Levels,0.019015359602025866,12.256626506024096,48.56698335666549,0.06652587684814328,"FADS2,APOE",GWAS_Catalog_2023
677,Raw Carrot Liking,0.019015359602025866,12.256626506024096,48.56698335666549,0.06652587684814328,"FTO,MSRA",GWAS_Catalog_2023
678,Sphingomyelin 38:1 [M+H]1+ Levels,0.019015359602025866,12.256626506024096,48.56698335666549,0.06652587684814328,"LPL,BUD13",GWAS_Catalog_2023
679,F-fatty/salty Food Liking (Derived Food-Liking Factor),0.019015359602025866,12.256626506024096,48.56698335666549,0.06652587684814328,"FTO,KANSL1",GWAS_Catalog_2023
680,High-density Lipoprotein 3 Cholesterol Levels,0.019015359602025866,12.256626506024096,48.56698335666549,0.06652587684814328,"FADS2,TOMM40",GWAS_Catalog_2023
681,Glutarylcarnitine (C5-Dc) Levels,0.019015359602025866,12.256626506024096,48.56698335666549,0.06652587684814328,"GCDH,SLC7A6",GWAS_Catalog_2023
682,Maximum Measurement Of Hepatic Fat,0.019015359602025866,12.256626506024096,48.56698335666549,0.06652587684814328,"SAMM50,CITED2",GWAS_Catalog_2023
683,Well-being Spectrum (Multivariate Analysis),0.019344051260332916,2.7365385359811096,10.796657960933258,0.0675767295858775,"MSRA,MFHAS1,UBXN2A,ERI1,BTN2A1,GALNT2,VRK2",GWAS_Catalog_2023
684,General Cognitive Ability,0.01944322869424749,1.7559876021414482,6.91904140283973,0.06782389424630776,"CEP57,MEF2C,THRB,ABCC2,BTN3A1,BCL11A,DENND4A,BTN2A1,ADAR,BTN3A2,VRK2,RHOA,MRPL33,PRC1,BLOC1S2,KIT,FLOT2,MAPT,SLC17A1",GWAS_Catalog_2023
685,Corneal Resistance Factor,0.019811341122747687,4.242006269592476,16.635030645892297,0.06900709477208172,"SLC25A37,SERTAD2,ZBTB38,NPHP3",GWAS_Catalog_2023
686,Type 2 Diabetes,0.020032633704717067,1.5775294586173776,6.168759600048086,0.06967618661728123,"FTO,MACF1,GCDH,MAST2,LPL,SPPL3,SPRED2,FADS2,CCND3,DSTYK,SAMM50,CCND2,BCL2L11,FIGNL1,LEPR,BEND3,APOE,JARID2,PLS1,GCKR,PABPC4,ZBTB38,BMP8A,MFHAS1,MSRA,PRC1,PPARG,MAPT",GWAS_Catalog_2023
687,Alcohol Consumption (Drinks Per Week),0.02064524868725465,2.9846577498033047,11.581278147197382,0.0717024212049339,"BRD3,GCKR,ALDH2,KANSL1,ZBTB38,GPN1",GWAS_Catalog_2023
688,Common Executive Function,0.020684680375260302,3.4221546774738263,13.272354423771738,0.07173495258048122,"MEF2C,ABCC2,BCL11A,VRK2,APOE",GWAS_Catalog_2023
689,Whole Brain Restricted Directional Diffusion (Multivariate Analysis),0.020721343367757293,2.3408144796380093,9.074380413116906,0.07175780156091277,"FADS2,MACF1,TF,AKAP10,COL26A1,TMPRSS6,HFE,APOE,SH2B3",GWAS_Catalog_2023
690,Mental Health Study Participation (Completed Survey),0.02111504710387186,5.7564199395770395,22.20694046489024,0.07280419420496859,"TOMM40,MAST3,APOE",GWAS_Catalog_2023
691,Feeling Fed-Up,0.02111504710387186,5.7564199395770395,22.20694046489024,0.07280419420496859,"KANSL1,UBXN2A,DDB2",GWAS_Catalog_2023
692,Fasting Blood Glucose (BMI Interaction),0.02111504710387186,5.7564199395770395,22.20694046489024,0.07280419420496859,"FADS2,GCKR,MRPL33",GWAS_Catalog_2023
693,Total Esterified Cholesterol Levels,0.021906526405921736,4.10020202020202,15.666751689594776,0.07531552162035918,"GCKR,DOCK7,LPL,APOB",GWAS_Catalog_2023
694,Male Puberty Timing (Age At Voice Breaking MTAG),0.021906526405921736,4.10020202020202,15.666751689594776,0.07531552162035918,"FTO,GCKR,KANSL1,FRS3",GWAS_Catalog_2023
695,Fasting Insulin,0.024132099380993526,3.9675464320625613,14.775985620607484,0.08272435810040418,"FTO,GCKR,PPARG,HDAC7",GWAS_Catalog_2023
696,Lung Cancer In Ever Smokers,0.024132099380993526,3.9675464320625613,14.775985620607484,0.08272435810040418,"FADS2,SCGN,BTN2A1,AK9",GWAS_Catalog_2023
697,Depression In Smokers,0.024269509920487396,5.417273858183757,20.14431947897334,0.08272435810040418,"FIG4,MICAL1,AK9",GWAS_Catalog_2023
698,Familial Combined Hyperlipidemia Defined By Mexico Criteria,0.024269509920487396,5.417273858183757,20.14431947897334,0.08272435810040418,"GCKR,DOCK7,PLTP",GWAS_Catalog_2023
699,"Age-related Diseases, Mortality And Associated Endophenotypes",0.024269509920487396,5.417273858183757,20.14431947897334,0.08272435810040418,"FTO,FADS2,GCKR",GWAS_Catalog_2023
700,Clinical LDL Cholesterol Levels,0.024269509920487396,5.417273858183757,20.14431947897334,0.08272435810040418,"DOCK7,APOB,PLTP",GWAS_Catalog_2023
701,Blood Metabolite Levels,0.024826956027899184,10.21285140562249,37.74491440057724,0.08273340374660258,"GCKR,SLC22A16",GWAS_Catalog_2023
702,Ischemic Stroke Or Factor VII Levels (Pleiotropy),0.024826956027899184,10.21285140562249,37.74491440057724,0.08273340374660258,"GCKR,SH2B3",GWAS_Catalog_2023
703,Alzheimer's Disease (Onset Between Ages 58 And 79),0.024826956027899184,10.21285140562249,37.74491440057724,0.08273340374660258,"TOMM40,APOE",GWAS_Catalog_2023
704,Emotional Recognition,0.024826956027899184,10.21285140562249,37.74491440057724,0.08273340374660258,"MYO1D,CPEB4",GWAS_Catalog_2023
705,LDL Cholesterol Levels In HIV Infection,0.024826956027899184,10.21285140562249,37.74491440057724,0.08273340374660258,"APOE,APOB",GWAS_Catalog_2023
706,Cerebral Amyloid Deposition (PET Imaging),0.024826956027899184,10.21285140562249,37.74491440057724,0.08273340374660258,"TOMM40,APOE",GWAS_Catalog_2023
707,Fasting Blood Glucose Adjusted For BMI,0.024826956027899184,10.21285140562249,37.74491440057724,0.08273340374660258,"GCKR,GPN1",GWAS_Catalog_2023
708,Serous Invasive Ovarian Cancer,0.024826956027899184,10.21285140562249,37.74491440057724,0.08273340374660258,"ACOXL,TERT",GWAS_Catalog_2023
709,Invasive Epithelial Ovarian Cancer,0.024826956027899184,10.21285140562249,37.74491440057724,0.08273340374660258,"ACOXL,TERT",GWAS_Catalog_2023
710,P Wave Duration,0.024826956027899184,10.21285140562249,37.74491440057724,0.08273340374660258,"FADS2,EPAS1",GWAS_Catalog_2023
711,Diacylglycerol 38:5 [M+H-H2O]1+ Levels,0.024826956027899184,10.21285140562249,37.74491440057724,0.08273340374660258,"FADS2,SAMM50",GWAS_Catalog_2023
712,X-21441 Levels,0.024826956027899184,10.21285140562249,37.74491440057724,0.08273340374660258,"ABCC2,DNMBP",GWAS_Catalog_2023
713,Phosphatidylethanolamine (18:0 18:2) Levels,0.024826956027899184,10.21285140562249,37.74491440057724,0.08273340374660258,"FADS2,SIDT2",GWAS_Catalog_2023
714,Phosphatidylethanolamine (18:1 18:2) Levels,0.024826956027899184,10.21285140562249,37.74491440057724,0.08273340374660258,"FADS2,SIDT2",GWAS_Catalog_2023
715,Phosphatidylethanolamine (15-MHDA 18:2) Levels,0.024826956027899184,10.21285140562249,37.74491440057724,0.08273340374660258,"FADS2,SIDT2",GWAS_Catalog_2023
716,Median Measurement Of Hepatic Fat,0.024826956027899184,10.21285140562249,37.74491440057724,0.08273340374660258,"SAMM50,ZNF217",GWAS_Catalog_2023
717,Insulin-like Growth Factor 1 Levels,0.024991868403413563,2.1506344307270235,7.934130802272322,0.08316680336198712,"RCL1,RTEL1-TNFRSF6B,PTPN1,GCKR,ACOXL,PPARG,ICAM5,JAK2,AP1M2,DDB2",GWAS_Catalog_2023
718,Rheumatoid Arthritis,0.02581936840722973,2.2453101736972703,8.210269338071646,0.08580085378781356,"BLK,FADS2,SPRED2,ACOXL,PRDM16,IL2RB,IL6R,SH2B3,UBE2L3",GWAS_Catalog_2023
719,Coronary Artery Disease,0.025920312413768746,1.7537343054714103,6.405915023978182,0.0860165026693355,"FTO,KANK2,HBS1L,GALNT2,LPL,MYO9B,RHOA,SIRT3,DSTYK,ZNF827,ALDH2,PRDM16,BUD13,APOE,APOB,SH2B3,IL6R",GWAS_Catalog_2023
720,Urea Levels,0.02818509059841866,2.7605569712413542,9.852323324049229,0.0934022585664263,"FTO,GCKR,APOE,PDE7A,DDB2,THBS3",GWAS_Catalog_2023
721,Coronary Artery Disease Or Factor VII Levels (Pleiotropy),0.028980505186219998,3.726354453627181,13.195512663727806,0.09590497277991805,"GCKR,ZSCAN26,BUD13,APOE",GWAS_Catalog_2023
722,"Alzheimer's Disease, Proxy Alzheimer's Disease Or Related Dementias",0.03125885600520284,8.75301204819277,30.333147929428307,0.10081177227645576,"MSRA,APOE",GWAS_Catalog_2023
723,Childhood Steroid-Sensitive Nephrotic Syndrome,0.03125885600520284,8.75301204819277,30.333147929428307,0.10081177227645576,"AHI1,PTPRC",GWAS_Catalog_2023
724,Alcohol Consumption (Heavy Vs. Light/Non-Drinkers),0.03125885600520284,8.75301204819277,30.333147929428307,0.10081177227645576,"FTO,GCKR",GWAS_Catalog_2023
725,Lactate Dehydrogenase Levels,0.03125885600520284,8.75301204819277,30.333147929428307,0.10081177227645576,"GCKR,SNX13",GWAS_Catalog_2023
726,Benign Prostatic Hyperplasia And Lower Urinary Tract Symptoms,0.03125885600520284,8.75301204819277,30.333147929428307,0.10081177227645576,"TERT,BCL11A",GWAS_Catalog_2023
727,Benign Prostatic Hyperplasia And Lower Urinary Tract Symptoms (Prostate Cancer Excluded),0.03125885600520284,8.75301204819277,30.333147929428307,0.10081177227645576,"TERT,BCL11A",GWAS_Catalog_2023
728,Lipoprotein Phospholipase A2 Activity In Cardiovascular Disease,0.03125885600520284,8.75301204819277,30.333147929428307,0.10081177227645576,"LPL,APOE",GWAS_Catalog_2023
729,Cardiometabolic And Hematological Traits,0.03125885600520284,8.75301204819277,30.333147929428307,0.10081177227645576,"CCND3,NPRL3",GWAS_Catalog_2023
730,Cognitive Impairment Test Score,0.03125885600520284,8.75301204819277,30.333147929428307,0.10081177227645576,"TOMM40,APOE",GWAS_Catalog_2023
731,C-reactive Protein Levels Or LDL-cholesterol Levels (Pleiotropy),0.03125885600520284,8.75301204819277,30.333147929428307,0.10081177227645576,"FADS2,GCKR",GWAS_Catalog_2023
732,PCSK9 Levels,0.03125885600520284,8.75301204819277,30.333147929428307,0.10081177227645576,"FADS2,APOB",GWAS_Catalog_2023
733,Facial Morphology (Segment 2),0.03125885600520284,8.75301204819277,30.333147929428307,0.10081177227645576,"ERI1,PRDM16",GWAS_Catalog_2023
734,Phosphatidylethanolamine (18:0 20:3) (A) Levels,0.03125885600520284,8.75301204819277,30.333147929428307,0.10081177227645576,"FADS2,SIDT2",GWAS_Catalog_2023
735,F-small Fish Liking (Derived Food-Liking Factor),0.03125885600520284,8.75301204819277,30.333147929428307,0.10081177227645576,"FTO,MAPT",GWAS_Catalog_2023
736,Leukocyte Telomere Length,0.03129721765568631,4.846080457942439,16.78791829934718,0.10081177227645576,"RTEL1-TNFRSF6B,RTEL1,TERT",GWAS_Catalog_2023
737,Parental Longevity (Mother'S Age At Death),0.03129721765568631,4.846080457942439,16.78791829934718,0.10081177227645576,"MEF2C,SUSD1,APOE",GWAS_Catalog_2023
738,Coronary Artery Calcified Atherosclerotic Plaque (90 Or 130 HU Threshold) In Type 2 Diabetes,0.03129721765568631,4.846080457942439,16.78791829934718,0.10081177227645576,"MSRA,MEF2C,FAM167A",GWAS_Catalog_2023
739,Free Cholesterol Levels In Medium LDL,0.03129721765568631,4.846080457942439,16.78791829934718,0.10081177227645576,"APOE,APOB,PLTP",GWAS_Catalog_2023
740,Age Of Onset Of Childhood Onset Asthma,0.031605749230535475,3.616399286987522,12.492548417395126,0.10081177227645576,"TLR1,RTEL1-TNFRSF6B,RTEL1,NDFIP1",GWAS_Catalog_2023
741,Youthful Appearance (Self-Reported),0.031605749230535475,3.616399286987522,12.492548417395126,0.10081177227645576,"FADS2,KITLG,PPARG,RHOA",GWAS_Catalog_2023
742,Systolic Blood Pressure X Alcohol Consumption Interaction (2Df Test),0.031605749230535475,3.616399286987522,12.492548417395126,0.10081177227645576,"FTO,RP1L1,MSRA,SH2B3",GWAS_Catalog_2023
743,Serum Cancer Antigen 15.3 Levels,0.031773031329377505,inf,inf,0.10081177227645576,THBS3,GWAS_Catalog_2023
744,Dihomo-linolenoylcarnitine (20:3N3 Or 6) Levels In Elite Athletes,0.031773031329377505,inf,inf,0.10081177227645576,SLC22A16,GWAS_Catalog_2023
745,Prenylcysteine Oxidase 1 Levels,0.031773031329377505,inf,inf,0.10081177227645576,FADS2,GWAS_Catalog_2023
746,Accelerometer-based Physical Activity Measurement (Average Acceleration),0.031773031329377505,inf,inf,0.10081177227645576,MEF2C,GWAS_Catalog_2023
747,Lymphoma,0.031773031329377505,inf,inf,0.10081177227645576,ZFP91,GWAS_Catalog_2023
748,N-acetylhistidine Levels,0.031773031329377505,inf,inf,0.10081177227645576,SLC17A1,GWAS_Catalog_2023
749,Vitamin D-binding Protein Levels (Adjusted For GC Haplotype),0.031773031329377505,inf,inf,0.10081177227645576,SH2B3,GWAS_Catalog_2023
750,HTLV-1 Associated Myelopathy,0.031773031329377505,inf,inf,0.10081177227645576,BTN2A1,GWAS_Catalog_2023
751,Beta-2 Microglubulin Plasma Levels,0.031773031329377505,inf,inf,0.10081177227645576,SH2B3,GWAS_Catalog_2023
752,Endothelial Monocyte-Activating Polypeptide 2 Levels,0.031773031329377505,inf,inf,0.10081177227645576,APOE,GWAS_Catalog_2023
753,Daytime Nap,0.03201432412229803,3.0177602956076046,10.385838875916175,0.10144246660797224,"HELZ2,FADS2,ZSCAN9,VRK2,MAPT",GWAS_Catalog_2023
754,Medication Use For T2D (Number Of Purchases),0.03436621263241387,3.5127272727272727,11.840284439957147,0.1084626763769041,"FTO,MACF1,CCND2,PPARG",GWAS_Catalog_2023
755,Vitamin D Levels,0.03436621263241387,3.5127272727272727,11.840284439957147,0.1084626763769041,"GCKR,PCSK7,APOE,APOB",GWAS_Catalog_2023
756,Morning Vs. Evening Chronotype,0.03436621263241387,3.5127272727272727,11.840284439957147,0.1084626763769041,"BLK,MSRA,ERI1,ZNF410",GWAS_Catalog_2023
757,Phospholipid Levels In LDL,0.0351677628365098,4.603323262839879,15.410202084003604,0.11069958064368386,"GCKR,DOCK7,APOB",GWAS_Catalog_2023
758,Phospholipid Levels In Large LDL,0.0351677628365098,4.603323262839879,15.410202084003604,0.11069958064368386,"DOCK7,APOB,PLTP",GWAS_Catalog_2023
759,Testosterone Levels,0.03723412466092187,2.205521472392638,7.257333707306683,0.11698459325558905,"SLC25A37,GCKR,SLC4A1AP,TRIM4,ZAN,SUSD1,MYO9B,SLC17A3",GWAS_Catalog_2023
760,Worry,0.037262485697505315,3.414814814814815,11.23394919967304,0.11698459325558905,"MSRA,HFE,MAPT,ARHGAP27",GWAS_Catalog_2023
761,Psoriasis Or Type 2 Diabetes (Trans-Disease Meta-Analysis),0.03826602016061806,7.658132530120482,24.989964301974165,0.11780996658481895,"FTO,CCND2",GWAS_Catalog_2023
762,Renal Underexcretion Gout,0.03826602016061806,7.658132530120482,24.989964301974165,0.11780996658481895,"GCKR,ALDH2",GWAS_Catalog_2023
763,Cognitive Decline (Age-Related),0.03826602016061806,7.658132530120482,24.989964301974165,0.11780996658481895,"TOMM40,APOE",GWAS_Catalog_2023
764,Fasting Glucose Adjusted For BMI,0.03826602016061806,7.658132530120482,24.989964301974165,0.11780996658481895,"FADS2,GCKR",GWAS_Catalog_2023
765,Anorectal Malformation,0.03826602016061806,7.658132530120482,24.989964301974165,0.11780996658481895,"RTEL1-TNFRSF6B,RTEL1",GWAS_Catalog_2023
766,Low High Density Lipoprotein Cholesterol Levels,0.03826602016061806,7.658132530120482,24.989964301974165,0.11780996658481895,"LPL,APOE",GWAS_Catalog_2023
767,Progressive Supranuclear Palsy,0.03826602016061806,7.658132530120482,24.989964301974165,0.11780996658481895,"MAPT,HK1",GWAS_Catalog_2023
768,Obesity (Early Onset Extreme),0.03826602016061806,7.658132530120482,24.989964301974165,0.11780996658481895,"FTO,LEPR",GWAS_Catalog_2023
769,Fasting Blood Insulin (BMI Interaction),0.03826602016061806,7.658132530120482,24.989964301974165,0.11780996658481895,"GCKR,PPARG",GWAS_Catalog_2023
770,Post-traumatic Stress Disorder (Phenotype Risk Score),0.03826602016061806,7.658132530120482,24.989964301974165,0.11780996658481895,"VRK2,MAPT",GWAS_Catalog_2023
771,Urinary Uromodulin Levels (Indexed To Creatinine),0.03826602016061806,7.658132530120482,24.989964301974165,0.11780996658481895,"FTO,SLC25A37",GWAS_Catalog_2023
772,Unstable Angina Pectoris,0.03826602016061806,7.658132530120482,24.989964301974165,0.11780996658481895,"ALDH2,APOB",GWAS_Catalog_2023
773,Vaginal Microbiome MetaCyc Pathway (ENTBACSYN-PWY|enterobactin Biosynthesis),0.03826602016061806,7.658132530120482,24.989964301974165,0.11780996658481895,"MACF1,TDP2",GWAS_Catalog_2023
774,F-strong Vegetable Liking (Derived Food-Liking Factor),0.03826602016061806,7.658132530120482,24.989964301974165,0.11780996658481895,"CEP57,MAPT",GWAS_Catalog_2023
775,F-savoury Food Liking (Derived Food-Liking Factor),0.03826602016061806,7.658132530120482,24.989964301974165,0.11780996658481895,"FTO,KANSL1",GWAS_Catalog_2023
776,Intelligence (MTAG),0.038564613671876816,2.075683122847302,6.757220698896577,0.11857624770760063,"CEP57,MEF2C,BTN3A1,BCL11A,BTN2A1,DENND4A,ZMIZ2,HFE,SLC17A1",GWAS_Catalog_2023
777,Total Phospholipid Levels In Lipoprotein Particles,0.03927315749651936,4.38368580060423,14.1909290839985,0.12051201011156057,"GCKR,DOCK7,UBE2L3",GWAS_Catalog_2023
778,Urate Levels,0.03929519860301514,1.7996495327102804,5.824840951955616,0.12051201011156057,"FTO,GCKR,SPRYD4,MAST3,RHOA,U2SURP,THBS3,FADS2,CCND2,ZNF827,PPARG,SLC17A1,SLC17A3",GWAS_Catalog_2023
779,COVID-19 (Hospitalized Vs Population),0.04136689434343933,2.797181541862393,8.909790677963274,0.12670270847682444,"CCND3,KANSL1,ZAN,SNX13,THBS3",GWAS_Catalog_2023
780,Estimated Glomerular Filtration Rate,0.041515368069330975,1.6467564884971058,5.239471295542282,0.1269944464274663,"BRD3,BLK,RTEL1-TNFRSF6B,GCKR,TOMM40,DENND4A,TRPC1,ZBTB38,TNK2,TFEB,THBS3,MFHAS1,MSRA,SLC7A6,APOE,PDE7A,CTSB",GWAS_Catalog_2023
781,Ankylosing Spondylitis,0.04361042637875409,4.184015380390003,13.106256718491624,0.13238216741672487,"IL6R,SH2B3,UBE2L3",GWAS_Catalog_2023
782,Fish- And Plant-Related Diet,0.04361042637875409,4.184015380390003,13.106256718491624,0.13238216741672487,"FTO,MFHAS1,MSRA",GWAS_Catalog_2023
783,Fasting Blood Glucose,0.04361042637875409,4.184015380390003,13.106256718491624,0.13238216741672487,"FADS2,GCKR,MRPL33",GWAS_Catalog_2023
784,Stable Angina Pectoris,0.04361042637875409,4.184015380390003,13.106256718491624,0.13238216741672487,"APOE,APOB,IL6R",GWAS_Catalog_2023
785,Total Cholesterol Minus HDL-C Levels,0.04361042637875409,4.184015380390003,13.106256718491624,0.13238216741672487,"GCKR,HFE,DOCK7",GWAS_Catalog_2023
786,Triglyceride Levels In Large HDL,0.04361042637875409,4.184015380390003,13.106256718491624,0.13238216741672487,"GCKR,DOCK7,PLTP",GWAS_Catalog_2023
787,Granulocyte Percentage Of Myeloid White Cells,0.04366503175061294,2.464146341463415,7.715753963759093,0.13238216741672487,"BRD3,FADS2,SPRED2,CCND3,ACOXL,BCL2L11",GWAS_Catalog_2023
788,Barrett's Esophagus Or Esophageal Adenocarcinoma,0.045805630168369055,6.806559571619813,20.986993652421944,0.13678627482068656,"MSRA,APOB",GWAS_Catalog_2023
789,Asthma And Cardiovascular Disease,0.045805630168369055,6.806559571619813,20.986993652421944,0.13678627482068656,"RAD50,PGAP3",GWAS_Catalog_2023
790,Visceral Adipose Tissue Volumes To Gluteofemoral Adipose Tissue Volumes Ratio,0.045805630168369055,6.806559571619813,20.986993652421944,0.13678627482068656,"PPARG,CPEB4",GWAS_Catalog_2023
791,Sleep Health Score,0.045805630168369055,6.806559571619813,20.986993652421944,0.13678627482068656,"USP49,ERI1",GWAS_Catalog_2023
792,Urinary Metabolite Modules (Eigenmetabolites) In Chronic Kidney Disease,0.045805630168369055,6.806559571619813,20.986993652421944,0.13678627482068656,"SLC17A1,SLC17A3",GWAS_Catalog_2023
793,L-selectin Levels,0.045805630168369055,6.806559571619813,20.986993652421944,0.13678627482068656,"GCKR,IL2RB",GWAS_Catalog_2023
794,Problematic Alcohol Use,0.045805630168369055,6.806559571619813,20.986993652421944,0.13678627482068656,"FTO,GCKR",GWAS_Catalog_2023
795,Corneal Endothelial Cell Size Variation Coefficient,0.045805630168369055,6.806559571619813,20.986993652421944,0.13678627482068656,"RP1L1,MSRA",GWAS_Catalog_2023
796,Prostate-specific Antigen Levels,0.045805630168369055,6.806559571619813,20.986993652421944,0.13678627482068656,"TERT,BCL11A",GWAS_Catalog_2023
797,High-grade Serous Ovarian Cancer,0.045805630168369055,6.806559571619813,20.986993652421944,0.13678627482068656,"ACOXL,TERT",GWAS_Catalog_2023
798,Cognitive Performance (Language Ability) (Longitudinal),0.045805630168369055,6.806559571619813,20.986993652421944,0.13678627482068656,"RRM1,COL26A1",GWAS_Catalog_2023
799,COVID-19 Hospitalization Or Rheumatoid Arthritis (MTAG),0.045805630168369055,6.806559571619813,20.986993652421944,0.13678627482068656,"TMEM50B,ZKSCAN3",GWAS_Catalog_2023
800,Chronic Obstructive Pulmonary Disease,0.04591029324806036,2.4314826700898586,7.491558422190064,0.13692744961234002,"MFHAS1,ALDH2,KANSL1,BTN2A1,ZBTB38,TM9SF4",GWAS_Catalog_2023
801,Cancer,0.046768568540565984,3.1512043512043513,9.650701707778818,0.1387932892261075,"BCL2L11,TERT,MYO9B,SH2B3",GWAS_Catalog_2023
802,Vertical Cup-Disc Ratio (Adjusted For Vertical Disc Diameter),0.046768568540565984,3.1512043512043513,9.650701707778818,0.1387932892261075,"PDGFRA,ACOXL,DUSP1,PRDM16",GWAS_Catalog_2023
803,Coronary Artery Disease Or Factor VIII Levels (Pleiotropy),0.046768568540565984,3.1512043512043513,9.650701707778818,0.1387932892261075,"SCGN,BTN2A1,ZSCAN26,APOE",GWAS_Catalog_2023
804,Depressed Affect,0.046768568540565984,3.1512043512043513,9.650701707778818,0.1387932892261075,"KANSL1,VRK2,MAPT,DDB2",GWAS_Catalog_2023
805,Mean Arterial Pressure X Alcohol Consumption Interaction (2Df Test),0.04817604921540808,4.001707605411796,12.136752127660227,0.1422624423613412,"FTO,RP1L1,SH2B3",GWAS_Catalog_2023
806,Experiencing Mood Swings,0.04817604921540808,4.001707605411796,12.136752127660227,0.1422624423613412,"KANSL1,VRK2,MAPT",GWAS_Catalog_2023
807,Cholesteryl Ester Levels In LDL,0.04817604921540808,4.001707605411796,12.136752127660227,0.1422624423613412,"GCKR,HFE,DOCK7",GWAS_Catalog_2023
808,Omega-3 Fatty Acid Levels,0.04817604921540808,4.001707605411796,12.136752127660227,0.1422624423613412,"GCKR,KANSL1,DOCK7",GWAS_Catalog_2023
809,White Matter Microstructure (Fractional Anisotropy),0.05020936719113392,3.0721212121212123,9.190415493744885,0.14771831087305243,"KANSL1,ERI1,ZSCAN9,MAPT",GWAS_Catalog_2023
810,Problematic Alcohol Use (MTAG),0.05020936719113392,3.0721212121212123,9.190415493744885,0.14771831087305243,"FTO,GCKR,ARPC1A,MAPT",GWAS_Catalog_2023
811,Colorectal Cancer Or Advanced Adenoma,0.05020936719113392,3.0721212121212123,9.190415493744885,0.14771831087305243,"RTEL1-TNFRSF6B,TOX2,RTEL1,CCND2",GWAS_Catalog_2023
812,Mosquito Bite Size,0.052211571037431126,2.6065117716758537,7.6955986550295075,0.15323100675929974,"BRD3,SLC25A37,XRN1,IL6R,CPEB4",GWAS_Catalog_2023
813,Rheumatoid Arthritis (Rheumatoid Factor And/Or Anti-Cyclic Citrullinated Peptide Seropositive),0.052211571037431126,2.6065117716758537,7.6955986550295075,0.15323100675929974,"SPRED2,ACOXL,IL6R,SH2B3,UBE2L3",GWAS_Catalog_2023
814,Concentration Of Large LDL Particles,0.052966013709009704,3.834592145015106,11.266433671260492,0.15447142335996508,"FADS2,GALNT2,DOCK7",GWAS_Catalog_2023
815,Ease Of Getting Up In The Morning,0.052966013709009704,3.834592145015106,11.266433671260492,0.15447142335996508,"FTO,ZMIZ2,MAPT",GWAS_Catalog_2023
816,Total Lipid Levels In IDL,0.052966013709009704,3.834592145015106,11.266433671260492,0.15447142335996508,"DOCK7,LPL,APOB",GWAS_Catalog_2023
817,Hip Circumference,0.0530710224662085,2.338453226304415,6.865989145639425,0.15447142335996508,"FTO,ACOXL,ZBTB38,LEPR,ARIH2,SLC39A13",GWAS_Catalog_2023
818,Intracranial Aneurysm,0.053785525323632795,2.9968957871396897,8.759179841215941,0.15447142335996508,"ALDH2,DNAJA4,SUSD1,SIRT3",GWAS_Catalog_2023
819,Depressive Symptoms (MTAG),0.053785525323632795,2.9968957871396897,8.759179841215941,0.15447142335996508,"BTN2A1,BTN3A2,VRK2,SPPL3",GWAS_Catalog_2023
820,Chronic Lymphocytic Leukemia,0.053785525323632795,2.9968957871396897,8.759179841215941,0.15447142335996508,"FTO,ACOXL,BCL2L11,TERT",GWAS_Catalog_2023
821,Alcohol Use Disorder,0.05383699378683079,6.125301204819277,17.89687095002477,0.15447142335996508,"FTO,GCKR",GWAS_Catalog_2023
822,Word Reading,0.05383699378683079,6.125301204819277,17.89687095002477,0.15447142335996508,"DOCK7,NLRP3",GWAS_Catalog_2023
823,Response To Statin Therapy,0.05383699378683079,6.125301204819277,17.89687095002477,0.15447142335996508,"FADS2,PRDM16",GWAS_Catalog_2023
824,Severe Influenza A (H1N1) Infection,0.05383699378683079,6.125301204819277,17.89687095002477,0.15447142335996508,"SPRED2,BUD13",GWAS_Catalog_2023
825,Familial Combined Hyperlipidemia Defined By Brunzell Criteria,0.05383699378683079,6.125301204819277,17.89687095002477,0.15447142335996508,"GCKR,DOCK7",GWAS_Catalog_2023
826,Phenylalanine Levels,0.05383699378683079,6.125301204819277,17.89687095002477,0.15447142335996508,"SLC17A1,SLC17A3",GWAS_Catalog_2023
827,Estimated Glomerular Filtration Rate (Creatinine),0.05506600265614363,1.478032286936056,4.285144853599197,0.15447142335996508,"BRD3,BLK,GCDH,GCKR,EPAS1,ZBTB38,TNK2,DOCK7,TFEB,ZFP90,MFHAS1,SPRED2,MSRA,FADS2,CCND3,FAM167A,SLC7A6,SERTAD2,ERI1,APOE,PDE7A,SLC17A3,CTSB",GWAS_Catalog_2023
828,Prostate Cancer,0.05690756892471903,1.9161167108753316,5.492216920154684,0.15447142335996508,"RTEL1-TNFRSF6B,RTEL1,ACOXL,BCL2L11,TERT,ZBTB38,MYO9B,ATP11B,ZNF322",GWAS_Catalog_2023
829,Body Fat Distribution (Arm Fat Ratio),0.057975865160158006,3.680845921450151,10.482049735111122,0.15447142335996508,"FTO,ERI1,ZBTB38",GWAS_Catalog_2023
830,Endometrial Cancer,0.057975865160158006,3.680845921450151,10.482049735111122,0.15447142335996508,"BCL11A,PPARG,SH2B3",GWAS_Catalog_2023
831,Cholesteryl Ester Levels In IDL,0.057975865160158006,3.680845921450151,10.482049735111122,0.15447142335996508,"KANK2,DOCK7,LPL",GWAS_Catalog_2023
832,Total Lipid Levels In Lipoprotein Particles,0.057975865160158006,3.680845921450151,10.482049735111122,0.15447142335996508,"GCKR,DOCK7,UBE2L3",GWAS_Catalog_2023
833,Free Cholesterol Levels In IDL,0.057975865160158006,3.680845921450151,10.482049735111122,0.15447142335996508,"LPL,APOE,APOB",GWAS_Catalog_2023
834,Cholesteryl Ester Levels In Medium VLDL,0.057975865160158006,3.680845921450151,10.482049735111122,0.15447142335996508,"TOMM40,DOCK7,APOB",GWAS_Catalog_2023
835,Offspring Birth Weight,0.05819930117046132,2.5205540883950373,7.168158229852214,0.15447142335996508,"SLC25A37,CCND2,DUSP1,ZBTB38,SH2B3",GWAS_Catalog_2023
836,Asthma (Childhood Onset),0.058446075531169844,2.114648917671044,6.004864354689299,0.15447142335996508,"TLR1,RAD50,NDFIP1,KLHL5,PGAP3,ZBTB38,SPPL3",GWAS_Catalog_2023
837,Metabolite Levels,0.06019192073717595,1.4282284616791658,4.013632106699394,0.15447142335996508,"RTEL1,THRB,MAX,MAST2,DOCK7,LPL,GMPR,MRPL33,SPRED2,FADS2,CCND3,ARIH2,APOB,CTSB,RTEL1-TNFRSF6B,GCKR,RRM1,USP49,SPRYD4,GALNT2,ZBTB38,SUSD1,NSMCE2,FIG4,BUD13,PDE7A",GWAS_Catalog_2023
838,Type 2 Diabetes (Adjusted For BMI),0.06134084599917283,2.8569415081042986,7.974607482337523,0.15447142335996508,"MACF1,GCKR,LPL,PPARG",GWAS_Catalog_2023
839,High-sensitivity Cardiac Troponin T Levels (MTAG),0.06232145365055438,5.567907995618839,15.453447752602834,0.15447142335996508,"MAP2K2,MAPT",GWAS_Catalog_2023
840,High-sensitivity Cardiac Troponin I Concentration (MTAG),0.06232145365055438,5.567907995618839,15.453447752602834,0.15447142335996508,"MAP2K2,MAPT",GWAS_Catalog_2023
841,Colorectal Or Endometrial Cancer,0.06232145365055438,5.567907995618839,15.453447752602834,0.15447142335996508,"TDP2,SH2B3",GWAS_Catalog_2023
842,Low Hand Grip Strength (60 Years And Older) (EWGSOP),0.06232145365055438,5.567907995618839,15.453447752602834,0.15447142335996508,"FTO,ZBTB38",GWAS_Catalog_2023
843,Tenofovir Clearance In HIV Infection,0.06232145365055438,5.567907995618839,15.453447752602834,0.15447142335996508,"SLC17A1,SLC17A3",GWAS_Catalog_2023
844,Medication Use (Vasodilators Used In Cardiac Diseases),0.06232145365055438,5.567907995618839,15.453447752602834,0.15447142335996508,"ALDH2,APOB",GWAS_Catalog_2023
845,Valine Levels,0.06232145365055438,5.567907995618839,15.453447752602834,0.15447142335996508,"GCKR,SPRYD4",GWAS_Catalog_2023
846,Indoleacetate Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FIGNL1,GWAS_Catalog_2023
847,Naive T-cell Telomere Length,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,TERT,GWAS_Catalog_2023
848,Ischemic Stroke Or Plasminogen Activator Inhibitor 1 Levels (Pleiotropy),0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,SH2B3,GWAS_Catalog_2023
849,Conjunctival UV Autofluorescence (CUVAF),0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,HDAC7,GWAS_Catalog_2023
850,Phosphatidylcholine (18:0 22:6) Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
851,Age Of Onset Of Parkinson Disease,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,APOE,GWAS_Catalog_2023
852,Brain-derived Neurotrophic Factor Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,BRD3,GWAS_Catalog_2023
853,Latent Autoimmune Diabetes Vs. Type 2 Diabetes,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,SH2B3,GWAS_Catalog_2023
854,Sleep Duration (Long Sleep),0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FTO,GWAS_Catalog_2023
855,Hazardous Alcohol Drinking,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,ALDH2,GWAS_Catalog_2023
856,Beta-defensin 1 Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,GCKR,GWAS_Catalog_2023
857,Gastrokine-2 Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,THBS3,GWAS_Catalog_2023
858,Parental Longevity (Mother'S Attained Age),0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,APOE,GWAS_Catalog_2023
859,Triacylglycerol 56:6 Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
860,End-stage Kidney Disease,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FTO,GWAS_Catalog_2023
861,Stroke (Ischemic),0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,ALDH2,GWAS_Catalog_2023
862,Lung Function (FEV1) And Waist Circumference Adjusted For BMI,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,ALDH2,GWAS_Catalog_2023
863,Phosphatidylcholine(36:2) [M+H]1+/Phosphatidylethanolamine(39:2) [M+H]1+/Phosphatidate(41:3) [M+NH4]1+ Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
864,10-Undecenoate (11:1N1) Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,MAST2,GWAS_Catalog_2023
865,2-Aminooctanoate Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,SLC17A3,GWAS_Catalog_2023
866,Phosphatidylcholine-O 35:4 [M+OAc]1-/Phosphatidylcholine-P 35:3 [M+OAc]1- Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
867,Phosphatidylcholine-O(38:5) [M+H]1+/Phosphatidylcholine-P(38:4) [M+H]1+ Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
868,Phosphatidylcholine-O(36:3) M+H]1+/Phosphatidylcholine-P(36:2) M+H]1+ Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
869,Phosphatidylcholine-O(36:4) [M+H]1+/Phosphatidylcholine-P(36:3) [M+H]1+ Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
870,Phosphatidylcholine-O(40:5) [M+H]1+/Phosphatidylcholine-P(40:4) [M+H]1+ Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
871,Phosphatidylcholine(34:2) [M+H]1+/Phosphatidylethanolamine(37:2) [M+H]1+/Phosphatidate(39:3) [M+NH4]1+ Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
872,Phosphatidylcholine(36:3) [M+OAc]1-/Phosphatidylserine(40:2) [M-H]1- Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
873,Phosphatidylcholine(36:4) [M+H]1+/Phosphatidylethanolamine(39:4) [M+H]1+/Phosphatidate(41:5) [M+NH4]1+ Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
874,Phosphatidylcholine(36:5) [M+OAc]1-/Phosphatidylserine(40:4) [M-H]1- Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
875,Phosphatidylcholine-O(40:6) [M+H]1+/Phosphatidylcholine-P(40:5) [M+H]1+ Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
876,Phosphatidylcholine(35:3) [M+H]1+/Phosphatidylethanolamine(38:3) [M+H]1+/Phosphatidate(40:4) [M+NH4]1+ Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
877,Phosphatidylcholine(37:4) [M+H]1+/Phosphatidylethanolamine(40:4) [M+H]1+/Phosphatidate(42:5) [M+NH4]1+ Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
878,Phosphatidylcholine 44:5 [M+OAc]1- Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
879,Phosphatidylcholine 52:4 [M+OAc]1- Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
880,1-Stearoyl-2-Arachidonoyl-Gpc (18:0/20:4) Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
881,N-acetylphenylalanine Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,SLC17A1,GWAS_Catalog_2023
882,Phosphatidylcholine-O 38:4 [M+H]1+/Phosphatidylcholine-P 38:3 [M+H]1+ Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
883,Phosphatidylcholine(37:4) [M+H]1+/Phosphatidylethanolamine(40:3) [M+H]1+ Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
884,Phosphatidylcholine 36:5 [M+H]1+/Phosphatidylethanolamine 39:5 [M+H]1+/Phosphatidate 41:6 [M+NH4]1+ Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
885,Phosphatidylcholine-O 33:3 [M+H]1+/Phosphatidylcholine-P 33:2 [M+H]1+/Phosphatidylethanolamine-O 36:3 [M+H]1+ Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
886,Phosphatidylcholine 38:6 [M+H]1+/Phosphatidylethanolamine 41:6 [M+H]1+ Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
887,Phosphatidylcholine 39:6 [M+OAc]1- Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
888,Phosphatidylcholine-O 40:6 [M+H]1+/Phosphatidylcholine-P 40:5 [M+H]1+ Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
889,Wg Lh Intensity-Contrast Rostralanteriorcingulate,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,KLF3,GWAS_Catalog_2023
890,Phosphatidylcholine(38:5) [M+H]1+/Phosphatidylethanolamine(41:5) [M+H]1+/Phosphatidate(43:6) [M+NH4]1+ Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
891,Phosphatidylcholine(39:6) [M+OAc]1-/Phosphatidylserine(43:5) [M-H]1- Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
892,Cholesteryl Ester(20:5) [M+NH4]1+ Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
893,Phosphatidylethanolamine-O 36:3 [M-H]1-/Phosphatidylethanolamine-P 36:2 [M-H]1- Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
894,Phosphatidylethanolamine-O 36:4 [M-H]1-/Phosphatidylethanolamine-P 36:3 [M-H]1- Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
895,Phosphatidylethanolamine-O(38:4) [M-H]1-/Phosphatidylcholine-O(35:4) [M-H]1-/Phosphatidylcholine-P(35:3) [M-H]1- Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
896,Phosphatidylethanolamine-O(38:6) [M+H]1+/Phosphatidylcholine-P(35:5) [M+H]1+ Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
897,Phosphatidylcholine(40:5) [M+H]1+ Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
898,Phosphatidylcholine(40:5) [M+OAc]1-/Phosphatidylserine(44:4) [M-H]1- Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
899,Phosphatidylcholine(38:4) [M+H]1+/Phosphatidylethanolamine(41:4) [M+H]1+ Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
900,Phosphatidylcholine(40:4) [M+OAc]1-/Phosphatidylserine(44:3) [M-H]1- Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
901,Cholesteryl Ester 22:5 [M+NH4]1+ Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
902,Phosphatidylethanolamine-O 38:6 [M-H]1-/Phosphatidylethanolamine-P 38:5 [M-H]1- Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
903,Lysophosphatidylcholine(20:4) [M+H]1+ Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
904,Phosphatidate(41:2) [M+H]1+ Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
905,Phosphatidylcholine 35:5 [M+OAc]1-/Phosphatidylserine 39:4 [M-H]1- Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
906,Phosphatidylinositol-O(33:0) [M-H]1- Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
907,Phosphatidylinositol 35:2 [M-H]1- Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
908,Lysophosphatidylethanolamine-O 18:1 [M-H]1-/Lysophosphatidylethanolamine-P 18:0 [M-H]1- Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
909,Phosphatidate 34:2 [M-H]1- Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
910,Phosphatidate(34:2) [M-H]1- Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
911,Phosphatidate(43:4) [M-H]1- Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
912,Phosphatidylinositol(36:0) [M+OAc]1- Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
913,Phosphatidylglycerol 34:0 [M-H]1- Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
914,Phosphatidylglycerol 36:0 [M-H]1- Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
915,Fatty Acid(18:4) [M-H]1- Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
916,Phosphatidylinositol 35:0 [M-H]1- Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
917,Phosphatidylglycerol(36:0) [M-H]1- Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
918,Phosphatidylglycerol(35:3) [M-H]1- Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
919,Phosphatidylglycerol(34:0) [M-H]1- Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
920,Fatty Acid(22:6) [M-H]1- Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
921,Phosphatidylcholine(38:4) [M+OAc]1-/Phosphatidylserine(42:3) [M-H]1- Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
922,Phosphatidylethanolamine-O 40:6 [M-H]1-/Phosphatidylethanolamine-P 40:5 [M-H]1- Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
923,Phosphatidylcholine(40:6) [M+H]1+/Phosphatidylethanolamine(43:6) [M+H]1+ Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
924,Cholesteryl Ester 18:2 [M+NH4]1+ Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
925,Phosphatidylcholine(40:8) [M+H]1+ Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
926,Phosphatidylcholine(42:4) [M+OAc]1- Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
927,Cholesteryl Ester 14:0 [M+NH4]1+ Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
928,Phosphatidylethanolamine 34:0 [M-H]1- Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
929,Phosphatidylinositol(36:1) [M+OAc]1- Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
930,Phosphatidylinositol(36:3) [M-H]1- Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
931,Cerebrospinal Fluid Levels Of Alzheimer's Disease-Related Proteins,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,IL6R,GWAS_Catalog_2023
932,Sickle Cell Anemia (Haemolysis),0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,NPRL3,GWAS_Catalog_2023
933,Diacylglycerol (18:2 20:4) Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
934,Lysophosphatidylcholine (22:5) [Sn1] (N6) Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
935,Diacylglycerol (16:0 20:4) Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
936,Lysophosphatidylcholine (20:4) [Sn1] Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
937,Phosphatidylcholine (15-MHDA 18:2) Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
938,Triacylglycerol 56:4 [M+NH4]1+ Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
939,Triacylglycerol 54:7 [M+NH4]1+ Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
940,Triacylglycerol(56:4) [M+NH4]1+ Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
941,Triacylglycerol 58:8 [M+NH4]1+ Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
942,Triacylglycerol 46:5 [M+NH4]1+ Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,LPL,GWAS_Catalog_2023
943,Triacylglycerol(58:9) [M+NH4]1+ Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
944,Triacylglycerol(56:7) [M+NH4]1+ Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
945,Sphingomyelin 40:2 [M+H]1+ Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,LPL,GWAS_Catalog_2023
946,Sphingomyelin(38:1) [M+H]1+ Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,BUD13,GWAS_Catalog_2023
947,Alkylphosphatidylcholine (O-18:0/20:4) Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
948,Phosphatidylcholines (36:3E)1 Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
949,Triacylglycerol (56:8) [NL-20:4] Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
950,Phosphatidylcholines (38:4)C Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
951,Sphingomyeline C16:1 Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
952,Phosphatidylcholine Diacyl C36:2 Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,DOCK7,GWAS_Catalog_2023
953,Phosphatidylserine-P 42:1 [M+H]1+/Phosphatidylglycerol-P 42:6 [M+NH4]1+ Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
954,Phosphatidylserine(35:2) [M+OAc]1- Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
955,Phosphatidylserine(42:5) [M+OAc]1- Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
956,Phosphatidylserine(42:7) [M+OAc]1- Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
957,Phosphatidylserine(44:6) [M+OAc]1- Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
958,Neutrophil Collagenase Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,APOE,GWAS_Catalog_2023
959,Alpha-2-Macroglobulin Receptor-Associated Protein Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,TRIM38,GWAS_Catalog_2023
960,ADP-ribosyl Cyclase/Cyclic ADP-ribose Hydrolase 2 Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FBXL5,GWAS_Catalog_2023
961,Plasma Protease C1 Inhibitor Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,SERPING1,GWAS_Catalog_2023
962,"Sphingomyelin (D18:1/22:1, D18:2/22:0, D16:1/24:1) Levels",0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,APOE,GWAS_Catalog_2023
963,"Sphingomyelin (D18:1/18:1, D18:2/18:0) Levels",0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
964,Ergothioneine Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,SLC22A16,GWAS_Catalog_2023
965,Kynurenine Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,SH2B3,GWAS_Catalog_2023
966,1-Palmitoyl-2-Docosahexaenoyl-Gpc (16:0/22:6) Levels,0.06253956201413506,30.56156156156156,84.71530180884244,0.15447142335996508,FADS2,GWAS_Catalog_2023
967,Uric Acid Levels,0.06320075302275012,3.538926330467116,9.772529409972307,0.15530071752037258,"GCKR,KLHL5,SLC17A1",GWAS_Catalog_2023
968,Cerebrospinal Fluid Biomarker Levels,0.06320075302275012,3.538926330467116,9.772529409972307,0.15530071752037258,"LEPR,APOE,IL6R",GWAS_Catalog_2023
969,Free Cholesterol Levels In Large LDL,0.06320075302275012,3.538926330467116,9.772529409972307,0.15530071752037258,"LPL,APOE,APOB",GWAS_Catalog_2023
970,Itch Intensity From Mosquito Bite,0.06320075302275012,3.538926330467116,9.772529409972307,0.15530071752037258,"RAD50,FAM167A,IL6R",GWAS_Catalog_2023
971,"Medication Use (Adrenergics, Inhalants)",0.06320075302275012,3.538926330467116,9.772529409972307,0.15530071752037258,"FADS2,NDFIP1,PTPRC",GWAS_Catalog_2023
972,Cholesteryl Ester Levels In Very Small VLDL,0.06863547451450196,3.4075193017791205,9.128559374404292,0.16848173064979596,"DOCK7,APOE,APOB",GWAS_Catalog_2023
973,Body Fat Distribution (Trunk Fat Ratio),0.06942650750229386,2.7294276094276095,7.28071138797702,0.17024835241569694,"FTO,SLC25A37,ERI1,ZBTB38",GWAS_Catalog_2023
974,LDL Cholesterol X Physical Activity Interaction (2Df Test),0.07122229964072589,5.103413654618474,13.482960195706973,0.17322773388661772,"FADS2,HFE",GWAS_Catalog_2023
975,Alcohol-associated Liver Disease In Non Drinkers,0.07122229964072589,5.103413654618474,13.482960195706973,0.17322773388661772,"ZNF827,DLG5",GWAS_Catalog_2023
976,Caffeine Consumption From Coffee Or Tea,0.07122229964072589,5.103413654618474,13.482960195706973,0.17322773388661772,"GCKR,XRN1",GWAS_Catalog_2023
977,Total Concentration Of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),0.07122229964072589,5.103413654618474,13.482960195706973,0.17322773388661772,"GCKR,SPRYD4",GWAS_Catalog_2023
978,Parental Longevity (Father'S Age At Death),0.07122229964072589,5.103413654618474,13.482960195706973,0.17322773388661772,"APOE,SH2B3",GWAS_Catalog_2023
979,Urate Levels In Overweight Individuals,0.07122229964072589,5.103413654618474,13.482960195706973,0.17322773388661772,"GCKR,SLC17A1",GWAS_Catalog_2023
980,Low Testosterone Levels,0.07122229964072589,5.103413654618474,13.482960195706973,0.17322773388661772,"GCKR,MAPT",GWAS_Catalog_2023
981,Leucine Levels,0.07122229964072589,5.103413654618474,13.482960195706973,0.17322773388661772,"GCKR,SPRYD4",GWAS_Catalog_2023
982,Heel Bone Mineral Density,0.0729659717899029,1.371197218082464,3.5894680904392158,0.17728799255672942,"FTO,BLK,MACF1,THRB,ZAN,HFE,SNX13,UBE2L3,THBS3,FADS2,CCND2,BCL2L11,ZNF827,SERTAD2,CTSB,PTPN1,BCL11A,BTN2A1,ZBTB38,ZFP91,PILRB,ARHGAP27,MSRA,KANSL1,XRN1,AXL,TMBIM1,PPARG,CPEB4",GWAS_Catalog_2023
983,Adult Body Size,0.0730854062411139,1.6215706964124208,4.2422341891773865,0.1773975374275664,"FTO,MACF1,MAST3,GALNT2,AGAP1,KLF3,MSRA,FIGNL1,ZMIZ2,KIT,LEPR,PPARG,APOE",GWAS_Catalog_2023
984,Gout,0.07366493077681577,2.669828722002635,6.963523177361515,0.17844114196292632,"GCKR,ALDH2,SLC17A1,THBS3",GWAS_Catalog_2023
985,Primary Biliary Cholangitis,0.07366493077681577,2.669828722002635,6.963523177361515,0.17844114196292632,"NDFIP1,MAST3,ANP32B,SH2B3",GWAS_Catalog_2023
986,Blood Protein Levels In Cardiovascular Risk,0.07427451545356177,3.285498489425982,8.542254613906618,0.1793714512876502,"GCKR,IL6R,C12ORF43",GWAS_Catalog_2023
987,LDL Cholesterol Levels X Alcohol Consumption (Regular Vs Non-Regular Drinkers) Interaction (2Df),0.07427451545356177,3.285498489425982,8.542254613906618,0.1793714512876502,"FADS2,DOCK7,SH2B3",GWAS_Catalog_2023
988,Heart Failure (Multivariate Analysis),0.07427451545356177,3.285498489425982,8.542254613906618,0.1793714512876502,"FTO,MAPT,SH2B3",GWAS_Catalog_2023
989,Self-reported Math Ability,0.0754537035320143,1.6904178796420375,4.36843875493245,0.18203492075569883,"BRD3,MSRA,SCGN,MFHAS1,MEF2C,FAM167A,ERI1,BCL11A,DNAJA4,VRK2,RBM23",GWAS_Catalog_2023
990,COVID-19 (Severe Vs Population),0.08011208835267787,3.171892905510991,8.00689972545036,0.18899437545545825,"DLG5,APOE,MAPT",GWAS_Catalog_2023
991,Nonatopic Asthma,0.08011208835267787,3.171892905510991,8.00689972545036,0.18899437545545825,"FADS2,RAD50,NDFIP1",GWAS_Catalog_2023
992,Cholelithiasis,0.08011208835267787,3.171892905510991,8.00689972545036,0.18899437545545825,"FTO,FADS2,GCKR",GWAS_Catalog_2023
993,Whole Brain Restricted Isotropic Diffusion (Multivariate Analysis),0.08025131620619555,1.853406522441072,4.675388680851013,0.18899437545545825,"TF,AKAP10,COL26A1,CD82,KANSL1,APOE,VRK2,THBS3",GWAS_Catalog_2023
994,Intrinsic Epigenetic Age Acceleration,0.08050468484980135,4.710379981464319,11.86751926644335,0.18899437545545825,"SCGN,TERT",GWAS_Catalog_2023
995,Meat-related Diet,0.08050468484980135,4.710379981464319,11.86751926644335,0.18899437545545825,"DSTYK,APOE",GWAS_Catalog_2023
996,Cerebrospinal Fluid t-tau:AB1-42 Ratio,0.08050468484980135,4.710379981464319,11.86751926644335,0.18899437545545825,"TOMM40,APOE",GWAS_Catalog_2023
997,Fibrinogen,0.08050468484980135,4.710379981464319,11.86751926644335,0.18899437545545825,"NLRP3,IL6R",GWAS_Catalog_2023
998,Urinary Tract Infection Frequency,0.08050468484980135,4.710379981464319,11.86751926644335,0.18899437545545825,"ZKSCAN4,BTN3A2",GWAS_Catalog_2023
999,Lung Cancer,0.08210766330015962,2.259520829608439,5.6481782786841706,0.18899437545545825,"CD164,CHURC1,TERT,BTN3A1,ADAR",GWAS_Catalog_2023
1000,Nicotine Dependence Symptom Count,0.08252496370555697,2.558080808080808,6.381527648423984,0.18899437545545825,"MYO1D,TF,PRDM16,FBXL5",GWAS_Catalog_2023
1001,Late-onset Alzheimer's Disease,0.08252496370555697,2.558080808080808,6.381527648423984,0.18899437545545825,"TOMM40,CDH1,TFEB,APOE",GWAS_Catalog_2023
1002,Inguinal Hernia,0.08252496370555697,2.558080808080808,6.381527648423984,0.18899437545545825,"MYO1D,COL26A1,BTN2A1,TRIM38",GWAS_Catalog_2023
1003,Medication Use (Diuretics),0.08252496370555697,2.558080808080808,6.381527648423984,0.18899437545545825,"FTO,MSRA,ERI1,SH2B3",GWAS_Catalog_2023
1004,Serum Uric Acid Levels,0.08345666121001587,1.704692722188118,4.233481312579051,0.18899437545545825,"FTO,GCKR,CCND2,ZNF827,ALDH2,PPARG,APOE,TMC6,SLC17A1,SLC17A3",GWAS_Catalog_2023
1005,Attention Deficit Hyperactivity Disorder Or Autism Spectrum Disorder Or Intelligence (Pleiotropy),0.08463297997022308,1.9239296636085628,4.751012042143918,0.18899437545545825,"MEF2C,THRB,BCL11A,MAST3,ZMIZ2,MAPT,RHOA",GWAS_Catalog_2023
1006,Serum Creatinine Levels,0.0849505399238888,1.6118822576289495,3.9743956373363654,0.18899437545545825,"FADS2,GCKR,SERTAD2,EPAS1,MAST2,TNK2,TFEB,TMC6,APOE,PDE7A,RHOA,THBS3",GWAS_Catalog_2023
1007,Tonsillectomy,0.08589195044138019,2.2265538963041274,5.465444282499133,0.18899437545545825,"SPRED2,MAP2K2,KLF13,ITSN1,SH2B3",GWAS_Catalog_2023
1008,LDL Cholesterol Levels X Alcohol Consumption (Drinkers Vs Non-Drinkers) Interaction (2Df),0.08614216815905654,3.065861027190332,7.516743872182359,0.18899437545545825,"FADS2,DOCK7,SH2B3",GWAS_Catalog_2023
1009,Waist-to-hip Ratio Adjusted For BMI X Sex X Age Interaction (4Df Test),0.08614216815905654,3.065861027190332,7.516743872182359,0.18899437545545825,"KLF13,PPARG,CPEB4",GWAS_Catalog_2023
1010,Total Free Cholesterol Levels,0.08614216815905654,3.065861027190332,7.516743872182359,0.18899437545545825,"KANK2,GCKR,DOCK7",GWAS_Catalog_2023
1011,Primary Sclerosing Cholangitis,0.09013554473473162,4.373493975903615,10.524553856726516,0.18899437545545825,"SH2B3,HDAC7",GWAS_Catalog_2023
1012,TPE Interval (Resting),0.09013554473473162,4.373493975903615,10.524553856726516,0.18899437545545825,"MSRA,SERTAD2",GWAS_Catalog_2023
1013,Retinal Detachment Or Retinal Break,0.09013554473473162,4.373493975903615,10.524553856726516,0.18899437545545825,"DLG5,MAPT",GWAS_Catalog_2023
1014,White Matter Hyperintensities,0.09013554473473162,4.373493975903615,10.524553856726516,0.18899437545545825,"ZAN,APOE",GWAS_Catalog_2023
1015,Parental Longevity (Mother'S Age At Death Or Mother'S Attained Age),0.09013554473473162,4.373493975903615,10.524553856726516,0.18899437545545825,"CDH1,APOE",GWAS_Catalog_2023
1016,Parental Longevity (Father'S Age At Death Or Father'S Attained Age),0.09013554473473162,4.373493975903615,10.524553856726516,0.18899437545545825,"LPL,APOE",GWAS_Catalog_2023
1017,Renal Cell Carcinoma,0.09013554473473162,4.373493975903615,10.524553856726516,0.18899437545545825,"EPAS1,PLD1",GWAS_Catalog_2023
1018,Fibrosis-4 Index In High Alcohol Intake,0.09013554473473162,4.373493975903615,10.524553856726516,0.18899437545545825,"TRABD,HBS1L",GWAS_Catalog_2023
1019,Medication Use (Antithrombotic Agents),0.09013554473473162,4.373493975903615,10.524553856726516,0.18899437545545825,"FTO,APOE",GWAS_Catalog_2023
1020,F-acquired Taste Liking (Derived Food-Liking Factor),0.09013554473473162,4.373493975903615,10.524553856726516,0.18899437545545825,"FTO,MEF2C",GWAS_Catalog_2023
1021,Myopia,0.09188351396770704,2.4552727272727273,5.861309690938717,0.18899437545545825,"MYO1D,THRB,ERI1,ZBTB38",GWAS_Catalog_2023
1022,Adult Onset Asthma And/Or Waist-To-Hip Ratio Adjusted For BMI,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,BCL2L11,GWAS_Catalog_2023
1023,IDP dMRI ProbtrackX L2 Fmi,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,CD82,GWAS_Catalog_2023
1024,Aspartate Transaminase Levels In High Alcohol Intake,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,HSD17B13,GWAS_Catalog_2023
1025,IDP dMRI TBSS ICVF Posterior Thalamic Radiation R,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,SLC17A3,GWAS_Catalog_2023
1026,Wg Lh Intensity-Contrast Parstriangularis,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,KLF3,GWAS_Catalog_2023
1027,Wg Lh Intensity-Contrast Posteriorcingulate,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,KLF3,GWAS_Catalog_2023
1028,Wg Lh Intensity-Contrast Parsorbitalis,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,KLF3,GWAS_Catalog_2023
1029,Wg Rh Intensity-Contrast Lateralorbitofrontal,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,KLF3,GWAS_Catalog_2023
1030,Wg Rh Intensity-Contrast Lingual,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,KLF3,GWAS_Catalog_2023
1031,Wg Rh Intensity-Contrast Parsorbitalis,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,KLF3,GWAS_Catalog_2023
1032,Wg Rh Intensity-Contrast Medialorbitofrontal,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,KLF3,GWAS_Catalog_2023
1033,Serum Levels Of Protein KLRC3,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,APOE,GWAS_Catalog_2023
1034,Severe COVID-19 Or Systemic Lupus Erythematosus,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,MAPT,GWAS_Catalog_2023
1035,Phosphatidylcholine Diacyl C32:0 Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,FADS2,GWAS_Catalog_2023
1036,1-palmitoyl-2-arachidonoyl-GPC (16:0/20:4N6) Levels In Elite Athletes,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,FADS2,GWAS_Catalog_2023
1037,1-palmitoyl-2-linoleoyl-GPE (16:0/18:2) Levels In Elite Athletes,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,FADS2,GWAS_Catalog_2023
1038,TestASV 38 (Ruminococcus) Abundance,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,FTO,GWAS_Catalog_2023
1039,Parkinson's Disease (Age Of Onset),0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,APOE,GWAS_Catalog_2023
1040,Cirrhosis,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,ALDH2,GWAS_Catalog_2023
1041,Postprandial Triglycerides Levels In IDL,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,APOE,GWAS_Catalog_2023
1042,Peripheral Artery Disease In Non Diabetes,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,SH2B3,GWAS_Catalog_2023
1043,Ischemic Stroke Or Tissue Plasminogen Activator Levels (Pleiotropy),0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,SH2B3,GWAS_Catalog_2023
1044,Fasting Total Phosphoglycerides,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,DOCK7,GWAS_Catalog_2023
1045,Postprandial Triglycerides In LDL,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,APOE,GWAS_Catalog_2023
1046,Postprandial Triglycerides Levels In Small LDL,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,APOE,GWAS_Catalog_2023
1047,Plasma Vanadium Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,THRB,GWAS_Catalog_2023
1048,Osteoporosis-related Phenotypes (MTAG),0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,FADS2,GWAS_Catalog_2023
1049,Postprandial Mean Diameter Of HDL Particles,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,LPL,GWAS_Catalog_2023
1050,Aortic Valve Stenosis,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,FADS2,GWAS_Catalog_2023
1051,Fasting Triglycerides Levels In IDL,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,APOE,GWAS_Catalog_2023
1052,Postprandial Triglycerides Levels In Very Large HDL,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,APOE,GWAS_Catalog_2023
1053,Fasting Triglycerides Levels In Large LDL,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,APOE,GWAS_Catalog_2023
1054,Fasting Triglycerides In LDL,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,APOE,GWAS_Catalog_2023
1055,Fasting Free Cholesterol In Large HDL,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,LPL,GWAS_Catalog_2023
1056,Dietary Macronutrient Intake,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,FTO,GWAS_Catalog_2023
1057,Phosphatidylcholine (18:1 18:2) Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,FADS2,GWAS_Catalog_2023
1058,Octadecandienylcarnitine Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,SLC22A16,GWAS_Catalog_2023
1059,Phosphatidylcholine Acyl-Alkyl C42:2 Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,FADS2,GWAS_Catalog_2023
1060,Accelerated Lung Function Decline (FVC) And Worsened/Persistent Change In Fatty Liver (Pleiotropy),0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,GALNT2,GWAS_Catalog_2023
1061,Metabolic Syndrome (Multivariate Analysis),0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,GCKR,GWAS_Catalog_2023
1062,Lateral Ventricle Volume Change Rate X Age Interaction (2Df),0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,APOE,GWAS_Catalog_2023
1063,Cyclic AMP-dependent Transcription Factor ATF-6 Alpha Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,GALNT2,GWAS_Catalog_2023
1064,Liver Carboxylesterase 1 Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,GCKR,GWAS_Catalog_2023
1065,Phosphatidylcholine-ether Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,FADS2,GWAS_Catalog_2023
1066,RBC Levels Of Sphingosine 1-Phosphate,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,FTO,GWAS_Catalog_2023
1067,Transmembrane Protein 106A Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,CTSB,GWAS_Catalog_2023
1068,Surfeit Locus Protein 1 Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,APOE,GWAS_Catalog_2023
1069,Eyebrow Thickness,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,FTO,GWAS_Catalog_2023
1070,Entorhinal Cortical Thickness,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,APOE,GWAS_Catalog_2023
1071,Protein C Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,GCKR,GWAS_Catalog_2023
1072,Blood Trace Element (Zn Levels),0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,MAX,GWAS_Catalog_2023
1073,Erythrocyte Sedimentation Rate,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,RSRP1,GWAS_Catalog_2023
1074,Biomedical Quantitative Traits,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,FTO,GWAS_Catalog_2023
1075,Pneumococcal Bacteremia,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,DOCK7,GWAS_Catalog_2023
1076,EGFR Mutation-Positive Lung Adenocarcinoma,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,TERT,GWAS_Catalog_2023
1077,Phosphatidylcholine-O 42:6 [M+OAc]1-/Phosphatidylcholine-P 42:5 [M+OAc]1- Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,FADS2,GWAS_Catalog_2023
1078,Lung Function (FEV1) And Body Mass Index,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,SH2B3,GWAS_Catalog_2023
1079,Butyrylcarnitine (C4) Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,UNC119B,GWAS_Catalog_2023
1080,1-palmitoyl-GPE (16:0) Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,GCKR,GWAS_Catalog_2023
1081,"5Alpha-Androstan-3Alpha,17Alpha-Diol Monosulfate Levels",0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,SLC17A1,GWAS_Catalog_2023
1082,"5Alpha-Androstan-3Beta,17Beta-Diol Monosulfate (2) Levels",0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,SLC17A1,GWAS_Catalog_2023
1083,Epiandrosterone Sulfate Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,SLC17A1,GWAS_Catalog_2023
1084,Oleoyl-arachidonoyl-glycerol (18:1/20:4) [2] Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,FADS2,GWAS_Catalog_2023
1085,Phosphatidylcholine 40:6 [M+H]1+/Phosphatidylethanolamine 43:6 [M+H]1+ Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,FADS2,GWAS_Catalog_2023
1086,Serum Levels Of Protein CXCL11,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,SH2B3,GWAS_Catalog_2023
1087,Wg Lh Intensity-Contrast Superiortemporal,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,CD82,GWAS_Catalog_2023
1088,IDP dMRI TBSS MD External Capsule L,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,CD82,GWAS_Catalog_2023
1089,Autoimmune Hepatitis Type-1,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,SH2B3,GWAS_Catalog_2023
1090,Wg Rh Intensity-Contrast Posteriorcingulate,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,KLF3,GWAS_Catalog_2023
1091,Cholesterol [M+H-H2O]1+ Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,BUD13,GWAS_Catalog_2023
1092,Phosphatidylethanolamine 37:2 [M-H]1- Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,FADS2,GWAS_Catalog_2023
1093,Phosphatidylethanolamine 37:3 [M-H]1- Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,FADS2,GWAS_Catalog_2023
1094,Phosphatidylethanolamine-O 38:3 [M-H]1-/Phosphatidylethanolamine-P 38:2 [M-H]1- Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,FADS2,GWAS_Catalog_2023
1095,Phosphatidate(39:1) [M+H]1+ Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,FADS2,GWAS_Catalog_2023
1096,Phosphatidate(40:5) [M+OAc]1-/Phosphatidylglycerol(39:5) [M-H]1- Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,FADS2,GWAS_Catalog_2023
1097,Phosphatidylcholine 32:0 [M+OAc]1- Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,FADS2,GWAS_Catalog_2023
1098,Phosphatidylinositol-O 36:0 [M-H]1- Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,FADS2,GWAS_Catalog_2023
1099,Phosphatidylinositol-O(36:0) [M-H]1-/Phosphatidylglycerol(37:0) [M+OAc]1- Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,FADS2,GWAS_Catalog_2023
1100,Lysophosphatidylcholine 22:6 [M+H]1+ Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,FADS2,GWAS_Catalog_2023
1101,Phosphatidylcholine 34:4 [M+H]1+/Phosphatidylethanolamine 37:4 [M+H]1+/Phosphatidate 39:5 [M+NH4]1+ Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,FADS2,GWAS_Catalog_2023
1102,Phosphatidylglycerol 35:3 [M-H]1- Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,FADS2,GWAS_Catalog_2023
1103,Fatty Acid(22:4) [M-H]1- Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,FADS2,GWAS_Catalog_2023
1104,Phosphatidylinositol 38:0 [M-H]1- Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,FADS2,GWAS_Catalog_2023
1105,Phosphatidylethanolamine 38:2 [M-H]1- Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,FADS2,GWAS_Catalog_2023
1106,Cholesteryl Ester 16:0 [M+NH4]1+ Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,FADS2,GWAS_Catalog_2023
1107,Phosphatidylinositol(36:4) [M-H]1- Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,FADS2,GWAS_Catalog_2023
1108,Obstructive Sleep Apnea,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,FTO,GWAS_Catalog_2023
1109,Plasminogen Activator Inhibitor Type 1 Levels (PAI-1),0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,PPARG,GWAS_Catalog_2023
1110,Response To Anti-Retroviral Therapy (ddI/d4T) In HIV-1 Infection (Grade 2 Peripheral Neuropathy),0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,IL6R,GWAS_Catalog_2023
1111,Lysophosphatidylcholine (18:2) [Sn1] Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,FADS2,GWAS_Catalog_2023
1112,Palmitoylcarnitine (C16) Levels In Elite Athletes,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,ACOXL,GWAS_Catalog_2023
1113,Lysophosphatidylethanolamine (16:0) [Sn1] Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,SIDT2,GWAS_Catalog_2023
1114,Ceramide (D18:2/20:0) Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,APOE,GWAS_Catalog_2023
1115,"Sphingomyelin (D18:1/20:2, D18:2/20:1, D16:1/22:2) Levels In Elite Athletes",0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,BMP8A,GWAS_Catalog_2023
1116,Lysophosphatidylethanolamine (16:0) [Sn2] Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,SIDT2,GWAS_Catalog_2023
1117,Phosphatidylcholine (16:0 20:5) Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,FADS2,GWAS_Catalog_2023
1118,Biological Age (PhenoAge),0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,GCKR,GWAS_Catalog_2023
1119,Peripheral Blood CD34+ Cell Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,TERT,GWAS_Catalog_2023
1120,Ovarian Cyst,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,TERT,GWAS_Catalog_2023
1121,Sphingomyelin(39:1) [M+H]1+ Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,BUD13,GWAS_Catalog_2023
1122,Sphingomyelin(44:9) [M+H]1- Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,FADS2,GWAS_Catalog_2023
1123,Triacylglycerol(56:6) [M+NH4]1+ Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,FADS2,GWAS_Catalog_2023
1124,Triacylglycerol 56:8 [M+NH4]1+ Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,FADS2,GWAS_Catalog_2023
1125,Glycocholenate Sulfate Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,ABCC2,GWAS_Catalog_2023
1126,Phosphatidylethanolamine (17:0 20:4) Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,SIDT2,GWAS_Catalog_2023
1127,Phosphatidylcholine (38:2) Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,FADS2,GWAS_Catalog_2023
1128,Phosphatidylcholine (38:5) (A) Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,FADS2,GWAS_Catalog_2023
1129,Phosphatidylcholine (38:6) (A) Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,FADS2,GWAS_Catalog_2023
1130,Total Trihexosylcermide Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,GCKR,GWAS_Catalog_2023
1131,Phosphatidylcholine (17:1 18:2) Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,FADS2,GWAS_Catalog_2023
1132,Phosphatidylethanolamine (16:0 16:1) Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,FADS2,GWAS_Catalog_2023
1133,Alkenylphosphatidylethanolamine (P-18:0/20:5) Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,APOE,GWAS_Catalog_2023
1134,COVID-19 (Critical Illness Vs Mild Symptoms),0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,THBS3,GWAS_Catalog_2023
1135,Cholesteryl Ester (20:2) Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,FADS2,GWAS_Catalog_2023
1136,Vaginal Microbiome Beta Diversity (Bray-curtis Dissimilarity),0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,SLC7A6,GWAS_Catalog_2023
1137,Phosphatidylcholine Diacyl C38:3 Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,FADS2,GWAS_Catalog_2023
1138,Phosphatidylcholine Acyl-Alkyl C34:2 Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,FADS2,GWAS_Catalog_2023
1139,Phosphatidylcholine Acyl-Alkyl C36:3 Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,FADS2,GWAS_Catalog_2023
1140,Vaginal Microbiome MetaCyc Pathway (PWY-5304|superpathway Of Sulfur Oxidation (Acidianus Ambivalens)),0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,RP1L1,GWAS_Catalog_2023
1141,F-caffeinated/sweet Liking (Derived Food-Liking Factor),0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,FTO,GWAS_Catalog_2023
1142,Phosphatidylserine 40:3 [M+H]1+/Phosphatidylglycerol 40:5 [M+NH4]1+ Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,FADS2,GWAS_Catalog_2023
1143,Phosphatidylserine 40:5 [M+H]1+/Phosphatidylglycerol 40:7 [M+NH4]1+ Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,FADS2,GWAS_Catalog_2023
1144,Killer Cell Immunoglobulin-Like Receptor 2DL5A Levels (KIR2DL5A.8000.17.3),0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,APOE,GWAS_Catalog_2023
1145,Low-carbohydrate Diet (LCD) Score,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,ALDH2,GWAS_Catalog_2023
1146,Interferon Alpha/Beta Receptor 1 Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,ITSN1,GWAS_Catalog_2023
1147,Complement Component C1q Receptor Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,GCKR,GWAS_Catalog_2023
1148,"Sphingomyelin (D18:1/20:0, D16:1/22:0) Levels",0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,APOE,GWAS_Catalog_2023
1149,"Sphingomyelin (D18:1/20:1, D18:2/20:0) Levels",0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,FADS2,GWAS_Catalog_2023
1150,1-Stearoyl-2-Docosahexaenoyl-Gpc (18:0/22:6) Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,FADS2,GWAS_Catalog_2023
1151,Linoleoyl-arachidonoyl-glycerol (18:2/20:4) [2] Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,FADS2,GWAS_Catalog_2023
1152,1-(1-Enyl-Palmitoyl)-2-Oleoyl-Gpc (P-16:0/18:1) Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,FADS2,GWAS_Catalog_2023
1153,Hydroxypalmitoyl Sphingomyelin (d18:1/16:0(OH)) Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,FADS2,GWAS_Catalog_2023
1154,16A-Hydroxy DHEA 3-Sulfate Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,SLC17A3,GWAS_Catalog_2023
1155,Andro Steroid Monosulfate C19H28O6S (1) Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,SLC17A3,GWAS_Catalog_2023
1156,1-eicosapentaenoyl-GPE (20:5) Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,FADS2,GWAS_Catalog_2023
1157,1-arachidonoyl-GPI (20:4) Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,FADS2,GWAS_Catalog_2023
1158,1-linoleoyl-GPI (18:2) Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,FADS2,GWAS_Catalog_2023
1159,Pregnenediol Disulfate (C21H34O8S2) Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,ABCC2,GWAS_Catalog_2023
1160,2-Hydroxy-3-Methylvalerate Levels,0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,C12ORF43,GWAS_Catalog_2023
1161,Severe COVID-19 Or Systemic Lupus Erythematosus (MTAG),0.09233130434472851,15.27927927927928,36.400927689928544,0.18899437545545825,BTN3A1,GWAS_Catalog_2023
1162,Concentration Of Very Small VLDL Particles,0.09235852547404205,2.9666699152129423,7.066836941790966,0.18899437545545825,"GCKR,DOCK7,APOB",GWAS_Catalog_2023
1163,Telomere Length,0.09235852547404205,2.9666699152129423,7.066836941790966,0.18899437545545825,"RTEL1-TNFRSF6B,RTEL1,TERT",GWAS_Catalog_2023
1164,Menopause (Age At Onset),0.09235852547404205,2.9666699152129423,7.066836941790966,0.18899437545545825,"FNDC4,PGAP3,SPPL3",GWAS_Catalog_2023
1165,Triglycerides To Total Lipids Ratio In Large VLDL,0.09235852547404205,2.9666699152129423,7.066836941790966,0.18899437545545825,"LPL,PCSK7,APOE",GWAS_Catalog_2023
1166,"COVID-19 (Severe Vs Tested, Not Severe)",0.09235852547404205,2.9666699152129423,7.066836941790966,0.18899437545545825,"DLG5,APOE,MAPT",GWAS_Catalog_2023
1167,Intraocular Pressure,0.0949082986861674,1.712136752136752,4.0318151814667305,0.1940455875451546,"BRD3,KANK2,COL26A1,PRDM16,WBP4,NPHP3,SH2B3,ETS2,UBE2L3",GWAS_Catalog_2023
1168,Life Satisfaction,0.09674457554585714,2.4068924539512775,5.621733010691669,0.19763061408597188,"UBXN2A,HFE,BTN3A2,VRK2",GWAS_Catalog_2023
1169,Total Lipid Levels In Very Small VLDL,0.09875475759999416,2.873678247734139,6.652897622714506,0.20122019780835704,"GCKR,DOCK7,APOB",GWAS_Catalog_2023
1170,Lung Adenocarcinoma,0.09875475759999416,2.873678247734139,6.652897622714506,0.20122019780835704,"RTEL1-TNFRSF6B,RTEL1,TERT",GWAS_Catalog_2023
1171,"Coronary Artery Disease (Myocardial Infarction, Percutaneous Transluminal Coronary Angioplasty, Coronary Artery Bypass Grafting, Angina Or Chromic Ischemic Heart Disease)",0.09875475759999416,2.873678247734139,6.652897622714506,0.20122019780835704,"APOE,IL6R,RHOA",GWAS_Catalog_2023
1172,Surgical Hip Osteoarthritis,0.10008351964589496,4.08152610441767,9.394653711297185,0.2027158555815835,"FTO,HFE",GWAS_Catalog_2023
1173,Male Puberty Timing (Late Vs. Average Onset Facial Hair),0.10008351964589496,4.08152610441767,9.394653711297185,0.2027158555815835,"GCKR,KANSL1",GWAS_Catalog_2023
1174,Systolic Blood Pressure X Smoking Status (Ever Vs Never) Interaction (2Df Test),0.10008351964589496,4.08152610441767,9.394653711297185,0.2027158555815835,"FTO,FAM167A",GWAS_Catalog_2023
1175,Headache,0.10008351964589496,4.08152610441767,9.394653711297185,0.2027158555815835,"MACF1,PRDM16",GWAS_Catalog_2023
1176,Carotid Intima Media Thickness,0.10008351964589496,4.08152610441767,9.394653711297185,0.2027158555815835,"GALNT2,APOE",GWAS_Catalog_2023
1177,Cholesterol To Total Lipids Ratio In Small LDL,0.10008351964589496,4.08152610441767,9.394653711297185,0.2027158555815835,"MACF1,DOCK7",GWAS_Catalog_2023
1178,Nonsyndromic Orofacial Cleft X Sex Interaction,0.10008351964589496,4.08152610441767,9.394653711297185,0.2027158555815835,"PRC1,AGAP1",GWAS_Catalog_2023
1179,Cognitive Performance (MTAG),0.10177737274239078,1.556448666423091,3.5564345734588403,0.20597185018095368,"CEP57,BRD3,MEF2C,BCL11A,DENND4A,ZMIZ2,HFE,AGAP1,FLOT2,BTN3A2,SPPL3,RHOA",GWAS_Catalog_2023
1180,Depression,0.10638064081237299,1.809498111171074,4.054599717053129,0.20936509203013018,"BLK,MSRA,ACOXL,BTN2A1,VRK2,BTN3A2,SPPL3",GWAS_Catalog_2023
1181,Cerebrospinal Fluid AB1-42 Levels,0.11031888038918752,3.82605421686747,8.434078137999961,0.20936509203013018,"TOMM40,APOE",GWAS_Catalog_2023
1182,Feeling Hurt,0.11031888038918752,3.82605421686747,8.434078137999961,0.20936509203013018,"KANSL1,MAPT",GWAS_Catalog_2023
1183,Pediatric Asthma,0.11031888038918752,3.82605421686747,8.434078137999961,0.20936509203013018,"TLR1,PTPRC",GWAS_Catalog_2023
1184,Lifetime Smoking (Without Educational Attainment),0.11031888038918752,3.82605421686747,8.434078137999961,0.20936509203013018,"MSRA,MAPT",GWAS_Catalog_2023
1185,Histidine Levels,0.11031888038918752,3.82605421686747,8.434078137999961,0.20936509203013018,"GCKR,SPRYD4",GWAS_Catalog_2023
1186,Basophil Percentage Of White Cells,0.11932823938519083,1.9936446532191212,4.2382438504965565,0.20936509203013018,"AHI1,SPRED2,DSTYK,TMCC2,CTSB",GWAS_Catalog_2023
1187,Childhood Obesity,0.12081345678782915,3.6006378454996457,7.6099754600801,0.20936509203013018,"FTO,PRDM16",GWAS_Catalog_2023
1188,Age-related Macular Degeneration Or COVID-19 Critical Illness (MTAG),0.12081345678782915,3.6006378454996457,7.6099754600801,0.20936509203013018,"ARHGAP21,APOE",GWAS_Catalog_2023
1189,Age-related Macular Degeneration Or COVID-19 Hospitalization (MTAG),0.12081345678782915,3.6006378454996457,7.6099754600801,0.20936509203013018,"ARHGAP21,APOE",GWAS_Catalog_2023
1190,Age-related Macular Degeneration Or COVID-19 Infection (MTAG),0.12081345678782915,3.6006378454996457,7.6099754600801,0.20936509203013018,"ARHGAP21,APOE",GWAS_Catalog_2023
1191,Diastolic Blood Pressure X Smoking Status (Current Vs Non-Current) Interaction (2Df Test),0.12081345678782915,3.6006378454996457,7.6099754600801,0.20936509203013018,"FTO,ACOXL",GWAS_Catalog_2023
1192,Disruptive Behavior (Multivariate Analysis),0.12081345678782915,3.6006378454996457,7.6099754600801,0.20936509203013018,"MFHAS1,MSRA",GWAS_Catalog_2023
1193,COVID-19 (Severe Vs Population) X Multiple Deprivation Index Interaction,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,BCL11A,GWAS_Catalog_2023
1194,Obstructive Sleep Apnea Trait (Minimum Oxyhemoglobin Saturation Across Sleep Episode),0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,HK1,GWAS_Catalog_2023
1195,Non-surgical Hip Osteoarthritis,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,HFE,GWAS_Catalog_2023
1196,Serum Levels Of Protein ANGPTL3,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,DOCK7,GWAS_Catalog_2023
1197,Machado-Joseph Disease (Age At Onset),0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,ATP11A,GWAS_Catalog_2023
1198,Adult Onset Asthma And/Or BMI,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,ACOXL,GWAS_Catalog_2023
1199,IDP dMRI ProbtrackX L1 Atr R,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,CD82,GWAS_Catalog_2023
1200,Wg Lh Intensity-Contrast Fusiform,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,KLF3,GWAS_Catalog_2023
1201,IDP dMRI ProbtrackX L3 Fmi,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,CD82,GWAS_Catalog_2023
1202,Lectin-like Oxidized LDL Receptor 1 Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,ZBTB38,GWAS_Catalog_2023
1203,Wg Rh Intensity-Contrast Inferiortemporal,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,KLF3,GWAS_Catalog_2023
1204,Wg Rh Intensity-Contrast Parstriangularis,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,KLF3,GWAS_Catalog_2023
1205,Neck Circumference,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FTO,GWAS_Catalog_2023
1206,High Chromosomal Aberration Frequency (Chromosome Type),0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FTO,GWAS_Catalog_2023
1207,Gout Vs Asymptomatic Hyperuricemia,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,GCKR,GWAS_Catalog_2023
1208,Acetoacetate Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,GALNT2,GWAS_Catalog_2023
1209,5-Bromotryptophan Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,SLC17A1,GWAS_Catalog_2023
1210,Metabolonic Lactone Sulfate (X-12063) Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,ARPC1A,GWAS_Catalog_2023
1211,"4-Androsten-3Beta,17Beta-Diol Monosulfate (2) Levels",0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,SLC17A3,GWAS_Catalog_2023
1212,1-palmitoyl-2-oleoyl-GPE (16:0/18:1) Levels In Elite Athletes,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,TRABD,GWAS_Catalog_2023
1213,Gout (Combined Type),0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,GCKR,GWAS_Catalog_2023
1214,Serum Docosahexaenoic Fatty Acid Concentration In Metabolic Syndrome,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1215,Serum Omega-6 To Omega-3 Polyunsaturated Fatty Acid Ratio In Metabolic Syndrome,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1216,Lymphocyte Telomere Length,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,TERT,GWAS_Catalog_2023
1217,N-(2-furoyl)glycine Levels In Elite Athletes,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,COL26A1,GWAS_Catalog_2023
1218,Fasting Very Large HDL Particle Concentration,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,LPL,GWAS_Catalog_2023
1219,Fasting Phospholipid Levels In Very Large HDL,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,LPL,GWAS_Catalog_2023
1220,Fasting Triglycerides Levels In Very Large HDL,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,APOE,GWAS_Catalog_2023
1221,Fasting Free Cholesterol In Very Large HDL,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,LPL,GWAS_Catalog_2023
1222,Fasting Total Lipids In Very Large HDL,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,LPL,GWAS_Catalog_2023
1223,Fasting Free Cholesterol In IDL,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,APOE,GWAS_Catalog_2023
1224,Postprandial Very Large HDL Particle Concentration,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,LPL,GWAS_Catalog_2023
1225,Ischemic Stroke Or Factor XI Levels (Pleiotropy),0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,SH2B3,GWAS_Catalog_2023
1226,Fasting Total Cholesterol In HDL2,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,LPL,GWAS_Catalog_2023
1227,Fasting Total Cholesterol In HDL,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,LPL,GWAS_Catalog_2023
1228,Postprandial Total Lipids In Very Large HDL,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,LPL,GWAS_Catalog_2023
1229,Fasting Large HDL Particle Concentration,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,LPL,GWAS_Catalog_2023
1230,Fasting Total Cholesterol In Large HDL,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,LPL,GWAS_Catalog_2023
1231,Phosphatidylglycerol (36:1) Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,SIDT2,GWAS_Catalog_2023
1232,Fasting Cholesterol Esters In Large HDL,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,LPL,GWAS_Catalog_2023
1233,Phosphatidylinositol (16:0 16:1) Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1234,Fasting Total Lipids In Large HDL,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,LPL,GWAS_Catalog_2023
1235,Epiandrosterone Sulfate Levels In Elite Athletes,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,TRIM4,GWAS_Catalog_2023
1236,Fasting Triglycerides Levels In Small LDL,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,APOE,GWAS_Catalog_2023
1237,Left Ventricular End-Diastolic Volume,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,SH2B3,GWAS_Catalog_2023
1238,Octadecanoylcarnitine Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,SLC22A16,GWAS_Catalog_2023
1239,Phosphatidylcholine Acyl-Alkyl C42:3 Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1240,Serum Urea Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,THBS3,GWAS_Catalog_2023
1241,Cutaneous Mastocytosis,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,BTN2A1,GWAS_Catalog_2023
1242,Central Cerebrospinal Fluid Amyloid Beta 42 To 40 Ratio (Abnormal Vs Normal),0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,APOE,GWAS_Catalog_2023
1243,Sweet Beverage Consumption,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FTO,GWAS_Catalog_2023
1244,Serum Total Cholesterol Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,APOE,GWAS_Catalog_2023
1245,Cerebral Aneurysm,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,SIRT3,GWAS_Catalog_2023
1246,Oral Cavity Cancer,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,GPN1,GWAS_Catalog_2023
1247,Tumor Necrosis Factor Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,SH2B3,GWAS_Catalog_2023
1248,"Procollagen-lysine,2-oxoglutarate 5-Dioxygenase 2 Levels",0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,MEF2C,GWAS_Catalog_2023
1249,Trigger Finger,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FTO,GWAS_Catalog_2023
1250,"Breast Cancer (Estrogen-Receptor Negative, Progesterone-Receptor Negative, And Human Epidermal Growth Factor-Receptor Negative)",0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,TERT,GWAS_Catalog_2023
1251,Hippocampus Volume Change Rate X Age Interaction (2Df),0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,APOE,GWAS_Catalog_2023
1252,Decadienedioic Acid (C10:2-Dc) (X-21792) Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,SLC17A3,GWAS_Catalog_2023
1253,Brain Surface Area Change Rate X Age Interaction (2Df),0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,TF,GWAS_Catalog_2023
1254,Oxysterols Receptor LXR-beta Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,SERPING1,GWAS_Catalog_2023
1255,Moderate To Vigorous Physical Activity Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,APOE,GWAS_Catalog_2023
1256,Cytochrome P450 3A4 Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,APOB,GWAS_Catalog_2023
1257,Pyridoxine-5-phosphate Oxidase Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,APOE,GWAS_Catalog_2023
1258,Strenuous Sports Or Other Exercises,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FTO,GWAS_Catalog_2023
1259,Beta-glucuronidase Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1260,Protein Kinase C And Casein Kinase Substrate In Neurons Protein 1 Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,NFE2,GWAS_Catalog_2023
1261,Lysophosphatidylethanolamine Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1262,Protein CREG1 Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,CTSB,GWAS_Catalog_2023
1263,Phosphatidylethanolamine-ether Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1264,C-C Motif Chemokine 28 Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,HBS1L,GWAS_Catalog_2023
1265,Metabolite Risk Score For Predicting Weight Gain,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1266,Cerebrospinal Fluid P-Tau Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,APOE,GWAS_Catalog_2023
1267,Breast Milk Fatty Acid Composition (Infant Genotype Effect),0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1268,Longevity (Age >99Th Survival Percentile),0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,APOE,GWAS_Catalog_2023
1269,Plasma Factor V Levels In Venous Thrombosis (Conditioned On Rs6027),0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,SUSD1,GWAS_Catalog_2023
1270,Beard Thickness,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,MACF1,GWAS_Catalog_2023
1271,Response To Alcohol Consumption (Flushing Response),0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,ALDH2,GWAS_Catalog_2023
1272,Hepcidin/transferrin Saturation Ratio,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,TMPRSS6,GWAS_Catalog_2023
1273,Low-grade Serous And Serous Borderline Ovarian Cancer,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,TERT,GWAS_Catalog_2023
1274,Serous Borderline Ovarian Cancer,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,TERT,GWAS_Catalog_2023
1275,Palmitic Acid (16:0) Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,GCKR,GWAS_Catalog_2023
1276,Economic And Political Preferences (Immigration/Crime),0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,ACOXL,GWAS_Catalog_2023
1277,Circulating Myeloperoxidase Levels (Serum),0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,GALNT2,GWAS_Catalog_2023
1278,Local Histogram Emphysema Pattern,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,MYO1D,GWAS_Catalog_2023
1279,Posterior Cortical Atrophy And Alzheimer's Disease,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,TOMM40,GWAS_Catalog_2023
1280,Declining Hemoglobin Trajectory In Blood Donors,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FLOT2,GWAS_Catalog_2023
1281,Metabolically Unhealthy In Normal Weight,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,GCKR,GWAS_Catalog_2023
1282,Phosphatidylcholine-O 44:5 [M+H]1+/Phosphatidylcholine-P 44:4 [M+H]1+ Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1283,Lung Function (FEV1) And Waist To Hip Ratio Adjusted For BMI,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,ALDH2,GWAS_Catalog_2023
1284,Phosphatidylcholine(33:2) [M+H]1+/Phosphatidylethanolamine(36:2) [M+H]1+/Phosphatidate(38:3) [M+NH4]1+ Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1285,Phosphatidylcholine(35:4) [M+H]1+/Phosphatidylethanolamine(38:4) [M+H]1+/Phosphatidate(40:5) [M+NH4]1+ Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1286,Phosphatidylcholine 40:7 [M+H]1+ Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1287,Phosphatidylcholine 42:4 [M+OAc]1- Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1288,Phosphatidylcholine 40:6 [M+OAc]1-/Phosphatidylserine 44:5 [M-H]1- Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1289,Vitamin D-binding Protein Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,SH2B3,GWAS_Catalog_2023
1290,Phosphatidylcholine 37:4 [M+H]1+/Phosphatidylethanolamine 40:4 [M+H]1+/Phosphatidate 42:5 [M+NH4]1+ Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1291,White Blood Cell Count (Eosinophil),0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,SH2B3,GWAS_Catalog_2023
1292,Phosphatidylcholine(33:3) [M+H]1+/Phosphatidylethanolamine(36:3) [M+H]1+/Phosphatidate(38:4) [M+NH4]1+ Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1293,Serum Levels Of Protein LGMN,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,CTSB,GWAS_Catalog_2023
1294,Phosphatidylcholine 36:2 [M+OAc]1-/Phosphatidylserine 40:1 [M-H]1- Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1295,Phosphatidylcholine-O 44:5 [M+OAc]1-/Phosphatidylcholine-P 44:4 [M+OAc]1- Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1296,Phosphatidylcholine 40:4 [M+H]1+/Phosphatidylethanolamine 43:4 [M+H]1+ Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1297,Phosphatidylcholine 40:5 [M+H]1+ Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1298,Phosphatidylcholine-O 38:5 [M+H]1+/Phosphatidylcholine-P 38:4 [M+H]1+ Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1299,Phosphatidylcholine-O 40:5 [M+H]1+/Phosphatidylcholine-P 40:4 [M+H]1+ Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1300,Serum Levels Of Protein CTSA,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,MEF2C,GWAS_Catalog_2023
1301,Phosphatidylcholine 38:5 [M+H]1+/Phosphatidylethanolamine 41:5 [M+H]1+/Phosphatidate 43:6 [M+NH4]1+ Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1302,BMI X Environmental Factors (Excluding Physical Activity) Interaction,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,MSRA,GWAS_Catalog_2023
1303,IDP dMRI TBSS ICVF Genu Of Corpus Callosum,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,MAPT,GWAS_Catalog_2023
1304,Wg Lh Intensity-Contrast Superiorfrontal,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,KLF3,GWAS_Catalog_2023
1305,IDP dMRI ProbtrackX MD Fmi,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,CD82,GWAS_Catalog_2023
1306,Wg Rh Intensity-Contrast Superiorfrontal,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,KLF3,GWAS_Catalog_2023
1307,Generalized Anxiety Disorder (Mental Health Questionnaire Or Predicted),0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,MAPT,GWAS_Catalog_2023
1308,Phosphatidylethanolamine-O 36:5 [M-H]1-/Phosphatidylethanolamine-P 36:4 [M-H]1- Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1309,Phosphatidylethanolamine 36:2 [M-H]1- Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1310,Phosphatidylethanolamine-O 34:3 [M-H]1-/Phosphatidylethanolamine-P 34:2 [M-H]1- Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1311,Phosphatidylethanolamine 40:6 [M-H]1- Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1312,Phosphatidylethanolamine 39:4 [M-H]1- Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1313,Cholesteryl Ester 20:5 [M+NH4]1+ Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1314,Cholesteryl Ester 22:6 [M+NH4]1+ Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1315,Phosphatidylethanolamine-O 38:5 [M-H]1-/Phosphatidylethanolamine-P 38:4 [M-H]1- Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1316,Lysophosphatidylethanolamine 18:2 [M-H]1- Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1317,Phosphatidylethanolamine(34:2) [M+H]1+ Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1318,Phosphatidylinositol 36:2 [M+H]1+ Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1319,Lysophosphatidylcholine-O 16:1 [M+H]1+/Lysophosphatidylcholine-P 16:0 [M+H]1+ Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1320,Phosphatidylinositol(34:2) [M-H]1- Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1321,Phosphatidylcholine 34:2 [M+OAc]1-/Phosphatidylserine 38:1 [M-H]1- Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1322,Opioid Dependence (Time To Event),0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FTO,GWAS_Catalog_2023
1323,Phosphatidylcholine 34:3 [M+H]1+/Phosphatidylethanolamine 37:3 [M+H]1+/Phosphatidate 39:4 [M+NH4]1+ Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1324,Fatty Acid(20:3) [M-H]1- Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1325,Fatty Acid(22:5) [M-H]1- Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1326,Phosphatidylethanolamine(38:5) [M-H]1- Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1327,Phosphatidylinositol 34:0 [M+H]1+ Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1328,Phosphatidylethanolamine-O 40:5 [M-H]1-/Phosphatidylethanolamine-P 40:4 [M-H]1- Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1329,Phosphatidylinositol(38:4) [M-H]1- Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1330,Plasma Omega-6 Polyunsaturated Fatty Acid Levels (Adrenic Acid),0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1331,Infant Length,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,ZBTB38,GWAS_Catalog_2023
1332,Systolic Blood Pressure In Sickle Cell Anemia,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,THRB,GWAS_Catalog_2023
1333,Red Blood Cell Fatty Acid Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1334,Conduct Disorder (Symptom Count),0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,TOX2,GWAS_Catalog_2023
1335,"Caffeine Metabolism (Plasma 1,7-Dimethylxanthine (Paraxanthine) To 1,3,7-Trimethylxanthine (Caffeine) Ratio)",0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,GCKR,GWAS_Catalog_2023
1336,Body Mass Index (Adult),0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FTO,GWAS_Catalog_2023
1337,Octanoylcarnitine (C8) Levels In Elite Athletes,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FIG4,GWAS_Catalog_2023
1338,Lysophosphatidylethanolamine (18:2) [Sn1] Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1339,Lysophosphatidylethanolamine (18:2) [Sn2] Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1340,Ceramide (D17:1/18:0) Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,DHRS13,GWAS_Catalog_2023
1341,Phosphatidylcholine (16:0 18:2) Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1342,Cholesteryl Ester (20:5) Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1343,Cholesteryl Ester (22:5) (N6) Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1344,Cholesteryl Ester (24:5) Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1345,Lysophosphatidylcholine (20:4) [Sn2] Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1346,Lysophosphatidylethanolamine (18:0) [Sn1] Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,SIDT2,GWAS_Catalog_2023
1347,Sphingomyelin(32:1) [M+H]1+ Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,BUD13,GWAS_Catalog_2023
1348,Triacylglycerol 56:5 [M+NH4]1+ Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1349,Triacylglycerol 58:10 [M+NH4]1+ Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1350,Triacylglycerol 58:9 [M+NH4]1+ Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1351,Liver Volume,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,GCKR,GWAS_Catalog_2023
1352,Sphingomyelin (D18:0/16:0) Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1353,Phosphatidylethanolamine (18:1 22:6) (A) Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,SIDT2,GWAS_Catalog_2023
1354,Sphingomyelin (D43:1) Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,APOB,GWAS_Catalog_2023
1355,Total Phosphatidylethanolamine Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,SIDT2,GWAS_Catalog_2023
1356,Phosphatidylcholines (37:4) Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1357,Phosphatidylcholines (38:4)A Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1358,Phosphatidylcholine (18:0 20:3) Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1359,Phosphatidylethanolamine (16:0 18:1) Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,SIDT2,GWAS_Catalog_2023
1360,Phosphatidylinositol (18:0 20:3) (A) Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1361,Alkenylphosphatidylcholine (P-16:0/20:4) Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1362,Phosphatidylcholine (40:7) (A) Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1363,Phosphatidylcholine Acyl-Alkyl C36:5 Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1364,Vaginal Microbiome MetaCyc Pathway (PWY-7456|mannan Degradation),0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,RP1L1,GWAS_Catalog_2023
1365,Lager Liking,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,MAPT,GWAS_Catalog_2023
1366,F-salad Vegetables Liking (Derived Food-Liking Factor),0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,MSRA,GWAS_Catalog_2023
1367,F-wine Liking (Derived Food-Liking Factor),0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,MEF2C,GWAS_Catalog_2023
1368,Alcohol Liking,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,MEF2C,GWAS_Catalog_2023
1369,F-bitter Food Liking (Derived Food-Liking Factor),0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,MEF2C,GWAS_Catalog_2023
1370,Sphingomyelin 33:1 [M+H]1+ Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,GCKR,GWAS_Catalog_2023
1371,Sphingomyelin 38:2 [M+H]1+ Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1372,Cathepsin D Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,GCKR,GWAS_Catalog_2023
1373,Low Affinity Immunoglobulin Gamma Fc Region Receptor III-B Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,SH2B3,GWAS_Catalog_2023
1374,Contactin-2 Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,TMCC2,GWAS_Catalog_2023
1375,Globe Artichoke Liking,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,MAPT,GWAS_Catalog_2023
1376,Spread Type: Flora Pro-Active/Benecol (UKB Data Field 1428 2),0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,APOE,GWAS_Catalog_2023
1377,Principal Component-Derived Dietary Pattern 4,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,PRDM16,GWAS_Catalog_2023
1378,X-21467 Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,ABCC2,GWAS_Catalog_2023
1379,6-Bromotryptophan Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,SLC17A1,GWAS_Catalog_2023
1380,2-arachidonoyl-GPE (20:4) Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,FADS2,GWAS_Catalog_2023
1381,X-13684 Levels,0.12117904111215834,10.185185185185185,21.49569225240779,0.20936509203013018,MPST,GWAS_Catalog_2023
1382,Longevity,0.12277341585362123,2.190909090909091,4.595245086959867,0.21196625920892928,"FTO,TOMM40,PRDM16,APOE",GWAS_Catalog_2023
1383,Menarche (Age At Onset),0.12584577998470942,1.6015117830146732,3.319450413874378,0.21707583020917925,"FTO,GCDH,THRB,USP49,MAST3,LEPR,AGAP1,SIRT3,BYSL",GWAS_Catalog_2023
1384,Autism Spectrum Disorder,0.12600587797138024,2.5533736153071502,5.289126339407087,0.21707583020917925,"KANSL1,MYO9B,MAPT",GWAS_Catalog_2023
1385,Autoimmune Traits,0.12600587797138024,2.5533736153071502,5.289126339407087,0.21707583020917925,"ALDH2,SH2B3,UBE2L3",GWAS_Catalog_2023
1386,Psoriasis,0.12830578924427197,2.1522594364699628,4.419317992941132,0.2208785087567337,"KLF13,ALDH2,BLOC1S2,TMEM50B",GWAS_Catalog_2023
1387,Waist Circumference,0.12913467573752097,1.8070301291248207,3.6988089254725662,0.22214515956000364,"FTO,CCND2,TOMM40,ZBTB38,SLC39A13,PPARG",GWAS_Catalog_2023
1388,Asthma Or Allergic Disease (Pleiotropy),0.1315405690685488,3.4002677376171353,6.897238970399704,0.22612089178498376,"RTEL1-TNFRSF6B,RTEL1",GWAS_Catalog_2023
1389,Body Surface Area,0.1371929187406133,1.4929010788178012,2.9654497025167172,0.23117780955099965,"FTO,MACF1,CCND3,GCKR,BTN3A1,MAX,ZBTB38,PSD4,TFEB,SLC39A13,MYO9B",GWAS_Catalog_2023
1390,Waist-hip Ratio,0.13724306782880039,1.357085520222291,2.6951741603722845,0.23117780955099965,"FTO,NUP205,KLF13,TOMM40,LPL,MYO9B,VRK2,PLD1,ARHGAP21,ACOXL,DSTYK,BCL2L11,XRN1,PRDM16,APOE,MAPT,P4HTM,CPEB4",GWAS_Catalog_2023
1391,Morning Person,0.1374321411679599,1.7719277673545966,3.516612149670679,0.23117780955099965,"FTO,MEF2C,ERI1,ARIH2,ZFP91,RHOA",GWAS_Catalog_2023
1392,Subcortical Volume (MOSTest),0.13803191798387332,1.8944425682014334,3.751508411270816,0.23117780955099965,"MAP3K1,KANSL1,PRDM16,BEND3,ATR",GWAS_Catalog_2023
1393,Brain Region Volumes,0.138307636938187,1.680762614678899,3.325010361954395,0.23117780955099965,"TRABD,RTEL1-TNFRSF6B,RTEL1,AKAP10,PRDM16,MAPT,DUSP15",GWAS_Catalog_2023
1394,Glycine Levels,0.14053600842899536,2.418508506916839,4.745818771158417,0.23117780955099965,"SPRYD4,MAST3,PPARG",GWAS_Catalog_2023
1395,Highest Math Class Taken,0.1421170885913041,1.6675675034966693,3.2535976156791664,0.23117780955099965,"BRD3,MEF2C,BCL11A,ARIH2,BTN3A2,VRK2,RBM23",GWAS_Catalog_2023
1396,Household Income,0.14247496211786,3.2209892200380468,6.276384160538291,0.23117780955099965,"KANSL1,MAPT",GWAS_Catalog_2023
1397,Asthma Onset (Childhood Vs Adult),0.14247496211786,3.2209892200380468,6.276384160538291,0.23117780955099965,"TLR1,RAD50",GWAS_Catalog_2023
1398,Cortical Surface Area (min-P),0.14247496211786,3.2209892200380468,6.276384160538291,0.23117780955099965,"MSRA,VRK2",GWAS_Catalog_2023
1399,"Allergic Disease (Asthma, Hay Fever And/Or Eczema) (Age Of Onset)",0.14247496211786,3.2209892200380468,6.276384160538291,0.23117780955099965,"TLR1,SPPL3",GWAS_Catalog_2023
1400,"Allergic Disease (Asthma, Hay Fever And/Or Eczema) (Multivariate Analysis)",0.14247496211786,3.2209892200380468,6.276384160538291,0.23117780955099965,"TLR1,SPPL3",GWAS_Catalog_2023
1401,Nonsyndromic Orofacial Cleft X Sex Interaction (2Df),0.14247496211786,3.2209892200380468,6.276384160538291,0.23117780955099965,"PRC1,AGAP1",GWAS_Catalog_2023
1402,Parental Longevity (Combined Parental Age At Death),0.14247496211786,3.2209892200380468,6.276384160538291,0.23117780955099965,"BEND3,APOE",GWAS_Catalog_2023
1403,Gut Microbiota (Functional Units),0.14247496211786,3.2209892200380468,6.276384160538291,0.23117780955099965,"TOMM40,PLTP",GWAS_Catalog_2023
1404,Skin Cancer,0.14247496211786,3.2209892200380468,6.276384160538291,0.23117780955099965,"FADS2,TERT",GWAS_Catalog_2023
1405,Calcium Levels,0.14415752268917717,1.5090171871217624,2.922737931466392,0.23117780955099965,"MACF1,LAPTM4B,TOX2,GCKR,CCND2,ICE2,TEX35,PPARG,SH2B3,THBS3",GWAS_Catalog_2023
1406,General Risk Tolerance (MTAG),0.14597341867906552,1.738150023009664,3.344775515996599,0.23117780955099965,"BLK,RP1L1,MSRA,DSTYK,CTSB,THBS3",GWAS_Catalog_2023
1407,Edge-level Brain Connectivity (Multivariate Analysis),0.1478408767813434,1.8484271432233492,3.5334879674283712,0.23117780955099965,"BTN3A1,VRK2,MAPT,SH2B3,KLF3",GWAS_Catalog_2023
1408,Medication Use (Beta Blocking Agents),0.14800311609084355,2.3562630722751567,4.501692321374702,0.23117780955099965,"FTO,APOE,SH2B3",GWAS_Catalog_2023
1409,"Malignant Lymphoma (Non-Hodgkin Lymphoma, Multiple Myeloma, Or Hodgkin Lymphoma)",0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,BCL2L11,GWAS_Catalog_2023
1410,Plasma Trimethylamine N-oxide Levels,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,FIG4,GWAS_Catalog_2023
1411,Serum Levels Of Protein NOG,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,MEF2C,GWAS_Catalog_2023
1412,IDP dMRI TBSS ICVF External Capsule R,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,CD82,GWAS_Catalog_2023
1413,Cerebral Microbleeds,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,APOE,GWAS_Catalog_2023
1414,Antipsychotic Drug-Induced Weight Gain In Schizophrenia,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,DMKN,GWAS_Catalog_2023
1415,Infant Head Circumference (MTAG),0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,ZBTB38,GWAS_Catalog_2023
1416,Andro Steroid Monosulfate (1) Levels,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,SLC17A3,GWAS_Catalog_2023
1417,Cerebral Amyloid Angiopathy,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,APOE,GWAS_Catalog_2023
1418,Treponema D Abundance In Stool,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,HEATR3,GWAS_Catalog_2023
1419,Serum Copper Levels,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,ALDH2,GWAS_Catalog_2023
1420,1-arachidonoyl-GPC (20:4N6) Levels In Elite Athletes,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,FADS2,GWAS_Catalog_2023
1421,Hirschsprung Disease,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,VRK2,GWAS_Catalog_2023
1422,1-(1-enyl-palmitoyl)-2-arachidonoyl-GPC (P-16:0/20:4) Levels In Elite Athletes,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,FADS2,GWAS_Catalog_2023
1423,Acylcarnitine (14:0) Levels,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,SLC22A16,GWAS_Catalog_2023
1424,Obese Vs. Thin,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,FTO,GWAS_Catalog_2023
1425,Sweet Taste Preference,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,ALDH2,GWAS_Catalog_2023
1426,Preeclampsia (Maternal Genotype Effect),0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,FTO,GWAS_Catalog_2023
1427,Parental Lifespan,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,APOE,GWAS_Catalog_2023
1428,Gut Microbiota Relative Abundance (Dorea),0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,ZNF827,GWAS_Catalog_2023
1429,Facial Morphology (Columella Inclination),0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,PRDM16,GWAS_Catalog_2023
1430,Cerebellum Cortex Volume Change Rate,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,EPAS1,GWAS_Catalog_2023
1431,Testicular Cancer,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,KITLG,GWAS_Catalog_2023
1432,Esophageal Or Stomach Cancer,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,MAST2,GWAS_Catalog_2023
1433,F-chocolate/coffee Liking (Derived Food-Liking Factor),0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,FTO,GWAS_Catalog_2023
1434,F-cheese Liking (Derived Food-Liking Factor),0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,FTO,GWAS_Catalog_2023
1435,ADP-ribosylation Factor GTPase-activating Protein 1 Levels,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,GCKR,GWAS_Catalog_2023
1436,PH And SEC7 Domain-Containing Protein 1 Levels,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,APOE,GWAS_Catalog_2023
1437,Immunoglobulin Lambda-Like Polypeptide 1 Levels,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,MEF2C,GWAS_Catalog_2023
1438,Type 2 Diabetes Nephropathy Including Microalbuminuria,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,FTO,GWAS_Catalog_2023
1439,Peak Cortisol Response To Low Dose Short Synacthen Test In Corticosteroid Treated Asthma,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,SCGN,GWAS_Catalog_2023
1440,Cisplatin-induced Ototoxicity,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,FAM167A,GWAS_Catalog_2023
1441,Ischemic Stroke (Small-Vessel),0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,SH2B3,GWAS_Catalog_2023
1442,Osteoarthritis Of The Knee (Hospital Diagnosed),0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,AGAP1,GWAS_Catalog_2023
1443,Systemic Lupus Erythematosus Or Rheumatoid Arthritis,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,UBE2L3,GWAS_Catalog_2023
1444,Clusterin Levels,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,PLTP,GWAS_Catalog_2023
1445,Disks Large Homolog 3 Levels,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,MEF2C,GWAS_Catalog_2023
1446,Cochlin Levels,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,MEF2C,GWAS_Catalog_2023
1447,Phosphatidylethanolamine Levels,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,FADS2,GWAS_Catalog_2023
1448,Protein CASC4 Levels,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,SIDT2,GWAS_Catalog_2023
1449,Cholesteryl Ester Levels,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,FADS2,GWAS_Catalog_2023
1450,Subjective Response To Placebo Treatment In Childhood Asthma (Change In Cough/Wheeze),0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,MDFI,GWAS_Catalog_2023
1451,Response To Placebo Treatment In Childhood Asthma (FVC Change),0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,SMOX,GWAS_Catalog_2023
1452,Body Mass Index In Physically Inactive Individuals,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,FTO,GWAS_Catalog_2023
1453,Hip Circumference Variance,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,FTO,GWAS_Catalog_2023
1454,Breast Milk Fatty Acid Composition (Maternal Genotype Effect),0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,FADS2,GWAS_Catalog_2023
1455,Longevity (Age >90Th Survival Percentile),0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,APOE,GWAS_Catalog_2023
1456,Loneliness (Multivariate Analysis),0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,MACF1,GWAS_Catalog_2023
1457,Advanced Glycation End-Product Levels,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,ZBTB38,GWAS_Catalog_2023
1458,Monocyte Chemoattractant Protein-3 Levels,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,RP1L1,GWAS_Catalog_2023
1459,Limited Cutaneous Systemic Scleroderma,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,TLR1,GWAS_Catalog_2023
1460,Two-hour Glucose Challenge,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,GCKR,GWAS_Catalog_2023
1461,Response To Citalopram Treatment,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,COL26A1,GWAS_Catalog_2023
1462,Nodular Sclerosis Hodgkin Lymphoma,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,AHI1,GWAS_Catalog_2023
1463,Cutaneous Psoriasis,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,USP49,GWAS_Catalog_2023
1464,Copper Levels,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,ALDH2,GWAS_Catalog_2023
1465,Body Mass Index (SNP X SNP Interaction),0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,FTO,GWAS_Catalog_2023
1466,Exploratory Eye Movement Dysfunction In Schizophrenia (Number Of Eye Fixations),0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,CCND3,GWAS_Catalog_2023
1467,Exploratory Eye Movement Dysfunction In Schizophrenia (Cognitive Search Score),0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,CCND3,GWAS_Catalog_2023
1468,Academic Attainment (Science),0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,MEF2C,GWAS_Catalog_2023
1469,Phosphatidylcholine(36:3) [M+H]1+/Phosphatidylethanolamine(39:3) [M+H]1+/Phosphatidate(41:4) [M+NH4]1+ Levels,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,FADS2,GWAS_Catalog_2023
1470,Ethylmalonate Levels,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,UNC119B,GWAS_Catalog_2023
1471,Asparagine Levels,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,GCKR,GWAS_Catalog_2023
1472,X-24947 Levels,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,SLC17A1,GWAS_Catalog_2023
1473,Phosphatidylcholine 37:3 [M+OAc]1-/Phosphatidylserine 41:2 [M-H]1- Levels,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,FADS2,GWAS_Catalog_2023
1474,Phosphatidylcholine 37:5 [M+H]1+/Phosphatidylethanolamine 40:5 [M+H]1+/Phosphatidate 42:6 [M+NH4]1+ Levels,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,FADS2,GWAS_Catalog_2023
1475,Phosphatidylcholine(38:3) [M+H]1+/Phosphatidylethanolamine(41:3) [M+H]1+/Phosphatidate(43:4) [M+NH4]1+ Levels,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,FADS2,GWAS_Catalog_2023
1476,Phosphatidylcholine(38:2) [M+H]1+/Phosphatidylethanolamine(41:2) [M+H]1+ Levels,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,FADS2,GWAS_Catalog_2023
1477,1-(1-enyl-palmitoyl)-2-palmitoyl-GPC (P-16:0/16:0) Levels,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,FADS2,GWAS_Catalog_2023
1478,Decadienedioic Acid (C10:2-DC) Levels,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,SLC17A1,GWAS_Catalog_2023
1479,"5Alpha-Androstan-3Alpha,17Beta-Diol Monosulfate (1) Levels",0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,SLC17A1,GWAS_Catalog_2023
1480,Serum Levels Of Protein MRPL58,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,GALNT2,GWAS_Catalog_2023
1481,Wg Lh Intensity-Contrast Superiorparietal,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,KLF3,GWAS_Catalog_2023
1482,Wg Lh Intensity-Contrast Supramarginal,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,CD82,GWAS_Catalog_2023
1483,Chitinase-3-like Protein 1 Levels,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,GCKR,GWAS_Catalog_2023
1484,Aseg Rh Intensity Putamen,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,TF,GWAS_Catalog_2023
1485,Anti-Mullerian Hormone Levels In Pre-Menopausal Women Of Late Reproductive Age,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,MEF2C,GWAS_Catalog_2023
1486,Wg Rh Intensity-Contrast Superiorparietal,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,KLF3,GWAS_Catalog_2023
1487,Wg Rh Intensity-Contrast Supramarginal,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,KLF3,GWAS_Catalog_2023
1488,Wg Rh Intensity-Contrast Precuneus,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,KLF3,GWAS_Catalog_2023
1489,Wg Rh Intensity-Contrast Rostralmiddlefrontal,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,KLF3,GWAS_Catalog_2023
1490,Diacylglycerol 38:6 [M+H-H2O]1+ Levels,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,FADS2,GWAS_Catalog_2023
1491,Phosphatidylcholine(38:3) [M+OAc]1-/Phosphatidylserine(42:2) [M-H]1- Levels,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,FADS2,GWAS_Catalog_2023
1492,Phosphatidylethanolamine 35:2 [M-H]1- Levels,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,FADS2,GWAS_Catalog_2023
1493,Phosphatidylcholine 32:2 [M+H]1+/Phosphatidylethanolamine 35:2 [M+H]1+/Phosphatidate 37:3 [M+NH4]1+ Levels,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,FADS2,GWAS_Catalog_2023
1494,Phosphatidylcholine 35:2 [M+H]1+/Phosphatidylethanolamine 38:2 [M+H]1+/Phosphatidate 40:3 [M+NH4]1+ Levels,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,FADS2,GWAS_Catalog_2023
1495,Plasma Amyloid Beta Peptide Concentrations (ABx-42),0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,APOE,GWAS_Catalog_2023
1496,Phosphatidylinositol 36:4 [M-H]1- Levels,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,FADS2,GWAS_Catalog_2023
1497,Glycemic Traits (Pregnancy),0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,GCKR,GWAS_Catalog_2023
1498,Colorectal Cancer (Diet Interaction),0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,ACOXL,GWAS_Catalog_2023
1499,Breast Cancer (Early Onset),0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,MAP3K1,GWAS_Catalog_2023
1500,Acute Anterior Uveitis (With Or Without Ankylosing Spondylitis),0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,IL6R,GWAS_Catalog_2023
1501,Body Mass Index (Age>50),0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,FTO,GWAS_Catalog_2023
1502,Trihexosylcermide (D18:1/24:0) Levels,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,APOE,GWAS_Catalog_2023
1503,IGF-1 And IGFBP-3 Levels (Bivariate Analysis),0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,GCKR,GWAS_Catalog_2023
1504,Trihexosylcermide (D18:1/22:0) Levels,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,GCKR,GWAS_Catalog_2023
1505,Indoleacetate Levels In Elite Athletes,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,AGAP1,GWAS_Catalog_2023
1506,Lysophosphatidylethanolamine (18:0) [Sn2] Levels,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,SIDT2,GWAS_Catalog_2023
1507,Cystatin C Plasma Levels,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,SH2B3,GWAS_Catalog_2023
1508,Cleft Lip With Or Without Cleft Palate Or Cleft Palate (Pleiotropy),0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,RAB8A,GWAS_Catalog_2023
1509,Age Related Hearing Loss-Related Regional Glucose Metabolism (Inferior Colliculus),0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,MYO1D,GWAS_Catalog_2023
1510,Alkenylphosphatidylethanolamine (P-20:0/18:2) Levels,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,FADS2,GWAS_Catalog_2023
1511,Alkenylphosphatidylethanolamine (P-20:1/20:4) Levels,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,FADS2,GWAS_Catalog_2023
1512,Glycosphingolipids (D41:1) Levels,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,APOB,GWAS_Catalog_2023
1513,Acylcarnitine (18:2) Levels,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,SLC22A16,GWAS_Catalog_2023
1514,Phosphatidylethanolamine (16:1 18:2) Levels,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,FADS2,GWAS_Catalog_2023
1515,Glycosphingolipids (D38:1) Levels,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,APOB,GWAS_Catalog_2023
1516,Phosphatidylcholine (20:0 20:4) Levels,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,FADS2,GWAS_Catalog_2023
1517,Total Alkyldiacylglycerol Levels,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,APOE,GWAS_Catalog_2023
1518,Alkyldiacylglycerol (O-52:2) [NL-16:0] Levels,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,APOE,GWAS_Catalog_2023
1519,Alkenylphosphatidylcholine (P-20:0/20:4) Levels,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,FADS2,GWAS_Catalog_2023
1520,Alkenylphosphatidylcholine (P-38:5) (A) Levels,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,FADS2,GWAS_Catalog_2023
1521,Sphingomyelin (D43:2) Levels,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,APOB,GWAS_Catalog_2023
1522,Alkenylphosphatidylcholine (P-36:3) Levels,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,FADS2,GWAS_Catalog_2023
1523,Acylcarnitine (15:0) (B) Levels,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,SLC22A16,GWAS_Catalog_2023
1524,BMI At 7 Years Old,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,FTO,GWAS_Catalog_2023
1525,BMI At 8 Years Old,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,FTO,GWAS_Catalog_2023
1526,Lamb Liking,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,APOE,GWAS_Catalog_2023
1527,Capers Liking,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,KANSL1,GWAS_Catalog_2023
1528,Verbal Learning (Visual Presentation),0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,TOMM40,GWAS_Catalog_2023
1529,"Tyrosine-protein Kinase Receptor Tie-1, Soluble Levels",0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,NPRL3,GWAS_Catalog_2023
1530,Intercellular Adhesion Molecule 1 Levels,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,ICAM5,GWAS_Catalog_2023
1531,Intercellular Adhesion Molecule 5 Levels,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,ICAM5,GWAS_Catalog_2023
1532,C-X-C Motif Chemokine 5 Levels,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,BRD3,GWAS_Catalog_2023
1533,F-dessert Liking (Derived Food-Liking Factor),0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,FAM167A,GWAS_Catalog_2023
1534,Never Eat Sugar Vs No Sugar Restrictions (UKB Data Field 6144),0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,USP49,GWAS_Catalog_2023
1535,X-21470 Levels,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,SLC17A1,GWAS_Catalog_2023
1536,1-dihomo-linolenoyl-GPE (20:3N3 Or 6) Levels,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,FADS2,GWAS_Catalog_2023
1537,Xanthurenate Levels,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,SLC17A3,GWAS_Catalog_2023
1538,1-arachidonoyl-GPE (20:4N6) Levels,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,FADS2,GWAS_Catalog_2023
1539,Isoleucine Levels,0.14911259383863723,7.638138138138138,14.535786243348012,0.23117780955099965,GCKR,GWAS_Catalog_2023
1540,Myocardial Infarction,0.15033304431816796,1.721734670617734,3.262518730193559,0.23291859983321347,"ALDH2,PRDM16,LPL,APOE,APOB,IL6R",GWAS_Catalog_2023
1541,Parkinson's Disease,0.15143025121536938,2.0103328365623447,3.794764869932429,0.23431425382611631,"KANSL1,AGAP1,MAPT,CTSB",GWAS_Catalog_2023
1542,Medication Use (Thyroid Preparations),0.15143025121536938,2.0103328365623447,3.794764869932429,0.23431425382611631,"FADS2,MSRA,SLC25A37,SH2B3",GWAS_Catalog_2023
1543,Breast Cancer (Estrogen-Receptor Negative),0.15359274232530412,3.0596385542168676,5.7320820213469,0.2359770014089991,"FTO,TERT",GWAS_Catalog_2023
1544,Pork Consumption,0.15359274232530412,3.0596385542168676,5.7320820213469,0.2359770014089991,"FTO,MSRA",GWAS_Catalog_2023
1545,Vascular Endothelial Growth Factor Levels,0.15359274232530412,3.0596385542168676,5.7320820213469,0.2359770014089991,"MEF2C,ZBTB38",GWAS_Catalog_2023
1546,Triamcinolone Acetonide-Induced Ocular Hypertension,0.15359274232530412,3.0596385542168676,5.7320820213469,0.2359770014089991,"ZNF217,TRIM38",GWAS_Catalog_2023
1547,Breast Size,0.15359274232530412,3.0596385542168676,5.7320820213469,0.2359770014089991,"FTO,GCKR",GWAS_Catalog_2023
1548,Pulse Pressure X Alcohol Consumption Interaction (2Df Test),0.15359274232530412,3.0596385542168676,5.7320820213469,0.2359770014089991,"FTO,MSRA",GWAS_Catalog_2023
1549,Urinary Sodium Excretion,0.15359274232530412,3.0596385542168676,5.7320820213469,0.2359770014089991,"FTO,GCKR",GWAS_Catalog_2023
1550,LDL Cholesterol Levels In Current Drinkers,0.15359274232530412,3.0596385542168676,5.7320820213469,0.2359770014089991,"FADS2,DOCK7",GWAS_Catalog_2023
1551,Systolic Blood Pressure X Smoking Status (Current Vs Non-Current) Interaction (2Df Test),0.15359274232530412,3.0596385542168676,5.7320820213469,0.2359770014089991,"FTO,FAM167A",GWAS_Catalog_2023
1552,Diastolic Blood Pressure (Cigarette Smoking Interaction),0.15359274232530412,3.0596385542168676,5.7320820213469,0.2359770014089991,"HFE,SH2B3",GWAS_Catalog_2023
1553,Free Cholesterol Levels In LDL,0.15359274232530412,3.0596385542168676,5.7320820213469,0.2359770014089991,"APOE,APOB",GWAS_Catalog_2023
1554,Height,0.15526080859291438,1.1302626641651032,2.1052825533577213,0.23838628655256994,"UBXN2A,ICE2,MPG,ZAN,ITSN1,PPP2R2A,UBE2L3,FADS2,CCND3,CCND2,ZMIZ2,LEPR,ARFIP1,FBXO7,IL6R,MAP2K2,ZBTB38,ATP11A,VRK2,DOK2,XRN1,FTO,C17ORF99,MACF1,GCDH,NUP205,MAX,EPAS1,AK3,LPL,GMPR,AGAP1,PLD1,HELZ2,ARHGAP21,BCL2L11,ZNF827,ERI1,MICAL1,FIGNL1,PRDM16,NLRP3,ZKSCAN4,AP1M2,GCKR,BCL11A,DENND4A,QKI,RCL1,MFHAS1,MSRA,RPS28,PTPRC,DNMBP,TDP2,DLG5,ANP32B,FBXL5,ZNF410,CNIH4,ATR,CPEB4,THRB,MAST3,MAST2,DOCK7,SNX13,ADAR,PCSK7,SPPL3,HK1,SPRED2,ACOXL,ALDH2,TRIM4,PSD4,JAK2,JARID2,UBXN6,CTSB,BRD3,KLF13,USP49,DUSP1,TRPC1,PABPC4,TFEB,DDB2,GIGYF1,ELF1,TOX2,PIK3CA,TMBIM1,PPARG,RBM23,MDFI,KANK2,PCOLCE2,HSD17B13,TM9SF4,LMF2,THBS3,HDAC7,SERTAD2,STX4,SLC17A1,P4HTM,SH2B3,PTPN1,NOP58,MAP3K1,SMOX,GALNT2,SUSD1,MYO9B,U2SURP,ASXL1,MYO1D,FIG4,SLC25A37,FAM167A,SLC25A39,TFAP4,KLHL5,KANSL1,AXL,ZNF217,TRIM38,CRLF3",GWAS_Catalog_2023
1555,Urinary Metabolite Levels In Chronic Kidney Disease,0.15559571008477832,2.297129909365559,4.273796959777195,0.238746858046483,"SLC17A1,FBXL5,SLC17A3",GWAS_Catalog_2023
1556,Sleep Duration,0.1574451531052338,1.9777126099706746,3.6561540210316963,0.2412743322473268,"FTO,FADS2,MAX,MAPT",GWAS_Catalog_2023
1557,Node-level Brain Connectivity (Multivariate Analysis),0.1574451531052338,1.9777126099706746,3.6561540210316963,0.2412743322473268,"CD82,MAST2,APOE,SH2B3",GWAS_Catalog_2023
1558,Vertical Cup-Disc Ratio (Multi-Trait Analysis),0.16330690860836444,2.2408812909881366,4.060754709535732,0.2499360384474391,"ACOXL,PRDM16,RBM23",GWAS_Catalog_2023
1559,Body Fat Distribution (Leg Fat Ratio),0.16330690860836444,2.2408812909881366,4.060754709535732,0.2499360384474391,"FTO,SLC25A37,ZBTB38",GWAS_Catalog_2023
1560,"Cognitive Ability, Years Of Educational Attainment Or Schizophrenia (Pleiotropy)",0.16375540753983456,1.674279379157428,3.0294099366929643,0.25046179640387517,"BRD3,MSRA,SPRED2,BCL11A,DENND4A,RBM23",GWAS_Catalog_2023
1561,Brain Morphology (MOSTest),0.1639677197517726,1.3698611111111112,2.47682628778547,0.2505623962903445,"CEP57,MACF1,COL26A1,AGAP1,VRK2,PLD1,UBE2L3,MSRA,FADS2,AKAP10,KANSL1,PRDM16,BEND3,APOE",GWAS_Catalog_2023
1562,Insomnia Symptoms (Never/Rarely Vs. Usually),0.16487131692197854,2.9136546184738954,5.252124698534515,0.2505623962903445,"MSRA,VRK2",GWAS_Catalog_2023
1563,White Matter Microstructure (Mode Of Anisotropy),0.16487131692197854,2.9136546184738954,5.252124698534515,0.2505623962903445,"MAST2,SH2B3",GWAS_Catalog_2023
1564,Urolithiasis,0.16487131692197854,2.9136546184738954,5.252124698534515,0.2505623962903445,"FTO,GCKR",GWAS_Catalog_2023
1565,Albumin-globulin Ratio,0.16487131692197854,2.9136546184738954,5.252124698534515,0.2505623962903445,"FADS2,ACOXL",GWAS_Catalog_2023
1566,Feeling Worry,0.16487131692197854,2.9136546184738954,5.252124698534515,0.2505623962903445,"KANSL1,MAPT",GWAS_Catalog_2023
1567,Diffusing Capacity Of Carbon Monoxide,0.16487131692197854,2.9136546184738954,5.252124698534515,0.2505623962903445,"COL26A1,NSMCE2",GWAS_Catalog_2023
1568,Small Cell Lung Carcinoma,0.16487131692197854,2.9136546184738954,5.252124698534515,0.2505623962903445,"FAM167A,BTN3A1",GWAS_Catalog_2023
1569,"Remnant Cholesterol (non-HDL, non-LDL -Cholesterol)",0.16487131692197854,2.9136546184738954,5.252124698534515,0.2505623962903445,"DOCK7,APOB",GWAS_Catalog_2023
1570,Free Cholesterol Levels In Small LDL,0.16487131692197854,2.9136546184738954,5.252124698534515,0.2505623962903445,"APOE,APOB",GWAS_Catalog_2023
1571,Whole Brain Free Water Diffusion (Multivariate Analysis),0.16830802307557988,1.762743248436572,3.1411370910914576,0.2526284417850958,"AKAP10,COL26A1,CD82,APOE,THBS3",GWAS_Catalog_2023
1572,Coffee Consumption,0.1711298670427318,2.187311178247734,3.8613316294113096,0.2526284417850958,"FTO,GCKR,ALDH2",GWAS_Catalog_2023
1573,Neurociticism,0.17600139071984627,1.8858741258741258,3.2762600622401497,0.2526284417850958,"MSRA,KANSL1,VRK2,MAPT",GWAS_Catalog_2023
1574,COVID-19 (Severe Vs Population) X Multiple Deprivation Index Interaction (Joint Test),0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,BCL11A,GWAS_Catalog_2023
1575,Metachronous Colorectal Adenoma,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,NLRP3,GWAS_Catalog_2023
1576,Vitamin C Levels,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,FADS2,GWAS_Catalog_2023
1577,Hypertriglyceridemia,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,GCKR,GWAS_Catalog_2023
1578,Physiological Traits,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,ZBTB38,GWAS_Catalog_2023
1579,Relative Fat Intake,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,FTO,GWAS_Catalog_2023
1580,Relative Protein Intake,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,GCKR,GWAS_Catalog_2023
1581,Gout Vs. Hyperuricemia,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,ALDH2,GWAS_Catalog_2023
1582,Dementia With Lewy Bodies,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,APOE,GWAS_Catalog_2023
1583,Morbidity In COVID-19 (Deceased Vs Asymptomatic),0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,MSRA,GWAS_Catalog_2023
1584,Abdominal Adipose Tissue Volumes To Gluteofemoral Adipose Tissue Volumes Ratio,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,FTO,GWAS_Catalog_2023
1585,Prostate Cancer (Advanced),0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,BCL2L11,GWAS_Catalog_2023
1586,Gastrointestinal Infection,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,MFHAS1,GWAS_Catalog_2023
1587,Total Bone Mineral Density X Gut Microbiota (?Genus Dialister) Interaction,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,PLD1,GWAS_Catalog_2023
1588,Androsterone Sulfate Levels In Elite Athletes,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,TRIM4,GWAS_Catalog_2023
1589,Left Ventricular End-Systolic Volume,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,SH2B3,GWAS_Catalog_2023
1590,Calcium/calmodulin-dependent Protein Kinase Type 1 Levels,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,IL6R,GWAS_Catalog_2023
1591,Response To Selenium Supplementation (Change In Plasma Selenium Concentration),0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,MSRA,GWAS_Catalog_2023
1592,Intrahepatic Cholestasis Of Pregnancy,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,GCKR,GWAS_Catalog_2023
1593,Central Cerebrospinal Fluid Amyloid Beta 42 To 40 Ratio,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,APOE,GWAS_Catalog_2023
1594,Response To TNF Inhibitor In Rheumatoid Arthritis (Change In Swollen 28-Joint Count),0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,FTO,GWAS_Catalog_2023
1595,F-coffee/alcohol Liking (Derived Food-Liking Factor),0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,MEF2C,GWAS_Catalog_2023
1596,F-cooking Vegetables Liking (Derived Food-Liking Factor),0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,MAPT,GWAS_Catalog_2023
1597,Suicide,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,RP1L1,GWAS_Catalog_2023
1598,Circulating Leptin Levels Adjusted For BMI,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,GCKR,GWAS_Catalog_2023
1599,Brain Surface Area Change Rate X Age Interaction (1Df),0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,TF,GWAS_Catalog_2023
1600,Aspartate Aminotransferase Levels In Non-Alcoholic Fatty Liver Disease,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,AGAP1,GWAS_Catalog_2023
1601,Suicide Attempts In Schizophrenia,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,SPRED2,GWAS_Catalog_2023
1602,Noggin Levels,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,MEF2C,GWAS_Catalog_2023
1603,Plasma Omega-6 Polyunsaturated Fatty Acid Levels (Dihomo-Gamma-Linolenic Acid),0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,FADS2,GWAS_Catalog_2023
1604,Plasma Omega-3 Polyunsaturated Fatty Acid Levels (Alphalinolenic Acid),0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,FADS2,GWAS_Catalog_2023
1605,Renal Function-Related Traits (sCR),0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,ALDH2,GWAS_Catalog_2023
1606,Response To Hepatitis C Treatment,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,AK9,GWAS_Catalog_2023
1607,Conduct Disorder (Maternal Expressed Emotions Interaction),0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,MFHAS1,GWAS_Catalog_2023
1608,Response To Antipsychotic Treatment In Schizophrenia (Reasoning),0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,ZFP90,GWAS_Catalog_2023
1609,Metabolite Levels (5-HIAA/ MHPG Ratio),0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,CCND3,GWAS_Catalog_2023
1610,Hyperactive-impulsive Symptoms,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,LPL,GWAS_Catalog_2023
1611,Liver Enzyme Levels,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,C12ORF43,GWAS_Catalog_2023
1612,QT Interval (Drug Interaction),0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,CCND2,GWAS_Catalog_2023
1613,Esophageal Cancer (Squamous Cell),0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,HEATR3,GWAS_Catalog_2023
1614,Psychosis And Alzheimer's Disease,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,TOMM40,GWAS_Catalog_2023
1615,Paget's Disease,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,NUP205,GWAS_Catalog_2023
1616,Exploratory Eye Movement Dysfunction In Schizophrenia (Responsive Search Score),0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,CCND3,GWAS_Catalog_2023
1617,Glycochenodeoxycholate Glucuronide (1) Levels,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,ABCC2,GWAS_Catalog_2023
1618,Body Fat Percentage And Type 2 Diabetes (Pairwise),0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,PPARG,GWAS_Catalog_2023
1619,Body Mass Index And HDL-C (Pairwise),0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,TOMM40,GWAS_Catalog_2023
1620,IDP SWI T2star Left Pallidum,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,TF,GWAS_Catalog_2023
1621,Mitochondrial Heteroplasmy Measurement,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,IL1RN,GWAS_Catalog_2023
1622,Childhood Body Fatness,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,FTO,GWAS_Catalog_2023
1623,Diacylglycerol 38:4 [M+H-H2O]1+ Levels,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,FADS2,GWAS_Catalog_2023
1624,Phosphatidylethanolamine 36:3 [M-H]1- Levels,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,FADS2,GWAS_Catalog_2023
1625,Lysophosphatidylethanolamine 20:4 [M-H]1- Levels,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,FADS2,GWAS_Catalog_2023
1626,Phosphatidylcholine 31:2 [M+H]1+/Phosphatidylethanolamine 34:2 [M+H]1+/Phosphatidate 36:3 [M+NH4]1+ Levels,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,FADS2,GWAS_Catalog_2023
1627,Phosphatidylcholine 35:4 [M+H]1+/Phosphatidylethanolamine 38:4 [M+H]1+/Phosphatidate 40:5 [M+NH4]1+ Levels,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,FADS2,GWAS_Catalog_2023
1628,Phosphatidylinositol 36:2 [M-H]1- Levels,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,FADS2,GWAS_Catalog_2023
1629,Phosphatidylinositol 34:2 [M-H]1- Levels,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,FADS2,GWAS_Catalog_2023
1630,Phosphatidylinositol 36:3 [M-H]1- Levels,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,FADS2,GWAS_Catalog_2023
1631,Fatty Acid(20:4) [M-H]1- Levels,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,FADS2,GWAS_Catalog_2023
1632,Phosphatidylinositol 38:4 [M-H]1- Levels,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,FADS2,GWAS_Catalog_2023
1633,Phosphatidylethanolamine 34:2 [M-H]1- Levels,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,FADS2,GWAS_Catalog_2023
1634,Phosphatidylethanolamine 38:4 [M-H]1- Levels,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,FADS2,GWAS_Catalog_2023
1635,Phosphatidylethanolamine 38:5 [M-H]1- Levels,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,FADS2,GWAS_Catalog_2023
1636,Factor VII Levels,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,GCKR,GWAS_Catalog_2023
1637,Lipoprotein(a) Levels Adjusted For Apolipoprotein(A) Isoforms,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,APOE,GWAS_Catalog_2023
1638,Pursuit Maintenance Gain In Psychotic Disorders,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,GIGYF1,GWAS_Catalog_2023
1639,Body Mass Index (Age <50),0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,FTO,GWAS_Catalog_2023
1640,"Facial Morphology (Factor 4, Facial Height Related To Vertical Position Of Gnathion)",0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,MEF2C,GWAS_Catalog_2023
1641,Medication Use (Antimigraine Preparations),0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,PRDM16,GWAS_Catalog_2023
1642,Phosphatidylcholine (16:0 20:3) (A) Levels,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,FADS2,GWAS_Catalog_2023
1643,Cholesteryl Ester (24:4) Levels,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,FADS2,GWAS_Catalog_2023
1644,Ceramide (D18:1/24:1) Levels,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,FADS2,GWAS_Catalog_2023
1645,Trihexosylcermide (D18:1/18:0) Levels,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,GCKR,GWAS_Catalog_2023
1646,Lysophosphatidylcholine (20:3) [Sn1] Levels,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,FADS2,GWAS_Catalog_2023
1647,Alkenylphosphatidylethanolamine (P-19:0/20:4) (A) Levels,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,FADS2,GWAS_Catalog_2023
1648,Glycosphingolipids (D42:2) Levels,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,APOB,GWAS_Catalog_2023
1649,Alkyldiacylglycerol (O-50:1) [NL-16:0] Levels,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,APOE,GWAS_Catalog_2023
1650,Triacylglycerol (56:6) [NL-20:4] Levels,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,FADS2,GWAS_Catalog_2023
1651,BMI At Birth,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,SH2B3,GWAS_Catalog_2023
1652,Vaginal Microbiome MetaCyc Pathway (P381-PWY|adenosylcobalamin Biosynthesis II (Late Cobalt Incorporation)),0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,GYPA,GWAS_Catalog_2023
1653,Acylcarnitine (17:0) (B) Levels,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,SLC22A16,GWAS_Catalog_2023
1654,Acylcarnitine (18:0) Levels,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,SLC22A16,GWAS_Catalog_2023
1655,Serum Amyloid A-1 Protein Levels,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,LEPR,GWAS_Catalog_2023
1656,Vitronectin Levels,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,SEZ6,GWAS_Catalog_2023
1657,X-24588 Levels,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,ABCC2,GWAS_Catalog_2023
1658,Uterine Leiomyoma Or ER Negative Breast Cancer (Pleiotropy),0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,TERT,GWAS_Catalog_2023
1659,P-selectin Glycoprotein Ligand 1 Levels,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,THBS3,GWAS_Catalog_2023
1660,Ornithine Levels,0.17616084684518224,6.10990990990991,10.608989721849268,0.2526284417850958,SLC7A6,GWAS_Catalog_2023
1661,Eosinophilic Esophagitis,0.1762893359481075,2.7809419496166483,4.8266826037987975,0.2526284417850958,"RAD50,JAK2",GWAS_Catalog_2023
1662,Family History Of Alzheimer's Disease,0.1762893359481075,2.7809419496166483,4.8266826037987975,0.2526284417850958,"TOMM40,APOE",GWAS_Catalog_2023
1663,Systolic Blood Pressure (Cigarette Smoking Interaction),0.1762893359481075,2.7809419496166483,4.8266826037987975,0.2526284417850958,"HFE,SH2B3",GWAS_Catalog_2023
1664,Endometriosis Or Asthma (Pleiotropy),0.1762893359481075,2.7809419496166483,4.8266826037987975,0.2526284417850958,"MFHAS1,FAM167A",GWAS_Catalog_2023
1665,Glutamine Levels,0.1762893359481075,2.7809419496166483,4.8266826037987975,0.2526284417850958,"GCKR,SPRYD4",GWAS_Catalog_2023
1666,Multiple Sclerosis,0.17765001170508862,1.5077722157401483,2.605339757555892,0.25442552696779197,"AHI1,MEF2C,TOX2,FAM167A,NDFIP1,TERT,ZBTB38,SH2B3",GWAS_Catalog_2023
1667,Metabolonic Lactone Sulfate Levels,0.1790577909998144,2.136232698658048,3.674419940740421,0.25628787602013026,"RCL1,ARPC1A,EPHB4",GWAS_Catalog_2023
1668,Coronary Heart Disease,0.18708394837205428,2.0874759681406205,3.499022711118496,0.2675548384393585,"ALDH2,IL6R,SH2B3",GWAS_Catalog_2023
1669,Cholesterol Levels In Very Small VLDL,0.187826636372978,2.6597695128339445,4.447762034614779,0.2675548384393585,"DOCK7,APOE",GWAS_Catalog_2023
1670,Serum Metabolite Concentrations In Chronic Kidney Disease,0.187826636372978,2.6597695128339445,4.447762034614779,0.2675548384393585,"FADS2,SLC22A16",GWAS_Catalog_2023
1671,Dental Caries,0.187826636372978,2.6597695128339445,4.447762034614779,0.2675548384393585,"RTEL1-TNFRSF6B,RTEL1",GWAS_Catalog_2023
1672,Thiazide-induced Adverse Metabolic Effects In Hypertensive Patients,0.187826636372978,2.6597695128339445,4.447762034614779,0.2675548384393585,"MEF2C,TMC6",GWAS_Catalog_2023
1673,Pneumonia,0.187826636372978,2.6597695128339445,4.447762034614779,0.2675548384393585,"HELZ2,IL6R",GWAS_Catalog_2023
1674,Waist-to-hip Ratio Adjusted For BMI (Adjusted For Smoking Behaviour),0.187826636372978,2.6597695128339445,4.447762034614779,0.2675548384393585,"KLF13,CPEB4",GWAS_Catalog_2023
1675,Concentration Of IDL Particles,0.187826636372978,2.6597695128339445,4.447762034614779,0.2675548384393585,"DOCK7,APOB",GWAS_Catalog_2023
1676,Body Mass Index,0.19057585483715297,1.1726600472470878,1.943924394949838,0.2713090630318896,"FTO,BLK,MACF1,TOMM40,MAST3,MAST2,AGAP1,GK5,ACOXL,AKAP10,CCND2,BCL2L11,ALDH2,ERI1,FIGNL1,ZMIZ2,PSD4,ARIH2,LEPR,APOE,P4HTM,SH2B3,GCKR,MEF2C,MAP2K2,USP49,SPRYD4,BCL11A,DENND4A,PABPC4,ARHGAP27,FRS3,KLF3,RP1L1,MSRA,SLC25A37,SLC7A6,KANSL1,KIAA0586,KIT,PPARG,MAPT,CPEB4",GWAS_Catalog_2023
1677,White Matter Microstructure (Radial Diusivities),0.19520168016594044,2.040886203423968,3.3342406851988353,0.27557724663282107,"CD82,KANSL1,MAPT",GWAS_Catalog_2023
1678,Autoimmune Thyroid Disease,0.19520168016594044,2.040886203423968,3.3342406851988353,0.27557724663282107,"GIGYF1,MSRA,SH2B3",GWAS_Catalog_2023
1679,Resting Heart Rate,0.19520168016594044,2.040886203423968,3.3342406851988353,0.27557724663282107,"FADS2,GCKR,UFSP1",GWAS_Catalog_2023
1680,Positive Affect,0.19525798515487663,1.8021390374331552,2.943674444835606,0.27557724663282107,"UBXN2A,VRK2,BTN3A2,TRIM38",GWAS_Catalog_2023
1681,COVID-19 (Severe Vs Non-Severe With Positive Test),0.1994641886930714,2.548694779116466,4.108803264933942,0.27557724663282107,"AGAP1,MAPT",GWAS_Catalog_2023
1682,BMI In Non-Smokers,0.1994641886930714,2.548694779116466,4.108803264933942,0.27557724663282107,"FTO,TOMM40",GWAS_Catalog_2023
1683,Phospholipid Levels In Small LDL,0.1994641886930714,2.548694779116466,4.108803264933942,0.27557724663282107,"GALNT2,APOE",GWAS_Catalog_2023
1684,Otosclerosis,0.1994641886930714,2.548694779116466,4.108803264933942,0.27557724663282107,"FAM167A,SLC7A6",GWAS_Catalog_2023
1685,Neuroticism Conditioned On Self-Rated Math Ability (Multi-Trait Conditioning And Joint Analysis),0.1994641886930714,2.548694779116466,4.108803264933942,0.27557724663282107,"MFHAS1,VRK2",GWAS_Catalog_2023
1686,Cholesterol Levels In Medium VLDL,0.1994641886930714,2.548694779116466,4.108803264933942,0.27557724663282107,"DOCK7,APOB",GWAS_Catalog_2023
1687,RS-10-hydroxywarfarin Levels,0.1994641886930714,2.548694779116466,4.108803264933942,0.27557724663282107,"TMBIM1,WIPI2",GWAS_Catalog_2023
1688,Anterior Thigh Muscle Fat Infiltration Percentage,0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,PPARG,GWAS_Catalog_2023
1689,Coffee Intake (Standard GWA),0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,FTO,GWAS_Catalog_2023
1690,Cirrhosis (Alcohol Related),0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,HSD17B13,GWAS_Catalog_2023
1691,Alanine Transaminase Levels In High Alcohol Intake,0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,HSD17B13,GWAS_Catalog_2023
1692,Epilepsy,0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,ALDH2,GWAS_Catalog_2023
1693,Processed Meat Consumption,0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,MSRA,GWAS_Catalog_2023
1694,Circulating Leptin Levels Or Type 2 Diabetes,0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,GCKR,GWAS_Catalog_2023
1695,Prostate Cancer (Early Onset),0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,MYO9B,GWAS_Catalog_2023
1696,Eye Color (Brightness),0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,DSTYK,GWAS_Catalog_2023
1697,Serum Chromium Levels,0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,FIG4,GWAS_Catalog_2023
1698,Alcohol Consumption X Playing Computer Games Interaction,0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,NUP205,GWAS_Catalog_2023
1699,Benign Childhood Epilepsy With Centro-Temporal Spikes,0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,GK5,GWAS_Catalog_2023
1700,Serum Nickel Levels,0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,SLC25A37,GWAS_Catalog_2023
1701,Ischemic Stroke Or Factor VIII Levels (Pleiotropy),0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,SH2B3,GWAS_Catalog_2023
1702,Acylcarnitine (16:1) Levels,0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,SLC22A16,GWAS_Catalog_2023
1703,Esophageal Cancer,0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,ALDH2,GWAS_Catalog_2023
1704,Type 2 Diabetes Nephropathy,0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,FTO,GWAS_Catalog_2023
1705,Vigorous Physical Activity,0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,APOE,GWAS_Catalog_2023
1706,Ischemic Stroke (Large Artery Atherosclerosis),0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,SH2B3,GWAS_Catalog_2023
1707,Calponin-1 Levels,0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,MEF2C,GWAS_Catalog_2023
1708,Nose Morphology,0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,PRDM16,GWAS_Catalog_2023
1709,Parental Longevity (Father'S Attained Age),0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,APOE,GWAS_Catalog_2023
1710,Perceived Intensity Of Neohesperidin Dihydrochalcone,0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,DMKN,GWAS_Catalog_2023
1711,Intake Of Sweets,0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,GALNT2,GWAS_Catalog_2023
1712,Urinary Albumin-To-Creatinine Ratio In Diabetes,0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,GCKR,GWAS_Catalog_2023
1713,Plasma Omega-6 Polyunsaturated Fatty Acid Levels (Arachidonic Acid),0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,FADS2,GWAS_Catalog_2023
1714,Plasma Omega-6 Polyunsaturated Fatty Acid Levels (Gamma-Linolenic Acid),0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,FADS2,GWAS_Catalog_2023
1715,Lewy Body Disease,0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,APOE,GWAS_Catalog_2023
1716,QRS Complex (Sokolow-Lyon),0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,CPEB4,GWAS_Catalog_2023
1717,Breast Cancer In BRCA1 Mutation Carriers,0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,TERT,GWAS_Catalog_2023
1718,Celiac Disease Or Rheumatoid Arthritis,0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,SPRED2,GWAS_Catalog_2023
1719,Bulimia Nervosa,0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,MSRA,GWAS_Catalog_2023
1720,Phosphatidylcholine 38:3 [M+H]1+/Phosphatidylethanolamine 41:3 [M+H]1+/Phosphatidate 43:4 [M+NH4]1+ Levels,0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,FADS2,GWAS_Catalog_2023
1721,Wg Lh Intensity-Contrast Precuneus,0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,KLF3,GWAS_Catalog_2023
1722,Body Fat Percentage And HDL-C (Pairwise),0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,TOMM40,GWAS_Catalog_2023
1723,Generalized Anxiety Disorder (Phenotype Risk Score),0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,MAPT,GWAS_Catalog_2023
1724,"Schizophrenia, Bipolar Disorder Or Major Depressive Disorder",0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,FTO,GWAS_Catalog_2023
1725,Lysophosphatidylethanolamine 22:4 [M-H]1- Levels,0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,FADS2,GWAS_Catalog_2023
1726,Lysophosphatidylcholine 20:4 [M+H]1+ Levels,0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,FADS2,GWAS_Catalog_2023
1727,Phosphatidylcholine 34:2 [M+H]1+/Phosphatidylethanolamine 37:2 [M+H]1+/Phosphatidate 39:3 [M+NH4]1+ Levels,0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,FADS2,GWAS_Catalog_2023
1728,Very Long-Chain Saturated Fatty Acid Levels (Fatty Acid 20:0),0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,DOCK7,GWAS_Catalog_2023
1729,Urate Levels (BMI Interaction),0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,MAP3K1,GWAS_Catalog_2023
1730,Alcohol Consumption In Current Drinkers,0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,GCKR,GWAS_Catalog_2023
1731,Craniofacial Microsomia,0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,AGAP1,GWAS_Catalog_2023
1732,Prostate-specific Antigen Levels (Conditioned On Lead SNPs),0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,ZBTB38,GWAS_Catalog_2023
1733,Hashimoto Thyroiditis,0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,SH2B3,GWAS_Catalog_2023
1734,Phosphatidylcholine (17:0 20:4) Levels,0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,FADS2,GWAS_Catalog_2023
1735,Quinate Levels In Elite Athletes,0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,LEPR,GWAS_Catalog_2023
1736,Phosphatidylcholine (16:0 20:4) Levels,0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,FADS2,GWAS_Catalog_2023
1737,Lysophosphatidylcholine (20:3) [Sn2] Levels,0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,FADS2,GWAS_Catalog_2023
1738,Phosphatidylcholine (18:1 20:3) Levels,0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,FADS2,GWAS_Catalog_2023
1739,Acylcarnitine (16:0) Levels,0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,SLC22A16,GWAS_Catalog_2023
1740,Cognitive Function (Delayed Memory) (Longitudinal),0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,PPARG,GWAS_Catalog_2023
1741,BMI At 3 Months Old,0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,LEPR,GWAS_Catalog_2023
1742,BMI At 2 Years Old,0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,LEPR,GWAS_Catalog_2023
1743,Salty Food Liking,0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,RHOA,GWAS_Catalog_2023
1744,Sardines Liking,0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,FTO,GWAS_Catalog_2023
1745,F-vegetarian Liking (Derived Food-Liking Factor),0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,MSRA,GWAS_Catalog_2023
1746,Butyrylcarnitine Levels,0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,UNC119B,GWAS_Catalog_2023
1747,Serine Levels,0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,GCKR,GWAS_Catalog_2023
1748,Facial Skin Hydration,0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,ARHGAP21,GWAS_Catalog_2023
1749,Ximenoylcarnitine (C26:1) Levels,0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,SLC22A16,GWAS_Catalog_2023
1750,Cerotoylcarnitine (C26) Levels,0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,SLC22A16,GWAS_Catalog_2023
1751,Bread Consumption (Slices Per Week) (UKB Data Field 1438),0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,VRK2,GWAS_Catalog_2023
1752,Minimum Measurement Of Hepatic Fat,0.20235177539845034,5.091091091091091,8.134278744250102,0.27557724663282107,SAMM50,GWAS_Catalog_2023
1753,"Gut Microbiota (Bacterial Taxa, Rank Normal Transformation Method)",0.2034044104295907,1.9963220806515172,3.1792609201776654,0.27685277996862717,"TRABD,MSRA,THRB",GWAS_Catalog_2023
1754,Cortical Thickness,0.20942104046166202,1.3320626948000986,2.0825581473544275,0.28487947693359494,"MACF1,MSRA,FADS2,MEF2C,KANSL1,MAST2,DOCK7,BEND3,AGAP1,APOE,VRK2,THBS3",GWAS_Catalog_2023
1755,Type 2 Diabetes Or Prostate Cancer (Pleiotropy),0.21118404556912293,2.4465060240963856,3.8043786951207514,0.28581119269876765,"BCL2L11,ZBTB38",GWAS_Catalog_2023
1756,Chronic Obstructive Pulmonary Disease X Current Smoker Interaction (2Df),0.21118404556912293,2.4465060240963856,3.8043786951207514,0.28581119269876765,"GYPE,ZBTB38",GWAS_Catalog_2023
1757,Chronic Obstructive Pulmonary Disease In Non-Current Smokers,0.21118404556912293,2.4465060240963856,3.8043786951207514,0.28581119269876765,"GYPE,ZBTB38",GWAS_Catalog_2023
1758,Chronic Obstructive Pulmonary Disease X Current Smoker Interaction (Main Effect),0.21118404556912293,2.4465060240963856,3.8043786951207514,0.28581119269876765,"GYPE,ZBTB38",GWAS_Catalog_2023
1759,Oily Fish Consumption,0.21118404556912293,2.4465060240963856,3.8043786951207514,0.28581119269876765,"FTO,MSRA",GWAS_Catalog_2023
1760,Osteoarthritis (Hip),0.21118404556912293,2.4465060240963856,3.8043786951207514,0.28581119269876765,"HFE,MAPT",GWAS_Catalog_2023
1761,Advanced Age-Related Macular Degeneration,0.21118404556912293,2.4465060240963856,3.8043786951207514,0.28581119269876765,"ARHGAP21,APOE",GWAS_Catalog_2023
1762,Inflammatory Skin Disease,0.21118404556912293,2.4465060240963856,3.8043786951207514,0.28581119269876765,"RAD50,ICAM5",GWAS_Catalog_2023
1763,Testosterone Levels In Postmenopausal Women,0.21118404556912293,2.4465060240963856,3.8043786951207514,0.28581119269876765,"SLC25A37,GCKR",GWAS_Catalog_2023
1764,Optic Disc Size,0.2116856551833833,1.953654303528958,3.0333469481816007,0.2863276492446443,"MACF1,PRDM16,UBE2L3",GWAS_Catalog_2023
1765,Cystatin C Levels,0.21187123740651398,1.5332317073170731,2.3792330237863912,0.2864163016724886,"FTO,GCKR,TOMM40,APOE,PDE7A,SH2B3",GWAS_Catalog_2023
1766,Bipolar Disorder,0.21693697850688473,1.5204091916952227,2.3234108572891348,0.2930983186395396,"MSRA,FADS2,PGAP3,BTN2A1,MRPL33,HDAC7",GWAS_Catalog_2023
1767,Hypertension,0.21797497000660154,1.5960612968591692,2.431399940777681,0.29416757830076434,"MSRA,ALDH2,HFE,PRDM16,MYO9B",GWAS_Catalog_2023
1768,Risk-taking Behavior (Multivariate Analysis),0.21797497000660154,1.5960612968591692,2.431399940777681,0.29416757830076434,"MFHAS1,BCL11A,ZKSCAN3,SLC39A13,MAPT",GWAS_Catalog_2023
1769,Arthritis (Juvenile Idiopathic),0.22296929257000844,2.3521779425393885,3.529963348017771,0.29836461414304716,"AHI1,UBE2L3",GWAS_Catalog_2023
1770,Coronary Artery Calcified Atherosclerotic Plaque (130 HU Threshold) In Type 2 Diabetes,0.22296929257000844,2.3521779425393885,3.529963348017771,0.29836461414304716,"MSRA,AGAP1",GWAS_Catalog_2023
1771,PR Interval,0.22719030583268718,1.4953896490184415,2.2161185023365157,0.29836461414304716,"FADS2,MACF1,THRB,EPAS1,TFEB,SLC12A7",GWAS_Catalog_2023
1772,Barrett's Esophagus,0.22771247374454687,4.363363363363363,6.4563445260378325,0.29836461414304716,MSRA,GWAS_Catalog_2023
1773,BMI (Weighted GWA),0.22771247374454687,4.363363363363363,6.4563445260378325,0.29836461414304716,FTO,GWAS_Catalog_2023
1774,Cholesterol,0.22771247374454687,4.363363363363363,6.4563445260378325,0.29836461414304716,GCKR,GWAS_Catalog_2023
1775,Age-related Cognitive Decline (Memory) (Slope Of Z-Scores),0.22771247374454687,4.363363363363363,6.4563445260378325,0.29836461414304716,APOE,GWAS_Catalog_2023
1776,Brainstem Volume,0.22771247374454687,4.363363363363363,6.4563445260378325,0.29836461414304716,PTPN1,GWAS_Catalog_2023
1777,Neuropathologic Traits (Pleiotropy),0.22771247374454687,4.363363363363363,6.4563445260378325,0.29836461414304716,APOE,GWAS_Catalog_2023
1778,Glucagon Levels In Response To Oral Glucose Tolerance Test (Fasting),0.22771247374454687,4.363363363363363,6.4563445260378325,0.29836461414304716,MACF1,GWAS_Catalog_2023
1779,Plasma Nickel Levels,0.22771247374454687,4.363363363363363,6.4563445260378325,0.29836461414304716,DMKN,GWAS_Catalog_2023
1780,Renal Overload Gout,0.22771247374454687,4.363363363363363,6.4563445260378325,0.29836461414304716,GCKR,GWAS_Catalog_2023
1781,Mucinous Adenocarcinoma In Colorectal Cancer,0.22771247374454687,4.363363363363363,6.4563445260378325,0.29836461414304716,SLC22A16,GWAS_Catalog_2023
1782,Homeostasis Model Assessment Of Insulin Resistance,0.22771247374454687,4.363363363363363,6.4563445260378325,0.29836461414304716,GCKR,GWAS_Catalog_2023
1783,Mammographic Density (Non-Dense Area),0.22771247374454687,4.363363363363363,6.4563445260378325,0.29836461414304716,PPARG,GWAS_Catalog_2023
1784,Percent Liver Fat,0.22771247374454687,4.363363363363363,6.4563445260378325,0.29836461414304716,APOE,GWAS_Catalog_2023
1785,Male Puberty Timing (Late Vs. Average Onset Voice Breaking),0.22771247374454687,4.363363363363363,6.4563445260378325,0.29836461414304716,KANSL1,GWAS_Catalog_2023
1786,Thyroid Cancer,0.22771247374454687,4.363363363363363,6.4563445260378325,0.29836461414304716,TERT,GWAS_Catalog_2023
1787,Interstitial Lung Diseases In Rheumatoid Arthritis,0.22771247374454687,4.363363363363363,6.4563445260378325,0.29836461414304716,EPAS1,GWAS_Catalog_2023
1788,Logical Memory (Delayed Recall) In Normal Cognition,0.22771247374454687,4.363363363363363,6.4563445260378325,0.29836461414304716,DENND4A,GWAS_Catalog_2023
1789,Antisaccade Task Score,0.22771247374454687,4.363363363363363,6.4563445260378325,0.29836461414304716,SERTAD2,GWAS_Catalog_2023
1790,California Verbal Learning Test Score,0.22771247374454687,4.363363363363363,6.4563445260378325,0.29836461414304716,BMP8A,GWAS_Catalog_2023
1791,Plasma Omega-3 Polyunsaturated Fatty Acid Level (Eicosapentaenoic Acid),0.22771247374454687,4.363363363363363,6.4563445260378325,0.29836461414304716,FADS2,GWAS_Catalog_2023
1792,Attention Function In Attention Deficit Hyperactive Disorder,0.22771247374454687,4.363363363363363,6.4563445260378325,0.29836461414304716,ACOXL,GWAS_Catalog_2023
1793,Alcohol Consumption (Max-Drinks),0.22771247374454687,4.363363363363363,6.4563445260378325,0.29836461414304716,ALDH2,GWAS_Catalog_2023
1794,Homeostasis Model Assessment Of Beta-Cell Function,0.22771247374454687,4.363363363363363,6.4563445260378325,0.29836461414304716,FADS2,GWAS_Catalog_2023
1795,Left Ventricular Mass,0.22771247374454687,4.363363363363363,6.4563445260378325,0.29836461414304716,FTO,GWAS_Catalog_2023
1796,"Breast Cancer, Ovarian Cancer Or Prostate Cancer (Pleiotropy)",0.22771247374454687,4.363363363363363,6.4563445260378325,0.29836461414304716,BCL2L11,GWAS_Catalog_2023
1797,Phosphatidylcholine 38:2 [M+H]1+/Phosphatidylethanolamine 41:2 [M+H]1+ Levels,0.22771247374454687,4.363363363363363,6.4563445260378325,0.29836461414304716,FADS2,GWAS_Catalog_2023
1798,Language Functional Connectivity,0.22771247374454687,4.363363363363363,6.4563445260378325,0.29836461414304716,SEZ6,GWAS_Catalog_2023
1799,Phosphatidylcholine 36:3 [M+H]1+/Phosphatidylethanolamine 39:3 [M+H]1+/Phosphatidate 41:4 [M+NH4]1+ Levels,0.22771247374454687,4.363363363363363,6.4563445260378325,0.29836461414304716,FADS2,GWAS_Catalog_2023
1800,Adipsin Levels In Type 2 Diabetes,0.22771247374454687,4.363363363363363,6.4563445260378325,0.29836461414304716,SERTAD2,GWAS_Catalog_2023
1801,Body Fat Percentage And Triglycerides (Pairwise),0.22771247374454687,4.363363363363363,6.4563445260378325,0.29836461414304716,TOMM40,GWAS_Catalog_2023
1802,Cholesteryl Ester 20:3 [M+NH4]1+ Levels,0.22771247374454687,4.363363363363363,6.4563445260378325,0.29836461414304716,FADS2,GWAS_Catalog_2023
1803,Body Fat Percentage Or Coronary Artery Disease (MTAG),0.22771247374454687,4.363363363363363,6.4563445260378325,0.29836461414304716,FTO,GWAS_Catalog_2023
1804,Phosphatidylcholine 35:3 [M+H]1+/Phosphatidylethanolamine 38:3 [M+H]1+/Phosphatidate 40:4 [M+NH4]1+ Levels,0.22771247374454687,4.363363363363363,6.4563445260378325,0.29836461414304716,FADS2,GWAS_Catalog_2023
1805,SARS-CoV-2 Infection,0.22771247374454687,4.363363363363363,6.4563445260378325,0.29836461414304716,KANSL1,GWAS_Catalog_2023
1806,Phosphatidylethanolamine 38:3 [M-H]1- Levels,0.22771247374454687,4.363363363363363,6.4563445260378325,0.29836461414304716,FADS2,GWAS_Catalog_2023
1807,Osteoprotegerin Levels,0.22771247374454687,4.363363363363363,6.4563445260378325,0.29836461414304716,SAMM50,GWAS_Catalog_2023
1808,Response To Chemotherapy In Breast Cancer Hypertensive Cases (Cumulative Dose) (Bevacizumab),0.22771247374454687,4.363363363363363,6.4563445260378325,0.29836461414304716,MSRA,GWAS_Catalog_2023
1809,Chickenpox,0.22771247374454687,4.363363363363363,6.4563445260378325,0.29836461414304716,MSRA,GWAS_Catalog_2023
1810,Nose Size,0.22771247374454687,4.363363363363363,6.4563445260378325,0.29836461414304716,MSRA,GWAS_Catalog_2023
1811,Diacylglycerol (18:1 20:3) Levels,0.22771247374454687,4.363363363363363,6.4563445260378325,0.29836461414304716,FADS2,GWAS_Catalog_2023
1812,Kidney Volume,0.22771247374454687,4.363363363363363,6.4563445260378325,0.29836461414304716,FTO,GWAS_Catalog_2023
1813,Acylcarnitine (18:1) Levels,0.22771247374454687,4.363363363363363,6.4563445260378325,0.29836461414304716,SLC22A16,GWAS_Catalog_2023
1814,Phosphatidylcholine (38:5) (B) Levels,0.22771247374454687,4.363363363363363,6.4563445260378325,0.29836461414304716,FADS2,GWAS_Catalog_2023
1815,Circulating Levels Of Total-Tau,0.22771247374454687,4.363363363363363,6.4563445260378325,0.29836461414304716,MAPT,GWAS_Catalog_2023
1816,Phosphatidylcholine (18:0 20:4) Levels,0.22771247374454687,4.363363363363363,6.4563445260378325,0.29836461414304716,FADS2,GWAS_Catalog_2023
1817,BMI At 1.5 Years Old,0.22771247374454687,4.363363363363363,6.4563445260378325,0.29836461414304716,LEPR,GWAS_Catalog_2023
1818,Sphingomyeline C18:0 Levels,0.22771247374454687,4.363363363363363,6.4563445260378325,0.29836461414304716,APOE,GWAS_Catalog_2023
1819,F-highly Palatable Foods Liking (Derived Food-Liking Factor),0.22771247374454687,4.363363363363363,6.4563445260378325,0.29836461414304716,SLC17A1,GWAS_Catalog_2023
1820,"Vaginal Microbiome MetaCyc Pathway (PWY-7013|L-1,2-propanediol Degradation)",0.22771247374454687,4.363363363363363,6.4563445260378325,0.29836461414304716,UBE2L3,GWAS_Catalog_2023
1821,Autoimmune Neurological Syndromes With anti-GAD65 Autoantibodies,0.22771247374454687,4.363363363363363,6.4563445260378325,0.29836461414304716,ZAN,GWAS_Catalog_2023
1822,Headache Or Migraine,0.2348040010823395,2.2648371262829095,3.2817583968441295,0.3066460572427269,"PRDM16,MAPT",GWAS_Catalog_2023
1823,Cutaneous Melanoma Or Hair Colour,0.2348040010823395,2.2648371262829095,3.2817583968441295,0.3066460572427269,"FTO,DSTYK",GWAS_Catalog_2023
1824,Squamous Cell Lung Carcinoma,0.2348040010823395,2.2648371262829095,3.2817583968441295,0.3066460572427269,"SCGN,ZNF322",GWAS_Catalog_2023
1825,Osteoarthritis,0.2348040010823395,2.2648371262829095,3.2817583968441295,0.3066460572427269,"FTO,MAPT",GWAS_Catalog_2023
1826,Testicular Germ Cell Tumor,0.2348040010823395,2.2648371262829095,3.2817583968441295,0.3066460572427269,"KITLG,TERT",GWAS_Catalog_2023
1827,Hodgkin's Lymphoma,0.2348040010823395,2.2648371262829095,3.2817583968441295,0.3066460572427269,"HBS1L,AHI1",GWAS_Catalog_2023
1828,Melanoma,0.2369371811649995,1.835891238670695,2.64361037278202,0.3090935561835368,"FTO,SLC22A16,TERT",GWAS_Catalog_2023
1829,Estimated Glomerular Filtration Rate In Non-Diabetics,0.2369371811649995,1.835891238670695,2.64361037278202,0.3090935561835368,"GCKR,TFEB,FBXL5",GWAS_Catalog_2023
1830,Cognitive Performance,0.2375971702025925,1.471170731707317,2.1143350947427275,0.309785162898025,"CEP57,BCL11A,ZMIZ2,HFE,PPARG,BTN3A2",GWAS_Catalog_2023
1831,Hand Grip Strength,0.24242283699095532,1.6328080808080807,2.3138063142352823,0.315904363222512,"FTO,KANSL1,JARID2,KLF3",GWAS_Catalog_2023
1832,Urinary Albumin-To-Creatinine Ratio,0.24546975040118685,1.7997156566554113,2.527847416712688,0.3197002316906287,"ACOXL,BCL2L11,THBS3",GWAS_Catalog_2023
1833,Free Cholesterol Levels In Very Small VLDL,0.24667318295277238,2.183734939759036,3.0565540638795885,0.32091723801816513,"DOCK7,APOB",GWAS_Catalog_2023
1834,Descending Thoracic Aortic Diameter,0.24667318295277238,2.183734939759036,3.0565540638795885,0.32091723801816513,"TAGLN,ALDH2",GWAS_Catalog_2023
1835,Body Fat Percentage,0.25165066524093543,1.3933833750347513,1.9224697170032272,0.32256927627289583,"BRD3,FTO,MACF1,KLF13,GALNT2,PPARG,KLF3",GWAS_Catalog_2023
1836,Large Artery Stroke (MTAG),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.32256927627289583,IL6R,GWAS_Catalog_2023
1837,Waist Circumference Adjusted For BMI In Smokers,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.32256927627289583,ZBTB38,GWAS_Catalog_2023
1838,Brain Shape (Segment 15),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.32256927627289583,MACF1,GWAS_Catalog_2023
1839,Crohn's Disease Vs Rheumatoid Arthritis (Ordinary Least Squares (OLS)),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.32256927627289583,FADS2,GWAS_Catalog_2023
1840,Raw Vegetable Consumption,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.32256927627289583,MSRA,GWAS_Catalog_2023
1841,Methotrexate-related Central Neurotoxicity In Children Treated For Acute Lymphoblastic Leukemia,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.32256927627289583,MACF1,GWAS_Catalog_2023
1842,Caffeine Consumption From Coffee,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.32256927627289583,FTO,GWAS_Catalog_2023
1843,Systolic Blood Pressure X Depressive Symptoms Interaction (2Df Test),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.32256927627289583,FTO,GWAS_Catalog_2023
1844,Diastolic Blood Pressure X Depressive Symptoms Interaction (2Df Test),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.32256927627289583,SH2B3,GWAS_Catalog_2023
1845,Alzheimer's Disease Progression Score,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.32256927627289583,APOE,GWAS_Catalog_2023
1846,Ideal Cardiovascular Health Score (Clinical And Behavioral),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.32256927627289583,FTO,GWAS_Catalog_2023
1847,Toxicity Response To Radiotherapy In Prostate Cancer (Decreased Urine Stream) (Time To Event),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.32256927627289583,PTPRC,GWAS_Catalog_2023
1848,Arrhythmia,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.32256927627289583,MAPT,GWAS_Catalog_2023
1849,Serum Metabolite Ratios In Chronic Kidney Disease,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.32256927627289583,FADS2,GWAS_Catalog_2023
1850,N-glycan Levels,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.32256927627289583,C12ORF43,GWAS_Catalog_2023
1851,Cognitive Performance (Processing Speed),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.32256927627289583,MAPT,GWAS_Catalog_2023
1852,Macular Telangiectasia Type 2,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.32256927627289583,GCKR,GWAS_Catalog_2023
1853,"B-cell Malignancies (Chronic Lymphocytic Leukemia, Hodgkin Lymphoma Or Multiple Myeloma) (Pleiotropy)",0.2522691825336226,3.8175675675675675,5.2577776753917025,0.32256927627289583,ACOXL,GWAS_Catalog_2023
1854,Body Mass Index X Sex X Age Interaction (4Df Test),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.32256927627289583,FTO,GWAS_Catalog_2023
1855,Hemostatic Factors And Hematological Phenotypes,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.32256927627289583,CD82,GWAS_Catalog_2023
1856,Palmitoleic Acid (16:1N-7) Levels,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.32256927627289583,GCKR,GWAS_Catalog_2023
1857,Cutaneous Leishmaniasis,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.32256927627289583,CRLF3,GWAS_Catalog_2023
1858,LDL Levels X SSRI Levels (Escitalopram Or Citalopram) Interaction In Schizophrenia Or Bipolar Disorder,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.32256927627289583,SNX13,GWAS_Catalog_2023
1859,Diacylglycerol 38:3 [M+H-H2O]1+ Levels,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.32256927627289583,FADS2,GWAS_Catalog_2023
1860,Asthma And Hay Fever,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.32256927627289583,TLR1,GWAS_Catalog_2023
1861,Response To Efavirenz-Containing Treatment In HIV 1 Infection (Virologic Failure),0.2522691825336226,3.8175675675675675,5.2577776753917025,0.32256927627289583,FAM167A,GWAS_Catalog_2023
1862,Cholecystitis,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.32256927627289583,GCKR,GWAS_Catalog_2023
1863,Phosphatidylcholine (15:0 20:4) Levels,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.32256927627289583,FADS2,GWAS_Catalog_2023
1864,Leucylglycine Levels In Elite Athletes,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.32256927627289583,THRB,GWAS_Catalog_2023
1865,Supranormal Left Ventricular Ejection Fraction,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.32256927627289583,MSRA,GWAS_Catalog_2023
1866,Arginine Levels,0.2522691825336226,3.8175675675675675,5.2577776753917025,0.32256927627289583,GYPE,GWAS_Catalog_2023
1867,Body Fat Mass,0.2585627471976888,2.1082260074781884,2.851622081860491,0.3302626952964055,"FTO,MAST3",GWAS_Catalog_2023
1868,Ischemic Stroke,0.2585627471976888,2.1082260074781884,2.851622081860491,0.3302626952964055,"ALDH2,SH2B3",GWAS_Catalog_2023
1869,Metabolic Biomarkers (Multivariate Analysis),0.2588281021180633,1.4249858196256382,1.9259982027512719,0.3304247467382017,"FTO,MACF1,KLF13,GALNT2,PPARG,KLF3",GWAS_Catalog_2023
1870,Free Testosterone Levels,0.262672288407135,1.731459841532235,2.314698756882004,0.3351529840317776,"DNMBP,LEPR,MAPT",GWAS_Catalog_2023
1871,Hypothyroidism,0.2633833594910324,1.5695415695415695,2.093995515393584,0.3358806497838607,"FADS2,SLC25A37,TERT,SH2B3",GWAS_Catalog_2023
1872,Fasting Glucose,0.2704465134065228,1.5495205216724204,2.0262784408178804,0.3441686760157743,"FADS2,GCKR,SPRYD4,ZBTB38",GWAS_Catalog_2023
1873,Alcohol Consumption (Drinks Per Week) (MTAG),0.2704465134065228,1.5495205216724204,2.0262784408178804,0.3441686760157743,"FTO,GCKR,KANSL1,SLC39A13",GWAS_Catalog_2023
1874,Uterine Leiomyomata,0.27045945831080337,2.0377510040160645,2.664630598797084,0.3441686760157743,"THRB,TERT",GWAS_Catalog_2023
1875,Gastroesophageal Reflux Disease,0.27045945831080337,2.0377510040160645,2.664630598797084,0.3441686760157743,"BTN2A1,APOB",GWAS_Catalog_2023
1876,Waist-to-hip Ratio Adjusted For BMI In Non-Smokers,0.2760473156248264,3.3930597263930595,4.367488779253821,0.34502299375633094,KLF13,GWAS_Catalog_2023
1877,Surgical Knee Osteoarthritis,0.2760473156248264,3.3930597263930595,4.367488779253821,0.34502299375633094,FTO,GWAS_Catalog_2023
1878,Brain Shape (Segment 7),0.2760473156248264,3.3930597263930595,4.367488779253821,0.34502299375633094,AGAP1,GWAS_Catalog_2023
1879,Triglycerides To Total Lipids Ratio In Chylomicrons And Extremely Large VLDL,0.2760473156248264,3.3930597263930595,4.367488779253821,0.34502299375633094,MAST3,GWAS_Catalog_2023
1880,Gluteofemoral Adipose Tissue Volumes,0.2760473156248264,3.3930597263930595,4.367488779253821,0.34502299375633094,FTO,GWAS_Catalog_2023
1881,Plasma Free Amino Acid Levels,0.2760473156248264,3.3930597263930595,4.367488779253821,0.34502299375633094,SPRYD4,GWAS_Catalog_2023
1882,Ratio Of Saturated Fatty Acids To Total Fatty Acids,0.2760473156248264,3.3930597263930595,4.367488779253821,0.34502299375633094,GCKR,GWAS_Catalog_2023
1883,Parkinson's Disease Progression (Cognitive),0.2760473156248264,3.3930597263930595,4.367488779253821,0.34502299375633094,APOE,GWAS_Catalog_2023
1884,Help-seeking From A GP,0.2760473156248264,3.3930597263930595,4.367488779253821,0.34502299375633094,BTN3A1,GWAS_Catalog_2023
1885,Opioid Use Disorder (MTAG),0.2760473156248264,3.3930597263930595,4.367488779253821,0.34502299375633094,FTO,GWAS_Catalog_2023
1886,Asthma (Age Of Onset),0.2760473156248264,3.3930597263930595,4.367488779253821,0.34502299375633094,TLR1,GWAS_Catalog_2023
1887,Chronic Obstructive Pulmonary Disease Or Resting Heart Rate (Pleiotropy),0.2760473156248264,3.3930597263930595,4.367488779253821,0.34502299375633094,BMP8A,GWAS_Catalog_2023
1888,Differentiated Thyroid Cancer,0.2760473156248264,3.3930597263930595,4.367488779253821,0.34502299375633094,TERT,GWAS_Catalog_2023
1889,Corneal Endothelial Cell Density,0.2760473156248264,3.3930597263930595,4.367488779253821,0.34502299375633094,BCL2L11,GWAS_Catalog_2023
1890,Neuropsychiatric Disorders,0.2760473156248264,3.3930597263930595,4.367488779253821,0.34502299375633094,VRK2,GWAS_Catalog_2023
1891,Cerebrospinal AB1-42 Levels In Normal Cognition,0.2760473156248264,3.3930597263930595,4.367488779253821,0.34502299375633094,APOE,GWAS_Catalog_2023
1892,Body Mass Index Variance,0.2760473156248264,3.3930597263930595,4.367488779253821,0.34502299375633094,FTO,GWAS_Catalog_2023
1893,Warfarin Maintenance Dose,0.2760473156248264,3.3930597263930595,4.367488779253821,0.34502299375633094,STX4,GWAS_Catalog_2023
1894,Mitral Valve Prolapse,0.2760473156248264,3.3930597263930595,4.367488779253821,0.34502299375633094,MSRA,GWAS_Catalog_2023
1895,IgE Levels,0.2760473156248264,3.3930597263930595,4.367488779253821,0.34502299375633094,RAD50,GWAS_Catalog_2023
1896,Tonometry,0.2760473156248264,3.3930597263930595,4.367488779253821,0.34502299375633094,MEF2C,GWAS_Catalog_2023
1897,Potassium Levels,0.2760473156248264,3.3930597263930595,4.367488779253821,0.34502299375633094,PPARG,GWAS_Catalog_2023
1898,Sense Of Smell,0.2760473156248264,3.3930597263930595,4.367488779253821,0.34502299375633094,TOMM40,GWAS_Catalog_2023
1899,Carpal Tunnel Syndrome,0.2760473156248264,3.3930597263930595,4.367488779253821,0.34502299375633094,THBS3,GWAS_Catalog_2023
1900,Lung Cancer In Never Smokers,0.2760473156248264,3.3930597263930595,4.367488779253821,0.34502299375633094,TERT,GWAS_Catalog_2023
1901,Body Fat Percentage And LDL-C (Pairwise),0.2760473156248264,3.3930597263930595,4.367488779253821,0.34502299375633094,TOMM40,GWAS_Catalog_2023
1902,Behavioural Disinhibition (Generation Interaction),0.2760473156248264,3.3930597263930595,4.367488779253821,0.34502299375633094,ZNF827,GWAS_Catalog_2023
1903,C-reactive Protein Levels Or Total Cholesterol Levels (Pleiotropy),0.2760473156248264,3.3930597263930595,4.367488779253821,0.34502299375633094,GCKR,GWAS_Catalog_2023
1904,BMI At 6 Months Old,0.2760473156248264,3.3930597263930595,4.367488779253821,0.34502299375633094,LEPR,GWAS_Catalog_2023
1905,Ascending Aorta Distensibility (MTAG),0.2760473156248264,3.3930597263930595,4.367488779253821,0.34502299375633094,ZNF827,GWAS_Catalog_2023
1906,Gestational Diabetes Mellitus,0.2760473156248264,3.3930597263930595,4.367488779253821,0.34502299375633094,GCKR,GWAS_Catalog_2023
1907,Vaginal Microbiome Relative Abundance (P Proteobacteria),0.2760473156248264,3.3930597263930595,4.367488779253821,0.34502299375633094,KANSL1,GWAS_Catalog_2023
1908,Vaginal Microbiome Relative Abundance (S Megasphaera Genomosp Type 1),0.2760473156248264,3.3930597263930595,4.367488779253821,0.34502299375633094,SLC25A37,GWAS_Catalog_2023
1909,Hernia,0.2760473156248264,3.3930597263930595,4.367488779253821,0.34502299375633094,ZNF391,GWAS_Catalog_2023
1910,Schizophrenia (MTAG),0.28002009647924414,1.6681680856907444,2.1234009892054697,0.3498052095285218,"BTN3A1,BCL11A,BTN3A2",GWAS_Catalog_2023
1911,Glucose Homeostasis Traits,0.28235089653244827,1.9718227749708512,2.493576284940006,0.35216374235568304,"GCKR,SLC22A16",GWAS_Catalog_2023
1912,Diastolic Blood Pressure X Alcohol Consumption Interaction (2Df Test),0.28235089653244827,1.9718227749708512,2.493576284940006,0.35216374235568304,"MSRA,SH2B3",GWAS_Catalog_2023
1913,Venous Thromboembolism Adjusted For Sickle Cell Variant rs77121243-T,0.28235089653244827,1.9718227749708512,2.493576284940006,0.35216374235568304,"NUP205,RAD50",GWAS_Catalog_2023
1914,Estimated Glomerular Filtration Rate (Cystatin C),0.2918217607684129,1.4923872875092388,1.8380421985244855,0.3637861657227969,"GCKR,TFEB,APOE,PDE7A",GWAS_Catalog_2023
1915,Bipolar I Disorder,0.294225419472405,1.9100150602409638,2.3367297533746547,0.3661285610729215,"FADS2,MRPL33",GWAS_Catalog_2023
1916,Basal Cell Carcinoma (MTAG),0.294225419472405,1.9100150602409638,2.3367297533746547,0.3661285610729215,"FADS2,ATP11A",GWAS_Catalog_2023
1917,Pulmonary Function,0.294225419472405,1.9100150602409638,2.3367297533746547,0.3661285610729215,"ZKSCAN3,IL6R",GWAS_Catalog_2023
1918,Brain Morphology (min-P),0.29746957034264254,1.6093178565749722,1.9512067232473926,0.3661285610729215,"FADS2,MSRA,PRDM16",GWAS_Catalog_2023
1919,Waist-to-hip Ratio Adjusted For BMI (Joint Analysis Main Effects And Smoking Interaction),0.29907148597280975,3.0534534534534536,3.685740153685031,0.3661285610729215,KLF13,GWAS_Catalog_2023
1920,BMI In Smokers,0.29907148597280975,3.0534534534534536,3.685740153685031,0.3661285610729215,FTO,GWAS_Catalog_2023
1921,Glaucoma (Multi-Trait Analysis),0.29907148597280975,3.0534534534534536,3.685740153685031,0.3661285610729215,SH2B3,GWAS_Catalog_2023
1922,QT Dynamics During Exercise,0.29907148597280975,3.0534534534534536,3.685740153685031,0.3661285610729215,FADS2,GWAS_Catalog_2023
1923,Behcet's Disease,0.29907148597280975,3.0534534534534536,3.685740153685031,0.3661285610729215,NSMCE2,GWAS_Catalog_2023
1924,Abdominal Adipose Tissue Volumes (Adjusted For BMI And Height),0.29907148597280975,3.0534534534534536,3.685740153685031,0.3661285610729215,PPARG,GWAS_Catalog_2023
1925,Plasma Free Amino Acid Levels (Adjusted For Twenty Other PFAAs),0.29907148597280975,3.0534534534534536,3.685740153685031,0.3661285610729215,SPRYD4,GWAS_Catalog_2023
1926,Caffeine Consumption From Tea,0.29907148597280975,3.0534534534534536,3.685740153685031,0.3661285610729215,FTO,GWAS_Catalog_2023
1927,Gut Microbiota Alpha Diversity (Shannon Index),0.29907148597280975,3.0534534534534536,3.685740153685031,0.3661285610729215,BEND3,GWAS_Catalog_2023
1928,Post-traumatic Stress Disorder (Re-Experiencing Symptoms),0.29907148597280975,3.0534534534534536,3.685740153685031,0.3661285610729215,MSRA,GWAS_Catalog_2023
1929,Hernia (Any Subtypes),0.29907148597280975,3.0534534534534536,3.685740153685031,0.3661285610729215,APOB,GWAS_Catalog_2023
1930,Estradiol Levels,0.29907148597280975,3.0534534534534536,3.685740153685031,0.3661285610729215,GCKR,GWAS_Catalog_2023
1931,Nevus Count,0.29907148597280975,3.0534534534534536,3.685740153685031,0.3661285610729215,KITLG,GWAS_Catalog_2023
1932,Cerebrospinal T-tau Levels,0.29907148597280975,3.0534534534534536,3.685740153685031,0.3661285610729215,APOE,GWAS_Catalog_2023
1933,Homocysteine Levels,0.29907148597280975,3.0534534534534536,3.685740153685031,0.3661285610729215,SLC17A3,GWAS_Catalog_2023
1934,Quantitative Traits,0.29907148597280975,3.0534534534534536,3.685740153685031,0.3661285610729215,SPPL3,GWAS_Catalog_2023
1935,Blood Sugar Levels,0.29907148597280975,3.0534534534534536,3.685740153685031,0.3661285610729215,GCKR,GWAS_Catalog_2023
1936,Heart Rate Response To Exercise,0.29907148597280975,3.0534534534534536,3.685740153685031,0.3661285610729215,RP1L1,GWAS_Catalog_2023
1937,Glycated Hemoglobin HbA1c Levels,0.29907148597280975,3.0534534534534536,3.685740153685031,0.3661285610729215,MYO9B,GWAS_Catalog_2023
1938,Body Mass Index And Type 2 Diabetes (Pairwise),0.29907148597280975,3.0534534534534536,3.685740153685031,0.3661285610729215,PPARG,GWAS_Catalog_2023
1939,Neuroticism (MTAG),0.29907148597280975,3.0534534534534536,3.685740153685031,0.3661285610729215,VRK2,GWAS_Catalog_2023
1940,Response To Paliperidone In Schizophrenia (Multivariate),0.29907148597280975,3.0534534534534536,3.685740153685031,0.3661285610729215,COL26A1,GWAS_Catalog_2023
1941,DNA Methylation Hannum Age Acceleration,0.29907148597280975,3.0534534534534536,3.685740153685031,0.3661285610729215,TERT,GWAS_Catalog_2023
1942,BMI At 8 Months Old,0.29907148597280975,3.0534534534534536,3.685740153685031,0.3661285610729215,LEPR,GWAS_Catalog_2023
1943,BMI At 1 Year Old,0.29907148597280975,3.0534534534534536,3.685740153685031,0.3661285610729215,LEPR,GWAS_Catalog_2023
1944,Vaginal Microbiome MetaCyc Pathway (PWY-5005|biotin Biosynthesis II),0.29907148597280975,3.0534534534534536,3.685740153685031,0.3661285610729215,GK5,GWAS_Catalog_2023
1945,Vaginal Microbiome MetaCyc Pathway (PWY-5182|toluene Degradation II (Aerobic) (Via 4-Methylcatechol)),0.29907148597280975,3.0534534534534536,3.685740153685031,0.3661285610729215,KANSL1,GWAS_Catalog_2023
1946,Vaginal Microbiome MetaCyc Pathway (PWY-6397|mycolyl-arabinogalactan-peptidoglycan Complex Biosynthesis),0.29907148597280975,3.0534534534534536,3.685740153685031,0.3661285610729215,KLF13,GWAS_Catalog_2023
1947,Hepatocyte Growth Factor-Like Protein Levels,0.29907148597280975,3.0534534534534536,3.685740153685031,0.3661285610729215,RHOA,GWAS_Catalog_2023
1948,F-fish Liking (Derived Food-Liking Factor),0.29907148597280975,3.0534534534534536,3.685740153685031,0.3661285610729215,FTO,GWAS_Catalog_2023
1949,Water Consumption (Glasses Per Day) (UKB Data Field 1528),0.29907148597280975,3.0534534534534536,3.685740153685031,0.3661285610729215,PSD4,GWAS_Catalog_2023
1950,Highest Math Class Taken (MTAG),0.30226166997327597,1.1777445967754099,1.4091268676223823,0.36984427925960844,"CEP57,BRD3,MEF2C,BCL11A,UBXN2A,DENND4A,ZBTB38,AGAP1,BTN3A2,VRK2,SPPL3,SPRED2,MSRA,FLOT2,RBM23,FBXL5",GWAS_Catalog_2023
1951,AFP Levels,0.3060721256646625,1.8519532676159183,2.192591365950232,0.3733467230730534,"GCKR,UBE2L3",GWAS_Catalog_2023
1952,Keratinocyte Cancer (MTAG),0.3060721256646625,1.8519532676159183,2.192591365950232,0.3733467230730534,"TERT,ATP11A",GWAS_Catalog_2023
1953,Neuroticism Conditioned On Cognitive Performance (Multi-Trait Conditioning And Joint Analysis),0.3060721256646625,1.8519532676159183,2.192591365950232,0.3733467230730534,"VRK2,ARHGAP27",GWAS_Catalog_2023
1954,QRS Duration,0.30619672351044575,1.4565656565656566,1.7238855047178703,0.3733467230730534,"FADS2,MFHAS1,EPAS1,PRDM16",GWAS_Catalog_2023
1955,Central Corneal Thickness (MTAG),0.30619672351044575,1.4565656565656566,1.7238855047178703,0.3733467230730534,"COL26A1,CCND2,ZBTB38,WBP4",GWAS_Catalog_2023
1956,Medication Use For Hypertension (Number Of Purchases),0.30619672351044575,1.4565656565656566,1.7238855047178703,0.3733467230730534,"KLF13,HFE,PRDM16,MYO9B",GWAS_Catalog_2023
1957,Systolic Blood Pressure (Standard GWA),0.3062194203914357,1.5814147307011146,1.8715305985704085,0.3733467230730534,"ZNF827,PRDM16,DDB2",GWAS_Catalog_2023
1958,Coronary Artery Disease Or Factor XI Levels (Pleiotropy),0.31788081930037987,1.7973068745570517,2.0598552135069905,0.386870916472422,"ZSCAN26,APOE",GWAS_Catalog_2023
1959,Posterior Thigh Muscle Fat Infiltration Percentage,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.386870916472422,PPARG,GWAS_Catalog_2023
1960,Sleep Apnea (MTAG),0.3213655307830429,2.7755937755937756,3.1507876577626246,0.386870916472422,MACF1,GWAS_Catalog_2023
1961,Facial Morphology,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.386870916472422,EPAS1,GWAS_Catalog_2023
1962,Caudate Nucleus Volume,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.386870916472422,PRDM16,GWAS_Catalog_2023
1963,Allergic Sensitization,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.386870916472422,TLR1,GWAS_Catalog_2023
1964,Response To Statins (LDL Cholesterol Change),0.3213655307830429,2.7755937755937756,3.1507876577626246,0.386870916472422,APOE,GWAS_Catalog_2023
1965,Ischemic Stroke Or Von Willebrand Factor Levels (Pleiotropy),0.3213655307830429,2.7755937755937756,3.1507876577626246,0.386870916472422,SH2B3,GWAS_Catalog_2023
1966,Percent Mammographic Density,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.386870916472422,PPARG,GWAS_Catalog_2023
1967,Factor VII Activity,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.386870916472422,GCKR,GWAS_Catalog_2023
1968,Lymphocytic Leukemia,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.386870916472422,ACOXL,GWAS_Catalog_2023
1969,"Aging Traits (Healthspan, Parental Lifespan Or Longevity) (Multivariate Analysis)",0.3213655307830429,2.7755937755937756,3.1507876577626246,0.386870916472422,APOE,GWAS_Catalog_2023
1970,Plasma Omega-6 Polyunsaturated Fatty Acid Levels (Linoleic Acid),0.3213655307830429,2.7755937755937756,3.1507876577626246,0.386870916472422,FADS2,GWAS_Catalog_2023
1971,HIV-1 Viral Setpoint,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.386870916472422,ZFP90,GWAS_Catalog_2023
1972,QRS Complex (12-Leadsum),0.3213655307830429,2.7755937755937756,3.1507876577626246,0.386870916472422,MAPT,GWAS_Catalog_2023
1973,Chloride Levels,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.386870916472422,GCKR,GWAS_Catalog_2023
1974,Left Ventricle Wall Thickness,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.386870916472422,TFEB,GWAS_Catalog_2023
1975,Left?right Brain Asymmetry,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.386870916472422,MAPT,GWAS_Catalog_2023
1976,Total Cerebellar Volume (Excluding Crus I Vermis),0.3213655307830429,2.7755937755937756,3.1507876577626246,0.386870916472422,HFE,GWAS_Catalog_2023
1977,Human Milk Oligosaccharide Concentration (lacto-N-fucopentaose III) In Non-Secretors,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.386870916472422,NCOA4,GWAS_Catalog_2023
1978,Urinary Uromodulin Levels (Raw),0.3213655307830429,2.7755937755937756,3.1507876577626246,0.386870916472422,MYO9B,GWAS_Catalog_2023
1979,Executive Function (Longitudinal),0.3213655307830429,2.7755937755937756,3.1507876577626246,0.386870916472422,ZBTB38,GWAS_Catalog_2023
1980,Shellfish Liking,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.386870916472422,FTO,GWAS_Catalog_2023
1981,F-seafood Liking (Derived Food-Liking Factor),0.3213655307830429,2.7755937755937756,3.1507876577626246,0.386870916472422,APOE,GWAS_Catalog_2023
1982,Verbal Learning,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.386870916472422,TOMM40,GWAS_Catalog_2023
1983,Height (Weighted GWA),0.32374458038296294,1.5283987915407855,1.7237287779939032,0.38934202056136574,"THRB,ZBTB38,MYO9B",GWAS_Catalog_2023
1984,Neutrophil-to-lymphocyte Ratio,0.32374458038296294,1.5283987915407855,1.7237287779939032,0.38934202056136574,"RCL1,ELF1,AK9",GWAS_Catalog_2023
1985,Cervical Cancer,0.32964197679430984,1.7457831325301205,1.9373795706862602,0.396035124184906,"ZKSCAN3,JARID2",GWAS_Catalog_2023
1986,Low Tan Response,0.32964197679430984,1.7457831325301205,1.9373795706862602,0.396035124184906,"ATP11A,TM9SF4",GWAS_Catalog_2023
1987,Peripheral Arterial Disease (Traffic-Related Air Pollution Interaction),0.3325104198689481,1.503194492595711,1.6551435270836612,0.3992802525451989,"MACF1,AHI1,BMP8A",GWAS_Catalog_2023
1988,Vertex-wise Cortical Thickness,0.34062003150356546,1.1821519743631526,1.2731631360174318,0.4052921002691195,"MACF1,MSRA,FADS2,MEF2C,MAST2,DOCK7,BEND3,AGAP1,APOE,VRK2,THBS3",GWAS_Catalog_2023
1989,Walking Pace,0.3413467144841261,1.6971218206157965,1.8241625223966422,0.4052921002691195,"FTO,MAST3",GWAS_Catalog_2023
1990,Vitiligo,0.3413467144841261,1.6971218206157965,1.8241625223966422,0.4052921002691195,"FADS2,PTPRC",GWAS_Catalog_2023
1991,Predicted Visceral Adipose Tissue,0.34240248525329164,1.3740551583248213,1.4726688661323915,0.4052921002691195,"FTO,MAST2,BMP8A,PPARG",GWAS_Catalog_2023
1992,Total Cholesterol Change In Response To Fenofibrate In Statin-Treated Type 2 Diabetes,0.3429525358102901,2.544044044044044,2.7225423684214074,0.4052921002691195,SCGN,GWAS_Catalog_2023
1993,Alopecia Areata,0.3429525358102901,2.544044044044044,2.7225423684214074,0.4052921002691195,ACOXL,GWAS_Catalog_2023
1994,Eudaimonic Well-Being,0.3429525358102901,2.544044044044044,2.7225423684214074,0.4052921002691195,SIRT3,GWAS_Catalog_2023
1995,Gamma Glutamyl Transferase Levels In Low Alcohol Consumption,0.3429525358102901,2.544044044044044,2.7225423684214074,0.4052921002691195,ZNF827,GWAS_Catalog_2023
1996,Aspartate Aminotransferase Levels In Excessive Alcohol Consumption,0.3429525358102901,2.544044044044044,2.7225423684214074,0.4052921002691195,PPP2R2A,GWAS_Catalog_2023
1997,Peripheral Artery Disease,0.3429525358102901,2.544044044044044,2.7225423684214074,0.4052921002691195,LPL,GWAS_Catalog_2023
1998,Primary Biliary Cirrhosis,0.3429525358102901,2.544044044044044,2.7225423684214074,0.4052921002691195,MAPT,GWAS_Catalog_2023
1999,COVID-19 (Critical Illness Vs Population),0.3429525358102901,2.544044044044044,2.7225423684214074,0.4052921002691195,THBS3,GWAS_Catalog_2023
2000,Response To Serotonin-Norepinephrine Reuptake Inhibitors (Responders Vs Non-Responders),0.3429525358102901,2.544044044044044,2.7225423684214074,0.4052921002691195,GK5,GWAS_Catalog_2023
2001,Bitter Non-Alcoholic Beverage Consumption,0.3429525358102901,2.544044044044044,2.7225423684214074,0.4052921002691195,ITSN1,GWAS_Catalog_2023
2002,Glycemic Traits (Pleiotropy),0.3429525358102901,2.544044044044044,2.7225423684214074,0.4052921002691195,GCKR,GWAS_Catalog_2023
2003,Extremely High Intelligence,0.3429525358102901,2.544044044044044,2.7225423684214074,0.4052921002691195,RHOA,GWAS_Catalog_2023
2004,Bitter Beverage Consumption,0.3429525358102901,2.544044044044044,2.7225423684214074,0.4052921002691195,GCKR,GWAS_Catalog_2023
2005,Sleep Duration (Short Sleep),0.3429525358102901,2.544044044044044,2.7225423684214074,0.4052921002691195,USP49,GWAS_Catalog_2023
2006,Resistant Hypertension,0.3429525358102901,2.544044044044044,2.7225423684214074,0.4052921002691195,THBS3,GWAS_Catalog_2023
2007,Cerebrospinal P-tau181p Levels,0.3429525358102901,2.544044044044044,2.7225423684214074,0.4052921002691195,APOE,GWAS_Catalog_2023
2008,IgA Nephropathy,0.3429525358102901,2.544044044044044,2.7225423684214074,0.4052921002691195,ACOXL,GWAS_Catalog_2023
2009,Periodontitis (CDC/AAP),0.3429525358102901,2.544044044044044,2.7225423684214074,0.4052921002691195,GPN1,GWAS_Catalog_2023
2010,Immune Reponse To Smallpox (Secreted IFN-alpha),0.3429525358102901,2.544044044044044,2.7225423684214074,0.4052921002691195,ZNF827,GWAS_Catalog_2023
2011,Ankle Injury,0.3429525358102901,2.544044044044044,2.7225423684214074,0.4052921002691195,TF,GWAS_Catalog_2023
2012,Sjögren's Syndrome,0.3429525358102901,2.544044044044044,2.7225423684214074,0.4052921002691195,BLK,GWAS_Catalog_2023
2013,Academic Attainment (Maths),0.3429525358102901,2.544044044044044,2.7225423684214074,0.4052921002691195,PRDM16,GWAS_Catalog_2023
2014,Oropharynx Cancer And Human Papilloma Virus 16 Negative Oropharyngeal Cancer,0.3429525358102901,2.544044044044044,2.7225423684214074,0.4052921002691195,FTO,GWAS_Catalog_2023
2015,Post-traumatic Stress Disorder (Mental Health Questionnaire Or Predicted),0.3429525358102901,2.544044044044044,2.7225423684214074,0.4052921002691195,MAPT,GWAS_Catalog_2023
2016,Bronchopulmonary Dysplasia,0.3429525358102901,2.544044044044044,2.7225423684214074,0.4052921002691195,TNK2,GWAS_Catalog_2023
2017,Vaginal Microbiome MetaCyc Pathway (KDO-NAGLIPASYN-PWY|superpathway Of (Kdo)2-lipid A Biosynthesis),0.3429525358102901,2.544044044044044,2.7225423684214074,0.4052921002691195,TDP2,GWAS_Catalog_2023
2018,Cholesterol To Total Lipids Ratio In Chylomicrons And Extremely Large VLDL,0.3429525358102901,2.544044044044044,2.7225423684214074,0.4052921002691195,MAST3,GWAS_Catalog_2023
2019,Skin Reflectance,0.3429525358102901,2.544044044044044,2.7225423684214074,0.4052921002691195,ATP11A,GWAS_Catalog_2023
2020,BMI (Adjusted For Smoking Behaviour),0.3529867577805054,1.6510908498860306,1.7193217435712793,0.4150943341864396,"FTO,TOMM40",GWAS_Catalog_2023
2021,Body Mass Index (Joint Analysis Main Effects And Smoking Interaction),0.3529867577805054,1.6510908498860306,1.7193217435712793,0.4150943341864396,"FTO,TOMM40",GWAS_Catalog_2023
2022,Post Bronchodilator FEV1/FVC Ratio In COPD,0.3529867577805054,1.6510908498860306,1.7193217435712793,0.4150943341864396,"TOX2,PRDM16",GWAS_Catalog_2023
2023,Spatial QRS-T Angle,0.3529867577805054,1.6510908498860306,1.7193217435712793,0.4150943341864396,"KANSL1,BMP8A",GWAS_Catalog_2023
2024,Cortical Thickness (MOSTest),0.3529867577805054,1.6510908498860306,1.7193217435712793,0.4150943341864396,"MSRA,COL26A1",GWAS_Catalog_2023
2025,Hyperopia,0.3529867577805054,1.6510908498860306,1.7193217435712793,0.4150943341864396,"ZBTB38,APOE",GWAS_Catalog_2023
2026,White Blood Cell Count (Basophil),0.3529867577805054,1.6510908498860306,1.7193217435712793,0.4150943341864396,"CD164,DSTYK",GWAS_Catalog_2023
2027,PR Interval In Tripanosoma Cruzi Seropositivity,0.3529867577805054,1.6510908498860306,1.7193217435712793,0.4150943341864396,"COL26A1,PCOLCE2",GWAS_Catalog_2023
2028,Predicted Developmental Stuttering,0.3529867577805054,1.6510908498860306,1.7193217435712793,0.4150943341864396,"TOX2,MAPT",GWAS_Catalog_2023
2029,"COVID-19 (Hospitalized Vs Tested, Not Hospitalized)",0.3529867577805054,1.6510908498860306,1.7193217435712793,0.4150943341864396,"CCND3,SNX13",GWAS_Catalog_2023
2030,Household Income (MTAG),0.35693442142411325,1.3435897435897435,1.3841704634990573,0.41952981749651935,"MEF2C,BCL11A,MAPT,RHOA",GWAS_Catalog_2023
2031,Macular Thickness,0.358767221010209,1.432307401812689,1.4682318345845138,0.421476410305445,"KANSL1,DLG5,TMEM72",GWAS_Catalog_2023
2032,Corneal Resistance Factor (MTAG),0.3590989157463551,1.2846415161809404,1.315675111442555,0.4216584709501984,"COL26A1,ZBTB38,WBP4,NPHP3,RHOA",GWAS_Catalog_2023
2033,Two-hour Glucose,0.36385485898912845,2.348117348117348,2.373947178787745,0.4218453321419147,GCKR,GWAS_Catalog_2023
2034,Chronic Obstructive Pulmonary Disease X Ever Smoker Interaction (Main Effect),0.36385485898912845,2.348117348117348,2.373947178787745,0.4218453321419147,ZBTB38,GWAS_Catalog_2023
2035,Automobile Speeding Propensity,0.36385485898912845,2.348117348117348,2.373947178787745,0.4218453321419147,MAPT,GWAS_Catalog_2023
2036,Red Vs. Brown/Black Hair Color,0.36385485898912845,2.348117348117348,2.373947178787745,0.4218453321419147,FTO,GWAS_Catalog_2023
2037,Chronic Obstructive Pulmonary Disease In Never Smokers,0.36385485898912845,2.348117348117348,2.373947178787745,0.4218453321419147,ZBTB38,GWAS_Catalog_2023
2038,Birth Length (MTAG),0.36385485898912845,2.348117348117348,2.373947178787745,0.4218453321419147,ZBTB38,GWAS_Catalog_2023
2039,Kidney Stones,0.36385485898912845,2.348117348117348,2.373947178787745,0.4218453321419147,GCKR,GWAS_Catalog_2023
2040,Adipose Morphology,0.36385485898912845,2.348117348117348,2.373947178787745,0.4218453321419147,PRDM16,GWAS_Catalog_2023
2041,Neuritic Plaque,0.36385485898912845,2.348117348117348,2.373947178787745,0.4218453321419147,APOE,GWAS_Catalog_2023
2042,Squamous Cell Carcinoma (MTAG),0.36385485898912845,2.348117348117348,2.373947178787745,0.4218453321419147,ATP11A,GWAS_Catalog_2023
2043,Carotid Intima Media Thickness X Smoking Interaction,0.36385485898912845,2.348117348117348,2.373947178787745,0.4218453321419147,THRB,GWAS_Catalog_2023
2044,Major Depressive Disorder In Trauma-Unexposed Individuals,0.36385485898912845,2.348117348117348,2.373947178787745,0.4218453321419147,THRB,GWAS_Catalog_2023
2045,Migraine And/Or Diastolic Blood Pressure,0.36385485898912845,2.348117348117348,2.373947178787745,0.4218453321419147,PRDM16,GWAS_Catalog_2023
2046,Mammographic Density (Dense Area),0.36385485898912845,2.348117348117348,2.373947178787745,0.4218453321419147,PPARG,GWAS_Catalog_2023
2047,Male Puberty Timing (Early Vs. Average Onset Facial Hair),0.36385485898912845,2.348117348117348,2.373947178787745,0.4218453321419147,KANSL1,GWAS_Catalog_2023
2048,Chronic Obstructive Pulmonary Disease Or High Blood Pressure (Pleiotropy),0.36385485898912845,2.348117348117348,2.373947178787745,0.4218453321419147,HDAC7,GWAS_Catalog_2023
2049,Hepatitis B,0.36385485898912845,2.348117348117348,2.373947178787745,0.4218453321419147,UBE2L3,GWAS_Catalog_2023
2050,Iris Color (A* Coordinate),0.36385485898912845,2.348117348117348,2.373947178787745,0.4218453321419147,HK1,GWAS_Catalog_2023
2051,Cognitive Traits (MTAG),0.36385485898912845,2.348117348117348,2.373947178787745,0.4218453321419147,RHOA,GWAS_Catalog_2023
2052,Cardio-cerebrovascular Disease In Diabetes Mellitus,0.36385485898912845,2.348117348117348,2.373947178787745,0.4218453321419147,CRLF3,GWAS_Catalog_2023
2053,Motion Sickness,0.36385485898912845,2.348117348117348,2.373947178787745,0.4218453321419147,PRDM16,GWAS_Catalog_2023
2054,Medication Use (Salicylic Acid And Derivatives),0.36385485898912845,2.348117348117348,2.373947178787745,0.4218453321419147,APOE,GWAS_Catalog_2023
2055,Vaginal Microbiome MetaCyc Pathway (PWY-6562|norspermidine Biosynthesis),0.36385485898912845,2.348117348117348,2.373947178787745,0.4218453321419147,CCND3,GWAS_Catalog_2023
2056,Uterine Leiomyoma Or Breast Cancer (Pleiotropy),0.36385485898912845,2.348117348117348,2.373947178787745,0.4218453321419147,TERT,GWAS_Catalog_2023
2057,Pulse Rate,0.36385485898912845,2.348117348117348,2.373947178787745,0.4218453321419147,FADS2,GWAS_Catalog_2023
2058,Facial Morphology (Multitrait Analysis),0.36385485898912845,2.348117348117348,2.373947178787745,0.4218453321419147,PRDM16,GWAS_Catalog_2023
2059,Waist-to-hip Ratio Adjusted For Body Mass Index,0.3645544116684055,1.6074825618262525,1.62207763724789,0.42245110550792403,"KLF13,CPEB4",GWAS_Catalog_2023
2060,Fat-free Mass,0.3714634091495741,1.314434669273379,1.3016911128521154,0.4300396381518116,"FTO,CCND3,GCKR,ZBTB38",GWAS_Catalog_2023
2061,Alzheimer's Disease,0.3714634091495741,1.314434669273379,1.3016911128521154,0.4300396381518116,"SLC4A1AP,TOMM40,APOE,CTSB",GWAS_Catalog_2023
2062,Lipoprotein (A) Levels,0.3760425324506758,1.5661105962310782,1.5317392042016418,0.4349187990437773,"SPRYD4,APOE",GWAS_Catalog_2023
2063,Ascending Aorta Minimum Area,0.3760425324506758,1.5661105962310782,1.5317392042016418,0.4349187990437773,"BLK,ZNF827",GWAS_Catalog_2023
2064,Age When Finished Full-Time Education (Standard GWA),0.3787206076273476,1.3003223726627982,1.2625564972739005,0.43780395823587764,"AKAP10,BCL11A,AGAP1,PPP2R2A",GWAS_Catalog_2023
2065,Gestational Age At Birth (Child Effect),0.38409415344077596,2.18018018018018,2.0861437006994428,0.44102437445124704,FADS2,GWAS_Catalog_2023
2066,Fibromuscular Dysplasia,0.38409415344077596,2.18018018018018,2.0861437006994428,0.44102437445124704,ZNF827,GWAS_Catalog_2023
2067,Gastric Cancer,0.38409415344077596,2.18018018018018,2.0861437006994428,0.44102437445124704,THBS3,GWAS_Catalog_2023
2068,Erosive Tooth Wear (Severe Vs Non-Severe),0.38409415344077596,2.18018018018018,2.0861437006994428,0.44102437445124704,PSD4,GWAS_Catalog_2023
2069,Waist-to-hip Ratio Adjusted For BMI In Active Individuals,0.38409415344077596,2.18018018018018,2.0861437006994428,0.44102437445124704,KLF13,GWAS_Catalog_2023
2070,Trans Fatty Acid Levels,0.38409415344077596,2.18018018018018,2.0861437006994428,0.44102437445124704,FADS2,GWAS_Catalog_2023
2071,Urate Levels In Lean Individuals,0.38409415344077596,2.18018018018018,2.0861437006994428,0.44102437445124704,SLC17A1,GWAS_Catalog_2023
2072,Number Of Common Colds,0.38409415344077596,2.18018018018018,2.0861437006994428,0.44102437445124704,SLC22A16,GWAS_Catalog_2023
2073,Rubella,0.38409415344077596,2.18018018018018,2.0861437006994428,0.44102437445124704,THRB,GWAS_Catalog_2023
2074,Allergy,0.38409415344077596,2.18018018018018,2.0861437006994428,0.44102437445124704,TLR1,GWAS_Catalog_2023
2075,Joint Mobility (Beighton Score),0.38409415344077596,2.18018018018018,2.0861437006994428,0.44102437445124704,MSRA,GWAS_Catalog_2023
2076,Time-dependent Creatinine Clearance Change Response To Tenofovir Treatment In HIV Infection (Time And Treatment Arm Interaction),0.38409415344077596,2.18018018018018,2.0861437006994428,0.44102437445124704,HSPA8,GWAS_Catalog_2023
2077,Added Salt Consumption,0.38409415344077596,2.18018018018018,2.0861437006994428,0.44102437445124704,ZFP90,GWAS_Catalog_2023
2078,COVID-19 Or Hypertension (Pleiotropy),0.38409415344077596,2.18018018018018,2.0861437006994428,0.44102437445124704,ICAM5,GWAS_Catalog_2023
2079,Alzheimer's Disease (Late Onset),0.38744450052350976,1.5268072289156627,1.4476921471045792,0.44422997513171275,"TOMM40,APOE",GWAS_Catalog_2023
2080,Waist Circumference Adjusted For BMI (Joint Analysis Main Effects And Smoking Interaction),0.38744450052350976,1.5268072289156627,1.4476921471045792,0.44422997513171275,"ZBTB38,CPEB4",GWAS_Catalog_2023
2081,Opioid Addiction,0.38744450052350976,1.5268072289156627,1.4476921471045792,0.44422997513171275,"FTO,MEF2C",GWAS_Catalog_2023
2082,Drinks Per Week,0.3898569390381802,1.1412843191450157,1.0750617874312183,0.44678129517055615,"FTO,GCKR,KANSL1,DLG5,KIT,PRDM16,ARIH2,PPP2R2A,MAPT,MRPL33",GWAS_Catalog_2023
2083,Lung Function (FEV1/FVC),0.39378295482842174,1.1098445595854922,1.0343256277385096,0.4510639127319319,"FTO,BCL11A,PABPC4,BMP8A,THBS3,MRPL33,ASXL1,ACOXL,SERTAD2,KIAA0586,PRDM16,SERPING1,ARFIP1,CRLF3",GWAS_Catalog_2023
2084,Sunburns,0.39875419464729916,1.4894210990302674,1.3693888097140368,0.45632014792731695,"USP49,ATP11A",GWAS_Catalog_2023
2085,Ascending Aorta Maximum Area,0.39875419464729916,1.4894210990302674,1.3693888097140368,0.45632014792731695,"MFHAS1,ZNF827",GWAS_Catalog_2023
2086,Waist-to-hip Ratio Adjusted For BMI (Joint Analysis For Main Effect And Physical Activity Interaction),0.4036913894708047,2.0346346346346347,1.8456263964772202,0.4591075573295233,KLF13,GWAS_Catalog_2023
2087,Optic Cup Area,0.4036913894708047,2.0346346346346347,1.8456263964772202,0.4591075573295233,DUSP1,GWAS_Catalog_2023
2088,Age At Loss Of Ambulation In Duchenne Muscular Dystrophy,0.4036913894708047,2.0346346346346347,1.8456263964772202,0.4591075573295233,PTPN1,GWAS_Catalog_2023
2089,Interleukin-6 Levels,0.4036913894708047,2.0346346346346347,1.8456263964772202,0.4591075573295233,IL6R,GWAS_Catalog_2023
2090,Time To Colon Cancer Recurrence,0.4036913894708047,2.0346346346346347,1.8456263964772202,0.4591075573295233,MACF1,GWAS_Catalog_2023
2091,Dietary Macronutrient Intake (Multi-Trait Analysis),0.4036913894708047,2.0346346346346347,1.8456263964772202,0.4591075573295233,FTO,GWAS_Catalog_2023
2092,Autoimmune Traits (Pleiotropy),0.4036913894708047,2.0346346346346347,1.8456263964772202,0.4591075573295233,UBE2L3,GWAS_Catalog_2023
2093,Diastolic Blood Pressure X Smoking Status (Ever Vs Never) Interaction (2Df Test),0.4036913894708047,2.0346346346346347,1.8456263964772202,0.4591075573295233,FTO,GWAS_Catalog_2023
2094,Selective IgA Deficiency,0.4036913894708047,2.0346346346346347,1.8456263964772202,0.4591075573295233,AHI1,GWAS_Catalog_2023
2095,Self-reported Allergy,0.4036913894708047,2.0346346346346347,1.8456263964772202,0.4591075573295233,TLR1,GWAS_Catalog_2023
2096,Strep Throat,0.4036913894708047,2.0346346346346347,1.8456263964772202,0.4591075573295233,ALDH5A1,GWAS_Catalog_2023
2097,Type Ii Diabetes,0.4036913894708047,2.0346346346346347,1.8456263964772202,0.4591075573295233,PPARG,GWAS_Catalog_2023
2098,Ratio Of Omega-6 Fatty Acids To Omega-3 Fatty Acids,0.4036913894708047,2.0346346346346347,1.8456263964772202,0.4591075573295233,GCKR,GWAS_Catalog_2023
2099,Cortical Surface Area,0.406364136105394,1.1044825199030806,0.9945927322514608,0.4619270265590615,"MACF1,MEF2C,ZAN,SNX13,AGAP1,MYO9B,VRK2,UBE2L3,MSRA,AKAP10,TFAP4,KIT,BEND3",GWAS_Catalog_2023
2100,Dyslexia,0.40996596694232024,1.4538152610441768,1.29633963505076,0.46537233501813724,"MAPT,SH2B3",GWAS_Catalog_2023
2101,RS-6-hydroxywarfarin Levels,0.40996596694232024,1.4538152610441768,1.29633963505076,0.46537233501813724,"UNC119B,ITSN1",GWAS_Catalog_2023
2102,Male-pattern Baldness,0.41017519721003465,1.1563104388792462,1.0304702148266256,0.46537233501813724,"FADS2,KANSL1,BCL11A,SMOX,ZBTB38,MAPT,MRPL33",GWAS_Catalog_2023
2103,Reaction Time,0.41017519721003465,1.1563104388792462,1.0304702148266256,0.46537233501813724,"KANSL1,FAXDC2,PPP2R2A,MAPT,JARID2,SH2B3,MRPL33",GWAS_Catalog_2023
2104,Blond Vs. Brown/Black Hair Color,0.41928118129141106,1.2902004170035317,1.1214596292787138,0.47547761338465155,"KITLG,ZBTB38,EPHB4",GWAS_Catalog_2023
2105,Waist Circumference Adjusted For BMI (Adjusted For Smoking Behaviour),0.4210746192897417,1.4198655085458112,1.228105881872269,0.47569960664058614,"ZBTB38,CPEB4",GWAS_Catalog_2023
2106,Subcutaneous Adipose Tissue,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.47569960664058614,FTO,GWAS_Catalog_2023
2107,Cryptic Phenotype That Captures Autosomal Dominant Polycystic Kidney Disease Severity,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.47569960664058614,SH2B3,GWAS_Catalog_2023
2108,Leisure Sedentary Behaviour (Computer Use),0.4226668759757094,1.9072822822822824,1.6424960710005596,0.47569960664058614,MEF2C,GWAS_Catalog_2023
2109,Cervical Cancer (MTAG),0.4226668759757094,1.9072822822822824,1.6424960710005596,0.47569960664058614,ZKSCAN3,GWAS_Catalog_2023
2110,Creatine Kinase Levels,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.47569960664058614,SNX13,GWAS_Catalog_2023
2111,HDL Cholesterol Levels In HIV Infection,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.47569960664058614,APOE,GWAS_Catalog_2023
2112,Osteoarthritis Of The Hip Or Knee,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.47569960664058614,FTO,GWAS_Catalog_2023
2113,Tyrosine Levels,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.47569960664058614,SPRYD4,GWAS_Catalog_2023
2114,Psoriasis Vulgaris,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.47569960664058614,UBE2L3,GWAS_Catalog_2023
2115,Worry Too Long After An Embarrassing Experience,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.47569960664058614,MAPT,GWAS_Catalog_2023
2116,Sitting Height Ratio,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.47569960664058614,UBXN2A,GWAS_Catalog_2023
2117,Mononucleosis,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.47569960664058614,HDAC7,GWAS_Catalog_2023
2118,Progression Free Survival In Serous Epithelial Ovarian Cancer Treated With Carboplatin And Paclitaxel,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.47569960664058614,PRDM16,GWAS_Catalog_2023
2119,Ratio Of Linoleic Acid To Total Fatty Acids,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.47569960664058614,GCKR,GWAS_Catalog_2023
2120,Fresh Fruit Consumption,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.47569960664058614,LEPR,GWAS_Catalog_2023
2121,Hair Color,0.4258525776894113,1.1375170798360337,0.971055167251405,0.4790590525068059,"FTO,ASXL1,DSTYK,THRB,AXL,ZBTB38,DDB2",GWAS_Catalog_2023
2122,Refractive Error,0.4288608962183504,1.1211797152023415,0.949216157166319,0.4822158804792573,"MYO1D,GCKR,THRB,ZBTB38,TMEM72,APOE,MAPT,SPPL3",GWAS_Catalog_2023
2123,Alzheimer's Disease Or Family History Of Alzheimer's Disease,0.4320753805020225,1.387458926615553,1.1642933925595615,0.4853728144434208,"TOMM40,APOE",GWAS_Catalog_2023
2124,Lifetime Smoking,0.4320753805020225,1.387458926615553,1.1642933925595615,0.4853728144434208,"MSRA,MAPT",GWAS_Catalog_2023
2125,Spherical Equivalent,0.4363003240310136,1.1973856209150326,0.9931409174573821,0.4898882697119993,"THRB,ZBTB38,APOE,ARHGAP27",GWAS_Catalog_2023
2126,Diabetes (Standard GWA),0.4410402814653663,1.7949125596184419,1.4693496440315028,0.4924296263810782,FTO,GWAS_Catalog_2023
2127,Insomnia Symptoms (Never/Rarely Vs. Sometimes/Usually),0.4410402814653663,1.7949125596184419,1.4693496440315028,0.4924296263810782,VRK2,GWAS_Catalog_2023
2128,Obesity (Extreme),0.4410402814653663,1.7949125596184419,1.4693496440315028,0.4924296263810782,FTO,GWAS_Catalog_2023
2129,Asthma (Moderate Or Severe),0.4410402814653663,1.7949125596184419,1.4693496440315028,0.4924296263810782,TLR1,GWAS_Catalog_2023
2130,Graves' Disease,0.4410402814653663,1.7949125596184419,1.4693496440315028,0.4924296263810782,ALDH2,GWAS_Catalog_2023
2131,Deep White Matter Hyperintensities,0.4410402814653663,1.7949125596184419,1.4693496440315028,0.4924296263810782,KLF13,GWAS_Catalog_2023
2132,Ischemic Stroke (Cardioembolic),0.4410402814653663,1.7949125596184419,1.4693496440315028,0.4924296263810782,HK1,GWAS_Catalog_2023
2133,Microalbuminuria,0.4410402814653663,1.7949125596184419,1.4693496440315028,0.4924296263810782,ACOXL,GWAS_Catalog_2023
2134,QRS Duration In Tripanosoma Cruzi Seropositivity,0.4410402814653663,1.7949125596184419,1.4693496440315028,0.4924296263810782,PLS1,GWAS_Catalog_2023
2135,Plasma Factor VII Activating Protease Levels,0.4410402814653663,1.7949125596184419,1.4693496440315028,0.4924296263810782,HELZ2,GWAS_Catalog_2023
2136,Urate Levels In Obese Individuals,0.4410402814653663,1.7949125596184419,1.4693496440315028,0.4924296263810782,GCKR,GWAS_Catalog_2023
2137,Subjective Well-Being (MTAG),0.4410402814653663,1.7949125596184419,1.4693496440315028,0.4924296263810782,VRK2,GWAS_Catalog_2023
2138,Major Depressive Disorder,0.4412725850511803,1.15662706088238,0.9462279096854319,0.4924585537568364,"MSRA,GMPR,BTN3A2,VRK2,SPPL3",GWAS_Catalog_2023
2139,Haemorrhoidal Disease,0.44296388473656995,1.3564926372155288,1.1045472398168368,0.49342288934708495,"SERTAD2,HDAC7",GWAS_Catalog_2023
2140,Coronary Artery Disease Or Von Willebrand Factor Levels (Pleiotropy),0.44296388473656995,1.3564926372155288,1.1045472398168368,0.49342288934708495,"ZSCAN26,APOE",GWAS_Catalog_2023
2141,Thyroid Stimulating Hormone Levels,0.44296388473656995,1.3564926372155288,1.1045472398168368,0.49342288934708495,"GTF2A1,SH2B3",GWAS_Catalog_2023
2142,Atrial Fibrillation/Atrial Flutter,0.44296388473656995,1.3564926372155288,1.1045472398168368,0.49342288934708495,"THRB,ALDH2",GWAS_Catalog_2023
2143,Age At First Sexual Intercourse,0.4434062248944468,1.185642836128273,0.9642464959882483,0.4936851388698787,"BLK,MFHAS1,VRK2,RHOA",GWAS_Catalog_2023
2144,Schizophrenia,0.445358722541865,1.0558845598845599,0.8540788382311348,0.4956277574556389,"GTF2A1,MEF2C,THRB,BTN3A1,BCL11A,GALNT2,HFE,ITSN1,AGAP1,VRK2,QKI,MRPL33,C12ORF43,MSRA,SLC7A6,KANSL1,KIT,ZKSCAN4,SLC17A3",GWAS_Catalog_2023
2145,Celiac Disease,0.4537361503852823,1.3268727082242011,1.048547114631643,0.5047153635521135,"SH2B3,UBE2L3",GWAS_Catalog_2023
2146,LDL (Weighted GWA),0.4588306540708931,1.6950283616950284,1.320552665492241,0.5080138935559865,APOB,GWAS_Catalog_2023
2147,Anorexia Nervosa,0.4588306540708931,1.6950283616950284,1.320552665492241,0.5080138935559865,MYO1D,GWAS_Catalog_2023
2148,Schizophrenia Vs Autism Spectrum Disorder (Ordinary Least Squares (OLS)),0.4588306540708931,1.6950283616950284,1.320552665492241,0.5080138935559865,MSRA,GWAS_Catalog_2023
2149,Venous Thromboembolism Or Factor VII Levels (Pleiotropy),0.4588306540708931,1.6950283616950284,1.320552665492241,0.5080138935559865,GCKR,GWAS_Catalog_2023
2150,Coffee Consumption (Cups Per Day),0.4588306540708931,1.6950283616950284,1.320552665492241,0.5080138935559865,GCKR,GWAS_Catalog_2023
2151,Age-related Macular Degeneration,0.4588306540708931,1.6950283616950284,1.320552665492241,0.5080138935559865,TOMM40,GWAS_Catalog_2023
2152,Iris Color (B* Coordinate),0.4588306540708931,1.6950283616950284,1.320552665492241,0.5080138935559865,HK1,GWAS_Catalog_2023
2153,Skin Reflectance (Melanin Index),0.4588306540708931,1.6950283616950284,1.320552665492241,0.5080138935559865,ACOXL,GWAS_Catalog_2023
2154,Response To Paliperidone In Schizophrenia (Positive Marder Score),0.4588306540708931,1.6950283616950284,1.320552665492241,0.5080138935559865,PLD1,GWAS_Catalog_2023
2155,Global Cognition (Mini Mental State Examination),0.4588306540708931,1.6950283616950284,1.320552665492241,0.5080138935559865,PPARG,GWAS_Catalog_2023
2156,Basal Cell Carcinoma,0.4643885605952292,1.2985132017431429,0.9960033364394497,0.5139290842208798,"TERT,ATP11A",GWAS_Catalog_2023
2157,Stimulated Adipocyte Lipolysis,0.47605644095165617,1.605658289868816,1.191749862810084,0.5258660500512276,AGAP1,GWAS_Catalog_2023
2158,Heart Rate,0.47605644095165617,1.605658289868816,1.191749862810084,0.5258660500512276,FADS2,GWAS_Catalog_2023
2159,Arterial Stiffness Index,0.47605644095165617,1.605658289868816,1.191749862810084,0.5258660500512276,PPARG,GWAS_Catalog_2023
2160,Coronary Artery Calcified Atherosclerotic Plaque Score In Type 2 Diabetes,0.47605644095165617,1.605658289868816,1.191749862810084,0.5258660500512276,TLR1,GWAS_Catalog_2023
2161,Balding Type 1,0.4784971650487183,1.1301907968574636,0.8330692791460639,0.5283175547460629,"FADS2,ZBTB38,DLG5,MAPT",GWAS_Catalog_2023
2162,Resistance To COVID-19 Infection (Exposed Negative Vs Positive),0.48187951506881194,1.066145149623597,0.7783511699035688,0.5318059773146093,"FIG4,MSRA,UBXN2A,ZNF391,TMBIM1,AGAP1,ARHGAP27,GPN1",GWAS_Catalog_2023
2163,DNA Methylation Variation (Age Effect),0.48459603305273447,1.0976143097679911,0.7951553337104517,0.5345566966545652,"TLR1,MSRA,GCKR,CD82,MRPL33",GWAS_Catalog_2023
2164,Height (Standard GWA),0.48548495183067825,1.0563550295857989,0.7633295250579213,0.5352897851515704,"SCGN,CCND3,THRB,ZBTB38,ARIH2,SNX13,MYO9B,FRS3,UBE2L3",GWAS_Catalog_2023
2165,Birth Weight,0.49229762070841715,1.1094214876033057,0.7862157505816472,0.5412831126308871,"CCND2,XRN1,EPAS1,SH2B3",GWAS_Catalog_2023
2166,Brown Vs. Black Hair Color,0.4927355073907322,1.5252252252252252,1.0795280967596923,0.5412831126308871,ZBTB38,GWAS_Catalog_2023
2167,Fruit Consumption,0.4927355073907322,1.5252252252252252,1.0795280967596923,0.5412831126308871,MSRA,GWAS_Catalog_2023
2168,Mood Instability,0.4927355073907322,1.5252252252252252,1.0795280967596923,0.5412831126308871,MSRA,GWAS_Catalog_2023
2169,Small Vessel Stroke,0.4927355073907322,1.5252252252252252,1.0795280967596923,0.5412831126308871,PRDM16,GWAS_Catalog_2023
2170,Alcohol Consumption X Experiences In Childhood (Felt Loved By Family Member) Interaction,0.4927355073907322,1.5252252252252252,1.0795280967596923,0.5412831126308871,KIAA0586,GWAS_Catalog_2023
2171,Testosterone Levels In Premenopausal Women,0.4927355073907322,1.5252252252252252,1.0795280967596923,0.5412831126308871,SUSD1,GWAS_Catalog_2023
2172,Citrate Levels,0.4927355073907322,1.5252252252252252,1.0795280967596923,0.5412831126308871,FADS2,GWAS_Catalog_2023
2173,LDL (Standard GWA),0.49559556311812764,1.2202409638554217,0.856603155253718,0.5436740292413115,"FADS2,APOB",GWAS_Catalog_2023
2174,Photoreceptor Cell Layer Thickness Phenotypes (MTAG),0.49559556311812764,1.2202409638554217,0.856603155253718,0.5436740292413115,"RP1L1,ZNF410",GWAS_Catalog_2023
2175,Attention Deficit Hyperactivity Disorder,0.49559556311812764,1.2202409638554217,0.856603155253718,0.5436740292413115,"MEF2C,BCL11A",GWAS_Catalog_2023
2176,Educational Attainment (Years Of Education),0.500765835761571,1.0229468824470038,0.7074871275230631,0.549093421014296,"CEP57,GCDH,MEF2C,BCL11A,DENND4A,ZBTB38,ITSN1,AGAP1,ATP11B,RHOA,SPRED2,ZMIZ2,ARIH2,MAPT,RBM23,SLC17A1,FBXL5",GWAS_Catalog_2023
2177,Chronic Obstructive Pulmonary Disease X Ever Smoker Interaction (2Df),0.5088851549511907,1.4524524524524525,0.981179441528542,0.5559523716637091,ZBTB38,GWAS_Catalog_2023
2178,Takayasu Arteritis,0.5088851549511907,1.4524524524524525,0.981179441528542,0.5559523716637091,EPHB4,GWAS_Catalog_2023
2179,Immune Response To Smallpox Vaccine (IL-6),0.5088851549511907,1.4524524524524525,0.981179441528542,0.5559523716637091,BLK,GWAS_Catalog_2023
2180,Mouth Ulcers,0.5088851549511907,1.4524524524524525,0.981179441528542,0.5559523716637091,NSMCE2,GWAS_Catalog_2023
2181,Age-related Hearing Impairment (MTAG),0.5088851549511907,1.4524524524524525,0.981179441528542,0.5559523716637091,FTO,GWAS_Catalog_2023
2182,Response To Paliperidone In Schizophrenia (Negative Marder Score),0.5088851549511907,1.4524524524524525,0.981179441528542,0.5559523716637091,NSMCE2,GWAS_Catalog_2023
2183,Colon Polyp,0.5088851549511907,1.4524524524524525,0.981179441528542,0.5559523716637091,SIRT3,GWAS_Catalog_2023
2184,QTc Interval,0.5088851549511907,1.4524524524524525,0.981179441528542,0.5559523716637091,LAPTM4B,GWAS_Catalog_2023
2185,Morningness,0.5127075604010686,1.079646017699115,0.7212571486244082,0.5598719629825856,"FTO,MEF2C,ZFP91,VRK2",GWAS_Catalog_2023
2186,Parkinson's Disease Or First Degree Relation To Individual With Parkinson's Disease,0.5157493756746305,1.1730769230769231,0.7767345113577714,0.5624213941314755,"KANSL1,CTSB",GWAS_Catalog_2023
2187,Fasting Plasma Glucose,0.5157493756746305,1.1730769230769231,0.7767345113577714,0.5624213941314755,"GCKR,ALDH2",GWAS_Catalog_2023
2188,Ascending Thoracic Aortic Diameter,0.5157493756746305,1.1730769230769231,0.7767345113577714,0.5624213941314755,"SLC25A37,MSRA",GWAS_Catalog_2023
2189,Smoking Cessation,0.5178856359622828,1.1023550394933208,0.725350543170526,0.5644929773439957,"UBXN2A,LEPR,BTN3A2",GWAS_Catalog_2023
2190,Pulse Pressure,0.521006828282979,1.0118040336227703,0.6596882682438188,0.567635749900999,"FTO,PDGFRA,MAST2,UBE2L3,MFHAS1,MSRA,FADS2,CCND2,ZNF827,KANSL1,PRDM16,CLDN23,PPARG,APOE,EPHB4",GWAS_Catalog_2023
2191,Electrocardiogram Morphology (Amplitude At Temporal Datapoints),0.5220265551430604,1.0395648558758315,0.6757554335878118,0.5684871568102885,"MFHAS1,THRB,EPAS1,AXL,PRDM16,PILRB",GWAS_Catalog_2023
2192,Eye Color,0.5245221393688277,1.3862953862953864,0.8945315544894749,0.5688681020609195,NUP205,GWAS_Catalog_2023
2193,Non-small Cell Lung Cancer,0.5245221393688277,1.3862953862953864,0.8945315544894749,0.5688681020609195,TERT,GWAS_Catalog_2023
2194,Pelvic Organ Prolapse,0.5245221393688277,1.3862953862953864,0.8945315544894749,0.5688681020609195,KLF13,GWAS_Catalog_2023
2195,Acceptance Of An Invitation To Participate In A Mental Health Questionnaire,0.5245221393688277,1.3862953862953864,0.8945315544894749,0.5688681020609195,APOE,GWAS_Catalog_2023
2196,Maximum Habitual Alcohol Consumption,0.5245221393688277,1.3862953862953864,0.8945315544894749,0.5688681020609195,GCKR,GWAS_Catalog_2023
2197,Intake Of Total Sugars,0.5245221393688277,1.3862953862953864,0.8945315544894749,0.5688681020609195,FTO,GWAS_Catalog_2023
2198,Gut Microbiota (Bacterial Taxa),0.5245221393688277,1.3862953862953864,0.8945315544894749,0.5688681020609195,ITSN1,GWAS_Catalog_2023
2199,Glomerular Filtration Rate In Non Diabetics (Creatinine),0.5245221393688277,1.3862953862953864,0.8945315544894749,0.5688681020609195,GCKR,GWAS_Catalog_2023
2200,Neuroticism Conditioned On Average Household Income Before Tax (Multi-Trait Conditioning And Joint Analysis),0.5245221393688277,1.3862953862953864,0.8945315544894749,0.5688681020609195,VRK2,GWAS_Catalog_2023
2201,Myopia (Age Of Diagnosis),0.5353637937478779,1.1294065149486836,0.7056631009235845,0.5800990063044671,"THRB,ZBTB38",GWAS_Catalog_2023
2202,Glomerular Filtration Rate (Creatinine),0.5353637937478779,1.1294065149486836,0.7056631009235845,0.5800990063044671,"SLC7A6,GCKR",GWAS_Catalog_2023
2203,Severe COVID-19 Infection,0.5382153855511259,1.011837181477993,0.6268295459979382,0.5829241533930942,"CEP57,MSRA,TOMM40,TST,MYB,ATP11A,MAPT,JARID2",GWAS_Catalog_2023
2204,Heart Failure,0.5396626874821041,1.3258911084998042,0.8178242038340053,0.5834323390721796,FTO,GWAS_Catalog_2023
2205,Childhood Body Mass Index,0.5396626874821041,1.3258911084998042,0.8178242038340053,0.5834323390721796,FTO,GWAS_Catalog_2023
2206,Systemic Sclerosis,0.5396626874821041,1.3258911084998042,0.8178242038340053,0.5834323390721796,BLK,GWAS_Catalog_2023
2207,"Alcohol Consumption (Drinks Per Month) (UKB Data Field 1578, 4424)",0.5396626874821041,1.3258911084998042,0.8178242038340053,0.5834323390721796,GCKR,GWAS_Catalog_2023
2208,Chronic Obstructive Pulmonary Disease Liability (Machine Learning-Based Score),0.5487080649806152,1.0103422719310067,0.6063960518072697,0.59269669450152,"FTO,BCL2L11,SERTAD2,PABPC4,ZBTB38,NSMCE2",GWAS_Catalog_2023
2209,Interferon-Related Traits,0.548728834096336,1.0512553390978228,0.6309118236548311,0.59269669450152,"MSRA,ACOXL,TOX2",GWAS_Catalog_2023
2210,Age When Finished Full-Time Education (Weighted GWA),0.5543225141392293,1.2705205205205206,0.7496180413790507,0.5971167127477206,BCL11A,GWAS_Catalog_2023
2211,Smoking Behaviour (Cigarettes Smoked Per Day),0.5543225141392293,1.2705205205205206,0.7496180413790507,0.5971167127477206,BCL11A,GWAS_Catalog_2023
2212,Bilirubin Levels,0.5543225141392293,1.2705205205205206,0.7496180413790507,0.5971167127477206,SPTA1,GWAS_Catalog_2023
2213,Gluteofemoral Adipose Tissue Volumes (Adjusted For BMI And Height),0.5543225141392293,1.2705205205205206,0.7496180413790507,0.5971167127477206,PPARG,GWAS_Catalog_2023
2214,Gut Microbiota (Beta Diversity),0.5543225141392293,1.2705205205205206,0.7496180413790507,0.5971167127477206,MACF1,GWAS_Catalog_2023
2215,Orbital Telorism,0.5543225141392293,1.2705205205205206,0.7496180413790507,0.5971167127477206,CCND2,GWAS_Catalog_2023
2216,Subcortical Volume (min-P),0.5637498388291526,1.0696470090889876,0.6130624863792062,0.6067240033587543,"FADS2,PRDM16",GWAS_Catalog_2023
2217,Ascending Aorta Diameter,0.5637498388291526,1.0696470090889876,0.6130624863792062,0.6067240033587543,"SLC25A37,ZNF827",GWAS_Catalog_2023
2218,Smoking Initiation,0.5657508236338442,0.98162647457981,0.5591359502934093,0.6086030050452446,"FTO,MACF1,TOMM40,MAST2,SEZ6,AGAP1,ADAR,PCSK7,PLD1,SPPL3,CDH1,PRDM16,MLEC,JARID2,PTPN1,USP49,WIPI2,VRK2,QKI,MSRA,KANSL1,XRN1,MAPT,PDE7A,CNIH4",GWAS_Catalog_2023
2219,R-6-hydroxywarfarin To R-warfarin Ratio,0.5685168380786577,1.2195795795795796,0.6887262826658954,0.6102029580097513,HK1,GWAS_Catalog_2023
2220,Descending Aorta Diameter,0.5685168380786577,1.2195795795795796,0.6887262826658954,0.6102029580097513,ALDH2,GWAS_Catalog_2023
2221,Coronary Artery Disease Or Plasminogen Activator Inhibitor 1 Levels (Pleiotropy),0.5685168380786577,1.2195795795795796,0.6887262826658954,0.6102029580097513,SH2B3,GWAS_Catalog_2023
2222,Familial Squamous Cell Lung Carcinoma,0.5685168380786577,1.2195795795795796,0.6887262826658954,0.6102029580097513,THRB,GWAS_Catalog_2023
2223,Alcohol Dependence,0.5685168380786577,1.2195795795795796,0.6887262826658954,0.6102029580097513,ALDH2,GWAS_Catalog_2023
2224,Self-reported Math Ability (MTAG),0.5727028052109762,0.9789230769230769,0.5456403297570096,0.6114759282795931,"RP1L1,BRD3,MSRA,MEF2C,BCL11A,PGAP3,DENND4A,FLOT2,VRK2",GWAS_Catalog_2023
2225,Vertical Cup-Disc Ratio,0.5778157226971848,0.9908844542990884,0.5435004006369398,0.6114759282795931,"PDGFRA,ACOXL,DUSP1,PRDM16",GWAS_Catalog_2023
2226,Brain Shape (Segment 1),0.5819730064684353,1.033183581784766,0.5592945215428038,0.6114759282795931,"MEF2C,KANSL1",GWAS_Catalog_2023
2227,"Anorexia Nervosa, Attention-Deficit/Hyperactivity Disorder, Autism Spectrum Disorder, Bipolar Disorder, Major Depression, Obsessive-Compulsive Disorder, Schizophrenia, Or Tourette Syndrome (Pleiotropy)",0.5819730064684353,1.033183581784766,0.5592945215428038,0.6114759282795931,"FADS2,SPPL3",GWAS_Catalog_2023
2228,Retinal Vascular Fractal Density,0.5819730064684353,1.033183581784766,0.5592945215428038,0.6114759282795931,"MEF2C,HK1",GWAS_Catalog_2023
2229,S-6-hydroxywarfarin To S-warfarin Ratio,0.5822603977582713,1.1725571725571726,0.634162904451109,0.6114759282795931,TFRC,GWAS_Catalog_2023
2230,Adiponectin Levels,0.5822603977582713,1.1725571725571726,0.634162904451109,0.6114759282795931,SNX13,GWAS_Catalog_2023
2231,Cholesterol Levels In IDL,0.5822603977582713,1.1725571725571726,0.634162904451109,0.6114759282795931,LPL,GWAS_Catalog_2023
2232,Mercuric Chloride-2 Levels,0.5822603977582713,1.1725571725571726,0.634162904451109,0.6114759282795931,NLRP3,GWAS_Catalog_2023
2233,Methoxychlor Levels,0.5822603977582713,1.1725571725571726,0.634162904451109,0.6114759282795931,NLRP3,GWAS_Catalog_2023
2234,Environmental Pollutants Exposure (POD Low),0.5822603977582713,1.1725571725571726,0.634162904451109,0.6114759282795931,NLRP3,GWAS_Catalog_2023
2235,Potassium Chromate Levels,0.5822603977582713,1.1725571725571726,0.634162904451109,0.6114759282795931,NLRP3,GWAS_Catalog_2023
2236,Environmental Pollutants Exposure (RfD High),0.5822603977582713,1.1725571725571726,0.634162904451109,0.6114759282795931,NLRP3,GWAS_Catalog_2023
2237,Parathion Levels,0.5822603977582713,1.1725571725571726,0.634162904451109,0.6114759282795931,NLRP3,GWAS_Catalog_2023
2238,Environmental Pollutants Exposure (RfD Low),0.5822603977582713,1.1725571725571726,0.634162904451109,0.6114759282795931,NLRP3,GWAS_Catalog_2023
2239,Heptachlor Levels,0.5822603977582713,1.1725571725571726,0.634162904451109,0.6114759282795931,NLRP3,GWAS_Catalog_2023
2240,Heptachlor Epoxide Levels,0.5822603977582713,1.1725571725571726,0.634162904451109,0.6114759282795931,NLRP3,GWAS_Catalog_2023
2241,Mercuric Chloride Levels,0.5822603977582713,1.1725571725571726,0.634162904451109,0.6114759282795931,NLRP3,GWAS_Catalog_2023
2242,Pentachlorophenol Levels,0.5822603977582713,1.1725571725571726,0.634162904451109,0.6114759282795931,NLRP3,GWAS_Catalog_2023
2243,Environmental Pollutants Exposure (POD High),0.5822603977582713,1.1725571725571726,0.634162904451109,0.6114759282795931,NLRP3,GWAS_Catalog_2023
2244,"2,4,5-Trichlorophenol Levels",0.5822603977582713,1.1725571725571726,0.634162904451109,0.6114759282795931,NLRP3,GWAS_Catalog_2023
2245,Environmental Pollutants Exposure (AC50 Low),0.5822603977582713,1.1725571725571726,0.634162904451109,0.6114759282795931,NLRP3,GWAS_Catalog_2023
2246,Aldrin Levels,0.5822603977582713,1.1725571725571726,0.634162904451109,0.6114759282795931,NLRP3,GWAS_Catalog_2023
2247,Azinphos Methyl Levels,0.5822603977582713,1.1725571725571726,0.634162904451109,0.6114759282795931,NLRP3,GWAS_Catalog_2023
2248,Cadmium Chloride Levels,0.5822603977582713,1.1725571725571726,0.634162904451109,0.6114759282795931,NLRP3,GWAS_Catalog_2023
2249,Chlorpyrifos Levels,0.5822603977582713,1.1725571725571726,0.634162904451109,0.6114759282795931,NLRP3,GWAS_Catalog_2023
2250,DDT Metabolite (DDD P-P') Levels,0.5822603977582713,1.1725571725571726,0.634162904451109,0.6114759282795931,NLRP3,GWAS_Catalog_2023
2251,DDT Metabolite (DDT O-P') Levels,0.5822603977582713,1.1725571725571726,0.634162904451109,0.6114759282795931,NLRP3,GWAS_Catalog_2023
2252,Environmental Pollutants Exposure (AC50 High),0.5822603977582713,1.1725571725571726,0.634162904451109,0.6114759282795931,NLRP3,GWAS_Catalog_2023
2253,DDT Metabolite (DDT P-P') Levels,0.5822603977582713,1.1725571725571726,0.634162904451109,0.6114759282795931,NLRP3,GWAS_Catalog_2023
2254,Disulfoton Levels,0.5822603977582713,1.1725571725571726,0.634162904451109,0.6114759282795931,NLRP3,GWAS_Catalog_2023
2255,Endosulfan Levels,0.5822603977582713,1.1725571725571726,0.634162904451109,0.6114759282795931,NLRP3,GWAS_Catalog_2023
2256,Endrin Levels,0.5822603977582713,1.1725571725571726,0.634162904451109,0.6114759282795931,NLRP3,GWAS_Catalog_2023
2257,"2,4,5-Trichlorophenol-2 Levels",0.5822603977582713,1.1725571725571726,0.634162904451109,0.6114759282795931,NLRP3,GWAS_Catalog_2023
2258,"4,6-Dinitro-O-Cresol Levels",0.5822603977582713,1.1725571725571726,0.634162904451109,0.6114759282795931,NLRP3,GWAS_Catalog_2023
2259,Ethion Levels,0.5822603977582713,1.1725571725571726,0.634162904451109,0.6114759282795931,NLRP3,GWAS_Catalog_2023
2260,Depression (Broad),0.5822603977582713,1.1725571725571726,0.634162904451109,0.6114759282795931,BTN3A1,GWAS_Catalog_2023
2261,Di-n-butyl Phthalate Levels,0.5822603977582713,1.1725571725571726,0.634162904451109,0.6114759282795931,NLRP3,GWAS_Catalog_2023
2262,Diazinon Levels,0.5822603977582713,1.1725571725571726,0.634162904451109,0.6114759282795931,NLRP3,GWAS_Catalog_2023
2263,Dicofol Levels,0.5822603977582713,1.1725571725571726,0.634162904451109,0.6114759282795931,NLRP3,GWAS_Catalog_2023
2264,Dieldrin Levels,0.5822603977582713,1.1725571725571726,0.634162904451109,0.6114759282795931,NLRP3,GWAS_Catalog_2023
2265,Environmental Pollutants Exposure (Expo High),0.5822603977582713,1.1725571725571726,0.634162904451109,0.6114759282795931,NLRP3,GWAS_Catalog_2023
2266,Environmental Pollutants Exposure (Expo Low),0.5822603977582713,1.1725571725571726,0.634162904451109,0.6114759282795931,NLRP3,GWAS_Catalog_2023
2267,Acute Lymphoblastic Leukemia (Childhood),0.5822603977582713,1.1725571725571726,0.634162904451109,0.6114759282795931,FIGNL1,GWAS_Catalog_2023
2268,Lumbar Spine Bone Mineral Density,0.5822603977582713,1.1725571725571726,0.634162904451109,0.6114759282795931,MAPT,GWAS_Catalog_2023
2269,Obesity,0.5822603977582713,1.1725571725571726,0.634162904451109,0.6114759282795931,FTO,GWAS_Catalog_2023
2270,Nickel Levels,0.5822603977582713,1.1725571725571726,0.634162904451109,0.6114759282795931,NLRP3,GWAS_Catalog_2023
2271,Cobalt Levels,0.5822603977582713,1.1725571725571726,0.634162904451109,0.6114759282795931,NLRP3,GWAS_Catalog_2023
2272,RS-10-hydroxywarfarin To RS-warfarin Ratio,0.5822603977582713,1.1725571725571726,0.634162904451109,0.6114759282795931,WIPI2,GWAS_Catalog_2023
2273,Vertex-wise Cortical Surface Area,0.5872530549019206,0.96639231824417,0.5144101027809483,0.6164477734254213,"MACF1,PTPN1,FADS2,AKAP10,DSTYK,TFAP4,KIT,BEND3,SNX13,AGAP1",GWAS_Catalog_2023
2274,Smoking Initiation (Ever Regular Vs Never Regular),0.5896071080694392,0.9700307823359727,0.5124661782317345,0.6186466841924723,"MSRA,KANSL1,MAST2,SEZ6,VRK2",GWAS_Catalog_2023
2275,Hip Index,0.5950973061507945,0.9637951598630295,0.5002389363169527,0.6232561291520597,"BCL2L11,KLF13,BEND3,PPARG,CPEB4",GWAS_Catalog_2023
2276,Bone Mineral Density,0.5955674662475675,1.1290179067956845,0.5851029209930787,0.6232561291520597,MEF2C,GWAS_Catalog_2023
2277,Bilateral Cleft Lip,0.5955674662475675,1.1290179067956845,0.5851029209930787,0.6232561291520597,COL26A1,GWAS_Catalog_2023
2278,Myopia (Pathological),0.5955674662475675,1.1290179067956845,0.5851029209930787,0.6232561291520597,ERI1,GWAS_Catalog_2023
2279,Parental Extreme Longevity (95 Years And Older),0.5955674662475675,1.1290179067956845,0.5851029209930787,0.6232561291520597,COL26A1,GWAS_Catalog_2023
2280,Childhood Ear Infection,0.5955674662475675,1.1290179067956845,0.5851029209930787,0.6232561291520597,SLC25A39,GWAS_Catalog_2023
2281,Body Size At Age 10,0.596365070312973,0.967003367003367,0.499846231011932,0.6238172107701683,"FTO,MSRA,SPRED2,LEPR",GWAS_Catalog_2023
2282,Glaucoma (Primary Open-Angle),0.5996310841894394,0.9991111988939364,0.5109861035185408,0.6269587059053473,"ACOXL,MAPT",GWAS_Catalog_2023
2283,Epithelial Ovarian Cancer,0.6082478734799617,0.9828993392926545,0.48867081019915476,0.6342359774517337,"ACOXL,TERT",GWAS_Catalog_2023
2284,Coronary Artery Disease Or Tissue Plasminogen Activator Levels (Pleiotropy),0.6084518660465291,1.0885885885885886,0.5408516027490681,0.6342359774517337,SH2B3,GWAS_Catalog_2023
2285,White Matter Hyperintensity Volume (Adjusted For Hypertension),0.6084518660465291,1.0885885885885886,0.5408516027490681,0.6342359774517337,APOE,GWAS_Catalog_2023
2286,Tea Consumption,0.6084518660465291,1.0885885885885886,0.5408516027490681,0.6342359774517337,ALDH2,GWAS_Catalog_2023
2287,Bipolar Disorder (MTAG),0.6084518660465291,1.0885885885885886,0.5408516027490681,0.6342359774517337,BTN3A1,GWAS_Catalog_2023
2288,Major Depressive Disorder (MTAG),0.6084518660465291,1.0885885885885886,0.5408516027490681,0.6342359774517337,VRK2,GWAS_Catalog_2023
2289,Phospholipid Levels In IDL,0.6084518660465291,1.0885885885885886,0.5408516027490681,0.6342359774517337,APOB,GWAS_Catalog_2023
2290,Educational Attainment,0.6149184436461353,0.96175279040926,0.4676673283857853,0.6406966840784624,"FTO,CEP57,GCDH,RTEL1,NUP205,THRB,MAST3,ITSN1,AGAP1,PPP2R2A,ADAR,SPPL3,UBE2L3,MRPL33,SPRED2,AKAP10,CCND2,CDH1,PRDM16,SNIP1,STX4,BRD3,RTEL1-TNFRSF6B,PDGFRA,MEF2C,MAP2K2,BCL11A,DENND4A,ZBTB38,ATP11B,WIPI2,VRK2,RHOA,MSRA,KANSL1,TMCC2,MAPT,RBM23,FBXL5",GWAS_Catalog_2023
2291,Atrial Fibrillation,0.6203301800385045,0.9368764568764569,0.4473616881489856,0.6460531687349941,"THRB,ERI1,MAPT,IL6R",GWAS_Catalog_2023
2292,Heart Rate In Heart Failure With Reduced Ejection Fraction,0.6209269832256007,1.0509474992233614,0.50082039544352,0.6461106768322212,GMPR,GWAS_Catalog_2023
2293,Neuroticism Conditioned On Highest Math Class (Multi-Trait Conditioning And Joint Analysis),0.6209269832256007,1.0509474992233614,0.50082039544352,0.6461106768322212,VRK2,GWAS_Catalog_2023
2294,Weight,0.6231262506790345,0.9403214445796247,0.44477780854764454,0.6481164926417508,"FTO,MSRA,FADS2,CCND3,GCKR,CCND2,BCL2L11,ZMIZ2,ZBTB38,BMP8A,AGAP1,CPEB4",GWAS_Catalog_2023
2295,Venous Thromboembolism,0.6250575623548842,0.9519954819277109,0.4473536570060607,0.6489936221839658,"MSRA,SUSD1",GWAS_Catalog_2023
2296,Cortical Surface Area (MOSTest),0.6250575623548842,0.9519954819277109,0.4473536570060607,0.6489936221839658,"MSRA,VRK2",GWAS_Catalog_2023
2297,Night Sleep Phenotypes,0.6250575623548842,0.9519954819277109,0.4473536570060607,0.6489936221839658,"SPTA1,MYO9B",GWAS_Catalog_2023
2298,Aerodigestive Squamous Cell Cancer (Pleiotropy),0.6250575623548842,0.9519954819277109,0.4473536570060607,0.6489936221839658,"SCGN,ZKSCAN3",GWAS_Catalog_2023
2299,Hippocampal Volume,0.6330057811196118,1.015815815815816,0.46450791261694185,0.6561041675722823,APOE,GWAS_Catalog_2023
2300,Periventricular White Matter Hyperintensities,0.6330057811196118,1.015815815815816,0.46450791261694185,0.6561041675722823,PRDM16,GWAS_Catalog_2023
2301,Trunk Fat Mass,0.6330057811196118,1.015815815815816,0.46450791261694185,0.6561041675722823,FTO,GWAS_Catalog_2023
2302,Ascending Aorta Maximum Area (MTAG),0.6330057811196118,1.015815815815816,0.46450791261694185,0.6561041675722823,ZNF827,GWAS_Catalog_2023
2303,Acne Vulgaris,0.6447008136176033,0.982950692628112,0.43148480853355703,0.6673562435104562,FADS2,GWAS_Catalog_2023
2304,White Matter Hyperintensity Volume,0.6447008136176033,0.982950692628112,0.43148480853355703,0.6673562435104562,APOE,GWAS_Catalog_2023
2305,Body Mass Index In Physically Active Individuals,0.6447008136176033,0.982950692628112,0.43148480853355703,0.6673562435104562,FTO,GWAS_Catalog_2023
2306,Stroke,0.656024238279089,0.9521396396396397,0.401381646245754,0.6784888740935874,SH2B3,GWAS_Catalog_2023
2307,Neuroticism Conditioned On Educational Attainment (Multi-Trait Conditioning And Joint Analysis),0.656024238279089,0.9521396396396397,0.401381646245754,0.6784888740935874,VRK2,GWAS_Catalog_2023
2308,Spherical Equivalent Or Myopia (Age Of Diagnosis),0.6569928554628606,0.8956413890857547,0.3762429469594908,0.6791962535244304,"THRB,ZBTB38",GWAS_Catalog_2023
2309,Non-melanoma Skin Cancer,0.664629521774859,0.8825737733542867,0.36055389529676907,0.6864961207596596,"FADS2,ZAN",GWAS_Catalog_2023
2310,Total Body Bone Mineral Density,0.664629521774859,0.8825737733542867,0.36055389529676907,0.6864961207596596,"GCKR,DDB2",GWAS_Catalog_2023
2311,Hearing Loss,0.6669878284427431,0.9231959231959231,0.3738790990315251,0.6877411230183167,FTO,GWAS_Catalog_2023
2312,Tuberculosis,0.6669878284427431,0.9231959231959231,0.3738790990315251,0.6877411230183167,IL2RB,GWAS_Catalog_2023
2313,Body Mass Index (Joint Analysis Main Effects And Physical Activity Interaction),0.6669878284427431,0.9231959231959231,0.3738790990315251,0.6877411230183167,FTO,GWAS_Catalog_2023
2314,Cognitive Function,0.6669878284427431,0.9231959231959231,0.3738790990315251,0.6877411230183167,TOMM40,GWAS_Catalog_2023
2315,Biological Sex,0.6721289855248117,0.8698795180722891,0.34560749422118214,0.6927428766575382,"FTO,ITSN1",GWAS_Catalog_2023
2316,Lean Body Mass,0.6776029857475239,0.8959547783077195,0.34869998145102127,0.6962793815648545,FTO,GWAS_Catalog_2023
2317,Waist Circumference Adjusted For BMI In Non-Smokers,0.6776029857475239,0.8959547783077195,0.34869998145102127,0.6962793815648545,ZBTB38,GWAS_Catalog_2023
2318,Corneal Astigmatism,0.6776029857475239,0.8959547783077195,0.34869998145102127,0.6962793815648545,PDGFRA,GWAS_Catalog_2023
2319,Essential Tremor,0.6776029857475239,0.8959547783077195,0.34869998145102127,0.6962793815648545,DHRS13,GWAS_Catalog_2023
2320,Macrophage Inflammatory Protein 1B Levels,0.6776029857475239,0.8959547783077195,0.34869998145102127,0.6962793815648545,ARIH2,GWAS_Catalog_2023
2321,Complement Factor H-related Protein 3 Levels,0.6776029857475239,0.8959547783077195,0.34869998145102127,0.6962793815648545,NUP205,GWAS_Catalog_2023
2322,S-warfarin To R-warfarin Ratio,0.6776029857475239,0.8959547783077195,0.34869998145102127,0.6962793815648545,MAX,GWAS_Catalog_2023
2323,Chronotype,0.6957627002200313,0.8537959769133567,0.30971160884482496,0.7146318565324987,"FTO,MSRA,KANSL1,UBXN2A,ZFP91",GWAS_Catalog_2023
2324,Amyotrophic Lateral Sclerosis,0.6978318177263308,0.8460126793460127,0.30437603408117725,0.7158326384759353,SUSD1,GWAS_Catalog_2023
2325,Waist-to-hip Ratio Adjusted For BMI (Additive Genetic Model),0.6978318177263308,0.8460126793460127,0.30437603408117725,0.7158326384759353,DSTYK,GWAS_Catalog_2023
2326,Smoking Cessation (MTAG),0.6978318177263308,0.8460126793460127,0.30437603408117725,0.7158326384759353,ASXL1,GWAS_Catalog_2023
2327,Asthma In Any Disease,0.707466539473974,0.823066309552796,0.2848343968281003,0.7244700271179836,FADS2,GWAS_Catalog_2023
2328,Neuroticism Conditioned On Townsend Deprivation Index (Multi-Trait Conditioning And Joint Analysis),0.707466539473974,0.823066309552796,0.2848343968281003,0.7244700271179836,VRK2,GWAS_Catalog_2023
2329,Pursuit Maintenance Gain,0.707466539473974,0.823066309552796,0.2848343968281003,0.7244700271179836,GIGYF1,GWAS_Catalog_2023
2330,Leisure Screen Time,0.707466539473974,0.823066309552796,0.2848343968281003,0.7244700271179836,BCL11A,GWAS_Catalog_2023
2331,Insomnia,0.7140953474143206,0.8775263826155736,0.2954971685562906,0.7309444439856579,"GCDH,TOMM40,USP49,BTN3A1,GALNT2,AGAP1,FRS3,QKI,ASXL1,MSRA,CCND3,APOE,SLC17A1",GWAS_Catalog_2023
2332,Verbal-numerical Reasoning,0.7167949438806269,0.8013276434329066,0.2668144362884767,0.7333931115348095,MEF2C,GWAS_Catalog_2023
2333,Vertigo,0.7258267414612338,0.7807037807037807,0.2501717960575722,0.7423157330160755,AHI1,GWAS_Catalog_2023
2334,Educational Attainment (MTAG),0.7292174568475661,0.873342175066313,0.27578687122369105,0.7454639468887287,"CEP57,MEF2C,NUP205,BCL11A,DENND4A,ZBTB38,ITSN1,AGAP1,ATP11B,SPPL3,SPRED2,MSRA,ZMIZ2,SLC17A1,FBXL5",GWAS_Catalog_2023
2335,Blood Protein Levels,0.7343918026253609,0.869815875761179,0.268523122041561,0.7502941810936823,"PDGFRA,MAX,DOCK7,PDCD5,ADAR,VRK2,ICAM5,TF,CDH1,LEPR,APOE,APOB,SH2B3,IL6R,CTSB",GWAS_Catalog_2023
2336,High-sensitivity Cardiac Troponin T Levels,0.734571335722901,0.7611111111111111,0.23477854903083212,0.7502941810936823,MAP2K2,GWAS_Catalog_2023
2337,S-6-hydroxywarfarin Levels,0.7398266338960455,0.7603915662650602,0.22913593739309557,0.7553386172340456,"AHI1,NPRL3",GWAS_Catalog_2023
2338,Age Of Smoking Initiation (MTAG),0.7458957076995787,0.7509296445039417,0.22014966132778285,0.7612092209457634,"SEZ6,ADAR",GWAS_Catalog_2023
2339,Waist Circumference Adjusted For BMI In Active Individuals,0.7512350512142344,0.7247247247247247,0.20729786278448545,0.766295580863306,ZBTB38,GWAS_Catalog_2023
2340,Cigarettes Smoked Per Day,0.7518432333616928,0.7416985013223626,0.2115527670378549,0.766295580863306,"BCL11A,ARIH2",GWAS_Catalog_2023
2341,Migraine,0.7518432333616928,0.7416985013223626,0.2115527670378549,0.766295580863306,"MACF1,PRDM16",GWAS_Catalog_2023
2342,Bitter Alcoholic Beverage Consumption,0.7591715303401266,0.7078008240798939,0.19501861416491995,0.7731042558222544,GCKR,GWAS_Catalog_2023
2343,Waist Circumference Adjusted For BMI (Joint Analysis Main Effects And Physical Activity Interaction),0.7591715303401266,0.7078008240798939,0.19501861416491995,0.7731042558222544,ZBTB38,GWAS_Catalog_2023
2344,Bipolar Disorder And Schizophrenia,0.766855539822249,0.6916461916461917,0.18360221228292864,0.7805961254333985,MSRA,GWAS_Catalog_2023
2345,Protein Quantitative Trait Loci (Liver),0.7686415265982939,0.856045051330609,0.2252516252380542,0.7820804616049165,"MPST,MACF1,UNC119B,GCDH,CHURC1,HSD17B13,ATP11A,SPPL3,MRPL33,HK1,C18ORF25,KANSL1,DNAJA4,NPHP3,MAPT,JAK2,PDE7A,EPHB4",GWAS_Catalog_2023
2346,Carotid Intima-media Thickness (Mean Of The Maximum cIMT),0.768972333491036,0.7153082919914954,0.1879116938704039,0.7820835412231935,"SLC22A16,ICE2",GWAS_Catalog_2023
2347,Glomerular Filtration Rate,0.7742950875876043,0.6762095428762095,0.17297590761971335,0.7871615163971128,GCKR,GWAS_Catalog_2023
2348,Lifetime Smoking Index,0.7814979285728179,0.6614440527484006,0.16307425538242756,0.793807602202956,PGAP3,GWAS_Catalog_2023
2349,Varicose Veins,0.7814979285728179,0.6614440527484006,0.16307425538242756,0.793807602202956,HDAC7,GWAS_Catalog_2023
2350,Central Corneal Thickness,0.7884715720346978,0.6473068813494346,0.15383825850563562,0.8002097706825984,BRD3,GWAS_Catalog_2023
2351,Amyotrophic Lateral Sclerosis (Sporadic),0.7884715720346978,0.6473068813494346,0.15383825850563562,0.8002097706825984,TAF8,GWAS_Catalog_2023
2352,Risk-taking Tendency (4-Domain Principal Component Model),0.8017601244090331,0.6207636207636208,0.1371551226226436,0.8133501942346739,MAPT,GWAS_Catalog_2023
2353,Blood Pressure (Pleiotropy Model 1 DBP Adjusted For Estimated Causal Effects X SBP),0.8022571664213717,0.7393431685076729,0.16289657183675227,0.8135085418960446,"FTO,FADS2,AXL,PPARG,PLD1",GWAS_Catalog_2023
2354,Obesity-related Traits,0.803010616676552,0.7759949661790153,0.17024347447628696,0.8139266488488757,"FTO,DSTYK,IL1RN,UBXN2A,SERPING1,TEX35,CPEB4,HDAC7",GWAS_Catalog_2023
2355,Chronic Kidney Disease,0.8201484449397144,0.5847770847770848,0.11594370856128416,0.8309444541936979,GCKR,GWAS_Catalog_2023
2356,BMI (Standard GWA),0.8275761280180568,0.6260712954912433,0.11848660862143386,0.8381140243850099,"FTO,MACF1",GWAS_Catalog_2023
2357,Noncognitive Aspects Of Educational Attainment,0.8368357162387334,0.5527163527163527,0.09845398469009083,0.8467726967538668,ARIH2,GWAS_Catalog_2023
2358,Retinal Vascular Fractal Dimension,0.8368357162387334,0.5527163527163527,0.09845398469009083,0.8467726967538668,ACOXL,GWAS_Catalog_2023
2359,Atopic Asthma,0.851978868417745,0.5239722481101792,0.08393697703450269,0.8610002456775687,AHI1,GWAS_Catalog_2023
2360,Alzheimer Disease And Age Of Onset,0.851978868417745,0.5239722481101792,0.08393697703450269,0.8610002456775687,SPRED2,GWAS_Catalog_2023
2361,Low Myopia Vs Hyperopia,0.851978868417745,0.5239722481101792,0.08393697703450269,0.8610002456775687,ZBTB38,GWAS_Catalog_2023
2362,Peak Expiratory Flow,0.8552517315353106,0.5835264133456904,0.0912398576905067,0.8639418422706399,"ZBTB38,BMP8A",GWAS_Catalog_2023
2363,Lung Function (FVC),0.8593826200411662,0.7072811512380719,0.10718211501367304,0.8677473260339494,"SPRED2,ALDH2,KANSL1,ZBTB38,LEPR,AGAP1,MAPT",GWAS_Catalog_2023
2364,R-warfarin Levels,0.8657203934049079,0.498055432481662,0.07181625335969878,0.8734075512321818,FTO,GWAS_Catalog_2023
2365,Lobe Attachment (Rater-Scored Or Self-Reported),0.8657203934049079,0.498055432481662,0.07181625335969878,0.8734075512321818,PDGFRA,GWAS_Catalog_2023
2366,Vertex-wise Sulcal Depth,0.866918890141015,0.7334564897419723,0.10474481780571313,0.8742470295335849,"MFHAS1,MACF1,FADS2,MEF2C,MAP3K1,SNX13,AGAP1,VRK2,RBM23,CPEB4",GWAS_Catalog_2023
2367,Smoking Initiation (Ever Regular Vs Never Regular) (MTAG),0.8769371792789719,0.6712737127371273,0.0881516106282928,0.8839763877311478,"CDH1,MAST2,SEZ6,ADAR,VRK2,PDE7A",GWAS_Catalog_2023
2368,Post Bronchodilator FEV1/FVC Ratio,0.8776122232418425,0.5938629228126295,0.07752906711108946,0.8842832621009443,"NUP205,GCKR,BUD13",GWAS_Catalog_2023
2369,Atrial Fibrillation (MTAG),0.8781896701457171,0.4745683183183183,0.061642952348711706,0.8844915799779153,THRB,GWAS_Catalog_2023
2370,Blood Pressure (Pleiotropy Model 2 SBP Adjusted For Estimated Causal Effects X DBP),0.8817440643361725,0.6205439005439005,0.07809758553138378,0.8876967668802141,"FTO,FADS2,PPARG,PLD1",GWAS_Catalog_2023
2371,Lung Function (Forced Vital Capacity),0.8848782088778988,0.5365710630131144,0.06562546365544407,0.8904763417893995,"LEPR,AGAP1",GWAS_Catalog_2023
2372,Itch Intensity From Mosquito Bite Adjusted By Bite Size,0.8895041675513641,0.45318452781139346,0.053063868797664594,0.8947541921490534,IL6R,GWAS_Catalog_2023
2373,Adventurousness,0.893037774879375,0.44647588765235824,0.050508208920914614,0.8979301015011331,MFHAS1,GWAS_Catalog_2023
2374,Leisure Sedentary Behaviour (Television Watching),0.8997705381698449,0.4336336336336336,0.045798435528203923,0.9039378964518946,BCL11A,GWAS_Catalog_2023
2375,3-Hydroxy-1-Methylpropylmercapturic Acid Levels In Smokers,0.8997705381698449,0.4336336336336336,0.045798435528203923,0.9039378964518946,TNK2,GWAS_Catalog_2023
2376,Alzheimer's Disease Or Gastroesophageal Reflux Disease,0.9029767457311958,0.42748382185001904,0.0436283482842391,0.906777152910199,TRIP6,GWAS_Catalog_2023
2377,Smoking Status (Ever Vs Never Smokers),0.9276000223619315,0.37905405405405407,0.02848767457150775,0.9307206279880439,MSRA,GWAS_Catalog_2023
2378,3-Hydroxypropylmercapturic Acid Levels In Smokers,0.9276000223619315,0.37905405405405407,0.02848767457150775,0.9307206279880439,MYO9B,GWAS_Catalog_2023
2379,COVID-19 (Covid Vs Negative),0.9384739746170548,0.356580109521286,0.02264289192820202,0.9412353524322373,AHI1,GWAS_Catalog_2023
2380,Adolescent Idiopathic Scoliosis,0.9449341459242454,0.6247435897435898,0.03538550239342713,0.9473163328467435,"FTO,ACOXL,DNMBP,DENND4A,NPRL3,PRDM16,SH2B3,TM9SF4,UBE2L3",GWAS_Catalog_2023
2381,Lung Function (FEV1),0.9463561919366785,0.4257593755302902,0.023474778158556895,0.9483435001935805,"LARP1,KANSL1",GWAS_Catalog_2023
2382,Externalizing Behaviour (Multivariate Analysis),0.9522030059847403,0.5062388591800356,0.024794073435629692,0.9538020034758985,"BCL11A,VRK2,MAPT,PDE7A",GWAS_Catalog_2023
2383,FEV1,0.954106627802011,0.3221519391732158,0.0151346480383557,0.9553077691714639,BMP8A,GWAS_Catalog_2023
2384,Post Bronchodilator FEV1,0.9570024037123258,0.31537787787787785,0.013860660878976227,0.9578052580778562,NUP205,GWAS_Catalog_2023
2385,"Gut Microbiota (Bacterial Taxa, Hurdle Binary Method)",0.9776081773854197,0.26048462255358806,0.005899019639657574,0.97801807599229,CEP57,GWAS_Catalog_2023
2386,IgG Glycosylation,0.990429473585303,0.21224040942350803,0.002041034988339079,0.990429473585303,EPAS1,GWAS_Catalog_2023
1,Thyroid cancer,0.00020494957373037238,8.444567627494457,71.71757292992177,0.04918789769528937,"MAP2K2,CDH1,GADD45A,NCOA4,PPARG,DDB2",KEGG_2021_Human
2,p53 signaling pathway,0.0010672350052291283,4.930358632193495,33.73688653273335,0.12806820062749538,"CCND3,CCND2,TP53I3,CD82,GADD45A,DDB2,ATR",KEGG_2021_Human
3,Pathways in cancer,0.0033168301315249006,2.0037053505261597,11.438644367615765,0.23385292507518804,"PDGFRA,CEBPA,MAP2K2,MAX,GADD45A,EPAS1,NCOA4,PLD1,RHOA,DDB2,KITLG,CCND3,BCL2L11,CCND2,TERT,PIK3CA,CDH1,KIT,IL2RB,PPARG,JAK2,IL6R",KEGG_2021_Human
4,Central carbon metabolism in cancer,0.004347259948424647,4.311542824730573,23.447073275278882,0.23385292507518804,"PDGFRA,MAP2K2,PIK3CA,KIT,HK1,SIRT3",KEGG_2021_Human
5,Tryptophan metabolism,0.0054936260994018216,6.481020733652312,33.72831260680547,0.23385292507518804,"GCDH,HADHA,ALDH2,ALDH8A1",KEGG_2021_Human
6,Melanoma,0.005846323126879701,4.02916224814422,20.71771996113338,0.23385292507518804,"PDGFRA,MAP2K2,PIK3CA,CDH1,GADD45A,DDB2",KEGG_2021_Human
7,Human T-cell leukemia virus 1 infection,0.007562888915075302,2.631303620004185,12.852607873879567,0.23848433098376662,"CCND3,MAP3K1,CCND2,MAP2K2,TERT,PIK3CA,TRRAP,IL2RB,ETS2,ATR",KEGG_2021_Human
8,Endometrial cancer,0.009212477677974914,4.281492738939548,20.068197543043876,0.23848433098376662,"MAP2K2,PIK3CA,CDH1,GADD45A,DDB2",KEGG_2021_Human
9,Sulfur relay system,0.009444937543148634,20.431726907630523,95.25835798349146,0.23848433098376662,"MPST,TST",KEGG_2021_Human
10,JAK-STAT signaling pathway,0.009936847124323609,2.8797260664859468,13.279872592196085,0.23848433098376662,"PDGFRA,CCND3,CCND2,PIK3CA,IL2RB,LEPR,JAK2,IL6R",KEGG_2021_Human
11,Sulfur metabolism,0.013871426046285067,15.322289156626505,65.54759211542967,0.26475829004168067,"MPST,TST",KEGG_2021_Human
12,Transcriptional misregulation in cancer,0.015613604520447506,2.466575901974132,10.260000349016883,0.26475829004168067,"CEBPA,MEF2C,CCND2,MAX,GADD45A,IL2RB,PPARG,KLF3,DDB2",KEGG_2021_Human
13,PPAR signaling pathway,0.016167734984698093,3.667679837892604,15.128217263537808,0.26475829004168067,"FADS2,LPL,PPARG,CPT1B,PLTP",KEGG_2021_Human
14,Colorectal cancer,0.016851280713423365,3.1373501446878875,12.810831631559623,0.26475829004168067,"MAP2K2,BCL2L11,PIK3CA,GADD45A,RHOA,DDB2",KEGG_2021_Human
15,Fatty acid degradation,0.017844695030163935,4.393939393939394,17.690215356276155,0.26475829004168067,"GCDH,HADHA,ALDH2,CPT1B",KEGG_2021_Human
16,PI3K-Akt signaling pathway,0.017875419983956583,1.9711255656108597,7.932457175278047,0.26475829004168067,"PDGFRA,MAP2K2,PPP2R2A,THBS3,KITLG,CCND3,BCL2L11,CCND2,PIK3CA,KIT,IL2RB,MYB,JAK2,IL6R",KEGG_2021_Human
17,Cholesterol metabolism,0.019811341122747687,4.242006269592476,16.635030645892297,0.26475829004168067,"LPL,APOE,APOB,PLTP",KEGG_2021_Human
18,beta-Alanine metabolism,0.02111504710387186,5.7564199395770395,22.20694046489024,0.26475829004168067,"HADHA,ALDH2,SMOX",KEGG_2021_Human
19,Lysine degradation,0.021906526405921736,4.10020202020202,15.666751689594776,0.26475829004168067,"HADHA,GCDH,ALDH2,PRDM16",KEGG_2021_Human
20,Hematopoietic cell lineage,0.024112149987976932,3.2758843691392356,12.202798399421988,0.26475829004168067,"GYPA,KITLG,TFRC,KIT,IL6R",KEGG_2021_Human
21,RNA degradation,0.024112149987976932,3.2758843691392356,12.202798399421988,0.26475829004168067,"XRN1,PABPC4,EXOSC9,WDR61,CNOT8",KEGG_2021_Human
22,Butanoate metabolism,0.024269509920487396,5.417273858183757,20.14431947897334,0.26475829004168067,"HMGCL,HADHA,ALDH5A1",KEGG_2021_Human
23,Cellular senescence,0.02689471683597508,2.541860046771002,9.190922150386779,0.2806405235058269,"CCND3,RAD50,CCND2,MAP2K2,PIK3CA,GADD45A,ATR",KEGG_2021_Human
24,Glioma,0.029905018384531586,3.078419452887538,10.804417947066764,0.29905018384531584,"PDGFRA,MAP2K2,PIK3CA,GADD45A,DDB2",KEGG_2021_Human
25,Endocytosis,0.03261297724385851,2.0495053552448694,7.015549048200101,0.3130845815410417,"PDGFRA,HSPA8,TFRC,PSD4,ARPC1A,IL2RB,AGAP1,PLD1,RAB8A,RHOA",KEGG_2021_Human
26,Bladder cancer,0.03927315749651936,4.38368580060423,14.1909290839985,0.3490947333023944,"MAP2K2,CDH1,TYMP",KEGG_2021_Human
27,Ferroptosis,0.03927315749651936,4.38368580060423,14.1909290839985,0.3490947333023944,"TF,TFRC,NCOA4",KEGG_2021_Human
28,HIF-1 signaling pathway,0.04148997273795147,2.4976928147659856,7.9484165906325455,0.35562833775386976,"TF,MAP2K2,TFRC,PIK3CA,IL6R,HK1",KEGG_2021_Human
29,Measles,0.04366503175061294,2.464146341463415,7.715753963759093,0.36136578000507263,"HSPA8,CCND3,CCND2,PIK3CA,IL2RB,ADAR",KEGG_2021_Human
30,MAPK signaling pathway,0.04967965743952257,1.8294883318352808,5.492416208635667,0.38785891933746103,"PDGFRA,HSPA8,MEF2C,KITLG,MAP3K1,MAP2K2,GADD45A,DUSP1,MAX,KIT,MAPT",KEGG_2021_Human
31,Acute myeloid leukemia,0.05020936719113392,3.0721212121212123,9.190415493744885,0.38785891933746103,"CEBPA,MAP2K2,PIK3CA,KIT",KEGG_2021_Human
32,Phospholipase D signaling pathway,0.051714522578328134,2.179377876625583,6.45535352664794,0.38785891933746103,"PDGFRA,KITLG,MAP2K2,PIK3CA,KIT,PLD1,RHOA",KEGG_2021_Human
33,Sphingolipid signaling pathway,0.05820172560691982,2.2802619692863595,6.484700825991727,0.42328527714123504,"SMPD2,MAP2K2,PIK3CA,PPP2R2A,PLD1,RHOA",KEGG_2021_Human
34,AMPK signaling pathway,0.0636194860495683,2.224875110196885,6.129164872415792,0.43545332511304297,"PIK3CA,LEPR,PPP2R2A,PPARG,CPT1B,RAB8A",KEGG_2021_Human
35,Non-alcoholic fatty liver disease,0.0636194860495683,2.224875110196885,6.129164872415792,0.43545332511304297,"CEBPA,BCL2L11,PIK3CA,LEPR,PPARG,IL6R",KEGG_2021_Human
36,Prolactin signaling pathway,0.06531799876695644,2.7917355371900827,7.617215931715123,0.43545332511304297,"CCND2,MAP2K2,PIK3CA,JAK2",KEGG_2021_Human
37,Bacterial invasion of epithelial cells,0.06942650750229386,2.7294276094276095,7.28071138797702,0.4503341027175818,"PIK3CA,CDH1,ARPC1A,RHOA",KEGG_2021_Human
38,Chronic myeloid leukemia,0.07366493077681577,2.669828722002635,6.963523177361515,0.4652521943798891,"MAP2K2,PIK3CA,GADD45A,DDB2",KEGG_2021_Human
39,Apoptosis,0.07841991658117532,2.0974223946784925,5.33936067483829,0.47051949948705196,"SPTA1,MAP2K2,BCL2L11,PIK3CA,GADD45A,CTSB",KEGG_2021_Human
40,Influenza A,0.07841991658117532,2.0974223946784925,5.33936067483829,0.47051949948705196,"CCND3,MAP2K2,PIK3CA,NLRP3,ADAR,JAK2",KEGG_2021_Human
41,Collecting duct acid secretion,0.08050468484980135,4.710379981464319,11.86751926644335,0.4712469357061542,"ATP6V1G3,SLC12A7",KEGG_2021_Human
42,Non-small cell lung cancer,0.08252496370555697,2.558080808080808,6.381527648423984,0.47157122117461125,"MAP2K2,PIK3CA,GADD45A,DDB2",KEGG_2021_Human
43,Neurotrophin signaling pathway,0.08589195044138019,2.2265538963041274,5.465444282499133,0.4793969326960755,"MAP2K2,MAP3K1,PIK3CA,SH2B3,RHOA",KEGG_2021_Human
44,"Valine, leucine and isoleucine degradation",0.09235852547404205,2.9666699152129423,7.066836941790966,0.5037737753129566,"HMGCL,HADHA,ALDH2",KEGG_2021_Human
45,Pancreatic cancer,0.09674457554585714,2.4068924539512775,5.621733010691669,0.5054054569961804,"PIK3CA,GADD45A,PLD1,DDB2",KEGG_2021_Human
46,Viral carcinogenesis,0.09852116184004087,1.9623767514270887,4.547776552409568,0.5054054569961804,"GTF2A1,CCND3,CCND2,PIK3CA,RHOA,HDAC7",KEGG_2021_Human
47,Gastric cancer,0.10211444155579133,1.941527599486521,4.429908034447698,0.5054054569961804,"MAP2K2,TERT,PIK3CA,CDH1,GADD45A,DDB2",KEGG_2021_Human
48,Ribosome biogenesis in eukaryotes,0.10532431745183514,2.786322438890415,6.271206427727801,0.5054054569961804,"RCL1,NOP58,XRN1",KEGG_2021_Human
49,Epstein-Barr virus infection,0.10577576850455202,1.9211128048780488,4.31565277102966,0.5054054569961804,"CCND3,CCND2,BCL2L11,PIK3CA,GADD45A,DDB2",KEGG_2021_Human
50,mTOR signaling pathway,0.10577576850455202,1.9211128048780488,4.31565277102966,0.5054054569961804,"MAP2K2,PIK3CA,NPRL3,ATP6V1G3,LAMTOR4,RHOA",KEGG_2021_Human
51,Ras signaling pathway,0.10815991831258209,1.722081599382213,3.8301581833808993,0.5054054569961804,"PDGFRA,KITLG,MAP2K2,PIK3CA,KIT,PLD1,RHOA,ETS2",KEGG_2021_Human
52,Tight junction,0.10950451568250577,1.9011189338697512,4.2048748799606335,0.5054054569961804,"MAP3K1,ARPC1A,CLDN23,PPP2R2A,RAB8A,RHOA",KEGG_2021_Human
53,Pyrimidine metabolism,0.11206054043565694,2.7041052070374976,5.918518370513306,0.5074439566897673,"RRM1,AK9,TYMP",KEGG_2021_Human
54,Purine metabolism,0.11932823938519083,1.9936446532191212,4.2382438504965565,0.5303477306008482,"RRM1,AK3,GMPR,PDE7A,AK9",KEGG_2021_Human
55,Autophagy,0.12852360658365375,1.9427878881151168,3.985906554683842,0.5513894882849142,"MAP2K2,PIK3CA,WIPI2,RAB8A,CTSB",KEGG_2021_Human
56,Rap1 signaling pathway,0.13049568172770257,1.6405725971370144,3.340886879961375,0.5513894882849142,"PDGFRA,KITLG,MAP2K2,PIK3CA,CDH1,KIT,PFN4,RHOA",KEGG_2021_Human
57,Coronavirus disease,0.13325245966885424,1.78930854842529,3.606368837729931,0.5513894882849142,"RPS28,PIK3CA,NLRP3,RPL22L1,ADAR,IL6R",KEGG_2021_Human
58,MicroRNAs in cancer,0.13325245966885424,1.78930854842529,3.606368837729931,0.5513894882849142,"PDGFRA,CCND2,MAP2K2,BCL2L11,PIK3CA,RHOA",KEGG_2021_Human
59,FoxO signaling pathway,0.14289961424906356,1.871154273852769,3.640541880929365,0.5591722268948897,"CCND2,MAP2K2,BCL2L11,PIK3CA,GADD45A",KEGG_2021_Human
60,Lysosome,0.14289961424906356,1.871154273852769,3.640541880929365,0.5591722268948897,"LAPTM4B,CD164,DNASE2,AP1M2,CTSB",KEGG_2021_Human
61,Lipid and atherosclerosis,0.14597676522517417,1.6545753940249353,3.1839123566483716,0.5591722268948897,"HSPA8,PIK3CA,NLRP3,PPARG,APOB,JAK2,RHOA",KEGG_2021_Human
62,Shigellosis,0.14597676522517417,1.6545753940249353,3.1839123566483716,0.5591722268948897,"PIK3CA,ARPC1A,PFN4,NLRP3,WIPI2,RHOA,HK1",KEGG_2021_Human
63,Insulin signaling pathway,0.1478408767813434,1.8484271432233492,3.5334879674283712,0.5591722268948897,"PTPN1,MAP2K2,PIK3CA,FLOT2,HK1",KEGG_2021_Human
64,"Neomycin, kanamycin and gentamicin biosynthesis",0.14911259383863723,7.638138138138138,14.535786243348012,0.5591722268948897,HK1,KEGG_2021_Human
65,Renal cell carcinoma,0.15559571008477832,2.297129909365559,4.273796959777195,0.5703586146005948,"MAP2K2,PIK3CA,EPAS1",KEGG_2021_Human
66,T cell receptor signaling pathway,0.1574451531052338,1.9777126099706746,3.6561540210316963,0.5703586146005948,"MAP2K2,PTPRC,PIK3CA,RHOA",KEGG_2021_Human
67,Hippo signaling pathway,0.15922511324266603,1.6898075632132468,3.1049137085256358,0.5703586146005948,"CCND3,CCND2,CDH1,DLG5,BMP8A,PPP2R2A",KEGG_2021_Human
68,Antigen processing and presentation,0.16487131692197854,2.9136546184738954,5.252124698534515,0.5818987656069831,"HSPA8,CTSB",KEGG_2021_Human
69,Small cell lung cancer,0.16973388555725094,1.915530303030303,3.39723790680724,0.5903787323730467,"PIK3CA,MAX,GADD45A,DDB2",KEGG_2021_Human
70,Yersinia infection,0.17359162212964624,1.742539375518099,3.0512731161580446,0.5951712758730728,"MAP2K2,PIK3CA,ARPC1A,NLRP3,RHOA",KEGG_2021_Human
71,Choline metabolism in cancer,0.1823467263515055,1.8571166207529843,3.1605252194047115,0.6150705151957948,"PDGFRA,MAP2K2,PIK3CA,PLD1",KEGG_2021_Human
72,GnRH secretion,0.18708394837205428,2.0874759681406205,3.499022711118496,0.6150705151957948,"MAP2K2,PIK3CA,TRPC1",KEGG_2021_Human
73,mRNA surveillance pathway,0.18708394837205428,2.0874759681406205,3.499022711118496,0.6150705151957948,"HBS1L,PABPC4,PPP2R2A",KEGG_2021_Human
74,Basal transcription factors,0.1994641886930714,2.548694779116466,4.108803264933942,0.6288571845408691,"GTF2A1,TAF8",KEGG_2021_Human
75,Human papillomavirus infection,0.2015118673704414,1.4177041420118344,2.2710301949593252,0.6288571845408691,"CCND3,CCND2,MAP2K2,TERT,PIK3CA,PPP2R2A,ATP6V1G3,ATR,THBS3",KEGG_2021_Human
76,Fc gamma R-mediated phagocytosis,0.2018174251552911,1.7758454106280193,2.842048479678181,0.6288571845408691,"PTPRC,PIK3CA,ARPC1A,PLD1",KEGG_2021_Human
77,Pertussis,0.2034044104295907,1.9963220806515172,3.1792609201776654,0.6288571845408691,"SERPING1,NLRP3,RHOA",KEGG_2021_Human
78,Breast cancer,0.20655339228932354,1.630343400375089,2.571371646785803,0.6288571845408691,"MAP2K2,PIK3CA,GADD45A,KIT,DDB2",KEGG_2021_Human
79,Arginine and proline metabolism,0.21118404556912293,2.4465060240963856,3.8043786951207514,0.6288571845408691,"ALDH2,SMOX",KEGG_2021_Human
80,Carbohydrate digestion and absorption,0.21118404556912293,2.4465060240963856,3.8043786951207514,0.6288571845408691,"PIK3CA,HK1",KEGG_2021_Human
81,Hepatitis B,0.21223929978254336,1.613021916493361,2.500249892085898,0.6288571845408691,"MAP2K2,MAP3K1,PIK3CA,JAK2,DDB2",KEGG_2021_Human
82,Cell cycle,0.2151276749735801,1.7254801536491677,2.6512409601924607,0.6296419755324295,"CCND3,CCND2,GADD45A,ATR",KEGG_2021_Human
83,Adipocytokine signaling pathway,0.22003903062749322,1.9127643504531722,2.89583023186509,0.63022968331262,"LEPR,JAK2,CPT1B",KEGG_2021_Human
84,Non-homologous end-joining,0.22771247374454687,4.363363363363363,6.4563445260378325,0.63022968331262,RAD50,KEGG_2021_Human
85,Synthesis and degradation of ketone bodies,0.22771247374454687,4.363363363363363,6.4563445260378325,0.63022968331262,HMGCL,KEGG_2021_Human
86,Adherens junction,0.22845826020082471,1.873543375053949,2.766102725198173,0.63022968331262,"PTPN1,CDH1,RHOA",KEGG_2021_Human
87,Ribosome,0.22845826020082471,1.873543375053949,2.766102725198173,0.63022968331262,"RPS28,RPL22L1,MRPL33",KEGG_2021_Human
88,Cysteine and methionine metabolism,0.24667318295277238,2.183734939759036,3.0565540638795885,0.6509767076161447,"MPST,TST",KEGG_2021_Human
89,Legionellosis,0.24667318295277238,2.183734939759036,3.0565540638795885,0.6509767076161447,"HBS1L,HSPA8",KEGG_2021_Human
90,Type II diabetes mellitus,0.24667318295277238,2.183734939759036,3.0565540638795885,0.6509767076161447,"PIK3CA,HK1",KEGG_2021_Human
91,Salmonella infection,0.24682866830445485,1.402630369171114,1.9623652135676997,0.6509767076161447,"MAP2K2,PTPRC,PIK3CA,ARPC1A,PFN4,NLRP3,RHOA",KEGG_2021_Human
92,Viral protein interaction with cytokine and cytokine receptor,0.262672288407135,1.731459841532235,2.314698756882004,0.6852320567142652,"IL37,IL2RB,IL6R",KEGG_2021_Human
93,Amyotrophic lateral sclerosis,0.2712127869148908,1.3575659040761816,1.7714220076062273,0.6999039662319763,"FIG4,NUP205,PSMB5,TOMM40,PFN4,WIPI2,RAB8A",KEGG_2021_Human
94,"Growth hormone synthesis, secretion and action",0.2775426585130613,1.53,1.9611243688551132,0.7086195536503693,"MAP2K2,MAP3K1,PIK3CA,JAK2",KEGG_2021_Human
95,Hepatocellular carcinoma,0.28378540986863177,1.4304178621140244,1.8016641162043363,0.7169315617733855,"MAP2K2,TERT,PIK3CA,GADD45A,DDB2",KEGG_2021_Human
96,Toll-like receptor signaling pathway,0.28873476314902763,1.6382175226586102,2.0350704536897366,0.721836907872569,"TLR1,MAP2K2,PIK3CA",KEGG_2021_Human
97,Malaria,0.294225419472405,1.9100150602409638,2.3367297533746547,0.727980419313167,"GYPA,THBS3",KEGG_2021_Human
98,PD-L1 expression and PD-1 checkpoint pathway in cancer,0.29746957034264254,1.6093178565749722,1.9512067232473926,0.7284969069615735,"MAP2K2,PIK3CA,JAK2",KEGG_2021_Human
99,Regulation of actin cytoskeleton,0.30265113230101737,1.3407067829802386,1.6023785795919783,0.7336997146691331,"PDGFRA,MAP2K2,PIK3CA,ARPC1A,PFN4,RHOA",KEGG_2021_Human
100,Focal adhesion,0.30822978982455046,1.3308589607635206,1.5663008246758157,0.7397514955789211,"PDGFRA,CCND3,CCND2,PIK3CA,RHOA,THBS3",KEGG_2021_Human
101,Histidine metabolism,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.7543563038049621,ALDH2,KEGG_2021_Human
102,Vitamin digestion and absorption,0.3213655307830429,2.7755937755937756,3.1507876577626246,0.7543563038049621,APOB,KEGG_2021_Human
103,GnRH signaling pathway,0.32374458038296294,1.5283987915407855,1.7237287779939032,0.7543563038049621,"MAP2K2,MAP3K1,PLD1",KEGG_2021_Human
104,Pathogenic Escherichia coli infection,0.3400975725074432,1.3182580442301646,1.4217712575615131,0.7619834782517715,"MYO1D,ARPC1A,CLDN23,NLRP3,RHOA",KEGG_2021_Human
105,Mitophagy,0.3413467144841261,1.6971218206157965,1.8241625223966422,0.7619834782517715,"CITED2,TFEB",KEGG_2021_Human
106,Alzheimer disease,0.3423165819980647,1.2453239456653153,1.3350112942172658,0.7619834782517715,"PSMB5,MAP2K2,PIK3CA,LPL,MAPT,WIPI2,APOE",KEGG_2021_Human
107,alpha-Linolenic acid metabolism,0.3429525358102901,2.544044044044044,2.7225423684214074,0.7619834782517715,FADS2,KEGG_2021_Human
108,Neutrophil extracellular trap formation,0.35002603721679515,1.4551863041289024,1.5275785270790472,0.7619834782517715,"MAP2K2,PIK3CA,HDAC7",KEGG_2021_Human
109,Glycerolipid metabolism,0.3529867577805054,1.6510908498860306,1.7193217435712793,0.7619834782517715,"ALDH2,LPL",KEGG_2021_Human
110,Hepatitis C,0.35693442142411325,1.3435897435897435,1.3841704634990573,0.7619834782517715,"MAP2K2,PIK3CA,CLDN23,PPP2R2A",KEGG_2021_Human
111,NOD-like receptor signaling pathway,0.35693442142411325,1.3435897435897435,1.3841704634990573,0.7619834782517715,"TRIP6,NLRP3,RHOA,CTSB",KEGG_2021_Human
112,Pancreatic secretion,0.358767221010209,1.432307401812689,1.4682318345845138,0.7619834782517715,"TRPC1,RAB8A,RHOA",KEGG_2021_Human
113,Th17 cell differentiation,0.358767221010209,1.432307401812689,1.4682318345845138,0.7619834782517715,"IL2RB,JAK2,IL6R",KEGG_2021_Human
114,Prostate cancer,0.36749183466707397,1.4101324657215897,1.4116189979925944,0.7628813659290797,"PDGFRA,MAP2K2,PIK3CA",KEGG_2021_Human
115,Signaling pathways regulating pluripotency of stem cells,0.3714634091495741,1.314434669273379,1.3016911128521154,0.7628813659290797,"MAP2K2,PIK3CA,JAK2,JARID2",KEGG_2021_Human
116,Glycolysis / Gluconeogenesis,0.3760425324506758,1.5661105962310782,1.5317392042016418,0.7628813659290797,"ALDH2,HK1",KEGG_2021_Human
117,C-type lectin receptor signaling pathway,0.37619594380196947,1.3886294973908266,1.3575868852155466,0.7628813659290797,"PIK3CA,NLRP3,RHOA",KEGG_2021_Human
118,Biosynthesis of unsaturated fatty acids,0.38409415344077596,2.18018018018018,2.0861437006994428,0.7628813659290797,FADS2,KEGG_2021_Human
119,Fatty acid elongation,0.38409415344077596,2.18018018018018,2.0861437006994428,0.7628813659290797,HADHA,KEGG_2021_Human
120,Protein export,0.38409415344077596,2.18018018018018,2.0861437006994428,0.7628813659290797,SRP14,KEGG_2021_Human
121,VEGF signaling pathway,0.38744450052350976,1.5268072289156627,1.4476921471045792,0.7628813659290797,"MAP2K2,PIK3CA",KEGG_2021_Human
122,Longevity regulating pathway,0.3935276266124674,1.3475208814643682,1.2567033724751988,0.7628813659290797,"HSPA8,PIK3CA,PPARG",KEGG_2021_Human
123,Fluid shear stress and atherosclerosis,0.4004346425124784,1.2597313339581382,1.1529120571296296,0.7628813659290797,"MEF2C,PIK3CA,DUSP1,RHOA",KEGG_2021_Human
124,Tuberculosis,0.4004346425124784,1.2597313339581382,1.1529120571296296,0.7628813659290797,"TLR1,CEBPG,JAK2,RHOA",KEGG_2021_Human
125,Pantothenate and CoA biosynthesis,0.4036913894708047,2.0346346346346347,1.8456263964772202,0.7628813659290797,ALDH2,KEGG_2021_Human
126,Primary immunodeficiency,0.4036913894708047,2.0346346346346347,1.8456263964772202,0.7628813659290797,PTPRC,KEGG_2021_Human
127,Proteasome,0.4036913894708047,2.0346346346346347,1.8456263964772202,0.7628813659290797,PSMB5,KEGG_2021_Human
128,Fc epsilon RI signaling pathway,0.40996596694232024,1.4538152610441768,1.29633963505076,0.7635737148961061,"MAP2K2,PIK3CA",KEGG_2021_Human
129,Cytokine-cytokine receptor interaction,0.41042087175665704,1.175187617260788,1.0465893386449088,0.7635737148961061,"IL1RN,IL37,IL2RB,BMP8A,LEPR,IL6R",KEGG_2021_Human
130,Melanogenesis,0.41928118129141106,1.2902004170035317,1.1214596292787138,0.7684852290467443,"KITLG,MAP2K2,KIT",KEGG_2021_Human
131,Ascorbate and aldarate metabolism,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.7684852290467443,ALDH2,KEGG_2021_Human
132,Base excision repair,0.4226668759757094,1.9072822822822824,1.6424960710005596,0.7684852290467443,MPG,KEGG_2021_Human
133,Basal cell carcinoma,0.4320753805020225,1.387458926615553,1.1642933925595615,0.7796848971465067,"GADD45A,DDB2",KEGG_2021_Human
134,Spinocerebellar ataxia,0.4362498561764909,1.2546041468360716,1.0407444935223196,0.781343025987745,"PSMB5,PIK3CA,WIPI2",KEGG_2021_Human
135,Inositol phosphate metabolism,0.44296388473656995,1.3564926372155288,1.1045472398168368,0.7847032847299483,"FIG4,PIK3CA",KEGG_2021_Human
136,"Parathyroid hormone synthesis, secretion and action",0.4446651946803041,1.2375275577692497,1.0029339774677757,0.7847032847299483,"MEF2C,PLD1,RHOA",KEGG_2021_Human
137,Parkinson disease,0.450485235309106,1.1741258741258742,0.9362831681881303,0.7891325593540992,"PSMB5,DUSP1,MAPT,UBE2L3",KEGG_2021_Human
138,Human cytomegalovirus infection,0.45375122162860704,1.1391371410425077,0.9001532327690693,0.7891325593540992,"PDGFRA,MAP2K2,PIK3CA,IL6R,RHOA",KEGG_2021_Human
139,Galactose metabolism,0.4588306540708931,1.6950283616950284,1.320552665492241,0.7908760463050543,HK1,KEGG_2021_Human
140,Leukocyte transendothelial migration,0.461344360344615,1.2047225314040388,0.9319860351516344,0.7908760463050543,"PIK3CA,CLDN23,RHOA",KEGG_2021_Human
141,Insulin resistance,0.46960316096530463,1.1889590771765999,0.8986952628694377,0.7935139945639629,"PTPN1,PIK3CA,CPT1B",KEGG_2021_Human
142,Phagosome,0.46960316096530463,1.1889590771765999,0.8986952628694377,0.7935139945639629,"TFRC,ATP6V1G3,THBS3",KEGG_2021_Human
143,Fructose and mannose metabolism,0.47605644095165617,1.605658289868816,1.191749862810084,0.7935139945639629,HK1,KEGG_2021_Human
144,Thermogenesis,0.4784971650487183,1.1301907968574636,0.8330692791460639,0.7935139945639629,"PRDM16,BMP8A,PPARG,CPT1B",KEGG_2021_Human
145,B cell receptor signaling pathway,0.4853210560706859,1.2452667814113598,0.9002589397254492,0.7935139945639629,"MAP2K2,PIK3CA",KEGG_2021_Human
146,Estrogen signaling pathway,0.4859475495128385,1.1586293930934262,0.836130212357224,0.7935139945639629,"HSPA8,MAP2K2,PIK3CA",KEGG_2021_Human
147,Vasopressin-regulated water reabsorption,0.4927355073907322,1.5252252252252252,1.0795280967596923,0.7935139945639629,STX4,KEGG_2021_Human
148,Pathways of neurodegeneration,0.49614787159931534,1.0520414639306115,0.7373561557165914,0.7935139945639629,"FIG4,PSMB5,MAP2K2,TOMM40,MAPT,WIPI2,RAB8A,UBE2L3",KEGG_2021_Human
149,Human immunodeficiency virus 1 infection,0.4991411069945305,1.0993174993174992,0.7638788412007249,0.7935139945639629,"MAP2K2,PIK3CA,AP1M2,ATR",KEGG_2021_Human
150,Th1 and Th2 cell differentiation,0.5057390240908062,1.1961965509095205,0.8154884640102932,0.7935139945639629,"IL2RB,JAK2",KEGG_2021_Human
151,SNARE interactions in vesicular transport,0.5088851549511907,1.4524524524524525,0.981179441528542,0.7935139945639629,STX4,KEGG_2021_Human
152,Progesterone-mediated oocyte maturation,0.5157493756746305,1.1730769230769231,0.7767345113577714,0.7935139945639629,"PIK3CA,CPEB4",KEGG_2021_Human
153,Fat digestion and absorption,0.5245221393688277,1.3862953862953864,0.8945315544894749,0.7935139945639629,APOB,KEGG_2021_Human
154,Homologous recombination,0.5245221393688277,1.3862953862953864,0.8945315544894749,0.7935139945639629,RAD50,KEGG_2021_Human
155,Mucin type O-glycan biosynthesis,0.5245221393688277,1.3862953862953864,0.8945315544894749,0.7935139945639629,GALNT2,KEGG_2021_Human
156,Propanoate metabolism,0.5245221393688277,1.3862953862953864,0.8945315544894749,0.7935139945639629,HADHA,KEGG_2021_Human
157,Starch and sucrose metabolism,0.5245221393688277,1.3862953862953864,0.8945315544894749,0.7935139945639629,HK1,KEGG_2021_Human
158,Thyroid hormone signaling pathway,0.5257030213986253,1.0891238670694865,0.7003271479661906,0.7935139945639629,"MAP2K2,THRB,PIK3CA",KEGG_2021_Human
159,Ubiquitin mediated proteolysis,0.5257030213986253,1.0891238670694865,0.7003271479661906,0.7935139945639629,"MAP3K1,UBE2L3,DDB2",KEGG_2021_Human
160,Cell adhesion molecules,0.5334502983754498,1.0762040163497424,0.6762751681445156,0.7946535556706577,"PTPRC,CDH1,CLDN23",KEGG_2021_Human
161,ErbB signaling pathway,0.5353637937478779,1.1294065149486836,0.7056631009235845,0.7946535556706577,"MAP2K2,PIK3CA",KEGG_2021_Human
162,Aldosterone-regulated sodium reabsorption,0.5396626874821041,1.3258911084998042,0.8178242038340053,0.7946535556706577,PIK3CA,KEGG_2021_Human
163,Gap junction,0.5449649876065206,1.108762322015334,0.6730561272473623,0.7946535556706577,"PDGFRA,MAP2K2",KEGG_2021_Human
164,"Alanine, aspartate and glutamate metabolism",0.5543225141392293,1.2705205205205206,0.7496180413790507,0.7946535556706577,ALDH5A1,KEGG_2021_Human
165,Cytosolic DNA-sensing pathway,0.5543225141392293,1.2705205205205206,0.7496180413790507,0.7946535556706577,ADAR,KEGG_2021_Human
166,Fanconi anemia pathway,0.5543225141392293,1.2705205205205206,0.7496180413790507,0.7946535556706577,ATR,KEGG_2021_Human
167,Nucleotide excision repair,0.5543225141392293,1.2705205205205206,0.7496180413790507,0.7946535556706577,DDB2,KEGG_2021_Human
168,Protein processing in endoplasmic reticulum,0.5562574889694604,1.0392062620159297,0.6095193952041892,0.7946535556706577,"HSPA8,UBXN2A,UBXN6",KEGG_2021_Human
169,Ether lipid metabolism,0.5685168380786577,1.2195795795795796,0.6887262826658954,0.8026120066992816,PLD1,KEGG_2021_Human
170,Nicotinate and nicotinamide metabolism,0.5685168380786577,1.2195795795795796,0.6887262826658954,0.8026120066992816,SIRT3,KEGG_2021_Human
171,Spliceosome,0.5729319111160833,1.0511009555463233,0.585451037466751,0.8041149629699414,"HSPA8,U2SURP",KEGG_2021_Human
172,Axon guidance,0.5902356998792261,0.9748363636363636,0.5139662227286381,0.8235846975058969,"PIK3CA,TRPC1,EPHB4,RHOA",KEGG_2021_Human
173,Sphingolipid metabolism,0.5955674662475675,1.1290179067956845,0.5851029209930787,0.8262207624243711,SMPD2,KEGG_2021_Human
174,Natural killer cell mediated cytotoxicity,0.5996310841894394,0.9991111988939364,0.5109861035185408,0.8270773575026752,"MAP2K2,PIK3CA",KEGG_2021_Human
175,Toxoplasmosis,0.6082478734799617,0.9828993392926545,0.48867081019915476,0.8297070900634488,"HSPA8,JAK2",KEGG_2021_Human
176,Pyruvate metabolism,0.6084518660465291,1.0885885885885886,0.5408516027490681,0.8297070900634488,ALDH2,KEGG_2021_Human
177,Apelin signaling pathway,0.6205149999954452,0.9419441243342573,0.4495009173749175,0.8396699730659322,"MEF2C,MAP2K2,CDH1",KEGG_2021_Human
178,Amino sugar and nucleotide sugar metabolism,0.6330057811196118,1.015815815815816,0.46450791261694185,0.8396699730659322,HK1,KEGG_2021_Human
179,Other types of O-glycan biosynthesis,0.6330057811196118,1.015815815815816,0.46450791261694185,0.8396699730659322,GALNT2,KEGG_2021_Human
180,Vibrio cholerae infection,0.6330057811196118,1.015815815815816,0.46450791261694185,0.8396699730659322,ATP6V1G3,KEGG_2021_Human
181,Drug metabolism,0.6332511046872239,0.93725671918443,0.42822157813249745,0.8396699730659322,"RRM1,TYMP",KEGG_2021_Human
182,TGF-beta signaling pathway,0.6413044091660259,0.922964585615188,0.4100279747303273,0.8455092637607912,"BMP8A,RHOA",KEGG_2021_Human
183,ABC transporters,0.6447008136176033,0.982950692628112,0.43148480853355703,0.8455092637607912,ABCC2,KEGG_2021_Human
184,Chagas disease,0.664629521774859,0.8825737733542867,0.36055389529676907,0.8592494095562203,"PIK3CA,PPP2R2A",KEGG_2021_Human
185,Proteoglycans in cancer,0.6655080090755185,0.8818620992534036,0.3590983091538088,0.8592494095562203,"TFAP4,MAP2K2,PIK3CA,RHOA",KEGG_2021_Human
186,Glutathione metabolism,0.6669878284427431,0.9231959231959231,0.3738790990315251,0.8592494095562203,RRM1,KEGG_2021_Human
187,AGE-RAGE signaling pathway in diabetic complications,0.6794922276624399,0.8575428474461225,0.3313626889966528,0.8592494095562203,"PIK3CA,JAK2",KEGG_2021_Human
188,Chemical carcinogenesis,0.6866789788073864,0.8566794707639778,0.32201585478272143,0.8592494095562203,"CCND3,MAP2K2,PIK3CA,JAK2",KEGG_2021_Human
189,Serotonergic synapse,0.6867203051250215,0.8455488621151271,0.3177811023435499,0.8592494095562203,"DUSP1,TRPC1",KEGG_2021_Human
190,Mineral absorption,0.6878807513214057,0.8702702702702703,0.3256027297563665,0.8592494095562203,TF,KEGG_2021_Human
191,cAMP signaling pathway,0.6969051336195738,0.8446127946127946,0.3049947344666288,0.8592494095562203,"MAP2K2,PIK3CA,PLD1,RHOA",KEGG_2021_Human
192,RIG-I-like receptor signaling pathway,0.6978318177263308,0.8460126793460127,0.30437603408117725,0.8592494095562203,MAP3K1,KEGG_2021_Human
193,Regulation of lipolysis in adipocytes,0.6978318177263308,0.8460126793460127,0.30437603408117725,0.8592494095562203,PIK3CA,KEGG_2021_Human
194,Oxytocin signaling pathway,0.7072783183928419,0.8219972238099126,0.28468314473258277,0.8592494095562203,"MEF2C,MAP2K2,RHOA",KEGG_2021_Human
195,RNA transport,0.7076051421916477,0.8114859437751004,0.2806678721653784,0.8592494095562203,"NUP205,PABPC4",KEGG_2021_Human
196,Wnt signaling pathway,0.7128534164148329,0.8145770392749244,0.27571760190478894,0.8592494095562203,"CCND3,CCND2,RHOA",KEGG_2021_Human
197,cGMP-PKG signaling pathway,0.7128534164148329,0.8145770392749244,0.27571760190478894,0.8592494095562203,"MEF2C,MAP2K2,RHOA",KEGG_2021_Human
198,Hedgehog signaling pathway,0.7167949438806269,0.8013276434329066,0.2668144362884767,0.8592494095562203,CCND2,KEGG_2021_Human
199,Herpes simplex virus 1 infection,0.7180549062247449,0.8300529838723072,0.2749212194360084,0.8592494095562203,"PIK3CA,PILRB,JAK2,ZFP90,ZNF211",KEGG_2021_Human
200,Prion disease,0.7183465577717884,0.8072881854396706,0.26705347905310617,0.8592494095562203,"HSPA8,PSMB5,PIK3CA",KEGG_2021_Human
201,Cholinergic synapse,0.7273176979850559,0.780043249922768,0.24835945109961277,0.8592494095562203,"PIK3CA,JAK2",KEGG_2021_Human
202,Glutamatergic synapse,0.7273176979850559,0.780043249922768,0.24835945109961277,0.8592494095562203,"TRPC1,PLD1",KEGG_2021_Human
203,Chemokine signaling pathway,0.7343380292543398,0.7861756432961767,0.24275989544338206,0.8592494095562203,"PIK3CA,JAK2,RHOA",KEGG_2021_Human
204,Leishmaniasis,0.734571335722901,0.7611111111111111,0.23477854903083212,0.8592494095562203,JAK2,KEGG_2021_Human
205,Necroptosis,0.7398266338960455,0.7603915662650602,0.22913593739309557,0.8592494095562203,"NLRP3,JAK2",KEGG_2021_Human
206,Osteoclast differentiation,0.7398266338960455,0.7603915662650602,0.22913593739309557,0.8592494095562203,"PIK3CA,PPARG",KEGG_2021_Human
207,Kaposi sarcoma-associated herpesvirus infection,0.7445967342727591,0.772697014696093,0.22787801100036778,0.8592494095562203,"MAP2K2,PIK3CA,JAK2",KEGG_2021_Human
208,Long-term depression,0.7512350512142344,0.7247247247247247,0.20729786278448545,0.8592494095562203,MAP2K2,KEGG_2021_Human
209,Long-term potentiation,0.7512350512142344,0.7247247247247247,0.20729786278448545,0.8592494095562203,MAP2K2,KEGG_2021_Human
210,Relaxin signaling pathway,0.7518432333616928,0.7416985013223626,0.2115527670378549,0.8592494095562203,"MAP2K2,PIK3CA",KEGG_2021_Human
211,Epithelial cell signaling in Helicobacter pylori infection,0.766855539822249,0.6916461916461917,0.18360221228292864,0.8681383469685837,ATP6V1G3,KEGG_2021_Human
212,Synaptic vesicle cycle,0.766855539822249,0.6916461916461917,0.18360221228292864,0.8681383469685837,ATP6V1G3,KEGG_2021_Human
213,Platelet activation,0.7798133344113339,0.6987259382357014,0.17377363190110687,0.8780077625080129,"PIK3CA,RHOA",KEGG_2021_Human
214,Oxidative phosphorylation,0.7884715720346978,0.6473068813494346,0.15383825850563562,0.8780077625080129,ATP6V1G3,KEGG_2021_Human
215,Renin secretion,0.7884715720346978,0.6473068813494346,0.15383825850563562,0.8780077625080129,CTSB,KEGG_2021_Human
216,Vascular smooth muscle contraction,0.7902069862572116,0.6828888588060106,0.16079325647888557,0.8780077625080129,"MAP2K2,RHOA",KEGG_2021_Human
217,Complement and coagulation cascades,0.8017601244090331,0.6207636207636208,0.1371551226226436,0.8826716965971008,SERPING1,KEGG_2021_Human
218,Rheumatoid arthritis,0.8017601244090331,0.6207636207636208,0.1371551226226436,0.8826716965971008,ATP6V1G3,KEGG_2021_Human
219,Huntington disease,0.8077968948312512,0.6897830266410326,0.14723047589508226,0.8852568710479465,"PSMB5,PPARG,WIPI2",KEGG_2021_Human
220,Glycerophospholipid metabolism,0.8258918121257055,0.5736868944416115,0.1097414220334155,0.900972885955315,PLD1,KEGG_2021_Human
221,Diabetic cardiomyopathy,0.8318018571892422,0.6196213425129088,0.11411009779445457,0.9033142340516657,"PIK3CA,CPT1B",KEGG_2021_Human
222,Peroxisome,0.8368357162387334,0.5527163527163527,0.09845398469009083,0.9046872607986308,HMGCL,KEGG_2021_Human
223,Alcoholism,0.856708466255799,0.5150404641930065,0.0796549208880451,0.9193490903414953,HDAC7,KEGG_2021_Human
224,Bile secretion,0.861287378964621,0.5064064064064064,0.0756201781962719,0.9193490903414953,ABCC2,KEGG_2021_Human
225,NF-kappa B signaling pathway,0.8657203934049079,0.498055432481662,0.07181625335969878,0.9193490903414953,GADD45A,KEGG_2021_Human
226,Phosphatidylinositol signaling system,0.8657203934049079,0.498055432481662,0.07181625335969878,0.9193490903414953,PIK3CA,KEGG_2021_Human
227,ECM-receptor interaction,0.870012144883489,0.4899738448125545,0.06822793075906583,0.9198366289517064,THBS3,KEGG_2021_Human
228,Morphine addiction,0.8858541824970396,0.4600964600964601,0.05576503513375435,0.9313856667463993,PDE7A,KEGG_2021_Human
229,Amoebiasis,0.8895041675513641,0.45318452781139346,0.053063868797664594,0.9313856667463993,PIK3CA,KEGG_2021_Human
230,Oocyte meiosis,0.893037774879375,0.44647588765235824,0.050508208920914614,0.9313856667463993,CPEB4,KEGG_2021_Human
231,Glucagon signaling pathway,0.8964587042434095,0.43996170083126607,0.048089155919102886,0.9313856667463993,CPT1B,KEGG_2021_Human
232,Inflammatory mediator regulation of TRP channels,0.9060806859763385,0.42150483817150486,0.04157172375816611,0.9333019941387177,PIK3CA,KEGG_2021_Human
233,Protein digestion and absorption,0.9060806859763385,0.42150483817150486,0.04157172375816611,0.9333019941387177,COL26A1,KEGG_2021_Human
234,TNF signaling pathway,0.9175372951671965,0.3991623202149518,0.03435272803783502,0.9410638924791759,PIK3CA,KEGG_2021_Human
235,Olfactory transduction,0.9384739746170548,0.356580109521286,0.02264289192820202,0.9584415059918857,OR13A1,KEGG_2021_Human
236,Dopaminergic synapse,0.9459879432258,0.3404190707561494,0.01890192379983075,0.9620216371787796,PPP2R2A,KEGG_2021_Human
237,Adrenergic signaling in cardiomyocytes,0.9622587444084035,0.3026426426426426,0.011643237301762617,0.972747691361177,PPP2R2A,KEGG_2021_Human
238,Cushing syndrome,0.9646414605998339,0.29664959076723785,0.010679026351983768,0.972747691361177,MAP2K2,KEGG_2021_Human
239,Neuroactive ligand-receptor interaction,0.9886670360835216,0.30363879761470125,0.003460775209402665,0.9928037182428668,"THRB,LEPR",KEGG_2021_Human
240,Calcium signaling pathway,0.9943331852662427,0.19044360816512715,0.0010822780838790707,0.9943331852662427,PDGFRA,KEGG_2021_Human
1,heme Metabolism,7.511386116732929e-08,5.361350999645096,87.94899964036033,3.6054653360318057e-06,"RBM38,NFE2,HBZ,GYPA,TFRC,SMOX,GYPE,NCOA4,KLF3,SPTA1,RCL1,MFHAS1,SLC25A37,CCND3,TMCC2,FBXO7,CTSB,SIDT2",MSigDB_Hallmark_2020
2,Adipogenesis,0.04560251935025568,2.1102197053117298,6.515920189189505,0.7049593179666512,"SAMM50,ALDH2,TST,GADD45A,ITSN1,LPL,PPARG,APOE",MSigDB_Hallmark_2020
3,Apical Surface,0.07427451545356177,3.285498489425982,8.542254613906618,0.7049593179666512,"IL2RB,FLOT2,EPHB4",MSigDB_Hallmark_2020
4,Interferon Alpha Response,0.07803166722629232,2.6127659574468085,6.664226784623739,0.7049593179666512,"HELZ2,ELF1,GMPR,ADAR",MSigDB_Hallmark_2020
5,Allograft Rejection,0.0789331140012874,1.95929941618015,4.9749638184354525,0.7049593179666512,"TLR1,CCND3,CCND2,PTPRC,IL2RB,NLRP3,JAK2",MSigDB_Hallmark_2020
6,Complement,0.0881199147458314,1.811981234211476,4.401405201677294,0.7049593179666512,"AKAP10,PIK3CA,TMPRSS6,SERPING1,STX4,JAK2,SH2B3,CTSB",MSigDB_Hallmark_2020
7,Xenobiotic Metabolism,0.1421170885913041,1.6675675034966693,3.2535976156791664,0.7771353599641762,"GCKR,ABCC2,ALDH2,SMOX,LONP1,APOE,ETS2",MSigDB_Hallmark_2020
8,Cholesterol Homeostasis,0.14800311609084355,2.3562630722751567,4.501692321374702,0.7771353599641762,"FADS2,LPL,PPARG",MSigDB_Hallmark_2020
9,UV Response Up,0.1789383482358493,1.7227895222157714,2.9644279736657295,0.7771353599641762,"CCND3,BCL2L11,TFRC,TST,CEBPG",MSigDB_Hallmark_2020
10,Angiogenesis,0.187826636372978,2.6597695128339445,4.447762034614779,0.7771353599641762,"CCND2,LPL",MSigDB_Hallmark_2020
11,Myc Targets V2,0.22296929257000844,2.3521779425393885,3.529963348017771,0.7771353599641762,"RCL1,BYSL",MSigDB_Hallmark_2020
12,Interferon Gamma Response,0.23237521970172767,1.4831825334382376,2.1645593887756425,0.7771353599641762,"HELZ2,PTPN1,IL2RB,SERPING1,ADAR,JAK2",MSigDB_Hallmark_2020
13,Pancreas Beta Cells,0.2348040010823395,2.2648371262829095,3.2817583968441295,0.7771353599641762,"SCGN,SRP14",MSigDB_Hallmark_2020
14,Mitotic Spindle,0.24285479998880505,1.4593495934959348,2.065405141085001,0.7771353599641762,"CEP57,BCL2L11,PRC1,ITSN1,MYO9B,ARHGAP27",MSigDB_Hallmark_2020
15,p53 Pathway,0.24285479998880505,1.4593495934959348,2.065405141085001,0.7771353599641762,"CEBPA,CCND3,CCND2,CD82,GADD45A,DDB2",MSigDB_Hallmark_2020
16,Estrogen Response Late,0.2750731648579639,1.3921840354767183,1.7969172203727788,0.8252194945738918,"TST,CDH1,DLG5,MYB,MAPT,JAK2",MSigDB_Hallmark_2020
17,Coagulation,0.30619672351044575,1.4565656565656566,1.7238855047178703,0.8645554546177292,"TF,TMPRSS6,SERPING1,CTSB",MSigDB_Hallmark_2020
18,Unfolded Protein Response,0.3325104198689481,1.503194492595711,1.6551435270836612,0.8760544049624551,"DNAJA4,EXOSC9,CEBPG",MSigDB_Hallmark_2020
19,mTORC1 Signaling,0.3590989157463551,1.2846415161809404,1.315675111442555,0.8760544049624551,"FADS2,NUP205,TOMM40,PSMB5,TFRC",MSigDB_Hallmark_2020
20,TGF-beta Signaling,0.3760425324506758,1.5661105962310782,1.5317392042016418,0.8760544049624551,"CDH1,RHOA",MSigDB_Hallmark_2020
21,Apical Junction,0.3908225157290855,1.232228649867634,1.1576809680440148,0.8760544049624551,"PTPRC,CDH1,STX4,ICAM5,THBS3",MSigDB_Hallmark_2020
22,DNA Repair,0.41928118129141106,1.2902004170035317,1.1214596292787138,0.8760544049624551,"MPG,AK3,DDB2",MSigDB_Hallmark_2020
23,Inflammatory Response,0.45375122162860704,1.1391371410425077,0.9001532327690693,0.8760544049624551,"TLR1,CD82,AXL,IL2RB,NLRP3",MSigDB_Hallmark_2020
24,IL-6/JAK/STAT3 Signaling,0.5057390240908062,1.1961965509095205,0.8154884640102932,0.8760544049624551,"PTPN1,LEPR",MSigDB_Hallmark_2020
25,Myc Targets V1,0.5099996906644908,1.1159089234396875,0.7513918723803886,0.8760544049624551,"RRM1,PABPC4,UBE2L3",MSigDB_Hallmark_2020
26,UV Response Dn,0.5194278769433858,1.0700691121743753,0.7009244918034175,0.8760544049624551,"CITED2,DUSP1,KIT,PPARG",MSigDB_Hallmark_2020
27,Wnt-beta Catenin Signaling,0.5955674662475675,1.1290179067956845,0.5851029209930787,0.8760544049624551,CCND2,MSigDB_Hallmark_2020
28,Hedgehog Signaling,0.5955674662475675,1.1290179067956845,0.5851029209930787,0.8760544049624551,ETS2,MSigDB_Hallmark_2020
29,E2F Targets,0.5998131604191327,0.9722954297100983,0.4969762386353951,0.8760544049624551,"NUP205,RAD50,TFRC",MSigDB_Hallmark_2020
30,Hypoxia,0.6377090541341621,0.9154704944178629,0.4118455745974548,0.8760544049624551,"MAP3K1,CITED2,DUSP1,HK1",MSigDB_Hallmark_2020
31,Estrogen Response Early,0.6600662278532682,0.8883875248838753,0.3690495958320004,0.8760544049624551,"ELF1,MYB,MAPT,JAK2",MSigDB_Hallmark_2020
32,Spermatogenesis,0.664629521774859,0.8825737733542867,0.36055389529676907,0.8760544049624551,"HBZ,MAST2",MSigDB_Hallmark_2020
33,Androgen Response,0.6721289855248117,0.8698795180722891,0.34560749422118214,0.8760544049624551,"CCND3,NCOA4",MSigDB_Hallmark_2020
34,Reactive Oxygen Species Pathway,0.6776029857475239,0.8959547783077195,0.34869998145102127,0.8760544049624551,MSRA,MSigDB_Hallmark_2020
35,Apoptosis,0.6781633995044333,0.8611981987117369,0.3344609762193773,0.8760544049624551,"CCND2,BCL2L11,GADD45A",MSigDB_Hallmark_2020
36,KRAS Signaling Up,0.6918220607216277,0.8506039415130324,0.3133850280525061,0.8760544049624551,"MAP3K1,CCND2,DNMBP,TRIB1",MSigDB_Hallmark_2020
37,IL-2/STAT5 Signaling,0.6969051336195738,0.8446127946127946,0.3049947344666288,0.8760544049624551,"SPRED2,CCND3,CCND2,IL2RB",MSigDB_Hallmark_2020
38,Bile Acid Metabolism,0.7076051421916477,0.8114859437751004,0.2806678721653784,0.8760544049624551,"FADS2,ALDH8A1",MSigDB_Hallmark_2020
39,TNF-alpha Signaling via NF-kB,0.7117942040319948,0.8271284271284272,0.28119591393257254,0.8760544049624551,"GADD45A,DUSP1,TRIB1,ETS2",MSigDB_Hallmark_2020
40,Fatty Acid Metabolism,0.8359341663070862,0.6133016916149446,0.10990698565929824,0.9390604710885871,"GCDH,HMGCL",MSigDB_Hallmark_2020
41,KRAS Signaling Dn,0.8399747038416917,0.6071084337349397,0.1058696948123909,0.9390604710885871,"THRB,MAST3",MSigDB_Hallmark_2020
42,G2-M Checkpoint,0.843925108085783,0.601037814624836,0.10199102203539363,0.9390604710885871,"HSPA8,PRC1",MSigDB_Hallmark_2020
43,Protein Secretion,0.8781896701457171,0.4745683183183183,0.061642952348711706,0.9390604710885871,ARFIP1,MSigDB_Hallmark_2020
44,Pperoxisome,0.8858541824970396,0.4600964600964601,0.05576503513375435,0.9390604710885871,HMGCL,MSigDB_Hallmark_2020
45,Glycolysis,0.8934382817040619,0.5225384295803905,0.058878596416447826,0.9390604710885871,"CITED2,AK3",MSigDB_Hallmark_2020
46,Epithelial Mesenchymal Transition,0.899932951459896,0.560367013539219,0.05908230549275985,0.9390604710885871,"TAGLN,PCOLCE2,GADD45A",MSigDB_Hallmark_2020
47,Myogenesis,0.9241270513795892,0.4692724385915756,0.037028277437575474,0.9437893290685165,"MEF2C,TAGLN",MSigDB_Hallmark_2020
48,Oxidative Phosphorylation,0.9597159647552134,0.3088803088803089,0.012700512230142218,0.9597159647552134,HADHA,MSigDB_Hallmark_2020
1,Erythroblasts,5.700906278797164e-07,6.607778112752487,95.00313483692882,8.551359418195745e-05,"NFE2,GYPA,TFRC,BCL11A,TMC8,SPTA1,SLC25A37,CCND3,ELF1,CDH1,KIT,FBXO7,SH2B3",PanglaoDB_Augmented_2021
2,Erythroid-like And Erythroid Precursor Cells,1.8104022934828564e-05,5.020124223602484,54.81662588590809,0.0013578017201121423,"SPTA1,RBM38,NFE2,SLC25A37,DOK2,GYPA,THRB,SLC25A39,NCOA4,KIT,TMCC2,FBXO7",PanglaoDB_Augmented_2021
3,Osteoclast Precursor Cells,0.0056475836663041476,3.5503584498922143,18.378528132905984,0.2823791833152074,"TLR1,IL1RN,PTPRC,NLRP3,TRIM38,IL6R,TYMP",PanglaoDB_Augmented_2021
4,Trophoblast Progenitor Cells,0.014607408800548272,3.248074454428755,13.727098095799386,0.5474596041074429,"HELZ2,IL1RN,PSD4,ARHGAP27,TMC6,TYMP",PanglaoDB_Augmented_2021
5,Microfold Cells,0.018248653470248098,2.7718968085940565,11.097743420286964,0.5474596041074429,"HELZ2,IL1RN,CLDN23,TMBIM1,ARHGAP27,CTSB,TYMP",PanglaoDB_Augmented_2021
6,Hemangioblasts,0.046768568540565984,3.1512043512043513,9.650701707778818,0.9786848928776297,"SPTA1,NFE2,HBZ,CCND3",PanglaoDB_Augmented_2021
7,Proximal Tubule Cells,0.055600547463256045,2.3089939024390245,6.67198157281898,0.9786848928776297,"GCDH,ABCC2,APOE,APOB,SLC17A1,SLC17A3",PanglaoDB_Augmented_2021
8,Sebocytes,0.08210766330015962,2.259520829608439,5.6481782786841706,0.9786848928776297,"CEBPA,IL1RN,CDH1,CLDN23,AP1M2",PanglaoDB_Augmented_2021
9,Undefined Placental Cells,0.09674457554585714,2.4068924539512775,5.621733010691669,0.9786848928776297,"TFRC,TLCD1,EPHB4,AP1M2",PanglaoDB_Augmented_2021
10,Embryonic Stem Cells,0.10971213346786135,1.7942405708460754,3.965083825954298,0.9786848928776297,"LAPTM4B,KITLG,CDH1,KIT,TAF8,EPHB4,MDFI",PanglaoDB_Augmented_2021
11,Hematopoietic Stem Cells,0.1345490539347525,1.6941655228876207,3.3982019879604324,0.9786848928776297,"NFE2,ELF1,KITLG,PTPRC,KIT,SERPING1,NKX2-3",PanglaoDB_Augmented_2021
12,T Cytotoxic Cells,0.14053600842899536,2.418508506916839,4.745818771158417,0.9786848928776297,"DOK2,PTPRC,IL2RB",PanglaoDB_Augmented_2021
13,Platelets,0.1498859997869494,1.6417816373695637,3.115904985837431,0.9786848928776297,"TLR1,DOK2,ALDH2,SMOX,HFE,NCOA4,SIRT3",PanglaoDB_Augmented_2021
14,Noradrenergic Neurons,0.16330690860836444,2.2408812909881366,4.060754709535732,0.9786848928776297,"SCGN,TMPRSS6,SLC17A1",PanglaoDB_Augmented_2021
15,Hepatoblasts,0.16354741372376325,1.9461279461279462,3.5237611166576324,0.9786848928776297,"CEBPA,CDH1,APOB,AP1M2",PanglaoDB_Augmented_2021
16,Adipocytes,0.1701506441195087,1.5806350062960963,2.799416967356585,0.9786848928776297,"PDGFRA,TAGLN,EPAS1,PRDM16,SERPING1,PPARG,CPT1B",PanglaoDB_Augmented_2021
17,Stromal Cells,0.18981376372093542,1.6845920037409399,2.799306542984121,0.9786848928776297,"TLR1,PDGFRA,TAGLN,KIT,SERPING1",PanglaoDB_Augmented_2021
18,Distal Tubule Cells,0.19533868594442352,1.6661160301308313,2.720801425988576,0.9786848928776297,"THRB,TFRC,PLD1,MUC20,CPEB4",PanglaoDB_Augmented_2021
19,Alveolar Macrophages,0.22187198583403833,1.7013468013468014,2.5616408142736593,0.9786848928776297,"TLR1,IL1RN,NLRP3,TYMP",PanglaoDB_Augmented_2021
20,Macrophages,0.22719030583268718,1.4953896490184415,2.2161185023365157,0.9786848928776297,"TLR1,DOK2,PTPRC,HFE,PPARG,PLTP",PanglaoDB_Augmented_2021
21,Reticulocytes,0.22845826020082471,1.873543375053949,2.766102725198173,0.9786848928776297,"NUP205,TFRC,PABPC4",PanglaoDB_Augmented_2021
22,Satellite Glial Cells,0.24936839163977695,1.611164274322169,2.2376235982317674,0.9786848928776297,"ALDH2,CDH1,SERPING1,JAK2",PanglaoDB_Augmented_2021
23,Tuft Cells,0.262672288407135,1.731459841532235,2.314698756882004,0.9786848928776297,"IL1RN,PTPRC,KLF3",PanglaoDB_Augmented_2021
24,T Helper Cells,0.2775426585130613,1.53,1.9611243688551132,0.9786848928776297,"DOK2,PTPRC,IL2RB,PPARG",PanglaoDB_Augmented_2021
25,Airway Goblet Cells,0.28002009647924414,1.6681680856907444,2.1234009892054697,0.9786848928776297,"CDH1,MUC20,AP1M2",PanglaoDB_Augmented_2021
26,Kupffer Cells,0.2918217607684129,1.4923872875092388,1.8380421985244855,0.9786848928776297,"DOK2,HFE,PLTP,TYMP",PanglaoDB_Augmented_2021
27,Podocytes,0.30265113230101737,1.3407067829802386,1.6023785795919783,0.9786848928776297,"MYO1D,KITLG,NLRP3,ZFP91,MAPT,QKI",PanglaoDB_Augmented_2021
28,B Cells Memory,0.30619672351044575,1.4565656565656566,1.7238855047178703,0.9786848928776297,"BLK,DOK2,PTPRC,TMC8",PanglaoDB_Augmented_2021
29,Clara Cells,0.3062194203914357,1.5814147307011146,1.8715305985704085,0.9786848928776297,"CDH1,LEPR,MUC20",PanglaoDB_Augmented_2021
30,Monocytes,0.308635626938945,1.3783236123661655,1.6203488291781132,0.9786848928776297,"TLR1,IL1RN,DOK2,PTPRC,TYMP",PanglaoDB_Augmented_2021
31,Adrenergic Neurons,0.31497935978187597,1.5544574735009473,1.7957841466387816,0.9786848928776297,"SCGN,COL26A1,SLC12A7",PanglaoDB_Augmented_2021
32,Epiblast Cells,0.31497935978187597,1.5544574735009473,1.7957841466387816,0.9786848928776297,"COL26A1,CDH1,BCL11A",PanglaoDB_Augmented_2021
33,B Cells Naive,0.32788816248201164,1.4059212817833509,1.5677184943562388,0.9786848928776297,"BLK,DOK2,PTPRC,TMC8",PanglaoDB_Augmented_2021
34,Follicular Cells,0.3325104198689481,1.503194492595711,1.6551435270836612,0.9786848928776297,"APOB,SLC17A1,SLC17A3",PanglaoDB_Augmented_2021
35,Dendritic Cells,0.33377966393278913,1.3298533104268535,1.4592137173684585,0.9786848928776297,"DOK2,PTPRC,AXL,HFE,KIT",PanglaoDB_Augmented_2021
36,NK Cells,0.335141804094657,1.3898071625344353,1.5193393316594606,0.9786848928776297,"DOK2,PTPRC,KIT,IL2RB",PanglaoDB_Augmented_2021
37,Hepatocytes,0.3400975725074432,1.3182580442301646,1.4217712575615131,0.9786848928776297,"CEBPA,CDH1,LEPR,APOB,SLC17A1",PanglaoDB_Augmented_2021
38,Germ Cells,0.34240248525329164,1.3740551583248213,1.4726688661323915,0.9786848928776297,"MYO1D,SPO11,TEX33,TEX35",PanglaoDB_Augmented_2021
39,Gastric Chief Cells,0.35002603721679515,1.4551863041289024,1.5275785270790472,0.9786848928776297,"ALDH2,CDH1,AP1M2",PanglaoDB_Augmented_2021
40,T Cells,0.35693442142411325,1.3435897435897435,1.3841704634990573,0.9786848928776297,"DOK2,PTPRC,MYB,IL2RB",PanglaoDB_Augmented_2021
41,Plasmacytoid Dendritic Cells,0.36420053547322007,1.3288537549407116,1.3422095875276232,0.9786848928776297,"DOK2,PTPRC,CDH1,BCL11A",PanglaoDB_Augmented_2021
42,Hepatic Stellate Cells,0.3714634091495741,1.314434669273379,1.3016911128521154,0.9786848928776297,"PDGFRA,TAGLN,MYB,PPARG",PanglaoDB_Augmented_2021
43,Sertoli Cells,0.3714634091495741,1.314434669273379,1.3016911128521154,0.9786848928776297,"TF,KITLG,EPAS1,SERPING1",PanglaoDB_Augmented_2021
44,Thymocytes,0.37619594380196947,1.3886294973908266,1.3575868852155466,0.9786848928776297,"DOK2,PTPRC,TMC8",PanglaoDB_Augmented_2021
45,Müller Cells,0.38596975174404835,1.2865071770334928,1.2247500415127373,0.9786848928776297,"PDGFRA,FNDC4,KIT,APOE",PanglaoDB_Augmented_2021
46,Decidual Cells,0.38744450052350976,1.5268072289156627,1.4476921471045792,0.9786848928776297,"DOK2,IL2RB",PanglaoDB_Augmented_2021
47,Mammary Epithelial Cells,0.3935276266124674,1.3475208814643682,1.2567033724751988,0.9786848928776297,"BTN3A1,CDH1,AP1M2",PanglaoDB_Augmented_2021
48,T Follicular Helper Cells,0.3935276266124674,1.3475208814643682,1.2567033724751988,0.9786848928776297,"DOK2,PTPRC,IL6R",PanglaoDB_Augmented_2021
49,Basal Cells,0.40214804341935495,1.3278602390647576,1.2095943548480383,0.9786848928776297,"SLC25A37,EPAS1,TYMP",PanglaoDB_Augmented_2021
50,Pulmonary Alveolar Type II Cells,0.41928118129141106,1.2902004170035317,1.1214596292787138,0.9786848928776297,"CEBPA,IL1RN,TYMP",PanglaoDB_Augmented_2021
51,Spermatozoa,0.41928118129141106,1.2902004170035317,1.1214596292787138,0.9786848928776297,"ALDH2,PLD1,CPEB4",PanglaoDB_Augmented_2021
52,Enterocytes,0.42201535451176975,1.2215757575757575,1.0538699956812572,0.9786848928776297,"ABCC2,FLOT2,PPARG,APOB",PanglaoDB_Augmented_2021
53,Natural Killer T Cells,0.427787574578638,1.2721550855991943,1.0802231748235642,0.9786848928776297,"DOK2,PTPRC,IL2RB",PanglaoDB_Augmented_2021
54,T Memory Cells,0.427787574578638,1.2721550855991943,1.0802231748235642,0.9786848928776297,"DOK2,PTPRC,TMC8",PanglaoDB_Augmented_2021
55,T Regulatory Cells,0.427787574578638,1.2721550855991943,1.0802231748235642,0.9786848928776297,"DOK2,PTPRC,IL2RB",PanglaoDB_Augmented_2021
56,Juxtaglomerular Cells,0.4362498561764909,1.2546041468360716,1.0407444935223196,0.9786848928776297,"PDGFRA,TAGLN,SERPING1",PanglaoDB_Augmented_2021
57,Loop Of Henle Cells,0.4434062248944468,1.185642836128273,0.9642464959882483,0.9786848928776297,"PDGFRA,ALDH2,EPAS1,SERPING1",PanglaoDB_Augmented_2021
58,Microglia,0.4434062248944468,1.185642836128273,0.9642464959882483,0.9786848928776297,"CEBPA,DOK2,PTPRC,IL6R",PanglaoDB_Augmented_2021
59,Pulmonary Vascular Smooth Muscle Cells,0.4446651946803041,1.2375275577692497,1.0029339774677757,0.9786848928776297,"PDGFRA,TAGLN,SERPING1",PanglaoDB_Augmented_2021
60,B Cells,0.450485235309106,1.1741258741258742,0.9362831681881303,0.9786848928776297,"DOK2,PTPRC,BCL11A,TMC8",PanglaoDB_Augmented_2021
61,Basophils,0.450485235309106,1.1741258741258742,0.9362831681881303,0.9786848928776297,"FADS2,CEBPA,IL1RN,CDH1",PanglaoDB_Augmented_2021
62,Spermatocytes,0.4537361503852823,1.3268727082242011,1.048547114631643,0.9786848928776297,"SPO11,TEX33",PanglaoDB_Augmented_2021
63,Enterochromaffin Cells,0.461344360344615,1.2047225314040388,0.9319860351516344,0.9786848928776297,"SCGN,PDGFRA,APOB",PanglaoDB_Augmented_2021
64,Choroid Plexus Cells,0.46960316096530463,1.1889590771765999,0.8986952628694377,0.9786848928776297,"FNDC4,AGAP1,APOE",PanglaoDB_Augmented_2021
65,Nuocytes,0.47491784384475805,1.2713353413654618,0.946653394938154,0.9786848928776297,"PTPRC,IL2RB",PanglaoDB_Augmented_2021
66,Trichocytes,0.47491784384475805,1.2713353413654618,0.946653394938154,0.9786848928776297,"DMKN,AP1M2",PanglaoDB_Augmented_2021
67,Enteric Neurons,0.48541581921896804,1.1197108701695857,0.8092703552807512,0.9786848928776297,"PIK3CA,FLOT2,DMKN,FBXO7",PanglaoDB_Augmented_2021
68,Transient Cells,0.4859475495128385,1.1586293930934262,0.836130212357224,0.9786848928776297,"MYO1D,EPAS1,TMEM50B",PanglaoDB_Augmented_2021
69,Merkel Cells,0.49559556311812764,1.2202409638554217,0.856603155253718,0.9786848928776297,"CDH1,PLS1",PanglaoDB_Augmented_2021
70,Serotonergic Neurons,0.49559556311812764,1.2202409638554217,0.856603155253718,0.9786848928776297,"SCGN,APOB",PanglaoDB_Augmented_2021
71,Osteoblasts,0.4991411069945305,1.0993174993174992,0.7638788412007249,0.9786848928776297,"PDGFRA,TAGLN,NLRP3,EPHB4",PanglaoDB_Augmented_2021
72,Pluripotent Stem Cells,0.5256248166650371,1.1508297340304614,0.7401763946491501,0.9786848928776297,"TERT,BEND3",PanglaoDB_Augmented_2021
73,Cardiac Stem And Precursor Cells,0.5334502983754498,1.0762040163497424,0.6762751681445156,0.9786848928776297,"LAPTM4B,KITLG,KIT",PanglaoDB_Augmented_2021
74,Schwann Cells,0.5334502983754498,1.0762040163497424,0.6762751681445156,0.9786848928776297,"TAGLN,CD82,TST",PanglaoDB_Augmented_2021
75,Urothelial Cells,0.5449649876065206,1.108762322015334,0.6730561272473623,0.9786848928776297,"PSD4,ARHGAP27",PanglaoDB_Augmented_2021
76,Adipocyte Progenitor Cells,0.548728834096336,1.0512553390978228,0.6309118236548311,0.9786848928776297,"KANK2,CEBPA,PPARG",PanglaoDB_Augmented_2021
77,T Cells Naive,0.5637498388291526,1.0696470090889876,0.6130624863792062,0.9786848928776297,"DOK2,PTPRC",PanglaoDB_Augmented_2021
78,Endothelial Cells (Aorta),0.5651856869928412,1.0074630603556223,0.5748593816301495,0.9786848928776297,"PCOLCE2,EPAS1,HFE,NKX2-3",PanglaoDB_Augmented_2021
79,Mast Cells,0.5672500645220853,0.9957883862764965,0.5645672459430656,0.9786848928776297,"PDGFRA,ALDH2,DUSP1,KIT,SERPING1",PanglaoDB_Augmented_2021
80,Leydig Cells,0.5856086104582441,0.9936293182713779,0.5316946379828277,0.9786848928776297,"PDGFRA,EPAS1,SERPING1",PanglaoDB_Augmented_2021
81,Airway Epithelial Cells,0.5908727885267967,1.015863453815261,0.5345011607121284,0.9786848928776297,"CDH1,MUC20",PanglaoDB_Augmented_2021
82,Myeloid-derived Suppressor Cells,0.5996310841894394,0.9991111988939364,0.5109861035185408,0.9786848928776297,"DOK2,PTPRC",PanglaoDB_Augmented_2021
83,Parathyroid Chief Cells,0.6250575623548842,0.9519954819277109,0.4473536570060607,0.9786848928776297,"SPRED2,DUSP15",PanglaoDB_Augmented_2021
84,Ependymal Cells,0.6413044091660259,0.922964585615188,0.4100279747303273,0.9786848928776297,"MYB,PLTP",PanglaoDB_Augmented_2021
85,Trophoblast Cells,0.6413044091660259,0.922964585615188,0.4100279747303273,0.9786848928776297,"IL1RN,TFEB",PanglaoDB_Augmented_2021
86,Eosinophils,0.649218087917489,0.9090990828987592,0.39271860540526976,0.9786848928776297,"DOK2,PTPRC",PanglaoDB_Augmented_2021
87,Osteoclasts,0.6533737162176463,0.8953261062733251,0.38105616887358496,0.9786848928776297,"IL1RN,SERPING1,CTSB",PanglaoDB_Augmented_2021
88,Epsilon Cells,0.6867203051250215,0.8455488621151271,0.3177811023435499,0.9786848928776297,"FAXDC2,APOB",PanglaoDB_Augmented_2021
89,Pancreatic Progenitor Cells,0.6867203051250215,0.8455488621151271,0.3177811023435499,0.9786848928776297,"EPAS1,DUSP15",PanglaoDB_Augmented_2021
90,Pancreatic Stellate Cells,0.6867203051250215,0.8455488621151271,0.3177811023435499,0.9786848928776297,"PDGFRA,TAGLN",PanglaoDB_Augmented_2021
91,Cholangiocytes,0.6938143452384443,0.8338834791219674,0.3048268298784471,0.9786848928776297,"CDH1,AP1M2",PanglaoDB_Augmented_2021
92,Endothelial Cells (Blood Brain Barrier),0.6938143452384443,0.8338834791219674,0.3048268298784471,0.9786848928776297,"FNDC4,AGAP1",PanglaoDB_Augmented_2021
93,Pericytes,0.6958809839325009,0.8372460434047507,0.3035658517174373,0.9786848928776297,"PDGFRA,TAGLN,SERPING1",PanglaoDB_Augmented_2021
94,Myofibroblasts,0.7007755403646384,0.8225333767502442,0.2924662535801967,0.9786848928776297,"PDGFRA,TAGLN",PanglaoDB_Augmented_2021
95,Osteocytes,0.7007755403646384,0.8225333767502442,0.2924662535801967,0.9786848928776297,"AXL,MDFI",PanglaoDB_Augmented_2021
96,Mesangial Cells,0.7016209372367871,0.8295523207909915,0.29396181638246527,0.9786848928776297,"PDGFRA,MEF2C,TAGLN",PanglaoDB_Augmented_2021
97,Olfactory Epithelial Cells,0.7128534164148329,0.8145770392749244,0.27571760190478894,0.9786848928776297,"KLHL5,PCOLCE2,AGAP1",PanglaoDB_Augmented_2021
98,Oligodendrocytes,0.7183465577717884,0.8072881854396706,0.26705347905310617,0.9786848928776297,"MYO1D,TF,DUSP15",PanglaoDB_Augmented_2021
99,Luminal Epithelial Cells,0.7208748419032562,0.7902519167579408,0.25864134939531713,0.9786848928776297,"CDH1,AP1M2",PanglaoDB_Augmented_2021
100,Intercalated Cells,0.7273176979850559,0.780043249922768,0.24835945109961277,0.9786848928776297,"ATP6V1G3,MUC20",PanglaoDB_Augmented_2021
101,Megakaryocytes,0.7273176979850559,0.780043249922768,0.24835945109961277,0.9786848928776297,"DOK2,PPARG",PanglaoDB_Augmented_2021
102,Principal Cells,0.7273176979850559,0.780043249922768,0.24835945109961277,0.9786848928776297,"CDH1,AP1M2",PanglaoDB_Augmented_2021
103,Epithelial Cells,0.7290884522465833,0.7930907657953501,0.25058513336587696,0.9786848928776297,"CDH1,PRC1,AP1M2",PanglaoDB_Augmented_2021
104,Airway Smooth Muscle Cells,0.7336344685650344,0.770093030349245,0.23853198333053405,0.9786848928776297,"PDGFRA,TAGLN",PanglaoDB_Augmented_2021
105,Ductal Cells,0.7336344685650344,0.770093030349245,0.23853198333053405,0.9786848928776297,"CDH1,SERPING1",PanglaoDB_Augmented_2021
106,Neural Stem/Precursor Cells,0.7633799431613524,0.7238955823293173,0.19545138161887624,0.9786848928776297,"CCND2,APOE",PanglaoDB_Augmented_2021
107,Meningeal Cells,0.7744495822213485,0.7069207060801345,0.18069085419601622,0.9786848928776297,"PDGFRA,FNDC4",PanglaoDB_Augmented_2021
108,Neutrophils,0.7744495822213485,0.7069207060801345,0.18069085419601622,0.9786848928776297,"DOK2,NLRP3",PanglaoDB_Augmented_2021
109,Peri-islet Schwann Cells,0.7798133344113339,0.6987259382357014,0.17377363190110687,0.9786848928776297,"ITSN1,AGAP1",PanglaoDB_Augmented_2021
110,Peritubular Myoid Cells,0.7850652468662721,0.6907174151150055,0.16714563503237886,0.9786848928776297,"PDGFRA,TAGLN",PanglaoDB_Augmented_2021
111,Alpha Cells,0.7902069862572116,0.6828888588060106,0.16079325647888557,0.9786848928776297,"SCGN,FNDC4",PanglaoDB_Augmented_2021
112,Chromaffin Cells,0.7952402263459671,0.6752342704149933,0.15470362490400075,0.9786848928776297,"ITSN1,PLD1",PanglaoDB_Augmented_2021
113,Glomus Cells,0.8049879276172716,0.6604243059193295,0.14326452279413956,0.9786848928776297,"FNDC4,EPAS1",PanglaoDB_Augmented_2021
114,Keratinocytes,0.8201484449397144,0.5847770847770848,0.11594370856128416,0.9786848928776297,DMKN,PanglaoDB_Augmented_2021
115,Oxyphil Cells,0.8201484449397144,0.5847770847770848,0.11594370856128416,0.9786848928776297,MAPT,PanglaoDB_Augmented_2021
116,Delta Cells,0.8275761280180568,0.6260712954912433,0.11848660862143386,0.9786848928776297,"SCGN,LEPR",PanglaoDB_Augmented_2021
117,Anterior Pituitary Gland Cells,0.8318018571892422,0.6196213425129088,0.11411009779445457,0.9786848928776297,"PDGFRA,CPEB4",PanglaoDB_Augmented_2021
118,Mesothelial Cells,0.8318018571892422,0.6196213425129088,0.11411009779445457,0.9786848928776297,"CDH1,EPAS1",PanglaoDB_Augmented_2021
119,Astrocytes,0.8359341663070862,0.6133016916149446,0.10990698565929824,0.9786848928776297,"APOE,BYSL",PanglaoDB_Augmented_2021
120,Melanocytes,0.8359341663070862,0.6133016916149446,0.10990698565929824,0.9786848928776297,"EPAS1,PPARG",PanglaoDB_Augmented_2021
121,Satellite Cells,0.8399747038416917,0.6071084337349397,0.1058696948123909,0.9786848928776297,"KITLG,CDH1",PanglaoDB_Augmented_2021
122,Pinealocytes,0.861287378964621,0.5064064064064064,0.0756201781962719,0.9786848928776297,RP1L1,PanglaoDB_Augmented_2021
123,Chondrocytes,0.8788231885174614,0.5463475523716488,0.07057256140788375,0.9786848928776297,"PDGFRA,TAGLN",PanglaoDB_Augmented_2021
124,Trophoblast Stem Cells,0.8858541824970396,0.4600964600964601,0.05576503513375435,0.9786848928776297,AP1M2,PanglaoDB_Augmented_2021
125,Endothelial Cells,0.8976470604188529,0.5639038486798896,0.06088938820472257,0.9786848928776297,"PDGFRA,CD82,EPAS1",PanglaoDB_Augmented_2021
126,Langerhans Cells,0.8997705381698449,0.4336336336336336,0.045798435528203923,0.9786848928776297,PTPRC,PanglaoDB_Augmented_2021
127,Dopaminergic Neurons,0.9029767457311958,0.42748382185001904,0.0436283482842391,0.9786848928776297,MAPT,PanglaoDB_Augmented_2021
128,Myoepithelial Cells,0.9060806859763385,0.42150483817150486,0.04157172375816611,0.9786848928776297,MDFI,PanglaoDB_Augmented_2021
129,Smooth Muscle Cells,0.9111662202208962,0.4924576354197277,0.0458133039244636,0.9786848928776297,"PDGFRA,TAGLN",PanglaoDB_Augmented_2021
130,Kidney Progenitor Cells,0.911994671007507,0.4100316532748965,0.03777258010406282,0.9786848928776297,LAPTM4B,PanglaoDB_Augmented_2021
131,Luteal Cells,0.9201766713623399,0.3939393939393939,0.03277165796104778,0.9786848928776297,FNDC4,PanglaoDB_Augmented_2021
132,Neuroblasts,0.9201766713623399,0.3939393939393939,0.03277165796104778,0.9786848928776297,SCGN,PanglaoDB_Augmented_2021
133,Oligodendrocyte Progenitor Cells,0.9201766713623399,0.3939393939393939,0.03277165796104778,0.9786848928776297,PDGFRA,PanglaoDB_Augmented_2021
134,Enteric Glia Cells,0.9227318117772643,0.38885038885038886,0.03127004490519238,0.9786848928776297,APOE,PanglaoDB_Augmented_2021
135,His Bundle Cells,0.9227318117772643,0.38885038885038886,0.03127004490519238,0.9786848928776297,ITSN1,PanglaoDB_Augmented_2021
136,Parietal Cells,0.9227318117772643,0.38885038885038886,0.03127004490519238,0.9786848928776297,AGAP1,PanglaoDB_Augmented_2021
137,Fibroblasts,0.9291148929252161,0.5121101950944749,0.037651813375150125,0.9786848928776297,"PDGFRA,TAGLN,P4HTM",PanglaoDB_Augmented_2021
138,Taste Receptor Cells,0.9299182011776355,0.3743373002632262,0.027198843789965167,0.9786848928776297,SEZ6,PanglaoDB_Augmented_2021
139,Crypt Cells,0.9343348753853254,0.3652447628351243,0.024807557992008768,0.9786848928776297,TERT,PanglaoDB_Augmented_2021
140,Vascular Smooth Muscle Cells,0.9384739746170548,0.356580109521286,0.02264289192820202,0.9786848928776297,PDGFRA,PanglaoDB_Augmented_2021
141,Immature Neurons,0.9404449130033864,0.3523989105384454,0.021638069790386794,0.9786848928776297,ICAM5,PanglaoDB_Augmented_2021
142,Retinal Ganglion Cells,0.9404449130033864,0.3523989105384454,0.021638069790386794,0.9786848928776297,TOX2,PanglaoDB_Augmented_2021
143,Enteroendocrine Cells,0.9459879432258,0.3404190707561494,0.01890192379983075,0.9786848928776297,SCGN,PanglaoDB_Augmented_2021
144,Tanycytes,0.9459879432258,0.3404190707561494,0.01890192379983075,0.9786848928776297,FNDC4,PanglaoDB_Augmented_2021
145,Myocytes,0.949394410368502,0.33287133287133286,0.01728632801340145,0.9786848928776297,PLD1,PanglaoDB_Augmented_2021
146,Pulmonary Alveolar Type I Cells,0.9525866290675595,0.32564822887403533,0.015818110979950964,0.9786848928776297,EPAS1,PanglaoDB_Augmented_2021
147,Gamma (PP) Cells,0.9622587444084035,0.3026426426426426,0.011643237301762617,0.9788269862460968,SCGN,PanglaoDB_Augmented_2021
148,Beta Cells,0.9657759597628154,0.2937403422840316,0.010229036665869731,0.9788269862460968,SCGN,PanglaoDB_Augmented_2021
149,Interneurons,0.9869363187245468,0.3116611523815469,0.0040982698743940215,0.993560052407262,"ARHGAP21,AGAP1",PanglaoDB_Augmented_2021
150,Neurons,0.9963000368520294,0.17573714064942136,0.000651426816272165,0.9963000368520294,ICAM5,PanglaoDB_Augmented_2021
